data_1mux_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1mux _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.242 0.544 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -56.37 -42.6 78.11 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.932 . . . . 0.0 110.502 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -56.24 -52.52 64.15 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.211 -0.93 . . . . 0.0 110.196 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.3 mt -55.26 -40.95 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 109.941 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.29 -37.56 80.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.893 . . . . 0.0 109.613 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -61.17 -48.99 79.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.423 -0.798 . . . . 0.0 109.9 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -65.8 -25.21 67.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.411 -0.806 . . . . 0.0 109.992 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.6 mtpt -75.84 -30.68 59.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.33 -0.856 . . . . 0.0 109.705 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -71.08 -41.5 70.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 0.0 109.556 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.478 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -68.27 -39.63 82.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.383 -0.823 . . . . 0.0 109.761 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -56.17 -55.07 37.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.377 -0.827 . . . . 0.0 110.088 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.2 m -60.65 -35.13 75.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.35 -0.844 . . . . 0.0 110.348 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.459 ' CD2' ' O ' ' A' ' 18' ' ' LEU . 4.9 tt -63.68 -29.42 70.66 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.191 -0.943 . . . . 0.0 110.202 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.478 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 12.3 m-85 -79.37 -57.76 3.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 0.0 110.485 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -61.2 106.27 0.59 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.127 -0.983 . . . . 0.0 109.97 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -109.6 47.61 0.93 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.228 -0.92 . . . . 0.0 110.726 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -162.44 22.22 0.1 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.245 -0.91 . . . . 0.0 110.504 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 47.58 78.32 0.09 OUTLIER Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -134.91 -36.83 0.82 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.223 -1.163 . . . . 0.0 110.57 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.91 -23.43 35.64 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.5 p -118.05 143.44 46.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.407 -1.055 . . . . 0.0 109.971 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 44.3 mt -92.03 113.01 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.259 -0.9 . . . . 0.0 110.427 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 80.9 p -97.11 -176.52 3.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 109.906 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.407 ' HA ' HD23 ' A' ' 48' ' ' LEU . 14.5 p -74.84 -28.49 60.7 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.253 -0.904 . . . . 0.0 110.07 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -70.81 -54.1 12.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 109.71 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.413 ' O ' HG21 ' A' ' 35' ' ' VAL . 91.5 mt-10 -56.1 -52.42 64.38 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.281 -0.887 . . . . 0.0 109.057 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.448 HD23 ' CD1' ' A' ' 52' ' ' ILE . 3.7 tp -55.05 -33.54 62.79 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.456 -0.778 . . . . 0.0 109.367 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.59 -49.78 67.5 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.2 m -69.17 -21.19 64.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.326 -1.102 . . . . 0.0 109.785 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.428 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 54.8 t -73.47 -31.03 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.446 -0.784 . . . . 0.0 109.787 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.2 mmt -90.91 -24.27 20.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.894 . . . . 0.0 110.189 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -84.36 -20.86 31.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.253 -0.905 . . . . 0.0 110.448 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.6 m -88.07 -19.34 27.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.197 -0.939 . . . . 0.0 110.151 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.5 mt -89.16 -78.35 0.35 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.269 -0.894 . . . . 0.0 110.295 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.73 55.74 0.2 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -152.67 157.96 41.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.227 -1.16 . . . . 0.0 110.299 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.512 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 80.5 m-20 -143.04 48.6 1.01 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.157 -0.964 . . . . 0.0 110.58 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.512 ' CD ' ' N ' ' A' ' 42' ' ' ASN . 42.5 Cg_endo -68.8 -159.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.653 1.344 . . . . 0.0 110.082 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.0 m -130.88 175.38 9.11 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.929 -1.107 . . . . 0.0 110.442 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -67.38 -32.71 73.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.272 -0.893 . . . . 0.0 110.054 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.02 -64.8 0.84 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 110.184 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 2.3 mt-10 -50.03 -38.93 40.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -1.0 . . . . 0.0 109.668 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 29' ' ' THR . 10.1 tt -57.65 -50.28 73.67 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.373 -0.829 . . . . 0.0 109.459 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -50.18 -38.25 38.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -0.939 . . . . 0.0 109.408 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 47' ' ' GLU . 36.3 m-20 -62.63 -42.83 99.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.377 -0.827 . . . . 0.0 109.77 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.9 ttp -67.05 -15.87 63.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.266 -0.896 . . . . 0.0 109.645 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.448 ' CD1' HD23 ' A' ' 32' ' ' LEU . 45.9 mm -88.66 -25.67 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.178 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -58.36 -36.6 73.71 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.111 -0.993 . . . . 0.0 110.124 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.419 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 8.2 pt-20 -74.21 -23.78 59.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.92 . . . . 0.0 109.993 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.453 ' CG1' HD11 ' A' ' 63' ' ' ILE . 42.8 t -98.8 23.53 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.905 . . . . 0.0 110.051 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -135.4 112.92 10.71 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.342 -0.849 . . . . 0.0 109.92 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.94 34.42 3.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.176 -0.952 . . . . 0.0 110.211 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 2.6 p30 -141.54 -34.12 0.49 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.373 -0.829 . . . . 0.0 110.843 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 95.44 52.84 1.65 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.449 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 24.6 p-10 -122.34 -12.32 8.24 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.442 -1.034 . . . . 0.0 110.682 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.465 ' O ' ' CG2' ' A' ' 62' ' ' THR . . . 78.42 27.56 57.25 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.206 -1.157 . . . . 0.0 110.206 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.465 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 0.9 OUTLIER -163.02 167.18 22.78 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.149 -1.206 . . . . 0.0 110.204 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.453 HD11 ' CG1' ' A' ' 55' ' ' VAL . 63.5 mt -117.39 150.6 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.12 -0.987 . . . . 0.0 110.127 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.434 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 1.5 m-20 -112.58 -162.97 0.82 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.316 -0.865 . . . . 0.0 110.425 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.575 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 7.0 t80 -81.55 -40.67 1.03 Allowed Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.411 -0.806 . . . . 0.0 111.914 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.4 Cg_endo -70.81 -21.4 28.65 Favored 'Trans proline' 0 N--CA 1.482 0.795 0 O-C-N 122.993 0.996 . . . . 0.0 110.974 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.425 ' OE1' ' OD1' ' A' ' 64' ' ' ASP . 57.2 mt-10 -86.12 -35.22 20.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.91 -1.119 . . . . 0.0 109.411 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.541 ' CE2' ' HE2' ' A' ' 72' ' ' MET . 11.6 t80 -70.78 -38.49 73.41 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.419 -0.801 . . . . 0.0 110.417 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.484 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 1.1 tp -80.55 -37.14 31.98 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.203 -0.936 . . . . 0.0 110.709 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 66' ' ' PRO . 88.9 m -71.35 -20.34 62.17 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.824 -1.173 . . . . 0.0 110.487 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 61.4 ttp -88.77 -42.33 11.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.139 -0.976 . . . . 0.0 110.86 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.541 ' HE2' ' CE2' ' A' ' 68' ' ' PHE . 59.0 mtt -90.51 -9.7 46.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.053 -1.03 . . . . 0.0 111.541 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.499 2.019 0 O-C-N 120.845 -1.16 . . . . 0.0 110.519 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.253 0.549 . . . . 0.0 110.389 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.51 HD11 ' CD1' ' A' ' 141' ' ' PHE . 38.8 mm -66.23 -10.23 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.224 -0.923 . . . . 0.0 110.339 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -73.48 -54.71 7.6 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.254 -0.904 . . . . 0.0 109.845 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -66.35 -35.52 80.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.362 -0.836 . . . . 0.0 109.615 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.513 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -57.32 -54.16 49.94 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.499 -0.751 . . . . 0.0 110.356 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.35 -27.41 69.0 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.882 -1.136 . . . . 0.0 110.247 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.35 -25.82 62.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.147 -0.971 . . . . 0.0 110.503 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.472 ' CG2' ' O ' ' A' ' 88' ' ' ALA . 34.3 m -95.1 -21.34 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.074 -1.016 . . . . 0.0 110.669 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.513 ' CD2' ' O ' ' A' ' 88' ' ' ALA . 21.7 m-85 -93.58 -11.91 30.71 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.16 -0.963 . . . . 0.0 110.574 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.417 ' OD2' ' HA2' ' A' ' 98' ' ' GLY . 40.5 t0 -114.23 92.1 3.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.209 -0.932 . . . . 0.0 110.269 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.49 -6.52 14.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.124 -0.985 . . . . 0.0 110.709 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.43 ' OD2' ' ND2' ' A' ' 97' ' ' ASN . 2.7 p-10 -91.93 -39.77 11.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.954 -1.091 . . . . 0.0 110.213 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 128.52 -35.36 2.69 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.546 -1.311 . . . . 0.0 111.091 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.52 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 42.4 p30 -47.88 -22.82 0.62 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.81 -1.406 . . . . 0.0 111.18 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.45 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 75.56 42.76 26.09 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 97' ' ' ASN . 77.2 m-85 -152.5 146.32 25.16 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.223 -1.163 . . . . 0.0 109.909 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.411 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 26.5 mt -94.41 121.28 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.171 -0.956 . . . . 0.0 109.994 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 74.5 m -109.01 151.36 26.44 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.477 -0.764 . . . . 0.0 109.956 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.432 ' HA ' HG13 ' A' ' 125' ' ' ILE . . . -51.23 -36.26 40.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.13 -0.981 . . . . 0.0 110.3 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.19 -59.87 4.41 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.287 -0.883 . . . . 0.0 110.307 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.415 ' O ' HG22 ' A' ' 108' ' ' VAL . 84.6 mt-10 -48.39 -51.23 27.49 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.189 -0.945 . . . . 0.0 110.161 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.411 ' CD2' HG11 ' A' ' 121' ' ' VAL . 13.0 tp -49.24 -40.58 34.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.917 . . . . 0.0 110.15 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -62.46 -41.41 98.74 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.224 -0.923 . . . . 0.0 110.492 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -77.21 -12.92 60.01 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.191 -0.943 . . . . 0.0 110.823 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 104' ' ' GLU . 53.2 t -88.57 -37.06 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.97 -1.081 . . . . 0.0 110.366 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 26.5 mmt -69.52 -32.27 71.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.147 -0.971 . . . . 0.0 110.471 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.0 p -76.36 -28.66 56.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.088 -1.008 . . . . 0.0 110.156 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -75.05 -44.16 49.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.222 -0.924 . . . . 0.0 110.176 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.7 mt -54.26 -36.28 63.43 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.187 -0.946 . . . . 0.0 110.369 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.87 31.37 1.03 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -116.19 -156.2 0.61 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.195 -1.179 . . . . 0.0 109.929 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -161.03 84.05 0.66 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.218 -0.926 . . . . 0.0 110.332 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.403 ' HG ' ' OE1' ' A' ' 120' ' ' GLU . 4.9 mp -108.68 131.82 54.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.336 -0.852 . . . . 0.0 110.08 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 19.8 m -77.94 159.99 28.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.221 -0.925 . . . . 0.0 110.224 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.0 -33.12 16.97 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.202 -0.936 . . . . 0.0 110.522 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -61.26 -42.47 98.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.153 -0.967 . . . . 0.0 110.54 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 124' ' ' MET . 85.4 mt-10 -67.71 -45.23 75.66 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.309 -0.87 . . . . 0.0 111.1 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 124' ' ' MET . 41.2 t -61.71 -56.21 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.049 -1.032 . . . . 0.0 110.605 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -52.07 -46.18 65.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.285 -0.884 . . . . 0.0 110.441 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -63.02 -33.1 74.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.295 -0.878 . . . . 0.0 110.242 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 80.6 mtp -65.24 -62.52 1.49 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.882 . . . . 0.0 109.873 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.432 HG13 ' HA ' ' A' ' 102' ' ' ALA . 21.9 mm -49.81 -30.38 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 110.148 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.0 ttt180 -70.24 -41.08 74.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.292 -0.88 . . . . 0.0 110.447 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.75 -28.7 68.62 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.215 -0.928 . . . . 0.0 110.485 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.425 ' CB ' ' SD ' ' A' ' 144' ' ' MET . . . -93.58 -17.01 23.8 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.119 -0.988 . . . . 0.0 110.753 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.477 ' OD1' ' CG2' ' A' ' 136' ' ' VAL . 1.6 m-20 -81.25 82.63 7.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.026 -1.047 . . . . 0.0 110.942 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.472 HG13 ' N ' ' A' ' 131' ' ' ASP . 21.9 pt -89.47 -32.49 5.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-O 121.429 0.633 . . . . 0.0 110.169 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 51.6 p-10 -121.83 -13.13 8.32 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.502 -0.749 . . . . 0.0 111.432 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . -95.2 -63.51 0.99 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.593 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 1.2 m-20 59.96 100.49 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.515 -0.991 . . . . 0.0 108.48 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 105.11 -20.97 36.86 Favored Glycine 0 C--N 1.294 -1.777 0 N-CA-C 107.824 -2.11 . . . . 0.0 107.824 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -162.1 153.23 17.96 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.659 -0.906 . . . . 0.0 109.859 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.477 ' CG2' ' OD1' ' A' ' 129' ' ' ASP . 46.5 t -122.1 152.66 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.258 -0.902 . . . . 0.0 110.532 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -129.95 -168.77 2.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.874 . . . . 0.0 110.594 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.462 ' CE1' HG23 ' A' ' 85' ' ' ILE . 1.7 t80 -59.57 -64.33 0.98 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.376 -0.828 . . . . 0.0 111.09 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -43.27 -55.46 4.01 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.4 -0.813 . . . . 0.0 111.146 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.446 ' OE1' ' HA ' ' A' ' 136' ' ' VAL . 5.9 mt-10 -48.44 -51.4 27.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.189 -0.945 . . . . 0.0 110.978 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.517 ' CE1' ' HE1' ' A' ' 145' ' ' MET . 2.9 t80 -59.65 -32.96 70.94 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.061 -1.024 . . . . 0.0 110.967 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 57.9 t -76.42 -27.16 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.068 -1.02 . . . . 0.0 111.506 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 46.1 tp60 -98.27 -11.09 22.98 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.88 -1.138 . . . . 0.0 110.882 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.509 ' HE3' ' CD2' ' A' ' 141' ' ' PHE . 19.7 ptt? -91.33 -34.18 15.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.014 -1.054 . . . . 0.0 110.642 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.517 ' HE1' ' CE1' ' A' ' 141' ' ' PHE . 23.4 tpp -82.83 -40.14 20.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 110.41 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 68.2 p . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.086 179.807 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.154 0.502 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -50.3 -34.5 23.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.263 -0.898 . . . . 0.0 109.874 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.526 ' HG2' ' CE2' ' A' ' 12' ' ' PHE . 45.0 tt0 -59.73 -48.29 82.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.395 -0.815 . . . . 0.0 109.95 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.7 mt -59.56 -45.1 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.033 -1.042 . . . . 0.0 109.597 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 13' ' ' LYS . . . -59.33 -25.76 64.46 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.387 -0.821 . . . . 0.0 109.505 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 15.0 tp10 -69.02 -44.76 72.1 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.377 -0.827 . . . . 0.0 109.707 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.526 ' CE2' ' HG2' ' A' ' 8' ' ' GLN . 20.3 m-85 -62.28 -47.7 83.15 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.253 -0.904 . . . . 0.0 109.808 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 6.1 mtpm? -56.17 -46.67 79.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.353 -0.842 . . . . 0.0 109.964 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -52.96 -46.17 68.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.22 -0.925 . . . . 0.0 109.631 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.458 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -58.92 -44.25 91.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.376 -0.827 . . . . 0.0 110.044 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.456 ' CE1' ' CD1' ' A' ' 27' ' ' ILE . 37.8 t80 -51.31 -40.72 59.62 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.11 -0.994 . . . . 0.0 109.742 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.4 t -66.1 -38.29 87.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -0.888 . . . . 0.0 109.595 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.5 tt -57.96 -31.78 67.2 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.325 -0.859 . . . . 0.0 109.956 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.458 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 32.1 m-85 -87.29 -25.59 23.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.313 -0.867 . . . . 0.0 110.287 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -100.92 114.47 28.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.313 -0.867 . . . . 0.0 109.925 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -103.7 -28.07 11.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.191 -0.943 . . . . 0.0 110.794 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.415 ' OD1' ' CB ' ' A' ' 24' ' ' ASP . 4.1 p30 -92.6 11.46 26.48 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.12 -0.988 . . . . 0.0 110.633 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 47.84 47.94 24.61 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.415 ' CB ' ' OD1' ' A' ' 22' ' ' ASP . 7.4 t70 -84.81 -27.45 26.8 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.263 -1.139 . . . . 0.0 110.501 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.09 -27.81 14.84 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.4 p -125.81 148.62 49.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.214 -1.168 . . . . 0.0 110.24 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.456 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 83.0 mt -96.03 126.84 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.293 -0.879 . . . . 0.0 110.114 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.7 p -108.8 -162.82 0.83 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.368 -0.832 . . . . 0.0 110.171 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.1 p -86.47 -28.36 23.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -0.987 . . . . 0.0 110.225 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -65.9 -58.36 5.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 109.698 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -54.95 -55.66 28.27 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.305 -0.872 . . . . 0.0 109.834 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 tp -54.16 -29.17 44.47 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.349 -0.845 . . . . 0.0 109.705 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.72 -49.68 73.83 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.0 m -68.81 -23.06 64.23 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.169 -1.195 . . . . 0.0 110.219 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.429 HG23 ' HA ' ' A' ' 19' ' ' PHE . 16.6 t -72.47 -37.77 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.275 -0.89 . . . . 0.0 109.881 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.4 mmt -90.28 -10.35 44.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 110.468 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -89.18 -36.66 15.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.134 -0.979 . . . . 0.0 110.658 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 72.8 p -79.33 -36.76 38.97 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.131 -0.981 . . . . 0.0 110.412 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.36 -11.19 55.14 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.268 -0.895 . . . . 0.0 110.482 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 151.07 89.6 0.07 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.69 143.8 57.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -1.118 . . . . 0.0 111.05 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.555 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 10.5 m-20 -159.85 -64.93 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.416 -0.803 . . . . 0.0 109.497 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.555 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 49.4 Cg_endo -74.47 150.22 40.6 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.423 1.222 . . . . 0.0 109.446 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 72.7 p -90.33 -137.79 0.14 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.054 -1.029 . . . . 0.0 109.415 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -100.9 -37.82 8.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.784 -1.198 . . . . 0.0 109.188 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.24 -58.1 3.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.409 -0.807 . . . . 0.0 109.236 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -51.81 -40.79 61.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.32 -0.862 . . . . 0.0 109.048 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' A' ' 44' ' ' THR . 9.4 tt -58.01 -42.61 85.61 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.611 -0.681 . . . . 0.0 109.182 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.407 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 35.1 tt0 -53.04 -39.71 63.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.905 . . . . 0.0 108.901 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -65.32 -37.32 86.76 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.218 -0.926 . . . . 0.0 108.66 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 13.5 ttt -66.39 -18.52 65.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.465 -0.772 . . . . 0.0 109.309 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 48' ' ' LEU . 33.3 mm -82.39 -31.69 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.372 -0.83 . . . . 0.0 109.802 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -59.33 -49.64 77.05 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.454 -0.779 . . . . 0.0 110.526 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -56.69 -19.16 15.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.079 -1.013 . . . . 0.0 110.124 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.463 HG13 ' CD1' ' A' ' 63' ' ' ILE . 56.0 t -94.48 -25.74 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.267 -0.895 . . . . 0.0 110.164 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -97.8 100.66 12.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.217 -0.927 . . . . 0.0 110.458 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -93.41 46.53 1.2 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.219 -0.925 . . . . 0.0 109.982 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -132.02 -66.49 0.7 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.218 -0.926 . . . . 0.0 110.484 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 135.84 53.94 0.06 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.439 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 12.4 p-10 -142.06 -46.41 0.35 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -1.139 . . . . 0.0 110.316 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.19 -72.55 0.48 Allowed Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.656 -1.259 . . . . 0.0 110.531 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.9 p -69.67 169.88 11.96 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.251 -1.147 . . . . 0.0 111.149 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.463 ' CD1' HG13 ' A' ' 55' ' ' VAL . 42.0 mt -115.83 143.89 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.309 -0.869 . . . . 0.0 110.258 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -96.12 -168.23 1.71 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.255 -0.903 . . . . 0.0 110.227 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.538 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 57.7 t80 -82.77 -41.78 0.89 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 111.459 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 43.4 Cg_endo -74.55 -29.34 9.17 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 O-C-N 123.05 1.026 . . . . 0.0 109.968 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -74.12 -27.26 60.78 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.322 -0.861 . . . . 0.0 108.775 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.494 ' CE2' ' HE2' ' A' ' 72' ' ' MET . 31.8 t80 -75.32 -47.43 27.79 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.621 -0.674 . . . . 0.0 110.04 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.456 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 1.8 tt -70.21 -20.76 63.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.297 -0.877 . . . . 0.0 110.167 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.0 m -78.6 -43.23 26.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 110.884 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 64.0 ttp -69.12 -48.18 63.17 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.1 -1.0 . . . . 0.0 110.93 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.494 ' HE2' ' CE2' ' A' ' 68' ' ' PHE . 28.7 mtt -78.68 -10.89 59.92 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.102 -0.998 . . . . 0.0 110.991 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.497 1.882 0 O-C-N 120.972 -1.08 . . . . 0.0 110.005 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.294 0.569 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.1 mt -51.53 -30.39 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.398 -0.814 . . . . 0.0 110.133 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -68.57 -42.09 78.8 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.231 -0.918 . . . . 0.0 109.846 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -62.38 -37.44 85.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.273 -0.892 . . . . 0.0 110.164 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.507 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -65.19 -62.44 1.54 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -0.9 . . . . 0.0 110.38 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.464 ' CE2' ' HA ' ' A' ' 138' ' ' TYR . 6.2 t80 -54.92 -28.0 47.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.18 -0.95 . . . . 0.0 110.211 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 -63.39 -53.26 55.25 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.255 -0.903 . . . . 0.0 110.559 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.511 HG21 ' CD1' ' A' ' 92' ' ' PHE . 31.0 m -70.68 -24.86 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.106 -0.996 . . . . 0.0 110.707 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.511 ' CD1' HG21 ' A' ' 91' ' ' VAL . 14.3 m-30 -73.41 -28.85 62.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.132 -0.98 . . . . 0.0 110.007 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -108.67 67.63 0.67 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 0.0 109.752 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -77.08 -30.33 55.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.348 -0.845 . . . . 0.0 110.485 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.417 ' OD2' ' HB2' ' A' ' 97' ' ' ASN . 30.8 p-10 -69.24 -7.13 33.89 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.171 -0.956 . . . . 0.0 110.491 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.52 28.57 70.91 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.417 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 1.8 t-20 -80.78 -75.87 0.26 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.296 -1.12 . . . . 0.0 110.01 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 151.18 -25.21 0.99 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.411 ' HB3' ' HB2' ' A' ' 135' ' ' GLN . 14.3 m-85 -118.88 131.69 56.07 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.193 -1.181 . . . . 0.0 110.092 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.425 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 83.3 mt -70.01 128.62 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.146 -0.971 . . . . 0.0 110.084 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 97.9 p -114.6 175.07 5.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.897 . . . . 0.0 110.226 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.14 -53.02 15.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 110.228 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -47.08 -56.62 6.22 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.179 -0.95 . . . . 0.0 110.244 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.401 ' OE2' ' OD2' ' A' ' 95' ' ' ASP . 94.4 mt-10 -58.69 -41.93 87.38 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 109.807 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.468 ' CD2' HG12 ' A' ' 121' ' ' VAL . 55.1 tp -54.86 -30.54 58.07 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.309 -0.869 . . . . 0.0 110.104 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.41 ' O ' ' OG1' ' A' ' 110' ' ' THR . 4.2 ttm180 -77.29 -42.72 35.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.92 . . . . 0.0 110.128 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -62.34 -19.44 63.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 110.312 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.8 t -92.67 -45.08 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.175 -0.953 . . . . 0.0 110.42 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' A' ' 105' ' ' LEU . 26.4 mmt -70.02 -18.34 63.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.272 -0.892 . . . . 0.0 110.555 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 89.9 m -75.83 -25.27 56.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.155 -0.965 . . . . 0.0 110.033 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -88.38 -38.73 14.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.303 -0.873 . . . . 0.0 110.075 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 50.6 mt -58.15 -42.6 86.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.369 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.09 0.83 7.51 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 2.4 mm-40 -72.85 -43.15 62.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.069 -1.253 . . . . 0.0 110.256 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 16.7 mmtp 55.74 106.99 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.42 -0.8 . . . . 0.0 110.414 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.6 mt -131.87 161.46 32.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.261 -0.9 . . . . 0.0 110.21 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 67.7 m -86.51 168.18 13.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 0.0 110.06 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -57.1 -43.64 82.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.268 -0.895 . . . . 0.0 110.688 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -66.31 -33.34 75.51 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.051 -1.031 . . . . 0.0 110.472 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -65.35 -59.12 4.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.044 -1.035 . . . . 0.0 109.908 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.468 HG12 ' CD2' ' A' ' 105' ' ' LEU . 70.4 t -52.04 -45.4 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.172 -0.955 . . . . 0.0 109.665 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -54.71 -41.47 70.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 0.0 109.528 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -64.57 -33.13 75.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.368 -0.833 . . . . 0.0 109.544 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 26.4 mmm -63.88 -49.54 72.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.879 . . . . 0.0 110.127 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 34.7 mm -64.83 -26.89 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.352 -0.843 . . . . 0.0 110.245 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -69.76 -50.12 46.38 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.153 -0.967 . . . . 0.0 110.129 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -57.74 -39.3 77.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.166 -0.959 . . . . 0.0 109.733 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.437 ' CB ' ' SD ' ' A' ' 144' ' ' MET . . . -70.9 -30.59 66.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.319 -0.863 . . . . 0.0 109.939 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -70.27 91.12 0.71 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.393 -0.817 . . . . 0.0 110.166 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 65.2 mt -74.69 -50.8 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.201 -0.937 . . . . 0.0 110.817 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 29.1 p30 -69.39 -17.95 63.72 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.104 -0.997 . . . . 0.0 110.877 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 71.49 72.18 0.95 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.407 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 6.6 p30 -125.73 -24.91 3.75 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.236 -1.156 . . . . 0.0 111.237 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 132.59 -24.52 3.89 Favored Glycine 0 N--CA 1.496 2.688 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.33 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.411 ' HB2' ' HB3' ' A' ' 99' ' ' TYR . 2.4 pp0? -140.25 167.51 21.96 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.055 -1.262 . . . . 0.0 110.558 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.425 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 57.9 t -102.86 144.25 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.21 -0.931 . . . . 0.0 110.68 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -106.93 166.22 10.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.363 -0.835 . . . . 0.0 109.476 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.464 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 51.8 t80 -52.94 -38.67 62.22 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.039 -1.038 . . . . 0.0 110.1 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -67.77 -60.35 2.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.213 -0.93 . . . . 0.0 110.623 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -47.13 -36.45 8.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.208 -0.933 . . . . 0.0 110.745 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.468 ' CE1' ' HE1' ' A' ' 145' ' ' MET . 10.2 t80 -65.51 -46.29 80.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.138 -0.976 . . . . 0.0 110.182 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 138' ' ' TYR . 52.4 t -66.48 -22.61 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.225 -0.922 . . . . 0.0 110.101 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -84.33 -25.29 29.33 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.378 -0.826 . . . . 0.0 111.019 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.459 ' HG3' ' N ' ' A' ' 145' ' ' MET . 10.1 ptt? -89.54 -23.1 22.1 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.003 -1.06 . . . . 0.0 110.756 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.468 ' HE1' ' CE1' ' A' ' 141' ' ' PHE . 38.4 tpp -88.58 -9.76 51.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.257 -0.902 . . . . 0.0 110.815 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.2 t . . . . . 0 N--CA 1.497 1.886 0 O-C-N 121.077 -1.014 . . . . 0.0 110.719 -179.792 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.089 0.471 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -63.72 -26.24 68.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.149 -0.969 . . . . 0.0 110.334 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -68.13 -49.87 58.29 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.194 -0.941 . . . . 0.0 110.014 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.8 mt -61.88 -47.95 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.167 -0.958 . . . . 0.0 109.805 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.24 -39.6 69.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.281 -0.887 . . . . 0.0 109.657 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -58.46 -43.92 89.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.42 -0.8 . . . . 0.0 109.619 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.452 ' CE1' ' HB3' ' A' ' 72' ' ' MET . 35.8 m-85 -63.18 -25.62 68.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.378 -0.826 . . . . 0.0 109.805 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -77.47 -28.26 52.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.333 -0.855 . . . . 0.0 110.249 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -73.05 -42.92 62.59 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.146 -0.972 . . . . 0.0 110.065 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.87 -50.68 16.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.178 -0.951 . . . . 0.0 109.48 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.538 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 77.9 t80 -49.93 -48.03 52.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 109.614 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.7 t -68.82 -35.83 77.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.553 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.427 ' CD1' ' O ' ' A' ' 18' ' ' LEU . 3.4 tm? -59.34 -24.35 63.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.423 -0.798 . . . . 0.0 109.309 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.453 ' HA ' HG23 ' A' ' 35' ' ' VAL . 13.8 m-85 -87.31 -62.28 1.54 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.513 -0.742 . . . . 0.0 109.68 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -51.65 115.58 1.7 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.53 -0.732 . . . . 0.0 110.076 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -105.85 -36.68 6.93 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.024 -1.048 . . . . 0.0 110.708 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -69.46 -25.83 64.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.148 -0.97 . . . . 0.0 110.167 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.93 95.43 0.42 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.409 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 9.1 p-10 -158.01 -46.3 0.06 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.237 -1.155 . . . . 0.0 110.609 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.458 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 126.5 23.88 1.47 Allowed Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.852 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.458 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 53.8 p -154.89 140.95 18.39 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.799 -1.413 . . . . 0.0 110.618 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.511 HD13 ' CD1' ' A' ' 16' ' ' PHE . 62.2 mt -99.63 112.72 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -0.918 . . . . 0.0 109.759 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.417 ' O ' ' HB2' ' A' ' 32' ' ' LEU . 4.5 m -97.67 -177.87 3.93 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.313 -0.867 . . . . 0.0 110.186 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.444 ' CG2' HD11 ' A' ' 52' ' ' ILE . 16.8 p -72.9 -31.62 64.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.145 -0.972 . . . . 0.0 110.929 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -62.21 1.58 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.898 -1.126 . . . . 0.0 110.09 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.418 ' O ' HG21 ' A' ' 35' ' ' VAL . 50.8 mt-10 -55.18 -47.63 74.93 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.158 -0.964 . . . . 0.0 109.437 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.422 ' O ' ' HB ' ' A' ' 35' ' ' VAL . 0.9 OUTLIER -55.7 -32.3 63.19 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.281 -0.887 . . . . 0.0 109.608 179.4 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.91 -51.62 57.84 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.9 m -70.27 -12.76 61.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.264 -1.139 . . . . 0.0 110.136 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.467 ' O ' ' CD1' ' A' ' 39' ' ' LEU . 59.5 t -78.36 -32.08 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.22 -0.925 . . . . 0.0 110.109 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -87.34 -27.52 22.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.108 -0.995 . . . . 0.0 110.205 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.408 ' HG2' ' HA ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -80.92 -46.2 15.55 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.128 -0.982 . . . . 0.0 109.946 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.6 t -57.08 -22.53 40.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.324 -0.86 . . . . 0.0 110.101 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.467 ' CD1' ' O ' ' A' ' 35' ' ' VAL . 75.7 mt -95.39 -69.72 0.74 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.341 -0.85 . . . . 0.0 109.997 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.16 88.96 0.07 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.407 ' O ' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -175.82 -56.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.229 -1.159 . . . . 0.0 110.275 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.408 ' HA ' ' HG2' ' A' ' 37' ' ' ARG . 41.9 t30 53.97 64.81 6.07 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.172 -0.955 . . . . 0.0 110.244 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -74.85 -163.04 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.765 1.403 . . . . 0.0 110.402 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.413 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 89.2 m -109.3 151.19 26.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.359 -0.838 . . . . 0.0 109.941 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -59.67 -41.9 91.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 110.03 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.79 -62.14 1.5 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.319 -0.863 . . . . 0.0 110.25 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -50.07 -24.98 3.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.247 -0.908 . . . . 0.0 109.893 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' A' ' 44' ' ' THR . 9.2 tt -70.74 -51.27 28.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.434 -0.791 . . . . 0.0 109.612 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -54.03 -30.1 46.31 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.292 -0.88 . . . . 0.0 109.085 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -75.96 -35.43 59.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.493 -0.755 . . . . 0.0 109.561 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.414 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 27.9 ttp -71.04 -19.93 62.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.469 -0.769 . . . . 0.0 110.081 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.444 HD11 ' CG2' ' A' ' 29' ' ' THR . 10.7 mt -88.15 -36.75 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -0.87 . . . . 0.0 109.684 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -55.0 -40.64 70.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.195 -0.94 . . . . 0.0 109.91 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.486 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 10.0 pt-20 -70.14 -30.58 67.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.256 -0.903 . . . . 0.0 110.131 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.517 ' CG1' ' CD1' ' A' ' 63' ' ' ILE . 59.0 t -74.35 -72.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.353 -0.842 . . . . 0.0 109.328 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -52.03 98.62 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.686 -0.634 . . . . 0.0 110.401 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -87.41 50.03 1.93 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.602 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -138.03 9.28 2.78 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.447 -0.783 . . . . 0.0 110.333 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 53.17 88.02 0.01 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -169.39 -60.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.217 -1.166 . . . . 0.0 110.077 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.404 ' O ' ' CG2' ' A' ' 52' ' ' ILE . . . 136.54 -57.83 0.67 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.8 p -90.13 143.51 26.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.203 -1.175 . . . . 0.0 110.712 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.517 ' CD1' ' CG1' ' A' ' 55' ' ' VAL . 86.6 mt -93.86 151.11 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.453 -0.78 . . . . 0.0 109.68 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -109.02 -162.79 0.83 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.237 -0.914 . . . . 0.0 110.531 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.523 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 28.1 t80 -79.39 -42.08 1.58 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.359 -0.838 . . . . 0.0 111.355 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 49.3 Cg_endo -75.73 -25.8 10.41 Favored 'Trans proline' 0 N--CA 1.481 0.75 0 O-C-N 123.124 1.065 . . . . 0.0 110.428 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 71' ' ' MET . 94.7 mt-10 -78.65 -28.06 45.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 0.0 109.188 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.538 ' CE2' ' HB2' ' A' ' 16' ' ' PHE . 88.2 t80 -78.11 -44.73 25.31 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.635 -0.666 . . . . 0.0 110.118 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.56 -32.22 60.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 0.0 110.894 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 83.2 m -78.56 -31.44 47.35 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.991 -1.068 . . . . 0.0 110.88 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.406 ' HG2' ' O ' ' A' ' 67' ' ' GLU . 18.7 ptt? -79.93 -31.48 40.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.92 -1.113 . . . . 0.0 110.777 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.525 ' HE2' ' CE1' ' A' ' 68' ' ' PHE . 53.9 mtt -89.22 -10.45 46.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.008 -1.058 . . . . 0.0 110.932 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.746 0 O-C-N 121.072 -1.017 . . . . 0.0 110.45 -179.719 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 121.202 0.525 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.6 mt -50.46 -23.77 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.146 -0.971 . . . . 0.0 110.255 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.23 -55.26 5.22 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.214 -0.929 . . . . 0.0 110.457 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 47.9 mt-10 -53.58 -38.55 64.01 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.221 -0.925 . . . . 0.0 110.147 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.444 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -65.25 -59.48 4.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.391 -0.818 . . . . 0.0 110.206 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -46.15 -28.74 1.31 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.358 -0.839 . . . . 0.0 110.267 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 71.6 mtp180 -71.13 -55.37 8.33 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.252 -0.905 . . . . 0.0 110.422 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' A' ' 88' ' ' ALA . 32.7 m -61.36 -19.64 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.152 -0.968 . . . . 0.0 110.579 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.444 ' CD2' ' O ' ' A' ' 88' ' ' ALA . 40.9 m-85 -92.12 -21.31 20.5 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.126 -0.984 . . . . 0.0 110.21 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -127.45 37.49 4.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 0.0 109.927 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -85.0 8.07 19.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.898 . . . . 0.0 110.658 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 3.0 p30 -81.92 -22.71 36.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.155 -0.966 . . . . 0.0 110.138 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.437 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 112.18 29.82 3.12 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.473 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 39.0 p-10 -127.09 -15.46 5.28 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.263 -1.139 . . . . 0.0 110.719 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 65.53 11.28 52.7 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.55 ' CD1' ' NE2' ' A' ' 135' ' ' GLN . 49.8 m-85 -121.41 139.54 53.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.026 -1.279 . . . . 0.0 110.241 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.515 ' CD1' ' CD2' ' A' ' 141' ' ' PHE . 21.8 mt -91.23 113.37 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.137 -0.977 . . . . 0.0 110.273 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 76.3 p -103.85 156.46 17.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.412 -0.805 . . . . 0.0 109.915 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.77 -34.95 55.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.127 -0.983 . . . . 0.0 110.307 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.42 -62.32 1.48 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.181 -0.949 . . . . 0.0 110.498 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.415 ' OE1' ' OD2' ' A' ' 95' ' ' ASP . 51.4 mt-10 -46.95 -42.98 18.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.179 -0.95 . . . . 0.0 110.254 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.401 HD13 ' HE3' ' A' ' 124' ' ' MET . 8.6 tt -55.07 -54.12 47.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.399 -0.813 . . . . 0.0 110.126 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.404 ' O ' ' HG3' ' A' ' 106' ' ' ARG . 3.1 tpt180 -63.1 -19.95 64.91 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.924 . . . . 0.0 109.986 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -77.89 -27.32 49.6 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.286 -0.884 . . . . 0.0 110.14 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 91' ' ' VAL . 78.4 t -83.77 -40.1 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.315 -0.865 . . . . 0.0 109.903 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.411 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.3 OUTLIER -59.87 -41.9 92.54 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.344 -0.848 . . . . 0.0 110.062 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.1 p -56.01 -44.68 78.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.33 -0.856 . . . . 0.0 110.335 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -61.28 -48.32 81.94 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.243 -0.911 . . . . 0.0 110.132 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.5 mt -64.48 -13.93 54.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.207 -0.933 . . . . 0.0 110.275 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.27 51.44 3.52 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -102.23 -177.47 3.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.129 -1.218 . . . . 0.0 110.015 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.15 47.6 0.99 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.166 -0.959 . . . . 0.0 110.577 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.444 ' CD2' ' OE1' ' A' ' 120' ' ' GLU . 7.0 mt -75.89 -175.73 3.12 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.264 -0.898 . . . . 0.0 110.158 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 88.8 m -135.92 170.08 16.57 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.293 -0.879 . . . . 0.0 110.288 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -52.87 -33.29 49.25 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.314 -0.866 . . . . 0.0 110.783 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -65.68 -53.1 45.71 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.127 -0.983 . . . . 0.0 110.613 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.444 ' OE1' ' CD2' ' A' ' 116' ' ' LEU . 74.2 mt-10 -60.57 -48.88 79.8 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.318 -0.864 . . . . 0.0 111.209 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.7 t -55.81 -53.31 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.231 -0.918 . . . . 0.0 110.833 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.75 -36.47 74.4 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.23 -0.919 . . . . 0.0 110.667 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.456 ' CG ' ' OE2' ' A' ' 127' ' ' GLU . 36.9 tt0 -71.63 -24.95 61.96 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.193 -0.942 . . . . 0.0 110.289 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.401 ' HE3' HD13 ' A' ' 105' ' ' LEU . 85.3 mtp -76.63 -49.18 16.87 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.183 -0.948 . . . . 0.0 110.068 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.416 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 19.2 mm -69.08 -26.53 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 110.326 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.43 -39.14 47.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.127 -0.983 . . . . 0.0 110.528 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.456 ' OE2' ' CG ' ' A' ' 123' ' ' GLU . 0.3 OUTLIER -69.78 -31.23 69.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.133 -0.979 . . . . 0.0 110.178 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.11 -27.91 24.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.208 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 56.8 t0 -68.29 93.58 0.48 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.374 -0.829 . . . . 0.0 110.224 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 55.6 mt -75.42 -47.9 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.287 -0.883 . . . . 0.0 110.739 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.409 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 47.7 p30 -73.19 -6.37 45.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.132 -0.98 . . . . 0.0 110.811 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.411 ' HA2' ' OD2' ' A' ' 129' ' ' ASP . . . 57.87 61.98 6.83 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -124.03 8.63 8.65 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.203 -1.175 . . . . 0.0 111.027 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.54 36.19 54.62 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.55 ' NE2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -170.96 137.36 1.19 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.354 -1.086 . . . . 0.0 109.964 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.418 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 46.8 t -110.35 118.16 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.157 -0.965 . . . . 0.0 110.318 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -87.37 177.2 7.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.163 -0.961 . . . . 0.0 110.022 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -61.5 -45.05 95.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.111 -0.993 . . . . 0.0 110.286 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -53.08 -55.56 22.96 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.282 -0.886 . . . . 0.0 110.077 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 144' ' ' MET . 56.7 mt-10 -64.86 -23.36 67.21 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.224 -0.922 . . . . 0.0 109.785 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.515 ' CD2' ' CD1' ' A' ' 100' ' ' ILE . 37.9 t80 -75.75 -22.86 56.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.551 -0.718 . . . . 0.0 109.757 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 84.9 t -90.1 -24.19 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.369 -0.832 . . . . 0.0 109.928 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -80.43 -34.24 36.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.372 -0.83 . . . . 0.0 110.217 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.491 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 0.1 OUTLIER -82.57 -13.67 56.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.286 -0.884 . . . . 0.0 110.257 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.501 ' HE1' ' CE1' ' A' ' 141' ' ' PHE . 15.1 mmt -87.49 -46.66 9.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 110.394 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.3 p . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.141 -0.974 . . . . 0.0 110.489 -179.769 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.117 0.484 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.67 -60.28 3.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.121 -0.987 . . . . 0.0 110.426 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.51 ' HG2' ' CE2' ' A' ' 12' ' ' PHE . 7.9 tt0 -62.7 -43.35 99.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.327 -0.858 . . . . 0.0 110.415 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.8 mt -55.0 -42.23 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.081 -1.012 . . . . 0.0 109.839 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.97 -34.9 78.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.317 -0.865 . . . . 0.0 110.029 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.91 -48.87 78.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 109.779 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.51 ' CE2' ' HG2' ' A' ' 8' ' ' GLN . 24.1 m-85 -60.08 -47.87 84.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.016 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -49.04 -42.04 37.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.17 -0.956 . . . . 0.0 110.072 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -66.5 -37.7 85.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.875 . . . . 0.0 110.307 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.81 -47.87 83.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.142 -0.974 . . . . 0.0 109.971 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -60.27 -45.26 93.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 110.146 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.3 t -62.84 -21.22 65.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.924 . . . . 0.0 109.991 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.7 tt -85.2 -25.18 27.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 109.939 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.477 ' HA ' ' CG2' ' A' ' 35' ' ' VAL . 8.3 m-85 -92.74 -67.98 0.83 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.219 -0.926 . . . . 0.0 110.412 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -70.99 86.78 0.72 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.382 -0.823 . . . . 0.0 110.235 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.409 ' HD3' ' O ' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -109.39 42.54 1.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.342 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -125.18 -43.2 1.96 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.136 -0.977 . . . . 0.0 110.25 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.93 -37.42 1.66 Allowed Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.86 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 49.9 p-10 -55.67 -17.85 6.67 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.96 -1.318 . . . . 0.0 110.952 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.428 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 63.13 13.59 49.52 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 34.0 p -122.21 116.05 23.46 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.023 -1.281 . . . . 0.0 110.286 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 62' ' ' THR . 61.2 mt -69.54 109.25 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.173 -0.954 . . . . 0.0 110.254 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 81.2 p -104.19 -157.85 0.63 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.881 . . . . 0.0 110.204 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.1 p -82.99 -36.85 24.73 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.198 -0.939 . . . . 0.0 110.636 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -64.94 -59.85 3.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.117 -0.99 . . . . 0.0 110.192 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -59.09 -52.5 65.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.166 -0.958 . . . . 0.0 109.805 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.486 HD23 ' CG1' ' A' ' 52' ' ' ILE . 2.6 tp -59.45 -21.82 60.6 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.241 -0.912 . . . . 0.0 109.682 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -68.23 -44.61 74.88 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 70.8 m -71.63 -34.14 69.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.349 -1.089 . . . . 0.0 110.176 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.477 ' CG2' ' HA ' ' A' ' 19' ' ' PHE . 63.6 t -69.6 -32.14 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.29 -0.881 . . . . 0.0 110.617 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.42 ' HE1' HD12 ' A' ' 32' ' ' LEU . 25.9 mmt -90.16 -18.47 25.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.221 -0.924 . . . . 0.0 110.241 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 10.7 tpt180 -79.06 -33.93 44.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 110.357 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.3 t -61.36 -21.07 63.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.289 -0.882 . . . . 0.0 110.383 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -144.98 76.38 1.49 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.175 -0.953 . . . . 0.0 110.255 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.24 -65.28 0.15 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 53.6 21.12 2.4 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.13 -1.218 . . . . 0.0 109.963 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.511 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.0 OUTLIER -105.56 -67.22 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.425 -0.797 . . . . 0.0 110.823 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.511 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 46.8 Cg_endo -72.31 170.64 18.7 Favored 'Trans proline' 0 C--N 1.321 -0.911 0 O-C-N 123.063 1.033 . . . . 0.0 110.467 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.417 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.6 OUTLIER -118.76 -140.63 0.36 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -0.887 . . . . 0.0 109.629 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -90.74 -30.67 16.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.908 -1.12 . . . . 0.0 110.189 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.62 -66.44 0.66 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.206 -0.933 . . . . 0.0 109.805 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 41.8 mt-10 -50.58 -36.22 33.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 109.54 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 44' ' ' THR . 6.0 tt -60.35 -45.2 94.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.84 . . . . 0.0 109.587 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -53.16 -39.36 63.5 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.282 -0.886 . . . . 0.0 108.629 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 47' ' ' GLU . 57.4 m-20 -64.31 -38.08 89.78 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.424 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -60.75 -23.84 65.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.439 -0.788 . . . . 0.0 108.919 178.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.486 ' CG1' HD23 ' A' ' 32' ' ' LEU . 10.7 mt -85.34 -24.86 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.456 -0.778 . . . . 0.0 109.786 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -73.54 -35.67 65.55 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.263 -0.898 . . . . 0.0 110.243 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 24.2 pt-20 -72.74 -42.54 63.96 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.174 -0.953 . . . . 0.0 110.166 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.474 HG13 ' CD1' ' A' ' 63' ' ' ILE . 68.0 t -69.87 -57.61 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.036 -1.04 . . . . 0.0 109.593 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.404 ' OD1' ' OE1' ' A' ' 67' ' ' GLU . 45.3 t0 -68.3 133.58 49.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.467 -0.77 . . . . 0.0 110.07 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.93 50.85 0.78 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.17 -0.956 . . . . 0.0 110.376 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.401 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 55.4 m-20 -136.48 -74.72 0.43 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.193 -0.942 . . . . 0.0 110.466 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.38 47.57 0.05 OUTLIER Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.417 ' OD1' ' OG1' ' A' ' 62' ' ' THR . 12.7 p30 -140.35 14.15 2.39 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.353 -1.086 . . . . 0.0 110.405 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 47.16 38.45 11.65 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.417 ' OG1' ' OD1' ' A' ' 60' ' ' ASN . 20.6 p -152.58 136.7 16.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.999 -1.294 . . . . 0.0 110.576 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.474 ' CD1' HG13 ' A' ' 55' ' ' VAL . 75.4 mt -111.67 123.74 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.884 . . . . 0.0 110.082 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.404 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.4 m-20 -83.73 -174.19 5.14 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.148 -0.97 . . . . 0.0 110.546 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.541 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -67.25 -46.71 50.82 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.436 -0.79 . . . . 0.0 111.032 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.6 Cg_endo -73.73 -31.12 8.82 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 O-C-N 123.415 1.218 . . . . 0.0 110.427 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.404 ' OE1' ' OD1' ' A' ' 56' ' ' ASP . 27.5 mt-10 -73.78 -23.65 59.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.158 -0.964 . . . . 0.0 109.176 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.519 ' CE1' ' HE1' ' A' ' 72' ' ' MET . 65.4 t80 -76.01 -55.51 5.53 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.638 -0.664 . . . . 0.0 110.281 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.4 tt -63.87 -28.86 70.13 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.349 -0.845 . . . . 0.0 110.297 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 66' ' ' PRO . 54.4 m -68.52 -57.59 5.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.221 -0.924 . . . . 0.0 110.375 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.479 ' HE2' ' CD1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -69.38 -12.67 61.85 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.167 -0.958 . . . . 0.0 110.673 -179.474 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.519 ' HE1' ' CE1' ' A' ' 68' ' ' PHE . 11.4 mmt -80.52 -24.93 39.01 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.05 -1.031 . . . . 0.0 110.085 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.475 0 O-C-N 121.334 -0.854 . . . . 0.0 109.899 179.618 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.149 0.5 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 65.5 mt -55.21 -45.19 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.115 -0.991 . . . . 0.0 110.097 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -58.6 -56.4 22.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.168 -0.957 . . . . 0.0 109.979 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 10.8 mt-10 -46.29 -44.57 16.7 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.336 -0.852 . . . . 0.0 110.172 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.524 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -57.22 -57.64 11.72 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.378 -0.826 . . . . 0.0 109.467 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.477 ' CE1' HG13 ' A' ' 100' ' ' ILE . 29.9 t80 -49.8 -25.28 2.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.115 -0.991 . . . . 0.0 109.638 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.4 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 15.7 ttt180 -67.05 -59.33 3.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.51 -0.744 . . . . 0.0 110.464 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.479 HG21 ' N ' ' A' ' 92' ' ' PHE . 34.7 m -61.52 -31.66 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.208 -0.933 . . . . 0.0 110.583 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.524 ' CD2' ' O ' ' A' ' 88' ' ' ALA . 31.1 m-85 -78.7 -15.96 57.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.084 -1.01 . . . . 0.0 110.663 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -114.61 73.21 0.82 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.965 -1.084 . . . . 0.0 110.463 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -99.42 54.91 0.97 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.259 -0.9 . . . . 0.0 110.761 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.3 p30 -140.04 -37.02 0.48 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.077 -1.014 . . . . 0.0 110.615 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.478 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 107.8 42.9 1.38 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.488 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 45.2 p-10 -135.46 -18.59 1.7 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.057 -1.261 . . . . 0.0 111.477 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.481 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 80.42 42.02 10.86 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.534 ' CD1' ' NE2' ' A' ' 135' ' ' GLN . 68.5 m-85 -152.33 145.39 24.55 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.335 -1.097 . . . . 0.0 110.093 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.477 HG13 ' CE1' ' A' ' 89' ' ' PHE . 31.9 mt -96.69 130.67 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.199 -0.938 . . . . 0.0 110.427 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.8 t -117.25 166.94 11.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.38 -0.825 . . . . 0.0 109.858 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.61 -32.21 73.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.181 -0.949 . . . . 0.0 110.678 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.6 -52.14 34.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.117 -0.99 . . . . 0.0 110.442 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -60.19 -40.18 89.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.275 -0.89 . . . . 0.0 110.755 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.478 HD21 ' CG1' ' A' ' 121' ' ' VAL . 6.7 tp -64.09 -36.82 85.28 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.087 -1.008 . . . . 0.0 110.541 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 106' ' ' ARG . 1.6 ttp-105 -66.65 -39.25 88.13 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.099 -1.001 . . . . 0.0 110.293 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -73.48 -22.81 60.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 0.0 110.384 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.519 ' CG1' ' CE1' ' A' ' 92' ' ' PHE . 77.0 t -82.15 -32.83 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.336 -0.853 . . . . 0.0 110.487 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.1 mmt -66.8 -28.78 68.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.129 -0.982 . . . . 0.0 110.272 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.4 p -63.3 -54.04 43.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.189 -0.945 . . . . 0.0 110.013 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -61.35 -40.38 94.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.253 -0.904 . . . . 0.0 110.153 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.7 mt -54.34 -30.24 50.78 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.188 -0.945 . . . . 0.0 110.232 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.39 26.0 7.11 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.458 ' CA ' ' OE1' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -127.35 107.4 9.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.272 -1.134 . . . . 0.0 110.041 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -86.09 109.23 18.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.915 . . . . 0.0 110.548 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.6 mp -112.71 -169.23 1.44 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.259 -0.901 . . . . 0.0 109.924 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 31.1 m -117.57 168.71 10.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.002 -1.061 . . . . 0.0 110.721 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -59.15 -36.22 74.87 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.4 -0.812 . . . . 0.0 110.295 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -67.0 -36.58 82.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.225 -0.922 . . . . 0.0 110.295 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 124' ' ' MET . 1.7 mt-10 -63.66 -51.72 63.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.38 -0.825 . . . . 0.0 110.361 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.478 ' CG1' HD21 ' A' ' 105' ' ' LEU . 50.3 t -63.42 -58.12 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.165 -0.959 . . . . 0.0 110.395 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -46.57 -43.13 16.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.338 -0.851 . . . . 0.0 110.395 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -67.01 -37.58 84.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.219 -0.925 . . . . 0.0 110.349 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.411 ' HG3' ' O ' ' A' ' 120' ' ' GLU . 90.9 mtp -59.27 -55.11 38.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 110.288 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 35.7 mm -56.16 -39.06 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 110.125 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -58.29 -44.36 88.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 109.952 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -69.01 -24.61 64.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.076 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.43 -21.48 38.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.174 -0.953 . . . . 0.0 110.074 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -67.76 89.42 0.26 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.314 -0.866 . . . . 0.0 110.427 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 47.7 mt -77.04 -29.74 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.791 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.7 p30 -99.37 -26.52 14.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.374 -0.829 . . . . 0.0 110.227 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 96.36 80.29 1.51 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 11.7 p-10 -144.68 -42.01 0.25 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -1.193 . . . . 0.0 110.358 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 126.51 -20.96 6.08 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.534 ' NE2' ' CD1' ' A' ' 99' ' ' TYR . 16.5 pt20 -119.16 158.91 24.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.095 -1.238 . . . . 0.0 110.524 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.5 t -119.42 113.14 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.269 -0.895 . . . . 0.0 110.055 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 12.4 p-10 -85.59 -157.98 0.36 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.125 -0.985 . . . . 0.0 110.321 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -68.93 -66.05 0.63 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.087 -1.008 . . . . 0.0 111.406 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -47.87 -47.42 31.74 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.143 -0.973 . . . . 0.0 110.854 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.409 ' OE2' ' OD2' ' A' ' 131' ' ' ASP . 33.1 mt-10 -66.29 -31.35 72.09 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.078 -1.014 . . . . 0.0 110.56 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.493 ' CD1' ' HE1' ' A' ' 144' ' ' MET . 15.5 t80 -70.61 -27.48 64.12 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.139 -0.976 . . . . 0.0 109.831 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.427 ' O ' ' CB ' ' A' ' 146' ' ' THR . 53.8 t -90.43 -23.14 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.523 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -83.83 -34.15 24.73 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.218 -0.926 . . . . 0.0 110.929 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.493 ' HE1' ' CD1' ' A' ' 141' ' ' PHE . 15.0 ptt? -64.17 -35.33 80.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.013 -1.054 . . . . 0.0 110.21 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.454 ' HE1' ' CE ' ' A' ' 144' ' ' MET . 12.4 mtt -90.19 -36.53 14.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 0.0 109.424 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.427 ' CB ' ' O ' ' A' ' 142' ' ' VAL . 22.7 m . . . . . 0 C--N 1.302 -1.487 0 O-C-N 121.538 -0.726 . . . . 0.0 110.109 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.066 0.46 . . . . 0.0 110.584 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -66.16 -51.11 60.97 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.039 -1.038 . . . . 0.0 110.458 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -64.35 -39.53 94.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -0.929 . . . . 0.0 110.083 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.5 mt -59.06 -42.69 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.143 -0.973 . . . . 0.0 109.604 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.14 95.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.353 -0.842 . . . . 0.0 109.545 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -60.03 -40.78 90.52 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.333 -0.855 . . . . 0.0 109.654 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -65.13 -31.54 72.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -0.841 . . . . 0.0 109.482 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.63 -50.59 68.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.852 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -60.79 -46.59 89.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.939 . . . . 0.0 109.839 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.505 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -48.82 -55.05 12.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.243 -0.911 . . . . 0.0 109.844 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -52.78 -52.47 56.58 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.399 -0.813 . . . . 0.0 110.347 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.0 m -53.58 -30.18 41.01 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.199 -0.938 . . . . 0.0 110.262 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.7 tt -70.52 -37.98 74.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.873 . . . . 0.0 110.142 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.558 ' CD1' ' CG1' ' A' ' 35' ' ' VAL . 78.5 m-85 -71.66 -65.24 0.78 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.433 -0.792 . . . . 0.0 110.353 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.401 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -53.74 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.149 -0.969 . . . . 0.0 110.351 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -105.16 51.94 0.75 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.264 -0.898 . . . . 0.0 110.235 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.482 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 23.0 p-10 -169.4 -33.06 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.263 -0.898 . . . . 0.0 110.936 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.73 93.98 2.33 Favored Glycine 0 N--CA 1.498 2.806 0 C-N-CA 119.669 -1.253 . . . . 0.0 110.678 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.43 ' OD2' ' OD2' ' A' ' 22' ' ' ASP . 43.7 m-20 -158.91 -45.83 0.06 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.44 -1.035 . . . . 0.0 110.038 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.88 -9.57 23.33 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.1 p -126.89 156.0 42.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.17 -1.194 . . . . 0.0 110.312 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 56.9 mt -105.42 119.64 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.465 -0.772 . . . . 0.0 110.031 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.3 p -103.21 -162.73 0.93 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.196 -0.94 . . . . 0.0 110.223 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.423 ' HA ' HD23 ' A' ' 48' ' ' LEU . 12.7 p -83.85 -27.99 28.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.162 -0.961 . . . . 0.0 110.609 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 mttp -71.21 -58.68 3.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.174 -0.954 . . . . 0.0 109.954 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.417 ' O ' HG21 ' A' ' 35' ' ' VAL . 49.8 mt-10 -56.52 -42.78 79.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.47 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.47 ' CD2' HD12 ' A' ' 52' ' ' ILE . 2.6 tp -67.57 -26.82 66.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.246 -0.909 . . . . 0.0 109.766 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.428 ' HA2' ' CD1' ' A' ' 48' ' ' LEU . . . -65.6 -38.69 94.91 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 38' ' ' SER . 50.2 m -83.0 -20.61 34.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -1.115 . . . . 0.0 109.885 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.558 ' CG1' ' CD1' ' A' ' 19' ' ' PHE . 60.4 t -74.4 -34.64 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 109.567 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 9.6 mmt -90.18 -31.66 16.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.431 -0.793 . . . . 0.0 109.636 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.2 tpt85 -78.99 -20.99 47.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.453 -0.779 . . . . 0.0 110.135 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 34' ' ' THR . 14.1 m -106.61 -6.52 17.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.336 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.6 tp -166.05 94.13 0.55 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.128 -0.983 . . . . 0.0 110.271 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.99 -103.79 0.32 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -123.45 -159.32 0.84 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -1.114 . . . . 0.0 110.288 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -130.87 60.35 52.48 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.239 -0.913 . . . . 0.0 110.06 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.5 -165.48 0.17 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.819 1.431 . . . . 0.0 110.156 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 5.9 m -125.39 -179.76 4.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.236 -0.915 . . . . 0.0 109.786 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.419 ' HA ' ' OE1' ' A' ' 45' ' ' GLU . 4.1 tp10 -69.04 -50.89 44.49 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.087 -1.008 . . . . 0.0 109.627 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.46 -57.15 11.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.196 -0.94 . . . . 0.0 109.876 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 3.4 tp10 -50.84 -39.74 54.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.915 . . . . 0.0 109.64 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.428 ' CD1' ' HA2' ' A' ' 33' ' ' GLY . 9.0 tt -54.79 -47.59 73.78 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.312 -0.868 . . . . 0.0 109.311 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -54.32 -44.4 72.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.78 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 47' ' ' GLU . 1.6 m-20 -51.31 -43.9 61.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 109.536 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.419 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 54.6 mtp -64.01 -34.85 78.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.202 -0.936 . . . . 0.0 109.794 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.47 HD12 ' CD2' ' A' ' 32' ' ' LEU . 28.0 mm -64.72 -27.97 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.299 -0.876 . . . . 0.0 110.063 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -68.06 -38.34 82.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.334 -0.854 . . . . 0.0 110.407 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 51' ' ' MET . 16.7 pt-20 -82.32 -10.49 59.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.084 -1.01 . . . . 0.0 110.154 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.9 t -104.97 -9.99 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.189 -0.944 . . . . 0.0 110.155 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -98.52 102.43 14.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.115 -0.991 . . . . 0.0 110.299 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.54 -11.12 21.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.193 -0.942 . . . . 0.0 110.538 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -69.99 -59.48 2.89 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.111 -0.993 . . . . 0.0 110.15 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 131.75 -13.7 5.3 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -76.64 -42.12 43.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.053 -1.263 . . . . 0.0 110.106 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.17 -63.63 0.6 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 57.0 p -76.67 167.28 22.11 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.243 -1.151 . . . . 0.0 110.47 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.474 HG21 ' N ' ' A' ' 64' ' ' ASP . 74.2 mt -96.19 152.29 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.208 -0.933 . . . . 0.0 109.98 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.474 ' N ' HG21 ' A' ' 63' ' ' ILE . 22.7 m-20 -114.18 -157.58 0.63 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.905 . . . . 0.0 110.472 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.533 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 7.6 t80 -84.79 -42.63 0.69 Allowed Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.414 -0.804 . . . . 0.0 111.526 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.6 Cg_endo -73.52 -24.1 16.52 Favored 'Trans proline' 0 N--CA 1.481 0.786 0 O-C-N 122.994 0.997 . . . . 0.0 110.776 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.408 ' OE1' ' HA ' ' A' ' 63' ' ' ILE . 31.2 tt0 -79.24 -31.36 43.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.138 -0.976 . . . . 0.0 108.97 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.479 ' CE1' ' SD ' ' A' ' 72' ' ' MET . 16.4 t80 -70.68 -45.21 65.44 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.788 -0.57 . . . . 0.0 110.165 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.453 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 34.5 tp -75.75 -25.03 56.17 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.263 -0.898 . . . . 0.0 110.533 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 53.4 m -84.97 -18.22 35.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.091 -1.005 . . . . 0.0 110.567 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.413 ' HE1' ' HB3' ' A' ' 71' ' ' MET . 14.7 tmm? -90.7 -38.19 13.23 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.045 -1.035 . . . . 0.0 110.876 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.479 ' SD ' ' CE1' ' A' ' 68' ' ' PHE . 66.5 mtt -90.0 -14.03 34.83 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.061 -1.024 . . . . 0.0 111.04 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.495 1.805 0 O-C-N 121.02 -1.05 . . . . 0.0 110.781 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.173 0.511 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.403 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 16.7 mt -47.91 -35.2 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.15 -0.969 . . . . 0.0 110.216 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -55.15 -54.54 42.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.179 -0.951 . . . . 0.0 109.712 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 55.5 mt-10 -54.62 -39.92 68.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.24 -0.912 . . . . 0.0 110.147 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.452 ' O ' ' CG2' ' A' ' 91' ' ' VAL . . . -56.19 -56.24 23.36 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.269 -0.894 . . . . 0.0 110.107 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -48.27 -40.16 23.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.141 -0.975 . . . . 0.0 110.23 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 45.6 mtt-85 -61.42 -41.24 96.85 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.266 -0.896 . . . . 0.0 110.829 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 88' ' ' ALA . 29.5 m -83.24 -10.13 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.936 -1.103 . . . . 0.0 110.783 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.564 ' CE1' ' CG1' ' A' ' 108' ' ' VAL . 35.6 m-85 -105.32 -1.77 24.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.116 -0.99 . . . . 0.0 110.695 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -135.67 73.77 1.48 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.06 -1.025 . . . . 0.0 110.257 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -78.05 -24.63 47.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.237 -0.914 . . . . 0.0 110.545 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.5 p30 -70.16 -28.99 65.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.315 -0.865 . . . . 0.0 110.402 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.454 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 77.93 61.45 2.53 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.438 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 16.6 p-10 -125.24 -34.94 2.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.257 -1.143 . . . . 0.0 110.432 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.432 ' C ' ' CG ' ' A' ' 99' ' ' TYR . . . 108.06 16.71 11.94 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.779 -1.201 . . . . 0.0 110.374 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.432 ' CG ' ' C ' ' A' ' 98' ' ' GLY . 35.4 m-85 -147.48 134.57 20.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.985 -1.303 . . . . 0.0 110.002 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.462 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 17.9 mt -90.48 120.61 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.809 -1.182 . . . . 0.0 109.664 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.8 t -96.9 171.69 8.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.402 -0.812 . . . . 0.0 110.056 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.01 -46.84 61.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.87 . . . . 0.0 110.284 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.05 -55.15 22.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.298 -0.876 . . . . 0.0 110.439 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -55.42 -50.06 70.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.259 -0.9 . . . . 0.0 110.613 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.421 HD23 ' HE3' ' A' ' 124' ' ' MET . 3.2 tt -49.92 -34.19 19.71 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.199 -0.938 . . . . 0.0 110.431 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.44 ' O ' ' CG2' ' A' ' 110' ' ' THR . 54.9 ttp180 -74.25 -36.76 63.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.153 -0.967 . . . . 0.0 110.001 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -74.49 -15.4 60.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.852 . . . . 0.0 110.075 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.564 ' CG1' ' CE1' ' A' ' 92' ' ' PHE . 77.1 t -85.91 -47.93 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.247 -0.908 . . . . 0.0 110.132 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.5 mmt -61.48 -32.72 72.74 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.965 . . . . 0.0 109.974 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.44 ' CG2' ' O ' ' A' ' 106' ' ' ARG . 66.7 p -59.93 -30.43 69.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.164 -0.96 . . . . 0.0 109.238 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -85.79 -31.08 22.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.555 -0.716 . . . . 0.0 109.974 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 77.5 mt -87.47 16.49 5.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 110.093 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 114' ' ' GLU . . . 61.91 83.27 0.07 OUTLIER Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.416 ' OE1' ' CA ' ' A' ' 114' ' ' GLU . 1.3 mm-40 -158.31 133.42 8.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.187 -1.184 . . . . 0.0 110.464 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -95.38 104.19 16.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 110.028 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.7 mt -136.06 117.43 14.66 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.278 -0.888 . . . . 0.0 110.504 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 38.2 m -71.44 172.81 8.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.314 -0.866 . . . . 0.0 109.91 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -62.13 -31.8 72.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 110.222 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -69.59 -48.71 59.25 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.247 -0.908 . . . . 0.0 110.205 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -57.37 -50.81 71.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.127 -0.983 . . . . 0.0 109.935 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 89.3 t -55.35 -49.56 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.401 -0.812 . . . . 0.0 110.177 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.406 ' OD1' ' HD2' ' A' ' 126' ' ' ARG . 8.5 t70 -57.42 -31.87 66.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 110.066 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -70.05 -32.0 69.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.201 -0.937 . . . . 0.0 109.911 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.421 ' HE3' HD23 ' A' ' 105' ' ' LEU . 84.8 mtp -67.9 -44.71 76.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.31 -0.869 . . . . 0.0 109.646 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 30.1 mm -62.51 -37.57 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.412 -0.805 . . . . 0.0 110.345 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.406 ' HD2' ' OD1' ' A' ' 122' ' ' ASP . 65.8 mtp180 -70.4 -37.05 74.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.24 -0.913 . . . . 0.0 110.252 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.414 ' HA ' ' OE1' ' A' ' 127' ' ' GLU . 6.0 mm-40 -71.39 -27.26 63.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.185 -0.947 . . . . 0.0 109.895 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.66 -27.29 29.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.38 -0.825 . . . . 0.0 109.992 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.403 ' OD1' ' OD1' ' A' ' 131' ' ' ASP . 11.9 t0 -65.15 94.73 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.0 110.008 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 68.7 mt -67.8 -31.42 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.225 -0.922 . . . . 0.0 110.231 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 19.5 p30 -100.84 -17.41 16.89 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.263 -0.898 . . . . 0.0 110.355 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 69.84 62.56 3.75 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.411 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 82.2 m-20 -101.56 -41.29 6.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.091 -1.241 . . . . 0.0 110.109 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.26 -22.06 1.09 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -142.57 162.75 34.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -1.148 . . . . 0.0 110.032 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.462 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 41.0 t -88.92 143.99 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.211 -0.93 . . . . 0.0 110.504 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -112.26 151.67 29.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 109.806 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -46.18 -37.15 6.68 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.194 -0.941 . . . . 0.0 110.459 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.411 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 5.8 mm-40 -72.15 -45.25 61.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.232 -0.917 . . . . 0.0 110.495 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' A' ' 144' ' ' MET . 55.7 mt-10 -62.24 -23.31 66.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.127 -0.983 . . . . 0.0 110.438 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.56 ' CD1' ' CE ' ' A' ' 144' ' ' MET . 23.2 t80 -81.21 -39.78 24.87 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.321 -0.862 . . . . 0.0 110.544 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 65.6 t -73.98 -21.83 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.239 -0.913 . . . . 0.0 110.564 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 68.9 mm-40 -88.27 -40.17 13.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.167 -0.958 . . . . 0.0 111.051 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.56 ' CE ' ' CD1' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -72.24 -20.47 61.54 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.865 -1.147 . . . . 0.0 110.943 -179.229 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.508 ' HE3' ' CZ ' ' A' ' 141' ' ' PHE . 19.7 ttm -90.43 -68.07 0.81 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.098 -1.001 . . . . 0.0 110.547 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.099 -1.0 . . . . 0.0 110.283 -179.866 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.139 0.495 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -74.52 -40.49 61.73 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.451 -0.78 . . . . 0.0 110.701 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.4 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 54.0 mt-30 -67.66 -51.59 47.98 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.144 -0.972 . . . . 0.0 110.329 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.0 mt -57.72 -48.99 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.075 -1.016 . . . . 0.0 109.522 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.3 -32.11 68.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 109.74 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 37.0 tt0 -59.81 -51.19 70.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.914 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -58.66 -34.11 70.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.291 -0.881 . . . . 0.0 109.662 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.6 -46.73 86.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.377 -0.827 . . . . 0.0 110.466 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -59.49 -45.69 90.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.226 -0.921 . . . . 0.0 110.451 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.415 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -60.15 -41.55 92.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.957 . . . . 0.0 110.1 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -58.52 -56.21 25.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.276 -0.89 . . . . 0.0 110.141 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.2 m -53.36 -29.17 32.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.149 -0.969 . . . . 0.0 109.668 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.424 ' CD2' ' C ' ' A' ' 18' ' ' LEU . 1.8 tt -66.43 -41.2 89.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.39 -0.819 . . . . 0.0 109.782 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.476 ' CD1' HG13 ' A' ' 35' ' ' VAL . 27.7 m-85 -77.61 -64.81 1.06 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.319 -0.863 . . . . 0.0 110.338 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -49.23 106.04 0.1 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.285 -0.884 . . . . 0.0 110.383 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -110.35 15.19 22.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.187 -0.946 . . . . 0.0 111.014 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.422 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 9.3 p-10 -126.19 -42.81 1.83 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.012 -1.055 . . . . 0.0 110.423 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.69 19.69 6.01 Favored Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.513 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.422 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 57.1 p-10 -91.39 -8.1 48.89 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.965 -1.314 . . . . 0.0 110.537 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.464 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 70.85 42.37 60.92 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.464 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 9.3 p -158.34 148.8 20.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.242 -1.152 . . . . 0.0 109.943 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.6 mt -108.81 105.36 18.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.182 -0.949 . . . . 0.0 109.937 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.457 ' HA ' ' CG2' ' A' ' 62' ' ' THR . 3.5 m -96.65 -175.74 3.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.413 -0.804 . . . . 0.0 109.747 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.44 ' HA ' HD23 ' A' ' 48' ' ' LEU . 23.5 p -72.1 -29.32 63.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.0 110.539 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -65.4 -62.06 1.75 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 0.0 110.366 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -57.12 -44.92 83.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.272 -0.893 . . . . 0.0 110.05 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.452 HD21 ' CG ' ' A' ' 48' ' ' LEU . 2.9 tp -63.85 -25.18 68.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -0.904 . . . . 0.0 109.665 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.14 -46.73 69.41 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.44 ' O ' ' CB ' ' A' ' 38' ' ' SER . 87.1 m -72.69 -21.77 61.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.311 -1.111 . . . . 0.0 109.498 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.476 HG13 ' CD1' ' A' ' 19' ' ' PHE . 58.0 t -71.14 -42.45 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.431 -0.793 . . . . 0.0 109.811 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.447 ' HE2' ' HE2' ' A' ' 51' ' ' MET . 26.0 mmt -75.46 -30.03 59.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 110.457 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -88.47 -9.38 52.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.156 -0.965 . . . . 0.0 110.301 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 34' ' ' THR . 47.7 t -101.09 8.84 42.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.09 -1.006 . . . . 0.0 110.542 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.424 HD13 ' O ' ' A' ' 35' ' ' VAL . 90.9 mt -127.68 -81.37 0.6 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.139 -0.976 . . . . 0.0 110.207 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.466 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . -156.48 36.73 0.59 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.466 ' NE2' ' O ' ' A' ' 40' ' ' GLY . 4.9 mp0 -140.09 171.92 13.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.504 -0.998 . . . . 0.0 109.851 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.468 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 23.8 p30 -155.87 52.55 0.68 Allowed Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.023 -1.048 . . . . 0.0 111.048 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.468 ' HD3' ' N ' ' A' ' 42' ' ' ASN . 50.0 Cg_endo -77.68 160.81 31.19 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.671 1.353 . . . . 0.0 110.229 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.0 p -92.45 -142.22 0.2 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.276 -0.89 . . . . 0.0 109.883 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -105.59 -32.22 8.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.937 -1.102 . . . . 0.0 110.053 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.96 -67.7 0.54 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -0.938 . . . . 0.0 109.655 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -49.83 -38.7 36.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 109.441 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.452 ' CG ' HD21 ' A' ' 32' ' ' LEU . 6.4 tt -57.07 -48.88 77.48 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.45 -0.781 . . . . 0.0 109.342 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -51.51 -42.07 61.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.434 -0.791 . . . . 0.0 109.551 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.39 -42.78 99.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.871 . . . . 0.0 109.816 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.447 ' HE2' ' HE2' ' A' ' 36' ' ' MET . 18.5 ttp -62.3 -19.8 63.66 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.283 -0.885 . . . . 0.0 109.353 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.4 mt -89.18 -24.52 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.426 -0.796 . . . . 0.0 109.887 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -67.97 -35.3 78.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.302 -0.874 . . . . 0.0 110.154 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 51' ' ' MET . 17.2 pt-20 -73.73 -33.75 64.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.224 -0.922 . . . . 0.0 110.04 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.433 ' CG1' ' SD ' ' A' ' 71' ' ' MET . 99.9 t -77.1 -68.78 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.285 -0.885 . . . . 0.0 109.806 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.429 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 64.1 t0 -47.0 125.72 7.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.276 -0.89 . . . . 0.0 110.051 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.67 28.78 5.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.217 -0.927 . . . . 0.0 110.206 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.416 ' HB2' ' OD1' ' A' ' 60' ' ' ASN . 40.5 m-20 -122.76 -62.08 1.39 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.405 -0.809 . . . . 0.0 110.05 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.82 36.16 0.6 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.416 ' OD1' ' HB2' ' A' ' 58' ' ' ASP . 6.8 m120 -103.85 -40.67 6.15 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.176 -1.19 . . . . 0.0 110.107 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 123.87 -14.79 7.97 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.457 ' CG2' ' HA ' ' A' ' 28' ' ' THR . 75.2 p -130.97 164.47 25.28 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.147 -1.208 . . . . 0.0 110.446 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.41 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 80.1 mt -110.21 122.15 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.246 -0.909 . . . . 0.0 110.237 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.438 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 55.0 m-20 -81.38 -168.32 1.81 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.307 -0.871 . . . . 0.0 110.399 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.532 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 42.4 t80 -72.99 -42.46 7.31 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 111.246 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 45.8 Cg_endo -75.76 -28.19 8.18 Favored 'Trans proline' 0 C--N 1.325 -0.703 0 O-C-N 123.035 1.018 . . . . 0.0 109.821 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.429 ' OE2' ' HA ' ' A' ' 56' ' ' ASP . 40.7 tt0 -73.52 -24.03 60.1 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.429 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 10.3 t80 -84.73 -43.01 14.68 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.429 0.633 . . . . 0.0 110.145 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.439 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 3.7 tt -72.3 -18.28 61.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.193 -0.942 . . . . 0.0 110.128 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.5 m -90.3 -43.04 10.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.125 -0.984 . . . . 0.0 110.493 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.47 ' HG3' ' N ' ' A' ' 72' ' ' MET . 6.5 ptt? -64.09 -40.99 97.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.145 -0.972 . . . . 0.0 110.518 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.47 ' N ' ' HG3' ' A' ' 71' ' ' MET . 32.7 mtt -84.32 -9.66 58.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.099 -1.001 . . . . 0.0 110.683 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.495 1.798 0 O-C-N 121.024 -1.047 . . . . 0.0 110.618 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 121.147 0.499 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.42 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 28.7 mt -68.0 -59.39 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.252 -0.905 . . . . 0.0 110.388 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.4 ttm-85 -53.02 -43.5 66.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.059 -1.025 . . . . 0.0 109.448 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -54.61 -43.83 72.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.361 -0.837 . . . . 0.0 109.629 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 85' ' ' ILE . . . -58.47 -37.73 76.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.35 -0.843 . . . . 0.0 109.667 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -65.03 -28.93 69.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.063 -1.023 . . . . 0.0 109.897 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -70.45 -58.95 3.16 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.494 -0.754 . . . . 0.0 111.118 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.1 m -62.94 -43.33 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.14 -0.975 . . . . 0.0 110.981 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.463 ' CZ ' ' HE3' ' A' ' 109' ' ' MET . 18.0 m-85 -69.72 -22.42 63.4 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.973 -1.08 . . . . 0.0 110.263 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.411 ' OD1' ' HA2' ' A' ' 98' ' ' GLY . 11.9 t70 -147.28 81.96 1.54 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.963 . . . . 0.0 110.483 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.6 pttt -109.68 47.43 0.94 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.355 -0.841 . . . . 0.0 109.907 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 1.8 p30 -115.31 -31.69 5.88 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.273 -0.892 . . . . 0.0 110.618 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.46 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 138.33 -54.09 0.7 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.279 -1.438 . . . . 0.0 110.959 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -48.77 -34.46 12.29 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 120.947 -1.325 . . . . 0.0 110.846 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.469 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 80.28 33.01 33.27 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.963 -1.113 . . . . 0.0 110.406 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.469 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 20.7 m-85 -130.2 127.58 39.95 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.951 -1.323 . . . . 0.0 109.884 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.511 ' CD1' ' CE1' ' A' ' 141' ' ' PHE . 8.8 mt -76.01 110.39 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.962 -1.086 . . . . 0.0 110.167 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.1 t -93.6 165.59 12.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.065 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.51 -41.39 96.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.291 -0.88 . . . . 0.0 110.341 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.4 -53.36 49.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.186 -0.946 . . . . 0.0 110.037 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -51.75 -37.73 52.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.426 -0.796 . . . . 0.0 110.103 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.0 tt -69.36 -35.2 75.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.4 -0.813 . . . . 0.0 110.121 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.419 ' O ' ' CG2' ' A' ' 110' ' ' THR . 58.0 ttp180 -66.36 -26.69 67.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.483 -0.76 . . . . 0.0 110.254 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -85.01 -31.54 23.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.281 -0.887 . . . . 0.0 110.514 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.2 t -76.37 -30.94 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.166 -0.959 . . . . 0.0 110.452 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.463 ' HE3' ' CZ ' ' A' ' 92' ' ' PHE . 23.4 mmt -75.99 -26.57 56.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.104 -0.998 . . . . 0.0 110.18 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' A' ' 106' ' ' ARG . 45.4 p -68.67 -40.61 80.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.27 -0.894 . . . . 0.0 110.146 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -80.01 -41.54 25.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.195 -0.94 . . . . 0.0 110.045 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.2 mt -47.63 -25.47 1.18 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.255 -0.903 . . . . 0.0 110.204 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.44 20.8 8.34 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -123.19 110.0 14.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.23 -1.159 . . . . 0.0 110.3 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.95 107.25 9.16 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.341 -0.85 . . . . 0.0 110.285 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.9 -174.85 2.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.184 -0.947 . . . . 0.0 110.19 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.5 m -136.8 166.65 23.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 110.209 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -55.07 -33.22 62.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -0.94 . . . . 0.0 110.359 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.18 -47.24 80.57 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.328 -0.857 . . . . 0.0 110.784 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -65.4 -58.39 5.98 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.118 -0.989 . . . . 0.0 110.613 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.2 t -49.64 -41.24 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.145 -0.972 . . . . 0.0 110.395 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 126' ' ' ARG . 38.4 t70 -64.39 -39.08 93.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.167 -0.958 . . . . 0.0 110.163 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -66.91 -30.06 70.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.223 -0.923 . . . . 0.0 110.152 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 78.7 mtp -75.83 -62.99 1.41 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.178 -0.951 . . . . 0.0 110.66 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.432 HD11 HG22 ' A' ' 136' ' ' VAL . 26.0 mm -52.05 -29.23 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.156 -0.965 . . . . 0.0 110.67 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 122' ' ' ASP . 73.1 mtp85 -71.75 -56.87 4.98 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.051 -1.031 . . . . 0.0 110.349 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -69.45 -8.28 45.4 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.197 -0.939 . . . . 0.0 110.361 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -98.83 -24.66 14.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -0.919 . . . . 0.0 110.104 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -83.51 83.65 7.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.075 -1.016 . . . . 0.0 109.915 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.5 mt -45.41 -69.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.33 -0.856 . . . . 0.0 110.688 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.8 p30 -60.91 -24.41 65.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.221 -0.924 . . . . 0.0 110.366 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.421 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 62.51 62.64 5.37 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -106.61 -31.51 8.45 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.24 -1.153 . . . . 0.0 110.205 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 161.96 -49.11 0.34 Allowed Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.13 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.463 ' CB ' ' HB3' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -123.42 170.43 10.36 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.033 -1.274 . . . . 0.0 110.107 -179.363 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.432 HG22 HD11 ' A' ' 125' ' ' ILE . 47.4 t -105.97 97.8 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.379 -0.826 . . . . 0.0 110.002 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -70.19 179.43 2.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.332 -0.855 . . . . 0.0 110.355 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -61.65 -41.43 97.5 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.311 -0.868 . . . . 0.0 111.268 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -53.15 -52.17 59.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.028 -1.045 . . . . 0.0 110.199 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.401 ' OE2' ' OD2' ' A' ' 131' ' ' ASP . 55.0 mt-10 -67.4 -21.25 65.6 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.275 -0.891 . . . . 0.0 109.879 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.511 ' CE1' ' CD1' ' A' ' 100' ' ' ILE . 1.9 t80 -77.54 -23.33 50.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.359 -0.838 . . . . 0.0 110.414 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 80.4 t -88.43 -23.05 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.197 -0.939 . . . . 0.0 110.511 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -91.65 -39.02 12.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.296 -0.877 . . . . 0.0 110.799 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.455 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -67.44 -17.75 64.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.981 -1.074 . . . . 0.0 110.358 -179.651 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.455 ' CE ' ' HE2' ' A' ' 144' ' ' MET . 52.2 mtt -88.13 -55.06 3.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.118 -0.989 . . . . 0.0 109.887 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.409 ' O ' HG21 ' A' ' 146' ' ' THR . 2.7 t . . . . . 0 N--CA 1.495 1.788 0 O-C-N 121.508 -0.745 . . . . 0.0 110.069 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.409 ' O ' ' HB1' ' A' ' 10' ' ' ALA . 2.2 mt-10 . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.336 0.588 . . . . 0.0 109.522 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -77.22 -33.03 56.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.402 -0.812 . . . . 0.0 109.457 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -67.57 -59.13 3.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.448 -0.782 . . . . 0.0 110.285 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.4 mt -59.71 -34.72 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 109.587 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 6' ' ' GLU . . . -64.28 -32.38 73.96 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.267 -0.896 . . . . 0.0 108.988 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -66.91 -51.75 51.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.459 -0.775 . . . . 0.0 109.426 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -59.46 -29.99 68.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.618 -0.676 . . . . 0.0 109.751 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -66.26 -55.99 13.44 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.4 -0.812 . . . . 0.0 110.191 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.411 ' O ' ' OG ' ' A' ' 17' ' ' SER . 25.0 tt0 -51.01 -38.25 50.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.16 -0.962 . . . . 0.0 109.969 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.514 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -62.13 -54.31 42.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.026 -1.046 . . . . 0.0 109.886 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.47 ' CE1' HD13 ' A' ' 27' ' ' ILE . 18.5 t80 -56.7 -26.9 57.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.294 -0.879 . . . . 0.0 110.687 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 14' ' ' GLU . 25.0 p -75.98 -35.06 59.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.179 -0.95 . . . . 0.0 109.888 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.1 tt -69.51 -26.8 64.71 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.313 -0.867 . . . . 0.0 109.644 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 30.4 m-85 -86.08 -69.19 0.68 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.375 -0.828 . . . . 0.0 109.938 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -56.18 105.07 0.17 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.312 -0.868 . . . . 0.0 110.283 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -105.75 -38.06 6.51 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.312 -0.867 . . . . 0.0 110.665 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -70.27 -26.11 63.67 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.141 -0.975 . . . . 0.0 110.505 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.89 106.44 0.83 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 7.7 p-10 -169.64 -39.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -1.177 . . . . 0.0 110.263 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.407 ' O ' HG21 ' A' ' 26' ' ' THR . . . 112.72 12.57 12.59 Favored Glycine 0 N--CA 1.495 2.632 0 C-N-CA 119.93 -1.129 . . . . 0.0 110.37 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.411 ' OG1' ' OD2' ' A' ' 24' ' ' ASP . 54.8 p -139.96 164.97 28.59 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.044 -1.269 . . . . 0.0 110.267 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.47 HD13 ' CE1' ' A' ' 16' ' ' PHE . 40.8 mt -123.47 120.56 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.135 -0.978 . . . . 0.0 110.191 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.2 m -113.75 -179.08 3.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.35 -0.844 . . . . 0.0 110.292 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.1 p -68.84 -27.49 65.88 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.267 -0.896 . . . . 0.0 110.754 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.3 mtmm -66.31 -61.34 2.06 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.059 -1.026 . . . . 0.0 109.929 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -60.91 -58.83 6.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.056 -1.028 . . . . 0.0 109.541 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.469 HD23 ' CD1' ' A' ' 52' ' ' ILE . 0.6 OUTLIER -52.1 -26.73 11.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 109.708 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.44 -52.42 46.69 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 97.2 m -65.77 -23.99 66.84 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.203 -1.174 . . . . 0.0 109.879 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.486 HG13 ' CD1' ' A' ' 19' ' ' PHE . 46.5 t -66.34 -42.83 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.442 -0.786 . . . . 0.0 109.904 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.422 ' HE2' ' CE ' ' A' ' 51' ' ' MET . 61.5 mtt -89.17 -11.63 43.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.376 -0.828 . . . . 0.0 110.379 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -89.85 -21.24 22.65 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.163 -0.961 . . . . 0.0 110.186 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.9 m -109.52 -22.51 11.95 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.197 -0.939 . . . . 0.0 110.432 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.46 66.1 1.08 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.147 -0.971 . . . . 0.0 110.637 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.02 51.64 0.16 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -48.08 102.26 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.236 -1.155 . . . . 0.0 110.304 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.523 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 2.4 t30 -156.67 -65.93 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.885 . . . . 0.0 110.234 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.523 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 46.3 Cg_endo -72.23 170.42 19.16 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.316 1.166 . . . . 0.0 110.311 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.406 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 10.8 t -119.39 -149.09 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.623 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -95.81 -31.84 12.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.831 -1.168 . . . . 0.0 110.115 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.64 -67.65 0.61 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.23 -0.919 . . . . 0.0 110.089 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -49.0 -31.55 7.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.135 -0.978 . . . . 0.0 109.744 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.43 HD12 ' CD2' ' A' ' 32' ' ' LEU . 9.1 tt -63.96 -51.7 63.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.92 . . . . 0.0 109.209 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.7 tm0? -49.5 -41.47 40.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.459 -0.776 . . . . 0.0 109.605 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -64.71 -39.46 93.69 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.36 -0.837 . . . . 0.0 109.709 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.428 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 25.4 ttp -70.27 -13.18 62.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.158 -0.963 . . . . 0.0 109.85 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.469 ' CD1' HD23 ' A' ' 32' ' ' LEU . 29.7 mm -84.75 -35.31 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.218 -0.926 . . . . 0.0 109.537 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -60.7 -39.88 90.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.463 -0.773 . . . . 0.0 110.504 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.456 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 12.3 pt-20 -69.39 -35.95 76.3 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.128 -0.983 . . . . 0.0 110.596 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.456 ' N ' ' HG3' ' A' ' 54' ' ' GLU . 79.6 t -71.39 -28.39 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.064 -1.023 . . . . 0.0 110.062 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -96.8 117.3 30.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.37 -0.832 . . . . 0.0 110.448 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.06 25.95 10.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -0.843 . . . . 0.0 109.773 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -106.61 -68.13 0.9 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.485 -0.759 . . . . 0.0 110.167 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.38 -14.27 2.06 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.421 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 27.7 p-10 -69.78 -14.11 62.61 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.15 -1.206 . . . . 0.0 110.287 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.445 ' O ' ' CG2' ' A' ' 62' ' ' THR . . . 79.24 23.86 62.42 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.011 -1.09 . . . . 0.0 110.545 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.445 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 7.1 p -156.44 167.65 29.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.996 -1.296 . . . . 0.0 110.414 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.451 HD13 ' CG1' ' A' ' 55' ' ' VAL . 82.9 mt -108.31 169.74 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.182 -0.949 . . . . 0.0 110.596 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 46.7 m-20 -131.44 -163.02 1.28 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.31 -0.869 . . . . 0.0 109.848 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.535 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 40.1 t80 -82.51 -43.26 0.95 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.068 -1.02 . . . . 0.0 111.357 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 47.2 Cg_endo -73.15 -28.53 12.62 Favored 'Trans proline' 0 N--CA 1.48 0.68 0 O-C-N 123.091 1.048 . . . . 0.0 110.304 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -78.34 -23.73 46.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.105 -0.997 . . . . 0.0 109.225 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 24.3 t80 -75.91 -48.64 20.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.624 -0.672 . . . . 0.0 110.201 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.402 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 2.8 tt -75.71 -21.49 57.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.353 -0.842 . . . . 0.0 110.349 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.7 m -89.57 -21.86 22.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -0.964 . . . . 0.0 110.713 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.455 ' HG3' ' N ' ' A' ' 72' ' ' MET . 8.1 ptt? -88.86 -36.08 16.2 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.964 -1.085 . . . . 0.0 110.515 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.455 ' N ' ' HG3' ' A' ' 71' ' ' MET . 52.5 mtt -84.72 -23.55 29.26 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.188 -0.945 . . . . 0.0 110.0 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.368 -0.832 . . . . 0.0 110.04 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.304 0.573 . . . . 0.0 110.361 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 40.7 mt -51.71 -34.93 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.112 -0.993 . . . . 0.0 109.733 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -58.08 -43.89 87.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.944 . . . . 0.0 109.398 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -62.23 -33.59 74.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.424 -0.798 . . . . 0.0 109.784 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.512 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -65.92 -66.48 0.54 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.416 -0.802 . . . . 0.0 109.889 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -49.62 -26.62 3.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.927 . . . . 0.0 110.308 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.412 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 16.0 tpt180 -68.78 -45.23 71.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.148 -0.97 . . . . 0.0 110.255 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' A' ' 88' ' ' ALA . 34.0 m -76.27 -15.79 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.283 -0.885 . . . . 0.0 110.443 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.512 ' CD2' ' O ' ' A' ' 88' ' ' ALA . 23.0 m-85 -90.85 -18.38 24.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.132 -0.98 . . . . 0.0 110.491 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -128.82 44.32 2.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.099 -1.001 . . . . 0.0 110.077 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 20.4 ptmt -106.46 47.62 0.87 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 110.403 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.414 ' OD2' ' OE1' ' A' ' 104' ' ' GLU . 2.8 p30 -116.88 -22.57 8.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.237 -0.915 . . . . 0.0 110.043 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.23 29.33 4.03 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -105.78 -71.09 0.76 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.405 -1.056 . . . . 0.0 110.091 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 151.9 -36.48 0.84 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -134.12 169.59 16.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -1.16 . . . . 0.0 110.133 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.5 mt -73.1 131.29 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 109.858 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.421 ' CB ' ' OE2' ' A' ' 104' ' ' GLU . 36.5 t -113.83 172.26 7.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.47 -0.769 . . . . 0.0 110.023 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.413 ' O ' HG12 ' A' ' 121' ' ' VAL . . . -68.65 -48.06 64.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -0.947 . . . . 0.0 110.144 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.89 -52.35 66.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.185 -0.947 . . . . 0.0 110.247 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.421 ' OE2' ' CB ' ' A' ' 101' ' ' SER . 46.2 mt-10 -48.97 -54.76 14.22 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.376 -0.827 . . . . 0.0 110.577 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.454 HD22 ' CG ' ' A' ' 109' ' ' MET . 5.2 tt -61.25 -30.33 70.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.379 -0.826 . . . . 0.0 110.763 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -67.24 -38.89 85.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.187 -0.945 . . . . 0.0 110.583 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -84.04 -14.2 51.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 110.472 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.409 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 71.8 t -84.29 -29.15 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.236 -0.915 . . . . 0.0 110.527 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.454 ' CG ' HD22 ' A' ' 105' ' ' LEU . 26.4 mmt -81.81 -46.65 13.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.946 . . . . 0.0 110.529 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.2 p -50.44 -32.97 19.34 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 110.268 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -86.16 -48.81 8.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.128 -0.982 . . . . 0.0 110.372 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 22.6 mt -47.07 -32.46 4.11 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.138 -0.976 . . . . 0.0 110.509 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.48 38.4 0.92 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -119.06 167.4 11.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.341 -1.094 . . . . 0.0 110.069 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -121.41 94.49 4.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.889 . . . . 0.0 110.061 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.5 mt -128.58 151.94 48.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.281 -0.887 . . . . 0.0 110.228 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 91.4 m -99.77 172.39 7.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.868 . . . . 0.0 110.002 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.45 -62.89 1.41 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.242 -0.911 . . . . 0.0 110.636 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -52.54 -41.4 63.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.143 -0.973 . . . . 0.0 110.315 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.422 ' OE1' ' HA ' ' A' ' 120' ' ' GLU . 6.4 mm-40 -52.08 -50.63 61.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.118 -0.989 . . . . 0.0 110.017 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 102' ' ' ALA . 63.8 t -57.54 -43.9 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.16 -0.962 . . . . 0.0 109.821 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -59.58 -28.53 67.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.297 -0.877 . . . . 0.0 109.729 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 24.4 tt0 -73.27 -37.44 66.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.352 -0.842 . . . . 0.0 109.863 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 74.9 mtp -66.4 -39.92 89.3 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.274 -0.891 . . . . 0.0 109.821 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 31.8 mm -69.22 -38.61 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -0.906 . . . . 0.0 110.188 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -62.77 -46.33 88.52 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.257 -0.902 . . . . 0.0 110.228 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -62.47 -38.84 91.41 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.292 -0.88 . . . . 0.0 110.162 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.14 -16.0 61.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -0.861 . . . . 0.0 110.21 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.411 ' OD1' ' OD1' ' A' ' 131' ' ' ASP . 57.7 t0 -87.78 60.95 6.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.365 -0.835 . . . . 0.0 110.129 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.45 HG13 ' N ' ' A' ' 131' ' ' ASP . 18.0 pt -56.02 -42.26 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.435 -0.791 . . . . 0.0 111.409 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.45 ' N ' HG13 ' A' ' 130' ' ' ILE . 47.8 p-10 -72.74 -18.99 61.46 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.037 -1.039 . . . . 0.0 111.125 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.34 72.19 0.88 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 33.7 p30 -126.15 -16.99 5.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.406 -1.055 . . . . 0.0 110.873 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.465 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 122.96 -49.89 0.87 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.409 ' NE2' ' C ' ' A' ' 135' ' ' GLN . 0.0 OUTLIER -119.18 164.7 15.19 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.086 -1.243 . . . . 0.0 110.772 -179.611 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.5 t -102.63 127.0 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.303 -0.873 . . . . 0.0 110.053 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -97.22 -172.12 2.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.953 -1.092 . . . . 0.0 110.459 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -64.4 -62.47 1.58 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.334 -0.854 . . . . 0.0 111.621 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -43.87 -53.53 5.99 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.239 -0.913 . . . . 0.0 111.141 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -56.77 -39.37 73.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.898 -1.126 . . . . 0.0 110.399 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.524 ' CE1' ' CE ' ' A' ' 145' ' ' MET . 20.2 t80 -66.82 -27.09 67.27 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.391 -0.818 . . . . 0.0 111.133 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 57.6 t -90.06 -20.67 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.024 -1.047 . . . . 0.0 110.77 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -83.81 -30.04 26.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.212 -0.93 . . . . 0.0 110.824 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.47 ' CE ' ' CD1' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -90.01 -13.19 36.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.112 -0.993 . . . . 0.0 110.608 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.524 ' CE ' ' CE1' ' A' ' 141' ' ' PHE . 30.0 ttm -89.98 -27.99 19.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.913 . . . . 0.0 110.537 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 60.0 p . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.134 -0.979 . . . . 0.0 110.194 179.847 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 10' ' ' ALA . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.331 0.586 . . . . 0.0 109.931 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -74.24 -66.07 0.77 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.28 -0.888 . . . . 0.0 109.814 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -54.77 -58.75 6.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.23 -0.919 . . . . 0.0 109.997 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 28.6 mt -47.73 -49.14 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.124 -0.985 . . . . 0.0 110.062 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 13' ' ' LYS . . . -52.83 -41.6 64.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.275 -0.89 . . . . 0.0 110.2 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -61.0 -41.44 96.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.879 . . . . 0.0 110.132 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -64.06 -30.17 71.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.279 -0.888 . . . . 0.0 109.734 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.434 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 30.1 mtpt -68.99 -38.97 79.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.535 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.31 -45.19 95.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.313 -0.867 . . . . 0.0 109.341 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.85 -44.8 86.77 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.317 -0.865 . . . . 0.0 109.452 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -56.22 -42.15 76.8 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.315 -0.865 . . . . 0.0 109.633 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.4 t -59.1 -42.63 90.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.428 -0.795 . . . . 0.0 109.641 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.8 tt -59.79 -29.36 68.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.464 -0.772 . . . . 0.0 109.456 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.564 ' CD1' ' CG1' ' A' ' 35' ' ' VAL . 5.8 m-30 -88.24 -18.29 28.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.464 -0.772 . . . . 0.0 110.043 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -104.17 64.06 0.76 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.397 -0.814 . . . . 0.0 109.35 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.475 ' HE3' ' CG2' ' A' ' 34' ' ' THR . 53.0 mttm -44.73 -52.96 7.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.586 -0.696 . . . . 0.0 111.267 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.424 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 6.7 p-10 -69.7 -43.22 72.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.906 -1.121 . . . . 0.0 110.017 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.83 51.52 1.64 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 3.5 p30 -105.66 -24.53 12.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.058 -1.26 . . . . 0.0 109.878 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.46 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 111.86 30.38 3.02 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.437 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 57.8 p -153.73 158.26 40.72 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.024 -1.28 . . . . 0.0 110.53 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.0 mt -124.22 109.21 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.317 -0.864 . . . . 0.0 109.934 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 68.9 p -95.66 -164.51 1.17 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.239 -0.913 . . . . 0.0 110.301 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.8 p -85.41 -26.13 26.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.246 -0.908 . . . . 0.0 110.206 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.87 -62.8 1.24 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.24 -0.912 . . . . 0.0 110.025 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.405 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 56.9 mt-10 -57.66 -46.06 84.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.137 -0.977 . . . . 0.0 109.763 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.448 ' CD2' HD12 ' A' ' 52' ' ' ILE . 0.8 OUTLIER -60.25 -32.04 70.78 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.269 -0.894 . . . . 0.0 109.676 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.54 -50.83 63.31 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.475 ' CG2' ' HE3' ' A' ' 21' ' ' LYS . 63.5 m -70.01 -22.3 63.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.105 -1.232 . . . . 0.0 109.611 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.564 ' CG1' ' CD1' ' A' ' 19' ' ' PHE . 51.4 t -70.21 -32.2 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.472 -0.768 . . . . 0.0 109.55 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.41 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 26.2 mmt -86.97 -22.72 25.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.375 -0.828 . . . . 0.0 109.622 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.4 mmm-85 -68.16 -45.25 74.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 0.0 109.875 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.1 m -94.73 8.73 41.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.308 -0.87 . . . . 0.0 110.296 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -164.09 74.78 0.31 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.102 -0.999 . . . . 0.0 110.19 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.31 -91.49 0.14 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -161.84 -145.37 0.11 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -1.145 . . . . 0.0 110.011 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -121.4 72.06 26.81 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.007 . . . . 0.0 110.299 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -76.18 135.97 17.55 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.874 1.46 . . . . 0.0 110.179 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 72.8 p -73.4 -149.83 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.209 -0.932 . . . . 0.0 110.282 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -104.39 -42.41 5.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 109.894 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.42 -63.72 1.01 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.241 -0.912 . . . . 0.0 109.744 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 38.4 tt0 -51.61 -41.32 61.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.914 . . . . 0.0 109.689 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.44 HD22 ' CD1' ' A' ' 52' ' ' ILE . 7.9 tt -55.27 -53.13 60.02 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.809 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -51.41 -37.56 49.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.364 -0.835 . . . . 0.0 109.767 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 7.4 t0 -63.11 -40.64 98.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.334 -0.854 . . . . 0.0 109.724 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.415 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 21.8 ttp -66.67 -19.24 65.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.329 -0.857 . . . . 0.0 109.636 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.448 HD12 ' CD2' ' A' ' 32' ' ' LEU . 26.3 mt -87.77 -25.48 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.252 -0.905 . . . . 0.0 110.479 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -62.5 -38.47 90.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.05 -1.031 . . . . 0.0 110.388 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 51' ' ' MET . 14.3 pt-20 -65.5 -18.76 65.56 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.123 -0.985 . . . . 0.0 110.343 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.436 ' CG1' ' HE1' ' A' ' 71' ' ' MET . 79.6 t -95.9 -69.7 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.247 -0.908 . . . . 0.0 110.065 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -45.1 123.33 3.85 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.385 -0.822 . . . . 0.0 110.531 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.33 36.74 2.95 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.894 . . . . 0.0 110.363 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.414 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 48.6 m-20 -123.68 -52.22 1.81 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.24 -0.912 . . . . 0.0 110.371 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.31 16.17 7.88 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.45 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 24.6 p30 -93.62 -20.97 19.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.257 -1.143 . . . . 0.0 110.023 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.45 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 109.91 -44.77 1.43 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.415 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 71.0 p -98.81 164.9 12.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.095 -1.238 . . . . 0.0 110.568 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.1 mt -101.88 158.59 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.148 -0.97 . . . . 0.0 110.132 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.421 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 32.4 m-20 -113.4 -167.82 1.25 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.372 -0.83 . . . . 0.0 110.797 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.536 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 41.8 t80 -76.37 -42.97 3.33 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.422 -0.799 . . . . 0.0 111.342 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.2 Cg_endo -72.6 -25.99 16.98 Favored 'Trans proline' 0 C--O 1.208 -1.02 0 O-C-N 123.033 1.017 . . . . 0.0 110.32 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.414 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 49.5 mt-10 -78.54 -24.32 45.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.038 -1.039 . . . . 0.0 109.351 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.484 ' CZ ' ' SD ' ' A' ' 72' ' ' MET . 55.7 t80 -78.12 -51.73 9.82 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.55 -0.719 . . . . 0.0 110.466 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.405 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 3.4 tt -75.1 -20.04 59.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.243 -0.911 . . . . 0.0 110.727 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.436 ' HB ' ' O ' ' A' ' 66' ' ' PRO . 18.9 m -82.21 -50.83 8.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.079 -1.013 . . . . 0.0 110.503 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.482 ' HE2' ' CE ' ' A' ' 72' ' ' MET . 0.1 OUTLIER -69.01 -29.66 67.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.093 -1.004 . . . . 0.0 109.867 -179.671 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.484 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 52.8 mtt -86.5 -12.91 47.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.218 -0.926 . . . . 0.0 110.188 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.405 ' HB1' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.233 -0.917 . . . . 0.0 110.636 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 . . . . . 0 N--CA 1.496 1.846 0 CA-C-O 121.342 0.591 . . . . 0.0 110.301 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 32.7 mt -58.86 -33.71 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.071 -1.018 . . . . 0.0 109.711 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -54.79 -44.92 74.18 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.273 -0.892 . . . . 0.0 109.408 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -64.78 -36.32 83.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.304 -0.873 . . . . 0.0 110.072 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.511 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -60.43 -61.95 2.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.33 -0.857 . . . . 0.0 110.293 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.507 ' CE1' ' HA ' ' A' ' 138' ' ' TYR . 1.1 t80 -55.13 -28.26 51.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.452 -0.78 . . . . 0.0 110.54 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.65 -47.75 65.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.151 -0.968 . . . . 0.0 110.844 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.53 HG21 ' CD1' ' A' ' 92' ' ' PHE . 27.2 m -69.59 -24.64 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.069 -1.019 . . . . 0.0 110.477 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.53 ' CD1' HG21 ' A' ' 91' ' ' VAL . 13.4 m-85 -86.18 -16.89 36.4 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.239 -0.913 . . . . 0.0 110.239 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -109.22 97.12 6.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.274 -0.891 . . . . 0.0 110.245 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -103.41 12.43 35.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.904 . . . . 0.0 110.545 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 1.9 p30 -116.64 -41.74 3.05 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.988 -1.07 . . . . 0.0 110.501 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.468 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 111.91 36.66 1.65 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.438 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 41.0 p30 -117.11 -9.54 11.03 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.941 -1.329 . . . . 0.0 110.844 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 70.82 35.89 65.98 Favored Glycine 0 N--CA 1.498 2.822 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 28.1 m-85 -140.25 136.77 33.67 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.205 -1.174 . . . . 0.0 109.66 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.401 HG22 ' HB3' ' A' ' 92' ' ' PHE . 12.8 mt -92.11 119.59 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.938 -1.101 . . . . 0.0 109.797 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 77.6 p -109.75 151.66 26.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.166 -0.959 . . . . 0.0 110.226 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.1 -29.41 60.58 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.197 -0.939 . . . . 0.0 110.413 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.72 -52.91 61.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.204 -0.935 . . . . 0.0 110.235 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.458 ' O ' ' CG2' ' A' ' 108' ' ' VAL . 98.7 mt-10 -66.51 -55.82 13.76 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.243 -0.911 . . . . 0.0 110.28 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.2 tp -53.41 -25.35 15.41 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.109 -0.994 . . . . 0.0 110.35 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.409 ' O ' ' OG1' ' A' ' 110' ' ' THR . 47.2 ttt85 -71.45 -49.83 37.67 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.262 -0.899 . . . . 0.0 110.313 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -79.63 -9.33 59.62 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.27 -0.894 . . . . 0.0 110.792 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.458 ' CG2' ' O ' ' A' ' 104' ' ' GLU . 91.0 t -83.97 -46.37 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.059 -1.026 . . . . 0.0 110.47 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.409 ' O ' ' HB2' ' A' ' 114' ' ' GLU . 25.8 mtt -82.0 -32.81 30.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.041 -1.037 . . . . 0.0 110.585 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 55.8 m -67.23 -31.04 71.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.215 -0.928 . . . . 0.0 110.347 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -87.64 -42.13 12.9 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.177 -0.952 . . . . 0.0 110.322 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 29.7 mt -46.13 -27.15 0.9 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.273 -0.892 . . . . 0.0 110.206 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.37 37.52 0.56 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 109' ' ' MET . 45.6 mt-10 -127.91 127.75 43.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.125 -1.221 . . . . 0.0 110.225 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -83.23 92.78 7.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 110.19 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.5 mt -118.83 -176.3 3.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.217 -0.927 . . . . 0.0 110.149 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.3 t -144.52 -178.41 5.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.25 -0.906 . . . . 0.0 110.45 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -61.85 -31.1 71.33 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.342 -0.848 . . . . 0.0 110.997 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.42 ' N ' ' CD ' ' A' ' 119' ' ' GLU . 6.2 mp0 -67.11 -41.1 86.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.26 -0.9 . . . . 0.0 110.708 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.402 ' OE1' ' HA ' ' A' ' 120' ' ' GLU . 6.1 mm-40 -67.72 -56.39 9.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.208 -0.932 . . . . 0.0 110.575 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 78.0 t -52.99 -49.3 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 0.0 110.412 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -57.54 -41.14 80.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.222 -0.924 . . . . 0.0 110.57 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -65.89 -32.74 74.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.22 -0.925 . . . . 0.0 110.796 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.401 ' HE3' ' HE2' ' A' ' 109' ' ' MET . 0.9 OUTLIER -73.11 -38.59 66.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.25 -0.906 . . . . 0.0 110.573 -179.679 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.44 HD11 ' CG2' ' A' ' 136' ' ' VAL . 31.5 mm -70.11 -27.61 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.113 -0.992 . . . . 0.0 109.99 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -72.93 -45.79 56.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.396 -0.815 . . . . 0.0 110.223 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -70.54 -28.76 65.18 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.078 -1.014 . . . . 0.0 110.103 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.62 -24.95 36.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.354 -0.841 . . . . 0.0 110.402 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -86.76 77.07 9.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.051 -1.031 . . . . 0.0 110.174 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.461 HD13 ' CB ' ' A' ' 140' ' ' GLU . 5.6 mt -45.91 -60.18 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.387 -0.82 . . . . 0.0 110.482 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.9 p30 -66.24 -26.97 67.61 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.074 -1.016 . . . . 0.0 110.398 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 65.48 66.18 2.56 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 2.6 p30 -107.54 -35.39 6.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.281 -1.129 . . . . 0.0 110.674 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 167.77 -37.77 0.22 Allowed Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.021 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -140.38 166.83 23.63 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.113 -1.228 . . . . 0.0 110.265 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.44 ' CG2' HD11 ' A' ' 125' ' ' ILE . 12.1 t -88.46 146.34 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.295 -0.878 . . . . 0.0 110.044 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -109.46 169.9 8.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 109.917 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.507 ' HA ' ' CE1' ' A' ' 89' ' ' PHE . 9.0 t80 -61.66 -47.87 83.42 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.183 -0.948 . . . . 0.0 110.545 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -59.91 -41.46 91.73 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.007 -1.058 . . . . 0.0 110.152 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.461 ' CB ' HD13 ' A' ' 130' ' ' ILE . 52.2 mt-10 -69.41 -24.72 63.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.92 . . . . 0.0 110.014 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.518 ' CZ ' ' CE ' ' A' ' 145' ' ' MET . 8.0 t80 -77.51 -25.23 50.13 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.378 -0.826 . . . . 0.0 109.977 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.0 t -80.34 -23.4 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.278 -0.889 . . . . 0.0 110.04 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -89.13 -31.74 17.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -0.9 . . . . 0.0 110.296 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.438 ' CE ' ' HE3' ' A' ' 145' ' ' MET . 0.0 OUTLIER -82.65 -22.51 34.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.153 -0.967 . . . . 0.0 110.243 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.518 ' CE ' ' CZ ' ' A' ' 141' ' ' PHE . 46.0 tpp -71.54 -29.95 65.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.337 -0.852 . . . . 0.0 109.97 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.1 p . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.363 -0.835 . . . . 0.0 110.306 -179.89 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.204 0.526 . . . . 0.0 110.262 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.413 ' O ' ' HB1' ' A' ' 10' ' ' ALA . 2.5 tp10 -46.81 -48.29 20.81 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.272 -0.892 . . . . 0.0 110.145 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.402 ' HA ' ' OE1' ' A' ' 8' ' ' GLN . 15.6 mm100 -53.97 -47.23 71.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.454 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.461 ' CG2' HD12 ' A' ' 69' ' ' LEU . 44.3 mt -56.38 -33.74 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.336 -0.852 . . . . 0.0 109.468 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -62.83 -37.44 86.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.39 -0.819 . . . . 0.0 109.373 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -63.09 -51.04 68.17 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.303 -0.873 . . . . 0.0 109.421 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -60.1 -28.11 67.56 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.471 -0.768 . . . . 0.0 109.891 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 2.4 mtpm? -64.25 -52.65 57.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 109.49 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -53.12 -38.07 62.32 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.348 -0.845 . . . . 0.0 109.304 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.04 -43.63 98.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.445 -0.784 . . . . 0.0 109.693 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.435 ' CE1' HD13 ' A' ' 27' ' ' ILE . 56.4 t80 -54.29 -39.65 67.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 109.377 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.7 t -73.03 -29.99 63.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.427 -0.796 . . . . 0.0 109.505 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.433 ' CD2' ' C ' ' A' ' 18' ' ' LEU . 5.1 tt -59.43 -35.97 75.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.447 -0.783 . . . . 0.0 109.388 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.402 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 9.8 m-85 -82.19 -56.7 3.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.436 -0.79 . . . . 0.0 109.874 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.415 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 9.8 t70 -52.96 106.2 0.15 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.452 -0.78 . . . . 0.0 110.214 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 19' ' ' PHE . 33.5 mttm -110.31 41.72 1.69 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.264 -0.898 . . . . 0.0 110.983 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 5.6 p-10 -150.12 -50.77 0.14 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.037 -1.039 . . . . 0.0 110.387 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.91 57.61 0.33 Allowed Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.744 -1.217 . . . . 0.0 110.333 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.413 ' O ' HG22 ' A' ' 26' ' ' THR . 56.5 p-10 -135.75 0.62 2.71 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.135 -1.215 . . . . 0.0 110.737 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.444 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 64.09 40.27 97.96 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.444 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 81.0 p -154.83 139.52 17.05 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.232 -1.158 . . . . 0.0 109.857 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.435 HD13 ' CE1' ' A' ' 16' ' ' PHE . 86.4 mt -105.12 132.36 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.125 -0.985 . . . . 0.0 110.205 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.412 ' OG1' HG23 ' A' ' 62' ' ' THR . 10.0 m -125.21 174.79 7.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.227 -0.921 . . . . 0.0 110.563 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.5 p -64.01 -21.12 66.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.439 -0.788 . . . . 0.0 109.954 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -70.84 -69.32 0.37 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.278 -0.888 . . . . 0.0 110.071 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.415 ' OE1' ' HA ' ' A' ' 20' ' ' ASP . 21.8 mt-10 -53.02 -46.61 68.47 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.331 -0.856 . . . . 0.0 109.61 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.457 HD22 ' CD1' ' A' ' 48' ' ' LEU . 0.9 OUTLIER -60.19 -32.85 71.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.886 . . . . 0.0 109.659 179.511 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.04 -42.19 98.31 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.9 m -72.08 -24.39 61.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -1.081 . . . . 0.0 109.612 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 42.3 t -69.37 -35.87 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.405 -0.809 . . . . 0.0 109.688 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.426 ' HE2' ' CE ' ' A' ' 51' ' ' MET . 25.4 mmt -90.25 -20.46 22.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 110.368 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.6 mtt85 -89.48 -18.1 27.37 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.023 -1.048 . . . . 0.0 110.651 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 92.4 p -101.54 -16.96 16.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.02 -1.05 . . . . 0.0 110.231 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.84 55.91 1.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.202 -0.936 . . . . 0.0 110.02 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 36' ' ' MET . . . 104.92 86.23 1.91 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 9.8 tt0 -83.14 67.48 9.18 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.459 -1.024 . . . . 0.0 110.634 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.481 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.8 m120 -85.05 -58.39 0.35 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.124 -0.985 . . . . 0.0 111.157 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.481 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 44.4 Cg_endo -73.88 -169.01 0.5 Allowed 'Trans proline' 0 C--N 1.315 -1.202 0 O-C-N 123.564 1.297 . . . . 0.0 111.056 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 10.9 t -132.94 -174.21 3.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.433 -0.792 . . . . 0.0 109.892 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -66.32 -43.94 84.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.141 -0.974 . . . . 0.0 110.595 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.89 -67.45 0.44 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.174 -0.954 . . . . 0.0 110.434 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -47.39 -29.86 2.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 0.0 110.1 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.457 ' CD1' HD22 ' A' ' 32' ' ' LEU . 8.6 tt -66.7 -49.36 66.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.931 . . . . 0.0 109.343 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -49.22 -38.88 27.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 109.243 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -64.2 -42.18 96.74 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.399 -0.813 . . . . 0.0 109.411 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.431 ' HG3' ' OE2' ' A' ' 54' ' ' GLU . 2.5 ttp -65.58 -14.56 61.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.264 -0.897 . . . . 0.0 109.946 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.412 HD12 HD23 ' A' ' 32' ' ' LEU . 25.4 mm -88.47 -33.61 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.302 -0.874 . . . . 0.0 110.3 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -65.25 -33.33 75.74 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.419 -0.8 . . . . 0.0 110.697 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.431 ' OE2' ' HG3' ' A' ' 51' ' ' MET . 22.7 pt-20 -71.3 -8.29 52.7 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.058 -1.026 . . . . 0.0 110.647 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.474 HG13 ' CD1' ' A' ' 63' ' ' ILE . 79.3 t -108.51 -18.84 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.069 -1.019 . . . . 0.0 110.107 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.415 ' OD2' ' O ' ' A' ' 62' ' ' THR . 4.6 t70 -109.04 109.27 20.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 111.053 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.76 15.19 23.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 109.66 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.73 -45.19 17.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.417 -0.802 . . . . 0.0 109.985 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.0 15.87 8.87 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -105.21 -31.73 8.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.053 -1.263 . . . . 0.0 110.171 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.38 -47.43 1.02 Allowed Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.84 -1.172 . . . . 0.0 110.248 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.415 ' O ' ' OD2' ' A' ' 56' ' ' ASP . 10.1 p -96.99 166.78 11.44 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.186 -1.185 . . . . 0.0 110.81 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.474 ' CD1' HG13 ' A' ' 55' ' ' VAL . 17.2 mt -102.95 161.34 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.202 -0.936 . . . . 0.0 110.316 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -113.65 -160.91 0.74 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.336 -0.853 . . . . 0.0 110.502 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.54 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 21.9 t80 -82.09 -43.4 1.02 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.896 . . . . 0.0 111.837 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.6 Cg_endo -72.42 -24.15 19.58 Favored 'Trans proline' 0 C--N 1.321 -0.894 0 O-C-N 123.027 1.014 . . . . 0.0 110.656 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -76.83 -33.78 57.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.143 -0.973 . . . . 0.0 109.087 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.571 ' CE1' ' CE ' ' A' ' 72' ' ' MET . 77.5 t80 -72.03 -40.27 68.55 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.572 -0.705 . . . . 0.0 109.852 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.461 HD12 ' CG2' ' A' ' 9' ' ' ILE . 8.2 tp -78.71 -17.93 55.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.446 -0.784 . . . . 0.0 110.607 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 66' ' ' PRO . 51.9 m -90.63 -23.34 20.83 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.022 -1.049 . . . . 0.0 110.651 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 48.6 ttp -90.8 -36.96 13.94 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.891 -1.131 . . . . 0.0 111.073 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.571 ' CE ' ' CE1' ' A' ' 68' ' ' PHE . 56.8 mtt -89.83 -53.25 4.59 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.054 -1.029 . . . . 0.0 111.496 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.498 1.974 0 O-C-N 120.931 -1.105 . . . . 0.0 110.882 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.435 ' O ' ' CB ' ' A' ' 88' ' ' ALA . 1.0 OUTLIER . . . . . 0 N--CA 1.498 1.952 0 CA-C-O 121.123 0.487 . . . . 0.0 110.761 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 79.5 mt -66.51 -59.31 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.192 -0.942 . . . . 0.0 110.093 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -63.08 -57.18 11.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.356 -0.84 . . . . 0.0 110.337 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -51.02 -32.02 20.15 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.244 -0.91 . . . . 0.0 110.451 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 84' ' ' GLU . . . -72.98 -40.72 65.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.192 -0.942 . . . . 0.0 110.414 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -62.79 -29.51 70.76 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.968 -1.083 . . . . 0.0 110.554 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 66.6 mtt85 -80.9 -52.12 7.82 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.201 -0.937 . . . . 0.0 110.938 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.501 HG22 ' CD2' ' A' ' 92' ' ' PHE . 19.6 m -59.09 -36.22 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.211 -0.931 . . . . 0.0 111.02 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.501 ' CD2' HG22 ' A' ' 91' ' ' VAL . 16.2 m-85 -78.85 -38.8 36.98 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.033 -1.042 . . . . 0.0 110.606 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -111.55 71.3 0.74 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.275 -0.891 . . . . 0.0 110.147 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.441 ' CD ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -108.06 42.59 1.34 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.146 -0.971 . . . . 0.0 110.499 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 2.7 p30 -125.77 -26.95 3.41 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.242 -0.912 . . . . 0.0 110.605 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.4 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 108.21 31.57 3.51 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.45 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 18.6 t-20 -93.12 -44.98 8.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -1.145 . . . . 0.0 110.135 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.476 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 111.24 -14.91 28.07 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 33.8 m-85 -144.28 147.27 33.32 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.218 -1.166 . . . . 0.0 110.108 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.429 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 26.0 mt -71.1 137.5 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.245 -0.909 . . . . 0.0 109.439 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.3 m -114.21 169.64 8.88 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.194 -0.941 . . . . 0.0 110.394 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.61 -46.01 56.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.236 -0.915 . . . . 0.0 110.115 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.91 -53.94 49.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -0.918 . . . . 0.0 109.986 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -58.57 -38.66 78.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.238 -0.914 . . . . 0.0 109.783 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.405 ' O ' HD21 ' A' ' 105' ' ' LEU . 1.4 tt -57.78 -36.83 72.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.32 -0.863 . . . . 0.0 110.105 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.6 ttt-85 -70.0 -44.44 69.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.343 -0.848 . . . . 0.0 110.304 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -70.64 -11.06 60.7 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.084 -1.01 . . . . 0.0 110.497 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 85.1 t -91.8 -40.79 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.135 -0.978 . . . . 0.0 110.163 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.2 mmt -69.9 -52.77 21.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.257 -0.902 . . . . 0.0 110.558 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.8 t -56.99 -24.33 52.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.229 -0.919 . . . . 0.0 110.689 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -85.31 -33.86 22.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.022 -1.049 . . . . 0.0 110.69 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 24.4 mt -73.58 -56.53 4.9 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.131 -0.981 . . . . 0.0 110.28 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 167.58 -32.1 0.19 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.41 ' HA ' ' OE1' ' A' ' 114' ' ' GLU . 6.3 mm-40 -70.96 140.31 50.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.322 -1.105 . . . . 0.0 110.203 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 3.4 pttp -114.77 101.57 9.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.169 -0.957 . . . . 0.0 110.392 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.3 mt -112.0 168.5 9.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.125 -0.985 . . . . 0.0 110.236 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.3 m -115.58 170.32 8.52 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.223 -0.923 . . . . 0.0 110.45 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.02 -35.44 34.16 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.339 -0.851 . . . . 0.0 110.962 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -62.36 -54.78 35.39 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.059 -1.026 . . . . 0.0 110.798 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.413 ' OE1' ' HA ' ' A' ' 120' ' ' GLU . 6.2 mm-40 -61.2 -54.6 42.26 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.221 -0.924 . . . . 0.0 110.702 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 79.6 t -50.65 -41.25 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.115 -0.991 . . . . 0.0 110.566 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.96 -40.62 91.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.118 -0.989 . . . . 0.0 110.214 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.443 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 12.4 mt-10 -71.1 -18.41 62.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.236 -0.915 . . . . 0.0 109.972 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.1 mmm -78.79 -48.67 14.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 110.155 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 30.4 mm -70.44 -36.4 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.312 -0.868 . . . . 0.0 110.334 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -72.11 -47.36 51.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.362 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.443 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 5.7 mm-40 -70.15 -23.85 63.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.207 -0.933 . . . . 0.0 110.186 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.79 -14.65 27.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.171 -0.956 . . . . 0.0 110.011 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 3.8 m-20 -79.92 88.33 5.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.098 -1.001 . . . . 0.0 110.922 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.449 ' N ' ' OE2' ' A' ' 140' ' ' GLU . 11.5 mm -67.24 -4.08 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.523 -0.736 . . . . 0.0 111.11 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 54.0 p30 -176.57 -19.71 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 O-C-N 120.709 -1.245 . . . . 0.0 112.223 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . -71.8 -52.06 13.27 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.566 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 1.2 m-20 56.48 96.32 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.468 -1.019 . . . . 0.0 108.418 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 105.28 -20.49 37.58 Favored Glycine 0 C--N 1.295 -1.748 0 N-CA-C 107.564 -2.214 . . . . 0.0 107.564 -177.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.458 ' HB2' ' CB ' ' A' ' 99' ' ' TYR . 2.5 pt20 -153.4 152.32 30.92 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.621 -0.929 . . . . 0.0 109.729 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.431 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 99.5 t -118.48 147.12 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.208 -0.933 . . . . 0.0 110.346 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.4 ' OD1' ' CD1' ' A' ' 99' ' ' TYR . 2.9 m120 -105.91 179.46 4.26 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.435 -0.791 . . . . 0.0 110.585 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -73.73 -49.54 25.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.312 -0.868 . . . . 0.0 108.884 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -59.29 -41.75 89.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.346 -0.846 . . . . 0.0 109.046 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.449 ' OE2' ' N ' ' A' ' 130' ' ' ILE . 36.1 tt0 -64.98 -33.27 75.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.484 -0.76 . . . . 0.0 109.968 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.406 ' O ' ' HG2' ' A' ' 144' ' ' MET . 13.4 t80 -68.91 -25.62 64.68 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.315 -0.866 . . . . 0.0 110.31 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.8 t -81.44 -36.28 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.122 -0.986 . . . . 0.0 109.726 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.49 -29.95 64.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 110.8 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.431 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 3.4 ptt? -74.59 -25.55 59.33 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.006 -1.059 . . . . 0.0 110.623 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.431 ' CE ' ' HE2' ' A' ' 144' ' ' MET . 20.5 mmt -87.11 -67.69 0.8 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.117 -0.989 . . . . 0.0 110.504 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 65.6 p . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.071 -1.018 . . . . 0.0 110.411 -179.72 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.105 0.479 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.86 -55.94 28.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.274 -0.891 . . . . 0.0 110.252 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -56.65 -33.28 66.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.301 -0.874 . . . . 0.0 109.75 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.0 mm -65.71 -35.95 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.509 -0.745 . . . . 0.0 109.807 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.15 -33.52 73.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.882 . . . . 0.0 109.587 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.8 -51.08 68.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.393 -0.817 . . . . 0.0 109.575 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -58.83 -38.67 79.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.378 -0.826 . . . . 0.0 109.835 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -63.85 -31.11 72.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.354 -0.841 . . . . 0.0 109.911 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -68.47 -45.63 71.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -0.862 . . . . 0.0 110.292 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.44 -44.66 93.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.309 -0.869 . . . . 0.0 110.355 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -58.79 -43.68 90.55 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.21 -0.931 . . . . 0.0 110.298 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.4 m -66.48 -33.95 76.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 110.077 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.429 ' CD2' ' C ' ' A' ' 18' ' ' LEU . 2.8 tt -62.46 -37.47 86.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 109.788 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.523 ' CD1' HG12 ' A' ' 35' ' ' VAL . 9.3 m-30 -72.51 -64.33 0.97 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.331 -0.856 . . . . 0.0 109.893 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -51.0 120.15 4.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.412 -0.805 . . . . 0.0 109.862 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -104.85 -8.73 18.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.907 -1.121 . . . . 0.0 110.885 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.415 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 6.9 p-10 -101.55 -42.29 6.29 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.9 -1.125 . . . . 0.0 110.238 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.12 55.4 0.92 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 58.5 p30 -123.5 -11.47 7.84 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.166 -1.197 . . . . 0.0 110.503 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.464 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 89.12 36.89 7.41 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.464 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 14.6 p -158.5 129.55 6.34 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.339 -1.095 . . . . 0.0 110.256 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 62' ' ' THR . 62.0 mt -93.19 118.32 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.315 -0.866 . . . . 0.0 109.993 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.416 HG23 ' OE2' ' A' ' 31' ' ' GLU . 8.9 t -104.24 -176.28 3.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.232 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.412 ' HA ' HD22 ' A' ' 48' ' ' LEU . 31.4 p -75.09 -35.08 61.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 110.475 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -62.37 -60.28 3.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.267 -0.896 . . . . 0.0 109.972 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.416 ' OE2' HG23 ' A' ' 28' ' ' THR . 46.2 mt-10 -58.83 -53.11 62.12 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.212 -0.93 . . . . 0.0 109.623 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.409 HD23 HG12 ' A' ' 52' ' ' ILE . 0.5 OUTLIER -58.88 -19.45 42.17 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.235 -0.916 . . . . 0.0 109.572 179.535 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.481 ' HA2' ' CD1' ' A' ' 48' ' ' LEU . . . -67.35 -49.53 51.2 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.0 m -70.84 -19.12 62.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.298 -1.119 . . . . 0.0 109.862 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.523 HG12 ' CD1' ' A' ' 19' ' ' PHE . 24.4 t -76.58 -38.45 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.394 -0.816 . . . . 0.0 110.334 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.479 ' HA ' ' CD2' ' A' ' 39' ' ' LEU . 26.5 mmt -84.48 -22.96 30.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.121 -0.987 . . . . 0.0 110.163 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 3.7 tpp180 -90.68 -16.9 27.72 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.329 -0.857 . . . . 0.0 110.417 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.9 t -92.0 10.11 30.38 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.995 -1.065 . . . . 0.0 110.982 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.479 ' CD2' ' HA ' ' A' ' 36' ' ' MET . 3.8 pp -107.27 -26.7 10.92 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.015 -1.053 . . . . 0.0 110.65 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.418 ' N ' HD13 ' A' ' 39' ' ' LEU . . . 150.55 -31.13 1.03 Allowed Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.065 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.412 ' HG3' HD12 ' A' ' 39' ' ' LEU . 67.3 mt-30 -81.01 158.75 25.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.101 -1.235 . . . . 0.0 110.323 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -130.43 61.09 56.91 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.25 -0.906 . . . . 0.0 110.131 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.05 -163.15 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.771 1.406 . . . . 0.0 110.234 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.411 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 58.4 m -135.55 171.98 13.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.253 -0.904 . . . . 0.0 110.119 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -59.56 -28.94 67.56 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.2 -0.937 . . . . 0.0 110.478 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.92 -67.48 0.49 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.153 -0.967 . . . . 0.0 110.064 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -53.42 -23.09 8.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -0.914 . . . . 0.0 109.512 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.481 ' CD1' ' HA2' ' A' ' 33' ' ' GLY . 0.7 OUTLIER -67.85 -58.0 5.32 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.564 -0.71 . . . . 0.0 110.011 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -51.22 -38.09 50.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.322 -0.861 . . . . 0.0 109.527 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -65.17 -38.99 92.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.367 -0.833 . . . . 0.0 109.508 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.421 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 1.6 ttp -66.98 -26.26 66.72 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.426 -0.796 . . . . 0.0 109.784 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.409 HG12 HD23 ' A' ' 32' ' ' LEU . 56.9 mt -83.17 -27.33 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.319 -0.863 . . . . 0.0 109.818 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -58.58 -46.84 86.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.384 -0.823 . . . . 0.0 110.401 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 51' ' ' MET . 13.2 pt-20 -64.39 -27.2 68.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -0.918 . . . . 0.0 110.071 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.415 ' N ' ' HG3' ' A' ' 54' ' ' GLU . 85.8 t -96.1 -3.97 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.344 -0.848 . . . . 0.0 110.338 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -126.11 105.86 9.17 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.028 -1.045 . . . . 0.0 110.159 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.24 33.66 4.34 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.111 -0.993 . . . . 0.0 110.465 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -104.82 -49.11 3.58 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.186 -0.946 . . . . 0.0 110.236 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 119.53 51.69 0.28 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.457 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 16.1 p-10 -148.02 -43.69 0.16 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -1.129 . . . . 0.0 110.15 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 116.76 -4.12 19.26 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.579 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 45.1 p -123.76 164.05 19.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.906 -1.349 . . . . 0.0 110.469 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 52.1 mt -114.05 130.82 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.257 -0.902 . . . . 0.0 110.165 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -83.3 -173.68 4.85 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 110.112 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.535 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 66.4 t80 -80.73 -42.63 1.25 Allowed Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.324 -0.86 . . . . 0.0 111.35 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 46.5 Cg_endo -74.66 -26.81 11.27 Favored 'Trans proline' 0 N--CA 1.48 0.72 0 O-C-N 123.082 1.043 . . . . 0.0 110.092 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 71' ' ' MET . 78.7 tt0 -78.09 -25.31 47.5 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.358 -0.839 . . . . 0.0 109.002 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 8.0 t80 -79.21 -54.34 6.07 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.607 -0.683 . . . . 0.0 110.025 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.469 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 0.6 OUTLIER -60.0 -34.78 73.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.329 -0.857 . . . . 0.0 110.427 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.407 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 86.4 m -77.02 -32.37 57.01 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.195 -0.941 . . . . 0.0 110.236 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 18.2 tmm? -61.9 -52.65 63.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.268 -0.895 . . . . 0.0 110.278 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.417 ' HG3' ' HE2' ' A' ' 71' ' ' MET . 47.5 mtt -81.55 -10.4 59.46 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.165 -0.96 . . . . 0.0 110.293 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.163 -0.961 . . . . 0.0 110.127 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.215 0.531 . . . . 0.0 109.953 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.4 mt -52.07 -45.45 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.213 -0.929 . . . . 0.0 109.527 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -55.07 -44.41 74.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 110.179 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -57.41 -51.68 68.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.932 . . . . 0.0 110.245 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 92' ' ' PHE . . . -54.96 -29.58 57.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.131 -0.981 . . . . 0.0 110.557 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.416 ' O ' ' HB3' ' A' ' 93' ' ' ASP . 3.2 t80 -72.6 -35.98 68.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.003 -1.06 . . . . 0.0 110.838 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -76.32 -42.85 43.74 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.08 -1.013 . . . . 0.0 111.256 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.512 HG22 ' CD1' ' A' ' 92' ' ' PHE . 19.7 m -70.64 -41.23 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.047 -1.033 . . . . 0.0 110.859 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.512 ' CD1' HG22 ' A' ' 91' ' ' VAL . 25.9 m-85 -75.46 -25.07 57.12 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.877 -1.139 . . . . 0.0 110.028 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.447 ' OD2' ' N ' ' A' ' 99' ' ' TYR . 11.5 t70 -125.33 70.29 1.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.937 . . . . 0.0 110.09 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.11 65.98 0.62 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.429 -0.794 . . . . 0.0 110.284 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.434 ' OD2' ' HB2' ' A' ' 97' ' ' ASN . 21.6 p-10 -150.62 26.49 0.75 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.23 -0.919 . . . . 0.0 110.051 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.04 24.58 60.87 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.434 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 11.1 t-20 -95.49 -70.65 0.7 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.249 -1.147 . . . . 0.0 110.193 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.31 -9.98 10.05 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.456 ' CD1' ' NE2' ' A' ' 135' ' ' GLN . 55.0 m-85 -133.08 153.07 51.85 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.196 -1.179 . . . . 0.0 110.342 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.414 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 13.3 mt -91.84 116.26 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.336 -0.853 . . . . 0.0 109.499 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.0 t -95.06 176.04 6.39 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.318 -0.864 . . . . 0.0 110.115 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.84 -41.81 67.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 110.16 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.88 -50.45 62.44 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.181 -0.949 . . . . 0.0 110.27 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -59.52 -40.9 88.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.187 -0.945 . . . . 0.0 109.87 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 30.6 tp -62.55 -33.83 75.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.381 -0.824 . . . . 0.0 110.046 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.461 ' NH2' ' OD2' ' A' ' 118' ' ' ASP . 6.7 ttp180 -69.16 -34.07 74.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.246 -0.909 . . . . 0.0 109.905 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 41.6 t60 -74.64 -24.18 58.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 110.276 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.486 HG13 ' CE2' ' A' ' 92' ' ' PHE . 21.8 t -77.04 -39.92 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.258 -0.902 . . . . 0.0 110.187 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.6 mmt -61.84 -36.67 81.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.882 . . . . 0.0 110.136 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.2 p -53.23 -43.48 67.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.155 -0.965 . . . . 0.0 109.71 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -60.14 -47.56 85.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.827 . . . . 0.0 110.219 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.5 mt -55.72 -36.3 67.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 110.124 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.07 41.88 2.74 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -119.87 133.59 55.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -1.168 . . . . 0.0 110.101 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.0 tttp -84.54 107.46 16.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.321 -0.862 . . . . 0.0 110.015 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.1 mt -126.29 164.21 21.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -0.869 . . . . 0.0 110.232 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 51.7 m -107.13 162.7 13.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 110.204 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.461 ' OD2' ' NH2' ' A' ' 106' ' ' ARG . 2.4 m-20 -58.2 -40.66 82.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 110.205 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -58.78 -35.55 72.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.312 -0.868 . . . . 0.0 110.526 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.02 -49.84 64.02 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.226 -0.921 . . . . 0.0 110.795 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.41 ' O ' ' HB2' ' A' ' 124' ' ' MET . 59.3 t -59.36 -53.31 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.225 -0.922 . . . . 0.0 110.174 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -53.61 -42.56 67.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.189 -0.944 . . . . 0.0 110.004 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 27.1 tt0 -63.03 -33.2 74.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.346 -0.846 . . . . 0.0 110.054 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.41 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 5.5 mmm -65.19 -53.29 47.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.179 -0.951 . . . . 0.0 109.989 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 34.8 mm -54.94 -32.21 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.255 -0.903 . . . . 0.0 110.089 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 -70.65 -42.73 70.42 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.298 -0.876 . . . . 0.0 110.136 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 49.9 mt-10 -65.82 -23.95 66.8 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.292 -0.88 . . . . 0.0 110.219 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.63 -22.48 19.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.322 -0.862 . . . . 0.0 110.066 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -72.67 90.43 1.38 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 110.228 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 59.0 mt -89.34 -25.61 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.14 -0.975 . . . . 0.0 110.304 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 41.7 p30 -87.4 -16.44 34.92 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.244 -0.91 . . . . 0.0 110.496 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.455 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 75.1 70.35 1.27 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -130.62 -33.9 1.59 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.21 -1.171 . . . . 0.0 110.427 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 111.61 18.43 7.99 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.456 ' NE2' ' CD1' ' A' ' 99' ' ' TYR . 4.0 pt20 -160.56 147.4 15.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.371 -1.076 . . . . 0.0 109.949 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.414 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 60.7 t -91.09 132.18 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 110.377 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -106.39 171.4 7.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 109.82 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -53.83 -38.34 64.53 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.174 -0.954 . . . . 0.0 110.351 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -68.03 -62.88 1.2 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.185 -0.947 . . . . 0.0 110.647 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -46.83 -33.72 4.72 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.283 -0.886 . . . . 0.0 110.899 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.412 ' CD1' ' C ' ' A' ' 141' ' ' PHE . 12.8 t80 -70.23 -40.94 74.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 111.133 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.418 ' O ' ' CG2' ' A' ' 146' ' ' THR . 99.2 t -77.48 -20.9 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.052 -1.03 . . . . 0.0 110.766 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -85.12 -28.11 25.79 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.257 -0.902 . . . . 0.0 110.959 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.442 ' HE2' ' HG3' ' A' ' 145' ' ' MET . 0.2 OUTLIER -83.05 -20.13 35.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.058 -1.026 . . . . 0.0 110.316 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.442 ' HG3' ' HE2' ' A' ' 144' ' ' MET . 26.0 mtt -90.24 -59.12 2.27 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.303 -0.873 . . . . 0.0 110.256 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.418 ' CG2' ' O ' ' A' ' 142' ' ' VAL . 13.7 t . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 110.004 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.039 0.447 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -64.54 -57.09 10.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.238 -0.914 . . . . 0.0 110.495 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.408 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 1.9 mp0 -47.16 -51.66 17.65 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.3 -0.875 . . . . 0.0 110.371 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 92.6 mt -57.41 -49.23 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.101 -0.999 . . . . 0.0 110.032 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.38 -26.08 39.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.398 -0.814 . . . . 0.0 109.804 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 16.0 tt0 -72.72 -57.82 3.81 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.366 -0.834 . . . . 0.0 109.636 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.416 ' O ' ' HB2' ' A' ' 16' ' ' PHE . 71.9 m-85 -56.4 -23.34 37.46 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.263 -0.898 . . . . 0.0 109.79 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.3 mttp -76.06 -40.35 53.43 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.283 -0.885 . . . . 0.0 110.033 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -62.66 -52.83 61.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 109.902 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.503 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.96 -47.19 85.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 109.998 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.511 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 14.3 t80 -47.76 -48.99 29.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.199 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.2 t -58.84 -42.76 90.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.904 . . . . 0.0 109.886 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.437 ' CD2' ' C ' ' A' ' 18' ' ' LEU . 3.6 tt -49.52 -44.41 46.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.287 -0.883 . . . . 0.0 110.171 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.503 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 37.3 m-85 -75.67 -30.28 59.35 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.175 -0.953 . . . . 0.0 110.401 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -80.35 107.52 13.21 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.108 -0.995 . . . . 0.0 110.43 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.401 ' HE3' ' CG2' ' A' ' 34' ' ' THR . 24.9 mttm -105.93 -35.36 7.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.0 110.436 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -74.07 -21.27 59.99 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.128 -0.982 . . . . 0.0 110.11 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.87 100.23 0.04 OUTLIER Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 35.1 p-10 -168.63 -26.21 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.354 -1.086 . . . . 0.0 111.41 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.414 ' O ' HG21 ' A' ' 26' ' ' THR . . . 111.09 27.56 4.2 Favored Glycine 0 N--CA 1.492 2.367 0 O-C-N 120.671 -1.268 . . . . 0.0 109.996 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.414 HG21 ' O ' ' A' ' 25' ' ' GLY . 72.2 p -153.36 170.21 21.22 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.052 -1.264 . . . . 0.0 110.337 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.419 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 12.2 mt -129.47 115.32 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.405 -0.81 . . . . 0.0 109.947 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.6 m -102.33 174.67 5.81 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.195 -0.941 . . . . 0.0 110.191 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.42 ' HA ' HD23 ' A' ' 48' ' ' LEU . 22.8 p -72.21 -21.41 61.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.146 -0.971 . . . . 0.0 110.059 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -70.73 -57.64 4.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.253 -0.905 . . . . 0.0 109.82 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -60.25 -57.62 12.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 0.0 109.71 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.409 HD23 HD12 ' A' ' 52' ' ' ILE . 2.0 tp -51.84 -35.43 44.57 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.279 -0.888 . . . . 0.0 109.584 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.26 -47.11 76.74 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.401 ' CG2' ' HE3' ' A' ' 21' ' ' LYS . 62.5 m -63.3 -31.21 72.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -1.139 . . . . 0.0 109.973 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.426 ' CG2' ' HA ' ' A' ' 19' ' ' PHE . 54.6 t -67.38 -31.48 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.195 -0.941 . . . . 0.0 109.833 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.4 mmt -90.55 -14.2 33.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.287 -0.883 . . . . 0.0 110.427 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.5 ttp180 -88.77 -31.5 18.36 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.153 -0.967 . . . . 0.0 110.435 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 88.7 p -91.44 -24.32 19.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.267 -0.896 . . . . 0.0 110.188 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.62 -67.31 0.86 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.247 -0.908 . . . . 0.0 109.932 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -129.32 89.33 0.31 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -59.68 116.5 4.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -1.119 . . . . 0.0 110.485 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.52 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 5.4 m-80 -172.1 -61.03 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.301 -0.874 . . . . 0.0 110.477 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.52 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 47.7 Cg_endo -74.82 144.35 30.84 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.595 1.313 . . . . 0.0 110.105 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.451 ' O ' ' CB ' ' A' ' 48' ' ' LEU . 7.2 t -107.34 -141.37 0.38 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.106 -0.996 . . . . 0.0 109.897 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.427 ' N ' ' CG2' ' A' ' 44' ' ' THR . 44.4 mt-10 -88.23 -30.78 19.44 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.901 -1.124 . . . . 0.0 110.088 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.21 -64.75 0.91 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 109.702 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 55.4 mt-10 -52.31 -48.56 65.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.181 -0.949 . . . . 0.0 109.333 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.451 ' CB ' ' O ' ' A' ' 44' ' ' THR . 7.5 tt -52.1 -40.84 61.85 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.354 -0.841 . . . . 0.0 109.154 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.4 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 62.8 tp60 -53.91 -44.63 70.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.508 -0.745 . . . . 0.0 109.578 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -57.91 -44.67 86.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.254 -0.904 . . . . 0.0 109.482 179.381 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.41 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 70.1 mtp -59.69 -26.61 65.72 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.319 -0.863 . . . . 0.0 109.842 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.409 HD12 HD23 ' A' ' 32' ' ' LEU . 29.9 mm -77.13 -29.53 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.898 . . . . 0.0 110.157 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -68.31 -43.26 78.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.336 -0.853 . . . . 0.0 110.454 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 51' ' ' MET . 22.7 pt-20 -68.0 -24.97 65.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.3 -0.875 . . . . 0.0 110.565 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.456 HG13 ' CD1' ' A' ' 63' ' ' ILE . 75.9 t -89.33 -21.73 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.178 -0.951 . . . . 0.0 110.113 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -101.49 107.79 19.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.362 -0.836 . . . . 0.0 110.359 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -95.69 17.32 15.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.07 -1.019 . . . . 0.0 110.149 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.408 ' HB2' ' OD1' ' A' ' 60' ' ' ASN . 34.2 m-20 -107.4 -52.24 2.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.354 -0.842 . . . . 0.0 110.046 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.53 19.95 5.6 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.408 ' OD1' ' HB2' ' A' ' 58' ' ' ASP . 22.0 m120 -88.24 -9.23 53.62 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.239 -1.154 . . . . 0.0 110.44 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.25 -38.62 3.15 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.5 p -110.22 160.64 16.33 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.109 -1.23 . . . . 0.0 110.772 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.456 ' CD1' HG13 ' A' ' 55' ' ' VAL . 49.8 mt -95.8 158.32 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.56 -0.713 . . . . 0.0 109.968 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.403 ' N ' HG21 ' A' ' 63' ' ' ILE . 1.1 m-20 -113.87 -170.67 1.75 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.279 -0.888 . . . . 0.0 110.411 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.536 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.8 t80 -77.23 -46.12 2.69 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.842 . . . . 0.0 111.124 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.1 Cg_endo -73.49 -16.15 24.45 Favored 'Trans proline' 0 C--N 1.318 -1.04 0 O-C-N 123.306 1.161 . . . . 0.0 110.403 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -84.46 -34.5 23.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -0.943 . . . . 0.0 109.043 178.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.488 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 5.5 t80 -70.04 -40.27 75.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.606 -0.684 . . . . 0.0 109.532 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.467 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 18.6 tp -76.61 -38.79 54.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.467 -0.771 . . . . 0.0 110.56 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.8 m -71.17 -22.05 62.09 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.163 -0.961 . . . . 0.0 110.656 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.419 ' CE ' ' HE1' ' A' ' 72' ' ' MET . 62.4 ttp -82.3 -51.01 8.31 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.065 -1.022 . . . . 0.0 110.095 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.468 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 57.1 mtt -79.05 -9.69 59.62 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.405 -0.809 . . . . 0.0 110.674 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.495 1.811 0 O-C-N 121.103 -0.998 . . . . 0.0 110.31 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.43 0.633 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.409 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 97.8 mt -52.87 -33.32 18.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.305 -0.872 . . . . 0.0 109.802 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.401 ' HD3' ' OE2' ' A' ' 87' ' ' GLU . 2.2 ttt180 -64.34 -46.81 81.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 109.353 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.401 ' OE2' ' HD3' ' A' ' 86' ' ' ARG . 4.7 mp0 -57.75 -29.09 64.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.35 -0.844 . . . . 0.0 109.66 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.508 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -65.92 -62.89 1.25 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.365 -0.834 . . . . 0.0 110.148 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.433 ' CE1' ' HA ' ' A' ' 138' ' ' TYR . 1.9 t80 -50.01 -29.35 8.47 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.357 -0.839 . . . . 0.0 110.416 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -68.44 -55.15 12.84 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.136 -0.977 . . . . 0.0 110.714 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 88' ' ' ALA . 29.7 m -63.72 -20.66 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.132 -0.98 . . . . 0.0 110.344 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.508 ' CD2' ' O ' ' A' ' 88' ' ' ALA . 24.6 m-85 -92.52 -14.06 28.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 0.0 110.34 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -123.93 66.25 1.04 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.234 -0.916 . . . . 0.0 109.714 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -95.61 61.97 2.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.863 . . . . 0.0 110.552 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.8 p30 -164.34 -35.84 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.117 -0.989 . . . . 0.0 110.717 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.454 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 110.04 38.88 1.62 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.445 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 3.8 t-20 -92.81 -57.97 2.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.389 -1.066 . . . . 0.0 110.184 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.425 ' C ' ' CD1' ' A' ' 99' ' ' TYR . . . 121.59 -22.31 7.81 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 27.4 m-85 -131.72 158.69 40.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.152 -1.205 . . . . 0.0 110.306 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.568 ' CD1' ' CD1' ' A' ' 141' ' ' PHE . 70.9 mt -93.89 135.49 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.331 -0.856 . . . . 0.0 110.587 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.5 t -117.47 176.0 5.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.498 -0.751 . . . . 0.0 109.837 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.63 -37.59 76.86 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.204 -0.935 . . . . 0.0 110.515 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.33 -59.03 6.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.19 -0.944 . . . . 0.0 110.258 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -52.54 -48.51 66.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.266 -0.896 . . . . 0.0 110.086 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.437 HD22 ' CG1' ' A' ' 121' ' ' VAL . 14.7 tp -54.38 -34.63 61.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -0.89 . . . . 0.0 110.356 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.9 ttt-85 -69.79 -33.29 72.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.08 -1.013 . . . . 0.0 110.367 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 53.2 m170 -68.04 -38.53 82.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.27 -0.894 . . . . 0.0 110.49 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.402 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 97.0 t -73.91 -49.59 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.165 -0.96 . . . . 0.0 110.558 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 105' ' ' LEU . 22.9 mmt -51.68 -62.69 1.47 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.221 -0.925 . . . . 0.0 110.886 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.6 p -44.96 -27.8 0.59 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.34 -0.85 . . . . 0.0 111.018 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 4.5 m120 -81.3 -39.7 24.8 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.007 -1.058 . . . . 0.0 110.68 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.5 mt -72.41 -15.54 61.84 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.29 -0.881 . . . . 0.0 110.383 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.48 53.12 1.08 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.431 ' HB3' ' CD1' ' A' ' 116' ' ' LEU . 13.5 mm-40 -128.49 100.44 5.77 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.341 -1.094 . . . . 0.0 110.098 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -87.88 106.8 18.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 110.213 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.431 ' CD1' ' HB3' ' A' ' 114' ' ' GLU . 4.3 mp -129.99 -178.37 4.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 0.0 109.998 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.8 m -102.77 155.94 17.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.135 -0.978 . . . . 0.0 110.224 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.408 ' O ' ' OD2' ' A' ' 122' ' ' ASP . 45.5 m-20 -49.16 -43.06 41.54 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.227 -0.921 . . . . 0.0 110.191 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -60.98 -42.59 98.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.187 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -52.37 -59.51 4.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.294 -0.879 . . . . 0.0 110.245 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.437 ' CG1' HD22 ' A' ' 105' ' ' LEU . 42.1 t -53.29 -45.51 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.099 -1.001 . . . . 0.0 110.051 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.408 ' OD2' ' O ' ' A' ' 118' ' ' ASP . 60.3 m-20 -52.49 -37.34 57.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.966 . . . . 0.0 109.77 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -70.67 -33.67 71.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.354 -0.842 . . . . 0.0 110.002 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 5.9 mmm -61.91 -55.35 30.48 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.279 -0.888 . . . . 0.0 110.066 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 22.8 mm -58.47 -38.86 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.272 -0.892 . . . . 0.0 110.1 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -71.24 -22.43 61.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.255 -0.903 . . . . 0.0 110.158 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.4 ' O ' ' OE1' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -76.28 -42.16 46.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 109.88 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.42 -33.68 71.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.025 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -59.58 97.64 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.147 -0.97 . . . . 0.0 109.895 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.8 mt -73.16 -44.12 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.396 -0.815 . . . . 0.0 111.421 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.5 p30 -85.62 -31.2 22.72 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.072 -1.018 . . . . 0.0 110.938 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 97.97 54.05 1.23 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -95.16 14.92 20.5 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.237 -1.155 . . . . 0.0 110.216 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 64.74 21.9 67.69 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.496 ' OE1' ' CD2' ' A' ' 99' ' ' TYR . 1.1 pp0? -170.1 140.87 2.03 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.588 -0.948 . . . . 0.0 109.719 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.4 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 70.8 t -86.11 149.39 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.154 -0.967 . . . . 0.0 110.307 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.462 ' OD1' ' CE2' ' A' ' 99' ' ' TYR . 48.3 t30 -125.83 169.32 12.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.158 -0.964 . . . . 0.0 110.272 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.461 ' C ' ' CD1' ' A' ' 138' ' ' TYR . 8.1 t80 -58.26 -51.01 71.57 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.401 -0.812 . . . . 0.0 110.671 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -54.99 -54.74 39.12 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.158 -0.964 . . . . 0.0 110.354 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.45 ' O ' ' CG ' ' A' ' 144' ' ' MET . 46.5 mt-10 -61.29 -20.71 63.2 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.155 -0.965 . . . . 0.0 109.932 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.568 ' CD1' ' CD1' ' A' ' 100' ' ' ILE . 13.4 t80 -75.71 -28.74 58.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.351 -0.843 . . . . 0.0 110.53 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.9 t -87.46 -23.44 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.214 -0.928 . . . . 0.0 110.998 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -101.78 -9.61 20.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.074 -1.016 . . . . 0.0 110.951 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.45 ' CG ' ' O ' ' A' ' 140' ' ' GLU . 0.1 OUTLIER -89.09 -28.31 20.18 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.022 -1.049 . . . . 0.0 110.132 179.706 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.405 ' HE2' ' HE1' ' A' ' 144' ' ' MET . 32.4 ttm -89.73 -43.11 10.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 110.284 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.202 -0.936 . . . . 0.0 109.997 179.875 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.458 0.647 . . . . 0.0 109.661 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -55.9 -28.47 56.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.242 -0.911 . . . . 0.0 109.541 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -66.97 -41.99 85.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.424 -0.798 . . . . 0.0 109.606 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.3 mt -60.79 -45.14 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.413 -0.804 . . . . 0.0 109.832 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.9 -42.67 98.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.82 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -55.25 -45.17 76.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.313 -0.867 . . . . 0.0 109.773 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.512 ' CE2' ' HB3' ' A' ' 73' ' ' ALA . 12.6 m-85 -56.97 -51.76 67.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 0.0 109.81 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -51.54 -34.77 38.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.0 110.261 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -66.54 -41.77 88.18 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.134 -0.979 . . . . 0.0 110.02 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.478 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . . . -63.87 -47.02 82.35 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.216 -0.928 . . . . 0.0 110.146 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -62.53 -33.08 74.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -0.903 . . . . 0.0 109.814 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.1 m -71.09 -32.64 69.31 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.277 -0.889 . . . . 0.0 109.468 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.443 ' CD1' ' O ' ' A' ' 18' ' ' LEU . 3.4 tm? -78.22 -23.74 47.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.482 -0.761 . . . . 0.0 109.878 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.478 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 15.7 m-30 -83.25 -67.03 0.82 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.351 -0.843 . . . . 0.0 109.786 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.409 ' OD2' ' HA2' ' A' ' 23' ' ' GLY . 46.1 t0 -48.43 111.75 0.5 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.248 -0.907 . . . . 0.0 109.832 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -78.53 -58.41 3.27 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.209 -0.932 . . . . 0.0 110.824 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.424 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 8.6 p-10 -69.34 -41.75 76.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.147 -0.971 . . . . 0.0 109.978 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.409 ' HA2' ' OD2' ' A' ' 20' ' ' ASP . . . 98.69 46.18 2.16 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 2.6 p30 -95.07 -24.87 16.69 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.054 -1.263 . . . . 0.0 110.051 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.434 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 109.83 32.5 2.86 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.422 HG21 ' O ' ' A' ' 25' ' ' GLY . 69.5 p -153.98 150.51 28.36 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.165 -1.197 . . . . 0.0 110.242 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 95.2 mt -117.67 107.96 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.27 -0.894 . . . . 0.0 110.131 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.421 ' CG2' HG22 ' A' ' 62' ' ' THR . 73.1 p -101.0 -174.31 2.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.834 . . . . 0.0 110.097 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.5 p -74.87 -24.84 58.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 110.06 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -71.75 -62.46 1.41 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.09 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -56.88 -49.27 76.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.091 -1.006 . . . . 0.0 109.709 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.433 ' CD2' HD13 ' A' ' 52' ' ' ILE . 1.9 tp -60.36 -31.46 70.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.274 -0.891 . . . . 0.0 109.529 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.51 -43.12 96.17 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.404 ' O ' ' HB2' ' A' ' 38' ' ' SER . 30.7 m -73.74 -24.95 59.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.396 -1.061 . . . . 0.0 109.891 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.5 t -70.64 -33.65 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.356 -0.84 . . . . 0.0 110.253 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.2 mmt -89.24 -23.93 22.22 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.356 -0.84 . . . . 0.0 110.382 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.418 ' NH1' ' HG2' ' A' ' 37' ' ' ARG . 11.3 tpt180 -90.62 -11.24 40.5 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.226 -0.921 . . . . 0.0 110.738 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 34' ' ' THR . 23.8 t -67.8 -68.92 0.35 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.106 -0.996 . . . . 0.0 110.414 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.42 68.39 1.37 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.301 -0.874 . . . . 0.0 110.179 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -158.89 -109.99 0.27 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -112.46 -164.54 0.92 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.319 -1.106 . . . . 0.0 110.05 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -124.82 64.53 42.58 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 110.453 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 152.49 51.71 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.862 1.454 . . . . 0.0 110.368 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.448 ' O ' ' CB ' ' A' ' 48' ' ' LEU . 35.6 m -100.73 173.47 6.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.183 -0.948 . . . . 0.0 109.826 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -66.78 -22.73 66.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.143 -0.973 . . . . 0.0 110.353 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.15 -70.96 0.41 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.124 -0.985 . . . . 0.0 109.991 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -52.56 -30.54 31.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.287 -0.883 . . . . 0.0 109.251 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.448 ' CB ' ' O ' ' A' ' 44' ' ' THR . 5.5 tt -66.56 -46.52 75.78 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.462 -0.774 . . . . 0.0 109.361 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.401 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 2.0 tt0 -50.62 -39.25 49.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.293 -0.879 . . . . 0.0 108.812 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.98 -45.7 93.74 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.211 178.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.414 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 0.4 OUTLIER -57.24 -24.37 54.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.404 178.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.433 HD13 ' CD2' ' A' ' 32' ' ' LEU . 46.9 mm -83.3 -31.26 8.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.456 -0.778 . . . . 0.0 109.913 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -76.38 -24.3 54.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.284 -0.885 . . . . 0.0 110.243 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.467 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 24.0 pt-20 -84.72 -36.23 21.97 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.193 -0.942 . . . . 0.0 110.377 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.467 ' N ' ' HG3' ' A' ' 54' ' ' GLU . 71.2 t -77.18 -32.67 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.128 -0.982 . . . . 0.0 109.942 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -97.1 100.46 11.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.342 -0.848 . . . . 0.0 110.169 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -100.21 22.74 11.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.164 -0.96 . . . . 0.0 110.042 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.413 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 29.5 m-20 -92.8 -56.57 2.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 110.133 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.94 25.93 1.45 Allowed Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.244 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -110.18 -41.32 4.45 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.825 -1.397 . . . . 0.0 110.005 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.14 -81.89 0.28 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.514 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.421 HG22 ' CG2' ' A' ' 28' ' ' THR . 69.7 p -79.26 170.71 16.22 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.324 -1.104 . . . . 0.0 111.025 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.406 ' CD1' HG13 ' A' ' 55' ' ' VAL . 65.7 mt -97.01 153.93 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.301 -0.874 . . . . 0.0 110.337 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 0.8 OUTLIER -105.86 -171.55 1.92 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.241 -0.912 . . . . 0.0 110.258 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.531 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 33.6 t80 -82.43 -41.88 0.94 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.343 -0.848 . . . . 0.0 111.76 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.0 Cg_endo -74.61 -20.26 18.03 Favored 'Trans proline' 0 C--N 1.323 -0.768 0 O-C-N 123.006 1.003 . . . . 0.0 110.187 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 71' ' ' MET . 41.9 tt0 -83.71 -28.46 28.27 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.22 -0.925 . . . . 0.0 109.408 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 6.5 t80 -74.58 -46.59 37.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.625 -0.672 . . . . 0.0 110.118 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.416 ' CD2' ' C ' ' A' ' 69' ' ' LEU . 8.3 tt -74.03 -32.91 63.55 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.288 -0.883 . . . . 0.0 110.609 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 66' ' ' PRO . 89.1 m -79.35 -22.4 44.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.245 -0.909 . . . . 0.0 110.892 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.493 ' HE1' ' CE ' ' A' ' 72' ' ' MET . 11.6 ptt? -89.65 -26.37 20.77 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.927 -1.108 . . . . 0.0 110.904 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.493 ' CE ' ' HE1' ' A' ' 71' ' ' MET . 52.5 mtt -90.72 -55.57 3.52 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.053 -1.029 . . . . 0.0 111.191 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.512 ' HB3' ' CE2' ' A' ' 12' ' ' PHE . . . . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.259 -0.901 . . . . 0.0 110.772 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.473 0.654 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.7 mt -58.35 -17.17 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.895 . . . . 0.0 109.93 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -68.54 -52.27 33.88 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.154 -0.966 . . . . 0.0 109.533 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 38.8 mm-40 -61.66 -35.21 77.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 109.801 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.464 ' O ' ' CG2' ' A' ' 91' ' ' VAL . . . -61.65 -61.14 2.73 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.221 -0.924 . . . . 0.0 109.737 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.478 ' CE2' ' HA ' ' A' ' 138' ' ' TYR . 31.9 t80 -54.44 -22.32 12.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.23 -0.919 . . . . 0.0 110.084 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 5.3 mtp180 -67.91 -44.98 75.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.097 -1.002 . . . . 0.0 109.817 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.464 ' CG2' ' O ' ' A' ' 88' ' ' ALA . 30.2 m -78.43 -21.59 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.344 -0.848 . . . . 0.0 110.576 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.453 ' N ' HG21 ' A' ' 91' ' ' VAL . 38.4 m-85 -86.48 -15.5 39.95 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.129 -0.982 . . . . 0.0 110.587 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -124.44 47.78 2.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.219 -0.925 . . . . 0.0 110.223 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -106.49 40.4 1.63 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.324 -0.86 . . . . 0.0 110.163 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -124.35 -25.66 4.05 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.278 -0.888 . . . . 0.0 110.54 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 119.37 -32.02 5.21 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -47.34 -38.63 13.27 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.335 -1.097 . . . . 0.0 110.462 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.462 ' C ' ' CD1' ' A' ' 99' ' ' TYR . . . 97.19 -14.72 63.37 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.542 ' CD2' ' NE2' ' A' ' 135' ' ' GLN . 46.4 m-85 -135.03 168.47 19.06 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.114 -1.227 . . . . 0.0 110.118 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.424 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 37.1 mt -87.01 126.58 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.269 -0.895 . . . . 0.0 109.983 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.0 m -113.67 175.26 5.53 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.456 -0.777 . . . . 0.0 109.665 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.9 -43.68 78.69 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.136 -0.977 . . . . 0.0 110.279 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.67 -52.13 62.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.282 -0.886 . . . . 0.0 110.23 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -53.71 -53.3 54.07 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.221 -0.924 . . . . 0.0 110.126 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.5 tt -49.73 -39.43 37.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.268 -0.895 . . . . 0.0 110.247 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.405 ' O ' HG22 ' A' ' 110' ' ' THR . 44.0 ttt-85 -64.09 -38.84 92.51 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.22 -0.925 . . . . 0.0 110.41 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.405 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 54.2 t-80 -72.23 -19.19 61.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.255 -0.903 . . . . 0.0 110.524 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.451 HG12 ' CE1' ' A' ' 92' ' ' PHE . 90.1 t -84.4 -46.39 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.192 -0.943 . . . . 0.0 110.624 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.6 mmt -61.12 -48.17 82.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.141 -0.974 . . . . 0.0 110.668 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 106' ' ' ARG . 47.0 p -49.24 -37.44 23.35 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.207 -0.933 . . . . 0.0 110.56 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.405 ' ND2' ' O ' ' A' ' 107' ' ' HIS . 76.7 m-20 -73.39 -48.62 32.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.288 -0.882 . . . . 0.0 110.455 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.8 mt -59.14 -21.79 59.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 110.37 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.8 46.89 4.69 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.426 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 6.0 mm-40 -110.37 -29.5 8.09 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.26 -1.141 . . . . 0.0 110.197 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 114' ' ' GLU . 47.4 tttt 55.46 99.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.337 -0.852 . . . . 0.0 110.418 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.68 151.73 48.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.282 -0.886 . . . . 0.0 110.183 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.2 m -76.52 157.68 31.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 109.998 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -64.59 -42.91 95.28 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.229 -0.919 . . . . 0.0 110.354 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -56.63 -40.01 74.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.116 -0.99 . . . . 0.0 110.307 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 124' ' ' MET . 33.7 mt-10 -63.31 -46.37 87.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.162 -0.961 . . . . 0.0 110.159 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 124' ' ' MET . 95.1 t -55.27 -51.5 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.045 -1.034 . . . . 0.0 110.214 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -55.65 -46.99 77.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 110.229 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -62.9 -25.17 68.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -0.924 . . . . 0.0 110.237 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.419 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 73.7 mtp -73.84 -46.68 43.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.048 -1.032 . . . . 0.0 109.971 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 30.6 mm -61.29 -30.68 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.11 -0.994 . . . . 0.0 110.011 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.61 -43.46 47.98 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.246 -0.908 . . . . 0.0 110.265 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -67.43 -24.95 65.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.926 . . . . 0.0 110.071 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.75 -35.84 24.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.888 . . . . 0.0 110.204 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.401 ' OD2' ' HA2' ' A' ' 132' ' ' GLY . 23.1 t0 -61.32 96.09 0.05 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.922 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 89.4 mt -67.77 -64.33 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.316 -0.865 . . . . 0.0 110.885 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.403 ' OD1' ' OE2' ' A' ' 140' ' ' GLU . 29.4 p30 -73.71 -19.79 60.71 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.234 -0.917 . . . . 0.0 110.906 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.401 ' HA2' ' OD2' ' A' ' 129' ' ' ASP . . . 80.66 75.4 1.08 Allowed Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.881 -1.152 . . . . 0.0 110.395 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 31.7 m-20 -111.35 -23.97 10.48 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.167 -1.196 . . . . 0.0 110.024 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 135.78 -39.3 1.68 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.542 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -132.76 170.71 14.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.567 -0.961 . . . . 0.0 109.69 179.633 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.424 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 91.1 t -95.28 133.83 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.972 -1.08 . . . . 0.0 110.231 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -102.56 170.58 7.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.113 -0.992 . . . . 0.0 110.1 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.478 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 21.7 t80 -56.06 -47.18 78.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.23 -0.918 . . . . 0.0 110.462 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -55.73 -55.53 31.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -0.955 . . . . 0.0 110.273 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.403 ' OE2' ' OD1' ' A' ' 131' ' ' ASP . 52.6 mt-10 -58.35 -26.46 63.14 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.312 -0.867 . . . . 0.0 110.239 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.456 ' CE1' ' HE2' ' A' ' 145' ' ' MET . 9.7 t80 -70.43 -32.1 69.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.253 -0.904 . . . . 0.0 110.151 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 87.0 t -82.33 -29.01 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.272 -0.892 . . . . 0.0 110.369 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -80.53 -23.79 39.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.275 -0.891 . . . . 0.0 110.424 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 54.7 ttp -80.51 -32.88 36.82 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.141 -0.975 . . . . 0.0 110.432 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.456 ' HE2' ' CE1' ' A' ' 141' ' ' PHE . 1.7 ttm -84.23 -11.47 56.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.246 -0.909 . . . . 0.0 110.803 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.7 p . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.092 -1.005 . . . . 0.0 110.214 179.805 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.035 0.445 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -66.95 -37.81 84.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.024 -1.047 . . . . 0.0 109.93 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.464 ' HG3' ' CE2' ' A' ' 12' ' ' PHE . 21.6 tp60 -72.33 -55.39 7.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.352 -0.842 . . . . 0.0 110.18 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.1 mt -52.2 -38.92 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 109.884 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 13' ' ' LYS . . . -65.87 -36.76 84.33 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.282 -0.886 . . . . 0.0 109.449 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -59.3 -50.05 75.48 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.388 -0.82 . . . . 0.0 109.832 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.464 ' CE2' ' HG3' ' A' ' 8' ' ' GLN . 23.0 m-85 -63.6 -32.66 74.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.279 -0.888 . . . . 0.0 109.918 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 31.7 mtpt -65.46 -36.62 84.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.27 -0.894 . . . . 0.0 110.163 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -69.63 -38.4 77.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 0.0 109.715 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.458 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -64.32 -39.46 93.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.289 -0.882 . . . . 0.0 109.999 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.401 ' CE2' HD13 ' A' ' 27' ' ' ILE . 64.2 t80 -62.52 -57.51 10.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.137 -0.977 . . . . 0.0 110.238 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.9 p -55.64 -26.53 44.88 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.264 -0.897 . . . . 0.0 109.516 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.46 HD11 ' CE1' ' A' ' 19' ' ' PHE . 2.1 tm? -71.91 -36.88 70.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.407 -0.808 . . . . 0.0 109.978 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.517 ' CD1' HG12 ' A' ' 35' ' ' VAL . 15.4 m-85 -71.04 -56.49 6.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.062 -1.024 . . . . 0.0 109.538 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.79 101.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.425 -0.797 . . . . 0.0 109.997 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.6 mmtt -67.0 -42.79 84.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 109.979 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 53.0 p-10 -86.56 -15.18 40.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.334 -0.854 . . . . 0.0 110.598 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.426 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 67.8 37.67 88.77 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -79.85 -17.75 52.47 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.359 -1.083 . . . . 0.0 110.502 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.97 -21.79 22.18 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.374 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.4 p -119.72 158.08 27.23 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.923 -1.339 . . . . 0.0 110.786 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.401 HD13 ' CE2' ' A' ' 16' ' ' PHE . 96.3 mt -117.08 125.99 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.421 -0.799 . . . . 0.0 110.08 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.1 p -104.35 -162.49 0.9 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.0 110.121 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.419 ' HA ' HD22 ' A' ' 48' ' ' LEU . 20.1 p -87.81 -39.94 14.46 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.132 -0.98 . . . . 0.0 110.924 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -57.48 10.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.036 -1.04 . . . . 0.0 110.401 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -57.04 -42.1 79.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.949 . . . . 0.0 109.671 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.401 ' O ' ' HG2' ' A' ' 36' ' ' MET . 5.3 tp -63.37 -28.38 69.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.35 -0.843 . . . . 0.0 109.747 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.97 -47.71 79.47 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.414 ' O ' ' OG ' ' A' ' 38' ' ' SER . 86.5 m -66.74 -28.5 68.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.269 -1.136 . . . . 0.0 109.554 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.517 HG12 ' CD1' ' A' ' 19' ' ' PHE . 37.7 t -73.17 -28.28 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.48 -0.763 . . . . 0.0 110.102 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 25.7 mmt -83.4 -25.73 31.04 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.212 -0.93 . . . . 0.0 110.121 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -89.67 -16.7 29.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.888 . . . . 0.0 110.217 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 34' ' ' THR . 50.6 m -50.96 -54.56 23.24 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.319 -0.863 . . . . 0.0 110.232 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.8 39.93 1.83 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.306 -0.871 . . . . 0.0 110.337 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -131.39 -100.71 0.84 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -138.3 -155.79 0.63 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -1.157 . . . . 0.0 110.006 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -125.12 69.03 58.45 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.118 -0.989 . . . . 0.0 110.165 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 -160.95 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.906 1.477 . . . . 0.0 110.109 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.4 m -134.73 166.5 22.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.127 -0.983 . . . . 0.0 110.266 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.407 ' HA ' ' OE1' ' A' ' 45' ' ' GLU . 5.9 mm-40 -63.24 -22.64 67.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.221 -0.924 . . . . 0.0 110.166 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.3 -70.03 0.39 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.102 -0.999 . . . . 0.0 110.043 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -50.57 -31.73 16.6 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.301 -0.875 . . . . 0.0 109.923 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 29' ' ' THR . 5.6 tt -62.9 -50.88 69.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 110.066 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.419 ' O ' ' OD1' ' A' ' 53' ' ' ASN . 37.4 tt0 -53.3 -42.81 67.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.119 -0.988 . . . . 0.0 109.306 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -62.35 -34.75 77.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.631 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 4.7 ttp -68.94 -22.27 64.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.412 -0.805 . . . . 0.0 109.787 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.413 HD13 HD22 ' A' ' 48' ' ' LEU . 35.9 mt -87.38 -30.05 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.328 -0.857 . . . . 0.0 109.979 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 49' ' ' GLN . 3.6 m-20 -51.77 -42.93 62.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.171 -0.955 . . . . 0.0 110.079 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 13.3 pt-20 -68.57 -29.98 68.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.228 -0.92 . . . . 0.0 110.419 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 57' ' ' ALA . 67.2 t -75.88 -69.87 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.208 -0.933 . . . . 0.0 110.166 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -43.17 94.15 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.541 -0.724 . . . . 0.0 110.881 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -109.89 61.4 0.6 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 109.773 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 1.7 p30 -164.0 -33.44 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.337 -0.852 . . . . 0.0 110.941 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.443 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 105.74 47.85 1.07 Allowed Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.098 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -117.73 -12.78 10.21 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.265 -1.138 . . . . 0.0 110.332 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.68 -56.59 4.14 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 59.4 p -109.31 170.3 8.14 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.255 -1.144 . . . . 0.0 110.248 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.41 HD13 HG12 ' A' ' 55' ' ' VAL . 39.6 mt -89.79 139.34 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.155 -0.966 . . . . 0.0 110.143 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.423 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 0.8 OUTLIER -103.56 179.68 4.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.219 -0.926 . . . . 0.0 110.176 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.544 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.2 t80 -73.56 -46.53 7.36 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 0.0 111.003 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.0 Cg_endo -71.66 -22.34 24.26 Favored 'Trans proline' 0 N--CA 1.482 0.807 0 O-C-N 123.186 1.098 . . . . 0.0 110.419 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -81.37 -37.69 27.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.173 -0.954 . . . . 0.0 109.166 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.421 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 16.6 t80 -66.52 -38.73 87.82 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.525 -0.735 . . . . 0.0 109.867 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.455 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 1.1 tt -72.83 -36.35 67.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.354 -0.841 . . . . 0.0 110.059 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 92.7 m -76.22 -12.43 60.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.102 -0.999 . . . . 0.0 110.3 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.1 tmm? -89.09 -44.41 10.37 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.105 -0.997 . . . . 0.0 110.837 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.411 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 64.6 mtt -90.48 -37.76 13.69 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.028 -1.045 . . . . 0.0 111.135 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.498 1.971 0 O-C-N 121.178 -0.951 . . . . 0.0 110.57 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.236 0.541 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 84.3 mt -53.42 -37.79 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.377 -0.827 . . . . 0.0 110.365 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.69 -55.44 23.37 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.136 -0.977 . . . . 0.0 109.777 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -49.46 -41.04 39.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.278 -0.889 . . . . 0.0 110.003 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.443 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -59.06 -59.9 4.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 110.028 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.403 ' O ' ' HB3' ' A' ' 93' ' ' ASP . 11.9 t80 -50.49 -22.58 1.99 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.314 -0.866 . . . . 0.0 110.134 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.3 ttt180 -72.26 -58.39 3.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 110.701 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.462 HG21 ' N ' ' A' ' 92' ' ' PHE . 30.3 m -60.19 -32.37 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.033 -1.042 . . . . 0.0 110.117 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.559 ' CE1' ' CG1' ' A' ' 108' ' ' VAL . 36.5 m-85 -80.47 -19.21 46.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.237 -0.914 . . . . 0.0 110.177 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.427 ' OD2' ' HA2' ' A' ' 98' ' ' GLY . 52.6 t0 -123.59 57.83 1.16 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.279 -0.888 . . . . 0.0 109.943 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.8 pttm -88.73 39.47 0.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.245 -0.91 . . . . 0.0 110.455 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.429 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 1.5 p30 -125.85 -30.64 2.99 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.31 -0.869 . . . . 0.0 110.316 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.93 38.78 3.06 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.721 -1.228 . . . . 0.0 111.006 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.507 ' O ' ' CE2' ' A' ' 99' ' ' TYR . 30.2 p30 -129.49 -21.84 3.11 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.75 -1.441 . . . . 0.0 110.99 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.507 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 79.93 48.65 6.44 Favored Glycine 0 N--CA 1.494 2.502 0 O-C-N 120.866 -1.146 . . . . 0.0 110.314 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 62.8 m-85 -151.19 142.53 23.36 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.172 -1.193 . . . . 0.0 110.323 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.459 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 21.2 mt -111.75 110.81 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.142 -0.974 . . . . 0.0 109.505 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.5 p -104.3 151.81 22.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.893 . . . . 0.0 110.181 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -46.84 -28.59 1.62 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.29 -0.881 . . . . 0.0 110.181 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.25 -56.01 10.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.281 -0.887 . . . . 0.0 110.241 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.461 ' O ' ' CG2' ' A' ' 108' ' ' VAL . 53.6 mt-10 -58.21 -31.13 67.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.206 -0.934 . . . . 0.0 110.182 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.468 ' CD2' HG11 ' A' ' 121' ' ' VAL . 39.5 tp -69.73 -34.59 74.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.973 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -77.79 -19.84 54.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.372 -0.83 . . . . 0.0 110.019 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -91.89 -20.29 21.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 0.0 110.167 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.559 ' CG1' ' CE1' ' A' ' 92' ' ' PHE . 46.5 t -92.43 -50.83 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.165 -0.959 . . . . 0.0 110.1 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 17.1 mmt -46.96 -34.35 5.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.333 -0.854 . . . . 0.0 110.512 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.1 p -62.98 -51.89 65.11 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.236 -0.915 . . . . 0.0 109.708 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -53.67 -42.75 68.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.343 -0.848 . . . . 0.0 110.164 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.4 mt -59.82 -37.7 79.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.282 -0.886 . . . . 0.0 110.152 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 125.03 -20.15 6.75 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -82.58 107.61 15.35 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.274 -1.133 . . . . 0.0 110.361 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -85.83 126.69 34.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.838 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 mt -130.38 156.95 43.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.204 -0.935 . . . . 0.0 110.287 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 91.7 m -91.37 155.44 18.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.28 -0.887 . . . . 0.0 110.393 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -46.42 -35.83 5.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.339 -0.851 . . . . 0.0 110.637 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -59.7 -64.38 0.97 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.155 -0.966 . . . . 0.0 110.669 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -50.24 -44.73 53.54 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.118 -0.989 . . . . 0.0 110.322 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.468 HG11 ' CD2' ' A' ' 105' ' ' LEU . 40.5 t -53.15 -48.23 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 110.056 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -61.22 -30.82 70.67 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.281 -0.887 . . . . 0.0 110.026 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -69.62 -36.92 76.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.337 -0.852 . . . . 0.0 110.168 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.1 mtp -71.98 -54.57 9.53 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.252 -0.905 . . . . 0.0 110.377 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 20.7 mm -52.42 -37.14 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.157 -0.964 . . . . 0.0 109.879 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 43.1 ttt-85 -66.84 -50.79 61.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.365 -0.835 . . . . 0.0 110.533 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -63.22 -21.0 65.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.177 -0.952 . . . . 0.0 110.492 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.57 -16.96 25.04 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.174 -0.954 . . . . 0.0 110.652 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -82.44 78.49 9.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.04 -1.038 . . . . 0.0 109.955 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.429 HD13 ' CB ' ' A' ' 140' ' ' GLU . 14.4 mt -48.95 -57.41 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.46 -0.775 . . . . 0.0 110.809 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 27.4 p30 -81.55 -19.12 42.71 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.035 -1.041 . . . . 0.0 110.903 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 76.5 69.24 1.42 Allowed Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.938 -1.125 . . . . 0.0 110.457 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.405 ' O ' ' HG2' ' A' ' 135' ' ' GLN . 53.8 m-20 -111.77 19.24 18.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.123 -1.222 . . . . 0.0 109.848 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 68.78 18.01 71.86 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 135' ' ' GLN . 2.1 pt20 -170.46 138.75 1.56 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.309 -1.113 . . . . 0.0 109.916 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 57.7 t -94.44 123.54 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.141 -0.974 . . . . 0.0 110.044 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -93.67 175.53 6.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.169 -0.957 . . . . 0.0 109.977 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.411 ' O ' HG22 ' A' ' 142' ' ' VAL . 23.5 t80 -59.06 -48.76 80.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.254 -0.904 . . . . 0.0 110.603 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.38 -50.83 64.28 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.103 -0.998 . . . . 0.0 110.665 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.429 ' CB ' HD13 ' A' ' 130' ' ' ILE . 54.4 mt-10 -64.03 -28.28 69.69 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.114 -0.991 . . . . 0.0 110.126 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.516 ' CZ ' ' HE2' ' A' ' 145' ' ' MET . 13.8 t80 -73.0 -20.9 60.92 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.335 -0.853 . . . . 0.0 110.03 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.433 ' O ' ' CG2' ' A' ' 146' ' ' THR . 79.0 t -87.39 -32.93 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.312 -0.868 . . . . 0.0 110.624 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.3 -20.1 32.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.133 -0.979 . . . . 0.0 111.272 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.476 ' CE ' ' HE2' ' A' ' 145' ' ' MET . 19.9 ptt? -82.82 -32.6 27.53 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.864 -1.147 . . . . 0.0 110.964 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.516 ' HE2' ' CZ ' ' A' ' 141' ' ' PHE . 54.9 mtt -90.48 -27.36 19.27 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.922 -1.111 . . . . 0.0 110.671 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.433 ' CG2' ' O ' ' A' ' 142' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.131 -0.981 . . . . 0.0 110.723 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.186 0.517 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -66.15 -27.67 68.2 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.226 -0.921 . . . . 0.0 109.983 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -70.69 -44.92 65.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.308 -0.87 . . . . 0.0 109.73 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 86.5 mt -63.07 -48.13 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.751 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.59 -31.8 70.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.317 -0.864 . . . . 0.0 109.9 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.75 -51.93 62.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.355 -0.841 . . . . 0.0 109.888 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.427 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 10.7 m-30 -56.35 -46.73 79.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.354 -0.841 . . . . 0.0 110.09 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -62.39 -26.08 68.28 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.329 -0.857 . . . . 0.0 110.34 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -69.85 -66.29 0.61 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.112 -0.992 . . . . 0.0 110.13 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.418 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -48.59 -39.27 23.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -0.913 . . . . 0.0 109.966 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -62.19 -43.82 97.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -0.942 . . . . 0.0 109.963 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.5 m -65.04 -18.46 65.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 109.85 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.431 ' C ' ' CD1' ' A' ' 18' ' ' LEU . 2.9 tm? -87.75 -31.03 19.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 110.022 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.418 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 21.4 m-85 -74.46 -43.88 54.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.15 -0.968 . . . . 0.0 110.138 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -71.73 125.77 27.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.339 -0.85 . . . . 0.0 110.255 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.404 ' HD2' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -108.47 -51.93 2.83 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.205 -0.934 . . . . 0.0 110.795 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 3.0 p30 -70.6 -22.22 62.57 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.137 -0.977 . . . . 0.0 110.16 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.417 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 83.92 51.01 4.15 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.417 ' OD1' ' OG1' ' A' ' 26' ' ' THR . 7.0 p30 -104.72 18.62 21.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.109 -1.23 . . . . 0.0 110.335 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.452 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 49.6 41.67 34.43 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.452 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 0.8 OUTLIER -166.56 160.47 15.25 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.306 -1.114 . . . . 0.0 110.291 179.803 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 55.3 mt -121.9 118.2 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.315 -0.865 . . . . 0.0 109.884 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.8 m -105.93 -179.82 4.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.495 -0.753 . . . . 0.0 110.034 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.424 HG21 HG13 ' A' ' 52' ' ' ILE . 13.5 p -71.58 -16.84 62.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.113 -0.992 . . . . 0.0 110.353 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -75.6 -67.72 0.64 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 109.846 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.402 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 50.6 mt-10 -53.71 -41.32 66.85 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.317 -0.865 . . . . 0.0 109.415 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.456 ' CD2' HD13 ' A' ' 52' ' ' ILE . 1.8 tp -63.88 -38.52 91.4 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.346 -0.846 . . . . 0.0 109.28 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.467 ' HA2' ' CD1' ' A' ' 48' ' ' LEU . . . -51.87 -42.31 53.18 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.5 m -70.4 -45.08 66.68 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.382 -1.069 . . . . 0.0 110.085 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.5 t -50.06 -43.4 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.357 -0.84 . . . . 0.0 110.735 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 21.8 mmt -85.34 -23.66 27.95 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.237 -0.914 . . . . 0.0 110.318 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 32.9 ttt180 -70.63 -16.7 62.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.381 -0.824 . . . . 0.0 110.139 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -102.61 -22.95 13.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 110.234 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -112.44 59.52 0.64 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.218 -0.926 . . . . 0.0 110.262 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.82 69.11 0.41 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.415 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 48.6 tt0 -58.17 106.72 0.4 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.241 -1.153 . . . . 0.0 110.114 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.557 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.9 m120 -155.54 -65.39 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.282 -0.886 . . . . 0.0 110.577 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.557 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 44.0 Cg_endo -70.15 166.08 29.26 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 123.429 1.226 . . . . 0.0 110.097 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.411 HG21 ' N ' ' A' ' 45' ' ' GLU . 41.8 m -132.32 -98.32 0.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.104 -0.997 . . . . 0.0 110.041 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.411 ' N ' HG21 ' A' ' 44' ' ' THR . 87.7 tt0 -110.77 -46.25 3.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.818 -1.176 . . . . 0.0 110.151 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.02 -63.25 1.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 109.971 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 29.1 mt-10 -50.24 -40.4 47.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.603 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.467 ' CD1' ' HA2' ' A' ' 33' ' ' GLY . 10.6 tt -54.92 -53.45 55.35 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.295 -0.878 . . . . 0.0 109.412 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -48.74 -39.8 26.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.815 . . . . 0.0 109.821 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.41 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 39.0 t70 -57.92 -44.93 87.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.325 -0.859 . . . . 0.0 109.528 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.418 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 0.7 OUTLIER -62.78 -24.83 67.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.376 -0.828 . . . . 0.0 109.731 179.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.456 HD13 ' CD2' ' A' ' 32' ' ' LEU . 46.2 mm -80.02 -23.38 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.408 -0.808 . . . . 0.0 110.174 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -79.14 -30.99 43.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.151 -0.968 . . . . 0.0 110.094 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -76.3 -13.63 60.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 110.136 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.437 ' CG1' HD12 ' A' ' 63' ' ' ILE . 93.2 t -103.01 -60.76 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.89 . . . . 0.0 110.117 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -45.87 108.75 0.14 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.397 -0.815 . . . . 0.0 110.185 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.41 13.34 25.59 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.312 -0.868 . . . . 0.0 110.539 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -110.38 -60.27 1.83 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.11 -0.994 . . . . 0.0 109.87 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 132.56 47.0 0.11 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.466 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 19.4 p30 -126.22 -31.27 2.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.372 -1.075 . . . . 0.0 110.526 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.466 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 115.49 -60.2 0.41 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.42 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 81.5 p -89.59 170.27 10.62 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.07 -1.253 . . . . 0.0 110.566 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.437 HD12 ' CG1' ' A' ' 55' ' ' VAL . 81.7 mt -108.21 152.26 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.054 -1.029 . . . . 0.0 110.291 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.422 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.4 m-20 -101.15 179.54 4.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.358 -0.839 . . . . 0.0 110.242 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.538 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 7.5 t80 -73.08 -42.45 7.16 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 111.038 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 46.6 Cg_endo -76.87 -30.28 4.75 Favored 'Trans proline' 0 C--N 1.327 -0.567 0 O-C-N 123.125 1.066 . . . . 0.0 109.837 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 71' ' ' MET . 47.6 tt0 -72.7 -20.76 61.16 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.425 -0.797 . . . . 0.0 109.147 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.514 ' CE2' ' CE ' ' A' ' 72' ' ' MET . 8.5 t80 -82.05 -49.47 10.18 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.589 -0.694 . . . . 0.0 110.048 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.87 -18.5 64.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.004 -1.06 . . . . 0.0 110.232 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 72.8 m -90.04 -33.82 16.18 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.168 -0.957 . . . . 0.0 110.47 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 68' ' ' PHE . 4.9 ptm -77.52 -25.15 50.02 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.171 -0.956 . . . . 0.0 110.265 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.514 ' CE ' ' CE2' ' A' ' 68' ' ' PHE . 1.1 mmt -84.4 -33.57 23.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.231 -0.918 . . . . 0.0 110.257 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.18 -0.95 . . . . 0.0 110.03 179.946 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 85' ' ' ILE . 15.8 pt-20 . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 121.404 0.621 . . . . 0.0 110.109 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.425 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 56.9 mt -53.43 -44.12 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.193 -0.942 . . . . 0.0 109.69 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -50.98 -49.65 59.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.354 -0.842 . . . . 0.0 110.039 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.406 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 4.7 mp0 -54.44 -41.84 69.87 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.234 -0.916 . . . . 0.0 110.145 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.452 ' O ' ' CG2' ' A' ' 91' ' ' VAL . . . -61.45 -63.94 1.11 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.255 -0.903 . . . . 0.0 110.285 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.466 ' CZ ' ' OD2' ' A' ' 93' ' ' ASP . 9.2 t80 -45.62 -27.85 0.86 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.281 -0.887 . . . . 0.0 110.466 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.406 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 34.7 ttm-85 -66.62 -50.76 61.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.184 -0.948 . . . . 0.0 109.705 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 88' ' ' ALA . 33.2 m -70.04 -18.38 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.269 -0.895 . . . . 0.0 110.329 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.418 ' N ' HG21 ' A' ' 91' ' ' VAL . 37.0 m-85 -94.52 -8.42 38.39 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.141 -0.974 . . . . 0.0 110.443 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.466 ' OD2' ' CZ ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -140.54 35.56 1.83 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.096 -1.002 . . . . 0.0 110.194 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.21 10.77 15.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 110.361 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 2.7 p30 -83.49 -19.61 35.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.082 -1.011 . . . . 0.0 110.196 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.68 29.21 5.39 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 17.9 t-20 -98.42 -72.49 0.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.332 -1.099 . . . . 0.0 110.102 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.494 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 135.83 -14.81 4.1 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.499 ' CE1' ' OD1' ' A' ' 137' ' ' ASN . 27.6 m-85 -139.18 152.07 47.1 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.018 -1.283 . . . . 0.0 109.971 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.416 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 37.9 mt -81.61 121.79 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.022 -1.049 . . . . 0.0 110.159 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.1 m -111.56 176.28 5.08 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.469 -0.769 . . . . 0.0 109.828 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.21 -56.24 10.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.155 -0.966 . . . . 0.0 110.194 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -49.78 -54.16 20.84 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.236 -0.915 . . . . 0.0 110.333 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -53.47 -43.67 68.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 tt -59.09 -37.95 78.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.324 -0.86 . . . . 0.0 110.38 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -69.47 -28.44 66.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.05 -1.031 . . . . 0.0 109.632 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.439 ' CD2' ' N ' ' A' ' 107' ' ' HIS . 35.0 m170 -71.55 -29.44 64.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.336 -0.853 . . . . 0.0 109.843 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.406 HG23 ' HA ' ' A' ' 92' ' ' PHE . 34.0 t -79.28 -50.2 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.316 -0.865 . . . . 0.0 110.073 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -49.95 -43.74 50.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.363 -0.836 . . . . 0.0 110.266 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.1 p -50.7 -43.41 57.68 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.284 -0.885 . . . . 0.0 110.023 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -58.46 -41.22 84.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.311 -0.868 . . . . 0.0 110.243 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.3 mt -62.09 -53.52 54.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.263 -0.898 . . . . 0.0 110.365 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.66 40.07 0.34 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.414 ' HA ' ' OE1' ' A' ' 114' ' ' GLU . 6.0 mm-40 -111.3 -175.04 2.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.164 -1.198 . . . . 0.0 110.197 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -144.23 81.14 1.66 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.921 . . . . 0.0 110.147 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.97 161.03 15.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.304 -0.873 . . . . 0.0 110.089 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.0 t -98.6 -165.4 1.24 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.887 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -80.98 -43.97 18.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.117 -0.989 . . . . 0.0 110.362 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.423 ' O ' ' HB3' ' A' ' 122' ' ' ASP . 65.2 mm-40 -50.61 -54.35 23.49 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.26 -0.9 . . . . 0.0 110.719 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -48.69 -61.93 1.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.12 -0.987 . . . . 0.0 110.698 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.2 t -47.73 -39.19 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.206 -0.933 . . . . 0.0 110.625 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 119' ' ' GLU . 38.7 t70 -56.57 -47.5 79.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.994 -1.066 . . . . 0.0 110.066 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 36.7 tt0 -66.46 -25.68 66.84 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.248 -0.908 . . . . 0.0 110.286 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 24.4 mmm -70.27 -57.06 5.3 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.187 -0.945 . . . . 0.0 110.14 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.412 HD11 HG22 ' A' ' 136' ' ' VAL . 25.4 mm -57.34 -31.39 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.381 -0.825 . . . . 0.0 110.409 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -76.64 -32.95 58.32 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.135 -0.978 . . . . 0.0 110.235 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 28.9 mt-10 -69.97 -33.23 71.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 0.0 110.141 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.422 ' HA ' ' HB2' ' A' ' 144' ' ' MET . . . -79.81 -43.41 22.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.927 . . . . 0.0 110.336 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -60.21 98.35 0.06 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.135 -0.978 . . . . 0.0 109.943 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.433 ' CD1' ' HA ' ' A' ' 140' ' ' GLU . 5.4 mt -56.22 -42.97 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.294 -0.879 . . . . 0.0 110.333 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 53.5 p-10 -76.65 -15.92 59.68 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.042 -1.036 . . . . 0.0 110.231 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.456 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 55.68 55.18 30.14 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -97.53 -21.77 16.92 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.207 -1.172 . . . . 0.0 110.267 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 130.66 0.56 5.27 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.384 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.95 151.01 28.01 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.862 -1.375 . . . . 0.0 110.6 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.416 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 71.8 t -100.25 142.14 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.202 -0.936 . . . . 0.0 110.305 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.499 ' OD1' ' CE1' ' A' ' 99' ' ' TYR . 2.5 t30 -111.2 -169.59 1.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.426 -0.796 . . . . 0.0 110.047 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -75.37 -57.06 4.12 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.26 -0.9 . . . . 0.0 110.264 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -55.68 -52.02 65.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.86 . . . . 0.0 110.604 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.433 ' HA ' ' CD1' ' A' ' 130' ' ' ILE . 51.7 mt-10 -56.82 -46.88 81.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 110.526 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.537 ' CE1' ' CE ' ' A' ' 144' ' ' MET . 35.2 t80 -59.82 -25.36 64.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.094 -1.004 . . . . 0.0 110.322 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.2 t -86.48 -22.25 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.247 -0.908 . . . . 0.0 110.383 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -98.82 -9.13 24.78 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.34 -0.85 . . . . 0.0 110.663 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.537 ' CE ' ' CE1' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -90.69 -30.93 16.82 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.002 -1.061 . . . . 0.0 110.806 -179.686 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.457 ' CE ' ' HE2' ' A' ' 144' ' ' MET . 43.4 ttm -88.98 -45.65 9.49 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.071 -1.018 . . . . 0.0 109.609 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 65.6 p . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.445 -0.784 . . . . 0.0 109.86 179.449 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.162 0.506 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -63.37 -28.37 69.95 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.065 -1.022 . . . . 0.0 110.202 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.412 ' HA ' ' OE1' ' A' ' 8' ' ' GLN . 13.9 mm100 -73.37 -53.7 10.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.18 -0.95 . . . . 0.0 110.278 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.3 mt -54.84 -44.49 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 110.103 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.32 -36.12 79.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.335 -0.853 . . . . 0.0 109.481 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -63.62 -36.98 85.6 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.301 -0.875 . . . . 0.0 109.766 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -73.61 -22.8 59.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.318 -0.864 . . . . 0.0 109.817 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -72.66 -39.62 66.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.8 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -70.85 -39.29 73.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.394 -0.816 . . . . 0.0 110.031 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.95 -53.06 52.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.186 -0.946 . . . . 0.0 109.996 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.523 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 26.5 t80 -55.5 -39.37 70.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 109.866 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.6 m -67.69 -30.8 70.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -0.876 . . . . 0.0 109.981 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -65.07 -38.58 91.24 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.347 -0.846 . . . . 0.0 110.033 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.409 ' CD1' HG12 ' A' ' 35' ' ' VAL . 23.1 m-85 -75.87 -61.92 1.77 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.77 112.74 0.7 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 110.027 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -109.23 -42.13 4.47 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.227 -0.921 . . . . 0.0 110.69 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.404 ' OD1' ' OE2' ' A' ' 31' ' ' GLU . 11.0 p-10 -71.34 -33.13 69.33 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.121 -0.987 . . . . 0.0 110.253 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.06 74.17 1.1 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -142.83 15.69 1.94 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.276 -1.132 . . . . 0.0 110.242 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.461 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 49.19 35.53 19.94 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.461 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 20.3 p -156.86 149.29 23.28 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.228 -1.16 . . . . 0.0 110.119 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.3 mt -112.87 121.78 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.274 -0.892 . . . . 0.0 110.388 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.8 t -122.39 -175.66 3.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -0.872 . . . . 0.0 109.779 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 29.0 p -62.16 -26.34 68.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.114 -0.991 . . . . 0.0 110.189 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -69.87 -60.36 2.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -0.907 . . . . 0.0 110.018 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.411 ' O ' HG21 ' A' ' 35' ' ' VAL . 84.8 mt-10 -59.07 -61.2 2.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.11 -0.994 . . . . 0.0 109.778 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.421 ' CD2' HD13 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -51.53 -33.38 31.69 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.272 -0.892 . . . . 0.0 109.761 179.768 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.29 -44.91 94.81 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.417 ' O ' ' HB2' ' A' ' 38' ' ' SER . 90.8 m -76.62 -17.4 59.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -1.148 . . . . 0.0 109.781 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.411 HG21 ' O ' ' A' ' 31' ' ' GLU . 54.2 t -73.42 -39.3 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.291 -0.881 . . . . 0.0 110.135 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 21.4 mmt -90.33 -27.58 19.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -0.896 . . . . 0.0 110.466 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -82.61 -26.9 31.84 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.273 -0.892 . . . . 0.0 110.588 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 34' ' ' THR . 22.4 t -51.81 -32.69 32.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.995 . . . . 0.0 110.126 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -158.46 69.18 0.49 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.897 . . . . 0.0 110.153 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . 177.4 -64.84 0.09 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' A' ' 40' ' ' GLY . 53.4 mt-30 55.14 19.62 2.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.256 -1.144 . . . . 0.0 110.314 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.506 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 2.6 m120 -72.35 -58.32 3.13 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.17 -0.956 . . . . 0.0 110.412 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.506 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 42.7 Cg_endo -70.66 -169.51 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.768 1.404 . . . . 0.0 110.299 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 m -135.72 -177.31 4.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.288 -0.883 . . . . 0.0 109.832 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' A' ' 48' ' ' LEU . 45.2 mt-10 -67.24 -50.3 61.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.087 -1.008 . . . . 0.0 110.252 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.79 -56.65 15.58 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.197 -0.939 . . . . 0.0 110.04 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -52.01 -34.78 44.37 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.207 -0.933 . . . . 0.0 109.408 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 45' ' ' GLU . 9.5 tt -63.68 -45.02 91.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.423 -0.798 . . . . 0.0 109.224 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -49.47 -43.65 45.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.348 -0.845 . . . . 0.0 109.172 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -62.83 -45.21 93.68 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.412 -0.805 . . . . 0.0 109.342 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.42 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 3.7 ttp -59.36 -17.65 31.7 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.345 -0.847 . . . . 0.0 109.772 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.421 HD13 ' CD2' ' A' ' 32' ' ' LEU . 31.0 mm -90.46 -28.73 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 110.195 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -74.9 -27.18 60.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.323 -0.86 . . . . 0.0 110.552 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 51' ' ' MET . 25.3 pt-20 -74.35 -9.14 58.31 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.095 -1.003 . . . . 0.0 110.497 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.46 HG13 ' CD1' ' A' ' 63' ' ' ILE . 44.0 t -112.01 -23.18 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.043 -1.036 . . . . 0.0 110.523 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -91.26 109.05 20.32 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.13 -0.981 . . . . 0.0 110.333 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.25 16.15 21.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 110.329 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 40.1 m-20 -97.82 -69.83 0.74 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.274 -0.892 . . . . 0.0 110.42 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.65 -22.1 0.33 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -69.53 -21.48 63.65 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.08 -1.247 . . . . 0.0 110.123 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.54 -41.46 2.3 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.8 p -89.8 170.22 10.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.128 -1.219 . . . . 0.0 110.52 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.46 ' CD1' HG13 ' A' ' 55' ' ' VAL . 75.1 mt -104.55 151.43 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.367 -0.833 . . . . 0.0 109.892 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.417 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 1.6 m-20 -112.03 -167.28 1.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 110.255 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.526 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 23.5 t80 -73.97 -43.35 6.25 Favored Pre-proline 0 C--N 1.303 -1.422 0 O-C-N 121.284 -0.885 . . . . 0.0 111.099 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.3 Cg_endo -74.42 -30.04 8.67 Favored 'Trans proline' 0 C--O 1.211 -0.859 0 O-C-N 123.026 1.014 . . . . 0.0 110.006 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.42 ' OE1' ' OD2' ' A' ' 58' ' ' ASP . 1.3 tt0 -75.02 -26.02 59.19 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.098 -1.001 . . . . 0.0 108.918 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.562 ' CE1' ' CE ' ' A' ' 72' ' ' MET . 80.4 t80 -75.36 -43.56 49.76 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.62 -0.675 . . . . 0.0 110.405 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.4 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 4.2 tp -80.8 -16.73 52.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.341 -0.85 . . . . 0.0 110.363 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 34.6 m -84.28 -34.02 23.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.065 -1.022 . . . . 0.0 110.651 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.5 ' HE2' ' CE ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -88.67 -30.11 19.39 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.94 -1.1 . . . . 0.0 110.52 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.562 ' CE ' ' CE1' ' A' ' 68' ' ' PHE . 25.3 mtt -81.56 -11.35 59.19 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.047 -1.033 . . . . 0.0 110.515 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.125 -0.984 . . . . 0.0 110.042 179.715 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.137 0.494 . . . . 0.0 110.61 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.4 HD12 ' CG2' ' A' ' 146' ' ' THR . 88.7 mt -59.8 -48.68 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.137 -0.977 . . . . 0.0 110.407 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -56.69 -53.4 58.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.185 -0.947 . . . . 0.0 110.112 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -46.93 -41.78 16.6 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.288 -0.883 . . . . 0.0 110.339 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.422 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -59.61 -59.36 5.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.147 -0.971 . . . . 0.0 110.099 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -49.63 -23.88 1.93 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.16 -0.963 . . . . 0.0 110.461 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -76.42 -43.95 38.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.285 -0.885 . . . . 0.0 111.171 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.513 HG21 ' CD1' ' A' ' 92' ' ' PHE . 16.6 m -79.42 -19.23 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.042 -1.036 . . . . 0.0 110.966 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.513 ' CD1' HG21 ' A' ' 91' ' ' VAL . 24.9 m-85 -89.36 -24.46 21.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.102 -0.999 . . . . 0.0 109.982 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -106.89 92.7 4.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.276 -0.89 . . . . 0.0 109.366 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -100.17 -33.55 10.4 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.167 -0.958 . . . . 0.0 111.402 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 3.1 p30 -69.61 -38.45 77.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.956 -1.09 . . . . 0.0 110.438 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 106.41 41.95 1.68 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.446 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 39.4 p-10 -110.96 -14.82 13.89 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.352 -1.087 . . . . 0.0 110.412 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.5 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 69.28 43.99 67.97 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.5 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 33.5 m-85 -157.8 116.51 3.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.448 -1.031 . . . . 0.0 110.15 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 24.2 mt -87.86 113.22 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.01 -1.056 . . . . 0.0 109.647 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 90.5 p -99.38 159.22 15.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.167 -0.958 . . . . 0.0 110.266 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.2 -18.26 24.76 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.139 -0.976 . . . . 0.0 110.098 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.75 -66.91 0.65 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.233 -0.917 . . . . 0.0 109.983 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.442 ' O ' ' CG2' ' A' ' 108' ' ' VAL . 92.0 mt-10 -51.65 -39.22 57.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.183 -0.948 . . . . 0.0 109.724 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.428 HD13 ' CD1' ' A' ' 125' ' ' ILE . 1.5 tt -64.27 -41.34 96.97 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.593 -0.692 . . . . 0.0 110.311 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 57.7 ttp85 -65.89 -23.15 66.58 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.221 -0.924 . . . . 0.0 110.027 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -94.52 -14.7 24.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.384 -0.822 . . . . 0.0 110.245 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.442 ' CG2' ' O ' ' A' ' 104' ' ' GLU . 72.2 t -82.45 -49.02 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.314 -0.866 . . . . 0.0 110.264 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.6 mmt -60.14 -55.48 33.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.165 -0.959 . . . . 0.0 110.387 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.3 p -49.67 -30.42 9.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.249 -0.907 . . . . 0.0 110.491 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -74.18 -58.48 3.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.218 -0.926 . . . . 0.0 110.293 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.3 mt -47.37 -76.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.257 -0.902 . . . . 0.0 110.326 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.35 43.09 0.06 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -125.3 159.61 31.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -1.208 . . . . 0.0 110.127 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.75 60.4 1.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 110.441 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.03 -174.22 4.35 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.253 -0.905 . . . . 0.0 109.88 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.9 t -126.92 173.32 9.7 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.073 -1.017 . . . . 0.0 110.277 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 88.4 m-20 -58.48 -39.04 78.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -0.89 . . . . 0.0 110.283 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.03 -68.16 0.34 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.27 -0.894 . . . . 0.0 111.057 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.448 ' N ' ' OE1' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -47.78 -47.14 30.89 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.271 -0.893 . . . . 0.0 111.194 -179.181 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 78.9 t -54.89 -48.58 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.011 -1.056 . . . . 0.0 110.412 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -61.84 -30.56 70.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.106 -0.996 . . . . 0.0 109.938 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.11 -32.36 70.36 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.281 -0.887 . . . . 0.0 109.728 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.404 ' HG3' ' O ' ' A' ' 120' ' ' GLU . 83.7 mtp -66.7 -53.7 30.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.359 -0.838 . . . . 0.0 109.75 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.428 ' CD1' HD13 ' A' ' 105' ' ' LEU . 44.0 mm -59.01 -29.25 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.303 -0.873 . . . . 0.0 110.114 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -77.9 -28.36 49.78 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.274 -0.892 . . . . 0.0 109.907 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.38 -29.26 62.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.441 -0.787 . . . . 0.0 110.06 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.412 ' HA ' ' HB3' ' A' ' 144' ' ' MET . . . -94.75 -24.13 17.24 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.344 -0.847 . . . . 0.0 110.401 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.458 ' HA ' ' OE2' ' A' ' 140' ' ' GLU . 3.7 m-20 -73.16 95.61 2.1 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.981 -1.074 . . . . 0.0 111.126 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.401 ' O ' HG21 ' A' ' 130' ' ' ILE . 54.8 mt -92.04 -9.52 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.495 -0.753 . . . . 0.0 110.544 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 57.2 p-10 -149.7 -18.22 0.27 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.056 -1.028 . . . . 0.0 112.106 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.492 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . -95.1 -51.75 1.86 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.569 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 2.6 m-20 60.69 107.95 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.667 -0.902 . . . . 0.0 108.642 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 100.58 -26.37 24.86 Favored Glycine 0 C--N 1.292 -1.875 0 N-CA-C 107.059 -2.416 . . . . 0.0 107.059 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.407 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 0.2 OUTLIER -139.71 134.92 32.6 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.811 -0.817 . . . . 0.0 109.444 179.036 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.412 HG22 HD11 ' A' ' 125' ' ' ILE . 98.5 t -105.92 142.14 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.311 -0.868 . . . . 0.0 110.494 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -112.25 -176.06 2.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.302 -0.874 . . . . 0.0 109.83 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.46 ' CE1' HG22 ' A' ' 142' ' ' VAL . 27.9 t80 -67.47 -36.47 81.21 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.075 -1.016 . . . . 0.0 110.224 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -71.82 -35.6 69.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.064 -1.023 . . . . 0.0 110.285 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.458 ' OE2' ' HA ' ' A' ' 129' ' ' ASP . 35.9 mt-10 -70.27 -31.78 69.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.203 -0.936 . . . . 0.0 110.497 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -79.34 -29.37 42.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.224 -0.923 . . . . 0.0 110.669 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.46 HG22 ' CE1' ' A' ' 138' ' ' TYR . 96.2 t -80.24 -23.11 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.098 -1.001 . . . . 0.0 110.701 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -93.23 -31.04 14.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.164 -0.96 . . . . 0.0 110.697 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.469 ' CE ' ' HE1' ' A' ' 145' ' ' MET . 0.0 OUTLIER -79.07 -29.94 43.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.099 -1.001 . . . . 0.0 110.314 -179.82 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.469 ' HE1' ' CE ' ' A' ' 144' ' ' MET . 59.0 tpp -89.12 -58.34 2.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 109.912 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.4 ' CG2' HD12 ' A' ' 85' ' ' ILE . 64.7 p . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.373 -0.829 . . . . 0.0 110.064 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.347 0.594 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -74.05 -46.43 43.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.255 -0.903 . . . . 0.0 109.694 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -65.88 -55.07 18.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.431 -0.793 . . . . 0.0 109.593 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.6 mt -53.46 -42.41 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.368 -0.832 . . . . 0.0 109.695 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -59.59 -36.17 75.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -0.881 . . . . 0.0 109.894 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -61.95 -54.53 40.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.624 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -54.68 -36.28 64.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.748 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 17.5 mttt -60.13 -43.14 95.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.327 -0.858 . . . . 0.0 109.914 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -61.31 -38.48 86.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.914 . . . . 0.0 109.791 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.437 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.96 -45.58 93.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.238 -0.914 . . . . 0.0 109.968 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -59.75 -47.51 85.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.165 -0.959 . . . . 0.0 109.768 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.9 m -59.19 -27.31 65.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.929 . . . . 0.0 109.376 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.509 HD11 ' CD1' ' A' ' 19' ' ' PHE . 3.4 tm? -73.75 -34.32 64.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.478 -0.764 . . . . 0.0 109.613 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.509 ' CD1' HD11 ' A' ' 18' ' ' LEU . 15.4 m-85 -80.91 -68.08 0.72 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.43 -0.794 . . . . 0.0 109.998 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.404 ' OD1' ' OD1' ' A' ' 24' ' ' ASP . 46.1 t0 -58.88 115.24 2.98 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.243 -0.911 . . . . 0.0 110.05 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -104.19 -36.83 7.52 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.197 -0.94 . . . . 0.0 110.166 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -70.19 -11.01 60.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.234 -0.916 . . . . 0.0 110.366 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.57 97.54 0.01 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 10.7 p-10 -150.58 -42.91 0.12 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.376 -1.073 . . . . 0.0 110.108 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.41 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 120.02 15.88 5.05 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.41 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 13.1 p -155.51 132.57 10.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.091 -1.241 . . . . 0.0 110.379 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.418 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 26.6 mt -90.46 127.7 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.282 -0.886 . . . . 0.0 110.109 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.7 p -107.28 -163.71 0.93 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 110.26 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.418 HG23 HD11 ' A' ' 52' ' ' ILE . 7.4 p -86.09 -38.06 18.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.295 -0.878 . . . . 0.0 110.557 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -60.76 -57.74 11.42 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.079 -1.013 . . . . 0.0 110.116 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -55.75 -53.63 54.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.37 -0.831 . . . . 0.0 109.999 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.413 HD22 HD13 ' A' ' 48' ' ' LEU . 4.5 tp -56.56 -24.93 50.53 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.095 -1.003 . . . . 0.0 109.549 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.21 -53.31 45.67 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.404 ' HA ' ' HB2' ' A' ' 37' ' ' ARG . 27.8 m -66.1 -35.83 81.56 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.251 -1.147 . . . . 0.0 109.793 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.423 HG23 ' HA ' ' A' ' 19' ' ' PHE . 70.5 t -56.11 -39.9 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.362 -0.836 . . . . 0.0 109.993 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.423 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 24.8 mmt -85.8 -15.31 42.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.353 -0.842 . . . . 0.0 109.954 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.48 ' CD ' ' HA ' ' A' ' 42' ' ' ASN . 0.5 OUTLIER -83.05 -14.74 53.24 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.283 -0.886 . . . . 0.0 110.514 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 56.3 m -95.92 -20.9 18.4 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.192 -0.942 . . . . 0.0 110.976 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.518 ' N ' ' CD2' ' A' ' 39' ' ' LEU . 4.5 mm? -99.75 50.08 0.92 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.03 -1.044 . . . . 0.0 110.474 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 48.38 93.32 0.01 OUTLIER Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.433 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -176.82 -41.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -1.151 . . . . 0.0 110.091 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.48 ' HA ' ' CD ' ' A' ' 37' ' ' ARG . 5.8 p-10 36.36 62.16 2.98 Favored Pre-proline 0 N--CA 1.508 2.44 0 O-C-N 121.948 -0.47 . . . . 0.0 111.191 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 49.0 Cg_endo -76.2 -176.5 3.1 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.835 1.44 . . . . 0.0 110.183 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.4 p -113.32 161.19 17.55 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.356 -0.84 . . . . 0.0 110.057 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -64.47 -29.34 70.38 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.258 -0.901 . . . . 0.0 110.325 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.83 -69.48 0.44 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.179 -0.951 . . . . 0.0 110.101 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -49.15 -30.72 7.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.135 -0.978 . . . . 0.0 109.432 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.414 HD22 HD13 ' A' ' 52' ' ' ILE . 5.5 tt -63.19 -47.5 82.31 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.48 -0.762 . . . . 0.0 109.719 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -54.72 -47.32 73.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.192 -0.943 . . . . 0.0 109.621 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.05 -33.49 72.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -0.892 . . . . 0.0 109.581 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.453 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 56.1 ttp -68.95 -27.66 65.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 109.743 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.418 HD11 HG23 ' A' ' 29' ' ' THR . 38.4 mt -79.84 -23.66 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.355 -0.84 . . . . 0.0 109.602 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -60.77 -32.17 71.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.405 -0.809 . . . . 0.0 110.166 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.453 ' CG ' ' O ' ' A' ' 51' ' ' MET . 1.6 pt-20 -81.54 -22.46 37.86 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.197 -0.94 . . . . 0.0 110.21 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.478 HG13 ' CD1' ' A' ' 63' ' ' ILE . 92.2 t -93.24 -11.08 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.129 -0.982 . . . . 0.0 110.325 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -118.43 113.98 22.2 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.046 -1.034 . . . . 0.0 110.549 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.21 9.7 28.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.41 -0.806 . . . . 0.0 109.814 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.9 OUTLIER -82.35 -54.77 4.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.292 -0.88 . . . . 0.0 110.13 -179.75 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.24 29.03 1.39 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -118.91 -22.97 7.09 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.247 -1.149 . . . . 0.0 110.221 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.39 -14.37 65.16 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 80.9 p -119.83 164.53 15.87 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.052 -1.263 . . . . 0.0 110.861 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.478 ' CD1' HG13 ' A' ' 55' ' ' VAL . 64.2 mt -106.86 158.08 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.354 -0.841 . . . . 0.0 110.401 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.406 ' OD2' ' HD2' ' A' ' 66' ' ' PRO . 8.5 t70 -113.44 -166.8 1.12 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.41 -0.807 . . . . 0.0 109.614 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.505 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 1.2 t80 -84.2 -44.86 0.75 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.075 -1.015 . . . . 0.0 111.389 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 45.7 Cg_endo -75.21 -21.02 15.89 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 O-C-N 123.191 1.101 . . . . 0.0 110.351 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -78.66 -32.94 47.4 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.281 -0.887 . . . . 0.0 108.735 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.515 ' CE1' ' HE2' ' A' ' 72' ' ' MET . 90.7 t80 -70.93 -53.25 15.65 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.433 0.635 . . . . 0.0 110.198 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.466 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 7.8 tt -60.56 -40.16 90.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.308 -0.87 . . . . 0.0 110.168 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.8 m -73.77 -17.65 61.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.164 -0.96 . . . . 0.0 110.47 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.483 ' CE ' ' CE ' ' A' ' 72' ' ' MET . 62.1 ttp -76.96 -50.75 12.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.069 -1.019 . . . . 0.0 110.771 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.515 ' HE2' ' CE1' ' A' ' 68' ' ' PHE . 45.6 mtt -90.59 -43.86 9.92 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.101 -0.999 . . . . 0.0 111.317 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.497 1.916 0 O-C-N 121.185 -0.947 . . . . 0.0 111.15 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 121.35 0.595 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 12.4 mt -55.94 -35.03 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 110.292 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.8 ttm-85 -50.61 -49.5 56.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 109.553 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -61.54 -49.03 78.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.27 -0.893 . . . . 0.0 109.418 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.44 ' O ' HG21 ' A' ' 91' ' ' VAL . . . -56.44 -19.44 15.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 109.852 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -82.42 -40.44 21.23 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.027 -1.045 . . . . 0.0 109.721 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -56.97 -40.86 77.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.527 -0.733 . . . . 0.0 109.835 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.456 HG22 ' N ' ' A' ' 92' ' ' PHE . 17.7 m -73.78 -42.86 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.127 -0.983 . . . . 0.0 110.602 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.49 ' CE1' ' CD1' ' A' ' 105' ' ' LEU . 15.8 m-85 -79.84 4.74 15.63 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.002 -1.061 . . . . 0.0 110.77 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -149.92 80.35 1.37 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.077 -1.014 . . . . 0.0 110.092 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -90.45 31.46 1.03 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -0.874 . . . . 0.0 110.249 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -127.88 -113.61 0.27 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -0.962 . . . . 0.0 110.057 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.54 32.13 0.18 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.45 ' HB2' ' CD2' ' A' ' 99' ' ' TYR . 14.2 p30 -111.26 -21.08 12.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.364 -1.08 . . . . 0.0 110.308 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 67.05 10.74 57.17 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.45 ' CD2' ' HB2' ' A' ' 97' ' ' ASN . 8.1 m-85 -107.49 105.15 14.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.155 -1.203 . . . . 0.0 109.88 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 31.0 mt -76.64 130.16 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.32 -0.862 . . . . 0.0 109.554 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.0 m -116.08 172.69 7.0 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.34 -0.85 . . . . 0.0 110.559 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.489 ' CB ' ' CG1' ' A' ' 121' ' ' VAL . . . -66.79 -37.79 85.27 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.557 -0.715 . . . . 0.0 110.275 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.41 -60.84 3.22 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.255 -0.903 . . . . 0.0 110.305 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.408 ' O ' HG21 ' A' ' 108' ' ' VAL . 50.0 mt-10 -56.43 -28.31 59.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.166 -0.959 . . . . 0.0 110.16 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.49 ' CD1' ' CE1' ' A' ' 92' ' ' PHE . 19.0 tp -66.12 -39.83 90.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.148 -0.97 . . . . 0.0 110.523 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.429 ' O ' ' CG2' ' A' ' 110' ' ' THR . 30.4 ttp180 -75.12 -29.81 60.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.062 -1.024 . . . . 0.0 110.078 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.62 -21.58 48.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.303 -0.873 . . . . 0.0 110.158 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.408 HG21 ' O ' ' A' ' 104' ' ' GLU . 54.0 t -83.74 -48.97 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 109.856 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.418 ' HE1' HD13 ' A' ' 105' ' ' LEU . 65.1 mtt -63.01 -32.45 73.82 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.385 -0.822 . . . . 0.0 109.985 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.429 ' CG2' ' O ' ' A' ' 106' ' ' ARG . 2.9 p -55.44 -41.28 72.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.341 -0.85 . . . . 0.0 109.64 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -73.76 -44.72 55.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.892 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.4 mt -58.78 -73.39 0.08 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.208 -0.933 . . . . 0.0 110.205 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 155.84 62.3 0.01 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 109' ' ' MET . 54.9 mm-40 -143.94 157.81 44.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.206 -1.173 . . . . 0.0 110.439 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.407 ' N ' ' CD ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -126.69 109.52 12.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.282 -0.886 . . . . 0.0 110.132 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.412 ' CD1' ' SD ' ' A' ' 109' ' ' MET . 4.2 mp -125.89 162.44 25.18 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.226 -0.921 . . . . 0.0 110.67 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 64.3 m -114.05 173.14 6.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.389 -0.819 . . . . 0.0 109.951 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.404 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 43.1 m-20 -53.23 -38.44 62.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.148 -0.97 . . . . 0.0 110.855 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -66.4 -50.23 64.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.961 -1.087 . . . . 0.0 110.735 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.446 ' N ' ' OE1' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -55.62 -57.68 10.96 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.17 -0.956 . . . . 0.0 110.494 -179.739 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.489 ' CG1' ' CB ' ' A' ' 102' ' ' ALA . 21.0 t -51.7 -47.4 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.347 -0.845 . . . . 0.0 110.209 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -57.65 -34.01 68.89 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.055 -1.028 . . . . 0.0 109.916 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.437 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 32.8 tt0 -75.48 -25.3 57.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.89 . . . . 0.0 110.093 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.418 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 10.4 mmm -75.35 -47.29 28.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.204 -0.935 . . . . 0.0 110.133 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.428 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 26.8 mm -70.94 -27.08 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.218 -0.926 . . . . 0.0 109.869 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -75.1 -56.05 5.12 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.403 -0.811 . . . . 0.0 110.216 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.455 ' OE1' ' N ' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -57.35 -31.62 65.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.092 -1.005 . . . . 0.0 109.725 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.455 ' N ' ' OE1' ' A' ' 127' ' ' GLU . . . -79.11 -27.86 42.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 109.087 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 47.6 t0 -63.59 95.37 0.1 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.455 -0.778 . . . . 0.0 109.925 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.402 HD11 ' HG2' ' A' ' 140' ' ' GLU . 50.2 mt -80.21 -28.76 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.255 -0.903 . . . . 0.0 110.783 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 2.8 p30 -86.11 -28.39 24.06 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.192 -0.942 . . . . 0.0 110.848 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 88.95 51.91 2.9 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 36.9 p-10 -118.91 -21.57 7.69 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.3 -1.118 . . . . 0.0 110.459 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.59 -25.99 7.45 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.263 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.403 ' CG ' ' OD2' ' A' ' 133' ' ' ASP . 9.0 pt20 -114.7 165.67 12.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.14 -1.212 . . . . 0.0 110.915 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.403 HG23 ' HB1' ' A' ' 128' ' ' ALA . 56.1 t -109.82 131.04 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.416 -0.803 . . . . 0.0 109.36 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 10.7 t30 -94.78 -175.13 3.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.065 -1.022 . . . . 0.0 110.675 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.42 ' CD1' ' C ' ' A' ' 138' ' ' TYR . 17.3 t80 -70.87 -59.69 2.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.383 -0.823 . . . . 0.0 110.65 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -52.2 -43.06 64.0 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.162 -0.961 . . . . 0.0 110.293 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.402 ' HG2' HD11 ' A' ' 130' ' ' ILE . 52.1 mt-10 -66.58 -33.31 75.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.022 -1.049 . . . . 0.0 109.896 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.562 ' CZ ' ' CE ' ' A' ' 145' ' ' MET . 25.5 t80 -68.79 -20.13 64.33 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.41 -0.806 . . . . 0.0 109.625 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 65.2 t -90.34 -41.76 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.304 -0.872 . . . . 0.0 110.891 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.55 -14.66 59.6 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.13 -0.982 . . . . 0.0 110.855 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.511 ' CE ' ' CD1' ' A' ' 141' ' ' PHE . 4.9 ptt? -85.35 -27.06 26.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.018 -1.051 . . . . 0.0 109.83 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.562 ' CE ' ' CZ ' ' A' ' 141' ' ' PHE . 52.5 mtt -84.82 -68.56 0.71 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.486 -0.759 . . . . 0.0 110.317 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.7 p . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.607 -0.683 . . . . 0.0 110.177 -179.946 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 121.047 0.451 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.414 ' O ' ' HB1' ' A' ' 10' ' ' ALA . 3.9 mt-10 -66.82 -69.63 0.3 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.968 -1.083 . . . . 0.0 110.426 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -49.18 -55.13 13.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.907 . . . . 0.0 110.083 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.9 mt -49.65 -40.41 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.166 -0.959 . . . . 0.0 109.896 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.414 ' HB1' ' O ' ' A' ' 7' ' ' GLU . . . -61.35 -40.53 94.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 110.0 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.32 -41.09 96.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 110.209 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -61.65 -52.82 62.77 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.253 -0.904 . . . . 0.0 110.002 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -49.64 -46.15 49.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.146 -0.971 . . . . 0.0 109.667 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -52.87 -50.58 63.53 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.305 -0.872 . . . . 0.0 109.736 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.66 -37.8 59.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.399 -0.813 . . . . 0.0 109.834 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.512 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 18.8 t80 -58.25 -49.87 75.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.432 -0.793 . . . . 0.0 109.831 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.2 t -60.49 -32.2 71.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.296 -0.878 . . . . 0.0 110.147 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.418 ' CD2' ' C ' ' A' ' 18' ' ' LEU . 5.4 tt -61.51 -44.57 96.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.264 -0.897 . . . . 0.0 110.065 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -70.48 -57.9 4.29 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.168 -0.957 . . . . 0.0 110.214 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -58.64 107.41 0.51 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.278 -0.888 . . . . 0.0 110.252 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -110.8 52.87 0.72 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.163 -0.961 . . . . 0.0 110.989 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.423 ' OD2' ' OD2' ' A' ' 24' ' ' ASP . 6.2 p-10 -151.72 -42.9 0.11 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.046 -1.034 . . . . 0.0 109.959 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.5 64.94 0.57 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 1.4 p30 -144.07 -44.56 0.26 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.049 -1.266 . . . . 0.0 110.207 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.455 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 113.22 32.89 2.07 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.388 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.447 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 43.6 p -148.95 145.0 27.17 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.938 -1.331 . . . . 0.0 110.336 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.3 mt -107.53 117.31 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.302 -0.874 . . . . 0.0 110.171 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.2 p -102.16 -167.15 1.37 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.246 -0.909 . . . . 0.0 109.99 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.412 HG23 HD11 ' A' ' 52' ' ' ILE . 25.0 p -83.21 -31.75 26.89 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.184 -0.947 . . . . 0.0 110.515 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.7 mtmt -65.18 -62.95 1.24 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.217 -0.927 . . . . 0.0 110.194 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -56.47 -58.7 6.88 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.168 -0.957 . . . . 0.0 109.385 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.462 ' CD2' HD13 ' A' ' 52' ' ' ILE . 6.0 tp -54.36 -22.6 12.66 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.268 -0.895 . . . . 0.0 109.195 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.494 ' HA2' ' CD1' ' A' ' 48' ' ' LEU . . . -63.58 -46.61 91.87 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.46 ' O ' ' CB ' ' A' ' 38' ' ' SER . 71.3 m -72.79 -21.58 60.96 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.252 -1.146 . . . . 0.0 110.272 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.418 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 53.0 t -72.78 -63.77 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.204 -0.935 . . . . 0.0 110.274 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.41 ' HE2' ' CE ' ' A' ' 51' ' ' MET . 12.4 tpp -67.35 -41.01 85.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 110.521 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.463 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 48.1 ttp180 -65.25 -32.59 74.34 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.174 -0.953 . . . . 0.0 110.739 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 34' ' ' THR . 10.8 t -86.97 10.42 16.4 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.938 -1.101 . . . . 0.0 110.635 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 35' ' ' VAL . 36.6 mt -136.33 63.54 1.58 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.002 -1.061 . . . . 0.0 110.403 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . 121.13 -34.14 4.11 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.453 ' CG ' ' O ' ' A' ' 37' ' ' ARG . 67.3 mt-30 54.86 40.08 31.8 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.215 -1.168 . . . . 0.0 110.846 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.538 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 2.4 t30 -86.26 -48.17 0.54 Allowed Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.986 -1.071 . . . . 0.0 110.217 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 42' ' ' ASN . 51.8 Cg_endo -84.85 -171.55 1.0 Allowed 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.696 1.366 . . . . 0.0 110.098 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 12.7 t -138.64 -174.27 3.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.176 -0.953 . . . . 0.0 109.666 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.56 -49.91 71.55 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.967 -1.083 . . . . 0.0 110.108 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.37 -66.11 0.59 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.187 -0.946 . . . . 0.0 110.451 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.416 ' HB3' HG21 ' A' ' 44' ' ' THR . 39.4 tt0 -45.93 -34.26 3.8 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.339 -0.85 . . . . 0.0 110.273 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.494 ' CD1' ' HA2' ' A' ' 33' ' ' GLY . 5.0 tt -60.67 -50.25 74.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.28 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.441 ' N ' HD21 ' A' ' 48' ' ' LEU . 5.4 tt0 -52.45 -40.17 61.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.389 -0.819 . . . . 0.0 109.257 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -62.97 -37.45 87.18 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.53 -0.731 . . . . 0.0 109.496 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.419 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 33.9 ttp -71.19 -16.78 62.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.411 -0.806 . . . . 0.0 109.94 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.462 HD13 ' CD2' ' A' ' 32' ' ' LEU . 22.6 mt -83.37 -33.53 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.186 -0.946 . . . . 0.0 109.98 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -52.4 -47.78 66.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.262 -0.899 . . . . 0.0 110.011 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 51' ' ' MET . 14.8 pt-20 -64.49 -29.11 70.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.269 -0.894 . . . . 0.0 109.875 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.505 ' CG1' ' CD1' ' A' ' 63' ' ' ILE . 76.7 t -85.0 -10.69 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.372 -0.83 . . . . 0.0 110.196 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -107.53 112.1 24.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.111 -0.993 . . . . 0.0 110.23 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -101.86 34.02 2.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.256 -0.902 . . . . 0.0 110.128 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.404 ' OD1' ' OE2' ' A' ' 67' ' ' GLU . 7.1 m-20 -116.33 -36.26 4.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -0.941 . . . . 0.0 110.316 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.91 56.56 2.06 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.441 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 14.5 p-10 -138.41 -41.88 0.5 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.249 -1.148 . . . . 0.0 110.325 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.448 ' O ' ' CG2' ' A' ' 62' ' ' THR . . . 126.19 20.7 1.97 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.797 -1.192 . . . . 0.0 110.571 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.448 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 0.8 OUTLIER -164.72 161.65 20.79 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.009 -1.289 . . . . 0.0 110.356 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.505 ' CD1' ' CG1' ' A' ' 55' ' ' VAL . 78.9 mt -103.79 161.08 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 110.228 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.431 ' N ' HG21 ' A' ' 63' ' ' ILE . 35.0 m-20 -125.84 -155.07 0.66 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.185 -0.947 . . . . 0.0 110.779 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.524 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 13.3 t80 -87.15 -41.34 0.53 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.399 -0.813 . . . . 0.0 112.21 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.0 Cg_endo -72.52 -19.02 25.31 Favored 'Trans proline' 0 C--O 1.211 -0.855 0 O-C-N 123.038 1.02 . . . . 0.0 110.621 -179.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.419 ' OE1' ' OD2' ' A' ' 64' ' ' ASP . 49.9 mt-10 -87.69 -31.64 19.62 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.078 -1.013 . . . . 0.0 109.383 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.512 ' CE1' ' HE2' ' A' ' 72' ' ' MET . 81.3 t80 -73.35 -41.0 63.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.717 -0.614 . . . . 0.0 110.242 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.479 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 0.6 OUTLIER -83.28 -37.73 23.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.37 -0.832 . . . . 0.0 110.767 -179.436 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 66' ' ' PRO . 60.8 m -68.5 -31.07 70.08 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.985 -1.072 . . . . 0.0 110.309 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.411 ' HE1' ' HG3' ' A' ' 72' ' ' MET . 57.4 ttp -81.1 -59.31 2.7 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.242 -0.911 . . . . 0.0 110.472 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.512 ' HE2' ' CE1' ' A' ' 68' ' ' PHE . 61.3 mtt -68.99 -9.46 52.46 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.355 -0.841 . . . . 0.0 110.642 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.134 -0.979 . . . . 0.0 110.444 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.115 0.483 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.7 mm -65.55 -51.86 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.067 -1.02 . . . . 0.0 110.134 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -62.65 -52.71 62.24 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.35 -0.844 . . . . 0.0 110.177 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -57.34 -28.75 63.4 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.228 -0.92 . . . . 0.0 110.305 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.501 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -67.04 -65.28 0.7 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.917 . . . . 0.0 110.274 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -52.15 -24.23 6.72 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.183 -0.948 . . . . 0.0 110.353 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.1 ttt-85 -74.57 -39.65 62.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.211 -0.931 . . . . 0.0 110.288 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.2 m -84.91 -11.04 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 110.545 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.501 ' CD2' ' O ' ' A' ' 88' ' ' ALA . 24.2 m-85 -101.41 -14.68 17.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.031 -1.043 . . . . 0.0 110.509 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 99' ' ' TYR . 83.8 m-20 -132.17 83.03 2.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.017 -1.052 . . . . 0.0 110.619 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -104.53 27.12 8.21 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.141 -0.975 . . . . 0.0 109.994 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.8 p30 -106.69 -24.12 12.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.273 -0.892 . . . . 0.0 109.914 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.441 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 99.49 43.1 2.58 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.504 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 30.6 p-10 -128.81 -24.45 2.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.335 -1.097 . . . . 0.0 110.877 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.452 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 75.2 35.07 49.91 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.504 ' CD2' ' O ' ' A' ' 97' ' ' ASN . 61.3 m-85 -147.46 144.86 28.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.319 -1.107 . . . . 0.0 109.654 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 23.9 mt -100.24 141.72 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.078 -1.014 . . . . 0.0 109.743 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.4 t -126.54 167.55 15.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.169 -0.957 . . . . 0.0 110.409 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.405 ' HA ' HG13 ' A' ' 125' ' ' ILE . . . -65.92 -52.02 53.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.366 -0.834 . . . . 0.0 110.039 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.3 -56.46 16.47 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.385 -0.822 . . . . 0.0 110.235 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -50.86 -45.01 59.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 110.039 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.6 tt -57.18 -38.37 73.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.384 -0.822 . . . . 0.0 110.018 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.412 ' O ' ' HB ' ' A' ' 110' ' ' THR . 66.4 ttt180 -69.27 -26.09 64.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.159 -0.963 . . . . 0.0 109.765 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -83.72 -14.36 51.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.348 -0.845 . . . . 0.0 109.993 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 79.1 t -88.37 -62.06 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.147 -0.971 . . . . 0.0 110.825 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.421 ' HE2' ' HE3' ' A' ' 124' ' ' MET . 60.9 mtt -65.46 -53.65 39.7 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.159 -0.963 . . . . 0.0 110.72 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 106' ' ' ARG . 28.8 m -47.32 -34.28 6.65 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.32 -0.863 . . . . 0.0 110.271 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -77.12 -41.28 42.61 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 110.402 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.2 mt -51.32 -49.05 62.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.147 -0.97 . . . . 0.0 110.273 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 139.7 48.06 0.06 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -135.22 149.26 49.85 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.213 -1.169 . . . . 0.0 110.098 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -95.79 104.27 16.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.273 -0.892 . . . . 0.0 110.454 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.0 mt -124.09 164.5 19.29 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.177 -0.952 . . . . 0.0 110.181 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 56.8 m -122.51 153.3 39.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.166 -0.959 . . . . 0.0 110.194 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -45.53 -30.06 1.34 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.277 -0.889 . . . . 0.0 110.549 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -65.08 -61.03 2.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.871 . . . . 0.0 110.457 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -49.81 -51.51 39.12 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.216 -0.927 . . . . 0.0 110.517 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 75.2 t -53.84 -45.69 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.251 -0.906 . . . . 0.0 110.501 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.15 -27.93 69.42 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.21 -0.931 . . . . 0.0 110.394 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -71.98 -31.75 66.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 0.0 110.107 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.421 ' HE3' ' HE2' ' A' ' 109' ' ' MET . 51.5 mtp -77.87 -45.67 23.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.336 -0.853 . . . . 0.0 110.36 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.405 HG13 ' HA ' ' A' ' 102' ' ' ALA . 19.3 mm -61.96 -41.44 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 110.212 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -63.95 -52.18 60.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.005 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -55.04 -36.44 65.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.202 -0.936 . . . . 0.0 110.23 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.16 -29.79 65.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.225 -0.922 . . . . 0.0 110.31 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -73.53 91.39 1.81 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.157 -0.964 . . . . 0.0 110.365 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 63.3 mt -84.5 1.3 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.243 -0.911 . . . . 0.0 110.767 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 2.4 p30 -112.03 -35.47 5.66 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.976 -1.077 . . . . 0.0 110.296 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.442 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 102.44 42.46 2.17 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 58.7 p30 -109.91 -12.7 14.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.161 -1.2 . . . . 0.0 110.541 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.467 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 98.74 -47.01 1.44 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -94.34 164.49 13.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.193 -1.181 . . . . 0.0 110.577 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.453 HG11 ' N ' ' A' ' 137' ' ' ASN . 58.2 t -112.61 152.99 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.353 -0.842 . . . . 0.0 109.878 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.453 ' N ' HG11 ' A' ' 136' ' ' VAL . 5.2 p-10 -128.66 -168.88 1.98 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.038 -1.039 . . . . 0.0 110.843 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.443 ' O ' ' CG2' ' A' ' 142' ' ' VAL . 4.3 t80 -64.64 -44.39 90.61 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.51 -0.744 . . . . 0.0 111.006 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.63 -61.05 2.79 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.232 -0.917 . . . . 0.0 111.219 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.4 ' OE2' ' OD2' ' A' ' 131' ' ' ASP . 53.8 mt-10 -56.59 -28.9 61.39 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.112 -0.992 . . . . 0.0 111.032 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.483 ' CE1' ' HE1' ' A' ' 145' ' ' MET . 23.2 t80 -78.86 -27.35 44.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.084 -1.01 . . . . 0.0 110.401 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.443 ' CG2' ' O ' ' A' ' 138' ' ' TYR . 86.3 t -83.6 -24.72 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.259 -0.901 . . . . 0.0 110.484 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -95.29 -22.28 17.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.137 -0.977 . . . . 0.0 110.738 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.449 ' CE ' ' HE3' ' A' ' 145' ' ' MET . 0.0 OUTLIER -89.0 -12.49 41.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.879 -1.138 . . . . 0.0 110.321 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.483 ' HE1' ' CE1' ' A' ' 141' ' ' PHE . 53.1 tpp -90.25 -48.04 7.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.187 -0.946 . . . . 0.0 110.311 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.323 -0.861 . . . . 0.0 110.588 -179.746 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.026 0.441 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -50.01 -46.84 53.13 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.126 -0.984 . . . . 0.0 110.348 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -59.67 -57.19 14.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.309 -0.869 . . . . 0.0 110.307 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.48 ' CG2' ' HE3' ' A' ' 13' ' ' LYS . 83.5 mt -49.97 -28.95 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.257 -0.902 . . . . 0.0 109.614 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.47 -42.15 68.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.329 -0.857 . . . . 0.0 110.045 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.34 -42.11 81.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 0.0 109.97 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -64.39 -47.07 80.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.294 -0.878 . . . . 0.0 110.194 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.48 ' HE3' ' CG2' ' A' ' 9' ' ' ILE . 87.5 mttt -50.84 -51.75 48.09 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.23 -0.919 . . . . 0.0 109.813 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 17' ' ' SER . 40.6 tt0 -53.35 -43.09 67.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.383 -0.823 . . . . 0.0 109.998 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.523 ' O ' ' CG ' ' A' ' 19' ' ' PHE . . . -57.32 -44.34 84.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.944 . . . . 0.0 109.767 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.447 ' CE2' HD13 ' A' ' 27' ' ' ILE . 3.2 t80 -63.49 -32.71 74.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.193 -0.942 . . . . 0.0 109.773 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 38.2 t -58.79 -61.58 2.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 110.325 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 15' ' ' ALA . 1.2 pp -67.3 -15.38 63.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.1 -1.0 . . . . 0.0 110.372 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.523 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 8.1 m-30 -69.29 -63.81 0.99 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.131 -0.98 . . . . 0.0 109.706 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.404 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 6.7 t0 -70.67 107.81 4.1 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.355 -0.84 . . . . 0.0 109.995 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.436 ' HD2' HG23 ' A' ' 34' ' ' THR . 91.8 mttt -107.37 -29.67 9.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.117 -0.989 . . . . 0.0 110.375 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 38.0 p30 -69.86 -11.2 60.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.185 -0.947 . . . . 0.0 110.485 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.452 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 66.24 99.03 0.02 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -155.21 -51.74 0.09 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.263 -1.14 . . . . 0.0 110.377 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.0 -5.12 5.04 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 77.4 p -145.37 152.05 39.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.001 -1.294 . . . . 0.0 110.207 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.447 HD13 ' CE2' ' A' ' 16' ' ' PHE . 46.8 mt -87.37 101.23 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.259 -0.901 . . . . 0.0 110.071 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.2 p -95.37 -177.59 4.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.381 -0.824 . . . . 0.0 109.909 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.0 p -63.1 -30.07 71.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.077 -1.015 . . . . 0.0 110.227 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -63.69 -56.94 11.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.131 -0.981 . . . . 0.0 110.203 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.442 ' CG ' ' OD2' ' A' ' 22' ' ' ASP . 32.0 mt-10 -57.31 -46.45 83.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.868 . . . . 0.0 110.023 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.465 HD21 ' CG ' ' A' ' 48' ' ' LEU . 11.0 tp -64.02 -23.25 67.26 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.19 -0.944 . . . . 0.0 109.774 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.04 -42.99 74.97 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.436 HG23 ' HD2' ' A' ' 21' ' ' LYS . 91.6 m -81.5 -18.77 43.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -1.131 . . . . 0.0 109.892 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.461 ' O ' ' CD1' ' A' ' 39' ' ' LEU . 51.6 t -79.59 -31.89 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.032 -1.043 . . . . 0.0 109.777 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.413 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 26.3 mmt -89.93 -25.4 20.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.297 -0.877 . . . . 0.0 110.163 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.429 ' HD2' ' HA ' ' A' ' 42' ' ' ASN . 3.3 tpt180 -89.37 -25.7 21.43 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.219 -0.926 . . . . 0.0 110.127 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 34' ' ' THR . 62.2 m -85.4 -14.2 47.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -0.926 . . . . 0.0 110.3 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.461 ' CD1' ' O ' ' A' ' 35' ' ' VAL . 30.5 mt -89.82 -88.03 0.17 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.234 -0.916 . . . . 0.0 110.334 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 41' ' ' GLN . . . -152.22 51.99 0.49 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.421 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 36.8 mt-30 -158.02 169.19 25.13 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.262 -1.14 . . . . 0.0 110.09 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.45 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 77.5 m-20 -144.4 58.24 5.53 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.496 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.45 ' HD3' ' N ' ' A' ' 42' ' ' ASN . 48.5 Cg_endo -79.19 -177.8 4.16 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.792 1.417 . . . . 0.0 110.369 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.3 m -112.68 169.42 8.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.25 -0.906 . . . . 0.0 110.159 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -66.84 -35.2 79.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.164 -0.96 . . . . 0.0 110.034 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.84 -66.72 0.6 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.266 -0.896 . . . . 0.0 109.88 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.405 ' OE1' ' HA ' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -47.25 -35.89 8.29 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.311 -0.868 . . . . 0.0 109.618 179.633 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.465 ' CG ' HD21 ' A' ' 32' ' ' LEU . 6.2 tt -61.99 -47.35 85.19 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.509 -0.744 . . . . 0.0 109.805 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.52 -43.54 65.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.929 . . . . 0.0 109.659 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -65.13 -33.02 75.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.923 . . . . 0.0 109.4 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.458 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 31.6 ttp -71.17 -17.69 62.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.341 -0.85 . . . . 0.0 109.481 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.9 mt -86.17 -27.39 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.353 -0.842 . . . . 0.0 109.85 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -59.03 -23.64 62.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 110.123 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.458 ' CG ' ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -83.88 -24.97 30.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.283 -0.886 . . . . 0.0 110.128 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.419 HG11 ' HE2' ' A' ' 71' ' ' MET . 80.2 t -85.57 -65.5 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.225 -0.922 . . . . 0.0 109.991 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.402 ' OD2' ' OD1' ' A' ' 60' ' ' ASN . 46.6 t0 -50.31 135.74 21.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.377 -0.827 . . . . 0.0 110.285 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -103.66 -27.04 12.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.279 -0.888 . . . . 0.0 109.789 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -69.97 -30.71 68.12 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.367 -0.833 . . . . 0.0 109.812 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.06 24.51 61.51 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.402 ' OD1' ' OD2' ' A' ' 56' ' ' ASP . 14.2 p-10 -81.55 -32.7 32.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.164 -1.198 . . . . 0.0 110.219 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 129.28 -18.35 5.52 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.756 -1.212 . . . . 0.0 110.094 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 41.3 p -144.74 170.09 16.77 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.103 -1.233 . . . . 0.0 110.366 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.401 ' HA ' ' OE1' ' A' ' 67' ' ' GLU . 45.7 mt -112.48 163.46 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.106 -0.997 . . . . 0.0 110.163 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -125.01 -164.74 1.31 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.19 -0.944 . . . . 0.0 110.531 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.54 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 57.1 t80 -78.81 -43.89 1.85 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.344 -0.847 . . . . 0.0 111.386 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.2 Cg_endo -72.51 -32.54 9.75 Favored 'Trans proline' 0 C--N 1.324 -0.739 0 O-C-N 123.001 1.001 . . . . 0.0 110.176 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 71' ' ' MET . 35.0 tt0 -76.55 -20.84 56.43 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.226 -0.921 . . . . 0.0 109.277 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.531 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 8.7 t80 -80.96 -44.35 18.33 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.501 -0.749 . . . . 0.0 109.703 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.428 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -71.47 -22.76 61.77 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.324 -0.86 . . . . 0.0 109.613 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.0 m -85.2 -41.28 15.78 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.419 -0.801 . . . . 0.0 110.242 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.478 ' HG3' ' N ' ' A' ' 72' ' ' MET . 19.5 ptm -66.11 -33.2 75.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.135 -0.978 . . . . 0.0 110.169 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.531 ' CE ' ' CZ ' ' A' ' 68' ' ' PHE . 20.6 mtt -90.15 -10.78 43.27 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.237 -0.914 . . . . 0.0 110.269 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.428 ' HB1' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.129 -0.982 . . . . 0.0 110.349 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 121.143 0.497 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 54.0 mt -46.72 -32.85 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.105 -0.997 . . . . 0.0 109.947 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.401 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 35.0 ttt180 -66.2 -47.21 74.61 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.421 -0.799 . . . . 0.0 109.354 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -49.27 -48.48 45.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.437 -0.789 . . . . 0.0 109.983 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.439 ' O ' ' CG2' ' A' ' 91' ' ' VAL . . . -62.9 -61.47 2.38 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.385 -0.822 . . . . 0.0 110.19 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -44.69 -26.98 0.44 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.428 -0.795 . . . . 0.0 110.644 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 86' ' ' ARG . 4.9 mmp_? -75.53 -47.66 25.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.273 -0.892 . . . . 0.0 110.469 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 88' ' ' ALA . 35.8 m -70.65 -9.75 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.201 -0.937 . . . . 0.0 110.864 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.564 ' CE1' ' CG1' ' A' ' 108' ' ' VAL . 42.7 m-85 -103.02 -22.89 13.73 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.099 -1.001 . . . . 0.0 110.77 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -114.23 77.67 1.08 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.078 -1.013 . . . . 0.0 110.306 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.9 ptpt -109.69 -7.28 15.1 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.251 -0.905 . . . . 0.0 110.55 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.418 ' OD2' ' OD1' ' A' ' 97' ' ' ASN . 10.8 p-10 -73.28 -37.78 66.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.033 -1.042 . . . . 0.0 110.121 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 121.62 -24.14 7.28 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.196 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.462 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 15.0 p-10 -58.71 -30.01 67.11 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.704 -1.469 . . . . 0.0 110.863 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.471 ' C ' ' CD1' ' A' ' 99' ' ' TYR . . . 94.0 16.25 45.36 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.576 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.481 ' CD2' ' NE2' ' A' ' 135' ' ' GLN . 86.4 m-85 -142.09 151.54 42.44 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.95 -1.323 . . . . 0.0 110.188 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.404 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 24.0 mt -91.97 130.69 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.11 -0.994 . . . . 0.0 109.729 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 44.4 t -114.98 165.67 12.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.292 -0.88 . . . . 0.0 110.113 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.408 ' HA ' HG13 ' A' ' 125' ' ' ILE . . . -59.07 -29.45 67.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.279 -0.888 . . . . 0.0 110.343 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.12 -54.5 7.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.189 -0.944 . . . . 0.0 110.414 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.451 ' O ' ' CG2' ' A' ' 108' ' ' VAL . 43.7 mt-10 -53.51 -40.65 65.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.216 -0.927 . . . . 0.0 110.282 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.7 tt -71.19 -32.94 69.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.146 -0.971 . . . . 0.0 110.492 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -71.36 -21.35 62.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.07 -1.019 . . . . 0.0 109.898 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.469 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 54.9 t60 -95.68 -20.27 19.05 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.247 -0.908 . . . . 0.0 109.729 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.564 ' CG1' ' CE1' ' A' ' 92' ' ' PHE . 93.2 t -84.14 -38.12 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.321 -0.862 . . . . 0.0 110.307 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.5 mmt -63.67 -30.45 71.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.867 . . . . 0.0 110.152 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.1 p -69.06 -39.16 79.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 109.965 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 107' ' ' HIS . 76.4 m-20 -66.6 -42.91 86.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.189 -0.944 . . . . 0.0 110.224 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.9 mt -66.54 -33.57 75.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.898 . . . . 0.0 110.125 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.51 -16.72 11.41 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.431 ' CD ' ' N ' ' A' ' 114' ' ' GLU . 5.6 mp0 -69.01 114.11 6.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -1.131 . . . . 0.0 110.288 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.29 121.39 32.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 110.384 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.59 169.82 12.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 110.104 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.404 HG21 ' N ' ' A' ' 118' ' ' ASP . 27.9 m -98.25 159.49 14.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.105 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.404 ' N ' HG21 ' A' ' 117' ' ' THR . 68.6 m-20 -54.35 -44.01 71.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.217 -0.927 . . . . 0.0 110.186 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -65.35 -43.31 91.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 110.409 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -55.76 -46.97 77.76 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.169 -0.957 . . . . 0.0 110.603 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 77.9 t -59.49 -55.41 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 110.254 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.44 -24.99 49.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.159 -0.963 . . . . 0.0 109.928 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -76.33 -33.99 59.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.356 -0.84 . . . . 0.0 110.064 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 54.5 mtp -71.51 -42.28 68.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 0.0 110.007 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.41 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 31.5 mm -66.71 -36.76 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.255 -0.903 . . . . 0.0 110.08 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.57 -57.37 7.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.278 -0.889 . . . . 0.0 110.129 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.414 ' HA ' ' OE1' ' A' ' 127' ' ' GLU . 3.1 mm-40 -51.2 -42.18 60.74 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.4 -0.812 . . . . 0.0 110.641 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -70.24 -30.61 67.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.203 -0.936 . . . . 0.0 110.449 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 6.8 t0 -74.62 84.09 2.07 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.282 -0.886 . . . . 0.0 110.267 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.4 mt -58.57 -37.91 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.215 -0.928 . . . . 0.0 110.034 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.9 p30 -77.13 -32.3 56.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.268 -0.895 . . . . 0.0 109.991 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.453 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 81.03 60.03 2.34 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 135' ' ' GLN . 56.3 p30 -117.21 8.12 13.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.161 -1.199 . . . . 0.0 110.442 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.61 -40.48 3.04 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.481 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 7.0 pt20 -98.17 158.03 15.8 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.062 -1.258 . . . . 0.0 110.485 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.404 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 76.2 t -114.3 134.05 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.384 -0.823 . . . . 0.0 110.232 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.454 ' OD1' ' CG ' ' A' ' 140' ' ' GLU . 24.2 p-10 -105.19 171.83 7.11 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.124 -0.985 . . . . 0.0 109.997 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -52.83 -60.59 3.08 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.228 -0.92 . . . . 0.0 111.471 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -44.3 -51.84 8.06 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.134 -0.979 . . . . 0.0 111.375 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.46 ' O ' ' CG ' ' A' ' 144' ' ' MET . 58.3 mt-10 -59.89 -37.25 78.85 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.985 -1.072 . . . . 0.0 110.459 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.57 ' CZ ' ' CE ' ' A' ' 145' ' ' MET . 87.4 t80 -66.38 -22.17 66.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.311 -0.868 . . . . 0.0 110.782 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 98.1 t -90.5 -42.18 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.026 -1.046 . . . . 0.0 111.231 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -78.61 -13.37 59.86 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.955 -1.091 . . . . 0.0 110.62 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.46 ' CG ' ' O ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -90.72 -9.91 44.98 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.064 -1.023 . . . . 0.0 110.582 -179.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.57 ' CE ' ' CZ ' ' A' ' 141' ' ' PHE . 18.9 mtt -90.68 -70.85 0.66 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.037 -1.04 . . . . 0.0 111.669 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.497 1.906 0 O-C-N 120.955 -1.091 . . . . 0.0 111.024 -178.966 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.16 0.505 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -69.14 -62.54 1.34 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.18 -0.95 . . . . 0.0 110.373 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.444 ' HG2' ' CE2' ' A' ' 12' ' ' PHE . 11.7 tt0 -58.76 -41.13 85.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 110.14 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.2 mt -58.38 -37.81 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.194 -0.941 . . . . 0.0 109.906 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -69.28 -33.24 72.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.295 -0.878 . . . . 0.0 109.963 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -61.2 -51.37 69.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 109.597 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.444 ' CE2' ' HG2' ' A' ' 8' ' ' GLN . 21.4 m-85 -58.64 -39.03 79.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.469 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -54.14 -42.5 69.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 109.554 179.463 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.414 ' O ' HD22 ' A' ' 18' ' ' LEU . 35.1 mt-10 -61.34 -45.04 96.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -0.895 . . . . 0.0 109.786 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.501 ' O ' ' CG ' ' A' ' 19' ' ' PHE . . . -53.49 -48.89 68.54 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.302 -0.873 . . . . 0.0 109.523 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.511 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 28.8 t80 -65.35 -26.67 68.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.383 -0.823 . . . . 0.0 109.797 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.91 -63.65 1.23 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.313 -0.867 . . . . 0.0 110.001 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.457 HD13 ' CE1' ' A' ' 19' ' ' PHE . 0.7 OUTLIER -64.37 -19.64 65.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.257 -0.902 . . . . 0.0 109.748 179.683 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.501 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 10.5 m-30 -69.61 -32.2 70.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.361 -0.837 . . . . 0.0 109.444 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -97.96 97.23 8.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -87.52 49.92 1.9 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 110.253 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 2.7 p30 -170.77 -32.45 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.384 -0.822 . . . . 0.0 110.583 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 77.08 60.87 2.78 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -108.03 -39.6 5.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -1.18 . . . . 0.0 110.816 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.412 ' C ' ' CG2' ' A' ' 26' ' ' THR . . . 135.83 -10.05 4.24 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.23 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.412 ' CG2' ' C ' ' A' ' 25' ' ' GLY . 68.1 p -151.06 168.28 25.1 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.1 -1.235 . . . . 0.0 110.425 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.409 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 65.6 mt -102.59 123.26 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.369 -0.832 . . . . 0.0 110.294 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.1 p -92.97 -163.78 1.09 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.332 -0.855 . . . . 0.0 110.179 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.436 HG21 ' CD1' ' A' ' 52' ' ' ILE . 4.5 p -90.31 -45.25 9.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.243 -0.911 . . . . 0.0 110.781 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.1 pttt -56.47 -45.83 80.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.987 -1.071 . . . . 0.0 110.16 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.406 ' O ' HG22 ' A' ' 35' ' ' VAL . 49.6 mt-10 -63.76 -48.75 75.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.98 -1.075 . . . . 0.0 109.34 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.419 ' O ' ' HG2' ' A' ' 36' ' ' MET . 13.1 tp -62.61 -15.68 52.82 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.45 -0.781 . . . . 0.0 109.753 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.46 ' HA2' ' CD1' ' A' ' 48' ' ' LEU . . . -75.89 -46.17 14.57 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 57.7 m -71.27 -20.18 62.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -1.094 . . . . 0.0 109.653 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 31' ' ' GLU . 54.3 t -83.33 -33.12 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.33 -0.856 . . . . 0.0 109.968 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 26.0 mmt -88.38 -18.34 28.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.155 -0.965 . . . . 0.0 109.899 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.408 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 5.9 tpt180 -90.83 -36.05 14.45 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.0 110.249 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.6 m -80.9 -45.08 17.33 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.243 -0.911 . . . . 0.0 110.045 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.7 mt -92.47 -36.49 13.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 110.079 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 36' ' ' MET . . . -68.64 -112.65 0.02 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -148.67 -70.29 0.21 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.254 -1.145 . . . . 0.0 110.351 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.508 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 51.6 t30 -163.39 49.7 0.24 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 0.0 110.463 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 42' ' ' ASN . 45.3 Cg_endo -71.52 -166.26 0.23 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.747 1.393 . . . . 0.0 110.127 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 4.9 t -141.31 173.15 11.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.132 -0.98 . . . . 0.0 110.277 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -68.21 -25.73 65.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.188 -0.945 . . . . 0.0 109.973 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.99 -65.62 0.82 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.294 -0.879 . . . . 0.0 109.606 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.416 ' OE1' ' HA ' ' A' ' 47' ' ' GLU . 6.0 tp10 -52.9 -23.55 7.37 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.419 -0.801 . . . . 0.0 109.406 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.46 ' CD1' ' HA2' ' A' ' 33' ' ' GLY . 3.6 tt -68.72 -56.44 8.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.439 -0.788 . . . . 0.0 109.244 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -47.69 -44.01 27.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 109.411 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -63.0 -40.21 97.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.518 -0.739 . . . . 0.0 109.597 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.421 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 6.3 ttp -66.02 -17.81 64.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.339 -0.851 . . . . 0.0 109.779 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.436 ' CD1' HG21 ' A' ' 29' ' ' THR . 33.8 mt -89.79 -24.97 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 109.608 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -66.0 -36.66 83.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 110.277 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.473 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 16.3 pt-20 -68.19 -36.8 80.16 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.099 -1.0 . . . . 0.0 110.251 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.473 ' N ' ' HG3' ' A' ' 54' ' ' GLU . 99.4 t -76.2 -67.96 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.115 -0.991 . . . . 0.0 110.293 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -43.91 105.9 0.06 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.591 -0.693 . . . . 0.0 110.491 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.12 33.2 4.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.909 . . . . 0.0 110.356 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.3 p30 -122.9 -40.49 2.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.919 . . . . 0.0 110.235 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 103.49 45.99 1.48 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.434 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 19.8 p-10 -122.73 -27.71 4.28 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.089 -1.242 . . . . 0.0 110.397 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.62 -74.54 0.41 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.674 -1.251 . . . . 0.0 110.268 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.8 p -86.1 170.1 12.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.207 -1.172 . . . . 0.0 110.575 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.409 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 20.5 mt -90.13 159.28 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.296 -0.878 . . . . 0.0 109.719 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.42 ' OD2' ' HD2' ' A' ' 66' ' ' PRO . 10.4 t0 -115.41 -179.48 3.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.243 -0.911 . . . . 0.0 110.489 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.56 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 10.6 t80 -74.98 -41.94 4.28 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.333 -0.855 . . . . 0.0 111.752 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.7 Cg_endo -72.07 -17.03 28.57 Favored 'Trans proline' 0 C--O 1.212 -0.823 0 O-C-N 123.105 1.055 . . . . 0.0 110.583 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 71' ' ' MET . 51.2 mt-10 -84.67 -37.52 20.9 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.006 -1.059 . . . . 0.0 108.916 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.511 ' CE2' ' HB2' ' A' ' 16' ' ' PHE . 73.1 t80 -63.67 -48.33 77.65 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.542 -0.723 . . . . 0.0 110.217 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 tp -74.4 -37.01 63.5 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.29 -0.881 . . . . 0.0 110.446 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.415 ' HB ' ' O ' ' A' ' 66' ' ' PRO . 71.4 m -74.63 -10.2 59.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.135 -0.978 . . . . 0.0 110.441 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.431 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 63.6 ttp -91.44 -49.89 6.09 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.885 -1.135 . . . . 0.0 109.746 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.48 ' CE ' ' CE1' ' A' ' 68' ' ' PHE . 39.4 mtt -91.75 -63.58 1.23 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.338 -0.851 . . . . 0.0 111.645 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.094 0 O-C-N 121.267 -0.896 . . . . 0.0 111.749 -178.361 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.123 0.487 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.516 HG21 ' CE2' ' A' ' 141' ' ' PHE . 41.5 mt -52.31 -40.1 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.232 -0.918 . . . . 0.0 110.121 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 20.1 ttt85 -55.12 -49.38 71.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.418 -0.801 . . . . 0.0 110.269 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.431 ' O ' HG11 ' A' ' 91' ' ' VAL . 48.5 mt-10 -64.59 -37.13 86.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.342 -0.849 . . . . 0.0 110.429 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 92' ' ' PHE . . . -64.94 -22.52 67.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 110.302 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.499 ' CD1' HD12 ' A' ' 100' ' ' ILE . 22.4 t80 -83.48 -38.86 21.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.091 -1.006 . . . . 0.0 110.201 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -70.66 -31.44 68.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.381 -0.824 . . . . 0.0 110.777 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.446 ' CG2' ' N ' ' A' ' 92' ' ' PHE . 7.2 m -83.56 -41.42 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.077 -1.014 . . . . 0.0 110.488 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.446 ' N ' ' CG2' ' A' ' 91' ' ' VAL . 9.5 m-85 -67.67 -23.48 65.32 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.971 -1.081 . . . . 0.0 110.012 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -108.6 81.03 1.4 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.219 -0.926 . . . . 0.0 109.935 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 91' ' ' VAL . 13.4 mtpt -97.26 1.55 49.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 0.0 110.89 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 2.3 p30 -79.39 -27.77 41.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.931 -1.106 . . . . 0.0 109.784 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.402 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 94.63 44.16 3.48 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.463 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 23.9 p-10 -128.57 -14.28 4.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.185 -1.185 . . . . 0.0 110.984 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.98 -5.88 84.32 Favored Glycine 0 N--CA 1.504 3.197 0 O-C-N 120.974 -1.079 . . . . 0.0 110.876 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.463 ' HB2' ' ND2' ' A' ' 97' ' ' ASN . 9.5 m-85 -116.61 139.03 50.97 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.954 -1.321 . . . . 0.0 110.309 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.499 HD12 ' CD1' ' A' ' 89' ' ' PHE . 22.0 mt -91.3 115.74 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.222 -0.924 . . . . 0.0 109.916 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.9 t -100.01 172.59 7.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 109.956 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.419 ' HA ' HG13 ' A' ' 125' ' ' ILE . . . -70.67 -41.85 71.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.196 -0.94 . . . . 0.0 110.215 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -55.08 -53.78 51.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.316 -0.865 . . . . 0.0 110.122 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -56.74 -49.84 74.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 110.047 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.414 ' HB3' HG12 ' A' ' 121' ' ' VAL . 1.5 tt -51.1 -34.7 31.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.892 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.417 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 9.5 ttm180 -66.72 -41.55 87.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.241 -0.912 . . . . 0.0 109.814 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -75.45 -10.08 59.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.312 -0.867 . . . . 0.0 110.283 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.418 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 97.4 t -86.64 -52.13 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.02 -1.05 . . . . 0.0 110.196 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 14.3 mmt -73.4 -60.43 2.25 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.203 -0.935 . . . . 0.0 110.434 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.1 m -46.66 -35.56 6.12 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.401 -0.812 . . . . 0.0 110.552 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -73.73 -45.13 53.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.175 -0.953 . . . . 0.0 110.415 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 41.4 mt -50.04 -52.25 35.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.204 -0.935 . . . . 0.0 110.285 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 157.04 -38.12 0.56 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -57.57 139.5 53.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.292 -1.122 . . . . 0.0 110.242 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -106.89 79.61 1.35 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -0.875 . . . . 0.0 110.335 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.61 -179.1 7.06 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.279 -0.888 . . . . 0.0 110.048 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 66.9 m -108.4 153.79 22.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.247 -0.908 . . . . 0.0 110.252 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.96 -40.87 64.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.321 -0.862 . . . . 0.0 110.466 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -59.04 -41.4 87.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.202 -0.936 . . . . 0.0 110.374 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -56.14 -56.91 15.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.333 -0.854 . . . . 0.0 110.496 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.414 HG12 ' HB3' ' A' ' 105' ' ' LEU . 97.6 t -54.5 -48.38 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 110.444 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -56.22 -33.37 65.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 0.0 110.225 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -74.4 -28.4 61.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 110.067 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.412 ' HB3' ' HE1' ' A' ' 124' ' ' MET . 95.5 mtp -71.65 -53.2 14.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.262 -0.899 . . . . 0.0 109.933 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.419 HG13 ' HA ' ' A' ' 102' ' ' ALA . 29.3 mm -61.51 -32.06 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 109.993 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 54.2 ttt-85 -64.91 -53.95 38.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.327 -0.858 . . . . 0.0 110.18 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -60.61 -32.47 71.6 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.128 -0.982 . . . . 0.0 110.131 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.456 ' CB ' HG23 ' A' ' 136' ' ' VAL . . . -70.18 -27.69 64.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.277 -0.889 . . . . 0.0 110.189 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -70.33 87.96 0.63 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.939 . . . . 0.0 110.178 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 68.7 mt -65.91 -43.01 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.232 -0.917 . . . . 0.0 110.111 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.402 ' OD1' ' OE2' ' A' ' 140' ' ' GLU . 5.4 p-10 -79.38 -42.39 25.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -0.95 . . . . 0.0 110.115 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.86 84.63 1.81 Allowed Glycine 0 N--CA 1.485 1.964 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.479 ' OD2' ' CG ' ' A' ' 135' ' ' GLN . 18.1 p-10 -147.96 -46.49 0.16 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.254 -1.145 . . . . 0.0 110.598 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 134.3 31.61 0.36 Allowed Glycine 0 N--CA 1.498 2.772 0 C-N-CA 119.491 -1.337 . . . . 0.0 110.889 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.479 ' CG ' ' OD2' ' A' ' 133' ' ' ASP . 8.8 pt20 -169.98 135.82 1.43 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.971 -1.311 . . . . 0.0 110.134 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.456 HG23 ' CB ' ' A' ' 128' ' ' ALA . 22.2 t -100.09 113.06 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -0.975 . . . . 0.0 110.283 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.422 ' ND2' ' OE1' ' A' ' 140' ' ' GLU . 13.8 p30 -89.3 -169.87 2.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.013 -1.054 . . . . 0.0 109.987 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -62.32 -48.03 81.63 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.078 -1.014 . . . . 0.0 111.095 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -56.05 -55.9 27.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.072 -1.017 . . . . 0.0 110.617 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.422 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 56.2 mt-10 -61.55 -22.69 65.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.275 -0.891 . . . . 0.0 110.748 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.516 ' CE2' HG21 ' A' ' 85' ' ' ILE . 9.8 t80 -79.83 -26.56 40.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.176 -0.952 . . . . 0.0 110.104 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.425 ' O ' ' HB ' ' A' ' 146' ' ' THR . 85.9 t -90.32 -24.21 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.255 -0.903 . . . . 0.0 110.287 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -83.29 -42.27 17.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.185 -0.947 . . . . 0.0 110.654 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.467 ' HG3' ' N ' ' A' ' 145' ' ' MET . 5.2 ptt? -59.73 -38.92 83.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.146 -0.971 . . . . 0.0 110.195 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.467 ' N ' ' HG3' ' A' ' 144' ' ' MET . 14.3 ttm -91.35 -9.33 45.29 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.248 -0.908 . . . . 0.0 110.343 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.425 ' HB ' ' O ' ' A' ' 142' ' ' VAL . 1.3 m . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.046 -1.034 . . . . 0.0 110.887 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 121.271 0.558 . . . . 0.0 109.784 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -59.94 -40.99 90.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.374 -0.828 . . . . 0.0 109.771 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.406 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 34.9 tp60 -58.98 -44.4 91.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.689 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 57.1 mt -58.47 -45.96 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.9 . . . . 0.0 109.65 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.18 -27.04 68.69 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.317 -0.864 . . . . 0.0 109.657 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.408 ' OE1' ' HA ' ' A' ' 11' ' ' GLU . 5.9 tp10 -67.62 -44.52 77.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.33 -0.856 . . . . 0.0 109.848 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -61.82 -52.62 63.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 0.0 109.641 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -51.93 -43.38 63.42 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.24 -0.913 . . . . 0.0 109.389 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -56.27 -42.21 77.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 0.0 109.555 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.44 -39.66 88.31 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.39 -0.819 . . . . 0.0 109.749 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -56.51 -49.88 73.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.66 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 64.8 m -59.93 -31.0 69.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 109.642 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.424 ' CD2' ' O ' ' A' ' 18' ' ' LEU . 2.5 tt -65.49 -32.79 74.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.419 -0.801 . . . . 0.0 109.853 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.505 ' CD1' HG12 ' A' ' 35' ' ' VAL . 5.2 m-85 -87.11 -67.06 0.85 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.395 -0.816 . . . . 0.0 109.999 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -48.24 95.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.957 -1.089 . . . . 0.0 109.988 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.458 ' HD2' ' O ' ' A' ' 19' ' ' PHE . 0.7 OUTLIER -84.33 -47.84 10.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.91 . . . . 0.0 110.455 -179.659 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 3.9 p30 -70.0 -20.89 63.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.108 -0.995 . . . . 0.0 110.025 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.463 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 74.83 72.84 0.99 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.406 ' OD2' ' OD1' ' A' ' 22' ' ' ASP . 65.1 m-20 -112.77 -23.4 10.18 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.145 -1.209 . . . . 0.0 109.932 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.44 -11.96 47.29 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.9 p -132.75 148.02 52.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.184 -1.186 . . . . 0.0 110.298 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.6 mt -102.86 124.77 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.97 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.5 p -114.55 -161.85 0.79 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.339 -0.85 . . . . 0.0 110.599 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.471 ' CG2' HG13 ' A' ' 52' ' ' ILE . 52.0 p -82.31 -21.04 36.27 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.376 -0.828 . . . . 0.0 110.48 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -74.66 -59.17 2.86 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.231 -0.918 . . . . 0.0 110.032 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.19 -45.92 91.25 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.314 -0.866 . . . . 0.0 109.874 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.461 HD23 ' CD1' ' A' ' 52' ' ' ILE . 3.5 tp -62.73 -36.58 83.46 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.193 -0.942 . . . . 0.0 109.74 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.06 -41.86 86.11 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 65.5 m -80.53 -23.37 40.06 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.128 -1.219 . . . . 0.0 110.503 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.505 HG12 ' CD1' ' A' ' 19' ' ' PHE . 38.1 t -72.59 -29.86 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.228 -0.92 . . . . 0.0 110.002 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -89.87 -30.23 18.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -0.882 . . . . 0.0 109.452 179.409 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.466 ' HD3' ' ND2' ' A' ' 42' ' ' ASN . 22.8 tpp180 -62.46 -58.15 8.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.475 -0.766 . . . . 0.0 110.236 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.2 t -95.13 10.36 36.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -0.891 . . . . 0.0 110.384 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.62 59.88 0.17 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.059 -1.025 . . . . 0.0 110.319 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 163.07 -97.89 0.15 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.419 ' O ' ' CD ' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -148.46 175.62 10.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -1.136 . . . . 0.0 110.099 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.466 ' ND2' ' HD3' ' A' ' 37' ' ' ARG . 1.7 m120 -107.71 73.77 0.42 Allowed Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.307 -0.871 . . . . 0.0 110.407 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.419 ' CD ' ' O ' ' A' ' 41' ' ' GLN . 46.9 Cg_endo -72.07 -178.56 3.27 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.719 1.378 . . . . 0.0 110.205 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.428 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 9.3 m -105.42 167.01 10.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.894 . . . . 0.0 109.542 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -54.71 -52.99 60.7 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.928 -1.108 . . . . 0.0 110.159 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.11 -62.72 1.28 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.185 -0.947 . . . . 0.0 110.645 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -45.23 -26.78 0.54 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.238 -0.914 . . . . 0.0 109.982 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 44' ' ' THR . 9.2 tt -70.44 -51.5 28.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.374 -0.829 . . . . 0.0 109.293 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.409 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 4.1 tp-100 -50.37 -38.26 41.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.201 -0.937 . . . . 0.0 109.349 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -61.65 -43.93 97.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.277 -0.89 . . . . 0.0 109.104 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.2 ttp -60.25 -22.93 63.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.446 -0.784 . . . . 0.0 109.353 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.471 HG13 ' CG2' ' A' ' 29' ' ' THR . 35.8 mm -81.68 -27.53 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.536 -0.727 . . . . 0.0 110.279 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -81.57 -15.18 55.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.207 -0.933 . . . . 0.0 110.825 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -88.47 -16.42 32.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.95 -1.094 . . . . 0.0 110.628 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.414 ' CG1' HD12 ' A' ' 63' ' ' ILE . 64.0 t -104.23 -36.88 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.097 -1.002 . . . . 0.0 110.403 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -84.9 103.23 13.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.959 . . . . 0.0 110.039 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.98 41.72 1.56 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.288 -0.882 . . . . 0.0 109.986 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -115.29 18.48 16.1 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.371 -0.831 . . . . 0.0 109.674 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.42 29.24 30.47 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -108.07 -63.97 1.26 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.256 -1.143 . . . . 0.0 110.409 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.28 -65.2 0.43 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 81.1 p -96.07 161.31 14.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -1.148 . . . . 0.0 109.709 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.414 HD12 ' CG1' ' A' ' 55' ' ' VAL . 78.6 mt -84.05 142.15 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.117 -0.989 . . . . 0.0 110.427 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.406 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 56.3 m-20 -101.83 -176.69 3.2 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.319 -0.863 . . . . 0.0 109.945 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.548 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -72.61 -47.24 9.51 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 111.089 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.6 Cg_endo -72.28 -24.4 19.77 Favored 'Trans proline' 0 C--N 1.321 -0.892 0 O-C-N 123.336 1.177 . . . . 0.0 110.408 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -77.34 -28.08 52.95 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.173 -0.955 . . . . 0.0 108.714 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.537 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 7.9 t80 -76.8 -38.07 54.61 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.639 -0.663 . . . . 0.0 109.976 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.454 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 27.5 tp -75.23 -26.42 58.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.359 -0.838 . . . . 0.0 110.271 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.0 m -79.95 -32.33 39.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.178 -0.951 . . . . 0.0 110.076 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.427 ' HG3' ' N ' ' A' ' 72' ' ' MET . 16.8 ptm -84.5 -29.09 26.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.333 -0.854 . . . . 0.0 110.634 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.537 ' CE ' ' CZ ' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -90.58 -29.53 17.77 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.198 -0.939 . . . . 0.0 110.74 -179.658 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.761 0 O-C-N 121.207 -0.933 . . . . 0.0 110.473 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.303 0.573 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.3 mm -67.71 -41.8 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 110.341 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -71.45 -43.81 65.98 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.27 -0.894 . . . . 0.0 110.267 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -58.71 -43.92 90.2 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.18 -0.95 . . . . 0.0 110.212 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.41 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -59.8 -60.29 4.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 0.0 109.751 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CZ ' ' O ' ' A' ' 98' ' ' GLY . 6.2 t80 -48.95 -25.72 2.1 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.323 -0.86 . . . . 0.0 109.805 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.414 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 21.9 ttt180 -69.29 -64.45 0.87 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.426 -0.796 . . . . 0.0 110.858 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.483 HG21 ' N ' ' A' ' 92' ' ' PHE . 32.9 m -56.59 -35.2 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.333 -0.854 . . . . 0.0 111.545 -178.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.508 ' CE1' HD11 ' A' ' 105' ' ' LEU . 44.4 m-85 -77.93 -21.81 50.55 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.824 -1.173 . . . . 0.0 110.932 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 89' ' ' PHE . 97.0 m-20 -128.03 40.76 3.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.053 -1.03 . . . . 0.0 109.944 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 21.2 pttp -91.85 25.19 2.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 110.022 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.419 ' OD1' ' HB2' ' A' ' 97' ' ' ASN . 2.8 p30 -107.19 0.58 23.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.368 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.04 16.82 36.97 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.419 ' HB2' ' OD1' ' A' ' 95' ' ' ASP . 21.4 t-20 -95.53 -62.13 1.35 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.097 -1.237 . . . . 0.0 110.287 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.504 ' O ' ' CZ ' ' A' ' 89' ' ' PHE . . . 121.46 -57.82 0.59 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.443 ' CE1' ' OD1' ' A' ' 137' ' ' ASN . 12.7 m-85 -91.5 159.76 15.77 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.267 -1.137 . . . . 0.0 110.138 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.449 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 17.5 mt -87.17 154.89 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.106 -0.996 . . . . 0.0 109.467 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.3 t -140.57 -177.43 5.05 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.137 -0.977 . . . . 0.0 110.611 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.74 -34.18 40.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.366 -0.833 . . . . 0.0 109.953 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.06 -54.91 9.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -0.963 . . . . 0.0 109.928 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -59.14 -43.76 92.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.251 -0.906 . . . . 0.0 109.846 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.508 HD11 ' CE1' ' A' ' 92' ' ' PHE . 56.8 tp -52.22 -50.41 62.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 110.28 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -67.55 -26.26 66.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -0.883 . . . . 0.0 110.471 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.418 ' O ' ' ND1' ' A' ' 107' ' ' HIS . 31.9 t-80 -75.85 -16.82 60.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.131 -0.981 . . . . 0.0 110.12 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.415 HG23 ' HA ' ' A' ' 92' ' ' PHE . 72.8 t -88.68 -50.56 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.359 -0.838 . . . . 0.0 110.267 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.419 ' HE2' HD13 ' A' ' 105' ' ' LEU . 55.6 mtt -68.57 -44.29 74.73 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.359 -0.838 . . . . 0.0 110.532 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 91.0 m -58.83 -44.49 90.9 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.271 -0.893 . . . . 0.0 110.457 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -64.84 -53.36 47.98 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.252 -0.905 . . . . 0.0 110.689 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 27.6 mt -46.86 -86.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.236 -0.915 . . . . 0.0 110.307 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -179.97 33.67 0.06 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -122.98 143.19 50.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -1.194 . . . . 0.0 110.156 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.424 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 39.4 pttt -113.8 117.55 31.77 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.265 -0.897 . . . . 0.0 109.942 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.8 mt -124.72 149.77 46.91 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.109 -0.994 . . . . 0.0 110.646 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 39.7 m -71.63 136.79 47.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.283 -0.886 . . . . 0.0 110.052 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -47.87 -44.06 29.01 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.186 -0.946 . . . . 0.0 110.218 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -55.44 -43.01 75.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.836 . . . . 0.0 110.579 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 124' ' ' MET . 45.9 mt-10 -60.37 -51.93 67.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.209 -0.932 . . . . 0.0 110.583 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.422 HG11 ' CD2' ' A' ' 105' ' ' LEU . 54.1 t -53.43 -48.22 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.074 -1.017 . . . . 0.0 110.339 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -58.43 -41.23 84.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.174 -0.954 . . . . 0.0 110.246 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -70.54 -20.64 62.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.913 . . . . 0.0 110.195 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.423 ' HG3' ' O ' ' A' ' 120' ' ' GLU . 85.2 mtp -76.94 -43.67 34.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.175 -0.953 . . . . 0.0 109.615 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 14.4 mm -67.7 -30.3 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.886 . . . . 0.0 109.926 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.8 ttp85 -75.91 -52.26 10.68 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.113 -0.992 . . . . 0.0 110.217 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -54.17 -38.5 65.62 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.214 -0.928 . . . . 0.0 110.151 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.22 -41.56 63.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.877 . . . . 0.0 109.802 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -69.22 92.99 0.59 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.383 -0.823 . . . . 0.0 109.771 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 75.9 mt -63.23 -44.14 99.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.368 -0.833 . . . . 0.0 110.777 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.9 p30 -74.31 -29.41 61.61 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.113 -0.992 . . . . 0.0 110.274 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.453 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 75.19 57.94 4.15 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.444 ' OD1' ' CG ' ' A' ' 135' ' ' GLN . 57.1 p-10 -106.82 0.98 24.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.127 -1.219 . . . . 0.0 110.6 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.14 26.47 12.37 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.444 ' CG ' ' OD1' ' A' ' 133' ' ' ASP . 7.6 pt20 -169.38 164.69 10.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.194 -1.18 . . . . 0.0 110.101 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.449 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 55.2 t -123.06 115.73 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.21 -0.931 . . . . 0.0 109.921 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.443 ' OD1' ' CE1' ' A' ' 99' ' ' TYR . 15.6 t30 -84.16 -174.89 5.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.293 -0.879 . . . . 0.0 110.62 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.404 ' O ' HG22 ' A' ' 142' ' ' VAL . 12.0 t80 -69.74 -42.65 73.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.4 -0.813 . . . . 0.0 110.682 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -61.55 -58.46 8.05 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.276 -0.89 . . . . 0.0 110.659 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -56.07 -36.82 68.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.089 -1.007 . . . . 0.0 110.362 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.54 ' CZ ' ' HE3' ' A' ' 145' ' ' MET . 13.5 t80 -67.08 -27.72 67.59 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.265 -0.897 . . . . 0.0 110.689 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.405 ' O ' HG11 ' A' ' 142' ' ' VAL . 98.5 t -89.93 -22.65 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.34 -0.85 . . . . 0.0 111.078 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -81.61 -36.48 28.89 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.08 -1.013 . . . . 0.0 110.991 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.517 ' HE3' ' CE1' ' A' ' 141' ' ' PHE . 4.7 ptt? -64.58 -28.91 69.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.939 -1.1 . . . . 0.0 110.093 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.54 ' HE3' ' CZ ' ' A' ' 141' ' ' PHE . 61.2 mtt -82.71 -23.26 34.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.879 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.2 p . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.339 -0.851 . . . . 0.0 109.915 179.735 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.144 0.497 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -48.32 -43.41 33.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.201 -0.937 . . . . 0.0 110.238 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.478 ' HG3' ' CE2' ' A' ' 12' ' ' PHE . 2.9 tp-100 -59.5 -42.06 91.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.913 . . . . 0.0 109.786 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.1 mm -61.59 -36.79 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.387 -0.82 . . . . 0.0 109.6 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.28 -30.06 66.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.324 -0.86 . . . . 0.0 109.815 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -64.74 -47.23 79.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.87 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.478 ' CE2' ' HG3' ' A' ' 8' ' ' GLN . 24.0 m-85 -65.26 -49.64 68.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.326 -0.859 . . . . 0.0 110.224 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -53.4 -40.14 64.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.198 -0.939 . . . . 0.0 110.105 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -59.32 -53.26 60.31 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.313 -0.867 . . . . 0.0 110.006 179.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.489 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -51.19 -36.92 43.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.201 -0.937 . . . . 0.0 109.668 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.524 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 60.3 t80 -65.95 -39.57 90.55 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.382 -0.824 . . . . 0.0 109.84 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.8 t -65.62 -21.59 66.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.879 179.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.47 HD21 ' CD1' ' A' ' 19' ' ' PHE . 7.9 tt -79.78 -41.5 26.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.398 -0.814 . . . . 0.0 110.048 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.489 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 16.3 m-85 -69.27 -42.09 75.99 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.344 -0.847 . . . . 0.0 110.385 -179.525 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -78.3 100.97 6.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.427 -0.795 . . . . 0.0 110.131 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -101.43 -20.73 15.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 110.491 -179.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.408 ' OD1' ' OE2' ' A' ' 31' ' ' GLU . 8.3 p-10 -86.25 -32.45 21.12 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.151 -0.968 . . . . 0.0 110.748 -179.478 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.36 79.81 1.47 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 39.3 p-10 -146.09 -22.86 0.45 Allowed 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.223 -1.163 . . . . 0.0 111.898 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.407 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 90.24 22.99 33.23 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.407 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 71.1 p -152.68 132.34 13.11 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.215 -1.168 . . . . 0.0 110.177 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 55.7 mt -95.55 111.91 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 110.114 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.402 HG22 ' HB2' ' A' ' 30' ' ' LYS . 10.6 t -106.62 -173.68 2.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.463 -0.773 . . . . 0.0 109.767 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.7 p -70.98 -22.45 62.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.142 -0.974 . . . . 0.0 110.408 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.402 ' HB2' HG22 ' A' ' 28' ' ' THR . 19.8 mtmt -67.91 -60.13 2.75 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.269 -0.894 . . . . 0.0 110.138 179.669 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.408 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 79.6 mt-10 -59.7 -58.53 8.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.251 -0.905 . . . . 0.0 109.762 179.549 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.441 HD21 ' CD2' ' A' ' 48' ' ' LEU . 1.8 tp -52.28 -30.96 30.49 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.312 -0.868 . . . . 0.0 109.818 179.686 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.86 -49.14 81.17 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 92.1 m -70.57 -23.58 62.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.2 -1.176 . . . . 0.0 110.104 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.0 t -71.35 -33.54 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.408 -0.808 . . . . 0.0 110.186 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.404 ' O ' ' O ' ' A' ' 40' ' ' GLY . 23.2 mmt -90.81 -24.24 20.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.221 -0.924 . . . . 0.0 110.365 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -89.92 -15.46 32.02 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.124 -0.985 . . . . 0.0 110.313 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.407 ' HB3' HD11 ' A' ' 39' ' ' LEU . 37.4 t -97.19 -44.03 7.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.193 -0.942 . . . . 0.0 110.18 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.407 HD11 ' HB3' ' A' ' 38' ' ' SER . 3.5 mp -117.51 64.93 0.73 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.12 -0.987 . . . . 0.0 110.054 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 36' ' ' MET . . . 127.92 58.89 0.12 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.407 ' OE1' ' N ' ' A' ' 42' ' ' ASN . 0.7 OUTLIER -58.66 132.95 55.37 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.316 -1.108 . . . . 0.0 110.695 -179.733 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.533 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.3 m-80 179.29 -59.96 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.4 -0.812 . . . . 0.0 110.001 179.726 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 46.2 Cg_endo -72.23 -163.84 0.16 Allowed 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.749 1.394 . . . . 0.0 110.252 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.457 HG21 ' N ' ' A' ' 45' ' ' GLU . 14.1 t -152.91 -136.52 0.06 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.593 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.457 ' N ' HG21 ' A' ' 44' ' ' THR . 30.8 mt-10 -101.5 -40.18 7.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.733 -1.229 . . . . 0.0 109.796 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.47 -67.11 0.66 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.884 . . . . 0.0 109.586 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -49.01 -44.09 40.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.308 -0.87 . . . . 0.0 109.468 179.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.447 ' CB ' ' O ' ' A' ' 44' ' ' THR . 5.7 tt -55.35 -46.31 76.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.425 -0.797 . . . . 0.0 109.459 179.206 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -51.01 -41.87 60.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.299 -0.876 . . . . 0.0 109.361 179.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.43 ' HA ' ' OD1' ' A' ' 53' ' ' ASN . 33.9 t70 -62.48 -43.33 99.08 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.459 -0.776 . . . . 0.0 109.63 179.344 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.432 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 21.5 ttp -61.18 -22.83 65.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.308 -0.87 . . . . 0.0 109.713 179.629 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.443 HD13 ' CD2' ' A' ' 48' ' ' LEU . 37.0 mt -84.13 -26.65 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -0.859 . . . . 0.0 109.863 179.635 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.43 ' OD1' ' HA ' ' A' ' 50' ' ' ASP . 33.3 m120 -65.22 -19.7 66.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.174 -0.954 . . . . 0.0 110.441 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -84.33 -23.84 30.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 110.037 179.763 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.507 ' CG1' ' CD1' ' A' ' 63' ' ' ILE . 85.1 t -93.0 -63.74 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.335 -0.853 . . . . 0.0 109.69 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -55.22 113.07 1.24 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.376 -0.828 . . . . 0.0 110.378 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -101.82 45.45 0.97 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.36 -0.837 . . . . 0.0 109.928 179.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.59 -47.41 1.56 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.351 -0.843 . . . . 0.0 110.395 -179.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.31 38.56 2.42 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.607 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.446 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 18.6 p-10 -125.38 -19.16 5.12 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.171 -1.194 . . . . 0.0 110.66 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.409 ' C ' ' CG2' ' A' ' 62' ' ' THR . . . 102.22 4.58 50.4 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.718 -1.229 . . . . 0.0 111.27 178.559 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.446 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 47.5 p -149.87 152.36 34.97 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.557 -1.555 . . . . 0.0 110.833 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.507 ' CD1' ' CG1' ' A' ' 55' ' ' VAL . 72.7 mt -100.6 130.94 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.339 -0.851 . . . . 0.0 109.987 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.415 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -77.35 -169.06 1.28 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.137 -0.977 . . . . 0.0 110.327 -179.927 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.534 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 4.1 t80 -80.14 -44.27 1.44 Allowed Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.221 -0.924 . . . . 0.0 111.294 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.3 Cg_endo -74.09 -27.01 12.27 Favored 'Trans proline' 0 C--N 1.322 -0.838 0 O-C-N 123.138 1.073 . . . . 0.0 109.984 -179.384 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -73.01 -30.81 64.05 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.355 -0.841 . . . . 0.0 108.811 179.197 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.524 ' CE2' ' HB2' ' A' ' 16' ' ' PHE . 84.9 t80 -72.01 -45.18 61.87 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.54 0.686 . . . . 0.0 109.618 179.271 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.1 tp -77.54 -15.41 59.28 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.367 -0.833 . . . . 0.0 109.719 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 66' ' ' PRO . 7.5 m -86.87 -22.52 25.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 110.216 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.47 ' CE ' ' CE ' ' A' ' 72' ' ' MET . 9.2 ptt? -90.61 -37.46 13.78 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.958 -1.089 . . . . 0.0 110.237 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.47 ' CE ' ' CE ' ' A' ' 71' ' ' MET . 59.8 mtt -90.15 -65.62 1.0 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.259 -0.901 . . . . 0.0 111.443 -179.208 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.951 0 O-C-N 121.467 -0.771 . . . . 0.0 111.708 -178.612 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 121.213 0.53 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.1 mt -50.39 -43.89 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.206 -0.934 . . . . 0.0 110.577 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -57.23 -43.17 82.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.91 . . . . 0.0 110.609 -179.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -63.5 -37.41 87.2 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.303 -0.873 . . . . 0.0 111.305 -179.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.477 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -64.55 -60.01 3.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.106 -0.996 . . . . 0.0 110.593 -179.421 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -51.36 -34.31 33.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.23 -0.918 . . . . 0.0 110.615 -179.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -45.36 88.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.106 -0.996 . . . . 0.0 110.557 -179.669 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 88' ' ' ALA . 33.0 m -77.38 -14.7 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.051 -1.031 . . . . 0.0 110.538 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' A' ' 88' ' ' ALA . 22.4 m-85 -93.82 -13.96 26.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.195 -0.941 . . . . 0.0 110.406 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -107.46 59.24 0.62 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.932 . . . . 0.0 109.837 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -63.54 -43.86 95.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.376 -0.827 . . . . 0.0 110.646 -179.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.436 ' OD2' ' HB3' ' A' ' 97' ' ' ASN . 18.1 p-10 -69.04 -26.8 65.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.194 -0.941 . . . . 0.0 110.106 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.18 8.33 71.98 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.168 178.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.436 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 20.6 p-10 -62.5 -30.09 71.02 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.599 -1.53 . . . . 0.0 110.105 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.497 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 107.69 7.73 31.31 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.497 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 30.1 m-85 -140.49 163.27 33.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.124 -1.221 . . . . 0.0 109.874 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.468 HD13 ' CD1' ' A' ' 141' ' ' PHE . 40.0 mt -100.08 129.31 50.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.198 -0.939 . . . . 0.0 109.876 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.6 t -110.37 147.21 34.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.445 -0.784 . . . . 0.0 109.721 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -51.26 -45.36 62.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.121 -0.987 . . . . 0.0 110.248 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -49.88 -55.52 14.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.154 -0.966 . . . . 0.0 110.293 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -61.35 -30.63 70.64 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.174 -0.954 . . . . 0.0 110.592 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 21.7 tp -58.42 -44.01 88.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.26 -0.9 . . . . 0.0 110.285 -179.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.08 -28.04 48.69 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.322 -0.861 . . . . 0.0 110.192 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -70.34 -19.46 63.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.2 -0.937 . . . . 0.0 110.151 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 70.2 t -101.78 -26.63 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.153 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.0 mmt -77.89 -24.57 48.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.159 -0.963 . . . . 0.0 110.248 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.6 m -90.61 -15.38 30.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -0.923 . . . . 0.0 110.431 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -90.21 -43.41 10.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.093 -1.004 . . . . 0.0 110.463 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 46.8 mt -59.83 -45.28 92.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 109.975 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 136.66 50.18 0.07 OUTLIER Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -136.94 126.91 25.88 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.208 -1.172 . . . . 0.0 110.095 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.36 112.98 25.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.2 -0.937 . . . . 0.0 110.448 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.5 mp -127.67 -169.5 2.06 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.342 -0.849 . . . . 0.0 109.905 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.402 HG22 ' HB2' ' A' ' 119' ' ' GLU . 6.2 t -144.53 164.9 29.53 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.144 -0.972 . . . . 0.0 110.607 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -53.81 -28.79 37.37 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.393 -0.817 . . . . 0.0 111.004 -179.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.402 ' HB2' HG22 ' A' ' 117' ' ' THR . 34.7 mt-10 -68.29 -51.54 43.77 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.145 -0.972 . . . . 0.0 110.957 -179.317 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -64.1 -51.58 63.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.189 -0.945 . . . . 0.0 110.782 -179.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.411 ' O ' ' HB2' ' A' ' 124' ' ' MET . 77.9 t -57.19 -45.89 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.236 -0.915 . . . . 0.0 110.728 -179.373 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -58.82 -53.56 57.03 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.061 -1.024 . . . . 0.0 110.505 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -62.64 -22.96 66.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -0.931 . . . . 0.0 110.418 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.411 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 5.8 mmm -71.56 -49.66 38.49 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.153 -0.967 . . . . 0.0 110.113 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 23.6 mm -69.4 -28.53 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.193 -0.942 . . . . 0.0 109.953 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -70.63 -43.36 69.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.964 . . . . 0.0 109.983 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -71.16 -27.59 63.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.211 -0.931 . . . . 0.0 109.816 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -78.29 -25.2 46.57 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.341 -0.849 . . . . 0.0 109.769 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -74.83 86.61 2.23 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.303 -0.873 . . . . 0.0 110.201 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 70.5 mt -69.08 -48.13 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.282 -0.886 . . . . 0.0 110.433 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 3.0 p30 -73.77 -21.97 60.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.229 -0.92 . . . . 0.0 110.278 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 68.79 68.15 1.74 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 36.8 p30 -118.35 -16.92 9.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.438 -1.037 . . . . 0.0 111.032 -179.309 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.466 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 124.71 -46.8 1.06 Allowed Glycine 0 N--CA 1.498 2.779 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.406 ' O ' ' OE1' ' A' ' 135' ' ' GLN . 0.0 OUTLIER -119.31 170.57 9.0 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.242 -1.152 . . . . 0.0 109.909 179.846 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.402 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 75.6 t -103.3 151.61 6.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.041 -1.037 . . . . 0.0 110.672 -179.345 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.494 ' OD1' ' CD1' ' A' ' 99' ' ' TYR . 72.6 m-20 -122.73 -172.74 2.54 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.494 -0.754 . . . . 0.0 109.82 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.421 ' O ' ' CG2' ' A' ' 142' ' ' VAL . 3.9 t80 -72.93 -19.91 61.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.195 -0.941 . . . . 0.0 109.727 179.595 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.41 -56.58 4.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.136 -0.978 . . . . 0.0 109.837 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -64.76 -25.37 67.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.146 -0.971 . . . . 0.0 109.691 179.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.489 ' CE2' ' CE ' ' A' ' 145' ' ' MET . 19.1 t80 -75.29 -29.16 60.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.399 -0.813 . . . . 0.0 109.967 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 138' ' ' TYR . 70.5 t -84.83 -27.85 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.233 -0.917 . . . . 0.0 110.27 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.83 -34.15 34.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.837 . . . . 0.0 110.646 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -82.6 -25.54 33.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 110.47 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.489 ' CE ' ' CE2' ' A' ' 141' ' ' PHE . 26.0 ttm -89.86 -57.36 2.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.277 -0.889 . . . . 0.0 110.104 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.401 HG21 ' O ' ' A' ' 142' ' ' VAL . 6.0 p . . . . . 0 N--CA 1.5 2.051 0 O-C-N 121.427 -0.796 . . . . 0.0 110.924 179.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.305 0.574 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.417 ' OE1' ' CA ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -52.65 -35.65 55.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 110.775 -179.594 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -56.57 -54.05 50.46 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.06 -1.025 . . . . 0.0 109.817 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 78.8 mt -58.95 -34.2 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.658 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.75 -28.07 67.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.256 -0.902 . . . . 0.0 110.073 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -72.45 -53.51 11.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.337 -0.852 . . . . 0.0 109.725 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -56.37 -45.7 80.39 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.327 -0.858 . . . . 0.0 109.819 179.616 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.85 -41.37 74.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 109.758 179.433 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -54.44 -52.53 61.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.402 -0.811 . . . . 0.0 109.953 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.23 -50.09 62.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.38 -0.825 . . . . 0.0 110.253 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -51.26 -45.56 62.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.186 -0.946 . . . . 0.0 109.828 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.9 m -55.14 -41.95 72.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.241 -0.912 . . . . 0.0 109.761 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.458 ' CD2' ' O ' ' A' ' 18' ' ' LEU . 1.1 tt -59.0 -34.32 71.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.375 -0.828 . . . . 0.0 109.647 179.575 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.549 ' CE2' HG13 ' A' ' 35' ' ' VAL . 10.5 m-85 -74.5 -69.97 0.43 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.325 -0.859 . . . . 0.0 110.541 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.412 ' OD1' ' HA2' ' A' ' 23' ' ' GLY . 0.9 OUTLIER -56.28 91.49 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.367 -0.833 . . . . 0.0 110.089 -179.751 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 19' ' ' PHE . 2.3 mttm -81.42 -28.29 34.33 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.341 -0.849 . . . . 0.0 109.943 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.403 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 5.0 p30 -104.89 -9.81 17.74 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.282 -0.886 . . . . 0.0 110.487 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.412 ' HA2' ' OD1' ' A' ' 20' ' ' ASP . . . 61.56 63.23 5.01 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -92.02 -15.68 27.53 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.184 -1.186 . . . . 0.0 110.012 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.461 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 114.88 -9.85 21.16 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.461 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 82.3 p -156.07 169.8 23.64 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.161 -1.199 . . . . 0.0 110.497 -179.818 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.4 mt -105.14 125.39 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.44 -0.788 . . . . 0.0 109.49 179.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 49.3 p -110.45 -171.98 1.94 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.198 -0.938 . . . . 0.0 110.437 -179.547 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 55.3 p -79.05 -25.49 43.18 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.328 -0.857 . . . . 0.0 110.422 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -70.26 -56.81 5.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.29 -0.881 . . . . 0.0 109.766 179.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.403 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 88.8 mt-10 -59.43 -48.34 82.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.311 -0.868 . . . . 0.0 109.318 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 tp -61.94 -26.73 68.37 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.468 -0.77 . . . . 0.0 109.426 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.52 -44.38 97.67 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.545 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.3 m -71.3 -27.2 63.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -1.116 . . . . 0.0 109.938 179.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.549 HG13 ' CE2' ' A' ' 19' ' ' PHE . 8.1 t -67.05 -38.7 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.291 -0.88 . . . . 0.0 109.99 179.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 20.8 mmt -89.56 -20.15 24.13 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.069 -1.019 . . . . 0.0 110.37 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -90.25 -13.28 35.72 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.22 -0.925 . . . . 0.0 110.721 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.42 ' CB ' HD21 ' A' ' 39' ' ' LEU . 14.9 p -65.59 -59.55 3.84 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.219 -0.925 . . . . 0.0 110.463 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.459 ' N ' HD21 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -132.85 47.25 2.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.098 -1.001 . . . . 0.0 110.125 179.975 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -166.98 43.69 0.25 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.44 ' OE1' ' N ' ' A' ' 42' ' ' ASN . 0.9 OUTLIER -49.38 115.08 1.19 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.217 -1.166 . . . . 0.0 110.162 -179.818 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.501 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 0.6 OUTLIER -174.81 -61.75 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.402 -0.811 . . . . 0.0 109.931 179.743 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.501 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 43.4 Cg_endo -70.67 165.73 31.05 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.549 1.289 . . . . 0.0 110.266 179.453 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.8 OUTLIER -119.93 -146.87 0.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.158 -0.964 . . . . 0.0 109.782 179.913 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.462 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 20.9 pt-20 -92.37 -41.34 10.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.133 -0.98 . . . . 0.0 109.694 179.54 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.462 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -71.12 -60.72 2.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.292 -0.88 . . . . 0.0 110.051 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -49.05 -30.5 6.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.068 -1.02 . . . . 0.0 109.477 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 44' ' ' THR . 8.0 tt -65.2 -52.19 56.36 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.556 -0.715 . . . . 0.0 109.5 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -49.67 -39.04 35.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.943 . . . . 0.0 109.356 179.242 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.88 -46.22 91.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.429 -0.794 . . . . 0.0 109.703 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 18.0 ttp -65.2 -17.92 64.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.903 . . . . 0.0 109.738 179.527 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 48' ' ' LEU . 36.3 mm -85.84 -28.75 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.395 -0.815 . . . . 0.0 110.133 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -62.54 -41.89 99.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.259 -0.901 . . . . 0.0 110.244 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.8 -24.44 65.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.273 -0.892 . . . . 0.0 109.898 179.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.472 HG13 ' CD1' ' A' ' 63' ' ' ILE . 74.0 t -92.65 -7.26 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.293 -0.879 . . . . 0.0 110.297 179.562 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.461 ' OD2' ' CA ' ' A' ' 61' ' ' GLY . 22.8 t0 -113.21 98.73 7.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.028 -1.045 . . . . 0.0 110.853 -179.564 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.91 25.53 9.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 0.0 109.146 178.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.413 ' OD2' ' OD1' ' A' ' 60' ' ' ASN . 8.8 t70 -98.55 -49.1 4.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.602 -0.686 . . . . 0.0 110.419 -179.705 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.47 -26.55 5.45 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.434 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 16.5 p-10 -70.46 -33.84 71.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.032 -1.276 . . . . 0.0 110.339 -179.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.461 ' CA ' ' OD2' ' A' ' 56' ' ' ASP . . . 119.38 -61.24 0.49 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.434 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 81.7 p -70.09 165.38 22.08 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.302 -1.117 . . . . 0.0 110.254 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.472 ' CD1' HG13 ' A' ' 55' ' ' VAL . 9.9 mt -100.21 157.71 3.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.272 -0.893 . . . . 0.0 109.768 179.629 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -111.7 -169.96 1.56 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.512 -179.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.547 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 9.8 t80 -78.19 -44.86 2.21 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.256 -0.902 . . . . 0.0 111.44 -179.549 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.3 Cg_endo -71.64 -17.66 29.56 Favored 'Trans proline' 0 C--O 1.205 -1.14 0 O-C-N 123.127 1.067 . . . . 0.0 110.252 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -84.71 -30.91 24.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.185 -0.947 . . . . 0.0 109.372 179.123 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.504 ' CE2' ' HE2' ' A' ' 72' ' ' MET . 9.0 t80 -71.45 -49.21 43.74 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.591 -0.693 . . . . 0.0 110.231 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.464 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 0.6 OUTLIER -76.64 -29.7 56.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.197 -0.939 . . . . 0.0 110.725 -179.661 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.448 ' HB ' ' O ' ' A' ' 66' ' ' PRO . 54.8 m -78.51 -19.57 52.68 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.774 -1.204 . . . . 0.0 110.334 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.468 ' CE ' ' HE1' ' A' ' 72' ' ' MET . 61.1 ttp -86.34 -49.8 7.39 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.135 -0.978 . . . . 0.0 110.573 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.504 ' HE2' ' CE2' ' A' ' 68' ' ' PHE . 38.2 mtt -83.1 -59.69 2.39 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.223 -0.923 . . . . 0.0 110.786 -179.43 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.464 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.497 1.896 0 O-C-N 121.046 -1.034 . . . . 0.0 110.558 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.258 0.552 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.9 mm -51.99 -46.27 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 110.451 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -62.43 -44.43 96.45 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.125 -0.984 . . . . 0.0 109.868 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -54.24 -37.14 64.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.352 -0.843 . . . . 0.0 110.118 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.455 ' O ' ' CG2' ' A' ' 91' ' ' VAL . . . -68.28 -63.91 0.97 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.305 -0.872 . . . . 0.0 110.438 -179.787 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -45.33 -27.73 0.72 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.239 -0.913 . . . . 0.0 110.612 -179.647 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.82 -54.6 9.63 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.23 -0.919 . . . . 0.0 110.408 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.455 ' CG2' ' O ' ' A' ' 88' ' ' ALA . 33.9 m -61.85 -21.22 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.23 -0.919 . . . . 0.0 110.26 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.438 ' N ' HG21 ' A' ' 91' ' ' VAL . 46.5 m-85 -93.23 -16.27 24.98 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.243 -0.911 . . . . 0.0 110.313 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.407 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 49.3 t0 -124.94 67.12 1.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.862 . . . . 0.0 109.863 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -95.22 2.06 54.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 110.855 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 2.7 p30 -95.81 -13.21 24.23 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.094 -1.004 . . . . 0.0 110.347 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.36 36.18 8.28 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.451 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 6.4 t-20 -93.25 -61.39 1.58 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.22 -1.165 . . . . 0.0 110.183 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.479 ' C ' ' CD1' ' A' ' 99' ' ' TYR . . . 128.59 -14.4 6.1 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 33.6 m-85 -136.73 146.91 46.38 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.129 -1.218 . . . . 0.0 110.225 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.412 HG22 ' HB3' ' A' ' 92' ' ' PHE . 39.8 mt -74.71 143.37 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.173 -0.954 . . . . 0.0 110.403 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.5 p -129.2 158.93 37.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.369 -0.832 . . . . 0.0 109.748 179.617 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.88 -25.14 56.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.148 -0.97 . . . . 0.0 110.545 -179.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.12 -64.5 1.04 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.181 -0.949 . . . . 0.0 110.507 -179.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.407 ' OE1' ' HA ' ' A' ' 93' ' ' ASP . 41.3 mt-10 -48.95 -40.95 32.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.231 -0.918 . . . . 0.0 110.068 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.4 tt -63.74 -40.12 95.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.0 110.156 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -58.71 -35.37 72.56 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.206 -0.934 . . . . 0.0 109.982 179.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.4 ' O ' ' OG1' ' A' ' 110' ' ' THR . 73.6 m-70 -77.32 -24.85 50.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.87 . . . . 0.0 110.619 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.414 HG22 ' CD1' ' A' ' 92' ' ' PHE . 90.4 t -77.16 -37.98 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.131 -0.98 . . . . 0.0 110.545 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.7 mmt -72.66 -26.07 61.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.23 -0.918 . . . . 0.0 110.562 -179.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 107' ' ' HIS . 39.4 p -64.6 -45.22 87.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.164 -0.96 . . . . 0.0 110.125 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -72.19 -42.9 65.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.19 -0.944 . . . . 0.0 110.021 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.7 mt -47.0 -25.85 0.89 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.255 -0.903 . . . . 0.0 110.403 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.2 43.96 3.64 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -132.95 136.28 46.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.29 -1.124 . . . . 0.0 110.033 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.01 109.11 21.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.241 -0.912 . . . . 0.0 110.618 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.7 mp -123.69 -177.94 3.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.345 -0.847 . . . . 0.0 109.745 179.507 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 57.8 m -129.03 155.53 45.26 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.122 -0.986 . . . . 0.0 110.256 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.419 ' O ' ' OD2' ' A' ' 122' ' ' ASP . 36.8 m-20 -49.07 -40.82 33.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.253 -0.905 . . . . 0.0 110.05 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -61.36 -50.74 71.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.231 -0.918 . . . . 0.0 110.268 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.414 ' OE1' ' HA ' ' A' ' 120' ' ' GLU . 6.0 mm-40 -52.82 -48.01 67.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.298 -0.876 . . . . 0.0 110.331 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 75.3 t -54.52 -50.31 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.192 -0.942 . . . . 0.0 110.255 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 118' ' ' ASP . 61.4 m-20 -53.61 -34.77 59.61 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 110.191 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -62.88 -47.62 82.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.194 -0.941 . . . . 0.0 109.971 179.957 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.4 mtp -63.13 -59.08 5.26 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.29 -0.881 . . . . 0.0 110.226 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.7 mm -50.89 -24.56 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.314 -0.866 . . . . 0.0 110.429 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -77.14 -49.15 15.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.207 -0.933 . . . . 0.0 110.071 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -63.02 -19.74 64.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -0.936 . . . . 0.0 110.017 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.43 ' CB ' ' SD ' ' A' ' 144' ' ' MET . . . -87.73 -40.98 13.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.358 -0.839 . . . . 0.0 110.088 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -64.54 88.07 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.297 -0.877 . . . . 0.0 110.243 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 140' ' ' GLU . 43.4 mt -63.28 -57.16 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.305 -0.872 . . . . 0.0 110.304 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.8 p30 -63.3 -30.43 71.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.193 -0.942 . . . . 0.0 110.167 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.446 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 72.35 68.65 1.55 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -116.42 -25.98 7.29 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.21 -1.171 . . . . 0.0 110.538 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 137.83 -6.42 3.48 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.28 179.822 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.439 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 2.6 pt20 -150.63 160.46 43.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.988 -1.301 . . . . 0.0 110.324 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 66.4 t -105.61 137.61 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 109.995 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -108.12 -170.26 1.65 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.056 -1.028 . . . . 0.0 110.279 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.55 ' CD1' HG22 ' A' ' 142' ' ' VAL . 11.2 t80 -66.56 -62.66 1.34 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.355 -0.841 . . . . 0.0 111.201 -179.063 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -44.9 -48.81 11.22 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.195 -0.941 . . . . 0.0 111.614 -179.106 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.414 ' HA ' HD13 ' A' ' 130' ' ' ILE . 75.6 mt-10 -58.84 -47.62 84.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.031 -1.043 . . . . 0.0 110.796 -179.174 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -64.58 -23.18 67.18 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 110.643 -179.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.55 HG22 ' CD1' ' A' ' 138' ' ' TYR . 76.5 t -90.63 -20.25 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.19 -0.944 . . . . 0.0 111.146 -179.533 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -89.36 -24.77 21.88 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.114 -0.991 . . . . 0.0 110.899 -179.105 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.43 ' SD ' ' CB ' ' A' ' 128' ' ' ALA . 20.4 ptt? -88.86 -31.81 18.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.021 -1.049 . . . . 0.0 110.442 -179.932 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.417 ' N ' ' HG3' ' A' ' 144' ' ' MET . 18.8 tpp -86.48 -9.49 56.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.215 -0.928 . . . . 0.0 110.3 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 142' ' ' VAL . 12.0 t . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.16 -0.962 . . . . 0.0 110.681 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.192 0.52 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.66 -36.24 34.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.167 -0.958 . . . . 0.0 109.912 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.82 -47.19 86.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -0.86 . . . . 0.0 109.706 179.682 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.401 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 11.5 mm -61.24 -39.38 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.517 179.678 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.29 -33.65 75.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.411 -0.806 . . . . 0.0 109.869 179.469 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.26 -53.08 54.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.673 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -53.1 -36.69 60.99 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.132 -0.98 . . . . 0.0 109.172 179.224 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 9' ' ' ILE . 78.1 mttt -65.63 -37.45 86.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.546 -0.721 . . . . 0.0 109.651 179.266 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -57.23 -47.12 82.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.459 -0.776 . . . . 0.0 109.967 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.18 -54.58 44.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.145 -0.972 . . . . 0.0 110.22 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -47.01 -48.53 21.85 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.241 -0.912 . . . . 0.0 110.331 179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.7 m -60.71 -37.77 82.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.421 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 tt -65.16 -22.74 66.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 110.026 -179.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -90.72 -69.32 0.74 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.308 -0.87 . . . . 0.0 110.028 179.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -56.69 120.48 7.88 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.117 -0.989 . . . . 0.0 109.585 179.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.6 mttt -110.33 -29.76 7.99 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.034 -1.041 . . . . 0.0 111.844 -178.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.438 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 10.4 p-10 -68.61 -44.91 73.28 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.801 -1.187 . . . . 0.0 110.144 -179.416 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.42 27.04 3.75 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.798 -1.192 . . . . 0.0 110.613 178.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.438 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 8.3 p-10 -95.69 -43.62 7.82 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.989 -1.3 . . . . 0.0 110.27 179.57 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.26 31.14 2.91 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.39 179.351 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.419 ' OG1' ' OD2' ' A' ' 24' ' ' ASP . 6.0 p -146.89 135.25 21.8 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.952 -1.323 . . . . 0.0 110.098 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 80.4 mt -106.53 98.91 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.345 -0.847 . . . . 0.0 110.034 179.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.83 -164.78 0.84 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.883 . . . . 0.0 110.064 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.1 p -83.76 -41.57 17.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.102 -0.999 . . . . 0.0 110.586 -179.78 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.491 ' HG3' ' N ' ' A' ' 31' ' ' GLU . 6.3 ptpt -69.68 -41.63 75.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.937 -1.102 . . . . 0.0 109.414 179.664 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 30' ' ' LYS . 60.1 mt-10 -61.78 -45.0 95.77 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.143 -0.973 . . . . 0.0 108.717 178.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.454 ' CD2' ' HG ' ' A' ' 48' ' ' LEU . 2.0 tp -64.21 -29.21 70.33 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.096 -0.641 . . . . 0.0 109.294 179.219 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.96 -40.2 96.61 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 179.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.5 m -69.74 -41.99 74.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.489 -1.006 . . . . 0.0 109.948 179.427 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.0 t -57.93 -34.2 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.298 -0.876 . . . . 0.0 109.994 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.3 mmt -89.73 -18.41 26.44 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.358 -0.839 . . . . 0.0 109.815 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -88.29 -13.31 41.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.389 -0.82 . . . . 0.0 110.578 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.441 ' HB3' HD22 ' A' ' 39' ' ' LEU . 44.0 t -68.2 -12.91 61.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.954 -1.091 . . . . 0.0 109.946 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.446 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 0.7 OUTLIER -169.21 88.2 0.18 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.173 -0.954 . . . . 0.0 110.207 -179.987 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.75 -52.0 0.84 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.402 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 49.6 tt0 51.56 31.85 8.2 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.22 -1.165 . . . . 0.0 109.972 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.481 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -76.5 -55.4 1.64 Allowed Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.412 -0.805 . . . . 0.0 110.957 -179.768 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 42' ' ' ASN . 45.1 Cg_endo -73.99 135.23 20.83 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.77 1.405 . . . . 0.0 110.534 -179.611 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 29.1 p -102.25 -130.75 0.26 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.308 -0.87 . . . . 0.0 109.569 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -100.88 -33.89 10.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.804 -1.185 . . . . 0.0 109.95 179.649 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.65 -66.23 0.77 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.337 -0.852 . . . . 0.0 110.077 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -51.21 -32.0 22.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 109.659 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.454 ' HG ' ' CD2' ' A' ' 32' ' ' LEU . 9.4 tt -64.26 -53.1 54.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.322 -0.861 . . . . 0.0 109.988 179.746 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -51.39 -39.0 56.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 109.827 179.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -66.03 -37.04 84.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.243 -0.911 . . . . 0.0 109.639 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.9 ttp -69.85 -20.08 63.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.323 -0.861 . . . . 0.0 109.735 179.57 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.449 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 32.7 mm -86.6 -24.65 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.391 -0.818 . . . . 0.0 109.899 179.644 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -70.58 -37.36 73.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.259 -0.901 . . . . 0.0 110.259 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.82 -19.36 48.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 110.485 -179.761 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -99.76 -14.09 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.098 -1.001 . . . . 0.0 110.11 -179.615 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 2.8 t70 -84.3 128.06 34.35 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.179 -0.951 . . . . 0.0 110.203 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -96.58 -12.86 23.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.202 -0.936 . . . . 0.0 110.402 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.402 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 61.1 m-20 -97.5 -73.46 0.61 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.124 -0.985 . . . . 0.0 110.486 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.429 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 134.94 41.49 0.14 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 62' ' ' THR . 16.6 p30 -116.02 -16.68 11.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.339 -1.094 . . . . 0.0 110.293 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.449 ' O ' ' CG2' ' A' ' 52' ' ' ILE . . . 106.87 -40.99 2.3 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.719 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.402 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 69.1 p -98.54 162.45 13.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.147 -1.207 . . . . 0.0 110.517 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.0 mt -115.04 144.87 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.4 -0.813 . . . . 0.0 110.081 179.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -101.69 -165.28 1.18 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.988 -1.07 . . . . 0.0 110.137 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.514 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 27.2 t80 -77.52 -44.32 2.56 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 111.276 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.0 Cg_endo -74.25 -27.86 11.15 Favored 'Trans proline' 0 C--N 1.324 -0.761 0 O-C-N 123.112 1.059 . . . . 0.0 110.02 -179.627 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.402 ' OE1' ' OD2' ' A' ' 58' ' ' ASP . 45.9 tt0 -77.21 -22.98 51.49 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.356 -0.84 . . . . 0.0 109.236 179.253 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.435 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 14.2 t80 -77.9 -44.5 26.87 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.506 -0.746 . . . . 0.0 110.252 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.4 -26.51 61.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 110.32 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 88.2 m -80.9 -29.76 35.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 0.0 110.497 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.427 ' CE ' ' HE1' ' A' ' 72' ' ' MET . 6.7 ptt? -86.13 -24.6 26.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.036 -1.04 . . . . 0.0 110.386 -179.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.427 ' HE1' ' CE ' ' A' ' 71' ' ' MET . 19.2 mmt -83.03 -27.53 30.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.281 -0.887 . . . . 0.0 110.403 -179.716 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.917 . . . . 0.0 110.778 -179.51 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.929 0 CA-C-O 121.177 0.513 . . . . 0.0 110.473 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.404 HG21 ' CE1' ' A' ' 141' ' ' PHE . 54.8 mt -57.54 -52.45 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.181 -0.949 . . . . 0.0 110.526 -179.632 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.0 ttm-85 -56.87 -50.55 72.11 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.221 -0.924 . . . . 0.0 110.378 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -54.01 -36.56 63.12 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.223 -0.923 . . . . 0.0 110.412 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.28 -63.93 1.12 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.195 -0.94 . . . . 0.0 110.163 -179.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -45.76 -33.32 2.97 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.435 -0.79 . . . . 0.0 110.485 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.4 ttt85 -63.98 -45.86 87.15 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.31 -0.869 . . . . 0.0 110.77 -179.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.428 ' HA ' ' HE2' ' A' ' 94' ' ' LYS . 32.4 m -84.47 -9.53 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.112 -0.992 . . . . 0.0 111.416 -179.296 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.498 ' CD1' HG12 ' A' ' 108' ' ' VAL . 21.9 m-85 -97.0 -14.04 21.91 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.955 -1.09 . . . . 0.0 110.772 -179.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.406 ' OD2' ' HA2' ' A' ' 98' ' ' GLY . 11.8 t0 -116.19 59.39 0.73 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.041 -1.037 . . . . 0.0 110.256 179.698 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.428 ' HE2' ' HA ' ' A' ' 91' ' ' VAL . 19.4 mttt -94.91 20.09 9.35 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.228 -0.92 . . . . 0.0 110.559 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.456 ' OD2' ' CB ' ' A' ' 97' ' ' ASN . 9.6 p-10 -114.07 -28.39 7.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.183 -0.948 . . . . 0.0 110.398 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.89 -26.67 12.15 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.456 ' CB ' ' OD2' ' A' ' 95' ' ' ASP . 25.5 t-20 -44.79 -28.93 0.7 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.37 -1.076 . . . . 0.0 110.521 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.406 ' HA2' ' OD2' ' A' ' 93' ' ' ASP . . . 90.9 -42.6 2.87 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.45 ' CG ' ' OE1' ' A' ' 135' ' ' GLN . 12.1 m-30 -93.3 170.7 9.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.239 -1.153 . . . . 0.0 110.504 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 18.0 mt -104.18 119.71 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.301 -0.874 . . . . 0.0 109.432 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.4 t -102.65 174.89 5.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.232 -0.917 . . . . 0.0 109.855 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.7 -45.02 63.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.035 -1.041 . . . . 0.0 109.909 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.5 -45.57 91.33 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.253 -0.904 . . . . 0.0 110.056 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.407 ' O ' HG21 ' A' ' 108' ' ' VAL . 48.4 mt-10 -61.93 -48.3 81.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.175 179.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.414 HD11 HD12 ' A' ' 125' ' ' ILE . 6.8 tt -53.7 -31.77 49.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 0.0 110.164 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.0 ttt-85 -73.07 -41.33 64.23 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.21 -0.932 . . . . 0.0 110.08 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -73.07 -11.29 60.5 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.297 -0.877 . . . . 0.0 110.503 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.498 HG12 ' CD1' ' A' ' 92' ' ' PHE . 92.9 t -92.93 -49.69 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.236 -0.915 . . . . 0.0 110.062 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.2 mmt -50.29 -45.16 54.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.413 -0.804 . . . . 0.0 110.435 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.8 p -52.79 -44.87 66.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.304 -0.872 . . . . 0.0 110.377 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -63.6 -43.43 96.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.126 -0.984 . . . . 0.0 110.023 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 13.6 mt -55.34 -40.7 71.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 110.123 179.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 125.83 45.65 0.24 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.417 ' OE1' HD13 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -156.54 146.53 21.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.25 -1.147 . . . . 0.0 110.045 179.98 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -123.25 138.07 54.72 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.192 -0.943 . . . . 0.0 110.284 -179.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.417 HD13 ' OE1' ' A' ' 114' ' ' GLU . 4.7 mp -139.9 -163.66 1.55 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.26 -0.9 . . . . 0.0 110.145 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.453 HG21 ' N ' ' A' ' 118' ' ' ASP . 57.4 m -120.08 164.46 16.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.228 -0.92 . . . . 0.0 110.236 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.453 ' N ' HG21 ' A' ' 117' ' ' THR . 0.9 OUTLIER -58.4 -34.39 70.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.29 -0.881 . . . . 0.0 110.411 179.942 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -56.25 -61.16 2.59 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.302 -0.874 . . . . 0.0 110.758 -179.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 124' ' ' MET . 96.0 mt-10 -52.18 -55.1 23.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.073 -1.017 . . . . 0.0 110.433 -179.654 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.4 t -54.24 -27.91 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.277 -0.889 . . . . 0.0 110.752 -179.648 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -75.4 -40.36 57.98 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.107 -0.996 . . . . 0.0 110.196 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 15.9 tt0 -74.91 -18.07 60.47 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.197 -0.94 . . . . 0.0 109.688 179.51 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.425 ' HG3' ' O ' ' A' ' 120' ' ' GLU . 96.3 mtp -78.06 -50.28 12.37 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 109.949 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.414 HD12 HD11 ' A' ' 105' ' ' LEU . 29.1 mm -65.03 -39.86 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.361 -0.837 . . . . 0.0 110.165 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -61.43 -55.86 26.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 110.255 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 58.1 mt-10 -57.79 -37.92 74.58 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.255 -0.903 . . . . 0.0 110.534 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.434 ' CB ' ' SD ' ' A' ' 144' ' ' MET . . . -70.53 -24.41 62.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 110.167 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -69.18 92.18 0.54 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.307 -0.87 . . . . 0.0 110.21 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 66.1 mt -75.68 -48.51 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.285 -0.884 . . . . 0.0 110.169 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.2 p30 -64.26 -30.37 71.42 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.348 -0.845 . . . . 0.0 110.188 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 87.66 52.63 2.94 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.653 179.198 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -117.64 -32.86 4.73 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.954 -1.321 . . . . 0.0 109.923 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 118.95 24.2 3.1 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.45 ' OE1' ' CG ' ' A' ' 99' ' ' TYR . 3.6 pp0? -159.61 149.02 18.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.203 -1.174 . . . . 0.0 110.143 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.4 t -109.0 125.95 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.244 -0.91 . . . . 0.0 110.721 -179.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -97.51 -165.6 1.28 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.879 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -68.06 -48.42 65.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.11 -0.994 . . . . 0.0 110.537 -179.745 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -63.52 -45.55 90.09 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.121 -0.987 . . . . 0.0 110.602 -179.683 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.414 ' OE2' ' OD2' ' A' ' 131' ' ' ASP . 37.0 mt-10 -58.6 -38.34 77.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.261 -0.899 . . . . 0.0 110.501 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.54 ' CD2' ' CE ' ' A' ' 144' ' ' MET . 6.5 t80 -72.39 -26.87 62.04 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.183 -0.948 . . . . 0.0 110.418 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.412 ' O ' HG21 ' A' ' 146' ' ' THR . 87.6 t -76.66 -24.46 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.078 -1.014 . . . . 0.0 110.676 -179.423 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -87.39 -51.17 6.09 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.142 -0.974 . . . . 0.0 110.452 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.54 ' CE ' ' CD2' ' A' ' 141' ' ' PHE . 21.5 ptt? -56.41 -32.86 65.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.903 . . . . 0.0 110.701 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.477 ' HE1' ' CZ ' ' A' ' 141' ' ' PHE . 28.2 tpp -72.83 -54.24 9.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.15 -0.969 . . . . 0.0 110.538 -179.526 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.428 ' O ' HG21 ' A' ' 146' ' ' THR . 5.2 t . . . . . 0 N--CA 1.496 1.836 0 O-C-N 121.08 -1.013 . . . . 0.0 110.42 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.415 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 52.2 mt-10 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.363 0.602 . . . . 0.0 109.83 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -57.34 -48.74 78.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.199 -0.938 . . . . 0.0 110.028 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.465 ' HG3' ' N ' ' A' ' 9' ' ' ILE . 3.5 pt20 -52.03 -38.19 56.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.719 179.711 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.465 ' N ' ' HG3' ' A' ' 8' ' ' GLN . 34.6 mt -62.24 -44.47 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.328 -0.857 . . . . 0.0 109.516 179.41 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.61 -37.18 70.33 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.281 -0.887 . . . . 0.0 109.486 179.373 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -62.78 -45.42 92.73 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.325 -0.859 . . . . 0.0 109.499 179.391 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -61.36 -33.1 73.08 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.429 -0.794 . . . . 0.0 109.849 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt -61.57 -49.51 76.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -0.915 . . . . 0.0 109.583 179.62 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -57.69 -39.62 77.6 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.451 -0.781 . . . . 0.0 109.627 179.537 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.462 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -60.21 -43.25 96.14 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.257 -0.902 . . . . 0.0 109.794 179.676 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.481 ' CE1' HD13 ' A' ' 27' ' ' ILE . 29.3 t80 -59.32 -39.13 82.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.161 -0.962 . . . . 0.0 109.29 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.3 t -70.16 -25.4 63.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.822 . . . . 0.0 109.181 178.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.424 ' C ' ' CD1' ' A' ' 18' ' ' LEU . 3.4 tm? -71.41 -29.12 64.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.471 -0.768 . . . . 0.0 109.551 179.45 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.462 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 20.8 m-85 -87.54 -64.59 1.12 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.401 -0.812 . . . . 0.0 109.972 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -85.44 74.43 10.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.348 -0.845 . . . . 0.0 109.799 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.417 ' CE ' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -99.02 47.64 0.97 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.279 -0.888 . . . . 0.0 110.414 -179.641 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.408 ' OD1' ' HB2' ' A' ' 24' ' ' ASP . 4.1 p30 -127.91 -5.02 5.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.169 -0.957 . . . . 0.0 110.583 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.47 48.68 5.21 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.408 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 13.6 m-20 -117.9 -72.69 0.68 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -1.131 . . . . 0.0 110.26 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.21 -10.52 4.43 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.6 p -132.33 150.26 52.19 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.136 -1.214 . . . . 0.0 110.364 -179.827 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.481 HD13 ' CE1' ' A' ' 16' ' ' PHE . 70.8 mt -97.12 131.62 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.222 -0.923 . . . . 0.0 110.241 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.8 t -120.72 -174.07 2.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.344 -0.847 . . . . 0.0 110.18 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.7 p -75.27 -31.84 60.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.223 -0.923 . . . . 0.0 110.692 -179.68 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -65.8 -59.76 3.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.116 -0.99 . . . . 0.0 109.805 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -57.21 -56.27 23.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.388 -0.82 . . . . 0.0 109.484 179.526 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.48 HD23 ' CD1' ' A' ' 52' ' ' ILE . 10.9 tp -57.22 -22.56 41.82 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.231 -0.918 . . . . 0.0 109.297 179.085 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.85 -42.62 96.91 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 38' ' ' SER . 54.8 m -69.21 -25.16 64.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.512 -0.993 . . . . 0.0 109.712 179.287 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.3 t -76.74 -33.43 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.415 -0.803 . . . . 0.0 110.956 -179.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.7 tpp -90.07 -23.48 21.41 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.921 -1.112 . . . . 0.0 110.898 -179.318 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.7 ttm-85 -90.91 -32.55 15.96 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.09 -1.006 . . . . 0.0 110.629 -179.752 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 34' ' ' THR . 71.1 m -79.94 -21.71 43.52 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.116 -0.99 . . . . 0.0 110.404 -179.752 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 mp -135.35 80.12 1.82 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 110.438 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.89 -54.06 0.52 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 50.48 74.25 0.23 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.214 -1.168 . . . . 0.0 109.871 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.524 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 2.6 t30 -152.22 -66.27 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.222 -0.924 . . . . 0.0 110.376 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.524 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 43.7 Cg_endo -71.56 -160.75 0.09 OUTLIER 'Trans proline' 0 C--N 1.317 -1.086 0 O-C-N 123.241 1.127 . . . . 0.0 110.145 179.458 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 40.2 p -147.09 -178.46 6.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.205 -0.935 . . . . 0.0 109.85 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -65.47 -32.89 74.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 110.05 179.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.34 -62.68 1.29 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.124 -0.985 . . . . 0.0 109.537 179.448 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -51.85 -27.56 13.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.184 -0.947 . . . . 0.0 109.042 179.062 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 44' ' ' THR . 6.2 tt -68.88 -43.88 74.41 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.478 -0.764 . . . . 0.0 109.472 179.332 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -53.46 -42.77 67.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.38 -0.825 . . . . 0.0 109.021 179.104 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -65.47 -33.92 77.07 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.428 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 0.5 OUTLIER -68.45 -20.3 64.62 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.587 -0.696 . . . . 0.0 109.359 179.001 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.48 ' CD1' HD23 ' A' ' 32' ' ' LEU . 32.4 mm -87.09 -26.5 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.399 -0.813 . . . . 0.0 110.087 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -73.79 -30.47 62.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.0 110.537 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 8.4 pt-20 -71.64 -26.74 62.68 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.088 -1.008 . . . . 0.0 110.204 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.445 ' N ' ' HG3' ' A' ' 54' ' ' GLU . 96.3 t -90.17 -30.46 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.163 -0.961 . . . . 0.0 109.717 179.608 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -76.48 115.92 16.68 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.438 -0.789 . . . . 0.0 110.206 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.69 18.88 21.46 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.256 -0.902 . . . . 0.0 110.239 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.433 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 61.6 m-20 -112.02 -65.72 1.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.354 -0.841 . . . . 0.0 109.968 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.16 -12.6 2.09 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -70.11 -36.7 75.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.971 -1.311 . . . . 0.0 110.534 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 119.73 -63.64 0.46 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 48.9 p -69.25 170.56 9.99 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.17 -1.194 . . . . 0.0 110.724 -179.437 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.459 HG21 ' N ' ' A' ' 64' ' ' ASP . 89.1 mt -115.09 149.46 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.244 -0.91 . . . . 0.0 110.309 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.459 ' N ' HG21 ' A' ' 63' ' ' ILE . 55.5 m-20 -98.37 -166.24 1.34 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 110.209 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.548 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 10.2 t80 -81.47 -38.26 0.93 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.162 -0.961 . . . . 0.0 112.118 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.6 Cg_endo -72.39 -25.9 17.77 Favored 'Trans proline' 0 C--O 1.209 -0.938 0 O-C-N 122.817 0.904 . . . . 0.0 111.269 -178.922 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.433 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 63.4 mt-10 -76.05 -33.61 59.61 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.827 -1.171 . . . . 0.0 109.524 179.421 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.504 ' CE2' ' HE2' ' A' ' 72' ' ' MET . 12.6 t80 -75.38 -53.0 9.45 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.537 -0.727 . . . . 0.0 110.064 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.479 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -65.31 -20.83 66.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.509 -0.745 . . . . 0.0 110.408 -179.824 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 66' ' ' PRO . 50.6 m -91.38 -22.97 20.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.907 -1.12 . . . . 0.0 111.18 -179.595 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 60.0 ttp -86.99 -43.64 12.2 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.877 -1.139 . . . . 0.0 111.153 -179.241 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.504 ' HE2' ' CE2' ' A' ' 68' ' ' PHE . 43.2 mtt -82.84 -34.56 26.82 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.905 -1.122 . . . . 0.0 110.595 -179.473 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.141 -0.975 . . . . 0.0 110.66 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.282 0.563 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.4 mt -69.62 -40.68 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.367 -0.833 . . . . 0.0 110.309 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.6 ttp180 -67.96 -56.87 7.39 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.17 -0.957 . . . . 0.0 110.034 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -47.78 -47.81 30.55 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.256 -0.903 . . . . 0.0 110.111 179.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.456 ' O ' ' CG2' ' A' ' 91' ' ' VAL . . . -54.82 -54.49 41.58 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.302 -0.874 . . . . 0.0 110.107 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -49.93 -28.7 7.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.291 -0.881 . . . . 0.0 110.259 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -71.97 -47.01 55.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.144 -0.973 . . . . 0.0 110.643 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' A' ' 88' ' ' ALA . 35.9 m -70.9 -20.14 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.17 -0.956 . . . . 0.0 110.4 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.41 ' HB3' HG22 ' A' ' 100' ' ' ILE . 25.5 m-85 -95.35 -12.85 25.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.325 -0.859 . . . . 0.0 110.345 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -107.18 73.87 0.95 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.167 -0.958 . . . . 0.0 110.59 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -74.98 -36.46 62.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.171 -0.956 . . . . 0.0 109.995 179.639 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.8 p30 -74.54 -25.41 59.29 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.312 -0.867 . . . . 0.0 110.51 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 76.46 60.79 2.93 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.432 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 26.0 p-10 -124.33 -10.07 7.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.357 -1.084 . . . . 0.0 110.476 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.526 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 86.27 16.03 63.36 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.08 -1.057 . . . . 0.0 110.493 179.005 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.557 ' CD1' ' NE2' ' A' ' 135' ' ' GLN . 38.2 m-85 -142.1 138.31 31.6 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.188 -1.184 . . . . 0.0 110.26 179.875 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.41 HG22 ' HB3' ' A' ' 92' ' ' PHE . 25.6 mt -94.06 129.75 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.327 -0.858 . . . . 0.0 110.16 -179.748 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.7 t -114.91 166.09 12.16 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.285 -0.885 . . . . 0.0 109.977 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.46 -26.56 68.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.297 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.42 -69.83 0.27 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.282 -0.886 . . . . 0.0 110.266 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.409 ' O ' HG22 ' A' ' 108' ' ' VAL . 37.1 mt-10 -52.71 -38.78 61.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 110.212 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.427 HD11 HD12 ' A' ' 125' ' ' ILE . 4.0 tt -52.69 -46.21 67.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.094 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.6 ttm-85 -66.72 -37.85 85.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.362 -0.836 . . . . 0.0 110.045 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -61.4 -23.86 66.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.165 -0.959 . . . . 0.0 110.248 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 104' ' ' GLU . 50.0 t -87.28 -41.0 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.119 -0.988 . . . . 0.0 110.616 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.408 ' HE1' HD22 ' A' ' 105' ' ' LEU . 21.6 mmt -68.17 -57.79 5.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.137 -0.977 . . . . 0.0 110.521 -179.613 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.8 t -50.13 -23.86 2.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.303 -0.873 . . . . 0.0 110.401 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -79.43 -50.37 10.9 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.18 -0.95 . . . . 0.0 110.276 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.8 mt -60.75 -23.47 64.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.208 -0.933 . . . . 0.0 110.302 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 114' ' ' GLU . . . 102.88 90.97 2.17 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 1.3 mm-40 -155.3 -164.46 1.77 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.326 -1.102 . . . . 0.0 110.029 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.69 99.56 2.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.131 -0.981 . . . . 0.0 110.28 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.6 mp -137.52 135.62 36.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.326 -0.859 . . . . 0.0 110.204 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.435 ' CG2' ' OE2' ' A' ' 120' ' ' GLU . 13.1 t -75.78 172.18 13.09 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.228 -0.92 . . . . 0.0 109.949 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 53.7 m-20 -59.95 -41.58 92.17 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.241 -0.912 . . . . 0.0 110.299 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.456 ' N ' ' OE1' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -53.26 -47.72 68.88 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.164 -0.96 . . . . 0.0 110.811 -179.672 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.451 ' N ' ' OE1' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -54.37 -56.22 20.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.99 -1.069 . . . . 0.0 110.897 -179.605 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 84.1 t -52.96 -44.74 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.913 -1.117 . . . . 0.0 110.675 -179.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 118' ' ' ASP . 1.5 m-20 -62.51 -30.8 71.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.145 -0.972 . . . . 0.0 110.611 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -72.48 -28.48 62.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.072 -1.018 . . . . 0.0 110.057 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.4 mtp -74.29 -45.77 45.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -0.874 . . . . 0.0 110.215 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.432 HG21 HG22 ' A' ' 136' ' ' VAL . 30.0 mm -64.65 -39.85 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.305 -0.872 . . . . 0.0 110.408 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.4 mtp180 -67.76 -51.0 54.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.158 -0.964 . . . . 0.0 110.115 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -55.41 -35.17 65.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.17 -0.956 . . . . 0.0 109.781 179.56 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.414 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -75.82 -28.72 58.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.361 -0.837 . . . . 0.0 109.812 179.685 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.409 ' OD2' ' HA2' ' A' ' 132' ' ' GLY . 16.0 t0 -71.92 91.93 1.23 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -0.871 . . . . 0.0 110.119 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 96.2 mt -73.14 -32.61 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.217 -0.927 . . . . 0.0 110.717 -179.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 23.4 p30 -99.59 -18.54 17.3 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.232 -0.918 . . . . 0.0 110.505 -179.776 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.467 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 77.0 72.11 1.14 Allowed Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.974 -1.108 . . . . 0.0 110.337 179.438 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.406 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 76.4 m-20 -113.93 6.1 16.44 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.072 -1.251 . . . . 0.0 110.118 179.175 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.32 16.3 69.45 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.557 ' NE2' ' CD1' ' A' ' 99' ' ' TYR . 11.2 pt20 -170.16 165.46 9.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.115 -1.226 . . . . 0.0 110.166 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.432 HG22 HG21 ' A' ' 125' ' ' ILE . 52.4 t -106.71 107.58 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.177 -0.952 . . . . 0.0 110.386 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -77.74 163.08 26.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.363 -0.836 . . . . 0.0 110.142 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -51.47 -30.16 18.92 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.24 -0.913 . . . . 0.0 110.278 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -70.47 -59.29 2.93 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.2 -0.937 . . . . 0.0 110.474 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 56.3 mt-10 -54.16 -25.66 23.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 0.0 110.221 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.525 ' CZ ' ' HE1' ' A' ' 145' ' ' MET . 16.7 t80 -77.93 -35.39 50.54 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.312 -0.867 . . . . 0.0 110.137 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.409 ' O ' HG21 ' A' ' 146' ' ' THR . 97.0 t -75.24 -22.83 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 110.364 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -83.31 -46.83 12.16 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.275 -0.89 . . . . 0.0 110.459 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.441 ' HE2' ' HE1' ' A' ' 145' ' ' MET . 0.2 OUTLIER -70.3 -13.22 62.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.027 -1.046 . . . . 0.0 110.293 -179.788 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.525 ' HE1' ' CZ ' ' A' ' 141' ' ' PHE . 13.4 mmt -89.28 -61.01 1.8 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.285 -0.884 . . . . 0.0 109.994 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.409 HG21 ' O ' ' A' ' 142' ' ' VAL . 9.5 t . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.188 -0.945 . . . . 0.0 110.105 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 121.423 0.63 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -76.78 -32.11 57.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.846 . . . . 0.0 109.728 179.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -65.38 -49.71 68.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.426 -0.796 . . . . 0.0 110.03 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.7 mt -68.48 -45.98 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.203 -0.936 . . . . 0.0 109.584 179.508 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 13' ' ' LYS . . . -59.32 -25.69 64.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.374 -0.828 . . . . 0.0 109.48 179.36 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.415 ' HA ' ' OE1' ' A' ' 11' ' ' GLU . 5.3 tp10 -69.59 -50.23 46.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.309 -0.87 . . . . 0.0 109.071 179.323 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -67.11 -17.24 64.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.368 -0.832 . . . . 0.0 109.58 179.075 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 25.6 mtpt -76.59 -49.49 16.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.153 -0.967 . . . . 0.0 109.796 179.596 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.9 -41.95 88.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.187 -0.946 . . . . 0.0 109.791 179.378 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.08 -49.99 67.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 109.791 179.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.458 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 40.3 t80 -54.68 -28.45 47.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.921 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.0 m -80.8 -32.73 35.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.342 -0.849 . . . . 0.0 109.497 179.63 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.419 ' O ' ' HE2' ' A' ' 21' ' ' LYS . 3.2 tt -69.57 -18.03 63.6 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.42 -0.8 . . . . 0.0 109.646 179.483 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.464 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 5.1 m-30 -96.7 -45.14 6.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.421 -0.799 . . . . 0.0 109.953 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.405 ' OD1' ' OD1' ' A' ' 22' ' ' ASP . 24.8 t0 -78.86 104.63 9.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.386 -0.821 . . . . 0.0 110.313 -179.741 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.419 ' HE2' ' O ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -110.4 64.68 0.61 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.161 -0.962 . . . . 0.0 110.837 -179.688 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.405 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 13.7 p-10 -170.89 -36.82 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.033 -1.042 . . . . 0.0 110.612 179.771 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 24' ' ' ASP . . . 101.57 100.31 2.45 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 -179.293 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 24.7 p-10 -176.97 -29.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.242 -1.152 . . . . 0.0 111.014 -179.619 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.444 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 88.21 52.83 2.79 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.444 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 0.3 OUTLIER -169.93 150.36 3.85 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.185 -1.186 . . . . 0.0 110.314 179.817 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.2 109.09 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.34 -0.85 . . . . 0.0 110.364 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.411 HG21 HG23 ' A' ' 62' ' ' THR . 65.6 p -93.24 -167.15 1.66 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.26 -0.9 . . . . 0.0 110.115 179.807 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.3 p -84.67 -20.7 30.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.23 -0.919 . . . . 0.0 110.207 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -72.69 -60.26 2.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.237 -0.914 . . . . 0.0 109.94 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -56.57 -49.29 75.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 109.624 179.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.434 ' O ' ' HB ' ' A' ' 35' ' ' VAL . 3.6 tp -60.73 -31.94 71.23 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.292 -0.88 . . . . 0.0 109.265 179.293 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.8 -42.33 94.46 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.709 -1.757 . . . . 0.0 108.709 179.298 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 66.9 m -71.58 -24.78 61.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -1.113 . . . . 0.0 109.477 179.311 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.436 ' O ' ' CG ' ' A' ' 39' ' ' LEU . 51.1 t -70.96 -34.84 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.413 -0.805 . . . . 0.0 110.279 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 21.9 mmt -90.76 -23.14 20.74 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.214 -0.929 . . . . 0.0 110.439 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.408 ' NH2' ' HG2' ' A' ' 37' ' ' ARG . 6.7 ttp85 -80.49 -31.8 37.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 110.238 -179.771 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.2 m -92.38 -31.98 15.13 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.148 -0.97 . . . . 0.0 110.569 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.436 ' CG ' ' O ' ' A' ' 35' ' ' VAL . 66.9 mt -86.08 -71.98 0.52 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.141 -0.975 . . . . 0.0 110.496 -179.754 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -118.77 88.74 0.45 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -62.49 123.01 17.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.284 -1.127 . . . . 0.0 110.036 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.484 ' HB3' ' CD ' ' A' ' 43' ' ' PRO . 0.9 OUTLIER 179.47 -59.31 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.175 -0.953 . . . . 0.0 110.305 -179.906 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.484 ' CD ' ' HB3' ' A' ' 42' ' ' ASN . 42.2 Cg_endo -68.41 158.43 57.65 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.593 1.312 . . . . 0.0 110.69 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 71.7 p -107.8 -138.21 0.37 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.368 -0.832 . . . . 0.0 109.619 179.826 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -99.16 -40.33 8.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.93 -1.106 . . . . 0.0 109.82 179.589 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.01 -59.42 2.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.306 -0.872 . . . . 0.0 109.915 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 37.2 tt0 -54.9 -30.59 58.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 109.792 179.587 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.471 ' CD2' HD13 ' A' ' 52' ' ' ILE . 7.5 tt -64.17 -52.6 58.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.358 -0.839 . . . . 0.0 109.775 179.785 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -52.92 -35.54 58.54 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.269 -0.894 . . . . 0.0 109.053 179.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 8.5 t70 -61.64 -41.76 97.94 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.383 -0.823 . . . . 0.0 109.524 179.297 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.411 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 32.1 ttp -68.18 -19.77 64.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.383 -0.823 . . . . 0.0 109.565 179.538 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.471 HD13 ' CD2' ' A' ' 48' ' ' LEU . 22.9 mt -83.57 -24.95 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.238 -0.914 . . . . 0.0 110.077 179.59 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -65.65 -46.18 80.15 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.162 -0.961 . . . . 0.0 110.07 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 21.3 pt-20 -59.45 -31.38 69.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.174 -0.954 . . . . 0.0 109.683 179.637 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.435 ' N ' ' HG3' ' A' ' 54' ' ' GLU . 75.8 t -87.0 -16.96 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.394 -0.816 . . . . 0.0 110.004 179.536 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.41 ' OD2' ' O ' ' A' ' 62' ' ' THR . 6.6 t0 -110.5 87.99 2.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.284 -0.885 . . . . 0.0 110.091 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.24 -12.65 61.85 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.253 -0.904 . . . . 0.0 110.752 -179.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -72.2 -59.3 2.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.14 -0.975 . . . . 0.0 110.439 -179.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.9 -1.35 21.35 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.349 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 20.2 p30 -69.96 -31.09 68.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.148 -1.207 . . . . 0.0 110.116 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.456 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 120.86 -59.8 0.55 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.411 HG23 HG21 ' A' ' 28' ' ' THR . 50.1 p -91.15 166.37 13.0 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.18 -1.188 . . . . 0.0 110.756 -179.447 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.41 HD12 HG13 ' A' ' 55' ' ' VAL . 42.8 mt -102.95 137.34 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.384 -0.822 . . . . 0.0 110.132 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.407 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 51.1 m-20 -92.62 178.44 5.8 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.273 -0.892 . . . . 0.0 110.305 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.555 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 25.2 t80 -71.66 -44.27 12.15 Favored Pre-proline 0 N--CA 1.486 1.357 0 O-C-N 121.166 -0.959 . . . . 0.0 111.069 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.3 Cg_endo -71.35 -21.6 26.29 Favored 'Trans proline' 0 C--N 1.324 -0.763 0 O-C-N 123.109 1.057 . . . . 0.0 109.874 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.409 ' OE2' ' HA ' ' A' ' 56' ' ' ASP . 84.7 tt0 -83.73 -30.51 26.65 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.38 -0.825 . . . . 0.0 109.265 178.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.458 ' CE2' ' HB2' ' A' ' 16' ' ' PHE . 43.2 t80 -70.81 -47.06 61.48 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.534 -0.729 . . . . 0.0 109.853 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.9 tt -74.28 -27.99 60.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.329 -0.857 . . . . 0.0 109.874 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.2 m -80.52 -16.67 53.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.224 -0.923 . . . . 0.0 110.142 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.446 ' HE2' ' CE ' ' A' ' 72' ' ' MET . 14.3 tmm? -88.36 -46.8 8.87 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.304 -0.872 . . . . 0.0 110.856 -179.523 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.446 ' CE ' ' HE2' ' A' ' 71' ' ' MET . 58.0 mtt -90.85 -59.49 2.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.01 -1.056 . . . . 0.0 111.275 -179.219 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.855 0 O-C-N 121.258 -0.901 . . . . 0.0 111.121 -178.952 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 121.375 0.607 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.0 mt -52.13 -22.91 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.312 -0.868 . . . . 0.0 109.732 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.9 ttm-85 -69.09 -51.26 40.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.318 -0.864 . . . . 0.0 109.827 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -55.42 -43.03 74.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.067 -1.02 . . . . 0.0 109.764 179.528 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.466 ' O ' ' CG2' ' A' ' 91' ' ' VAL . . . -58.04 -56.08 26.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.894 . . . . 0.0 109.978 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -48.91 -30.85 6.38 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.19 -0.944 . . . . 0.0 110.586 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.6 ttp85 -70.33 -48.77 55.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.22 -0.925 . . . . 0.0 111.15 -179.362 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.481 HG21 ' CD2' ' A' ' 92' ' ' PHE . 27.5 m -64.78 -26.99 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.808 -1.183 . . . . 0.0 110.521 -179.54 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.481 ' CD2' HG21 ' A' ' 91' ' ' VAL . 38.6 m-85 -88.27 -14.95 37.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.256 -0.903 . . . . 0.0 110.24 179.687 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.25 77.16 1.77 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.0 109.893 179.512 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -94.56 -21.9 18.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.268 -0.895 . . . . 0.0 110.707 -179.477 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 2.0 p30 -71.11 -14.52 62.33 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.132 -0.98 . . . . 0.0 110.775 -179.297 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.86 30.36 23.71 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.598 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.456 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 1.7 t-20 -76.0 -78.12 0.12 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.246 -1.15 . . . . 0.0 109.939 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 145.28 -16.61 1.89 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.521 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -133.57 155.29 49.89 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.228 -1.16 . . . . 0.0 109.577 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.427 ' CD1' ' CD1' ' A' ' 141' ' ' PHE . 18.5 mt -94.74 118.6 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 120.988 -1.07 . . . . 0.0 109.541 179.784 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.8 m -102.37 168.8 9.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 110.128 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.28 -44.98 89.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.177 -0.952 . . . . 0.0 110.178 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.4 -58.15 9.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.125 -0.984 . . . . 0.0 110.011 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -49.88 -50.17 46.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.17 -0.956 . . . . 0.0 109.946 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -48.89 -40.31 29.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.44 -0.787 . . . . 0.0 110.151 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.406 ' O ' ' OG1' ' A' ' 110' ' ' THR . 5.1 tpt85 -64.02 -42.7 97.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.241 -0.912 . . . . 0.0 109.839 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -59.84 -27.05 66.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.301 -0.874 . . . . 0.0 110.209 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 92.4 t -84.35 -68.46 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.319 -0.863 . . . . 0.0 110.999 -179.275 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.401 ' HB3' HD12 ' A' ' 116' ' ' LEU . 20.2 mmt -50.19 -27.88 6.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.235 -0.916 . . . . 0.0 110.681 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 68.7 m -75.51 -42.22 53.28 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.238 -0.914 . . . . 0.0 110.653 -179.734 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -87.76 -2.15 58.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.153 -0.967 . . . . 0.0 110.775 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.2 mt -88.57 -68.7 0.75 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.964 -1.085 . . . . 0.0 110.176 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 166.6 37.94 0.02 OUTLIER Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -135.43 154.45 51.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.264 -1.139 . . . . 0.0 110.263 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -120.52 99.48 6.58 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.32 -0.863 . . . . 0.0 110.21 179.759 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.421 HD11 ' N ' ' A' ' 116' ' ' LEU . 4.8 mp -110.3 -166.77 1.12 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.167 -0.958 . . . . 0.0 110.423 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.1 t -135.19 -164.74 1.57 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.371 -0.831 . . . . 0.0 109.632 179.668 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 118' ' ' ASP . 1.2 m-20 -81.08 -45.74 16.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.022 -1.048 . . . . 0.0 110.653 -179.704 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -58.7 -39.52 81.0 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.417 -0.802 . . . . 0.0 110.819 -179.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.63 -49.89 73.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.117 -0.99 . . . . 0.0 110.766 -179.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 76.0 t -58.63 -37.4 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.101 -0.999 . . . . 0.0 110.43 -179.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -64.81 -47.77 76.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.141 -0.974 . . . . 0.0 110.294 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.408 ' HG2' ' OE2' ' A' ' 127' ' ' GLU . 6.4 tm-20 -66.3 -21.86 66.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.229 -0.919 . . . . 0.0 109.843 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 28.8 mmm -73.88 -56.5 4.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.389 -0.819 . . . . 0.0 110.231 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 22.3 mm -66.72 -25.42 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.296 -0.878 . . . . 0.0 110.344 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -72.66 -57.98 3.71 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.194 -0.941 . . . . 0.0 110.225 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.445 ' CA ' ' OE1' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -63.05 -19.22 64.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 110.069 179.908 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.79 -34.2 27.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.256 -0.902 . . . . 0.0 110.013 179.674 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.87 90.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 110.114 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 92.5 mt -61.25 -18.9 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.895 . . . . 0.0 110.335 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.4 p30 -114.45 -30.34 6.58 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.217 -0.927 . . . . 0.0 110.195 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.458 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 89.39 80.62 1.32 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.409 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 33.0 p30 -139.1 13.76 2.63 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.334 -1.098 . . . . 0.0 110.565 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.25 24.6 76.13 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.159 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.413 ' O ' ' HG3' ' A' ' 135' ' ' GLN . 0.3 OUTLIER -170.5 143.66 2.29 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.137 -1.214 . . . . 0.0 110.268 179.639 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.407 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 91.7 t -93.73 129.24 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 110.453 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -88.43 174.53 8.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.423 -0.798 . . . . 0.0 110.23 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.453 ' C ' ' CD1' ' A' ' 138' ' ' TYR . 8.0 t80 -68.03 -51.72 43.67 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.281 -0.887 . . . . 0.0 109.456 179.302 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -62.31 -40.99 98.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.331 -0.856 . . . . 0.0 109.789 179.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -65.25 -29.72 70.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 109.981 179.585 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.492 ' CD1' ' HE3' ' A' ' 144' ' ' MET . 78.6 t80 -74.12 -28.21 61.24 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.271 -0.893 . . . . 0.0 110.128 -179.827 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.3 t -88.46 -20.78 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.245 -0.909 . . . . 0.0 110.446 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -98.2 -17.35 19.04 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.356 -0.84 . . . . 0.0 110.904 -179.416 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.492 ' HE3' ' CD1' ' A' ' 141' ' ' PHE . 15.0 ptt? -81.32 -27.71 34.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.045 -1.034 . . . . 0.0 110.357 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 4.7 tpp -89.58 -68.56 0.77 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.9 . . . . 0.0 109.919 179.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 67.9 p . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.211 -0.931 . . . . 0.0 110.126 179.932 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.244 0.545 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -58.75 -44.0 90.44 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.192 -0.942 . . . . 0.0 110.789 -179.649 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -59.63 -48.0 83.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.077 -1.014 . . . . 0.0 109.986 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 61.8 mt -59.9 -30.07 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.155 -0.966 . . . . 0.0 109.665 179.545 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.97 -30.02 67.26 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.273 -0.892 . . . . 0.0 109.705 179.88 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -69.77 -58.15 4.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.42 -0.8 . . . . 0.0 109.997 179.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -59.01 -36.26 74.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.175 -0.953 . . . . 0.0 109.439 179.426 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 9.6 tmtt? -65.36 -33.86 76.95 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.507 -0.746 . . . . 0.0 109.609 179.619 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -63.56 -42.67 98.33 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.358 -0.839 . . . . 0.0 109.634 179.421 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.86 -48.22 82.58 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.329 -0.857 . . . . 0.0 110.041 179.695 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -55.43 -54.29 45.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.287 -0.883 . . . . 0.0 110.188 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.1 m -58.7 -27.75 65.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.154 -0.966 . . . . 0.0 109.827 179.653 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.461 ' CD2' ' O ' ' A' ' 18' ' ' LEU . 1.4 tt -71.06 -32.23 68.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.441 -0.787 . . . . 0.0 110.05 -179.978 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.414 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 6.1 m-85 -84.31 -62.82 1.46 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.264 -0.897 . . . . 0.0 110.889 -179.184 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -82.12 85.1 6.83 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.226 -0.921 . . . . 0.0 110.625 -179.329 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.412 ' HD3' ' O ' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -106.48 52.74 0.71 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.141 -0.974 . . . . 0.0 109.972 179.375 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 1.7 p30 -137.08 -35.41 0.7 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.21 -0.931 . . . . 0.0 110.695 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 113.09 39.83 1.11 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.835 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -101.61 -33.0 10.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.357 -1.084 . . . . 0.0 110.032 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.58 -15.14 63.15 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.8 p -139.97 160.66 39.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.972 -1.31 . . . . 0.0 110.502 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.8 mt -103.17 111.99 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.362 -0.836 . . . . 0.0 109.983 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 49.8 p -101.93 -164.9 1.14 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.211 -0.93 . . . . 0.0 110.263 -179.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 42.4 p -78.11 -36.58 47.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.221 -0.924 . . . . 0.0 110.243 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.5 mttm -68.58 -56.62 7.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 0.0 109.706 179.592 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.457 ' O ' ' CG2' ' A' ' 34' ' ' THR . 98.9 mt-10 -58.1 -40.9 82.32 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.284 -0.885 . . . . 0.0 109.626 179.413 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.419 ' CD2' ' HG ' ' A' ' 48' ' ' LEU . 7.0 tp -66.81 -26.76 67.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.26 -0.9 . . . . 0.0 109.401 179.186 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.0 -43.99 95.09 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.662 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.457 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 7.0 t -75.41 -21.6 58.08 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.058 -1.26 . . . . 0.0 110.123 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 31' ' ' GLU . 29.5 t -78.21 -29.81 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.2 -0.938 . . . . 0.0 109.972 179.535 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.8 mmt -90.17 -28.0 19.21 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.185 -0.947 . . . . 0.0 110.288 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.4 mtm180 -89.61 -17.51 28.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.234 -0.916 . . . . 0.0 110.447 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 34' ' ' THR . 29.7 t -49.6 -52.86 27.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.17 -0.957 . . . . 0.0 110.249 -179.766 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.26 61.32 1.53 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 110.214 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . -171.58 -62.57 0.04 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' A' ' 40' ' ' GLY . 25.6 mt-30 54.81 102.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.232 -1.158 . . . . 0.0 110.115 -179.808 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.509 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.8 t30 -164.84 -63.03 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.343 -0.848 . . . . 0.0 110.077 179.839 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.509 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 45.2 Cg_endo -71.12 171.49 15.84 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.392 1.206 . . . . 0.0 109.9 179.608 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.409 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 81.1 p -120.27 -170.74 2.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.141 -0.974 . . . . 0.0 109.94 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -74.55 -29.03 61.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.127 -0.983 . . . . 0.0 110.197 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.07 -57.22 4.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.201 -0.937 . . . . 0.0 109.827 179.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -62.08 -24.72 67.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 0.0 109.889 179.616 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.445 HD21 ' N ' ' A' ' 49' ' ' GLN . 4.8 tt -70.23 -52.99 18.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.312 -0.867 . . . . 0.0 109.677 179.506 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.445 ' N ' HD21 ' A' ' 48' ' ' LEU . 51.3 tt0 -54.33 -37.61 65.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.182 -0.949 . . . . 0.0 109.449 179.271 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -68.79 -35.55 77.17 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.356 -0.84 . . . . 0.0 109.296 179.386 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.442 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 54.5 ttp -68.51 -17.45 64.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.326 -0.859 . . . . 0.0 109.675 179.417 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.8 mt -88.25 -37.88 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.888 . . . . 0.0 109.769 179.43 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -53.49 -35.61 60.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.912 . . . . 0.0 110.022 179.603 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.468 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 7.4 pt-20 -71.22 -32.56 68.95 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.355 -0.841 . . . . 0.0 110.273 -179.824 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.468 ' N ' ' HG3' ' A' ' 54' ' ' GLU . 71.5 t -76.38 -67.94 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.121 -0.987 . . . . 0.0 109.588 179.544 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -46.01 125.55 6.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.506 -0.746 . . . . 0.0 110.176 179.787 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.83 -26.07 10.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.143 -0.973 . . . . 0.0 110.842 -179.589 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 2.8 p30 -70.03 -34.76 73.68 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.228 -0.92 . . . . 0.0 110.455 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.457 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 92.5 76.37 1.33 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.822 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.409 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 18.6 p-10 -142.9 -43.55 0.3 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.222 -1.163 . . . . 0.0 110.179 179.391 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.467 ' O ' ' CG2' ' A' ' 62' ' ' THR . . . 132.61 2.61 3.94 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.842 179.323 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.467 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 49.5 p -154.24 167.17 30.79 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.803 -1.41 . . . . 0.0 111.093 -179.858 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.451 HG21 ' N ' ' A' ' 64' ' ' ASP . 49.3 mt -104.98 146.25 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.385 -0.822 . . . . 0.0 109.775 179.662 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.451 ' N ' HG21 ' A' ' 63' ' ' ILE . 48.7 m-20 -105.45 170.51 7.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.095 -1.003 . . . . 0.0 110.293 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.526 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 32.9 t80 -67.07 -42.3 40.3 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.877 . . . . 0.0 111.412 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 46.1 Cg_endo -74.73 -26.3 11.62 Favored 'Trans proline' 0 C--O 1.212 -0.782 0 O-C-N 123.087 1.046 . . . . 0.0 110.146 -179.587 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 71' ' ' MET . 35.1 tt0 -78.99 -27.95 43.41 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.289 -0.882 . . . . 0.0 109.369 179.378 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -74.57 -61.07 2.0 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.318 -0.864 . . . . 0.0 109.728 179.647 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.481 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 5.0 tt -56.92 -38.09 72.38 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.291 -0.88 . . . . 0.0 109.826 179.669 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' A' ' 66' ' ' PRO . 52.1 m -73.77 -26.4 60.63 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.192 -0.943 . . . . 0.0 110.325 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.473 ' CE ' ' CE ' ' A' ' 72' ' ' MET . 34.4 ttp -63.37 -50.18 70.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 110.208 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.473 ' CE ' ' CE ' ' A' ' 71' ' ' MET . 36.5 mtt -90.5 -15.2 31.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.286 -0.884 . . . . 0.0 111.188 -179.372 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.481 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.503 2.201 0 O-C-N 120.955 -1.091 . . . . 0.0 111.23 -179.664 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 121.339 0.59 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.6 mt -53.44 -46.54 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.077 -1.014 . . . . 0.0 110.02 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -55.49 -42.38 74.33 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.178 -0.951 . . . . 0.0 109.071 179.437 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.412 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -49.6 -50.68 41.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.398 -0.814 . . . . 0.0 109.39 179.259 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.468 ' O ' ' CG2' ' A' ' 91' ' ' VAL . . . -52.54 -44.73 65.97 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.358 -0.838 . . . . 0.0 109.281 179.134 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.426 ' CE1' HD13 ' A' ' 100' ' ' ILE . 4.0 t80 -54.16 -39.6 66.7 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.166 -0.958 . . . . 0.0 109.987 179.782 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -59.07 -51.37 70.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.231 -0.918 . . . . 0.0 110.242 -179.874 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.468 ' CG2' ' O ' ' A' ' 88' ' ' ALA . 26.6 m -68.28 -18.49 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.125 -0.985 . . . . 0.0 109.745 179.817 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.436 ' CD2' ' O ' ' A' ' 88' ' ' ALA . 29.0 m-85 -103.41 4.38 36.13 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.36 -0.837 . . . . 0.0 110.317 179.657 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.415 ' OD2' ' HA2' ' A' ' 98' ' ' GLY . 59.1 t0 -146.19 70.21 1.22 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -0.939 . . . . 0.0 109.749 179.748 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -107.3 59.01 0.62 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 110.708 -179.557 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.2 p30 -138.31 -40.0 0.52 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.128 -0.983 . . . . 0.0 110.309 179.567 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.469 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 135.56 17.81 0.83 Allowed Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.225 -1.464 . . . . 0.0 111.827 178.846 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.469 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 27.6 p30 -131.58 -122.16 0.2 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.352 -1.675 . . . . 0.0 109.89 179.192 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.469 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . -170.09 44.53 0.2 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 23.5 m-85 -131.95 128.52 38.64 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.39 -1.065 . . . . 0.0 110.294 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.429 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 24.0 mt -95.92 124.38 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.195 -0.941 . . . . 0.0 109.972 179.702 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.4 t -113.51 157.55 21.87 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.256 -0.903 . . . . 0.0 110.258 -179.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.25 -26.54 12.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 110.15 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.448 ' O ' ' HG3' ' A' ' 106' ' ' ARG . . . -69.72 -59.31 3.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.198 -0.939 . . . . 0.0 110.09 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -51.92 -38.92 58.14 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.064 -1.022 . . . . 0.0 110.264 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.5 tt -59.1 -48.98 79.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 110.488 -179.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.475 ' HG3' ' N ' ' A' ' 107' ' ' HIS . 0.0 OUTLIER -65.81 -21.7 66.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.907 -1.121 . . . . 0.0 109.999 -179.905 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.475 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 21.1 t-160 -72.3 -34.63 68.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.416 -0.802 . . . . 0.0 110.035 -179.969 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.465 ' CG2' ' O ' ' A' ' 91' ' ' VAL . 96.8 t -78.88 -42.12 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.319 -0.863 . . . . 0.0 110.434 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 4.7 mmt -66.52 -56.96 8.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.215 -179.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.449 ' CG2' ' O ' ' A' ' 106' ' ' ARG . 44.1 p -46.61 -48.97 19.66 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.447 -0.783 . . . . 0.0 110.714 -179.819 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -59.13 -55.67 32.08 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.179 -0.95 . . . . 0.0 110.258 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 79.6 mt -52.36 -72.6 0.05 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.14 -0.975 . . . . 0.0 109.924 179.658 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.08 40.37 0.02 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.869 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -121.71 93.24 3.94 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.233 -1.157 . . . . 0.0 110.089 179.799 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -74.63 111.4 9.78 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.269 -0.894 . . . . 0.0 110.208 -179.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -117.43 177.56 4.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -0.862 . . . . 0.0 110.285 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 59.0 m -100.87 158.87 15.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.334 -0.854 . . . . 0.0 110.173 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -59.91 -41.98 92.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.289 -0.882 . . . . 0.0 110.6 -179.765 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -60.08 -50.64 72.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.291 -0.881 . . . . 0.0 110.716 -179.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -53.23 -52.79 57.82 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.144 -0.972 . . . . 0.0 110.877 -179.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.5 t -55.32 -55.81 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.144 -0.973 . . . . 0.0 110.371 -179.607 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -54.54 -26.66 33.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.303 -0.873 . . . . 0.0 110.35 -179.693 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 7.1 tt0 -76.3 -34.71 59.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 110.069 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.401 ' HB3' ' HE1' ' A' ' 124' ' ' MET . 72.0 mtp -67.58 -47.08 70.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.214 -0.929 . . . . 0.0 110.122 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 29.6 mm -64.11 -45.0 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 110.234 179.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.5 -33.7 75.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.192 -0.942 . . . . 0.0 110.041 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 41.2 mm-40 -67.93 -33.95 75.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.018 179.79 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.42 ' HB1' HG23 ' A' ' 136' ' ' VAL . . . -71.18 -42.13 69.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.284 -0.885 . . . . 0.0 110.464 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -56.92 92.39 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.159 -0.963 . . . . 0.0 110.385 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 76.3 mt -64.4 -31.89 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.194 -0.941 . . . . 0.0 110.236 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 22.4 p30 -101.99 -18.58 15.58 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.193 -0.942 . . . . 0.0 110.536 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.454 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 77.3 75.7 0.91 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.645 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 40.4 m-20 -109.8 -49.3 3.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.227 -1.161 . . . . 0.0 110.053 179.711 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 157.17 -23.59 0.45 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.708 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -143.74 155.91 44.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.329 -1.1 . . . . 0.0 110.115 179.727 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.429 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 77.7 t -91.6 108.51 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.203 -0.936 . . . . 0.0 110.315 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -82.63 165.55 19.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.948 . . . . 0.0 110.249 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -44.68 -34.46 2.23 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.369 -0.832 . . . . 0.0 111.766 -178.823 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -65.22 -67.05 0.47 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.867 -1.145 . . . . 0.0 110.726 -179.223 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -52.86 -26.16 13.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.207 -0.933 . . . . 0.0 110.359 -179.589 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.504 ' CE1' ' HE2' ' A' ' 145' ' ' MET . 7.9 t80 -68.44 -40.43 81.14 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 109.985 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 43.5 t -82.01 -20.25 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.294 -0.879 . . . . 0.0 110.554 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -80.5 -28.25 37.54 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.341 -0.849 . . . . 0.0 110.696 -179.534 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.451 ' CE ' ' HE2' ' A' ' 145' ' ' MET . 4.3 ptt? -84.53 -21.68 30.43 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.053 -1.029 . . . . 0.0 110.462 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.504 ' HE2' ' CE1' ' A' ' 141' ' ' PHE . 46.4 mtt -89.02 -39.83 13.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.203 -0.936 . . . . 0.0 110.524 -179.801 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.207 -0.933 . . . . 0.0 110.383 -179.8 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.084 0.469 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -55.5 -54.61 41.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.167 -0.958 . . . . 0.0 109.969 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -50.97 -45.03 60.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.908 . . . . 0.0 109.788 179.581 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.411 HD11 HD12 ' A' ' 69' ' ' LEU . 31.3 mm -52.87 -40.92 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.884 . . . . 0.0 109.646 179.667 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -59.94 -44.4 94.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.361 -0.837 . . . . 0.0 109.89 179.615 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -53.29 -51.31 62.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 109.954 179.805 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -60.7 -33.87 73.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 109.896 179.737 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 72.1 mttt -66.07 -27.46 68.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.888 179.626 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -73.19 -53.05 11.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.35 -0.843 . . . . 0.0 109.913 179.763 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.444 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -58.89 -34.84 72.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.21 -0.931 . . . . 0.0 109.98 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -66.99 -54.25 23.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.883 . . . . 0.0 109.975 179.867 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.0 m -56.64 -21.39 26.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.238 -0.914 . . . . 0.0 110.021 179.654 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.425 ' C ' ' CD1' ' A' ' 18' ' ' LEU . 3.1 tm? -78.6 -35.44 45.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.443 -0.786 . . . . 0.0 109.791 179.878 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.444 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 22.7 m-85 -70.46 -55.58 8.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.386 -0.821 . . . . 0.0 110.454 -179.889 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.424 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 0.5 OUTLIER -55.79 113.16 1.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.209 -0.932 . . . . 0.0 110.412 -179.897 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -109.96 54.58 0.66 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 110.143 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.439 ' OD2' ' CB ' ' A' ' 24' ' ' ASP . 10.2 p-10 -162.51 -37.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.111 -0.993 . . . . 0.0 110.598 -179.788 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.81 39.66 2.48 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.439 ' CB ' ' OD2' ' A' ' 22' ' ' ASP . 6.8 t70 -103.54 -67.67 0.88 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.369 -1.077 . . . . 0.0 110.101 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.416 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 135.92 23.47 0.55 Allowed Glycine 0 N--CA 1.499 2.842 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.621 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.416 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 74.4 p -154.15 144.17 21.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.896 -1.355 . . . . 0.0 109.534 179.534 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.6 mt -96.37 107.18 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.109 -0.994 . . . . 0.0 110.328 -179.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.451 ' CG2' HG23 ' A' ' 62' ' ' THR . 72.4 p -103.28 -176.98 3.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.374 -0.829 . . . . 0.0 110.178 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.5 p -68.31 -26.68 65.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.277 -0.89 . . . . 0.0 110.14 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -68.67 -62.44 1.39 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.21 -0.931 . . . . 0.0 109.921 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.424 ' OE1' ' HA ' ' A' ' 20' ' ' ASP . 35.2 mt-10 -56.42 -55.36 34.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.325 -0.859 . . . . 0.0 109.458 179.602 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.437 HD21 HD12 ' A' ' 52' ' ' ILE . 6.6 tp -57.57 -23.77 52.49 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.177 -0.952 . . . . 0.0 109.296 179.144 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.477 ' HA2' ' CD1' ' A' ' 48' ' ' LEU . . . -62.85 -46.93 92.59 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.444 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.466 ' O ' ' CB ' ' A' ' 38' ' ' SER . 96.4 m -78.54 -14.45 59.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.332 -1.099 . . . . 0.0 109.934 179.636 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.403 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 50.5 t -78.77 -36.57 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.172 -0.955 . . . . 0.0 110.21 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.7 mmt -90.72 -38.09 13.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.352 -0.843 . . . . 0.0 110.756 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.7 mtm180 -75.74 -36.32 59.93 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.714 -179.497 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 34' ' ' THR . 8.4 t -76.99 -23.93 52.24 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.876 -1.14 . . . . 0.0 110.054 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 3.9 mm? -119.85 56.61 0.95 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.314 -0.866 . . . . 0.0 110.169 179.8 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.49 56.95 0.07 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -48.43 104.92 0.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.178 -1.19 . . . . 0.0 110.479 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.539 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 5.9 m-20 -159.66 -63.61 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.318 -0.864 . . . . 0.0 110.329 179.314 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.539 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 46.6 Cg_endo -73.87 -179.32 4.49 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.332 1.175 . . . . 0.0 109.864 179.439 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 8.7 t -134.72 -175.64 3.96 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.108 -0.995 . . . . 0.0 110.102 -179.852 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.06 -42.0 93.58 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.034 -1.041 . . . . 0.0 110.333 -179.832 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.47 -68.46 0.38 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.22 -0.925 . . . . 0.0 110.411 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -47.14 -26.21 1.07 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.221 -0.924 . . . . 0.0 109.984 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.477 ' CD1' ' HA2' ' A' ' 33' ' ' GLY . 9.1 tt -70.56 -49.48 47.53 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.313 -0.867 . . . . 0.0 109.764 179.52 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -52.45 -41.18 63.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.118 -0.989 . . . . 0.0 109.222 179.224 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.78 -35.38 79.94 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.423 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 3.5 ttt -68.16 -15.05 63.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.646 -0.659 . . . . 0.0 109.573 179.007 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.471 ' CD1' HD22 ' A' ' 48' ' ' LEU . 57.3 mt -88.56 -35.17 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.397 -0.814 . . . . 0.0 109.834 179.39 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -51.83 -45.38 63.93 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.274 -0.891 . . . . 0.0 110.657 -179.802 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.479 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 22.0 pt-20 -56.93 -34.27 67.81 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.177 -0.952 . . . . 0.0 110.476 -179.658 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.479 ' N ' ' HG3' ' A' ' 54' ' ' GLU . 95.3 t -84.49 -71.73 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.202 -0.936 . . . . 0.0 110.284 -179.696 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.445 ' HB2' ' CG1' ' A' ' 63' ' ' ILE . 24.2 t70 -56.53 124.33 17.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.335 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.34 5.29 21.48 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.23 -0.919 . . . . 0.0 110.702 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.83 -23.22 36.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.077 -1.015 . . . . 0.0 110.198 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.26 14.43 76.66 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.737 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -91.56 -37.39 13.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.014 -1.286 . . . . 0.0 110.165 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.14 -52.02 0.83 Allowed Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.231 179.567 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.451 HG23 ' CG2' ' A' ' 28' ' ' THR . 66.7 p -101.87 167.55 9.99 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.067 -1.255 . . . . 0.0 110.728 -179.379 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.448 HG21 ' N ' ' A' ' 64' ' ' ASP . 48.7 mt -115.29 157.17 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.287 -0.883 . . . . 0.0 110.055 179.662 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.475 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 1.4 m-20 -112.6 -172.37 2.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.241 -0.912 . . . . 0.0 110.728 -179.648 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.547 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 50.3 t80 -65.3 -42.62 60.31 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.473 -0.767 . . . . 0.0 111.976 -179.686 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.5 Cg_endo -71.67 -33.35 10.56 Favored 'Trans proline' 0 C--N 1.323 -0.787 0 O-C-N 123.069 1.036 . . . . 0.0 110.893 -179.146 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.414 ' HB2' ' CG2' ' A' ' 63' ' ' ILE . 48.6 mt-10 -71.43 -30.16 65.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.021 -1.049 . . . . 0.0 108.844 179.169 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.491 ' CZ ' ' SD ' ' A' ' 72' ' ' MET . 64.9 t80 -73.46 -43.0 61.24 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.512 0.672 . . . . 0.0 109.654 179.738 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.49 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 15.5 tp -77.19 -12.12 59.91 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.49 -0.756 . . . . 0.0 110.344 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 66' ' ' PRO . 54.7 m -90.68 -28.42 18.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.929 -1.107 . . . . 0.0 110.44 -179.988 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.471 ' HE2' ' CE ' ' A' ' 72' ' ' MET . 18.9 tmm? -90.61 -37.02 14.07 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.178 -0.951 . . . . 0.0 111.197 -179.488 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.491 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 48.9 mtt -91.3 -11.8 36.97 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.112 -0.993 . . . . 0.0 111.975 -178.646 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.5 2.03 0 O-C-N 120.772 -1.205 . . . . 0.0 111.126 -179.401 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.032 0.444 . . . . 0.0 110.314 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.475 HG13 ' CE2' ' A' ' 141' ' ' PHE . 3.8 tp -48.06 -34.87 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.168 -0.958 . . . . 0.0 109.536 179.834 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -59.95 -48.7 80.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.392 -0.818 . . . . 0.0 109.499 179.282 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 7.8 mm-40 -54.13 -41.6 68.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.255 -0.903 . . . . 0.0 109.563 179.39 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.413 ' O ' HG21 ' A' ' 91' ' ' VAL . . . -59.15 -46.41 88.45 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.312 -0.867 . . . . 0.0 109.66 179.528 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.408 ' O ' ' HB3' ' A' ' 93' ' ' ASP . 0.4 OUTLIER -63.38 -20.82 65.86 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.179 179.736 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -74.05 -49.74 22.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.365 -0.834 . . . . 0.0 110.882 -179.489 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.424 ' CG2' ' N ' ' A' ' 92' ' ' PHE . 16.5 m -75.1 -41.04 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.133 -0.979 . . . . 0.0 111.416 -179.089 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.571 ' CE1' ' CG1' ' A' ' 108' ' ' VAL . 37.7 m-85 -72.78 -28.18 62.45 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.068 -1.02 . . . . 0.0 111.248 -179.141 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 10.4 t70 -111.15 51.6 0.77 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.859 -1.151 . . . . 0.0 110.348 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.74 2.63 32.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 110.49 179.882 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 3.0 p30 -85.96 -37.77 18.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.128 -0.983 . . . . 0.0 110.296 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 104.38 47.64 1.2 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.449 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 15.8 p-10 -122.77 -32.77 3.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.151 -1.205 . . . . 0.0 110.295 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.48 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 100.36 16.16 28.03 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.901 -1.142 . . . . 0.0 110.312 179.274 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 37.6 m-85 -144.79 161.44 39.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.051 -1.264 . . . . 0.0 110.303 179.762 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.44 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 23.0 mt -107.0 118.39 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.256 -0.903 . . . . 0.0 109.419 179.323 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.3 m -102.13 163.36 12.28 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.44 -0.788 . . . . 0.0 109.632 179.8 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.87 -49.76 76.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.063 -1.023 . . . . 0.0 110.167 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -50.43 -50.45 52.0 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.274 -0.891 . . . . 0.0 110.573 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -57.95 -45.73 86.19 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.356 -0.84 . . . . 0.0 110.136 -179.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.569 ' CD1' ' CE1' ' A' ' 92' ' ' PHE . 40.5 tp -59.15 -23.88 62.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.438 -0.789 . . . . 0.0 110.319 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.44 -43.3 27.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.307 -0.871 . . . . 0.0 110.403 -179.933 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.414 ' O ' ' OG1' ' A' ' 110' ' ' THR . 81.6 m-70 -68.18 -30.27 69.33 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.216 -0.927 . . . . 0.0 110.551 -179.927 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.571 ' CG1' ' CE1' ' A' ' 92' ' ' PHE . 48.1 t -75.17 -47.82 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.02 -1.05 . . . . 0.0 109.866 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.485 ' HE2' ' CG ' ' A' ' 105' ' ' LEU . 63.7 mtt -65.36 -10.42 33.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.174 -0.954 . . . . 0.0 110.509 179.911 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 107' ' ' HIS . 1.1 p -90.17 -26.41 20.16 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.018 -1.051 . . . . 0.0 109.858 179.245 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -88.47 -52.92 4.92 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.146 -0.971 . . . . 0.0 110.117 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.1 mt -47.73 -72.85 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.165 -0.959 . . . . 0.0 110.278 179.811 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 162.97 40.78 0.02 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.477 ' HB3' ' CD1' ' A' ' 116' ' ' LEU . 51.5 mt-10 -120.85 121.45 38.13 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.323 -1.104 . . . . 0.0 110.462 -179.786 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -106.81 66.03 0.68 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.206 -0.934 . . . . 0.0 110.109 179.702 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.477 ' CD1' ' HB3' ' A' ' 114' ' ' GLU . 3.4 mp -88.04 167.98 13.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.261 -0.899 . . . . 0.0 110.364 -179.895 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 22.9 m -86.24 163.21 17.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.334 -0.854 . . . . 0.0 109.969 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -60.77 -54.44 45.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.159 -0.963 . . . . 0.0 110.379 -179.805 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -47.07 -40.23 14.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.947 . . . . 0.0 110.276 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 124' ' ' MET . 58.2 mm-40 -56.76 -60.09 4.07 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.251 -0.906 . . . . 0.0 110.441 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.1 t -47.22 -39.72 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.143 -0.973 . . . . 0.0 110.371 -179.622 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -62.68 -44.07 97.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.135 -0.978 . . . . 0.0 109.99 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -69.11 -20.51 64.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.199 179.839 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' A' ' 120' ' ' GLU . 85.1 mtp -77.78 -46.52 21.41 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.126 -0.984 . . . . 0.0 109.993 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.414 HG21 HG22 ' A' ' 136' ' ' VAL . 26.0 mm -65.57 -29.38 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.158 -0.964 . . . . 0.0 110.007 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -75.91 -54.79 6.36 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.2 -0.938 . . . . 0.0 110.132 179.576 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -54.94 -33.52 62.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.226 -0.921 . . . . 0.0 109.995 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -75.13 -37.43 61.41 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.209 -0.932 . . . . 0.0 109.811 179.701 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.404 ' OD2' ' HA2' ' A' ' 132' ' ' GLY . 13.7 t0 -57.89 95.46 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.317 -0.864 . . . . 0.0 109.809 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.407 HD11 ' HG2' ' A' ' 140' ' ' GLU . 21.8 mt -62.07 -46.96 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.888 . . . . 0.0 110.402 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 21.6 p30 -86.6 -19.69 28.99 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.185 -0.947 . . . . 0.0 110.059 179.854 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.445 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 67.48 65.56 2.69 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 178.871 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.426 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 34.4 m-20 -98.28 -35.62 10.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.178 -1.19 . . . . 0.0 109.719 179.048 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.75 -28.62 1.04 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 -179.664 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.412 ' O ' ' OE1' ' A' ' 135' ' ' GLN . 0.0 OUTLIER -137.08 169.62 17.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.471 -1.017 . . . . 0.0 109.709 179.589 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.44 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 84.4 t -99.28 145.23 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 120.97 -1.081 . . . . 0.0 110.752 -179.447 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.405 ' N ' HG11 ' A' ' 136' ' ' VAL . 35.7 t30 -106.67 178.79 4.46 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.365 -0.835 . . . . 0.0 110.193 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -69.07 -44.7 72.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.231 -0.918 . . . . 0.0 110.441 -179.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.58 -33.32 73.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.242 -0.911 . . . . 0.0 110.27 -179.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.407 ' HG2' HD11 ' A' ' 130' ' ' ILE . 48.3 mt-10 -71.27 -35.6 71.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.146 -0.971 . . . . 0.0 110.085 179.818 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.479 ' CD1' ' HE1' ' A' ' 144' ' ' MET . 57.4 t80 -71.13 -32.72 69.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.212 -0.93 . . . . 0.0 110.657 -179.847 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.405 ' HB ' ' OE1' ' A' ' 143' ' ' GLN . 59.4 t -78.7 -29.54 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.12 -0.987 . . . . 0.0 110.72 -179.734 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.424 ' OE1' ' N ' ' A' ' 143' ' ' GLN . 0.6 OUTLIER -97.06 -9.74 27.46 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.129 -0.982 . . . . 0.0 111.456 -179.068 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.479 ' HE1' ' CD1' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -89.31 -31.56 17.77 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.705 -1.247 . . . . 0.0 110.372 -179.958 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 56.0 ttm -85.97 -48.77 8.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.938 179.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.5 p . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.351 -0.843 . . . . 0.0 110.091 179.682 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.098 0.475 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -62.08 -55.06 32.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.032 -1.042 . . . . 0.0 110.764 -179.661 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -59.76 -50.89 72.05 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.208 -0.932 . . . . 0.0 110.217 -179.544 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.416 ' O ' ' HB2' ' A' ' 12' ' ' PHE . 22.9 mt -48.91 -42.74 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.045 -1.034 . . . . 0.0 109.664 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.02 -43.1 99.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 109.571 179.301 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -58.65 -29.1 66.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 109.555 179.463 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.416 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 12.5 m-85 -72.91 -36.23 67.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.279 -0.888 . . . . 0.0 109.934 179.656 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -70.46 -27.1 63.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.917 . . . . 0.0 109.858 179.623 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.83 -43.83 52.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.352 -0.843 . . . . 0.0 109.845 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.56 -42.86 86.45 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.246 -0.909 . . . . 0.0 109.7 179.484 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -57.14 -44.62 83.54 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.269 -0.894 . . . . 0.0 109.651 179.685 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 98.3 p -64.12 -35.6 81.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -0.904 . . . . 0.0 109.337 179.388 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.442 ' CD2' ' O ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -58.69 -33.17 69.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.466 -0.771 . . . . 0.0 109.381 179.438 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.504 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 3.5 m-30 -87.09 -24.08 24.69 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.39 -0.819 . . . . 0.0 109.92 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -101.69 92.67 4.96 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.334 -0.854 . . . . 0.0 109.912 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.52 -14.29 15.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 110.59 -179.548 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -78.89 -37.34 40.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.184 -0.948 . . . . 0.0 110.299 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.72 83.13 1.71 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 23.5 p-10 -156.53 -32.41 0.09 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.122 -1.223 . . . . 0.0 111.207 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.81 22.85 9.76 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.56 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.403 ' OG1' ' OD2' ' A' ' 24' ' ' ASP . 75.9 p -149.69 155.01 39.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.164 -1.198 . . . . 0.0 109.988 179.863 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.5 mt -109.43 124.93 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.069 -1.02 . . . . 0.0 110.218 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.433 ' CG2' HG23 ' A' ' 62' ' ' THR . 41.4 p -108.0 -159.01 0.67 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.426 -0.796 . . . . 0.0 110.189 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.414 HG22 ' OE1' ' A' ' 49' ' ' GLN . 32.0 p -90.23 -34.04 15.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.218 179.921 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.49 -58.88 6.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -0.906 . . . . 0.0 109.995 -179.952 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.437 ' HB3' ' O ' ' A' ' 19' ' ' PHE . 48.8 mt-10 -60.49 -54.64 43.03 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.32 -0.862 . . . . 0.0 109.709 179.831 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 tp -57.26 -20.18 26.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.269 -0.894 . . . . 0.0 109.713 179.533 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.35 -46.85 46.84 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 179.542 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.437 ' O ' ' CB ' ' A' ' 38' ' ' SER . 38.4 m -68.8 -20.22 64.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.447 -1.031 . . . . 0.0 109.805 179.349 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.436 HG23 ' HA ' ' A' ' 19' ' ' PHE . 54.9 t -75.48 -58.1 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.385 -0.822 . . . . 0.0 110.332 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.506 ' CE ' ' CE ' ' A' ' 51' ' ' MET . 58.7 mtt -72.9 -18.8 61.38 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.279 -0.888 . . . . 0.0 110.785 -179.391 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -89.93 -29.33 18.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.021 -1.049 . . . . 0.0 110.09 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 34' ' ' THR . 40.5 t -82.41 -30.73 29.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.237 -0.915 . . . . 0.0 110.101 179.756 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.415 HD11 ' O ' ' A' ' 35' ' ' VAL . 1.3 mt -104.35 64.93 0.77 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.376 -0.828 . . . . 0.0 109.663 179.608 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.22 78.16 1.34 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.411 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -63.24 88.38 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.282 -1.128 . . . . 0.0 110.55 -179.459 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.534 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 3.2 m120 -114.28 -66.66 0.03 OUTLIER Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.375 -0.828 . . . . 0.0 110.689 179.72 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.534 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 47.1 Cg_endo -73.49 -169.44 0.54 Allowed 'Trans proline' 0 C--N 1.32 -0.934 0 O-C-N 123.092 1.048 . . . . 0.0 110.341 179.484 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 35.0 p -138.54 -175.3 4.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.321 -0.862 . . . . 0.0 110.07 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -66.56 -31.5 72.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.222 -0.923 . . . . 0.0 109.974 179.683 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.23 -67.28 0.5 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 0.0 109.953 179.73 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -50.6 -31.11 15.02 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.354 -0.841 . . . . 0.0 109.688 179.718 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.41 ' HB2' ' O ' ' A' ' 44' ' ' THR . 8.8 tt -65.63 -47.94 73.89 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.395 -0.815 . . . . 0.0 110.066 179.65 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.414 ' OE1' HG22 ' A' ' 29' ' ' THR . 4.6 tp-100 -54.46 -44.95 72.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 109.217 179.465 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 1.0 OUTLIER -67.87 -27.35 66.6 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.345 -0.847 . . . . 0.0 109.307 179.355 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.506 ' CE ' ' CE ' ' A' ' 36' ' ' MET . 20.2 ttp -76.15 -15.18 60.12 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.497 -0.752 . . . . 0.0 109.719 179.413 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.411 HD11 HG23 ' A' ' 29' ' ' THR . 6.4 mt -90.51 -38.45 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.132 -0.98 . . . . 0.0 109.823 179.378 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -52.99 -28.64 24.91 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.158 -0.964 . . . . 0.0 109.75 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.462 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 9.6 pt-20 -79.95 -33.84 39.27 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 109.541 179.245 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.462 ' N ' ' HG3' ' A' ' 54' ' ' GLU . 85.3 t -69.48 -65.76 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.192 -0.943 . . . . 0.0 109.202 178.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -56.35 101.51 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.435 -0.791 . . . . 0.0 109.845 179.419 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.43 58.36 0.8 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.128 -0.983 . . . . 0.0 110.711 -179.523 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.425 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 15.3 m-20 -141.81 -49.79 0.39 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.261 -0.899 . . . . 0.0 109.852 179.565 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.64 50.77 0.55 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.647 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -129.14 -48.29 1.21 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.27 -1.135 . . . . 0.0 110.443 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.95 -86.66 0.13 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.3 -1.429 . . . . 0.0 110.8 179.6 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.433 HG23 ' CG2' ' A' ' 28' ' ' THR . 73.7 p -91.22 170.59 9.88 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.246 -1.149 . . . . 0.0 111.34 -178.662 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.46 HD12 ' CG1' ' A' ' 55' ' ' VAL . 33.1 mt -88.9 159.7 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.515 -0.741 . . . . 0.0 109.917 179.628 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.412 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 20.7 t0 -108.29 -176.93 3.19 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.276 -0.89 . . . . 0.0 110.417 -179.969 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.556 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 23.5 t80 -72.81 -43.79 8.49 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.406 -0.809 . . . . 0.0 111.174 179.86 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.7 Cg_endo -72.18 -19.08 26.45 Favored 'Trans proline' 0 C--O 1.213 -0.748 0 O-C-N 123.122 1.064 . . . . 0.0 110.562 -179.844 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.425 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 39.9 mt-10 -78.57 -27.81 45.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.021 -1.049 . . . . 0.0 108.919 179.029 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 7.5 t80 -76.88 -48.62 17.81 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.287 0.565 . . . . 0.0 110.419 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.476 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 17.0 tp -78.26 -17.39 56.73 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.193 -0.942 . . . . 0.0 111.236 -179.388 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.405 ' CB ' ' O ' ' A' ' 66' ' ' PRO . 43.1 m -87.77 -38.83 15.42 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.706 -1.246 . . . . 0.0 110.56 -179.797 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.479 ' HE1' ' CE ' ' A' ' 72' ' ' MET . 4.8 ptt? -78.38 -31.62 48.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.157 -0.964 . . . . 0.0 110.332 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.479 ' CE ' ' HE1' ' A' ' 71' ' ' MET . 48.2 mtt -89.79 -9.58 48.7 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.156 -0.965 . . . . 0.0 110.671 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.476 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.141 -0.974 . . . . 0.0 110.394 -179.808 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 121.183 0.516 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 26.1 mm -67.02 -29.93 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.449 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -56.52 10.03 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.158 -0.964 . . . . 0.0 109.838 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -55.08 -42.33 72.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.346 -0.846 . . . . 0.0 110.161 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.41 -39.3 92.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.9 . . . . 0.0 110.558 -179.667 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.44 ' O ' ' CB ' ' A' ' 93' ' ' ASP . 5.0 t80 -63.46 -33.26 75.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.914 -1.116 . . . . 0.0 110.387 -179.631 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -75.52 -55.04 6.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.086 -1.009 . . . . 0.0 111.003 -179.481 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.454 HG22 ' N ' ' A' ' 92' ' ' PHE . 19.2 m -56.26 -42.9 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.095 -1.003 . . . . 0.0 110.813 -179.35 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.454 ' N ' HG22 ' A' ' 91' ' ' VAL . 30.3 m-85 -77.44 -20.77 54.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.135 -0.978 . . . . 0.0 110.211 179.88 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 89' ' ' PHE . 35.5 t0 -113.71 53.21 0.78 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.154 -0.966 . . . . 0.0 109.471 179.127 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -86.36 56.17 3.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.543 -0.723 . . . . 0.0 110.757 -179.419 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.436 ' OD2' ' HB2' ' A' ' 97' ' ' ASN . 26.3 p-10 -158.26 29.94 0.25 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.103 -0.998 . . . . 0.0 110.335 179.731 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.44 33.12 4.2 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.524 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.436 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 18.1 t-20 -91.93 -60.01 1.97 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.236 -1.155 . . . . 0.0 110.083 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.458 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 112.07 -5.49 27.14 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.742 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.559 ' CD1' ' NE2' ' A' ' 135' ' ' GLN . 37.3 m-85 -138.93 140.06 38.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.938 -1.331 . . . . 0.0 110.465 -179.826 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.417 HG22 ' HB3' ' A' ' 92' ' ' PHE . 39.5 mt -85.97 118.25 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.315 -0.866 . . . . 0.0 110.161 179.813 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.3 t -102.91 174.15 6.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.451 -0.781 . . . . 0.0 109.462 179.514 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.25 -41.21 73.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.039 -1.038 . . . . 0.0 109.988 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.42 -54.55 44.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.211 -0.931 . . . . 0.0 110.091 179.64 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.403 ' OE2' ' OD2' ' A' ' 95' ' ' ASP . 45.9 mt-10 -59.58 -45.34 92.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.224 -0.922 . . . . 0.0 110.043 179.765 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.416 ' CD2' HG12 ' A' ' 121' ' ' VAL . 32.5 tp -58.52 -21.12 51.26 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.429 -0.794 . . . . 0.0 110.534 -179.927 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.8 ttt-85 -83.52 -40.08 19.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.213 -0.929 . . . . 0.0 110.097 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -73.22 -22.65 60.39 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.28 -0.887 . . . . 0.0 110.125 179.88 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 97.3 t -89.92 -44.15 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -0.882 . . . . 0.0 110.068 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 4.7 mmt -49.5 -24.41 2.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.908 . . . . 0.0 110.163 179.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 64.6 p -82.34 -41.75 19.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 110.081 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -57.04 -45.18 83.36 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.234 -0.917 . . . . 0.0 110.177 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.4 ' HB2' ' OE1' ' A' ' 114' ' ' GLU . 80.4 mt -64.12 -55.91 18.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.317 -0.865 . . . . 0.0 110.31 -179.969 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 142.52 53.07 0.04 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.758 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.415 ' HB3' HD13 ' A' ' 116' ' ' LEU . 49.5 mp0 -139.11 -62.83 0.53 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.168 -1.195 . . . . 0.0 110.068 179.693 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 114' ' ' GLU . 70.3 tttt 55.78 104.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.299 -0.876 . . . . 0.0 110.417 179.751 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.418 HD11 ' N ' ' A' ' 116' ' ' LEU . 4.8 mp -122.58 -175.82 3.24 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.165 -0.959 . . . . 0.0 110.529 -179.948 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.5 t -87.89 -177.8 5.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.361 -0.837 . . . . 0.0 110.184 -179.986 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -68.96 -34.8 75.93 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.178 -0.951 . . . . 0.0 110.448 -179.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -65.47 -53.24 45.45 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.232 -0.917 . . . . 0.0 110.779 -179.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.417 ' OE1' ' HA ' ' A' ' 120' ' ' GLU . 5.7 mm-40 -54.32 -50.45 67.35 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.127 -0.983 . . . . 0.0 110.56 -179.54 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.416 HG12 ' CD2' ' A' ' 105' ' ' LEU . 56.1 t -56.44 -47.98 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.162 -0.961 . . . . 0.0 110.133 -179.978 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -62.68 -23.69 67.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.184 -0.948 . . . . 0.0 109.868 179.677 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.422 ' HG3' ' OE1' ' A' ' 127' ' ' GLU . 16.5 tp10 -75.07 -30.01 60.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.395 -0.816 . . . . 0.0 109.917 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 23.3 mtm -77.33 -46.24 23.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.368 -0.833 . . . . 0.0 110.1 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.418 HD11 HG22 ' A' ' 136' ' ' VAL . 24.9 mm -68.7 -33.22 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.025 -1.047 . . . . 0.0 109.879 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -71.97 -55.86 6.69 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.392 -0.818 . . . . 0.0 110.636 -179.63 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.422 ' OE1' ' HG3' ' A' ' 123' ' ' GLU . 54.5 mt-10 -61.06 -36.4 79.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.176 -0.953 . . . . 0.0 110.116 -179.768 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.437 ' CB ' ' SD ' ' A' ' 144' ' ' MET . . . -70.23 -26.98 64.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.814 179.799 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -63.3 94.69 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.867 . . . . 0.0 109.991 179.76 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 128' ' ' ALA . 97.8 mt -79.8 -43.94 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.218 -0.926 . . . . 0.0 110.854 -179.646 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 23.4 p30 -79.27 -19.51 50.4 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.016 -1.053 . . . . 0.0 110.791 -179.655 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 79.0 70.79 1.29 Allowed Glycine 0 N--CA 1.495 2.632 0 C-N-CA 120.031 -1.081 . . . . 0.0 110.53 179.344 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -125.5 -26.67 3.53 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.186 -1.185 . . . . 0.0 110.578 179.545 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 118.35 -37.43 3.24 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.689 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.559 ' NE2' ' CD1' ' A' ' 99' ' ' TYR . 9.0 pt20 -113.14 156.72 22.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.278 -1.13 . . . . 0.0 109.922 179.81 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.418 HG22 HD11 ' A' ' 125' ' ' ILE . 62.4 t -99.5 118.41 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.203 -0.935 . . . . 0.0 110.423 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 37.8 p30 -93.25 -163.93 1.11 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.244 -0.91 . . . . 0.0 110.131 179.669 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -69.63 -62.55 1.34 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.095 -1.003 . . . . 0.0 111.127 -179.289 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -44.06 -59.48 2.29 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.275 -0.891 . . . . 0.0 111.191 -179.121 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.413 ' OE2' ' OD1' ' A' ' 131' ' ' ASP . 51.7 mt-10 -51.44 -51.37 55.48 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 121.198 -0.939 . . . . 0.0 110.538 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.418 ' HB2' ' O ' ' A' ' 137' ' ' ASN . 0.8 OUTLIER -54.08 -31.3 51.37 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.291 -0.88 . . . . 0.0 110.551 -179.582 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.403 ' O ' ' OG1' ' A' ' 146' ' ' THR . 94.9 t -72.1 -62.86 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.285 -0.884 . . . . 0.0 110.691 -179.51 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -64.9 -9.66 22.84 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.222 -0.924 . . . . 0.0 110.87 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.437 ' SD ' ' CB ' ' A' ' 128' ' ' ALA . 49.3 ttp -59.46 -60.54 3.69 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.13 -0.981 . . . . 0.0 110.786 -179.704 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.412 ' HE1' ' HE1' ' A' ' 144' ' ' MET . 38.3 mtt -89.88 -44.3 10.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.448 -0.783 . . . . 0.0 110.857 -179.368 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 142' ' ' VAL . 66.6 p . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.05 -1.031 . . . . 0.0 110.122 -179.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.355 0.598 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -66.49 -44.59 82.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.375 -0.828 . . . . 0.0 110.331 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.416 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 7.3 tt0 -55.67 -47.25 77.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 110.177 -179.856 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.0 mt -60.07 -40.6 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.052 -1.03 . . . . 0.0 109.482 179.427 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.79 -26.91 68.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.349 -0.844 . . . . 0.0 109.329 179.15 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 38.2 tt0 -67.64 -46.49 72.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.347 -0.846 . . . . 0.0 109.365 179.411 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -63.53 -32.11 73.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.908 . . . . 0.0 109.465 179.157 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.17 -40.44 82.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.5 -0.75 . . . . 0.0 110.165 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -63.14 -45.26 92.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.2 -0.937 . . . . 0.0 110.187 -179.835 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.33 -37.39 87.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.141 -0.974 . . . . 0.0 110.074 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -63.92 -37.38 87.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.189 -0.945 . . . . 0.0 109.945 179.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.9 m -65.9 -39.93 91.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.388 -0.82 . . . . 0.0 110.286 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.409 ' O ' HD12 ' A' ' 18' ' ' LEU . 3.5 tm? -66.56 -35.96 81.49 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.183 -0.948 . . . . 0.0 110.13 -179.936 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.436 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 12.0 m-30 -69.65 -64.78 0.81 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.224 -0.923 . . . . 0.0 109.931 179.718 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -83.0 96.07 8.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.35 -0.844 . . . . 0.0 109.856 179.674 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.415 ' CD ' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -109.66 48.57 0.88 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.256 -0.902 . . . . 0.0 110.524 -179.758 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -131.22 -35.24 1.37 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.105 -0.997 . . . . 0.0 110.368 179.768 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 24' ' ' ASP . . . 113.32 86.21 1.49 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 21.1 p-10 -178.13 -34.19 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.302 -1.117 . . . . 0.0 110.617 179.654 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.91 42.19 7.78 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.131 179.633 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 59.3 p -151.28 107.47 3.44 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.095 -1.238 . . . . 0.0 110.389 179.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.4 mt -74.68 124.63 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.828 179.559 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.9 p -112.78 -157.21 0.61 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.332 -0.855 . . . . 0.0 110.08 -179.865 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.424 HG21 HG13 ' A' ' 52' ' ' ILE . 38.0 p -87.53 -27.06 22.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.212 -0.93 . . . . 0.0 110.253 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -70.72 -56.8 5.58 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.147 -0.97 . . . . 0.0 109.676 179.553 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -57.27 -36.08 70.55 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.303 -0.873 . . . . 0.0 109.685 179.555 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.471 ' CD2' HD12 ' A' ' 52' ' ' ILE . 9.0 tp -68.87 -31.78 70.96 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.349 -0.845 . . . . 0.0 109.707 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.82 -41.6 98.77 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.413 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 66.1 m -72.42 -33.65 67.28 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.317 -1.108 . . . . 0.0 109.967 179.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.7 t -71.15 -26.98 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.377 -0.827 . . . . 0.0 110.444 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.1 mmt -86.91 -32.29 20.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 110.467 -179.619 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.402 ' HD3' ' OE1' ' A' ' 41' ' ' GLN . 5.9 ttp180 -90.79 -11.07 40.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.228 -0.92 . . . . 0.0 110.775 -179.783 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 97.3 p -97.41 -23.03 16.26 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.981 -1.074 . . . . 0.0 110.48 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.6 mt -107.79 -46.85 3.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.118 -0.989 . . . . 0.0 110.388 -179.871 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.65 84.01 0.1 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.402 ' OE1' ' HD3' ' A' ' 37' ' ' ARG . 65.3 tp60 -50.92 161.32 0.38 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.357 -1.084 . . . . 0.0 110.558 -179.81 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.488 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.3 t30 177.03 -56.3 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.488 -0.758 . . . . 0.0 109.976 179.647 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.488 ' HD3' ' HB3' ' A' ' 42' ' ' ASN . 54.6 Cg_endo -76.76 -163.2 0.19 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.483 1.254 . . . . 0.0 110.864 179.671 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.431 ' CG2' ' N ' ' A' ' 45' ' ' GLU . 11.1 t -137.18 -140.19 0.15 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.077 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.431 ' N ' ' CG2' ' A' ' 44' ' ' THR . 52.1 mt-10 -97.89 -45.22 6.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.818 -1.176 . . . . 0.0 110.031 179.593 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.51 -52.98 26.2 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.198 -0.939 . . . . 0.0 109.618 179.389 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -59.07 -20.91 57.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.364 -0.835 . . . . 0.0 109.723 179.639 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 44' ' ' THR . 7.9 tt -71.93 -53.43 13.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.895 . . . . 0.0 109.481 179.368 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -50.92 -42.76 59.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.219 179.253 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -63.92 -39.69 94.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.362 -0.837 . . . . 0.0 109.6 179.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.41 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 36.4 ttp -66.21 -19.42 65.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -0.878 . . . . 0.0 109.566 179.375 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.471 HD12 ' CD2' ' A' ' 32' ' ' LEU . 5.6 mm -84.26 -29.73 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.407 -0.808 . . . . 0.0 109.683 179.413 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -71.6 -46.42 59.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.398 -0.814 . . . . 0.0 110.888 -179.45 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.45 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 24.2 pt-20 -51.35 -33.96 31.83 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.101 -1.0 . . . . 0.0 110.379 -179.711 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.45 ' N ' ' HG3' ' A' ' 54' ' ' GLU . 48.6 t -82.15 -39.77 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.247 -0.908 . . . . 0.0 110.147 179.943 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -78.31 111.72 14.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.395 -0.816 . . . . 0.0 110.562 -179.67 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.77 54.98 0.65 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.206 -0.934 . . . . 0.0 109.925 179.741 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -134.96 -53.91 0.81 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.401 -0.812 . . . . 0.0 109.891 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 128.45 60.54 0.12 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.662 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.491 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 6.8 p-10 -151.34 -52.78 0.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -1.115 . . . . 0.0 110.131 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.6 -5.89 9.87 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.785 179.032 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.5 p -120.96 141.69 50.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.79 -1.418 . . . . 0.0 110.573 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 77.1 mt -92.32 121.38 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -0.949 . . . . 0.0 110.11 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.424 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 9.7 t70 -84.2 -167.0 1.59 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.285 -0.885 . . . . 0.0 110.196 -179.778 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.562 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 40.5 t80 -78.32 -44.38 2.13 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.05 -1.031 . . . . 0.0 111.631 -179.674 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.0 Cg_endo -70.76 -21.56 28.68 Favored 'Trans proline' 0 N--CA 1.482 0.802 0 O-C-N 123.079 1.041 . . . . 0.0 110.505 -179.579 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 71' ' ' MET . 53.0 mt-10 -81.12 -27.78 35.4 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.191 -0.943 . . . . 0.0 109.174 179.227 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.542 ' CE2' ' CE ' ' A' ' 72' ' ' MET . 36.0 t80 -77.26 -36.38 54.48 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.492 -0.755 . . . . 0.0 109.813 179.612 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.403 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 13.7 tp -76.81 -32.49 57.66 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.404 -0.81 . . . . 0.0 110.235 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 97.1 m -80.88 -23.78 38.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.337 -0.852 . . . . 0.0 110.41 -179.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.422 ' CE ' HG12 ' A' ' 55' ' ' VAL . 13.8 tmm? -84.33 -45.3 12.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.256 -0.903 . . . . 0.0 110.372 -179.723 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.542 ' CE ' ' CE2' ' A' ' 68' ' ' PHE . 9.5 mtt -79.17 -16.42 56.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 110.671 -179.272 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.403 ' HB1' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.095 -1.003 . . . . 0.0 108.902 179.098 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.158 0.504 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 60.3 mt -55.76 -35.89 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.138 -0.976 . . . . 0.0 110.114 -179.781 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.0 tpt180 -64.4 -53.0 55.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.956 . . . . 0.0 109.358 179.346 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -57.29 -23.57 49.31 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.358 -0.839 . . . . 0.0 109.443 179.28 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.414 ' O ' HG21 ' A' ' 91' ' ' VAL . . . -67.92 -60.47 2.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.416 -0.802 . . . . 0.0 109.859 179.768 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -55.76 -24.17 33.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.175 -0.953 . . . . 0.0 110.16 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.484 ' HA ' ' NE ' ' A' ' 90' ' ' ARG . 8.6 tpm_? -73.0 -58.29 3.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.317 -0.864 . . . . 0.0 110.707 -179.723 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 88' ' ' ALA . 20.2 m -70.36 -12.14 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.121 -0.987 . . . . 0.0 110.684 -179.592 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.412 ' CE1' HG13 ' A' ' 108' ' ' VAL . 10.6 m-85 -101.05 -13.31 18.27 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.091 -1.006 . . . . 0.0 110.606 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -132.71 44.44 2.86 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.094 -1.004 . . . . 0.0 110.329 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -108.71 3.57 22.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.118 -0.989 . . . . 0.0 110.769 179.979 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 3.0 p30 -70.58 -30.74 67.52 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.134 -0.979 . . . . 0.0 110.573 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.8 34.94 1.94 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -179.361 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.404 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 23.1 t-20 -110.16 -47.36 3.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.355 -1.085 . . . . 0.0 110.319 -179.679 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 125.24 -35.32 3.12 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.833 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 0.8 OUTLIER -132.8 169.56 16.55 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.075 -1.25 . . . . 0.0 109.663 -179.753 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 38.3 mt -80.63 129.19 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.112 -0.992 . . . . 0.0 109.62 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.9 t -118.56 174.02 6.5 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.333 -0.855 . . . . 0.0 109.814 179.714 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.405 ' O ' HG12 ' A' ' 121' ' ' VAL . . . -69.19 -38.76 78.82 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.155 -0.966 . . . . 0.0 110.048 -179.886 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.66 87.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.237 -0.915 . . . . 0.0 110.033 179.746 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -62.03 -54.13 45.88 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.246 -0.909 . . . . 0.0 110.094 179.825 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.408 HD12 ' HE3' ' A' ' 124' ' ' MET . 4.3 tt -47.76 -34.36 8.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 110.1 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.8 ttt-85 -70.97 -44.05 66.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.293 -0.879 . . . . 0.0 110.329 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 48.1 m170 -69.94 -10.4 58.42 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.129 -0.982 . . . . 0.0 110.622 -179.824 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.412 HG13 ' CE1' ' A' ' 92' ' ' PHE . 61.5 t -92.29 -57.06 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.124 -0.985 . . . . 0.0 110.538 -179.749 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 64.8 mtt -71.41 -26.81 62.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.194 -0.941 . . . . 0.0 110.584 -179.693 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.2 m -69.35 -42.32 75.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.201 -0.937 . . . . 0.0 110.29 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -75.02 -34.33 61.9 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.188 -0.945 . . . . 0.0 110.265 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.2 mt -60.62 -32.2 71.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.168 -0.958 . . . . 0.0 110.229 179.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.42 -13.7 4.28 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.64 134.55 34.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -1.175 . . . . 0.0 110.27 -179.961 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -101.61 120.23 40.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.945 . . . . 0.0 110.208 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.83 179.25 4.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.21 -0.931 . . . . 0.0 110.546 -179.766 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.7 m -122.56 175.88 6.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.406 -0.809 . . . . 0.0 109.944 179.741 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.54 -51.95 56.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.161 -0.962 . . . . 0.0 110.544 -179.821 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -64.97 -34.82 79.35 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.084 -1.01 . . . . 0.0 110.446 -179.807 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.41 ' OE1' ' HA ' ' A' ' 120' ' ' GLU . 7.9 mm-40 -61.37 -46.04 91.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.108 -0.995 . . . . 0.0 110.079 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 102' ' ' ALA . 72.4 t -64.06 -56.47 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 109.808 179.656 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -51.4 -26.3 7.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.975 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -70.09 -52.97 19.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.18 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.408 ' HE3' HD12 ' A' ' 105' ' ' LEU . 42.4 mtp -58.21 -48.22 81.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.174 -0.954 . . . . 0.0 110.141 179.875 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 25.7 mm -60.89 -29.24 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.072 -1.018 . . . . 0.0 109.599 179.585 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -66.74 -40.83 88.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.374 -0.829 . . . . 0.0 109.991 179.887 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -70.48 -28.37 64.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.285 -0.884 . . . . 0.0 110.237 179.919 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.402 ' O ' HG13 ' A' ' 130' ' ' ILE . . . -80.32 -25.05 39.52 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.311 -0.868 . . . . 0.0 110.469 -179.819 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -70.11 92.16 0.73 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.227 -0.921 . . . . 0.0 109.995 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 128' ' ' ALA . 74.4 mt -85.31 -34.54 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.3 -0.875 . . . . 0.0 110.594 -179.639 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 6.3 p30 -84.98 -25.79 27.54 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.073 -1.017 . . . . 0.0 110.299 179.845 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.455 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 89.94 71.56 1.25 Allowed Glycine 0 N--CA 1.494 2.562 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.316 179.337 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.411 ' OD2' ' OD1' ' A' ' 131' ' ' ASP . 73.1 m-20 -136.5 -38.69 0.66 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.205 -1.173 . . . . 0.0 110.021 179.294 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 121.96 -7.28 10.12 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.507 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -126.61 150.92 48.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.157 -1.202 . . . . 0.0 110.153 179.953 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.2 t -115.2 109.41 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.19 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -82.34 -167.73 1.7 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.18 -0.95 . . . . 0.0 110.195 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -62.18 -45.22 94.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.255 -0.903 . . . . 0.0 111.284 -179.134 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -62.69 -56.73 14.99 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.942 -1.099 . . . . 0.0 110.921 -179.248 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 144' ' ' MET . 50.5 mt-10 -57.1 -24.27 52.89 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.13 -0.981 . . . . 0.0 110.725 -179.591 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.436 ' CZ ' ' HE2' ' A' ' 145' ' ' MET . 89.2 t80 -78.66 -35.09 45.78 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.232 -0.917 . . . . 0.0 110.944 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 84.6 t -83.09 -22.96 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.108 -0.995 . . . . 0.0 110.869 -179.509 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -92.53 -23.42 19.09 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.18 -0.95 . . . . 0.0 110.882 -179.617 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.465 ' HG3' ' N ' ' A' ' 145' ' ' MET . 1.0 OUTLIER -71.29 -20.26 62.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.003 -1.061 . . . . 0.0 110.496 -179.707 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.465 ' N ' ' HG3' ' A' ' 144' ' ' MET . 63.5 mtt -84.85 -70.37 0.58 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.223 -0.923 . . . . 0.0 110.537 -179.694 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 59.0 p . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.2 -0.938 . . . . 0.0 110.183 -179.672 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.102 0.477 . . . . 0.0 110.119 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -65.34 -64.9 0.75 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.104 -0.998 . . . . 0.0 109.985 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -55.13 -39.97 70.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.144 -0.973 . . . . 0.0 109.476 179.685 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 55.3 mt -56.8 -37.73 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.389 -0.819 . . . . 0.0 109.478 179.315 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.97 -43.06 99.63 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.278 -0.889 . . . . 0.0 109.341 179.386 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.03 -36.73 82.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.486 -0.759 . . . . 0.0 109.837 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -76.03 -20.08 58.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.406 -0.808 . . . . 0.0 109.665 179.525 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -79.53 -33.53 41.88 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.289 -0.882 . . . . 0.0 109.416 179.183 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -74.27 -39.95 62.65 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.391 -0.818 . . . . 0.0 109.857 179.735 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.75 -48.31 39.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.2 -0.938 . . . . 0.0 109.599 179.54 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.545 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 1.2 t80 -58.68 -34.07 70.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.415 -0.803 . . . . 0.0 109.47 179.334 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.2 t -72.11 -38.49 69.31 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.465 -0.772 . . . . 0.0 109.817 179.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.492 HD11 ' CD1' ' A' ' 19' ' ' PHE . 3.2 tm? -65.92 -24.06 66.75 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.526 -0.734 . . . . 0.0 109.663 179.768 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.492 ' CD1' HD11 ' A' ' 18' ' ' LEU . 17.0 m-85 -82.15 -59.29 2.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.323 -0.861 . . . . 0.0 110.339 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.414 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 7.9 t0 -76.52 97.49 4.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 109.772 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.428 ' HD2' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -110.53 46.37 1.05 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.068 -1.02 . . . . 0.0 110.843 -179.644 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.404 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 12.0 p-10 -132.33 -33.31 1.29 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.236 -0.915 . . . . 0.0 110.513 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.38 76.32 1.05 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.89 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 15.3 p-10 -159.49 -45.26 0.05 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.02 -1.283 . . . . 0.0 110.579 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.9 -2.97 25.79 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.728 -1.225 . . . . 0.0 110.324 179.674 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 34.5 p -121.1 165.16 15.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.943 -1.328 . . . . 0.0 110.197 179.878 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.3 mt -112.64 130.24 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.187 -0.946 . . . . 0.0 110.094 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.6 p -114.5 177.05 4.78 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.429 -0.794 . . . . 0.0 109.895 -179.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.432 HG21 HG13 ' A' ' 52' ' ' ILE . 12.7 p -66.67 -28.67 68.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 0.0 110.112 179.877 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -57.66 6.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -0.933 . . . . 0.0 109.905 179.521 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.414 ' OE1' ' HA ' ' A' ' 20' ' ' ASP . 28.4 mt-10 -57.23 -56.01 27.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 0.0 110.123 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.459 ' CD2' HD13 ' A' ' 52' ' ' ILE . 1.4 tp -57.51 -24.71 57.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.855 179.665 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.74 -42.9 95.0 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.1 m -76.16 -23.14 54.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.3 -1.117 . . . . 0.0 110.04 179.835 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.446 ' CG2' ' HA ' ' A' ' 19' ' ' PHE . 54.9 t -72.57 -42.54 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.402 -0.811 . . . . 0.0 110.526 -179.727 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.404 ' O ' ' O ' ' A' ' 40' ' ' GLY . 22.5 mmt -90.13 -14.93 32.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.167 -0.958 . . . . 0.0 110.735 -179.692 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -90.65 -59.91 2.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.209 -0.932 . . . . 0.0 111.076 -179.348 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.0 m -59.76 -51.44 69.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.254 -0.904 . . . . 0.0 111.361 -178.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.9 mp -69.53 -30.45 68.29 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.1 -1.0 . . . . 0.0 111.207 -178.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 36' ' ' MET . . . -161.42 80.57 0.14 Allowed Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.229 -1.462 . . . . 0.0 110.422 -179.775 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -55.94 126.97 28.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.163 -1.198 . . . . 0.0 109.725 179.365 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.482 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 3.0 t30 -171.53 -60.91 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.224 -0.923 . . . . 0.0 110.609 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' A' ' 42' ' ' ASN . 44.1 Cg_endo -70.01 -161.84 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.249 1.131 . . . . 0.0 110.117 179.801 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.9 t -150.96 -178.67 6.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.931 . . . . 0.0 110.282 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -59.89 -33.6 72.06 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.246 -0.909 . . . . 0.0 110.464 -179.798 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.1 -70.66 0.25 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.211 -0.93 . . . . 0.0 110.257 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -49.76 -25.05 2.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.104 -0.997 . . . . 0.0 109.713 179.762 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.447 ' HG ' ' CD2' ' A' ' 32' ' ' LEU . 3.6 tt -65.21 -60.01 3.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.465 -0.772 . . . . 0.0 109.719 179.466 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.402 ' O ' ' OD1' ' A' ' 53' ' ' ASN . 8.9 tt0 -50.5 -33.91 23.17 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.296 -0.878 . . . . 0.0 109.756 179.616 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -61.57 -46.43 89.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.191 -0.943 . . . . 0.0 109.967 179.809 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.404 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 21.8 mtm -65.58 -22.59 66.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.929 . . . . 0.0 109.82 179.667 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.459 HD13 ' CD2' ' A' ' 32' ' ' LEU . 39.7 mm -80.88 -23.26 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.251 -0.906 . . . . 0.0 109.969 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 49' ' ' GLN . 5.1 m120 -88.34 -26.62 22.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.303 -0.873 . . . . 0.0 110.2 179.885 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 51' ' ' MET . 10.7 pt-20 -77.69 -24.3 49.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.201 -0.937 . . . . 0.0 110.075 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.8 t -88.86 -54.53 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.673 179.454 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.413 ' OD2' ' OD1' ' A' ' 60' ' ' ASN . 12.8 t70 -67.09 120.32 13.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.405 -0.809 . . . . 0.0 110.051 179.82 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.6 30.94 5.83 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.16 -0.962 . . . . 0.0 110.663 -179.66 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -113.33 -60.87 1.82 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.116 -0.99 . . . . 0.0 110.088 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.52 -18.25 1.3 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.729 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.413 ' OD1' ' OD2' ' A' ' 56' ' ' ASP . 17.0 p30 -69.52 -29.48 67.1 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.175 -1.191 . . . . 0.0 110.295 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.418 ' O ' ' CG2' ' A' ' 52' ' ' ILE . . . 99.18 -52.61 1.08 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.754 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.406 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 66.0 p -72.11 146.49 47.46 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.183 -1.186 . . . . 0.0 110.38 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.407 ' O ' ' HB ' ' A' ' 26' ' ' THR . 64.3 mt -86.43 161.09 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 110.254 179.908 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -111.81 -173.35 2.23 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.371 -0.831 . . . . 0.0 109.898 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.537 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 5.0 t80 -75.6 -44.82 4.25 Favored Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.235 -0.915 . . . . 0.0 111.423 -179.882 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.0 Cg_endo -73.33 -23.89 17.18 Favored 'Trans proline' 0 C--N 1.322 -0.845 0 O-C-N 123.288 1.151 . . . . 0.0 110.255 -179.259 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -77.23 -29.09 53.96 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.252 -0.905 . . . . 0.0 109.1 179.094 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.545 ' CE1' ' HB2' ' A' ' 16' ' ' PHE . 47.8 t80 -73.54 -50.74 19.81 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.545 -0.722 . . . . 0.0 110.309 179.826 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.96 -30.98 71.26 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.304 -0.873 . . . . 0.0 110.965 -179.527 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 78.9 m -71.1 -40.91 71.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.172 -0.955 . . . . 0.0 110.983 -179.388 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.445 ' HE2' ' CE ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -89.94 -9.37 49.07 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.903 -1.123 . . . . 0.0 110.95 -179.51 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.521 ' HG3' ' CE1' ' A' ' 68' ' ' PHE . 15.6 mmt -90.26 -19.89 23.6 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.989 -1.07 . . . . 0.0 110.556 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.721 0 O-C-N 121.155 -0.966 . . . . 0.0 110.354 -179.874 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.071 0.463 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.9 mt -64.93 -60.23 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.141 -0.974 . . . . 0.0 110.263 -179.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -51.57 -50.49 60.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.174 -0.954 . . . . 0.0 109.711 179.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 49.7 mt-10 -50.05 -41.6 48.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 0.0 109.79 179.52 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.2 -50.27 71.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.34 -0.85 . . . . 0.0 110.032 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.475 ' CZ ' ' O ' ' A' ' 98' ' ' GLY . 2.3 t80 -57.34 -28.76 63.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.262 -0.899 . . . . 0.0 110.213 179.983 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.4 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 3.7 tpt180 -71.1 -45.88 62.83 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.342 -0.849 . . . . 0.0 111.185 -179.442 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.443 HG21 ' N ' ' A' ' 92' ' ' PHE . 34.4 m -77.17 -20.35 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.088 -1.007 . . . . 0.0 110.775 -179.33 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.443 ' N ' HG21 ' A' ' 91' ' ' VAL . 10.0 m-85 -89.58 -17.04 29.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.169 -0.957 . . . . 0.0 109.904 179.631 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -126.89 81.32 2.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.295 -0.878 . . . . 0.0 110.144 179.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -104.35 49.96 0.8 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.398 -0.814 . . . . 0.0 110.483 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 3.1 p30 -141.56 -43.58 0.36 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.089 -1.007 . . . . 0.0 110.705 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.486 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 147.97 -57.18 0.49 Allowed Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.28 -1.438 . . . . 0.0 110.995 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.473 ' ND2' ' OD1' ' A' ' 95' ' ' ASP . 22.6 p30 -43.56 -31.23 0.7 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.141 -1.211 . . . . 0.0 111.161 -178.738 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.475 ' O ' ' CZ ' ' A' ' 89' ' ' PHE . . . 80.14 -8.19 53.01 Favored Glycine 0 N--CA 1.495 2.6 0 C-N-CA 119.803 -1.189 . . . . 0.0 110.477 179.561 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -89.41 131.81 35.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.962 -1.316 . . . . 0.0 109.989 179.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 16.6 mt -78.99 112.32 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.185 -0.947 . . . . 0.0 109.796 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 44.6 t -96.56 155.91 16.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.264 -0.897 . . . . 0.0 110.154 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.64 -44.74 77.43 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.141 -0.974 . . . . 0.0 110.063 -179.956 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.96 -58.7 6.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.827 . . . . 0.0 110.016 179.844 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -51.51 -38.99 56.74 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.317 -0.865 . . . . 0.0 110.224 179.847 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.81 -41.82 87.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.349 -0.844 . . . . 0.0 109.829 179.937 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.411 ' O ' ' HB ' ' A' ' 110' ' ' THR . 48.1 ttp180 -68.2 -25.51 65.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.384 -0.822 . . . . 0.0 109.942 179.807 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -90.95 -12.66 35.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.329 -0.857 . . . . 0.0 110.373 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 77.2 t -91.17 -64.61 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.255 -0.903 . . . . 0.0 110.316 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.429 ' HE3' ' CE ' ' A' ' 124' ' ' MET . 57.8 mtt -61.13 -51.18 70.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.251 -0.906 . . . . 0.0 110.367 -179.693 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 106' ' ' ARG . 36.8 m -50.99 -29.52 12.56 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.266 -0.896 . . . . 0.0 110.304 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -78.69 -46.09 19.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.184 -0.948 . . . . 0.0 110.406 -179.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.8 mt -48.83 -73.98 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.143 -0.973 . . . . 0.0 110.109 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.85 66.59 0.02 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.872 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -136.9 -176.37 4.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.313 -1.11 . . . . 0.0 110.068 179.714 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -130.18 87.96 2.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.948 . . . . 0.0 110.374 -179.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.8 mt -125.93 -171.88 2.48 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.284 -0.885 . . . . 0.0 110.137 179.857 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.6 t -143.91 -159.95 1.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.138 -0.976 . . . . 0.0 110.201 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.63 -42.16 25.45 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.077 -1.014 . . . . 0.0 110.917 -179.525 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -59.61 -55.49 33.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.942 . . . . 0.0 111.125 -179.469 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.421 ' OE1' ' HA ' ' A' ' 120' ' ' GLU . 5.9 mm-40 -51.72 -38.48 55.39 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.196 -0.94 . . . . 0.0 111.058 -179.445 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 73.9 t -67.7 -47.47 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.158 -0.963 . . . . 0.0 110.457 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.79 -36.38 72.11 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.333 -0.855 . . . . 0.0 110.137 -179.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 36.6 tt0 -72.5 -35.15 68.07 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.324 -0.86 . . . . 0.0 109.633 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.429 ' CE ' ' HE3' ' A' ' 109' ' ' MET . 5.7 mmm -59.03 -60.34 4.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.271 -0.893 . . . . 0.0 109.936 179.466 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 27.9 mm -56.69 -41.89 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.372 -0.83 . . . . 0.0 110.376 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 16.5 ttp180 -57.09 -36.81 71.03 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -0.907 . . . . 0.0 110.191 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 49.7 mt-10 -67.09 -49.65 64.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.197 -0.94 . . . . 0.0 110.087 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.437 ' CB ' ' SD ' ' A' ' 144' ' ' MET . . . -80.03 -2.33 43.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.349 -0.844 . . . . 0.0 110.665 -179.811 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -90.29 71.75 7.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.947 -1.096 . . . . 0.0 110.299 -179.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 131' ' ' ASP . 23.4 pt -70.52 -41.94 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -0.929 . . . . 0.0 111.171 -179.561 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.47 ' N ' HG13 ' A' ' 130' ' ' ILE . 50.6 p-10 -67.28 -19.42 65.49 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.963 -1.086 . . . . 0.0 111.264 -179.173 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 75.45 75.93 0.8 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.909 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -146.35 15.0 1.29 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.379 -1.071 . . . . 0.0 110.56 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 60.27 34.89 86.54 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -171.01 167.16 7.32 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.13 -1.217 . . . . 0.0 110.061 179.563 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 84.6 t -131.0 120.29 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.155 -0.966 . . . . 0.0 110.18 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -94.54 -165.07 1.25 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.209 -0.932 . . . . 0.0 110.9 -179.637 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -66.91 -58.58 4.72 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.356 -0.84 . . . . 0.0 111.307 -178.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -47.61 -51.74 20.25 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.845 -1.159 . . . . 0.0 110.381 -179.548 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -58.71 -34.91 71.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.103 -0.998 . . . . 0.0 109.97 179.62 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.525 ' CG ' ' HE3' ' A' ' 144' ' ' MET . 6.5 t80 -64.94 -32.72 74.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.514 -0.741 . . . . 0.0 110.623 -179.762 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.4 t -82.96 -23.92 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.261 -0.899 . . . . 0.0 110.586 -179.471 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -90.26 -17.47 27.4 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.133 -0.979 . . . . 0.0 110.422 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.525 ' HE3' ' CG ' ' A' ' 141' ' ' PHE . 17.0 ptt? -90.09 -27.82 19.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.145 -0.972 . . . . 0.0 110.376 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.433 ' CE ' ' HE1' ' A' ' 144' ' ' MET . 27.7 tpp -88.9 -65.45 1.02 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.287 -0.883 . . . . 0.0 110.439 -179.607 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.414 ' O ' HG21 ' A' ' 146' ' ' THR . 5.1 t . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.151 -0.968 . . . . 0.0 110.438 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.237 0.542 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 4.4 m-20 -110.02 148.25 32.02 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.23 -0.919 . . . . 0.0 110.455 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.421 ' N ' ' CD ' ' A' ' 3' ' ' GLN . 1.9 mp0 -108.31 114.35 28.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.318 -0.864 . . . . 0.0 109.872 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.3 pp -68.45 149.21 49.57 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.203 -0.935 . . . . 0.0 110.144 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.9 p -122.06 146.66 46.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.28 -0.887 . . . . 0.0 110.218 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -57.18 -17.07 9.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.3 -0.875 . . . . 0.0 110.307 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -56.37 -42.6 78.11 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.932 . . . . 0.0 110.502 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -56.24 -52.52 64.15 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.211 -0.93 . . . . 0.0 110.196 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.3 mt -55.26 -40.95 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 109.941 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.29 -37.56 80.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.893 . . . . 0.0 109.613 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -61.17 -48.99 79.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.423 -0.798 . . . . 0.0 109.9 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -65.8 -25.21 67.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.411 -0.806 . . . . 0.0 109.992 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.6 mtpt -75.84 -30.68 59.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.33 -0.856 . . . . 0.0 109.705 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -71.08 -41.5 70.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 0.0 109.556 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.478 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -68.27 -39.63 82.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.383 -0.823 . . . . 0.0 109.761 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -56.17 -55.07 37.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.377 -0.827 . . . . 0.0 110.088 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.2 m -60.65 -35.13 75.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.35 -0.844 . . . . 0.0 110.348 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.459 ' CD2' ' O ' ' A' ' 18' ' ' LEU . 4.9 tt -63.68 -29.42 70.66 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.191 -0.943 . . . . 0.0 110.202 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.478 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 12.3 m-85 -79.37 -57.76 3.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 0.0 110.485 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -61.2 106.27 0.59 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.127 -0.983 . . . . 0.0 109.97 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -109.6 47.61 0.93 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.228 -0.92 . . . . 0.0 110.726 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -162.44 22.22 0.1 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.245 -0.91 . . . . 0.0 110.504 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 47.58 78.32 0.09 OUTLIER Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -134.91 -36.83 0.82 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.223 -1.163 . . . . 0.0 110.57 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.91 -23.43 35.64 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.5 p -118.05 143.44 46.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.407 -1.055 . . . . 0.0 109.971 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 44.3 mt -92.03 113.01 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.259 -0.9 . . . . 0.0 110.427 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 80.9 p -97.11 -176.52 3.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 109.906 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.407 ' HA ' HD23 ' A' ' 48' ' ' LEU . 14.5 p -74.84 -28.49 60.7 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.253 -0.904 . . . . 0.0 110.07 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -70.81 -54.1 12.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 109.71 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.413 ' O ' HG21 ' A' ' 35' ' ' VAL . 91.5 mt-10 -56.1 -52.42 64.38 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.281 -0.887 . . . . 0.0 109.057 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.448 HD23 ' CD1' ' A' ' 52' ' ' ILE . 3.7 tp -55.05 -33.54 62.79 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.456 -0.778 . . . . 0.0 109.367 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.59 -49.78 67.5 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.2 m -69.17 -21.19 64.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.326 -1.102 . . . . 0.0 109.785 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.428 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 54.8 t -73.47 -31.03 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.446 -0.784 . . . . 0.0 109.787 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.2 mmt -90.91 -24.27 20.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.894 . . . . 0.0 110.189 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -84.36 -20.86 31.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.253 -0.905 . . . . 0.0 110.448 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.6 m -88.07 -19.34 27.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.197 -0.939 . . . . 0.0 110.151 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.47 ' CD1' H141 ' A' ' 153' ' ' WW7 . 90.5 mt -89.16 -78.35 0.35 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.269 -0.894 . . . . 0.0 110.295 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.73 55.74 0.2 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -152.67 157.96 41.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.227 -1.16 . . . . 0.0 110.299 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.512 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 80.5 m-20 -143.04 48.6 1.01 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.157 -0.964 . . . . 0.0 110.58 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.512 ' CD ' ' N ' ' A' ' 42' ' ' ASN . 42.5 Cg_endo -68.8 -159.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.653 1.344 . . . . 0.0 110.082 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.0 m -130.88 175.38 9.11 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.929 -1.107 . . . . 0.0 110.442 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -67.38 -32.71 73.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.272 -0.893 . . . . 0.0 110.054 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.02 -64.8 0.84 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 110.184 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 2.3 mt-10 -50.03 -38.93 40.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -1.0 . . . . 0.0 109.668 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 29' ' ' THR . 10.1 tt -57.65 -50.28 73.67 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.373 -0.829 . . . . 0.0 109.459 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -50.18 -38.25 38.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -0.939 . . . . 0.0 109.408 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 47' ' ' GLU . 36.3 m-20 -62.63 -42.83 99.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.377 -0.827 . . . . 0.0 109.77 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.9 ttp -67.05 -15.87 63.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.266 -0.896 . . . . 0.0 109.645 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.448 ' CD1' HD23 ' A' ' 32' ' ' LEU . 45.9 mm -88.66 -25.67 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.178 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -58.36 -36.6 73.71 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.111 -0.993 . . . . 0.0 110.124 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.419 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 8.2 pt-20 -74.21 -23.78 59.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.92 . . . . 0.0 109.993 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.453 ' CG1' HD11 ' A' ' 63' ' ' ILE . 42.8 t -98.8 23.53 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.905 . . . . 0.0 110.051 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -135.4 112.92 10.71 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.342 -0.849 . . . . 0.0 109.92 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.94 34.42 3.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.176 -0.952 . . . . 0.0 110.211 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 2.6 p30 -141.54 -34.12 0.49 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.373 -0.829 . . . . 0.0 110.843 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 95.44 52.84 1.65 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.449 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 24.6 p-10 -122.34 -12.32 8.24 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.442 -1.034 . . . . 0.0 110.682 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.465 ' O ' ' CG2' ' A' ' 62' ' ' THR . . . 78.42 27.56 57.25 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.206 -1.157 . . . . 0.0 110.206 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.465 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 0.9 OUTLIER -163.02 167.18 22.78 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.149 -1.206 . . . . 0.0 110.204 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.453 HD11 ' CG1' ' A' ' 55' ' ' VAL . 63.5 mt -117.39 150.6 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.12 -0.987 . . . . 0.0 110.127 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.434 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 1.5 m-20 -112.58 -162.97 0.82 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.316 -0.865 . . . . 0.0 110.425 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.575 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 7.0 t80 -81.55 -40.67 1.03 Allowed Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.411 -0.806 . . . . 0.0 111.914 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.4 Cg_endo -70.81 -21.4 28.65 Favored 'Trans proline' 0 N--CA 1.482 0.795 0 O-C-N 122.993 0.996 . . . . 0.0 110.974 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.425 ' OE1' ' OD1' ' A' ' 64' ' ' ASP . 57.2 mt-10 -86.12 -35.22 20.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.91 -1.119 . . . . 0.0 109.411 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.541 ' CE2' ' HE2' ' A' ' 72' ' ' MET . 11.6 t80 -70.78 -38.49 73.41 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.419 -0.801 . . . . 0.0 110.417 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.484 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 1.1 tp -80.55 -37.14 31.98 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.203 -0.936 . . . . 0.0 110.709 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 66' ' ' PRO . 88.9 m -71.35 -20.34 62.17 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.824 -1.173 . . . . 0.0 110.487 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 61.4 ttp -88.77 -42.33 11.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.139 -0.976 . . . . 0.0 110.86 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.541 ' HE2' ' CE2' ' A' ' 68' ' ' PHE . 59.0 mtt -90.51 -9.7 46.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.053 -1.03 . . . . 0.0 111.541 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -85.07 -9.95 57.41 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.845 -1.16 . . . . 0.0 110.519 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -84.14 -81.56 0.18 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.068 -1.02 . . . . 0.0 110.293 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.496 ' O ' ' CB ' ' A' ' 76' ' ' MET . 52.5 mttp -107.43 -87.11 0.49 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.273 -0.892 . . . . 0.0 110.656 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.496 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 19.4 ttt 80.14 -40.48 0.19 Allowed 'General case' 0 N--CA 1.525 3.28 0 O-C-N 121.904 -0.498 . . . . 0.0 111.077 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -157.11 -173.47 4.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.808 -1.182 . . . . 0.0 109.923 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -138.92 114.3 9.66 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.104 -0.998 . . . . 0.0 110.631 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.6 m -130.89 80.25 1.93 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.411 -0.805 . . . . 0.0 109.85 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -56.23 141.49 40.92 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.241 -0.912 . . . . 0.0 110.611 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.414 ' HA ' ' OH ' ' A' ' 138' ' ' TYR . 33.7 t -133.62 102.35 5.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.372 -0.83 . . . . 0.0 110.104 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 51.9 tt0 -119.4 160.48 22.23 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.254 -0.904 . . . . 0.0 110.106 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -65.55 -11.11 40.94 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.255 -0.903 . . . . 0.0 110.715 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.451 ' HA ' ' N2 ' ' A' ' 154' ' ' WW7 . 41.7 mm-40 -88.9 -65.17 1.05 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 110.389 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.51 HD11 ' CD1' ' A' ' 141' ' ' PHE . 38.8 mm -66.23 -10.23 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.224 -0.923 . . . . 0.0 110.339 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 2.5 ttt180 -73.48 -54.71 7.6 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.254 -0.904 . . . . 0.0 109.845 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -66.35 -35.52 80.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.362 -0.836 . . . . 0.0 109.615 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.513 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -57.32 -54.16 49.94 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.499 -0.751 . . . . 0.0 110.356 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.35 -27.41 69.0 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.882 -1.136 . . . . 0.0 110.247 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.35 -25.82 62.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.147 -0.971 . . . . 0.0 110.503 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.472 ' CG2' ' O ' ' A' ' 88' ' ' ALA . 34.3 m -95.1 -21.34 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.074 -1.016 . . . . 0.0 110.669 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.514 ' CZ ' ' H2 ' ' A' ' 154' ' ' WW7 . 21.7 m-85 -93.58 -11.91 30.71 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.16 -0.963 . . . . 0.0 110.574 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.417 ' OD2' ' HA2' ' A' ' 98' ' ' GLY . 40.5 t0 -114.23 92.1 3.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.209 -0.932 . . . . 0.0 110.269 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.49 -6.52 14.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.124 -0.985 . . . . 0.0 110.709 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.43 ' OD2' ' ND2' ' A' ' 97' ' ' ASN . 2.7 p-10 -91.93 -39.77 11.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.954 -1.091 . . . . 0.0 110.213 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 128.52 -35.36 2.69 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.546 -1.311 . . . . 0.0 111.091 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.52 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 42.4 p30 -47.88 -22.82 0.62 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.81 -1.406 . . . . 0.0 111.18 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.45 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 75.56 42.76 26.09 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 97' ' ' ASN . 77.2 m-85 -152.5 146.32 25.16 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.223 -1.163 . . . . 0.0 109.909 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.411 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 26.5 mt -94.41 121.28 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.171 -0.956 . . . . 0.0 109.994 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 74.5 m -109.01 151.36 26.44 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.477 -0.764 . . . . 0.0 109.956 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.432 ' HA ' HG13 ' A' ' 125' ' ' ILE . . . -51.23 -36.26 40.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.13 -0.981 . . . . 0.0 110.3 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.19 -59.87 4.41 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.287 -0.883 . . . . 0.0 110.307 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.415 ' O ' HG22 ' A' ' 108' ' ' VAL . 84.6 mt-10 -48.39 -51.23 27.49 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.189 -0.945 . . . . 0.0 110.161 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.411 ' CD2' HG11 ' A' ' 121' ' ' VAL . 13.0 tp -49.24 -40.58 34.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.917 . . . . 0.0 110.15 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -62.46 -41.41 98.74 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.224 -0.923 . . . . 0.0 110.492 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -77.21 -12.92 60.01 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.191 -0.943 . . . . 0.0 110.823 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 104' ' ' GLU . 53.2 t -88.57 -37.06 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.97 -1.081 . . . . 0.0 110.366 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 26.5 mmt -69.52 -32.27 71.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.147 -0.971 . . . . 0.0 110.471 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.0 p -76.36 -28.66 56.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.088 -1.008 . . . . 0.0 110.156 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -75.05 -44.16 49.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.222 -0.924 . . . . 0.0 110.176 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.7 mt -54.26 -36.28 63.43 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.187 -0.946 . . . . 0.0 110.369 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.87 31.37 1.03 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -116.19 -156.2 0.61 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.195 -1.179 . . . . 0.0 109.929 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -161.03 84.05 0.66 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.218 -0.926 . . . . 0.0 110.332 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.403 ' HG ' ' OE1' ' A' ' 120' ' ' GLU . 4.9 mp -108.68 131.82 54.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.336 -0.852 . . . . 0.0 110.08 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 19.8 m -77.94 159.99 28.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.221 -0.925 . . . . 0.0 110.224 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.0 -33.12 16.97 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.202 -0.936 . . . . 0.0 110.522 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -61.26 -42.47 98.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.153 -0.967 . . . . 0.0 110.54 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 124' ' ' MET . 85.4 mt-10 -67.71 -45.23 75.66 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.309 -0.87 . . . . 0.0 111.1 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 124' ' ' MET . 41.2 t -61.71 -56.21 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.049 -1.032 . . . . 0.0 110.605 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -52.07 -46.18 65.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.285 -0.884 . . . . 0.0 110.441 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -63.02 -33.1 74.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.295 -0.878 . . . . 0.0 110.242 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 80.6 mtp -65.24 -62.52 1.49 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.882 . . . . 0.0 109.873 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.432 HG13 ' HA ' ' A' ' 102' ' ' ALA . 21.9 mm -49.81 -30.38 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 110.148 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.0 ttt180 -70.24 -41.08 74.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.292 -0.88 . . . . 0.0 110.447 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.75 -28.7 68.62 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.215 -0.928 . . . . 0.0 110.485 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.48 ' CB ' ' H6 ' ' A' ' 154' ' ' WW7 . . . -93.58 -17.01 23.8 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.119 -0.988 . . . . 0.0 110.753 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.477 ' OD1' ' CG2' ' A' ' 136' ' ' VAL . 1.6 m-20 -81.25 82.63 7.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.026 -1.047 . . . . 0.0 110.942 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.472 HG13 ' N ' ' A' ' 131' ' ' ASP . 21.9 pt -89.47 -32.49 5.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-O 121.429 0.633 . . . . 0.0 110.169 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 51.6 p-10 -121.83 -13.13 8.32 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.502 -0.749 . . . . 0.0 111.432 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . -95.2 -63.51 0.99 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.593 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 1.2 m-20 59.96 100.49 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.515 -0.991 . . . . 0.0 108.48 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 105.11 -20.97 36.86 Favored Glycine 0 C--N 1.294 -1.777 0 N-CA-C 107.824 -2.11 . . . . 0.0 107.824 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -162.1 153.23 17.96 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.659 -0.906 . . . . 0.0 109.859 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.477 ' CG2' ' OD1' ' A' ' 129' ' ' ASP . 46.5 t -122.1 152.66 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.258 -0.902 . . . . 0.0 110.532 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -129.95 -168.77 2.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.874 . . . . 0.0 110.594 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.462 ' CE1' HG23 ' A' ' 85' ' ' ILE . 1.7 t80 -59.57 -64.33 0.98 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.376 -0.828 . . . . 0.0 111.09 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -43.27 -55.46 4.01 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.4 -0.813 . . . . 0.0 111.146 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.446 ' OE1' ' HA ' ' A' ' 136' ' ' VAL . 5.9 mt-10 -48.44 -51.4 27.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.189 -0.945 . . . . 0.0 110.978 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.517 ' CE1' ' HE1' ' A' ' 145' ' ' MET . 2.9 t80 -59.65 -32.96 70.94 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.061 -1.024 . . . . 0.0 110.967 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 57.9 t -76.42 -27.16 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.068 -1.02 . . . . 0.0 111.506 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 46.1 tp60 -98.27 -11.09 22.98 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.88 -1.138 . . . . 0.0 110.882 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.509 ' HE3' ' CD2' ' A' ' 141' ' ' PHE . 19.7 ptt? -91.33 -34.18 15.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.014 -1.054 . . . . 0.0 110.642 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.517 ' HE1' ' CE1' ' A' ' 141' ' ' PHE . 23.4 tpp -82.83 -40.14 20.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 110.41 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 68.2 p -92.0 130.38 37.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.086 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -175.16 128.4 0.28 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.181 -0.949 . . . . 0.0 110.395 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 28.2 mmtt . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.138 179.78 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' WW7 . . . . . 0.475 ' H3 ' ' CD2' ' A' ' 19' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' WW7 . . . . . 0.514 ' H2 ' ' CZ ' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.211 0.529 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.54 128.34 35.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 109.846 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -106.1 -12.77 15.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.098 -1.001 . . . . 0.0 110.76 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 54.0 mt -97.02 32.02 2.25 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.037 -1.039 . . . . 0.0 110.12 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.2 m -73.39 -56.54 4.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 110.148 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -81.82 -30.85 32.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 110.217 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -50.3 -34.5 23.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.263 -0.898 . . . . 0.0 109.874 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.526 ' HG2' ' CE2' ' A' ' 12' ' ' PHE . 45.0 tt0 -59.73 -48.29 82.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.395 -0.815 . . . . 0.0 109.95 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.7 mt -59.56 -45.1 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.033 -1.042 . . . . 0.0 109.597 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 13' ' ' LYS . . . -59.33 -25.76 64.46 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.387 -0.821 . . . . 0.0 109.505 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 15.0 tp10 -69.02 -44.76 72.1 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.377 -0.827 . . . . 0.0 109.707 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.526 ' CE2' ' HG2' ' A' ' 8' ' ' GLN . 20.3 m-85 -62.28 -47.7 83.15 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.253 -0.904 . . . . 0.0 109.808 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 6.1 mtpm? -56.17 -46.67 79.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.353 -0.842 . . . . 0.0 109.964 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -52.96 -46.17 68.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.22 -0.925 . . . . 0.0 109.631 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.458 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -58.92 -44.25 91.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.376 -0.827 . . . . 0.0 110.044 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.456 ' CE1' ' CD1' ' A' ' 27' ' ' ILE . 37.8 t80 -51.31 -40.72 59.62 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.11 -0.994 . . . . 0.0 109.742 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.4 t -66.1 -38.29 87.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -0.888 . . . . 0.0 109.595 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.5 tt -57.96 -31.78 67.2 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.325 -0.859 . . . . 0.0 109.956 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.458 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 32.1 m-85 -87.29 -25.59 23.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.313 -0.867 . . . . 0.0 110.287 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -100.92 114.47 28.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.313 -0.867 . . . . 0.0 109.925 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -103.7 -28.07 11.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.191 -0.943 . . . . 0.0 110.794 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.415 ' OD1' ' CB ' ' A' ' 24' ' ' ASP . 4.1 p30 -92.6 11.46 26.48 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.12 -0.988 . . . . 0.0 110.633 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 47.84 47.94 24.61 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.415 ' CB ' ' OD1' ' A' ' 22' ' ' ASP . 7.4 t70 -84.81 -27.45 26.8 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.263 -1.139 . . . . 0.0 110.501 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.09 -27.81 14.84 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.4 p -125.81 148.62 49.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.214 -1.168 . . . . 0.0 110.24 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.456 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 83.0 mt -96.03 126.84 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.293 -0.879 . . . . 0.0 110.114 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.7 p -108.8 -162.82 0.83 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.368 -0.832 . . . . 0.0 110.171 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.1 p -86.47 -28.36 23.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -0.987 . . . . 0.0 110.225 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -65.9 -58.36 5.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 109.698 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -54.95 -55.66 28.27 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.305 -0.872 . . . . 0.0 109.834 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 tp -54.16 -29.17 44.47 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.349 -0.845 . . . . 0.0 109.705 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.72 -49.68 73.83 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.0 m -68.81 -23.06 64.23 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.169 -1.195 . . . . 0.0 110.219 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.429 HG23 ' HA ' ' A' ' 19' ' ' PHE . 16.6 t -72.47 -37.77 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.275 -0.89 . . . . 0.0 109.881 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.4 mmt -90.28 -10.35 44.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 110.468 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -89.18 -36.66 15.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.134 -0.979 . . . . 0.0 110.658 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 72.8 p -79.33 -36.76 38.97 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.131 -0.981 . . . . 0.0 110.412 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.36 -11.19 55.14 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.268 -0.895 . . . . 0.0 110.482 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 151.07 89.6 0.07 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.69 143.8 57.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -1.118 . . . . 0.0 111.05 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.555 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 10.5 m-20 -159.85 -64.93 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.416 -0.803 . . . . 0.0 109.497 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.555 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 49.4 Cg_endo -74.47 150.22 40.6 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.423 1.222 . . . . 0.0 109.446 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 72.7 p -90.33 -137.79 0.14 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.054 -1.029 . . . . 0.0 109.415 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -100.9 -37.82 8.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.784 -1.198 . . . . 0.0 109.188 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.24 -58.1 3.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.409 -0.807 . . . . 0.0 109.236 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -51.81 -40.79 61.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.32 -0.862 . . . . 0.0 109.048 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' A' ' 44' ' ' THR . 9.4 tt -58.01 -42.61 85.61 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.611 -0.681 . . . . 0.0 109.182 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.407 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 35.1 tt0 -53.04 -39.71 63.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.905 . . . . 0.0 108.901 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -65.32 -37.32 86.76 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.218 -0.926 . . . . 0.0 108.66 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 13.5 ttt -66.39 -18.52 65.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.465 -0.772 . . . . 0.0 109.309 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.456 ' CD1' 'CL1 ' ' A' ' 153' ' ' WW7 . 33.3 mm -82.39 -31.69 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.372 -0.83 . . . . 0.0 109.802 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -59.33 -49.64 77.05 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.454 -0.779 . . . . 0.0 110.526 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -56.69 -19.16 15.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.079 -1.013 . . . . 0.0 110.124 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.463 HG13 ' CD1' ' A' ' 63' ' ' ILE . 56.0 t -94.48 -25.74 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.267 -0.895 . . . . 0.0 110.164 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -97.8 100.66 12.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.217 -0.927 . . . . 0.0 110.458 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -93.41 46.53 1.2 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.219 -0.925 . . . . 0.0 109.982 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -132.02 -66.49 0.7 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.218 -0.926 . . . . 0.0 110.484 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 135.84 53.94 0.06 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.439 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 12.4 p-10 -142.06 -46.41 0.35 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -1.139 . . . . 0.0 110.316 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.19 -72.55 0.48 Allowed Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.656 -1.259 . . . . 0.0 110.531 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.9 p -69.67 169.88 11.96 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.251 -1.147 . . . . 0.0 111.149 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.463 ' CD1' HG13 ' A' ' 55' ' ' VAL . 42.0 mt -115.83 143.89 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.309 -0.869 . . . . 0.0 110.258 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -96.12 -168.23 1.71 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.255 -0.903 . . . . 0.0 110.227 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.538 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 57.7 t80 -82.77 -41.78 0.89 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 111.459 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 43.4 Cg_endo -74.55 -29.34 9.17 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 O-C-N 123.05 1.026 . . . . 0.0 109.968 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -74.12 -27.26 60.78 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.322 -0.861 . . . . 0.0 108.775 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.494 ' CE2' ' HE2' ' A' ' 72' ' ' MET . 31.8 t80 -75.32 -47.43 27.79 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.621 -0.674 . . . . 0.0 110.04 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.456 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 1.8 tt -70.21 -20.76 63.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.297 -0.877 . . . . 0.0 110.167 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.0 m -78.6 -43.23 26.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 110.884 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 64.0 ttp -69.12 -48.18 63.17 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.1 -1.0 . . . . 0.0 110.93 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.494 ' HE2' ' CE2' ' A' ' 68' ' ' PHE . 28.7 mtt -78.68 -10.89 59.92 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.102 -0.998 . . . . 0.0 110.991 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -66.54 -42.15 87.6 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.972 -1.08 . . . . 0.0 110.005 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -108.82 45.96 1.0 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.382 -0.824 . . . . 0.0 110.521 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.06 45.77 1.25 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.022 -1.049 . . . . 0.0 110.666 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 17.6 ptp -83.31 138.74 33.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.095 -1.003 . . . . 0.0 110.34 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -94.49 -20.31 19.78 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.303 -0.873 . . . . 0.0 110.081 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -163.25 157.84 20.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.889 . . . . 0.0 110.185 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.407 ' O ' HG21 ' A' ' 79' ' ' THR . 5.6 t -122.34 69.2 0.96 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.197 -0.939 . . . . 0.0 110.491 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -113.62 170.69 8.07 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.089 -1.007 . . . . 0.0 110.222 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.8 t -155.15 59.99 0.65 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.203 -0.936 . . . . 0.0 110.278 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -123.21 -178.01 3.86 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.244 -0.91 . . . . 0.0 110.196 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 46.13 85.34 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.168 -0.958 . . . . 0.0 110.606 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -90.86 -33.66 15.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.006 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.1 mt -51.53 -30.39 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.398 -0.814 . . . . 0.0 110.133 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -68.57 -42.09 78.8 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.231 -0.918 . . . . 0.0 109.846 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -62.38 -37.44 85.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.273 -0.892 . . . . 0.0 110.164 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.507 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -65.19 -62.44 1.54 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -0.9 . . . . 0.0 110.38 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.464 ' CE2' ' HA ' ' A' ' 138' ' ' TYR . 6.2 t80 -54.92 -28.0 47.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.18 -0.95 . . . . 0.0 110.211 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 -63.39 -53.26 55.25 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.255 -0.903 . . . . 0.0 110.559 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.511 HG21 ' CD1' ' A' ' 92' ' ' PHE . 31.0 m -70.68 -24.86 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.106 -0.996 . . . . 0.0 110.707 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.511 ' CD1' HG21 ' A' ' 91' ' ' VAL . 14.3 m-30 -73.41 -28.85 62.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.132 -0.98 . . . . 0.0 110.007 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -108.67 67.63 0.67 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 0.0 109.752 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -77.08 -30.33 55.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.348 -0.845 . . . . 0.0 110.485 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.417 ' OD2' ' HB2' ' A' ' 97' ' ' ASN . 30.8 p-10 -69.24 -7.13 33.89 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.171 -0.956 . . . . 0.0 110.491 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.52 28.57 70.91 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.417 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 1.8 t-20 -80.78 -75.87 0.26 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.296 -1.12 . . . . 0.0 110.01 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 151.18 -25.21 0.99 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.411 ' HB3' ' HB2' ' A' ' 135' ' ' GLN . 14.3 m-85 -118.88 131.69 56.07 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.193 -1.181 . . . . 0.0 110.092 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.425 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 83.3 mt -70.01 128.62 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.146 -0.971 . . . . 0.0 110.084 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 97.9 p -114.6 175.07 5.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.897 . . . . 0.0 110.226 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.14 -53.02 15.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 110.228 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -47.08 -56.62 6.22 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.179 -0.95 . . . . 0.0 110.244 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.401 ' OE2' ' OD2' ' A' ' 95' ' ' ASP . 94.4 mt-10 -58.69 -41.93 87.38 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 109.807 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.468 ' CD2' HG12 ' A' ' 121' ' ' VAL . 55.1 tp -54.86 -30.54 58.07 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.309 -0.869 . . . . 0.0 110.104 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.41 ' O ' ' OG1' ' A' ' 110' ' ' THR . 4.2 ttm180 -77.29 -42.72 35.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.92 . . . . 0.0 110.128 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -62.34 -19.44 63.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 110.312 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.8 t -92.67 -45.08 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.175 -0.953 . . . . 0.0 110.42 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' A' ' 105' ' ' LEU . 26.4 mmt -70.02 -18.34 63.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.272 -0.892 . . . . 0.0 110.555 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 89.9 m -75.83 -25.27 56.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.155 -0.965 . . . . 0.0 110.033 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -88.38 -38.73 14.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.303 -0.873 . . . . 0.0 110.075 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 50.6 mt -58.15 -42.6 86.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.369 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.09 0.83 7.51 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 2.4 mm-40 -72.85 -43.15 62.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.069 -1.253 . . . . 0.0 110.256 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 16.7 mmtp 55.74 106.99 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.42 -0.8 . . . . 0.0 110.414 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.6 mt -131.87 161.46 32.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.261 -0.9 . . . . 0.0 110.21 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 67.7 m -86.51 168.18 13.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 0.0 110.06 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -57.1 -43.64 82.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.268 -0.895 . . . . 0.0 110.688 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -66.31 -33.34 75.51 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.051 -1.031 . . . . 0.0 110.472 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -65.35 -59.12 4.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.044 -1.035 . . . . 0.0 109.908 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.468 HG12 ' CD2' ' A' ' 105' ' ' LEU . 70.4 t -52.04 -45.4 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.172 -0.955 . . . . 0.0 109.665 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -54.71 -41.47 70.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 0.0 109.528 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -64.57 -33.13 75.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.368 -0.833 . . . . 0.0 109.544 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 26.4 mmm -63.88 -49.54 72.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.879 . . . . 0.0 110.127 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 34.7 mm -64.83 -26.89 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.352 -0.843 . . . . 0.0 110.245 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -69.76 -50.12 46.38 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.153 -0.967 . . . . 0.0 110.129 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -57.74 -39.3 77.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.166 -0.959 . . . . 0.0 109.733 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.437 ' CB ' ' SD ' ' A' ' 144' ' ' MET . . . -70.9 -30.59 66.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.319 -0.863 . . . . 0.0 109.939 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -70.27 91.12 0.71 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.393 -0.817 . . . . 0.0 110.166 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 65.2 mt -74.69 -50.8 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.201 -0.937 . . . . 0.0 110.817 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 29.1 p30 -69.39 -17.95 63.72 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.104 -0.997 . . . . 0.0 110.877 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 71.49 72.18 0.95 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.407 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 6.6 p30 -125.73 -24.91 3.75 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.236 -1.156 . . . . 0.0 111.237 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 132.59 -24.52 3.89 Favored Glycine 0 N--CA 1.496 2.688 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.33 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.411 ' HB2' ' HB3' ' A' ' 99' ' ' TYR . 2.4 pp0? -140.25 167.51 21.96 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.055 -1.262 . . . . 0.0 110.558 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.425 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 57.9 t -102.86 144.25 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.21 -0.931 . . . . 0.0 110.68 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -106.93 166.22 10.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.363 -0.835 . . . . 0.0 109.476 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.464 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 51.8 t80 -52.94 -38.67 62.22 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.039 -1.038 . . . . 0.0 110.1 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -67.77 -60.35 2.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.213 -0.93 . . . . 0.0 110.623 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -47.13 -36.45 8.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.208 -0.933 . . . . 0.0 110.745 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.468 ' CE1' ' HE1' ' A' ' 145' ' ' MET . 10.2 t80 -65.51 -46.29 80.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.138 -0.976 . . . . 0.0 110.182 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 138' ' ' TYR . 52.4 t -66.48 -22.61 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.225 -0.922 . . . . 0.0 110.101 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -84.33 -25.29 29.33 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.378 -0.826 . . . . 0.0 111.019 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.459 ' HG3' ' N ' ' A' ' 145' ' ' MET . 10.1 ptt? -89.54 -23.1 22.1 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.003 -1.06 . . . . 0.0 110.756 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.468 ' HE1' ' CE1' ' A' ' 141' ' ' PHE . 38.4 tpp -88.58 -9.76 51.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.257 -0.902 . . . . 0.0 110.815 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.2 t -114.6 -30.22 6.57 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.077 -1.014 . . . . 0.0 110.719 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -94.81 130.15 41.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.029 -1.044 . . . . 0.0 110.516 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.137 179.895 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' WW7 . . . . . 0.524 H132 ' N2 ' ' A' ' 153' ' ' WW7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' WW7 . . . . . 0.493 ' H2 ' ' CZ ' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.223 0.535 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.76 -6.04 48.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.261 -0.899 . . . . 0.0 110.446 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.405 ' O ' ' O ' ' A' ' 4' ' ' LEU . 8.5 pt20 -128.74 -177.03 4.03 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.137 -0.977 . . . . 0.0 110.5 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.405 ' O ' ' O ' ' A' ' 3' ' ' GLN . 0.8 OUTLIER -57.12 -162.54 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.319 -0.863 . . . . 0.0 110.396 -179.708 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.4 m -138.52 149.52 45.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.253 -0.905 . . . . 0.0 109.945 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -76.09 -11.41 59.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.237 -0.914 . . . . 0.0 110.436 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -63.72 -26.24 68.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.149 -0.969 . . . . 0.0 110.334 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -68.13 -49.87 58.29 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.194 -0.941 . . . . 0.0 110.014 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.8 mt -61.88 -47.95 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.167 -0.958 . . . . 0.0 109.805 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.24 -39.6 69.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.281 -0.887 . . . . 0.0 109.657 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -58.46 -43.92 89.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.42 -0.8 . . . . 0.0 109.619 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.452 ' CE1' ' HB3' ' A' ' 72' ' ' MET . 35.8 m-85 -63.18 -25.62 68.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.378 -0.826 . . . . 0.0 109.805 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -77.47 -28.26 52.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.333 -0.855 . . . . 0.0 110.249 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -73.05 -42.92 62.59 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.146 -0.972 . . . . 0.0 110.065 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.87 -50.68 16.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.178 -0.951 . . . . 0.0 109.48 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.538 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 77.9 t80 -49.93 -48.03 52.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 109.614 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.7 t -68.82 -35.83 77.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.553 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.427 ' CD1' ' O ' ' A' ' 18' ' ' LEU . 3.4 tm? -59.34 -24.35 63.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.423 -0.798 . . . . 0.0 109.309 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.453 ' HA ' HG23 ' A' ' 35' ' ' VAL . 13.8 m-85 -87.31 -62.28 1.54 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.513 -0.742 . . . . 0.0 109.68 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -51.65 115.58 1.7 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.53 -0.732 . . . . 0.0 110.076 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -105.85 -36.68 6.93 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.024 -1.048 . . . . 0.0 110.708 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -69.46 -25.83 64.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.148 -0.97 . . . . 0.0 110.167 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.93 95.43 0.42 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.409 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 9.1 p-10 -158.01 -46.3 0.06 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.237 -1.155 . . . . 0.0 110.609 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.458 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 126.5 23.88 1.47 Allowed Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.852 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.458 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 53.8 p -154.89 140.95 18.39 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.799 -1.413 . . . . 0.0 110.618 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.511 HD13 ' CD1' ' A' ' 16' ' ' PHE . 62.2 mt -99.63 112.72 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -0.918 . . . . 0.0 109.759 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.417 ' O ' ' HB2' ' A' ' 32' ' ' LEU . 4.5 m -97.67 -177.87 3.93 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.313 -0.867 . . . . 0.0 110.186 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.444 ' CG2' HD11 ' A' ' 52' ' ' ILE . 16.8 p -72.9 -31.62 64.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.145 -0.972 . . . . 0.0 110.929 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -62.21 1.58 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.898 -1.126 . . . . 0.0 110.09 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.418 ' O ' HG21 ' A' ' 35' ' ' VAL . 50.8 mt-10 -55.18 -47.63 74.93 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.158 -0.964 . . . . 0.0 109.437 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.442 ' CD1' 'CL1 ' ' A' ' 153' ' ' WW7 . 0.9 OUTLIER -55.7 -32.3 63.19 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.281 -0.887 . . . . 0.0 109.608 179.4 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.91 -51.62 57.84 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.9 m -70.27 -12.76 61.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.264 -1.139 . . . . 0.0 110.136 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.467 ' O ' ' CD1' ' A' ' 39' ' ' LEU . 59.5 t -78.36 -32.08 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.22 -0.925 . . . . 0.0 110.109 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -87.34 -27.52 22.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.108 -0.995 . . . . 0.0 110.205 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.408 ' HG2' ' HA ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -80.92 -46.2 15.55 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.128 -0.982 . . . . 0.0 109.946 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.6 t -57.08 -22.53 40.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.324 -0.86 . . . . 0.0 110.101 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.467 ' CD1' ' O ' ' A' ' 35' ' ' VAL . 75.7 mt -95.39 -69.72 0.74 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.341 -0.85 . . . . 0.0 109.997 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.16 88.96 0.07 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.407 ' O ' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -175.82 -56.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.229 -1.159 . . . . 0.0 110.275 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.408 ' HA ' ' HG2' ' A' ' 37' ' ' ARG . 41.9 t30 53.97 64.81 6.07 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.172 -0.955 . . . . 0.0 110.244 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -74.85 -163.04 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.765 1.403 . . . . 0.0 110.402 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.413 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 89.2 m -109.3 151.19 26.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.359 -0.838 . . . . 0.0 109.941 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -59.67 -41.9 91.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 110.03 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.79 -62.14 1.5 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.319 -0.863 . . . . 0.0 110.25 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -50.07 -24.98 3.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.247 -0.908 . . . . 0.0 109.893 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' A' ' 44' ' ' THR . 9.2 tt -70.74 -51.27 28.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.434 -0.791 . . . . 0.0 109.612 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -54.03 -30.1 46.31 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.292 -0.88 . . . . 0.0 109.085 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -75.96 -35.43 59.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.493 -0.755 . . . . 0.0 109.561 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.414 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 27.9 ttp -71.04 -19.93 62.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.469 -0.769 . . . . 0.0 110.081 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.444 HD11 ' CG2' ' A' ' 29' ' ' THR . 10.7 mt -88.15 -36.75 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -0.87 . . . . 0.0 109.684 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -55.0 -40.64 70.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.195 -0.94 . . . . 0.0 109.91 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.486 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 10.0 pt-20 -70.14 -30.58 67.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.256 -0.903 . . . . 0.0 110.131 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.517 ' CG1' ' CD1' ' A' ' 63' ' ' ILE . 59.0 t -74.35 -72.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.353 -0.842 . . . . 0.0 109.328 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -52.03 98.62 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.686 -0.634 . . . . 0.0 110.401 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -87.41 50.03 1.93 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.602 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -138.03 9.28 2.78 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.447 -0.783 . . . . 0.0 110.333 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 53.17 88.02 0.01 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -169.39 -60.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.217 -1.166 . . . . 0.0 110.077 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.404 ' O ' ' CG2' ' A' ' 52' ' ' ILE . . . 136.54 -57.83 0.67 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.8 p -90.13 143.51 26.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.203 -1.175 . . . . 0.0 110.712 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.517 ' CD1' ' CG1' ' A' ' 55' ' ' VAL . 86.6 mt -93.86 151.11 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.453 -0.78 . . . . 0.0 109.68 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -109.02 -162.79 0.83 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.237 -0.914 . . . . 0.0 110.531 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.523 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 28.1 t80 -79.39 -42.08 1.58 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.359 -0.838 . . . . 0.0 111.355 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 49.3 Cg_endo -75.73 -25.8 10.41 Favored 'Trans proline' 0 N--CA 1.481 0.75 0 O-C-N 123.124 1.065 . . . . 0.0 110.428 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 71' ' ' MET . 94.7 mt-10 -78.65 -28.06 45.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 0.0 109.188 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.538 ' CE2' ' HB2' ' A' ' 16' ' ' PHE . 88.2 t80 -78.11 -44.73 25.31 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.635 -0.666 . . . . 0.0 110.118 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.56 -32.22 60.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 0.0 110.894 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 83.2 m -78.56 -31.44 47.35 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.991 -1.068 . . . . 0.0 110.88 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.406 ' HG2' ' O ' ' A' ' 67' ' ' GLU . 18.7 ptt? -79.93 -31.48 40.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.92 -1.113 . . . . 0.0 110.777 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.525 ' HE2' ' CE1' ' A' ' 68' ' ' PHE . 53.9 mtt -89.22 -10.45 46.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.008 -1.058 . . . . 0.0 110.932 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.02 -21.45 54.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.072 -1.017 . . . . 0.0 110.45 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' A' ' 75' ' ' LYS . 4.1 mmt85 -110.52 -28.56 8.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.105 -0.997 . . . . 0.0 110.761 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 5.6 mttp 60.79 132.29 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.467 -0.771 . . . . 0.0 110.307 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 89.7 mtp -140.24 174.78 10.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.014 -1.054 . . . . 0.0 110.462 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -108.94 115.12 29.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 110.376 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -150.36 75.46 1.23 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.337 -0.852 . . . . 0.0 110.091 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.422 ' O ' ' HB2' ' A' ' 80' ' ' ASP . 70.8 m -104.3 151.3 23.59 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.313 -0.867 . . . . 0.0 110.146 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 79' ' ' THR . 0.7 OUTLIER 57.11 115.38 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.513 -0.742 . . . . 0.0 110.861 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.0 t -104.5 74.12 1.14 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.918 . . . . 0.0 109.988 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 18.1 tt0 -99.61 -42.04 7.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.162 -0.961 . . . . 0.0 110.673 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 9.1 tp10 -177.11 101.02 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.249 -0.907 . . . . 0.0 110.333 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -61.24 -43.13 99.38 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.261 -0.899 . . . . 0.0 110.203 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.6 mt -50.46 -23.77 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.146 -0.971 . . . . 0.0 110.255 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.23 -55.26 5.22 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.214 -0.929 . . . . 0.0 110.457 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 47.9 mt-10 -53.58 -38.55 64.01 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.221 -0.925 . . . . 0.0 110.147 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.444 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -65.25 -59.48 4.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.391 -0.818 . . . . 0.0 110.206 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -46.15 -28.74 1.31 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.358 -0.839 . . . . 0.0 110.267 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 71.6 mtp180 -71.13 -55.37 8.33 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.252 -0.905 . . . . 0.0 110.422 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' A' ' 88' ' ' ALA . 32.7 m -61.36 -19.64 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.152 -0.968 . . . . 0.0 110.579 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.525 ' CE2' ' H2 ' ' A' ' 154' ' ' WW7 . 40.9 m-85 -92.12 -21.31 20.5 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.126 -0.984 . . . . 0.0 110.21 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -127.45 37.49 4.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 0.0 109.927 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -85.0 8.07 19.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.898 . . . . 0.0 110.658 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 3.0 p30 -81.92 -22.71 36.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.155 -0.966 . . . . 0.0 110.138 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.437 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 112.18 29.82 3.12 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.473 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 39.0 p-10 -127.09 -15.46 5.28 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.263 -1.139 . . . . 0.0 110.719 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 65.53 11.28 52.7 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.613 ' O ' 'CA ' ' A' ' 151' ' ' ' CA' . 49.8 m-85 -121.41 139.54 53.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.026 -1.279 . . . . 0.0 110.241 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.515 ' CD1' ' CD2' ' A' ' 141' ' ' PHE . 21.8 mt -91.23 113.37 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.137 -0.977 . . . . 0.0 110.273 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 76.3 p -103.85 156.46 17.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.412 -0.805 . . . . 0.0 109.915 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.77 -34.95 55.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.127 -0.983 . . . . 0.0 110.307 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.42 -62.32 1.48 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.181 -0.949 . . . . 0.0 110.498 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.415 ' OE1' ' OD2' ' A' ' 95' ' ' ASP . 51.4 mt-10 -46.95 -42.98 18.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.179 -0.95 . . . . 0.0 110.254 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.401 HD13 ' HE3' ' A' ' 124' ' ' MET . 8.6 tt -55.07 -54.12 47.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.399 -0.813 . . . . 0.0 110.126 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.404 ' O ' ' HG3' ' A' ' 106' ' ' ARG . 3.1 tpt180 -63.1 -19.95 64.91 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.924 . . . . 0.0 109.986 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -77.89 -27.32 49.6 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.286 -0.884 . . . . 0.0 110.14 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 91' ' ' VAL . 78.4 t -83.77 -40.1 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.315 -0.865 . . . . 0.0 109.903 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.411 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.3 OUTLIER -59.87 -41.9 92.54 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.344 -0.848 . . . . 0.0 110.062 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.1 p -56.01 -44.68 78.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.33 -0.856 . . . . 0.0 110.335 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -61.28 -48.32 81.94 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.243 -0.911 . . . . 0.0 110.132 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.5 mt -64.48 -13.93 54.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.207 -0.933 . . . . 0.0 110.275 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.27 51.44 3.52 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -102.23 -177.47 3.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.129 -1.218 . . . . 0.0 110.015 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.15 47.6 0.99 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.166 -0.959 . . . . 0.0 110.577 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.444 ' CD2' ' OE1' ' A' ' 120' ' ' GLU . 7.0 mt -75.89 -175.73 3.12 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.264 -0.898 . . . . 0.0 110.158 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 88.8 m -135.92 170.08 16.57 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.293 -0.879 . . . . 0.0 110.288 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -52.87 -33.29 49.25 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.314 -0.866 . . . . 0.0 110.783 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -65.68 -53.1 45.71 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.127 -0.983 . . . . 0.0 110.613 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.444 ' OE1' ' CD2' ' A' ' 116' ' ' LEU . 74.2 mt-10 -60.57 -48.88 79.8 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.318 -0.864 . . . . 0.0 111.209 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.7 t -55.81 -53.31 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.231 -0.918 . . . . 0.0 110.833 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.75 -36.47 74.4 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.23 -0.919 . . . . 0.0 110.667 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.456 ' CG ' ' OE2' ' A' ' 127' ' ' GLU . 36.9 tt0 -71.63 -24.95 61.96 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.193 -0.942 . . . . 0.0 110.289 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.401 ' HE3' HD13 ' A' ' 105' ' ' LEU . 85.3 mtp -76.63 -49.18 16.87 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.183 -0.948 . . . . 0.0 110.068 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.416 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 19.2 mm -69.08 -26.53 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 110.326 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.43 -39.14 47.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.127 -0.983 . . . . 0.0 110.528 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.456 ' OE2' ' CG ' ' A' ' 123' ' ' GLU . 0.3 OUTLIER -69.78 -31.23 69.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.133 -0.979 . . . . 0.0 110.178 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.11 -27.91 24.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.208 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 56.8 t0 -68.29 93.58 0.48 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.374 -0.829 . . . . 0.0 110.224 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 55.6 mt -75.42 -47.9 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.287 -0.883 . . . . 0.0 110.739 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.409 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 47.7 p30 -73.19 -6.37 45.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.132 -0.98 . . . . 0.0 110.811 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.411 ' HA2' ' OD2' ' A' ' 129' ' ' ASP . . . 57.87 61.98 6.83 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -124.03 8.63 8.65 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.203 -1.175 . . . . 0.0 111.027 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.54 36.19 54.62 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.55 ' NE2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -170.96 137.36 1.19 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.354 -1.086 . . . . 0.0 109.964 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.418 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 46.8 t -110.35 118.16 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.157 -0.965 . . . . 0.0 110.318 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -87.37 177.2 7.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.163 -0.961 . . . . 0.0 110.022 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -61.5 -45.05 95.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.111 -0.993 . . . . 0.0 110.286 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -53.08 -55.56 22.96 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.282 -0.886 . . . . 0.0 110.077 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 144' ' ' MET . 56.7 mt-10 -64.86 -23.36 67.21 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.224 -0.922 . . . . 0.0 109.785 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.515 ' CD2' ' CD1' ' A' ' 100' ' ' ILE . 37.9 t80 -75.75 -22.86 56.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.551 -0.718 . . . . 0.0 109.757 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 84.9 t -90.1 -24.19 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.369 -0.832 . . . . 0.0 109.928 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -80.43 -34.24 36.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.372 -0.83 . . . . 0.0 110.217 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.491 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 0.1 OUTLIER -82.57 -13.67 56.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.286 -0.884 . . . . 0.0 110.257 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.501 ' HE1' ' CE1' ' A' ' 141' ' ' PHE . 15.1 mmt -87.49 -46.66 9.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 110.394 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.3 p -92.97 -53.18 4.25 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.141 -0.974 . . . . 0.0 110.489 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -94.19 -164.72 1.21 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.149 -0.969 . . . . 0.0 110.583 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.6 mttp . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.236 -179.851 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . 0.613 'CA ' ' O ' ' A' ' 99' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' WW7 . . . . . 0.442 'CL1 ' ' CD1' ' A' ' 32' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' WW7 . . . . . 0.525 ' H2 ' ' CE2' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.345 0.593 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -135.68 175.28 9.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.365 -0.834 . . . . 0.0 109.985 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -122.35 -177.59 3.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 0.0 109.999 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 4' ' ' LEU . 0.4 OUTLIER -151.94 126.67 9.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.173 -0.954 . . . . 0.0 110.262 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 p -156.64 -66.39 0.1 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.171 -0.956 . . . . 0.0 110.313 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -80.21 -9.89 59.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 110.53 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.67 -60.28 3.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.121 -0.987 . . . . 0.0 110.426 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.51 ' HG2' ' CE2' ' A' ' 12' ' ' PHE . 7.9 tt0 -62.7 -43.35 99.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.327 -0.858 . . . . 0.0 110.415 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.8 mt -55.0 -42.23 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.081 -1.012 . . . . 0.0 109.839 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.97 -34.9 78.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.317 -0.865 . . . . 0.0 110.029 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.91 -48.87 78.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 109.779 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.51 ' CE2' ' HG2' ' A' ' 8' ' ' GLN . 24.1 m-85 -60.08 -47.87 84.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.016 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -49.04 -42.04 37.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.17 -0.956 . . . . 0.0 110.072 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -66.5 -37.7 85.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.875 . . . . 0.0 110.307 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.81 -47.87 83.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.142 -0.974 . . . . 0.0 109.971 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -60.27 -45.26 93.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 110.146 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.3 t -62.84 -21.22 65.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.924 . . . . 0.0 109.991 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.7 tt -85.2 -25.18 27.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 109.939 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.477 ' HA ' ' CG2' ' A' ' 35' ' ' VAL . 8.3 m-85 -92.74 -67.98 0.83 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.219 -0.926 . . . . 0.0 110.412 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -70.99 86.78 0.72 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.382 -0.823 . . . . 0.0 110.235 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.409 ' HD3' ' O ' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -109.39 42.54 1.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.342 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -125.18 -43.2 1.96 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.136 -0.977 . . . . 0.0 110.25 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.93 -37.42 1.66 Allowed Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.86 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 49.9 p-10 -55.67 -17.85 6.67 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.96 -1.318 . . . . 0.0 110.952 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.428 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 63.13 13.59 49.52 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 34.0 p -122.21 116.05 23.46 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.023 -1.281 . . . . 0.0 110.286 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 62' ' ' THR . 61.2 mt -69.54 109.25 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.173 -0.954 . . . . 0.0 110.254 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 81.2 p -104.19 -157.85 0.63 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.881 . . . . 0.0 110.204 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.1 p -82.99 -36.85 24.73 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.198 -0.939 . . . . 0.0 110.636 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -64.94 -59.85 3.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.117 -0.99 . . . . 0.0 110.192 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -59.09 -52.5 65.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.166 -0.958 . . . . 0.0 109.805 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.486 HD23 ' CG1' ' A' ' 52' ' ' ILE . 2.6 tp -59.45 -21.82 60.6 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.241 -0.912 . . . . 0.0 109.682 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -68.23 -44.61 74.88 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 70.8 m -71.63 -34.14 69.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.349 -1.089 . . . . 0.0 110.176 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.477 ' CG2' ' HA ' ' A' ' 19' ' ' PHE . 63.6 t -69.6 -32.14 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.29 -0.881 . . . . 0.0 110.617 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.42 ' HE1' HD12 ' A' ' 32' ' ' LEU . 25.9 mmt -90.16 -18.47 25.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.221 -0.924 . . . . 0.0 110.241 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 10.7 tpt180 -79.06 -33.93 44.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 110.357 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.3 t -61.36 -21.07 63.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.289 -0.882 . . . . 0.0 110.383 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -144.98 76.38 1.49 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.175 -0.953 . . . . 0.0 110.255 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.24 -65.28 0.15 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 53.6 21.12 2.4 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.13 -1.218 . . . . 0.0 109.963 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.511 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.0 OUTLIER -105.56 -67.22 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.425 -0.797 . . . . 0.0 110.823 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.511 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 46.8 Cg_endo -72.31 170.64 18.7 Favored 'Trans proline' 0 C--N 1.321 -0.911 0 O-C-N 123.063 1.033 . . . . 0.0 110.467 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.417 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.6 OUTLIER -118.76 -140.63 0.36 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -0.887 . . . . 0.0 109.629 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -90.74 -30.67 16.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.908 -1.12 . . . . 0.0 110.189 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.62 -66.44 0.66 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.206 -0.933 . . . . 0.0 109.805 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 41.8 mt-10 -50.58 -36.22 33.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 109.54 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 44' ' ' THR . 6.0 tt -60.35 -45.2 94.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.84 . . . . 0.0 109.587 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -53.16 -39.36 63.5 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.282 -0.886 . . . . 0.0 108.629 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 47' ' ' GLU . 57.4 m-20 -64.31 -38.08 89.78 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.424 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -60.75 -23.84 65.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.439 -0.788 . . . . 0.0 108.919 178.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.486 ' CG1' HD23 ' A' ' 32' ' ' LEU . 10.7 mt -85.34 -24.86 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.456 -0.778 . . . . 0.0 109.786 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -73.54 -35.67 65.55 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.263 -0.898 . . . . 0.0 110.243 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 24.2 pt-20 -72.74 -42.54 63.96 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.174 -0.953 . . . . 0.0 110.166 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.474 HG13 ' CD1' ' A' ' 63' ' ' ILE . 68.0 t -69.87 -57.61 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.036 -1.04 . . . . 0.0 109.593 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.404 ' OD1' ' OE1' ' A' ' 67' ' ' GLU . 45.3 t0 -68.3 133.58 49.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.467 -0.77 . . . . 0.0 110.07 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.93 50.85 0.78 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.17 -0.956 . . . . 0.0 110.376 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.401 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 55.4 m-20 -136.48 -74.72 0.43 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.193 -0.942 . . . . 0.0 110.466 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.38 47.57 0.05 OUTLIER Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.417 ' OD1' ' OG1' ' A' ' 62' ' ' THR . 12.7 p30 -140.35 14.15 2.39 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.353 -1.086 . . . . 0.0 110.405 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 47.16 38.45 11.65 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.417 ' OG1' ' OD1' ' A' ' 60' ' ' ASN . 20.6 p -152.58 136.7 16.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.999 -1.294 . . . . 0.0 110.576 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.474 ' CD1' HG13 ' A' ' 55' ' ' VAL . 75.4 mt -111.67 123.74 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.884 . . . . 0.0 110.082 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.404 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.4 m-20 -83.73 -174.19 5.14 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.148 -0.97 . . . . 0.0 110.546 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.541 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -67.25 -46.71 50.82 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.436 -0.79 . . . . 0.0 111.032 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.6 Cg_endo -73.73 -31.12 8.82 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 O-C-N 123.415 1.218 . . . . 0.0 110.427 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.404 ' OE1' ' OD1' ' A' ' 56' ' ' ASP . 27.5 mt-10 -73.78 -23.65 59.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.158 -0.964 . . . . 0.0 109.176 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.519 ' CE1' ' HE1' ' A' ' 72' ' ' MET . 65.4 t80 -76.01 -55.51 5.53 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.638 -0.664 . . . . 0.0 110.281 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.4 tt -63.87 -28.86 70.13 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.349 -0.845 . . . . 0.0 110.297 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 66' ' ' PRO . 54.4 m -68.52 -57.59 5.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.221 -0.924 . . . . 0.0 110.375 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.479 ' HE2' ' CD1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -69.38 -12.67 61.85 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.167 -0.958 . . . . 0.0 110.673 -179.474 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.519 ' HE1' ' CE1' ' A' ' 68' ' ' PHE . 11.4 mmt -80.52 -24.93 39.01 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.05 -1.031 . . . . 0.0 110.085 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.53 -36.16 81.7 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.334 -0.854 . . . . 0.0 109.899 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.428 ' O ' ' CG ' ' A' ' 74' ' ' ARG . 1.8 ttp180 -110.85 65.11 0.61 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.408 -0.807 . . . . 0.0 110.839 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.83 134.62 47.66 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.913 -1.117 . . . . 0.0 110.041 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 36.9 ttp -125.89 128.64 47.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.223 -0.923 . . . . 0.0 110.384 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -82.69 165.14 20.23 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.301 -0.874 . . . . 0.0 109.853 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -135.5 136.91 41.62 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.127 -0.983 . . . . 0.0 110.692 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 77.9 p -81.29 164.35 22.28 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.355 -0.84 . . . . 0.0 110.418 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -122.57 -155.31 0.64 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.226 -0.921 . . . . 0.0 109.842 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.1 m -133.21 157.06 46.33 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.126 -0.984 . . . . 0.0 110.311 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -96.16 -149.05 0.31 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.285 -0.884 . . . . 0.0 110.356 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.431 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . 44.9 mm-40 52.01 87.76 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.256 -0.902 . . . . 0.0 110.187 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -69.99 -16.08 63.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 110.461 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 65.5 mt -55.21 -45.19 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.115 -0.991 . . . . 0.0 110.097 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -58.6 -56.4 22.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.168 -0.957 . . . . 0.0 109.979 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 10.8 mt-10 -46.29 -44.57 16.7 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.336 -0.852 . . . . 0.0 110.172 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.524 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -57.22 -57.64 11.72 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.378 -0.826 . . . . 0.0 109.467 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.477 ' CE1' HG13 ' A' ' 100' ' ' ILE . 29.9 t80 -49.8 -25.28 2.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.115 -0.991 . . . . 0.0 109.638 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.4 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 15.7 ttt180 -67.05 -59.33 3.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.51 -0.744 . . . . 0.0 110.464 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.479 HG21 ' N ' ' A' ' 92' ' ' PHE . 34.7 m -61.52 -31.66 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.208 -0.933 . . . . 0.0 110.583 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.524 ' CD2' ' O ' ' A' ' 88' ' ' ALA . 31.1 m-85 -78.7 -15.96 57.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.084 -1.01 . . . . 0.0 110.663 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -114.61 73.21 0.82 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.965 -1.084 . . . . 0.0 110.463 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -99.42 54.91 0.97 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.259 -0.9 . . . . 0.0 110.761 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.3 p30 -140.04 -37.02 0.48 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.077 -1.014 . . . . 0.0 110.615 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.478 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 107.8 42.9 1.38 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.488 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 45.2 p-10 -135.46 -18.59 1.7 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.057 -1.261 . . . . 0.0 111.477 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.481 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 80.42 42.02 10.86 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.534 ' CD1' ' NE2' ' A' ' 135' ' ' GLN . 68.5 m-85 -152.33 145.39 24.55 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.335 -1.097 . . . . 0.0 110.093 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.477 HG13 ' CE1' ' A' ' 89' ' ' PHE . 31.9 mt -96.69 130.67 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.199 -0.938 . . . . 0.0 110.427 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.8 t -117.25 166.94 11.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.38 -0.825 . . . . 0.0 109.858 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.61 -32.21 73.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.181 -0.949 . . . . 0.0 110.678 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.6 -52.14 34.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.117 -0.99 . . . . 0.0 110.442 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -60.19 -40.18 89.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.275 -0.89 . . . . 0.0 110.755 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.478 HD21 ' CG1' ' A' ' 121' ' ' VAL . 6.7 tp -64.09 -36.82 85.28 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.087 -1.008 . . . . 0.0 110.541 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 106' ' ' ARG . 1.6 ttp-105 -66.65 -39.25 88.13 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.099 -1.001 . . . . 0.0 110.293 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -73.48 -22.81 60.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 0.0 110.384 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.519 ' CG1' ' CE1' ' A' ' 92' ' ' PHE . 77.0 t -82.15 -32.83 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.336 -0.853 . . . . 0.0 110.487 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.1 mmt -66.8 -28.78 68.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.129 -0.982 . . . . 0.0 110.272 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.4 p -63.3 -54.04 43.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.189 -0.945 . . . . 0.0 110.013 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -61.35 -40.38 94.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.253 -0.904 . . . . 0.0 110.153 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.7 mt -54.34 -30.24 50.78 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.188 -0.945 . . . . 0.0 110.232 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.39 26.0 7.11 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.458 ' CA ' ' OE1' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -127.35 107.4 9.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.272 -1.134 . . . . 0.0 110.041 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -86.09 109.23 18.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.915 . . . . 0.0 110.548 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.6 mp -112.71 -169.23 1.44 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.259 -0.901 . . . . 0.0 109.924 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 31.1 m -117.57 168.71 10.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.002 -1.061 . . . . 0.0 110.721 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -59.15 -36.22 74.87 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.4 -0.812 . . . . 0.0 110.295 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -67.0 -36.58 82.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.225 -0.922 . . . . 0.0 110.295 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 124' ' ' MET . 1.7 mt-10 -63.66 -51.72 63.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.38 -0.825 . . . . 0.0 110.361 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.478 ' CG1' HD21 ' A' ' 105' ' ' LEU . 50.3 t -63.42 -58.12 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.165 -0.959 . . . . 0.0 110.395 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -46.57 -43.13 16.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.338 -0.851 . . . . 0.0 110.395 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -67.01 -37.58 84.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.219 -0.925 . . . . 0.0 110.349 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.411 ' HG3' ' O ' ' A' ' 120' ' ' GLU . 90.9 mtp -59.27 -55.11 38.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 110.288 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 35.7 mm -56.16 -39.06 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 110.125 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -58.29 -44.36 88.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 109.952 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -69.01 -24.61 64.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.076 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.43 -21.48 38.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.174 -0.953 . . . . 0.0 110.074 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -67.76 89.42 0.26 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.314 -0.866 . . . . 0.0 110.427 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 47.7 mt -77.04 -29.74 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.791 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.7 p30 -99.37 -26.52 14.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.374 -0.829 . . . . 0.0 110.227 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 96.36 80.29 1.51 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 11.7 p-10 -144.68 -42.01 0.25 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -1.193 . . . . 0.0 110.358 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 126.51 -20.96 6.08 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.534 ' NE2' ' CD1' ' A' ' 99' ' ' TYR . 16.5 pt20 -119.16 158.91 24.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.095 -1.238 . . . . 0.0 110.524 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.5 t -119.42 113.14 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.269 -0.895 . . . . 0.0 110.055 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 12.4 p-10 -85.59 -157.98 0.36 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.125 -0.985 . . . . 0.0 110.321 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -68.93 -66.05 0.63 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.087 -1.008 . . . . 0.0 111.406 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -47.87 -47.42 31.74 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.143 -0.973 . . . . 0.0 110.854 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.409 ' OE2' ' OD2' ' A' ' 131' ' ' ASP . 33.1 mt-10 -66.29 -31.35 72.09 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.078 -1.014 . . . . 0.0 110.56 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.493 ' CD1' ' HE1' ' A' ' 144' ' ' MET . 15.5 t80 -70.61 -27.48 64.12 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.139 -0.976 . . . . 0.0 109.831 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.427 ' O ' ' CB ' ' A' ' 146' ' ' THR . 53.8 t -90.43 -23.14 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.523 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -83.83 -34.15 24.73 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.218 -0.926 . . . . 0.0 110.929 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.493 ' HE1' ' CD1' ' A' ' 141' ' ' PHE . 15.0 ptt? -64.17 -35.33 80.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.013 -1.054 . . . . 0.0 110.21 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.454 ' HE1' ' CE ' ' A' ' 144' ' ' MET . 12.4 mtt -90.19 -36.53 14.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 0.0 109.424 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.427 ' CB ' ' O ' ' A' ' 142' ' ' VAL . 22.7 m -86.11 85.39 7.36 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.538 -0.726 . . . . 0.0 110.109 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -116.93 98.58 6.56 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.233 -0.917 . . . . 0.0 110.117 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 148' ' ' LYS . 9.2 tttp . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.269 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' WW7 . . . . . 0.549 H142 ' N1 ' ' A' ' 153' ' ' WW7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' WW7 . . . . . 0.52 ' H2 ' ' CZ ' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.178 0.513 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.406 ' O ' ' O ' ' A' ' 3' ' ' GLN . 50.7 m-20 -109.11 99.94 9.17 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.274 -0.891 . . . . 0.0 110.524 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.406 ' O ' ' O ' ' A' ' 2' ' ' ASP . 37.5 tt0 59.96 119.23 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.377 -0.827 . . . . 0.0 110.729 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.419 HD21 ' OE1' ' A' ' 8' ' ' GLN . 32.3 mt -72.13 162.3 29.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.253 -0.904 . . . . 0.0 110.321 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.0 p -129.48 -178.48 4.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 110.206 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.16 -9.72 58.9 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.231 -0.918 . . . . 0.0 110.584 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -66.16 -51.11 60.97 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.039 -1.038 . . . . 0.0 110.458 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.419 ' OE1' HD21 ' A' ' 4' ' ' LEU . 31.2 mt-30 -64.35 -39.53 94.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -0.929 . . . . 0.0 110.083 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.5 mt -59.06 -42.69 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.143 -0.973 . . . . 0.0 109.604 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.14 95.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.353 -0.842 . . . . 0.0 109.545 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -60.03 -40.78 90.52 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.333 -0.855 . . . . 0.0 109.654 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -65.13 -31.54 72.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -0.841 . . . . 0.0 109.482 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.63 -50.59 68.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.852 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -60.79 -46.59 89.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.939 . . . . 0.0 109.839 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.505 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -48.82 -55.05 12.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.243 -0.911 . . . . 0.0 109.844 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -52.78 -52.47 56.58 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.399 -0.813 . . . . 0.0 110.347 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.0 m -53.58 -30.18 41.01 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.199 -0.938 . . . . 0.0 110.262 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.7 tt -70.52 -37.98 74.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.873 . . . . 0.0 110.142 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.558 ' CD1' ' CG1' ' A' ' 35' ' ' VAL . 78.5 m-85 -71.66 -65.24 0.78 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.433 -0.792 . . . . 0.0 110.353 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.401 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -53.74 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.149 -0.969 . . . . 0.0 110.351 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -105.16 51.94 0.75 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.264 -0.898 . . . . 0.0 110.235 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.482 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 23.0 p-10 -169.4 -33.06 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.263 -0.898 . . . . 0.0 110.936 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.73 93.98 2.33 Favored Glycine 0 N--CA 1.498 2.806 0 C-N-CA 119.669 -1.253 . . . . 0.0 110.678 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.438 ' HB2' 'CA ' ' A' ' 149' ' ' ' CA' . 43.7 m-20 -158.91 -45.83 0.06 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.44 -1.035 . . . . 0.0 110.038 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.88 -9.57 23.33 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.1 p -126.89 156.0 42.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.17 -1.194 . . . . 0.0 110.312 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 56.9 mt -105.42 119.64 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.465 -0.772 . . . . 0.0 110.031 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.3 p -103.21 -162.73 0.93 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.196 -0.94 . . . . 0.0 110.223 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.423 ' HA ' HD23 ' A' ' 48' ' ' LEU . 12.7 p -83.85 -27.99 28.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.162 -0.961 . . . . 0.0 110.609 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 mttp -71.21 -58.68 3.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.174 -0.954 . . . . 0.0 109.954 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.417 ' O ' HG21 ' A' ' 35' ' ' VAL . 49.8 mt-10 -56.52 -42.78 79.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.47 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.47 ' CD2' HD12 ' A' ' 52' ' ' ILE . 2.6 tp -67.57 -26.82 66.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.246 -0.909 . . . . 0.0 109.766 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.428 ' HA2' ' CD1' ' A' ' 48' ' ' LEU . . . -65.6 -38.69 94.91 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 38' ' ' SER . 50.2 m -83.0 -20.61 34.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -1.115 . . . . 0.0 109.885 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.558 ' CG1' ' CD1' ' A' ' 19' ' ' PHE . 60.4 t -74.4 -34.64 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 109.567 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 9.6 mmt -90.18 -31.66 16.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.431 -0.793 . . . . 0.0 109.636 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.2 tpt85 -78.99 -20.99 47.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.453 -0.779 . . . . 0.0 110.135 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 34' ' ' THR . 14.1 m -106.61 -6.52 17.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.336 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.41 HD22 ' C15' ' A' ' 153' ' ' WW7 . 1.6 tp -166.05 94.13 0.55 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.128 -0.983 . . . . 0.0 110.271 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.99 -103.79 0.32 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -123.45 -159.32 0.84 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -1.114 . . . . 0.0 110.288 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -130.87 60.35 52.48 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.239 -0.913 . . . . 0.0 110.06 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.5 -165.48 0.17 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.819 1.431 . . . . 0.0 110.156 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 5.9 m -125.39 -179.76 4.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.236 -0.915 . . . . 0.0 109.786 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.419 ' HA ' ' OE1' ' A' ' 45' ' ' GLU . 4.1 tp10 -69.04 -50.89 44.49 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.087 -1.008 . . . . 0.0 109.627 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.46 -57.15 11.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.196 -0.94 . . . . 0.0 109.876 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 3.4 tp10 -50.84 -39.74 54.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.915 . . . . 0.0 109.64 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.428 ' CD1' ' HA2' ' A' ' 33' ' ' GLY . 9.0 tt -54.79 -47.59 73.78 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.312 -0.868 . . . . 0.0 109.311 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -54.32 -44.4 72.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.78 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 47' ' ' GLU . 1.6 m-20 -51.31 -43.9 61.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 109.536 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.419 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 54.6 mtp -64.01 -34.85 78.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.202 -0.936 . . . . 0.0 109.794 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.47 HD12 ' CD2' ' A' ' 32' ' ' LEU . 28.0 mm -64.72 -27.97 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.299 -0.876 . . . . 0.0 110.063 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -68.06 -38.34 82.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.334 -0.854 . . . . 0.0 110.407 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 51' ' ' MET . 16.7 pt-20 -82.32 -10.49 59.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.084 -1.01 . . . . 0.0 110.154 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.9 t -104.97 -9.99 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.189 -0.944 . . . . 0.0 110.155 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -98.52 102.43 14.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.115 -0.991 . . . . 0.0 110.299 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.54 -11.12 21.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.193 -0.942 . . . . 0.0 110.538 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -69.99 -59.48 2.89 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.111 -0.993 . . . . 0.0 110.15 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 131.75 -13.7 5.3 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -76.64 -42.12 43.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.053 -1.263 . . . . 0.0 110.106 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.17 -63.63 0.6 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 57.0 p -76.67 167.28 22.11 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.243 -1.151 . . . . 0.0 110.47 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.474 HG21 ' N ' ' A' ' 64' ' ' ASP . 74.2 mt -96.19 152.29 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.208 -0.933 . . . . 0.0 109.98 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.474 ' N ' HG21 ' A' ' 63' ' ' ILE . 22.7 m-20 -114.18 -157.58 0.63 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.905 . . . . 0.0 110.472 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.533 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 7.6 t80 -84.79 -42.63 0.69 Allowed Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.414 -0.804 . . . . 0.0 111.526 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.6 Cg_endo -73.52 -24.1 16.52 Favored 'Trans proline' 0 N--CA 1.481 0.786 0 O-C-N 122.994 0.997 . . . . 0.0 110.776 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.408 ' OE1' ' HA ' ' A' ' 63' ' ' ILE . 31.2 tt0 -79.24 -31.36 43.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.138 -0.976 . . . . 0.0 108.97 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.479 ' CE1' ' SD ' ' A' ' 72' ' ' MET . 16.4 t80 -70.68 -45.21 65.44 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.788 -0.57 . . . . 0.0 110.165 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.453 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 34.5 tp -75.75 -25.03 56.17 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.263 -0.898 . . . . 0.0 110.533 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.418 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 53.4 m -84.97 -18.22 35.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.091 -1.005 . . . . 0.0 110.567 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.413 ' HE1' ' HB3' ' A' ' 71' ' ' MET . 14.7 tmm? -90.7 -38.19 13.23 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.045 -1.035 . . . . 0.0 110.876 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.479 ' SD ' ' CE1' ' A' ' 68' ' ' PHE . 66.5 mtt -90.0 -14.03 34.83 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.061 -1.024 . . . . 0.0 111.04 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -89.8 -10.41 45.58 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.02 -1.05 . . . . 0.0 110.781 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 70' ' ' THR . 60.9 mtp180 -67.12 -39.5 86.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.013 -1.055 . . . . 0.0 110.267 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -86.57 153.96 21.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.371 -0.83 . . . . 0.0 110.264 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 13.3 ptp -95.82 179.25 5.17 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.256 -0.903 . . . . 0.0 110.436 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.97 -154.05 0.45 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.347 -0.846 . . . . 0.0 109.806 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -102.32 120.91 41.28 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.225 -0.922 . . . . 0.0 109.934 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t -151.59 145.02 24.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.165 -0.96 . . . . 0.0 110.517 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -132.01 159.64 38.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.33 -0.856 . . . . 0.0 110.113 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 84.0 p -80.04 149.53 30.67 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.164 -0.96 . . . . 0.0 110.084 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.444 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 21.8 pt-20 -73.28 120.55 19.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.261 -0.899 . . . . 0.0 110.423 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 21.8 pt-20 -172.77 65.68 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.26 -0.9 . . . . 0.0 110.149 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -92.04 -58.67 2.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.242 -0.911 . . . . 0.0 110.465 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.403 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 16.7 mt -47.91 -35.2 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.15 -0.969 . . . . 0.0 110.216 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -55.15 -54.54 42.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.179 -0.951 . . . . 0.0 109.712 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 55.5 mt-10 -54.62 -39.92 68.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.24 -0.912 . . . . 0.0 110.147 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.452 ' O ' ' CG2' ' A' ' 91' ' ' VAL . . . -56.19 -56.24 23.36 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.269 -0.894 . . . . 0.0 110.107 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -48.27 -40.16 23.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.141 -0.975 . . . . 0.0 110.23 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 45.6 mtt-85 -61.42 -41.24 96.85 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.266 -0.896 . . . . 0.0 110.829 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 88' ' ' ALA . 29.5 m -83.24 -10.13 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.936 -1.103 . . . . 0.0 110.783 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.564 ' CE1' ' CG1' ' A' ' 108' ' ' VAL . 35.6 m-85 -105.32 -1.77 24.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.116 -0.99 . . . . 0.0 110.695 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -135.67 73.77 1.48 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.06 -1.025 . . . . 0.0 110.257 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -78.05 -24.63 47.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.237 -0.914 . . . . 0.0 110.545 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.618 ' OD2' 'CA ' ' A' ' 151' ' ' ' CA' . 2.5 p30 -70.16 -28.99 65.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.315 -0.865 . . . . 0.0 110.402 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.454 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 77.93 61.45 2.53 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.438 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 16.6 p-10 -125.24 -34.94 2.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.257 -1.143 . . . . 0.0 110.432 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.432 ' C ' ' CG ' ' A' ' 99' ' ' TYR . . . 108.06 16.71 11.94 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.779 -1.201 . . . . 0.0 110.374 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.432 ' CG ' ' C ' ' A' ' 98' ' ' GLY . 35.4 m-85 -147.48 134.57 20.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.985 -1.303 . . . . 0.0 110.002 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.462 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 17.9 mt -90.48 120.61 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.809 -1.182 . . . . 0.0 109.664 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.8 t -96.9 171.69 8.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.402 -0.812 . . . . 0.0 110.056 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.01 -46.84 61.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.87 . . . . 0.0 110.284 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.05 -55.15 22.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.298 -0.876 . . . . 0.0 110.439 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -55.42 -50.06 70.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.259 -0.9 . . . . 0.0 110.613 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.421 HD23 ' HE3' ' A' ' 124' ' ' MET . 3.2 tt -49.92 -34.19 19.71 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.199 -0.938 . . . . 0.0 110.431 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.44 ' O ' ' CG2' ' A' ' 110' ' ' THR . 54.9 ttp180 -74.25 -36.76 63.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.153 -0.967 . . . . 0.0 110.001 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -74.49 -15.4 60.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.852 . . . . 0.0 110.075 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.564 ' CG1' ' CE1' ' A' ' 92' ' ' PHE . 77.1 t -85.91 -47.93 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.247 -0.908 . . . . 0.0 110.132 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.5 mmt -61.48 -32.72 72.74 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.965 . . . . 0.0 109.974 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.44 ' CG2' ' O ' ' A' ' 106' ' ' ARG . 66.7 p -59.93 -30.43 69.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.164 -0.96 . . . . 0.0 109.238 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -85.79 -31.08 22.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.555 -0.716 . . . . 0.0 109.974 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 77.5 mt -87.47 16.49 5.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 110.093 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 114' ' ' GLU . . . 61.91 83.27 0.07 OUTLIER Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.416 ' OE1' ' CA ' ' A' ' 114' ' ' GLU . 1.3 mm-40 -158.31 133.42 8.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.187 -1.184 . . . . 0.0 110.464 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -95.38 104.19 16.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 110.028 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.7 mt -136.06 117.43 14.66 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.278 -0.888 . . . . 0.0 110.504 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 38.2 m -71.44 172.81 8.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.314 -0.866 . . . . 0.0 109.91 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -62.13 -31.8 72.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 110.222 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -69.59 -48.71 59.25 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.247 -0.908 . . . . 0.0 110.205 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -57.37 -50.81 71.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.127 -0.983 . . . . 0.0 109.935 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 89.3 t -55.35 -49.56 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.401 -0.812 . . . . 0.0 110.177 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.406 ' OD1' ' HD2' ' A' ' 126' ' ' ARG . 8.5 t70 -57.42 -31.87 66.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 110.066 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -70.05 -32.0 69.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.201 -0.937 . . . . 0.0 109.911 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.421 ' HE3' HD23 ' A' ' 105' ' ' LEU . 84.8 mtp -67.9 -44.71 76.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.31 -0.869 . . . . 0.0 109.646 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 30.1 mm -62.51 -37.57 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.412 -0.805 . . . . 0.0 110.345 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.406 ' HD2' ' OD1' ' A' ' 122' ' ' ASP . 65.8 mtp180 -70.4 -37.05 74.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.24 -0.913 . . . . 0.0 110.252 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.414 ' HA ' ' OE1' ' A' ' 127' ' ' GLU . 6.0 mm-40 -71.39 -27.26 63.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.185 -0.947 . . . . 0.0 109.895 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.66 -27.29 29.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.38 -0.825 . . . . 0.0 109.992 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.403 ' OD1' ' OD1' ' A' ' 131' ' ' ASP . 11.9 t0 -65.15 94.73 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.0 110.008 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 68.7 mt -67.8 -31.42 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.225 -0.922 . . . . 0.0 110.231 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 19.5 p30 -100.84 -17.41 16.89 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.263 -0.898 . . . . 0.0 110.355 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 69.84 62.56 3.75 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.411 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 82.2 m-20 -101.56 -41.29 6.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.091 -1.241 . . . . 0.0 110.109 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.26 -22.06 1.09 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -142.57 162.75 34.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -1.148 . . . . 0.0 110.032 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.462 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 41.0 t -88.92 143.99 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.211 -0.93 . . . . 0.0 110.504 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -112.26 151.67 29.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 109.806 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -46.18 -37.15 6.68 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.194 -0.941 . . . . 0.0 110.459 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.411 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 5.8 mm-40 -72.15 -45.25 61.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.232 -0.917 . . . . 0.0 110.495 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' A' ' 144' ' ' MET . 55.7 mt-10 -62.24 -23.31 66.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.127 -0.983 . . . . 0.0 110.438 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.56 ' CD1' ' CE ' ' A' ' 144' ' ' MET . 23.2 t80 -81.21 -39.78 24.87 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.321 -0.862 . . . . 0.0 110.544 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 65.6 t -73.98 -21.83 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.239 -0.913 . . . . 0.0 110.564 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 68.9 mm-40 -88.27 -40.17 13.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.167 -0.958 . . . . 0.0 111.051 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.56 ' CE ' ' CD1' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -72.24 -20.47 61.54 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.865 -1.147 . . . . 0.0 110.943 -179.229 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.508 ' HE3' ' CZ ' ' A' ' 141' ' ' PHE . 19.7 ttm -90.43 -68.07 0.81 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.098 -1.001 . . . . 0.0 110.547 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 68.7 p -58.9 -53.71 55.29 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.099 -1.0 . . . . 0.0 110.283 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.86 140.74 53.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.916 . . . . 0.0 110.372 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 91.9 mttt . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.196 179.928 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . 0.438 'CA ' ' HB2' ' A' ' 24' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . 0.618 'CA ' ' OD2' ' A' ' 95' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' WW7 . . . . . 0.445 ' H3 ' ' CZ ' ' A' ' 19' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' WW7 . . . . . 0.546 ' H3 ' ' CD2' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.289 0.566 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -138.57 69.81 1.38 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.881 . . . . 0.0 110.075 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -63.0 -75.1 0.08 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.309 -0.869 . . . . 0.0 110.399 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.423 HD22 ' OE1' ' A' ' 7' ' ' GLU . 1.6 mp -67.31 167.98 11.41 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.14 -0.975 . . . . 0.0 110.074 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 t -167.43 -55.64 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.139 -0.976 . . . . 0.0 110.685 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -90.97 -18.38 24.76 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.864 -1.147 . . . . 0.0 110.174 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.423 ' OE1' HD22 ' A' ' 4' ' ' LEU . 8.4 mt-10 -74.52 -40.49 61.73 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.451 -0.78 . . . . 0.0 110.701 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.4 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 54.0 mt-30 -67.66 -51.59 47.98 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.144 -0.972 . . . . 0.0 110.329 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.0 mt -57.72 -48.99 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.075 -1.016 . . . . 0.0 109.522 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.3 -32.11 68.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 109.74 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 37.0 tt0 -59.81 -51.19 70.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.914 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -58.66 -34.11 70.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.291 -0.881 . . . . 0.0 109.662 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.6 -46.73 86.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.377 -0.827 . . . . 0.0 110.466 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -59.49 -45.69 90.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.226 -0.921 . . . . 0.0 110.451 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.415 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -60.15 -41.55 92.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.957 . . . . 0.0 110.1 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -58.52 -56.21 25.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.276 -0.89 . . . . 0.0 110.141 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.2 m -53.36 -29.17 32.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.149 -0.969 . . . . 0.0 109.668 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.424 ' CD2' ' C ' ' A' ' 18' ' ' LEU . 1.8 tt -66.43 -41.2 89.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.39 -0.819 . . . . 0.0 109.782 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.48 ' CE2' ' H3 ' ' A' ' 153' ' ' WW7 . 27.7 m-85 -77.61 -64.81 1.06 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.319 -0.863 . . . . 0.0 110.338 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -49.23 106.04 0.1 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.285 -0.884 . . . . 0.0 110.383 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -110.35 15.19 22.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.187 -0.946 . . . . 0.0 111.014 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.422 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 9.3 p-10 -126.19 -42.81 1.83 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.012 -1.055 . . . . 0.0 110.423 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.69 19.69 6.01 Favored Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.513 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.422 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 57.1 p-10 -91.39 -8.1 48.89 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.965 -1.314 . . . . 0.0 110.537 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.464 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 70.85 42.37 60.92 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.464 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 9.3 p -158.34 148.8 20.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.242 -1.152 . . . . 0.0 109.943 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.6 mt -108.81 105.36 18.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.182 -0.949 . . . . 0.0 109.937 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.457 ' HA ' ' CG2' ' A' ' 62' ' ' THR . 3.5 m -96.65 -175.74 3.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.413 -0.804 . . . . 0.0 109.747 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.44 ' HA ' HD23 ' A' ' 48' ' ' LEU . 23.5 p -72.1 -29.32 63.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.0 110.539 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -65.4 -62.06 1.75 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 0.0 110.366 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -57.12 -44.92 83.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.272 -0.893 . . . . 0.0 110.05 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.452 HD21 ' CG ' ' A' ' 48' ' ' LEU . 2.9 tp -63.85 -25.18 68.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -0.904 . . . . 0.0 109.665 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.14 -46.73 69.41 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.44 ' O ' ' CB ' ' A' ' 38' ' ' SER . 87.1 m -72.69 -21.77 61.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.311 -1.111 . . . . 0.0 109.498 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.476 HG13 ' CD1' ' A' ' 19' ' ' PHE . 58.0 t -71.14 -42.45 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.431 -0.793 . . . . 0.0 109.811 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.447 ' HE2' ' HE2' ' A' ' 51' ' ' MET . 26.0 mmt -75.46 -30.03 59.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 110.457 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -88.47 -9.38 52.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.156 -0.965 . . . . 0.0 110.301 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 34' ' ' THR . 47.7 t -101.09 8.84 42.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.09 -1.006 . . . . 0.0 110.542 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.424 HD13 ' O ' ' A' ' 35' ' ' VAL . 90.9 mt -127.68 -81.37 0.6 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.139 -0.976 . . . . 0.0 110.207 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.466 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . -156.48 36.73 0.59 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.466 ' NE2' ' O ' ' A' ' 40' ' ' GLY . 4.9 mp0 -140.09 171.92 13.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.504 -0.998 . . . . 0.0 109.851 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.468 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 23.8 p30 -155.87 52.55 0.68 Allowed Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.023 -1.048 . . . . 0.0 111.048 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.468 ' HD3' ' N ' ' A' ' 42' ' ' ASN . 50.0 Cg_endo -77.68 160.81 31.19 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.671 1.353 . . . . 0.0 110.229 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.0 p -92.45 -142.22 0.2 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.276 -0.89 . . . . 0.0 109.883 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -105.59 -32.22 8.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.937 -1.102 . . . . 0.0 110.053 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.96 -67.7 0.54 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -0.938 . . . . 0.0 109.655 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -49.83 -38.7 36.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 109.441 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.452 ' CG ' HD21 ' A' ' 32' ' ' LEU . 6.4 tt -57.07 -48.88 77.48 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.45 -0.781 . . . . 0.0 109.342 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -51.51 -42.07 61.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.434 -0.791 . . . . 0.0 109.551 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.39 -42.78 99.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.871 . . . . 0.0 109.816 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.447 ' HE2' ' HE2' ' A' ' 36' ' ' MET . 18.5 ttp -62.3 -19.8 63.66 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.283 -0.885 . . . . 0.0 109.353 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.4 mt -89.18 -24.52 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.426 -0.796 . . . . 0.0 109.887 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -67.97 -35.3 78.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.302 -0.874 . . . . 0.0 110.154 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 51' ' ' MET . 17.2 pt-20 -73.73 -33.75 64.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.224 -0.922 . . . . 0.0 110.04 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.433 ' CG1' ' SD ' ' A' ' 71' ' ' MET . 99.9 t -77.1 -68.78 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.285 -0.885 . . . . 0.0 109.806 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.429 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 64.1 t0 -47.0 125.72 7.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.276 -0.89 . . . . 0.0 110.051 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.67 28.78 5.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.217 -0.927 . . . . 0.0 110.206 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.416 ' HB2' ' OD1' ' A' ' 60' ' ' ASN . 40.5 m-20 -122.76 -62.08 1.39 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.405 -0.809 . . . . 0.0 110.05 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.82 36.16 0.6 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.416 ' OD1' ' HB2' ' A' ' 58' ' ' ASP . 6.8 m120 -103.85 -40.67 6.15 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.176 -1.19 . . . . 0.0 110.107 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 123.87 -14.79 7.97 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.457 ' CG2' ' HA ' ' A' ' 28' ' ' THR . 75.2 p -130.97 164.47 25.28 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.147 -1.208 . . . . 0.0 110.446 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.41 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 80.1 mt -110.21 122.15 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.246 -0.909 . . . . 0.0 110.237 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.438 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 55.0 m-20 -81.38 -168.32 1.81 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.307 -0.871 . . . . 0.0 110.399 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.532 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 42.4 t80 -72.99 -42.46 7.31 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 111.246 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 45.8 Cg_endo -75.76 -28.19 8.18 Favored 'Trans proline' 0 C--N 1.325 -0.703 0 O-C-N 123.035 1.018 . . . . 0.0 109.821 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.429 ' OE2' ' HA ' ' A' ' 56' ' ' ASP . 40.7 tt0 -73.52 -24.03 60.1 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.429 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 10.3 t80 -84.73 -43.01 14.68 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.429 0.633 . . . . 0.0 110.145 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.439 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 3.7 tt -72.3 -18.28 61.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.193 -0.942 . . . . 0.0 110.128 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.5 m -90.3 -43.04 10.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.125 -0.984 . . . . 0.0 110.493 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.47 ' HG3' ' N ' ' A' ' 72' ' ' MET . 6.5 ptt? -64.09 -40.99 97.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.145 -0.972 . . . . 0.0 110.518 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.47 ' N ' ' HG3' ' A' ' 71' ' ' MET . 32.7 mtt -84.32 -9.66 58.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.099 -1.001 . . . . 0.0 110.683 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -90.6 -25.02 20.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.024 -1.047 . . . . 0.0 110.618 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.43 52.16 0.8 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.215 -0.928 . . . . 0.0 110.732 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -94.73 -3.7 48.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.068 -1.02 . . . . 0.0 110.635 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 22.9 mmt -146.54 -49.51 0.2 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.065 -1.022 . . . . 0.0 110.434 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -109.42 -171.18 1.79 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.106 -0.996 . . . . 0.0 110.342 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -140.52 20.25 2.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 110.029 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.402 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 97.8 m -60.64 91.81 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.244 -0.91 . . . . 0.0 110.402 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 79' ' ' THR . 22.4 m-20 -152.73 125.62 8.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.118 -0.989 . . . . 0.0 110.62 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.1 m -89.57 -153.28 0.27 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.247 -0.908 . . . . 0.0 109.915 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 33.0 mt-10 -150.64 146.49 26.53 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.218 -0.926 . . . . 0.0 110.652 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 82' ' ' GLU . 11.5 mt-10 -154.61 87.37 1.16 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.558 -0.714 . . . . 0.0 109.863 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.8 -25.12 68.04 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.326 -0.859 . . . . 0.0 110.409 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.42 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 28.7 mt -68.0 -59.39 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.252 -0.905 . . . . 0.0 110.388 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.4 ttm-85 -53.02 -43.5 66.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.059 -1.025 . . . . 0.0 109.448 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -54.61 -43.83 72.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.361 -0.837 . . . . 0.0 109.629 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 85' ' ' ILE . . . -58.47 -37.73 76.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.35 -0.843 . . . . 0.0 109.667 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -65.03 -28.93 69.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.063 -1.023 . . . . 0.0 109.897 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -70.45 -58.95 3.16 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.494 -0.754 . . . . 0.0 111.118 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.1 m -62.94 -43.33 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.14 -0.975 . . . . 0.0 110.981 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.543 ' CD2' ' H3 ' ' A' ' 154' ' ' WW7 . 18.0 m-85 -69.72 -22.42 63.4 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.973 -1.08 . . . . 0.0 110.263 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.411 ' OD1' ' HA2' ' A' ' 98' ' ' GLY . 11.9 t70 -147.28 81.96 1.54 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.963 . . . . 0.0 110.483 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.6 pttt -109.68 47.43 0.94 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.355 -0.841 . . . . 0.0 109.907 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 1.8 p30 -115.31 -31.69 5.88 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.273 -0.892 . . . . 0.0 110.618 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.46 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 138.33 -54.09 0.7 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.279 -1.438 . . . . 0.0 110.959 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -48.77 -34.46 12.29 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 120.947 -1.325 . . . . 0.0 110.846 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.469 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 80.28 33.01 33.27 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.963 -1.113 . . . . 0.0 110.406 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.469 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 20.7 m-85 -130.2 127.58 39.95 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.951 -1.323 . . . . 0.0 109.884 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.511 ' CD1' ' CE1' ' A' ' 141' ' ' PHE . 8.8 mt -76.01 110.39 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.962 -1.086 . . . . 0.0 110.167 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.1 t -93.6 165.59 12.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.065 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.51 -41.39 96.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.291 -0.88 . . . . 0.0 110.341 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.4 -53.36 49.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.186 -0.946 . . . . 0.0 110.037 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -51.75 -37.73 52.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.426 -0.796 . . . . 0.0 110.103 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.0 tt -69.36 -35.2 75.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.4 -0.813 . . . . 0.0 110.121 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.419 ' O ' ' CG2' ' A' ' 110' ' ' THR . 58.0 ttp180 -66.36 -26.69 67.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.483 -0.76 . . . . 0.0 110.254 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -85.01 -31.54 23.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.281 -0.887 . . . . 0.0 110.514 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.2 t -76.37 -30.94 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.166 -0.959 . . . . 0.0 110.452 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.463 ' HE3' ' CZ ' ' A' ' 92' ' ' PHE . 23.4 mmt -75.99 -26.57 56.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.104 -0.998 . . . . 0.0 110.18 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' A' ' 106' ' ' ARG . 45.4 p -68.67 -40.61 80.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.27 -0.894 . . . . 0.0 110.146 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -80.01 -41.54 25.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.195 -0.94 . . . . 0.0 110.045 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.2 mt -47.63 -25.47 1.18 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.255 -0.903 . . . . 0.0 110.204 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.44 20.8 8.34 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -123.19 110.0 14.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.23 -1.159 . . . . 0.0 110.3 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.95 107.25 9.16 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.341 -0.85 . . . . 0.0 110.285 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.9 -174.85 2.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.184 -0.947 . . . . 0.0 110.19 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.5 m -136.8 166.65 23.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 110.209 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -55.07 -33.22 62.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -0.94 . . . . 0.0 110.359 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.18 -47.24 80.57 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.328 -0.857 . . . . 0.0 110.784 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -65.4 -58.39 5.98 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.118 -0.989 . . . . 0.0 110.613 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.2 t -49.64 -41.24 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.145 -0.972 . . . . 0.0 110.395 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 126' ' ' ARG . 38.4 t70 -64.39 -39.08 93.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.167 -0.958 . . . . 0.0 110.163 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -66.91 -30.06 70.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.223 -0.923 . . . . 0.0 110.152 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 78.7 mtp -75.83 -62.99 1.41 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.178 -0.951 . . . . 0.0 110.66 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.432 HD11 HG22 ' A' ' 136' ' ' VAL . 26.0 mm -52.05 -29.23 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.156 -0.965 . . . . 0.0 110.67 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 122' ' ' ASP . 73.1 mtp85 -71.75 -56.87 4.98 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.051 -1.031 . . . . 0.0 110.349 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -69.45 -8.28 45.4 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.197 -0.939 . . . . 0.0 110.361 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.411 ' HB3' ' H6 ' ' A' ' 154' ' ' WW7 . . . -98.83 -24.66 14.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -0.919 . . . . 0.0 110.104 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -83.51 83.65 7.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.075 -1.016 . . . . 0.0 109.915 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.5 mt -45.41 -69.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.33 -0.856 . . . . 0.0 110.688 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.8 p30 -60.91 -24.41 65.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.221 -0.924 . . . . 0.0 110.366 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.421 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 62.51 62.64 5.37 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -106.61 -31.51 8.45 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.24 -1.153 . . . . 0.0 110.205 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 161.96 -49.11 0.34 Allowed Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.13 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.463 ' CB ' ' HB3' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -123.42 170.43 10.36 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.033 -1.274 . . . . 0.0 110.107 -179.363 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.432 HG22 HD11 ' A' ' 125' ' ' ILE . 47.4 t -105.97 97.8 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.379 -0.826 . . . . 0.0 110.002 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -70.19 179.43 2.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.332 -0.855 . . . . 0.0 110.355 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -61.65 -41.43 97.5 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.311 -0.868 . . . . 0.0 111.268 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -53.15 -52.17 59.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.028 -1.045 . . . . 0.0 110.199 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -67.4 -21.25 65.6 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.275 -0.891 . . . . 0.0 109.879 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.511 ' CE1' ' CD1' ' A' ' 100' ' ' ILE . 1.9 t80 -77.54 -23.33 50.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.359 -0.838 . . . . 0.0 110.414 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 80.4 t -88.43 -23.05 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.197 -0.939 . . . . 0.0 110.511 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -91.65 -39.02 12.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.296 -0.877 . . . . 0.0 110.799 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.455 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -67.44 -17.75 64.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.981 -1.074 . . . . 0.0 110.358 -179.651 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.455 ' CE ' ' HE2' ' A' ' 144' ' ' MET . 52.2 mtt -88.13 -55.06 3.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.118 -0.989 . . . . 0.0 109.887 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.409 ' O ' HG21 ' A' ' 146' ' ' THR . 2.7 t -116.55 117.09 28.91 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.508 -0.745 . . . . 0.0 110.069 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -117.13 114.8 24.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.163 -0.961 . . . . 0.0 110.441 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.217 179.947 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' WW7 . . . . . 0.523 H121 H161 ' A' ' 153' ' ' WW7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' WW7 . . . . . 0.543 ' H3 ' ' CD2' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.288 0.566 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -83.62 131.55 34.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.163 -0.961 . . . . 0.0 110.209 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -97.46 133.22 42.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.22 -0.925 . . . . 0.0 110.234 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 4' ' ' LEU . 0.5 OUTLIER -156.93 143.73 18.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 110.464 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.3 p -125.65 9.36 7.69 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.194 -0.941 . . . . 0.0 110.191 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.409 ' O ' ' HB1' ' A' ' 10' ' ' ALA . 2.2 mt-10 -73.25 -34.84 66.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.08 -1.012 . . . . 0.0 109.522 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -77.22 -33.03 56.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.402 -0.812 . . . . 0.0 109.457 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -67.57 -59.13 3.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.448 -0.782 . . . . 0.0 110.285 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.4 mt -59.71 -34.72 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 109.587 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 6' ' ' GLU . . . -64.28 -32.38 73.96 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.267 -0.896 . . . . 0.0 108.988 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -66.91 -51.75 51.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.459 -0.775 . . . . 0.0 109.426 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -59.46 -29.99 68.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.618 -0.676 . . . . 0.0 109.751 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -66.26 -55.99 13.44 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.4 -0.812 . . . . 0.0 110.191 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.411 ' O ' ' OG ' ' A' ' 17' ' ' SER . 25.0 tt0 -51.01 -38.25 50.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.16 -0.962 . . . . 0.0 109.969 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.514 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -62.13 -54.31 42.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.026 -1.046 . . . . 0.0 109.886 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.47 ' CE1' HD13 ' A' ' 27' ' ' ILE . 18.5 t80 -56.7 -26.9 57.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.294 -0.879 . . . . 0.0 110.687 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 14' ' ' GLU . 25.0 p -75.98 -35.06 59.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.179 -0.95 . . . . 0.0 109.888 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.1 tt -69.51 -26.8 64.71 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.313 -0.867 . . . . 0.0 109.644 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 30.4 m-85 -86.08 -69.19 0.68 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.375 -0.828 . . . . 0.0 109.938 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -56.18 105.07 0.17 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.312 -0.868 . . . . 0.0 110.283 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -105.75 -38.06 6.51 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.312 -0.867 . . . . 0.0 110.665 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -70.27 -26.11 63.67 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.141 -0.975 . . . . 0.0 110.505 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.89 106.44 0.83 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 7.7 p-10 -169.64 -39.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -1.177 . . . . 0.0 110.263 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.407 ' O ' HG21 ' A' ' 26' ' ' THR . . . 112.72 12.57 12.59 Favored Glycine 0 N--CA 1.495 2.632 0 C-N-CA 119.93 -1.129 . . . . 0.0 110.37 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.411 ' OG1' ' OD2' ' A' ' 24' ' ' ASP . 54.8 p -139.96 164.97 28.59 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.044 -1.269 . . . . 0.0 110.267 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.47 HD13 ' CE1' ' A' ' 16' ' ' PHE . 40.8 mt -123.47 120.56 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.135 -0.978 . . . . 0.0 110.191 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.2 m -113.75 -179.08 3.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.35 -0.844 . . . . 0.0 110.292 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.1 p -68.84 -27.49 65.88 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.267 -0.896 . . . . 0.0 110.754 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.3 mtmm -66.31 -61.34 2.06 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.059 -1.026 . . . . 0.0 109.929 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -60.91 -58.83 6.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.056 -1.028 . . . . 0.0 109.541 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.469 HD23 ' CD1' ' A' ' 52' ' ' ILE . 0.6 OUTLIER -52.1 -26.73 11.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 109.708 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.44 -52.42 46.69 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 97.2 m -65.77 -23.99 66.84 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.203 -1.174 . . . . 0.0 109.879 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.486 HG13 ' CD1' ' A' ' 19' ' ' PHE . 46.5 t -66.34 -42.83 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.442 -0.786 . . . . 0.0 109.904 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.422 ' HE2' ' CE ' ' A' ' 51' ' ' MET . 61.5 mtt -89.17 -11.63 43.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.376 -0.828 . . . . 0.0 110.379 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -89.85 -21.24 22.65 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.163 -0.961 . . . . 0.0 110.186 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.9 m -109.52 -22.51 11.95 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.197 -0.939 . . . . 0.0 110.432 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.46 66.1 1.08 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.147 -0.971 . . . . 0.0 110.637 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.02 51.64 0.16 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -48.08 102.26 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.236 -1.155 . . . . 0.0 110.304 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.523 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 2.4 t30 -156.67 -65.93 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.885 . . . . 0.0 110.234 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.523 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 46.3 Cg_endo -72.23 170.42 19.16 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.316 1.166 . . . . 0.0 110.311 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.406 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 10.8 t -119.39 -149.09 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.623 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -95.81 -31.84 12.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.831 -1.168 . . . . 0.0 110.115 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.64 -67.65 0.61 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.23 -0.919 . . . . 0.0 110.089 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -49.0 -31.55 7.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.135 -0.978 . . . . 0.0 109.744 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.43 HD12 ' CD2' ' A' ' 32' ' ' LEU . 9.1 tt -63.96 -51.7 63.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.92 . . . . 0.0 109.209 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.7 tm0? -49.5 -41.47 40.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.459 -0.776 . . . . 0.0 109.605 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -64.71 -39.46 93.69 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.36 -0.837 . . . . 0.0 109.709 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.428 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 25.4 ttp -70.27 -13.18 62.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.158 -0.963 . . . . 0.0 109.85 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.469 ' CD1' HD23 ' A' ' 32' ' ' LEU . 29.7 mm -84.75 -35.31 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.218 -0.926 . . . . 0.0 109.537 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -60.7 -39.88 90.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.463 -0.773 . . . . 0.0 110.504 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.456 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 12.3 pt-20 -69.39 -35.95 76.3 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.128 -0.983 . . . . 0.0 110.596 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.456 ' N ' ' HG3' ' A' ' 54' ' ' GLU . 79.6 t -71.39 -28.39 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.064 -1.023 . . . . 0.0 110.062 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -96.8 117.3 30.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.37 -0.832 . . . . 0.0 110.448 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.06 25.95 10.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -0.843 . . . . 0.0 109.773 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -106.61 -68.13 0.9 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.485 -0.759 . . . . 0.0 110.167 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.38 -14.27 2.06 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.421 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 27.7 p-10 -69.78 -14.11 62.61 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.15 -1.206 . . . . 0.0 110.287 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.445 ' O ' ' CG2' ' A' ' 62' ' ' THR . . . 79.24 23.86 62.42 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.011 -1.09 . . . . 0.0 110.545 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.445 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 7.1 p -156.44 167.65 29.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.996 -1.296 . . . . 0.0 110.414 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.451 HD13 ' CG1' ' A' ' 55' ' ' VAL . 82.9 mt -108.31 169.74 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.182 -0.949 . . . . 0.0 110.596 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 46.7 m-20 -131.44 -163.02 1.28 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.31 -0.869 . . . . 0.0 109.848 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.535 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 40.1 t80 -82.51 -43.26 0.95 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.068 -1.02 . . . . 0.0 111.357 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 47.2 Cg_endo -73.15 -28.53 12.62 Favored 'Trans proline' 0 N--CA 1.48 0.68 0 O-C-N 123.091 1.048 . . . . 0.0 110.304 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -78.34 -23.73 46.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.105 -0.997 . . . . 0.0 109.225 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 24.3 t80 -75.91 -48.64 20.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.624 -0.672 . . . . 0.0 110.201 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.402 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 2.8 tt -75.71 -21.49 57.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.353 -0.842 . . . . 0.0 110.349 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.7 m -89.57 -21.86 22.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -0.964 . . . . 0.0 110.713 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.455 ' HG3' ' N ' ' A' ' 72' ' ' MET . 8.1 ptt? -88.86 -36.08 16.2 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.964 -1.085 . . . . 0.0 110.515 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.455 ' N ' ' HG3' ' A' ' 71' ' ' MET . 52.5 mtt -84.72 -23.55 29.26 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.188 -0.945 . . . . 0.0 110.0 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 69' ' ' LEU . . . -83.83 -52.0 6.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.368 -0.832 . . . . 0.0 110.04 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.8 mpp_? -110.24 63.79 0.61 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.417 -0.802 . . . . 0.0 110.039 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -89.51 91.14 8.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.422 -0.799 . . . . 0.0 110.425 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.3 ttt -84.86 140.69 30.98 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.173 -0.954 . . . . 0.0 110.116 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.8 mtmt -86.52 107.21 18.0 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.184 -0.948 . . . . 0.0 110.44 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -153.26 128.38 9.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 0.0 110.21 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.1 m -126.96 148.12 50.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.218 -0.926 . . . . 0.0 110.2 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -167.31 99.01 0.51 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.286 -0.884 . . . . 0.0 110.02 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.5 t -138.26 178.15 7.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.131 -0.981 . . . . 0.0 110.394 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -151.11 99.3 2.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.259 -0.901 . . . . 0.0 110.206 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.401 ' OE2' ' OH ' ' A' ' 138' ' ' TYR . 23.4 tt0 -171.5 97.68 0.19 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.151 -0.968 . . . . 0.0 110.157 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -60.28 -30.92 69.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.446 -0.784 . . . . 0.0 110.361 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 40.7 mt -51.71 -34.93 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.112 -0.993 . . . . 0.0 109.733 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -58.08 -43.89 87.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.944 . . . . 0.0 109.398 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -62.23 -33.59 74.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.424 -0.798 . . . . 0.0 109.784 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.512 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -65.92 -66.48 0.54 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.416 -0.802 . . . . 0.0 109.889 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -49.62 -26.62 3.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.927 . . . . 0.0 110.308 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.412 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 16.0 tpt180 -68.78 -45.23 71.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.148 -0.97 . . . . 0.0 110.255 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' A' ' 88' ' ' ALA . 34.0 m -76.27 -15.79 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.283 -0.885 . . . . 0.0 110.443 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.525 ' CZ ' ' H2 ' ' A' ' 154' ' ' WW7 . 23.0 m-85 -90.85 -18.38 24.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.132 -0.98 . . . . 0.0 110.491 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -128.82 44.32 2.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.099 -1.001 . . . . 0.0 110.077 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 20.4 ptmt -106.46 47.62 0.87 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 110.403 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.414 ' OD2' ' OE1' ' A' ' 104' ' ' GLU . 2.8 p30 -116.88 -22.57 8.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.237 -0.915 . . . . 0.0 110.043 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.23 29.33 4.03 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -105.78 -71.09 0.76 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.405 -1.056 . . . . 0.0 110.091 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 151.9 -36.48 0.84 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -134.12 169.59 16.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -1.16 . . . . 0.0 110.133 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.5 mt -73.1 131.29 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 109.858 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.421 ' CB ' ' OE2' ' A' ' 104' ' ' GLU . 36.5 t -113.83 172.26 7.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.47 -0.769 . . . . 0.0 110.023 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.413 ' O ' HG12 ' A' ' 121' ' ' VAL . . . -68.65 -48.06 64.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -0.947 . . . . 0.0 110.144 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.89 -52.35 66.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.185 -0.947 . . . . 0.0 110.247 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.421 ' OE2' ' CB ' ' A' ' 101' ' ' SER . 46.2 mt-10 -48.97 -54.76 14.22 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.376 -0.827 . . . . 0.0 110.577 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.454 HD22 ' CG ' ' A' ' 109' ' ' MET . 5.2 tt -61.25 -30.33 70.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.379 -0.826 . . . . 0.0 110.763 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -67.24 -38.89 85.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.187 -0.945 . . . . 0.0 110.583 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -84.04 -14.2 51.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 110.472 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.409 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 71.8 t -84.29 -29.15 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.236 -0.915 . . . . 0.0 110.527 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.454 ' CG ' HD22 ' A' ' 105' ' ' LEU . 26.4 mmt -81.81 -46.65 13.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.946 . . . . 0.0 110.529 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.2 p -50.44 -32.97 19.34 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 110.268 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -86.16 -48.81 8.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.128 -0.982 . . . . 0.0 110.372 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 22.6 mt -47.07 -32.46 4.11 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.138 -0.976 . . . . 0.0 110.509 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.48 38.4 0.92 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -119.06 167.4 11.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.341 -1.094 . . . . 0.0 110.069 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -121.41 94.49 4.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.889 . . . . 0.0 110.061 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.5 mt -128.58 151.94 48.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.281 -0.887 . . . . 0.0 110.228 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 91.4 m -99.77 172.39 7.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.868 . . . . 0.0 110.002 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.45 -62.89 1.41 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.242 -0.911 . . . . 0.0 110.636 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -52.54 -41.4 63.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.143 -0.973 . . . . 0.0 110.315 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.422 ' OE1' ' HA ' ' A' ' 120' ' ' GLU . 6.4 mm-40 -52.08 -50.63 61.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.118 -0.989 . . . . 0.0 110.017 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 102' ' ' ALA . 63.8 t -57.54 -43.9 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.16 -0.962 . . . . 0.0 109.821 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -59.58 -28.53 67.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.297 -0.877 . . . . 0.0 109.729 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 24.4 tt0 -73.27 -37.44 66.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.352 -0.842 . . . . 0.0 109.863 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 74.9 mtp -66.4 -39.92 89.3 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.274 -0.891 . . . . 0.0 109.821 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 31.8 mm -69.22 -38.61 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -0.906 . . . . 0.0 110.188 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -62.77 -46.33 88.52 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.257 -0.902 . . . . 0.0 110.228 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -62.47 -38.84 91.41 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.292 -0.88 . . . . 0.0 110.162 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.14 -16.0 61.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -0.861 . . . . 0.0 110.21 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.411 ' OD1' ' OD1' ' A' ' 131' ' ' ASP . 57.7 t0 -87.78 60.95 6.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.365 -0.835 . . . . 0.0 110.129 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.45 HG13 ' N ' ' A' ' 131' ' ' ASP . 18.0 pt -56.02 -42.26 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.435 -0.791 . . . . 0.0 111.409 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.45 ' N ' HG13 ' A' ' 130' ' ' ILE . 47.8 p-10 -72.74 -18.99 61.46 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.037 -1.039 . . . . 0.0 111.125 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.34 72.19 0.88 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 33.7 p30 -126.15 -16.99 5.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.406 -1.055 . . . . 0.0 110.873 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.465 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 122.96 -49.89 0.87 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.409 ' NE2' ' C ' ' A' ' 135' ' ' GLN . 0.0 OUTLIER -119.18 164.7 15.19 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.086 -1.243 . . . . 0.0 110.772 -179.611 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.5 t -102.63 127.0 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.303 -0.873 . . . . 0.0 110.053 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -97.22 -172.12 2.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.953 -1.092 . . . . 0.0 110.459 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.401 ' OH ' ' OE2' ' A' ' 83' ' ' GLU . 31.0 t80 -64.4 -62.47 1.58 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.334 -0.854 . . . . 0.0 111.621 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -43.87 -53.53 5.99 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.239 -0.913 . . . . 0.0 111.141 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -56.77 -39.37 73.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.898 -1.126 . . . . 0.0 110.399 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.524 ' CE1' ' CE ' ' A' ' 145' ' ' MET . 20.2 t80 -66.82 -27.09 67.27 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.391 -0.818 . . . . 0.0 111.133 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 57.6 t -90.06 -20.67 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.024 -1.047 . . . . 0.0 110.77 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.506 ' NE2' ' CB ' ' A' ' 147' ' ' ALA . 1.4 mm-40 -83.81 -30.04 26.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.212 -0.93 . . . . 0.0 110.824 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.47 ' CE ' ' CD1' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -90.01 -13.19 36.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.112 -0.993 . . . . 0.0 110.608 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.524 ' CE ' ' CE1' ' A' ' 141' ' ' PHE . 30.0 ttm -89.98 -27.99 19.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.913 . . . . 0.0 110.537 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 60.0 p -121.77 -50.82 2.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.134 -0.979 . . . . 0.0 110.194 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.506 ' CB ' ' NE2' ' A' ' 143' ' ' GLN . . . -75.06 126.88 31.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.958 . . . . 0.0 110.042 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 90.6 mttt . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.252 -179.806 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' WW7 . . . . . 0.469 ' H2 ' ' C11' ' A' ' 153' ' ' WW7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' WW7 . . . . . 0.525 ' H2 ' ' CZ ' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.268 0.556 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -67.2 109.08 2.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.168 -0.957 . . . . 0.0 110.215 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -148.42 151.77 35.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.286 -0.884 . . . . 0.0 110.167 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 68.1 mt -57.93 129.76 43.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -0.943 . . . . 0.0 110.311 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 97.7 m -161.87 -45.32 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 109.798 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 10' ' ' ALA . 1.0 OUTLIER -88.21 -15.73 35.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.329 -0.857 . . . . 0.0 109.931 179.555 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -74.24 -66.07 0.77 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.28 -0.888 . . . . 0.0 109.814 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -54.77 -58.75 6.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.23 -0.919 . . . . 0.0 109.997 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 28.6 mt -47.73 -49.14 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.124 -0.985 . . . . 0.0 110.062 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 13' ' ' LYS . . . -52.83 -41.6 64.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.275 -0.89 . . . . 0.0 110.2 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -61.0 -41.44 96.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.879 . . . . 0.0 110.132 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -64.06 -30.17 71.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.279 -0.888 . . . . 0.0 109.734 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.434 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 30.1 mtpt -68.99 -38.97 79.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.535 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.31 -45.19 95.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.313 -0.867 . . . . 0.0 109.341 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.85 -44.8 86.77 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.317 -0.865 . . . . 0.0 109.452 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -56.22 -42.15 76.8 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.315 -0.865 . . . . 0.0 109.633 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.4 t -59.1 -42.63 90.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.428 -0.795 . . . . 0.0 109.641 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.8 tt -59.79 -29.36 68.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.464 -0.772 . . . . 0.0 109.456 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.564 ' CD1' ' CG1' ' A' ' 35' ' ' VAL . 5.8 m-30 -88.24 -18.29 28.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.464 -0.772 . . . . 0.0 110.043 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -104.17 64.06 0.76 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.397 -0.814 . . . . 0.0 109.35 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.475 ' HE3' ' CG2' ' A' ' 34' ' ' THR . 53.0 mttm -44.73 -52.96 7.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.586 -0.696 . . . . 0.0 111.267 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.424 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 6.7 p-10 -69.7 -43.22 72.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.906 -1.121 . . . . 0.0 110.017 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.83 51.52 1.64 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 3.5 p30 -105.66 -24.53 12.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.058 -1.26 . . . . 0.0 109.878 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.46 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 111.86 30.38 3.02 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.437 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 57.8 p -153.73 158.26 40.72 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.024 -1.28 . . . . 0.0 110.53 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.0 mt -124.22 109.21 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.317 -0.864 . . . . 0.0 109.934 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 68.9 p -95.66 -164.51 1.17 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.239 -0.913 . . . . 0.0 110.301 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.8 p -85.41 -26.13 26.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.246 -0.908 . . . . 0.0 110.206 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.87 -62.8 1.24 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.24 -0.912 . . . . 0.0 110.025 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.405 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 56.9 mt-10 -57.66 -46.06 84.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.137 -0.977 . . . . 0.0 109.763 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.448 ' CD2' HD12 ' A' ' 52' ' ' ILE . 0.8 OUTLIER -60.25 -32.04 70.78 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.269 -0.894 . . . . 0.0 109.676 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.54 -50.83 63.31 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.475 ' CG2' ' HE3' ' A' ' 21' ' ' LYS . 63.5 m -70.01 -22.3 63.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.105 -1.232 . . . . 0.0 109.611 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.564 ' CG1' ' CD1' ' A' ' 19' ' ' PHE . 51.4 t -70.21 -32.2 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.472 -0.768 . . . . 0.0 109.55 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.41 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 26.2 mmt -86.97 -22.72 25.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.375 -0.828 . . . . 0.0 109.622 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.4 mmm-85 -68.16 -45.25 74.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 0.0 109.875 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.1 m -94.73 8.73 41.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.308 -0.87 . . . . 0.0 110.296 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -164.09 74.78 0.31 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.102 -0.999 . . . . 0.0 110.19 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.31 -91.49 0.14 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -161.84 -145.37 0.11 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -1.145 . . . . 0.0 110.011 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -121.4 72.06 26.81 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.007 . . . . 0.0 110.299 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -76.18 135.97 17.55 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.874 1.46 . . . . 0.0 110.179 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 72.8 p -73.4 -149.83 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.209 -0.932 . . . . 0.0 110.282 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -104.39 -42.41 5.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 109.894 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.42 -63.72 1.01 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.241 -0.912 . . . . 0.0 109.744 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 38.4 tt0 -51.61 -41.32 61.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.914 . . . . 0.0 109.689 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.44 HD22 ' CD1' ' A' ' 52' ' ' ILE . 7.9 tt -55.27 -53.13 60.02 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.809 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -51.41 -37.56 49.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.364 -0.835 . . . . 0.0 109.767 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 7.4 t0 -63.11 -40.64 98.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.334 -0.854 . . . . 0.0 109.724 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.415 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 21.8 ttp -66.67 -19.24 65.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.329 -0.857 . . . . 0.0 109.636 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.448 HD12 ' CD2' ' A' ' 32' ' ' LEU . 26.3 mt -87.77 -25.48 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.252 -0.905 . . . . 0.0 110.479 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -62.5 -38.47 90.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.05 -1.031 . . . . 0.0 110.388 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 51' ' ' MET . 14.3 pt-20 -65.5 -18.76 65.56 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.123 -0.985 . . . . 0.0 110.343 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.436 ' CG1' ' HE1' ' A' ' 71' ' ' MET . 79.6 t -95.9 -69.7 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.247 -0.908 . . . . 0.0 110.065 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -45.1 123.33 3.85 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.385 -0.822 . . . . 0.0 110.531 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.33 36.74 2.95 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.894 . . . . 0.0 110.363 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.414 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 48.6 m-20 -123.68 -52.22 1.81 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.24 -0.912 . . . . 0.0 110.371 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.31 16.17 7.88 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.45 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 24.6 p30 -93.62 -20.97 19.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.257 -1.143 . . . . 0.0 110.023 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.45 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 109.91 -44.77 1.43 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.415 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 71.0 p -98.81 164.9 12.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.095 -1.238 . . . . 0.0 110.568 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.1 mt -101.88 158.59 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.148 -0.97 . . . . 0.0 110.132 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.421 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 32.4 m-20 -113.4 -167.82 1.25 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.372 -0.83 . . . . 0.0 110.797 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.536 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 41.8 t80 -76.37 -42.97 3.33 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.422 -0.799 . . . . 0.0 111.342 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.2 Cg_endo -72.6 -25.99 16.98 Favored 'Trans proline' 0 C--O 1.208 -1.02 0 O-C-N 123.033 1.017 . . . . 0.0 110.32 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.414 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 49.5 mt-10 -78.54 -24.32 45.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.038 -1.039 . . . . 0.0 109.351 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.484 ' CZ ' ' SD ' ' A' ' 72' ' ' MET . 55.7 t80 -78.12 -51.73 9.82 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.55 -0.719 . . . . 0.0 110.466 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.405 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 3.4 tt -75.1 -20.04 59.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.243 -0.911 . . . . 0.0 110.727 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.436 ' HB ' ' O ' ' A' ' 66' ' ' PRO . 18.9 m -82.21 -50.83 8.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.079 -1.013 . . . . 0.0 110.503 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.482 ' HE2' ' CE ' ' A' ' 72' ' ' MET . 0.1 OUTLIER -69.01 -29.66 67.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.093 -1.004 . . . . 0.0 109.867 -179.671 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.484 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 52.8 mtt -86.5 -12.91 47.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.218 -0.926 . . . . 0.0 110.188 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.405 ' HB1' ' O ' ' A' ' 69' ' ' LEU . . . -74.96 -25.84 59.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.233 -0.917 . . . . 0.0 110.636 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -99.99 33.74 2.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.179 -0.951 . . . . 0.0 110.5 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -53.75 123.49 12.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.185 -0.947 . . . . 0.0 109.55 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.5 ttt -139.38 127.27 22.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.137 -0.977 . . . . 0.0 110.771 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -126.51 164.05 22.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.331 -0.856 . . . . 0.0 109.523 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -145.62 152.81 40.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.052 -1.03 . . . . 0.0 110.592 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.7 m -153.78 152.43 30.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 0.0 110.079 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -100.4 163.54 12.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 110.485 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 77.1 p -154.32 -173.72 4.69 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.366 -0.834 . . . . 0.0 110.105 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -137.46 164.24 29.15 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.195 -0.941 . . . . 0.0 110.221 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.419 ' N ' ' CD ' ' A' ' 83' ' ' GLU . 1.2 pm0 -162.45 72.23 0.34 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.135 -0.978 . . . . 0.0 110.532 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -106.46 -70.49 0.79 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.199 -0.938 . . . . 0.0 110.301 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 32.7 mt -58.86 -33.71 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.071 -1.018 . . . . 0.0 109.711 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -54.79 -44.92 74.18 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.273 -0.892 . . . . 0.0 109.408 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -64.78 -36.32 83.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.304 -0.873 . . . . 0.0 110.072 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.511 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -60.43 -61.95 2.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.33 -0.857 . . . . 0.0 110.293 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.507 ' CE1' ' HA ' ' A' ' 138' ' ' TYR . 1.1 t80 -55.13 -28.26 51.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.452 -0.78 . . . . 0.0 110.54 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.65 -47.75 65.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.151 -0.968 . . . . 0.0 110.844 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.53 HG21 ' CD1' ' A' ' 92' ' ' PHE . 27.2 m -69.59 -24.64 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.069 -1.019 . . . . 0.0 110.477 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.53 ' CD1' HG21 ' A' ' 91' ' ' VAL . 13.4 m-85 -86.18 -16.89 36.4 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.239 -0.913 . . . . 0.0 110.239 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -109.22 97.12 6.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.274 -0.891 . . . . 0.0 110.245 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -103.41 12.43 35.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.904 . . . . 0.0 110.545 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 1.9 p30 -116.64 -41.74 3.05 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.988 -1.07 . . . . 0.0 110.501 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.468 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 111.91 36.66 1.65 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.438 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 41.0 p30 -117.11 -9.54 11.03 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.941 -1.329 . . . . 0.0 110.844 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 70.82 35.89 65.98 Favored Glycine 0 N--CA 1.498 2.822 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 28.1 m-85 -140.25 136.77 33.67 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.205 -1.174 . . . . 0.0 109.66 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.401 HG22 ' HB3' ' A' ' 92' ' ' PHE . 12.8 mt -92.11 119.59 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.938 -1.101 . . . . 0.0 109.797 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 77.6 p -109.75 151.66 26.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.166 -0.959 . . . . 0.0 110.226 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.1 -29.41 60.58 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.197 -0.939 . . . . 0.0 110.413 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.72 -52.91 61.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.204 -0.935 . . . . 0.0 110.235 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.458 ' O ' ' CG2' ' A' ' 108' ' ' VAL . 98.7 mt-10 -66.51 -55.82 13.76 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.243 -0.911 . . . . 0.0 110.28 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.2 tp -53.41 -25.35 15.41 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.109 -0.994 . . . . 0.0 110.35 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.409 ' O ' ' OG1' ' A' ' 110' ' ' THR . 47.2 ttt85 -71.45 -49.83 37.67 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.262 -0.899 . . . . 0.0 110.313 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -79.63 -9.33 59.62 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.27 -0.894 . . . . 0.0 110.792 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.458 ' CG2' ' O ' ' A' ' 104' ' ' GLU . 91.0 t -83.97 -46.37 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.059 -1.026 . . . . 0.0 110.47 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.409 ' O ' ' HB2' ' A' ' 114' ' ' GLU . 25.8 mtt -82.0 -32.81 30.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.041 -1.037 . . . . 0.0 110.585 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 55.8 m -67.23 -31.04 71.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.215 -0.928 . . . . 0.0 110.347 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -87.64 -42.13 12.9 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.177 -0.952 . . . . 0.0 110.322 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 29.7 mt -46.13 -27.15 0.9 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.273 -0.892 . . . . 0.0 110.206 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.37 37.52 0.56 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 109' ' ' MET . 45.6 mt-10 -127.91 127.75 43.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.125 -1.221 . . . . 0.0 110.225 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -83.23 92.78 7.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 110.19 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.5 mt -118.83 -176.3 3.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.217 -0.927 . . . . 0.0 110.149 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.3 t -144.52 -178.41 5.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.25 -0.906 . . . . 0.0 110.45 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -61.85 -31.1 71.33 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.342 -0.848 . . . . 0.0 110.997 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.42 ' N ' ' CD ' ' A' ' 119' ' ' GLU . 6.2 mp0 -67.11 -41.1 86.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.26 -0.9 . . . . 0.0 110.708 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.402 ' OE1' ' HA ' ' A' ' 120' ' ' GLU . 6.1 mm-40 -67.72 -56.39 9.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.208 -0.932 . . . . 0.0 110.575 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 78.0 t -52.99 -49.3 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 0.0 110.412 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -57.54 -41.14 80.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.222 -0.924 . . . . 0.0 110.57 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -65.89 -32.74 74.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.22 -0.925 . . . . 0.0 110.796 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.401 ' HE3' ' HE2' ' A' ' 109' ' ' MET . 0.9 OUTLIER -73.11 -38.59 66.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.25 -0.906 . . . . 0.0 110.573 -179.679 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.44 HD11 ' CG2' ' A' ' 136' ' ' VAL . 31.5 mm -70.11 -27.61 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.113 -0.992 . . . . 0.0 109.99 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -72.93 -45.79 56.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.396 -0.815 . . . . 0.0 110.223 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -70.54 -28.76 65.18 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.078 -1.014 . . . . 0.0 110.103 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.62 -24.95 36.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.354 -0.841 . . . . 0.0 110.402 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -86.76 77.07 9.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.051 -1.031 . . . . 0.0 110.174 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.461 HD13 ' CB ' ' A' ' 140' ' ' GLU . 5.6 mt -45.91 -60.18 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.387 -0.82 . . . . 0.0 110.482 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.9 p30 -66.24 -26.97 67.61 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.074 -1.016 . . . . 0.0 110.398 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 65.48 66.18 2.56 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 2.6 p30 -107.54 -35.39 6.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.281 -1.129 . . . . 0.0 110.674 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 167.77 -37.77 0.22 Allowed Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.021 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -140.38 166.83 23.63 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.113 -1.228 . . . . 0.0 110.265 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.44 ' CG2' HD11 ' A' ' 125' ' ' ILE . 12.1 t -88.46 146.34 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.295 -0.878 . . . . 0.0 110.044 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -109.46 169.9 8.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 109.917 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.507 ' HA ' ' CE1' ' A' ' 89' ' ' PHE . 9.0 t80 -61.66 -47.87 83.42 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.183 -0.948 . . . . 0.0 110.545 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -59.91 -41.46 91.73 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.007 -1.058 . . . . 0.0 110.152 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.461 ' CB ' HD13 ' A' ' 130' ' ' ILE . 52.2 mt-10 -69.41 -24.72 63.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.92 . . . . 0.0 110.014 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.518 ' CZ ' ' CE ' ' A' ' 145' ' ' MET . 8.0 t80 -77.51 -25.23 50.13 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.378 -0.826 . . . . 0.0 109.977 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.0 t -80.34 -23.4 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.278 -0.889 . . . . 0.0 110.04 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -89.13 -31.74 17.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -0.9 . . . . 0.0 110.296 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.438 ' CE ' ' HE3' ' A' ' 145' ' ' MET . 0.0 OUTLIER -82.65 -22.51 34.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.153 -0.967 . . . . 0.0 110.243 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.518 ' CE ' ' CZ ' ' A' ' 141' ' ' PHE . 46.0 tpp -71.54 -29.95 65.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.337 -0.852 . . . . 0.0 109.97 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.1 p -117.71 54.15 0.91 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.363 -0.835 . . . . 0.0 110.306 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -96.91 -179.48 4.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 110.278 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.156 -179.963 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' WW7 . . . . . 0.5 ' H3 ' ' CE2' ' A' ' 19' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' WW7 . . . . . 0.519 ' H2 ' ' CZ ' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.252 0.548 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 15.0 p-10 -143.66 -162.44 1.46 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.257 -0.902 . . . . 0.0 110.133 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.412 ' OE1' ' HA ' ' A' ' 3' ' ' GLN . 11.8 mm100 -71.49 143.49 49.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.138 -0.976 . . . . 0.0 110.376 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -104.72 -168.24 1.45 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -0.889 . . . . 0.0 110.201 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.8 p -133.42 -162.63 1.26 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.244 -0.91 . . . . 0.0 109.834 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.87 -15.39 30.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.142 -0.974 . . . . 0.0 110.262 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.413 ' O ' ' HB1' ' A' ' 10' ' ' ALA . 2.5 tp10 -46.81 -48.29 20.81 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.272 -0.892 . . . . 0.0 110.145 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.402 ' HA ' ' OE1' ' A' ' 8' ' ' GLN . 15.6 mm100 -53.97 -47.23 71.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.454 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.461 ' CG2' HD12 ' A' ' 69' ' ' LEU . 44.3 mt -56.38 -33.74 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.336 -0.852 . . . . 0.0 109.468 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -62.83 -37.44 86.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.39 -0.819 . . . . 0.0 109.373 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -63.09 -51.04 68.17 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.303 -0.873 . . . . 0.0 109.421 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -60.1 -28.11 67.56 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.471 -0.768 . . . . 0.0 109.891 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 2.4 mtpm? -64.25 -52.65 57.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 109.49 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -53.12 -38.07 62.32 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.348 -0.845 . . . . 0.0 109.304 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.04 -43.63 98.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.445 -0.784 . . . . 0.0 109.693 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.435 ' CE1' HD13 ' A' ' 27' ' ' ILE . 56.4 t80 -54.29 -39.65 67.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 109.377 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.7 t -73.03 -29.99 63.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.427 -0.796 . . . . 0.0 109.505 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.433 ' CD2' ' C ' ' A' ' 18' ' ' LEU . 5.1 tt -59.43 -35.97 75.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.447 -0.783 . . . . 0.0 109.388 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.542 ' CE2' ' H3 ' ' A' ' 153' ' ' WW7 . 9.8 m-85 -82.19 -56.7 3.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.436 -0.79 . . . . 0.0 109.874 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.415 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 9.8 t70 -52.96 106.2 0.15 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.452 -0.78 . . . . 0.0 110.214 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 19' ' ' PHE . 33.5 mttm -110.31 41.72 1.69 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.264 -0.898 . . . . 0.0 110.983 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 5.6 p-10 -150.12 -50.77 0.14 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.037 -1.039 . . . . 0.0 110.387 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.91 57.61 0.33 Allowed Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.744 -1.217 . . . . 0.0 110.333 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.413 ' O ' HG22 ' A' ' 26' ' ' THR . 56.5 p-10 -135.75 0.62 2.71 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.135 -1.215 . . . . 0.0 110.737 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.444 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 64.09 40.27 97.96 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.444 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 81.0 p -154.83 139.52 17.05 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.232 -1.158 . . . . 0.0 109.857 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.435 HD13 ' CE1' ' A' ' 16' ' ' PHE . 86.4 mt -105.12 132.36 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.125 -0.985 . . . . 0.0 110.205 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.412 ' OG1' HG23 ' A' ' 62' ' ' THR . 10.0 m -125.21 174.79 7.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.227 -0.921 . . . . 0.0 110.563 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.5 p -64.01 -21.12 66.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.439 -0.788 . . . . 0.0 109.954 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -70.84 -69.32 0.37 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.278 -0.888 . . . . 0.0 110.071 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.415 ' OE1' ' HA ' ' A' ' 20' ' ' ASP . 21.8 mt-10 -53.02 -46.61 68.47 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.331 -0.856 . . . . 0.0 109.61 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.457 HD22 ' CD1' ' A' ' 48' ' ' LEU . 0.9 OUTLIER -60.19 -32.85 71.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.886 . . . . 0.0 109.659 179.511 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.04 -42.19 98.31 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.9 m -72.08 -24.39 61.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -1.081 . . . . 0.0 109.612 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 42.3 t -69.37 -35.87 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.405 -0.809 . . . . 0.0 109.688 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.426 ' HE2' ' CE ' ' A' ' 51' ' ' MET . 25.4 mmt -90.25 -20.46 22.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 110.368 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.6 mtt85 -89.48 -18.1 27.37 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.023 -1.048 . . . . 0.0 110.651 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 92.4 p -101.54 -16.96 16.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.02 -1.05 . . . . 0.0 110.231 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.84 55.91 1.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.202 -0.936 . . . . 0.0 110.02 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 36' ' ' MET . . . 104.92 86.23 1.91 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 9.8 tt0 -83.14 67.48 9.18 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.459 -1.024 . . . . 0.0 110.634 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.481 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.8 m120 -85.05 -58.39 0.35 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.124 -0.985 . . . . 0.0 111.157 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.481 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 44.4 Cg_endo -73.88 -169.01 0.5 Allowed 'Trans proline' 0 C--N 1.315 -1.202 0 O-C-N 123.564 1.297 . . . . 0.0 111.056 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 10.9 t -132.94 -174.21 3.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.433 -0.792 . . . . 0.0 109.892 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -66.32 -43.94 84.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.141 -0.974 . . . . 0.0 110.595 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.89 -67.45 0.44 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.174 -0.954 . . . . 0.0 110.434 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -47.39 -29.86 2.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 0.0 110.1 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.457 ' CD1' HD22 ' A' ' 32' ' ' LEU . 8.6 tt -66.7 -49.36 66.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.931 . . . . 0.0 109.343 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -49.22 -38.88 27.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 109.243 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -64.2 -42.18 96.74 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.399 -0.813 . . . . 0.0 109.411 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.431 ' HG3' ' OE2' ' A' ' 54' ' ' GLU . 2.5 ttp -65.58 -14.56 61.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.264 -0.897 . . . . 0.0 109.946 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.438 ' CD1' 'CL1 ' ' A' ' 153' ' ' WW7 . 25.4 mm -88.47 -33.61 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.302 -0.874 . . . . 0.0 110.3 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -65.25 -33.33 75.74 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.419 -0.8 . . . . 0.0 110.697 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.431 ' OE2' ' HG3' ' A' ' 51' ' ' MET . 22.7 pt-20 -71.3 -8.29 52.7 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.058 -1.026 . . . . 0.0 110.647 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.474 HG13 ' CD1' ' A' ' 63' ' ' ILE . 79.3 t -108.51 -18.84 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.069 -1.019 . . . . 0.0 110.107 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.415 ' OD2' ' O ' ' A' ' 62' ' ' THR . 4.6 t70 -109.04 109.27 20.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 111.053 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.76 15.19 23.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 109.66 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.73 -45.19 17.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.417 -0.802 . . . . 0.0 109.985 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.0 15.87 8.87 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -105.21 -31.73 8.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.053 -1.263 . . . . 0.0 110.171 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.38 -47.43 1.02 Allowed Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.84 -1.172 . . . . 0.0 110.248 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.415 ' O ' ' OD2' ' A' ' 56' ' ' ASP . 10.1 p -96.99 166.78 11.44 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.186 -1.185 . . . . 0.0 110.81 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.474 ' CD1' HG13 ' A' ' 55' ' ' VAL . 17.2 mt -102.95 161.34 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.202 -0.936 . . . . 0.0 110.316 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -113.65 -160.91 0.74 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.336 -0.853 . . . . 0.0 110.502 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.54 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 21.9 t80 -82.09 -43.4 1.02 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.896 . . . . 0.0 111.837 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.6 Cg_endo -72.42 -24.15 19.58 Favored 'Trans proline' 0 C--N 1.321 -0.894 0 O-C-N 123.027 1.014 . . . . 0.0 110.656 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -76.83 -33.78 57.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.143 -0.973 . . . . 0.0 109.087 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.571 ' CE1' ' CE ' ' A' ' 72' ' ' MET . 77.5 t80 -72.03 -40.27 68.55 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.572 -0.705 . . . . 0.0 109.852 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.461 HD12 ' CG2' ' A' ' 9' ' ' ILE . 8.2 tp -78.71 -17.93 55.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.446 -0.784 . . . . 0.0 110.607 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.418 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 51.9 m -90.63 -23.34 20.83 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.022 -1.049 . . . . 0.0 110.651 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 48.6 ttp -90.8 -36.96 13.94 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.891 -1.131 . . . . 0.0 111.073 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.571 ' CE ' ' CE1' ' A' ' 68' ' ' PHE . 56.8 mtt -89.83 -53.25 4.59 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.054 -1.029 . . . . 0.0 111.496 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 69' ' ' LEU . . . -65.89 -10.15 35.9 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.931 -1.105 . . . . 0.0 110.882 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.425 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 5.0 tpt180 -86.72 10.24 16.38 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.041 -1.037 . . . . 0.0 110.442 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.98 177.82 4.78 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.007 -1.058 . . . . 0.0 110.131 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 54.36 101.6 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.262 -0.899 . . . . 0.0 110.186 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -145.37 15.73 1.48 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.178 -0.951 . . . . 0.0 110.269 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -62.53 151.79 36.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 109.751 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.7 t -115.74 138.77 50.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.179 -0.95 . . . . 0.0 110.203 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 1.7 m-20 -108.71 117.54 34.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.185 -0.947 . . . . 0.0 109.921 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 81.0 p -122.79 112.55 18.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 110.819 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -121.35 -0.04 9.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.36 -0.837 . . . . 0.0 109.935 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -149.04 89.76 1.69 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.289 -0.882 . . . . 0.0 109.66 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.435 ' O ' ' CB ' ' A' ' 88' ' ' ALA . 1.0 OUTLIER -44.0 -26.75 0.31 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.449 -0.782 . . . . 0.0 110.761 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 79.5 mt -66.51 -59.31 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.192 -0.942 . . . . 0.0 110.093 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -63.08 -57.18 11.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.356 -0.84 . . . . 0.0 110.337 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -51.02 -32.02 20.15 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.244 -0.91 . . . . 0.0 110.451 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 84' ' ' GLU . . . -72.98 -40.72 65.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.192 -0.942 . . . . 0.0 110.414 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -62.79 -29.51 70.76 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.968 -1.083 . . . . 0.0 110.554 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 66.6 mtt85 -80.9 -52.12 7.82 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.201 -0.937 . . . . 0.0 110.938 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.501 HG22 ' CD2' ' A' ' 92' ' ' PHE . 19.6 m -59.09 -36.22 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.211 -0.931 . . . . 0.0 111.02 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.522 ' CD2' ' H3 ' ' A' ' 154' ' ' WW7 . 16.2 m-85 -78.85 -38.8 36.98 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.033 -1.042 . . . . 0.0 110.606 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -111.55 71.3 0.74 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.275 -0.891 . . . . 0.0 110.147 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.441 ' CD ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -108.06 42.59 1.34 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.146 -0.971 . . . . 0.0 110.499 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 2.7 p30 -125.77 -26.95 3.41 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.242 -0.912 . . . . 0.0 110.605 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.4 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 108.21 31.57 3.51 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.45 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 18.6 t-20 -93.12 -44.98 8.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -1.145 . . . . 0.0 110.135 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.476 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 111.24 -14.91 28.07 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 33.8 m-85 -144.28 147.27 33.32 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.218 -1.166 . . . . 0.0 110.108 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.429 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 26.0 mt -71.1 137.5 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.245 -0.909 . . . . 0.0 109.439 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.3 m -114.21 169.64 8.88 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.194 -0.941 . . . . 0.0 110.394 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.61 -46.01 56.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.236 -0.915 . . . . 0.0 110.115 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.91 -53.94 49.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -0.918 . . . . 0.0 109.986 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -58.57 -38.66 78.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.238 -0.914 . . . . 0.0 109.783 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.405 ' O ' HD21 ' A' ' 105' ' ' LEU . 1.4 tt -57.78 -36.83 72.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.32 -0.863 . . . . 0.0 110.105 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.6 ttt-85 -70.0 -44.44 69.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.343 -0.848 . . . . 0.0 110.304 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -70.64 -11.06 60.7 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.084 -1.01 . . . . 0.0 110.497 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 85.1 t -91.8 -40.79 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.135 -0.978 . . . . 0.0 110.163 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.2 mmt -69.9 -52.77 21.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.257 -0.902 . . . . 0.0 110.558 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.8 t -56.99 -24.33 52.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.229 -0.919 . . . . 0.0 110.689 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -85.31 -33.86 22.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.022 -1.049 . . . . 0.0 110.69 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 24.4 mt -73.58 -56.53 4.9 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.131 -0.981 . . . . 0.0 110.28 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 167.58 -32.1 0.19 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.41 ' HA ' ' OE1' ' A' ' 114' ' ' GLU . 6.3 mm-40 -70.96 140.31 50.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.322 -1.105 . . . . 0.0 110.203 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 3.4 pttp -114.77 101.57 9.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.169 -0.957 . . . . 0.0 110.392 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.3 mt -112.0 168.5 9.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.125 -0.985 . . . . 0.0 110.236 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.3 m -115.58 170.32 8.52 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.223 -0.923 . . . . 0.0 110.45 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.02 -35.44 34.16 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.339 -0.851 . . . . 0.0 110.962 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -62.36 -54.78 35.39 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.059 -1.026 . . . . 0.0 110.798 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.413 ' OE1' ' HA ' ' A' ' 120' ' ' GLU . 6.2 mm-40 -61.2 -54.6 42.26 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.221 -0.924 . . . . 0.0 110.702 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 79.6 t -50.65 -41.25 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.115 -0.991 . . . . 0.0 110.566 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.96 -40.62 91.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.118 -0.989 . . . . 0.0 110.214 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.443 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 12.4 mt-10 -71.1 -18.41 62.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.236 -0.915 . . . . 0.0 109.972 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.1 mmm -78.79 -48.67 14.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 110.155 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 30.4 mm -70.44 -36.4 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.312 -0.868 . . . . 0.0 110.334 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -72.11 -47.36 51.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.362 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.443 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 5.7 mm-40 -70.15 -23.85 63.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.207 -0.933 . . . . 0.0 110.186 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.79 -14.65 27.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.171 -0.956 . . . . 0.0 110.011 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 3.8 m-20 -79.92 88.33 5.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.098 -1.001 . . . . 0.0 110.922 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.449 ' N ' ' OE2' ' A' ' 140' ' ' GLU . 11.5 mm -67.24 -4.08 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.523 -0.736 . . . . 0.0 111.11 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 54.0 p30 -176.57 -19.71 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 O-C-N 120.709 -1.245 . . . . 0.0 112.223 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . -71.8 -52.06 13.27 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.566 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 1.2 m-20 56.48 96.32 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.468 -1.019 . . . . 0.0 108.418 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 105.28 -20.49 37.58 Favored Glycine 0 C--N 1.295 -1.748 0 N-CA-C 107.564 -2.214 . . . . 0.0 107.564 -177.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.458 ' HB2' ' CB ' ' A' ' 99' ' ' TYR . 2.5 pt20 -153.4 152.32 30.92 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.621 -0.929 . . . . 0.0 109.729 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.431 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 99.5 t -118.48 147.12 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.208 -0.933 . . . . 0.0 110.346 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.4 ' OD1' ' CD1' ' A' ' 99' ' ' TYR . 2.9 m120 -105.91 179.46 4.26 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.435 -0.791 . . . . 0.0 110.585 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -73.73 -49.54 25.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.312 -0.868 . . . . 0.0 108.884 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -59.29 -41.75 89.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.346 -0.846 . . . . 0.0 109.046 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.449 ' OE2' ' N ' ' A' ' 130' ' ' ILE . 36.1 tt0 -64.98 -33.27 75.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.484 -0.76 . . . . 0.0 109.968 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.406 ' O ' ' HG2' ' A' ' 144' ' ' MET . 13.4 t80 -68.91 -25.62 64.68 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.315 -0.866 . . . . 0.0 110.31 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.8 t -81.44 -36.28 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.122 -0.986 . . . . 0.0 109.726 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.49 -29.95 64.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 110.8 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.431 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 3.4 ptt? -74.59 -25.55 59.33 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.006 -1.059 . . . . 0.0 110.623 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.482 ' HE2' ' N1 ' ' A' ' 154' ' ' WW7 . 20.5 mmt -87.11 -67.69 0.8 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.117 -0.989 . . . . 0.0 110.504 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 65.6 p -64.58 127.46 31.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.071 -1.018 . . . . 0.0 110.411 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.74 -150.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.445 -0.785 . . . . 0.0 110.358 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.226 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' WW7 . . . . . 0.542 ' H3 ' ' CE2' ' A' ' 19' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' WW7 . . . . . 0.531 H132 ' N2 ' ' A' ' 154' ' ' WW7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.244 0.545 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -95.58 73.54 3.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.166 -0.959 . . . . 0.0 110.089 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -84.9 -68.33 0.73 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.405 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.6 mt -51.39 167.34 0.09 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.229 -0.919 . . . . 0.0 110.25 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.6 p -92.99 175.07 6.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.246 -0.909 . . . . 0.0 110.228 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -88.49 -19.05 26.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.275 -0.891 . . . . 0.0 110.247 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.86 -55.94 28.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.274 -0.891 . . . . 0.0 110.252 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -56.65 -33.28 66.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.301 -0.874 . . . . 0.0 109.75 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.0 mm -65.71 -35.95 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.509 -0.745 . . . . 0.0 109.807 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.15 -33.52 73.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.882 . . . . 0.0 109.587 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.8 -51.08 68.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.393 -0.817 . . . . 0.0 109.575 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -58.83 -38.67 79.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.378 -0.826 . . . . 0.0 109.835 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -63.85 -31.11 72.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.354 -0.841 . . . . 0.0 109.911 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -68.47 -45.63 71.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -0.862 . . . . 0.0 110.292 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.44 -44.66 93.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.309 -0.869 . . . . 0.0 110.355 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -58.79 -43.68 90.55 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.21 -0.931 . . . . 0.0 110.298 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.4 m -66.48 -33.95 76.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 110.077 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.429 ' CD2' ' C ' ' A' ' 18' ' ' LEU . 2.8 tt -62.46 -37.47 86.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 109.788 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.523 ' CD1' HG12 ' A' ' 35' ' ' VAL . 9.3 m-30 -72.51 -64.33 0.97 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.331 -0.856 . . . . 0.0 109.893 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -51.0 120.15 4.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.412 -0.805 . . . . 0.0 109.862 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -104.85 -8.73 18.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.907 -1.121 . . . . 0.0 110.885 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.415 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 6.9 p-10 -101.55 -42.29 6.29 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.9 -1.125 . . . . 0.0 110.238 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.12 55.4 0.92 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 58.5 p30 -123.5 -11.47 7.84 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.166 -1.197 . . . . 0.0 110.503 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.464 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 89.12 36.89 7.41 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.464 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 14.6 p -158.5 129.55 6.34 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.339 -1.095 . . . . 0.0 110.256 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 62' ' ' THR . 62.0 mt -93.19 118.32 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.315 -0.866 . . . . 0.0 109.993 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.416 HG23 ' OE2' ' A' ' 31' ' ' GLU . 8.9 t -104.24 -176.28 3.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.232 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.412 ' HA ' HD22 ' A' ' 48' ' ' LEU . 31.4 p -75.09 -35.08 61.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 110.475 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -62.37 -60.28 3.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.267 -0.896 . . . . 0.0 109.972 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.416 ' OE2' HG23 ' A' ' 28' ' ' THR . 46.2 mt-10 -58.83 -53.11 62.12 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.212 -0.93 . . . . 0.0 109.623 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.445 ' CD1' 'CL1 ' ' A' ' 153' ' ' WW7 . 0.5 OUTLIER -58.88 -19.45 42.17 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.235 -0.916 . . . . 0.0 109.572 179.535 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.481 ' HA2' ' CD1' ' A' ' 48' ' ' LEU . . . -67.35 -49.53 51.2 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.0 m -70.84 -19.12 62.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.298 -1.119 . . . . 0.0 109.862 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.523 HG12 ' CD1' ' A' ' 19' ' ' PHE . 24.4 t -76.58 -38.45 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.394 -0.816 . . . . 0.0 110.334 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.479 ' HA ' ' CD2' ' A' ' 39' ' ' LEU . 26.5 mmt -84.48 -22.96 30.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.121 -0.987 . . . . 0.0 110.163 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 3.7 tpp180 -90.68 -16.9 27.72 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.329 -0.857 . . . . 0.0 110.417 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.9 t -92.0 10.11 30.38 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.995 -1.065 . . . . 0.0 110.982 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.479 ' CD2' ' HA ' ' A' ' 36' ' ' MET . 3.8 pp -107.27 -26.7 10.92 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.015 -1.053 . . . . 0.0 110.65 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.418 ' N ' HD13 ' A' ' 39' ' ' LEU . . . 150.55 -31.13 1.03 Allowed Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.065 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.412 ' HG3' HD12 ' A' ' 39' ' ' LEU . 67.3 mt-30 -81.01 158.75 25.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.101 -1.235 . . . . 0.0 110.323 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -130.43 61.09 56.91 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.25 -0.906 . . . . 0.0 110.131 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.05 -163.15 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.771 1.406 . . . . 0.0 110.234 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.411 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 58.4 m -135.55 171.98 13.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.253 -0.904 . . . . 0.0 110.119 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -59.56 -28.94 67.56 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.2 -0.937 . . . . 0.0 110.478 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.92 -67.48 0.49 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.153 -0.967 . . . . 0.0 110.064 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -53.42 -23.09 8.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -0.914 . . . . 0.0 109.512 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.481 ' CD1' ' HA2' ' A' ' 33' ' ' GLY . 0.7 OUTLIER -67.85 -58.0 5.32 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.564 -0.71 . . . . 0.0 110.011 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -51.22 -38.09 50.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.322 -0.861 . . . . 0.0 109.527 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -65.17 -38.99 92.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.367 -0.833 . . . . 0.0 109.508 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.421 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 1.6 ttp -66.98 -26.26 66.72 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.426 -0.796 . . . . 0.0 109.784 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.409 HG12 HD23 ' A' ' 32' ' ' LEU . 56.9 mt -83.17 -27.33 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.319 -0.863 . . . . 0.0 109.818 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -58.58 -46.84 86.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.384 -0.823 . . . . 0.0 110.401 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 51' ' ' MET . 13.2 pt-20 -64.39 -27.2 68.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -0.918 . . . . 0.0 110.071 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.415 ' N ' ' HG3' ' A' ' 54' ' ' GLU . 85.8 t -96.1 -3.97 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.344 -0.848 . . . . 0.0 110.338 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -126.11 105.86 9.17 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.028 -1.045 . . . . 0.0 110.159 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.24 33.66 4.34 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.111 -0.993 . . . . 0.0 110.465 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -104.82 -49.11 3.58 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.186 -0.946 . . . . 0.0 110.236 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 119.53 51.69 0.28 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.457 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 16.1 p-10 -148.02 -43.69 0.16 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -1.129 . . . . 0.0 110.15 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 116.76 -4.12 19.26 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.579 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 45.1 p -123.76 164.05 19.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.906 -1.349 . . . . 0.0 110.469 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.447 ' CD1' 'CL1 ' ' A' ' 153' ' ' WW7 . 52.1 mt -114.05 130.82 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.257 -0.902 . . . . 0.0 110.165 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -83.3 -173.68 4.85 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 110.112 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.535 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 66.4 t80 -80.73 -42.63 1.25 Allowed Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.324 -0.86 . . . . 0.0 111.35 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 46.5 Cg_endo -74.66 -26.81 11.27 Favored 'Trans proline' 0 N--CA 1.48 0.72 0 O-C-N 123.082 1.043 . . . . 0.0 110.092 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 71' ' ' MET . 78.7 tt0 -78.09 -25.31 47.5 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.358 -0.839 . . . . 0.0 109.002 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 8.0 t80 -79.21 -54.34 6.07 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.607 -0.683 . . . . 0.0 110.025 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.469 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 0.6 OUTLIER -60.0 -34.78 73.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.329 -0.857 . . . . 0.0 110.427 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.407 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 86.4 m -77.02 -32.37 57.01 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.195 -0.941 . . . . 0.0 110.236 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 18.2 tmm? -61.9 -52.65 63.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.268 -0.895 . . . . 0.0 110.278 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.417 ' HG3' ' HE2' ' A' ' 71' ' ' MET . 47.5 mtt -81.55 -10.4 59.46 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.165 -0.96 . . . . 0.0 110.293 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -81.36 -23.41 37.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.163 -0.961 . . . . 0.0 110.127 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 32.3 ttm180 -106.88 62.34 0.63 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.17 -0.956 . . . . 0.0 110.309 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -101.4 -47.24 4.75 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.069 -1.019 . . . . 0.0 109.734 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 4.2 tpp -124.18 122.07 36.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.453 -0.779 . . . . 0.0 109.93 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.81 164.67 14.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.179 -0.951 . . . . 0.0 110.167 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -60.0 -174.71 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 110.133 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.0 t -132.61 -175.4 3.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.925 . . . . 0.0 110.092 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -114.7 132.74 56.31 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.277 -0.889 . . . . 0.0 109.932 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.2 m -124.55 104.94 8.99 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.168 -0.958 . . . . 0.0 110.533 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -88.07 164.4 15.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.252 -0.905 . . . . 0.0 110.085 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.21 -53.04 42.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.198 -0.939 . . . . 0.0 110.379 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -56.03 -48.73 75.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 109.953 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.4 mt -52.07 -45.45 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.213 -0.929 . . . . 0.0 109.527 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -55.07 -44.41 74.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 110.179 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -57.41 -51.68 68.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.932 . . . . 0.0 110.245 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 92' ' ' PHE . . . -54.96 -29.58 57.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.131 -0.981 . . . . 0.0 110.557 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.416 ' O ' ' HB3' ' A' ' 93' ' ' ASP . 3.2 t80 -72.6 -35.98 68.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.003 -1.06 . . . . 0.0 110.838 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -76.32 -42.85 43.74 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.08 -1.013 . . . . 0.0 111.256 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.512 HG22 ' CD1' ' A' ' 92' ' ' PHE . 19.7 m -70.64 -41.23 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.047 -1.033 . . . . 0.0 110.859 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.538 ' CG ' ' H3 ' ' A' ' 154' ' ' WW7 . 25.9 m-85 -75.46 -25.07 57.12 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.877 -1.139 . . . . 0.0 110.028 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.447 ' OD2' ' N ' ' A' ' 99' ' ' TYR . 11.5 t70 -125.33 70.29 1.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.937 . . . . 0.0 110.09 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.11 65.98 0.62 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.429 -0.794 . . . . 0.0 110.284 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.434 ' OD2' ' HB2' ' A' ' 97' ' ' ASN . 21.6 p-10 -150.62 26.49 0.75 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.23 -0.919 . . . . 0.0 110.051 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.04 24.58 60.87 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.434 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 11.1 t-20 -95.49 -70.65 0.7 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.249 -1.147 . . . . 0.0 110.193 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.31 -9.98 10.05 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.456 ' CD1' ' NE2' ' A' ' 135' ' ' GLN . 55.0 m-85 -133.08 153.07 51.85 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.196 -1.179 . . . . 0.0 110.342 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.414 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 13.3 mt -91.84 116.26 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.336 -0.853 . . . . 0.0 109.499 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.0 t -95.06 176.04 6.39 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.318 -0.864 . . . . 0.0 110.115 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.84 -41.81 67.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 110.16 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.88 -50.45 62.44 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.181 -0.949 . . . . 0.0 110.27 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -59.52 -40.9 88.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.187 -0.945 . . . . 0.0 109.87 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 30.6 tp -62.55 -33.83 75.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.381 -0.824 . . . . 0.0 110.046 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.461 ' NH2' ' OD2' ' A' ' 118' ' ' ASP . 6.7 ttp180 -69.16 -34.07 74.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.246 -0.909 . . . . 0.0 109.905 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 41.6 t60 -74.64 -24.18 58.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 110.276 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.486 HG13 ' CE2' ' A' ' 92' ' ' PHE . 21.8 t -77.04 -39.92 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.258 -0.902 . . . . 0.0 110.187 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.6 mmt -61.84 -36.67 81.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.882 . . . . 0.0 110.136 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.2 p -53.23 -43.48 67.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.155 -0.965 . . . . 0.0 109.71 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -60.14 -47.56 85.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.827 . . . . 0.0 110.219 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.5 mt -55.72 -36.3 67.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 110.124 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.07 41.88 2.74 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -119.87 133.59 55.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -1.168 . . . . 0.0 110.101 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.0 tttp -84.54 107.46 16.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.321 -0.862 . . . . 0.0 110.015 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.1 mt -126.29 164.21 21.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -0.869 . . . . 0.0 110.232 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 51.7 m -107.13 162.7 13.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 110.204 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.461 ' OD2' ' NH2' ' A' ' 106' ' ' ARG . 2.4 m-20 -58.2 -40.66 82.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 110.205 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -58.78 -35.55 72.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.312 -0.868 . . . . 0.0 110.526 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.02 -49.84 64.02 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.226 -0.921 . . . . 0.0 110.795 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.41 ' O ' ' HB2' ' A' ' 124' ' ' MET . 59.3 t -59.36 -53.31 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.225 -0.922 . . . . 0.0 110.174 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -53.61 -42.56 67.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.189 -0.944 . . . . 0.0 110.004 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 27.1 tt0 -63.03 -33.2 74.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.346 -0.846 . . . . 0.0 110.054 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.41 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 5.5 mmm -65.19 -53.29 47.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.179 -0.951 . . . . 0.0 109.989 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 34.8 mm -54.94 -32.21 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.255 -0.903 . . . . 0.0 110.089 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 -70.65 -42.73 70.42 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.298 -0.876 . . . . 0.0 110.136 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 49.9 mt-10 -65.82 -23.95 66.8 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.292 -0.88 . . . . 0.0 110.219 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.63 -22.48 19.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.322 -0.862 . . . . 0.0 110.066 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -72.67 90.43 1.38 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 110.228 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 59.0 mt -89.34 -25.61 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.14 -0.975 . . . . 0.0 110.304 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 41.7 p30 -87.4 -16.44 34.92 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.244 -0.91 . . . . 0.0 110.496 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.455 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 75.1 70.35 1.27 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -130.62 -33.9 1.59 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.21 -1.171 . . . . 0.0 110.427 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 111.61 18.43 7.99 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.456 ' NE2' ' CD1' ' A' ' 99' ' ' TYR . 4.0 pt20 -160.56 147.4 15.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.371 -1.076 . . . . 0.0 109.949 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.414 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 60.7 t -91.09 132.18 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 110.377 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -106.39 171.4 7.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 109.82 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -53.83 -38.34 64.53 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.174 -0.954 . . . . 0.0 110.351 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -68.03 -62.88 1.2 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.185 -0.947 . . . . 0.0 110.647 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -46.83 -33.72 4.72 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.283 -0.886 . . . . 0.0 110.899 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.412 ' CD1' ' C ' ' A' ' 141' ' ' PHE . 12.8 t80 -70.23 -40.94 74.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 111.133 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.418 ' O ' ' CG2' ' A' ' 146' ' ' THR . 99.2 t -77.48 -20.9 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.052 -1.03 . . . . 0.0 110.766 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -85.12 -28.11 25.79 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.257 -0.902 . . . . 0.0 110.959 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.442 ' HE2' ' HG3' ' A' ' 145' ' ' MET . 0.2 OUTLIER -83.05 -20.13 35.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.058 -1.026 . . . . 0.0 110.316 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.442 ' HG3' ' HE2' ' A' ' 144' ' ' MET . 26.0 mtt -90.24 -59.12 2.27 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.303 -0.873 . . . . 0.0 110.256 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.418 ' CG2' ' O ' ' A' ' 142' ' ' VAL . 13.7 t -54.21 132.08 42.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 110.004 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -174.11 126.28 0.35 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 0.0 110.286 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.115 179.966 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' WW7 . . . . . 0.516 ' H3 ' ' CE2' ' A' ' 19' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' WW7 . . . . . 0.538 ' H3 ' ' CG ' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.322 0.582 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -152.06 121.99 7.06 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.185 -0.947 . . . . 0.0 110.248 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -142.74 145.68 33.57 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.191 -0.943 . . . . 0.0 110.04 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.474 ' O ' ' CG2' ' A' ' 5' ' ' THR . 0.5 OUTLIER -124.79 -27.61 3.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -0.943 . . . . 0.0 110.591 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 4' ' ' LEU . 17.9 p -158.2 157.45 32.66 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.159 -0.963 . . . . 0.0 110.513 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -89.01 -8.95 53.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.263 -0.898 . . . . 0.0 110.03 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -64.54 -57.09 10.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.238 -0.914 . . . . 0.0 110.495 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.408 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 1.9 mp0 -47.16 -51.66 17.65 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.3 -0.875 . . . . 0.0 110.371 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 92.6 mt -57.41 -49.23 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.101 -0.999 . . . . 0.0 110.032 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.38 -26.08 39.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.398 -0.814 . . . . 0.0 109.804 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 16.0 tt0 -72.72 -57.82 3.81 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.366 -0.834 . . . . 0.0 109.636 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.416 ' O ' ' HB2' ' A' ' 16' ' ' PHE . 71.9 m-85 -56.4 -23.34 37.46 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.263 -0.898 . . . . 0.0 109.79 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.3 mttp -76.06 -40.35 53.43 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.283 -0.885 . . . . 0.0 110.033 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -62.66 -52.83 61.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 109.902 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.503 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.96 -47.19 85.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 109.998 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.511 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 14.3 t80 -47.76 -48.99 29.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.199 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.2 t -58.84 -42.76 90.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.904 . . . . 0.0 109.886 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.437 ' CD2' ' C ' ' A' ' 18' ' ' LEU . 3.6 tt -49.52 -44.41 46.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.287 -0.883 . . . . 0.0 110.171 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.507 ' CZ ' ' H3 ' ' A' ' 153' ' ' WW7 . 37.3 m-85 -75.67 -30.28 59.35 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.175 -0.953 . . . . 0.0 110.401 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -80.35 107.52 13.21 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.108 -0.995 . . . . 0.0 110.43 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.401 ' HE3' ' CG2' ' A' ' 34' ' ' THR . 24.9 mttm -105.93 -35.36 7.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.0 110.436 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -74.07 -21.27 59.99 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.128 -0.982 . . . . 0.0 110.11 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.87 100.23 0.04 OUTLIER Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 35.1 p-10 -168.63 -26.21 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.354 -1.086 . . . . 0.0 111.41 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.414 ' O ' HG21 ' A' ' 26' ' ' THR . . . 111.09 27.56 4.2 Favored Glycine 0 N--CA 1.492 2.367 0 O-C-N 120.671 -1.268 . . . . 0.0 109.996 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.414 HG21 ' O ' ' A' ' 25' ' ' GLY . 72.2 p -153.36 170.21 21.22 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.052 -1.264 . . . . 0.0 110.337 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.419 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 12.2 mt -129.47 115.32 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.405 -0.81 . . . . 0.0 109.947 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.6 m -102.33 174.67 5.81 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.195 -0.941 . . . . 0.0 110.191 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.42 ' HA ' HD23 ' A' ' 48' ' ' LEU . 22.8 p -72.21 -21.41 61.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.146 -0.971 . . . . 0.0 110.059 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -70.73 -57.64 4.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.253 -0.905 . . . . 0.0 109.82 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -60.25 -57.62 12.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 0.0 109.71 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.409 HD23 HD12 ' A' ' 52' ' ' ILE . 2.0 tp -51.84 -35.43 44.57 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.279 -0.888 . . . . 0.0 109.584 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.26 -47.11 76.74 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.401 ' CG2' ' HE3' ' A' ' 21' ' ' LYS . 62.5 m -63.3 -31.21 72.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -1.139 . . . . 0.0 109.973 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.426 ' CG2' ' HA ' ' A' ' 19' ' ' PHE . 54.6 t -67.38 -31.48 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.195 -0.941 . . . . 0.0 109.833 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.4 mmt -90.55 -14.2 33.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.287 -0.883 . . . . 0.0 110.427 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.5 ttp180 -88.77 -31.5 18.36 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.153 -0.967 . . . . 0.0 110.435 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 88.7 p -91.44 -24.32 19.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.267 -0.896 . . . . 0.0 110.188 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.62 -67.31 0.86 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.247 -0.908 . . . . 0.0 109.932 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -129.32 89.33 0.31 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -59.68 116.5 4.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -1.119 . . . . 0.0 110.485 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.52 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 5.4 m-80 -172.1 -61.03 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.301 -0.874 . . . . 0.0 110.477 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.52 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 47.7 Cg_endo -74.82 144.35 30.84 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.595 1.313 . . . . 0.0 110.105 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.451 ' O ' ' CB ' ' A' ' 48' ' ' LEU . 7.2 t -107.34 -141.37 0.38 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.106 -0.996 . . . . 0.0 109.897 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.427 ' N ' ' CG2' ' A' ' 44' ' ' THR . 44.4 mt-10 -88.23 -30.78 19.44 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.901 -1.124 . . . . 0.0 110.088 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.21 -64.75 0.91 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 109.702 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 55.4 mt-10 -52.31 -48.56 65.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.181 -0.949 . . . . 0.0 109.333 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.451 ' CB ' ' O ' ' A' ' 44' ' ' THR . 7.5 tt -52.1 -40.84 61.85 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.354 -0.841 . . . . 0.0 109.154 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.4 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 62.8 tp60 -53.91 -44.63 70.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.508 -0.745 . . . . 0.0 109.578 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -57.91 -44.67 86.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.254 -0.904 . . . . 0.0 109.482 179.381 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.41 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 70.1 mtp -59.69 -26.61 65.72 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.319 -0.863 . . . . 0.0 109.842 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.409 HD12 HD23 ' A' ' 32' ' ' LEU . 29.9 mm -77.13 -29.53 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.898 . . . . 0.0 110.157 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -68.31 -43.26 78.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.336 -0.853 . . . . 0.0 110.454 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 51' ' ' MET . 22.7 pt-20 -68.0 -24.97 65.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.3 -0.875 . . . . 0.0 110.565 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.456 HG13 ' CD1' ' A' ' 63' ' ' ILE . 75.9 t -89.33 -21.73 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.178 -0.951 . . . . 0.0 110.113 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -101.49 107.79 19.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.362 -0.836 . . . . 0.0 110.359 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -95.69 17.32 15.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.07 -1.019 . . . . 0.0 110.149 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.408 ' HB2' ' OD1' ' A' ' 60' ' ' ASN . 34.2 m-20 -107.4 -52.24 2.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.354 -0.842 . . . . 0.0 110.046 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.53 19.95 5.6 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.408 ' OD1' ' HB2' ' A' ' 58' ' ' ASP . 22.0 m120 -88.24 -9.23 53.62 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.239 -1.154 . . . . 0.0 110.44 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.25 -38.62 3.15 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.5 p -110.22 160.64 16.33 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.109 -1.23 . . . . 0.0 110.772 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.456 ' CD1' HG13 ' A' ' 55' ' ' VAL . 49.8 mt -95.8 158.32 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.56 -0.713 . . . . 0.0 109.968 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.403 ' N ' HG21 ' A' ' 63' ' ' ILE . 1.1 m-20 -113.87 -170.67 1.75 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.279 -0.888 . . . . 0.0 110.411 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.536 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.8 t80 -77.23 -46.12 2.69 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.842 . . . . 0.0 111.124 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.1 Cg_endo -73.49 -16.15 24.45 Favored 'Trans proline' 0 C--N 1.318 -1.04 0 O-C-N 123.306 1.161 . . . . 0.0 110.403 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -84.46 -34.5 23.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -0.943 . . . . 0.0 109.043 178.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.488 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 5.5 t80 -70.04 -40.27 75.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.606 -0.684 . . . . 0.0 109.532 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.467 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 18.6 tp -76.61 -38.79 54.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.467 -0.771 . . . . 0.0 110.56 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.8 m -71.17 -22.05 62.09 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.163 -0.961 . . . . 0.0 110.656 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.419 ' CE ' ' HE1' ' A' ' 72' ' ' MET . 62.4 ttp -82.3 -51.01 8.31 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.065 -1.022 . . . . 0.0 110.095 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.468 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 57.1 mtt -79.05 -9.69 59.62 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.405 -0.809 . . . . 0.0 110.674 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -75.48 -22.09 57.51 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.103 -0.998 . . . . 0.0 110.31 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.5 ttm-85 -106.38 41.24 1.46 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.2 -0.938 . . . . 0.0 110.043 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -138.85 -178.49 5.34 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.221 -0.924 . . . . 0.0 110.163 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.56 164.91 2.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.12 -0.988 . . . . 0.0 109.962 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -129.43 -176.29 3.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.403 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -143.38 113.95 7.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.36 -0.837 . . . . 0.0 109.765 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 40.8 m -153.97 45.32 0.59 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.255 -0.903 . . . . 0.0 110.501 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -150.96 42.43 0.78 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.07 -1.019 . . . . 0.0 110.232 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.9 m -141.41 -177.4 5.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.246 -0.909 . . . . 0.0 110.354 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -91.24 -152.35 0.28 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.273 -0.892 . . . . 0.0 110.033 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -114.38 -92.81 0.49 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.286 -0.884 . . . . 0.0 110.129 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -101.55 -31.96 10.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.045 -1.035 . . . . 0.0 109.766 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.409 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 97.8 mt -52.87 -33.32 18.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.305 -0.872 . . . . 0.0 109.802 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.401 ' HD3' ' OE2' ' A' ' 87' ' ' GLU . 2.2 ttt180 -64.34 -46.81 81.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 109.353 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.401 ' OE2' ' HD3' ' A' ' 86' ' ' ARG . 4.7 mp0 -57.75 -29.09 64.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.35 -0.844 . . . . 0.0 109.66 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.508 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -65.92 -62.89 1.25 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.365 -0.834 . . . . 0.0 110.148 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.433 ' CE1' ' HA ' ' A' ' 138' ' ' TYR . 1.9 t80 -50.01 -29.35 8.47 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.357 -0.839 . . . . 0.0 110.416 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -68.44 -55.15 12.84 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.136 -0.977 . . . . 0.0 110.714 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 88' ' ' ALA . 29.7 m -63.72 -20.66 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.132 -0.98 . . . . 0.0 110.344 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.518 ' CZ ' ' H3 ' ' A' ' 154' ' ' WW7 . 24.6 m-85 -92.52 -14.06 28.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 0.0 110.34 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -123.93 66.25 1.04 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.234 -0.916 . . . . 0.0 109.714 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -95.61 61.97 2.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.863 . . . . 0.0 110.552 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.8 p30 -164.34 -35.84 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.117 -0.989 . . . . 0.0 110.717 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.454 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 110.04 38.88 1.62 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.445 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 3.8 t-20 -92.81 -57.97 2.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.389 -1.066 . . . . 0.0 110.184 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.425 ' C ' ' CD1' ' A' ' 99' ' ' TYR . . . 121.59 -22.31 7.81 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 27.4 m-85 -131.72 158.69 40.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.152 -1.205 . . . . 0.0 110.306 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.568 ' CD1' ' CD1' ' A' ' 141' ' ' PHE . 70.9 mt -93.89 135.49 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.331 -0.856 . . . . 0.0 110.587 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.5 t -117.47 176.0 5.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.498 -0.751 . . . . 0.0 109.837 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.63 -37.59 76.86 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.204 -0.935 . . . . 0.0 110.515 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.33 -59.03 6.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.19 -0.944 . . . . 0.0 110.258 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -52.54 -48.51 66.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.266 -0.896 . . . . 0.0 110.086 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.437 HD22 ' CG1' ' A' ' 121' ' ' VAL . 14.7 tp -54.38 -34.63 61.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -0.89 . . . . 0.0 110.356 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.9 ttt-85 -69.79 -33.29 72.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.08 -1.013 . . . . 0.0 110.367 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 53.2 m170 -68.04 -38.53 82.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.27 -0.894 . . . . 0.0 110.49 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.402 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 97.0 t -73.91 -49.59 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.165 -0.96 . . . . 0.0 110.558 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 105' ' ' LEU . 22.9 mmt -51.68 -62.69 1.47 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.221 -0.925 . . . . 0.0 110.886 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.6 p -44.96 -27.8 0.59 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.34 -0.85 . . . . 0.0 111.018 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 4.5 m120 -81.3 -39.7 24.8 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.007 -1.058 . . . . 0.0 110.68 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.5 mt -72.41 -15.54 61.84 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.29 -0.881 . . . . 0.0 110.383 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.48 53.12 1.08 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.431 ' HB3' ' CD1' ' A' ' 116' ' ' LEU . 13.5 mm-40 -128.49 100.44 5.77 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.341 -1.094 . . . . 0.0 110.098 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -87.88 106.8 18.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 110.213 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.431 ' CD1' ' HB3' ' A' ' 114' ' ' GLU . 4.3 mp -129.99 -178.37 4.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 0.0 109.998 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.8 m -102.77 155.94 17.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.135 -0.978 . . . . 0.0 110.224 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.408 ' O ' ' OD2' ' A' ' 122' ' ' ASP . 45.5 m-20 -49.16 -43.06 41.54 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.227 -0.921 . . . . 0.0 110.191 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -60.98 -42.59 98.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.187 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -52.37 -59.51 4.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.294 -0.879 . . . . 0.0 110.245 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.437 ' CG1' HD22 ' A' ' 105' ' ' LEU . 42.1 t -53.29 -45.51 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.099 -1.001 . . . . 0.0 110.051 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.408 ' OD2' ' O ' ' A' ' 118' ' ' ASP . 60.3 m-20 -52.49 -37.34 57.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.966 . . . . 0.0 109.77 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -70.67 -33.67 71.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.354 -0.842 . . . . 0.0 110.002 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 5.9 mmm -61.91 -55.35 30.48 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.279 -0.888 . . . . 0.0 110.066 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 22.8 mm -58.47 -38.86 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.272 -0.892 . . . . 0.0 110.1 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -71.24 -22.43 61.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.255 -0.903 . . . . 0.0 110.158 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.4 ' O ' ' OE1' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -76.28 -42.16 46.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 109.88 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.461 ' CB ' ' H6 ' ' A' ' 154' ' ' WW7 . . . -70.42 -33.68 71.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.025 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -59.58 97.64 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.147 -0.97 . . . . 0.0 109.895 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.8 mt -73.16 -44.12 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.396 -0.815 . . . . 0.0 111.421 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.5 p30 -85.62 -31.2 22.72 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.072 -1.018 . . . . 0.0 110.938 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 97.97 54.05 1.23 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -95.16 14.92 20.5 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.237 -1.155 . . . . 0.0 110.216 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 64.74 21.9 67.69 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.496 ' OE1' ' CD2' ' A' ' 99' ' ' TYR . 1.1 pp0? -170.1 140.87 2.03 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.588 -0.948 . . . . 0.0 109.719 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.4 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 70.8 t -86.11 149.39 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.154 -0.967 . . . . 0.0 110.307 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.462 ' OD1' ' CE2' ' A' ' 99' ' ' TYR . 48.3 t30 -125.83 169.32 12.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.158 -0.964 . . . . 0.0 110.272 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.461 ' C ' ' CD1' ' A' ' 138' ' ' TYR . 8.1 t80 -58.26 -51.01 71.57 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.401 -0.812 . . . . 0.0 110.671 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -54.99 -54.74 39.12 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.158 -0.964 . . . . 0.0 110.354 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.45 ' O ' ' CG ' ' A' ' 144' ' ' MET . 46.5 mt-10 -61.29 -20.71 63.2 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.155 -0.965 . . . . 0.0 109.932 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.568 ' CD1' ' CD1' ' A' ' 100' ' ' ILE . 13.4 t80 -75.71 -28.74 58.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.351 -0.843 . . . . 0.0 110.53 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.9 t -87.46 -23.44 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.214 -0.928 . . . . 0.0 110.998 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -101.78 -9.61 20.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.074 -1.016 . . . . 0.0 110.951 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.45 ' CG ' ' O ' ' A' ' 140' ' ' GLU . 0.1 OUTLIER -89.09 -28.31 20.18 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.022 -1.049 . . . . 0.0 110.132 179.706 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.405 ' HE2' ' HE1' ' A' ' 144' ' ' MET . 32.4 ttm -89.73 -43.11 10.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 110.284 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.9 t -54.63 -21.71 11.36 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.202 -0.936 . . . . 0.0 109.997 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -49.36 123.48 7.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.233 -0.917 . . . . 0.0 110.177 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 27.4 pttt . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.272 179.967 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' WW7 . . . . . 0.507 ' H3 ' ' CZ ' ' A' ' 19' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' WW7 . . . . . 0.528 ' N2 ' H131 ' A' ' 154' ' ' WW7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.389 0.614 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -76.59 -49.7 15.69 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.239 -0.913 . . . . 0.0 110.262 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -134.51 140.24 46.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.229 -0.919 . . . . 0.0 110.026 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.0 137.38 54.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.096 -1.002 . . . . 0.0 110.371 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.64 -74.23 0.06 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.288 -0.883 . . . . 0.0 110.201 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -83.25 -22.78 32.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.039 -1.038 . . . . 0.0 109.661 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -55.9 -28.47 56.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.242 -0.911 . . . . 0.0 109.541 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -66.97 -41.99 85.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.424 -0.798 . . . . 0.0 109.606 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.3 mt -60.79 -45.14 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.413 -0.804 . . . . 0.0 109.832 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.9 -42.67 98.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.82 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -55.25 -45.17 76.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.313 -0.867 . . . . 0.0 109.773 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.512 ' CE2' ' HB3' ' A' ' 73' ' ' ALA . 12.6 m-85 -56.97 -51.76 67.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 0.0 109.81 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -51.54 -34.77 38.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.0 110.261 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -66.54 -41.77 88.18 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.134 -0.979 . . . . 0.0 110.02 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.478 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . . . -63.87 -47.02 82.35 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.216 -0.928 . . . . 0.0 110.146 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -62.53 -33.08 74.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -0.903 . . . . 0.0 109.814 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.1 m -71.09 -32.64 69.31 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.277 -0.889 . . . . 0.0 109.468 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.443 ' CD1' ' O ' ' A' ' 18' ' ' LEU . 3.4 tm? -78.22 -23.74 47.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.482 -0.761 . . . . 0.0 109.878 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.478 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 15.7 m-30 -83.25 -67.03 0.82 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.351 -0.843 . . . . 0.0 109.786 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.409 ' OD2' ' HA2' ' A' ' 23' ' ' GLY . 46.1 t0 -48.43 111.75 0.5 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.248 -0.907 . . . . 0.0 109.832 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -78.53 -58.41 3.27 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.209 -0.932 . . . . 0.0 110.824 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.424 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 8.6 p-10 -69.34 -41.75 76.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.147 -0.971 . . . . 0.0 109.978 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.409 ' HA2' ' OD2' ' A' ' 20' ' ' ASP . . . 98.69 46.18 2.16 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 2.6 p30 -95.07 -24.87 16.69 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.054 -1.263 . . . . 0.0 110.051 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.434 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 109.83 32.5 2.86 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.422 HG21 ' O ' ' A' ' 25' ' ' GLY . 69.5 p -153.98 150.51 28.36 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.165 -1.197 . . . . 0.0 110.242 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 95.2 mt -117.67 107.96 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.27 -0.894 . . . . 0.0 110.131 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.421 ' CG2' HG22 ' A' ' 62' ' ' THR . 73.1 p -101.0 -174.31 2.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.834 . . . . 0.0 110.097 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.5 p -74.87 -24.84 58.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 110.06 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -71.75 -62.46 1.41 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.09 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -56.88 -49.27 76.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.091 -1.006 . . . . 0.0 109.709 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.443 ' CD1' 'CL1 ' ' A' ' 153' ' ' WW7 . 1.9 tp -60.36 -31.46 70.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.274 -0.891 . . . . 0.0 109.529 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.51 -43.12 96.17 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.404 ' O ' ' HB2' ' A' ' 38' ' ' SER . 30.7 m -73.74 -24.95 59.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.396 -1.061 . . . . 0.0 109.891 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.5 t -70.64 -33.65 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.356 -0.84 . . . . 0.0 110.253 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.2 mmt -89.24 -23.93 22.22 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.356 -0.84 . . . . 0.0 110.382 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.418 ' NH1' ' HG2' ' A' ' 37' ' ' ARG . 11.3 tpt180 -90.62 -11.24 40.5 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.226 -0.921 . . . . 0.0 110.738 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 34' ' ' THR . 23.8 t -67.8 -68.92 0.35 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.106 -0.996 . . . . 0.0 110.414 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.461 HD13 ' C16' ' A' ' 153' ' ' WW7 . 0.5 OUTLIER -139.42 68.39 1.37 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.301 -0.874 . . . . 0.0 110.179 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -158.89 -109.99 0.27 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -112.46 -164.54 0.92 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.319 -1.106 . . . . 0.0 110.05 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -124.82 64.53 42.58 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 110.453 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 152.49 51.71 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.862 1.454 . . . . 0.0 110.368 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.448 ' O ' ' CB ' ' A' ' 48' ' ' LEU . 35.6 m -100.73 173.47 6.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.183 -0.948 . . . . 0.0 109.826 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -66.78 -22.73 66.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.143 -0.973 . . . . 0.0 110.353 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.15 -70.96 0.41 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.124 -0.985 . . . . 0.0 109.991 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -52.56 -30.54 31.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.287 -0.883 . . . . 0.0 109.251 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.448 ' CB ' ' O ' ' A' ' 44' ' ' THR . 5.5 tt -66.56 -46.52 75.78 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.462 -0.774 . . . . 0.0 109.361 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.401 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 2.0 tt0 -50.62 -39.25 49.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.293 -0.879 . . . . 0.0 108.812 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.98 -45.7 93.74 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.211 178.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.414 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 0.4 OUTLIER -57.24 -24.37 54.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.404 178.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.433 HD13 ' CD2' ' A' ' 32' ' ' LEU . 46.9 mm -83.3 -31.26 8.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.456 -0.778 . . . . 0.0 109.913 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -76.38 -24.3 54.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.284 -0.885 . . . . 0.0 110.243 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.467 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 24.0 pt-20 -84.72 -36.23 21.97 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.193 -0.942 . . . . 0.0 110.377 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.467 ' N ' ' HG3' ' A' ' 54' ' ' GLU . 71.2 t -77.18 -32.67 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.128 -0.982 . . . . 0.0 109.942 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -97.1 100.46 11.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.342 -0.848 . . . . 0.0 110.169 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -100.21 22.74 11.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.164 -0.96 . . . . 0.0 110.042 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.413 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 29.5 m-20 -92.8 -56.57 2.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 110.133 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.94 25.93 1.45 Allowed Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.244 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -110.18 -41.32 4.45 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.825 -1.397 . . . . 0.0 110.005 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.14 -81.89 0.28 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.514 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.421 HG22 ' CG2' ' A' ' 28' ' ' THR . 69.7 p -79.26 170.71 16.22 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.324 -1.104 . . . . 0.0 111.025 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.406 ' CD1' HG13 ' A' ' 55' ' ' VAL . 65.7 mt -97.01 153.93 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.301 -0.874 . . . . 0.0 110.337 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 0.8 OUTLIER -105.86 -171.55 1.92 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.241 -0.912 . . . . 0.0 110.258 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.531 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 33.6 t80 -82.43 -41.88 0.94 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.343 -0.848 . . . . 0.0 111.76 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.0 Cg_endo -74.61 -20.26 18.03 Favored 'Trans proline' 0 C--N 1.323 -0.768 0 O-C-N 123.006 1.003 . . . . 0.0 110.187 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 71' ' ' MET . 41.9 tt0 -83.71 -28.46 28.27 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.22 -0.925 . . . . 0.0 109.408 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 6.5 t80 -74.58 -46.59 37.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.625 -0.672 . . . . 0.0 110.118 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.416 ' CD2' ' C ' ' A' ' 69' ' ' LEU . 8.3 tt -74.03 -32.91 63.55 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.288 -0.883 . . . . 0.0 110.609 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 66' ' ' PRO . 89.1 m -79.35 -22.4 44.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.245 -0.909 . . . . 0.0 110.892 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.493 ' HE1' ' CE ' ' A' ' 72' ' ' MET . 11.6 ptt? -89.65 -26.37 20.77 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.927 -1.108 . . . . 0.0 110.904 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.493 ' CE ' ' HE1' ' A' ' 71' ' ' MET . 52.5 mtt -90.72 -55.57 3.52 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.053 -1.029 . . . . 0.0 111.191 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.512 ' HB3' ' CE2' ' A' ' 12' ' ' PHE . . . -60.04 -57.88 10.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.259 -0.901 . . . . 0.0 110.772 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -110.81 65.04 0.61 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.246 -0.909 . . . . 0.0 110.692 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.455 ' HG3' ' N ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -58.6 -21.06 52.33 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.2 -0.938 . . . . 0.0 109.946 179.75 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.455 ' N ' ' HG3' ' A' ' 75' ' ' LYS . 31.4 ttm -89.12 95.97 10.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.314 -0.867 . . . . 0.0 110.326 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -103.97 153.89 20.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 110.125 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -174.97 99.68 0.08 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.106 -0.996 . . . . 0.0 110.383 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.4 m -88.51 -176.71 5.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.157 -0.964 . . . . 0.0 109.839 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -116.18 122.74 45.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.126 -0.984 . . . . 0.0 110.39 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.4 p -109.89 -161.54 0.76 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.186 -0.946 . . . . 0.0 109.849 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -175.36 157.19 2.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -0.957 . . . . 0.0 110.278 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 56.75 21.75 6.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.864 . . . . 0.0 110.164 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -110.03 -44.93 3.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.37 -0.831 . . . . 0.0 109.911 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.7 mt -58.35 -17.17 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.895 . . . . 0.0 109.93 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -68.54 -52.27 33.88 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.154 -0.966 . . . . 0.0 109.533 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 38.8 mm-40 -61.66 -35.21 77.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 109.801 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.464 ' O ' ' CG2' ' A' ' 91' ' ' VAL . . . -61.65 -61.14 2.73 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.221 -0.924 . . . . 0.0 109.737 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.478 ' CE2' ' HA ' ' A' ' 138' ' ' TYR . 31.9 t80 -54.44 -22.32 12.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.23 -0.919 . . . . 0.0 110.084 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 5.3 mtp180 -67.91 -44.98 75.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.097 -1.002 . . . . 0.0 109.817 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.464 ' CG2' ' O ' ' A' ' 88' ' ' ALA . 30.2 m -78.43 -21.59 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.344 -0.848 . . . . 0.0 110.576 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.512 ' CE2' ' H2 ' ' A' ' 154' ' ' WW7 . 38.4 m-85 -86.48 -15.5 39.95 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.129 -0.982 . . . . 0.0 110.587 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -124.44 47.78 2.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.219 -0.925 . . . . 0.0 110.223 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -106.49 40.4 1.63 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.324 -0.86 . . . . 0.0 110.163 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -124.35 -25.66 4.05 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.278 -0.888 . . . . 0.0 110.54 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 119.37 -32.02 5.21 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -47.34 -38.63 13.27 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.335 -1.097 . . . . 0.0 110.462 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.462 ' C ' ' CD1' ' A' ' 99' ' ' TYR . . . 97.19 -14.72 63.37 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.542 ' CD2' ' NE2' ' A' ' 135' ' ' GLN . 46.4 m-85 -135.03 168.47 19.06 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.114 -1.227 . . . . 0.0 110.118 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.424 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 37.1 mt -87.01 126.58 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.269 -0.895 . . . . 0.0 109.983 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.0 m -113.67 175.26 5.53 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.456 -0.777 . . . . 0.0 109.665 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.9 -43.68 78.69 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.136 -0.977 . . . . 0.0 110.279 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.67 -52.13 62.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.282 -0.886 . . . . 0.0 110.23 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -53.71 -53.3 54.07 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.221 -0.924 . . . . 0.0 110.126 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.5 tt -49.73 -39.43 37.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.268 -0.895 . . . . 0.0 110.247 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.405 ' O ' HG22 ' A' ' 110' ' ' THR . 44.0 ttt-85 -64.09 -38.84 92.51 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.22 -0.925 . . . . 0.0 110.41 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.405 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 54.2 t-80 -72.23 -19.19 61.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.255 -0.903 . . . . 0.0 110.524 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.451 HG12 ' CE1' ' A' ' 92' ' ' PHE . 90.1 t -84.4 -46.39 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.192 -0.943 . . . . 0.0 110.624 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.6 mmt -61.12 -48.17 82.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.141 -0.974 . . . . 0.0 110.668 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 106' ' ' ARG . 47.0 p -49.24 -37.44 23.35 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.207 -0.933 . . . . 0.0 110.56 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.405 ' ND2' ' O ' ' A' ' 107' ' ' HIS . 76.7 m-20 -73.39 -48.62 32.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.288 -0.882 . . . . 0.0 110.455 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.8 mt -59.14 -21.79 59.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 110.37 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.8 46.89 4.69 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.426 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 6.0 mm-40 -110.37 -29.5 8.09 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.26 -1.141 . . . . 0.0 110.197 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 114' ' ' GLU . 47.4 tttt 55.46 99.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.337 -0.852 . . . . 0.0 110.418 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.68 151.73 48.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.282 -0.886 . . . . 0.0 110.183 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.2 m -76.52 157.68 31.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 109.998 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -64.59 -42.91 95.28 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.229 -0.919 . . . . 0.0 110.354 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -56.63 -40.01 74.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.116 -0.99 . . . . 0.0 110.307 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 124' ' ' MET . 33.7 mt-10 -63.31 -46.37 87.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.162 -0.961 . . . . 0.0 110.159 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 124' ' ' MET . 95.1 t -55.27 -51.5 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.045 -1.034 . . . . 0.0 110.214 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -55.65 -46.99 77.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 110.229 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -62.9 -25.17 68.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -0.924 . . . . 0.0 110.237 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.419 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 73.7 mtp -73.84 -46.68 43.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.048 -1.032 . . . . 0.0 109.971 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 30.6 mm -61.29 -30.68 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.11 -0.994 . . . . 0.0 110.011 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.61 -43.46 47.98 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.246 -0.908 . . . . 0.0 110.265 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -67.43 -24.95 65.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.926 . . . . 0.0 110.071 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.75 -35.84 24.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.888 . . . . 0.0 110.204 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.401 ' OD2' ' HA2' ' A' ' 132' ' ' GLY . 23.1 t0 -61.32 96.09 0.05 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.922 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 89.4 mt -67.77 -64.33 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.316 -0.865 . . . . 0.0 110.885 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.403 ' OD1' ' OE2' ' A' ' 140' ' ' GLU . 29.4 p30 -73.71 -19.79 60.71 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.234 -0.917 . . . . 0.0 110.906 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.401 ' HA2' ' OD2' ' A' ' 129' ' ' ASP . . . 80.66 75.4 1.08 Allowed Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.881 -1.152 . . . . 0.0 110.395 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 31.7 m-20 -111.35 -23.97 10.48 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.167 -1.196 . . . . 0.0 110.024 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 135.78 -39.3 1.68 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.542 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -132.76 170.71 14.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.567 -0.961 . . . . 0.0 109.69 179.633 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.424 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 91.1 t -95.28 133.83 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.972 -1.08 . . . . 0.0 110.231 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -102.56 170.58 7.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.113 -0.992 . . . . 0.0 110.1 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.478 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 21.7 t80 -56.06 -47.18 78.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.23 -0.918 . . . . 0.0 110.462 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -55.73 -55.53 31.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -0.955 . . . . 0.0 110.273 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.403 ' OE2' ' OD1' ' A' ' 131' ' ' ASP . 52.6 mt-10 -58.35 -26.46 63.14 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.312 -0.867 . . . . 0.0 110.239 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.456 ' CE1' ' HE2' ' A' ' 145' ' ' MET . 9.7 t80 -70.43 -32.1 69.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.253 -0.904 . . . . 0.0 110.151 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 87.0 t -82.33 -29.01 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.272 -0.892 . . . . 0.0 110.369 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -80.53 -23.79 39.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.275 -0.891 . . . . 0.0 110.424 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 54.7 ttp -80.51 -32.88 36.82 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.141 -0.975 . . . . 0.0 110.432 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.456 ' HE2' ' CE1' ' A' ' 141' ' ' PHE . 1.7 ttm -84.23 -11.47 56.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.246 -0.909 . . . . 0.0 110.803 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.7 p -118.4 133.46 55.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.092 -1.005 . . . . 0.0 110.214 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 58.57 157.82 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.251 -0.906 . . . . 0.0 110.674 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.177 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' WW7 . . . . . 0.461 ' C16' HD13 ' A' ' 39' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' WW7 . . . . . 0.512 ' H2 ' ' CE2' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.365 0.602 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -110.72 150.47 29.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.251 -0.906 . . . . 0.0 110.269 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.458 ' O ' ' N ' ' A' ' 5' ' ' THR . 69.4 mt-30 -81.6 5.74 17.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.19 -0.944 . . . . 0.0 110.399 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.44 ' O ' ' OG1' ' A' ' 5' ' ' THR . 7.6 mp 53.51 -88.8 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.283 -0.885 . . . . 0.0 110.533 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.458 ' N ' ' O ' ' A' ' 3' ' ' GLN . 3.7 p 54.65 -168.87 0.07 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.318 -0.864 . . . . 0.0 110.45 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -58.68 -17.21 20.58 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.313 -0.867 . . . . 0.0 110.815 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -66.95 -37.81 84.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.024 -1.047 . . . . 0.0 109.93 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.464 ' HG3' ' CE2' ' A' ' 12' ' ' PHE . 21.6 tp60 -72.33 -55.39 7.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.352 -0.842 . . . . 0.0 110.18 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.1 mt -52.2 -38.92 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 109.884 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 13' ' ' LYS . . . -65.87 -36.76 84.33 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.282 -0.886 . . . . 0.0 109.449 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -59.3 -50.05 75.48 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.388 -0.82 . . . . 0.0 109.832 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.464 ' CE2' ' HG3' ' A' ' 8' ' ' GLN . 23.0 m-85 -63.6 -32.66 74.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.279 -0.888 . . . . 0.0 109.918 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 31.7 mtpt -65.46 -36.62 84.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.27 -0.894 . . . . 0.0 110.163 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -69.63 -38.4 77.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 0.0 109.715 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.458 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -64.32 -39.46 93.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.289 -0.882 . . . . 0.0 109.999 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.401 ' CE2' HD13 ' A' ' 27' ' ' ILE . 64.2 t80 -62.52 -57.51 10.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.137 -0.977 . . . . 0.0 110.238 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.9 p -55.64 -26.53 44.88 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.264 -0.897 . . . . 0.0 109.516 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.46 HD11 ' CE1' ' A' ' 19' ' ' PHE . 2.1 tm? -71.91 -36.88 70.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.407 -0.808 . . . . 0.0 109.978 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.517 ' CD1' HG12 ' A' ' 35' ' ' VAL . 15.4 m-85 -71.04 -56.49 6.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.062 -1.024 . . . . 0.0 109.538 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.79 101.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.425 -0.797 . . . . 0.0 109.997 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.6 mmtt -67.0 -42.79 84.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 109.979 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 53.0 p-10 -86.56 -15.18 40.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.334 -0.854 . . . . 0.0 110.598 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.426 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 67.8 37.67 88.77 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -79.85 -17.75 52.47 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.359 -1.083 . . . . 0.0 110.502 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.97 -21.79 22.18 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.374 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.4 p -119.72 158.08 27.23 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.923 -1.339 . . . . 0.0 110.786 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.401 HD13 ' CE2' ' A' ' 16' ' ' PHE . 96.3 mt -117.08 125.99 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.421 -0.799 . . . . 0.0 110.08 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.1 p -104.35 -162.49 0.9 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.0 110.121 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.419 ' HA ' HD22 ' A' ' 48' ' ' LEU . 20.1 p -87.81 -39.94 14.46 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.132 -0.98 . . . . 0.0 110.924 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -57.48 10.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.036 -1.04 . . . . 0.0 110.401 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -57.04 -42.1 79.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.949 . . . . 0.0 109.671 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.401 ' O ' ' HG2' ' A' ' 36' ' ' MET . 5.3 tp -63.37 -28.38 69.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.35 -0.843 . . . . 0.0 109.747 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.97 -47.71 79.47 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.414 ' O ' ' OG ' ' A' ' 38' ' ' SER . 86.5 m -66.74 -28.5 68.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.269 -1.136 . . . . 0.0 109.554 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.517 HG12 ' CD1' ' A' ' 19' ' ' PHE . 37.7 t -73.17 -28.28 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.48 -0.763 . . . . 0.0 110.102 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 25.7 mmt -83.4 -25.73 31.04 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.212 -0.93 . . . . 0.0 110.121 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -89.67 -16.7 29.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.888 . . . . 0.0 110.217 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 34' ' ' THR . 50.6 m -50.96 -54.56 23.24 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.319 -0.863 . . . . 0.0 110.232 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.8 39.93 1.83 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.306 -0.871 . . . . 0.0 110.337 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -131.39 -100.71 0.84 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -138.3 -155.79 0.63 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -1.157 . . . . 0.0 110.006 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -125.12 69.03 58.45 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.118 -0.989 . . . . 0.0 110.165 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 -160.95 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.906 1.477 . . . . 0.0 110.109 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.4 m -134.73 166.5 22.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.127 -0.983 . . . . 0.0 110.266 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.407 ' HA ' ' OE1' ' A' ' 45' ' ' GLU . 5.9 mm-40 -63.24 -22.64 67.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.221 -0.924 . . . . 0.0 110.166 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.3 -70.03 0.39 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.102 -0.999 . . . . 0.0 110.043 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -50.57 -31.73 16.6 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.301 -0.875 . . . . 0.0 109.923 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 29' ' ' THR . 5.6 tt -62.9 -50.88 69.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 110.066 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.419 ' O ' ' OD1' ' A' ' 53' ' ' ASN . 37.4 tt0 -53.3 -42.81 67.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.119 -0.988 . . . . 0.0 109.306 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -62.35 -34.75 77.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.631 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.417 ' HG2' ' H7 ' ' A' ' 153' ' ' WW7 . 4.7 ttp -68.94 -22.27 64.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.412 -0.805 . . . . 0.0 109.787 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.413 HD13 HD22 ' A' ' 48' ' ' LEU . 35.9 mt -87.38 -30.05 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.328 -0.857 . . . . 0.0 109.979 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 49' ' ' GLN . 3.6 m-20 -51.77 -42.93 62.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.171 -0.955 . . . . 0.0 110.079 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 13.3 pt-20 -68.57 -29.98 68.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.228 -0.92 . . . . 0.0 110.419 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 57' ' ' ALA . 67.2 t -75.88 -69.87 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.208 -0.933 . . . . 0.0 110.166 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -43.17 94.15 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.541 -0.724 . . . . 0.0 110.881 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -109.89 61.4 0.6 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 109.773 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 1.7 p30 -164.0 -33.44 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.337 -0.852 . . . . 0.0 110.941 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.443 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 105.74 47.85 1.07 Allowed Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.098 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -117.73 -12.78 10.21 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.265 -1.138 . . . . 0.0 110.332 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.68 -56.59 4.14 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 59.4 p -109.31 170.3 8.14 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.255 -1.144 . . . . 0.0 110.248 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.44 ' CD1' 'CL1 ' ' A' ' 153' ' ' WW7 . 39.6 mt -89.79 139.34 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.155 -0.966 . . . . 0.0 110.143 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.423 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 0.8 OUTLIER -103.56 179.68 4.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.219 -0.926 . . . . 0.0 110.176 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.544 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.2 t80 -73.56 -46.53 7.36 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 0.0 111.003 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.0 Cg_endo -71.66 -22.34 24.26 Favored 'Trans proline' 0 N--CA 1.482 0.807 0 O-C-N 123.186 1.098 . . . . 0.0 110.419 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -81.37 -37.69 27.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.173 -0.954 . . . . 0.0 109.166 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.421 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 16.6 t80 -66.52 -38.73 87.82 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.525 -0.735 . . . . 0.0 109.867 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.455 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 1.1 tt -72.83 -36.35 67.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.354 -0.841 . . . . 0.0 110.059 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 92.7 m -76.22 -12.43 60.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.102 -0.999 . . . . 0.0 110.3 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.1 tmm? -89.09 -44.41 10.37 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.105 -0.997 . . . . 0.0 110.837 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.411 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 64.6 mtt -90.48 -37.76 13.69 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.028 -1.045 . . . . 0.0 111.135 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -57.4 -17.82 14.77 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.178 -0.951 . . . . 0.0 110.57 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -50.01 -29.39 8.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.208 -0.933 . . . . 0.0 110.648 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 76' ' ' MET . 14.5 tptt -60.66 97.69 0.06 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.221 -0.925 . . . . 0.0 110.729 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.41 ' O ' ' O ' ' A' ' 75' ' ' LYS . 56.9 mtm 48.3 -174.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.191 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.43 145.0 0.31 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.095 -1.003 . . . . 0.0 110.328 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -149.05 133.61 17.69 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.335 -0.853 . . . . 0.0 110.004 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 86.9 m -142.34 143.56 32.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.255 -0.903 . . . . 0.0 110.288 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -178.33 80.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.361 -0.837 . . . . 0.0 110.049 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 56.2 m -96.82 -173.52 2.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.316 -0.865 . . . . 0.0 110.296 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.461 ' OE1' ' N ' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -86.81 125.03 33.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.307 -0.871 . . . . 0.0 110.103 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -179.76 98.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -0.935 . . . . 0.0 110.336 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.78 -43.07 98.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.233 -0.917 . . . . 0.0 110.058 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 84.3 mt -53.42 -37.79 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.377 -0.827 . . . . 0.0 110.365 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.69 -55.44 23.37 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.136 -0.977 . . . . 0.0 109.777 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -49.46 -41.04 39.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.278 -0.889 . . . . 0.0 110.003 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.443 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -59.06 -59.9 4.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 110.028 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.403 ' O ' ' HB3' ' A' ' 93' ' ' ASP . 11.9 t80 -50.49 -22.58 1.99 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.314 -0.866 . . . . 0.0 110.134 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.3 ttt180 -72.26 -58.39 3.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 110.701 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.462 HG21 ' N ' ' A' ' 92' ' ' PHE . 30.3 m -60.19 -32.37 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.033 -1.042 . . . . 0.0 110.117 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.559 ' CE1' ' CG1' ' A' ' 108' ' ' VAL . 36.5 m-85 -80.47 -19.21 46.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.237 -0.914 . . . . 0.0 110.177 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.427 ' OD2' ' HA2' ' A' ' 98' ' ' GLY . 52.6 t0 -123.59 57.83 1.16 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.279 -0.888 . . . . 0.0 109.943 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.8 pttm -88.73 39.47 0.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.245 -0.91 . . . . 0.0 110.455 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.429 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 1.5 p30 -125.85 -30.64 2.99 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.31 -0.869 . . . . 0.0 110.316 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.93 38.78 3.06 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.721 -1.228 . . . . 0.0 111.006 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.507 ' O ' ' CE2' ' A' ' 99' ' ' TYR . 30.2 p30 -129.49 -21.84 3.11 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.75 -1.441 . . . . 0.0 110.99 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.507 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 79.93 48.65 6.44 Favored Glycine 0 N--CA 1.494 2.502 0 O-C-N 120.866 -1.146 . . . . 0.0 110.314 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 62.8 m-85 -151.19 142.53 23.36 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.172 -1.193 . . . . 0.0 110.323 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.459 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 21.2 mt -111.75 110.81 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.142 -0.974 . . . . 0.0 109.505 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.5 p -104.3 151.81 22.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.893 . . . . 0.0 110.181 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -46.84 -28.59 1.62 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.29 -0.881 . . . . 0.0 110.181 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.25 -56.01 10.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.281 -0.887 . . . . 0.0 110.241 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.461 ' O ' ' CG2' ' A' ' 108' ' ' VAL . 53.6 mt-10 -58.21 -31.13 67.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.206 -0.934 . . . . 0.0 110.182 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.468 ' CD2' HG11 ' A' ' 121' ' ' VAL . 39.5 tp -69.73 -34.59 74.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.973 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -77.79 -19.84 54.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.372 -0.83 . . . . 0.0 110.019 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -91.89 -20.29 21.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 0.0 110.167 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.559 ' CG1' ' CE1' ' A' ' 92' ' ' PHE . 46.5 t -92.43 -50.83 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.165 -0.959 . . . . 0.0 110.1 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 17.1 mmt -46.96 -34.35 5.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.333 -0.854 . . . . 0.0 110.512 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.1 p -62.98 -51.89 65.11 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.236 -0.915 . . . . 0.0 109.708 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -53.67 -42.75 68.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.343 -0.848 . . . . 0.0 110.164 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.4 mt -59.82 -37.7 79.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.282 -0.886 . . . . 0.0 110.152 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 125.03 -20.15 6.75 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -82.58 107.61 15.35 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.274 -1.133 . . . . 0.0 110.361 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -85.83 126.69 34.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.838 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 mt -130.38 156.95 43.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.204 -0.935 . . . . 0.0 110.287 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 91.7 m -91.37 155.44 18.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.28 -0.887 . . . . 0.0 110.393 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -46.42 -35.83 5.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.339 -0.851 . . . . 0.0 110.637 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -59.7 -64.38 0.97 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.155 -0.966 . . . . 0.0 110.669 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -50.24 -44.73 53.54 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.118 -0.989 . . . . 0.0 110.322 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.468 HG11 ' CD2' ' A' ' 105' ' ' LEU . 40.5 t -53.15 -48.23 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 110.056 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -61.22 -30.82 70.67 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.281 -0.887 . . . . 0.0 110.026 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -69.62 -36.92 76.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.337 -0.852 . . . . 0.0 110.168 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.1 mtp -71.98 -54.57 9.53 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.252 -0.905 . . . . 0.0 110.377 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.424 ' CD1' 'CL1 ' ' A' ' 154' ' ' WW7 . 20.7 mm -52.42 -37.14 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.157 -0.964 . . . . 0.0 109.879 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 43.1 ttt-85 -66.84 -50.79 61.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.365 -0.835 . . . . 0.0 110.533 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -63.22 -21.0 65.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.177 -0.952 . . . . 0.0 110.492 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.57 -16.96 25.04 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.174 -0.954 . . . . 0.0 110.652 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -82.44 78.49 9.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.04 -1.038 . . . . 0.0 109.955 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.429 HD13 ' CB ' ' A' ' 140' ' ' GLU . 14.4 mt -48.95 -57.41 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.46 -0.775 . . . . 0.0 110.809 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 27.4 p30 -81.55 -19.12 42.71 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.035 -1.041 . . . . 0.0 110.903 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 76.5 69.24 1.42 Allowed Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.938 -1.125 . . . . 0.0 110.457 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.405 ' O ' ' HG2' ' A' ' 135' ' ' GLN . 53.8 m-20 -111.77 19.24 18.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.123 -1.222 . . . . 0.0 109.848 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 68.78 18.01 71.86 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 135' ' ' GLN . 2.1 pt20 -170.46 138.75 1.56 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.309 -1.113 . . . . 0.0 109.916 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 57.7 t -94.44 123.54 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.141 -0.974 . . . . 0.0 110.044 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -93.67 175.53 6.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.169 -0.957 . . . . 0.0 109.977 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.411 ' O ' HG22 ' A' ' 142' ' ' VAL . 23.5 t80 -59.06 -48.76 80.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.254 -0.904 . . . . 0.0 110.603 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.38 -50.83 64.28 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.103 -0.998 . . . . 0.0 110.665 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.429 ' CB ' HD13 ' A' ' 130' ' ' ILE . 54.4 mt-10 -64.03 -28.28 69.69 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.114 -0.991 . . . . 0.0 110.126 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.516 ' CZ ' ' HE2' ' A' ' 145' ' ' MET . 13.8 t80 -73.0 -20.9 60.92 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.335 -0.853 . . . . 0.0 110.03 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.433 ' O ' ' CG2' ' A' ' 146' ' ' THR . 79.0 t -87.39 -32.93 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.312 -0.868 . . . . 0.0 110.624 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.3 -20.1 32.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.133 -0.979 . . . . 0.0 111.272 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.476 ' CE ' ' HE2' ' A' ' 145' ' ' MET . 19.9 ptt? -82.82 -32.6 27.53 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.864 -1.147 . . . . 0.0 110.964 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.516 ' HE2' ' CZ ' ' A' ' 141' ' ' PHE . 54.9 mtt -90.48 -27.36 19.27 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.922 -1.111 . . . . 0.0 110.671 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.433 ' CG2' ' O ' ' A' ' 142' ' ' VAL . 0.9 OUTLIER -51.25 -81.8 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.131 -0.981 . . . . 0.0 110.723 -179.682 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -138.14 153.48 49.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.17 -0.956 . . . . 0.0 110.472 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.195 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' WW7 . . . . . 0.44 'CL1 ' ' CD1' ' A' ' 63' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' WW7 . . . . . 0.568 ' N2 ' H131 ' A' ' 154' ' ' WW7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.293 0.568 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 2' ' ' ASP . 1.8 p30 -141.14 60.04 1.51 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.307 -0.871 . . . . 0.0 110.15 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -97.33 -60.98 1.47 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.38 -0.825 . . . . 0.0 110.384 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.1 mt -122.76 -133.05 0.28 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.218 -0.926 . . . . 0.0 110.257 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.3 m -108.83 167.45 10.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.796 -1.19 . . . . 0.0 110.509 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -64.67 -14.3 57.72 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.282 -0.886 . . . . 0.0 110.222 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -66.15 -27.67 68.2 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.226 -0.921 . . . . 0.0 109.983 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -70.69 -44.92 65.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.308 -0.87 . . . . 0.0 109.73 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 86.5 mt -63.07 -48.13 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.751 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.59 -31.8 70.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.317 -0.864 . . . . 0.0 109.9 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.75 -51.93 62.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.355 -0.841 . . . . 0.0 109.888 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.427 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 10.7 m-30 -56.35 -46.73 79.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.354 -0.841 . . . . 0.0 110.09 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -62.39 -26.08 68.28 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.329 -0.857 . . . . 0.0 110.34 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -69.85 -66.29 0.61 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.112 -0.992 . . . . 0.0 110.13 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.418 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -48.59 -39.27 23.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -0.913 . . . . 0.0 109.966 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -62.19 -43.82 97.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -0.942 . . . . 0.0 109.963 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.5 m -65.04 -18.46 65.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 109.85 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.431 ' C ' ' CD1' ' A' ' 18' ' ' LEU . 2.9 tm? -87.75 -31.03 19.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 110.022 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.418 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 21.4 m-85 -74.46 -43.88 54.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.15 -0.968 . . . . 0.0 110.138 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -71.73 125.77 27.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.339 -0.85 . . . . 0.0 110.255 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.404 ' HD2' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -108.47 -51.93 2.83 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.205 -0.934 . . . . 0.0 110.795 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 3.0 p30 -70.6 -22.22 62.57 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.137 -0.977 . . . . 0.0 110.16 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.417 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 83.92 51.01 4.15 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.417 ' OD1' ' OG1' ' A' ' 26' ' ' THR . 7.0 p30 -104.72 18.62 21.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.109 -1.23 . . . . 0.0 110.335 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.452 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 49.6 41.67 34.43 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.452 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 0.8 OUTLIER -166.56 160.47 15.25 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.306 -1.114 . . . . 0.0 110.291 179.803 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 55.3 mt -121.9 118.2 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.315 -0.865 . . . . 0.0 109.884 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.8 m -105.93 -179.82 4.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.495 -0.753 . . . . 0.0 110.034 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.424 HG21 HG13 ' A' ' 52' ' ' ILE . 13.5 p -71.58 -16.84 62.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.113 -0.992 . . . . 0.0 110.353 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -75.6 -67.72 0.64 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 109.846 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.402 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 50.6 mt-10 -53.71 -41.32 66.85 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.317 -0.865 . . . . 0.0 109.415 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.456 ' CD2' HD13 ' A' ' 52' ' ' ILE . 1.8 tp -63.88 -38.52 91.4 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.346 -0.846 . . . . 0.0 109.28 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.467 ' HA2' ' CD1' ' A' ' 48' ' ' LEU . . . -51.87 -42.31 53.18 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.5 m -70.4 -45.08 66.68 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.382 -1.069 . . . . 0.0 110.085 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.5 t -50.06 -43.4 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.357 -0.84 . . . . 0.0 110.735 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 21.8 mmt -85.34 -23.66 27.95 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.237 -0.914 . . . . 0.0 110.318 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 32.9 ttt180 -70.63 -16.7 62.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.381 -0.824 . . . . 0.0 110.139 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -102.61 -22.95 13.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 110.234 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.463 HD13 ' N2 ' ' A' ' 153' ' ' WW7 . 3.3 mm? -112.44 59.52 0.64 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.218 -0.926 . . . . 0.0 110.262 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.82 69.11 0.41 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.415 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 48.6 tt0 -58.17 106.72 0.4 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.241 -1.153 . . . . 0.0 110.114 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.557 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.9 m120 -155.54 -65.39 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.282 -0.886 . . . . 0.0 110.577 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.557 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 44.0 Cg_endo -70.15 166.08 29.26 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 123.429 1.226 . . . . 0.0 110.097 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.411 HG21 ' N ' ' A' ' 45' ' ' GLU . 41.8 m -132.32 -98.32 0.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.104 -0.997 . . . . 0.0 110.041 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.411 ' N ' HG21 ' A' ' 44' ' ' THR . 87.7 tt0 -110.77 -46.25 3.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.818 -1.176 . . . . 0.0 110.151 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.02 -63.25 1.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 109.971 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 29.1 mt-10 -50.24 -40.4 47.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.603 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.467 ' CD1' ' HA2' ' A' ' 33' ' ' GLY . 10.6 tt -54.92 -53.45 55.35 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.295 -0.878 . . . . 0.0 109.412 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -48.74 -39.8 26.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.815 . . . . 0.0 109.821 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.41 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 39.0 t70 -57.92 -44.93 87.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.325 -0.859 . . . . 0.0 109.528 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.418 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 0.7 OUTLIER -62.78 -24.83 67.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.376 -0.828 . . . . 0.0 109.731 179.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.456 HD13 ' CD2' ' A' ' 32' ' ' LEU . 46.2 mm -80.02 -23.38 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.408 -0.808 . . . . 0.0 110.174 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -79.14 -30.99 43.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.151 -0.968 . . . . 0.0 110.094 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -76.3 -13.63 60.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 110.136 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.437 ' CG1' HD12 ' A' ' 63' ' ' ILE . 93.2 t -103.01 -60.76 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.89 . . . . 0.0 110.117 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -45.87 108.75 0.14 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.397 -0.815 . . . . 0.0 110.185 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.41 13.34 25.59 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.312 -0.868 . . . . 0.0 110.539 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -110.38 -60.27 1.83 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.11 -0.994 . . . . 0.0 109.87 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 132.56 47.0 0.11 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.466 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 19.4 p30 -126.22 -31.27 2.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.372 -1.075 . . . . 0.0 110.526 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.466 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 115.49 -60.2 0.41 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.42 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 81.5 p -89.59 170.27 10.62 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.07 -1.253 . . . . 0.0 110.566 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.437 HD12 ' CG1' ' A' ' 55' ' ' VAL . 81.7 mt -108.21 152.26 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.054 -1.029 . . . . 0.0 110.291 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.422 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.4 m-20 -101.15 179.54 4.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.358 -0.839 . . . . 0.0 110.242 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.538 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 7.5 t80 -73.08 -42.45 7.16 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 111.038 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 46.6 Cg_endo -76.87 -30.28 4.75 Favored 'Trans proline' 0 C--N 1.327 -0.567 0 O-C-N 123.125 1.066 . . . . 0.0 109.837 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 71' ' ' MET . 47.6 tt0 -72.7 -20.76 61.16 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.425 -0.797 . . . . 0.0 109.147 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.514 ' CE2' ' CE ' ' A' ' 72' ' ' MET . 8.5 t80 -82.05 -49.47 10.18 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.589 -0.694 . . . . 0.0 110.048 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.87 -18.5 64.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.004 -1.06 . . . . 0.0 110.232 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 72.8 m -90.04 -33.82 16.18 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.168 -0.957 . . . . 0.0 110.47 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 68' ' ' PHE . 4.9 ptm -77.52 -25.15 50.02 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.171 -0.956 . . . . 0.0 110.265 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.514 ' CE ' ' CE2' ' A' ' 68' ' ' PHE . 1.1 mmt -84.4 -33.57 23.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.231 -0.918 . . . . 0.0 110.257 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.09 -52.49 10.9 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.18 -0.95 . . . . 0.0 110.03 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 76' ' ' MET . 1.7 tpt180 -110.65 73.14 0.81 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.333 -0.855 . . . . 0.0 109.879 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.58 94.95 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.722 -0.611 . . . . 0.0 110.666 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.45 ' N ' ' O ' ' A' ' 74' ' ' ARG . 61.2 mtt -64.25 139.97 58.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.387 -0.821 . . . . 0.0 110.52 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.8 tttt -100.0 -40.18 7.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.381 -0.824 . . . . 0.0 110.192 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -174.84 -56.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.199 -0.938 . . . . 0.0 110.157 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.1 p -104.71 149.83 25.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 0.0 110.092 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -140.08 132.3 28.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.235 -0.916 . . . . 0.0 110.384 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 24.3 m -132.15 142.91 49.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.328 -0.858 . . . . 0.0 110.087 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -48.69 -33.18 9.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.924 . . . . 0.0 110.076 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 45.01 75.67 0.1 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.393 -0.817 . . . . 0.0 110.641 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 85' ' ' ILE . 15.8 pt-20 -73.01 -32.35 65.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.136 -0.977 . . . . 0.0 110.109 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.425 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 56.9 mt -53.43 -44.12 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.193 -0.942 . . . . 0.0 109.69 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -50.98 -49.65 59.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.354 -0.842 . . . . 0.0 110.039 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.406 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 4.7 mp0 -54.44 -41.84 69.87 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.234 -0.916 . . . . 0.0 110.145 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.463 ' HB3' ' C12' ' A' ' 154' ' ' WW7 . . . -61.45 -63.94 1.11 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.255 -0.903 . . . . 0.0 110.285 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.466 ' CZ ' ' OD2' ' A' ' 93' ' ' ASP . 9.2 t80 -45.62 -27.85 0.86 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.281 -0.887 . . . . 0.0 110.466 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.406 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 34.7 ttm-85 -66.62 -50.76 61.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.184 -0.948 . . . . 0.0 109.705 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 88' ' ' ALA . 33.2 m -70.04 -18.38 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.269 -0.895 . . . . 0.0 110.329 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.532 ' CD2' ' H3 ' ' A' ' 154' ' ' WW7 . 37.0 m-85 -94.52 -8.42 38.39 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.141 -0.974 . . . . 0.0 110.443 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.466 ' OD2' ' CZ ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -140.54 35.56 1.83 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.096 -1.002 . . . . 0.0 110.194 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.21 10.77 15.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 110.361 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 2.7 p30 -83.49 -19.61 35.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.082 -1.011 . . . . 0.0 110.196 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.68 29.21 5.39 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 17.9 t-20 -98.42 -72.49 0.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.332 -1.099 . . . . 0.0 110.102 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.494 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 135.83 -14.81 4.1 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.499 ' CE1' ' OD1' ' A' ' 137' ' ' ASN . 27.6 m-85 -139.18 152.07 47.1 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.018 -1.283 . . . . 0.0 109.971 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.416 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 37.9 mt -81.61 121.79 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.022 -1.049 . . . . 0.0 110.159 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.1 m -111.56 176.28 5.08 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.469 -0.769 . . . . 0.0 109.828 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.21 -56.24 10.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.155 -0.966 . . . . 0.0 110.194 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -49.78 -54.16 20.84 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.236 -0.915 . . . . 0.0 110.333 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -53.47 -43.67 68.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 tt -59.09 -37.95 78.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.324 -0.86 . . . . 0.0 110.38 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -69.47 -28.44 66.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.05 -1.031 . . . . 0.0 109.632 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.439 ' CD2' ' N ' ' A' ' 107' ' ' HIS . 35.0 m170 -71.55 -29.44 64.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.336 -0.853 . . . . 0.0 109.843 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.406 HG23 ' HA ' ' A' ' 92' ' ' PHE . 34.0 t -79.28 -50.2 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.316 -0.865 . . . . 0.0 110.073 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -49.95 -43.74 50.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.363 -0.836 . . . . 0.0 110.266 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.1 p -50.7 -43.41 57.68 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.284 -0.885 . . . . 0.0 110.023 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -58.46 -41.22 84.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.311 -0.868 . . . . 0.0 110.243 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.3 mt -62.09 -53.52 54.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.263 -0.898 . . . . 0.0 110.365 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.66 40.07 0.34 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.414 ' HA ' ' OE1' ' A' ' 114' ' ' GLU . 6.0 mm-40 -111.3 -175.04 2.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.164 -1.198 . . . . 0.0 110.197 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -144.23 81.14 1.66 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.921 . . . . 0.0 110.147 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.97 161.03 15.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.304 -0.873 . . . . 0.0 110.089 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.0 t -98.6 -165.4 1.24 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.887 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -80.98 -43.97 18.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.117 -0.989 . . . . 0.0 110.362 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.423 ' O ' ' HB3' ' A' ' 122' ' ' ASP . 65.2 mm-40 -50.61 -54.35 23.49 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.26 -0.9 . . . . 0.0 110.719 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -48.69 -61.93 1.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.12 -0.987 . . . . 0.0 110.698 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.2 t -47.73 -39.19 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.206 -0.933 . . . . 0.0 110.625 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 119' ' ' GLU . 38.7 t70 -56.57 -47.5 79.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.994 -1.066 . . . . 0.0 110.066 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 36.7 tt0 -66.46 -25.68 66.84 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.248 -0.908 . . . . 0.0 110.286 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 24.4 mmm -70.27 -57.06 5.3 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.187 -0.945 . . . . 0.0 110.14 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.412 HD11 HG22 ' A' ' 136' ' ' VAL . 25.4 mm -57.34 -31.39 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.381 -0.825 . . . . 0.0 110.409 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -76.64 -32.95 58.32 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.135 -0.978 . . . . 0.0 110.235 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 28.9 mt-10 -69.97 -33.23 71.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 0.0 110.141 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.422 ' HA ' ' HB2' ' A' ' 144' ' ' MET . . . -79.81 -43.41 22.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.927 . . . . 0.0 110.336 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -60.21 98.35 0.06 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.135 -0.978 . . . . 0.0 109.943 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.433 ' CD1' ' HA ' ' A' ' 140' ' ' GLU . 5.4 mt -56.22 -42.97 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.294 -0.879 . . . . 0.0 110.333 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 53.5 p-10 -76.65 -15.92 59.68 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.042 -1.036 . . . . 0.0 110.231 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.456 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 55.68 55.18 30.14 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -97.53 -21.77 16.92 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.207 -1.172 . . . . 0.0 110.267 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 130.66 0.56 5.27 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.384 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.95 151.01 28.01 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.862 -1.375 . . . . 0.0 110.6 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.416 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 71.8 t -100.25 142.14 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.202 -0.936 . . . . 0.0 110.305 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.499 ' OD1' ' CE1' ' A' ' 99' ' ' TYR . 2.5 t30 -111.2 -169.59 1.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.426 -0.796 . . . . 0.0 110.047 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -75.37 -57.06 4.12 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.26 -0.9 . . . . 0.0 110.264 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -55.68 -52.02 65.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.86 . . . . 0.0 110.604 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.433 ' HA ' ' CD1' ' A' ' 130' ' ' ILE . 51.7 mt-10 -56.82 -46.88 81.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 110.526 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.537 ' CE1' ' CE ' ' A' ' 144' ' ' MET . 35.2 t80 -59.82 -25.36 64.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.094 -1.004 . . . . 0.0 110.322 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.2 t -86.48 -22.25 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.247 -0.908 . . . . 0.0 110.383 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -98.82 -9.13 24.78 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.34 -0.85 . . . . 0.0 110.663 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.537 ' CE ' ' CE1' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -90.69 -30.93 16.82 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.002 -1.061 . . . . 0.0 110.806 -179.686 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.457 ' CE ' ' HE2' ' A' ' 144' ' ' MET . 43.4 ttm -88.98 -45.65 9.49 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.071 -1.018 . . . . 0.0 109.609 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 65.6 p -74.28 122.66 23.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.445 -0.784 . . . . 0.0 109.86 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -174.08 85.98 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.116 -0.99 . . . . 0.0 110.412 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 7.5 mptt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.162 179.958 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' WW7 . . . . . 0.463 ' N2 ' HD13 ' A' ' 39' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' WW7 . . . . . 0.532 ' H3 ' ' CD2' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.254 0.549 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -134.33 112.39 10.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.905 . . . . 0.0 109.971 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -131.7 69.99 1.47 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.89 . . . . 0.0 110.029 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.44 175.78 9.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.835 . . . . 0.0 110.125 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 50.4 m -117.64 137.02 52.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.944 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -74.68 -15.62 60.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.299 -0.876 . . . . 0.0 110.598 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -63.37 -28.37 69.95 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.065 -1.022 . . . . 0.0 110.202 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.412 ' HA ' ' OE1' ' A' ' 8' ' ' GLN . 13.9 mm100 -73.37 -53.7 10.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.18 -0.95 . . . . 0.0 110.278 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.3 mt -54.84 -44.49 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 110.103 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.32 -36.12 79.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.335 -0.853 . . . . 0.0 109.481 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -63.62 -36.98 85.6 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.301 -0.875 . . . . 0.0 109.766 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -73.61 -22.8 59.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.318 -0.864 . . . . 0.0 109.817 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -72.66 -39.62 66.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.8 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -70.85 -39.29 73.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.394 -0.816 . . . . 0.0 110.031 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.95 -53.06 52.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.186 -0.946 . . . . 0.0 109.996 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.523 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 26.5 t80 -55.5 -39.37 70.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 109.866 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.6 m -67.69 -30.8 70.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -0.876 . . . . 0.0 109.981 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -65.07 -38.58 91.24 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.347 -0.846 . . . . 0.0 110.033 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.468 ' CE2' ' H3 ' ' A' ' 153' ' ' WW7 . 23.1 m-85 -75.87 -61.92 1.77 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.77 112.74 0.7 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 110.027 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -109.23 -42.13 4.47 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.227 -0.921 . . . . 0.0 110.69 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -71.34 -33.13 69.33 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.121 -0.987 . . . . 0.0 110.253 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.06 74.17 1.1 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -142.83 15.69 1.94 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.276 -1.132 . . . . 0.0 110.242 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.461 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 49.19 35.53 19.94 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.461 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 20.3 p -156.86 149.29 23.28 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.228 -1.16 . . . . 0.0 110.119 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.3 mt -112.87 121.78 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.274 -0.892 . . . . 0.0 110.388 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.8 t -122.39 -175.66 3.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -0.872 . . . . 0.0 109.779 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 29.0 p -62.16 -26.34 68.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.114 -0.991 . . . . 0.0 110.189 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -69.87 -60.36 2.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -0.907 . . . . 0.0 110.018 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.411 ' O ' HG21 ' A' ' 35' ' ' VAL . 84.8 mt-10 -59.07 -61.2 2.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.11 -0.994 . . . . 0.0 109.778 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.421 ' CD2' HD13 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -51.53 -33.38 31.69 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.272 -0.892 . . . . 0.0 109.761 179.768 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.29 -44.91 94.81 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.417 ' O ' ' HB2' ' A' ' 38' ' ' SER . 90.8 m -76.62 -17.4 59.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -1.148 . . . . 0.0 109.781 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.411 HG21 ' O ' ' A' ' 31' ' ' GLU . 54.2 t -73.42 -39.3 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.291 -0.881 . . . . 0.0 110.135 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 21.4 mmt -90.33 -27.58 19.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -0.896 . . . . 0.0 110.466 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -82.61 -26.9 31.84 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.273 -0.892 . . . . 0.0 110.588 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 34' ' ' THR . 22.4 t -51.81 -32.69 32.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.995 . . . . 0.0 110.126 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.418 ' CD2' ' N2 ' ' A' ' 153' ' ' WW7 . 0.5 OUTLIER -158.46 69.18 0.49 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.897 . . . . 0.0 110.153 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . 177.4 -64.84 0.09 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' A' ' 40' ' ' GLY . 53.4 mt-30 55.14 19.62 2.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.256 -1.144 . . . . 0.0 110.314 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.506 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 2.6 m120 -72.35 -58.32 3.13 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.17 -0.956 . . . . 0.0 110.412 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.506 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 42.7 Cg_endo -70.66 -169.51 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.768 1.404 . . . . 0.0 110.299 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 m -135.72 -177.31 4.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.288 -0.883 . . . . 0.0 109.832 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' A' ' 48' ' ' LEU . 45.2 mt-10 -67.24 -50.3 61.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.087 -1.008 . . . . 0.0 110.252 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.79 -56.65 15.58 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.197 -0.939 . . . . 0.0 110.04 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -52.01 -34.78 44.37 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.207 -0.933 . . . . 0.0 109.408 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 45' ' ' GLU . 9.5 tt -63.68 -45.02 91.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.423 -0.798 . . . . 0.0 109.224 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -49.47 -43.65 45.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.348 -0.845 . . . . 0.0 109.172 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -62.83 -45.21 93.68 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.412 -0.805 . . . . 0.0 109.342 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.421 ' O ' ' H6 ' ' A' ' 153' ' ' WW7 . 3.7 ttp -59.36 -17.65 31.7 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.345 -0.847 . . . . 0.0 109.772 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.421 HD13 ' CD2' ' A' ' 32' ' ' LEU . 31.0 mm -90.46 -28.73 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 110.195 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -74.9 -27.18 60.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.323 -0.86 . . . . 0.0 110.552 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 51' ' ' MET . 25.3 pt-20 -74.35 -9.14 58.31 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.095 -1.003 . . . . 0.0 110.497 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.46 HG13 ' CD1' ' A' ' 63' ' ' ILE . 44.0 t -112.01 -23.18 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.043 -1.036 . . . . 0.0 110.523 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -91.26 109.05 20.32 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.13 -0.981 . . . . 0.0 110.333 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.25 16.15 21.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 110.329 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 40.1 m-20 -97.82 -69.83 0.74 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.274 -0.892 . . . . 0.0 110.42 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.65 -22.1 0.33 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -69.53 -21.48 63.65 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.08 -1.247 . . . . 0.0 110.123 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.54 -41.46 2.3 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.8 p -89.8 170.22 10.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.128 -1.219 . . . . 0.0 110.52 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.46 ' CD1' HG13 ' A' ' 55' ' ' VAL . 75.1 mt -104.55 151.43 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.367 -0.833 . . . . 0.0 109.892 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.417 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 1.6 m-20 -112.03 -167.28 1.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 110.255 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.526 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 23.5 t80 -73.97 -43.35 6.25 Favored Pre-proline 0 C--N 1.303 -1.422 0 O-C-N 121.284 -0.885 . . . . 0.0 111.099 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.3 Cg_endo -74.42 -30.04 8.67 Favored 'Trans proline' 0 C--O 1.211 -0.859 0 O-C-N 123.026 1.014 . . . . 0.0 110.006 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.42 ' OE1' ' OD2' ' A' ' 58' ' ' ASP . 1.3 tt0 -75.02 -26.02 59.19 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.098 -1.001 . . . . 0.0 108.918 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.562 ' CE1' ' CE ' ' A' ' 72' ' ' MET . 80.4 t80 -75.36 -43.56 49.76 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.62 -0.675 . . . . 0.0 110.405 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.4 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 4.2 tp -80.8 -16.73 52.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.341 -0.85 . . . . 0.0 110.363 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 34.6 m -84.28 -34.02 23.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.065 -1.022 . . . . 0.0 110.651 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.5 ' HE2' ' CE ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -88.67 -30.11 19.39 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.94 -1.1 . . . . 0.0 110.52 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.562 ' CE ' ' CE1' ' A' ' 68' ' ' PHE . 25.3 mtt -81.56 -11.35 59.19 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.047 -1.033 . . . . 0.0 110.515 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.07 -22.1 66.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.125 -0.984 . . . . 0.0 110.042 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -110.25 61.61 0.6 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.219 -0.926 . . . . 0.0 110.505 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.33 147.97 22.94 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.228 -0.92 . . . . 0.0 110.069 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 51.6 mtt -117.31 166.18 12.59 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.143 -0.973 . . . . 0.0 110.923 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.9 mtmm -103.87 129.44 51.36 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.408 -0.807 . . . . 0.0 110.132 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -172.85 110.72 0.21 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.292 -0.88 . . . . 0.0 110.204 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -130.08 152.78 49.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.215 -0.928 . . . . 0.0 110.094 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -59.23 124.88 21.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.29 -0.881 . . . . 0.0 110.683 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.0 m -88.0 130.25 35.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.195 -0.94 . . . . 0.0 110.016 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -120.92 -26.02 5.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.211 -0.93 . . . . 0.0 110.358 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.404 ' O ' ' OE2' ' A' ' 87' ' ' GLU . 12.9 tt0 -156.37 75.96 0.88 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.281 -0.887 . . . . 0.0 109.793 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.405 ' OE2' H151 ' A' ' 154' ' ' WW7 . 29.1 tt0 -105.84 -46.26 4.17 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.288 -0.883 . . . . 0.0 110.61 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.4 HD12 ' CG2' ' A' ' 146' ' ' THR . 88.7 mt -59.8 -48.68 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.137 -0.977 . . . . 0.0 110.407 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -56.69 -53.4 58.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.185 -0.947 . . . . 0.0 110.112 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.404 ' OE2' ' O ' ' A' ' 83' ' ' GLU . 34.9 mt-10 -46.93 -41.78 16.6 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.288 -0.883 . . . . 0.0 110.339 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.422 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -59.61 -59.36 5.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.147 -0.971 . . . . 0.0 110.099 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -49.63 -23.88 1.93 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.16 -0.963 . . . . 0.0 110.461 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -76.42 -43.95 38.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.285 -0.885 . . . . 0.0 111.171 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.513 HG21 ' CD1' ' A' ' 92' ' ' PHE . 16.6 m -79.42 -19.23 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.042 -1.036 . . . . 0.0 110.966 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.513 ' CD1' HG21 ' A' ' 91' ' ' VAL . 24.9 m-85 -89.36 -24.46 21.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.102 -0.999 . . . . 0.0 109.982 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -106.89 92.7 4.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.276 -0.89 . . . . 0.0 109.366 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -100.17 -33.55 10.4 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.167 -0.958 . . . . 0.0 111.402 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 3.1 p30 -69.61 -38.45 77.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.956 -1.09 . . . . 0.0 110.438 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 106.41 41.95 1.68 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.446 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 39.4 p-10 -110.96 -14.82 13.89 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.352 -1.087 . . . . 0.0 110.412 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.5 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 69.28 43.99 67.97 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.5 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 33.5 m-85 -157.8 116.51 3.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.448 -1.031 . . . . 0.0 110.15 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 24.2 mt -87.86 113.22 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.01 -1.056 . . . . 0.0 109.647 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 90.5 p -99.38 159.22 15.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.167 -0.958 . . . . 0.0 110.266 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.2 -18.26 24.76 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.139 -0.976 . . . . 0.0 110.098 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.75 -66.91 0.65 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.233 -0.917 . . . . 0.0 109.983 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.442 ' O ' ' CG2' ' A' ' 108' ' ' VAL . 92.0 mt-10 -51.65 -39.22 57.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.183 -0.948 . . . . 0.0 109.724 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.428 HD13 ' CD1' ' A' ' 125' ' ' ILE . 1.5 tt -64.27 -41.34 96.97 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.593 -0.692 . . . . 0.0 110.311 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 57.7 ttp85 -65.89 -23.15 66.58 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.221 -0.924 . . . . 0.0 110.027 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -94.52 -14.7 24.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.384 -0.822 . . . . 0.0 110.245 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.442 ' CG2' ' O ' ' A' ' 104' ' ' GLU . 72.2 t -82.45 -49.02 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.314 -0.866 . . . . 0.0 110.264 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.6 mmt -60.14 -55.48 33.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.165 -0.959 . . . . 0.0 110.387 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.3 p -49.67 -30.42 9.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.249 -0.907 . . . . 0.0 110.491 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -74.18 -58.48 3.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.218 -0.926 . . . . 0.0 110.293 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.3 mt -47.37 -76.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.257 -0.902 . . . . 0.0 110.326 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.35 43.09 0.06 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -125.3 159.61 31.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -1.208 . . . . 0.0 110.127 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.75 60.4 1.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 110.441 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.03 -174.22 4.35 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.253 -0.905 . . . . 0.0 109.88 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.9 t -126.92 173.32 9.7 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.073 -1.017 . . . . 0.0 110.277 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 88.4 m-20 -58.48 -39.04 78.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -0.89 . . . . 0.0 110.283 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.03 -68.16 0.34 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.27 -0.894 . . . . 0.0 111.057 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.448 ' N ' ' OE1' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -47.78 -47.14 30.89 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.271 -0.893 . . . . 0.0 111.194 -179.181 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 78.9 t -54.89 -48.58 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.011 -1.056 . . . . 0.0 110.412 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -61.84 -30.56 70.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.106 -0.996 . . . . 0.0 109.938 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.11 -32.36 70.36 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.281 -0.887 . . . . 0.0 109.728 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.404 ' HG3' ' O ' ' A' ' 120' ' ' GLU . 83.7 mtp -66.7 -53.7 30.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.359 -0.838 . . . . 0.0 109.75 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.428 ' CD1' HD13 ' A' ' 105' ' ' LEU . 44.0 mm -59.01 -29.25 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.303 -0.873 . . . . 0.0 110.114 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -77.9 -28.36 49.78 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.274 -0.892 . . . . 0.0 109.907 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.38 -29.26 62.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.441 -0.787 . . . . 0.0 110.06 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.412 ' HA ' ' HB3' ' A' ' 144' ' ' MET . . . -94.75 -24.13 17.24 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.344 -0.847 . . . . 0.0 110.401 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.458 ' HA ' ' OE2' ' A' ' 140' ' ' GLU . 3.7 m-20 -73.16 95.61 2.1 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.981 -1.074 . . . . 0.0 111.126 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.401 ' O ' HG21 ' A' ' 130' ' ' ILE . 54.8 mt -92.04 -9.52 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.495 -0.753 . . . . 0.0 110.544 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 57.2 p-10 -149.7 -18.22 0.27 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.056 -1.028 . . . . 0.0 112.106 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.492 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . -95.1 -51.75 1.86 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.569 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 2.6 m-20 60.69 107.95 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.667 -0.902 . . . . 0.0 108.642 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 100.58 -26.37 24.86 Favored Glycine 0 C--N 1.292 -1.875 0 N-CA-C 107.059 -2.416 . . . . 0.0 107.059 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.407 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 0.2 OUTLIER -139.71 134.92 32.6 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.811 -0.817 . . . . 0.0 109.444 179.036 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.412 HG22 HD11 ' A' ' 125' ' ' ILE . 98.5 t -105.92 142.14 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.311 -0.868 . . . . 0.0 110.494 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -112.25 -176.06 2.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.302 -0.874 . . . . 0.0 109.83 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.46 ' CE1' HG22 ' A' ' 142' ' ' VAL . 27.9 t80 -67.47 -36.47 81.21 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.075 -1.016 . . . . 0.0 110.224 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -71.82 -35.6 69.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.064 -1.023 . . . . 0.0 110.285 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.458 ' OE2' ' HA ' ' A' ' 129' ' ' ASP . 35.9 mt-10 -70.27 -31.78 69.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.203 -0.936 . . . . 0.0 110.497 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -79.34 -29.37 42.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.224 -0.923 . . . . 0.0 110.669 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.46 HG22 ' CE1' ' A' ' 138' ' ' TYR . 96.2 t -80.24 -23.11 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.098 -1.001 . . . . 0.0 110.701 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -93.23 -31.04 14.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.164 -0.96 . . . . 0.0 110.697 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.469 ' CE ' ' HE1' ' A' ' 145' ' ' MET . 0.0 OUTLIER -79.07 -29.94 43.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.099 -1.001 . . . . 0.0 110.314 -179.82 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.469 ' HE1' ' CE ' ' A' ' 144' ' ' MET . 59.0 tpp -89.12 -58.34 2.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 109.912 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.4 ' CG2' HD12 ' A' ' 85' ' ' ILE . 64.7 p -107.64 102.32 11.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.373 -0.829 . . . . 0.0 110.064 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -121.49 130.71 53.72 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.274 -0.891 . . . . 0.0 110.324 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.418 ' HD3' ' OXT' ' A' ' 148' ' ' LYS . 10.5 tmtt? . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.087 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' WW7 . . . . . 0.468 ' H3 ' ' CE2' ' A' ' 19' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' WW7 . . . . . 0.442 ' C3 ' ' CZ ' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.283 0.563 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -153.82 -59.9 0.13 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.226 -0.921 . . . . 0.0 110.186 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -115.51 169.93 8.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.214 -0.929 . . . . 0.0 110.188 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.1 mt -77.94 -169.76 1.67 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.243 -0.91 . . . . 0.0 110.486 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 m -85.46 131.12 34.43 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.295 -0.878 . . . . 0.0 110.558 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -58.15 -20.51 41.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.179 -0.951 . . . . 0.0 109.654 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -74.05 -46.43 43.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.255 -0.903 . . . . 0.0 109.694 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -65.88 -55.07 18.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.431 -0.793 . . . . 0.0 109.593 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.6 mt -53.46 -42.41 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.368 -0.832 . . . . 0.0 109.695 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -59.59 -36.17 75.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -0.881 . . . . 0.0 109.894 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -61.95 -54.53 40.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.624 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -54.68 -36.28 64.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.748 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 17.5 mttt -60.13 -43.14 95.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.327 -0.858 . . . . 0.0 109.914 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -61.31 -38.48 86.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.914 . . . . 0.0 109.791 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.437 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.96 -45.58 93.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.238 -0.914 . . . . 0.0 109.968 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -59.75 -47.51 85.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.165 -0.959 . . . . 0.0 109.768 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.9 m -59.19 -27.31 65.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.929 . . . . 0.0 109.376 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.509 HD11 ' CD1' ' A' ' 19' ' ' PHE . 3.4 tm? -73.75 -34.32 64.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.478 -0.764 . . . . 0.0 109.613 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.509 ' CD1' HD11 ' A' ' 18' ' ' LEU . 15.4 m-85 -80.91 -68.08 0.72 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.43 -0.794 . . . . 0.0 109.998 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -58.88 115.24 2.98 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.243 -0.911 . . . . 0.0 110.05 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -104.19 -36.83 7.52 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.197 -0.94 . . . . 0.0 110.166 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -70.19 -11.01 60.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.234 -0.916 . . . . 0.0 110.366 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.57 97.54 0.01 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 10.7 p-10 -150.58 -42.91 0.12 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.376 -1.073 . . . . 0.0 110.108 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.41 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 120.02 15.88 5.05 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.41 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 13.1 p -155.51 132.57 10.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.091 -1.241 . . . . 0.0 110.379 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.418 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 26.6 mt -90.46 127.7 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.282 -0.886 . . . . 0.0 110.109 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.7 p -107.28 -163.71 0.93 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 110.26 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.418 HG23 HD11 ' A' ' 52' ' ' ILE . 7.4 p -86.09 -38.06 18.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.295 -0.878 . . . . 0.0 110.557 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -60.76 -57.74 11.42 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.079 -1.013 . . . . 0.0 110.116 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -55.75 -53.63 54.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.37 -0.831 . . . . 0.0 109.999 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.413 HD22 HD13 ' A' ' 48' ' ' LEU . 4.5 tp -56.56 -24.93 50.53 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.095 -1.003 . . . . 0.0 109.549 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.21 -53.31 45.67 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.404 ' HA ' ' HB2' ' A' ' 37' ' ' ARG . 27.8 m -66.1 -35.83 81.56 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.251 -1.147 . . . . 0.0 109.793 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.423 HG23 ' HA ' ' A' ' 19' ' ' PHE . 70.5 t -56.11 -39.9 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.362 -0.836 . . . . 0.0 109.993 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.423 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 24.8 mmt -85.8 -15.31 42.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.353 -0.842 . . . . 0.0 109.954 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.48 ' CD ' ' HA ' ' A' ' 42' ' ' ASN . 0.5 OUTLIER -83.05 -14.74 53.24 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.283 -0.886 . . . . 0.0 110.514 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 56.3 m -95.92 -20.9 18.4 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.192 -0.942 . . . . 0.0 110.976 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.518 ' N ' ' CD2' ' A' ' 39' ' ' LEU . 4.5 mm? -99.75 50.08 0.92 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.03 -1.044 . . . . 0.0 110.474 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 48.38 93.32 0.01 OUTLIER Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.433 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -176.82 -41.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -1.151 . . . . 0.0 110.091 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.48 ' HA ' ' CD ' ' A' ' 37' ' ' ARG . 5.8 p-10 36.36 62.16 2.98 Favored Pre-proline 0 N--CA 1.508 2.44 0 O-C-N 121.948 -0.47 . . . . 0.0 111.191 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 49.0 Cg_endo -76.2 -176.5 3.1 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.835 1.44 . . . . 0.0 110.183 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.4 p -113.32 161.19 17.55 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.356 -0.84 . . . . 0.0 110.057 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -64.47 -29.34 70.38 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.258 -0.901 . . . . 0.0 110.325 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.83 -69.48 0.44 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.179 -0.951 . . . . 0.0 110.101 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -49.15 -30.72 7.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.135 -0.978 . . . . 0.0 109.432 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.414 HD22 HD13 ' A' ' 52' ' ' ILE . 5.5 tt -63.19 -47.5 82.31 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.48 -0.762 . . . . 0.0 109.719 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -54.72 -47.32 73.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.192 -0.943 . . . . 0.0 109.621 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.05 -33.49 72.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -0.892 . . . . 0.0 109.581 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.453 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 56.1 ttp -68.95 -27.66 65.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 109.743 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.418 HD11 HG23 ' A' ' 29' ' ' THR . 38.4 mt -79.84 -23.66 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.355 -0.84 . . . . 0.0 109.602 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -60.77 -32.17 71.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.405 -0.809 . . . . 0.0 110.166 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.453 ' CG ' ' O ' ' A' ' 51' ' ' MET . 1.6 pt-20 -81.54 -22.46 37.86 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.197 -0.94 . . . . 0.0 110.21 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.478 HG13 ' CD1' ' A' ' 63' ' ' ILE . 92.2 t -93.24 -11.08 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.129 -0.982 . . . . 0.0 110.325 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -118.43 113.98 22.2 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.046 -1.034 . . . . 0.0 110.549 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.21 9.7 28.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.41 -0.806 . . . . 0.0 109.814 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.9 OUTLIER -82.35 -54.77 4.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.292 -0.88 . . . . 0.0 110.13 -179.75 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.24 29.03 1.39 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -118.91 -22.97 7.09 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.247 -1.149 . . . . 0.0 110.221 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.39 -14.37 65.16 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 80.9 p -119.83 164.53 15.87 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.052 -1.263 . . . . 0.0 110.861 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.478 ' CD1' HG13 ' A' ' 55' ' ' VAL . 64.2 mt -106.86 158.08 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.354 -0.841 . . . . 0.0 110.401 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.406 ' OD2' ' HD2' ' A' ' 66' ' ' PRO . 8.5 t70 -113.44 -166.8 1.12 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.41 -0.807 . . . . 0.0 109.614 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.505 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 1.2 t80 -84.2 -44.86 0.75 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.075 -1.015 . . . . 0.0 111.389 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 45.7 Cg_endo -75.21 -21.02 15.89 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 O-C-N 123.191 1.101 . . . . 0.0 110.351 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -78.66 -32.94 47.4 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.281 -0.887 . . . . 0.0 108.735 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.515 ' CE1' ' HE2' ' A' ' 72' ' ' MET . 90.7 t80 -70.93 -53.25 15.65 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.433 0.635 . . . . 0.0 110.198 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.466 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 7.8 tt -60.56 -40.16 90.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.308 -0.87 . . . . 0.0 110.168 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.406 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 89.8 m -73.77 -17.65 61.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.164 -0.96 . . . . 0.0 110.47 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.483 ' CE ' ' CE ' ' A' ' 72' ' ' MET . 62.1 ttp -76.96 -50.75 12.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.069 -1.019 . . . . 0.0 110.771 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.515 ' HE2' ' CE1' ' A' ' 68' ' ' PHE . 45.6 mtt -90.59 -43.86 9.92 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.101 -0.999 . . . . 0.0 111.317 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -61.11 -13.12 15.07 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.185 -0.947 . . . . 0.0 111.15 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 70' ' ' THR . 5.2 tpt180 -98.63 44.99 1.01 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.965 -1.084 . . . . 0.0 110.644 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -111.08 41.6 1.8 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.193 -0.942 . . . . 0.0 109.793 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 18.0 mmt -109.17 175.48 5.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.247 -0.908 . . . . 0.0 110.588 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -133.4 -153.52 0.55 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.349 -0.845 . . . . 0.0 109.68 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -142.21 125.4 16.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.107 -0.996 . . . . 0.0 110.017 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.4 p -107.87 121.73 45.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 110.315 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' A' ' 81' ' ' SER . 0.4 OUTLIER -119.66 177.08 5.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.34 -0.85 . . . . 0.0 109.848 179.556 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 80' ' ' ASP . 88.9 p -175.15 171.66 2.93 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.104 -0.998 . . . . 0.0 110.745 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.402 ' HB3' ' OE2' ' A' ' 84' ' ' GLU . 2.4 tt0 -174.93 -73.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.368 -0.832 . . . . 0.0 109.907 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 60.93 86.98 0.1 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.33 -0.856 . . . . 0.0 110.608 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.402 ' OE2' ' HB3' ' A' ' 82' ' ' GLU . 7.5 mp0 -87.13 -15.01 39.68 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.181 -0.949 . . . . 0.0 110.258 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 12.4 mt -55.94 -35.03 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 110.292 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.8 ttm-85 -50.61 -49.5 56.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 109.553 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -61.54 -49.03 78.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.27 -0.893 . . . . 0.0 109.418 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.44 ' O ' HG21 ' A' ' 91' ' ' VAL . . . -56.44 -19.44 15.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 109.852 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -82.42 -40.44 21.23 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.027 -1.045 . . . . 0.0 109.721 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -56.97 -40.86 77.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.527 -0.733 . . . . 0.0 109.835 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.456 HG22 ' N ' ' A' ' 92' ' ' PHE . 17.7 m -73.78 -42.86 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.127 -0.983 . . . . 0.0 110.602 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.525 ' CG ' ' H3 ' ' A' ' 154' ' ' WW7 . 15.8 m-85 -79.84 4.74 15.63 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.002 -1.061 . . . . 0.0 110.77 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -149.92 80.35 1.37 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.077 -1.014 . . . . 0.0 110.092 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -90.45 31.46 1.03 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -0.874 . . . . 0.0 110.249 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -127.88 -113.61 0.27 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -0.962 . . . . 0.0 110.057 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.54 32.13 0.18 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.45 ' HB2' ' CD2' ' A' ' 99' ' ' TYR . 14.2 p30 -111.26 -21.08 12.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.364 -1.08 . . . . 0.0 110.308 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 67.05 10.74 57.17 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.45 ' CD2' ' HB2' ' A' ' 97' ' ' ASN . 8.1 m-85 -107.49 105.15 14.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.155 -1.203 . . . . 0.0 109.88 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 31.0 mt -76.64 130.16 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.32 -0.862 . . . . 0.0 109.554 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.0 m -116.08 172.69 7.0 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.34 -0.85 . . . . 0.0 110.559 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.489 ' CB ' ' CG1' ' A' ' 121' ' ' VAL . . . -66.79 -37.79 85.27 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.557 -0.715 . . . . 0.0 110.275 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.41 -60.84 3.22 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.255 -0.903 . . . . 0.0 110.305 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.408 ' O ' HG21 ' A' ' 108' ' ' VAL . 50.0 mt-10 -56.43 -28.31 59.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.166 -0.959 . . . . 0.0 110.16 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.49 ' CD1' ' CE1' ' A' ' 92' ' ' PHE . 19.0 tp -66.12 -39.83 90.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.148 -0.97 . . . . 0.0 110.523 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.429 ' O ' ' CG2' ' A' ' 110' ' ' THR . 30.4 ttp180 -75.12 -29.81 60.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.062 -1.024 . . . . 0.0 110.078 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.62 -21.58 48.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.303 -0.873 . . . . 0.0 110.158 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.408 HG21 ' O ' ' A' ' 104' ' ' GLU . 54.0 t -83.74 -48.97 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 109.856 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.418 ' HE1' HD13 ' A' ' 105' ' ' LEU . 65.1 mtt -63.01 -32.45 73.82 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.385 -0.822 . . . . 0.0 109.985 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.429 ' CG2' ' O ' ' A' ' 106' ' ' ARG . 2.9 p -55.44 -41.28 72.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.341 -0.85 . . . . 0.0 109.64 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -73.76 -44.72 55.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.892 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.4 mt -58.78 -73.39 0.08 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.208 -0.933 . . . . 0.0 110.205 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 155.84 62.3 0.01 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 109' ' ' MET . 54.9 mm-40 -143.94 157.81 44.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.206 -1.173 . . . . 0.0 110.439 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.407 ' N ' ' CD ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -126.69 109.52 12.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.282 -0.886 . . . . 0.0 110.132 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.412 ' CD1' ' SD ' ' A' ' 109' ' ' MET . 4.2 mp -125.89 162.44 25.18 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.226 -0.921 . . . . 0.0 110.67 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 64.3 m -114.05 173.14 6.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.389 -0.819 . . . . 0.0 109.951 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.404 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 43.1 m-20 -53.23 -38.44 62.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.148 -0.97 . . . . 0.0 110.855 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -66.4 -50.23 64.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.961 -1.087 . . . . 0.0 110.735 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.446 ' N ' ' OE1' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -55.62 -57.68 10.96 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.17 -0.956 . . . . 0.0 110.494 -179.739 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.489 ' CG1' ' CB ' ' A' ' 102' ' ' ALA . 21.0 t -51.7 -47.4 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.347 -0.845 . . . . 0.0 110.209 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -57.65 -34.01 68.89 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.055 -1.028 . . . . 0.0 109.916 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.437 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 32.8 tt0 -75.48 -25.3 57.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.89 . . . . 0.0 110.093 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.418 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 10.4 mmm -75.35 -47.29 28.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.204 -0.935 . . . . 0.0 110.133 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.428 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 26.8 mm -70.94 -27.08 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.218 -0.926 . . . . 0.0 109.869 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -75.1 -56.05 5.12 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.403 -0.811 . . . . 0.0 110.216 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.455 ' OE1' ' N ' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -57.35 -31.62 65.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.092 -1.005 . . . . 0.0 109.725 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.455 ' N ' ' OE1' ' A' ' 127' ' ' GLU . . . -79.11 -27.86 42.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 109.087 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 47.6 t0 -63.59 95.37 0.1 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.455 -0.778 . . . . 0.0 109.925 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.402 HD11 ' HG2' ' A' ' 140' ' ' GLU . 50.2 mt -80.21 -28.76 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.255 -0.903 . . . . 0.0 110.783 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 2.8 p30 -86.11 -28.39 24.06 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.192 -0.942 . . . . 0.0 110.848 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 88.95 51.91 2.9 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 36.9 p-10 -118.91 -21.57 7.69 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.3 -1.118 . . . . 0.0 110.459 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.59 -25.99 7.45 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.263 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.403 ' CG ' ' OD2' ' A' ' 133' ' ' ASP . 9.0 pt20 -114.7 165.67 12.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.14 -1.212 . . . . 0.0 110.915 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.403 HG23 ' HB1' ' A' ' 128' ' ' ALA . 56.1 t -109.82 131.04 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.416 -0.803 . . . . 0.0 109.36 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 10.7 t30 -94.78 -175.13 3.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.065 -1.022 . . . . 0.0 110.675 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.42 ' CD1' ' C ' ' A' ' 138' ' ' TYR . 17.3 t80 -70.87 -59.69 2.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.383 -0.823 . . . . 0.0 110.65 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -52.2 -43.06 64.0 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.162 -0.961 . . . . 0.0 110.293 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.402 ' HG2' HD11 ' A' ' 130' ' ' ILE . 52.1 mt-10 -66.58 -33.31 75.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.022 -1.049 . . . . 0.0 109.896 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.562 ' CZ ' ' CE ' ' A' ' 145' ' ' MET . 25.5 t80 -68.79 -20.13 64.33 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.41 -0.806 . . . . 0.0 109.625 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 65.2 t -90.34 -41.76 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.304 -0.872 . . . . 0.0 110.891 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.55 -14.66 59.6 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.13 -0.982 . . . . 0.0 110.855 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.511 ' CE ' ' CD1' ' A' ' 141' ' ' PHE . 4.9 ptt? -85.35 -27.06 26.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.018 -1.051 . . . . 0.0 109.83 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.562 ' CE ' ' CZ ' ' A' ' 141' ' ' PHE . 52.5 mtt -84.82 -68.56 0.71 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.486 -0.759 . . . . 0.0 110.317 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.7 p -45.28 123.94 4.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.607 -0.683 . . . . 0.0 110.177 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -97.21 -150.89 0.35 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.342 -0.849 . . . . 0.0 110.793 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.1 tptt . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 117.888 -1.053 . . . . 0.0 110.105 -179.74 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' WW7 . . . . . 0.505 H151 ' C11' ' A' ' 153' ' ' WW7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' WW7 . . . . . 0.525 ' H3 ' ' CG ' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.223 0.535 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -76.14 90.74 3.1 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.227 -0.92 . . . . 0.0 110.22 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -83.87 152.58 24.49 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.265 -0.897 . . . . 0.0 110.328 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.427 ' CD2' ' OE1' ' A' ' 8' ' ' GLN . 2.9 mt -84.48 168.44 15.46 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.265 -0.897 . . . . 0.0 110.324 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -139.01 -175.77 4.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.265 -0.897 . . . . 0.0 110.048 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -81.06 -9.61 59.8 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.194 -0.942 . . . . 0.0 110.885 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.414 ' O ' ' HB1' ' A' ' 10' ' ' ALA . 3.9 mt-10 -66.82 -69.63 0.3 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.968 -1.083 . . . . 0.0 110.426 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.427 ' OE1' ' CD2' ' A' ' 4' ' ' LEU . 49.5 mt-30 -49.18 -55.13 13.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.907 . . . . 0.0 110.083 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.9 mt -49.65 -40.41 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.166 -0.959 . . . . 0.0 109.896 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.414 ' HB1' ' O ' ' A' ' 7' ' ' GLU . . . -61.35 -40.53 94.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 110.0 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.32 -41.09 96.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 110.209 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -61.65 -52.82 62.77 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.253 -0.904 . . . . 0.0 110.002 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -49.64 -46.15 49.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.146 -0.971 . . . . 0.0 109.667 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -52.87 -50.58 63.53 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.305 -0.872 . . . . 0.0 109.736 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.66 -37.8 59.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.399 -0.813 . . . . 0.0 109.834 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.512 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 18.8 t80 -58.25 -49.87 75.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.432 -0.793 . . . . 0.0 109.831 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.2 t -60.49 -32.2 71.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.296 -0.878 . . . . 0.0 110.147 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.418 ' CD2' ' C ' ' A' ' 18' ' ' LEU . 5.4 tt -61.51 -44.57 96.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.264 -0.897 . . . . 0.0 110.065 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -70.48 -57.9 4.29 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.168 -0.957 . . . . 0.0 110.214 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -58.64 107.41 0.51 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.278 -0.888 . . . . 0.0 110.252 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -110.8 52.87 0.72 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.163 -0.961 . . . . 0.0 110.989 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.423 ' OD2' ' OD2' ' A' ' 24' ' ' ASP . 6.2 p-10 -151.72 -42.9 0.11 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.046 -1.034 . . . . 0.0 109.959 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.5 64.94 0.57 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 1.4 p30 -144.07 -44.56 0.26 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.049 -1.266 . . . . 0.0 110.207 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.455 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 113.22 32.89 2.07 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.388 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.447 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 43.6 p -148.95 145.0 27.17 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.938 -1.331 . . . . 0.0 110.336 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.3 mt -107.53 117.31 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.302 -0.874 . . . . 0.0 110.171 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.2 p -102.16 -167.15 1.37 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.246 -0.909 . . . . 0.0 109.99 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.412 HG23 HD11 ' A' ' 52' ' ' ILE . 25.0 p -83.21 -31.75 26.89 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.184 -0.947 . . . . 0.0 110.515 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.7 mtmt -65.18 -62.95 1.24 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.217 -0.927 . . . . 0.0 110.194 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -56.47 -58.7 6.88 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.168 -0.957 . . . . 0.0 109.385 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.462 ' CD2' HD13 ' A' ' 52' ' ' ILE . 6.0 tp -54.36 -22.6 12.66 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.268 -0.895 . . . . 0.0 109.195 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.494 ' HA2' ' CD1' ' A' ' 48' ' ' LEU . . . -63.58 -46.61 91.87 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.46 ' O ' ' CB ' ' A' ' 38' ' ' SER . 71.3 m -72.79 -21.58 60.96 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.252 -1.146 . . . . 0.0 110.272 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.418 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 53.0 t -72.78 -63.77 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.204 -0.935 . . . . 0.0 110.274 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.41 ' HE2' ' CE ' ' A' ' 51' ' ' MET . 12.4 tpp -67.35 -41.01 85.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 110.521 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.463 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 48.1 ttp180 -65.25 -32.59 74.34 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.174 -0.953 . . . . 0.0 110.739 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 34' ' ' THR . 10.8 t -86.97 10.42 16.4 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.938 -1.101 . . . . 0.0 110.635 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 35' ' ' VAL . 36.6 mt -136.33 63.54 1.58 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.002 -1.061 . . . . 0.0 110.403 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . 121.13 -34.14 4.11 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.453 ' CG ' ' O ' ' A' ' 37' ' ' ARG . 67.3 mt-30 54.86 40.08 31.8 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.215 -1.168 . . . . 0.0 110.846 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.538 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 2.4 t30 -86.26 -48.17 0.54 Allowed Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.986 -1.071 . . . . 0.0 110.217 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 42' ' ' ASN . 51.8 Cg_endo -84.85 -171.55 1.0 Allowed 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.696 1.366 . . . . 0.0 110.098 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 12.7 t -138.64 -174.27 3.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.176 -0.953 . . . . 0.0 109.666 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.56 -49.91 71.55 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.967 -1.083 . . . . 0.0 110.108 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.37 -66.11 0.59 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.187 -0.946 . . . . 0.0 110.451 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.416 ' HB3' HG21 ' A' ' 44' ' ' THR . 39.4 tt0 -45.93 -34.26 3.8 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.339 -0.85 . . . . 0.0 110.273 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.494 ' CD1' ' HA2' ' A' ' 33' ' ' GLY . 5.0 tt -60.67 -50.25 74.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.28 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.441 ' N ' HD21 ' A' ' 48' ' ' LEU . 5.4 tt0 -52.45 -40.17 61.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.389 -0.819 . . . . 0.0 109.257 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -62.97 -37.45 87.18 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.53 -0.731 . . . . 0.0 109.496 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.419 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 33.9 ttp -71.19 -16.78 62.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.411 -0.806 . . . . 0.0 109.94 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.462 HD13 ' CD2' ' A' ' 32' ' ' LEU . 22.6 mt -83.37 -33.53 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.186 -0.946 . . . . 0.0 109.98 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -52.4 -47.78 66.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.262 -0.899 . . . . 0.0 110.011 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 51' ' ' MET . 14.8 pt-20 -64.49 -29.11 70.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.269 -0.894 . . . . 0.0 109.875 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.505 ' CG1' ' CD1' ' A' ' 63' ' ' ILE . 76.7 t -85.0 -10.69 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.372 -0.83 . . . . 0.0 110.196 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -107.53 112.1 24.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.111 -0.993 . . . . 0.0 110.23 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -101.86 34.02 2.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.256 -0.902 . . . . 0.0 110.128 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.404 ' OD1' ' OE2' ' A' ' 67' ' ' GLU . 7.1 m-20 -116.33 -36.26 4.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -0.941 . . . . 0.0 110.316 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.91 56.56 2.06 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.441 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 14.5 p-10 -138.41 -41.88 0.5 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.249 -1.148 . . . . 0.0 110.325 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.448 ' O ' ' CG2' ' A' ' 62' ' ' THR . . . 126.19 20.7 1.97 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.797 -1.192 . . . . 0.0 110.571 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.448 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 0.8 OUTLIER -164.72 161.65 20.79 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.009 -1.289 . . . . 0.0 110.356 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.505 ' CD1' ' CG1' ' A' ' 55' ' ' VAL . 78.9 mt -103.79 161.08 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 110.228 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.431 ' N ' HG21 ' A' ' 63' ' ' ILE . 35.0 m-20 -125.84 -155.07 0.66 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.185 -0.947 . . . . 0.0 110.779 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.524 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 13.3 t80 -87.15 -41.34 0.53 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.399 -0.813 . . . . 0.0 112.21 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.0 Cg_endo -72.52 -19.02 25.31 Favored 'Trans proline' 0 C--O 1.211 -0.855 0 O-C-N 123.038 1.02 . . . . 0.0 110.621 -179.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.419 ' OE1' ' OD2' ' A' ' 64' ' ' ASP . 49.9 mt-10 -87.69 -31.64 19.62 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.078 -1.013 . . . . 0.0 109.383 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.512 ' CE1' ' HE2' ' A' ' 72' ' ' MET . 81.3 t80 -73.35 -41.0 63.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.717 -0.614 . . . . 0.0 110.242 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.479 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 0.6 OUTLIER -83.28 -37.73 23.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.37 -0.832 . . . . 0.0 110.767 -179.436 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 66' ' ' PRO . 60.8 m -68.5 -31.07 70.08 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.985 -1.072 . . . . 0.0 110.309 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.411 ' HE1' ' HG3' ' A' ' 72' ' ' MET . 57.4 ttp -81.1 -59.31 2.7 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.242 -0.911 . . . . 0.0 110.472 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.512 ' HE2' ' CE1' ' A' ' 68' ' ' PHE . 61.3 mtt -68.99 -9.46 52.46 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.355 -0.841 . . . . 0.0 110.642 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -54.85 -55.66 27.9 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.134 -0.979 . . . . 0.0 110.444 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.414 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 4.1 ptp85 -110.18 50.85 0.78 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.355 -0.841 . . . . 0.0 110.627 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -146.12 99.84 3.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.131 -0.981 . . . . 0.0 110.637 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 64.3 mtt -104.32 174.76 5.74 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.335 -0.853 . . . . 0.0 109.657 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -173.2 88.61 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.148 -0.97 . . . . 0.0 110.232 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 17.5 p-10 -168.1 153.11 6.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 110.183 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t -93.99 167.05 11.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.262 -0.899 . . . . 0.0 110.492 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -150.64 60.58 0.94 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.302 -0.873 . . . . 0.0 110.425 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.2 t -166.33 137.38 3.52 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.201 -0.937 . . . . 0.0 110.027 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 34.6 tt0 -58.22 129.52 42.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 110.4 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 88.8 tt0 -177.13 -34.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.41 -0.806 . . . . 0.0 110.218 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.481 ' OE1' ' N2 ' ' A' ' 154' ' ' WW7 . 45.9 mt-10 -107.62 -13.9 14.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.925 . . . . 0.0 110.611 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.7 mm -65.55 -51.86 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.067 -1.02 . . . . 0.0 110.134 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -62.65 -52.71 62.24 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.35 -0.844 . . . . 0.0 110.177 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -57.34 -28.75 63.4 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.228 -0.92 . . . . 0.0 110.305 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.501 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -67.04 -65.28 0.7 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.917 . . . . 0.0 110.274 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -52.15 -24.23 6.72 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.183 -0.948 . . . . 0.0 110.353 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.1 ttt-85 -74.57 -39.65 62.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.211 -0.931 . . . . 0.0 110.288 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.2 m -84.91 -11.04 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 110.545 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.513 ' CZ ' ' H3 ' ' A' ' 154' ' ' WW7 . 24.2 m-85 -101.41 -14.68 17.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.031 -1.043 . . . . 0.0 110.509 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 99' ' ' TYR . 83.8 m-20 -132.17 83.03 2.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.017 -1.052 . . . . 0.0 110.619 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -104.53 27.12 8.21 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.141 -0.975 . . . . 0.0 109.994 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.8 p30 -106.69 -24.12 12.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.273 -0.892 . . . . 0.0 109.914 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.441 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 99.49 43.1 2.58 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.504 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 30.6 p-10 -128.81 -24.45 2.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.335 -1.097 . . . . 0.0 110.877 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.452 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 75.2 35.07 49.91 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.504 ' CD2' ' O ' ' A' ' 97' ' ' ASN . 61.3 m-85 -147.46 144.86 28.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.319 -1.107 . . . . 0.0 109.654 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 23.9 mt -100.24 141.72 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.078 -1.014 . . . . 0.0 109.743 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.4 t -126.54 167.55 15.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.169 -0.957 . . . . 0.0 110.409 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.405 ' HA ' HG13 ' A' ' 125' ' ' ILE . . . -65.92 -52.02 53.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.366 -0.834 . . . . 0.0 110.039 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.3 -56.46 16.47 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.385 -0.822 . . . . 0.0 110.235 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -50.86 -45.01 59.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 110.039 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.6 tt -57.18 -38.37 73.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.384 -0.822 . . . . 0.0 110.018 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.412 ' O ' ' HB ' ' A' ' 110' ' ' THR . 66.4 ttt180 -69.27 -26.09 64.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.159 -0.963 . . . . 0.0 109.765 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -83.72 -14.36 51.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.348 -0.845 . . . . 0.0 109.993 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 79.1 t -88.37 -62.06 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.147 -0.971 . . . . 0.0 110.825 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.421 ' HE2' ' HE3' ' A' ' 124' ' ' MET . 60.9 mtt -65.46 -53.65 39.7 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.159 -0.963 . . . . 0.0 110.72 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 106' ' ' ARG . 28.8 m -47.32 -34.28 6.65 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.32 -0.863 . . . . 0.0 110.271 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -77.12 -41.28 42.61 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 110.402 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.2 mt -51.32 -49.05 62.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.147 -0.97 . . . . 0.0 110.273 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 139.7 48.06 0.06 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -135.22 149.26 49.85 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.213 -1.169 . . . . 0.0 110.098 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -95.79 104.27 16.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.273 -0.892 . . . . 0.0 110.454 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.0 mt -124.09 164.5 19.29 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.177 -0.952 . . . . 0.0 110.181 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 56.8 m -122.51 153.3 39.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.166 -0.959 . . . . 0.0 110.194 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -45.53 -30.06 1.34 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.277 -0.889 . . . . 0.0 110.549 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -65.08 -61.03 2.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.871 . . . . 0.0 110.457 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -49.81 -51.51 39.12 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.216 -0.927 . . . . 0.0 110.517 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 75.2 t -53.84 -45.69 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.251 -0.906 . . . . 0.0 110.501 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.15 -27.93 69.42 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.21 -0.931 . . . . 0.0 110.394 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -71.98 -31.75 66.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 0.0 110.107 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.421 ' HE3' ' HE2' ' A' ' 109' ' ' MET . 51.5 mtp -77.87 -45.67 23.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.336 -0.853 . . . . 0.0 110.36 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.405 HG13 ' HA ' ' A' ' 102' ' ' ALA . 19.3 mm -61.96 -41.44 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 110.212 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -63.95 -52.18 60.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.005 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -55.04 -36.44 65.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.202 -0.936 . . . . 0.0 110.23 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.16 -29.79 65.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.225 -0.922 . . . . 0.0 110.31 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -73.53 91.39 1.81 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.157 -0.964 . . . . 0.0 110.365 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 63.3 mt -84.5 1.3 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.243 -0.911 . . . . 0.0 110.767 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.602 ' OD2' 'CA ' ' A' ' 152' ' ' ' CA' . 2.4 p30 -112.03 -35.47 5.66 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.976 -1.077 . . . . 0.0 110.296 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.442 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 102.44 42.46 2.17 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 58.7 p30 -109.91 -12.7 14.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.161 -1.2 . . . . 0.0 110.541 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.467 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 98.74 -47.01 1.44 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -94.34 164.49 13.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.193 -1.181 . . . . 0.0 110.577 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.453 HG11 ' N ' ' A' ' 137' ' ' ASN . 58.2 t -112.61 152.99 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.353 -0.842 . . . . 0.0 109.878 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.453 ' N ' HG11 ' A' ' 136' ' ' VAL . 5.2 p-10 -128.66 -168.88 1.98 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.038 -1.039 . . . . 0.0 110.843 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.443 ' O ' ' CG2' ' A' ' 142' ' ' VAL . 4.3 t80 -64.64 -44.39 90.61 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.51 -0.744 . . . . 0.0 111.006 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.63 -61.05 2.79 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.232 -0.917 . . . . 0.0 111.219 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.4 ' OE2' ' OD2' ' A' ' 131' ' ' ASP . 53.8 mt-10 -56.59 -28.9 61.39 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.112 -0.992 . . . . 0.0 111.032 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.483 ' CE1' ' HE1' ' A' ' 145' ' ' MET . 23.2 t80 -78.86 -27.35 44.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.084 -1.01 . . . . 0.0 110.401 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.443 ' CG2' ' O ' ' A' ' 138' ' ' TYR . 86.3 t -83.6 -24.72 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.259 -0.901 . . . . 0.0 110.484 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.417 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 85.2 mt-30 -95.29 -22.28 17.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.137 -0.977 . . . . 0.0 110.738 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.449 ' CE ' ' HE3' ' A' ' 145' ' ' MET . 0.0 OUTLIER -89.0 -12.49 41.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.879 -1.138 . . . . 0.0 110.321 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.483 ' HE1' ' CE1' ' A' ' 141' ' ' PHE . 53.1 tpp -90.25 -48.04 7.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.187 -0.946 . . . . 0.0 110.311 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.7 p -85.04 -56.61 3.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.323 -0.861 . . . . 0.0 110.588 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' A' ' 143' ' ' GLN . . . -72.71 144.87 47.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.172 -0.955 . . . . 0.0 109.967 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.279 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . 0.602 'CA ' ' OD2' ' A' ' 131' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' WW7 . . . . . 0.456 ' O1 ' ' H8 ' ' A' ' 153' ' ' WW7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' WW7 . . . . . 0.513 ' H3 ' ' CZ ' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 121.199 0.523 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.404 ' HB3' ' CD2' ' A' ' 4' ' ' LEU . 1.3 m-20 -117.23 113.07 21.68 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 0.0 110.228 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -113.26 81.9 1.58 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.334 -0.854 . . . . 0.0 110.011 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.42 ' N ' ' CD2' ' A' ' 4' ' ' LEU . 0.6 OUTLIER -136.75 150.25 48.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.309 -0.869 . . . . 0.0 110.427 -179.608 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.7 m -55.09 166.97 0.46 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.111 -0.993 . . . . 0.0 109.308 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -89.98 -23.51 21.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.042 -1.036 . . . . 0.0 110.7 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -50.01 -46.84 53.13 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.126 -0.984 . . . . 0.0 110.348 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -59.67 -57.19 14.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.309 -0.869 . . . . 0.0 110.307 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.48 ' CG2' ' HE3' ' A' ' 13' ' ' LYS . 83.5 mt -49.97 -28.95 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.257 -0.902 . . . . 0.0 109.614 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.47 -42.15 68.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.329 -0.857 . . . . 0.0 110.045 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.34 -42.11 81.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 0.0 109.97 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -64.39 -47.07 80.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.294 -0.878 . . . . 0.0 110.194 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.48 ' HE3' ' CG2' ' A' ' 9' ' ' ILE . 87.5 mttt -50.84 -51.75 48.09 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.23 -0.919 . . . . 0.0 109.813 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 17' ' ' SER . 40.6 tt0 -53.35 -43.09 67.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.383 -0.823 . . . . 0.0 109.998 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.523 ' O ' ' CG ' ' A' ' 19' ' ' PHE . . . -57.32 -44.34 84.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.944 . . . . 0.0 109.767 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.447 ' CE2' HD13 ' A' ' 27' ' ' ILE . 3.2 t80 -63.49 -32.71 74.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.193 -0.942 . . . . 0.0 109.773 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 38.2 t -58.79 -61.58 2.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 110.325 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 15' ' ' ALA . 1.2 pp -67.3 -15.38 63.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.1 -1.0 . . . . 0.0 110.372 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.523 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 8.1 m-30 -69.29 -63.81 0.99 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.131 -0.98 . . . . 0.0 109.706 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.404 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 6.7 t0 -70.67 107.81 4.1 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.355 -0.84 . . . . 0.0 109.995 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.436 ' HD2' HG23 ' A' ' 34' ' ' THR . 91.8 mttt -107.37 -29.67 9.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.117 -0.989 . . . . 0.0 110.375 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 38.0 p30 -69.86 -11.2 60.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.185 -0.947 . . . . 0.0 110.485 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.452 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 66.24 99.03 0.02 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -155.21 -51.74 0.09 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.263 -1.14 . . . . 0.0 110.377 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.0 -5.12 5.04 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 77.4 p -145.37 152.05 39.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.001 -1.294 . . . . 0.0 110.207 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.447 HD13 ' CE2' ' A' ' 16' ' ' PHE . 46.8 mt -87.37 101.23 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.259 -0.901 . . . . 0.0 110.071 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.2 p -95.37 -177.59 4.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.381 -0.824 . . . . 0.0 109.909 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.0 p -63.1 -30.07 71.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.077 -1.015 . . . . 0.0 110.227 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -63.69 -56.94 11.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.131 -0.981 . . . . 0.0 110.203 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.442 ' CG ' ' OD2' ' A' ' 22' ' ' ASP . 32.0 mt-10 -57.31 -46.45 83.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.868 . . . . 0.0 110.023 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.465 HD21 ' CG ' ' A' ' 48' ' ' LEU . 11.0 tp -64.02 -23.25 67.26 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.19 -0.944 . . . . 0.0 109.774 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.04 -42.99 74.97 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.436 HG23 ' HD2' ' A' ' 21' ' ' LYS . 91.6 m -81.5 -18.77 43.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -1.131 . . . . 0.0 109.892 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.461 ' O ' ' CD1' ' A' ' 39' ' ' LEU . 51.6 t -79.59 -31.89 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.032 -1.043 . . . . 0.0 109.777 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.413 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 26.3 mmt -89.93 -25.4 20.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.297 -0.877 . . . . 0.0 110.163 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.429 ' HD2' ' HA ' ' A' ' 42' ' ' ASN . 3.3 tpt180 -89.37 -25.7 21.43 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.219 -0.926 . . . . 0.0 110.127 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 34' ' ' THR . 62.2 m -85.4 -14.2 47.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -0.926 . . . . 0.0 110.3 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.467 ' CD1' H141 ' A' ' 153' ' ' WW7 . 30.5 mt -89.82 -88.03 0.17 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.234 -0.916 . . . . 0.0 110.334 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 41' ' ' GLN . . . -152.22 51.99 0.49 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.421 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 36.8 mt-30 -158.02 169.19 25.13 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.262 -1.14 . . . . 0.0 110.09 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.45 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 77.5 m-20 -144.4 58.24 5.53 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.496 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.45 ' HD3' ' N ' ' A' ' 42' ' ' ASN . 48.5 Cg_endo -79.19 -177.8 4.16 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.792 1.417 . . . . 0.0 110.369 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.3 m -112.68 169.42 8.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.25 -0.906 . . . . 0.0 110.159 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -66.84 -35.2 79.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.164 -0.96 . . . . 0.0 110.034 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.84 -66.72 0.6 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.266 -0.896 . . . . 0.0 109.88 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.405 ' OE1' ' HA ' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -47.25 -35.89 8.29 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.311 -0.868 . . . . 0.0 109.618 179.633 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.465 ' CG ' HD21 ' A' ' 32' ' ' LEU . 6.2 tt -61.99 -47.35 85.19 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.509 -0.744 . . . . 0.0 109.805 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.52 -43.54 65.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.929 . . . . 0.0 109.659 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -65.13 -33.02 75.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.923 . . . . 0.0 109.4 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.458 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 31.6 ttp -71.17 -17.69 62.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.341 -0.85 . . . . 0.0 109.481 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.9 mt -86.17 -27.39 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.353 -0.842 . . . . 0.0 109.85 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -59.03 -23.64 62.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 110.123 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.458 ' CG ' ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -83.88 -24.97 30.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.283 -0.886 . . . . 0.0 110.128 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.419 HG11 ' HE2' ' A' ' 71' ' ' MET . 80.2 t -85.57 -65.5 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.225 -0.922 . . . . 0.0 109.991 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.402 ' OD2' ' OD1' ' A' ' 60' ' ' ASN . 46.6 t0 -50.31 135.74 21.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.377 -0.827 . . . . 0.0 110.285 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -103.66 -27.04 12.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.279 -0.888 . . . . 0.0 109.789 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -69.97 -30.71 68.12 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.367 -0.833 . . . . 0.0 109.812 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.06 24.51 61.51 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.402 ' OD1' ' OD2' ' A' ' 56' ' ' ASP . 14.2 p-10 -81.55 -32.7 32.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.164 -1.198 . . . . 0.0 110.219 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 129.28 -18.35 5.52 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.756 -1.212 . . . . 0.0 110.094 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 41.3 p -144.74 170.09 16.77 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.103 -1.233 . . . . 0.0 110.366 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.401 ' HA ' ' OE1' ' A' ' 67' ' ' GLU . 45.7 mt -112.48 163.46 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.106 -0.997 . . . . 0.0 110.163 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -125.01 -164.74 1.31 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.19 -0.944 . . . . 0.0 110.531 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.54 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 57.1 t80 -78.81 -43.89 1.85 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.344 -0.847 . . . . 0.0 111.386 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.2 Cg_endo -72.51 -32.54 9.75 Favored 'Trans proline' 0 C--N 1.324 -0.739 0 O-C-N 123.001 1.001 . . . . 0.0 110.176 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 71' ' ' MET . 35.0 tt0 -76.55 -20.84 56.43 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.226 -0.921 . . . . 0.0 109.277 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.531 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 8.7 t80 -80.96 -44.35 18.33 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.501 -0.749 . . . . 0.0 109.703 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.428 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -71.47 -22.76 61.77 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.324 -0.86 . . . . 0.0 109.613 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.0 m -85.2 -41.28 15.78 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.419 -0.801 . . . . 0.0 110.242 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.478 ' HG3' ' N ' ' A' ' 72' ' ' MET . 19.5 ptm -66.11 -33.2 75.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.135 -0.978 . . . . 0.0 110.169 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.531 ' CE ' ' CZ ' ' A' ' 68' ' ' PHE . 20.6 mtt -90.15 -10.78 43.27 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.237 -0.914 . . . . 0.0 110.269 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.428 ' HB1' ' O ' ' A' ' 69' ' ' LEU . . . -72.8 -13.26 61.27 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.129 -0.982 . . . . 0.0 110.349 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -53.31 -69.41 0.12 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.212 -0.93 . . . . 0.0 110.264 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -49.76 131.08 21.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.36 -0.838 . . . . 0.0 110.378 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 32.0 mtt -105.82 128.94 54.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.24 -0.912 . . . . 0.0 110.25 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -108.62 -23.97 11.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.103 -0.998 . . . . 0.0 109.913 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -139.94 149.69 43.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -0.881 . . . . 0.0 110.033 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 94.6 m -150.09 65.48 0.97 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.241 -0.912 . . . . 0.0 110.015 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -62.67 -160.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.224 -0.922 . . . . 0.0 110.128 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.428 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 48.3 t -162.99 -55.33 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.343 -0.848 . . . . 0.0 109.743 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 81' ' ' SER . 2.8 mt-10 -167.07 77.29 0.18 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.361 -0.837 . . . . 0.0 110.059 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -162.34 53.44 0.22 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 110.232 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -77.0 -64.57 1.1 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.232 -0.917 . . . . 0.0 110.941 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 54.0 mt -46.72 -32.85 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.105 -0.997 . . . . 0.0 109.947 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.401 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 35.0 ttt180 -66.2 -47.21 74.61 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.421 -0.799 . . . . 0.0 109.354 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -49.27 -48.48 45.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.437 -0.789 . . . . 0.0 109.983 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.439 ' O ' ' CG2' ' A' ' 91' ' ' VAL . . . -62.9 -61.47 2.38 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.385 -0.822 . . . . 0.0 110.19 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -44.69 -26.98 0.44 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.428 -0.795 . . . . 0.0 110.644 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 86' ' ' ARG . 4.9 mmp_? -75.53 -47.66 25.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.273 -0.892 . . . . 0.0 110.469 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 88' ' ' ALA . 35.8 m -70.65 -9.75 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.201 -0.937 . . . . 0.0 110.864 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.564 ' CE1' ' CG1' ' A' ' 108' ' ' VAL . 42.7 m-85 -103.02 -22.89 13.73 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.099 -1.001 . . . . 0.0 110.77 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -114.23 77.67 1.08 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.078 -1.013 . . . . 0.0 110.306 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.9 ptpt -109.69 -7.28 15.1 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.251 -0.905 . . . . 0.0 110.55 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.418 ' OD2' ' OD1' ' A' ' 97' ' ' ASN . 10.8 p-10 -73.28 -37.78 66.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.033 -1.042 . . . . 0.0 110.121 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 121.62 -24.14 7.28 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.196 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.462 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 15.0 p-10 -58.71 -30.01 67.11 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.704 -1.469 . . . . 0.0 110.863 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.471 ' C ' ' CD1' ' A' ' 99' ' ' TYR . . . 94.0 16.25 45.36 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.576 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.626 ' O ' 'CA ' ' A' ' 151' ' ' ' CA' . 86.4 m-85 -142.09 151.54 42.44 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.95 -1.323 . . . . 0.0 110.188 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.404 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 24.0 mt -91.97 130.69 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.11 -0.994 . . . . 0.0 109.729 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 44.4 t -114.98 165.67 12.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.292 -0.88 . . . . 0.0 110.113 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.408 ' HA ' HG13 ' A' ' 125' ' ' ILE . . . -59.07 -29.45 67.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.279 -0.888 . . . . 0.0 110.343 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.12 -54.5 7.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.189 -0.944 . . . . 0.0 110.414 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.451 ' O ' ' CG2' ' A' ' 108' ' ' VAL . 43.7 mt-10 -53.51 -40.65 65.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.216 -0.927 . . . . 0.0 110.282 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.7 tt -71.19 -32.94 69.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.146 -0.971 . . . . 0.0 110.492 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -71.36 -21.35 62.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.07 -1.019 . . . . 0.0 109.898 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.469 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 54.9 t60 -95.68 -20.27 19.05 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.247 -0.908 . . . . 0.0 109.729 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.564 ' CG1' ' CE1' ' A' ' 92' ' ' PHE . 93.2 t -84.14 -38.12 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.321 -0.862 . . . . 0.0 110.307 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.5 mmt -63.67 -30.45 71.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.867 . . . . 0.0 110.152 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.1 p -69.06 -39.16 79.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 109.965 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 107' ' ' HIS . 76.4 m-20 -66.6 -42.91 86.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.189 -0.944 . . . . 0.0 110.224 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.9 mt -66.54 -33.57 75.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.898 . . . . 0.0 110.125 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.51 -16.72 11.41 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.431 ' CD ' ' N ' ' A' ' 114' ' ' GLU . 5.6 mp0 -69.01 114.11 6.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -1.131 . . . . 0.0 110.288 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.29 121.39 32.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 110.384 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.59 169.82 12.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 110.104 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.404 HG21 ' N ' ' A' ' 118' ' ' ASP . 27.9 m -98.25 159.49 14.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.105 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.404 ' N ' HG21 ' A' ' 117' ' ' THR . 68.6 m-20 -54.35 -44.01 71.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.217 -0.927 . . . . 0.0 110.186 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -65.35 -43.31 91.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 110.409 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -55.76 -46.97 77.76 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.169 -0.957 . . . . 0.0 110.603 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 77.9 t -59.49 -55.41 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 110.254 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.44 -24.99 49.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.159 -0.963 . . . . 0.0 109.928 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -76.33 -33.99 59.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.356 -0.84 . . . . 0.0 110.064 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 54.5 mtp -71.51 -42.28 68.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 0.0 110.007 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.41 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 31.5 mm -66.71 -36.76 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.255 -0.903 . . . . 0.0 110.08 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.57 -57.37 7.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.278 -0.889 . . . . 0.0 110.129 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.414 ' HA ' ' OE1' ' A' ' 127' ' ' GLU . 3.1 mm-40 -51.2 -42.18 60.74 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.4 -0.812 . . . . 0.0 110.641 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -70.24 -30.61 67.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.203 -0.936 . . . . 0.0 110.449 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 6.8 t0 -74.62 84.09 2.07 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.282 -0.886 . . . . 0.0 110.267 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.4 mt -58.57 -37.91 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.215 -0.928 . . . . 0.0 110.034 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.9 p30 -77.13 -32.3 56.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.268 -0.895 . . . . 0.0 109.991 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.453 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 81.03 60.03 2.34 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 135' ' ' GLN . 56.3 p30 -117.21 8.12 13.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.161 -1.199 . . . . 0.0 110.442 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.61 -40.48 3.04 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.481 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 7.0 pt20 -98.17 158.03 15.8 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.062 -1.258 . . . . 0.0 110.485 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.404 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 76.2 t -114.3 134.05 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.384 -0.823 . . . . 0.0 110.232 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.454 ' OD1' ' CG ' ' A' ' 140' ' ' GLU . 24.2 p-10 -105.19 171.83 7.11 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.124 -0.985 . . . . 0.0 109.997 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -52.83 -60.59 3.08 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.228 -0.92 . . . . 0.0 111.471 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -44.3 -51.84 8.06 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.134 -0.979 . . . . 0.0 111.375 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.46 ' O ' ' CG ' ' A' ' 144' ' ' MET . 58.3 mt-10 -59.89 -37.25 78.85 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.985 -1.072 . . . . 0.0 110.459 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.57 ' CZ ' ' CE ' ' A' ' 145' ' ' MET . 87.4 t80 -66.38 -22.17 66.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.311 -0.868 . . . . 0.0 110.782 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 98.1 t -90.5 -42.18 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.026 -1.046 . . . . 0.0 111.231 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.458 ' O ' ' CB ' ' A' ' 147' ' ' ALA . 75.5 mt-30 -78.61 -13.37 59.86 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.955 -1.091 . . . . 0.0 110.62 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.46 ' CG ' ' O ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -90.72 -9.91 44.98 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.064 -1.023 . . . . 0.0 110.582 -179.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.57 ' CE ' ' CZ ' ' A' ' 141' ' ' PHE . 18.9 mtt -90.68 -70.85 0.66 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.037 -1.04 . . . . 0.0 111.669 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.9 t -118.23 37.88 3.87 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.955 -1.091 . . . . 0.0 111.024 -178.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 143' ' ' GLN . . . -110.16 143.83 39.69 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.153 -0.967 . . . . 0.0 109.778 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.406 ' OXT' ' O ' ' A' ' 147' ' ' ALA . 18.9 tttm . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.123 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . 0.626 'CA ' ' O ' ' A' ' 99' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' WW7 . . . . . 0.544 ' N2 ' H131 ' A' ' 153' ' ' WW7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' WW7 . . . . . 0.544 ' H2 ' ' CE2' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.213 0.53 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -98.66 100.79 12.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.298 -0.876 . . . . 0.0 110.345 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -109.98 96.25 6.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.325 -0.859 . . . . 0.0 110.206 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 31.2 mt -56.71 173.86 0.18 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.265 -0.897 . . . . 0.0 110.298 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.6 p -79.32 151.67 30.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.304 -0.873 . . . . 0.0 109.951 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -63.22 -16.0 58.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.33 -0.857 . . . . 0.0 110.275 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -69.14 -62.54 1.34 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.18 -0.95 . . . . 0.0 110.373 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.444 ' HG2' ' CE2' ' A' ' 12' ' ' PHE . 11.7 tt0 -58.76 -41.13 85.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 110.14 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.2 mt -58.38 -37.81 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.194 -0.941 . . . . 0.0 109.906 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -69.28 -33.24 72.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.295 -0.878 . . . . 0.0 109.963 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -61.2 -51.37 69.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 109.597 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.444 ' CE2' ' HG2' ' A' ' 8' ' ' GLN . 21.4 m-85 -58.64 -39.03 79.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.469 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -54.14 -42.5 69.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 109.554 179.463 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.414 ' O ' HD22 ' A' ' 18' ' ' LEU . 35.1 mt-10 -61.34 -45.04 96.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -0.895 . . . . 0.0 109.786 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.501 ' O ' ' CG ' ' A' ' 19' ' ' PHE . . . -53.49 -48.89 68.54 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.302 -0.873 . . . . 0.0 109.523 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.511 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 28.8 t80 -65.35 -26.67 68.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.383 -0.823 . . . . 0.0 109.797 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.91 -63.65 1.23 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.313 -0.867 . . . . 0.0 110.001 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.457 HD13 ' CE1' ' A' ' 19' ' ' PHE . 0.7 OUTLIER -64.37 -19.64 65.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.257 -0.902 . . . . 0.0 109.748 179.683 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.501 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 10.5 m-30 -69.61 -32.2 70.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.361 -0.837 . . . . 0.0 109.444 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -97.96 97.23 8.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -87.52 49.92 1.9 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 110.253 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 2.7 p30 -170.77 -32.45 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.384 -0.822 . . . . 0.0 110.583 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 77.08 60.87 2.78 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -108.03 -39.6 5.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -1.18 . . . . 0.0 110.816 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.412 ' C ' ' CG2' ' A' ' 26' ' ' THR . . . 135.83 -10.05 4.24 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.23 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.412 ' CG2' ' C ' ' A' ' 25' ' ' GLY . 68.1 p -151.06 168.28 25.1 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.1 -1.235 . . . . 0.0 110.425 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.409 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 65.6 mt -102.59 123.26 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.369 -0.832 . . . . 0.0 110.294 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.1 p -92.97 -163.78 1.09 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.332 -0.855 . . . . 0.0 110.179 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.436 HG21 ' CD1' ' A' ' 52' ' ' ILE . 4.5 p -90.31 -45.25 9.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.243 -0.911 . . . . 0.0 110.781 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.1 pttt -56.47 -45.83 80.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.987 -1.071 . . . . 0.0 110.16 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.406 ' O ' HG22 ' A' ' 35' ' ' VAL . 49.6 mt-10 -63.76 -48.75 75.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.98 -1.075 . . . . 0.0 109.34 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.432 ' CD1' 'CL1 ' ' A' ' 153' ' ' WW7 . 13.1 tp -62.61 -15.68 52.82 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.45 -0.781 . . . . 0.0 109.753 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.46 ' HA2' ' CD1' ' A' ' 48' ' ' LEU . . . -75.89 -46.17 14.57 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 57.7 m -71.27 -20.18 62.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -1.094 . . . . 0.0 109.653 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 31' ' ' GLU . 54.3 t -83.33 -33.12 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.33 -0.856 . . . . 0.0 109.968 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 26.0 mmt -88.38 -18.34 28.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.155 -0.965 . . . . 0.0 109.899 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.408 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 5.9 tpt180 -90.83 -36.05 14.45 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.0 110.249 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.6 m -80.9 -45.08 17.33 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.243 -0.911 . . . . 0.0 110.045 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.7 mt -92.47 -36.49 13.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 110.079 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 36' ' ' MET . . . -68.64 -112.65 0.02 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -148.67 -70.29 0.21 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.254 -1.145 . . . . 0.0 110.351 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.508 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 51.6 t30 -163.39 49.7 0.24 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 0.0 110.463 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 42' ' ' ASN . 45.3 Cg_endo -71.52 -166.26 0.23 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.747 1.393 . . . . 0.0 110.127 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 4.9 t -141.31 173.15 11.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.132 -0.98 . . . . 0.0 110.277 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -68.21 -25.73 65.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.188 -0.945 . . . . 0.0 109.973 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.99 -65.62 0.82 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.294 -0.879 . . . . 0.0 109.606 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.416 ' OE1' ' HA ' ' A' ' 47' ' ' GLU . 6.0 tp10 -52.9 -23.55 7.37 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.419 -0.801 . . . . 0.0 109.406 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.46 ' CD1' ' HA2' ' A' ' 33' ' ' GLY . 3.6 tt -68.72 -56.44 8.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.439 -0.788 . . . . 0.0 109.244 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -47.69 -44.01 27.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 109.411 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -63.0 -40.21 97.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.518 -0.739 . . . . 0.0 109.597 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.421 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 6.3 ttp -66.02 -17.81 64.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.339 -0.851 . . . . 0.0 109.779 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.436 ' CD1' HG21 ' A' ' 29' ' ' THR . 33.8 mt -89.79 -24.97 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 109.608 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -66.0 -36.66 83.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 110.277 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.473 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 16.3 pt-20 -68.19 -36.8 80.16 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.099 -1.0 . . . . 0.0 110.251 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.473 ' N ' ' HG3' ' A' ' 54' ' ' GLU . 99.4 t -76.2 -67.96 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.115 -0.991 . . . . 0.0 110.293 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -43.91 105.9 0.06 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.591 -0.693 . . . . 0.0 110.491 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.12 33.2 4.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.909 . . . . 0.0 110.356 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.3 p30 -122.9 -40.49 2.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.919 . . . . 0.0 110.235 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 103.49 45.99 1.48 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.434 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 19.8 p-10 -122.73 -27.71 4.28 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.089 -1.242 . . . . 0.0 110.397 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.62 -74.54 0.41 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.674 -1.251 . . . . 0.0 110.268 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.8 p -86.1 170.1 12.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.207 -1.172 . . . . 0.0 110.575 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.437 ' CD1' 'CL1 ' ' A' ' 153' ' ' WW7 . 20.5 mt -90.13 159.28 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.296 -0.878 . . . . 0.0 109.719 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.42 ' OD2' ' HD2' ' A' ' 66' ' ' PRO . 10.4 t0 -115.41 -179.48 3.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.243 -0.911 . . . . 0.0 110.489 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.56 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 10.6 t80 -74.98 -41.94 4.28 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.333 -0.855 . . . . 0.0 111.752 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.7 Cg_endo -72.07 -17.03 28.57 Favored 'Trans proline' 0 C--O 1.212 -0.823 0 O-C-N 123.105 1.055 . . . . 0.0 110.583 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 71' ' ' MET . 51.2 mt-10 -84.67 -37.52 20.9 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.006 -1.059 . . . . 0.0 108.916 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.511 ' CE2' ' HB2' ' A' ' 16' ' ' PHE . 73.1 t80 -63.67 -48.33 77.65 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.542 -0.723 . . . . 0.0 110.217 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 tp -74.4 -37.01 63.5 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.29 -0.881 . . . . 0.0 110.446 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.475 ' O ' ' HB3' ' A' ' 74' ' ' ARG . 71.4 m -74.63 -10.2 59.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.135 -0.978 . . . . 0.0 110.441 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.431 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 63.6 ttp -91.44 -49.89 6.09 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.885 -1.135 . . . . 0.0 109.746 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.48 ' CE ' ' CE1' ' A' ' 68' ' ' PHE . 39.4 mtt -91.75 -63.58 1.23 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.338 -0.851 . . . . 0.0 111.645 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.78 -14.18 3.17 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.267 -0.896 . . . . 0.0 111.749 -178.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.475 ' HB3' ' O ' ' A' ' 70' ' ' THR . 11.7 ttt180 -110.12 53.67 0.69 Allowed 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.799 -1.188 . . . . 0.0 110.773 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 33.9 tttt -93.75 138.76 31.61 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.167 -0.958 . . . . 0.0 109.962 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 13.2 ptp -146.17 -179.41 6.71 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.974 -1.078 . . . . 0.0 110.942 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -159.27 128.88 5.51 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.544 -0.723 . . . . 0.0 109.516 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -118.12 15.86 14.11 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.066 -1.021 . . . . 0.0 110.925 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 31.2 p -78.07 84.47 4.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.99 -1.069 . . . . 0.0 109.837 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -168.36 153.71 6.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.411 -0.805 . . . . 0.0 109.921 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.8 m -72.07 -169.51 0.49 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.173 -0.955 . . . . 0.0 110.213 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -132.93 55.37 1.9 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.22 -0.925 . . . . 0.0 110.203 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 37.5 tt0 -150.59 17.99 0.81 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 110.067 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -58.4 -27.42 64.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.076 -1.015 . . . . 0.0 110.343 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.516 HG21 ' CE2' ' A' ' 141' ' ' PHE . 41.5 mt -52.31 -40.1 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.232 -0.918 . . . . 0.0 110.121 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 20.1 ttt85 -55.12 -49.38 71.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.418 -0.801 . . . . 0.0 110.269 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.431 ' O ' HG11 ' A' ' 91' ' ' VAL . 48.5 mt-10 -64.59 -37.13 86.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.342 -0.849 . . . . 0.0 110.429 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 92' ' ' PHE . . . -64.94 -22.52 67.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 110.302 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.499 ' CD1' HD12 ' A' ' 100' ' ' ILE . 22.4 t80 -83.48 -38.86 21.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.091 -1.006 . . . . 0.0 110.201 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -70.66 -31.44 68.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.381 -0.824 . . . . 0.0 110.777 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.446 ' CG2' ' N ' ' A' ' 92' ' ' PHE . 7.2 m -83.56 -41.42 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.077 -1.014 . . . . 0.0 110.488 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.476 ' CD1' ' H3 ' ' A' ' 154' ' ' WW7 . 9.5 m-85 -67.67 -23.48 65.32 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.971 -1.081 . . . . 0.0 110.012 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -108.6 81.03 1.4 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.219 -0.926 . . . . 0.0 109.935 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 91' ' ' VAL . 13.4 mtpt -97.26 1.55 49.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 0.0 110.89 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.699 ' OD2' 'CA ' ' A' ' 151' ' ' ' CA' . 2.3 p30 -79.39 -27.77 41.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.931 -1.106 . . . . 0.0 109.784 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.402 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 94.63 44.16 3.48 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.463 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 23.9 p-10 -128.57 -14.28 4.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.185 -1.185 . . . . 0.0 110.984 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.98 -5.88 84.32 Favored Glycine 0 N--CA 1.504 3.197 0 O-C-N 120.974 -1.079 . . . . 0.0 110.876 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.463 ' HB2' ' ND2' ' A' ' 97' ' ' ASN . 9.5 m-85 -116.61 139.03 50.97 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.954 -1.321 . . . . 0.0 110.309 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.499 HD12 ' CD1' ' A' ' 89' ' ' PHE . 22.0 mt -91.3 115.74 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.222 -0.924 . . . . 0.0 109.916 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.9 t -100.01 172.59 7.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 109.956 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.419 ' HA ' HG13 ' A' ' 125' ' ' ILE . . . -70.67 -41.85 71.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.196 -0.94 . . . . 0.0 110.215 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -55.08 -53.78 51.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.316 -0.865 . . . . 0.0 110.122 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -56.74 -49.84 74.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 110.047 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.414 ' HB3' HG12 ' A' ' 121' ' ' VAL . 1.5 tt -51.1 -34.7 31.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.892 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.417 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 9.5 ttm180 -66.72 -41.55 87.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.241 -0.912 . . . . 0.0 109.814 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -75.45 -10.08 59.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.312 -0.867 . . . . 0.0 110.283 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.418 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 97.4 t -86.64 -52.13 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.02 -1.05 . . . . 0.0 110.196 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 14.3 mmt -73.4 -60.43 2.25 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.203 -0.935 . . . . 0.0 110.434 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.1 m -46.66 -35.56 6.12 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.401 -0.812 . . . . 0.0 110.552 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -73.73 -45.13 53.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.175 -0.953 . . . . 0.0 110.415 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 41.4 mt -50.04 -52.25 35.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.204 -0.935 . . . . 0.0 110.285 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 157.04 -38.12 0.56 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -57.57 139.5 53.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.292 -1.122 . . . . 0.0 110.242 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -106.89 79.61 1.35 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -0.875 . . . . 0.0 110.335 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.61 -179.1 7.06 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.279 -0.888 . . . . 0.0 110.048 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 66.9 m -108.4 153.79 22.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.247 -0.908 . . . . 0.0 110.252 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.96 -40.87 64.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.321 -0.862 . . . . 0.0 110.466 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -59.04 -41.4 87.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.202 -0.936 . . . . 0.0 110.374 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -56.14 -56.91 15.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.333 -0.854 . . . . 0.0 110.496 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.414 HG12 ' HB3' ' A' ' 105' ' ' LEU . 97.6 t -54.5 -48.38 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 110.444 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -56.22 -33.37 65.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 0.0 110.225 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -74.4 -28.4 61.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 110.067 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.412 ' HB3' ' HE1' ' A' ' 124' ' ' MET . 95.5 mtp -71.65 -53.2 14.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.262 -0.899 . . . . 0.0 109.933 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.419 HG13 ' HA ' ' A' ' 102' ' ' ALA . 29.3 mm -61.51 -32.06 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 109.993 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 54.2 ttt-85 -64.91 -53.95 38.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.327 -0.858 . . . . 0.0 110.18 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -60.61 -32.47 71.6 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.128 -0.982 . . . . 0.0 110.131 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.456 ' CB ' HG23 ' A' ' 136' ' ' VAL . . . -70.18 -27.69 64.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.277 -0.889 . . . . 0.0 110.189 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -70.33 87.96 0.63 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.939 . . . . 0.0 110.178 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 68.7 mt -65.91 -43.01 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.232 -0.917 . . . . 0.0 110.111 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -79.38 -42.39 25.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -0.95 . . . . 0.0 110.115 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.86 84.63 1.81 Allowed Glycine 0 N--CA 1.485 1.964 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.479 ' OD2' ' CG ' ' A' ' 135' ' ' GLN . 18.1 p-10 -147.96 -46.49 0.16 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.254 -1.145 . . . . 0.0 110.598 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 134.3 31.61 0.36 Allowed Glycine 0 N--CA 1.498 2.772 0 C-N-CA 119.491 -1.337 . . . . 0.0 110.889 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.479 ' CG ' ' OD2' ' A' ' 133' ' ' ASP . 8.8 pt20 -169.98 135.82 1.43 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.971 -1.311 . . . . 0.0 110.134 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.456 HG23 ' CB ' ' A' ' 128' ' ' ALA . 22.2 t -100.09 113.06 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -0.975 . . . . 0.0 110.283 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.422 ' ND2' ' OE1' ' A' ' 140' ' ' GLU . 13.8 p30 -89.3 -169.87 2.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.013 -1.054 . . . . 0.0 109.987 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -62.32 -48.03 81.63 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.078 -1.014 . . . . 0.0 111.095 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -56.05 -55.9 27.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.072 -1.017 . . . . 0.0 110.617 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.422 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 56.2 mt-10 -61.55 -22.69 65.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.275 -0.891 . . . . 0.0 110.748 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.516 ' CE2' HG21 ' A' ' 85' ' ' ILE . 9.8 t80 -79.83 -26.56 40.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.176 -0.952 . . . . 0.0 110.104 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.425 ' O ' ' HB ' ' A' ' 146' ' ' THR . 85.9 t -90.32 -24.21 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.255 -0.903 . . . . 0.0 110.287 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -83.29 -42.27 17.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.185 -0.947 . . . . 0.0 110.654 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.467 ' HG3' ' N ' ' A' ' 145' ' ' MET . 5.2 ptt? -59.73 -38.92 83.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.146 -0.971 . . . . 0.0 110.195 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.467 ' N ' ' HG3' ' A' ' 144' ' ' MET . 14.3 ttm -91.35 -9.33 45.29 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.248 -0.908 . . . . 0.0 110.343 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.425 ' HB ' ' O ' ' A' ' 142' ' ' VAL . 1.3 m -142.4 94.55 2.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.046 -1.034 . . . . 0.0 110.887 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -106.08 -171.42 1.9 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.155 -0.965 . . . . 0.0 109.829 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 6.8 tttp . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.334 179.955 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . 0.699 'CA ' ' OD2' ' A' ' 95' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' WW7 . . . . . 0.485 H121 H162 ' A' ' 153' ' ' WW7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' WW7 . . . . . 0.476 ' H3 ' ' CD1' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.229 0.537 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.58 123.77 33.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 110.198 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -141.42 119.53 12.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 110.296 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.8 pp -156.2 125.22 6.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 110.276 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.6 m -138.18 -58.81 0.65 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.288 -0.883 . . . . 0.0 110.1 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -69.73 -32.03 70.35 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.325 -0.859 . . . . 0.0 109.784 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -59.94 -40.99 90.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.374 -0.828 . . . . 0.0 109.771 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.406 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 34.9 tp60 -58.98 -44.4 91.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.689 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 57.1 mt -58.47 -45.96 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.9 . . . . 0.0 109.65 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.18 -27.04 68.69 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.317 -0.864 . . . . 0.0 109.657 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.408 ' OE1' ' HA ' ' A' ' 11' ' ' GLU . 5.9 tp10 -67.62 -44.52 77.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.33 -0.856 . . . . 0.0 109.848 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -61.82 -52.62 63.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 0.0 109.641 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -51.93 -43.38 63.42 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.24 -0.913 . . . . 0.0 109.389 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -56.27 -42.21 77.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 0.0 109.555 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.44 -39.66 88.31 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.39 -0.819 . . . . 0.0 109.749 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -56.51 -49.88 73.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.66 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 64.8 m -59.93 -31.0 69.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 109.642 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.424 ' CD2' ' O ' ' A' ' 18' ' ' LEU . 2.5 tt -65.49 -32.79 74.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.419 -0.801 . . . . 0.0 109.853 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.505 ' CD1' HG12 ' A' ' 35' ' ' VAL . 5.2 m-85 -87.11 -67.06 0.85 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.395 -0.816 . . . . 0.0 109.999 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -48.24 95.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.957 -1.089 . . . . 0.0 109.988 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.458 ' HD2' ' O ' ' A' ' 19' ' ' PHE . 0.7 OUTLIER -84.33 -47.84 10.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.91 . . . . 0.0 110.455 -179.659 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 3.9 p30 -70.0 -20.89 63.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.108 -0.995 . . . . 0.0 110.025 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.463 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 74.83 72.84 0.99 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.406 ' OD2' ' OD1' ' A' ' 22' ' ' ASP . 65.1 m-20 -112.77 -23.4 10.18 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.145 -1.209 . . . . 0.0 109.932 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.44 -11.96 47.29 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.9 p -132.75 148.02 52.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.184 -1.186 . . . . 0.0 110.298 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.6 mt -102.86 124.77 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.97 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.5 p -114.55 -161.85 0.79 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.339 -0.85 . . . . 0.0 110.599 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.471 ' CG2' HG13 ' A' ' 52' ' ' ILE . 52.0 p -82.31 -21.04 36.27 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.376 -0.828 . . . . 0.0 110.48 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -74.66 -59.17 2.86 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.231 -0.918 . . . . 0.0 110.032 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.19 -45.92 91.25 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.314 -0.866 . . . . 0.0 109.874 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.461 HD23 ' CD1' ' A' ' 52' ' ' ILE . 3.5 tp -62.73 -36.58 83.46 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.193 -0.942 . . . . 0.0 109.74 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.06 -41.86 86.11 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 65.5 m -80.53 -23.37 40.06 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.128 -1.219 . . . . 0.0 110.503 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.505 HG12 ' CD1' ' A' ' 19' ' ' PHE . 38.1 t -72.59 -29.86 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.228 -0.92 . . . . 0.0 110.002 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -89.87 -30.23 18.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -0.882 . . . . 0.0 109.452 179.409 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.466 ' HD3' ' ND2' ' A' ' 42' ' ' ASN . 22.8 tpp180 -62.46 -58.15 8.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.475 -0.766 . . . . 0.0 110.236 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.2 t -95.13 10.36 36.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -0.891 . . . . 0.0 110.384 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.62 59.88 0.17 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.059 -1.025 . . . . 0.0 110.319 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.491 ' HA2' ' N2 ' ' A' ' 153' ' ' WW7 . . . 163.07 -97.89 0.15 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.419 ' O ' ' CD ' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -148.46 175.62 10.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -1.136 . . . . 0.0 110.099 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.466 ' ND2' ' HD3' ' A' ' 37' ' ' ARG . 1.7 m120 -107.71 73.77 0.42 Allowed Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.307 -0.871 . . . . 0.0 110.407 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.419 ' CD ' ' O ' ' A' ' 41' ' ' GLN . 46.9 Cg_endo -72.07 -178.56 3.27 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.719 1.378 . . . . 0.0 110.205 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.428 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 9.3 m -105.42 167.01 10.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.894 . . . . 0.0 109.542 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -54.71 -52.99 60.7 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.928 -1.108 . . . . 0.0 110.159 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.11 -62.72 1.28 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.185 -0.947 . . . . 0.0 110.645 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -45.23 -26.78 0.54 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.238 -0.914 . . . . 0.0 109.982 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 44' ' ' THR . 9.2 tt -70.44 -51.5 28.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.374 -0.829 . . . . 0.0 109.293 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.409 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 4.1 tp-100 -50.37 -38.26 41.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.201 -0.937 . . . . 0.0 109.349 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -61.65 -43.93 97.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.277 -0.89 . . . . 0.0 109.104 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.2 ttp -60.25 -22.93 63.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.446 -0.784 . . . . 0.0 109.353 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.471 HG13 ' CG2' ' A' ' 29' ' ' THR . 35.8 mm -81.68 -27.53 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.536 -0.727 . . . . 0.0 110.279 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -81.57 -15.18 55.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.207 -0.933 . . . . 0.0 110.825 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -88.47 -16.42 32.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.95 -1.094 . . . . 0.0 110.628 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.414 ' CG1' HD12 ' A' ' 63' ' ' ILE . 64.0 t -104.23 -36.88 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.097 -1.002 . . . . 0.0 110.403 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -84.9 103.23 13.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.959 . . . . 0.0 110.039 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.98 41.72 1.56 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.288 -0.882 . . . . 0.0 109.986 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -115.29 18.48 16.1 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.371 -0.831 . . . . 0.0 109.674 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.42 29.24 30.47 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -108.07 -63.97 1.26 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.256 -1.143 . . . . 0.0 110.409 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.28 -65.2 0.43 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 81.1 p -96.07 161.31 14.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -1.148 . . . . 0.0 109.709 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.414 HD12 ' CG1' ' A' ' 55' ' ' VAL . 78.6 mt -84.05 142.15 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.117 -0.989 . . . . 0.0 110.427 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.406 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 56.3 m-20 -101.83 -176.69 3.2 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.319 -0.863 . . . . 0.0 109.945 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.548 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -72.61 -47.24 9.51 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 111.089 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.6 Cg_endo -72.28 -24.4 19.77 Favored 'Trans proline' 0 C--N 1.321 -0.892 0 O-C-N 123.336 1.177 . . . . 0.0 110.408 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -77.34 -28.08 52.95 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.173 -0.955 . . . . 0.0 108.714 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.537 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 7.9 t80 -76.8 -38.07 54.61 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.639 -0.663 . . . . 0.0 109.976 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.454 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 27.5 tp -75.23 -26.42 58.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.359 -0.838 . . . . 0.0 110.271 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.0 m -79.95 -32.33 39.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.178 -0.951 . . . . 0.0 110.076 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.427 ' HG3' ' N ' ' A' ' 72' ' ' MET . 16.8 ptm -84.5 -29.09 26.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.333 -0.854 . . . . 0.0 110.634 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.537 ' CE ' ' CZ ' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -90.58 -29.53 17.77 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.198 -0.939 . . . . 0.0 110.74 -179.658 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -84.53 -37.11 21.66 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.207 -0.933 . . . . 0.0 110.473 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.45 ' C ' ' CG ' ' A' ' 75' ' ' LYS . 16.4 ttt-85 -102.9 -28.7 11.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.934 . . . . 0.0 110.184 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.45 ' CG ' ' C ' ' A' ' 74' ' ' ARG . 15.7 ptpt 36.87 -161.07 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.692 0 O-C-N 121.953 -0.467 . . . . 0.0 111.012 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.446 ' O ' ' HG3' ' A' ' 76' ' ' MET . 22.5 ptp -133.12 55.08 1.92 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.815 -1.178 . . . . 0.0 110.768 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.32 -47.95 3.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.071 -1.018 . . . . 0.0 110.423 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.59 127.99 53.47 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.091 -1.005 . . . . 0.0 110.565 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.5 p -60.0 161.88 6.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.198 -0.939 . . . . 0.0 109.816 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 9.8 t70 -156.62 48.89 0.47 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.118 -0.989 . . . . 0.0 110.0 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 79.4 p -68.96 159.04 33.48 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.151 -0.968 . . . . 0.0 110.218 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -64.23 -139.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.873 . . . . 0.0 110.101 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 47.93 87.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.092 -1.005 . . . . 0.0 110.673 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -68.07 -17.56 64.42 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.21 -0.931 . . . . 0.0 109.963 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.3 mm -67.71 -41.8 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 110.341 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -71.45 -43.81 65.98 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.27 -0.894 . . . . 0.0 110.267 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -58.71 -43.92 90.2 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.18 -0.95 . . . . 0.0 110.212 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.41 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -59.8 -60.29 4.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 0.0 109.751 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CZ ' ' O ' ' A' ' 98' ' ' GLY . 6.2 t80 -48.95 -25.72 2.1 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.323 -0.86 . . . . 0.0 109.805 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.414 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 21.9 ttt180 -69.29 -64.45 0.87 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.426 -0.796 . . . . 0.0 110.858 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.483 HG21 ' N ' ' A' ' 92' ' ' PHE . 32.9 m -56.59 -35.2 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.333 -0.854 . . . . 0.0 111.545 -178.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.528 ' CE2' ' H2 ' ' A' ' 154' ' ' WW7 . 44.4 m-85 -77.93 -21.81 50.55 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.824 -1.173 . . . . 0.0 110.932 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 89' ' ' PHE . 97.0 m-20 -128.03 40.76 3.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.053 -1.03 . . . . 0.0 109.944 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 21.2 pttp -91.85 25.19 2.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 110.022 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.419 ' OD1' ' HB2' ' A' ' 97' ' ' ASN . 2.8 p30 -107.19 0.58 23.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.368 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.04 16.82 36.97 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.419 ' HB2' ' OD1' ' A' ' 95' ' ' ASP . 21.4 t-20 -95.53 -62.13 1.35 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.097 -1.237 . . . . 0.0 110.287 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.504 ' O ' ' CZ ' ' A' ' 89' ' ' PHE . . . 121.46 -57.82 0.59 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.443 ' CE1' ' OD1' ' A' ' 137' ' ' ASN . 12.7 m-85 -91.5 159.76 15.77 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.267 -1.137 . . . . 0.0 110.138 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.449 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 17.5 mt -87.17 154.89 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.106 -0.996 . . . . 0.0 109.467 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.3 t -140.57 -177.43 5.05 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.137 -0.977 . . . . 0.0 110.611 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.74 -34.18 40.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.366 -0.833 . . . . 0.0 109.953 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.06 -54.91 9.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -0.963 . . . . 0.0 109.928 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -59.14 -43.76 92.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.251 -0.906 . . . . 0.0 109.846 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.508 HD11 ' CE1' ' A' ' 92' ' ' PHE . 56.8 tp -52.22 -50.41 62.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 110.28 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -67.55 -26.26 66.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -0.883 . . . . 0.0 110.471 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.418 ' O ' ' ND1' ' A' ' 107' ' ' HIS . 31.9 t-80 -75.85 -16.82 60.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.131 -0.981 . . . . 0.0 110.12 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.415 HG23 ' HA ' ' A' ' 92' ' ' PHE . 72.8 t -88.68 -50.56 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.359 -0.838 . . . . 0.0 110.267 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.419 ' HE2' HD13 ' A' ' 105' ' ' LEU . 55.6 mtt -68.57 -44.29 74.73 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.359 -0.838 . . . . 0.0 110.532 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 91.0 m -58.83 -44.49 90.9 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.271 -0.893 . . . . 0.0 110.457 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -64.84 -53.36 47.98 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.252 -0.905 . . . . 0.0 110.689 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 27.6 mt -46.86 -86.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.236 -0.915 . . . . 0.0 110.307 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -179.97 33.67 0.06 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -122.98 143.19 50.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -1.194 . . . . 0.0 110.156 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.424 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 39.4 pttt -113.8 117.55 31.77 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.265 -0.897 . . . . 0.0 109.942 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.8 mt -124.72 149.77 46.91 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.109 -0.994 . . . . 0.0 110.646 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 39.7 m -71.63 136.79 47.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.283 -0.886 . . . . 0.0 110.052 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -47.87 -44.06 29.01 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.186 -0.946 . . . . 0.0 110.218 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -55.44 -43.01 75.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.836 . . . . 0.0 110.579 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 124' ' ' MET . 45.9 mt-10 -60.37 -51.93 67.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.209 -0.932 . . . . 0.0 110.583 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.422 HG11 ' CD2' ' A' ' 105' ' ' LEU . 54.1 t -53.43 -48.22 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.074 -1.017 . . . . 0.0 110.339 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -58.43 -41.23 84.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.174 -0.954 . . . . 0.0 110.246 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -70.54 -20.64 62.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.913 . . . . 0.0 110.195 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.423 ' HG3' ' O ' ' A' ' 120' ' ' GLU . 85.2 mtp -76.94 -43.67 34.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.175 -0.953 . . . . 0.0 109.615 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 14.4 mm -67.7 -30.3 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.886 . . . . 0.0 109.926 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.8 ttp85 -75.91 -52.26 10.68 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.113 -0.992 . . . . 0.0 110.217 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -54.17 -38.5 65.62 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.214 -0.928 . . . . 0.0 110.151 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.22 -41.56 63.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.877 . . . . 0.0 109.802 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -69.22 92.99 0.59 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.383 -0.823 . . . . 0.0 109.771 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 75.9 mt -63.23 -44.14 99.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.368 -0.833 . . . . 0.0 110.777 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.9 p30 -74.31 -29.41 61.61 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.113 -0.992 . . . . 0.0 110.274 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.453 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 75.19 57.94 4.15 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.444 ' OD1' ' CG ' ' A' ' 135' ' ' GLN . 57.1 p-10 -106.82 0.98 24.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.127 -1.219 . . . . 0.0 110.6 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.14 26.47 12.37 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.444 ' CG ' ' OD1' ' A' ' 133' ' ' ASP . 7.6 pt20 -169.38 164.69 10.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.194 -1.18 . . . . 0.0 110.101 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.449 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 55.2 t -123.06 115.73 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.21 -0.931 . . . . 0.0 109.921 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.443 ' OD1' ' CE1' ' A' ' 99' ' ' TYR . 15.6 t30 -84.16 -174.89 5.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.293 -0.879 . . . . 0.0 110.62 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.404 ' O ' HG22 ' A' ' 142' ' ' VAL . 12.0 t80 -69.74 -42.65 73.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.4 -0.813 . . . . 0.0 110.682 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -61.55 -58.46 8.05 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.276 -0.89 . . . . 0.0 110.659 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -56.07 -36.82 68.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.089 -1.007 . . . . 0.0 110.362 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.54 ' CZ ' ' HE3' ' A' ' 145' ' ' MET . 13.5 t80 -67.08 -27.72 67.59 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.265 -0.897 . . . . 0.0 110.689 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.405 ' O ' HG11 ' A' ' 142' ' ' VAL . 98.5 t -89.93 -22.65 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.34 -0.85 . . . . 0.0 111.078 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -81.61 -36.48 28.89 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.08 -1.013 . . . . 0.0 110.991 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.517 ' HE3' ' CE1' ' A' ' 141' ' ' PHE . 4.7 ptt? -64.58 -28.91 69.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.939 -1.1 . . . . 0.0 110.093 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.54 ' HE3' ' CZ ' ' A' ' 141' ' ' PHE . 61.2 mtt -82.71 -23.26 34.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.879 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.2 p -84.34 136.68 33.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.339 -0.851 . . . . 0.0 109.915 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 60.73 150.94 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.179 -0.951 . . . . 0.0 110.235 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 34.8 mttt . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.139 179.954 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' WW7 . . . . . 0.491 ' N2 ' ' HA2' ' A' ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' WW7 . . . . . 0.528 ' H2 ' ' CE2' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.199 0.523 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -99.39 56.11 1.0 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.255 -0.903 . . . . 0.0 110.001 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -135.05 163.12 30.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.31 -0.869 . . . . 0.0 110.012 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.5 mt -66.13 -83.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.237 -0.914 . . . . 0.0 110.445 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.409 ' CG2' ' HB2' ' A' ' 7' ' ' GLU . 10.0 t -166.86 174.9 8.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.195 -0.941 . . . . 0.0 110.199 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -70.92 -26.05 63.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 110.218 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.409 ' HB2' ' CG2' ' A' ' 5' ' ' THR . 16.7 mm-40 -48.32 -43.41 33.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.201 -0.937 . . . . 0.0 110.238 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.478 ' HG3' ' CE2' ' A' ' 12' ' ' PHE . 2.9 tp-100 -59.5 -42.06 91.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.913 . . . . 0.0 109.786 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.1 mm -61.59 -36.79 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.387 -0.82 . . . . 0.0 109.6 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.28 -30.06 66.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.324 -0.86 . . . . 0.0 109.815 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -64.74 -47.23 79.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.87 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.478 ' CE2' ' HG3' ' A' ' 8' ' ' GLN . 24.0 m-85 -65.26 -49.64 68.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.326 -0.859 . . . . 0.0 110.224 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -53.4 -40.14 64.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.198 -0.939 . . . . 0.0 110.105 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -59.32 -53.26 60.31 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.313 -0.867 . . . . 0.0 110.006 179.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.489 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -51.19 -36.92 43.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.201 -0.937 . . . . 0.0 109.668 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.524 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 60.3 t80 -65.95 -39.57 90.55 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.382 -0.824 . . . . 0.0 109.84 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.8 t -65.62 -21.59 66.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.879 179.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.47 HD21 ' CD1' ' A' ' 19' ' ' PHE . 7.9 tt -79.78 -41.5 26.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.398 -0.814 . . . . 0.0 110.048 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.512 ' CE2' ' H3 ' ' A' ' 153' ' ' WW7 . 16.3 m-85 -69.27 -42.09 75.99 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.344 -0.847 . . . . 0.0 110.385 -179.525 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -78.3 100.97 6.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.427 -0.795 . . . . 0.0 110.131 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -101.43 -20.73 15.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 110.491 -179.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -86.25 -32.45 21.12 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.151 -0.968 . . . . 0.0 110.748 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.36 79.81 1.47 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 39.3 p-10 -146.09 -22.86 0.45 Allowed 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.223 -1.163 . . . . 0.0 111.898 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.407 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 90.24 22.99 33.23 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.407 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 71.1 p -152.68 132.34 13.11 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.215 -1.168 . . . . 0.0 110.177 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 55.7 mt -95.55 111.91 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 110.114 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.402 HG22 ' HB2' ' A' ' 30' ' ' LYS . 10.6 t -106.62 -173.68 2.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.463 -0.773 . . . . 0.0 109.767 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.7 p -70.98 -22.45 62.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.142 -0.974 . . . . 0.0 110.408 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.402 ' HB2' HG22 ' A' ' 28' ' ' THR . 19.8 mtmt -67.91 -60.13 2.75 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.269 -0.894 . . . . 0.0 110.138 179.669 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -59.7 -58.53 8.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.251 -0.905 . . . . 0.0 109.762 179.549 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.441 HD21 ' CD2' ' A' ' 48' ' ' LEU . 1.8 tp -52.28 -30.96 30.49 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.312 -0.868 . . . . 0.0 109.818 179.686 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.86 -49.14 81.17 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 92.1 m -70.57 -23.58 62.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.2 -1.176 . . . . 0.0 110.104 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.0 t -71.35 -33.54 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.408 -0.808 . . . . 0.0 110.186 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.404 ' O ' ' O ' ' A' ' 40' ' ' GLY . 23.2 mmt -90.81 -24.24 20.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.221 -0.924 . . . . 0.0 110.365 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -89.92 -15.46 32.02 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.124 -0.985 . . . . 0.0 110.313 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.407 ' HB3' HD11 ' A' ' 39' ' ' LEU . 37.4 t -97.19 -44.03 7.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.193 -0.942 . . . . 0.0 110.18 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.407 HD11 ' HB3' ' A' ' 38' ' ' SER . 3.5 mp -117.51 64.93 0.73 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.12 -0.987 . . . . 0.0 110.054 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 36' ' ' MET . . . 127.92 58.89 0.12 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.407 ' OE1' ' N ' ' A' ' 42' ' ' ASN . 0.7 OUTLIER -58.66 132.95 55.37 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.316 -1.108 . . . . 0.0 110.695 -179.733 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.533 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.3 m-80 179.29 -59.96 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.4 -0.812 . . . . 0.0 110.001 179.726 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 46.2 Cg_endo -72.23 -163.84 0.16 Allowed 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.749 1.394 . . . . 0.0 110.252 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.457 HG21 ' N ' ' A' ' 45' ' ' GLU . 14.1 t -152.91 -136.52 0.06 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.593 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.457 ' N ' HG21 ' A' ' 44' ' ' THR . 30.8 mt-10 -101.5 -40.18 7.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.733 -1.229 . . . . 0.0 109.796 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.47 -67.11 0.66 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.884 . . . . 0.0 109.586 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -49.01 -44.09 40.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.308 -0.87 . . . . 0.0 109.468 179.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.447 ' CB ' ' O ' ' A' ' 44' ' ' THR . 5.7 tt -55.35 -46.31 76.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.425 -0.797 . . . . 0.0 109.459 179.206 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -51.01 -41.87 60.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.299 -0.876 . . . . 0.0 109.361 179.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.43 ' HA ' ' OD1' ' A' ' 53' ' ' ASN . 33.9 t70 -62.48 -43.33 99.08 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.459 -0.776 . . . . 0.0 109.63 179.344 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.432 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 21.5 ttp -61.18 -22.83 65.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.308 -0.87 . . . . 0.0 109.713 179.629 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.443 HD13 ' CD2' ' A' ' 48' ' ' LEU . 37.0 mt -84.13 -26.65 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -0.859 . . . . 0.0 109.863 179.635 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.43 ' OD1' ' HA ' ' A' ' 50' ' ' ASP . 33.3 m120 -65.22 -19.7 66.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.174 -0.954 . . . . 0.0 110.441 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -84.33 -23.84 30.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 110.037 179.763 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.507 ' CG1' ' CD1' ' A' ' 63' ' ' ILE . 85.1 t -93.0 -63.74 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.335 -0.853 . . . . 0.0 109.69 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -55.22 113.07 1.24 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.376 -0.828 . . . . 0.0 110.378 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -101.82 45.45 0.97 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.36 -0.837 . . . . 0.0 109.928 179.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.59 -47.41 1.56 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.351 -0.843 . . . . 0.0 110.395 -179.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.31 38.56 2.42 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.607 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.446 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 18.6 p-10 -125.38 -19.16 5.12 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.171 -1.194 . . . . 0.0 110.66 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.409 ' C ' ' CG2' ' A' ' 62' ' ' THR . . . 102.22 4.58 50.4 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.718 -1.229 . . . . 0.0 111.27 178.559 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.446 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 47.5 p -149.87 152.36 34.97 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.557 -1.555 . . . . 0.0 110.833 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.507 ' CD1' ' CG1' ' A' ' 55' ' ' VAL . 72.7 mt -100.6 130.94 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.339 -0.851 . . . . 0.0 109.987 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.415 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -77.35 -169.06 1.28 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.137 -0.977 . . . . 0.0 110.327 -179.927 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.534 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 4.1 t80 -80.14 -44.27 1.44 Allowed Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.221 -0.924 . . . . 0.0 111.294 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.3 Cg_endo -74.09 -27.01 12.27 Favored 'Trans proline' 0 C--N 1.322 -0.838 0 O-C-N 123.138 1.073 . . . . 0.0 109.984 -179.384 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -73.01 -30.81 64.05 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.355 -0.841 . . . . 0.0 108.811 179.197 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.524 ' CE2' ' HB2' ' A' ' 16' ' ' PHE . 84.9 t80 -72.01 -45.18 61.87 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.54 0.686 . . . . 0.0 109.618 179.271 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.1 tp -77.54 -15.41 59.28 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.367 -0.833 . . . . 0.0 109.719 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.468 ' O ' ' CB ' ' A' ' 74' ' ' ARG . 7.5 m -86.87 -22.52 25.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 110.216 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.47 ' CE ' ' CE ' ' A' ' 72' ' ' MET . 9.2 ptt? -90.61 -37.46 13.78 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.958 -1.089 . . . . 0.0 110.237 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.47 ' CE ' ' CE ' ' A' ' 71' ' ' MET . 59.8 mtt -90.15 -65.62 1.0 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.259 -0.901 . . . . 0.0 111.443 -179.208 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.77 -11.62 8.14 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.467 -0.771 . . . . 0.0 111.708 -178.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.468 ' CB ' ' O ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -96.43 35.53 1.47 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.712 -1.242 . . . . 0.0 110.899 -179.501 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.39 104.8 0.1 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.059 -1.026 . . . . 0.0 109.9 179.686 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.0 ttt -144.2 89.43 2.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.267 -0.896 . . . . 0.0 110.138 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.6 tttt -110.57 -108.53 0.35 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 110.059 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -136.2 57.84 1.76 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.672 -1.267 . . . . 0.0 110.034 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 47.6 p -120.54 -48.0 2.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 110.429 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -147.62 -56.31 0.24 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.159 -0.963 . . . . 0.0 110.29 -179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 79.6 p -66.64 120.54 13.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.25 -0.906 . . . . 0.0 110.357 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -174.07 -146.63 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.22 -0.925 . . . . 0.0 110.501 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -159.96 93.88 1.09 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.883 . . . . 0.0 109.865 -179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -76.62 -35.08 58.29 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.318 -0.864 . . . . 0.0 110.541 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.1 mt -50.39 -43.89 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.206 -0.934 . . . . 0.0 110.577 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -57.23 -43.17 82.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.91 . . . . 0.0 110.609 -179.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -63.5 -37.41 87.2 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.303 -0.873 . . . . 0.0 111.305 -179.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.477 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -64.55 -60.01 3.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.106 -0.996 . . . . 0.0 110.593 -179.421 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -51.36 -34.31 33.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.23 -0.918 . . . . 0.0 110.615 -179.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -45.36 88.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.106 -0.996 . . . . 0.0 110.557 -179.669 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 88' ' ' ALA . 33.0 m -77.38 -14.7 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.051 -1.031 . . . . 0.0 110.538 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.504 ' CZ ' ' H2 ' ' A' ' 154' ' ' WW7 . 22.4 m-85 -93.82 -13.96 26.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.195 -0.941 . . . . 0.0 110.406 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -107.46 59.24 0.62 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.932 . . . . 0.0 109.837 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -63.54 -43.86 95.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.376 -0.827 . . . . 0.0 110.646 -179.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.436 ' OD2' ' HB3' ' A' ' 97' ' ' ASN . 18.1 p-10 -69.04 -26.8 65.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.194 -0.941 . . . . 0.0 110.106 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.18 8.33 71.98 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.168 178.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.436 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 20.6 p-10 -62.5 -30.09 71.02 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.599 -1.53 . . . . 0.0 110.105 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.497 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 107.69 7.73 31.31 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.497 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 30.1 m-85 -140.49 163.27 33.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.124 -1.221 . . . . 0.0 109.874 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.468 HD13 ' CD1' ' A' ' 141' ' ' PHE . 40.0 mt -100.08 129.31 50.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.198 -0.939 . . . . 0.0 109.876 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.6 t -110.37 147.21 34.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.445 -0.784 . . . . 0.0 109.721 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -51.26 -45.36 62.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.121 -0.987 . . . . 0.0 110.248 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -49.88 -55.52 14.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.154 -0.966 . . . . 0.0 110.293 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -61.35 -30.63 70.64 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.174 -0.954 . . . . 0.0 110.592 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 21.7 tp -58.42 -44.01 88.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.26 -0.9 . . . . 0.0 110.285 -179.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.08 -28.04 48.69 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.322 -0.861 . . . . 0.0 110.192 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -70.34 -19.46 63.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.2 -0.937 . . . . 0.0 110.151 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 70.2 t -101.78 -26.63 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.153 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.0 mmt -77.89 -24.57 48.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.159 -0.963 . . . . 0.0 110.248 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.6 m -90.61 -15.38 30.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -0.923 . . . . 0.0 110.431 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -90.21 -43.41 10.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.093 -1.004 . . . . 0.0 110.463 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 46.8 mt -59.83 -45.28 92.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 109.975 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 136.66 50.18 0.07 OUTLIER Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -136.94 126.91 25.88 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.208 -1.172 . . . . 0.0 110.095 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.36 112.98 25.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.2 -0.937 . . . . 0.0 110.448 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.5 mp -127.67 -169.5 2.06 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.342 -0.849 . . . . 0.0 109.905 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.402 HG22 ' HB2' ' A' ' 119' ' ' GLU . 6.2 t -144.53 164.9 29.53 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.144 -0.972 . . . . 0.0 110.607 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -53.81 -28.79 37.37 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.393 -0.817 . . . . 0.0 111.004 -179.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.402 ' HB2' HG22 ' A' ' 117' ' ' THR . 34.7 mt-10 -68.29 -51.54 43.77 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.145 -0.972 . . . . 0.0 110.957 -179.317 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -64.1 -51.58 63.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.189 -0.945 . . . . 0.0 110.782 -179.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.411 ' O ' ' HB2' ' A' ' 124' ' ' MET . 77.9 t -57.19 -45.89 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.236 -0.915 . . . . 0.0 110.728 -179.373 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -58.82 -53.56 57.03 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.061 -1.024 . . . . 0.0 110.505 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -62.64 -22.96 66.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -0.931 . . . . 0.0 110.418 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.411 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 5.8 mmm -71.56 -49.66 38.49 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.153 -0.967 . . . . 0.0 110.113 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 23.6 mm -69.4 -28.53 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.193 -0.942 . . . . 0.0 109.953 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -70.63 -43.36 69.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.964 . . . . 0.0 109.983 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -71.16 -27.59 63.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.211 -0.931 . . . . 0.0 109.816 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.45 ' CB ' ' H6 ' ' A' ' 154' ' ' WW7 . . . -78.29 -25.2 46.57 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.341 -0.849 . . . . 0.0 109.769 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -74.83 86.61 2.23 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.303 -0.873 . . . . 0.0 110.201 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 70.5 mt -69.08 -48.13 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.282 -0.886 . . . . 0.0 110.433 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 3.0 p30 -73.77 -21.97 60.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.229 -0.92 . . . . 0.0 110.278 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 68.79 68.15 1.74 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 36.8 p30 -118.35 -16.92 9.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.438 -1.037 . . . . 0.0 111.032 -179.309 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.466 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 124.71 -46.8 1.06 Allowed Glycine 0 N--CA 1.498 2.779 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.406 ' O ' ' OE1' ' A' ' 135' ' ' GLN . 0.0 OUTLIER -119.31 170.57 9.0 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.242 -1.152 . . . . 0.0 109.909 179.846 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.402 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 75.6 t -103.3 151.61 6.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.041 -1.037 . . . . 0.0 110.672 -179.345 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.494 ' OD1' ' CD1' ' A' ' 99' ' ' TYR . 72.6 m-20 -122.73 -172.74 2.54 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.494 -0.754 . . . . 0.0 109.82 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.421 ' O ' ' CG2' ' A' ' 142' ' ' VAL . 3.9 t80 -72.93 -19.91 61.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.195 -0.941 . . . . 0.0 109.727 179.595 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.41 -56.58 4.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.136 -0.978 . . . . 0.0 109.837 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -64.76 -25.37 67.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.146 -0.971 . . . . 0.0 109.691 179.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.489 ' CE2' ' CE ' ' A' ' 145' ' ' MET . 19.1 t80 -75.29 -29.16 60.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.399 -0.813 . . . . 0.0 109.967 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 138' ' ' TYR . 70.5 t -84.83 -27.85 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.233 -0.917 . . . . 0.0 110.27 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.83 -34.15 34.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.837 . . . . 0.0 110.646 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -82.6 -25.54 33.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 110.47 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.489 ' CE ' ' CE2' ' A' ' 141' ' ' PHE . 26.0 ttm -89.86 -57.36 2.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.277 -0.889 . . . . 0.0 110.104 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.401 HG21 ' O ' ' A' ' 142' ' ' VAL . 6.0 p 42.96 94.47 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.427 -0.796 . . . . 0.0 110.924 179.826 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -109.46 45.65 1.06 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.343 -0.848 . . . . 0.0 110.077 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.249 -179.855 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' WW7 . . . . . 0.512 ' H3 ' ' CE2' ' A' ' 19' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' WW7 . . . . . 0.504 ' H2 ' ' CZ ' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.263 0.554 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -53.18 110.36 0.53 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.902 . . . . 0.0 110.26 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -100.13 153.74 19.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.236 -0.915 . . . . 0.0 110.154 179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 48.7 mt -129.22 121.73 28.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.237 -0.914 . . . . 0.0 110.211 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.8 p -134.59 -55.46 0.84 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.243 -0.911 . . . . 0.0 110.097 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -81.85 -41.34 21.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.306 -0.871 . . . . 0.0 110.295 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.417 ' OE1' ' CA ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -52.65 -35.65 55.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 110.775 -179.594 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -56.57 -54.05 50.46 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.06 -1.025 . . . . 0.0 109.817 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 78.8 mt -58.95 -34.2 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.658 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.75 -28.07 67.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.256 -0.902 . . . . 0.0 110.073 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -72.45 -53.51 11.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.337 -0.852 . . . . 0.0 109.725 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -56.37 -45.7 80.39 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.327 -0.858 . . . . 0.0 109.819 179.616 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.85 -41.37 74.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 109.758 179.433 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -54.44 -52.53 61.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.402 -0.811 . . . . 0.0 109.953 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.23 -50.09 62.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.38 -0.825 . . . . 0.0 110.253 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -51.26 -45.56 62.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.186 -0.946 . . . . 0.0 109.828 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.9 m -55.14 -41.95 72.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.241 -0.912 . . . . 0.0 109.761 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.458 ' CD2' ' O ' ' A' ' 18' ' ' LEU . 1.1 tt -59.0 -34.32 71.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.375 -0.828 . . . . 0.0 109.647 179.575 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.549 ' CE2' HG13 ' A' ' 35' ' ' VAL . 10.5 m-85 -74.5 -69.97 0.43 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.325 -0.859 . . . . 0.0 110.541 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.412 ' OD1' ' HA2' ' A' ' 23' ' ' GLY . 0.9 OUTLIER -56.28 91.49 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.367 -0.833 . . . . 0.0 110.089 -179.751 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 19' ' ' PHE . 2.3 mttm -81.42 -28.29 34.33 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.341 -0.849 . . . . 0.0 109.943 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.403 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 5.0 p30 -104.89 -9.81 17.74 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.282 -0.886 . . . . 0.0 110.487 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.412 ' HA2' ' OD1' ' A' ' 20' ' ' ASP . . . 61.56 63.23 5.01 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.642 ' OD2' 'CA ' ' A' ' 149' ' ' ' CA' . 1.8 p30 -92.02 -15.68 27.53 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.184 -1.186 . . . . 0.0 110.012 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.461 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 114.88 -9.85 21.16 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.461 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 82.3 p -156.07 169.8 23.64 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.161 -1.199 . . . . 0.0 110.497 -179.818 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.4 mt -105.14 125.39 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.44 -0.788 . . . . 0.0 109.49 179.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 49.3 p -110.45 -171.98 1.94 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.198 -0.938 . . . . 0.0 110.437 -179.547 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 55.3 p -79.05 -25.49 43.18 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.328 -0.857 . . . . 0.0 110.422 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -70.26 -56.81 5.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.29 -0.881 . . . . 0.0 109.766 179.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.403 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 88.8 mt-10 -59.43 -48.34 82.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.311 -0.868 . . . . 0.0 109.318 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.404 HD12 'CL1 ' ' A' ' 153' ' ' WW7 . 1.3 tp -61.94 -26.73 68.37 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.468 -0.77 . . . . 0.0 109.426 179.428 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.52 -44.38 97.67 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.545 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.3 m -71.3 -27.2 63.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -1.116 . . . . 0.0 109.938 179.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.549 HG13 ' CE2' ' A' ' 19' ' ' PHE . 8.1 t -67.05 -38.7 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.291 -0.88 . . . . 0.0 109.99 179.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 20.8 mmt -89.56 -20.15 24.13 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.069 -1.019 . . . . 0.0 110.37 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -90.25 -13.28 35.72 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.22 -0.925 . . . . 0.0 110.721 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.42 ' CB ' HD21 ' A' ' 39' ' ' LEU . 14.9 p -65.59 -59.55 3.84 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.219 -0.925 . . . . 0.0 110.463 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.459 ' N ' HD21 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -132.85 47.25 2.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.098 -1.001 . . . . 0.0 110.125 179.975 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -166.98 43.69 0.25 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.44 ' OE1' ' N ' ' A' ' 42' ' ' ASN . 0.9 OUTLIER -49.38 115.08 1.19 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.217 -1.166 . . . . 0.0 110.162 -179.818 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.501 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 0.6 OUTLIER -174.81 -61.75 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.402 -0.811 . . . . 0.0 109.931 179.743 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.501 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 43.4 Cg_endo -70.67 165.73 31.05 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.549 1.289 . . . . 0.0 110.266 179.453 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.8 OUTLIER -119.93 -146.87 0.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.158 -0.964 . . . . 0.0 109.782 179.913 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.462 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 20.9 pt-20 -92.37 -41.34 10.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.133 -0.98 . . . . 0.0 109.694 179.54 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.462 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -71.12 -60.72 2.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.292 -0.88 . . . . 0.0 110.051 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -49.05 -30.5 6.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.068 -1.02 . . . . 0.0 109.477 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 44' ' ' THR . 8.0 tt -65.2 -52.19 56.36 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.556 -0.715 . . . . 0.0 109.5 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -49.67 -39.04 35.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.943 . . . . 0.0 109.356 179.242 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.88 -46.22 91.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.429 -0.794 . . . . 0.0 109.703 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 18.0 ttp -65.2 -17.92 64.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.903 . . . . 0.0 109.738 179.527 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.438 ' CD1' 'CL1 ' ' A' ' 153' ' ' WW7 . 36.3 mm -85.84 -28.75 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.395 -0.815 . . . . 0.0 110.133 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -62.54 -41.89 99.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.259 -0.901 . . . . 0.0 110.244 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.8 -24.44 65.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.273 -0.892 . . . . 0.0 109.898 179.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.472 HG13 ' CD1' ' A' ' 63' ' ' ILE . 74.0 t -92.65 -7.26 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.293 -0.879 . . . . 0.0 110.297 179.562 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.461 ' OD2' ' CA ' ' A' ' 61' ' ' GLY . 22.8 t0 -113.21 98.73 7.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.028 -1.045 . . . . 0.0 110.853 -179.564 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.91 25.53 9.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 0.0 109.146 178.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.413 ' OD2' ' OD1' ' A' ' 60' ' ' ASN . 8.8 t70 -98.55 -49.1 4.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.602 -0.686 . . . . 0.0 110.419 -179.705 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.47 -26.55 5.45 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.434 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 16.5 p-10 -70.46 -33.84 71.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.032 -1.276 . . . . 0.0 110.339 -179.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.461 ' CA ' ' OD2' ' A' ' 56' ' ' ASP . . . 119.38 -61.24 0.49 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.434 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 81.7 p -70.09 165.38 22.08 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.302 -1.117 . . . . 0.0 110.254 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.472 ' CD1' HG13 ' A' ' 55' ' ' VAL . 9.9 mt -100.21 157.71 3.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.272 -0.893 . . . . 0.0 109.768 179.629 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -111.7 -169.96 1.56 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.512 -179.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.547 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 9.8 t80 -78.19 -44.86 2.21 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.256 -0.902 . . . . 0.0 111.44 -179.549 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.3 Cg_endo -71.64 -17.66 29.56 Favored 'Trans proline' 0 C--O 1.205 -1.14 0 O-C-N 123.127 1.067 . . . . 0.0 110.252 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -84.71 -30.91 24.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.185 -0.947 . . . . 0.0 109.372 179.123 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.504 ' CE2' ' HE2' ' A' ' 72' ' ' MET . 9.0 t80 -71.45 -49.21 43.74 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.591 -0.693 . . . . 0.0 110.231 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.464 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 0.6 OUTLIER -76.64 -29.7 56.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.197 -0.939 . . . . 0.0 110.725 -179.661 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.448 ' HB ' ' O ' ' A' ' 66' ' ' PRO . 54.8 m -78.51 -19.57 52.68 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.774 -1.204 . . . . 0.0 110.334 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.468 ' CE ' ' HE1' ' A' ' 72' ' ' MET . 61.1 ttp -86.34 -49.8 7.39 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.135 -0.978 . . . . 0.0 110.573 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.504 ' HE2' ' CE2' ' A' ' 68' ' ' PHE . 38.2 mtt -83.1 -59.69 2.39 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.223 -0.923 . . . . 0.0 110.786 -179.43 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.464 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -47.11 -35.28 6.93 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.046 -1.034 . . . . 0.0 110.558 -179.492 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.46 ' NH1' ' OG1' ' A' ' 79' ' ' THR . 52.1 mtt180 -108.97 62.63 0.6 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.227 -0.921 . . . . 0.0 110.196 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.96 -28.84 60.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -0.888 . . . . 0.0 110.181 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 9.7 ptm -142.02 14.36 2.07 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.231 -0.918 . . . . 0.0 110.43 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.04 93.26 3.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.159 -0.963 . . . . 0.0 109.984 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -77.67 169.26 18.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.915 . . . . 0.0 110.39 -179.67 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.46 ' OG1' ' NH1' ' A' ' 74' ' ' ARG . 55.1 m -93.99 -34.95 12.85 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.291 -0.881 . . . . 0.0 110.432 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 65.3 t0 54.31 55.06 8.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 109.951 -179.584 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.5 m -136.43 -46.62 0.62 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.199 -0.938 . . . . 0.0 110.138 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 25.8 tt0 55.36 29.98 14.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.912 . . . . 0.0 110.301 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -89.0 53.47 2.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.922 . . . . 0.0 110.197 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.49 ' HB2' ' N2 ' ' A' ' 154' ' ' WW7 . 48.2 mt-10 -93.96 -25.77 17.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.234 -0.916 . . . . 0.0 110.331 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.9 mm -51.99 -46.27 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 110.451 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -62.43 -44.43 96.45 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.125 -0.984 . . . . 0.0 109.868 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -54.24 -37.14 64.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.352 -0.843 . . . . 0.0 110.118 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.455 ' O ' ' CG2' ' A' ' 91' ' ' VAL . . . -68.28 -63.91 0.97 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.305 -0.872 . . . . 0.0 110.438 -179.787 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -45.33 -27.73 0.72 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.239 -0.913 . . . . 0.0 110.612 -179.647 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.82 -54.6 9.63 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.23 -0.919 . . . . 0.0 110.408 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.455 ' CG2' ' O ' ' A' ' 88' ' ' ALA . 33.9 m -61.85 -21.22 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.23 -0.919 . . . . 0.0 110.26 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.534 ' CE2' ' H3 ' ' A' ' 154' ' ' WW7 . 46.5 m-85 -93.23 -16.27 24.98 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.243 -0.911 . . . . 0.0 110.313 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.407 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 49.3 t0 -124.94 67.12 1.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.862 . . . . 0.0 109.863 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -95.22 2.06 54.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 110.855 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 2.7 p30 -95.81 -13.21 24.23 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.094 -1.004 . . . . 0.0 110.347 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.36 36.18 8.28 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.451 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 6.4 t-20 -93.25 -61.39 1.58 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.22 -1.165 . . . . 0.0 110.183 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.479 ' C ' ' CD1' ' A' ' 99' ' ' TYR . . . 128.59 -14.4 6.1 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 33.6 m-85 -136.73 146.91 46.38 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.129 -1.218 . . . . 0.0 110.225 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.412 HG22 ' HB3' ' A' ' 92' ' ' PHE . 39.8 mt -74.71 143.37 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.173 -0.954 . . . . 0.0 110.403 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.5 p -129.2 158.93 37.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.369 -0.832 . . . . 0.0 109.748 179.617 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.88 -25.14 56.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.148 -0.97 . . . . 0.0 110.545 -179.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.12 -64.5 1.04 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.181 -0.949 . . . . 0.0 110.507 -179.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.407 ' OE1' ' HA ' ' A' ' 93' ' ' ASP . 41.3 mt-10 -48.95 -40.95 32.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.231 -0.918 . . . . 0.0 110.068 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.4 tt -63.74 -40.12 95.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.0 110.156 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -58.71 -35.37 72.56 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.206 -0.934 . . . . 0.0 109.982 179.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.4 ' O ' ' OG1' ' A' ' 110' ' ' THR . 73.6 m-70 -77.32 -24.85 50.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.87 . . . . 0.0 110.619 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.414 HG22 ' CD1' ' A' ' 92' ' ' PHE . 90.4 t -77.16 -37.98 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.131 -0.98 . . . . 0.0 110.545 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.7 mmt -72.66 -26.07 61.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.23 -0.918 . . . . 0.0 110.562 -179.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 107' ' ' HIS . 39.4 p -64.6 -45.22 87.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.164 -0.96 . . . . 0.0 110.125 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -72.19 -42.9 65.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.19 -0.944 . . . . 0.0 110.021 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.7 mt -47.0 -25.85 0.89 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.255 -0.903 . . . . 0.0 110.403 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.2 43.96 3.64 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -132.95 136.28 46.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.29 -1.124 . . . . 0.0 110.033 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.01 109.11 21.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.241 -0.912 . . . . 0.0 110.618 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.7 mp -123.69 -177.94 3.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.345 -0.847 . . . . 0.0 109.745 179.507 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 57.8 m -129.03 155.53 45.26 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.122 -0.986 . . . . 0.0 110.256 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.419 ' O ' ' OD2' ' A' ' 122' ' ' ASP . 36.8 m-20 -49.07 -40.82 33.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.253 -0.905 . . . . 0.0 110.05 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -61.36 -50.74 71.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.231 -0.918 . . . . 0.0 110.268 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.414 ' OE1' ' HA ' ' A' ' 120' ' ' GLU . 6.0 mm-40 -52.82 -48.01 67.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.298 -0.876 . . . . 0.0 110.331 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 75.3 t -54.52 -50.31 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.192 -0.942 . . . . 0.0 110.255 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 118' ' ' ASP . 61.4 m-20 -53.61 -34.77 59.61 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 110.191 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -62.88 -47.62 82.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.194 -0.941 . . . . 0.0 109.971 179.957 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.407 ' O ' ' H6 ' ' A' ' 154' ' ' WW7 . 60.4 mtp -63.13 -59.08 5.26 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.29 -0.881 . . . . 0.0 110.226 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.425 ' CD1' 'CL1 ' ' A' ' 154' ' ' WW7 . 28.7 mm -50.89 -24.56 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.314 -0.866 . . . . 0.0 110.429 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -77.14 -49.15 15.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.207 -0.933 . . . . 0.0 110.071 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -63.02 -19.74 64.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -0.936 . . . . 0.0 110.017 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.43 ' CB ' ' SD ' ' A' ' 144' ' ' MET . . . -87.73 -40.98 13.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.358 -0.839 . . . . 0.0 110.088 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -64.54 88.07 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.297 -0.877 . . . . 0.0 110.243 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 140' ' ' GLU . 43.4 mt -63.28 -57.16 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.305 -0.872 . . . . 0.0 110.304 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.8 p30 -63.3 -30.43 71.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.193 -0.942 . . . . 0.0 110.167 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.446 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 72.35 68.65 1.55 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -116.42 -25.98 7.29 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.21 -1.171 . . . . 0.0 110.538 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 137.83 -6.42 3.48 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.28 179.822 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.439 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 2.6 pt20 -150.63 160.46 43.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.988 -1.301 . . . . 0.0 110.324 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 66.4 t -105.61 137.61 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 109.995 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -108.12 -170.26 1.65 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.056 -1.028 . . . . 0.0 110.279 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.55 ' CD1' HG22 ' A' ' 142' ' ' VAL . 11.2 t80 -66.56 -62.66 1.34 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.355 -0.841 . . . . 0.0 111.201 -179.063 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -44.9 -48.81 11.22 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.195 -0.941 . . . . 0.0 111.614 -179.106 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.414 ' HA ' HD13 ' A' ' 130' ' ' ILE . 75.6 mt-10 -58.84 -47.62 84.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.031 -1.043 . . . . 0.0 110.796 -179.174 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -64.58 -23.18 67.18 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 110.643 -179.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.55 HG22 ' CD1' ' A' ' 138' ' ' TYR . 76.5 t -90.63 -20.25 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.19 -0.944 . . . . 0.0 111.146 -179.533 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -89.36 -24.77 21.88 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.114 -0.991 . . . . 0.0 110.899 -179.105 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.43 ' SD ' ' CB ' ' A' ' 128' ' ' ALA . 20.4 ptt? -88.86 -31.81 18.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.021 -1.049 . . . . 0.0 110.442 -179.932 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.417 ' N ' ' HG3' ' A' ' 144' ' ' MET . 18.8 tpp -86.48 -9.49 56.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.215 -0.928 . . . . 0.0 110.3 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 142' ' ' VAL . 12.0 t -95.75 6.7 48.27 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.16 -0.962 . . . . 0.0 110.681 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -143.85 153.75 42.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.128 -0.982 . . . . 0.0 110.288 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.7 mttp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.31 -179.952 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . 0.642 'CA ' ' OD2' ' A' ' 24' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' WW7 . . . . . 0.468 ' C3 ' ' CE2' ' A' ' 19' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' WW7 . . . . . 0.534 ' H3 ' ' CE2' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.228 0.537 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.8 74.32 1.19 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.243 -0.911 . . . . 0.0 110.131 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -151.52 122.78 7.75 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.323 -0.861 . . . . 0.0 110.297 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 pp -72.94 -171.36 0.86 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.016 -1.053 . . . . 0.0 109.416 179.336 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.8 t -140.73 150.56 43.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.081 -1.012 . . . . 0.0 110.637 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -86.9 -11.98 49.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.445 -0.784 . . . . 0.0 109.896 179.301 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.66 -36.24 34.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.167 -0.958 . . . . 0.0 109.912 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.82 -47.19 86.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -0.86 . . . . 0.0 109.706 179.682 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.401 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 11.5 mm -61.24 -39.38 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.517 179.678 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.29 -33.65 75.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.411 -0.806 . . . . 0.0 109.869 179.469 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.26 -53.08 54.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.673 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -53.1 -36.69 60.99 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.132 -0.98 . . . . 0.0 109.172 179.224 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 9' ' ' ILE . 78.1 mttt -65.63 -37.45 86.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.546 -0.721 . . . . 0.0 109.651 179.266 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -57.23 -47.12 82.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.459 -0.776 . . . . 0.0 109.967 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.18 -54.58 44.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.145 -0.972 . . . . 0.0 110.22 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -47.01 -48.53 21.85 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.241 -0.912 . . . . 0.0 110.331 179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.7 m -60.71 -37.77 82.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.421 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 tt -65.16 -22.74 66.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 110.026 -179.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.492 ' CE2' ' H3 ' ' A' ' 153' ' ' WW7 . 10.0 m-85 -90.72 -69.32 0.74 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.308 -0.87 . . . . 0.0 110.028 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -56.69 120.48 7.88 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.117 -0.989 . . . . 0.0 109.585 179.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.6 mttt -110.33 -29.76 7.99 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.034 -1.041 . . . . 0.0 111.844 -178.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.438 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 10.4 p-10 -68.61 -44.91 73.28 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.801 -1.187 . . . . 0.0 110.144 -179.416 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.42 27.04 3.75 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.798 -1.192 . . . . 0.0 110.613 178.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.438 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 8.3 p-10 -95.69 -43.62 7.82 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.989 -1.3 . . . . 0.0 110.27 179.57 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.26 31.14 2.91 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.39 179.351 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.419 ' OG1' ' OD2' ' A' ' 24' ' ' ASP . 6.0 p -146.89 135.25 21.8 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.952 -1.323 . . . . 0.0 110.098 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 80.4 mt -106.53 98.91 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.345 -0.847 . . . . 0.0 110.034 179.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.83 -164.78 0.84 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.883 . . . . 0.0 110.064 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.1 p -83.76 -41.57 17.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.102 -0.999 . . . . 0.0 110.586 -179.78 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.491 ' HG3' ' N ' ' A' ' 31' ' ' GLU . 6.3 ptpt -69.68 -41.63 75.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.937 -1.102 . . . . 0.0 109.414 179.664 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 30' ' ' LYS . 60.1 mt-10 -61.78 -45.0 95.77 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.143 -0.973 . . . . 0.0 108.717 178.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.454 ' CD2' ' HG ' ' A' ' 48' ' ' LEU . 2.0 tp -64.21 -29.21 70.33 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.096 -0.641 . . . . 0.0 109.294 179.219 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.96 -40.2 96.61 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 179.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.5 m -69.74 -41.99 74.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.489 -1.006 . . . . 0.0 109.948 179.427 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.0 t -57.93 -34.2 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.298 -0.876 . . . . 0.0 109.994 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.3 mmt -89.73 -18.41 26.44 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.358 -0.839 . . . . 0.0 109.815 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -88.29 -13.31 41.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.389 -0.82 . . . . 0.0 110.578 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.441 ' HB3' HD22 ' A' ' 39' ' ' LEU . 44.0 t -68.2 -12.91 61.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.954 -1.091 . . . . 0.0 109.946 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.446 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 0.7 OUTLIER -169.21 88.2 0.18 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.173 -0.954 . . . . 0.0 110.207 -179.987 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.75 -52.0 0.84 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.402 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 49.6 tt0 51.56 31.85 8.2 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.22 -1.165 . . . . 0.0 109.972 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.481 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -76.5 -55.4 1.64 Allowed Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.412 -0.805 . . . . 0.0 110.957 -179.768 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 42' ' ' ASN . 45.1 Cg_endo -73.99 135.23 20.83 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.77 1.405 . . . . 0.0 110.534 -179.611 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 29.1 p -102.25 -130.75 0.26 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.308 -0.87 . . . . 0.0 109.569 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -100.88 -33.89 10.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.804 -1.185 . . . . 0.0 109.95 179.649 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.65 -66.23 0.77 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.337 -0.852 . . . . 0.0 110.077 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -51.21 -32.0 22.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 109.659 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.454 ' HG ' ' CD2' ' A' ' 32' ' ' LEU . 9.4 tt -64.26 -53.1 54.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.322 -0.861 . . . . 0.0 109.988 179.746 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -51.39 -39.0 56.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 109.827 179.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -66.03 -37.04 84.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.243 -0.911 . . . . 0.0 109.639 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.9 ttp -69.85 -20.08 63.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.323 -0.861 . . . . 0.0 109.735 179.57 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.449 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 32.7 mm -86.6 -24.65 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.391 -0.818 . . . . 0.0 109.899 179.644 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -70.58 -37.36 73.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.259 -0.901 . . . . 0.0 110.259 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.82 -19.36 48.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 110.485 -179.761 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -99.76 -14.09 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.098 -1.001 . . . . 0.0 110.11 -179.615 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 2.8 t70 -84.3 128.06 34.35 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.179 -0.951 . . . . 0.0 110.203 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -96.58 -12.86 23.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.202 -0.936 . . . . 0.0 110.402 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.402 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 61.1 m-20 -97.5 -73.46 0.61 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.124 -0.985 . . . . 0.0 110.486 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.429 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 134.94 41.49 0.14 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 62' ' ' THR . 16.6 p30 -116.02 -16.68 11.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.339 -1.094 . . . . 0.0 110.293 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.449 ' O ' ' CG2' ' A' ' 52' ' ' ILE . . . 106.87 -40.99 2.3 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.719 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.402 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 69.1 p -98.54 162.45 13.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.147 -1.207 . . . . 0.0 110.517 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.0 mt -115.04 144.87 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.4 -0.813 . . . . 0.0 110.081 179.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -101.69 -165.28 1.18 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.988 -1.07 . . . . 0.0 110.137 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.514 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 27.2 t80 -77.52 -44.32 2.56 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 111.276 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.0 Cg_endo -74.25 -27.86 11.15 Favored 'Trans proline' 0 C--N 1.324 -0.761 0 O-C-N 123.112 1.059 . . . . 0.0 110.02 -179.627 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.402 ' OE1' ' OD2' ' A' ' 58' ' ' ASP . 45.9 tt0 -77.21 -22.98 51.49 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.356 -0.84 . . . . 0.0 109.236 179.253 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.435 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 14.2 t80 -77.9 -44.5 26.87 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.506 -0.746 . . . . 0.0 110.252 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.4 -26.51 61.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 110.32 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 88.2 m -80.9 -29.76 35.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 0.0 110.497 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.427 ' CE ' ' HE1' ' A' ' 72' ' ' MET . 6.7 ptt? -86.13 -24.6 26.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.036 -1.04 . . . . 0.0 110.386 -179.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.427 ' HE1' ' CE ' ' A' ' 71' ' ' MET . 19.2 mmt -83.03 -27.53 30.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.281 -0.887 . . . . 0.0 110.403 -179.716 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.99 -42.81 10.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.917 . . . . 0.0 110.778 -179.51 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 -101.05 -25.36 14.08 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.241 -0.912 . . . . 0.0 110.656 -179.482 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt 49.19 83.34 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.115 -0.99 . . . . 0.0 110.282 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 89.9 mtp -72.28 160.21 32.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.259 -0.901 . . . . 0.0 110.169 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.07 156.72 44.72 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.084 -1.01 . . . . 0.0 110.201 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -169.06 126.13 0.95 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.185 -0.947 . . . . 0.0 110.463 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.11 131.87 52.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.317 -0.864 . . . . 0.0 109.77 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -144.7 -42.04 0.25 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.076 -1.015 . . . . 0.0 110.553 -179.635 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.1 m -160.07 136.46 8.86 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.148 -0.97 . . . . 0.0 110.14 -179.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.445 ' OE1' ' N ' ' A' ' 82' ' ' GLU . 0.4 OUTLIER -89.17 -171.66 3.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.239 -0.913 . . . . 0.0 110.164 179.955 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.408 ' HB3' ' OE1' ' A' ' 84' ' ' GLU . 5.1 tt0 -177.87 -51.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.245 -0.909 . . . . 0.0 110.449 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.408 ' OE1' ' HB3' ' A' ' 83' ' ' GLU . 0.4 OUTLIER -79.55 -35.35 40.0 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.111 -0.993 . . . . 0.0 110.473 179.955 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.404 HG21 ' CE1' ' A' ' 141' ' ' PHE . 54.8 mt -57.54 -52.45 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.181 -0.949 . . . . 0.0 110.526 -179.632 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.0 ttm-85 -56.87 -50.55 72.11 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.221 -0.924 . . . . 0.0 110.378 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -54.01 -36.56 63.12 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.223 -0.923 . . . . 0.0 110.412 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.28 -63.93 1.12 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.195 -0.94 . . . . 0.0 110.163 -179.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -45.76 -33.32 2.97 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.435 -0.79 . . . . 0.0 110.485 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.4 ttt85 -63.98 -45.86 87.15 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.31 -0.869 . . . . 0.0 110.77 -179.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.428 ' HA ' ' HE2' ' A' ' 94' ' ' LYS . 32.4 m -84.47 -9.53 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.112 -0.992 . . . . 0.0 111.416 -179.296 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.536 ' CD2' ' H3 ' ' A' ' 154' ' ' WW7 . 21.9 m-85 -97.0 -14.04 21.91 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.955 -1.09 . . . . 0.0 110.772 -179.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.406 ' OD2' ' HA2' ' A' ' 98' ' ' GLY . 11.8 t0 -116.19 59.39 0.73 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.041 -1.037 . . . . 0.0 110.256 179.698 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.428 ' HE2' ' HA ' ' A' ' 91' ' ' VAL . 19.4 mttt -94.91 20.09 9.35 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.228 -0.92 . . . . 0.0 110.559 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.456 ' OD2' ' CB ' ' A' ' 97' ' ' ASN . 9.6 p-10 -114.07 -28.39 7.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.183 -0.948 . . . . 0.0 110.398 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.89 -26.67 12.15 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.456 ' CB ' ' OD2' ' A' ' 95' ' ' ASP . 25.5 t-20 -44.79 -28.93 0.7 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.37 -1.076 . . . . 0.0 110.521 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.406 ' HA2' ' OD2' ' A' ' 93' ' ' ASP . . . 90.9 -42.6 2.87 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.45 ' CG ' ' OE1' ' A' ' 135' ' ' GLN . 12.1 m-30 -93.3 170.7 9.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.239 -1.153 . . . . 0.0 110.504 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 18.0 mt -104.18 119.71 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.301 -0.874 . . . . 0.0 109.432 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.4 t -102.65 174.89 5.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.232 -0.917 . . . . 0.0 109.855 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.7 -45.02 63.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.035 -1.041 . . . . 0.0 109.909 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.5 -45.57 91.33 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.253 -0.904 . . . . 0.0 110.056 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.407 ' O ' HG21 ' A' ' 108' ' ' VAL . 48.4 mt-10 -61.93 -48.3 81.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.175 179.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.414 HD11 HD12 ' A' ' 125' ' ' ILE . 6.8 tt -53.7 -31.77 49.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 0.0 110.164 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.0 ttt-85 -73.07 -41.33 64.23 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.21 -0.932 . . . . 0.0 110.08 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -73.07 -11.29 60.5 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.297 -0.877 . . . . 0.0 110.503 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.498 HG12 ' CD1' ' A' ' 92' ' ' PHE . 92.9 t -92.93 -49.69 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.236 -0.915 . . . . 0.0 110.062 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.2 mmt -50.29 -45.16 54.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.413 -0.804 . . . . 0.0 110.435 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.8 p -52.79 -44.87 66.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.304 -0.872 . . . . 0.0 110.377 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -63.6 -43.43 96.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.126 -0.984 . . . . 0.0 110.023 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 13.6 mt -55.34 -40.7 71.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 110.123 179.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 125.83 45.65 0.24 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.417 ' OE1' HD13 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -156.54 146.53 21.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.25 -1.147 . . . . 0.0 110.045 179.98 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -123.25 138.07 54.72 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.192 -0.943 . . . . 0.0 110.284 -179.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.417 HD13 ' OE1' ' A' ' 114' ' ' GLU . 4.7 mp -139.9 -163.66 1.55 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.26 -0.9 . . . . 0.0 110.145 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.453 HG21 ' N ' ' A' ' 118' ' ' ASP . 57.4 m -120.08 164.46 16.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.228 -0.92 . . . . 0.0 110.236 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.453 ' N ' HG21 ' A' ' 117' ' ' THR . 0.9 OUTLIER -58.4 -34.39 70.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.29 -0.881 . . . . 0.0 110.411 179.942 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -56.25 -61.16 2.59 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.302 -0.874 . . . . 0.0 110.758 -179.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 124' ' ' MET . 96.0 mt-10 -52.18 -55.1 23.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.073 -1.017 . . . . 0.0 110.433 -179.654 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.4 t -54.24 -27.91 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.277 -0.889 . . . . 0.0 110.752 -179.648 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -75.4 -40.36 57.98 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.107 -0.996 . . . . 0.0 110.196 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 15.9 tt0 -74.91 -18.07 60.47 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.197 -0.94 . . . . 0.0 109.688 179.51 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.425 ' HG3' ' O ' ' A' ' 120' ' ' GLU . 96.3 mtp -78.06 -50.28 12.37 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 109.949 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.414 HD12 HD11 ' A' ' 105' ' ' LEU . 29.1 mm -65.03 -39.86 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.361 -0.837 . . . . 0.0 110.165 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -61.43 -55.86 26.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 110.255 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 58.1 mt-10 -57.79 -37.92 74.58 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.255 -0.903 . . . . 0.0 110.534 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.434 ' CB ' ' SD ' ' A' ' 144' ' ' MET . . . -70.53 -24.41 62.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 110.167 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -69.18 92.18 0.54 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.307 -0.87 . . . . 0.0 110.21 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 66.1 mt -75.68 -48.51 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.285 -0.884 . . . . 0.0 110.169 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.2 p30 -64.26 -30.37 71.42 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.348 -0.845 . . . . 0.0 110.188 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 87.66 52.63 2.94 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.653 179.198 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -117.64 -32.86 4.73 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.954 -1.321 . . . . 0.0 109.923 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 118.95 24.2 3.1 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.45 ' OE1' ' CG ' ' A' ' 99' ' ' TYR . 3.6 pp0? -159.61 149.02 18.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.203 -1.174 . . . . 0.0 110.143 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.4 t -109.0 125.95 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.244 -0.91 . . . . 0.0 110.721 -179.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -97.51 -165.6 1.28 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.879 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -68.06 -48.42 65.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.11 -0.994 . . . . 0.0 110.537 -179.745 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -63.52 -45.55 90.09 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.121 -0.987 . . . . 0.0 110.602 -179.683 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.414 ' OE2' ' OD2' ' A' ' 131' ' ' ASP . 37.0 mt-10 -58.6 -38.34 77.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.261 -0.899 . . . . 0.0 110.501 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.54 ' CD2' ' CE ' ' A' ' 144' ' ' MET . 6.5 t80 -72.39 -26.87 62.04 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.183 -0.948 . . . . 0.0 110.418 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.412 ' O ' HG21 ' A' ' 146' ' ' THR . 87.6 t -76.66 -24.46 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.078 -1.014 . . . . 0.0 110.676 -179.423 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -87.39 -51.17 6.09 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.142 -0.974 . . . . 0.0 110.452 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.54 ' CE ' ' CD2' ' A' ' 141' ' ' PHE . 21.5 ptt? -56.41 -32.86 65.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.903 . . . . 0.0 110.701 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.477 ' HE1' ' CZ ' ' A' ' 141' ' ' PHE . 28.2 tpp -72.83 -54.24 9.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.15 -0.969 . . . . 0.0 110.538 -179.526 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.428 ' O ' HG21 ' A' ' 146' ' ' THR . 5.2 t -118.11 105.08 11.46 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.08 -1.013 . . . . 0.0 110.42 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.71 150.12 45.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.145 -0.972 . . . . 0.0 110.284 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.188 179.903 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' WW7 . . . . . 0.492 ' H3 ' ' CE2' ' A' ' 19' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' WW7 . . . . . 0.536 ' H3 ' ' CD2' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.201 0.524 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -123.15 141.52 51.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.157 -0.964 . . . . 0.0 110.468 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -136.48 55.52 1.84 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.322 -0.862 . . . . 0.0 110.149 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.6 mt -91.01 104.12 16.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.233 -0.917 . . . . 0.0 110.517 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.412 ' O ' ' HG2' ' A' ' 8' ' ' GLN . 57.4 m -108.42 -69.72 0.84 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.29 -0.881 . . . . 0.0 109.607 179.47 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.415 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 52.2 mt-10 -90.46 -29.22 18.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.394 -0.816 . . . . 0.0 109.83 179.316 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -57.34 -48.74 78.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.199 -0.938 . . . . 0.0 110.028 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.465 ' HG3' ' N ' ' A' ' 9' ' ' ILE . 3.5 pt20 -52.03 -38.19 56.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.719 179.711 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.465 ' N ' ' HG3' ' A' ' 8' ' ' GLN . 34.6 mt -62.24 -44.47 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.328 -0.857 . . . . 0.0 109.516 179.41 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.61 -37.18 70.33 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.281 -0.887 . . . . 0.0 109.486 179.373 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -62.78 -45.42 92.73 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.325 -0.859 . . . . 0.0 109.499 179.391 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -61.36 -33.1 73.08 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.429 -0.794 . . . . 0.0 109.849 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt -61.57 -49.51 76.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -0.915 . . . . 0.0 109.583 179.62 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -57.69 -39.62 77.6 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.451 -0.781 . . . . 0.0 109.627 179.537 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.462 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -60.21 -43.25 96.14 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.257 -0.902 . . . . 0.0 109.794 179.676 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.481 ' CE1' HD13 ' A' ' 27' ' ' ILE . 29.3 t80 -59.32 -39.13 82.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.161 -0.962 . . . . 0.0 109.29 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.3 t -70.16 -25.4 63.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.822 . . . . 0.0 109.181 178.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.424 ' C ' ' CD1' ' A' ' 18' ' ' LEU . 3.4 tm? -71.41 -29.12 64.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.471 -0.768 . . . . 0.0 109.551 179.45 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.506 ' CZ ' ' H3 ' ' A' ' 153' ' ' WW7 . 20.8 m-85 -87.54 -64.59 1.12 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.401 -0.812 . . . . 0.0 109.972 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -85.44 74.43 10.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.348 -0.845 . . . . 0.0 109.799 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.417 ' CE ' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -99.02 47.64 0.97 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.279 -0.888 . . . . 0.0 110.414 -179.641 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.408 ' OD1' ' HB2' ' A' ' 24' ' ' ASP . 4.1 p30 -127.91 -5.02 5.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.169 -0.957 . . . . 0.0 110.583 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.47 48.68 5.21 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.408 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 13.6 m-20 -117.9 -72.69 0.68 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -1.131 . . . . 0.0 110.26 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.21 -10.52 4.43 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.6 p -132.33 150.26 52.19 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.136 -1.214 . . . . 0.0 110.364 -179.827 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.481 HD13 ' CE1' ' A' ' 16' ' ' PHE . 70.8 mt -97.12 131.62 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.222 -0.923 . . . . 0.0 110.241 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.8 t -120.72 -174.07 2.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.344 -0.847 . . . . 0.0 110.18 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.7 p -75.27 -31.84 60.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.223 -0.923 . . . . 0.0 110.692 -179.68 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -65.8 -59.76 3.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.116 -0.99 . . . . 0.0 109.805 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -57.21 -56.27 23.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.388 -0.82 . . . . 0.0 109.484 179.526 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.48 HD23 ' CD1' ' A' ' 52' ' ' ILE . 10.9 tp -57.22 -22.56 41.82 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.231 -0.918 . . . . 0.0 109.297 179.085 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.85 -42.62 96.91 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 38' ' ' SER . 54.8 m -69.21 -25.16 64.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.512 -0.993 . . . . 0.0 109.712 179.287 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.3 t -76.74 -33.43 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.415 -0.803 . . . . 0.0 110.956 -179.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.7 tpp -90.07 -23.48 21.41 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.921 -1.112 . . . . 0.0 110.898 -179.318 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.7 ttm-85 -90.91 -32.55 15.96 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.09 -1.006 . . . . 0.0 110.629 -179.752 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 34' ' ' THR . 71.1 m -79.94 -21.71 43.52 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.116 -0.99 . . . . 0.0 110.404 -179.752 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 mp -135.35 80.12 1.82 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 110.438 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.89 -54.06 0.52 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 50.48 74.25 0.23 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.214 -1.168 . . . . 0.0 109.871 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.524 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 2.6 t30 -152.22 -66.27 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.222 -0.924 . . . . 0.0 110.376 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.524 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 43.7 Cg_endo -71.56 -160.75 0.09 OUTLIER 'Trans proline' 0 C--N 1.317 -1.086 0 O-C-N 123.241 1.127 . . . . 0.0 110.145 179.458 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 40.2 p -147.09 -178.46 6.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.205 -0.935 . . . . 0.0 109.85 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -65.47 -32.89 74.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 110.05 179.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.34 -62.68 1.29 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.124 -0.985 . . . . 0.0 109.537 179.448 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -51.85 -27.56 13.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.184 -0.947 . . . . 0.0 109.042 179.062 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 44' ' ' THR . 6.2 tt -68.88 -43.88 74.41 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.478 -0.764 . . . . 0.0 109.472 179.332 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -53.46 -42.77 67.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.38 -0.825 . . . . 0.0 109.021 179.104 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -65.47 -33.92 77.07 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.431 ' O ' ' H6 ' ' A' ' 153' ' ' WW7 . 0.5 OUTLIER -68.45 -20.3 64.62 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.587 -0.696 . . . . 0.0 109.359 179.001 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.48 ' CD1' HD23 ' A' ' 32' ' ' LEU . 32.4 mm -87.09 -26.5 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.399 -0.813 . . . . 0.0 110.087 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -73.79 -30.47 62.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.0 110.537 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 8.4 pt-20 -71.64 -26.74 62.68 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.088 -1.008 . . . . 0.0 110.204 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.445 ' N ' ' HG3' ' A' ' 54' ' ' GLU . 96.3 t -90.17 -30.46 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.163 -0.961 . . . . 0.0 109.717 179.608 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -76.48 115.92 16.68 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.438 -0.789 . . . . 0.0 110.206 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.69 18.88 21.46 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.256 -0.902 . . . . 0.0 110.239 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.433 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 61.6 m-20 -112.02 -65.72 1.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.354 -0.841 . . . . 0.0 109.968 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.16 -12.6 2.09 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -70.11 -36.7 75.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.971 -1.311 . . . . 0.0 110.534 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 119.73 -63.64 0.46 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 48.9 p -69.25 170.56 9.99 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.17 -1.194 . . . . 0.0 110.724 -179.437 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.459 HG21 ' N ' ' A' ' 64' ' ' ASP . 89.1 mt -115.09 149.46 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.244 -0.91 . . . . 0.0 110.309 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.459 ' N ' HG21 ' A' ' 63' ' ' ILE . 55.5 m-20 -98.37 -166.24 1.34 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 110.209 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.548 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 10.2 t80 -81.47 -38.26 0.93 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.162 -0.961 . . . . 0.0 112.118 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.6 Cg_endo -72.39 -25.9 17.77 Favored 'Trans proline' 0 C--O 1.209 -0.938 0 O-C-N 122.817 0.904 . . . . 0.0 111.269 -178.922 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.433 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 63.4 mt-10 -76.05 -33.61 59.61 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.827 -1.171 . . . . 0.0 109.524 179.421 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.504 ' CE2' ' HE2' ' A' ' 72' ' ' MET . 12.6 t80 -75.38 -53.0 9.45 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.537 -0.727 . . . . 0.0 110.064 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.479 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -65.31 -20.83 66.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.509 -0.745 . . . . 0.0 110.408 -179.824 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 66' ' ' PRO . 50.6 m -91.38 -22.97 20.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.907 -1.12 . . . . 0.0 111.18 -179.595 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 60.0 ttp -86.99 -43.64 12.2 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.877 -1.139 . . . . 0.0 111.153 -179.241 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.504 ' HE2' ' CE2' ' A' ' 68' ' ' PHE . 43.2 mtt -82.84 -34.56 26.82 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.905 -1.122 . . . . 0.0 110.595 -179.473 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -69.0 -8.58 46.15 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.141 -0.975 . . . . 0.0 110.66 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.4 tpt85 -40.16 -36.9 0.55 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.551 -0.718 . . . . 0.0 110.77 -179.566 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -73.4 88.14 1.57 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.296 -0.877 . . . . 0.0 109.586 179.395 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 50.7 ttp -105.2 131.85 52.15 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.259 -0.901 . . . . 0.0 110.812 -179.243 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -141.29 112.92 7.64 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.291 -0.881 . . . . 0.0 109.682 179.424 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -113.75 134.17 54.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.18 -0.95 . . . . 0.0 110.712 -179.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.58 153.38 30.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.425 -0.797 . . . . 0.0 109.894 179.593 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 51.5 p-10 -150.58 153.44 35.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.301 -0.874 . . . . 0.0 110.248 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.7 t -122.9 -55.23 1.8 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.336 -0.852 . . . . 0.0 109.852 179.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -96.88 88.26 4.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 109.855 179.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -159.12 77.52 0.73 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.169 -0.957 . . . . 0.0 110.345 -179.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -90.7 -24.49 20.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 110.142 179.831 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.4 mt -69.62 -40.68 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.367 -0.833 . . . . 0.0 110.309 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.6 ttp180 -67.96 -56.87 7.39 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.17 -0.957 . . . . 0.0 110.034 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -47.78 -47.81 30.55 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.256 -0.903 . . . . 0.0 110.111 179.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.456 ' O ' ' CG2' ' A' ' 91' ' ' VAL . . . -54.82 -54.49 41.58 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.302 -0.874 . . . . 0.0 110.107 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -49.93 -28.7 7.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.291 -0.881 . . . . 0.0 110.259 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -71.97 -47.01 55.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.144 -0.973 . . . . 0.0 110.643 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' A' ' 88' ' ' ALA . 35.9 m -70.9 -20.14 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.17 -0.956 . . . . 0.0 110.4 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.526 ' CE2' ' H2 ' ' A' ' 154' ' ' WW7 . 25.5 m-85 -95.35 -12.85 25.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.325 -0.859 . . . . 0.0 110.345 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -107.18 73.87 0.95 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.167 -0.958 . . . . 0.0 110.59 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -74.98 -36.46 62.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.171 -0.956 . . . . 0.0 109.995 179.639 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.8 p30 -74.54 -25.41 59.29 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.312 -0.867 . . . . 0.0 110.51 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 76.46 60.79 2.93 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.432 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 26.0 p-10 -124.33 -10.07 7.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.357 -1.084 . . . . 0.0 110.476 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.526 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 86.27 16.03 63.36 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.08 -1.057 . . . . 0.0 110.493 179.005 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.557 ' CD1' ' NE2' ' A' ' 135' ' ' GLN . 38.2 m-85 -142.1 138.31 31.6 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.188 -1.184 . . . . 0.0 110.26 179.875 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.41 HG22 ' HB3' ' A' ' 92' ' ' PHE . 25.6 mt -94.06 129.75 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.327 -0.858 . . . . 0.0 110.16 -179.748 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.7 t -114.91 166.09 12.16 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.285 -0.885 . . . . 0.0 109.977 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.46 -26.56 68.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.297 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.42 -69.83 0.27 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.282 -0.886 . . . . 0.0 110.266 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.409 ' O ' HG22 ' A' ' 108' ' ' VAL . 37.1 mt-10 -52.71 -38.78 61.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 110.212 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.427 HD11 HD12 ' A' ' 125' ' ' ILE . 4.0 tt -52.69 -46.21 67.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.094 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.6 ttm-85 -66.72 -37.85 85.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.362 -0.836 . . . . 0.0 110.045 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -61.4 -23.86 66.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.165 -0.959 . . . . 0.0 110.248 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 104' ' ' GLU . 50.0 t -87.28 -41.0 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.119 -0.988 . . . . 0.0 110.616 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.408 ' HE1' HD22 ' A' ' 105' ' ' LEU . 21.6 mmt -68.17 -57.79 5.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.137 -0.977 . . . . 0.0 110.521 -179.613 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.8 t -50.13 -23.86 2.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.303 -0.873 . . . . 0.0 110.401 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -79.43 -50.37 10.9 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.18 -0.95 . . . . 0.0 110.276 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.8 mt -60.75 -23.47 64.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.208 -0.933 . . . . 0.0 110.302 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 114' ' ' GLU . . . 102.88 90.97 2.17 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 1.3 mm-40 -155.3 -164.46 1.77 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.326 -1.102 . . . . 0.0 110.029 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.69 99.56 2.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.131 -0.981 . . . . 0.0 110.28 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.6 mp -137.52 135.62 36.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.326 -0.859 . . . . 0.0 110.204 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.435 ' CG2' ' OE2' ' A' ' 120' ' ' GLU . 13.1 t -75.78 172.18 13.09 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.228 -0.92 . . . . 0.0 109.949 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 53.7 m-20 -59.95 -41.58 92.17 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.241 -0.912 . . . . 0.0 110.299 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.456 ' N ' ' OE1' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -53.26 -47.72 68.88 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.164 -0.96 . . . . 0.0 110.811 -179.672 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.451 ' N ' ' OE1' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -54.37 -56.22 20.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.99 -1.069 . . . . 0.0 110.897 -179.605 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 84.1 t -52.96 -44.74 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.913 -1.117 . . . . 0.0 110.675 -179.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 118' ' ' ASP . 1.5 m-20 -62.51 -30.8 71.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.145 -0.972 . . . . 0.0 110.611 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -72.48 -28.48 62.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.072 -1.018 . . . . 0.0 110.057 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.4 mtp -74.29 -45.77 45.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -0.874 . . . . 0.0 110.215 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.432 HG21 HG22 ' A' ' 136' ' ' VAL . 30.0 mm -64.65 -39.85 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.305 -0.872 . . . . 0.0 110.408 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.4 mtp180 -67.76 -51.0 54.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.158 -0.964 . . . . 0.0 110.115 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -55.41 -35.17 65.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.17 -0.956 . . . . 0.0 109.781 179.56 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.414 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -75.82 -28.72 58.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.361 -0.837 . . . . 0.0 109.812 179.685 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.409 ' OD2' ' HA2' ' A' ' 132' ' ' GLY . 16.0 t0 -71.92 91.93 1.23 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -0.871 . . . . 0.0 110.119 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 96.2 mt -73.14 -32.61 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.217 -0.927 . . . . 0.0 110.717 -179.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 23.4 p30 -99.59 -18.54 17.3 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.232 -0.918 . . . . 0.0 110.505 -179.776 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.467 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 77.0 72.11 1.14 Allowed Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.974 -1.108 . . . . 0.0 110.337 179.438 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.406 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 76.4 m-20 -113.93 6.1 16.44 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.072 -1.251 . . . . 0.0 110.118 179.175 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.32 16.3 69.45 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.557 ' NE2' ' CD1' ' A' ' 99' ' ' TYR . 11.2 pt20 -170.16 165.46 9.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.115 -1.226 . . . . 0.0 110.166 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.432 HG22 HG21 ' A' ' 125' ' ' ILE . 52.4 t -106.71 107.58 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.177 -0.952 . . . . 0.0 110.386 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -77.74 163.08 26.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.363 -0.836 . . . . 0.0 110.142 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -51.47 -30.16 18.92 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.24 -0.913 . . . . 0.0 110.278 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -70.47 -59.29 2.93 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.2 -0.937 . . . . 0.0 110.474 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 56.3 mt-10 -54.16 -25.66 23.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 0.0 110.221 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.525 ' CZ ' ' HE1' ' A' ' 145' ' ' MET . 16.7 t80 -77.93 -35.39 50.54 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.312 -0.867 . . . . 0.0 110.137 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.409 ' O ' HG21 ' A' ' 146' ' ' THR . 97.0 t -75.24 -22.83 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 110.364 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -83.31 -46.83 12.16 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.275 -0.89 . . . . 0.0 110.459 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.441 ' HE2' ' HE1' ' A' ' 145' ' ' MET . 0.2 OUTLIER -70.3 -13.22 62.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.027 -1.046 . . . . 0.0 110.293 -179.788 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.525 ' HE1' ' CZ ' ' A' ' 141' ' ' PHE . 13.4 mmt -89.28 -61.01 1.8 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.285 -0.884 . . . . 0.0 109.994 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.409 HG21 ' O ' ' A' ' 142' ' ' VAL . 9.5 t -111.33 -17.16 13.21 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.188 -0.945 . . . . 0.0 110.105 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 58.01 108.7 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.324 -0.86 . . . . 0.0 110.273 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.9 tptt . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.2 179.974 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' WW7 . . . . . 0.506 ' H3 ' ' CZ ' ' A' ' 19' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' WW7 . . . . . 0.526 ' H2 ' ' CE2' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.293 0.568 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -77.65 130.54 36.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.258 -0.901 . . . . 0.0 110.168 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.449 ' NE2' ' O ' ' A' ' 3' ' ' GLN . 1.0 OUTLIER -168.42 76.75 0.13 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.276 -0.89 . . . . 0.0 110.121 179.955 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.6 mt -105.26 177.36 4.87 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.312 -0.868 . . . . 0.0 110.203 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.5 t -109.4 -30.39 7.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 109.796 179.69 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -78.49 -28.21 46.31 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.222 -0.924 . . . . 0.0 109.719 179.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -76.78 -32.11 57.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.846 . . . . 0.0 109.728 179.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -65.38 -49.71 68.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.426 -0.796 . . . . 0.0 110.03 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.7 mt -68.48 -45.98 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.203 -0.936 . . . . 0.0 109.584 179.508 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 13' ' ' LYS . . . -59.32 -25.69 64.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.374 -0.828 . . . . 0.0 109.48 179.36 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.415 ' HA ' ' OE1' ' A' ' 11' ' ' GLU . 5.3 tp10 -69.59 -50.23 46.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.309 -0.87 . . . . 0.0 109.071 179.323 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -67.11 -17.24 64.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.368 -0.832 . . . . 0.0 109.58 179.075 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 25.6 mtpt -76.59 -49.49 16.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.153 -0.967 . . . . 0.0 109.796 179.596 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.9 -41.95 88.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.187 -0.946 . . . . 0.0 109.791 179.378 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.08 -49.99 67.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 109.791 179.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.458 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 40.3 t80 -54.68 -28.45 47.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.921 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.0 m -80.8 -32.73 35.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.342 -0.849 . . . . 0.0 109.497 179.63 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.419 ' O ' ' HE2' ' A' ' 21' ' ' LYS . 3.2 tt -69.57 -18.03 63.6 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.42 -0.8 . . . . 0.0 109.646 179.483 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.52 ' CE2' ' H3 ' ' A' ' 153' ' ' WW7 . 5.1 m-30 -96.7 -45.14 6.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.421 -0.799 . . . . 0.0 109.953 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.623 ' OD1' 'CA ' ' A' ' 149' ' ' ' CA' . 24.8 t0 -78.86 104.63 9.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.386 -0.821 . . . . 0.0 110.313 -179.741 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.419 ' HE2' ' O ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -110.4 64.68 0.61 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.161 -0.962 . . . . 0.0 110.837 -179.688 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.405 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 13.7 p-10 -170.89 -36.82 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.033 -1.042 . . . . 0.0 110.612 179.771 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 24' ' ' ASP . . . 101.57 100.31 2.45 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 -179.293 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 24.7 p-10 -176.97 -29.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.242 -1.152 . . . . 0.0 111.014 -179.619 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.444 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 88.21 52.83 2.79 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.444 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 0.3 OUTLIER -169.93 150.36 3.85 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.185 -1.186 . . . . 0.0 110.314 179.817 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.2 109.09 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.34 -0.85 . . . . 0.0 110.364 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.411 HG21 HG23 ' A' ' 62' ' ' THR . 65.6 p -93.24 -167.15 1.66 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.26 -0.9 . . . . 0.0 110.115 179.807 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.3 p -84.67 -20.7 30.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.23 -0.919 . . . . 0.0 110.207 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -72.69 -60.26 2.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.237 -0.914 . . . . 0.0 109.94 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -56.57 -49.29 75.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 109.624 179.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.434 ' O ' ' HB ' ' A' ' 35' ' ' VAL . 3.6 tp -60.73 -31.94 71.23 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.292 -0.88 . . . . 0.0 109.265 179.293 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.8 -42.33 94.46 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.709 -1.757 . . . . 0.0 108.709 179.298 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 66.9 m -71.58 -24.78 61.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -1.113 . . . . 0.0 109.477 179.311 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.436 ' O ' ' CG ' ' A' ' 39' ' ' LEU . 51.1 t -70.96 -34.84 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.413 -0.805 . . . . 0.0 110.279 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 21.9 mmt -90.76 -23.14 20.74 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.214 -0.929 . . . . 0.0 110.439 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.408 ' NH2' ' HG2' ' A' ' 37' ' ' ARG . 6.7 ttp85 -80.49 -31.8 37.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 110.238 -179.771 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.2 m -92.38 -31.98 15.13 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.148 -0.97 . . . . 0.0 110.569 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.436 ' CG ' ' O ' ' A' ' 35' ' ' VAL . 66.9 mt -86.08 -71.98 0.52 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.141 -0.975 . . . . 0.0 110.496 -179.754 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -118.77 88.74 0.45 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -62.49 123.01 17.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.284 -1.127 . . . . 0.0 110.036 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.484 ' HB3' ' CD ' ' A' ' 43' ' ' PRO . 0.9 OUTLIER 179.47 -59.31 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.175 -0.953 . . . . 0.0 110.305 -179.906 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.484 ' CD ' ' HB3' ' A' ' 42' ' ' ASN . 42.2 Cg_endo -68.41 158.43 57.65 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.593 1.312 . . . . 0.0 110.69 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 71.7 p -107.8 -138.21 0.37 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.368 -0.832 . . . . 0.0 109.619 179.826 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -99.16 -40.33 8.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.93 -1.106 . . . . 0.0 109.82 179.589 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.01 -59.42 2.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.306 -0.872 . . . . 0.0 109.915 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 37.2 tt0 -54.9 -30.59 58.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 109.792 179.587 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.471 ' CD2' HD13 ' A' ' 52' ' ' ILE . 7.5 tt -64.17 -52.6 58.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.358 -0.839 . . . . 0.0 109.775 179.785 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -52.92 -35.54 58.54 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.269 -0.894 . . . . 0.0 109.053 179.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 8.5 t70 -61.64 -41.76 97.94 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.383 -0.823 . . . . 0.0 109.524 179.297 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.411 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 32.1 ttp -68.18 -19.77 64.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.383 -0.823 . . . . 0.0 109.565 179.538 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.471 HD13 ' CD2' ' A' ' 48' ' ' LEU . 22.9 mt -83.57 -24.95 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.238 -0.914 . . . . 0.0 110.077 179.59 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -65.65 -46.18 80.15 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.162 -0.961 . . . . 0.0 110.07 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 21.3 pt-20 -59.45 -31.38 69.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.174 -0.954 . . . . 0.0 109.683 179.637 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.435 ' N ' ' HG3' ' A' ' 54' ' ' GLU . 75.8 t -87.0 -16.96 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.394 -0.816 . . . . 0.0 110.004 179.536 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.41 ' OD2' ' O ' ' A' ' 62' ' ' THR . 6.6 t0 -110.5 87.99 2.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.284 -0.885 . . . . 0.0 110.091 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.24 -12.65 61.85 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.253 -0.904 . . . . 0.0 110.752 -179.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -72.2 -59.3 2.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.14 -0.975 . . . . 0.0 110.439 -179.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.9 -1.35 21.35 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.349 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 20.2 p30 -69.96 -31.09 68.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.148 -1.207 . . . . 0.0 110.116 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.456 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 120.86 -59.8 0.55 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.411 HG23 HG21 ' A' ' 28' ' ' THR . 50.1 p -91.15 166.37 13.0 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.18 -1.188 . . . . 0.0 110.756 -179.447 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.41 HD12 HG13 ' A' ' 55' ' ' VAL . 42.8 mt -102.95 137.34 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.384 -0.822 . . . . 0.0 110.132 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.407 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 51.1 m-20 -92.62 178.44 5.8 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.273 -0.892 . . . . 0.0 110.305 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.555 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 25.2 t80 -71.66 -44.27 12.15 Favored Pre-proline 0 N--CA 1.486 1.357 0 O-C-N 121.166 -0.959 . . . . 0.0 111.069 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.3 Cg_endo -71.35 -21.6 26.29 Favored 'Trans proline' 0 C--N 1.324 -0.763 0 O-C-N 123.109 1.057 . . . . 0.0 109.874 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.409 ' OE2' ' HA ' ' A' ' 56' ' ' ASP . 84.7 tt0 -83.73 -30.51 26.65 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.38 -0.825 . . . . 0.0 109.265 178.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.458 ' CE2' ' HB2' ' A' ' 16' ' ' PHE . 43.2 t80 -70.81 -47.06 61.48 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.534 -0.729 . . . . 0.0 109.853 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.9 tt -74.28 -27.99 60.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.329 -0.857 . . . . 0.0 109.874 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.43 ' HA ' ' HB2' ' A' ' 74' ' ' ARG . 18.2 m -80.52 -16.67 53.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.224 -0.923 . . . . 0.0 110.142 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.446 ' HE2' ' CE ' ' A' ' 72' ' ' MET . 14.3 tmm? -88.36 -46.8 8.87 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.304 -0.872 . . . . 0.0 110.856 -179.523 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.446 ' CE ' ' HE2' ' A' ' 71' ' ' MET . 58.0 mtt -90.85 -59.49 2.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.01 -1.056 . . . . 0.0 111.275 -179.219 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.34 -50.99 71.17 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.258 -0.901 . . . . 0.0 111.121 -178.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.43 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 0.7 OUTLIER -60.62 -69.3 0.23 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.154 -0.966 . . . . 0.0 110.816 -179.178 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 74' ' ' ARG . 6.6 tptp 55.32 102.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.319 -0.863 . . . . 0.0 110.289 -179.426 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -90.18 -165.31 1.32 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.291 -0.881 . . . . 0.0 110.221 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.9 pttt -141.08 156.12 46.04 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -0.834 . . . . 0.0 109.948 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -123.6 171.34 9.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.934 . . . . 0.0 110.482 -179.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.5 t -118.54 -16.83 9.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.307 -0.87 . . . . 0.0 110.348 -179.821 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -81.2 125.58 30.46 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.155 -0.966 . . . . 0.0 110.288 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.406 ' O ' ' HB3' ' A' ' 82' ' ' GLU . 64.1 m -111.65 -38.09 5.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.2 -0.938 . . . . 0.0 110.21 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.406 ' HB3' ' O ' ' A' ' 81' ' ' SER . 28.7 tt0 59.81 167.71 0.07 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.288 -0.882 . . . . 0.0 110.181 -179.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.419 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . 6.0 mm-40 -99.91 39.54 1.32 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.268 -0.895 . . . . 0.0 110.493 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -80.53 -47.13 14.69 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.208 -0.932 . . . . 0.0 109.809 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.0 mt -52.13 -22.91 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.312 -0.868 . . . . 0.0 109.732 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.9 ttm-85 -69.09 -51.26 40.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.318 -0.864 . . . . 0.0 109.827 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -55.42 -43.03 74.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.067 -1.02 . . . . 0.0 109.764 179.528 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.466 ' O ' ' CG2' ' A' ' 91' ' ' VAL . . . -58.04 -56.08 26.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.894 . . . . 0.0 109.978 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -48.91 -30.85 6.38 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.19 -0.944 . . . . 0.0 110.586 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.6 ttp85 -70.33 -48.77 55.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.22 -0.925 . . . . 0.0 111.15 -179.362 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.481 HG21 ' CD2' ' A' ' 92' ' ' PHE . 27.5 m -64.78 -26.99 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.808 -1.183 . . . . 0.0 110.521 -179.54 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.516 ' CG ' ' H3 ' ' A' ' 154' ' ' WW7 . 38.6 m-85 -88.27 -14.95 37.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.256 -0.903 . . . . 0.0 110.24 179.687 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.25 77.16 1.77 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.0 109.893 179.512 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -94.56 -21.9 18.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.268 -0.895 . . . . 0.0 110.707 -179.477 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 2.0 p30 -71.11 -14.52 62.33 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.132 -0.98 . . . . 0.0 110.775 -179.297 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.86 30.36 23.71 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.598 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.456 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 1.7 t-20 -76.0 -78.12 0.12 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.246 -1.15 . . . . 0.0 109.939 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 145.28 -16.61 1.89 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.521 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -133.57 155.29 49.89 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.228 -1.16 . . . . 0.0 109.577 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.427 ' CD1' ' CD1' ' A' ' 141' ' ' PHE . 18.5 mt -94.74 118.6 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 120.988 -1.07 . . . . 0.0 109.541 179.784 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.8 m -102.37 168.8 9.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 110.128 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.28 -44.98 89.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.177 -0.952 . . . . 0.0 110.178 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.4 -58.15 9.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.125 -0.984 . . . . 0.0 110.011 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -49.88 -50.17 46.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.17 -0.956 . . . . 0.0 109.946 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -48.89 -40.31 29.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.44 -0.787 . . . . 0.0 110.151 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.406 ' O ' ' OG1' ' A' ' 110' ' ' THR . 5.1 tpt85 -64.02 -42.7 97.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.241 -0.912 . . . . 0.0 109.839 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -59.84 -27.05 66.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.301 -0.874 . . . . 0.0 110.209 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 92.4 t -84.35 -68.46 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.319 -0.863 . . . . 0.0 110.999 -179.275 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.401 ' HB3' HD12 ' A' ' 116' ' ' LEU . 20.2 mmt -50.19 -27.88 6.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.235 -0.916 . . . . 0.0 110.681 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 68.7 m -75.51 -42.22 53.28 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.238 -0.914 . . . . 0.0 110.653 -179.734 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -87.76 -2.15 58.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.153 -0.967 . . . . 0.0 110.775 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.2 mt -88.57 -68.7 0.75 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.964 -1.085 . . . . 0.0 110.176 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 166.6 37.94 0.02 OUTLIER Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -135.43 154.45 51.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.264 -1.139 . . . . 0.0 110.263 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -120.52 99.48 6.58 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.32 -0.863 . . . . 0.0 110.21 179.759 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.421 HD11 ' N ' ' A' ' 116' ' ' LEU . 4.8 mp -110.3 -166.77 1.12 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.167 -0.958 . . . . 0.0 110.423 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.1 t -135.19 -164.74 1.57 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.371 -0.831 . . . . 0.0 109.632 179.668 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 118' ' ' ASP . 1.2 m-20 -81.08 -45.74 16.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.022 -1.048 . . . . 0.0 110.653 -179.704 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -58.7 -39.52 81.0 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.417 -0.802 . . . . 0.0 110.819 -179.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.63 -49.89 73.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.117 -0.99 . . . . 0.0 110.766 -179.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 76.0 t -58.63 -37.4 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.101 -0.999 . . . . 0.0 110.43 -179.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -64.81 -47.77 76.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.141 -0.974 . . . . 0.0 110.294 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.408 ' HG2' ' OE2' ' A' ' 127' ' ' GLU . 6.4 tm-20 -66.3 -21.86 66.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.229 -0.919 . . . . 0.0 109.843 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 28.8 mmm -73.88 -56.5 4.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.389 -0.819 . . . . 0.0 110.231 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 22.3 mm -66.72 -25.42 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.296 -0.878 . . . . 0.0 110.344 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -72.66 -57.98 3.71 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.194 -0.941 . . . . 0.0 110.225 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.445 ' CA ' ' OE1' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -63.05 -19.22 64.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 110.069 179.908 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.412 ' HB3' ' H6 ' ' A' ' 154' ' ' WW7 . . . -82.79 -34.2 27.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.256 -0.902 . . . . 0.0 110.013 179.674 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.87 90.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 110.114 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 92.5 mt -61.25 -18.9 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.895 . . . . 0.0 110.335 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.4 p30 -114.45 -30.34 6.58 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.217 -0.927 . . . . 0.0 110.195 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.458 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 89.39 80.62 1.32 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.409 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 33.0 p30 -139.1 13.76 2.63 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.334 -1.098 . . . . 0.0 110.565 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.25 24.6 76.13 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.159 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.413 ' O ' ' HG3' ' A' ' 135' ' ' GLN . 0.3 OUTLIER -170.5 143.66 2.29 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.137 -1.214 . . . . 0.0 110.268 179.639 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.407 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 91.7 t -93.73 129.24 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 110.453 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -88.43 174.53 8.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.423 -0.798 . . . . 0.0 110.23 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.453 ' C ' ' CD1' ' A' ' 138' ' ' TYR . 8.0 t80 -68.03 -51.72 43.67 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.281 -0.887 . . . . 0.0 109.456 179.302 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -62.31 -40.99 98.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.331 -0.856 . . . . 0.0 109.789 179.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -65.25 -29.72 70.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 109.981 179.585 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.492 ' CD1' ' HE3' ' A' ' 144' ' ' MET . 78.6 t80 -74.12 -28.21 61.24 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.271 -0.893 . . . . 0.0 110.128 -179.827 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.3 t -88.46 -20.78 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.245 -0.909 . . . . 0.0 110.446 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -98.2 -17.35 19.04 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.356 -0.84 . . . . 0.0 110.904 -179.416 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.492 ' HE3' ' CD1' ' A' ' 141' ' ' PHE . 15.0 ptt? -81.32 -27.71 34.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.045 -1.034 . . . . 0.0 110.357 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 4.7 tpp -89.58 -68.56 0.77 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.9 . . . . 0.0 109.919 179.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 67.9 p -73.24 103.43 3.95 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.211 -0.931 . . . . 0.0 110.126 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -111.75 144.38 41.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 0.0 110.363 -179.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.218 179.971 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . 0.623 'CA ' ' OD1' ' A' ' 20' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' WW7 . . . . . 0.52 ' H3 ' ' CE2' ' A' ' 19' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' WW7 . . . . . 0.516 ' H3 ' ' CG ' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.29 0.566 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -115.15 -161.76 0.79 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.161 -0.962 . . . . 0.0 109.95 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -138.34 -168.13 2.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.068 -1.02 . . . . 0.0 110.36 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.406 ' O ' ' OG1' ' A' ' 5' ' ' THR . 12.2 mt -94.95 -154.32 0.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.438 -0.788 . . . . 0.0 109.999 179.948 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 4' ' ' LEU . 90.7 m -163.63 -63.17 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.319 -0.863 . . . . 0.0 110.014 179.948 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.0 -38.33 85.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.437 -0.789 . . . . 0.0 110.489 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -58.75 -44.0 90.44 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.192 -0.942 . . . . 0.0 110.789 -179.649 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -59.63 -48.0 83.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.077 -1.014 . . . . 0.0 109.986 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 61.8 mt -59.9 -30.07 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.155 -0.966 . . . . 0.0 109.665 179.545 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.97 -30.02 67.26 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.273 -0.892 . . . . 0.0 109.705 179.88 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -69.77 -58.15 4.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.42 -0.8 . . . . 0.0 109.997 179.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -59.01 -36.26 74.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.175 -0.953 . . . . 0.0 109.439 179.426 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 9.6 tmtt? -65.36 -33.86 76.95 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.507 -0.746 . . . . 0.0 109.609 179.619 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -63.56 -42.67 98.33 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.358 -0.839 . . . . 0.0 109.634 179.421 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.86 -48.22 82.58 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.329 -0.857 . . . . 0.0 110.041 179.695 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -55.43 -54.29 45.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.287 -0.883 . . . . 0.0 110.188 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.1 m -58.7 -27.75 65.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.154 -0.966 . . . . 0.0 109.827 179.653 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.461 ' CD2' ' O ' ' A' ' 18' ' ' LEU . 1.4 tt -71.06 -32.23 68.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.441 -0.787 . . . . 0.0 110.05 -179.978 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.537 ' CD2' ' H3 ' ' A' ' 153' ' ' WW7 . 6.1 m-85 -84.31 -62.82 1.46 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.264 -0.897 . . . . 0.0 110.889 -179.184 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -82.12 85.1 6.83 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.226 -0.921 . . . . 0.0 110.625 -179.329 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.412 ' HD3' ' O ' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -106.48 52.74 0.71 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.141 -0.974 . . . . 0.0 109.972 179.375 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 1.7 p30 -137.08 -35.41 0.7 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.21 -0.931 . . . . 0.0 110.695 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 113.09 39.83 1.11 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.835 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -101.61 -33.0 10.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.357 -1.084 . . . . 0.0 110.032 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.58 -15.14 63.15 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.8 p -139.97 160.66 39.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.972 -1.31 . . . . 0.0 110.502 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.8 mt -103.17 111.99 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.362 -0.836 . . . . 0.0 109.983 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 49.8 p -101.93 -164.9 1.14 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.211 -0.93 . . . . 0.0 110.263 -179.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 42.4 p -78.11 -36.58 47.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.221 -0.924 . . . . 0.0 110.243 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.5 mttm -68.58 -56.62 7.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 0.0 109.706 179.592 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.457 ' O ' ' CG2' ' A' ' 34' ' ' THR . 98.9 mt-10 -58.1 -40.9 82.32 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.284 -0.885 . . . . 0.0 109.626 179.413 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.419 ' CD2' ' HG ' ' A' ' 48' ' ' LEU . 7.0 tp -66.81 -26.76 67.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.26 -0.9 . . . . 0.0 109.401 179.186 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.0 -43.99 95.09 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.662 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.457 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 7.0 t -75.41 -21.6 58.08 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.058 -1.26 . . . . 0.0 110.123 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 31' ' ' GLU . 29.5 t -78.21 -29.81 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.2 -0.938 . . . . 0.0 109.972 179.535 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.8 mmt -90.17 -28.0 19.21 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.185 -0.947 . . . . 0.0 110.288 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.4 mtm180 -89.61 -17.51 28.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.234 -0.916 . . . . 0.0 110.447 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 34' ' ' THR . 29.7 t -49.6 -52.86 27.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.17 -0.957 . . . . 0.0 110.249 -179.766 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.26 61.32 1.53 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 110.214 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . -171.58 -62.57 0.04 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' A' ' 40' ' ' GLY . 25.6 mt-30 54.81 102.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.232 -1.158 . . . . 0.0 110.115 -179.808 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.509 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.8 t30 -164.84 -63.03 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.343 -0.848 . . . . 0.0 110.077 179.839 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.509 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 45.2 Cg_endo -71.12 171.49 15.84 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.392 1.206 . . . . 0.0 109.9 179.608 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.409 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 81.1 p -120.27 -170.74 2.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.141 -0.974 . . . . 0.0 109.94 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -74.55 -29.03 61.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.127 -0.983 . . . . 0.0 110.197 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.07 -57.22 4.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.201 -0.937 . . . . 0.0 109.827 179.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -62.08 -24.72 67.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 0.0 109.889 179.616 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.445 HD21 ' N ' ' A' ' 49' ' ' GLN . 4.8 tt -70.23 -52.99 18.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.312 -0.867 . . . . 0.0 109.677 179.506 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.445 ' N ' HD21 ' A' ' 48' ' ' LEU . 51.3 tt0 -54.33 -37.61 65.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.182 -0.949 . . . . 0.0 109.449 179.271 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -68.79 -35.55 77.17 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.356 -0.84 . . . . 0.0 109.296 179.386 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.442 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 54.5 ttp -68.51 -17.45 64.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.326 -0.859 . . . . 0.0 109.675 179.417 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.8 mt -88.25 -37.88 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.888 . . . . 0.0 109.769 179.43 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -53.49 -35.61 60.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.912 . . . . 0.0 110.022 179.603 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.468 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 7.4 pt-20 -71.22 -32.56 68.95 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.355 -0.841 . . . . 0.0 110.273 -179.824 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.468 ' N ' ' HG3' ' A' ' 54' ' ' GLU . 71.5 t -76.38 -67.94 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.121 -0.987 . . . . 0.0 109.588 179.544 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.698 ' OD1' 'CA ' ' A' ' 150' ' ' ' CA' . 20.3 t70 -46.01 125.55 6.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.506 -0.746 . . . . 0.0 110.176 179.787 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.83 -26.07 10.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.143 -0.973 . . . . 0.0 110.842 -179.589 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.609 ' OD2' 'CA ' ' A' ' 150' ' ' ' CA' . 2.8 p30 -70.03 -34.76 73.68 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.228 -0.92 . . . . 0.0 110.455 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.457 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 92.5 76.37 1.33 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.822 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.409 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 18.6 p-10 -142.9 -43.55 0.3 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.222 -1.163 . . . . 0.0 110.179 179.391 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.467 ' O ' ' CG2' ' A' ' 62' ' ' THR . . . 132.61 2.61 3.94 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.842 179.323 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.467 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 49.5 p -154.24 167.17 30.79 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.803 -1.41 . . . . 0.0 111.093 -179.858 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.451 HG21 ' N ' ' A' ' 64' ' ' ASP . 49.3 mt -104.98 146.25 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.385 -0.822 . . . . 0.0 109.775 179.662 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.451 ' N ' HG21 ' A' ' 63' ' ' ILE . 48.7 m-20 -105.45 170.51 7.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.095 -1.003 . . . . 0.0 110.293 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.526 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 32.9 t80 -67.07 -42.3 40.3 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.877 . . . . 0.0 111.412 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 46.1 Cg_endo -74.73 -26.3 11.62 Favored 'Trans proline' 0 C--O 1.212 -0.782 0 O-C-N 123.087 1.046 . . . . 0.0 110.146 -179.587 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 71' ' ' MET . 35.1 tt0 -78.99 -27.95 43.41 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.289 -0.882 . . . . 0.0 109.369 179.378 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -74.57 -61.07 2.0 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.318 -0.864 . . . . 0.0 109.728 179.647 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.481 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 5.0 tt -56.92 -38.09 72.38 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.291 -0.88 . . . . 0.0 109.826 179.669 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' A' ' 66' ' ' PRO . 52.1 m -73.77 -26.4 60.63 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.192 -0.943 . . . . 0.0 110.325 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.473 ' CE ' ' CE ' ' A' ' 72' ' ' MET . 34.4 ttp -63.37 -50.18 70.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 110.208 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.473 ' CE ' ' CE ' ' A' ' 71' ' ' MET . 36.5 mtt -90.5 -15.2 31.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.286 -0.884 . . . . 0.0 111.188 -179.372 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.481 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -91.27 -9.68 44.25 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.955 -1.091 . . . . 0.0 111.23 -179.664 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.4 ' HB3' ' O ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -87.68 27.08 1.18 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.064 -1.022 . . . . 0.0 111.454 -178.765 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -89.19 116.55 27.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.888 -1.132 . . . . 0.0 110.047 179.316 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.407 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -155.05 169.5 23.96 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.186 -0.946 . . . . 0.0 110.188 -179.816 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.41 ' O ' ' C ' ' A' ' 78' ' ' ASP . 21.7 tttm -120.62 6.96 10.51 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.162 -0.961 . . . . 0.0 110.811 -179.84 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 77' ' ' LYS . 3.0 p30 37.05 -153.47 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.576 0 O-C-N 121.673 -0.642 . . . . 0.0 111.251 179.781 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.409 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 9.0 t -123.49 155.72 36.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -0.878 . . . . 0.0 110.501 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.55 138.25 52.67 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.37 -0.831 . . . . 0.0 110.128 179.921 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 71.1 m -146.34 -81.61 0.14 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.186 -0.947 . . . . 0.0 110.394 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -134.64 97.44 3.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 0.0 109.89 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.443 ' HB2' ' HB3' ' A' ' 86' ' ' ARG . 8.6 pt-20 -167.33 75.38 0.15 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.236 -0.915 . . . . 0.0 110.601 -179.323 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -71.89 -67.79 0.51 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.125 -0.985 . . . . 0.0 110.339 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.6 mt -53.44 -46.54 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.077 -1.014 . . . . 0.0 110.02 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.443 ' HB3' ' HB2' ' A' ' 83' ' ' GLU . 27.1 ttt180 -55.49 -42.38 74.33 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.178 -0.951 . . . . 0.0 109.071 179.437 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.412 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -49.6 -50.68 41.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.398 -0.814 . . . . 0.0 109.39 179.259 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.468 ' O ' ' CG2' ' A' ' 91' ' ' VAL . . . -52.54 -44.73 65.97 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.358 -0.838 . . . . 0.0 109.281 179.134 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.426 ' CE1' HD13 ' A' ' 100' ' ' ILE . 4.0 t80 -54.16 -39.6 66.7 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.166 -0.958 . . . . 0.0 109.987 179.782 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -59.07 -51.37 70.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.231 -0.918 . . . . 0.0 110.242 -179.874 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.468 ' CG2' ' O ' ' A' ' 88' ' ' ALA . 26.6 m -68.28 -18.49 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.125 -0.985 . . . . 0.0 109.745 179.817 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.518 ' CE2' ' H3 ' ' A' ' 154' ' ' WW7 . 29.0 m-85 -103.41 4.38 36.13 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.36 -0.837 . . . . 0.0 110.317 179.657 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.415 ' OD2' ' HA2' ' A' ' 98' ' ' GLY . 59.1 t0 -146.19 70.21 1.22 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -0.939 . . . . 0.0 109.749 179.748 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -107.3 59.01 0.62 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 110.708 -179.557 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.2 p30 -138.31 -40.0 0.52 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.128 -0.983 . . . . 0.0 110.309 179.567 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.469 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 135.56 17.81 0.83 Allowed Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.225 -1.464 . . . . 0.0 111.827 178.846 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.469 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 27.6 p30 -131.58 -122.16 0.2 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.352 -1.675 . . . . 0.0 109.89 179.192 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.469 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . -170.09 44.53 0.2 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 23.5 m-85 -131.95 128.52 38.64 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.39 -1.065 . . . . 0.0 110.294 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.429 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 24.0 mt -95.92 124.38 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.195 -0.941 . . . . 0.0 109.972 179.702 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.4 t -113.51 157.55 21.87 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.256 -0.903 . . . . 0.0 110.258 -179.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.25 -26.54 12.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 110.15 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.448 ' O ' ' HG3' ' A' ' 106' ' ' ARG . . . -69.72 -59.31 3.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.198 -0.939 . . . . 0.0 110.09 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -51.92 -38.92 58.14 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.064 -1.022 . . . . 0.0 110.264 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.5 tt -59.1 -48.98 79.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 110.488 -179.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.475 ' HG3' ' N ' ' A' ' 107' ' ' HIS . 0.0 OUTLIER -65.81 -21.7 66.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.907 -1.121 . . . . 0.0 109.999 -179.905 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.475 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 21.1 t-160 -72.3 -34.63 68.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.416 -0.802 . . . . 0.0 110.035 -179.969 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.465 ' CG2' ' O ' ' A' ' 91' ' ' VAL . 96.8 t -78.88 -42.12 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.319 -0.863 . . . . 0.0 110.434 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 4.7 mmt -66.52 -56.96 8.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.215 -179.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.449 ' CG2' ' O ' ' A' ' 106' ' ' ARG . 44.1 p -46.61 -48.97 19.66 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.447 -0.783 . . . . 0.0 110.714 -179.819 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -59.13 -55.67 32.08 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.179 -0.95 . . . . 0.0 110.258 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 79.6 mt -52.36 -72.6 0.05 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.14 -0.975 . . . . 0.0 109.924 179.658 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.08 40.37 0.02 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.869 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -121.71 93.24 3.94 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.233 -1.157 . . . . 0.0 110.089 179.799 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -74.63 111.4 9.78 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.269 -0.894 . . . . 0.0 110.208 -179.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -117.43 177.56 4.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -0.862 . . . . 0.0 110.285 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 59.0 m -100.87 158.87 15.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.334 -0.854 . . . . 0.0 110.173 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -59.91 -41.98 92.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.289 -0.882 . . . . 0.0 110.6 -179.765 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -60.08 -50.64 72.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.291 -0.881 . . . . 0.0 110.716 -179.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -53.23 -52.79 57.82 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.144 -0.972 . . . . 0.0 110.877 -179.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.5 t -55.32 -55.81 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.144 -0.973 . . . . 0.0 110.371 -179.607 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -54.54 -26.66 33.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.303 -0.873 . . . . 0.0 110.35 -179.693 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 7.1 tt0 -76.3 -34.71 59.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 110.069 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.401 ' HB3' ' HE1' ' A' ' 124' ' ' MET . 72.0 mtp -67.58 -47.08 70.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.214 -0.929 . . . . 0.0 110.122 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.427 ' CD1' 'CL1 ' ' A' ' 154' ' ' WW7 . 29.6 mm -64.11 -45.0 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 110.234 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.5 -33.7 75.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.192 -0.942 . . . . 0.0 110.041 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 41.2 mm-40 -67.93 -33.95 75.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.018 179.79 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.42 ' HB1' HG23 ' A' ' 136' ' ' VAL . . . -71.18 -42.13 69.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.284 -0.885 . . . . 0.0 110.464 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -56.92 92.39 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.159 -0.963 . . . . 0.0 110.385 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 76.3 mt -64.4 -31.89 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.194 -0.941 . . . . 0.0 110.236 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 22.4 p30 -101.99 -18.58 15.58 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.193 -0.942 . . . . 0.0 110.536 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.454 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 77.3 75.7 0.91 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.645 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 40.4 m-20 -109.8 -49.3 3.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.227 -1.161 . . . . 0.0 110.053 179.711 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 157.17 -23.59 0.45 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.708 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -143.74 155.91 44.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.329 -1.1 . . . . 0.0 110.115 179.727 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.429 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 77.7 t -91.6 108.51 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.203 -0.936 . . . . 0.0 110.315 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -82.63 165.55 19.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.948 . . . . 0.0 110.249 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -44.68 -34.46 2.23 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.369 -0.832 . . . . 0.0 111.766 -178.823 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -65.22 -67.05 0.47 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.867 -1.145 . . . . 0.0 110.726 -179.223 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -52.86 -26.16 13.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.207 -0.933 . . . . 0.0 110.359 -179.589 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.504 ' CE1' ' HE2' ' A' ' 145' ' ' MET . 7.9 t80 -68.44 -40.43 81.14 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 109.985 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 43.5 t -82.01 -20.25 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.294 -0.879 . . . . 0.0 110.554 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -80.5 -28.25 37.54 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.341 -0.849 . . . . 0.0 110.696 -179.534 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.451 ' CE ' ' HE2' ' A' ' 145' ' ' MET . 4.3 ptt? -84.53 -21.68 30.43 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.053 -1.029 . . . . 0.0 110.462 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.504 ' HE2' ' CE1' ' A' ' 141' ' ' PHE . 46.4 mtt -89.02 -39.83 13.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.203 -0.936 . . . . 0.0 110.524 -179.801 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.1 p -63.23 -68.12 0.37 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.207 -0.933 . . . . 0.0 110.383 -179.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -171.61 -178.95 2.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.221 -0.924 . . . . 0.0 110.152 179.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.154 -0.966 . . . . 0.0 110.179 -179.934 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . 0.698 'CA ' ' OD1' ' A' ' 56' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 153' ' ' WW7 . . . . . 0.537 ' H3 ' ' CD2' ' A' ' 19' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 154' ' ' WW7 . . . . . 0.518 ' H3 ' ' CE2' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 121.201 0.524 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -116.99 89.92 3.22 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.162 -0.961 . . . . 0.0 110.354 179.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -171.36 -44.66 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.184 -0.948 . . . . 0.0 110.024 179.915 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.458 ' O ' ' CG2' ' A' ' 5' ' ' THR . 7.1 mt -134.73 131.51 37.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.298 -0.876 . . . . 0.0 110.077 179.813 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.458 ' CG2' ' O ' ' A' ' 4' ' ' LEU . 0.4 OUTLIER -170.54 -61.29 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.287 -0.883 . . . . 0.0 110.307 -179.959 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -89.19 -23.65 22.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.352 -0.843 . . . . 0.0 110.497 -179.629 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -55.5 -54.61 41.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.167 -0.958 . . . . 0.0 109.969 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -50.97 -45.03 60.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.908 . . . . 0.0 109.788 179.581 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.411 HD11 HD12 ' A' ' 69' ' ' LEU . 31.3 mm -52.87 -40.92 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.884 . . . . 0.0 109.646 179.667 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -59.94 -44.4 94.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.361 -0.837 . . . . 0.0 109.89 179.615 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -53.29 -51.31 62.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 109.954 179.805 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -60.7 -33.87 73.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 109.896 179.737 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 72.1 mttt -66.07 -27.46 68.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.888 179.626 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -73.19 -53.05 11.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.35 -0.843 . . . . 0.0 109.913 179.763 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.444 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -58.89 -34.84 72.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.21 -0.931 . . . . 0.0 109.98 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -66.99 -54.25 23.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.883 . . . . 0.0 109.975 179.867 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.0 m -56.64 -21.39 26.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.238 -0.914 . . . . 0.0 110.021 179.654 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.425 ' C ' ' CD1' ' A' ' 18' ' ' LEU . 3.1 tm? -78.6 -35.44 45.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.443 -0.786 . . . . 0.0 109.791 179.878 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.444 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 22.7 m-85 -70.46 -55.58 8.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.386 -0.821 . . . . 0.0 110.454 -179.889 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.424 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 0.5 OUTLIER -55.79 113.16 1.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.209 -0.932 . . . . 0.0 110.412 -179.897 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -109.96 54.58 0.66 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 110.143 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.439 ' OD2' ' CB ' ' A' ' 24' ' ' ASP . 10.2 p-10 -162.51 -37.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.111 -0.993 . . . . 0.0 110.598 -179.788 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.81 39.66 2.48 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.439 ' CB ' ' OD2' ' A' ' 22' ' ' ASP . 6.8 t70 -103.54 -67.67 0.88 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.369 -1.077 . . . . 0.0 110.101 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.416 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 135.92 23.47 0.55 Allowed Glycine 0 N--CA 1.499 2.842 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.621 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.416 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 74.4 p -154.15 144.17 21.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.896 -1.355 . . . . 0.0 109.534 179.534 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.6 mt -96.37 107.18 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.109 -0.994 . . . . 0.0 110.328 -179.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.451 ' CG2' HG23 ' A' ' 62' ' ' THR . 72.4 p -103.28 -176.98 3.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.374 -0.829 . . . . 0.0 110.178 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.5 p -68.31 -26.68 65.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.277 -0.89 . . . . 0.0 110.14 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -68.67 -62.44 1.39 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.21 -0.931 . . . . 0.0 109.921 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.424 ' OE1' ' HA ' ' A' ' 20' ' ' ASP . 35.2 mt-10 -56.42 -55.36 34.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.325 -0.859 . . . . 0.0 109.458 179.602 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.437 HD21 HD12 ' A' ' 52' ' ' ILE . 6.6 tp -57.57 -23.77 52.49 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.177 -0.952 . . . . 0.0 109.296 179.144 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.477 ' HA2' ' CD1' ' A' ' 48' ' ' LEU . . . -62.85 -46.93 92.59 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.444 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.466 ' O ' ' CB ' ' A' ' 38' ' ' SER . 96.4 m -78.54 -14.45 59.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.332 -1.099 . . . . 0.0 109.934 179.636 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.403 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 50.5 t -78.77 -36.57 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.172 -0.955 . . . . 0.0 110.21 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.7 mmt -90.72 -38.09 13.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.352 -0.843 . . . . 0.0 110.756 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.7 mtm180 -75.74 -36.32 59.93 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.714 -179.497 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 34' ' ' THR . 8.4 t -76.99 -23.93 52.24 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.876 -1.14 . . . . 0.0 110.054 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 3.9 mm? -119.85 56.61 0.95 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.314 -0.866 . . . . 0.0 110.169 179.8 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.49 56.95 0.07 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -48.43 104.92 0.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.178 -1.19 . . . . 0.0 110.479 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.539 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 5.9 m-20 -159.66 -63.61 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.318 -0.864 . . . . 0.0 110.329 179.314 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.539 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 46.6 Cg_endo -73.87 -179.32 4.49 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.332 1.175 . . . . 0.0 109.864 179.439 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 8.7 t -134.72 -175.64 3.96 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.108 -0.995 . . . . 0.0 110.102 -179.852 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.06 -42.0 93.58 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.034 -1.041 . . . . 0.0 110.333 -179.832 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.47 -68.46 0.38 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.22 -0.925 . . . . 0.0 110.411 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -47.14 -26.21 1.07 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.221 -0.924 . . . . 0.0 109.984 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.477 ' CD1' ' HA2' ' A' ' 33' ' ' GLY . 9.1 tt -70.56 -49.48 47.53 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.313 -0.867 . . . . 0.0 109.764 179.52 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -52.45 -41.18 63.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.118 -0.989 . . . . 0.0 109.222 179.224 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.78 -35.38 79.94 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.423 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 3.5 ttt -68.16 -15.05 63.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.646 -0.659 . . . . 0.0 109.573 179.007 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.471 ' CD1' HD22 ' A' ' 48' ' ' LEU . 57.3 mt -88.56 -35.17 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.397 -0.814 . . . . 0.0 109.834 179.39 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -51.83 -45.38 63.93 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.274 -0.891 . . . . 0.0 110.657 -179.802 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.479 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 22.0 pt-20 -56.93 -34.27 67.81 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.177 -0.952 . . . . 0.0 110.476 -179.658 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.479 ' N ' ' HG3' ' A' ' 54' ' ' GLU . 95.3 t -84.49 -71.73 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.202 -0.936 . . . . 0.0 110.284 -179.696 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.445 ' HB2' ' CG1' ' A' ' 63' ' ' ILE . 24.2 t70 -56.53 124.33 17.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.335 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.34 5.29 21.48 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.23 -0.919 . . . . 0.0 110.702 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.83 -23.22 36.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.077 -1.015 . . . . 0.0 110.198 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.26 14.43 76.66 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.737 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -91.56 -37.39 13.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.014 -1.286 . . . . 0.0 110.165 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.14 -52.02 0.83 Allowed Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.231 179.567 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.451 HG23 ' CG2' ' A' ' 28' ' ' THR . 66.7 p -101.87 167.55 9.99 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.067 -1.255 . . . . 0.0 110.728 -179.379 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.448 HG21 ' N ' ' A' ' 64' ' ' ASP . 48.7 mt -115.29 157.17 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.287 -0.883 . . . . 0.0 110.055 179.662 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.475 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 1.4 m-20 -112.6 -172.37 2.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.241 -0.912 . . . . 0.0 110.728 -179.648 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.547 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 50.3 t80 -65.3 -42.62 60.31 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.473 -0.767 . . . . 0.0 111.976 -179.686 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.5 Cg_endo -71.67 -33.35 10.56 Favored 'Trans proline' 0 C--N 1.323 -0.787 0 O-C-N 123.069 1.036 . . . . 0.0 110.893 -179.146 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.414 ' HB2' ' CG2' ' A' ' 63' ' ' ILE . 48.6 mt-10 -71.43 -30.16 65.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.021 -1.049 . . . . 0.0 108.844 179.169 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.491 ' CZ ' ' SD ' ' A' ' 72' ' ' MET . 64.9 t80 -73.46 -43.0 61.24 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.512 0.672 . . . . 0.0 109.654 179.738 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.49 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 15.5 tp -77.19 -12.12 59.91 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.49 -0.756 . . . . 0.0 110.344 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 66' ' ' PRO . 54.7 m -90.68 -28.42 18.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.929 -1.107 . . . . 0.0 110.44 -179.988 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.471 ' HE2' ' CE ' ' A' ' 72' ' ' MET . 18.9 tmm? -90.61 -37.02 14.07 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.178 -0.951 . . . . 0.0 111.197 -179.488 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.491 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 48.9 mtt -91.3 -11.8 36.97 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.112 -0.993 . . . . 0.0 111.975 -178.646 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -85.13 -23.5 28.4 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.772 -1.205 . . . . 0.0 111.126 -179.401 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.21 -51.95 13.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.983 -1.073 . . . . 0.0 110.513 -179.441 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.82 138.04 39.59 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.167 -0.958 . . . . 0.0 110.291 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 13.2 tpt -174.46 135.08 0.41 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.255 -0.903 . . . . 0.0 110.29 179.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.75 -165.53 1.37 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.312 -0.867 . . . . 0.0 110.512 -179.963 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -163.8 -62.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.429 -0.794 . . . . 0.0 109.912 179.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.65 119.22 38.47 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.333 -0.854 . . . . 0.0 109.755 179.664 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -112.21 66.43 0.64 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.2 -0.938 . . . . 0.0 110.391 -179.622 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.5 t -135.84 158.85 43.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 109.861 179.656 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -168.38 149.75 4.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.187 -0.946 . . . . 0.0 110.077 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 33.4 tt0 -131.17 24.05 4.88 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.332 -0.855 . . . . 0.0 109.882 179.887 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -77.36 -25.14 50.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.366 -0.834 . . . . 0.0 110.314 -179.848 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.475 HG13 ' CE2' ' A' ' 141' ' ' PHE . 3.8 tp -48.06 -34.87 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.168 -0.958 . . . . 0.0 109.536 179.834 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -59.95 -48.7 80.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.392 -0.818 . . . . 0.0 109.499 179.282 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 7.8 mm-40 -54.13 -41.6 68.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.255 -0.903 . . . . 0.0 109.563 179.39 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.413 ' O ' HG21 ' A' ' 91' ' ' VAL . . . -59.15 -46.41 88.45 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.312 -0.867 . . . . 0.0 109.66 179.528 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.408 ' O ' ' HB3' ' A' ' 93' ' ' ASP . 0.4 OUTLIER -63.38 -20.82 65.86 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.179 179.736 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -74.05 -49.74 22.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.365 -0.834 . . . . 0.0 110.882 -179.489 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.424 ' CG2' ' N ' ' A' ' 92' ' ' PHE . 16.5 m -75.1 -41.04 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.133 -0.979 . . . . 0.0 111.416 -179.089 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.571 ' CE1' ' CG1' ' A' ' 108' ' ' VAL . 37.7 m-85 -72.78 -28.18 62.45 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.068 -1.02 . . . . 0.0 111.248 -179.141 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 10.4 t70 -111.15 51.6 0.77 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.859 -1.151 . . . . 0.0 110.348 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.74 2.63 32.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 110.49 179.882 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 3.0 p30 -85.96 -37.77 18.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.128 -0.983 . . . . 0.0 110.296 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 104.38 47.64 1.2 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.449 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 15.8 p-10 -122.77 -32.77 3.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.151 -1.205 . . . . 0.0 110.295 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.48 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 100.36 16.16 28.03 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.901 -1.142 . . . . 0.0 110.312 179.274 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 37.6 m-85 -144.79 161.44 39.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.051 -1.264 . . . . 0.0 110.303 179.762 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.44 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 23.0 mt -107.0 118.39 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.256 -0.903 . . . . 0.0 109.419 179.323 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.3 m -102.13 163.36 12.28 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.44 -0.788 . . . . 0.0 109.632 179.8 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.87 -49.76 76.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.063 -1.023 . . . . 0.0 110.167 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -50.43 -50.45 52.0 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.274 -0.891 . . . . 0.0 110.573 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -57.95 -45.73 86.19 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.356 -0.84 . . . . 0.0 110.136 -179.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.569 ' CD1' ' CE1' ' A' ' 92' ' ' PHE . 40.5 tp -59.15 -23.88 62.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.438 -0.789 . . . . 0.0 110.319 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.44 -43.3 27.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.307 -0.871 . . . . 0.0 110.403 -179.933 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.414 ' O ' ' OG1' ' A' ' 110' ' ' THR . 81.6 m-70 -68.18 -30.27 69.33 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.216 -0.927 . . . . 0.0 110.551 -179.927 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.571 ' CG1' ' CE1' ' A' ' 92' ' ' PHE . 48.1 t -75.17 -47.82 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.02 -1.05 . . . . 0.0 109.866 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.485 ' HE2' ' CG ' ' A' ' 105' ' ' LEU . 63.7 mtt -65.36 -10.42 33.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.174 -0.954 . . . . 0.0 110.509 179.911 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 107' ' ' HIS . 1.1 p -90.17 -26.41 20.16 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.018 -1.051 . . . . 0.0 109.858 179.245 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -88.47 -52.92 4.92 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.146 -0.971 . . . . 0.0 110.117 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.1 mt -47.73 -72.85 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.165 -0.959 . . . . 0.0 110.278 179.811 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 162.97 40.78 0.02 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.477 ' HB3' ' CD1' ' A' ' 116' ' ' LEU . 51.5 mt-10 -120.85 121.45 38.13 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.323 -1.104 . . . . 0.0 110.462 -179.786 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -106.81 66.03 0.68 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.206 -0.934 . . . . 0.0 110.109 179.702 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.477 ' CD1' ' HB3' ' A' ' 114' ' ' GLU . 3.4 mp -88.04 167.98 13.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.261 -0.899 . . . . 0.0 110.364 -179.895 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 22.9 m -86.24 163.21 17.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.334 -0.854 . . . . 0.0 109.969 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -60.77 -54.44 45.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.159 -0.963 . . . . 0.0 110.379 -179.805 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -47.07 -40.23 14.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.947 . . . . 0.0 110.276 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 124' ' ' MET . 58.2 mm-40 -56.76 -60.09 4.07 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.251 -0.906 . . . . 0.0 110.441 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.1 t -47.22 -39.72 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.143 -0.973 . . . . 0.0 110.371 -179.622 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -62.68 -44.07 97.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.135 -0.978 . . . . 0.0 109.99 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -69.11 -20.51 64.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.199 179.839 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.405 ' O ' ' H6 ' ' A' ' 154' ' ' WW7 . 85.1 mtp -77.78 -46.52 21.41 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.126 -0.984 . . . . 0.0 109.993 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.414 HG21 HG22 ' A' ' 136' ' ' VAL . 26.0 mm -65.57 -29.38 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.158 -0.964 . . . . 0.0 110.007 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -75.91 -54.79 6.36 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.2 -0.938 . . . . 0.0 110.132 179.576 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -54.94 -33.52 62.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.226 -0.921 . . . . 0.0 109.995 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.463 ' CB ' ' H6 ' ' A' ' 154' ' ' WW7 . . . -75.13 -37.43 61.41 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.209 -0.932 . . . . 0.0 109.811 179.701 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.404 ' OD2' ' HA2' ' A' ' 132' ' ' GLY . 13.7 t0 -57.89 95.46 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.317 -0.864 . . . . 0.0 109.809 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.407 HD11 ' HG2' ' A' ' 140' ' ' GLU . 21.8 mt -62.07 -46.96 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.888 . . . . 0.0 110.402 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 21.6 p30 -86.6 -19.69 28.99 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.185 -0.947 . . . . 0.0 110.059 179.854 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.445 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 67.48 65.56 2.69 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 178.871 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.426 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 34.4 m-20 -98.28 -35.62 10.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.178 -1.19 . . . . 0.0 109.719 179.048 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.75 -28.62 1.04 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 -179.664 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.412 ' O ' ' OE1' ' A' ' 135' ' ' GLN . 0.0 OUTLIER -137.08 169.62 17.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.471 -1.017 . . . . 0.0 109.709 179.589 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.44 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 84.4 t -99.28 145.23 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 120.97 -1.081 . . . . 0.0 110.752 -179.447 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.405 ' N ' HG11 ' A' ' 136' ' ' VAL . 35.7 t30 -106.67 178.79 4.46 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.365 -0.835 . . . . 0.0 110.193 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -69.07 -44.7 72.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.231 -0.918 . . . . 0.0 110.441 -179.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.58 -33.32 73.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.242 -0.911 . . . . 0.0 110.27 -179.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.407 ' HG2' HD11 ' A' ' 130' ' ' ILE . 48.3 mt-10 -71.27 -35.6 71.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.146 -0.971 . . . . 0.0 110.085 179.818 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.479 ' CD1' ' HE1' ' A' ' 144' ' ' MET . 57.4 t80 -71.13 -32.72 69.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.212 -0.93 . . . . 0.0 110.657 -179.847 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.405 ' HB ' ' OE1' ' A' ' 143' ' ' GLN . 59.4 t -78.7 -29.54 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.12 -0.987 . . . . 0.0 110.72 -179.734 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.424 ' OE1' ' N ' ' A' ' 143' ' ' GLN . 0.6 OUTLIER -97.06 -9.74 27.46 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.129 -0.982 . . . . 0.0 111.456 -179.068 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.479 ' HE1' ' CD1' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -89.31 -31.56 17.77 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.705 -1.247 . . . . 0.0 110.372 -179.958 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 56.0 ttm -85.97 -48.77 8.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.938 179.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.5 p -61.43 126.07 26.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.351 -0.843 . . . . 0.0 110.091 179.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -140.14 43.63 1.91 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.195 -0.941 . . . . 0.0 110.433 -179.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.2 mttm . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.282 179.725 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 153' ' ' WW7 . . . . . 0.447 ' O1 ' ' H8 ' ' A' ' 153' ' ' WW7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 154' ' ' WW7 . . . . . 0.545 ' H3 ' ' CD2' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.168 0.509 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -96.1 -169.81 1.99 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.233 -0.917 . . . . 0.0 110.238 -179.986 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -168.97 115.74 0.62 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.311 -0.868 . . . . 0.0 109.946 179.685 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 80.7 mt -75.62 -158.06 0.08 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.414 -0.804 . . . . 0.0 110.613 -179.535 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.3 p -138.15 -178.97 5.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.452 -0.78 . . . . 0.0 110.072 179.833 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -82.63 -9.6 59.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.227 -0.92 . . . . 0.0 110.586 -179.88 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -62.08 -55.06 32.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.032 -1.042 . . . . 0.0 110.764 -179.661 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -59.76 -50.89 72.05 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.208 -0.932 . . . . 0.0 110.217 -179.544 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.416 ' O ' ' HB2' ' A' ' 12' ' ' PHE . 22.9 mt -48.91 -42.74 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.045 -1.034 . . . . 0.0 109.664 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.02 -43.1 99.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 109.571 179.301 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -58.65 -29.1 66.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 109.555 179.463 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.416 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 12.5 m-85 -72.91 -36.23 67.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.279 -0.888 . . . . 0.0 109.934 179.656 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -70.46 -27.1 63.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.917 . . . . 0.0 109.858 179.623 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.83 -43.83 52.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.352 -0.843 . . . . 0.0 109.845 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.56 -42.86 86.45 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.246 -0.909 . . . . 0.0 109.7 179.484 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -57.14 -44.62 83.54 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.269 -0.894 . . . . 0.0 109.651 179.685 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 98.3 p -64.12 -35.6 81.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -0.904 . . . . 0.0 109.337 179.388 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.442 ' CD2' ' O ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -58.69 -33.17 69.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.466 -0.771 . . . . 0.0 109.381 179.438 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.526 ' CE2' ' H3 ' ' A' ' 153' ' ' WW7 . 3.5 m-30 -87.09 -24.08 24.69 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.39 -0.819 . . . . 0.0 109.92 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -101.69 92.67 4.96 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.334 -0.854 . . . . 0.0 109.912 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.52 -14.29 15.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 110.59 -179.548 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -78.89 -37.34 40.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.184 -0.948 . . . . 0.0 110.299 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.72 83.13 1.71 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 23.5 p-10 -156.53 -32.41 0.09 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.122 -1.223 . . . . 0.0 111.207 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.81 22.85 9.76 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.56 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.403 ' OG1' ' OD2' ' A' ' 24' ' ' ASP . 75.9 p -149.69 155.01 39.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.164 -1.198 . . . . 0.0 109.988 179.863 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.5 mt -109.43 124.93 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.069 -1.02 . . . . 0.0 110.218 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.433 ' CG2' HG23 ' A' ' 62' ' ' THR . 41.4 p -108.0 -159.01 0.67 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.426 -0.796 . . . . 0.0 110.189 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.414 HG22 ' OE1' ' A' ' 49' ' ' GLN . 32.0 p -90.23 -34.04 15.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.218 179.921 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.49 -58.88 6.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -0.906 . . . . 0.0 109.995 -179.952 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.437 ' HB3' ' O ' ' A' ' 19' ' ' PHE . 48.8 mt-10 -60.49 -54.64 43.03 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.32 -0.862 . . . . 0.0 109.709 179.831 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 tp -57.26 -20.18 26.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.269 -0.894 . . . . 0.0 109.713 179.533 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.35 -46.85 46.84 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 179.542 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.437 ' O ' ' CB ' ' A' ' 38' ' ' SER . 38.4 m -68.8 -20.22 64.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.447 -1.031 . . . . 0.0 109.805 179.349 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.436 HG23 ' HA ' ' A' ' 19' ' ' PHE . 54.9 t -75.48 -58.1 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.385 -0.822 . . . . 0.0 110.332 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.506 ' CE ' ' CE ' ' A' ' 51' ' ' MET . 58.7 mtt -72.9 -18.8 61.38 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.279 -0.888 . . . . 0.0 110.785 -179.391 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -89.93 -29.33 18.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.021 -1.049 . . . . 0.0 110.09 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 34' ' ' THR . 40.5 t -82.41 -30.73 29.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.237 -0.915 . . . . 0.0 110.101 179.756 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.415 HD11 ' O ' ' A' ' 35' ' ' VAL . 1.3 mt -104.35 64.93 0.77 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.376 -0.828 . . . . 0.0 109.663 179.608 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.22 78.16 1.34 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.411 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -63.24 88.38 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.282 -1.128 . . . . 0.0 110.55 -179.459 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.534 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 3.2 m120 -114.28 -66.66 0.03 OUTLIER Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.375 -0.828 . . . . 0.0 110.689 179.72 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.534 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 47.1 Cg_endo -73.49 -169.44 0.54 Allowed 'Trans proline' 0 C--N 1.32 -0.934 0 O-C-N 123.092 1.048 . . . . 0.0 110.341 179.484 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 35.0 p -138.54 -175.3 4.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.321 -0.862 . . . . 0.0 110.07 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -66.56 -31.5 72.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.222 -0.923 . . . . 0.0 109.974 179.683 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.23 -67.28 0.5 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 0.0 109.953 179.73 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -50.6 -31.11 15.02 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.354 -0.841 . . . . 0.0 109.688 179.718 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.41 ' HB2' ' O ' ' A' ' 44' ' ' THR . 8.8 tt -65.63 -47.94 73.89 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.395 -0.815 . . . . 0.0 110.066 179.65 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.414 ' OE1' HG22 ' A' ' 29' ' ' THR . 4.6 tp-100 -54.46 -44.95 72.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 109.217 179.465 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 1.0 OUTLIER -67.87 -27.35 66.6 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.345 -0.847 . . . . 0.0 109.307 179.355 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.506 ' CE ' ' CE ' ' A' ' 36' ' ' MET . 20.2 ttp -76.15 -15.18 60.12 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.497 -0.752 . . . . 0.0 109.719 179.413 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.411 HD11 HG23 ' A' ' 29' ' ' THR . 6.4 mt -90.51 -38.45 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.132 -0.98 . . . . 0.0 109.823 179.378 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -52.99 -28.64 24.91 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.158 -0.964 . . . . 0.0 109.75 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.462 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 9.6 pt-20 -79.95 -33.84 39.27 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 109.541 179.245 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.462 ' N ' ' HG3' ' A' ' 54' ' ' GLU . 85.3 t -69.48 -65.76 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.192 -0.943 . . . . 0.0 109.202 178.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -56.35 101.51 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.435 -0.791 . . . . 0.0 109.845 179.419 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.43 58.36 0.8 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.128 -0.983 . . . . 0.0 110.711 -179.523 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.425 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 15.3 m-20 -141.81 -49.79 0.39 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.261 -0.899 . . . . 0.0 109.852 179.565 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.64 50.77 0.55 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.647 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -129.14 -48.29 1.21 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.27 -1.135 . . . . 0.0 110.443 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.95 -86.66 0.13 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.3 -1.429 . . . . 0.0 110.8 179.6 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.433 HG23 ' CG2' ' A' ' 28' ' ' THR . 73.7 p -91.22 170.59 9.88 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.246 -1.149 . . . . 0.0 111.34 -178.662 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.46 HD12 ' CG1' ' A' ' 55' ' ' VAL . 33.1 mt -88.9 159.7 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.515 -0.741 . . . . 0.0 109.917 179.628 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.412 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 20.7 t0 -108.29 -176.93 3.19 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.276 -0.89 . . . . 0.0 110.417 -179.969 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.556 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 23.5 t80 -72.81 -43.79 8.49 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.406 -0.809 . . . . 0.0 111.174 179.86 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.7 Cg_endo -72.18 -19.08 26.45 Favored 'Trans proline' 0 C--O 1.213 -0.748 0 O-C-N 123.122 1.064 . . . . 0.0 110.562 -179.844 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.425 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 39.9 mt-10 -78.57 -27.81 45.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.021 -1.049 . . . . 0.0 108.919 179.029 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 7.5 t80 -76.88 -48.62 17.81 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.287 0.565 . . . . 0.0 110.419 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.476 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 17.0 tp -78.26 -17.39 56.73 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.193 -0.942 . . . . 0.0 111.236 -179.388 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.405 ' CB ' ' O ' ' A' ' 66' ' ' PRO . 43.1 m -87.77 -38.83 15.42 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.706 -1.246 . . . . 0.0 110.56 -179.797 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.479 ' HE1' ' CE ' ' A' ' 72' ' ' MET . 4.8 ptt? -78.38 -31.62 48.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.157 -0.964 . . . . 0.0 110.332 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.479 ' CE ' ' HE1' ' A' ' 71' ' ' MET . 48.2 mtt -89.79 -9.58 48.7 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.156 -0.965 . . . . 0.0 110.671 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.476 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -83.53 -34.52 25.25 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.141 -0.974 . . . . 0.0 110.394 -179.808 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.98 59.65 1.19 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.38 -0.825 . . . . 0.0 110.161 -179.595 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.0 tttt -131.22 85.38 2.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 0.0 110.308 179.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 11.0 tpt -121.7 129.12 52.51 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.231 -0.918 . . . . 0.0 109.873 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -78.25 134.89 37.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.286 -0.884 . . . . 0.0 110.423 -179.764 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.409 ' O ' ' HB ' ' A' ' 79' ' ' THR . 33.4 t70 -152.08 79.94 1.25 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.304 -0.873 . . . . 0.0 110.359 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.409 ' HB ' ' O ' ' A' ' 78' ' ' ASP . 9.7 t -176.51 163.5 2.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.273 -0.892 . . . . 0.0 110.063 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -103.3 -171.26 1.91 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.163 -0.961 . . . . 0.0 110.245 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.6 t -50.62 -72.62 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.876 . . . . 0.0 110.359 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.448 ' HG2' ' HG3' ' A' ' 84' ' ' GLU . 44.5 tt0 -153.15 -71.23 0.14 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.196 -0.94 . . . . 0.0 110.187 -179.728 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 46.48 86.64 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.215 -0.928 . . . . 0.0 110.506 179.713 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.448 ' HG3' ' HG2' ' A' ' 82' ' ' GLU . 42.3 mt-10 -98.18 -34.61 10.67 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.116 -0.99 . . . . 0.0 110.322 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 26.1 mm -67.02 -29.93 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.449 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -56.52 10.03 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.158 -0.964 . . . . 0.0 109.838 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -55.08 -42.33 72.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.346 -0.846 . . . . 0.0 110.161 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.41 -39.3 92.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.9 . . . . 0.0 110.558 -179.667 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.44 ' O ' ' CB ' ' A' ' 93' ' ' ASP . 5.0 t80 -63.46 -33.26 75.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.914 -1.116 . . . . 0.0 110.387 -179.631 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -75.52 -55.04 6.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.086 -1.009 . . . . 0.0 111.003 -179.481 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.454 HG22 ' N ' ' A' ' 92' ' ' PHE . 19.2 m -56.26 -42.9 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.095 -1.003 . . . . 0.0 110.813 -179.35 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.517 ' CD2' ' H3 ' ' A' ' 154' ' ' WW7 . 30.3 m-85 -77.44 -20.77 54.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.135 -0.978 . . . . 0.0 110.211 179.88 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 89' ' ' PHE . 35.5 t0 -113.71 53.21 0.78 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.154 -0.966 . . . . 0.0 109.471 179.127 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -86.36 56.17 3.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.543 -0.723 . . . . 0.0 110.757 -179.419 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.436 ' OD2' ' HB2' ' A' ' 97' ' ' ASN . 26.3 p-10 -158.26 29.94 0.25 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.103 -0.998 . . . . 0.0 110.335 179.731 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.44 33.12 4.2 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.524 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.436 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 18.1 t-20 -91.93 -60.01 1.97 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.236 -1.155 . . . . 0.0 110.083 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.458 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 112.07 -5.49 27.14 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.742 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.559 ' CD1' ' NE2' ' A' ' 135' ' ' GLN . 37.3 m-85 -138.93 140.06 38.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.938 -1.331 . . . . 0.0 110.465 -179.826 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.417 HG22 ' HB3' ' A' ' 92' ' ' PHE . 39.5 mt -85.97 118.25 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.315 -0.866 . . . . 0.0 110.161 179.813 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.3 t -102.91 174.15 6.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.451 -0.781 . . . . 0.0 109.462 179.514 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.25 -41.21 73.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.039 -1.038 . . . . 0.0 109.988 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.42 -54.55 44.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.211 -0.931 . . . . 0.0 110.091 179.64 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.403 ' OE2' ' OD2' ' A' ' 95' ' ' ASP . 45.9 mt-10 -59.58 -45.34 92.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.224 -0.922 . . . . 0.0 110.043 179.765 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.416 ' CD2' HG12 ' A' ' 121' ' ' VAL . 32.5 tp -58.52 -21.12 51.26 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.429 -0.794 . . . . 0.0 110.534 -179.927 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.8 ttt-85 -83.52 -40.08 19.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.213 -0.929 . . . . 0.0 110.097 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -73.22 -22.65 60.39 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.28 -0.887 . . . . 0.0 110.125 179.88 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 97.3 t -89.92 -44.15 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -0.882 . . . . 0.0 110.068 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 4.7 mmt -49.5 -24.41 2.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.908 . . . . 0.0 110.163 179.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 64.6 p -82.34 -41.75 19.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 110.081 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -57.04 -45.18 83.36 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.234 -0.917 . . . . 0.0 110.177 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.4 ' HB2' ' OE1' ' A' ' 114' ' ' GLU . 80.4 mt -64.12 -55.91 18.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.317 -0.865 . . . . 0.0 110.31 -179.969 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 142.52 53.07 0.04 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.758 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.415 ' HB3' HD13 ' A' ' 116' ' ' LEU . 49.5 mp0 -139.11 -62.83 0.53 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.168 -1.195 . . . . 0.0 110.068 179.693 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 114' ' ' GLU . 70.3 tttt 55.78 104.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.299 -0.876 . . . . 0.0 110.417 179.751 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.418 HD11 ' N ' ' A' ' 116' ' ' LEU . 4.8 mp -122.58 -175.82 3.24 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.165 -0.959 . . . . 0.0 110.529 -179.948 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.5 t -87.89 -177.8 5.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.361 -0.837 . . . . 0.0 110.184 -179.986 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -68.96 -34.8 75.93 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.178 -0.951 . . . . 0.0 110.448 -179.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -65.47 -53.24 45.45 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.232 -0.917 . . . . 0.0 110.779 -179.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.417 ' OE1' ' HA ' ' A' ' 120' ' ' GLU . 5.7 mm-40 -54.32 -50.45 67.35 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.127 -0.983 . . . . 0.0 110.56 -179.54 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.416 HG12 ' CD2' ' A' ' 105' ' ' LEU . 56.1 t -56.44 -47.98 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.162 -0.961 . . . . 0.0 110.133 -179.978 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -62.68 -23.69 67.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.184 -0.948 . . . . 0.0 109.868 179.677 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.422 ' HG3' ' OE1' ' A' ' 127' ' ' GLU . 16.5 tp10 -75.07 -30.01 60.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.395 -0.816 . . . . 0.0 109.917 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.426 ' O ' ' H6 ' ' A' ' 154' ' ' WW7 . 23.3 mtm -77.33 -46.24 23.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.368 -0.833 . . . . 0.0 110.1 -179.978 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.418 HD11 HG22 ' A' ' 136' ' ' VAL . 24.9 mm -68.7 -33.22 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.025 -1.047 . . . . 0.0 109.879 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -71.97 -55.86 6.69 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.392 -0.818 . . . . 0.0 110.636 -179.63 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.422 ' OE1' ' HG3' ' A' ' 123' ' ' GLU . 54.5 mt-10 -61.06 -36.4 79.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.176 -0.953 . . . . 0.0 110.116 -179.768 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.437 ' CB ' ' SD ' ' A' ' 144' ' ' MET . . . -70.23 -26.98 64.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.814 179.799 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -63.3 94.69 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.867 . . . . 0.0 109.991 179.76 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 128' ' ' ALA . 97.8 mt -79.8 -43.94 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.218 -0.926 . . . . 0.0 110.854 -179.646 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 23.4 p30 -79.27 -19.51 50.4 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.016 -1.053 . . . . 0.0 110.791 -179.655 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 79.0 70.79 1.29 Allowed Glycine 0 N--CA 1.495 2.632 0 C-N-CA 120.031 -1.081 . . . . 0.0 110.53 179.344 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -125.5 -26.67 3.53 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.186 -1.185 . . . . 0.0 110.578 179.545 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 118.35 -37.43 3.24 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.689 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.559 ' NE2' ' CD1' ' A' ' 99' ' ' TYR . 9.0 pt20 -113.14 156.72 22.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.278 -1.13 . . . . 0.0 109.922 179.81 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.418 HG22 HD11 ' A' ' 125' ' ' ILE . 62.4 t -99.5 118.41 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.203 -0.935 . . . . 0.0 110.423 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 37.8 p30 -93.25 -163.93 1.11 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.244 -0.91 . . . . 0.0 110.131 179.669 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -69.63 -62.55 1.34 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.095 -1.003 . . . . 0.0 111.127 -179.289 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -44.06 -59.48 2.29 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.275 -0.891 . . . . 0.0 111.191 -179.121 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.413 ' OE2' ' OD1' ' A' ' 131' ' ' ASP . 51.7 mt-10 -51.44 -51.37 55.48 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 121.198 -0.939 . . . . 0.0 110.538 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.418 ' HB2' ' O ' ' A' ' 137' ' ' ASN . 0.8 OUTLIER -54.08 -31.3 51.37 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.291 -0.88 . . . . 0.0 110.551 -179.582 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.403 ' O ' ' OG1' ' A' ' 146' ' ' THR . 94.9 t -72.1 -62.86 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.285 -0.884 . . . . 0.0 110.691 -179.51 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -64.9 -9.66 22.84 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.222 -0.924 . . . . 0.0 110.87 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.437 ' SD ' ' CB ' ' A' ' 128' ' ' ALA . 49.3 ttp -59.46 -60.54 3.69 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.13 -0.981 . . . . 0.0 110.786 -179.704 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.429 ' SD ' ' C16' ' A' ' 154' ' ' WW7 . 38.3 mtt -89.88 -44.3 10.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.448 -0.783 . . . . 0.0 110.857 -179.368 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 142' ' ' VAL . 66.6 p -70.64 138.07 50.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.05 -1.031 . . . . 0.0 110.122 -179.901 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 62.57 164.06 0.1 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.273 -0.892 . . . . 0.0 110.298 -179.912 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.423 ' C ' ' CD ' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.251 -179.957 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 153' ' ' WW7 . . . . . 0.526 ' H3 ' ' CE2' ' A' ' 19' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 154' ' ' WW7 . . . . . 0.517 ' H3 ' ' CD2' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.286 0.565 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -154.6 143.51 20.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.228 -0.92 . . . . 0.0 110.161 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.402 ' O ' ' OH ' ' A' ' 99' ' ' TYR . 47.2 mt-30 -133.22 87.87 2.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.281 -0.887 . . . . 0.0 110.365 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.26 -177.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.134 -0.979 . . . . 0.0 110.168 179.835 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.4 t -99.74 -28.1 13.33 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.148 -0.97 . . . . 0.0 110.468 -179.786 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -89.97 -34.35 16.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.183 -0.948 . . . . 0.0 110.08 179.9 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -66.49 -44.59 82.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.375 -0.828 . . . . 0.0 110.331 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.416 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 7.3 tt0 -55.67 -47.25 77.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 110.177 -179.856 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.0 mt -60.07 -40.6 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.052 -1.03 . . . . 0.0 109.482 179.427 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.79 -26.91 68.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.349 -0.844 . . . . 0.0 109.329 179.15 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 38.2 tt0 -67.64 -46.49 72.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.347 -0.846 . . . . 0.0 109.365 179.411 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -63.53 -32.11 73.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.908 . . . . 0.0 109.465 179.157 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.17 -40.44 82.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.5 -0.75 . . . . 0.0 110.165 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -63.14 -45.26 92.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.2 -0.937 . . . . 0.0 110.187 -179.835 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.33 -37.39 87.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.141 -0.974 . . . . 0.0 110.074 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -63.92 -37.38 87.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.189 -0.945 . . . . 0.0 109.945 179.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.9 m -65.9 -39.93 91.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.388 -0.82 . . . . 0.0 110.286 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.409 ' O ' HD12 ' A' ' 18' ' ' LEU . 3.5 tm? -66.56 -35.96 81.49 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.183 -0.948 . . . . 0.0 110.13 -179.936 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.475 ' CE2' ' H3 ' ' A' ' 153' ' ' WW7 . 12.0 m-30 -69.65 -64.78 0.81 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.224 -0.923 . . . . 0.0 109.931 179.718 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -83.0 96.07 8.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.35 -0.844 . . . . 0.0 109.856 179.674 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.415 ' CD ' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -109.66 48.57 0.88 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.256 -0.902 . . . . 0.0 110.524 -179.758 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -131.22 -35.24 1.37 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.105 -0.997 . . . . 0.0 110.368 179.768 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 24' ' ' ASP . . . 113.32 86.21 1.49 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 21.1 p-10 -178.13 -34.19 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.302 -1.117 . . . . 0.0 110.617 179.654 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.91 42.19 7.78 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.131 179.633 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 59.3 p -151.28 107.47 3.44 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.095 -1.238 . . . . 0.0 110.389 179.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.4 mt -74.68 124.63 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.828 179.559 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.9 p -112.78 -157.21 0.61 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.332 -0.855 . . . . 0.0 110.08 -179.865 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.424 HG21 HG13 ' A' ' 52' ' ' ILE . 38.0 p -87.53 -27.06 22.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.212 -0.93 . . . . 0.0 110.253 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -70.72 -56.8 5.58 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.147 -0.97 . . . . 0.0 109.676 179.553 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -57.27 -36.08 70.55 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.303 -0.873 . . . . 0.0 109.685 179.555 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.471 ' CD2' HD12 ' A' ' 52' ' ' ILE . 9.0 tp -68.87 -31.78 70.96 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.349 -0.845 . . . . 0.0 109.707 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.82 -41.6 98.77 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.413 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 66.1 m -72.42 -33.65 67.28 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.317 -1.108 . . . . 0.0 109.967 179.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.7 t -71.15 -26.98 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.377 -0.827 . . . . 0.0 110.444 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.1 mmt -86.91 -32.29 20.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 110.467 -179.619 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.402 ' HD3' ' OE1' ' A' ' 41' ' ' GLN . 5.9 ttp180 -90.79 -11.07 40.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.228 -0.92 . . . . 0.0 110.775 -179.783 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 97.3 p -97.41 -23.03 16.26 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.981 -1.074 . . . . 0.0 110.48 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.6 mt -107.79 -46.85 3.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.118 -0.989 . . . . 0.0 110.388 -179.871 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.65 84.01 0.1 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.402 ' OE1' ' HD3' ' A' ' 37' ' ' ARG . 65.3 tp60 -50.92 161.32 0.38 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.357 -1.084 . . . . 0.0 110.558 -179.81 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.488 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.3 t30 177.03 -56.3 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.488 -0.758 . . . . 0.0 109.976 179.647 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.488 ' HD3' ' HB3' ' A' ' 42' ' ' ASN . 54.6 Cg_endo -76.76 -163.2 0.19 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.483 1.254 . . . . 0.0 110.864 179.671 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.431 ' CG2' ' N ' ' A' ' 45' ' ' GLU . 11.1 t -137.18 -140.19 0.15 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.077 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.431 ' N ' ' CG2' ' A' ' 44' ' ' THR . 52.1 mt-10 -97.89 -45.22 6.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.818 -1.176 . . . . 0.0 110.031 179.593 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.51 -52.98 26.2 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.198 -0.939 . . . . 0.0 109.618 179.389 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -59.07 -20.91 57.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.364 -0.835 . . . . 0.0 109.723 179.639 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 44' ' ' THR . 7.9 tt -71.93 -53.43 13.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.895 . . . . 0.0 109.481 179.368 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -50.92 -42.76 59.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.219 179.253 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -63.92 -39.69 94.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.362 -0.837 . . . . 0.0 109.6 179.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.41 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 36.4 ttp -66.21 -19.42 65.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -0.878 . . . . 0.0 109.566 179.375 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.471 HD12 ' CD2' ' A' ' 32' ' ' LEU . 5.6 mm -84.26 -29.73 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.407 -0.808 . . . . 0.0 109.683 179.413 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -71.6 -46.42 59.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.398 -0.814 . . . . 0.0 110.888 -179.45 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.45 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 24.2 pt-20 -51.35 -33.96 31.83 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.101 -1.0 . . . . 0.0 110.379 -179.711 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.45 ' N ' ' HG3' ' A' ' 54' ' ' GLU . 48.6 t -82.15 -39.77 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.247 -0.908 . . . . 0.0 110.147 179.943 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -78.31 111.72 14.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.395 -0.816 . . . . 0.0 110.562 -179.67 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.77 54.98 0.65 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.206 -0.934 . . . . 0.0 109.925 179.741 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -134.96 -53.91 0.81 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.401 -0.812 . . . . 0.0 109.891 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 128.45 60.54 0.12 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.662 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.491 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 6.8 p-10 -151.34 -52.78 0.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -1.115 . . . . 0.0 110.131 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.6 -5.89 9.87 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.785 179.032 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.5 p -120.96 141.69 50.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.79 -1.418 . . . . 0.0 110.573 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 77.1 mt -92.32 121.38 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -0.949 . . . . 0.0 110.11 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.424 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 9.7 t70 -84.2 -167.0 1.59 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.285 -0.885 . . . . 0.0 110.196 -179.778 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.562 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 40.5 t80 -78.32 -44.38 2.13 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.05 -1.031 . . . . 0.0 111.631 -179.674 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.0 Cg_endo -70.76 -21.56 28.68 Favored 'Trans proline' 0 N--CA 1.482 0.802 0 O-C-N 123.079 1.041 . . . . 0.0 110.505 -179.579 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 71' ' ' MET . 53.0 mt-10 -81.12 -27.78 35.4 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.191 -0.943 . . . . 0.0 109.174 179.227 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.542 ' CE2' ' CE ' ' A' ' 72' ' ' MET . 36.0 t80 -77.26 -36.38 54.48 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.492 -0.755 . . . . 0.0 109.813 179.612 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.403 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 13.7 tp -76.81 -32.49 57.66 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.404 -0.81 . . . . 0.0 110.235 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 97.1 m -80.88 -23.78 38.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.337 -0.852 . . . . 0.0 110.41 -179.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.422 ' CE ' HG12 ' A' ' 55' ' ' VAL . 13.8 tmm? -84.33 -45.3 12.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.256 -0.903 . . . . 0.0 110.372 -179.723 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.542 ' CE ' ' CE2' ' A' ' 68' ' ' PHE . 9.5 mtt -79.17 -16.42 56.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 110.671 -179.272 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.403 ' HB1' ' O ' ' A' ' 69' ' ' LEU . . . -54.2 -57.24 11.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.095 -1.003 . . . . 0.0 108.902 179.098 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -110.71 61.15 0.61 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.561 -0.712 . . . . 0.0 109.158 178.871 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.01 111.04 0.25 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.46 -0.775 . . . . 0.0 110.891 -179.13 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 13.9 mmt -88.56 96.15 10.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -0.889 . . . . 0.0 109.801 179.626 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -127.37 77.56 1.75 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.301 -0.875 . . . . 0.0 110.237 -179.589 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -149.49 176.21 10.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.353 -0.842 . . . . 0.0 110.132 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 70.9 p -111.41 -162.01 0.78 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -0.897 . . . . 0.0 110.039 179.82 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -100.06 97.48 8.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.333 -0.854 . . . . 0.0 110.124 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 75.4 m -152.52 -59.9 0.15 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.431 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -124.57 109.05 12.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.132 -0.98 . . . . 0.0 110.548 -179.824 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -103.35 -1.74 28.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.36 -0.838 . . . . 0.0 110.52 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -80.67 -36.71 32.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.119 -0.988 . . . . 0.0 110.64 -179.71 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 60.3 mt -55.76 -35.89 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.138 -0.976 . . . . 0.0 110.114 -179.781 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.0 tpt180 -64.4 -53.0 55.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.956 . . . . 0.0 109.358 179.346 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -57.29 -23.57 49.31 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.358 -0.839 . . . . 0.0 109.443 179.28 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.414 ' O ' HG21 ' A' ' 91' ' ' VAL . . . -67.92 -60.47 2.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.416 -0.802 . . . . 0.0 109.859 179.768 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -55.76 -24.17 33.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.175 -0.953 . . . . 0.0 110.16 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.484 ' HA ' ' NE ' ' A' ' 90' ' ' ARG . 8.6 tpm_? -73.0 -58.29 3.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.317 -0.864 . . . . 0.0 110.707 -179.723 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 88' ' ' ALA . 20.2 m -70.36 -12.14 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.121 -0.987 . . . . 0.0 110.684 -179.592 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.526 ' CD2' ' H3 ' ' A' ' 154' ' ' WW7 . 10.6 m-85 -101.05 -13.31 18.27 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.091 -1.006 . . . . 0.0 110.606 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -132.71 44.44 2.86 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.094 -1.004 . . . . 0.0 110.329 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -108.71 3.57 22.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.118 -0.989 . . . . 0.0 110.769 179.979 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 3.0 p30 -70.58 -30.74 67.52 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.134 -0.979 . . . . 0.0 110.573 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.8 34.94 1.94 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -179.361 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.404 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 23.1 t-20 -110.16 -47.36 3.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.355 -1.085 . . . . 0.0 110.319 -179.679 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 125.24 -35.32 3.12 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.833 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 0.8 OUTLIER -132.8 169.56 16.55 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.075 -1.25 . . . . 0.0 109.663 -179.753 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 38.3 mt -80.63 129.19 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.112 -0.992 . . . . 0.0 109.62 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.9 t -118.56 174.02 6.5 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.333 -0.855 . . . . 0.0 109.814 179.714 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.405 ' O ' HG12 ' A' ' 121' ' ' VAL . . . -69.19 -38.76 78.82 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.155 -0.966 . . . . 0.0 110.048 -179.886 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.66 87.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.237 -0.915 . . . . 0.0 110.033 179.746 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -62.03 -54.13 45.88 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.246 -0.909 . . . . 0.0 110.094 179.825 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.408 HD12 ' HE3' ' A' ' 124' ' ' MET . 4.3 tt -47.76 -34.36 8.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 110.1 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.8 ttt-85 -70.97 -44.05 66.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.293 -0.879 . . . . 0.0 110.329 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 48.1 m170 -69.94 -10.4 58.42 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.129 -0.982 . . . . 0.0 110.622 -179.824 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.412 HG13 ' CE1' ' A' ' 92' ' ' PHE . 61.5 t -92.29 -57.06 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.124 -0.985 . . . . 0.0 110.538 -179.749 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 64.8 mtt -71.41 -26.81 62.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.194 -0.941 . . . . 0.0 110.584 -179.693 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.2 m -69.35 -42.32 75.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.201 -0.937 . . . . 0.0 110.29 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -75.02 -34.33 61.9 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.188 -0.945 . . . . 0.0 110.265 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.2 mt -60.62 -32.2 71.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.168 -0.958 . . . . 0.0 110.229 179.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.42 -13.7 4.28 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.64 134.55 34.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -1.175 . . . . 0.0 110.27 -179.961 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -101.61 120.23 40.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.945 . . . . 0.0 110.208 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.83 179.25 4.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.21 -0.931 . . . . 0.0 110.546 -179.766 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.7 m -122.56 175.88 6.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.406 -0.809 . . . . 0.0 109.944 179.741 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.54 -51.95 56.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.161 -0.962 . . . . 0.0 110.544 -179.821 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -64.97 -34.82 79.35 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.084 -1.01 . . . . 0.0 110.446 -179.807 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.41 ' OE1' ' HA ' ' A' ' 120' ' ' GLU . 7.9 mm-40 -61.37 -46.04 91.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.108 -0.995 . . . . 0.0 110.079 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 102' ' ' ALA . 72.4 t -64.06 -56.47 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 109.808 179.656 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -51.4 -26.3 7.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.975 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -70.09 -52.97 19.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.18 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.408 ' HE3' HD12 ' A' ' 105' ' ' LEU . 42.4 mtp -58.21 -48.22 81.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.174 -0.954 . . . . 0.0 110.141 179.875 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 25.7 mm -60.89 -29.24 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.072 -1.018 . . . . 0.0 109.599 179.585 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -66.74 -40.83 88.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.374 -0.829 . . . . 0.0 109.991 179.887 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -70.48 -28.37 64.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.285 -0.884 . . . . 0.0 110.237 179.919 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.402 ' O ' HG13 ' A' ' 130' ' ' ILE . . . -80.32 -25.05 39.52 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.311 -0.868 . . . . 0.0 110.469 -179.819 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -70.11 92.16 0.73 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.227 -0.921 . . . . 0.0 109.995 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 128' ' ' ALA . 74.4 mt -85.31 -34.54 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.3 -0.875 . . . . 0.0 110.594 -179.639 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 6.3 p30 -84.98 -25.79 27.54 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.073 -1.017 . . . . 0.0 110.299 179.845 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.455 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 89.94 71.56 1.25 Allowed Glycine 0 N--CA 1.494 2.562 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.316 179.337 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.411 ' OD2' ' OD1' ' A' ' 131' ' ' ASP . 73.1 m-20 -136.5 -38.69 0.66 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.205 -1.173 . . . . 0.0 110.021 179.294 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 121.96 -7.28 10.12 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.507 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -126.61 150.92 48.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.157 -1.202 . . . . 0.0 110.153 179.953 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.2 t -115.2 109.41 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.19 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -82.34 -167.73 1.7 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.18 -0.95 . . . . 0.0 110.195 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -62.18 -45.22 94.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.255 -0.903 . . . . 0.0 111.284 -179.134 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -62.69 -56.73 14.99 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.942 -1.099 . . . . 0.0 110.921 -179.248 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 144' ' ' MET . 50.5 mt-10 -57.1 -24.27 52.89 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.13 -0.981 . . . . 0.0 110.725 -179.591 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.436 ' CZ ' ' HE2' ' A' ' 145' ' ' MET . 89.2 t80 -78.66 -35.09 45.78 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.232 -0.917 . . . . 0.0 110.944 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 84.6 t -83.09 -22.96 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.108 -0.995 . . . . 0.0 110.869 -179.509 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -92.53 -23.42 19.09 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.18 -0.95 . . . . 0.0 110.882 -179.617 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.465 ' HG3' ' N ' ' A' ' 145' ' ' MET . 1.0 OUTLIER -71.29 -20.26 62.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.003 -1.061 . . . . 0.0 110.496 -179.707 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.465 ' N ' ' HG3' ' A' ' 144' ' ' MET . 63.5 mtt -84.85 -70.37 0.58 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.223 -0.923 . . . . 0.0 110.537 -179.694 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 59.0 p -51.65 -28.43 14.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.2 -0.938 . . . . 0.0 110.183 -179.672 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 49.76 39.64 18.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.319 -0.863 . . . . 0.0 110.575 179.833 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.182 179.87 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 153' ' ' WW7 . . . . . 0.475 ' H3 ' ' CE2' ' A' ' 19' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 154' ' ' WW7 . . . . . 0.526 ' H3 ' ' CD2' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 121.228 0.537 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -151.84 110.95 3.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.226 -0.921 . . . . 0.0 109.86 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -112.1 -58.3 2.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.179 -0.951 . . . . 0.0 110.47 -179.805 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.438 ' CD1' ' HB2' ' A' ' 8' ' ' GLN . 0.6 OUTLIER -114.3 -155.45 0.57 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.899 . . . . 0.0 110.419 -179.574 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.2 t -64.73 168.83 5.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.859 . . . . 0.0 110.177 179.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -88.54 -9.72 51.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.203 -0.936 . . . . 0.0 110.119 179.673 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -65.34 -64.9 0.75 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.104 -0.998 . . . . 0.0 109.985 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.438 ' HB2' ' CD1' ' A' ' 4' ' ' LEU . 72.3 mt-30 -55.13 -39.97 70.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.144 -0.973 . . . . 0.0 109.476 179.685 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 55.3 mt -56.8 -37.73 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.389 -0.819 . . . . 0.0 109.478 179.315 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.97 -43.06 99.63 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.278 -0.889 . . . . 0.0 109.341 179.386 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.03 -36.73 82.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.486 -0.759 . . . . 0.0 109.837 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -76.03 -20.08 58.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.406 -0.808 . . . . 0.0 109.665 179.525 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -79.53 -33.53 41.88 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.289 -0.882 . . . . 0.0 109.416 179.183 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -74.27 -39.95 62.65 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.391 -0.818 . . . . 0.0 109.857 179.735 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.75 -48.31 39.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.2 -0.938 . . . . 0.0 109.599 179.54 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.545 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 1.2 t80 -58.68 -34.07 70.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.415 -0.803 . . . . 0.0 109.47 179.334 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.2 t -72.11 -38.49 69.31 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.465 -0.772 . . . . 0.0 109.817 179.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.492 HD11 ' CD1' ' A' ' 19' ' ' PHE . 3.2 tm? -65.92 -24.06 66.75 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.526 -0.734 . . . . 0.0 109.663 179.768 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.492 ' CD1' HD11 ' A' ' 18' ' ' LEU . 17.0 m-85 -82.15 -59.29 2.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.323 -0.861 . . . . 0.0 110.339 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.414 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 7.9 t0 -76.52 97.49 4.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 109.772 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.428 ' HD2' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -110.53 46.37 1.05 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.068 -1.02 . . . . 0.0 110.843 -179.644 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.404 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 12.0 p-10 -132.33 -33.31 1.29 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.236 -0.915 . . . . 0.0 110.513 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.38 76.32 1.05 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.89 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 15.3 p-10 -159.49 -45.26 0.05 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.02 -1.283 . . . . 0.0 110.579 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.9 -2.97 25.79 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.728 -1.225 . . . . 0.0 110.324 179.674 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 34.5 p -121.1 165.16 15.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.943 -1.328 . . . . 0.0 110.197 179.878 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.3 mt -112.64 130.24 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.187 -0.946 . . . . 0.0 110.094 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.6 p -114.5 177.05 4.78 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.429 -0.794 . . . . 0.0 109.895 -179.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.432 HG21 HG13 ' A' ' 52' ' ' ILE . 12.7 p -66.67 -28.67 68.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 0.0 110.112 179.877 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -57.66 6.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -0.933 . . . . 0.0 109.905 179.521 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.414 ' OE1' ' HA ' ' A' ' 20' ' ' ASP . 28.4 mt-10 -57.23 -56.01 27.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 0.0 110.123 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.459 ' CD2' HD13 ' A' ' 52' ' ' ILE . 1.4 tp -57.51 -24.71 57.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.855 179.665 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.74 -42.9 95.0 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.1 m -76.16 -23.14 54.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.3 -1.117 . . . . 0.0 110.04 179.835 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.446 ' CG2' ' HA ' ' A' ' 19' ' ' PHE . 54.9 t -72.57 -42.54 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.402 -0.811 . . . . 0.0 110.526 -179.727 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.404 ' O ' ' O ' ' A' ' 40' ' ' GLY . 22.5 mmt -90.13 -14.93 32.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.167 -0.958 . . . . 0.0 110.735 -179.692 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -90.65 -59.91 2.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.209 -0.932 . . . . 0.0 111.076 -179.348 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.0 m -59.76 -51.44 69.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.254 -0.904 . . . . 0.0 111.361 -178.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.9 mp -69.53 -30.45 68.29 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.1 -1.0 . . . . 0.0 111.207 -178.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 36' ' ' MET . . . -161.42 80.57 0.14 Allowed Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.229 -1.462 . . . . 0.0 110.422 -179.775 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -55.94 126.97 28.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.163 -1.198 . . . . 0.0 109.725 179.365 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.482 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 3.0 t30 -171.53 -60.91 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.224 -0.923 . . . . 0.0 110.609 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' A' ' 42' ' ' ASN . 44.1 Cg_endo -70.01 -161.84 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.249 1.131 . . . . 0.0 110.117 179.801 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.9 t -150.96 -178.67 6.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.931 . . . . 0.0 110.282 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -59.89 -33.6 72.06 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.246 -0.909 . . . . 0.0 110.464 -179.798 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.1 -70.66 0.25 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.211 -0.93 . . . . 0.0 110.257 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -49.76 -25.05 2.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.104 -0.997 . . . . 0.0 109.713 179.762 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.447 ' HG ' ' CD2' ' A' ' 32' ' ' LEU . 3.6 tt -65.21 -60.01 3.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.465 -0.772 . . . . 0.0 109.719 179.466 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.402 ' O ' ' OD1' ' A' ' 53' ' ' ASN . 8.9 tt0 -50.5 -33.91 23.17 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.296 -0.878 . . . . 0.0 109.756 179.616 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -61.57 -46.43 89.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.191 -0.943 . . . . 0.0 109.967 179.809 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.404 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 21.8 mtm -65.58 -22.59 66.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.929 . . . . 0.0 109.82 179.667 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.459 HD13 ' CD2' ' A' ' 32' ' ' LEU . 39.7 mm -80.88 -23.26 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.251 -0.906 . . . . 0.0 109.969 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 49' ' ' GLN . 5.1 m120 -88.34 -26.62 22.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.303 -0.873 . . . . 0.0 110.2 179.885 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 51' ' ' MET . 10.7 pt-20 -77.69 -24.3 49.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.201 -0.937 . . . . 0.0 110.075 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.8 t -88.86 -54.53 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.673 179.454 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.413 ' OD2' ' OD1' ' A' ' 60' ' ' ASN . 12.8 t70 -67.09 120.32 13.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.405 -0.809 . . . . 0.0 110.051 179.82 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.6 30.94 5.83 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.16 -0.962 . . . . 0.0 110.663 -179.66 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -113.33 -60.87 1.82 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.116 -0.99 . . . . 0.0 110.088 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.52 -18.25 1.3 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.729 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.413 ' OD1' ' OD2' ' A' ' 56' ' ' ASP . 17.0 p30 -69.52 -29.48 67.1 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.175 -1.191 . . . . 0.0 110.295 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.418 ' O ' ' CG2' ' A' ' 52' ' ' ILE . . . 99.18 -52.61 1.08 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.754 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.406 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 66.0 p -72.11 146.49 47.46 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.183 -1.186 . . . . 0.0 110.38 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.421 ' CD1' 'CL1 ' ' A' ' 153' ' ' WW7 . 64.3 mt -86.43 161.09 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 110.254 179.908 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -111.81 -173.35 2.23 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.371 -0.831 . . . . 0.0 109.898 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.537 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 5.0 t80 -75.6 -44.82 4.25 Favored Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.235 -0.915 . . . . 0.0 111.423 -179.882 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.0 Cg_endo -73.33 -23.89 17.18 Favored 'Trans proline' 0 C--N 1.322 -0.845 0 O-C-N 123.288 1.151 . . . . 0.0 110.255 -179.259 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -77.23 -29.09 53.96 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.252 -0.905 . . . . 0.0 109.1 179.094 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.545 ' CE1' ' HB2' ' A' ' 16' ' ' PHE . 47.8 t80 -73.54 -50.74 19.81 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.545 -0.722 . . . . 0.0 110.309 179.826 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.96 -30.98 71.26 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.304 -0.873 . . . . 0.0 110.965 -179.527 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 78.9 m -71.1 -40.91 71.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.172 -0.955 . . . . 0.0 110.983 -179.388 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.445 ' HE2' ' CE ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -89.94 -9.37 49.07 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.903 -1.123 . . . . 0.0 110.95 -179.51 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.521 ' HG3' ' CE1' ' A' ' 68' ' ' PHE . 15.6 mmt -90.26 -19.89 23.6 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.989 -1.07 . . . . 0.0 110.556 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.62 -15.38 59.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.155 -0.966 . . . . 0.0 110.354 -179.874 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -97.02 46.81 1.04 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.094 -1.004 . . . . 0.0 110.303 -179.956 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.1 tttm -123.2 154.69 38.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.951 . . . . 0.0 109.93 179.885 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 39.1 ttp -107.46 107.88 18.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.04 -1.037 . . . . 0.0 110.397 -179.835 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -100.61 27.76 5.6 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.311 -0.868 . . . . 0.0 110.151 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -115.72 25.0 11.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -0.887 . . . . 0.0 110.214 -179.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 93.6 m -48.9 105.12 0.07 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.219 -0.926 . . . . 0.0 110.042 179.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -108.0 88.17 2.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.902 . . . . 0.0 110.169 -179.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.4 t -60.43 -176.94 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.216 -0.927 . . . . 0.0 110.247 -179.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -159.29 124.26 4.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.244 -0.91 . . . . 0.0 110.271 179.833 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -131.49 78.93 1.85 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.295 -0.878 . . . . 0.0 109.732 179.519 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -53.59 -30.97 44.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.46 -0.775 . . . . 0.0 110.883 -179.491 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.9 mt -64.93 -60.23 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.141 -0.974 . . . . 0.0 110.263 -179.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -51.57 -50.49 60.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.174 -0.954 . . . . 0.0 109.711 179.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 49.7 mt-10 -50.05 -41.6 48.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 0.0 109.79 179.52 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.2 -50.27 71.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.34 -0.85 . . . . 0.0 110.032 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.475 ' CZ ' ' O ' ' A' ' 98' ' ' GLY . 2.3 t80 -57.34 -28.76 63.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.262 -0.899 . . . . 0.0 110.213 179.983 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.4 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 3.7 tpt180 -71.1 -45.88 62.83 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.342 -0.849 . . . . 0.0 111.185 -179.442 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.443 HG21 ' N ' ' A' ' 92' ' ' PHE . 34.4 m -77.17 -20.35 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.088 -1.007 . . . . 0.0 110.775 -179.33 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.443 ' N ' HG21 ' A' ' 91' ' ' VAL . 10.0 m-85 -89.58 -17.04 29.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.169 -0.957 . . . . 0.0 109.904 179.631 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -126.89 81.32 2.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.295 -0.878 . . . . 0.0 110.144 179.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -104.35 49.96 0.8 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.398 -0.814 . . . . 0.0 110.483 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 3.1 p30 -141.56 -43.58 0.36 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.089 -1.007 . . . . 0.0 110.705 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.486 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 147.97 -57.18 0.49 Allowed Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.28 -1.438 . . . . 0.0 110.995 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.473 ' ND2' ' OD1' ' A' ' 95' ' ' ASP . 22.6 p30 -43.56 -31.23 0.7 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.141 -1.211 . . . . 0.0 111.161 -178.738 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.475 ' O ' ' CZ ' ' A' ' 89' ' ' PHE . . . 80.14 -8.19 53.01 Favored Glycine 0 N--CA 1.495 2.6 0 C-N-CA 119.803 -1.189 . . . . 0.0 110.477 179.561 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -89.41 131.81 35.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.962 -1.316 . . . . 0.0 109.989 179.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 16.6 mt -78.99 112.32 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.185 -0.947 . . . . 0.0 109.796 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 44.6 t -96.56 155.91 16.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.264 -0.897 . . . . 0.0 110.154 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.64 -44.74 77.43 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.141 -0.974 . . . . 0.0 110.063 -179.956 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.96 -58.7 6.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.827 . . . . 0.0 110.016 179.844 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -51.51 -38.99 56.74 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.317 -0.865 . . . . 0.0 110.224 179.847 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.81 -41.82 87.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.349 -0.844 . . . . 0.0 109.829 179.937 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.411 ' O ' ' HB ' ' A' ' 110' ' ' THR . 48.1 ttp180 -68.2 -25.51 65.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.384 -0.822 . . . . 0.0 109.942 179.807 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -90.95 -12.66 35.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.329 -0.857 . . . . 0.0 110.373 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 77.2 t -91.17 -64.61 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.255 -0.903 . . . . 0.0 110.316 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.429 ' HE3' ' CE ' ' A' ' 124' ' ' MET . 57.8 mtt -61.13 -51.18 70.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.251 -0.906 . . . . 0.0 110.367 -179.693 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 106' ' ' ARG . 36.8 m -50.99 -29.52 12.56 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.266 -0.896 . . . . 0.0 110.304 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -78.69 -46.09 19.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.184 -0.948 . . . . 0.0 110.406 -179.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.8 mt -48.83 -73.98 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.143 -0.973 . . . . 0.0 110.109 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.85 66.59 0.02 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.872 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -136.9 -176.37 4.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.313 -1.11 . . . . 0.0 110.068 179.714 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -130.18 87.96 2.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.948 . . . . 0.0 110.374 -179.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.8 mt -125.93 -171.88 2.48 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.284 -0.885 . . . . 0.0 110.137 179.857 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.6 t -143.91 -159.95 1.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.138 -0.976 . . . . 0.0 110.201 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.63 -42.16 25.45 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.077 -1.014 . . . . 0.0 110.917 -179.525 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -59.61 -55.49 33.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.942 . . . . 0.0 111.125 -179.469 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.421 ' OE1' ' HA ' ' A' ' 120' ' ' GLU . 5.9 mm-40 -51.72 -38.48 55.39 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.196 -0.94 . . . . 0.0 111.058 -179.445 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 73.9 t -67.7 -47.47 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.158 -0.963 . . . . 0.0 110.457 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.79 -36.38 72.11 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.333 -0.855 . . . . 0.0 110.137 -179.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 36.6 tt0 -72.5 -35.15 68.07 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.324 -0.86 . . . . 0.0 109.633 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.429 ' CE ' ' HE3' ' A' ' 109' ' ' MET . 5.7 mmm -59.03 -60.34 4.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.271 -0.893 . . . . 0.0 109.936 179.466 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 27.9 mm -56.69 -41.89 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.372 -0.83 . . . . 0.0 110.376 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 16.5 ttp180 -57.09 -36.81 71.03 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -0.907 . . . . 0.0 110.191 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 49.7 mt-10 -67.09 -49.65 64.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.197 -0.94 . . . . 0.0 110.087 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.437 ' CB ' ' SD ' ' A' ' 144' ' ' MET . . . -80.03 -2.33 43.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.349 -0.844 . . . . 0.0 110.665 -179.811 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -90.29 71.75 7.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.947 -1.096 . . . . 0.0 110.299 -179.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 131' ' ' ASP . 23.4 pt -70.52 -41.94 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -0.929 . . . . 0.0 111.171 -179.561 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.47 ' N ' HG13 ' A' ' 130' ' ' ILE . 50.6 p-10 -67.28 -19.42 65.49 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.963 -1.086 . . . . 0.0 111.264 -179.173 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 75.45 75.93 0.8 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.909 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -146.35 15.0 1.29 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.379 -1.071 . . . . 0.0 110.56 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 60.27 34.89 86.54 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -171.01 167.16 7.32 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.13 -1.217 . . . . 0.0 110.061 179.563 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 84.6 t -131.0 120.29 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.155 -0.966 . . . . 0.0 110.18 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -94.54 -165.07 1.25 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.209 -0.932 . . . . 0.0 110.9 -179.637 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -66.91 -58.58 4.72 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.356 -0.84 . . . . 0.0 111.307 -178.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -47.61 -51.74 20.25 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.845 -1.159 . . . . 0.0 110.381 -179.548 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -58.71 -34.91 71.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.103 -0.998 . . . . 0.0 109.97 179.62 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.525 ' CG ' ' HE3' ' A' ' 144' ' ' MET . 6.5 t80 -64.94 -32.72 74.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.514 -0.741 . . . . 0.0 110.623 -179.762 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.4 t -82.96 -23.92 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.261 -0.899 . . . . 0.0 110.586 -179.471 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -90.26 -17.47 27.4 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.133 -0.979 . . . . 0.0 110.422 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.525 ' HE3' ' CG ' ' A' ' 141' ' ' PHE . 17.0 ptt? -90.09 -27.82 19.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.145 -0.972 . . . . 0.0 110.376 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.433 ' CE ' ' HE1' ' A' ' 144' ' ' MET . 27.7 tpp -88.9 -65.45 1.02 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.287 -0.883 . . . . 0.0 110.439 -179.607 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.414 ' O ' HG21 ' A' ' 146' ' ' THR . 5.1 t -124.97 116.77 22.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.151 -0.968 . . . . 0.0 110.438 -179.771 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 148' ' ' LYS . . . -135.56 -160.36 1.05 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.276 -0.89 . . . . 0.0 110.116 179.726 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 147' ' ' ALA . 42.7 tttp . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.346 179.898 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 153' ' ' WW7 . . . . . 0.421 'CL1 ' ' CD1' ' A' ' 63' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 154' ' ' WW7 . . . . . 0.427 ' H3 ' ' CD2' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.242 0.544 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -56.37 -42.6 78.11 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.932 . . . . 0.0 110.502 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -56.24 -52.52 64.15 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.211 -0.93 . . . . 0.0 110.196 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.3 mt -55.26 -40.95 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 109.941 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.29 -37.56 80.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.893 . . . . 0.0 109.613 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -61.17 -48.99 79.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.423 -0.798 . . . . 0.0 109.9 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -65.8 -25.21 67.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.411 -0.806 . . . . 0.0 109.992 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.6 mtpt -75.84 -30.68 59.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.33 -0.856 . . . . 0.0 109.705 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -71.08 -41.5 70.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 0.0 109.556 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.605 ' HB1' ' CZ ' ' A' ' 19' ' ' PHE . . . -68.27 -39.63 82.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.383 -0.823 . . . . 0.0 109.761 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -56.17 -55.07 37.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.377 -0.827 . . . . 0.0 110.088 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.2 m -60.65 -35.13 75.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.35 -0.844 . . . . 0.0 110.348 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.947 ' O ' HD23 ' A' ' 18' ' ' LEU . 4.9 tt -63.68 -29.42 70.66 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.191 -0.943 . . . . 0.0 110.202 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.605 ' CZ ' ' HB1' ' A' ' 15' ' ' ALA . 12.3 m-85 -79.37 -57.76 3.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 0.0 110.485 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -61.2 106.27 0.59 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.127 -0.983 . . . . 0.0 109.97 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -109.6 47.61 0.93 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.228 -0.92 . . . . 0.0 110.726 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -162.44 22.22 0.1 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.245 -0.91 . . . . 0.0 110.504 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 47.58 78.32 0.09 OUTLIER Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -134.91 -36.83 0.82 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.223 -1.163 . . . . 0.0 110.57 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.91 -23.43 35.64 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.5 p -118.05 143.44 46.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.407 -1.055 . . . . 0.0 109.971 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 44.3 mt -92.03 113.01 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.259 -0.9 . . . . 0.0 110.427 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.524 ' HA ' HG22 ' A' ' 62' ' ' THR . 80.9 p -97.11 -176.52 3.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 109.906 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.5 p -74.84 -28.49 60.7 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.253 -0.904 . . . . 0.0 110.07 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -70.81 -54.1 12.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 109.71 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.427 ' O ' HG23 ' A' ' 35' ' ' VAL . 91.5 mt-10 -56.1 -52.42 64.38 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.281 -0.887 . . . . 0.0 109.057 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.935 HD22 HD11 ' A' ' 52' ' ' ILE . 3.7 tp -55.05 -33.54 62.79 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.456 -0.778 . . . . 0.0 109.367 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.59 -49.78 67.5 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.2 m -69.17 -21.19 64.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.326 -1.102 . . . . 0.0 109.785 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 19' ' ' PHE . 54.8 t -73.47 -31.03 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.446 -0.784 . . . . 0.0 109.787 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.2 mmt -90.91 -24.27 20.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.894 . . . . 0.0 110.189 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -84.36 -20.86 31.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.253 -0.905 . . . . 0.0 110.448 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.6 m -88.07 -19.34 27.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.197 -0.939 . . . . 0.0 110.151 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.5 mt -89.16 -78.35 0.35 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.269 -0.894 . . . . 0.0 110.295 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.73 55.74 0.2 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -152.67 157.96 41.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.227 -1.16 . . . . 0.0 110.299 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.512 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 80.5 m-20 -143.04 48.6 1.01 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.157 -0.964 . . . . 0.0 110.58 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.512 ' CD ' ' N ' ' A' ' 42' ' ' ASN . 42.5 Cg_endo -68.8 -159.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.653 1.344 . . . . 0.0 110.082 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.512 HG22 ' H ' ' A' ' 45' ' ' GLU . 18.0 m -130.88 175.38 9.11 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.929 -1.107 . . . . 0.0 110.442 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.512 ' H ' HG22 ' A' ' 44' ' ' THR . 13.6 tp10 -67.38 -32.71 73.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.272 -0.893 . . . . 0.0 110.054 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.02 -64.8 0.84 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 110.184 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 2.3 mt-10 -50.03 -38.93 40.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -1.0 . . . . 0.0 109.668 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.523 HD11 HD23 ' A' ' 32' ' ' LEU . 10.1 tt -57.65 -50.28 73.67 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.373 -0.829 . . . . 0.0 109.459 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -50.18 -38.25 38.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -0.939 . . . . 0.0 109.408 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 47' ' ' GLU . 36.3 m-20 -62.63 -42.83 99.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.377 -0.827 . . . . 0.0 109.77 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.9 ttp -67.05 -15.87 63.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.266 -0.896 . . . . 0.0 109.645 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.935 HD11 HD22 ' A' ' 32' ' ' LEU . 45.9 mm -88.66 -25.67 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.178 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -58.36 -36.6 73.71 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.111 -0.993 . . . . 0.0 110.124 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.848 ' HG3' HG23 ' A' ' 55' ' ' VAL . 8.2 pt-20 -74.21 -23.78 59.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.92 . . . . 0.0 109.993 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.848 HG23 ' HG3' ' A' ' 54' ' ' GLU . 42.8 t -98.8 23.53 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.905 . . . . 0.0 110.051 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -135.4 112.92 10.71 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.342 -0.849 . . . . 0.0 109.92 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.94 34.42 3.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.176 -0.952 . . . . 0.0 110.211 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 2.6 p30 -141.54 -34.12 0.49 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.373 -0.829 . . . . 0.0 110.843 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 95.44 52.84 1.65 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.449 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 24.6 p-10 -122.34 -12.32 8.24 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.442 -1.034 . . . . 0.0 110.682 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.786 ' O ' HG23 ' A' ' 62' ' ' THR . . . 78.42 27.56 57.25 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.206 -1.157 . . . . 0.0 110.206 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 61' ' ' GLY . 0.9 OUTLIER -163.02 167.18 22.78 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.149 -1.206 . . . . 0.0 110.204 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.744 HD13 HG11 ' A' ' 55' ' ' VAL . 63.5 mt -117.39 150.6 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.12 -0.987 . . . . 0.0 110.127 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.445 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 1.5 m-20 -112.58 -162.97 0.82 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.316 -0.865 . . . . 0.0 110.425 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.609 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 7.0 t80 -81.55 -40.67 1.03 Allowed Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.411 -0.806 . . . . 0.0 111.914 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.4 Cg_endo -70.81 -21.4 28.65 Favored 'Trans proline' 0 N--CA 1.482 0.795 0 O-C-N 122.993 0.996 . . . . 0.0 110.974 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.425 ' OE1' ' OD1' ' A' ' 64' ' ' ASP . 57.2 mt-10 -86.12 -35.22 20.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.91 -1.119 . . . . 0.0 109.411 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.487 ' CZ ' ' SD ' ' A' ' 72' ' ' MET . 11.6 t80 -70.78 -38.49 73.41 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.419 -0.801 . . . . 0.0 110.417 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.484 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 1.1 tp -80.55 -37.14 31.98 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.203 -0.936 . . . . 0.0 110.709 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 88.9 m -71.35 -20.34 62.17 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.824 -1.173 . . . . 0.0 110.487 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 61.4 ttp -88.77 -42.33 11.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.139 -0.976 . . . . 0.0 110.86 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.487 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 59.0 mtt -90.51 -9.7 46.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.053 -1.03 . . . . 0.0 111.541 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.499 2.019 0 O-C-N 120.845 -1.16 . . . . 0.0 110.519 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.253 0.549 . . . . 0.0 110.389 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.741 HD12 ' HD1' ' A' ' 141' ' ' PHE . 38.8 mm -66.23 -10.23 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.224 -0.923 . . . . 0.0 110.339 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -73.48 -54.71 7.6 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.254 -0.904 . . . . 0.0 109.845 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -66.35 -35.52 80.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.362 -0.836 . . . . 0.0 109.615 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.714 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -57.32 -54.16 49.94 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.499 -0.751 . . . . 0.0 110.356 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.35 -27.41 69.0 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.882 -1.136 . . . . 0.0 110.247 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.35 -25.82 62.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.147 -0.971 . . . . 0.0 110.503 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.714 HG22 ' O ' ' A' ' 88' ' ' ALA . 34.3 m -95.1 -21.34 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.074 -1.016 . . . . 0.0 110.669 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.513 ' CD2' ' O ' ' A' ' 88' ' ' ALA . 21.7 m-85 -93.58 -11.91 30.71 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.16 -0.963 . . . . 0.0 110.574 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.425 ' OD2' ' HA2' ' A' ' 98' ' ' GLY . 40.5 t0 -114.23 92.1 3.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.209 -0.932 . . . . 0.0 110.269 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.49 -6.52 14.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.124 -0.985 . . . . 0.0 110.709 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.43 ' OD2' ' ND2' ' A' ' 97' ' ' ASN . 2.7 p-10 -91.93 -39.77 11.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.954 -1.091 . . . . 0.0 110.213 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 128.52 -35.36 2.69 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.546 -1.311 . . . . 0.0 111.091 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.52 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 42.4 p30 -47.88 -22.82 0.62 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.81 -1.406 . . . . 0.0 111.18 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.45 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 75.56 42.76 26.09 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 97' ' ' ASN . 77.2 m-85 -152.5 146.32 25.16 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.223 -1.163 . . . . 0.0 109.909 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.435 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 26.5 mt -94.41 121.28 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.171 -0.956 . . . . 0.0 109.994 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 74.5 m -109.01 151.36 26.44 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.477 -0.764 . . . . 0.0 109.956 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.41 ' HA ' HG13 ' A' ' 125' ' ' ILE . . . -51.23 -36.26 40.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.13 -0.981 . . . . 0.0 110.3 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.19 -59.87 4.41 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.287 -0.883 . . . . 0.0 110.307 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -48.39 -51.23 27.49 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.189 -0.945 . . . . 0.0 110.161 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.872 HD23 HG13 ' A' ' 121' ' ' VAL . 13.0 tp -49.24 -40.58 34.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.917 . . . . 0.0 110.15 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -62.46 -41.41 98.74 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.224 -0.923 . . . . 0.0 110.492 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -77.21 -12.92 60.01 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.191 -0.943 . . . . 0.0 110.823 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 53.2 t -88.57 -37.06 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.97 -1.081 . . . . 0.0 110.366 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 26.5 mmt -69.52 -32.27 71.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.147 -0.971 . . . . 0.0 110.471 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.0 p -76.36 -28.66 56.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.088 -1.008 . . . . 0.0 110.156 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -75.05 -44.16 49.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.222 -0.924 . . . . 0.0 110.176 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.7 mt -54.26 -36.28 63.43 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.187 -0.946 . . . . 0.0 110.369 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.87 31.37 1.03 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -116.19 -156.2 0.61 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.195 -1.179 . . . . 0.0 109.929 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -161.03 84.05 0.66 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.218 -0.926 . . . . 0.0 110.332 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.409 ' HG ' ' OE1' ' A' ' 120' ' ' GLU . 4.9 mp -108.68 131.82 54.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.336 -0.852 . . . . 0.0 110.08 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 19.8 m -77.94 159.99 28.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.221 -0.925 . . . . 0.0 110.224 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.0 -33.12 16.97 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.202 -0.936 . . . . 0.0 110.522 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -61.26 -42.47 98.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.153 -0.967 . . . . 0.0 110.54 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.409 ' OE1' ' HG ' ' A' ' 116' ' ' LEU . 85.4 mt-10 -67.71 -45.23 75.66 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.309 -0.87 . . . . 0.0 111.1 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.872 HG13 HD23 ' A' ' 105' ' ' LEU . 41.2 t -61.71 -56.21 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.049 -1.032 . . . . 0.0 110.605 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -52.07 -46.18 65.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.285 -0.884 . . . . 0.0 110.441 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -63.02 -33.1 74.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.295 -0.878 . . . . 0.0 110.242 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.423 ' HB3' ' HE2' ' A' ' 124' ' ' MET . 80.6 mtp -65.24 -62.52 1.49 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.882 . . . . 0.0 109.873 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 21.9 mm -49.81 -30.38 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 110.148 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.0 ttt180 -70.24 -41.08 74.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.292 -0.88 . . . . 0.0 110.447 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.75 -28.7 68.62 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.215 -0.928 . . . . 0.0 110.485 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.656 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -93.58 -17.01 23.8 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.119 -0.988 . . . . 0.0 110.753 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.93 ' OD1' HG22 ' A' ' 136' ' ' VAL . 1.6 m-20 -81.25 82.63 7.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.026 -1.047 . . . . 0.0 110.942 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.486 HG13 ' N ' ' A' ' 131' ' ' ASP . 21.9 pt -89.47 -32.49 5.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-O 121.429 0.633 . . . . 0.0 110.169 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 51.6 p-10 -121.83 -13.13 8.32 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.502 -0.749 . . . . 0.0 111.432 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . -95.2 -63.51 0.99 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.593 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 1.2 m-20 59.96 100.49 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.515 -0.991 . . . . 0.0 108.48 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 105.11 -20.97 36.86 Favored Glycine 0 C--N 1.294 -1.777 0 N-CA-C 107.824 -2.11 . . . . 0.0 107.824 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -162.1 153.23 17.96 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.659 -0.906 . . . . 0.0 109.859 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.93 HG22 ' OD1' ' A' ' 129' ' ' ASP . 46.5 t -122.1 152.66 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.258 -0.902 . . . . 0.0 110.532 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -129.95 -168.77 2.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.874 . . . . 0.0 110.594 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -59.57 -64.33 0.98 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.376 -0.828 . . . . 0.0 111.09 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -43.27 -55.46 4.01 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.4 -0.813 . . . . 0.0 111.146 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.479 ' OE2' ' HA ' ' A' ' 129' ' ' ASP . 5.9 mt-10 -48.44 -51.4 27.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.189 -0.945 . . . . 0.0 110.978 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.741 ' HD1' HD12 ' A' ' 85' ' ' ILE . 2.9 t80 -59.65 -32.96 70.94 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.061 -1.024 . . . . 0.0 110.967 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.693 HG22 HG21 ' A' ' 85' ' ' ILE . 57.9 t -76.42 -27.16 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.068 -1.02 . . . . 0.0 111.506 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 46.1 tp60 -98.27 -11.09 22.98 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.88 -1.138 . . . . 0.0 110.882 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.656 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 19.7 ptt? -91.33 -34.18 15.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.014 -1.054 . . . . 0.0 110.642 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.461 ' N ' ' HG3' ' A' ' 144' ' ' MET . 23.4 tpp -82.83 -40.14 20.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 110.41 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 68.2 p . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.086 179.807 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.154 0.502 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -50.3 -34.5 23.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.263 -0.898 . . . . 0.0 109.874 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.538 ' HG2' ' CE2' ' A' ' 12' ' ' PHE . 45.0 tt0 -59.73 -48.29 82.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.395 -0.815 . . . . 0.0 109.95 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.7 mt -59.56 -45.1 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.033 -1.042 . . . . 0.0 109.597 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.33 -25.76 64.46 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.387 -0.821 . . . . 0.0 109.505 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 15.0 tp10 -69.02 -44.76 72.1 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.377 -0.827 . . . . 0.0 109.707 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.538 ' CE2' ' HG2' ' A' ' 8' ' ' GLN . 20.3 m-85 -62.28 -47.7 83.15 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.253 -0.904 . . . . 0.0 109.808 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -56.17 -46.67 79.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.353 -0.842 . . . . 0.0 109.964 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -52.96 -46.17 68.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.22 -0.925 . . . . 0.0 109.631 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.458 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -58.92 -44.25 91.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.376 -0.827 . . . . 0.0 110.044 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.456 ' CE1' ' CD1' ' A' ' 27' ' ' ILE . 37.8 t80 -51.31 -40.72 59.62 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.11 -0.994 . . . . 0.0 109.742 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.4 t -66.1 -38.29 87.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -0.888 . . . . 0.0 109.595 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.494 ' C ' HD23 ' A' ' 18' ' ' LEU . 10.5 tt -57.96 -31.78 67.2 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.325 -0.859 . . . . 0.0 109.956 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.512 ' HA ' HG21 ' A' ' 35' ' ' VAL . 32.1 m-85 -87.29 -25.59 23.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.313 -0.867 . . . . 0.0 110.287 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -100.92 114.47 28.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.313 -0.867 . . . . 0.0 109.925 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -103.7 -28.07 11.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.191 -0.943 . . . . 0.0 110.794 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.42 ' OD1' ' HB2' ' A' ' 24' ' ' ASP . 4.1 p30 -92.6 11.46 26.48 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.12 -0.988 . . . . 0.0 110.633 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 47.84 47.94 24.61 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.42 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 7.4 t70 -84.81 -27.45 26.8 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.263 -1.139 . . . . 0.0 110.501 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.09 -27.81 14.84 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.4 p -125.81 148.62 49.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.214 -1.168 . . . . 0.0 110.24 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.456 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 83.0 mt -96.03 126.84 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.293 -0.879 . . . . 0.0 110.114 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.7 p -108.8 -162.82 0.83 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.368 -0.832 . . . . 0.0 110.171 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.1 p -86.47 -28.36 23.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -0.987 . . . . 0.0 110.225 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -65.9 -58.36 5.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 109.698 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -54.95 -55.66 28.27 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.305 -0.872 . . . . 0.0 109.834 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.964 HD22 HD11 ' A' ' 52' ' ' ILE . 2.7 tp -54.16 -29.17 44.47 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.349 -0.845 . . . . 0.0 109.705 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.72 -49.68 73.83 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.0 m -68.81 -23.06 64.23 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.169 -1.195 . . . . 0.0 110.219 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.512 HG21 ' HA ' ' A' ' 19' ' ' PHE . 16.6 t -72.47 -37.77 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.275 -0.89 . . . . 0.0 109.881 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.4 mmt -90.28 -10.35 44.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 110.468 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -89.18 -36.66 15.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.134 -0.979 . . . . 0.0 110.658 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 72.8 p -79.33 -36.76 38.97 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.131 -0.981 . . . . 0.0 110.412 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.36 -11.19 55.14 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.268 -0.895 . . . . 0.0 110.482 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 151.07 89.6 0.07 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.69 143.8 57.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -1.118 . . . . 0.0 111.05 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.555 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 10.5 m-20 -159.85 -64.93 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.416 -0.803 . . . . 0.0 109.497 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.555 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 49.4 Cg_endo -74.47 150.22 40.6 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.423 1.222 . . . . 0.0 109.446 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 72.7 p -90.33 -137.79 0.14 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.054 -1.029 . . . . 0.0 109.415 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -100.9 -37.82 8.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.784 -1.198 . . . . 0.0 109.188 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -75.24 -58.1 3.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.409 -0.807 . . . . 0.0 109.236 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -51.81 -40.79 61.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.32 -0.862 . . . . 0.0 109.048 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.623 HD21 HD23 ' A' ' 32' ' ' LEU . 9.4 tt -58.01 -42.61 85.61 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.611 -0.681 . . . . 0.0 109.182 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.414 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 35.1 tt0 -53.04 -39.71 63.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.905 . . . . 0.0 108.901 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -65.32 -37.32 86.76 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.218 -0.926 . . . . 0.0 108.66 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.418 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 13.5 ttt -66.39 -18.52 65.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.465 -0.772 . . . . 0.0 109.309 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.964 HD11 HD22 ' A' ' 32' ' ' LEU . 33.3 mm -82.39 -31.69 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.372 -0.83 . . . . 0.0 109.802 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -59.33 -49.64 77.05 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.454 -0.779 . . . . 0.0 110.526 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.491 ' HG3' HG23 ' A' ' 55' ' ' VAL . 21.7 pt-20 -56.69 -19.16 15.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.079 -1.013 . . . . 0.0 110.124 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.511 HG13 ' SD ' ' A' ' 71' ' ' MET . 56.0 t -94.48 -25.74 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.267 -0.895 . . . . 0.0 110.164 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -97.8 100.66 12.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.217 -0.927 . . . . 0.0 110.458 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -93.41 46.53 1.2 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.219 -0.925 . . . . 0.0 109.982 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -132.02 -66.49 0.7 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.218 -0.926 . . . . 0.0 110.484 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 135.84 53.94 0.06 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.439 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 12.4 p-10 -142.06 -46.41 0.35 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -1.139 . . . . 0.0 110.316 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.19 -72.55 0.48 Allowed Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.656 -1.259 . . . . 0.0 110.531 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.9 p -69.67 169.88 11.96 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.251 -1.147 . . . . 0.0 111.149 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.473 HD13 HG11 ' A' ' 55' ' ' VAL . 42.0 mt -115.83 143.89 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.309 -0.869 . . . . 0.0 110.258 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.42 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 57.3 m-20 -96.12 -168.23 1.71 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.255 -0.903 . . . . 0.0 110.227 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.563 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 57.7 t80 -82.77 -41.78 0.89 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 111.459 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.4 Cg_endo -74.55 -29.34 9.17 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 O-C-N 123.05 1.026 . . . . 0.0 109.968 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -74.12 -27.26 60.78 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.322 -0.861 . . . . 0.0 108.775 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -75.32 -47.43 27.79 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.621 -0.674 . . . . 0.0 110.04 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.892 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 1.8 tt -70.21 -20.76 63.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.297 -0.877 . . . . 0.0 110.167 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.0 m -78.6 -43.23 26.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 110.884 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.511 ' SD ' HG13 ' A' ' 55' ' ' VAL . 64.0 ttp -69.12 -48.18 63.17 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.1 -1.0 . . . . 0.0 110.93 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 28.7 mtt -78.68 -10.89 59.92 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.102 -0.998 . . . . 0.0 110.991 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.892 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.497 1.882 0 O-C-N 120.972 -1.08 . . . . 0.0 110.005 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.294 0.569 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.1 mt -51.53 -30.39 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.398 -0.814 . . . . 0.0 110.133 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -68.57 -42.09 78.8 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.231 -0.918 . . . . 0.0 109.846 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -62.38 -37.44 85.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.273 -0.892 . . . . 0.0 110.164 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.728 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -65.19 -62.44 1.54 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -0.9 . . . . 0.0 110.38 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.42 ' CE2' ' HA ' ' A' ' 138' ' ' TYR . 6.2 t80 -54.92 -28.0 47.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.18 -0.95 . . . . 0.0 110.211 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 -63.39 -53.26 55.25 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.255 -0.903 . . . . 0.0 110.559 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.701 HG23 ' CD1' ' A' ' 92' ' ' PHE . 31.0 m -70.68 -24.86 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.106 -0.996 . . . . 0.0 110.707 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.728 ' CE2' ' HB1' ' A' ' 88' ' ' ALA . 14.3 m-30 -73.41 -28.85 62.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.132 -0.98 . . . . 0.0 110.007 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -108.67 67.63 0.67 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 0.0 109.752 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -77.08 -30.33 55.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.348 -0.845 . . . . 0.0 110.485 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.445 ' OD2' ' HB2' ' A' ' 97' ' ' ASN . 30.8 p-10 -69.24 -7.13 33.89 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.171 -0.956 . . . . 0.0 110.491 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.52 28.57 70.91 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.445 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 1.8 t-20 -80.78 -75.87 0.26 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.296 -1.12 . . . . 0.0 110.01 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 151.18 -25.21 0.99 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.439 ' HB3' ' HB2' ' A' ' 135' ' ' GLN . 14.3 m-85 -118.88 131.69 56.07 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.193 -1.181 . . . . 0.0 110.092 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.447 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 83.3 mt -70.01 128.62 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.146 -0.971 . . . . 0.0 110.084 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 97.9 p -114.6 175.07 5.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.897 . . . . 0.0 110.226 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 105' ' ' LEU . . . -71.14 -53.02 15.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 110.228 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -47.08 -56.62 6.22 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.179 -0.95 . . . . 0.0 110.244 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.465 ' O ' HG23 ' A' ' 108' ' ' VAL . 94.4 mt-10 -58.69 -41.93 87.38 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 109.807 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.825 HD23 HG13 ' A' ' 121' ' ' VAL . 55.1 tp -54.86 -30.54 58.07 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.309 -0.869 . . . . 0.0 110.104 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -77.29 -42.72 35.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.92 . . . . 0.0 110.128 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -62.34 -19.44 63.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 110.312 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 104' ' ' GLU . 47.8 t -92.67 -45.08 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.175 -0.953 . . . . 0.0 110.42 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.491 ' HA ' HD12 ' A' ' 112' ' ' LEU . 26.4 mmt -70.02 -18.34 63.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.272 -0.892 . . . . 0.0 110.555 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.9 m -75.83 -25.27 56.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.155 -0.965 . . . . 0.0 110.033 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -88.38 -38.73 14.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.303 -0.873 . . . . 0.0 110.075 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.491 HD12 ' HA ' ' A' ' 109' ' ' MET . 50.6 mt -58.15 -42.6 86.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.369 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.09 0.83 7.51 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 2.4 mm-40 -72.85 -43.15 62.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.069 -1.253 . . . . 0.0 110.256 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 16.7 mmtp 55.74 106.99 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.42 -0.8 . . . . 0.0 110.414 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.4 HD12 ' HB3' ' A' ' 109' ' ' MET . 1.6 mt -131.87 161.46 32.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.261 -0.9 . . . . 0.0 110.21 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.479 HG22 ' N ' ' A' ' 118' ' ' ASP . 67.7 m -86.51 168.18 13.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 0.0 110.06 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.479 ' N ' HG22 ' A' ' 117' ' ' THR . 50.6 m-20 -57.1 -43.64 82.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.268 -0.895 . . . . 0.0 110.688 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -66.31 -33.34 75.51 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.051 -1.031 . . . . 0.0 110.472 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -65.35 -59.12 4.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.044 -1.035 . . . . 0.0 109.908 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.825 HG13 HD23 ' A' ' 105' ' ' LEU . 70.4 t -52.04 -45.4 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.172 -0.955 . . . . 0.0 109.665 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -54.71 -41.47 70.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 0.0 109.528 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -64.57 -33.13 75.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.368 -0.833 . . . . 0.0 109.544 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 26.4 mmm -63.88 -49.54 72.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.879 . . . . 0.0 110.127 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.414 HG23 HG23 ' A' ' 136' ' ' VAL . 34.7 mm -64.83 -26.89 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.352 -0.843 . . . . 0.0 110.245 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -69.76 -50.12 46.38 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.153 -0.967 . . . . 0.0 110.129 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -57.74 -39.3 77.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.166 -0.959 . . . . 0.0 109.733 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.496 ' HB2' ' SD ' ' A' ' 144' ' ' MET . . . -70.9 -30.59 66.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.319 -0.863 . . . . 0.0 109.939 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -70.27 91.12 0.71 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.393 -0.817 . . . . 0.0 110.166 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 65.2 mt -74.69 -50.8 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.201 -0.937 . . . . 0.0 110.817 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 29.1 p30 -69.39 -17.95 63.72 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.104 -0.997 . . . . 0.0 110.877 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 71.49 72.18 0.95 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.407 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 6.6 p30 -125.73 -24.91 3.75 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.236 -1.156 . . . . 0.0 111.237 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 132.59 -24.52 3.89 Favored Glycine 0 N--CA 1.496 2.688 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.33 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 99' ' ' TYR . 2.4 pp0? -140.25 167.51 21.96 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.055 -1.262 . . . . 0.0 110.558 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.447 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 57.9 t -102.86 144.25 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.21 -0.931 . . . . 0.0 110.68 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -106.93 166.22 10.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.363 -0.835 . . . . 0.0 109.476 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.498 ' O ' HG23 ' A' ' 142' ' ' VAL . 51.8 t80 -52.94 -38.67 62.22 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.039 -1.038 . . . . 0.0 110.1 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -67.77 -60.35 2.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.213 -0.93 . . . . 0.0 110.623 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -47.13 -36.45 8.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.208 -0.933 . . . . 0.0 110.745 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.565 ' CD2' ' HE1' ' A' ' 144' ' ' MET . 10.2 t80 -65.51 -46.29 80.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.138 -0.976 . . . . 0.0 110.182 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 138' ' ' TYR . 52.4 t -66.48 -22.61 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.225 -0.922 . . . . 0.0 110.101 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -84.33 -25.29 29.33 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.378 -0.826 . . . . 0.0 111.019 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.565 ' HE1' ' CD2' ' A' ' 141' ' ' PHE . 10.1 ptt? -89.54 -23.1 22.1 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.003 -1.06 . . . . 0.0 110.756 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.508 ' HE2' ' HB2' ' A' ' 145' ' ' MET . 38.4 tpp -88.58 -9.76 51.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.257 -0.902 . . . . 0.0 110.815 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 142' ' ' VAL . 14.2 t . . . . . 0 N--CA 1.497 1.886 0 O-C-N 121.077 -1.014 . . . . 0.0 110.719 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.089 0.471 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -63.72 -26.24 68.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.149 -0.969 . . . . 0.0 110.334 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -68.13 -49.87 58.29 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.194 -0.941 . . . . 0.0 110.014 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.8 mt -61.88 -47.95 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.167 -0.958 . . . . 0.0 109.805 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 13' ' ' LYS . . . -55.24 -39.6 69.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.281 -0.887 . . . . 0.0 109.657 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -58.46 -43.92 89.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.42 -0.8 . . . . 0.0 109.619 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.476 ' CE1' ' HB3' ' A' ' 72' ' ' MET . 35.8 m-85 -63.18 -25.62 68.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.378 -0.826 . . . . 0.0 109.805 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 17.8 mtpt -77.47 -28.26 52.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.333 -0.855 . . . . 0.0 110.249 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 2.6 tt0 -73.05 -42.92 62.59 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.146 -0.972 . . . . 0.0 110.065 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.87 -50.68 16.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.178 -0.951 . . . . 0.0 109.48 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.544 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 77.9 t80 -49.93 -48.03 52.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 109.614 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.7 t -68.82 -35.83 77.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.553 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.917 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.4 tm? -59.34 -24.35 63.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.423 -0.798 . . . . 0.0 109.309 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.425 ' CD1' HG13 ' A' ' 35' ' ' VAL . 13.8 m-85 -87.31 -62.28 1.54 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.513 -0.742 . . . . 0.0 109.68 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -51.65 115.58 1.7 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.53 -0.732 . . . . 0.0 110.076 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -105.85 -36.68 6.93 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.024 -1.048 . . . . 0.0 110.708 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -69.46 -25.83 64.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.148 -0.97 . . . . 0.0 110.167 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.93 95.43 0.42 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.409 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 9.1 p-10 -158.01 -46.3 0.06 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.237 -1.155 . . . . 0.0 110.609 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.523 ' C ' HG23 ' A' ' 26' ' ' THR . . . 126.5 23.88 1.47 Allowed Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.852 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.523 HG23 ' C ' ' A' ' 25' ' ' GLY . 53.8 p -154.89 140.95 18.39 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.799 -1.413 . . . . 0.0 110.618 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 62.2 mt -99.63 112.72 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -0.918 . . . . 0.0 109.759 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.644 HG22 ' H ' ' A' ' 29' ' ' THR . 4.5 m -97.67 -177.87 3.93 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.313 -0.867 . . . . 0.0 110.186 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.923 HG22 HD12 ' A' ' 52' ' ' ILE . 16.8 p -72.9 -31.62 64.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.145 -0.972 . . . . 0.0 110.929 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -62.21 1.58 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.898 -1.126 . . . . 0.0 110.09 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.657 ' O ' HG23 ' A' ' 35' ' ' VAL . 50.8 mt-10 -55.18 -47.63 74.93 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.158 -0.964 . . . . 0.0 109.437 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.705 HD22 HD11 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -55.7 -32.3 63.19 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.281 -0.887 . . . . 0.0 109.608 179.4 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.91 -51.62 57.84 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.9 m -70.27 -12.76 61.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.264 -1.139 . . . . 0.0 110.136 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 31' ' ' GLU . 59.5 t -78.36 -32.08 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.22 -0.925 . . . . 0.0 110.109 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -87.34 -27.52 22.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.108 -0.995 . . . . 0.0 110.205 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.92 -46.2 15.55 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.128 -0.982 . . . . 0.0 109.946 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.6 t -57.08 -22.53 40.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.324 -0.86 . . . . 0.0 110.101 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.524 HD12 ' O ' ' A' ' 35' ' ' VAL . 75.7 mt -95.39 -69.72 0.74 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.341 -0.85 . . . . 0.0 109.997 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.16 88.96 0.07 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.405 ' O ' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -175.82 -56.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.229 -1.159 . . . . 0.0 110.275 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' A' ' 41' ' ' GLN . 41.9 t30 53.97 64.81 6.07 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.172 -0.955 . . . . 0.0 110.244 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -74.85 -163.04 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.765 1.403 . . . . 0.0 110.402 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 47' ' ' GLU . 89.2 m -109.3 151.19 26.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.359 -0.838 . . . . 0.0 109.941 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -59.67 -41.9 91.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 110.03 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.79 -62.14 1.5 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.319 -0.863 . . . . 0.0 110.25 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.435 ' HB3' ' HB ' ' A' ' 44' ' ' THR . 41.6 tt0 -50.07 -24.98 3.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.247 -0.908 . . . . 0.0 109.893 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 44' ' ' THR . 9.2 tt -70.74 -51.27 28.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.434 -0.791 . . . . 0.0 109.612 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -54.03 -30.1 46.31 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.292 -0.88 . . . . 0.0 109.085 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -75.96 -35.43 59.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.493 -0.755 . . . . 0.0 109.561 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.434 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 27.9 ttp -71.04 -19.93 62.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.469 -0.769 . . . . 0.0 110.081 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.923 HD12 HG22 ' A' ' 29' ' ' THR . 10.7 mt -88.15 -36.75 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -0.87 . . . . 0.0 109.684 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -55.0 -40.64 70.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.195 -0.94 . . . . 0.0 109.91 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.504 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 10.0 pt-20 -70.14 -30.58 67.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.256 -0.903 . . . . 0.0 110.131 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.609 ' CG1' HD11 ' A' ' 63' ' ' ILE . 59.0 t -74.35 -72.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.353 -0.842 . . . . 0.0 109.328 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -52.03 98.62 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.686 -0.634 . . . . 0.0 110.401 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -87.41 50.03 1.93 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.602 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -138.03 9.28 2.78 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.447 -0.783 . . . . 0.0 110.333 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 53.17 88.02 0.01 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -169.39 -60.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.217 -1.166 . . . . 0.0 110.077 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.404 ' O ' ' CG2' ' A' ' 52' ' ' ILE . . . 136.54 -57.83 0.67 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.436 HG22 HG23 ' A' ' 28' ' ' THR . 68.8 p -90.13 143.51 26.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.203 -1.175 . . . . 0.0 110.712 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.609 HD11 ' CG1' ' A' ' 55' ' ' VAL . 86.6 mt -93.86 151.11 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.453 -0.78 . . . . 0.0 109.68 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.411 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 47.8 m-20 -109.02 -162.79 0.83 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.237 -0.914 . . . . 0.0 110.531 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.547 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 28.1 t80 -79.39 -42.08 1.58 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.359 -0.838 . . . . 0.0 111.355 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 49.3 Cg_endo -75.73 -25.8 10.41 Favored 'Trans proline' 0 N--CA 1.481 0.75 0 O-C-N 123.124 1.065 . . . . 0.0 110.428 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -78.65 -28.06 45.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 0.0 109.188 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.629 ' CE1' ' HE3' ' A' ' 72' ' ' MET . 88.2 t80 -78.11 -44.73 25.31 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.635 -0.666 . . . . 0.0 110.118 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.56 -32.22 60.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 0.0 110.894 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 83.2 m -78.56 -31.44 47.35 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.991 -1.068 . . . . 0.0 110.88 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.43 ' HG3' ' HG3' ' A' ' 72' ' ' MET . 18.7 ptt? -79.93 -31.48 40.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.92 -1.113 . . . . 0.0 110.777 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.629 ' HE3' ' CE1' ' A' ' 68' ' ' PHE . 53.9 mtt -89.22 -10.45 46.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.008 -1.058 . . . . 0.0 110.932 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.746 0 O-C-N 121.072 -1.017 . . . . 0.0 110.45 -179.719 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 121.202 0.525 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.6 mt -50.46 -23.77 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.146 -0.971 . . . . 0.0 110.255 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.23 -55.26 5.22 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.214 -0.929 . . . . 0.0 110.457 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 47.9 mt-10 -53.58 -38.55 64.01 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.221 -0.925 . . . . 0.0 110.147 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.746 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -65.25 -59.48 4.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.391 -0.818 . . . . 0.0 110.206 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.638 ' CD1' HD11 ' A' ' 100' ' ' ILE . 20.8 t80 -46.15 -28.74 1.31 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.358 -0.839 . . . . 0.0 110.267 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 71.6 mtp180 -71.13 -55.37 8.33 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.252 -0.905 . . . . 0.0 110.422 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.746 HG22 ' O ' ' A' ' 88' ' ' ALA . 32.7 m -61.36 -19.64 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.152 -0.968 . . . . 0.0 110.579 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.525 ' HB3' HG23 ' A' ' 100' ' ' ILE . 40.9 m-85 -92.12 -21.31 20.5 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.126 -0.984 . . . . 0.0 110.21 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -127.45 37.49 4.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 0.0 109.927 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -85.0 8.07 19.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.898 . . . . 0.0 110.658 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 3.0 p30 -81.92 -22.71 36.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.155 -0.966 . . . . 0.0 110.138 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.437 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 112.18 29.82 3.12 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.473 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 39.0 p-10 -127.09 -15.46 5.28 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.263 -1.139 . . . . 0.0 110.719 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 65.53 11.28 52.7 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.55 ' CD1' ' NE2' ' A' ' 135' ' ' GLN . 49.8 m-85 -121.41 139.54 53.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.026 -1.279 . . . . 0.0 110.241 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.638 HD11 ' CD1' ' A' ' 89' ' ' PHE . 21.8 mt -91.23 113.37 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.137 -0.977 . . . . 0.0 110.273 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 76.3 p -103.85 156.46 17.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.412 -0.805 . . . . 0.0 109.915 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.77 -34.95 55.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.127 -0.983 . . . . 0.0 110.307 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.42 -62.32 1.48 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.181 -0.949 . . . . 0.0 110.498 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.415 ' OE1' ' OD2' ' A' ' 95' ' ' ASP . 51.4 mt-10 -46.95 -42.98 18.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.179 -0.95 . . . . 0.0 110.254 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.621 HD22 HG13 ' A' ' 121' ' ' VAL . 8.6 tt -55.07 -54.12 47.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.399 -0.813 . . . . 0.0 110.126 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.411 ' O ' ' HG3' ' A' ' 106' ' ' ARG . 3.1 tpt180 -63.1 -19.95 64.91 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.924 . . . . 0.0 109.986 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -77.89 -27.32 49.6 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.286 -0.884 . . . . 0.0 110.14 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.452 HG21 ' CD1' ' A' ' 92' ' ' PHE . 78.4 t -83.77 -40.1 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.315 -0.865 . . . . 0.0 109.903 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.42 ' HG2' ' CD1' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -59.87 -41.9 92.54 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.344 -0.848 . . . . 0.0 110.062 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.1 p -56.01 -44.68 78.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.33 -0.856 . . . . 0.0 110.335 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -61.28 -48.32 81.94 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.243 -0.911 . . . . 0.0 110.132 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.5 mt -64.48 -13.93 54.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.207 -0.933 . . . . 0.0 110.275 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.27 51.44 3.52 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -102.23 -177.47 3.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.129 -1.218 . . . . 0.0 110.015 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.15 47.6 0.99 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.166 -0.959 . . . . 0.0 110.577 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.815 HD23 ' OE1' ' A' ' 120' ' ' GLU . 7.0 mt -75.89 -175.73 3.12 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.264 -0.898 . . . . 0.0 110.158 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.531 HG22 ' N ' ' A' ' 118' ' ' ASP . 88.8 m -135.92 170.08 16.57 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.293 -0.879 . . . . 0.0 110.288 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.531 ' N ' HG22 ' A' ' 117' ' ' THR . 75.1 m-20 -52.87 -33.29 49.25 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.314 -0.866 . . . . 0.0 110.783 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -65.68 -53.1 45.71 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.127 -0.983 . . . . 0.0 110.613 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.815 ' OE1' HD23 ' A' ' 116' ' ' LEU . 74.2 mt-10 -60.57 -48.88 79.8 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.318 -0.864 . . . . 0.0 111.209 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.621 HG13 HD22 ' A' ' 105' ' ' LEU . 95.7 t -55.81 -53.31 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.231 -0.918 . . . . 0.0 110.833 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.75 -36.47 74.4 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.23 -0.919 . . . . 0.0 110.667 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.456 ' CG ' ' OE2' ' A' ' 127' ' ' GLU . 36.9 tt0 -71.63 -24.95 61.96 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.193 -0.942 . . . . 0.0 110.289 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.486 ' HE2' HD11 ' A' ' 105' ' ' LEU . 85.3 mtp -76.63 -49.18 16.87 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.183 -0.948 . . . . 0.0 110.068 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.44 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 19.2 mm -69.08 -26.53 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 110.326 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.43 -39.14 47.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.127 -0.983 . . . . 0.0 110.528 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.456 ' OE2' ' CG ' ' A' ' 123' ' ' GLU . 0.3 OUTLIER -69.78 -31.23 69.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.133 -0.979 . . . . 0.0 110.178 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.11 -27.91 24.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.208 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 56.8 t0 -68.29 93.58 0.48 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.374 -0.829 . . . . 0.0 110.224 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 55.6 mt -75.42 -47.9 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.287 -0.883 . . . . 0.0 110.739 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.409 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 47.7 p30 -73.19 -6.37 45.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.132 -0.98 . . . . 0.0 110.811 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.406 ' HA2' ' OD2' ' A' ' 129' ' ' ASP . . . 57.87 61.98 6.83 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -124.03 8.63 8.65 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.203 -1.175 . . . . 0.0 111.027 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.54 36.19 54.62 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.55 ' NE2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -170.96 137.36 1.19 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.354 -1.086 . . . . 0.0 109.964 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.437 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 46.8 t -110.35 118.16 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.157 -0.965 . . . . 0.0 110.318 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -87.37 177.2 7.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.163 -0.961 . . . . 0.0 110.022 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.538 ' O ' HG23 ' A' ' 142' ' ' VAL . 16.0 t80 -61.5 -45.05 95.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.111 -0.993 . . . . 0.0 110.286 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -53.08 -55.56 22.96 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.282 -0.886 . . . . 0.0 110.077 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.441 ' O ' ' HG2' ' A' ' 144' ' ' MET . 56.7 mt-10 -64.86 -23.36 67.21 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.224 -0.922 . . . . 0.0 109.785 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.517 ' CE1' ' HE2' ' A' ' 145' ' ' MET . 37.9 t80 -75.75 -22.86 56.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.551 -0.718 . . . . 0.0 109.757 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 138' ' ' TYR . 84.9 t -90.1 -24.19 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.369 -0.832 . . . . 0.0 109.928 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -80.43 -34.24 36.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.372 -0.83 . . . . 0.0 110.217 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.573 ' HE3' ' CE ' ' A' ' 145' ' ' MET . 0.1 OUTLIER -82.57 -13.67 56.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.286 -0.884 . . . . 0.0 110.257 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.573 ' CE ' ' HE3' ' A' ' 144' ' ' MET . 15.1 mmt -87.49 -46.66 9.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 110.394 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.3 p . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.141 -0.974 . . . . 0.0 110.489 -179.769 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.117 0.484 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.67 -60.28 3.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.121 -0.987 . . . . 0.0 110.426 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.526 ' HG2' ' CE2' ' A' ' 12' ' ' PHE . 51.2 tt0 -62.7 -43.35 99.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.327 -0.858 . . . . 0.0 110.415 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.8 mt -55.0 -42.23 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.081 -1.012 . . . . 0.0 109.839 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.97 -34.9 78.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.317 -0.865 . . . . 0.0 110.029 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.91 -48.87 78.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 109.779 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.526 ' CE2' ' HG2' ' A' ' 8' ' ' GLN . 24.1 m-85 -60.08 -47.87 84.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.016 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -49.04 -42.04 37.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.17 -0.956 . . . . 0.0 110.072 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -66.5 -37.7 85.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.875 . . . . 0.0 110.307 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.81 -47.87 83.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.142 -0.974 . . . . 0.0 109.971 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -60.27 -45.26 93.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 110.146 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.3 t -62.84 -21.22 65.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.924 . . . . 0.0 109.991 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.73 ' O ' HD23 ' A' ' 18' ' ' LEU . 4.7 tt -85.2 -25.18 27.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 109.939 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.564 ' HA ' HG21 ' A' ' 35' ' ' VAL . 8.3 m-85 -92.74 -67.98 0.83 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.219 -0.926 . . . . 0.0 110.412 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -70.99 86.78 0.72 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.382 -0.823 . . . . 0.0 110.235 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.39 42.54 1.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.342 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -125.18 -43.2 1.96 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.136 -0.977 . . . . 0.0 110.25 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.93 -37.42 1.66 Allowed Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.86 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 49.9 p-10 -55.67 -17.85 6.67 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.96 -1.318 . . . . 0.0 110.952 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.428 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 63.13 13.59 49.52 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 34.0 p -122.21 116.05 23.46 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.023 -1.281 . . . . 0.0 110.286 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 62' ' ' THR . 61.2 mt -69.54 109.25 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.173 -0.954 . . . . 0.0 110.254 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.534 HG22 HG22 ' A' ' 62' ' ' THR . 81.2 p -104.19 -157.85 0.63 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.881 . . . . 0.0 110.204 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.1 p -82.99 -36.85 24.73 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.198 -0.939 . . . . 0.0 110.636 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -64.94 -59.85 3.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.117 -0.99 . . . . 0.0 110.192 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -59.09 -52.5 65.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.166 -0.958 . . . . 0.0 109.805 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.717 HD23 HD21 ' A' ' 48' ' ' LEU . 2.6 tp -59.45 -21.82 60.6 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.241 -0.912 . . . . 0.0 109.682 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -68.23 -44.61 74.88 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 70.8 m -71.63 -34.14 69.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.349 -1.089 . . . . 0.0 110.176 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.564 HG21 ' HA ' ' A' ' 19' ' ' PHE . 63.6 t -69.6 -32.14 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.29 -0.881 . . . . 0.0 110.617 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 25.9 mmt -90.16 -18.47 25.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.221 -0.924 . . . . 0.0 110.241 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 10.7 tpt180 -79.06 -33.93 44.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 110.357 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.3 t -61.36 -21.07 63.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.289 -0.882 . . . . 0.0 110.383 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -144.98 76.38 1.49 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.175 -0.953 . . . . 0.0 110.255 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.24 -65.28 0.15 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 53.6 21.12 2.4 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.13 -1.218 . . . . 0.0 109.963 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.522 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.0 OUTLIER -105.56 -67.22 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.425 -0.797 . . . . 0.0 110.823 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 42' ' ' ASN . 46.8 Cg_endo -72.31 170.64 18.7 Favored 'Trans proline' 0 C--N 1.321 -0.911 0 O-C-N 123.063 1.033 . . . . 0.0 110.467 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.442 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.6 OUTLIER -118.76 -140.63 0.36 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -0.887 . . . . 0.0 109.629 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -90.74 -30.67 16.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.908 -1.12 . . . . 0.0 110.189 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.62 -66.44 0.66 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.206 -0.933 . . . . 0.0 109.805 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 41.8 mt-10 -50.58 -36.22 33.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 109.54 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.717 HD21 HD23 ' A' ' 32' ' ' LEU . 6.0 tt -60.35 -45.2 94.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.84 . . . . 0.0 109.587 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -53.16 -39.36 63.5 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.282 -0.886 . . . . 0.0 108.629 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 47' ' ' GLU . 57.4 m-20 -64.31 -38.08 89.78 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.434 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -60.75 -23.84 65.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.439 -0.788 . . . . 0.0 108.919 178.746 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.702 HD11 HD22 ' A' ' 32' ' ' LEU . 10.7 mt -85.34 -24.86 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.456 -0.778 . . . . 0.0 109.786 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -73.54 -35.67 65.55 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.263 -0.898 . . . . 0.0 110.243 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.478 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 24.2 pt-20 -72.74 -42.54 63.96 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.174 -0.953 . . . . 0.0 110.166 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.635 HG13 ' SD ' ' A' ' 71' ' ' MET . 68.0 t -69.87 -57.61 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.036 -1.04 . . . . 0.0 109.593 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.404 ' OD1' ' OE1' ' A' ' 67' ' ' GLU . 45.3 t0 -68.3 133.58 49.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.467 -0.77 . . . . 0.0 110.07 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.93 50.85 0.78 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.17 -0.956 . . . . 0.0 110.376 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.401 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 55.4 m-20 -136.48 -74.72 0.43 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.193 -0.942 . . . . 0.0 110.466 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.38 47.57 0.05 OUTLIER Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -140.35 14.15 2.39 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.353 -1.086 . . . . 0.0 110.405 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 62' ' ' THR . . . 47.16 38.45 11.65 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.534 HG22 HG22 ' A' ' 28' ' ' THR . 20.6 p -152.58 136.7 16.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.999 -1.294 . . . . 0.0 110.576 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 75.4 mt -111.67 123.74 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.884 . . . . 0.0 110.082 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.447 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.4 m-20 -83.73 -174.19 5.14 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.148 -0.97 . . . . 0.0 110.546 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.563 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -67.25 -46.71 50.82 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.436 -0.79 . . . . 0.0 111.032 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.6 Cg_endo -73.73 -31.12 8.82 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 O-C-N 123.415 1.218 . . . . 0.0 110.427 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.404 ' OE1' ' OD1' ' A' ' 56' ' ' ASP . 27.5 mt-10 -73.78 -23.65 59.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.158 -0.964 . . . . 0.0 109.176 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.785 ' CE1' ' HE2' ' A' ' 72' ' ' MET . 65.4 t80 -76.01 -55.51 5.53 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.638 -0.664 . . . . 0.0 110.281 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.708 ' O ' HD23 ' A' ' 69' ' ' LEU . 5.4 tt -63.87 -28.86 70.13 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.349 -0.845 . . . . 0.0 110.297 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.4 m -68.52 -57.59 5.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.221 -0.924 . . . . 0.0 110.375 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.635 ' SD ' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -69.38 -12.67 61.85 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.167 -0.958 . . . . 0.0 110.673 -179.474 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.785 ' HE2' ' CE1' ' A' ' 68' ' ' PHE . 11.4 mmt -80.52 -24.93 39.01 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.05 -1.031 . . . . 0.0 110.085 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.475 0 O-C-N 121.334 -0.854 . . . . 0.0 109.899 179.618 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.149 0.5 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 65.5 mt -55.21 -45.19 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.115 -0.991 . . . . 0.0 110.097 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -58.6 -56.4 22.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.168 -0.957 . . . . 0.0 109.979 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 10.8 mt-10 -46.29 -44.57 16.7 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.336 -0.852 . . . . 0.0 110.172 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.596 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -57.22 -57.64 11.72 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.378 -0.826 . . . . 0.0 109.467 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.49 ' CE1' HG13 ' A' ' 100' ' ' ILE . 29.9 t80 -49.8 -25.28 2.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.115 -0.991 . . . . 0.0 109.638 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.424 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 15.7 ttt180 -67.05 -59.33 3.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.51 -0.744 . . . . 0.0 110.464 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 88' ' ' ALA . 34.7 m -61.52 -31.66 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.208 -0.933 . . . . 0.0 110.583 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.821 ' CE1' HG11 ' A' ' 108' ' ' VAL . 31.1 m-85 -78.7 -15.96 57.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.084 -1.01 . . . . 0.0 110.663 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -114.61 73.21 0.82 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.965 -1.084 . . . . 0.0 110.463 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -99.42 54.91 0.97 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.259 -0.9 . . . . 0.0 110.761 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.3 p30 -140.04 -37.02 0.48 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.077 -1.014 . . . . 0.0 110.615 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.478 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 107.8 42.9 1.38 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.501 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 45.2 p-10 -135.46 -18.59 1.7 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.057 -1.261 . . . . 0.0 111.477 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.481 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 80.42 42.02 10.86 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.501 ' HB2' ' ND2' ' A' ' 97' ' ' ASN . 68.5 m-85 -152.33 145.39 24.55 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.335 -1.097 . . . . 0.0 110.093 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.49 HG13 ' CE1' ' A' ' 89' ' ' PHE . 31.9 mt -96.69 130.67 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.199 -0.938 . . . . 0.0 110.427 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.8 t -117.25 166.94 11.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.38 -0.825 . . . . 0.0 109.858 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.61 -32.21 73.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.181 -0.949 . . . . 0.0 110.678 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.6 -52.14 34.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.117 -0.99 . . . . 0.0 110.442 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.641 ' O ' HG23 ' A' ' 108' ' ' VAL . 53.8 mt-10 -60.19 -40.18 89.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.275 -0.89 . . . . 0.0 110.755 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.056 HD23 HG13 ' A' ' 121' ' ' VAL . 6.7 tp -64.09 -36.82 85.28 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.087 -1.008 . . . . 0.0 110.541 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 106' ' ' ARG . 1.6 ttp-105 -66.65 -39.25 88.13 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.099 -1.001 . . . . 0.0 110.293 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -73.48 -22.81 60.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 0.0 110.384 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.821 HG11 ' CE1' ' A' ' 92' ' ' PHE . 77.0 t -82.15 -32.83 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.336 -0.853 . . . . 0.0 110.487 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.408 ' HG2' ' O ' ' A' ' 105' ' ' LEU . 24.1 mmt -66.8 -28.78 68.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.129 -0.982 . . . . 0.0 110.272 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.4 p -63.3 -54.04 43.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.189 -0.945 . . . . 0.0 110.013 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -61.35 -40.38 94.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.253 -0.904 . . . . 0.0 110.153 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.7 mt -54.34 -30.24 50.78 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.188 -0.945 . . . . 0.0 110.232 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.39 26.0 7.11 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.49 ' O ' HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -127.35 107.4 9.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.272 -1.134 . . . . 0.0 110.041 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -86.09 109.23 18.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.915 . . . . 0.0 110.548 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.49 HD12 ' O ' ' A' ' 114' ' ' GLU . 1.6 mp -112.71 -169.23 1.44 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.259 -0.901 . . . . 0.0 109.924 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.48 HG22 ' N ' ' A' ' 118' ' ' ASP . 31.1 m -117.57 168.71 10.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.002 -1.061 . . . . 0.0 110.721 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.48 ' N ' HG22 ' A' ' 117' ' ' THR . 26.4 m-20 -59.15 -36.22 74.87 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.4 -0.812 . . . . 0.0 110.295 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -67.0 -36.58 82.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.225 -0.922 . . . . 0.0 110.295 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 124' ' ' MET . 1.7 mt-10 -63.66 -51.72 63.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.38 -0.825 . . . . 0.0 110.361 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 1.056 HG13 HD23 ' A' ' 105' ' ' LEU . 50.3 t -63.42 -58.12 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.165 -0.959 . . . . 0.0 110.395 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -46.57 -43.13 16.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.338 -0.851 . . . . 0.0 110.395 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -67.01 -37.58 84.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.219 -0.925 . . . . 0.0 110.349 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.405 ' HG3' ' O ' ' A' ' 120' ' ' GLU . 90.9 mtp -59.27 -55.11 38.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 110.288 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 35.7 mm -56.16 -39.06 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 110.125 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -58.29 -44.36 88.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 109.952 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -69.01 -24.61 64.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.076 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.45 ' CB ' HG21 ' A' ' 136' ' ' VAL . . . -81.43 -21.48 38.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.174 -0.953 . . . . 0.0 110.074 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -67.76 89.42 0.26 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.314 -0.866 . . . . 0.0 110.427 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 140' ' ' GLU . 47.7 mt -77.04 -29.74 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.791 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.7 p30 -99.37 -26.52 14.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.374 -0.829 . . . . 0.0 110.227 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 96.36 80.29 1.51 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 11.7 p-10 -144.68 -42.01 0.25 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -1.193 . . . . 0.0 110.358 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 126.51 -20.96 6.08 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.45 ' CG ' ' OD2' ' A' ' 133' ' ' ASP . 5.2 pt20 -119.16 158.91 24.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.095 -1.238 . . . . 0.0 110.524 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.45 HG21 ' CB ' ' A' ' 128' ' ' ALA . 59.5 t -119.42 113.14 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.269 -0.895 . . . . 0.0 110.055 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 12.4 p-10 -85.59 -157.98 0.36 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.125 -0.985 . . . . 0.0 110.321 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -68.93 -66.05 0.63 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.087 -1.008 . . . . 0.0 111.406 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -47.87 -47.42 31.74 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.143 -0.973 . . . . 0.0 110.854 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.414 ' HA ' HD12 ' A' ' 130' ' ' ILE . 33.1 mt-10 -66.29 -31.35 72.09 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.078 -1.014 . . . . 0.0 110.56 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' ' 137' ' ' ASN . 15.5 t80 -70.61 -27.48 64.12 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.139 -0.976 . . . . 0.0 109.831 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.427 ' O ' ' CB ' ' A' ' 146' ' ' THR . 53.8 t -90.43 -23.14 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.523 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -83.83 -34.15 24.73 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.218 -0.926 . . . . 0.0 110.929 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.613 ' HE2' ' HE3' ' A' ' 145' ' ' MET . 15.0 ptt? -64.17 -35.33 80.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.013 -1.054 . . . . 0.0 110.21 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.613 ' HE3' ' HE2' ' A' ' 144' ' ' MET . 12.4 mtt -90.19 -36.53 14.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 0.0 109.424 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.427 ' CB ' ' O ' ' A' ' 142' ' ' VAL . 22.7 m . . . . . 0 C--N 1.302 -1.487 0 O-C-N 121.538 -0.726 . . . . 0.0 110.109 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.547 ' OE1' HD12 ' A' ' 9' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.066 0.46 . . . . 0.0 110.584 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -66.16 -51.11 60.97 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.039 -1.038 . . . . 0.0 110.458 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -64.35 -39.53 94.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -0.929 . . . . 0.0 110.083 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.547 HD12 ' OE1' ' A' ' 6' ' ' GLU . 32.5 mt -59.06 -42.69 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.143 -0.973 . . . . 0.0 109.604 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.14 95.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.353 -0.842 . . . . 0.0 109.545 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -60.03 -40.78 90.52 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.333 -0.855 . . . . 0.0 109.654 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -65.13 -31.54 72.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -0.841 . . . . 0.0 109.482 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.63 -50.59 68.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.852 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -60.79 -46.59 89.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.939 . . . . 0.0 109.839 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.505 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -48.82 -55.05 12.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.243 -0.911 . . . . 0.0 109.844 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -52.78 -52.47 56.58 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.399 -0.813 . . . . 0.0 110.347 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.0 m -53.58 -30.18 41.01 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.199 -0.938 . . . . 0.0 110.262 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.68 ' O ' HD23 ' A' ' 18' ' ' LEU . 6.7 tt -70.52 -37.98 74.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.873 . . . . 0.0 110.142 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 1.086 ' CD1' HG11 ' A' ' 35' ' ' VAL . 78.5 m-85 -71.66 -65.24 0.78 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.433 -0.792 . . . . 0.0 110.353 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.444 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -53.74 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.149 -0.969 . . . . 0.0 110.351 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -105.16 51.94 0.75 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.264 -0.898 . . . . 0.0 110.235 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.482 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 23.0 p-10 -169.4 -33.06 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.263 -0.898 . . . . 0.0 110.936 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.73 93.98 2.33 Favored Glycine 0 N--CA 1.498 2.806 0 C-N-CA 119.669 -1.253 . . . . 0.0 110.678 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.43 ' OD2' ' OD2' ' A' ' 22' ' ' ASP . 43.7 m-20 -158.91 -45.83 0.06 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.44 -1.035 . . . . 0.0 110.038 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.88 -9.57 23.33 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.1 p -126.89 156.0 42.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.17 -1.194 . . . . 0.0 110.312 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 56.9 mt -105.42 119.64 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.465 -0.772 . . . . 0.0 110.031 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.3 p -103.21 -162.73 0.93 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.196 -0.94 . . . . 0.0 110.223 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.518 HG21 ' HG2' ' A' ' 49' ' ' GLN . 12.7 p -83.85 -27.99 28.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.162 -0.961 . . . . 0.0 110.609 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 mttp -71.21 -58.68 3.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.174 -0.954 . . . . 0.0 109.954 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.735 ' O ' HG23 ' A' ' 35' ' ' VAL . 49.8 mt-10 -56.52 -42.78 79.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.47 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.89 HD22 HD11 ' A' ' 52' ' ' ILE . 2.6 tp -67.57 -26.82 66.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.246 -0.909 . . . . 0.0 109.766 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.437 ' HA2' ' CD1' ' A' ' 48' ' ' LEU . . . -65.6 -38.69 94.91 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.2 m -83.0 -20.61 34.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -1.115 . . . . 0.0 109.885 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 1.086 HG11 ' CD1' ' A' ' 19' ' ' PHE . 60.4 t -74.4 -34.64 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 109.567 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 9.6 mmt -90.18 -31.66 16.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.431 -0.793 . . . . 0.0 109.636 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.2 tpt85 -78.99 -20.99 47.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.453 -0.779 . . . . 0.0 110.135 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.1 m -106.61 -6.52 17.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.336 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.6 tp -166.05 94.13 0.55 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.128 -0.983 . . . . 0.0 110.271 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.99 -103.79 0.32 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -123.45 -159.32 0.84 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -1.114 . . . . 0.0 110.288 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -130.87 60.35 52.48 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.239 -0.913 . . . . 0.0 110.06 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.5 -165.48 0.17 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.819 1.431 . . . . 0.0 110.156 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.584 HG22 ' H ' ' A' ' 45' ' ' GLU . 5.9 m -125.39 -179.76 4.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.236 -0.915 . . . . 0.0 109.786 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.584 ' H ' HG22 ' A' ' 44' ' ' THR . 4.1 tp10 -69.04 -50.89 44.49 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.087 -1.008 . . . . 0.0 109.627 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.46 -57.15 11.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.196 -0.94 . . . . 0.0 109.876 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 3.4 tp10 -50.84 -39.74 54.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.915 . . . . 0.0 109.64 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.536 ' CG ' HD23 ' A' ' 32' ' ' LEU . 9.0 tt -54.79 -47.59 73.78 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.312 -0.868 . . . . 0.0 109.311 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.518 ' HG2' HG21 ' A' ' 29' ' ' THR . 1.6 mt-30 -54.32 -44.4 72.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.78 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 47' ' ' GLU . 1.6 m-20 -51.31 -43.9 61.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 109.536 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.445 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 54.6 mtp -64.01 -34.85 78.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.202 -0.936 . . . . 0.0 109.794 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.89 HD11 HD22 ' A' ' 32' ' ' LEU . 28.0 mm -64.72 -27.97 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.299 -0.876 . . . . 0.0 110.063 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -68.06 -38.34 82.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.334 -0.854 . . . . 0.0 110.407 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.589 ' HG3' HG23 ' A' ' 55' ' ' VAL . 16.7 pt-20 -82.32 -10.49 59.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.084 -1.01 . . . . 0.0 110.154 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.589 HG23 ' HG3' ' A' ' 54' ' ' GLU . 69.9 t -104.97 -9.99 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.189 -0.944 . . . . 0.0 110.155 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -98.52 102.43 14.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.115 -0.991 . . . . 0.0 110.299 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.54 -11.12 21.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.193 -0.942 . . . . 0.0 110.538 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -69.99 -59.48 2.89 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.111 -0.993 . . . . 0.0 110.15 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 131.75 -13.7 5.3 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -76.64 -42.12 43.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.053 -1.263 . . . . 0.0 110.106 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.17 -63.63 0.6 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 57.0 p -76.67 167.28 22.11 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.243 -1.151 . . . . 0.0 110.47 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.5 HG23 ' OE1' ' A' ' 67' ' ' GLU . 74.2 mt -96.19 152.29 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.208 -0.933 . . . . 0.0 109.98 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.404 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 22.7 m-20 -114.18 -157.58 0.63 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.905 . . . . 0.0 110.472 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.563 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 7.6 t80 -84.79 -42.63 0.69 Allowed Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.414 -0.804 . . . . 0.0 111.526 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.6 Cg_endo -73.52 -24.1 16.52 Favored 'Trans proline' 0 N--CA 1.481 0.786 0 O-C-N 122.994 0.997 . . . . 0.0 110.776 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.5 ' OE1' HG23 ' A' ' 63' ' ' ILE . 31.2 tt0 -79.24 -31.36 43.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.138 -0.976 . . . . 0.0 108.97 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.479 ' CE1' ' SD ' ' A' ' 72' ' ' MET . 16.4 t80 -70.68 -45.21 65.44 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.788 -0.57 . . . . 0.0 110.165 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.453 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 34.5 tp -75.75 -25.03 56.17 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.263 -0.898 . . . . 0.0 110.533 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 53.4 m -84.97 -18.22 35.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.091 -1.005 . . . . 0.0 110.567 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.7 tmm? -90.7 -38.19 13.23 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.045 -1.035 . . . . 0.0 110.876 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.479 ' SD ' ' CE1' ' A' ' 68' ' ' PHE . 66.5 mtt -90.0 -14.03 34.83 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.061 -1.024 . . . . 0.0 111.04 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.495 1.805 0 O-C-N 121.02 -1.05 . . . . 0.0 110.781 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.173 0.511 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.412 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 16.7 mt -47.91 -35.2 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.15 -0.969 . . . . 0.0 110.216 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -55.15 -54.54 42.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.179 -0.951 . . . . 0.0 109.712 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 55.5 mt-10 -54.62 -39.92 68.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.24 -0.912 . . . . 0.0 110.147 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.649 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -56.19 -56.24 23.36 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.269 -0.894 . . . . 0.0 110.107 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -48.27 -40.16 23.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.141 -0.975 . . . . 0.0 110.23 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 45.6 mtt-85 -61.42 -41.24 96.85 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.266 -0.896 . . . . 0.0 110.829 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.649 HG22 ' O ' ' A' ' 88' ' ' ALA . 29.5 m -83.24 -10.13 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.936 -1.103 . . . . 0.0 110.783 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.95 ' CE1' HG11 ' A' ' 108' ' ' VAL . 35.6 m-85 -105.32 -1.77 24.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.116 -0.99 . . . . 0.0 110.695 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -135.67 73.77 1.48 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.06 -1.025 . . . . 0.0 110.257 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -78.05 -24.63 47.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.237 -0.914 . . . . 0.0 110.545 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.5 p30 -70.16 -28.99 65.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.315 -0.865 . . . . 0.0 110.402 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.454 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 77.93 61.45 2.53 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.438 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 16.6 p-10 -125.24 -34.94 2.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.257 -1.143 . . . . 0.0 110.432 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.432 ' C ' ' CG ' ' A' ' 99' ' ' TYR . . . 108.06 16.71 11.94 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.779 -1.201 . . . . 0.0 110.374 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.432 ' CG ' ' C ' ' A' ' 98' ' ' GLY . 35.4 m-85 -147.48 134.57 20.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.985 -1.303 . . . . 0.0 110.002 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.497 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 17.9 mt -90.48 120.61 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.809 -1.182 . . . . 0.0 109.664 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.8 t -96.9 171.69 8.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.402 -0.812 . . . . 0.0 110.056 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.01 -46.84 61.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.87 . . . . 0.0 110.284 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.05 -55.15 22.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.298 -0.876 . . . . 0.0 110.439 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.615 ' O ' HG23 ' A' ' 108' ' ' VAL . 57.1 mt-10 -55.42 -50.06 70.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.259 -0.9 . . . . 0.0 110.613 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.683 ' O ' HD23 ' A' ' 105' ' ' LEU . 3.2 tt -49.92 -34.19 19.71 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.199 -0.938 . . . . 0.0 110.431 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.852 ' O ' HG23 ' A' ' 110' ' ' THR . 54.9 ttp180 -74.25 -36.76 63.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.153 -0.967 . . . . 0.0 110.001 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -74.49 -15.4 60.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.852 . . . . 0.0 110.075 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.95 HG11 ' CE1' ' A' ' 92' ' ' PHE . 77.1 t -85.91 -47.93 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.247 -0.908 . . . . 0.0 110.132 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.467 ' HG3' HD13 ' A' ' 116' ' ' LEU . 25.5 mmt -61.48 -32.72 72.74 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.965 . . . . 0.0 109.974 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.852 HG23 ' O ' ' A' ' 106' ' ' ARG . 66.7 p -59.93 -30.43 69.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.164 -0.96 . . . . 0.0 109.238 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -85.79 -31.08 22.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.555 -0.716 . . . . 0.0 109.974 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 77.5 mt -87.47 16.49 5.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 110.093 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 61.91 83.27 0.07 OUTLIER Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.49 ' HB3' HD12 ' A' ' 116' ' ' LEU . 1.3 mm-40 -158.31 133.42 8.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.187 -1.184 . . . . 0.0 110.464 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -95.38 104.19 16.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 110.028 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.49 HD12 ' HB3' ' A' ' 114' ' ' GLU . 1.7 mt -136.06 117.43 14.66 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.278 -0.888 . . . . 0.0 110.504 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.507 HG22 ' N ' ' A' ' 118' ' ' ASP . 38.2 m -71.44 172.81 8.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.314 -0.866 . . . . 0.0 109.91 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.507 ' N ' HG22 ' A' ' 117' ' ' THR . 4.6 m-20 -62.13 -31.8 72.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 110.222 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -69.59 -48.71 59.25 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.247 -0.908 . . . . 0.0 110.205 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.408 ' HB3' HD23 ' A' ' 116' ' ' LEU . 42.8 mt-10 -57.37 -50.81 71.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.127 -0.983 . . . . 0.0 109.935 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.402 HG13 ' HB3' ' A' ' 105' ' ' LEU . 89.3 t -55.35 -49.56 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.401 -0.812 . . . . 0.0 110.177 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.435 ' OD1' ' HD2' ' A' ' 126' ' ' ARG . 8.5 t70 -57.42 -31.87 66.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 110.066 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -70.05 -32.0 69.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.201 -0.937 . . . . 0.0 109.911 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 84.8 mtp -67.9 -44.71 76.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.31 -0.869 . . . . 0.0 109.646 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.464 HD11 HD12 ' A' ' 105' ' ' LEU . 30.1 mm -62.51 -37.57 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.412 -0.805 . . . . 0.0 110.345 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.435 ' HD2' ' OD1' ' A' ' 122' ' ' ASP . 65.8 mtp180 -70.4 -37.05 74.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.24 -0.913 . . . . 0.0 110.252 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -71.39 -27.26 63.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.185 -0.947 . . . . 0.0 109.895 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.66 -27.29 29.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.38 -0.825 . . . . 0.0 109.992 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.403 ' OD1' ' OD1' ' A' ' 131' ' ' ASP . 11.9 t0 -65.15 94.73 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.0 110.008 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 140' ' ' GLU . 68.7 mt -67.8 -31.42 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.225 -0.922 . . . . 0.0 110.231 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 19.5 p30 -100.84 -17.41 16.89 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.263 -0.898 . . . . 0.0 110.355 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 69.84 62.56 3.75 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.411 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 82.2 m-20 -101.56 -41.29 6.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.091 -1.241 . . . . 0.0 110.109 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.26 -22.06 1.09 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.57 162.75 34.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -1.148 . . . . 0.0 110.032 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 41.0 t -88.92 143.99 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.211 -0.93 . . . . 0.0 110.504 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -112.26 151.67 29.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 109.806 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.419 ' O ' HG23 ' A' ' 142' ' ' VAL . 55.4 t80 -46.18 -37.15 6.68 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.194 -0.941 . . . . 0.0 110.459 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -72.15 -45.25 61.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.232 -0.917 . . . . 0.0 110.495 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' A' ' 144' ' ' MET . 55.7 mt-10 -62.24 -23.31 66.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.127 -0.983 . . . . 0.0 110.438 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.56 ' CD1' ' CE ' ' A' ' 144' ' ' MET . 23.2 t80 -81.21 -39.78 24.87 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.321 -0.862 . . . . 0.0 110.544 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 138' ' ' TYR . 65.6 t -73.98 -21.83 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.239 -0.913 . . . . 0.0 110.564 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 68.9 mm-40 -88.27 -40.17 13.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.167 -0.958 . . . . 0.0 111.051 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.56 ' CE ' ' CD1' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -72.24 -20.47 61.54 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.865 -1.147 . . . . 0.0 110.943 -179.229 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.485 ' N ' ' HG3' ' A' ' 144' ' ' MET . 19.7 ttm -90.43 -68.07 0.81 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.098 -1.001 . . . . 0.0 110.547 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.099 -1.0 . . . . 0.0 110.283 -179.866 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.139 0.495 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -74.52 -40.49 61.73 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.451 -0.78 . . . . 0.0 110.701 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.417 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 54.0 mt-30 -67.66 -51.59 47.98 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.144 -0.972 . . . . 0.0 110.329 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.0 mt -57.72 -48.99 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.075 -1.016 . . . . 0.0 109.522 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.3 -32.11 68.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 109.74 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 37.0 tt0 -59.81 -51.19 70.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.914 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -58.66 -34.11 70.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.291 -0.881 . . . . 0.0 109.662 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.6 -46.73 86.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.377 -0.827 . . . . 0.0 110.466 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -59.49 -45.69 90.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.226 -0.921 . . . . 0.0 110.451 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.415 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -60.15 -41.55 92.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.957 . . . . 0.0 110.1 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -58.52 -56.21 25.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.276 -0.89 . . . . 0.0 110.141 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.2 m -53.36 -29.17 32.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.149 -0.969 . . . . 0.0 109.668 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.7 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.8 tt -66.43 -41.2 89.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.39 -0.819 . . . . 0.0 109.782 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.616 ' CD1' HG11 ' A' ' 35' ' ' VAL . 27.7 m-85 -77.61 -64.81 1.06 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.319 -0.863 . . . . 0.0 110.338 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.408 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 55.7 t0 -49.23 106.04 0.1 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.285 -0.884 . . . . 0.0 110.383 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -110.35 15.19 22.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.187 -0.946 . . . . 0.0 111.014 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.407 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 9.3 p-10 -126.19 -42.81 1.83 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.012 -1.055 . . . . 0.0 110.423 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.69 19.69 6.01 Favored Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.513 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.407 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 57.1 p-10 -91.39 -8.1 48.89 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.965 -1.314 . . . . 0.0 110.537 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.655 ' O ' HG23 ' A' ' 26' ' ' THR . . . 70.85 42.37 60.92 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.655 HG23 ' O ' ' A' ' 25' ' ' GLY . 9.3 p -158.34 148.8 20.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.242 -1.152 . . . . 0.0 109.943 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.6 mt -108.81 105.36 18.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.182 -0.949 . . . . 0.0 109.937 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.922 ' HA ' HG22 ' A' ' 62' ' ' THR . 3.5 m -96.65 -175.74 3.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.413 -0.804 . . . . 0.0 109.747 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.646 ' H ' HG22 ' A' ' 28' ' ' THR . 23.5 p -72.1 -29.32 63.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.0 110.539 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -65.4 -62.06 1.75 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 0.0 110.366 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.72 ' O ' HG23 ' A' ' 35' ' ' VAL . 49.5 mt-10 -57.12 -44.92 83.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.272 -0.893 . . . . 0.0 110.05 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.597 HD22 HD11 ' A' ' 52' ' ' ILE . 2.9 tp -63.85 -25.18 68.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -0.904 . . . . 0.0 109.665 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.14 -46.73 69.41 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.44 ' O ' ' CB ' ' A' ' 38' ' ' SER . 87.1 m -72.69 -21.77 61.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.311 -1.111 . . . . 0.0 109.498 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 31' ' ' GLU . 58.0 t -71.14 -42.45 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.431 -0.793 . . . . 0.0 109.811 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 26.0 mmt -75.46 -30.03 59.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 110.457 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -88.47 -9.38 52.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.156 -0.965 . . . . 0.0 110.301 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 34' ' ' THR . 47.7 t -101.09 8.84 42.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.09 -1.006 . . . . 0.0 110.542 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.9 mt -127.68 -81.37 0.6 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.139 -0.976 . . . . 0.0 110.207 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.48 36.73 0.59 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.46 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.2 mp0 -140.09 171.92 13.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.504 -0.998 . . . . 0.0 109.851 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.503 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -155.87 52.55 0.68 Allowed Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.023 -1.048 . . . . 0.0 111.048 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.478 ' HD3' ' N ' ' A' ' 42' ' ' ASN . 50.0 Cg_endo -77.68 160.81 31.19 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.671 1.353 . . . . 0.0 110.229 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.0 p -92.45 -142.22 0.2 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.276 -0.89 . . . . 0.0 109.883 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -105.59 -32.22 8.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.937 -1.102 . . . . 0.0 110.053 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.96 -67.7 0.54 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -0.938 . . . . 0.0 109.655 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -49.83 -38.7 36.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 109.441 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.497 HD11 HD23 ' A' ' 32' ' ' LEU . 6.4 tt -57.07 -48.88 77.48 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.45 -0.781 . . . . 0.0 109.342 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -51.51 -42.07 61.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.434 -0.791 . . . . 0.0 109.551 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.39 -42.78 99.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.871 . . . . 0.0 109.816 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.441 ' HA ' ' OE2' ' A' ' 54' ' ' GLU . 18.5 ttp -62.3 -19.8 63.66 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.283 -0.885 . . . . 0.0 109.353 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.597 HD11 HD22 ' A' ' 32' ' ' LEU . 25.4 mt -89.18 -24.52 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.426 -0.796 . . . . 0.0 109.887 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -67.97 -35.3 78.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.302 -0.874 . . . . 0.0 110.154 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.444 ' HG3' HG23 ' A' ' 55' ' ' VAL . 17.2 pt-20 -73.73 -33.75 64.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.224 -0.922 . . . . 0.0 110.04 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.444 HG23 ' HG3' ' A' ' 54' ' ' GLU . 99.9 t -77.1 -68.78 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.285 -0.885 . . . . 0.0 109.806 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.411 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 64.1 t0 -47.0 125.72 7.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.276 -0.89 . . . . 0.0 110.051 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.67 28.78 5.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.217 -0.927 . . . . 0.0 110.206 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.443 ' HB2' ' OD1' ' A' ' 60' ' ' ASN . 40.5 m-20 -122.76 -62.08 1.39 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.405 -0.809 . . . . 0.0 110.05 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.82 36.16 0.6 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.443 ' OD1' ' HB2' ' A' ' 58' ' ' ASP . 6.8 m120 -103.85 -40.67 6.15 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.176 -1.19 . . . . 0.0 110.107 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.413 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 123.87 -14.79 7.97 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.922 HG22 ' HA ' ' A' ' 28' ' ' THR . 75.2 p -130.97 164.47 25.28 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.147 -1.208 . . . . 0.0 110.446 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 80.1 mt -110.21 122.15 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.246 -0.909 . . . . 0.0 110.237 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.447 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 55.0 m-20 -81.38 -168.32 1.81 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.307 -0.871 . . . . 0.0 110.399 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.547 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 42.4 t80 -72.99 -42.46 7.31 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 111.246 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.8 Cg_endo -75.76 -28.19 8.18 Favored 'Trans proline' 0 C--N 1.325 -0.703 0 O-C-N 123.035 1.018 . . . . 0.0 109.821 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.413 ' OE1' ' OD2' ' A' ' 58' ' ' ASP . 40.7 tt0 -73.52 -24.03 60.1 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.446 ' O ' ' HG2' ' A' ' 71' ' ' MET . 10.3 t80 -84.73 -43.01 14.68 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.429 0.633 . . . . 0.0 110.145 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.627 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 3.7 tt -72.3 -18.28 61.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.193 -0.942 . . . . 0.0 110.128 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.5 m -90.3 -43.04 10.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.125 -0.984 . . . . 0.0 110.493 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.488 ' HG3' ' N ' ' A' ' 72' ' ' MET . 6.5 ptt? -64.09 -40.99 97.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.145 -0.972 . . . . 0.0 110.518 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.488 ' N ' ' HG3' ' A' ' 71' ' ' MET . 32.7 mtt -84.32 -9.66 58.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.099 -1.001 . . . . 0.0 110.683 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.627 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.495 1.798 0 O-C-N 121.024 -1.047 . . . . 0.0 110.618 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 121.147 0.499 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.7 mt -68.0 -59.39 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.252 -0.905 . . . . 0.0 110.388 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.4 ttm-85 -53.02 -43.5 66.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.059 -1.025 . . . . 0.0 109.448 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -54.61 -43.83 72.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.361 -0.837 . . . . 0.0 109.629 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 92' ' ' PHE . . . -58.47 -37.73 76.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.35 -0.843 . . . . 0.0 109.667 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -65.03 -28.93 69.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.063 -1.023 . . . . 0.0 109.897 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -70.45 -58.95 3.16 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.494 -0.754 . . . . 0.0 111.118 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.557 HG23 ' N ' ' A' ' 92' ' ' PHE . 30.1 m -62.94 -43.33 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.14 -0.975 . . . . 0.0 110.981 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.695 ' HA ' HG21 ' A' ' 108' ' ' VAL . 18.0 m-85 -69.72 -22.42 63.4 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.973 -1.08 . . . . 0.0 110.263 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.409 ' OD2' ' O ' ' A' ' 99' ' ' TYR . 11.9 t70 -147.28 81.96 1.54 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.963 . . . . 0.0 110.483 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.6 pttt -109.68 47.43 0.94 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.355 -0.841 . . . . 0.0 109.907 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 1.8 p30 -115.31 -31.69 5.88 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.273 -0.892 . . . . 0.0 110.618 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.46 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 138.33 -54.09 0.7 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.279 -1.438 . . . . 0.0 110.959 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -48.77 -34.46 12.29 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 120.947 -1.325 . . . . 0.0 110.846 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.469 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 80.28 33.01 33.27 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.963 -1.113 . . . . 0.0 110.406 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.483 ' HB3' ' CB ' ' A' ' 135' ' ' GLN . 20.7 m-85 -130.2 127.58 39.95 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.951 -1.323 . . . . 0.0 109.884 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.647 HD13 ' CE1' ' A' ' 141' ' ' PHE . 8.8 mt -76.01 110.39 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.962 -1.086 . . . . 0.0 110.167 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.1 t -93.6 165.59 12.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.065 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.51 -41.39 96.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.291 -0.88 . . . . 0.0 110.341 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.4 -53.36 49.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.186 -0.946 . . . . 0.0 110.037 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.427 ' O ' HG23 ' A' ' 108' ' ' VAL . 51.0 mt-10 -51.75 -37.73 52.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.426 -0.796 . . . . 0.0 110.103 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.0 tt -69.36 -35.2 75.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.4 -0.813 . . . . 0.0 110.121 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.785 ' O ' HG23 ' A' ' 110' ' ' THR . 58.0 ttp180 -66.36 -26.69 67.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.483 -0.76 . . . . 0.0 110.254 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -85.01 -31.54 23.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.281 -0.887 . . . . 0.0 110.514 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.695 HG21 ' HA ' ' A' ' 92' ' ' PHE . 98.2 t -76.37 -30.94 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.166 -0.959 . . . . 0.0 110.452 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.4 mmt -75.99 -26.57 56.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.104 -0.998 . . . . 0.0 110.18 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.785 HG23 ' O ' ' A' ' 106' ' ' ARG . 45.4 p -68.67 -40.61 80.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.27 -0.894 . . . . 0.0 110.146 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -80.01 -41.54 25.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.195 -0.94 . . . . 0.0 110.045 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.444 ' HA ' HD23 ' A' ' 112' ' ' LEU . 9.2 mt -47.63 -25.47 1.18 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.255 -0.903 . . . . 0.0 110.204 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.44 20.8 8.34 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -123.19 110.0 14.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.23 -1.159 . . . . 0.0 110.3 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.95 107.25 9.16 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.341 -0.85 . . . . 0.0 110.285 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.9 -174.85 2.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.184 -0.947 . . . . 0.0 110.19 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 118' ' ' ASP . 30.5 m -136.8 166.65 23.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 110.209 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.425 ' N ' HG22 ' A' ' 117' ' ' THR . 22.5 m-20 -55.07 -33.22 62.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -0.94 . . . . 0.0 110.359 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.18 -47.24 80.57 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.328 -0.857 . . . . 0.0 110.784 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -65.4 -58.39 5.98 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.118 -0.989 . . . . 0.0 110.613 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.2 t -49.64 -41.24 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.145 -0.972 . . . . 0.0 110.395 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -64.39 -39.08 93.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.167 -0.958 . . . . 0.0 110.163 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -66.91 -30.06 70.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.223 -0.923 . . . . 0.0 110.152 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 78.7 mtp -75.83 -62.99 1.41 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.178 -0.951 . . . . 0.0 110.66 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 26.0 mm -52.05 -29.23 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.156 -0.965 . . . . 0.0 110.67 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.1 mtp85 -71.75 -56.87 4.98 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.051 -1.031 . . . . 0.0 110.349 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -69.45 -8.28 45.4 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.197 -0.939 . . . . 0.0 110.361 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -98.83 -24.66 14.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -0.919 . . . . 0.0 110.104 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -83.51 83.65 7.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.075 -1.016 . . . . 0.0 109.915 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.519 HD12 ' HG2' ' A' ' 140' ' ' GLU . 18.5 mt -45.41 -69.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.33 -0.856 . . . . 0.0 110.688 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.8 p30 -60.91 -24.41 65.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.221 -0.924 . . . . 0.0 110.366 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.421 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 62.51 62.64 5.37 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -106.61 -31.51 8.45 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.24 -1.153 . . . . 0.0 110.205 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 161.96 -49.11 0.34 Allowed Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.13 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.483 ' CB ' ' HB3' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -123.42 170.43 10.36 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.033 -1.274 . . . . 0.0 110.107 -179.363 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.4 t -105.97 97.8 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.379 -0.826 . . . . 0.0 110.002 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.409 ' OD1' ' HB3' ' A' ' 139' ' ' GLU . 9.8 p30 -70.19 179.43 2.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.332 -0.855 . . . . 0.0 110.355 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.441 ' O ' HG23 ' A' ' 142' ' ' VAL . 18.9 t80 -61.65 -41.43 97.5 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.311 -0.868 . . . . 0.0 111.268 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.409 ' HB3' ' OD1' ' A' ' 137' ' ' ASN . 25.2 tt0 -53.15 -52.17 59.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.028 -1.045 . . . . 0.0 110.199 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.519 ' HG2' HD12 ' A' ' 130' ' ' ILE . 55.0 mt-10 -67.4 -21.25 65.6 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.275 -0.891 . . . . 0.0 109.879 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.647 ' CE1' HD13 ' A' ' 100' ' ' ILE . 1.9 t80 -77.54 -23.33 50.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.359 -0.838 . . . . 0.0 110.414 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 138' ' ' TYR . 80.4 t -88.43 -23.05 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.197 -0.939 . . . . 0.0 110.511 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -91.65 -39.02 12.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.296 -0.877 . . . . 0.0 110.799 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.496 ' HE3' ' HG3' ' A' ' 145' ' ' MET . 0.0 OUTLIER -67.44 -17.75 64.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.981 -1.074 . . . . 0.0 110.358 -179.651 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.496 ' HG3' ' HE3' ' A' ' 144' ' ' MET . 52.2 mtt -88.13 -55.06 3.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.118 -0.989 . . . . 0.0 109.887 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 146' ' ' THR . 2.7 t . . . . . 0 N--CA 1.495 1.788 0 O-C-N 121.508 -0.745 . . . . 0.0 110.069 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.336 0.588 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -77.22 -33.03 56.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.402 -0.812 . . . . 0.0 109.457 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -67.57 -59.13 3.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.448 -0.782 . . . . 0.0 110.285 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.4 mt -59.71 -34.72 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 109.587 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.28 -32.38 73.96 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.267 -0.896 . . . . 0.0 108.988 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -66.91 -51.75 51.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.459 -0.775 . . . . 0.0 109.426 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -59.46 -29.99 68.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.618 -0.676 . . . . 0.0 109.751 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -66.26 -55.99 13.44 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.4 -0.812 . . . . 0.0 110.191 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -51.01 -38.25 50.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.16 -0.962 . . . . 0.0 109.969 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.514 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -62.13 -54.31 42.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.026 -1.046 . . . . 0.0 109.886 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.453 ' CE1' HD11 ' A' ' 27' ' ' ILE . 18.5 t80 -56.7 -26.9 57.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.294 -0.879 . . . . 0.0 110.687 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.0 p -75.98 -35.06 59.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.179 -0.95 . . . . 0.0 109.888 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.642 ' O ' HD23 ' A' ' 18' ' ' LEU . 3.1 tt -69.51 -26.8 64.71 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.313 -0.867 . . . . 0.0 109.644 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.645 ' CD1' HG11 ' A' ' 35' ' ' VAL . 30.4 m-85 -86.08 -69.19 0.68 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.375 -0.828 . . . . 0.0 109.938 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -56.18 105.07 0.17 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.312 -0.868 . . . . 0.0 110.283 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -105.75 -38.06 6.51 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.312 -0.867 . . . . 0.0 110.665 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -70.27 -26.11 63.67 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.141 -0.975 . . . . 0.0 110.505 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.89 106.44 0.83 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 7.7 p-10 -169.64 -39.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -1.177 . . . . 0.0 110.263 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.72 12.57 12.59 Favored Glycine 0 N--CA 1.495 2.632 0 C-N-CA 119.93 -1.129 . . . . 0.0 110.37 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 54.8 p -139.96 164.97 28.59 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.044 -1.269 . . . . 0.0 110.267 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.468 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 40.8 mt -123.47 120.56 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.135 -0.978 . . . . 0.0 110.191 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.613 HG22 ' H ' ' A' ' 29' ' ' THR . 5.2 m -113.75 -179.08 3.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.35 -0.844 . . . . 0.0 110.292 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.613 ' H ' HG22 ' A' ' 28' ' ' THR . 56.1 p -68.84 -27.49 65.88 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.267 -0.896 . . . . 0.0 110.754 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.3 mtmm -66.31 -61.34 2.06 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.059 -1.026 . . . . 0.0 109.929 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -60.91 -58.83 6.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.056 -1.028 . . . . 0.0 109.541 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.991 HD23 HD11 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -52.1 -26.73 11.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 109.708 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.44 -52.42 46.69 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 97.2 m -65.77 -23.99 66.84 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.203 -1.174 . . . . 0.0 109.879 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.645 HG11 ' CD1' ' A' ' 19' ' ' PHE . 46.5 t -66.34 -42.83 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.442 -0.786 . . . . 0.0 109.904 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.466 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 61.5 mtt -89.17 -11.63 43.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.376 -0.828 . . . . 0.0 110.379 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -89.85 -21.24 22.65 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.163 -0.961 . . . . 0.0 110.186 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.9 m -109.52 -22.51 11.95 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.197 -0.939 . . . . 0.0 110.432 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.46 66.1 1.08 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.147 -0.971 . . . . 0.0 110.637 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.02 51.64 0.16 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -48.08 102.26 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.236 -1.155 . . . . 0.0 110.304 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.523 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 2.4 t30 -156.67 -65.93 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.885 . . . . 0.0 110.234 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.523 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 46.3 Cg_endo -72.23 170.42 19.16 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.316 1.166 . . . . 0.0 110.311 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.5 HG23 ' N ' ' A' ' 45' ' ' GLU . 10.8 t -119.39 -149.09 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.623 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.5 ' N ' HG23 ' A' ' 44' ' ' THR . 22.0 tt0 -95.81 -31.84 12.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.831 -1.168 . . . . 0.0 110.115 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.481 ' H ' HG23 ' A' ' 44' ' ' THR . . . -74.64 -67.65 0.61 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.23 -0.919 . . . . 0.0 110.089 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -49.0 -31.55 7.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.135 -0.978 . . . . 0.0 109.744 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.991 HD11 HD23 ' A' ' 32' ' ' LEU . 9.1 tt -63.96 -51.7 63.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.92 . . . . 0.0 109.209 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.7 tm0? -49.5 -41.47 40.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.459 -0.776 . . . . 0.0 109.605 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -64.71 -39.46 93.69 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.36 -0.837 . . . . 0.0 109.709 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.452 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 25.4 ttp -70.27 -13.18 62.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.158 -0.963 . . . . 0.0 109.85 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.978 HD11 HD22 ' A' ' 32' ' ' LEU . 29.7 mm -84.75 -35.31 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.218 -0.926 . . . . 0.0 109.537 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -60.7 -39.88 90.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.463 -0.773 . . . . 0.0 110.504 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.473 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 12.3 pt-20 -69.39 -35.95 76.3 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.128 -0.983 . . . . 0.0 110.596 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.641 HG11 HD11 ' A' ' 63' ' ' ILE . 79.6 t -71.39 -28.39 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.064 -1.023 . . . . 0.0 110.062 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -96.8 117.3 30.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.37 -0.832 . . . . 0.0 110.448 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.06 25.95 10.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -0.843 . . . . 0.0 109.773 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -106.61 -68.13 0.9 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.485 -0.759 . . . . 0.0 110.167 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.38 -14.27 2.06 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.421 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 27.7 p-10 -69.78 -14.11 62.61 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.15 -1.206 . . . . 0.0 110.287 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.642 ' O ' HG23 ' A' ' 62' ' ' THR . . . 79.24 23.86 62.42 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.011 -1.09 . . . . 0.0 110.545 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.642 HG23 ' O ' ' A' ' 61' ' ' GLY . 7.1 p -156.44 167.65 29.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.996 -1.296 . . . . 0.0 110.414 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.641 HD11 HG11 ' A' ' 55' ' ' VAL . 82.9 mt -108.31 169.74 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.182 -0.949 . . . . 0.0 110.596 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.546 ' N ' HG22 ' A' ' 63' ' ' ILE . 46.7 m-20 -131.44 -163.02 1.28 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.31 -0.869 . . . . 0.0 109.848 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.562 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 40.1 t80 -82.51 -43.26 0.95 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.068 -1.02 . . . . 0.0 111.357 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 47.2 Cg_endo -73.15 -28.53 12.62 Favored 'Trans proline' 0 N--CA 1.48 0.68 0 O-C-N 123.091 1.048 . . . . 0.0 110.304 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -78.34 -23.73 46.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.105 -0.997 . . . . 0.0 109.225 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.456 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 24.3 t80 -75.91 -48.64 20.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.624 -0.672 . . . . 0.0 110.201 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.589 ' O ' HD23 ' A' ' 69' ' ' LEU . 2.8 tt -75.71 -21.49 57.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.353 -0.842 . . . . 0.0 110.349 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.7 m -89.57 -21.86 22.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -0.964 . . . . 0.0 110.713 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.471 ' HG3' ' N ' ' A' ' 72' ' ' MET . 8.1 ptt? -88.86 -36.08 16.2 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.964 -1.085 . . . . 0.0 110.515 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.471 ' N ' ' HG3' ' A' ' 71' ' ' MET . 52.5 mtt -84.72 -23.55 29.26 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.188 -0.945 . . . . 0.0 110.0 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.368 -0.832 . . . . 0.0 110.04 179.827 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.304 0.573 . . . . 0.0 110.361 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 40.7 mt -51.71 -34.93 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.112 -0.993 . . . . 0.0 109.733 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -58.08 -43.89 87.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.944 . . . . 0.0 109.398 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -62.23 -33.59 74.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.424 -0.798 . . . . 0.0 109.784 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.783 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -65.92 -66.48 0.54 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.416 -0.802 . . . . 0.0 109.889 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -49.62 -26.62 3.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.927 . . . . 0.0 110.308 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.412 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 16.0 tpt180 -68.78 -45.23 71.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.148 -0.97 . . . . 0.0 110.255 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.783 HG22 ' O ' ' A' ' 88' ' ' ALA . 34.0 m -76.27 -15.79 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.283 -0.885 . . . . 0.0 110.443 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.757 ' HE2' ' HB1' ' A' ' 88' ' ' ALA . 23.0 m-85 -90.85 -18.38 24.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.132 -0.98 . . . . 0.0 110.491 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -128.82 44.32 2.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.099 -1.001 . . . . 0.0 110.077 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 20.4 ptmt -106.46 47.62 0.87 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 110.403 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.414 ' OD2' ' OE1' ' A' ' 104' ' ' GLU . 2.8 p30 -116.88 -22.57 8.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.237 -0.915 . . . . 0.0 110.043 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.23 29.33 4.03 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -105.78 -71.09 0.76 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.405 -1.056 . . . . 0.0 110.091 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 151.9 -36.48 0.84 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -134.12 169.59 16.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -1.16 . . . . 0.0 110.133 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.5 mt -73.1 131.29 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 109.858 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.425 ' HB3' ' OE2' ' A' ' 104' ' ' GLU . 36.5 t -113.83 172.26 7.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.47 -0.769 . . . . 0.0 110.023 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.455 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -68.65 -48.06 64.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -0.947 . . . . 0.0 110.144 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.89 -52.35 66.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.185 -0.947 . . . . 0.0 110.247 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.721 ' O ' HG23 ' A' ' 108' ' ' VAL . 46.2 mt-10 -48.97 -54.76 14.22 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.376 -0.827 . . . . 0.0 110.577 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 105' ' ' LEU . 5.2 tt -61.25 -30.33 70.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.379 -0.826 . . . . 0.0 110.763 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.528 ' HG3' HG21 ' A' ' 121' ' ' VAL . 17.0 ttp180 -67.24 -38.89 85.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.187 -0.945 . . . . 0.0 110.583 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -84.04 -14.2 51.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 110.472 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 104' ' ' GLU . 71.8 t -84.29 -29.15 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.236 -0.915 . . . . 0.0 110.527 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.598 ' HB3' HD12 ' A' ' 116' ' ' LEU . 26.4 mmt -81.81 -46.65 13.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.946 . . . . 0.0 110.529 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.2 p -50.44 -32.97 19.34 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 110.268 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -86.16 -48.81 8.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.128 -0.982 . . . . 0.0 110.372 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 112' ' ' LEU . 22.6 mt -47.07 -32.46 4.11 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.138 -0.976 . . . . 0.0 110.509 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.48 38.4 0.92 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -119.06 167.4 11.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.341 -1.094 . . . . 0.0 110.069 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -121.41 94.49 4.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.889 . . . . 0.0 110.061 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.598 HD12 ' HB3' ' A' ' 109' ' ' MET . 5.5 mt -128.58 151.94 48.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.281 -0.887 . . . . 0.0 110.228 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.536 HG22 ' N ' ' A' ' 118' ' ' ASP . 91.4 m -99.77 172.39 7.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.868 . . . . 0.0 110.002 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.536 ' N ' HG22 ' A' ' 117' ' ' THR . 1.4 m-20 -56.45 -62.89 1.41 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.242 -0.911 . . . . 0.0 110.636 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -52.54 -41.4 63.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.143 -0.973 . . . . 0.0 110.315 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.435 ' O ' ' HB3' ' A' ' 123' ' ' GLU . 6.4 mm-40 -52.08 -50.63 61.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.118 -0.989 . . . . 0.0 110.017 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.528 HG21 ' HG3' ' A' ' 106' ' ' ARG . 63.8 t -57.54 -43.9 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.16 -0.962 . . . . 0.0 109.821 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -59.58 -28.53 67.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.297 -0.877 . . . . 0.0 109.729 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 24.4 tt0 -73.27 -37.44 66.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.352 -0.842 . . . . 0.0 109.863 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 74.9 mtp -66.4 -39.92 89.3 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.274 -0.891 . . . . 0.0 109.821 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 31.8 mm -69.22 -38.61 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -0.906 . . . . 0.0 110.188 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -62.77 -46.33 88.52 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.257 -0.902 . . . . 0.0 110.228 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -62.47 -38.84 91.41 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.292 -0.88 . . . . 0.0 110.162 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.14 -16.0 61.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -0.861 . . . . 0.0 110.21 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.411 ' OD1' ' OD1' ' A' ' 131' ' ' ASP . 57.7 t0 -87.78 60.95 6.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.365 -0.835 . . . . 0.0 110.129 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.469 HG13 ' N ' ' A' ' 131' ' ' ASP . 18.0 pt -56.02 -42.26 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.435 -0.791 . . . . 0.0 111.409 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.469 ' N ' HG13 ' A' ' 130' ' ' ILE . 47.8 p-10 -72.74 -18.99 61.46 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.037 -1.039 . . . . 0.0 111.125 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.34 72.19 0.88 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.512 ' CG ' ' NE2' ' A' ' 135' ' ' GLN . 33.7 p30 -126.15 -16.99 5.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.406 -1.055 . . . . 0.0 110.873 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.465 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 122.96 -49.89 0.87 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.512 ' NE2' ' CG ' ' A' ' 133' ' ' ASP . 0.5 OUTLIER -119.18 164.7 15.19 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.086 -1.243 . . . . 0.0 110.772 -179.611 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.5 t -102.63 127.0 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.303 -0.873 . . . . 0.0 110.053 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -97.22 -172.12 2.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.953 -1.092 . . . . 0.0 110.459 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -64.4 -62.47 1.58 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.334 -0.854 . . . . 0.0 111.621 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -43.87 -53.53 5.99 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.239 -0.913 . . . . 0.0 111.141 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -56.77 -39.37 73.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.898 -1.126 . . . . 0.0 110.399 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.525 ' CZ ' ' HE1' ' A' ' 145' ' ' MET . 20.2 t80 -66.82 -27.09 67.27 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.391 -0.818 . . . . 0.0 111.133 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 57.6 t -90.06 -20.67 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.024 -1.047 . . . . 0.0 110.77 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -83.81 -30.04 26.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.212 -0.93 . . . . 0.0 110.824 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.47 ' CE ' ' CD1' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -90.01 -13.19 36.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.112 -0.993 . . . . 0.0 110.608 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.525 ' HE1' ' CZ ' ' A' ' 141' ' ' PHE . 30.0 ttm -89.98 -27.99 19.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.913 . . . . 0.0 110.537 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 60.0 p . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.134 -0.979 . . . . 0.0 110.194 179.847 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.586 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.331 0.586 . . . . 0.0 109.931 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -74.24 -66.07 0.77 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.28 -0.888 . . . . 0.0 109.814 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -54.77 -58.75 6.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.23 -0.919 . . . . 0.0 109.997 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 9' ' ' ILE . 28.6 mt -47.73 -49.14 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.124 -0.985 . . . . 0.0 110.062 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 6' ' ' GLU . . . -52.83 -41.6 64.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.275 -0.89 . . . . 0.0 110.2 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -61.0 -41.44 96.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.879 . . . . 0.0 110.132 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -64.06 -30.17 71.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.279 -0.888 . . . . 0.0 109.734 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.478 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 30.1 mtpt -68.99 -38.97 79.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.535 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.31 -45.19 95.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.313 -0.867 . . . . 0.0 109.341 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.85 -44.8 86.77 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.317 -0.865 . . . . 0.0 109.452 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -56.22 -42.15 76.8 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.315 -0.865 . . . . 0.0 109.633 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.4 t -59.1 -42.63 90.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.428 -0.795 . . . . 0.0 109.641 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.582 ' O ' HD23 ' A' ' 18' ' ' LEU . 5.8 tt -59.79 -29.36 68.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.464 -0.772 . . . . 0.0 109.456 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.672 ' HA ' HG21 ' A' ' 35' ' ' VAL . 5.8 m-30 -88.24 -18.29 28.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.464 -0.772 . . . . 0.0 110.043 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -104.17 64.06 0.76 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.397 -0.814 . . . . 0.0 109.35 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.497 ' HE3' ' CG2' ' A' ' 34' ' ' THR . 53.0 mttm -44.73 -52.96 7.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.586 -0.696 . . . . 0.0 111.267 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.417 ' OD2' ' OD2' ' A' ' 24' ' ' ASP . 6.7 p-10 -69.7 -43.22 72.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.906 -1.121 . . . . 0.0 110.017 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.83 51.52 1.64 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 3.5 p30 -105.66 -24.53 12.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.058 -1.26 . . . . 0.0 109.878 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.549 ' C ' HG23 ' A' ' 26' ' ' THR . . . 111.86 30.38 3.02 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.549 HG23 ' C ' ' A' ' 25' ' ' GLY . 57.8 p -153.73 158.26 40.72 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.024 -1.28 . . . . 0.0 110.53 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.0 mt -124.22 109.21 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.317 -0.864 . . . . 0.0 109.934 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.601 HG22 ' CG2' ' A' ' 62' ' ' THR . 68.9 p -95.66 -164.51 1.17 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.239 -0.913 . . . . 0.0 110.301 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.455 HG22 HD12 ' A' ' 52' ' ' ILE . 35.8 p -85.41 -26.13 26.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.246 -0.908 . . . . 0.0 110.206 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.87 -62.8 1.24 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.24 -0.912 . . . . 0.0 110.025 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.74 ' O ' HG23 ' A' ' 35' ' ' VAL . 56.9 mt-10 -57.66 -46.06 84.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.137 -0.977 . . . . 0.0 109.763 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.872 HD22 HD11 ' A' ' 52' ' ' ILE . 0.8 OUTLIER -60.25 -32.04 70.78 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.269 -0.894 . . . . 0.0 109.676 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.54 -50.83 63.31 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.497 ' CG2' ' HE3' ' A' ' 21' ' ' LYS . 63.5 m -70.01 -22.3 63.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.105 -1.232 . . . . 0.0 109.611 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 31' ' ' GLU . 51.4 t -70.21 -32.2 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.472 -0.768 . . . . 0.0 109.55 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.425 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 26.2 mmt -86.97 -22.72 25.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.375 -0.828 . . . . 0.0 109.622 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.4 mmm-85 -68.16 -45.25 74.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 0.0 109.875 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.1 m -94.73 8.73 41.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.308 -0.87 . . . . 0.0 110.296 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -164.09 74.78 0.31 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.102 -0.999 . . . . 0.0 110.19 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.31 -91.49 0.14 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -161.84 -145.37 0.11 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -1.145 . . . . 0.0 110.011 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -121.4 72.06 26.81 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.007 . . . . 0.0 110.299 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -76.18 135.97 17.55 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.874 1.46 . . . . 0.0 110.179 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 72.8 p -73.4 -149.83 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.209 -0.932 . . . . 0.0 110.282 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -104.39 -42.41 5.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 109.894 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.42 -63.72 1.01 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.241 -0.912 . . . . 0.0 109.744 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 38.4 tt0 -51.61 -41.32 61.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.914 . . . . 0.0 109.689 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.456 HD11 HD23 ' A' ' 32' ' ' LEU . 7.9 tt -55.27 -53.13 60.02 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.809 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -51.41 -37.56 49.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.364 -0.835 . . . . 0.0 109.767 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 7.4 t0 -63.11 -40.64 98.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.334 -0.854 . . . . 0.0 109.724 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.432 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 21.8 ttp -66.67 -19.24 65.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.329 -0.857 . . . . 0.0 109.636 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.872 HD11 HD22 ' A' ' 32' ' ' LEU . 26.3 mt -87.77 -25.48 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.252 -0.905 . . . . 0.0 110.479 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -62.5 -38.47 90.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.05 -1.031 . . . . 0.0 110.388 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.547 ' HG3' HG23 ' A' ' 55' ' ' VAL . 14.3 pt-20 -65.5 -18.76 65.56 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.123 -0.985 . . . . 0.0 110.343 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.547 HG23 ' HG3' ' A' ' 54' ' ' GLU . 79.6 t -95.9 -69.7 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.247 -0.908 . . . . 0.0 110.065 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -45.1 123.33 3.85 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.385 -0.822 . . . . 0.0 110.531 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.33 36.74 2.95 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.894 . . . . 0.0 110.363 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.414 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 48.6 m-20 -123.68 -52.22 1.81 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.24 -0.912 . . . . 0.0 110.371 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.31 16.17 7.88 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.45 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 24.6 p30 -93.62 -20.97 19.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.257 -1.143 . . . . 0.0 110.023 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.45 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 109.91 -44.77 1.43 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.601 ' CG2' HG22 ' A' ' 28' ' ' THR . 71.0 p -98.81 164.9 12.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.095 -1.238 . . . . 0.0 110.568 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.1 mt -101.88 158.59 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.148 -0.97 . . . . 0.0 110.132 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.43 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 32.4 m-20 -113.4 -167.82 1.25 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.372 -0.83 . . . . 0.0 110.797 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.563 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 41.8 t80 -76.37 -42.97 3.33 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.422 -0.799 . . . . 0.0 111.342 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.2 Cg_endo -72.6 -25.99 16.98 Favored 'Trans proline' 0 C--O 1.208 -1.02 0 O-C-N 123.033 1.017 . . . . 0.0 110.32 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.414 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 49.5 mt-10 -78.54 -24.32 45.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.038 -1.039 . . . . 0.0 109.351 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.484 ' CZ ' ' SD ' ' A' ' 72' ' ' MET . 55.7 t80 -78.12 -51.73 9.82 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.55 -0.719 . . . . 0.0 110.466 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.754 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 3.4 tt -75.1 -20.04 59.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.243 -0.911 . . . . 0.0 110.727 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.437 ' HB ' ' O ' ' A' ' 66' ' ' PRO . 18.9 m -82.21 -50.83 8.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.079 -1.013 . . . . 0.0 110.503 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.01 -29.66 67.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.093 -1.004 . . . . 0.0 109.867 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.484 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 52.8 mtt -86.5 -12.91 47.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.218 -0.926 . . . . 0.0 110.188 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.233 -0.917 . . . . 0.0 110.636 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 . . . . . 0 N--CA 1.496 1.846 0 CA-C-O 121.342 0.591 . . . . 0.0 110.301 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 32.7 mt -58.86 -33.71 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.071 -1.018 . . . . 0.0 109.711 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -54.79 -44.92 74.18 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.273 -0.892 . . . . 0.0 109.408 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -64.78 -36.32 83.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.304 -0.873 . . . . 0.0 110.072 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.682 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -60.43 -61.95 2.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.33 -0.857 . . . . 0.0 110.293 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.469 ' CE1' ' HA ' ' A' ' 138' ' ' TYR . 1.1 t80 -55.13 -28.26 51.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.452 -0.78 . . . . 0.0 110.54 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.65 -47.75 65.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.151 -0.968 . . . . 0.0 110.844 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.734 HG23 ' CD1' ' A' ' 92' ' ' PHE . 27.2 m -69.59 -24.64 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.069 -1.019 . . . . 0.0 110.477 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.734 ' CD1' HG23 ' A' ' 91' ' ' VAL . 13.4 m-85 -86.18 -16.89 36.4 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.239 -0.913 . . . . 0.0 110.239 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -109.22 97.12 6.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.274 -0.891 . . . . 0.0 110.245 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -103.41 12.43 35.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.904 . . . . 0.0 110.545 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 1.9 p30 -116.64 -41.74 3.05 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.988 -1.07 . . . . 0.0 110.501 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.468 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 111.91 36.66 1.65 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.438 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 41.0 p30 -117.11 -9.54 11.03 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.941 -1.329 . . . . 0.0 110.844 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 70.82 35.89 65.98 Favored Glycine 0 N--CA 1.498 2.822 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 28.1 m-85 -140.25 136.77 33.67 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.205 -1.174 . . . . 0.0 109.66 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.424 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 12.8 mt -92.11 119.59 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.938 -1.101 . . . . 0.0 109.797 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 77.6 p -109.75 151.66 26.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.166 -0.959 . . . . 0.0 110.226 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.1 -29.41 60.58 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.197 -0.939 . . . . 0.0 110.413 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.72 -52.91 61.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.204 -0.935 . . . . 0.0 110.235 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.841 ' O ' HG23 ' A' ' 108' ' ' VAL . 98.7 mt-10 -66.51 -55.82 13.76 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.243 -0.911 . . . . 0.0 110.28 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.611 HD23 HG13 ' A' ' 121' ' ' VAL . 17.2 tp -53.41 -25.35 15.41 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.109 -0.994 . . . . 0.0 110.35 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 47.2 ttt85 -71.45 -49.83 37.67 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.262 -0.899 . . . . 0.0 110.313 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -79.63 -9.33 59.62 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.27 -0.894 . . . . 0.0 110.792 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 104' ' ' GLU . 91.0 t -83.97 -46.37 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.059 -1.026 . . . . 0.0 110.47 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.405 ' O ' ' HB2' ' A' ' 114' ' ' GLU . 25.8 mtt -82.0 -32.81 30.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.041 -1.037 . . . . 0.0 110.585 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 55.8 m -67.23 -31.04 71.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.215 -0.928 . . . . 0.0 110.347 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -87.64 -42.13 12.9 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.177 -0.952 . . . . 0.0 110.322 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.434 HD12 ' O ' ' A' ' 108' ' ' VAL . 29.7 mt -46.13 -27.15 0.9 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.273 -0.892 . . . . 0.0 110.206 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.37 37.52 0.56 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 109' ' ' MET . 45.6 mt-10 -127.91 127.75 43.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.125 -1.221 . . . . 0.0 110.225 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -83.23 92.78 7.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 110.19 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.5 mt -118.83 -176.3 3.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.217 -0.927 . . . . 0.0 110.149 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.3 t -144.52 -178.41 5.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.25 -0.906 . . . . 0.0 110.45 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -61.85 -31.1 71.33 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.342 -0.848 . . . . 0.0 110.997 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.42 ' N ' ' CD ' ' A' ' 119' ' ' GLU . 6.2 mp0 -67.11 -41.1 86.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.26 -0.9 . . . . 0.0 110.708 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -67.72 -56.39 9.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.208 -0.932 . . . . 0.0 110.575 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.611 HG13 HD23 ' A' ' 105' ' ' LEU . 78.0 t -52.99 -49.3 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 0.0 110.412 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -57.54 -41.14 80.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.222 -0.924 . . . . 0.0 110.57 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -65.89 -32.74 74.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.22 -0.925 . . . . 0.0 110.796 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -73.11 -38.59 66.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.25 -0.906 . . . . 0.0 110.573 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 31.5 mm -70.11 -27.61 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.113 -0.992 . . . . 0.0 109.99 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -72.93 -45.79 56.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.396 -0.815 . . . . 0.0 110.223 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -70.54 -28.76 65.18 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.078 -1.014 . . . . 0.0 110.103 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.62 -24.95 36.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.354 -0.841 . . . . 0.0 110.402 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -86.76 77.07 9.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.051 -1.031 . . . . 0.0 110.174 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.72 HD12 ' HG2' ' A' ' 140' ' ' GLU . 5.6 mt -45.91 -60.18 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.387 -0.82 . . . . 0.0 110.482 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.9 p30 -66.24 -26.97 67.61 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.074 -1.016 . . . . 0.0 110.398 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 65.48 66.18 2.56 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 2.6 p30 -107.54 -35.39 6.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.281 -1.129 . . . . 0.0 110.674 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 167.77 -37.77 0.22 Allowed Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.021 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.409 ' HG3' ' HB3' ' A' ' 99' ' ' TYR . 2.7 pm0 -140.38 166.83 23.63 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.113 -1.228 . . . . 0.0 110.265 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.424 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 12.1 t -88.46 146.34 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.295 -0.878 . . . . 0.0 110.044 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -109.46 169.9 8.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 109.917 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.485 ' O ' HG23 ' A' ' 142' ' ' VAL . 9.0 t80 -61.66 -47.87 83.42 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.183 -0.948 . . . . 0.0 110.545 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -59.91 -41.46 91.73 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.007 -1.058 . . . . 0.0 110.152 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.72 ' HG2' HD12 ' A' ' 130' ' ' ILE . 52.2 mt-10 -69.41 -24.72 63.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.92 . . . . 0.0 110.014 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.518 ' CZ ' ' CE ' ' A' ' 145' ' ' MET . 8.0 t80 -77.51 -25.23 50.13 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.378 -0.826 . . . . 0.0 109.977 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 138' ' ' TYR . 90.0 t -80.34 -23.4 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.278 -0.889 . . . . 0.0 110.04 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -89.13 -31.74 17.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -0.9 . . . . 0.0 110.296 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.434 ' CE ' ' CD2' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -82.65 -22.51 34.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.153 -0.967 . . . . 0.0 110.243 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.518 ' CE ' ' CZ ' ' A' ' 141' ' ' PHE . 46.0 tpp -71.54 -29.95 65.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.337 -0.852 . . . . 0.0 109.97 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.1 p . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.363 -0.835 . . . . 0.0 110.306 -179.89 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.204 0.526 . . . . 0.0 110.262 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 2.5 tp10 -46.81 -48.29 20.81 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.272 -0.892 . . . . 0.0 110.145 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -53.97 -47.23 71.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.454 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.887 HG23 HD11 ' A' ' 69' ' ' LEU . 44.3 mt -56.38 -33.74 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.336 -0.852 . . . . 0.0 109.468 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -62.83 -37.44 86.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.39 -0.819 . . . . 0.0 109.373 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -63.09 -51.04 68.17 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.303 -0.873 . . . . 0.0 109.421 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -60.1 -28.11 67.56 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.471 -0.768 . . . . 0.0 109.891 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 2.4 mtpm? -64.25 -52.65 57.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 109.49 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -53.12 -38.07 62.32 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.348 -0.845 . . . . 0.0 109.304 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.04 -43.63 98.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.445 -0.784 . . . . 0.0 109.693 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -54.29 -39.65 67.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 109.377 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.7 t -73.03 -29.99 63.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.427 -0.796 . . . . 0.0 109.505 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.842 ' O ' HD23 ' A' ' 18' ' ' LEU . 5.1 tt -59.43 -35.97 75.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.447 -0.783 . . . . 0.0 109.388 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -82.19 -56.7 3.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.436 -0.79 . . . . 0.0 109.874 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.457 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 9.8 t70 -52.96 106.2 0.15 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.452 -0.78 . . . . 0.0 110.214 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -110.31 41.72 1.69 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.264 -0.898 . . . . 0.0 110.983 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 5.6 p-10 -150.12 -50.77 0.14 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.037 -1.039 . . . . 0.0 110.387 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.91 57.61 0.33 Allowed Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.744 -1.217 . . . . 0.0 110.333 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 56.5 p-10 -135.75 0.62 2.71 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.135 -1.215 . . . . 0.0 110.737 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.555 ' C ' HG23 ' A' ' 26' ' ' THR . . . 64.09 40.27 97.96 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.555 HG23 ' C ' ' A' ' 25' ' ' GLY . 81.0 p -154.83 139.52 17.05 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.232 -1.158 . . . . 0.0 109.857 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 86.4 mt -105.12 132.36 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.125 -0.985 . . . . 0.0 110.205 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.515 HG22 ' H ' ' A' ' 29' ' ' THR . 10.0 m -125.21 174.79 7.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.227 -0.921 . . . . 0.0 110.563 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.515 ' H ' HG22 ' A' ' 28' ' ' THR . 43.5 p -64.01 -21.12 66.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.439 -0.788 . . . . 0.0 109.954 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -70.84 -69.32 0.37 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.278 -0.888 . . . . 0.0 110.071 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.457 ' OE1' ' HA ' ' A' ' 20' ' ' ASP . 21.8 mt-10 -53.02 -46.61 68.47 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.331 -0.856 . . . . 0.0 109.61 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.979 HD22 HD11 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -60.19 -32.85 71.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.886 . . . . 0.0 109.659 179.511 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.04 -42.19 98.31 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.9 m -72.08 -24.39 61.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -1.081 . . . . 0.0 109.612 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.416 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 42.3 t -69.37 -35.87 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.405 -0.809 . . . . 0.0 109.688 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.412 ' O ' ' O ' ' A' ' 40' ' ' GLY . 25.4 mmt -90.25 -20.46 22.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 110.368 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.6 mtt85 -89.48 -18.1 27.37 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.023 -1.048 . . . . 0.0 110.651 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 92.4 p -101.54 -16.96 16.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.02 -1.05 . . . . 0.0 110.231 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.84 55.91 1.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.202 -0.936 . . . . 0.0 110.02 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 36' ' ' MET . . . 104.92 86.23 1.91 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.417 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 66.3 tt0 -83.14 67.48 9.18 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.459 -1.024 . . . . 0.0 110.634 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.484 ' HB2' ' HD3' ' A' ' 43' ' ' PRO . 1.8 m120 -85.05 -58.39 0.35 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.124 -0.985 . . . . 0.0 111.157 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' A' ' 42' ' ' ASN . 44.4 Cg_endo -73.88 -169.01 0.5 Allowed 'Trans proline' 0 C--N 1.315 -1.202 0 O-C-N 123.564 1.297 . . . . 0.0 111.056 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 10.9 t -132.94 -174.21 3.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.433 -0.792 . . . . 0.0 109.892 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -66.32 -43.94 84.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.141 -0.974 . . . . 0.0 110.595 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.89 -67.45 0.44 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.174 -0.954 . . . . 0.0 110.434 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -47.39 -29.86 2.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 0.0 110.1 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.863 HD11 HD23 ' A' ' 32' ' ' LEU . 8.6 tt -66.7 -49.36 66.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.931 . . . . 0.0 109.343 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -49.22 -38.88 27.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 109.243 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -64.2 -42.18 96.74 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.399 -0.813 . . . . 0.0 109.411 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.451 ' HG3' ' OE2' ' A' ' 54' ' ' GLU . 2.5 ttp -65.58 -14.56 61.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.264 -0.897 . . . . 0.0 109.946 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.979 HD11 HD22 ' A' ' 32' ' ' LEU . 25.4 mm -88.47 -33.61 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.302 -0.874 . . . . 0.0 110.3 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -65.25 -33.33 75.74 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.419 -0.8 . . . . 0.0 110.697 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.555 ' HG3' HG23 ' A' ' 55' ' ' VAL . 22.7 pt-20 -71.3 -8.29 52.7 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.058 -1.026 . . . . 0.0 110.647 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.76 HG22 ' SD ' ' A' ' 71' ' ' MET . 79.3 t -108.51 -18.84 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.069 -1.019 . . . . 0.0 110.107 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.532 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 4.6 t70 -109.04 109.27 20.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 111.053 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.76 15.19 23.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 109.66 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.73 -45.19 17.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.417 -0.802 . . . . 0.0 109.985 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.0 15.87 8.87 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.78 HD21 ' H ' ' A' ' 60' ' ' ASN . 0.1 OUTLIER -105.21 -31.73 8.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.053 -1.263 . . . . 0.0 110.171 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.38 -47.43 1.02 Allowed Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.84 -1.172 . . . . 0.0 110.248 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.415 ' O ' ' OD2' ' A' ' 56' ' ' ASP . 10.1 p -96.99 166.78 11.44 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.186 -1.185 . . . . 0.0 110.81 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.48 HD13 HG11 ' A' ' 55' ' ' VAL . 17.2 mt -102.95 161.34 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.202 -0.936 . . . . 0.0 110.316 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -113.65 -160.91 0.74 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.336 -0.853 . . . . 0.0 110.502 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.57 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 21.9 t80 -82.09 -43.4 1.02 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.896 . . . . 0.0 111.837 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.6 Cg_endo -72.42 -24.15 19.58 Favored 'Trans proline' 0 C--N 1.321 -0.894 0 O-C-N 123.027 1.014 . . . . 0.0 110.656 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -76.83 -33.78 57.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.143 -0.973 . . . . 0.0 109.087 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.571 ' CE1' ' CE ' ' A' ' 72' ' ' MET . 77.5 t80 -72.03 -40.27 68.55 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.572 -0.705 . . . . 0.0 109.852 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.887 HD11 HG23 ' A' ' 9' ' ' ILE . 8.2 tp -78.71 -17.93 55.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.446 -0.784 . . . . 0.0 110.607 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.9 m -90.63 -23.34 20.83 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.022 -1.049 . . . . 0.0 110.651 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.76 ' SD ' HG22 ' A' ' 55' ' ' VAL . 48.6 ttp -90.8 -36.96 13.94 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.891 -1.131 . . . . 0.0 111.073 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.571 ' CE ' ' CE1' ' A' ' 68' ' ' PHE . 56.8 mtt -89.83 -53.25 4.59 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.054 -1.029 . . . . 0.0 111.496 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.498 1.974 0 O-C-N 120.931 -1.105 . . . . 0.0 110.882 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 1.0 OUTLIER . . . . . 0 N--CA 1.498 1.952 0 CA-C-O 121.123 0.487 . . . . 0.0 110.761 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 79.5 mt -66.51 -59.31 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.192 -0.942 . . . . 0.0 110.093 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -63.08 -57.18 11.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.356 -0.84 . . . . 0.0 110.337 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.583 ' O ' HG13 ' A' ' 91' ' ' VAL . 51.3 mm-40 -51.02 -32.02 20.15 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.244 -0.91 . . . . 0.0 110.451 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' A' ' 84' ' ' GLU . . . -72.98 -40.72 65.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.192 -0.942 . . . . 0.0 110.414 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -62.79 -29.51 70.76 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.968 -1.083 . . . . 0.0 110.554 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 66.6 mtt85 -80.9 -52.12 7.82 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.201 -0.937 . . . . 0.0 110.938 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 87' ' ' GLU . 19.6 m -59.09 -36.22 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.211 -0.931 . . . . 0.0 111.02 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.507 ' CD2' HG23 ' A' ' 91' ' ' VAL . 16.2 m-85 -78.85 -38.8 36.98 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.033 -1.042 . . . . 0.0 110.606 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -111.55 71.3 0.74 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.275 -0.891 . . . . 0.0 110.147 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.441 ' CD ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -108.06 42.59 1.34 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.146 -0.971 . . . . 0.0 110.499 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 2.7 p30 -125.77 -26.95 3.41 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.242 -0.912 . . . . 0.0 110.605 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.4 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 108.21 31.57 3.51 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.45 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 18.6 t-20 -93.12 -44.98 8.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -1.145 . . . . 0.0 110.135 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.476 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 111.24 -14.91 28.07 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 33.8 m-85 -144.28 147.27 33.32 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.218 -1.166 . . . . 0.0 110.108 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.45 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 26.0 mt -71.1 137.5 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.245 -0.909 . . . . 0.0 109.439 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.3 m -114.21 169.64 8.88 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.194 -0.941 . . . . 0.0 110.394 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.61 -46.01 56.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.236 -0.915 . . . . 0.0 110.115 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.91 -53.94 49.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -0.918 . . . . 0.0 109.986 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.774 ' O ' HG23 ' A' ' 108' ' ' VAL . 31.2 mt-10 -58.57 -38.66 78.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.238 -0.914 . . . . 0.0 109.783 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.836 HD12 HD11 ' A' ' 125' ' ' ILE . 1.4 tt -57.78 -36.83 72.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.32 -0.863 . . . . 0.0 110.105 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.68 ' O ' HG22 ' A' ' 110' ' ' THR . 6.6 ttt-85 -70.0 -44.44 69.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.343 -0.848 . . . . 0.0 110.304 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -70.64 -11.06 60.7 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.084 -1.01 . . . . 0.0 110.497 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 104' ' ' GLU . 85.1 t -91.8 -40.79 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.135 -0.978 . . . . 0.0 110.163 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.2 mmt -69.9 -52.77 21.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.257 -0.902 . . . . 0.0 110.558 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.68 HG22 ' O ' ' A' ' 106' ' ' ARG . 5.8 t -56.99 -24.33 52.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.229 -0.919 . . . . 0.0 110.689 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -85.31 -33.86 22.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.022 -1.049 . . . . 0.0 110.69 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 24.4 mt -73.58 -56.53 4.9 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.131 -0.981 . . . . 0.0 110.28 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 167.58 -32.1 0.19 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -70.96 140.31 50.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.322 -1.105 . . . . 0.0 110.203 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 3.4 pttp -114.77 101.57 9.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.169 -0.957 . . . . 0.0 110.392 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.3 mt -112.0 168.5 9.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.125 -0.985 . . . . 0.0 110.236 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.544 HG22 ' N ' ' A' ' 118' ' ' ASP . 85.3 m -115.58 170.32 8.52 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.223 -0.923 . . . . 0.0 110.45 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.544 ' N ' HG22 ' A' ' 117' ' ' THR . 0.9 OUTLIER -51.02 -35.44 34.16 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.339 -0.851 . . . . 0.0 110.962 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -62.36 -54.78 35.39 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.059 -1.026 . . . . 0.0 110.798 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -61.2 -54.6 42.26 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.221 -0.924 . . . . 0.0 110.702 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' A' ' 105' ' ' LEU . 79.6 t -50.65 -41.25 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.115 -0.991 . . . . 0.0 110.566 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.96 -40.62 91.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.118 -0.989 . . . . 0.0 110.214 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.443 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 12.4 mt-10 -71.1 -18.41 62.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.236 -0.915 . . . . 0.0 109.972 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.1 mmm -78.79 -48.67 14.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 110.155 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.836 HD11 HD12 ' A' ' 105' ' ' LEU . 30.4 mm -70.44 -36.4 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.312 -0.868 . . . . 0.0 110.334 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -72.11 -47.36 51.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.362 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.443 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 5.7 mm-40 -70.15 -23.85 63.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.207 -0.933 . . . . 0.0 110.186 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.79 -14.65 27.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.171 -0.956 . . . . 0.0 110.011 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.76 ' OD1' HG22 ' A' ' 136' ' ' VAL . 3.8 m-20 -79.92 88.33 5.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.098 -1.001 . . . . 0.0 110.922 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.478 HG22 ' O ' ' A' ' 130' ' ' ILE . 11.5 mm -67.24 -4.08 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.523 -0.736 . . . . 0.0 111.11 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 54.0 p30 -176.57 -19.71 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 O-C-N 120.709 -1.245 . . . . 0.0 112.223 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . -71.8 -52.06 13.27 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 1.2 m-20 56.48 96.32 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.468 -1.019 . . . . 0.0 108.418 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 105.28 -20.49 37.58 Favored Glycine 0 C--N 1.295 -1.748 0 N-CA-C 107.564 -2.214 . . . . 0.0 107.564 -177.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.469 ' HB2' ' CB ' ' A' ' 99' ' ' TYR . 2.5 pt20 -153.4 152.32 30.92 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.621 -0.929 . . . . 0.0 109.729 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.76 HG22 ' OD1' ' A' ' 129' ' ' ASP . 99.5 t -118.48 147.12 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.208 -0.933 . . . . 0.0 110.346 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.4 ' OD1' ' CD1' ' A' ' 99' ' ' TYR . 2.9 m120 -105.91 179.46 4.26 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.435 -0.791 . . . . 0.0 110.585 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -73.73 -49.54 25.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.312 -0.868 . . . . 0.0 108.884 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -59.29 -41.75 89.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.346 -0.846 . . . . 0.0 109.046 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.45 ' OE1' ' HA ' ' A' ' 136' ' ' VAL . 36.1 tt0 -64.98 -33.27 75.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.484 -0.76 . . . . 0.0 109.968 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.429 ' O ' ' HG2' ' A' ' 144' ' ' MET . 13.4 t80 -68.91 -25.62 64.68 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.315 -0.866 . . . . 0.0 110.31 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.8 t -81.44 -36.28 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.122 -0.986 . . . . 0.0 109.726 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.49 -29.95 64.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 110.8 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.48 ' HE3' ' CE ' ' A' ' 145' ' ' MET . 3.4 ptt? -74.59 -25.55 59.33 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.006 -1.059 . . . . 0.0 110.623 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.48 ' CE ' ' HE3' ' A' ' 144' ' ' MET . 20.5 mmt -87.11 -67.69 0.8 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.117 -0.989 . . . . 0.0 110.504 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 65.6 p . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.071 -1.018 . . . . 0.0 110.411 -179.72 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.105 0.479 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.86 -55.94 28.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.274 -0.891 . . . . 0.0 110.252 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -56.65 -33.28 66.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.301 -0.874 . . . . 0.0 109.75 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.0 mm -65.71 -35.95 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.509 -0.745 . . . . 0.0 109.807 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.15 -33.52 73.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.882 . . . . 0.0 109.587 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.8 -51.08 68.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.393 -0.817 . . . . 0.0 109.575 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -58.83 -38.67 79.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.378 -0.826 . . . . 0.0 109.835 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -63.85 -31.11 72.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.354 -0.841 . . . . 0.0 109.911 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -68.47 -45.63 71.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -0.862 . . . . 0.0 110.292 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.44 -44.66 93.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.309 -0.869 . . . . 0.0 110.355 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -58.79 -43.68 90.55 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.21 -0.931 . . . . 0.0 110.298 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.4 m -66.48 -33.95 76.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 110.077 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.799 ' O ' HD23 ' A' ' 18' ' ' LEU . 2.8 tt -62.46 -37.47 86.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 109.788 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.581 ' HA ' HG21 ' A' ' 35' ' ' VAL . 9.3 m-30 -72.51 -64.33 0.97 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.331 -0.856 . . . . 0.0 109.893 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -51.0 120.15 4.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.412 -0.805 . . . . 0.0 109.862 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -104.85 -8.73 18.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.907 -1.121 . . . . 0.0 110.885 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.402 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 6.9 p-10 -101.55 -42.29 6.29 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.9 -1.125 . . . . 0.0 110.238 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.12 55.4 0.92 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 58.5 p30 -123.5 -11.47 7.84 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.166 -1.197 . . . . 0.0 110.503 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.643 ' O ' HG23 ' A' ' 26' ' ' THR . . . 89.12 36.89 7.41 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 25' ' ' GLY . 14.6 p -158.5 129.55 6.34 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.339 -1.095 . . . . 0.0 110.256 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 62' ' ' THR . 62.0 mt -93.19 118.32 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.315 -0.866 . . . . 0.0 109.993 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 t -104.24 -176.28 3.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.232 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.63 HG22 HD12 ' A' ' 52' ' ' ILE . 31.4 p -75.09 -35.08 61.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 110.475 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -62.37 -60.28 3.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.267 -0.896 . . . . 0.0 109.972 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -58.83 -53.11 62.12 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.212 -0.93 . . . . 0.0 109.623 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.739 HD22 HD11 ' A' ' 52' ' ' ILE . 0.5 OUTLIER -58.88 -19.45 42.17 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.235 -0.916 . . . . 0.0 109.572 179.535 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.493 ' HA2' ' CD1' ' A' ' 48' ' ' LEU . . . -67.35 -49.53 51.2 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 38' ' ' SER . 60.0 m -70.84 -19.12 62.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.298 -1.119 . . . . 0.0 109.862 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.581 HG21 ' HA ' ' A' ' 19' ' ' PHE . 24.4 t -76.58 -38.45 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.394 -0.816 . . . . 0.0 110.334 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.714 ' HA ' HD23 ' A' ' 39' ' ' LEU . 26.5 mmt -84.48 -22.96 30.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.121 -0.987 . . . . 0.0 110.163 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.452 ' HD3' ' HA ' ' A' ' 42' ' ' ASN . 3.7 tpp180 -90.68 -16.9 27.72 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.329 -0.857 . . . . 0.0 110.417 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 34' ' ' THR . 32.9 t -92.0 10.11 30.38 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.995 -1.065 . . . . 0.0 110.982 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.714 HD23 ' HA ' ' A' ' 36' ' ' MET . 3.8 pp -107.27 -26.7 10.92 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.015 -1.053 . . . . 0.0 110.65 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.55 -31.13 1.03 Allowed Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.065 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.603 ' HG3' HD11 ' A' ' 39' ' ' LEU . 67.3 mt-30 -81.01 158.75 25.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.101 -1.235 . . . . 0.0 110.323 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.452 ' HA ' ' HD3' ' A' ' 37' ' ' ARG . 77.1 m-20 -130.43 61.09 56.91 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.25 -0.906 . . . . 0.0 110.131 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.05 -163.15 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.771 1.406 . . . . 0.0 110.234 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.527 HG22 ' N ' ' A' ' 45' ' ' GLU . 58.4 m -135.55 171.98 13.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.253 -0.904 . . . . 0.0 110.119 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.527 ' N ' HG22 ' A' ' 44' ' ' THR . 69.3 mt-10 -59.56 -28.94 67.56 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.2 -0.937 . . . . 0.0 110.478 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.92 -67.48 0.49 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.153 -0.967 . . . . 0.0 110.064 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -53.42 -23.09 8.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -0.914 . . . . 0.0 109.512 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.508 HD11 HD23 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -67.85 -58.0 5.32 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.564 -0.71 . . . . 0.0 110.011 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -51.22 -38.09 50.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.322 -0.861 . . . . 0.0 109.527 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -65.17 -38.99 92.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.367 -0.833 . . . . 0.0 109.508 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.444 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 1.6 ttp -66.98 -26.26 66.72 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.426 -0.796 . . . . 0.0 109.784 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.739 HD11 HD22 ' A' ' 32' ' ' LEU . 56.9 mt -83.17 -27.33 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.319 -0.863 . . . . 0.0 109.818 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -58.58 -46.84 86.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.384 -0.823 . . . . 0.0 110.401 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.828 ' HG3' HG23 ' A' ' 55' ' ' VAL . 13.2 pt-20 -64.39 -27.2 68.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -0.918 . . . . 0.0 110.071 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.828 HG23 ' HG3' ' A' ' 54' ' ' GLU . 85.8 t -96.1 -3.97 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.344 -0.848 . . . . 0.0 110.338 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -126.11 105.86 9.17 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.028 -1.045 . . . . 0.0 110.159 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.24 33.66 4.34 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.111 -0.993 . . . . 0.0 110.465 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -104.82 -49.11 3.58 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.186 -0.946 . . . . 0.0 110.236 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 119.53 51.69 0.28 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.457 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 16.1 p-10 -148.02 -43.69 0.16 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -1.129 . . . . 0.0 110.15 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 116.76 -4.12 19.26 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.579 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 45.1 p -123.76 164.05 19.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.906 -1.349 . . . . 0.0 110.469 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 52.1 mt -114.05 130.82 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.257 -0.902 . . . . 0.0 110.165 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.428 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 56.0 m-20 -83.3 -173.68 4.85 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 110.112 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.559 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 66.4 t80 -80.73 -42.63 1.25 Allowed Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.324 -0.86 . . . . 0.0 111.35 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 46.5 Cg_endo -74.66 -26.81 11.27 Favored 'Trans proline' 0 N--CA 1.48 0.72 0 O-C-N 123.082 1.043 . . . . 0.0 110.092 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 71' ' ' MET . 78.7 tt0 -78.09 -25.31 47.5 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.358 -0.839 . . . . 0.0 109.002 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 8.0 t80 -79.21 -54.34 6.07 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.607 -0.683 . . . . 0.0 110.025 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.687 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 0.6 OUTLIER -60.0 -34.78 73.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.329 -0.857 . . . . 0.0 110.427 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.4 m -77.02 -32.37 57.01 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.195 -0.941 . . . . 0.0 110.236 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.526 ' HE3' ' HG3' ' A' ' 72' ' ' MET . 18.2 tmm? -61.9 -52.65 63.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.268 -0.895 . . . . 0.0 110.278 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.526 ' HG3' ' HE3' ' A' ' 71' ' ' MET . 47.5 mtt -81.55 -10.4 59.46 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.165 -0.96 . . . . 0.0 110.293 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.163 -0.961 . . . . 0.0 110.127 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.215 0.531 . . . . 0.0 109.953 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.4 mt -52.07 -45.45 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.213 -0.929 . . . . 0.0 109.527 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -55.07 -44.41 74.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 110.179 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -57.41 -51.68 68.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.932 . . . . 0.0 110.245 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 92' ' ' PHE . . . -54.96 -29.58 57.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.131 -0.981 . . . . 0.0 110.557 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.433 ' O ' ' HB3' ' A' ' 93' ' ' ASP . 3.2 t80 -72.6 -35.98 68.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.003 -1.06 . . . . 0.0 110.838 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -76.32 -42.85 43.74 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.08 -1.013 . . . . 0.0 111.256 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.556 HG23 ' CD1' ' A' ' 92' ' ' PHE . 19.7 m -70.64 -41.23 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.047 -1.033 . . . . 0.0 110.859 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.556 ' CD1' HG23 ' A' ' 91' ' ' VAL . 25.9 m-85 -75.46 -25.07 57.12 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.877 -1.139 . . . . 0.0 110.028 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.447 ' OD2' ' N ' ' A' ' 99' ' ' TYR . 11.5 t70 -125.33 70.29 1.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.937 . . . . 0.0 110.09 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.11 65.98 0.62 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.429 -0.794 . . . . 0.0 110.284 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.461 ' OD2' ' HB2' ' A' ' 97' ' ' ASN . 21.6 p-10 -150.62 26.49 0.75 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.23 -0.919 . . . . 0.0 110.051 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.04 24.58 60.87 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.461 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 11.1 t-20 -95.49 -70.65 0.7 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.249 -1.147 . . . . 0.0 110.193 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.31 -9.98 10.05 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.447 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 55.0 m-85 -133.08 153.07 51.85 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.196 -1.179 . . . . 0.0 110.342 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.444 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 13.3 mt -91.84 116.26 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.336 -0.853 . . . . 0.0 109.499 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.0 t -95.06 176.04 6.39 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.318 -0.864 . . . . 0.0 110.115 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.468 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -71.84 -41.81 67.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 110.16 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.88 -50.45 62.44 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.181 -0.949 . . . . 0.0 110.27 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.865 ' O ' HG23 ' A' ' 108' ' ' VAL . 24.0 tt0 -59.52 -40.9 88.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.187 -0.945 . . . . 0.0 109.87 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 105' ' ' LEU . 30.6 tp -62.55 -33.83 75.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.381 -0.824 . . . . 0.0 110.046 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.59 ' O ' HG23 ' A' ' 110' ' ' THR . 6.7 ttp180 -69.16 -34.07 74.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.246 -0.909 . . . . 0.0 109.905 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 41.6 t60 -74.64 -24.18 58.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 110.276 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 104' ' ' GLU . 21.8 t -77.04 -39.92 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.258 -0.902 . . . . 0.0 110.187 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.6 mmt -61.84 -36.67 81.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.882 . . . . 0.0 110.136 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 106' ' ' ARG . 48.2 p -53.23 -43.48 67.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.155 -0.965 . . . . 0.0 109.71 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -60.14 -47.56 85.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.827 . . . . 0.0 110.219 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.5 mt -55.72 -36.3 67.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 110.124 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.07 41.88 2.74 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -119.87 133.59 55.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -1.168 . . . . 0.0 110.101 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.0 tttp -84.54 107.46 16.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.321 -0.862 . . . . 0.0 110.015 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.1 mt -126.29 164.21 21.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -0.869 . . . . 0.0 110.232 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 51.7 m -107.13 162.7 13.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 110.204 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.461 ' OD2' ' NH2' ' A' ' 106' ' ' ARG . 2.4 m-20 -58.2 -40.66 82.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 110.205 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -58.78 -35.55 72.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.312 -0.868 . . . . 0.0 110.526 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.02 -49.84 64.02 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.226 -0.921 . . . . 0.0 110.795 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.468 HG11 ' O ' ' A' ' 102' ' ' ALA . 59.3 t -59.36 -53.31 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.225 -0.922 . . . . 0.0 110.174 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -53.61 -42.56 67.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.189 -0.944 . . . . 0.0 110.004 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 27.1 tt0 -63.03 -33.2 74.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.346 -0.846 . . . . 0.0 110.054 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.406 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 5.5 mmm -65.19 -53.29 47.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.179 -0.951 . . . . 0.0 109.989 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 34.8 mm -54.94 -32.21 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.255 -0.903 . . . . 0.0 110.089 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 -70.65 -42.73 70.42 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.298 -0.876 . . . . 0.0 110.136 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 49.9 mt-10 -65.82 -23.95 66.8 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.292 -0.88 . . . . 0.0 110.219 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.63 -22.48 19.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.322 -0.862 . . . . 0.0 110.066 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -72.67 90.43 1.38 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 110.228 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 59.0 mt -89.34 -25.61 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.14 -0.975 . . . . 0.0 110.304 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 41.7 p30 -87.4 -16.44 34.92 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.244 -0.91 . . . . 0.0 110.496 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.455 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 75.1 70.35 1.27 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -130.62 -33.9 1.59 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.21 -1.171 . . . . 0.0 110.427 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 111.61 18.43 7.99 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.438 ' HB2' ' HB3' ' A' ' 99' ' ' TYR . 1.4 pt20 -160.56 147.4 15.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.371 -1.076 . . . . 0.0 109.949 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.444 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 60.7 t -91.09 132.18 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 110.377 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -106.39 171.4 7.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 109.82 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -53.83 -38.34 64.53 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.174 -0.954 . . . . 0.0 110.351 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -68.03 -62.88 1.2 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.185 -0.947 . . . . 0.0 110.647 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -46.83 -33.72 4.72 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.283 -0.886 . . . . 0.0 110.899 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.427 ' O ' ' HG3' ' A' ' 144' ' ' MET . 12.8 t80 -70.23 -40.94 74.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 111.133 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.632 ' O ' HG22 ' A' ' 146' ' ' THR . 99.2 t -77.48 -20.9 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.052 -1.03 . . . . 0.0 110.766 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -85.12 -28.11 25.79 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.257 -0.902 . . . . 0.0 110.959 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.455 ' CE ' ' HG3' ' A' ' 145' ' ' MET . 0.2 OUTLIER -83.05 -20.13 35.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.058 -1.026 . . . . 0.0 110.316 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.455 ' HG3' ' CE ' ' A' ' 144' ' ' MET . 26.0 mtt -90.24 -59.12 2.27 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.303 -0.873 . . . . 0.0 110.256 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.632 HG22 ' O ' ' A' ' 142' ' ' VAL . 13.7 t . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 110.004 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.039 0.447 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -64.54 -57.09 10.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.238 -0.914 . . . . 0.0 110.495 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.425 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 1.9 mp0 -47.16 -51.66 17.65 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.3 -0.875 . . . . 0.0 110.371 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 92.6 mt -57.41 -49.23 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.101 -0.999 . . . . 0.0 110.032 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.38 -26.08 39.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.398 -0.814 . . . . 0.0 109.804 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 16.0 tt0 -72.72 -57.82 3.81 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.366 -0.834 . . . . 0.0 109.636 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.438 ' O ' ' HB2' ' A' ' 16' ' ' PHE . 71.9 m-85 -56.4 -23.34 37.46 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.263 -0.898 . . . . 0.0 109.79 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.3 mttp -76.06 -40.35 53.43 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.283 -0.885 . . . . 0.0 110.033 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -62.66 -52.83 61.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 109.902 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.503 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.96 -47.19 85.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 109.998 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.507 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 14.3 t80 -47.76 -48.99 29.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.199 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.2 t -58.84 -42.76 90.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.904 . . . . 0.0 109.886 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.712 ' O ' HD23 ' A' ' 18' ' ' LEU . 3.6 tt -49.52 -44.41 46.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.287 -0.883 . . . . 0.0 110.171 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.83 ' CD1' HG11 ' A' ' 35' ' ' VAL . 37.3 m-85 -75.67 -30.28 59.35 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.175 -0.953 . . . . 0.0 110.401 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -80.35 107.52 13.21 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.108 -0.995 . . . . 0.0 110.43 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.402 ' HE3' ' CG2' ' A' ' 34' ' ' THR . 24.9 mttm -105.93 -35.36 7.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.0 110.436 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -74.07 -21.27 59.99 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.128 -0.982 . . . . 0.0 110.11 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.87 100.23 0.04 OUTLIER Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 35.1 p-10 -168.63 -26.21 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.354 -1.086 . . . . 0.0 111.41 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.52 ' C ' HG23 ' A' ' 26' ' ' THR . . . 111.09 27.56 4.2 Favored Glycine 0 N--CA 1.492 2.367 0 O-C-N 120.671 -1.268 . . . . 0.0 109.996 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.52 HG23 ' C ' ' A' ' 25' ' ' GLY . 72.2 p -153.36 170.21 21.22 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.052 -1.264 . . . . 0.0 110.337 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.441 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 12.2 mt -129.47 115.32 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.405 -0.81 . . . . 0.0 109.947 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.495 HG22 ' N ' ' A' ' 29' ' ' THR . 20.6 m -102.33 174.67 5.81 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.195 -0.941 . . . . 0.0 110.191 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.57 HG21 ' OE1' ' A' ' 49' ' ' GLN . 22.8 p -72.21 -21.41 61.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.146 -0.971 . . . . 0.0 110.059 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -70.73 -57.64 4.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.253 -0.905 . . . . 0.0 109.82 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -60.25 -57.62 12.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 0.0 109.71 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.738 HD22 HD11 ' A' ' 52' ' ' ILE . 2.0 tp -51.84 -35.43 44.57 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.279 -0.888 . . . . 0.0 109.584 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.26 -47.11 76.74 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.402 ' CG2' ' HE3' ' A' ' 21' ' ' LYS . 62.5 m -63.3 -31.21 72.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -1.139 . . . . 0.0 109.973 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.83 HG11 ' CD1' ' A' ' 19' ' ' PHE . 54.6 t -67.38 -31.48 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.195 -0.941 . . . . 0.0 109.833 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.4 mmt -90.55 -14.2 33.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.287 -0.883 . . . . 0.0 110.427 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.5 ttp180 -88.77 -31.5 18.36 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.153 -0.967 . . . . 0.0 110.435 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 88.7 p -91.44 -24.32 19.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.267 -0.896 . . . . 0.0 110.188 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -92.62 -67.31 0.86 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.247 -0.908 . . . . 0.0 109.932 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -129.32 89.33 0.31 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -59.68 116.5 4.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -1.119 . . . . 0.0 110.485 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.527 ' CB ' ' HD3' ' A' ' 43' ' ' PRO . 1.4 m120 -172.1 -61.03 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.301 -0.874 . . . . 0.0 110.477 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.527 ' HD3' ' CB ' ' A' ' 42' ' ' ASN . 47.7 Cg_endo -74.82 144.35 30.84 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.595 1.313 . . . . 0.0 110.105 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.698 HG23 ' H ' ' A' ' 46' ' ' ALA . 7.2 t -107.34 -141.37 0.38 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.106 -0.996 . . . . 0.0 109.897 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.672 ' N ' HG23 ' A' ' 44' ' ' THR . 44.4 mt-10 -88.23 -30.78 19.44 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.901 -1.124 . . . . 0.0 110.088 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.698 ' H ' HG23 ' A' ' 44' ' ' THR . . . -73.21 -64.75 0.91 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 109.702 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 55.4 mt-10 -52.31 -48.56 65.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.181 -0.949 . . . . 0.0 109.333 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.69 HD11 HD23 ' A' ' 32' ' ' LEU . 7.5 tt -52.1 -40.84 61.85 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.354 -0.841 . . . . 0.0 109.154 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.57 ' OE1' HG21 ' A' ' 29' ' ' THR . 62.8 tp60 -53.91 -44.63 70.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.508 -0.745 . . . . 0.0 109.578 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -57.91 -44.67 86.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.254 -0.904 . . . . 0.0 109.482 179.381 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.434 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 70.1 mtp -59.69 -26.61 65.72 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.319 -0.863 . . . . 0.0 109.842 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.738 HD11 HD22 ' A' ' 32' ' ' LEU . 29.9 mm -77.13 -29.53 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.898 . . . . 0.0 110.157 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -68.31 -43.26 78.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.336 -0.853 . . . . 0.0 110.454 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.519 ' HG3' HG23 ' A' ' 55' ' ' VAL . 22.7 pt-20 -68.0 -24.97 65.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.3 -0.875 . . . . 0.0 110.565 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.813 HG13 ' SD ' ' A' ' 71' ' ' MET . 75.9 t -89.33 -21.73 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.178 -0.951 . . . . 0.0 110.113 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -101.49 107.79 19.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.362 -0.836 . . . . 0.0 110.359 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -95.69 17.32 15.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.07 -1.019 . . . . 0.0 110.149 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.434 ' HB2' ' OD1' ' A' ' 60' ' ' ASN . 34.2 m-20 -107.4 -52.24 2.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.354 -0.842 . . . . 0.0 110.046 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.53 19.95 5.6 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.434 ' OD1' ' HB2' ' A' ' 58' ' ' ASP . 22.0 m120 -88.24 -9.23 53.62 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.239 -1.154 . . . . 0.0 110.44 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.25 -38.62 3.15 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.5 p -110.22 160.64 16.33 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.109 -1.23 . . . . 0.0 110.772 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.749 HD13 HG11 ' A' ' 55' ' ' VAL . 49.8 mt -95.8 158.32 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.56 -0.713 . . . . 0.0 109.968 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.432 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.1 m-20 -113.87 -170.67 1.75 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.279 -0.888 . . . . 0.0 110.411 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.563 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.8 t80 -77.23 -46.12 2.69 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.842 . . . . 0.0 111.124 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.1 Cg_endo -73.49 -16.15 24.45 Favored 'Trans proline' 0 C--N 1.318 -1.04 0 O-C-N 123.306 1.161 . . . . 0.0 110.403 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -84.46 -34.5 23.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -0.943 . . . . 0.0 109.043 178.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.488 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 5.5 t80 -70.04 -40.27 75.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.606 -0.684 . . . . 0.0 109.532 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.695 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 18.6 tp -76.61 -38.79 54.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.467 -0.771 . . . . 0.0 110.56 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.8 m -71.17 -22.05 62.09 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.163 -0.961 . . . . 0.0 110.656 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.813 ' SD ' HG13 ' A' ' 55' ' ' VAL . 62.4 ttp -82.3 -51.01 8.31 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.065 -1.022 . . . . 0.0 110.095 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.468 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 57.1 mtt -79.05 -9.69 59.62 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.405 -0.809 . . . . 0.0 110.674 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.695 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.495 1.811 0 O-C-N 121.103 -0.998 . . . . 0.0 110.31 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.43 0.633 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 97.8 mt -52.87 -33.32 18.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.305 -0.872 . . . . 0.0 109.802 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.437 ' HD3' ' OE2' ' A' ' 87' ' ' GLU . 2.2 ttt180 -64.34 -46.81 81.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 109.353 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.437 ' OE2' ' HD3' ' A' ' 86' ' ' ARG . 4.7 mp0 -57.75 -29.09 64.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.35 -0.844 . . . . 0.0 109.66 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.597 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -65.92 -62.89 1.25 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.365 -0.834 . . . . 0.0 110.148 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.607 ' CD1' HD11 ' A' ' 100' ' ' ILE . 1.9 t80 -50.01 -29.35 8.47 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.357 -0.839 . . . . 0.0 110.416 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -68.44 -55.15 12.84 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.136 -0.977 . . . . 0.0 110.714 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 88' ' ' ALA . 29.7 m -63.72 -20.66 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.132 -0.98 . . . . 0.0 110.344 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.672 ' CE1' HG11 ' A' ' 108' ' ' VAL . 24.6 m-85 -92.52 -14.06 28.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 0.0 110.34 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -123.93 66.25 1.04 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.234 -0.916 . . . . 0.0 109.714 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -95.61 61.97 2.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.863 . . . . 0.0 110.552 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.8 p30 -164.34 -35.84 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.117 -0.989 . . . . 0.0 110.717 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.454 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 110.04 38.88 1.62 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.445 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 3.8 t-20 -92.81 -57.97 2.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.389 -1.066 . . . . 0.0 110.184 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.425 ' C ' ' CD1' ' A' ' 99' ' ' TYR . . . 121.59 -22.31 7.81 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.641 ' CD2' ' NE2' ' A' ' 135' ' ' GLN . 27.4 m-85 -131.72 158.69 40.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.152 -1.205 . . . . 0.0 110.306 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.607 HD11 ' CD1' ' A' ' 89' ' ' PHE . 70.9 mt -93.89 135.49 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.331 -0.856 . . . . 0.0 110.587 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.5 t -117.47 176.0 5.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.498 -0.751 . . . . 0.0 109.837 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.63 -37.59 76.86 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.204 -0.935 . . . . 0.0 110.515 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.33 -59.03 6.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.19 -0.944 . . . . 0.0 110.258 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -52.54 -48.51 66.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.266 -0.896 . . . . 0.0 110.086 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.0 HD23 HG13 ' A' ' 121' ' ' VAL . 14.7 tp -54.38 -34.63 61.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -0.89 . . . . 0.0 110.356 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.9 ttt-85 -69.79 -33.29 72.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.08 -1.013 . . . . 0.0 110.367 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 53.2 m170 -68.04 -38.53 82.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.27 -0.894 . . . . 0.0 110.49 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.672 HG11 ' CE1' ' A' ' 92' ' ' PHE . 97.0 t -73.91 -49.59 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.165 -0.96 . . . . 0.0 110.558 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.437 ' HG2' ' O ' ' A' ' 105' ' ' LEU . 22.9 mmt -51.68 -62.69 1.47 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.221 -0.925 . . . . 0.0 110.886 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.6 p -44.96 -27.8 0.59 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.34 -0.85 . . . . 0.0 111.018 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 4.5 m120 -81.3 -39.7 24.8 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.007 -1.058 . . . . 0.0 110.68 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 112' ' ' LEU . 80.5 mt -72.41 -15.54 61.84 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.29 -0.881 . . . . 0.0 110.383 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.48 53.12 1.08 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.609 ' OE1' HD11 ' A' ' 116' ' ' LEU . 13.5 mm-40 -128.49 100.44 5.77 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.341 -1.094 . . . . 0.0 110.098 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -87.88 106.8 18.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 110.213 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.609 HD11 ' OE1' ' A' ' 114' ' ' GLU . 4.3 mp -129.99 -178.37 4.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 0.0 109.998 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.8 m -102.77 155.94 17.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.135 -0.978 . . . . 0.0 110.224 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.408 ' O ' ' OD2' ' A' ' 122' ' ' ASP . 45.5 m-20 -49.16 -43.06 41.54 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.227 -0.921 . . . . 0.0 110.191 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -60.98 -42.59 98.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.187 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -52.37 -59.51 4.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.294 -0.879 . . . . 0.0 110.245 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 1.0 HG13 HD23 ' A' ' 105' ' ' LEU . 42.1 t -53.29 -45.51 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.099 -1.001 . . . . 0.0 110.051 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.408 ' OD2' ' O ' ' A' ' 118' ' ' ASP . 60.3 m-20 -52.49 -37.34 57.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.966 . . . . 0.0 109.77 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -70.67 -33.67 71.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.354 -0.842 . . . . 0.0 110.002 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 5.9 mmm -61.91 -55.35 30.48 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.279 -0.888 . . . . 0.0 110.066 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.654 HG23 HG23 ' A' ' 136' ' ' VAL . 22.8 mm -58.47 -38.86 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.272 -0.892 . . . . 0.0 110.1 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -71.24 -22.43 61.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.255 -0.903 . . . . 0.0 110.158 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.4 ' O ' ' OE1' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -76.28 -42.16 46.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 109.88 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.42 -33.68 71.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.025 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -59.58 97.64 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.147 -0.97 . . . . 0.0 109.895 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.8 mt -73.16 -44.12 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.396 -0.815 . . . . 0.0 111.421 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.5 p30 -85.62 -31.2 22.72 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.072 -1.018 . . . . 0.0 110.938 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 97.97 54.05 1.23 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -95.16 14.92 20.5 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.237 -1.155 . . . . 0.0 110.216 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 64.74 21.9 67.69 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.641 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -170.1 140.87 2.03 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.588 -0.948 . . . . 0.0 109.719 -179.715 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.654 HG23 HG23 ' A' ' 125' ' ' ILE . 70.8 t -86.11 149.39 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.154 -0.967 . . . . 0.0 110.307 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.614 ' ND2' ' CE2' ' A' ' 99' ' ' TYR . 15.6 t-20 -125.83 169.32 12.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.158 -0.964 . . . . 0.0 110.272 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 138' ' ' TYR . 8.1 t80 -58.26 -51.01 71.57 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.401 -0.812 . . . . 0.0 110.671 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -54.99 -54.74 39.12 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.158 -0.964 . . . . 0.0 110.354 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.45 ' O ' ' CG ' ' A' ' 144' ' ' MET . 46.5 mt-10 -61.29 -20.71 63.2 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.155 -0.965 . . . . 0.0 109.932 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.568 ' CD1' ' CD1' ' A' ' 100' ' ' ILE . 13.4 t80 -75.71 -28.74 58.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.351 -0.843 . . . . 0.0 110.53 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.9 t -87.46 -23.44 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.214 -0.928 . . . . 0.0 110.998 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.402 ' HA ' ' CG2' ' A' ' 146' ' ' THR . 76.0 mt-30 -101.78 -9.61 20.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.074 -1.016 . . . . 0.0 110.951 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.45 ' CG ' ' O ' ' A' ' 140' ' ' GLU . 0.1 OUTLIER -89.09 -28.31 20.18 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.022 -1.049 . . . . 0.0 110.132 179.706 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 32.4 ttm -89.73 -43.11 10.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 110.284 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.402 ' CG2' ' HA ' ' A' ' 143' ' ' GLN . 8.9 t . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.202 -0.936 . . . . 0.0 109.997 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.458 0.647 . . . . 0.0 109.661 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -55.9 -28.47 56.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.242 -0.911 . . . . 0.0 109.541 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -66.97 -41.99 85.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.424 -0.798 . . . . 0.0 109.606 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.3 mt -60.79 -45.14 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.413 -0.804 . . . . 0.0 109.832 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.9 -42.67 98.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.82 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -55.25 -45.17 76.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.313 -0.867 . . . . 0.0 109.773 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.492 ' CE2' ' HB2' ' A' ' 73' ' ' ALA . 12.6 m-85 -56.97 -51.76 67.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 0.0 109.81 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -51.54 -34.77 38.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.0 110.261 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -66.54 -41.77 88.18 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.134 -0.979 . . . . 0.0 110.02 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.445 ' HB1' ' CE2' ' A' ' 19' ' ' PHE . . . -63.87 -47.02 82.35 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.216 -0.928 . . . . 0.0 110.146 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -62.53 -33.08 74.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -0.903 . . . . 0.0 109.814 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.1 m -71.09 -32.64 69.31 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.277 -0.889 . . . . 0.0 109.468 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.943 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.4 tm? -78.22 -23.74 47.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.482 -0.761 . . . . 0.0 109.878 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.445 ' CE2' ' HB1' ' A' ' 15' ' ' ALA . 15.7 m-30 -83.25 -67.03 0.82 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.351 -0.843 . . . . 0.0 109.786 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -48.43 111.75 0.5 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.248 -0.907 . . . . 0.0 109.832 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -78.53 -58.41 3.27 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.209 -0.932 . . . . 0.0 110.824 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.413 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 8.6 p-10 -69.34 -41.75 76.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.147 -0.971 . . . . 0.0 109.978 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.69 46.18 2.16 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 2.6 p30 -95.07 -24.87 16.69 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.054 -1.263 . . . . 0.0 110.051 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.534 ' C ' HG23 ' A' ' 26' ' ' THR . . . 109.83 32.5 2.86 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.534 HG23 ' C ' ' A' ' 25' ' ' GLY . 69.5 p -153.98 150.51 28.36 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.165 -1.197 . . . . 0.0 110.242 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 95.2 mt -117.67 107.96 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.27 -0.894 . . . . 0.0 110.131 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.944 HG22 HG21 ' A' ' 62' ' ' THR . 73.1 p -101.0 -174.31 2.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.834 . . . . 0.0 110.097 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.635 HG22 HG13 ' A' ' 52' ' ' ILE . 43.5 p -74.87 -24.84 58.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 110.06 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -71.75 -62.46 1.41 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.09 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -56.88 -49.27 76.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.091 -1.006 . . . . 0.0 109.709 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.025 HD22 HD11 ' A' ' 52' ' ' ILE . 1.9 tp -60.36 -31.46 70.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.274 -0.891 . . . . 0.0 109.529 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.51 -43.12 96.17 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 38' ' ' SER . 30.7 m -73.74 -24.95 59.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.396 -1.061 . . . . 0.0 109.891 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.5 t -70.64 -33.65 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.356 -0.84 . . . . 0.0 110.253 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.2 mmt -89.24 -23.93 22.22 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.356 -0.84 . . . . 0.0 110.382 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.431 ' NH1' ' HG2' ' A' ' 37' ' ' ARG . 11.3 tpt180 -90.62 -11.24 40.5 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.226 -0.921 . . . . 0.0 110.738 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 34' ' ' THR . 23.8 t -67.8 -68.92 0.35 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.106 -0.996 . . . . 0.0 110.414 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.42 68.39 1.37 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.301 -0.874 . . . . 0.0 110.179 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -158.89 -109.99 0.27 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -112.46 -164.54 0.92 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.319 -1.106 . . . . 0.0 110.05 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -124.82 64.53 42.58 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 110.453 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 152.49 51.71 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.862 1.454 . . . . 0.0 110.368 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.511 HG22 ' N ' ' A' ' 45' ' ' GLU . 35.6 m -100.73 173.47 6.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.183 -0.948 . . . . 0.0 109.826 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.511 ' N ' HG22 ' A' ' 44' ' ' THR . 1.8 mp0 -66.78 -22.73 66.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.143 -0.973 . . . . 0.0 110.353 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.15 -70.96 0.41 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.124 -0.985 . . . . 0.0 109.991 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -52.56 -30.54 31.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.287 -0.883 . . . . 0.0 109.251 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.538 HD11 HD23 ' A' ' 32' ' ' LEU . 5.5 tt -66.56 -46.52 75.78 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.462 -0.774 . . . . 0.0 109.361 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.408 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 2.0 tt0 -50.62 -39.25 49.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.293 -0.879 . . . . 0.0 108.812 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.98 -45.7 93.74 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.211 178.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.44 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 0.4 OUTLIER -57.24 -24.37 54.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.404 178.953 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.025 HD11 HD22 ' A' ' 32' ' ' LEU . 46.9 mm -83.3 -31.26 8.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.456 -0.778 . . . . 0.0 109.913 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -76.38 -24.3 54.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.284 -0.885 . . . . 0.0 110.243 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.485 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 24.0 pt-20 -84.72 -36.23 21.97 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.193 -0.942 . . . . 0.0 110.377 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.485 ' N ' ' HG3' ' A' ' 54' ' ' GLU . 71.2 t -77.18 -32.67 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.128 -0.982 . . . . 0.0 109.942 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -97.1 100.46 11.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.342 -0.848 . . . . 0.0 110.169 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -100.21 22.74 11.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.164 -0.96 . . . . 0.0 110.042 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.413 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 29.5 m-20 -92.8 -56.57 2.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 110.133 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.94 25.93 1.45 Allowed Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.244 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -110.18 -41.32 4.45 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.825 -1.397 . . . . 0.0 110.005 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.14 -81.89 0.28 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.514 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.944 HG21 HG22 ' A' ' 28' ' ' THR . 69.7 p -79.26 170.71 16.22 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.324 -1.104 . . . . 0.0 111.025 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.7 mt -97.01 153.93 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.301 -0.874 . . . . 0.0 110.337 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.458 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 0.8 OUTLIER -105.86 -171.55 1.92 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.241 -0.912 . . . . 0.0 110.258 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.558 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 33.6 t80 -82.43 -41.88 0.94 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.343 -0.848 . . . . 0.0 111.76 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.0 Cg_endo -74.61 -20.26 18.03 Favored 'Trans proline' 0 C--N 1.323 -0.768 0 O-C-N 123.006 1.003 . . . . 0.0 110.187 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.413 ' OE1' ' OD2' ' A' ' 58' ' ' ASP . 41.9 tt0 -83.71 -28.46 28.27 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.22 -0.925 . . . . 0.0 109.408 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 6.5 t80 -74.58 -46.59 37.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.625 -0.672 . . . . 0.0 110.118 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.687 ' O ' HD23 ' A' ' 69' ' ' LEU . 8.3 tt -74.03 -32.91 63.55 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.288 -0.883 . . . . 0.0 110.609 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.1 m -79.35 -22.4 44.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.245 -0.909 . . . . 0.0 110.892 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.666 ' HE2' ' HE3' ' A' ' 72' ' ' MET . 11.6 ptt? -89.65 -26.37 20.77 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.927 -1.108 . . . . 0.0 110.904 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.666 ' HE3' ' HE2' ' A' ' 71' ' ' MET . 52.5 mtt -90.72 -55.57 3.52 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.053 -1.029 . . . . 0.0 111.191 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.492 ' HB2' ' CE2' ' A' ' 12' ' ' PHE . . . . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.259 -0.901 . . . . 0.0 110.772 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.473 0.654 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.544 HG23 ' CE1' ' A' ' 141' ' ' PHE . 13.7 mt -58.35 -17.17 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.895 . . . . 0.0 109.93 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -68.54 -52.27 33.88 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.154 -0.966 . . . . 0.0 109.533 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 38.8 mm-40 -61.66 -35.21 77.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 109.801 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.746 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -61.65 -61.14 2.73 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.221 -0.924 . . . . 0.0 109.737 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.427 ' CE2' ' HA ' ' A' ' 138' ' ' TYR . 31.9 t80 -54.44 -22.32 12.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.23 -0.919 . . . . 0.0 110.084 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 5.3 mtp180 -67.91 -44.98 75.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.097 -1.002 . . . . 0.0 109.817 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.746 HG22 ' O ' ' A' ' 88' ' ' ALA . 30.2 m -78.43 -21.59 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.344 -0.848 . . . . 0.0 110.576 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.845 ' CE1' HG11 ' A' ' 108' ' ' VAL . 38.4 m-85 -86.48 -15.5 39.95 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.129 -0.982 . . . . 0.0 110.587 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -124.44 47.78 2.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.219 -0.925 . . . . 0.0 110.223 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -106.49 40.4 1.63 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.324 -0.86 . . . . 0.0 110.163 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -124.35 -25.66 4.05 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.278 -0.888 . . . . 0.0 110.54 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 119.37 -32.02 5.21 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -47.34 -38.63 13.27 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.335 -1.097 . . . . 0.0 110.462 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.462 ' C ' ' CD1' ' A' ' 99' ' ' TYR . . . 97.19 -14.72 63.37 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.542 ' CD2' ' NE2' ' A' ' 135' ' ' GLN . 46.4 m-85 -135.03 168.47 19.06 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.114 -1.227 . . . . 0.0 110.118 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.446 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 37.1 mt -87.01 126.58 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.269 -0.895 . . . . 0.0 109.983 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.0 m -113.67 175.26 5.53 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.456 -0.777 . . . . 0.0 109.665 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.9 -43.68 78.69 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.136 -0.977 . . . . 0.0 110.279 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.67 -52.13 62.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.282 -0.886 . . . . 0.0 110.23 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -53.71 -53.3 54.07 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.221 -0.924 . . . . 0.0 110.126 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.5 tt -49.73 -39.43 37.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.268 -0.895 . . . . 0.0 110.247 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.436 ' O ' HG23 ' A' ' 110' ' ' THR . 44.0 ttt-85 -64.09 -38.84 92.51 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.22 -0.925 . . . . 0.0 110.41 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.405 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 54.2 t-80 -72.23 -19.19 61.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.255 -0.903 . . . . 0.0 110.524 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.845 HG11 ' CE1' ' A' ' 92' ' ' PHE . 90.1 t -84.4 -46.39 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.192 -0.943 . . . . 0.0 110.624 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.438 ' HB3' HD12 ' A' ' 116' ' ' LEU . 25.6 mmt -61.12 -48.17 82.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.141 -0.974 . . . . 0.0 110.668 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 106' ' ' ARG . 47.0 p -49.24 -37.44 23.35 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.207 -0.933 . . . . 0.0 110.56 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.405 ' ND2' ' O ' ' A' ' 107' ' ' HIS . 76.7 m-20 -73.39 -48.62 32.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.288 -0.882 . . . . 0.0 110.455 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.8 mt -59.14 -21.79 59.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 110.37 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.8 46.89 4.69 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 6.0 mm-40 -110.37 -29.5 8.09 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.26 -1.141 . . . . 0.0 110.197 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 114' ' ' GLU . 47.4 tttt 55.46 99.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.337 -0.852 . . . . 0.0 110.418 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.438 HD12 ' HB3' ' A' ' 109' ' ' MET . 0.5 OUTLIER -127.68 151.73 48.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.282 -0.886 . . . . 0.0 110.183 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.2 m -76.52 157.68 31.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 109.998 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -64.59 -42.91 95.28 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.229 -0.919 . . . . 0.0 110.354 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -56.63 -40.01 74.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.116 -0.99 . . . . 0.0 110.307 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 124' ' ' MET . 33.7 mt-10 -63.31 -46.37 87.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.162 -0.961 . . . . 0.0 110.159 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.418 ' O ' ' HB2' ' A' ' 124' ' ' MET . 95.1 t -55.27 -51.5 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.045 -1.034 . . . . 0.0 110.214 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -55.65 -46.99 77.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 110.229 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -62.9 -25.17 68.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -0.924 . . . . 0.0 110.237 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.418 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 73.7 mtp -73.84 -46.68 43.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.048 -1.032 . . . . 0.0 109.971 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 30.6 mm -61.29 -30.68 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.11 -0.994 . . . . 0.0 110.011 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.61 -43.46 47.98 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.246 -0.908 . . . . 0.0 110.265 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -67.43 -24.95 65.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.926 . . . . 0.0 110.071 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.75 -35.84 24.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.888 . . . . 0.0 110.204 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.4 ' OD2' ' HA2' ' A' ' 132' ' ' GLY . 23.1 t0 -61.32 96.09 0.05 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.922 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 140' ' ' GLU . 89.4 mt -67.77 -64.33 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.316 -0.865 . . . . 0.0 110.885 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.403 ' OD1' ' OE2' ' A' ' 140' ' ' GLU . 29.4 p30 -73.71 -19.79 60.71 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.234 -0.917 . . . . 0.0 110.906 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.4 ' HA2' ' OD2' ' A' ' 129' ' ' ASP . . . 80.66 75.4 1.08 Allowed Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.881 -1.152 . . . . 0.0 110.395 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 31.7 m-20 -111.35 -23.97 10.48 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.167 -1.196 . . . . 0.0 110.024 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 135.78 -39.3 1.68 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.542 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -132.76 170.71 14.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.567 -0.961 . . . . 0.0 109.69 179.633 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.446 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 91.1 t -95.28 133.83 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.972 -1.08 . . . . 0.0 110.231 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.506 ' ND2' ' CE2' ' A' ' 99' ' ' TYR . 17.1 t-20 -102.56 170.58 7.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.113 -0.992 . . . . 0.0 110.1 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.427 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 21.7 t80 -56.06 -47.18 78.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.23 -0.918 . . . . 0.0 110.462 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -55.73 -55.53 31.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -0.955 . . . . 0.0 110.273 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.419 ' HA ' HD12 ' A' ' 130' ' ' ILE . 52.6 mt-10 -58.35 -26.46 63.14 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.312 -0.867 . . . . 0.0 110.239 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.544 ' CE1' HG23 ' A' ' 85' ' ' ILE . 9.7 t80 -70.43 -32.1 69.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.253 -0.904 . . . . 0.0 110.151 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 87.0 t -82.33 -29.01 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.272 -0.892 . . . . 0.0 110.369 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -80.53 -23.79 39.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.275 -0.891 . . . . 0.0 110.424 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 54.7 ttp -80.51 -32.88 36.82 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.141 -0.975 . . . . 0.0 110.432 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.7 ttm -84.23 -11.47 56.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.246 -0.909 . . . . 0.0 110.803 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.7 p . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.092 -1.005 . . . . 0.0 110.214 179.805 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.035 0.445 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -66.95 -37.81 84.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.024 -1.047 . . . . 0.0 109.93 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.484 ' HG3' ' CE2' ' A' ' 12' ' ' PHE . 21.6 tp60 -72.33 -55.39 7.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.352 -0.842 . . . . 0.0 110.18 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.441 HG22 ' HD2' ' A' ' 13' ' ' LYS . 64.1 mt -52.2 -38.92 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 109.884 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.455 ' HA ' ' HD3' ' A' ' 13' ' ' LYS . . . -65.87 -36.76 84.33 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.282 -0.886 . . . . 0.0 109.449 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -59.3 -50.05 75.48 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.388 -0.82 . . . . 0.0 109.832 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.484 ' CE2' ' HG3' ' A' ' 8' ' ' GLN . 23.0 m-85 -63.6 -32.66 74.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.279 -0.888 . . . . 0.0 109.918 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.455 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 31.7 mtpt -65.46 -36.62 84.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.27 -0.894 . . . . 0.0 110.163 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -69.63 -38.4 77.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 0.0 109.715 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.458 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -64.32 -39.46 93.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.289 -0.882 . . . . 0.0 109.999 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -62.52 -57.51 10.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.137 -0.977 . . . . 0.0 110.238 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.9 p -55.64 -26.53 44.88 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.264 -0.897 . . . . 0.0 109.516 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.562 HD13 ' C ' ' A' ' 18' ' ' LEU . 2.1 tm? -71.91 -36.88 70.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.407 -0.808 . . . . 0.0 109.978 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.458 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 15.4 m-85 -71.04 -56.49 6.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.062 -1.024 . . . . 0.0 109.538 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.79 101.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.425 -0.797 . . . . 0.0 109.997 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.6 mmtt -67.0 -42.79 84.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 109.979 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 53.0 p-10 -86.56 -15.18 40.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.334 -0.854 . . . . 0.0 110.598 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.426 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 67.8 37.67 88.77 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -79.85 -17.75 52.47 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.359 -1.083 . . . . 0.0 110.502 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.97 -21.79 22.18 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.374 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.4 p -119.72 158.08 27.23 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.923 -1.339 . . . . 0.0 110.786 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 96.3 mt -117.08 125.99 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.421 -0.799 . . . . 0.0 110.08 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.1 p -104.35 -162.49 0.9 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.0 110.121 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.673 HG22 HD12 ' A' ' 52' ' ' ILE . 20.1 p -87.81 -39.94 14.46 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.132 -0.98 . . . . 0.0 110.924 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -57.48 10.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.036 -1.04 . . . . 0.0 110.401 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -57.04 -42.1 79.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.949 . . . . 0.0 109.671 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.709 HD22 HD11 ' A' ' 52' ' ' ILE . 5.3 tp -63.37 -28.38 69.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.35 -0.843 . . . . 0.0 109.747 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.97 -47.71 79.47 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.5 m -66.74 -28.5 68.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.269 -1.136 . . . . 0.0 109.554 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.7 t -73.17 -28.28 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.48 -0.763 . . . . 0.0 110.102 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.416 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 25.7 mmt -83.4 -25.73 31.04 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.212 -0.93 . . . . 0.0 110.121 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -89.67 -16.7 29.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.888 . . . . 0.0 110.217 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.6 m -50.96 -54.56 23.24 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.319 -0.863 . . . . 0.0 110.232 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.8 39.93 1.83 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.306 -0.871 . . . . 0.0 110.337 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -131.39 -100.71 0.84 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -138.3 -155.79 0.63 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -1.157 . . . . 0.0 110.006 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -125.12 69.03 58.45 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.118 -0.989 . . . . 0.0 110.165 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 -160.95 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.906 1.477 . . . . 0.0 110.109 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.432 HG22 ' N ' ' A' ' 45' ' ' GLU . 35.4 m -134.73 166.5 22.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.127 -0.983 . . . . 0.0 110.266 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.432 ' N ' HG22 ' A' ' 44' ' ' THR . 5.9 mm-40 -63.24 -22.64 67.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.221 -0.924 . . . . 0.0 110.166 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.3 -70.03 0.39 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.102 -0.999 . . . . 0.0 110.043 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -50.57 -31.73 16.6 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.301 -0.875 . . . . 0.0 109.923 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.482 HD21 ' HA ' ' A' ' 29' ' ' THR . 5.6 tt -62.9 -50.88 69.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 110.066 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.419 ' O ' ' OD1' ' A' ' 53' ' ' ASN . 37.4 tt0 -53.3 -42.81 67.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.119 -0.988 . . . . 0.0 109.306 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -62.35 -34.75 77.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.631 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.418 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 4.7 ttp -68.94 -22.27 64.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.412 -0.805 . . . . 0.0 109.787 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.709 HD11 HD22 ' A' ' 32' ' ' LEU . 35.9 mt -87.38 -30.05 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.328 -0.857 . . . . 0.0 109.979 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 49' ' ' GLN . 3.6 m-20 -51.77 -42.93 62.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.171 -0.955 . . . . 0.0 110.079 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.438 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 13.3 pt-20 -68.57 -29.98 68.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.228 -0.92 . . . . 0.0 110.419 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.646 HG11 HD11 ' A' ' 63' ' ' ILE . 67.2 t -75.88 -69.87 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.208 -0.933 . . . . 0.0 110.166 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.428 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 54.2 t0 -43.17 94.15 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.541 -0.724 . . . . 0.0 110.881 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -109.89 61.4 0.6 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 109.773 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 1.7 p30 -164.0 -33.44 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.337 -0.852 . . . . 0.0 110.941 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.443 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 105.74 47.85 1.07 Allowed Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.098 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -117.73 -12.78 10.21 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.265 -1.138 . . . . 0.0 110.332 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.68 -56.59 4.14 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 59.4 p -109.31 170.3 8.14 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.255 -1.144 . . . . 0.0 110.248 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.646 HD11 HG11 ' A' ' 55' ' ' VAL . 39.6 mt -89.79 139.34 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.155 -0.966 . . . . 0.0 110.143 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.4 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 0.8 OUTLIER -103.56 179.68 4.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.219 -0.926 . . . . 0.0 110.176 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.569 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.2 t80 -73.56 -46.53 7.36 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 0.0 111.003 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.0 Cg_endo -71.66 -22.34 24.26 Favored 'Trans proline' 0 N--CA 1.482 0.807 0 O-C-N 123.186 1.098 . . . . 0.0 110.419 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.428 ' OE2' ' HA ' ' A' ' 56' ' ' ASP . 80.5 tt0 -81.37 -37.69 27.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.173 -0.954 . . . . 0.0 109.166 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.421 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 16.6 t80 -66.52 -38.73 87.82 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.525 -0.735 . . . . 0.0 109.867 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.497 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 1.1 tt -72.83 -36.35 67.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.354 -0.841 . . . . 0.0 110.059 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 92.7 m -76.22 -12.43 60.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.102 -0.999 . . . . 0.0 110.3 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.1 tmm? -89.09 -44.41 10.37 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.105 -0.997 . . . . 0.0 110.837 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.411 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 64.6 mtt -90.48 -37.76 13.69 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.028 -1.045 . . . . 0.0 111.135 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.498 1.971 0 O-C-N 121.178 -0.951 . . . . 0.0 110.57 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.236 0.541 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 84.3 mt -53.42 -37.79 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.377 -0.827 . . . . 0.0 110.365 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.69 -55.44 23.37 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.136 -0.977 . . . . 0.0 109.777 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -49.46 -41.04 39.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.278 -0.889 . . . . 0.0 110.003 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.536 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -59.06 -59.9 4.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 110.028 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.428 ' O ' ' HB3' ' A' ' 93' ' ' ASP . 11.9 t80 -50.49 -22.58 1.99 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.314 -0.866 . . . . 0.0 110.134 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.3 ttt180 -72.26 -58.39 3.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 110.701 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 88' ' ' ALA . 30.3 m -60.19 -32.37 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.033 -1.042 . . . . 0.0 110.117 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.694 ' CE1' HG11 ' A' ' 108' ' ' VAL . 36.5 m-85 -80.47 -19.21 46.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.237 -0.914 . . . . 0.0 110.177 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 52.6 t0 -123.59 57.83 1.16 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.279 -0.888 . . . . 0.0 109.943 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.8 pttm -88.73 39.47 0.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.245 -0.91 . . . . 0.0 110.455 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.429 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 1.5 p30 -125.85 -30.64 2.99 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.31 -0.869 . . . . 0.0 110.316 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.93 38.78 3.06 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.721 -1.228 . . . . 0.0 111.006 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.507 ' O ' ' CE2' ' A' ' 99' ' ' TYR . 30.2 p30 -129.49 -21.84 3.11 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.75 -1.441 . . . . 0.0 110.99 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.507 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 79.93 48.65 6.44 Favored Glycine 0 N--CA 1.494 2.502 0 O-C-N 120.866 -1.146 . . . . 0.0 110.314 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 62.8 m-85 -151.19 142.53 23.36 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.172 -1.193 . . . . 0.0 110.323 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.485 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 21.2 mt -111.75 110.81 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.142 -0.974 . . . . 0.0 109.505 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.5 p -104.3 151.81 22.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.893 . . . . 0.0 110.181 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -46.84 -28.59 1.62 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.29 -0.881 . . . . 0.0 110.181 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.25 -56.01 10.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.281 -0.887 . . . . 0.0 110.241 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.85 ' O ' HG23 ' A' ' 108' ' ' VAL . 53.6 mt-10 -58.21 -31.13 67.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.206 -0.934 . . . . 0.0 110.182 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.001 HD23 HG13 ' A' ' 121' ' ' VAL . 39.5 tp -69.73 -34.59 74.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.973 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -77.79 -19.84 54.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.372 -0.83 . . . . 0.0 110.019 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -91.89 -20.29 21.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 0.0 110.167 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 104' ' ' GLU . 46.5 t -92.43 -50.83 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.165 -0.959 . . . . 0.0 110.1 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.616 ' HA ' HD12 ' A' ' 112' ' ' LEU . 17.1 mmt -46.96 -34.35 5.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.333 -0.854 . . . . 0.0 110.512 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.1 p -62.98 -51.89 65.11 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.236 -0.915 . . . . 0.0 109.708 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -53.67 -42.75 68.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.343 -0.848 . . . . 0.0 110.164 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.616 HD12 ' HA ' ' A' ' 109' ' ' MET . 17.4 mt -59.82 -37.7 79.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.282 -0.886 . . . . 0.0 110.152 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 125.03 -20.15 6.75 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -82.58 107.61 15.35 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.274 -1.133 . . . . 0.0 110.361 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -85.83 126.69 34.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.838 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 mt -130.38 156.95 43.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.204 -0.935 . . . . 0.0 110.287 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 91.7 m -91.37 155.44 18.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.28 -0.887 . . . . 0.0 110.393 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -46.42 -35.83 5.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.339 -0.851 . . . . 0.0 110.637 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -59.7 -64.38 0.97 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.155 -0.966 . . . . 0.0 110.669 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -50.24 -44.73 53.54 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.118 -0.989 . . . . 0.0 110.322 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 1.001 HG13 HD23 ' A' ' 105' ' ' LEU . 40.5 t -53.15 -48.23 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 110.056 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -61.22 -30.82 70.67 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.281 -0.887 . . . . 0.0 110.026 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -69.62 -36.92 76.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.337 -0.852 . . . . 0.0 110.168 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.1 mtp -71.98 -54.57 9.53 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.252 -0.905 . . . . 0.0 110.377 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 20.7 mm -52.42 -37.14 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.157 -0.964 . . . . 0.0 109.879 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 43.1 ttt-85 -66.84 -50.79 61.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.365 -0.835 . . . . 0.0 110.533 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -63.22 -21.0 65.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.177 -0.952 . . . . 0.0 110.492 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.494 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -92.57 -16.96 25.04 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.174 -0.954 . . . . 0.0 110.652 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -82.44 78.49 9.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.04 -1.038 . . . . 0.0 109.955 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.425 HD12 ' CB ' ' A' ' 140' ' ' GLU . 14.4 mt -48.95 -57.41 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.46 -0.775 . . . . 0.0 110.809 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 27.4 p30 -81.55 -19.12 42.71 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.035 -1.041 . . . . 0.0 110.903 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 76.5 69.24 1.42 Allowed Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.938 -1.125 . . . . 0.0 110.457 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.427 ' O ' ' HG2' ' A' ' 135' ' ' GLN . 53.8 m-20 -111.77 19.24 18.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.123 -1.222 . . . . 0.0 109.848 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 68.78 18.01 71.86 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 133' ' ' ASP . 2.1 pt20 -170.46 138.75 1.56 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.309 -1.113 . . . . 0.0 109.916 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.485 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 57.7 t -94.44 123.54 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.141 -0.974 . . . . 0.0 110.044 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -93.67 175.53 6.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.169 -0.957 . . . . 0.0 109.977 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.415 ' O ' HG23 ' A' ' 142' ' ' VAL . 23.5 t80 -59.06 -48.76 80.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.254 -0.904 . . . . 0.0 110.603 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.38 -50.83 64.28 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.103 -0.998 . . . . 0.0 110.665 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.425 ' CB ' HD12 ' A' ' 130' ' ' ILE . 54.4 mt-10 -64.03 -28.28 69.69 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.114 -0.991 . . . . 0.0 110.126 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.71 ' CZ ' ' HE3' ' A' ' 145' ' ' MET . 13.8 t80 -73.0 -20.9 60.92 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.335 -0.853 . . . . 0.0 110.03 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.64 ' O ' HG23 ' A' ' 146' ' ' THR . 79.0 t -87.39 -32.93 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.312 -0.868 . . . . 0.0 110.624 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.3 -20.1 32.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.133 -0.979 . . . . 0.0 111.272 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.494 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 19.9 ptt? -82.82 -32.6 27.53 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.864 -1.147 . . . . 0.0 110.964 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.71 ' HE3' ' CZ ' ' A' ' 141' ' ' PHE . 54.9 mtt -90.48 -27.36 19.27 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.922 -1.111 . . . . 0.0 110.671 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.64 HG23 ' O ' ' A' ' 142' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.131 -0.981 . . . . 0.0 110.723 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.186 0.517 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -66.15 -27.67 68.2 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.226 -0.921 . . . . 0.0 109.983 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -70.69 -44.92 65.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.308 -0.87 . . . . 0.0 109.73 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 86.5 mt -63.07 -48.13 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.751 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.59 -31.8 70.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.317 -0.864 . . . . 0.0 109.9 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.75 -51.93 62.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.355 -0.841 . . . . 0.0 109.888 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.427 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 10.7 m-30 -56.35 -46.73 79.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.354 -0.841 . . . . 0.0 110.09 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -62.39 -26.08 68.28 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.329 -0.857 . . . . 0.0 110.34 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -69.85 -66.29 0.61 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.112 -0.992 . . . . 0.0 110.13 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.418 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -48.59 -39.27 23.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -0.913 . . . . 0.0 109.966 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -62.19 -43.82 97.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -0.942 . . . . 0.0 109.963 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.5 m -65.04 -18.46 65.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 109.85 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.891 HD13 ' O ' ' A' ' 18' ' ' LEU . 2.9 tm? -87.75 -31.03 19.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 110.022 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.418 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 21.4 m-85 -74.46 -43.88 54.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.15 -0.968 . . . . 0.0 110.138 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -71.73 125.77 27.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.339 -0.85 . . . . 0.0 110.255 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.402 ' HD2' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -108.47 -51.93 2.83 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.205 -0.934 . . . . 0.0 110.795 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 3.0 p30 -70.6 -22.22 62.57 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.137 -0.977 . . . . 0.0 110.16 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.417 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 83.92 51.01 4.15 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.417 ' OD1' ' OG1' ' A' ' 26' ' ' THR . 7.0 p30 -104.72 18.62 21.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.109 -1.23 . . . . 0.0 110.335 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.812 ' O ' HG23 ' A' ' 26' ' ' THR . . . 49.6 41.67 34.43 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.812 HG23 ' O ' ' A' ' 25' ' ' GLY . 0.8 OUTLIER -166.56 160.47 15.25 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.306 -1.114 . . . . 0.0 110.291 179.803 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 55.3 mt -121.9 118.2 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.315 -0.865 . . . . 0.0 109.884 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.591 HG22 ' H ' ' A' ' 29' ' ' THR . 5.8 m -105.93 -179.82 4.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.495 -0.753 . . . . 0.0 110.034 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.591 ' H ' HG22 ' A' ' 28' ' ' THR . 13.5 p -71.58 -16.84 62.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.113 -0.992 . . . . 0.0 110.353 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -75.6 -67.72 0.64 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 109.846 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.402 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 50.6 mt-10 -53.71 -41.32 66.85 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.317 -0.865 . . . . 0.0 109.415 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.039 HD22 HD11 ' A' ' 52' ' ' ILE . 1.8 tp -63.88 -38.52 91.4 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.346 -0.846 . . . . 0.0 109.28 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.49 ' HA2' HD12 ' A' ' 48' ' ' LEU . . . -51.87 -42.31 53.18 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.5 m -70.4 -45.08 66.68 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.382 -1.069 . . . . 0.0 110.085 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.5 t -50.06 -43.4 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.357 -0.84 . . . . 0.0 110.735 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 21.8 mmt -85.34 -23.66 27.95 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.237 -0.914 . . . . 0.0 110.318 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 32.9 ttt180 -70.63 -16.7 62.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.381 -0.824 . . . . 0.0 110.139 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -102.61 -22.95 13.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 110.234 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.441 HD13 ' HA ' ' A' ' 39' ' ' LEU . 3.3 mm? -112.44 59.52 0.64 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.218 -0.926 . . . . 0.0 110.262 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.82 69.11 0.41 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.415 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 48.6 tt0 -58.17 106.72 0.4 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.241 -1.153 . . . . 0.0 110.114 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.557 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.9 m120 -155.54 -65.39 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.282 -0.886 . . . . 0.0 110.577 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.557 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 44.0 Cg_endo -70.15 166.08 29.26 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 123.429 1.226 . . . . 0.0 110.097 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.612 HG22 ' N ' ' A' ' 45' ' ' GLU . 41.8 m -132.32 -98.32 0.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.104 -0.997 . . . . 0.0 110.041 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.612 ' N ' HG22 ' A' ' 44' ' ' THR . 87.7 tt0 -110.77 -46.25 3.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.818 -1.176 . . . . 0.0 110.151 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.02 -63.25 1.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 109.971 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 29.1 mt-10 -50.24 -40.4 47.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.603 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.524 HD23 ' C ' ' A' ' 48' ' ' LEU . 10.6 tt -54.92 -53.45 55.35 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.295 -0.878 . . . . 0.0 109.412 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -48.74 -39.8 26.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.815 . . . . 0.0 109.821 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 39.0 t70 -57.92 -44.93 87.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.325 -0.859 . . . . 0.0 109.528 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.448 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 0.7 OUTLIER -62.78 -24.83 67.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.376 -0.828 . . . . 0.0 109.731 179.549 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.039 HD11 HD22 ' A' ' 32' ' ' LEU . 46.2 mm -80.02 -23.38 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.408 -0.808 . . . . 0.0 110.174 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -79.14 -30.99 43.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.151 -0.968 . . . . 0.0 110.094 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.565 ' HG3' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -76.3 -13.63 60.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 110.136 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.565 HG23 ' HG3' ' A' ' 54' ' ' GLU . 93.2 t -103.01 -60.76 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.89 . . . . 0.0 110.117 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -45.87 108.75 0.14 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.397 -0.815 . . . . 0.0 110.185 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.41 13.34 25.59 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.312 -0.868 . . . . 0.0 110.539 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -110.38 -60.27 1.83 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.11 -0.994 . . . . 0.0 109.87 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 132.56 47.0 0.11 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.466 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 19.4 p30 -126.22 -31.27 2.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.372 -1.075 . . . . 0.0 110.526 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.466 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 115.49 -60.2 0.41 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.42 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 81.5 p -89.59 170.27 10.62 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.07 -1.253 . . . . 0.0 110.566 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.493 ' CD1' HG11 ' A' ' 55' ' ' VAL . 81.7 mt -108.21 152.26 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.054 -1.029 . . . . 0.0 110.291 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.452 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.4 m-20 -101.15 179.54 4.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.358 -0.839 . . . . 0.0 110.242 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.542 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 7.5 t80 -73.08 -42.45 7.16 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 111.038 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 46.6 Cg_endo -76.87 -30.28 4.75 Favored 'Trans proline' 0 C--N 1.327 -0.567 0 O-C-N 123.125 1.066 . . . . 0.0 109.837 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -72.7 -20.76 61.16 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.425 -0.797 . . . . 0.0 109.147 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.546 ' CE2' ' HE3' ' A' ' 72' ' ' MET . 8.5 t80 -82.05 -49.47 10.18 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.589 -0.694 . . . . 0.0 110.048 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.87 -18.5 64.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.004 -1.06 . . . . 0.0 110.232 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 72.8 m -90.04 -33.82 16.18 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.168 -0.957 . . . . 0.0 110.47 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.49 ' SD ' HG13 ' A' ' 55' ' ' VAL . 4.9 ptm -77.52 -25.15 50.02 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.171 -0.956 . . . . 0.0 110.265 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.546 ' HE3' ' CE2' ' A' ' 68' ' ' PHE . 1.1 mmt -84.4 -33.57 23.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.231 -0.918 . . . . 0.0 110.257 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.18 -0.95 . . . . 0.0 110.03 179.946 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.441 ' HG3' ' N ' ' A' ' 85' ' ' ILE . 15.8 pt-20 . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 121.404 0.621 . . . . 0.0 110.109 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.441 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 56.9 mt -53.43 -44.12 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.193 -0.942 . . . . 0.0 109.69 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -50.98 -49.65 59.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.354 -0.842 . . . . 0.0 110.039 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 4.7 mp0 -54.44 -41.84 69.87 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.234 -0.916 . . . . 0.0 110.145 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.81 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -61.45 -63.94 1.11 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.255 -0.903 . . . . 0.0 110.285 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.466 ' CZ ' ' OD2' ' A' ' 93' ' ' ASP . 9.2 t80 -45.62 -27.85 0.86 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.281 -0.887 . . . . 0.0 110.466 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.428 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 34.7 ttm-85 -66.62 -50.76 61.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.184 -0.948 . . . . 0.0 109.705 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.81 HG22 ' O ' ' A' ' 88' ' ' ALA . 33.2 m -70.04 -18.38 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.269 -0.895 . . . . 0.0 110.329 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.531 ' HA ' HG21 ' A' ' 108' ' ' VAL . 37.0 m-85 -94.52 -8.42 38.39 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.141 -0.974 . . . . 0.0 110.443 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.466 ' OD2' ' CZ ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -140.54 35.56 1.83 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.096 -1.002 . . . . 0.0 110.194 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.21 10.77 15.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 110.361 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 2.7 p30 -83.49 -19.61 35.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.082 -1.011 . . . . 0.0 110.196 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.68 29.21 5.39 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 17.9 t-20 -98.42 -72.49 0.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.332 -1.099 . . . . 0.0 110.102 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.494 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 135.83 -14.81 4.1 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.499 ' CE1' ' OD1' ' A' ' 137' ' ' ASN . 27.6 m-85 -139.18 152.07 47.1 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.018 -1.283 . . . . 0.0 109.971 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.439 HG23 ' HB3' ' A' ' 92' ' ' PHE . 37.9 mt -81.61 121.79 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.022 -1.049 . . . . 0.0 110.159 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.1 m -111.56 176.28 5.08 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.469 -0.769 . . . . 0.0 109.828 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.21 -56.24 10.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.155 -0.966 . . . . 0.0 110.194 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -49.78 -54.16 20.84 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.236 -0.915 . . . . 0.0 110.333 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.462 ' O ' HG23 ' A' ' 108' ' ' VAL . 50.7 mt-10 -53.47 -43.67 68.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 tt -59.09 -37.95 78.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.324 -0.86 . . . . 0.0 110.38 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.818 ' O ' HG23 ' A' ' 110' ' ' THR . 2.5 tmt_? -69.47 -28.44 66.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.05 -1.031 . . . . 0.0 109.632 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -71.55 -29.44 64.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.336 -0.853 . . . . 0.0 109.843 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.531 HG21 ' HA ' ' A' ' 92' ' ' PHE . 34.0 t -79.28 -50.2 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.316 -0.865 . . . . 0.0 110.073 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -49.95 -43.74 50.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.363 -0.836 . . . . 0.0 110.266 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.818 HG23 ' O ' ' A' ' 106' ' ' ARG . 69.1 p -50.7 -43.41 57.68 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.284 -0.885 . . . . 0.0 110.023 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -58.46 -41.22 84.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.311 -0.868 . . . . 0.0 110.243 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.3 mt -62.09 -53.52 54.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.263 -0.898 . . . . 0.0 110.365 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.66 40.07 0.34 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -111.3 -175.04 2.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.164 -1.198 . . . . 0.0 110.197 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -144.23 81.14 1.66 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.921 . . . . 0.0 110.147 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.97 161.03 15.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.304 -0.873 . . . . 0.0 110.089 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.431 HG22 ' HG2' ' A' ' 120' ' ' GLU . 11.0 t -98.6 -165.4 1.24 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.887 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -80.98 -43.97 18.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.117 -0.989 . . . . 0.0 110.362 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 122' ' ' ASP . 65.2 mm-40 -50.61 -54.35 23.49 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.26 -0.9 . . . . 0.0 110.719 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.431 ' HG2' HG22 ' A' ' 117' ' ' THR . 69.9 mm-40 -48.69 -61.93 1.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.12 -0.987 . . . . 0.0 110.698 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.2 t -47.73 -39.19 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.206 -0.933 . . . . 0.0 110.625 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.441 ' HB3' ' O ' ' A' ' 119' ' ' GLU . 38.7 t70 -56.57 -47.5 79.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.994 -1.066 . . . . 0.0 110.066 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.46 -25.68 66.84 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.248 -0.908 . . . . 0.0 110.286 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 24.4 mmm -70.27 -57.06 5.3 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.187 -0.945 . . . . 0.0 110.14 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.589 HG23 HG23 ' A' ' 136' ' ' VAL . 25.4 mm -57.34 -31.39 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.381 -0.825 . . . . 0.0 110.409 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -76.64 -32.95 58.32 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.135 -0.978 . . . . 0.0 110.235 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -69.97 -33.23 71.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 0.0 110.141 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.475 ' HA ' ' HB2' ' A' ' 144' ' ' MET . . . -79.81 -43.41 22.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.927 . . . . 0.0 110.336 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -60.21 98.35 0.06 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.135 -0.978 . . . . 0.0 109.943 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.442 ' CD1' ' HA ' ' A' ' 140' ' ' GLU . 5.4 mt -56.22 -42.97 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.294 -0.879 . . . . 0.0 110.333 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 53.5 p-10 -76.65 -15.92 59.68 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.042 -1.036 . . . . 0.0 110.231 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.456 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 55.68 55.18 30.14 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.425 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 2.5 p30 -97.53 -21.77 16.92 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.207 -1.172 . . . . 0.0 110.267 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 130.66 0.56 5.27 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.384 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.425 ' HG3' ' OD1' ' A' ' 133' ' ' ASP . 0.1 OUTLIER -154.95 151.01 28.01 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.862 -1.375 . . . . 0.0 110.6 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.589 HG23 HG23 ' A' ' 125' ' ' ILE . 71.8 t -100.25 142.14 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.202 -0.936 . . . . 0.0 110.305 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.499 ' OD1' ' CE1' ' A' ' 99' ' ' TYR . 2.5 t30 -111.2 -169.59 1.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.426 -0.796 . . . . 0.0 110.047 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.683 ' O ' HG23 ' A' ' 142' ' ' VAL . 49.3 t80 -75.37 -57.06 4.12 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.26 -0.9 . . . . 0.0 110.264 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -55.68 -52.02 65.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.86 . . . . 0.0 110.604 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.442 ' HA ' ' CD1' ' A' ' 130' ' ' ILE . 51.7 mt-10 -56.82 -46.88 81.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 110.526 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.588 ' CD1' ' HE2' ' A' ' 144' ' ' MET . 35.2 t80 -59.82 -25.36 64.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.094 -1.004 . . . . 0.0 110.322 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 138' ' ' TYR . 60.2 t -86.48 -22.25 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.247 -0.908 . . . . 0.0 110.383 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -98.82 -9.13 24.78 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.34 -0.85 . . . . 0.0 110.663 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.588 ' HE2' ' CD1' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -90.69 -30.93 16.82 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.002 -1.061 . . . . 0.0 110.806 -179.686 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.415 ' HE2' ' HE1' ' A' ' 144' ' ' MET . 43.4 ttm -88.98 -45.65 9.49 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.071 -1.018 . . . . 0.0 109.609 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 65.6 p . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.445 -0.784 . . . . 0.0 109.86 179.449 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.162 0.506 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -63.37 -28.37 69.95 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.065 -1.022 . . . . 0.0 110.202 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -73.37 -53.7 10.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.18 -0.95 . . . . 0.0 110.278 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.3 mt -54.84 -44.49 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 110.103 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.32 -36.12 79.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.335 -0.853 . . . . 0.0 109.481 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -63.62 -36.98 85.6 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.301 -0.875 . . . . 0.0 109.766 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -73.61 -22.8 59.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.318 -0.864 . . . . 0.0 109.817 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -72.66 -39.62 66.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.8 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -70.85 -39.29 73.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.394 -0.816 . . . . 0.0 110.031 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.95 -53.06 52.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.186 -0.946 . . . . 0.0 109.996 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.519 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 26.5 t80 -55.5 -39.37 70.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 109.866 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.6 m -67.69 -30.8 70.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -0.876 . . . . 0.0 109.981 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.772 HD13 ' O ' ' A' ' 18' ' ' LEU . 1.9 tm? -65.07 -38.58 91.24 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.347 -0.846 . . . . 0.0 110.033 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -75.87 -61.92 1.77 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.77 112.74 0.7 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 110.027 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -109.23 -42.13 4.47 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.227 -0.921 . . . . 0.0 110.69 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.404 ' OD1' ' OE2' ' A' ' 31' ' ' GLU . 11.0 p-10 -71.34 -33.13 69.33 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.121 -0.987 . . . . 0.0 110.253 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.06 74.17 1.1 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -142.83 15.69 1.94 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.276 -1.132 . . . . 0.0 110.242 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.594 ' O ' HG23 ' A' ' 26' ' ' THR . . . 49.19 35.53 19.94 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 25' ' ' GLY . 20.3 p -156.86 149.29 23.28 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.228 -1.16 . . . . 0.0 110.119 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.3 mt -112.87 121.78 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.274 -0.892 . . . . 0.0 110.388 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.577 HG23 ' H ' ' A' ' 30' ' ' LYS . 8.8 t -122.39 -175.66 3.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -0.872 . . . . 0.0 109.779 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.532 HG21 ' OE1' ' A' ' 49' ' ' GLN . 29.0 p -62.16 -26.34 68.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.114 -0.991 . . . . 0.0 110.189 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.577 ' H ' HG23 ' A' ' 28' ' ' THR . 19.0 mtmt -69.87 -60.36 2.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -0.907 . . . . 0.0 110.018 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.449 ' O ' HG23 ' A' ' 35' ' ' VAL . 84.8 mt-10 -59.07 -61.2 2.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.11 -0.994 . . . . 0.0 109.778 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.04 HD22 HD11 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -51.53 -33.38 31.69 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.272 -0.892 . . . . 0.0 109.761 179.768 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.29 -44.91 94.81 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.446 ' O ' ' HB2' ' A' ' 38' ' ' SER . 90.8 m -76.62 -17.4 59.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -1.148 . . . . 0.0 109.781 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 31' ' ' GLU . 54.2 t -73.42 -39.3 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.291 -0.881 . . . . 0.0 110.135 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 21.4 mmt -90.33 -27.58 19.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -0.896 . . . . 0.0 110.466 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -82.61 -26.9 31.84 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.273 -0.892 . . . . 0.0 110.588 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.479 ' CB ' HD23 ' A' ' 39' ' ' LEU . 22.4 t -51.81 -32.69 32.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.995 . . . . 0.0 110.126 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.479 HD23 ' CB ' ' A' ' 38' ' ' SER . 0.5 OUTLIER -158.46 69.18 0.49 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.897 . . . . 0.0 110.153 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . 177.4 -64.84 0.09 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 40' ' ' GLY . 53.4 mt-30 55.14 19.62 2.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.256 -1.144 . . . . 0.0 110.314 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.506 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 2.6 m120 -72.35 -58.32 3.13 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.17 -0.956 . . . . 0.0 110.412 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.506 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 42.7 Cg_endo -70.66 -169.51 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.768 1.404 . . . . 0.0 110.299 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.626 HG22 ' H ' ' A' ' 45' ' ' GLU . 4.1 m -135.72 -177.31 4.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.288 -0.883 . . . . 0.0 109.832 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.626 ' H ' HG22 ' A' ' 44' ' ' THR . 45.2 mt-10 -67.24 -50.3 61.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.087 -1.008 . . . . 0.0 110.252 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.79 -56.65 15.58 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.197 -0.939 . . . . 0.0 110.04 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -52.01 -34.78 44.37 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.207 -0.933 . . . . 0.0 109.408 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.757 HD11 HD23 ' A' ' 32' ' ' LEU . 9.5 tt -63.68 -45.02 91.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.423 -0.798 . . . . 0.0 109.224 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.532 ' OE1' HG21 ' A' ' 29' ' ' THR . 1.5 tp-100 -49.47 -43.65 45.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.348 -0.845 . . . . 0.0 109.172 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -62.83 -45.21 93.68 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.412 -0.805 . . . . 0.0 109.342 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.438 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 3.7 ttp -59.36 -17.65 31.7 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.345 -0.847 . . . . 0.0 109.772 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.04 HD11 HD22 ' A' ' 32' ' ' LEU . 31.0 mm -90.46 -28.73 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 110.195 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -74.9 -27.18 60.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.323 -0.86 . . . . 0.0 110.552 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.637 ' HG3' HG23 ' A' ' 55' ' ' VAL . 25.3 pt-20 -74.35 -9.14 58.31 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.095 -1.003 . . . . 0.0 110.497 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.637 HG23 ' HG3' ' A' ' 54' ' ' GLU . 44.0 t -112.01 -23.18 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.043 -1.036 . . . . 0.0 110.523 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -91.26 109.05 20.32 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.13 -0.981 . . . . 0.0 110.333 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.25 16.15 21.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 110.329 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 40.1 m-20 -97.82 -69.83 0.74 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.274 -0.892 . . . . 0.0 110.42 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.65 -22.1 0.33 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -69.53 -21.48 63.65 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.08 -1.247 . . . . 0.0 110.123 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.54 -41.46 2.3 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.8 p -89.8 170.22 10.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.128 -1.219 . . . . 0.0 110.52 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.439 HD13 HG11 ' A' ' 55' ' ' VAL . 75.1 mt -104.55 151.43 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.367 -0.833 . . . . 0.0 109.892 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.425 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 1.6 m-20 -112.03 -167.28 1.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 110.255 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.552 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 23.5 t80 -73.97 -43.35 6.25 Favored Pre-proline 0 C--N 1.303 -1.422 0 O-C-N 121.284 -0.885 . . . . 0.0 111.099 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.3 Cg_endo -74.42 -30.04 8.67 Favored 'Trans proline' 0 C--O 1.211 -0.859 0 O-C-N 123.026 1.014 . . . . 0.0 110.006 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.435 ' HB3' HG23 ' A' ' 63' ' ' ILE . 1.3 tt0 -75.02 -26.02 59.19 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.098 -1.001 . . . . 0.0 108.918 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.562 ' CE1' ' CE ' ' A' ' 72' ' ' MET . 80.4 t80 -75.36 -43.56 49.76 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.62 -0.675 . . . . 0.0 110.405 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.406 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 4.2 tp -80.8 -16.73 52.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.341 -0.85 . . . . 0.0 110.363 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 34.6 m -84.28 -34.02 23.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.065 -1.022 . . . . 0.0 110.651 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.523 ' HE3' ' HG3' ' A' ' 72' ' ' MET . 0.0 OUTLIER -88.67 -30.11 19.39 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.94 -1.1 . . . . 0.0 110.52 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.562 ' CE ' ' CE1' ' A' ' 68' ' ' PHE . 25.3 mtt -81.56 -11.35 59.19 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.047 -1.033 . . . . 0.0 110.515 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.125 -0.984 . . . . 0.0 110.042 179.715 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.137 0.494 . . . . 0.0 110.61 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.915 HD11 HG21 ' A' ' 146' ' ' THR . 88.7 mt -59.8 -48.68 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.137 -0.977 . . . . 0.0 110.407 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -56.69 -53.4 58.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.185 -0.947 . . . . 0.0 110.112 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -46.93 -41.78 16.6 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.288 -0.883 . . . . 0.0 110.339 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.517 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -59.61 -59.36 5.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.147 -0.971 . . . . 0.0 110.099 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -49.63 -23.88 1.93 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.16 -0.963 . . . . 0.0 110.461 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -76.42 -43.95 38.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.285 -0.885 . . . . 0.0 111.171 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 88' ' ' ALA . 16.6 m -79.42 -19.23 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.042 -1.036 . . . . 0.0 110.966 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.489 ' CD1' HG23 ' A' ' 91' ' ' VAL . 24.9 m-85 -89.36 -24.46 21.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.102 -0.999 . . . . 0.0 109.982 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -106.89 92.7 4.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.276 -0.89 . . . . 0.0 109.366 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -100.17 -33.55 10.4 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.167 -0.958 . . . . 0.0 111.402 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 3.1 p30 -69.61 -38.45 77.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.956 -1.09 . . . . 0.0 110.438 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 106.41 41.95 1.68 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.446 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 39.4 p-10 -110.96 -14.82 13.89 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.352 -1.087 . . . . 0.0 110.412 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.5 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 69.28 43.99 67.97 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.5 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 33.5 m-85 -157.8 116.51 3.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.448 -1.031 . . . . 0.0 110.15 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 24.2 mt -87.86 113.22 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.01 -1.056 . . . . 0.0 109.647 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 90.5 p -99.38 159.22 15.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.167 -0.958 . . . . 0.0 110.266 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.2 -18.26 24.76 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.139 -0.976 . . . . 0.0 110.098 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.75 -66.91 0.65 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.233 -0.917 . . . . 0.0 109.983 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.915 ' O ' HG23 ' A' ' 108' ' ' VAL . 92.0 mt-10 -51.65 -39.22 57.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.183 -0.948 . . . . 0.0 109.724 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.959 HD12 HD11 ' A' ' 125' ' ' ILE . 1.5 tt -64.27 -41.34 96.97 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.593 -0.692 . . . . 0.0 110.311 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 57.7 ttp85 -65.89 -23.15 66.58 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.221 -0.924 . . . . 0.0 110.027 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -94.52 -14.7 24.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.384 -0.822 . . . . 0.0 110.245 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.915 HG23 ' O ' ' A' ' 104' ' ' GLU . 72.2 t -82.45 -49.02 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.314 -0.866 . . . . 0.0 110.264 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.6 mmt -60.14 -55.48 33.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.165 -0.959 . . . . 0.0 110.387 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.3 p -49.67 -30.42 9.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.249 -0.907 . . . . 0.0 110.491 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -74.18 -58.48 3.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.218 -0.926 . . . . 0.0 110.293 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.3 mt -47.37 -76.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.257 -0.902 . . . . 0.0 110.326 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.35 43.09 0.06 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -125.3 159.61 31.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -1.208 . . . . 0.0 110.127 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.75 60.4 1.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 110.441 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.03 -174.22 4.35 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.253 -0.905 . . . . 0.0 109.88 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 121' ' ' VAL . 6.9 t -126.92 173.32 9.7 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.073 -1.017 . . . . 0.0 110.277 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 88.4 m-20 -58.48 -39.04 78.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -0.89 . . . . 0.0 110.283 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.03 -68.16 0.34 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.27 -0.894 . . . . 0.0 111.057 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.448 ' OE1' ' N ' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -47.78 -47.14 30.89 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.271 -0.893 . . . . 0.0 111.194 -179.181 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 117' ' ' THR . 78.9 t -54.89 -48.58 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.011 -1.056 . . . . 0.0 110.412 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -61.84 -30.56 70.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.106 -0.996 . . . . 0.0 109.938 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.11 -32.36 70.36 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.281 -0.887 . . . . 0.0 109.728 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' A' ' 120' ' ' GLU . 83.7 mtp -66.7 -53.7 30.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.359 -0.838 . . . . 0.0 109.75 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.959 HD11 HD12 ' A' ' 105' ' ' LEU . 44.0 mm -59.01 -29.25 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.303 -0.873 . . . . 0.0 110.114 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -77.9 -28.36 49.78 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.274 -0.892 . . . . 0.0 109.907 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.38 -29.26 62.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.441 -0.787 . . . . 0.0 110.06 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.492 ' HB1' ' HG2' ' A' ' 144' ' ' MET . . . -94.75 -24.13 17.24 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.344 -0.847 . . . . 0.0 110.401 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.522 ' OD1' HG22 ' A' ' 136' ' ' VAL . 3.7 m-20 -73.16 95.61 2.1 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.981 -1.074 . . . . 0.0 111.126 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 54.8 mt -92.04 -9.52 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.495 -0.753 . . . . 0.0 110.544 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 57.2 p-10 -149.7 -18.22 0.27 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.056 -1.028 . . . . 0.0 112.106 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.492 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . -95.1 -51.75 1.86 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 2.6 m-20 60.69 107.95 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.667 -0.902 . . . . 0.0 108.642 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 100.58 -26.37 24.86 Favored Glycine 0 C--N 1.292 -1.875 0 N-CA-C 107.059 -2.416 . . . . 0.0 107.059 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.407 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 0.2 OUTLIER -139.71 134.92 32.6 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.811 -0.817 . . . . 0.0 109.444 179.036 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.759 HG23 HG23 ' A' ' 125' ' ' ILE . 98.5 t -105.92 142.14 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.311 -0.868 . . . . 0.0 110.494 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -112.25 -176.06 2.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.302 -0.874 . . . . 0.0 109.83 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.57 ' O ' HG23 ' A' ' 142' ' ' VAL . 27.9 t80 -67.47 -36.47 81.21 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.075 -1.016 . . . . 0.0 110.224 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -71.82 -35.6 69.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.064 -1.023 . . . . 0.0 110.285 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.512 ' OE2' ' HA ' ' A' ' 129' ' ' ASP . 35.9 mt-10 -70.27 -31.78 69.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.203 -0.936 . . . . 0.0 110.497 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.617 ' HE2' HG23 ' A' ' 85' ' ' ILE . 65.6 t80 -79.34 -29.37 42.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.224 -0.923 . . . . 0.0 110.669 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 138' ' ' TYR . 96.2 t -80.24 -23.11 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.098 -1.001 . . . . 0.0 110.701 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -93.23 -31.04 14.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.164 -0.96 . . . . 0.0 110.697 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.492 ' HG2' ' HB1' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -79.07 -29.94 43.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.099 -1.001 . . . . 0.0 110.314 -179.82 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 59.0 tpp -89.12 -58.34 2.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 109.912 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.915 HG21 HD11 ' A' ' 85' ' ' ILE . 64.7 p . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.373 -0.829 . . . . 0.0 110.064 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.347 0.594 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -74.05 -46.43 43.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.255 -0.903 . . . . 0.0 109.694 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -65.88 -55.07 18.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.431 -0.793 . . . . 0.0 109.593 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.63 HG23 HD11 ' A' ' 69' ' ' LEU . 65.6 mt -53.46 -42.41 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.368 -0.832 . . . . 0.0 109.695 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -59.59 -36.17 75.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -0.881 . . . . 0.0 109.894 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -61.95 -54.53 40.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.624 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -54.68 -36.28 64.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.748 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 17.5 mttt -60.13 -43.14 95.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.327 -0.858 . . . . 0.0 109.914 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -61.31 -38.48 86.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.914 . . . . 0.0 109.791 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.437 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.96 -45.58 93.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.238 -0.914 . . . . 0.0 109.968 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -59.75 -47.51 85.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.165 -0.959 . . . . 0.0 109.768 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.9 m -59.19 -27.31 65.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.929 . . . . 0.0 109.376 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.748 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.4 tm? -73.75 -34.32 64.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.478 -0.764 . . . . 0.0 109.613 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.437 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 15.4 m-85 -80.91 -68.08 0.72 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.43 -0.794 . . . . 0.0 109.998 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.404 ' OD1' ' OD1' ' A' ' 24' ' ' ASP . 46.1 t0 -58.88 115.24 2.98 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.243 -0.911 . . . . 0.0 110.05 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -104.19 -36.83 7.52 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.197 -0.94 . . . . 0.0 110.166 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -70.19 -11.01 60.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.234 -0.916 . . . . 0.0 110.366 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.57 97.54 0.01 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 10.7 p-10 -150.58 -42.91 0.12 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.376 -1.073 . . . . 0.0 110.108 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.578 ' O ' HG23 ' A' ' 26' ' ' THR . . . 120.02 15.88 5.05 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 25' ' ' GLY . 13.1 p -155.51 132.57 10.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.091 -1.241 . . . . 0.0 110.379 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.436 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 26.6 mt -90.46 127.7 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.282 -0.886 . . . . 0.0 110.109 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.7 p -107.28 -163.71 0.93 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 110.26 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.768 HG22 HD12 ' A' ' 52' ' ' ILE . 7.4 p -86.09 -38.06 18.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.295 -0.878 . . . . 0.0 110.557 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -60.76 -57.74 11.42 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.079 -1.013 . . . . 0.0 110.116 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -55.75 -53.63 54.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.37 -0.831 . . . . 0.0 109.999 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.5 tp -56.56 -24.93 50.53 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.095 -1.003 . . . . 0.0 109.549 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.21 -53.31 45.67 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.461 ' HA ' ' HB2' ' A' ' 37' ' ' ARG . 27.8 m -66.1 -35.83 81.56 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.251 -1.147 . . . . 0.0 109.793 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.5 t -56.11 -39.9 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.362 -0.836 . . . . 0.0 109.993 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.46 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 24.8 mmt -85.8 -15.31 42.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.353 -0.842 . . . . 0.0 109.954 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.461 ' HB2' ' HA ' ' A' ' 34' ' ' THR . 0.5 OUTLIER -83.05 -14.74 53.24 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.283 -0.886 . . . . 0.0 110.514 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.515 ' C ' HD22 ' A' ' 39' ' ' LEU . 56.3 m -95.92 -20.9 18.4 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.192 -0.942 . . . . 0.0 110.976 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 39' ' ' LEU . 4.5 mm? -99.75 50.08 0.92 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.03 -1.044 . . . . 0.0 110.474 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 48.38 93.32 0.01 OUTLIER Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.452 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -176.82 -41.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -1.151 . . . . 0.0 110.091 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.459 ' HA ' ' CD ' ' A' ' 37' ' ' ARG . 5.8 p-10 36.36 62.16 2.98 Favored Pre-proline 0 N--CA 1.508 2.44 0 O-C-N 121.948 -0.47 . . . . 0.0 111.191 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.46 ' HG3' ' HB3' ' A' ' 36' ' ' MET . 49.0 Cg_endo -76.2 -176.5 3.1 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.835 1.44 . . . . 0.0 110.183 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.406 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 72.4 p -113.32 161.19 17.55 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.356 -0.84 . . . . 0.0 110.057 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -64.47 -29.34 70.38 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.258 -0.901 . . . . 0.0 110.325 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.83 -69.48 0.44 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.179 -0.951 . . . . 0.0 110.101 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -49.15 -30.72 7.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.135 -0.978 . . . . 0.0 109.432 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.507 HD21 ' HA ' ' A' ' 29' ' ' THR . 5.5 tt -63.19 -47.5 82.31 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.48 -0.762 . . . . 0.0 109.719 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.454 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 37.3 tt0 -54.72 -47.32 73.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.192 -0.943 . . . . 0.0 109.621 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.05 -33.49 72.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -0.892 . . . . 0.0 109.581 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.453 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 56.1 ttp -68.95 -27.66 65.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 109.743 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.768 HD12 HG22 ' A' ' 29' ' ' THR . 38.4 mt -79.84 -23.66 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.355 -0.84 . . . . 0.0 109.602 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 49' ' ' GLN . 3.1 m-80 -60.77 -32.17 71.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.405 -0.809 . . . . 0.0 110.166 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.581 ' HG3' HG23 ' A' ' 55' ' ' VAL . 1.6 pt-20 -81.54 -22.46 37.86 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.197 -0.94 . . . . 0.0 110.21 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.776 HG13 ' SD ' ' A' ' 71' ' ' MET . 92.2 t -93.24 -11.08 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.129 -0.982 . . . . 0.0 110.325 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -118.43 113.98 22.2 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.046 -1.034 . . . . 0.0 110.549 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.21 9.7 28.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.41 -0.806 . . . . 0.0 109.814 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 0.9 OUTLIER -82.35 -54.77 4.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.292 -0.88 . . . . 0.0 110.13 -179.75 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.24 29.03 1.39 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -118.91 -22.97 7.09 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.247 -1.149 . . . . 0.0 110.221 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.39 -14.37 65.16 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 80.9 p -119.83 164.53 15.87 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.052 -1.263 . . . . 0.0 110.861 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.436 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 64.2 mt -106.86 158.08 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.354 -0.841 . . . . 0.0 110.401 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.424 ' OD2' ' HD2' ' A' ' 66' ' ' PRO . 8.5 t70 -113.44 -166.8 1.12 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.41 -0.807 . . . . 0.0 109.614 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.523 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.2 t80 -84.2 -44.86 0.75 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.075 -1.015 . . . . 0.0 111.389 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.7 Cg_endo -75.21 -21.02 15.89 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 O-C-N 123.191 1.101 . . . . 0.0 110.351 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -78.66 -32.94 47.4 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.281 -0.887 . . . . 0.0 108.735 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -70.93 -53.25 15.65 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.433 0.635 . . . . 0.0 110.198 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.708 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 7.8 tt -60.56 -40.16 90.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.308 -0.87 . . . . 0.0 110.168 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.8 m -73.77 -17.65 61.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.164 -0.96 . . . . 0.0 110.47 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.776 ' SD ' HG13 ' A' ' 55' ' ' VAL . 62.1 ttp -76.96 -50.75 12.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.069 -1.019 . . . . 0.0 110.771 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.588 ' HE3' ' CE ' ' A' ' 71' ' ' MET . 45.6 mtt -90.59 -43.86 9.92 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.101 -0.999 . . . . 0.0 111.317 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.497 1.916 0 O-C-N 121.185 -0.947 . . . . 0.0 111.15 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 121.35 0.595 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 12.4 mt -55.94 -35.03 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 110.292 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.8 ttm-85 -50.61 -49.5 56.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 109.553 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -61.54 -49.03 78.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.27 -0.893 . . . . 0.0 109.418 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.4 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -56.44 -19.44 15.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 109.852 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -82.42 -40.44 21.23 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.027 -1.045 . . . . 0.0 109.721 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -56.97 -40.86 77.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.527 -0.733 . . . . 0.0 109.835 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 92' ' ' PHE . 17.7 m -73.78 -42.86 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.127 -0.983 . . . . 0.0 110.602 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.94 ' CE1' HD12 ' A' ' 105' ' ' LEU . 15.8 m-85 -79.84 4.74 15.63 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.002 -1.061 . . . . 0.0 110.77 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -149.92 80.35 1.37 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.077 -1.014 . . . . 0.0 110.092 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -90.45 31.46 1.03 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -0.874 . . . . 0.0 110.249 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -127.88 -113.61 0.27 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -0.962 . . . . 0.0 110.057 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.54 32.13 0.18 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.455 ' HB2' ' CD2' ' A' ' 99' ' ' TYR . 14.2 p30 -111.26 -21.08 12.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.364 -1.08 . . . . 0.0 110.308 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 67.05 10.74 57.17 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.455 ' CD2' ' HB2' ' A' ' 97' ' ' ASN . 8.1 m-85 -107.49 105.15 14.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.155 -1.203 . . . . 0.0 109.88 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 31.0 mt -76.64 130.16 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.32 -0.862 . . . . 0.0 109.554 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.0 m -116.08 172.69 7.0 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.34 -0.85 . . . . 0.0 110.559 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.718 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -66.79 -37.79 85.27 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.557 -0.715 . . . . 0.0 110.275 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.41 -60.84 3.22 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.255 -0.903 . . . . 0.0 110.305 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.707 ' O ' HG23 ' A' ' 108' ' ' VAL . 50.0 mt-10 -56.43 -28.31 59.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.166 -0.959 . . . . 0.0 110.16 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.94 HD12 ' CE1' ' A' ' 92' ' ' PHE . 19.0 tp -66.12 -39.83 90.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.148 -0.97 . . . . 0.0 110.523 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.72 ' O ' HG23 ' A' ' 110' ' ' THR . 30.4 ttp180 -75.12 -29.81 60.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.062 -1.024 . . . . 0.0 110.078 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.62 -21.58 48.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.303 -0.873 . . . . 0.0 110.158 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 104' ' ' GLU . 54.0 t -83.74 -48.97 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 109.856 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.652 ' SD ' HD13 ' A' ' 116' ' ' LEU . 65.1 mtt -63.01 -32.45 73.82 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.385 -0.822 . . . . 0.0 109.985 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.72 HG23 ' O ' ' A' ' 106' ' ' ARG . 2.9 p -55.44 -41.28 72.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.341 -0.85 . . . . 0.0 109.64 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -73.76 -44.72 55.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.892 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.4 mt -58.78 -73.39 0.08 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.208 -0.933 . . . . 0.0 110.205 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 155.84 62.3 0.01 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.5 ' HB3' HD11 ' A' ' 116' ' ' LEU . 54.9 mm-40 -143.94 157.81 44.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.206 -1.173 . . . . 0.0 110.439 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.407 ' N ' ' CD ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -126.69 109.52 12.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.282 -0.886 . . . . 0.0 110.132 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.652 HD13 ' SD ' ' A' ' 109' ' ' MET . 4.2 mp -125.89 162.44 25.18 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.226 -0.921 . . . . 0.0 110.67 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.529 HG22 ' N ' ' A' ' 118' ' ' ASP . 64.3 m -114.05 173.14 6.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.389 -0.819 . . . . 0.0 109.951 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.529 ' N ' HG22 ' A' ' 117' ' ' THR . 43.1 m-20 -53.23 -38.44 62.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.148 -0.97 . . . . 0.0 110.855 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -66.4 -50.23 64.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.961 -1.087 . . . . 0.0 110.735 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.446 ' OE1' ' N ' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -55.62 -57.68 10.96 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.17 -0.956 . . . . 0.0 110.494 -179.739 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.718 ' CG1' ' HB1' ' A' ' 102' ' ' ALA . 21.0 t -51.7 -47.4 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.347 -0.845 . . . . 0.0 110.209 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -57.65 -34.01 68.89 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.055 -1.028 . . . . 0.0 109.916 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.437 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 32.8 tt0 -75.48 -25.3 57.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.89 . . . . 0.0 110.093 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.561 ' HE2' HD21 ' A' ' 105' ' ' LEU . 10.4 mmm -75.35 -47.29 28.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.204 -0.935 . . . . 0.0 110.133 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.447 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 26.8 mm -70.94 -27.08 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.218 -0.926 . . . . 0.0 109.869 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -75.1 -56.05 5.12 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.403 -0.811 . . . . 0.0 110.216 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.455 ' OE1' ' N ' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -57.35 -31.62 65.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.092 -1.005 . . . . 0.0 109.725 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.455 ' N ' ' OE1' ' A' ' 127' ' ' GLU . . . -79.11 -27.86 42.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 109.087 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 47.6 t0 -63.59 95.37 0.1 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.455 -0.778 . . . . 0.0 109.925 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.54 HD12 ' HG2' ' A' ' 140' ' ' GLU . 50.2 mt -80.21 -28.76 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.255 -0.903 . . . . 0.0 110.783 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 2.8 p30 -86.11 -28.39 24.06 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.192 -0.942 . . . . 0.0 110.848 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 88.95 51.91 2.9 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 36.9 p-10 -118.91 -21.57 7.69 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.3 -1.118 . . . . 0.0 110.459 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.59 -25.99 7.45 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.263 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.403 ' CG ' ' OD2' ' A' ' 133' ' ' ASP . 9.0 pt20 -114.7 165.67 12.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.14 -1.212 . . . . 0.0 110.915 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.412 ' CG2' ' HB3' ' A' ' 128' ' ' ALA . 56.1 t -109.82 131.04 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.416 -0.803 . . . . 0.0 109.36 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 10.7 t30 -94.78 -175.13 3.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.065 -1.022 . . . . 0.0 110.675 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.42 ' CD1' ' C ' ' A' ' 138' ' ' TYR . 17.3 t80 -70.87 -59.69 2.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.383 -0.823 . . . . 0.0 110.65 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -52.2 -43.06 64.0 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.162 -0.961 . . . . 0.0 110.293 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.54 ' HG2' HD12 ' A' ' 130' ' ' ILE . 52.1 mt-10 -66.58 -33.31 75.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.022 -1.049 . . . . 0.0 109.896 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.742 ' CZ ' ' HE3' ' A' ' 145' ' ' MET . 25.5 t80 -68.79 -20.13 64.33 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.41 -0.806 . . . . 0.0 109.625 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 138' ' ' TYR . 65.2 t -90.34 -41.76 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.304 -0.872 . . . . 0.0 110.891 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.55 -14.66 59.6 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.13 -0.982 . . . . 0.0 110.855 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.511 ' CE ' ' CD1' ' A' ' 141' ' ' PHE . 4.9 ptt? -85.35 -27.06 26.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.018 -1.051 . . . . 0.0 109.83 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.742 ' HE3' ' CZ ' ' A' ' 141' ' ' PHE . 52.5 mtt -84.82 -68.56 0.71 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.486 -0.759 . . . . 0.0 110.317 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.7 p . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.607 -0.683 . . . . 0.0 110.177 -179.946 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 121.047 0.451 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 3.9 mt-10 -66.82 -69.63 0.3 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.968 -1.083 . . . . 0.0 110.426 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -49.18 -55.13 13.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.907 . . . . 0.0 110.083 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 9' ' ' ILE . 65.9 mt -49.65 -40.41 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.166 -0.959 . . . . 0.0 109.896 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -61.35 -40.53 94.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 110.0 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.32 -41.09 96.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 110.209 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -61.65 -52.82 62.77 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.253 -0.904 . . . . 0.0 110.002 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -49.64 -46.15 49.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.146 -0.971 . . . . 0.0 109.667 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -52.87 -50.58 63.53 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.305 -0.872 . . . . 0.0 109.736 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.66 -37.8 59.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.399 -0.813 . . . . 0.0 109.834 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.507 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 18.8 t80 -58.25 -49.87 75.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.432 -0.793 . . . . 0.0 109.831 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.2 t -60.49 -32.2 71.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.296 -0.878 . . . . 0.0 110.147 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.696 ' O ' HD23 ' A' ' 18' ' ' LEU . 5.4 tt -61.51 -44.57 96.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.264 -0.897 . . . . 0.0 110.065 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -70.48 -57.9 4.29 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.168 -0.957 . . . . 0.0 110.214 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -58.64 107.41 0.51 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.278 -0.888 . . . . 0.0 110.252 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -110.8 52.87 0.72 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.163 -0.961 . . . . 0.0 110.989 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.423 ' OD2' ' OD2' ' A' ' 24' ' ' ASP . 6.2 p-10 -151.72 -42.9 0.11 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.046 -1.034 . . . . 0.0 109.959 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.5 64.94 0.57 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 1.4 p30 -144.07 -44.56 0.26 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.049 -1.266 . . . . 0.0 110.207 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.466 ' C ' HG23 ' A' ' 26' ' ' THR . . . 113.22 32.89 2.07 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.388 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.466 HG23 ' C ' ' A' ' 25' ' ' GLY . 43.6 p -148.95 145.0 27.17 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.938 -1.331 . . . . 0.0 110.336 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.401 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 63.3 mt -107.53 117.31 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.302 -0.874 . . . . 0.0 110.171 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.413 ' HA ' HG22 ' A' ' 62' ' ' THR . 76.2 p -102.16 -167.15 1.37 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.246 -0.909 . . . . 0.0 109.99 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.546 HG22 HD12 ' A' ' 52' ' ' ILE . 25.0 p -83.21 -31.75 26.89 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.184 -0.947 . . . . 0.0 110.515 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.7 mtmt -65.18 -62.95 1.24 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.217 -0.927 . . . . 0.0 110.194 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -56.47 -58.7 6.88 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.168 -0.957 . . . . 0.0 109.385 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.737 HD23 HD21 ' A' ' 48' ' ' LEU . 6.0 tp -54.36 -22.6 12.66 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.268 -0.895 . . . . 0.0 109.195 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.537 ' HA2' HD13 ' A' ' 48' ' ' LEU . . . -63.58 -46.61 91.87 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.46 ' O ' ' CB ' ' A' ' 38' ' ' SER . 71.3 m -72.79 -21.58 60.96 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.252 -1.146 . . . . 0.0 110.272 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.42 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 53.0 t -72.78 -63.77 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.204 -0.935 . . . . 0.0 110.274 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 12.4 tpp -67.35 -41.01 85.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 110.521 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.463 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 48.1 ttp180 -65.25 -32.59 74.34 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.174 -0.953 . . . . 0.0 110.739 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 34' ' ' THR . 10.8 t -86.97 10.42 16.4 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.938 -1.101 . . . . 0.0 110.635 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 38' ' ' SER . 36.6 mt -136.33 63.54 1.58 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.002 -1.061 . . . . 0.0 110.403 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . 121.13 -34.14 4.11 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.453 ' CG ' ' O ' ' A' ' 37' ' ' ARG . 67.3 mt-30 54.86 40.08 31.8 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.215 -1.168 . . . . 0.0 110.846 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.538 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 2.4 t30 -86.26 -48.17 0.54 Allowed Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.986 -1.071 . . . . 0.0 110.217 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 42' ' ' ASN . 51.8 Cg_endo -84.85 -171.55 1.0 Allowed 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.696 1.366 . . . . 0.0 110.098 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.658 HG22 ' HB3' ' A' ' 47' ' ' GLU . 12.7 t -138.64 -174.27 3.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.176 -0.953 . . . . 0.0 109.666 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.56 -49.91 71.55 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.967 -1.083 . . . . 0.0 110.108 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.37 -66.11 0.59 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.187 -0.946 . . . . 0.0 110.451 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.658 ' HB3' HG22 ' A' ' 44' ' ' THR . 39.4 tt0 -45.93 -34.26 3.8 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.339 -0.85 . . . . 0.0 110.273 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.737 HD21 HD23 ' A' ' 32' ' ' LEU . 5.0 tt -60.67 -50.25 74.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.28 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.635 ' N ' HD23 ' A' ' 48' ' ' LEU . 5.4 tt0 -52.45 -40.17 61.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.389 -0.819 . . . . 0.0 109.257 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -62.97 -37.45 87.18 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.53 -0.731 . . . . 0.0 109.496 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.442 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 33.9 ttp -71.19 -16.78 62.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.411 -0.806 . . . . 0.0 109.94 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.546 HD12 HG22 ' A' ' 29' ' ' THR . 22.6 mt -83.37 -33.53 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.186 -0.946 . . . . 0.0 109.98 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -52.4 -47.78 66.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.262 -0.899 . . . . 0.0 110.011 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.56 ' HG3' HG23 ' A' ' 55' ' ' VAL . 14.8 pt-20 -64.49 -29.11 70.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.269 -0.894 . . . . 0.0 109.875 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.56 HG23 ' HG3' ' A' ' 54' ' ' GLU . 76.7 t -85.0 -10.69 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.372 -0.83 . . . . 0.0 110.196 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -107.53 112.1 24.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.111 -0.993 . . . . 0.0 110.23 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -101.86 34.02 2.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.256 -0.902 . . . . 0.0 110.128 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.404 ' OD1' ' OE2' ' A' ' 67' ' ' GLU . 7.1 m-20 -116.33 -36.26 4.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -0.941 . . . . 0.0 110.316 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.91 56.56 2.06 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.626 ' N ' HD21 ' A' ' 60' ' ' ASN . 0.1 OUTLIER -138.41 -41.88 0.5 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.249 -1.148 . . . . 0.0 110.325 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.798 ' O ' HG23 ' A' ' 62' ' ' THR . . . 126.19 20.7 1.97 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.797 -1.192 . . . . 0.0 110.571 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.798 HG23 ' O ' ' A' ' 61' ' ' GLY . 0.8 OUTLIER -164.72 161.65 20.79 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.009 -1.289 . . . . 0.0 110.356 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.505 ' CD1' ' CG1' ' A' ' 55' ' ' VAL . 78.9 mt -103.79 161.08 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 110.228 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.419 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 35.0 m-20 -125.84 -155.07 0.66 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.185 -0.947 . . . . 0.0 110.779 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.557 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 13.3 t80 -87.15 -41.34 0.53 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.399 -0.813 . . . . 0.0 112.21 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.0 Cg_endo -72.52 -19.02 25.31 Favored 'Trans proline' 0 C--O 1.211 -0.855 0 O-C-N 123.038 1.02 . . . . 0.0 110.621 -179.095 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.419 ' OE1' ' OD2' ' A' ' 64' ' ' ASP . 49.9 mt-10 -87.69 -31.64 19.62 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.078 -1.013 . . . . 0.0 109.383 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.507 ' CE2' ' HB2' ' A' ' 16' ' ' PHE . 81.3 t80 -73.35 -41.0 63.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.717 -0.614 . . . . 0.0 110.242 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.915 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 0.6 OUTLIER -83.28 -37.73 23.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.37 -0.832 . . . . 0.0 110.767 -179.436 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 66' ' ' PRO . 60.8 m -68.5 -31.07 70.08 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.985 -1.072 . . . . 0.0 110.309 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.403 ' SD ' HG13 ' A' ' 55' ' ' VAL . 57.4 ttp -81.1 -59.31 2.7 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.242 -0.911 . . . . 0.0 110.472 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.3 mtt -68.99 -9.46 52.46 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.355 -0.841 . . . . 0.0 110.642 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.915 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.134 -0.979 . . . . 0.0 110.444 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.115 0.483 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.7 mm -65.55 -51.86 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.067 -1.02 . . . . 0.0 110.134 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -62.65 -52.71 62.24 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.35 -0.844 . . . . 0.0 110.177 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.441 ' O ' HG13 ' A' ' 91' ' ' VAL . 55.5 mt-10 -57.34 -28.75 63.4 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.228 -0.92 . . . . 0.0 110.305 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.643 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -67.04 -65.28 0.7 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.917 . . . . 0.0 110.274 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -52.15 -24.23 6.72 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.183 -0.948 . . . . 0.0 110.353 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.1 ttt-85 -74.57 -39.65 62.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.211 -0.931 . . . . 0.0 110.288 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 88' ' ' ALA . 23.2 m -84.91 -11.04 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 110.545 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.501 ' CD2' ' O ' ' A' ' 88' ' ' ALA . 24.2 m-85 -101.41 -14.68 17.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.031 -1.043 . . . . 0.0 110.509 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 99' ' ' TYR . 83.8 m-20 -132.17 83.03 2.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.017 -1.052 . . . . 0.0 110.619 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -104.53 27.12 8.21 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.141 -0.975 . . . . 0.0 109.994 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.8 p30 -106.69 -24.12 12.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.273 -0.892 . . . . 0.0 109.914 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.441 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 99.49 43.1 2.58 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.504 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 30.6 p-10 -128.81 -24.45 2.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.335 -1.097 . . . . 0.0 110.877 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.452 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 75.2 35.07 49.91 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.504 ' CD2' ' O ' ' A' ' 97' ' ' ASN . 61.3 m-85 -147.46 144.86 28.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.319 -1.107 . . . . 0.0 109.654 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.435 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 23.9 mt -100.24 141.72 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.078 -1.014 . . . . 0.0 109.743 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.4 t -126.54 167.55 15.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.169 -0.957 . . . . 0.0 110.409 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.92 -52.02 53.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.366 -0.834 . . . . 0.0 110.039 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.3 -56.46 16.47 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.385 -0.822 . . . . 0.0 110.235 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.479 ' O ' HG23 ' A' ' 108' ' ' VAL . 97.3 mt-10 -50.86 -45.01 59.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 110.039 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.713 HD12 HD11 ' A' ' 125' ' ' ILE . 2.6 tt -57.18 -38.37 73.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.384 -0.822 . . . . 0.0 110.018 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.415 ' O ' ' HB ' ' A' ' 110' ' ' THR . 66.4 ttt180 -69.27 -26.09 64.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.159 -0.963 . . . . 0.0 109.765 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -83.72 -14.36 51.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.348 -0.845 . . . . 0.0 109.993 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 104' ' ' GLU . 79.1 t -88.37 -62.06 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.147 -0.971 . . . . 0.0 110.825 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 60.9 mtt -65.46 -53.65 39.7 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.159 -0.963 . . . . 0.0 110.72 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.415 ' HB ' ' O ' ' A' ' 106' ' ' ARG . 28.8 m -47.32 -34.28 6.65 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.32 -0.863 . . . . 0.0 110.271 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -77.12 -41.28 42.61 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 110.402 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.437 ' HA ' HD23 ' A' ' 112' ' ' LEU . 16.2 mt -51.32 -49.05 62.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.147 -0.97 . . . . 0.0 110.273 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 139.7 48.06 0.06 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -135.22 149.26 49.85 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.213 -1.169 . . . . 0.0 110.098 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -95.79 104.27 16.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.273 -0.892 . . . . 0.0 110.454 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.0 mt -124.09 164.5 19.29 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.177 -0.952 . . . . 0.0 110.181 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 56.8 m -122.51 153.3 39.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.166 -0.959 . . . . 0.0 110.194 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -45.53 -30.06 1.34 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.277 -0.889 . . . . 0.0 110.549 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -65.08 -61.03 2.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.871 . . . . 0.0 110.457 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -49.81 -51.51 39.12 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.216 -0.927 . . . . 0.0 110.517 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 75.2 t -53.84 -45.69 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.251 -0.906 . . . . 0.0 110.501 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.15 -27.93 69.42 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.21 -0.931 . . . . 0.0 110.394 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -71.98 -31.75 66.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 0.0 110.107 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.5 mtp -77.87 -45.67 23.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.336 -0.853 . . . . 0.0 110.36 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.713 HD11 HD12 ' A' ' 105' ' ' LEU . 19.3 mm -61.96 -41.44 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 110.212 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -63.95 -52.18 60.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.005 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -55.04 -36.44 65.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.202 -0.936 . . . . 0.0 110.23 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.16 -29.79 65.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.225 -0.922 . . . . 0.0 110.31 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -73.53 91.39 1.81 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.157 -0.964 . . . . 0.0 110.365 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 130' ' ' ILE . 63.3 mt -84.5 1.3 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.243 -0.911 . . . . 0.0 110.767 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 2.4 p30 -112.03 -35.47 5.66 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.976 -1.077 . . . . 0.0 110.296 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.442 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 102.44 42.46 2.17 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 58.7 p30 -109.91 -12.7 14.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.161 -1.2 . . . . 0.0 110.541 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.467 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 98.74 -47.01 1.44 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -94.34 164.49 13.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.193 -1.181 . . . . 0.0 110.577 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.435 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 58.2 t -112.61 152.99 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.353 -0.842 . . . . 0.0 109.878 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.401 ' ND2' ' HB3' ' A' ' 139' ' ' GLU . 5.2 p-10 -128.66 -168.88 1.98 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.038 -1.039 . . . . 0.0 110.843 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.841 ' O ' HG23 ' A' ' 142' ' ' VAL . 4.3 t80 -64.64 -44.39 90.61 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.51 -0.744 . . . . 0.0 111.006 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.401 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 35.4 tt0 -61.63 -61.05 2.79 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.232 -0.917 . . . . 0.0 111.219 -179.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.4 ' OE2' ' OD2' ' A' ' 131' ' ' ASP . 53.8 mt-10 -56.59 -28.9 61.39 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.112 -0.992 . . . . 0.0 111.032 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.409 ' CZ ' ' HB1' ' A' ' 88' ' ' ALA . 23.2 t80 -78.86 -27.35 44.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.084 -1.01 . . . . 0.0 110.401 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 138' ' ' TYR . 86.3 t -83.6 -24.72 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.259 -0.901 . . . . 0.0 110.484 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -95.29 -22.28 17.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.137 -0.977 . . . . 0.0 110.738 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.0 -12.49 41.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.879 -1.138 . . . . 0.0 110.321 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.465 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 53.1 tpp -90.25 -48.04 7.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.187 -0.946 . . . . 0.0 110.311 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.323 -0.861 . . . . 0.0 110.588 -179.746 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.026 0.441 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.506 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 52.4 mt-10 -50.01 -46.84 53.13 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.126 -0.984 . . . . 0.0 110.348 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -59.67 -57.19 14.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.309 -0.869 . . . . 0.0 110.307 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 1.025 HG22 ' HE3' ' A' ' 13' ' ' LYS . 83.5 mt -49.97 -28.95 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.257 -0.902 . . . . 0.0 109.614 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -71.47 -42.15 68.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.329 -0.857 . . . . 0.0 110.045 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.34 -42.11 81.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 0.0 109.97 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -64.39 -47.07 80.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.294 -0.878 . . . . 0.0 110.194 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 1.025 ' HE3' HG22 ' A' ' 9' ' ' ILE . 87.5 mttt -50.84 -51.75 48.09 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.23 -0.919 . . . . 0.0 109.813 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 17' ' ' SER . 40.6 tt0 -53.35 -43.09 67.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.383 -0.823 . . . . 0.0 109.998 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.568 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -57.32 -44.34 84.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.944 . . . . 0.0 109.767 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.43 ' O ' ' HB2' ' A' ' 19' ' ' PHE . 3.2 t80 -63.49 -32.71 74.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.193 -0.942 . . . . 0.0 109.773 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 38.2 t -58.79 -61.58 2.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 110.325 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.568 HD21 ' HA ' ' A' ' 15' ' ' ALA . 1.2 pp -67.3 -15.38 63.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.1 -1.0 . . . . 0.0 110.372 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.523 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 8.1 m-30 -69.29 -63.81 0.99 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.131 -0.98 . . . . 0.0 109.706 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -70.67 107.81 4.1 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.355 -0.84 . . . . 0.0 109.995 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -107.37 -29.67 9.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.117 -0.989 . . . . 0.0 110.375 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 38.0 p30 -69.86 -11.2 60.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.185 -0.947 . . . . 0.0 110.485 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.452 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 66.24 99.03 0.02 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -155.21 -51.74 0.09 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.263 -1.14 . . . . 0.0 110.377 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.0 -5.12 5.04 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 77.4 p -145.37 152.05 39.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.001 -1.294 . . . . 0.0 110.207 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.8 mt -87.37 101.23 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.259 -0.901 . . . . 0.0 110.071 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.2 p -95.37 -177.59 4.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.381 -0.824 . . . . 0.0 109.909 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.64 HG22 HD12 ' A' ' 52' ' ' ILE . 12.0 p -63.1 -30.07 71.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.077 -1.015 . . . . 0.0 110.227 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -63.69 -56.94 11.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.131 -0.981 . . . . 0.0 110.203 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.553 ' O ' HG23 ' A' ' 35' ' ' VAL . 32.0 mt-10 -57.31 -46.45 83.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.868 . . . . 0.0 110.023 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.594 HD23 ' CG ' ' A' ' 48' ' ' LEU . 11.0 tp -64.02 -23.25 67.26 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.19 -0.944 . . . . 0.0 109.774 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.04 -42.99 74.97 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.436 ' O ' ' CB ' ' A' ' 38' ' ' SER . 91.6 m -81.5 -18.77 43.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -1.131 . . . . 0.0 109.892 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.751 ' O ' HD12 ' A' ' 39' ' ' LEU . 51.6 t -79.59 -31.89 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.032 -1.043 . . . . 0.0 109.777 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.423 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 26.3 mmt -89.93 -25.4 20.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.297 -0.877 . . . . 0.0 110.163 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.463 ' HD2' ' HA ' ' A' ' 42' ' ' ASN . 3.3 tpt180 -89.37 -25.7 21.43 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.219 -0.926 . . . . 0.0 110.127 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 34' ' ' THR . 62.2 m -85.4 -14.2 47.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -0.926 . . . . 0.0 110.3 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.751 HD12 ' O ' ' A' ' 35' ' ' VAL . 30.5 mt -89.82 -88.03 0.17 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.234 -0.916 . . . . 0.0 110.334 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 41' ' ' GLN . . . -152.22 51.99 0.49 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.444 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 36.8 mt-30 -158.02 169.19 25.13 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.262 -1.14 . . . . 0.0 110.09 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.463 ' HA ' ' HD2' ' A' ' 37' ' ' ARG . 77.5 m-20 -144.4 58.24 5.53 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.496 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 42' ' ' ASN . 48.5 Cg_endo -79.19 -177.8 4.16 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.792 1.417 . . . . 0.0 110.369 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.455 HG22 ' N ' ' A' ' 45' ' ' GLU . 32.3 m -112.68 169.42 8.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.25 -0.906 . . . . 0.0 110.159 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.455 ' N ' HG22 ' A' ' 44' ' ' THR . 37.9 tt0 -66.84 -35.2 79.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.164 -0.96 . . . . 0.0 110.034 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.84 -66.72 0.6 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.266 -0.896 . . . . 0.0 109.88 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -47.25 -35.89 8.29 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.311 -0.868 . . . . 0.0 109.618 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.594 ' CG ' HD23 ' A' ' 32' ' ' LEU . 6.2 tt -61.99 -47.35 85.19 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.509 -0.744 . . . . 0.0 109.805 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.445 ' N ' HD23 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -52.52 -43.54 65.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.929 . . . . 0.0 109.659 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -65.13 -33.02 75.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.923 . . . . 0.0 109.4 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.458 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 31.6 ttp -71.17 -17.69 62.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.341 -0.85 . . . . 0.0 109.481 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.64 HD12 HG22 ' A' ' 29' ' ' THR . 44.9 mt -86.17 -27.39 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.353 -0.842 . . . . 0.0 109.85 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 -59.03 -23.64 62.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 110.123 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.458 ' CG ' ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -83.88 -24.97 30.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.283 -0.886 . . . . 0.0 110.128 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.511 ' CG1' HD11 ' A' ' 63' ' ' ILE . 80.2 t -85.57 -65.5 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.225 -0.922 . . . . 0.0 109.991 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.402 ' OD2' ' OD1' ' A' ' 60' ' ' ASN . 46.6 t0 -50.31 135.74 21.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.377 -0.827 . . . . 0.0 110.285 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -103.66 -27.04 12.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.279 -0.888 . . . . 0.0 109.789 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -69.97 -30.71 68.12 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.367 -0.833 . . . . 0.0 109.812 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.06 24.51 61.51 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.402 ' OD1' ' OD2' ' A' ' 56' ' ' ASP . 14.2 p-10 -81.55 -32.7 32.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.164 -1.198 . . . . 0.0 110.219 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 129.28 -18.35 5.52 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.756 -1.212 . . . . 0.0 110.094 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 41.3 p -144.74 170.09 16.77 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.103 -1.233 . . . . 0.0 110.366 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.511 HD11 ' CG1' ' A' ' 55' ' ' VAL . 45.7 mt -112.48 163.46 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.106 -0.997 . . . . 0.0 110.163 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.464 ' N ' HG22 ' A' ' 63' ' ' ILE . 73.8 m-20 -125.01 -164.74 1.31 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.19 -0.944 . . . . 0.0 110.531 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.564 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 57.1 t80 -78.81 -43.89 1.85 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.344 -0.847 . . . . 0.0 111.386 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.2 Cg_endo -72.51 -32.54 9.75 Favored 'Trans proline' 0 C--N 1.324 -0.739 0 O-C-N 123.001 1.001 . . . . 0.0 110.176 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.43 ' OE1' ' HA ' ' A' ' 63' ' ' ILE . 35.0 tt0 -76.55 -20.84 56.43 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.226 -0.921 . . . . 0.0 109.277 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.531 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 8.7 t80 -80.96 -44.35 18.33 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.501 -0.749 . . . . 0.0 109.703 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.579 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -71.47 -22.76 61.77 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.324 -0.86 . . . . 0.0 109.613 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.0 m -85.2 -41.28 15.78 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.419 -0.801 . . . . 0.0 110.242 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.491 ' HG3' ' N ' ' A' ' 72' ' ' MET . 19.5 ptm -66.11 -33.2 75.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.135 -0.978 . . . . 0.0 110.169 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.531 ' CE ' ' CZ ' ' A' ' 68' ' ' PHE . 20.6 mtt -90.15 -10.78 43.27 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.237 -0.914 . . . . 0.0 110.269 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.579 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.129 -0.982 . . . . 0.0 110.349 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 121.143 0.497 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 54.0 mt -46.72 -32.85 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.105 -0.997 . . . . 0.0 109.947 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.413 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 35.0 ttt180 -66.2 -47.21 74.61 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.421 -0.799 . . . . 0.0 109.354 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 2.8 tt0 -49.27 -48.48 45.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.437 -0.789 . . . . 0.0 109.983 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.737 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -62.9 -61.47 2.38 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.385 -0.822 . . . . 0.0 110.19 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -44.69 -26.98 0.44 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.428 -0.795 . . . . 0.0 110.644 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 86' ' ' ARG . 4.9 mmp_? -75.53 -47.66 25.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.273 -0.892 . . . . 0.0 110.469 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.737 HG22 ' O ' ' A' ' 88' ' ' ALA . 35.8 m -70.65 -9.75 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.201 -0.937 . . . . 0.0 110.864 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.754 ' CE1' HG11 ' A' ' 108' ' ' VAL . 42.7 m-85 -103.02 -22.89 13.73 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.099 -1.001 . . . . 0.0 110.77 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -114.23 77.67 1.08 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.078 -1.013 . . . . 0.0 110.306 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.9 ptpt -109.69 -7.28 15.1 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.251 -0.905 . . . . 0.0 110.55 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.418 ' OD2' ' OD1' ' A' ' 97' ' ' ASN . 10.8 p-10 -73.28 -37.78 66.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.033 -1.042 . . . . 0.0 110.121 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 121.62 -24.14 7.28 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.196 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.463 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 15.0 p-10 -58.71 -30.01 67.11 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.704 -1.469 . . . . 0.0 110.863 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.471 ' C ' ' CD1' ' A' ' 99' ' ' TYR . . . 94.0 16.25 45.36 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.576 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.471 ' CD1' ' C ' ' A' ' 98' ' ' GLY . 86.4 m-85 -142.09 151.54 42.44 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.95 -1.323 . . . . 0.0 110.188 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.418 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 24.0 mt -91.97 130.69 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.11 -0.994 . . . . 0.0 109.729 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 44.4 t -114.98 165.67 12.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.292 -0.88 . . . . 0.0 110.113 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.07 -29.45 67.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.279 -0.888 . . . . 0.0 110.343 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.12 -54.5 7.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.189 -0.944 . . . . 0.0 110.414 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.838 ' O ' HG23 ' A' ' 108' ' ' VAL . 43.7 mt-10 -53.51 -40.65 65.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.216 -0.927 . . . . 0.0 110.282 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.759 HD22 HG13 ' A' ' 121' ' ' VAL . 8.7 tt -71.19 -32.94 69.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.146 -0.971 . . . . 0.0 110.492 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -71.36 -21.35 62.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.07 -1.019 . . . . 0.0 109.898 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -95.68 -20.27 19.05 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.247 -0.908 . . . . 0.0 109.729 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.838 HG23 ' O ' ' A' ' 104' ' ' GLU . 93.2 t -84.14 -38.12 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.321 -0.862 . . . . 0.0 110.307 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.5 mmt -63.67 -30.45 71.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.867 . . . . 0.0 110.152 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.1 p -69.06 -39.16 79.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 109.965 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -66.6 -42.91 86.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.189 -0.944 . . . . 0.0 110.224 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.4 ' HB3' ' OE1' ' A' ' 114' ' ' GLU . 89.9 mt -66.54 -33.57 75.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.898 . . . . 0.0 110.125 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.51 -16.72 11.41 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.431 ' CD ' ' N ' ' A' ' 114' ' ' GLU . 5.6 mp0 -69.01 114.11 6.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -1.131 . . . . 0.0 110.288 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.29 121.39 32.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 110.384 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.59 169.82 12.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 110.104 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 27.9 m -98.25 159.49 14.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.105 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -54.35 -44.01 71.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.217 -0.927 . . . . 0.0 110.186 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -65.35 -43.31 91.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 110.409 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -55.76 -46.97 77.76 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.169 -0.957 . . . . 0.0 110.603 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.759 HG13 HD22 ' A' ' 105' ' ' LEU . 77.9 t -59.49 -55.41 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 110.254 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.44 -24.99 49.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.159 -0.963 . . . . 0.0 109.928 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -76.33 -33.99 59.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.356 -0.84 . . . . 0.0 110.064 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.426 ' HE2' HD11 ' A' ' 105' ' ' LEU . 54.5 mtp -71.51 -42.28 68.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 0.0 110.007 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 31.5 mm -66.71 -36.76 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.255 -0.903 . . . . 0.0 110.08 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.57 -57.37 7.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.278 -0.889 . . . . 0.0 110.129 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.403 ' HA ' ' OE1' ' A' ' 127' ' ' GLU . 3.1 mm-40 -51.2 -42.18 60.74 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.4 -0.812 . . . . 0.0 110.641 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -70.24 -30.61 67.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.203 -0.936 . . . . 0.0 110.449 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 6.8 t0 -74.62 84.09 2.07 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.282 -0.886 . . . . 0.0 110.267 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.4 mt -58.57 -37.91 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.215 -0.928 . . . . 0.0 110.034 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.9 p30 -77.13 -32.3 56.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.268 -0.895 . . . . 0.0 109.991 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.453 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 81.03 60.03 2.34 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 135' ' ' GLN . 56.3 p30 -117.21 8.12 13.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.161 -1.199 . . . . 0.0 110.442 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.61 -40.48 3.04 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.401 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 2.3 pt20 -98.17 158.03 15.8 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.062 -1.258 . . . . 0.0 110.485 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.418 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 76.2 t -114.3 134.05 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.384 -0.823 . . . . 0.0 110.232 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.454 ' OD1' ' CG ' ' A' ' 140' ' ' GLU . 24.2 p-10 -105.19 171.83 7.11 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.124 -0.985 . . . . 0.0 109.997 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -52.83 -60.59 3.08 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.228 -0.92 . . . . 0.0 111.471 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -44.3 -51.84 8.06 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.134 -0.979 . . . . 0.0 111.375 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.46 ' O ' ' CG ' ' A' ' 144' ' ' MET . 58.3 mt-10 -59.89 -37.25 78.85 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.985 -1.072 . . . . 0.0 110.459 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.645 ' CZ ' ' HE3' ' A' ' 145' ' ' MET . 87.4 t80 -66.38 -22.17 66.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.311 -0.868 . . . . 0.0 110.782 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 98.1 t -90.5 -42.18 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.026 -1.046 . . . . 0.0 111.231 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -78.61 -13.37 59.86 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.955 -1.091 . . . . 0.0 110.62 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.482 ' HE3' ' HG3' ' A' ' 145' ' ' MET . 0.0 OUTLIER -90.72 -9.91 44.98 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.064 -1.023 . . . . 0.0 110.582 -179.883 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.645 ' HE3' ' CZ ' ' A' ' 141' ' ' PHE . 18.9 mtt -90.68 -70.85 0.66 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.037 -1.04 . . . . 0.0 111.669 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.497 1.906 0 O-C-N 120.955 -1.091 . . . . 0.0 111.024 -178.966 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.16 0.505 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -69.14 -62.54 1.34 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.18 -0.95 . . . . 0.0 110.373 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.46 ' HG2' ' CE2' ' A' ' 12' ' ' PHE . 11.7 tt0 -58.76 -41.13 85.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 110.14 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.2 mt -58.38 -37.81 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.194 -0.941 . . . . 0.0 109.906 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -69.28 -33.24 72.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.295 -0.878 . . . . 0.0 109.963 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -61.2 -51.37 69.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 109.597 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.46 ' CE2' ' HG2' ' A' ' 8' ' ' GLN . 21.4 m-85 -58.64 -39.03 79.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.469 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -54.14 -42.5 69.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 109.554 179.463 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 17' ' ' SER . 35.1 mt-10 -61.34 -45.04 96.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -0.895 . . . . 0.0 109.786 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.501 ' O ' ' CG ' ' A' ' 19' ' ' PHE . . . -53.49 -48.89 68.54 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.302 -0.873 . . . . 0.0 109.523 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.513 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 28.8 t80 -65.35 -26.67 68.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.383 -0.823 . . . . 0.0 109.797 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -59.91 -63.65 1.23 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.313 -0.867 . . . . 0.0 110.001 179.722 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.465 HD21 ' HA ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -64.37 -19.64 65.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.257 -0.902 . . . . 0.0 109.748 179.683 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.501 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 10.5 m-30 -69.61 -32.2 70.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.361 -0.837 . . . . 0.0 109.444 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -97.96 97.23 8.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -87.52 49.92 1.9 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 110.253 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 2.7 p30 -170.77 -32.45 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.384 -0.822 . . . . 0.0 110.583 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 77.08 60.87 2.78 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -108.03 -39.6 5.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -1.18 . . . . 0.0 110.816 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.521 ' C ' HG23 ' A' ' 26' ' ' THR . . . 135.83 -10.05 4.24 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.23 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.521 HG23 ' C ' ' A' ' 25' ' ' GLY . 68.1 p -151.06 168.28 25.1 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.1 -1.235 . . . . 0.0 110.425 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 65.6 mt -102.59 123.26 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.369 -0.832 . . . . 0.0 110.294 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.1 p -92.97 -163.78 1.09 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.332 -0.855 . . . . 0.0 110.179 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.462 HG22 HD12 ' A' ' 52' ' ' ILE . 4.5 p -90.31 -45.25 9.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.243 -0.911 . . . . 0.0 110.781 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.441 ' HG3' ' HG3' ' A' ' 31' ' ' GLU . 6.1 pttt -56.47 -45.83 80.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.987 -1.071 . . . . 0.0 110.16 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.441 ' HG3' ' HG3' ' A' ' 30' ' ' LYS . 49.6 mt-10 -63.76 -48.75 75.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.98 -1.075 . . . . 0.0 109.34 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.45 ' C ' HD11 ' A' ' 48' ' ' LEU . 13.1 tp -62.61 -15.68 52.82 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.45 -0.781 . . . . 0.0 109.753 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.469 ' HA2' ' CD1' ' A' ' 48' ' ' LEU . . . -75.89 -46.17 14.57 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 57.7 m -71.27 -20.18 62.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -1.094 . . . . 0.0 109.653 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.3 t -83.33 -33.12 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.33 -0.856 . . . . 0.0 109.968 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.435 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 26.0 mmt -88.38 -18.34 28.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.155 -0.965 . . . . 0.0 109.899 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -90.83 -36.05 14.45 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.0 110.249 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.6 m -80.9 -45.08 17.33 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.243 -0.911 . . . . 0.0 110.045 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.7 mt -92.47 -36.49 13.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 110.079 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 36' ' ' MET . . . -68.64 -112.65 0.02 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -148.67 -70.29 0.21 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.254 -1.145 . . . . 0.0 110.351 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.508 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 51.6 t30 -163.39 49.7 0.24 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 0.0 110.463 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 42' ' ' ASN . 45.3 Cg_endo -71.52 -166.26 0.23 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.747 1.393 . . . . 0.0 110.127 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.61 HG23 ' H ' ' A' ' 47' ' ' GLU . 4.9 t -141.31 173.15 11.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.132 -0.98 . . . . 0.0 110.277 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -68.21 -25.73 65.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.188 -0.945 . . . . 0.0 109.973 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.99 -65.62 0.82 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.294 -0.879 . . . . 0.0 109.606 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.61 ' H ' HG23 ' A' ' 44' ' ' THR . 6.0 tp10 -52.9 -23.55 7.37 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.419 -0.801 . . . . 0.0 109.406 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.469 ' CD1' ' HA2' ' A' ' 33' ' ' GLY . 3.6 tt -68.72 -56.44 8.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.439 -0.788 . . . . 0.0 109.244 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -47.69 -44.01 27.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 109.411 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -63.0 -40.21 97.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.518 -0.739 . . . . 0.0 109.597 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.439 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 6.3 ttp -66.02 -17.81 64.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.339 -0.851 . . . . 0.0 109.779 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.462 HD12 HG22 ' A' ' 29' ' ' THR . 33.8 mt -89.79 -24.97 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 109.608 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -66.0 -36.66 83.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 110.277 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.536 ' HG3' HG23 ' A' ' 55' ' ' VAL . 16.3 pt-20 -68.19 -36.8 80.16 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.099 -1.0 . . . . 0.0 110.251 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.82 HG13 ' SD ' ' A' ' 71' ' ' MET . 99.4 t -76.2 -67.96 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.115 -0.991 . . . . 0.0 110.293 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -43.91 105.9 0.06 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.591 -0.693 . . . . 0.0 110.491 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.12 33.2 4.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.909 . . . . 0.0 110.356 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.3 p30 -122.9 -40.49 2.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.919 . . . . 0.0 110.235 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 103.49 45.99 1.48 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.434 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 19.8 p-10 -122.73 -27.71 4.28 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.089 -1.242 . . . . 0.0 110.397 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.62 -74.54 0.41 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.674 -1.251 . . . . 0.0 110.268 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.8 p -86.1 170.1 12.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.207 -1.172 . . . . 0.0 110.575 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.563 HD13 HG11 ' A' ' 55' ' ' VAL . 20.5 mt -90.13 159.28 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.296 -0.878 . . . . 0.0 109.719 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.435 ' OD2' ' HD2' ' A' ' 66' ' ' PRO . 10.4 t0 -115.41 -179.48 3.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.243 -0.911 . . . . 0.0 110.489 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.591 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 10.6 t80 -74.98 -41.94 4.28 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.333 -0.855 . . . . 0.0 111.752 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.7 Cg_endo -72.07 -17.03 28.57 Favored 'Trans proline' 0 C--O 1.212 -0.823 0 O-C-N 123.105 1.055 . . . . 0.0 110.583 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 71' ' ' MET . 51.2 mt-10 -84.67 -37.52 20.9 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.006 -1.059 . . . . 0.0 108.916 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.513 ' CE2' ' HB2' ' A' ' 16' ' ' PHE . 73.1 t80 -63.67 -48.33 77.65 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.542 -0.723 . . . . 0.0 110.217 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.469 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 1.8 tp -74.4 -37.01 63.5 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.29 -0.881 . . . . 0.0 110.446 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.424 ' HB ' ' O ' ' A' ' 66' ' ' PRO . 71.4 m -74.63 -10.2 59.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.135 -0.978 . . . . 0.0 110.441 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.82 ' SD ' HG13 ' A' ' 55' ' ' VAL . 63.6 ttp -91.44 -49.89 6.09 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.885 -1.135 . . . . 0.0 109.746 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.481 ' HE1' ' CE1' ' A' ' 68' ' ' PHE . 39.4 mtt -91.75 -63.58 1.23 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.338 -0.851 . . . . 0.0 111.645 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.501 2.094 0 O-C-N 121.267 -0.896 . . . . 0.0 111.749 -178.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.123 0.487 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.5 mt -52.31 -40.1 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.232 -0.918 . . . . 0.0 110.121 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 20.1 ttt85 -55.12 -49.38 71.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.418 -0.801 . . . . 0.0 110.269 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.59 ' O ' HG13 ' A' ' 91' ' ' VAL . 48.5 mt-10 -64.59 -37.13 86.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.342 -0.849 . . . . 0.0 110.429 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 92' ' ' PHE . . . -64.94 -22.52 67.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 110.302 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.561 ' CD1' HD11 ' A' ' 100' ' ' ILE . 22.4 t80 -83.48 -38.86 21.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.091 -1.006 . . . . 0.0 110.201 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -70.66 -31.44 68.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.381 -0.824 . . . . 0.0 110.777 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.59 HG13 ' O ' ' A' ' 87' ' ' GLU . 7.2 m -83.56 -41.42 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.077 -1.014 . . . . 0.0 110.488 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.516 ' N ' HG23 ' A' ' 91' ' ' VAL . 9.5 m-85 -67.67 -23.48 65.32 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.971 -1.081 . . . . 0.0 110.012 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -108.6 81.03 1.4 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.219 -0.926 . . . . 0.0 109.935 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 91' ' ' VAL . 13.4 mtpt -97.26 1.55 49.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 0.0 110.89 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 2.3 p30 -79.39 -27.77 41.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.931 -1.106 . . . . 0.0 109.784 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.402 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 94.63 44.16 3.48 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.463 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 23.9 p-10 -128.57 -14.28 4.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.185 -1.185 . . . . 0.0 110.984 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.98 -5.88 84.32 Favored Glycine 0 N--CA 1.504 3.197 0 O-C-N 120.974 -1.079 . . . . 0.0 110.876 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.463 ' HB2' ' ND2' ' A' ' 97' ' ' ASN . 9.5 m-85 -116.61 139.03 50.97 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.954 -1.321 . . . . 0.0 110.309 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.561 HD11 ' CD1' ' A' ' 89' ' ' PHE . 22.0 mt -91.3 115.74 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.222 -0.924 . . . . 0.0 109.916 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.9 t -100.01 172.59 7.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 109.956 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.67 -41.85 71.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.196 -0.94 . . . . 0.0 110.215 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -55.08 -53.78 51.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.316 -0.865 . . . . 0.0 110.122 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.726 ' O ' HG23 ' A' ' 108' ' ' VAL . 51.1 mt-10 -56.74 -49.84 74.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 110.047 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.593 HD12 HD11 ' A' ' 125' ' ' ILE . 1.5 tt -51.1 -34.7 31.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.892 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.432 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 9.5 ttm180 -66.72 -41.55 87.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.241 -0.912 . . . . 0.0 109.814 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -75.45 -10.08 59.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.312 -0.867 . . . . 0.0 110.283 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 104' ' ' GLU . 97.4 t -86.64 -52.13 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.02 -1.05 . . . . 0.0 110.196 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 14.3 mmt -73.4 -60.43 2.25 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.203 -0.935 . . . . 0.0 110.434 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.1 m -46.66 -35.56 6.12 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.401 -0.812 . . . . 0.0 110.552 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -73.73 -45.13 53.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.175 -0.953 . . . . 0.0 110.415 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 41.4 mt -50.04 -52.25 35.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.204 -0.935 . . . . 0.0 110.285 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 157.04 -38.12 0.56 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -57.57 139.5 53.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.292 -1.122 . . . . 0.0 110.242 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -106.89 79.61 1.35 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -0.875 . . . . 0.0 110.335 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.61 -179.1 7.06 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.279 -0.888 . . . . 0.0 110.048 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 66.9 m -108.4 153.79 22.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.247 -0.908 . . . . 0.0 110.252 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.96 -40.87 64.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.321 -0.862 . . . . 0.0 110.466 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -59.04 -41.4 87.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.202 -0.936 . . . . 0.0 110.374 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -56.14 -56.91 15.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.333 -0.854 . . . . 0.0 110.496 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.431 HG13 HD13 ' A' ' 105' ' ' LEU . 97.6 t -54.5 -48.38 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 110.444 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -56.22 -33.37 65.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 0.0 110.225 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -74.4 -28.4 61.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 110.067 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 95.5 mtp -71.65 -53.2 14.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.262 -0.899 . . . . 0.0 109.933 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.593 HD11 HD12 ' A' ' 105' ' ' LEU . 29.3 mm -61.51 -32.06 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 109.993 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 54.2 ttt-85 -64.91 -53.95 38.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.327 -0.858 . . . . 0.0 110.18 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -60.61 -32.47 71.6 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.128 -0.982 . . . . 0.0 110.131 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.18 -27.69 64.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.277 -0.889 . . . . 0.0 110.189 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -70.33 87.96 0.63 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.939 . . . . 0.0 110.178 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 68.7 mt -65.91 -43.01 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.232 -0.917 . . . . 0.0 110.111 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.402 ' OD1' ' OE2' ' A' ' 140' ' ' GLU . 5.4 p-10 -79.38 -42.39 25.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -0.95 . . . . 0.0 110.115 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.86 84.63 1.81 Allowed Glycine 0 N--CA 1.485 1.964 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.479 ' OD2' ' CG ' ' A' ' 135' ' ' GLN . 18.1 p-10 -147.96 -46.49 0.16 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.254 -1.145 . . . . 0.0 110.598 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 134.3 31.61 0.36 Allowed Glycine 0 N--CA 1.498 2.772 0 C-N-CA 119.491 -1.337 . . . . 0.0 110.889 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.479 ' CG ' ' OD2' ' A' ' 133' ' ' ASP . 8.8 pt20 -169.98 135.82 1.43 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.971 -1.311 . . . . 0.0 110.134 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.2 t -100.09 113.06 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -0.975 . . . . 0.0 110.283 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.433 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 13.8 p30 -89.3 -169.87 2.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.013 -1.054 . . . . 0.0 109.987 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.401 ' O ' HG23 ' A' ' 142' ' ' VAL . 2.4 t80 -62.32 -48.03 81.63 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.078 -1.014 . . . . 0.0 111.095 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -56.05 -55.9 27.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.072 -1.017 . . . . 0.0 110.617 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.422 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 56.2 mt-10 -61.55 -22.69 65.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.275 -0.891 . . . . 0.0 110.748 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.447 ' CE1' ' CD1' ' A' ' 100' ' ' ILE . 9.8 t80 -79.83 -26.56 40.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.176 -0.952 . . . . 0.0 110.104 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.433 ' O ' ' HB ' ' A' ' 146' ' ' THR . 85.9 t -90.32 -24.21 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.255 -0.903 . . . . 0.0 110.287 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -83.29 -42.27 17.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.185 -0.947 . . . . 0.0 110.654 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.484 ' HG3' ' N ' ' A' ' 145' ' ' MET . 5.2 ptt? -59.73 -38.92 83.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.146 -0.971 . . . . 0.0 110.195 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.484 ' N ' ' HG3' ' A' ' 144' ' ' MET . 14.3 ttm -91.35 -9.33 45.29 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.248 -0.908 . . . . 0.0 110.343 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 142' ' ' VAL . 1.3 m . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.046 -1.034 . . . . 0.0 110.887 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 121.271 0.558 . . . . 0.0 109.784 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -59.94 -40.99 90.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.374 -0.828 . . . . 0.0 109.771 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.425 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 34.9 tp60 -58.98 -44.4 91.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.689 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 57.1 mt -58.47 -45.96 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.9 . . . . 0.0 109.65 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.18 -27.04 68.69 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.317 -0.864 . . . . 0.0 109.657 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 5.9 tp10 -67.62 -44.52 77.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.33 -0.856 . . . . 0.0 109.848 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -61.82 -52.62 63.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 0.0 109.641 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.443 ' HE3' HD13 ' A' ' 69' ' ' LEU . 82.4 mttt -51.93 -43.38 63.42 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.24 -0.913 . . . . 0.0 109.389 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -56.27 -42.21 77.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 0.0 109.555 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.44 -39.66 88.31 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.39 -0.819 . . . . 0.0 109.749 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -56.51 -49.88 73.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.66 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 64.8 m -59.93 -31.0 69.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 109.642 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.806 ' O ' HD23 ' A' ' 18' ' ' LEU . 2.5 tt -65.49 -32.79 74.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.419 -0.801 . . . . 0.0 109.853 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.473 ' O ' ' HD2' ' A' ' 21' ' ' LYS . 5.2 m-85 -87.11 -67.06 0.85 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.395 -0.816 . . . . 0.0 109.999 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -48.24 95.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.957 -1.089 . . . . 0.0 109.988 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.473 ' HD2' ' O ' ' A' ' 19' ' ' PHE . 0.7 OUTLIER -84.33 -47.84 10.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.91 . . . . 0.0 110.455 -179.659 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 3.9 p30 -70.0 -20.89 63.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.108 -0.995 . . . . 0.0 110.025 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.463 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 74.83 72.84 0.99 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.406 ' OD2' ' OD1' ' A' ' 22' ' ' ASP . 65.1 m-20 -112.77 -23.4 10.18 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.145 -1.209 . . . . 0.0 109.932 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.44 -11.96 47.29 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.9 p -132.75 148.02 52.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.184 -1.186 . . . . 0.0 110.298 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.6 mt -102.86 124.77 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.97 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.5 p -114.55 -161.85 0.79 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.339 -0.85 . . . . 0.0 110.599 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.883 HG22 HG13 ' A' ' 52' ' ' ILE . 52.0 p -82.31 -21.04 36.27 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.376 -0.828 . . . . 0.0 110.48 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -74.66 -59.17 2.86 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.231 -0.918 . . . . 0.0 110.032 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.449 ' O ' HG23 ' A' ' 35' ' ' VAL . 43.7 mt-10 -62.19 -45.92 91.25 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.314 -0.866 . . . . 0.0 109.874 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.953 HD22 HD11 ' A' ' 52' ' ' ILE . 3.5 tp -62.73 -36.58 83.46 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.193 -0.942 . . . . 0.0 109.74 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.06 -41.86 86.11 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 65.5 m -80.53 -23.37 40.06 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.128 -1.219 . . . . 0.0 110.503 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 31' ' ' GLU . 38.1 t -72.59 -29.86 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.228 -0.92 . . . . 0.0 110.002 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -89.87 -30.23 18.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -0.882 . . . . 0.0 109.452 179.409 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -62.46 -58.15 8.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.475 -0.766 . . . . 0.0 110.236 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.2 t -95.13 10.36 36.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -0.891 . . . . 0.0 110.384 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.62 59.88 0.17 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.059 -1.025 . . . . 0.0 110.319 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 163.07 -97.89 0.15 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.423 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -148.46 175.62 10.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -1.136 . . . . 0.0 110.099 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -107.71 73.77 0.42 Allowed Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.307 -0.871 . . . . 0.0 110.407 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 41' ' ' GLN . 46.9 Cg_endo -72.07 -178.56 3.27 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.719 1.378 . . . . 0.0 110.205 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 9.3 m -105.42 167.01 10.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.894 . . . . 0.0 109.542 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.423 ' O ' ' HB3' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -54.71 -52.99 60.7 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.928 -1.108 . . . . 0.0 110.159 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.11 -62.72 1.28 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.185 -0.947 . . . . 0.0 110.645 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -45.23 -26.78 0.54 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.238 -0.914 . . . . 0.0 109.982 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.564 HD23 ' C ' ' A' ' 48' ' ' LEU . 9.2 tt -70.44 -51.5 28.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.374 -0.829 . . . . 0.0 109.293 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.449 ' HA ' ' OE1' ' A' ' 49' ' ' GLN . 4.1 tp-100 -50.37 -38.26 41.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.201 -0.937 . . . . 0.0 109.349 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -61.65 -43.93 97.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.277 -0.89 . . . . 0.0 109.104 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.45 ' HA ' ' HG2' ' A' ' 54' ' ' GLU . 2.2 ttp -60.25 -22.93 63.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.446 -0.784 . . . . 0.0 109.353 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.953 HD11 HD22 ' A' ' 32' ' ' LEU . 35.8 mm -81.68 -27.53 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.536 -0.727 . . . . 0.0 110.279 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -81.57 -15.18 55.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.207 -0.933 . . . . 0.0 110.825 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.74 ' HG3' HG23 ' A' ' 55' ' ' VAL . 2.8 pt-20 -88.47 -16.42 32.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.95 -1.094 . . . . 0.0 110.628 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.74 HG23 ' HG3' ' A' ' 54' ' ' GLU . 64.0 t -104.23 -36.88 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.097 -1.002 . . . . 0.0 110.403 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -84.9 103.23 13.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.959 . . . . 0.0 110.039 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.98 41.72 1.56 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.288 -0.882 . . . . 0.0 109.986 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -115.29 18.48 16.1 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.371 -0.831 . . . . 0.0 109.674 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.42 29.24 30.47 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -108.07 -63.97 1.26 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.256 -1.143 . . . . 0.0 110.409 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.28 -65.2 0.43 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 81.1 p -96.07 161.31 14.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -1.148 . . . . 0.0 109.709 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 78.6 mt -84.05 142.15 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.117 -0.989 . . . . 0.0 110.427 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.448 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 56.3 m-20 -101.83 -176.69 3.2 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.319 -0.863 . . . . 0.0 109.945 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.577 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -72.61 -47.24 9.51 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 111.089 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.6 Cg_endo -72.28 -24.4 19.77 Favored 'Trans proline' 0 C--N 1.321 -0.892 0 O-C-N 123.336 1.177 . . . . 0.0 110.408 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -77.34 -28.08 52.95 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.173 -0.955 . . . . 0.0 108.714 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.537 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 7.9 t80 -76.8 -38.07 54.61 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.639 -0.663 . . . . 0.0 109.976 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.537 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 27.5 tp -75.23 -26.42 58.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.359 -0.838 . . . . 0.0 110.271 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.0 m -79.95 -32.33 39.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.178 -0.951 . . . . 0.0 110.076 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.442 ' HG3' ' N ' ' A' ' 72' ' ' MET . 16.8 ptm -84.5 -29.09 26.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.333 -0.854 . . . . 0.0 110.634 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.537 ' CE ' ' CZ ' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -90.58 -29.53 17.77 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.198 -0.939 . . . . 0.0 110.74 -179.658 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.761 0 O-C-N 121.207 -0.933 . . . . 0.0 110.473 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.303 0.573 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.527 ' CG2' HG22 ' A' ' 142' ' ' VAL . 47.3 mm -67.71 -41.8 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 110.341 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -71.45 -43.81 65.98 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.27 -0.894 . . . . 0.0 110.267 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 66.2 mt-10 -58.71 -43.92 90.2 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.18 -0.95 . . . . 0.0 110.212 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.507 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -59.8 -60.29 4.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 0.0 109.751 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CZ ' ' O ' ' A' ' 98' ' ' GLY . 6.2 t80 -48.95 -25.72 2.1 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.323 -0.86 . . . . 0.0 109.805 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 21.9 ttt180 -69.29 -64.45 0.87 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.426 -0.796 . . . . 0.0 110.858 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 88' ' ' ALA . 32.9 m -56.59 -35.2 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.333 -0.854 . . . . 0.0 111.545 -178.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.868 ' CE1' HD12 ' A' ' 105' ' ' LEU . 44.4 m-85 -77.93 -21.81 50.55 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.824 -1.173 . . . . 0.0 110.932 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 89' ' ' PHE . 97.0 m-20 -128.03 40.76 3.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.053 -1.03 . . . . 0.0 109.944 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 21.2 pttp -91.85 25.19 2.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 110.022 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.437 ' OD1' ' HB2' ' A' ' 97' ' ' ASN . 2.8 p30 -107.19 0.58 23.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.368 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.04 16.82 36.97 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.437 ' HB2' ' OD1' ' A' ' 95' ' ' ASP . 21.4 t-20 -95.53 -62.13 1.35 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.097 -1.237 . . . . 0.0 110.287 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.504 ' O ' ' CZ ' ' A' ' 89' ' ' PHE . . . 121.46 -57.82 0.59 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.443 ' CE1' ' OD1' ' A' ' 137' ' ' ASN . 12.7 m-85 -91.5 159.76 15.77 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.267 -1.137 . . . . 0.0 110.138 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.569 HG23 ' HB3' ' A' ' 92' ' ' PHE . 17.5 mt -87.17 154.89 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.106 -0.996 . . . . 0.0 109.467 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 105' ' ' LEU . 23.3 t -140.57 -177.43 5.05 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.137 -0.977 . . . . 0.0 110.611 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.74 -34.18 40.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.366 -0.833 . . . . 0.0 109.953 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.06 -54.91 9.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -0.963 . . . . 0.0 109.928 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -59.14 -43.76 92.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.251 -0.906 . . . . 0.0 109.846 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.966 HD23 HG13 ' A' ' 121' ' ' VAL . 56.8 tp -52.22 -50.41 62.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 110.28 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -67.55 -26.26 66.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -0.883 . . . . 0.0 110.471 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.418 ' ND1' ' O ' ' A' ' 107' ' ' HIS . 31.9 t-80 -75.85 -16.82 60.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.131 -0.981 . . . . 0.0 110.12 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 72.8 t -88.68 -50.56 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.359 -0.838 . . . . 0.0 110.267 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 55.6 mtt -68.57 -44.29 74.73 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.359 -0.838 . . . . 0.0 110.532 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 91.0 m -58.83 -44.49 90.9 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.271 -0.893 . . . . 0.0 110.457 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -64.84 -53.36 47.98 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.252 -0.905 . . . . 0.0 110.689 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.432 ' HA ' HD23 ' A' ' 112' ' ' LEU . 27.6 mt -46.86 -86.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.236 -0.915 . . . . 0.0 110.307 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -179.97 33.67 0.06 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -122.98 143.19 50.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -1.194 . . . . 0.0 110.156 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 39.4 pttt -113.8 117.55 31.77 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.265 -0.897 . . . . 0.0 109.942 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.8 mt -124.72 149.77 46.91 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.109 -0.994 . . . . 0.0 110.646 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.401 ' HB ' ' HG3' ' A' ' 120' ' ' GLU . 39.7 m -71.63 136.79 47.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.283 -0.886 . . . . 0.0 110.052 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -47.87 -44.06 29.01 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.186 -0.946 . . . . 0.0 110.218 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -55.44 -43.01 75.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.836 . . . . 0.0 110.579 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 124' ' ' MET . 45.9 mt-10 -60.37 -51.93 67.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.209 -0.932 . . . . 0.0 110.583 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.966 HG13 HD23 ' A' ' 105' ' ' LEU . 54.1 t -53.43 -48.22 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.074 -1.017 . . . . 0.0 110.339 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -58.43 -41.23 84.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.174 -0.954 . . . . 0.0 110.246 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -70.54 -20.64 62.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.913 . . . . 0.0 110.195 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.419 ' HG3' ' O ' ' A' ' 120' ' ' GLU . 85.2 mtp -76.94 -43.67 34.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.175 -0.953 . . . . 0.0 109.615 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 14.4 mm -67.7 -30.3 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.886 . . . . 0.0 109.926 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.8 ttp85 -75.91 -52.26 10.68 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.113 -0.992 . . . . 0.0 110.217 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -54.17 -38.5 65.62 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.214 -0.928 . . . . 0.0 110.151 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.22 -41.56 63.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.877 . . . . 0.0 109.802 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -69.22 92.99 0.59 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.383 -0.823 . . . . 0.0 109.771 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 75.9 mt -63.23 -44.14 99.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.368 -0.833 . . . . 0.0 110.777 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.9 p30 -74.31 -29.41 61.61 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.113 -0.992 . . . . 0.0 110.274 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.453 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 75.19 57.94 4.15 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.444 ' OD1' ' CG ' ' A' ' 135' ' ' GLN . 57.1 p-10 -106.82 0.98 24.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.127 -1.219 . . . . 0.0 110.6 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.14 26.47 12.37 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.444 ' CG ' ' OD1' ' A' ' 133' ' ' ASP . 7.6 pt20 -169.38 164.69 10.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.194 -1.18 . . . . 0.0 110.101 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.479 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 55.2 t -123.06 115.73 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.21 -0.931 . . . . 0.0 109.921 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.443 ' OD1' ' CE1' ' A' ' 99' ' ' TYR . 15.6 t30 -84.16 -174.89 5.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.293 -0.879 . . . . 0.0 110.62 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.682 ' O ' HG23 ' A' ' 142' ' ' VAL . 12.0 t80 -69.74 -42.65 73.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.4 -0.813 . . . . 0.0 110.682 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -61.55 -58.46 8.05 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.276 -0.89 . . . . 0.0 110.659 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -56.07 -36.82 68.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.089 -1.007 . . . . 0.0 110.362 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.583 ' CZ ' ' HE1' ' A' ' 145' ' ' MET . 13.5 t80 -67.08 -27.72 67.59 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.265 -0.897 . . . . 0.0 110.689 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 138' ' ' TYR . 98.5 t -89.93 -22.65 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.34 -0.85 . . . . 0.0 111.078 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -81.61 -36.48 28.89 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.08 -1.013 . . . . 0.0 110.991 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.622 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 4.7 ptt? -64.58 -28.91 69.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.939 -1.1 . . . . 0.0 110.093 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.622 ' CE ' ' HE2' ' A' ' 144' ' ' MET . 61.2 mtt -82.71 -23.26 34.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.879 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.654 HG23 ' O ' ' A' ' 142' ' ' VAL . 47.2 p . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.339 -0.851 . . . . 0.0 109.915 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.144 0.497 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -48.32 -43.41 33.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.201 -0.937 . . . . 0.0 110.238 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.503 ' HG3' ' CE2' ' A' ' 12' ' ' PHE . 2.9 tp-100 -59.5 -42.06 91.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.913 . . . . 0.0 109.786 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.1 mm -61.59 -36.79 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.387 -0.82 . . . . 0.0 109.6 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.28 -30.06 66.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.324 -0.86 . . . . 0.0 109.815 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -64.74 -47.23 79.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.87 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.503 ' CE2' ' HG3' ' A' ' 8' ' ' GLN . 24.0 m-85 -65.26 -49.64 68.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.326 -0.859 . . . . 0.0 110.224 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -53.4 -40.14 64.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.198 -0.939 . . . . 0.0 110.105 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -59.32 -53.26 60.31 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.313 -0.867 . . . . 0.0 110.006 179.816 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.489 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -51.19 -36.92 43.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.201 -0.937 . . . . 0.0 109.668 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.525 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 60.3 t80 -65.95 -39.57 90.55 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.382 -0.824 . . . . 0.0 109.84 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.8 t -65.62 -21.59 66.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.879 179.639 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.694 ' C ' HD23 ' A' ' 18' ' ' LEU . 7.9 tt -79.78 -41.5 26.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.398 -0.814 . . . . 0.0 110.048 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.489 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 16.3 m-85 -69.27 -42.09 75.99 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.344 -0.847 . . . . 0.0 110.385 -179.525 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -78.3 100.97 6.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.427 -0.795 . . . . 0.0 110.131 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -101.43 -20.73 15.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 110.491 -179.636 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.408 ' OD1' ' OE2' ' A' ' 31' ' ' GLU . 8.3 p-10 -86.25 -32.45 21.12 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.151 -0.968 . . . . 0.0 110.748 -179.478 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.36 79.81 1.47 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.795 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 39.3 p-10 -146.09 -22.86 0.45 Allowed 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.223 -1.163 . . . . 0.0 111.898 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.529 ' C ' HG23 ' A' ' 26' ' ' THR . . . 90.24 22.99 33.23 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.529 HG23 ' C ' ' A' ' 25' ' ' GLY . 71.1 p -152.68 132.34 13.11 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.215 -1.168 . . . . 0.0 110.177 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 55.7 mt -95.55 111.91 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 110.114 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.589 HG23 ' H ' ' A' ' 30' ' ' LYS . 10.6 t -106.62 -173.68 2.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.463 -0.773 . . . . 0.0 109.767 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.673 HG22 HD12 ' A' ' 52' ' ' ILE . 40.7 p -70.98 -22.45 62.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.142 -0.974 . . . . 0.0 110.408 179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.589 ' H ' HG23 ' A' ' 28' ' ' THR . 19.8 mtmt -67.91 -60.13 2.75 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.269 -0.894 . . . . 0.0 110.138 179.669 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.408 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 79.6 mt-10 -59.7 -58.53 8.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.251 -0.905 . . . . 0.0 109.762 179.549 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.732 HD23 HD11 ' A' ' 48' ' ' LEU . 1.8 tp -52.28 -30.96 30.49 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.312 -0.868 . . . . 0.0 109.818 179.686 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.86 -49.14 81.17 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 92.1 m -70.57 -23.58 62.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.2 -1.176 . . . . 0.0 110.104 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.0 t -71.35 -33.54 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.408 -0.808 . . . . 0.0 110.186 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.404 ' O ' ' O ' ' A' ' 40' ' ' GLY . 23.2 mmt -90.81 -24.24 20.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.221 -0.924 . . . . 0.0 110.365 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -89.92 -15.46 32.02 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.124 -0.985 . . . . 0.0 110.313 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.553 ' HB3' HD12 ' A' ' 39' ' ' LEU . 37.4 t -97.19 -44.03 7.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.193 -0.942 . . . . 0.0 110.18 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.553 HD12 ' HB3' ' A' ' 38' ' ' SER . 3.5 mp -117.51 64.93 0.73 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.12 -0.987 . . . . 0.0 110.054 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 36' ' ' MET . . . 127.92 58.89 0.12 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.407 ' OE1' ' N ' ' A' ' 42' ' ' ASN . 0.7 OUTLIER -58.66 132.95 55.37 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.316 -1.108 . . . . 0.0 110.695 -179.733 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.533 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.3 m-80 179.29 -59.96 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.4 -0.812 . . . . 0.0 110.001 179.726 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 46.2 Cg_endo -72.23 -163.84 0.16 Allowed 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.749 1.394 . . . . 0.0 110.252 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.632 HG23 ' N ' ' A' ' 45' ' ' GLU . 14.1 t -152.91 -136.52 0.06 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.593 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.632 ' N ' HG23 ' A' ' 44' ' ' THR . 30.8 mt-10 -101.5 -40.18 7.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.733 -1.229 . . . . 0.0 109.796 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.47 -67.11 0.66 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.884 . . . . 0.0 109.586 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -49.01 -44.09 40.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.308 -0.87 . . . . 0.0 109.468 179.321 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.732 HD11 HD23 ' A' ' 32' ' ' LEU . 5.7 tt -55.35 -46.31 76.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.425 -0.797 . . . . 0.0 109.459 179.206 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.527 ' N ' HD23 ' A' ' 48' ' ' LEU . 43.5 tt0 -51.01 -41.87 60.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.299 -0.876 . . . . 0.0 109.361 179.306 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.447 ' HA ' ' OD1' ' A' ' 53' ' ' ASN . 33.9 t70 -62.48 -43.33 99.08 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.459 -0.776 . . . . 0.0 109.63 179.344 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.432 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 21.5 ttp -61.18 -22.83 65.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.308 -0.87 . . . . 0.0 109.713 179.629 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.673 HD12 HG22 ' A' ' 29' ' ' THR . 37.0 mt -84.13 -26.65 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -0.859 . . . . 0.0 109.863 179.635 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.447 ' OD1' ' HA ' ' A' ' 50' ' ' ASP . 33.3 m120 -65.22 -19.7 66.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.174 -0.954 . . . . 0.0 110.441 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -84.33 -23.84 30.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 110.037 179.763 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.581 ' CG1' HD11 ' A' ' 63' ' ' ILE . 85.1 t -93.0 -63.74 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.335 -0.853 . . . . 0.0 109.69 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -55.22 113.07 1.24 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.376 -0.828 . . . . 0.0 110.378 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -101.82 45.45 0.97 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.36 -0.837 . . . . 0.0 109.928 179.849 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.59 -47.41 1.56 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.351 -0.843 . . . . 0.0 110.395 -179.516 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.31 38.56 2.42 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.607 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.446 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 18.6 p-10 -125.38 -19.16 5.12 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.171 -1.194 . . . . 0.0 110.66 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.508 ' C ' HG23 ' A' ' 62' ' ' THR . . . 102.22 4.58 50.4 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.718 -1.229 . . . . 0.0 111.27 178.559 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.508 HG23 ' C ' ' A' ' 61' ' ' GLY . 47.5 p -149.87 152.36 34.97 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.557 -1.555 . . . . 0.0 110.833 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.581 HD11 ' CG1' ' A' ' 55' ' ' VAL . 72.7 mt -100.6 130.94 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.339 -0.851 . . . . 0.0 109.987 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.456 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -77.35 -169.06 1.28 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.137 -0.977 . . . . 0.0 110.327 -179.927 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.56 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 4.1 t80 -80.14 -44.27 1.44 Allowed Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.221 -0.924 . . . . 0.0 111.294 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.3 Cg_endo -74.09 -27.01 12.27 Favored 'Trans proline' 0 C--N 1.322 -0.838 0 O-C-N 123.138 1.073 . . . . 0.0 109.984 -179.384 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -73.01 -30.81 64.05 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.355 -0.841 . . . . 0.0 108.811 179.197 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.525 ' CE2' ' HB2' ' A' ' 16' ' ' PHE . 84.9 t80 -72.01 -45.18 61.87 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.54 0.686 . . . . 0.0 109.618 179.271 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.545 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 9.1 tp -77.54 -15.41 59.28 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.367 -0.833 . . . . 0.0 109.719 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.5 m -86.87 -22.52 25.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 110.216 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.481 ' HE2' ' HE3' ' A' ' 72' ' ' MET . 9.2 ptt? -90.61 -37.46 13.78 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.958 -1.089 . . . . 0.0 110.237 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.481 ' HE3' ' HE2' ' A' ' 71' ' ' MET . 59.8 mtt -90.15 -65.62 1.0 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.259 -0.901 . . . . 0.0 111.443 -179.208 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.498 1.951 0 O-C-N 121.467 -0.771 . . . . 0.0 111.708 -178.612 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 121.213 0.53 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.1 mt -50.39 -43.89 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.206 -0.934 . . . . 0.0 110.577 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -57.23 -43.17 82.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.91 . . . . 0.0 110.609 -179.767 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -63.5 -37.41 87.2 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.303 -0.873 . . . . 0.0 111.305 -179.378 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.707 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -64.55 -60.01 3.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.106 -0.996 . . . . 0.0 110.593 -179.421 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -51.36 -34.31 33.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.23 -0.918 . . . . 0.0 110.615 -179.492 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -45.36 88.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.106 -0.996 . . . . 0.0 110.557 -179.669 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.707 HG22 ' O ' ' A' ' 88' ' ' ALA . 33.0 m -77.38 -14.7 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.051 -1.031 . . . . 0.0 110.538 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.684 ' HE2' ' HB1' ' A' ' 88' ' ' ALA . 22.4 m-85 -93.82 -13.96 26.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.195 -0.941 . . . . 0.0 110.406 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -107.46 59.24 0.62 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.932 . . . . 0.0 109.837 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -63.54 -43.86 95.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.376 -0.827 . . . . 0.0 110.646 -179.686 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.429 ' OD2' ' HB3' ' A' ' 97' ' ' ASN . 18.1 p-10 -69.04 -26.8 65.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.194 -0.941 . . . . 0.0 110.106 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.18 8.33 71.98 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.168 178.614 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.429 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 20.6 p-10 -62.5 -30.09 71.02 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.599 -1.53 . . . . 0.0 110.105 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.497 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 107.69 7.73 31.31 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.497 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 30.1 m-85 -140.49 163.27 33.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.124 -1.221 . . . . 0.0 109.874 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.461 ' CD1' ' CD1' ' A' ' 141' ' ' PHE . 40.0 mt -100.08 129.31 50.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.198 -0.939 . . . . 0.0 109.876 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.6 t -110.37 147.21 34.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.445 -0.784 . . . . 0.0 109.721 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -51.26 -45.36 62.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.121 -0.987 . . . . 0.0 110.248 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -49.88 -55.52 14.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.154 -0.966 . . . . 0.0 110.293 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -61.35 -30.63 70.64 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.174 -0.954 . . . . 0.0 110.592 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.755 HD23 HG13 ' A' ' 121' ' ' VAL . 21.7 tp -58.42 -44.01 88.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.26 -0.9 . . . . 0.0 110.285 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.08 -28.04 48.69 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.322 -0.861 . . . . 0.0 110.192 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -70.34 -19.46 63.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.2 -0.937 . . . . 0.0 110.151 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 70.2 t -101.78 -26.63 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.153 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.657 ' HB3' HD13 ' A' ' 116' ' ' LEU . 23.0 mmt -77.89 -24.57 48.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.159 -0.963 . . . . 0.0 110.248 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.6 m -90.61 -15.38 30.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -0.923 . . . . 0.0 110.431 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -90.21 -43.41 10.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.093 -1.004 . . . . 0.0 110.463 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 46.8 mt -59.83 -45.28 92.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 109.975 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 136.66 50.18 0.07 OUTLIER Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.451 ' HB3' HD11 ' A' ' 116' ' ' LEU . 65.6 mm-40 -136.94 126.91 25.88 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.208 -1.172 . . . . 0.0 110.095 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.36 112.98 25.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.2 -0.937 . . . . 0.0 110.448 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.657 HD13 ' HB3' ' A' ' 109' ' ' MET . 3.5 mp -127.67 -169.5 2.06 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.342 -0.849 . . . . 0.0 109.905 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.2 t -144.53 164.9 29.53 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.144 -0.972 . . . . 0.0 110.607 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -53.81 -28.79 37.37 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.393 -0.817 . . . . 0.0 111.004 -179.552 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.29 -51.54 43.77 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.145 -0.972 . . . . 0.0 110.957 -179.317 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -64.1 -51.58 63.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.189 -0.945 . . . . 0.0 110.782 -179.426 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.755 HG13 HD23 ' A' ' 105' ' ' LEU . 77.9 t -57.19 -45.89 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.236 -0.915 . . . . 0.0 110.728 -179.373 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -58.82 -53.56 57.03 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.061 -1.024 . . . . 0.0 110.505 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -62.64 -22.96 66.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -0.931 . . . . 0.0 110.418 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 5.8 mmm -71.56 -49.66 38.49 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.153 -0.967 . . . . 0.0 110.113 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 23.6 mm -69.4 -28.53 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.193 -0.942 . . . . 0.0 109.953 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -70.63 -43.36 69.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.964 . . . . 0.0 109.983 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -71.16 -27.59 63.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.211 -0.931 . . . . 0.0 109.816 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -78.29 -25.2 46.57 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.341 -0.849 . . . . 0.0 109.769 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -74.83 86.61 2.23 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.303 -0.873 . . . . 0.0 110.201 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 70.5 mt -69.08 -48.13 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.282 -0.886 . . . . 0.0 110.433 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 3.0 p30 -73.77 -21.97 60.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.229 -0.92 . . . . 0.0 110.278 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 68.79 68.15 1.74 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 36.8 p30 -118.35 -16.92 9.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.438 -1.037 . . . . 0.0 111.032 -179.309 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.466 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 124.71 -46.8 1.06 Allowed Glycine 0 N--CA 1.498 2.779 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.406 ' O ' ' OE1' ' A' ' 135' ' ' GLN . 0.0 OUTLIER -119.31 170.57 9.0 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.242 -1.152 . . . . 0.0 109.909 179.846 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.424 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 75.6 t -103.3 151.61 6.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.041 -1.037 . . . . 0.0 110.672 -179.345 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.494 ' OD1' ' CD1' ' A' ' 99' ' ' TYR . 72.6 m-20 -122.73 -172.74 2.54 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.494 -0.754 . . . . 0.0 109.82 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.722 ' O ' HG23 ' A' ' 142' ' ' VAL . 3.9 t80 -72.93 -19.91 61.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.195 -0.941 . . . . 0.0 109.727 179.595 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.41 -56.58 4.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.136 -0.978 . . . . 0.0 109.837 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -64.76 -25.37 67.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.146 -0.971 . . . . 0.0 109.691 179.561 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.493 ' CE2' ' HE3' ' A' ' 145' ' ' MET . 19.1 t80 -75.29 -29.16 60.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.399 -0.813 . . . . 0.0 109.967 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 138' ' ' TYR . 70.5 t -84.83 -27.85 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.233 -0.917 . . . . 0.0 110.27 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.83 -34.15 34.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.837 . . . . 0.0 110.646 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -82.6 -25.54 33.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 110.47 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.493 ' HE3' ' CE2' ' A' ' 141' ' ' PHE . 26.0 ttm -89.86 -57.36 2.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.277 -0.889 . . . . 0.0 110.104 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.5 2.051 0 O-C-N 121.427 -0.796 . . . . 0.0 110.924 179.826 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.305 0.574 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.417 ' OE1' ' CA ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -52.65 -35.65 55.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 110.775 -179.594 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -56.57 -54.05 50.46 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.06 -1.025 . . . . 0.0 109.817 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 78.8 mt -58.95 -34.2 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.658 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.75 -28.07 67.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.256 -0.902 . . . . 0.0 110.073 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -72.45 -53.51 11.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.337 -0.852 . . . . 0.0 109.725 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -56.37 -45.7 80.39 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.327 -0.858 . . . . 0.0 109.819 179.616 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.85 -41.37 74.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 109.758 179.433 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -54.44 -52.53 61.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.402 -0.811 . . . . 0.0 109.953 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.23 -50.09 62.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.38 -0.825 . . . . 0.0 110.253 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -51.26 -45.56 62.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.186 -0.946 . . . . 0.0 109.828 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.9 m -55.14 -41.95 72.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.241 -0.912 . . . . 0.0 109.761 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.718 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.1 tt -59.0 -34.32 71.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.375 -0.828 . . . . 0.0 109.647 179.575 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.622 ' CZ ' HG11 ' A' ' 35' ' ' VAL . 10.5 m-85 -74.5 -69.97 0.43 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.325 -0.859 . . . . 0.0 110.541 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.28 91.49 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.367 -0.833 . . . . 0.0 110.089 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 19' ' ' PHE . 2.3 mttm -81.42 -28.29 34.33 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.341 -0.849 . . . . 0.0 109.943 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.403 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 5.0 p30 -104.89 -9.81 17.74 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.282 -0.886 . . . . 0.0 110.487 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 61.56 63.23 5.01 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -92.02 -15.68 27.53 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.184 -1.186 . . . . 0.0 110.012 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.551 ' C ' HG23 ' A' ' 26' ' ' THR . . . 114.88 -9.85 21.16 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.551 HG23 ' C ' ' A' ' 25' ' ' GLY . 82.3 p -156.07 169.8 23.64 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.161 -1.199 . . . . 0.0 110.497 -179.818 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.4 mt -105.14 125.39 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.44 -0.788 . . . . 0.0 109.49 179.229 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 49.3 p -110.45 -171.98 1.94 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.198 -0.938 . . . . 0.0 110.437 -179.547 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.61 HG21 ' HG2' ' A' ' 49' ' ' GLN . 55.3 p -79.05 -25.49 43.18 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.328 -0.857 . . . . 0.0 110.422 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -70.26 -56.81 5.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.29 -0.881 . . . . 0.0 109.766 179.606 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.403 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 88.8 mt-10 -59.43 -48.34 82.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.311 -0.868 . . . . 0.0 109.318 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.068 HD22 HD11 ' A' ' 52' ' ' ILE . 1.3 tp -61.94 -26.73 68.37 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.468 -0.77 . . . . 0.0 109.426 179.428 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.52 -44.38 97.67 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.545 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.3 m -71.3 -27.2 63.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -1.116 . . . . 0.0 109.938 179.569 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.622 HG11 ' CZ ' ' A' ' 19' ' ' PHE . 8.1 t -67.05 -38.7 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.291 -0.88 . . . . 0.0 109.99 179.761 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 20.8 mmt -89.56 -20.15 24.13 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.069 -1.019 . . . . 0.0 110.37 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -90.25 -13.28 35.72 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.22 -0.925 . . . . 0.0 110.721 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.664 ' OG ' HD23 ' A' ' 39' ' ' LEU . 14.9 p -65.59 -59.55 3.84 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.219 -0.925 . . . . 0.0 110.463 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.664 HD23 ' OG ' ' A' ' 38' ' ' SER . 0.5 OUTLIER -132.85 47.25 2.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.098 -1.001 . . . . 0.0 110.125 179.975 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -166.98 43.69 0.25 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.44 ' OE1' ' N ' ' A' ' 42' ' ' ASN . 0.9 OUTLIER -49.38 115.08 1.19 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.217 -1.166 . . . . 0.0 110.162 -179.818 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.501 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 0.6 OUTLIER -174.81 -61.75 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.402 -0.811 . . . . 0.0 109.931 179.743 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.501 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 43.4 Cg_endo -70.67 165.73 31.05 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.549 1.289 . . . . 0.0 110.266 179.453 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.484 HG22 ' H ' ' A' ' 45' ' ' GLU . 0.8 OUTLIER -119.93 -146.87 0.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.158 -0.964 . . . . 0.0 109.782 179.913 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.484 ' H ' HG22 ' A' ' 44' ' ' THR . 20.9 pt-20 -92.37 -41.34 10.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.133 -0.98 . . . . 0.0 109.694 179.54 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.469 ' N ' ' HG3' ' A' ' 45' ' ' GLU . . . -71.12 -60.72 2.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.292 -0.88 . . . . 0.0 110.051 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -49.05 -30.5 6.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.068 -1.02 . . . . 0.0 109.477 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.592 HD11 HD23 ' A' ' 32' ' ' LEU . 8.0 tt -65.2 -52.19 56.36 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.556 -0.715 . . . . 0.0 109.5 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.61 ' HG2' HG21 ' A' ' 29' ' ' THR . 70.3 mt-30 -49.67 -39.04 35.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.943 . . . . 0.0 109.356 179.242 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.88 -46.22 91.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.429 -0.794 . . . . 0.0 109.703 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.415 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 18.0 ttp -65.2 -17.92 64.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.903 . . . . 0.0 109.738 179.527 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.068 HD11 HD22 ' A' ' 32' ' ' LEU . 36.3 mm -85.84 -28.75 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.395 -0.815 . . . . 0.0 110.133 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -62.54 -41.89 99.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.259 -0.901 . . . . 0.0 110.244 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.608 ' HG3' HG23 ' A' ' 55' ' ' VAL . 12.0 pt-20 -67.8 -24.44 65.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.273 -0.892 . . . . 0.0 109.898 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.896 HG13 ' SD ' ' A' ' 71' ' ' MET . 74.0 t -92.65 -7.26 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.293 -0.879 . . . . 0.0 110.297 179.562 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.461 ' OD2' ' CA ' ' A' ' 61' ' ' GLY . 22.8 t0 -113.21 98.73 7.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.028 -1.045 . . . . 0.0 110.853 -179.564 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.91 25.53 9.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 0.0 109.146 178.928 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.413 ' OD2' ' OD1' ' A' ' 60' ' ' ASN . 8.8 t70 -98.55 -49.1 4.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.602 -0.686 . . . . 0.0 110.419 -179.705 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.47 -26.55 5.45 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.434 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 16.5 p-10 -70.46 -33.84 71.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.032 -1.276 . . . . 0.0 110.339 -179.833 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.461 ' CA ' ' OD2' ' A' ' 56' ' ' ASP . . . 119.38 -61.24 0.49 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.434 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 81.7 p -70.09 165.38 22.08 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.302 -1.117 . . . . 0.0 110.254 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.471 HG12 HG12 ' A' ' 55' ' ' VAL . 9.9 mt -100.21 157.71 3.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.272 -0.893 . . . . 0.0 109.768 179.629 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.439 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 46.0 m-20 -111.7 -169.96 1.56 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.512 -179.538 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.575 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 9.8 t80 -78.19 -44.86 2.21 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.256 -0.902 . . . . 0.0 111.44 -179.549 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.3 Cg_endo -71.64 -17.66 29.56 Favored 'Trans proline' 0 C--O 1.205 -1.14 0 O-C-N 123.127 1.067 . . . . 0.0 110.252 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -84.71 -30.91 24.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.185 -0.947 . . . . 0.0 109.372 179.123 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 9.0 t80 -71.45 -49.21 43.74 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.591 -0.693 . . . . 0.0 110.231 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.834 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 0.6 OUTLIER -76.64 -29.7 56.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.197 -0.939 . . . . 0.0 110.725 -179.661 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 66' ' ' PRO . 54.8 m -78.51 -19.57 52.68 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.774 -1.204 . . . . 0.0 110.334 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.896 ' SD ' HG13 ' A' ' 55' ' ' VAL . 61.1 ttp -86.34 -49.8 7.39 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.135 -0.978 . . . . 0.0 110.573 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.446 ' HE2' ' CE ' ' A' ' 71' ' ' MET . 38.2 mtt -83.1 -59.69 2.39 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.223 -0.923 . . . . 0.0 110.786 -179.43 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.834 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.497 1.896 0 O-C-N 121.046 -1.034 . . . . 0.0 110.558 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.258 0.552 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.9 mm -51.99 -46.27 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 110.451 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -62.43 -44.43 96.45 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.125 -0.984 . . . . 0.0 109.868 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -54.24 -37.14 64.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.352 -0.843 . . . . 0.0 110.118 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.792 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -68.28 -63.91 0.97 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.305 -0.872 . . . . 0.0 110.438 -179.787 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -45.33 -27.73 0.72 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.239 -0.913 . . . . 0.0 110.612 -179.647 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.82 -54.6 9.63 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.23 -0.919 . . . . 0.0 110.408 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.792 HG22 ' O ' ' A' ' 88' ' ' ALA . 33.9 m -61.85 -21.22 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.23 -0.919 . . . . 0.0 110.26 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.643 ' CE1' HG11 ' A' ' 108' ' ' VAL . 46.5 m-85 -93.23 -16.27 24.98 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.243 -0.911 . . . . 0.0 110.313 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.424 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 49.3 t0 -124.94 67.12 1.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.862 . . . . 0.0 109.863 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -95.22 2.06 54.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 110.855 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 2.7 p30 -95.81 -13.21 24.23 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.094 -1.004 . . . . 0.0 110.347 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.36 36.18 8.28 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.451 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 6.4 t-20 -93.25 -61.39 1.58 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.22 -1.165 . . . . 0.0 110.183 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.479 ' C ' ' CD1' ' A' ' 99' ' ' TYR . . . 128.59 -14.4 6.1 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 33.6 m-85 -136.73 146.91 46.38 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.129 -1.218 . . . . 0.0 110.225 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 100' ' ' ILE . 39.8 mt -74.71 143.37 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.173 -0.954 . . . . 0.0 110.403 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.5 p -129.2 158.93 37.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.369 -0.832 . . . . 0.0 109.748 179.617 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.88 -25.14 56.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.148 -0.97 . . . . 0.0 110.545 -179.58 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.12 -64.5 1.04 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.181 -0.949 . . . . 0.0 110.507 -179.731 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.566 ' O ' HG23 ' A' ' 108' ' ' VAL . 41.3 mt-10 -48.95 -40.95 32.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.231 -0.918 . . . . 0.0 110.068 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.46 ' O ' HD23 ' A' ' 105' ' ' LEU . 6.4 tt -63.74 -40.12 95.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.0 110.156 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.753 ' O ' HG23 ' A' ' 110' ' ' THR . 2.5 tpm_? -58.71 -35.37 72.56 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.206 -0.934 . . . . 0.0 109.982 179.775 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.4 ' O ' ' OG1' ' A' ' 110' ' ' THR . 73.6 m-70 -77.32 -24.85 50.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.87 . . . . 0.0 110.619 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.643 HG11 ' CE1' ' A' ' 92' ' ' PHE . 90.4 t -77.16 -37.98 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.131 -0.98 . . . . 0.0 110.545 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.768 ' HA ' HD12 ' A' ' 112' ' ' LEU . 24.7 mmt -72.66 -26.07 61.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.23 -0.918 . . . . 0.0 110.562 -179.52 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.753 HG23 ' O ' ' A' ' 106' ' ' ARG . 39.4 p -64.6 -45.22 87.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.164 -0.96 . . . . 0.0 110.125 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -72.19 -42.9 65.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.19 -0.944 . . . . 0.0 110.021 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.768 HD12 ' HA ' ' A' ' 109' ' ' MET . 39.7 mt -47.0 -25.85 0.89 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.255 -0.903 . . . . 0.0 110.403 179.785 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.2 43.96 3.64 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -132.95 136.28 46.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.29 -1.124 . . . . 0.0 110.033 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.01 109.11 21.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.241 -0.912 . . . . 0.0 110.618 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.7 mp -123.69 -177.94 3.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.345 -0.847 . . . . 0.0 109.745 179.507 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 57.8 m -129.03 155.53 45.26 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.122 -0.986 . . . . 0.0 110.256 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.419 ' O ' ' OD2' ' A' ' 122' ' ' ASP . 36.8 m-20 -49.07 -40.82 33.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.253 -0.905 . . . . 0.0 110.05 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -61.36 -50.74 71.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.231 -0.918 . . . . 0.0 110.268 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 123' ' ' GLU . 6.0 mm-40 -52.82 -48.01 67.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.298 -0.876 . . . . 0.0 110.331 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 75.3 t -54.52 -50.31 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.192 -0.942 . . . . 0.0 110.255 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 118' ' ' ASP . 61.4 m-20 -53.61 -34.77 59.61 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 110.191 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -62.88 -47.62 82.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.194 -0.941 . . . . 0.0 109.971 179.957 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.43 ' HB3' ' HE2' ' A' ' 124' ' ' MET . 60.4 mtp -63.13 -59.08 5.26 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.29 -0.881 . . . . 0.0 110.226 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.7 mm -50.89 -24.56 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.314 -0.866 . . . . 0.0 110.429 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -77.14 -49.15 15.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.207 -0.933 . . . . 0.0 110.071 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -63.02 -19.74 64.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -0.936 . . . . 0.0 110.017 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.467 ' HB2' ' SD ' ' A' ' 144' ' ' MET . . . -87.73 -40.98 13.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.358 -0.839 . . . . 0.0 110.088 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -64.54 88.07 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.297 -0.877 . . . . 0.0 110.243 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 43.4 mt -63.28 -57.16 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.305 -0.872 . . . . 0.0 110.304 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.8 p30 -63.3 -30.43 71.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.193 -0.942 . . . . 0.0 110.167 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.446 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 72.35 68.65 1.55 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.421 ' OD1' ' HG2' ' A' ' 135' ' ' GLN . 2.9 p30 -116.42 -25.98 7.29 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.21 -1.171 . . . . 0.0 110.538 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 137.83 -6.42 3.48 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.28 179.822 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.421 ' HG2' ' OD1' ' A' ' 133' ' ' ASP . 0.8 OUTLIER -150.63 160.46 43.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.988 -1.301 . . . . 0.0 110.324 -179.883 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 66.4 t -105.61 137.61 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 109.995 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.4 ' ND2' ' HB2' ' A' ' 139' ' ' GLU . 6.7 p-10 -108.12 -170.26 1.65 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.056 -1.028 . . . . 0.0 110.279 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.583 ' CE1' HG21 ' A' ' 142' ' ' VAL . 11.2 t80 -66.56 -62.66 1.34 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.355 -0.841 . . . . 0.0 111.201 -179.063 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.4 ' HB2' ' ND2' ' A' ' 137' ' ' ASN . 32.8 mt-10 -44.9 -48.81 11.22 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.195 -0.941 . . . . 0.0 111.614 -179.106 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -58.84 -47.62 84.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.031 -1.043 . . . . 0.0 110.796 -179.174 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -64.58 -23.18 67.18 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 110.643 -179.698 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.583 HG21 ' CE1' ' A' ' 138' ' ' TYR . 76.5 t -90.63 -20.25 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.19 -0.944 . . . . 0.0 111.146 -179.533 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -89.36 -24.77 21.88 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.114 -0.991 . . . . 0.0 110.899 -179.105 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.467 ' SD ' ' HB2' ' A' ' 128' ' ' ALA . 20.4 ptt? -88.86 -31.81 18.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.021 -1.049 . . . . 0.0 110.442 -179.932 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.432 ' N ' ' HG3' ' A' ' 144' ' ' MET . 18.8 tpp -86.48 -9.49 56.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.215 -0.928 . . . . 0.0 110.3 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 142' ' ' VAL . 12.0 t . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.16 -0.962 . . . . 0.0 110.681 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.192 0.52 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.66 -36.24 34.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.167 -0.958 . . . . 0.0 109.912 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.82 -47.19 86.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -0.86 . . . . 0.0 109.706 179.682 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.5 mm -61.24 -39.38 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.517 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.29 -33.65 75.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.411 -0.806 . . . . 0.0 109.869 179.469 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.26 -53.08 54.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.673 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -53.1 -36.69 60.99 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.132 -0.98 . . . . 0.0 109.172 179.224 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -65.63 -37.45 86.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.546 -0.721 . . . . 0.0 109.651 179.266 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -57.23 -47.12 82.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.459 -0.776 . . . . 0.0 109.967 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.18 -54.58 44.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.145 -0.972 . . . . 0.0 110.22 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -47.01 -48.53 21.85 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.241 -0.912 . . . . 0.0 110.331 179.94 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.7 m -60.71 -37.77 82.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.421 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.87 ' O ' HD23 ' A' ' 18' ' ' LEU . 6.8 tt -65.16 -22.74 66.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 110.026 -179.861 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -90.72 -69.32 0.74 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.308 -0.87 . . . . 0.0 110.028 179.829 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -56.69 120.48 7.88 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.117 -0.989 . . . . 0.0 109.585 179.716 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.6 mttt -110.33 -29.76 7.99 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.034 -1.041 . . . . 0.0 111.844 -178.935 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.436 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 10.4 p-10 -68.61 -44.91 73.28 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.801 -1.187 . . . . 0.0 110.144 -179.416 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.42 27.04 3.75 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.798 -1.192 . . . . 0.0 110.613 178.922 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.436 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 8.3 p-10 -95.69 -43.62 7.82 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.989 -1.3 . . . . 0.0 110.27 179.57 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.26 31.14 2.91 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.39 179.351 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.0 p -146.89 135.25 21.8 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.952 -1.323 . . . . 0.0 110.098 179.466 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 80.4 mt -106.53 98.91 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.345 -0.847 . . . . 0.0 110.034 179.787 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.802 HG23 HG22 ' A' ' 62' ' ' THR . 1.0 OUTLIER -81.83 -164.78 0.84 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.883 . . . . 0.0 110.064 -179.925 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.628 ' H ' HG22 ' A' ' 28' ' ' THR . 5.1 p -83.76 -41.57 17.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.102 -0.999 . . . . 0.0 110.586 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.515 ' HG3' ' N ' ' A' ' 31' ' ' GLU . 6.3 ptpt -69.68 -41.63 75.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.937 -1.102 . . . . 0.0 109.414 179.664 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.515 ' N ' ' HG3' ' A' ' 30' ' ' LYS . 60.1 mt-10 -61.78 -45.0 95.77 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.143 -0.973 . . . . 0.0 108.717 178.849 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.831 HD23 HD11 ' A' ' 48' ' ' LEU . 2.0 tp -64.21 -29.21 70.33 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.096 -0.641 . . . . 0.0 109.294 179.219 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.96 -40.2 96.61 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 179.292 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.5 m -69.74 -41.99 74.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.489 -1.006 . . . . 0.0 109.948 179.427 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.0 t -57.93 -34.2 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.298 -0.876 . . . . 0.0 109.994 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.3 mmt -89.73 -18.41 26.44 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.358 -0.839 . . . . 0.0 109.815 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -88.29 -13.31 41.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.389 -0.82 . . . . 0.0 110.578 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.409 ' HB3' HD23 ' A' ' 39' ' ' LEU . 44.0 t -68.2 -12.91 61.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.954 -1.091 . . . . 0.0 109.946 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.446 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 0.7 OUTLIER -169.21 88.2 0.18 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.173 -0.954 . . . . 0.0 110.207 -179.987 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.75 -52.0 0.84 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 51.56 31.85 8.2 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.22 -1.165 . . . . 0.0 109.972 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.495 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -76.5 -55.4 1.64 Allowed Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.412 -0.805 . . . . 0.0 110.957 -179.768 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 42' ' ' ASN . 45.1 Cg_endo -73.99 135.23 20.83 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.77 1.405 . . . . 0.0 110.534 -179.611 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.451 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 29.1 p -102.25 -130.75 0.26 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.308 -0.87 . . . . 0.0 109.569 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -100.88 -33.89 10.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.804 -1.185 . . . . 0.0 109.95 179.649 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.65 -66.23 0.77 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.337 -0.852 . . . . 0.0 110.077 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -51.21 -32.0 22.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 109.659 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.831 HD11 HD23 ' A' ' 32' ' ' LEU . 9.4 tt -64.26 -53.1 54.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.322 -0.861 . . . . 0.0 109.988 179.746 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -51.39 -39.0 56.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 109.827 179.614 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -66.03 -37.04 84.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.243 -0.911 . . . . 0.0 109.639 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.9 ttp -69.85 -20.08 63.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.323 -0.861 . . . . 0.0 109.735 179.57 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.83 HD11 HD22 ' A' ' 32' ' ' LEU . 32.7 mm -86.6 -24.65 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.391 -0.818 . . . . 0.0 109.899 179.644 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -70.58 -37.36 73.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.259 -0.901 . . . . 0.0 110.259 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.82 -19.36 48.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 110.485 -179.761 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.561 ' CG1' HD11 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -99.76 -14.09 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.098 -1.001 . . . . 0.0 110.11 -179.615 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 2.8 t70 -84.3 128.06 34.35 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.179 -0.951 . . . . 0.0 110.203 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -96.58 -12.86 23.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.202 -0.936 . . . . 0.0 110.402 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.402 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 61.1 m-20 -97.5 -73.46 0.61 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.124 -0.985 . . . . 0.0 110.486 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.429 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 134.94 41.49 0.14 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 62' ' ' THR . 16.6 p30 -116.02 -16.68 11.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.339 -1.094 . . . . 0.0 110.293 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.663 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 106.87 -40.99 2.3 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.719 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.802 HG22 HG23 ' A' ' 28' ' ' THR . 69.1 p -98.54 162.45 13.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.147 -1.207 . . . . 0.0 110.517 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.561 HD11 ' CG1' ' A' ' 55' ' ' VAL . 70.0 mt -115.04 144.87 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.4 -0.813 . . . . 0.0 110.081 179.817 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -101.69 -165.28 1.18 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.988 -1.07 . . . . 0.0 110.137 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.543 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 27.2 t80 -77.52 -44.32 2.56 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 111.276 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.0 Cg_endo -74.25 -27.86 11.15 Favored 'Trans proline' 0 C--N 1.324 -0.761 0 O-C-N 123.112 1.059 . . . . 0.0 110.02 -179.627 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.402 ' OE1' ' OD2' ' A' ' 58' ' ' ASP . 45.9 tt0 -77.21 -22.98 51.49 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.356 -0.84 . . . . 0.0 109.236 179.253 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.435 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 14.2 t80 -77.9 -44.5 26.87 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.506 -0.746 . . . . 0.0 110.252 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.4 -26.51 61.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 110.32 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 88.2 m -80.9 -29.76 35.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 0.0 110.497 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.423 ' HG2' ' O ' ' A' ' 68' ' ' PHE . 6.7 ptt? -86.13 -24.6 26.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.036 -1.04 . . . . 0.0 110.386 -179.828 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 68' ' ' PHE . 19.2 mmt -83.03 -27.53 30.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.281 -0.887 . . . . 0.0 110.403 -179.716 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.917 . . . . 0.0 110.778 -179.51 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.929 0 CA-C-O 121.177 0.513 . . . . 0.0 110.473 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.857 HG23 ' CE1' ' A' ' 141' ' ' PHE . 54.8 mt -57.54 -52.45 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.181 -0.949 . . . . 0.0 110.526 -179.632 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.0 ttm-85 -56.87 -50.55 72.11 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.221 -0.924 . . . . 0.0 110.378 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -54.01 -36.56 63.12 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.223 -0.923 . . . . 0.0 110.412 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.561 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -61.28 -63.93 1.12 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.195 -0.94 . . . . 0.0 110.163 -179.697 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.502 ' CE1' HD11 ' A' ' 100' ' ' ILE . 1.1 t80 -45.76 -33.32 2.97 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.435 -0.79 . . . . 0.0 110.485 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.4 ttt85 -63.98 -45.86 87.15 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.31 -0.869 . . . . 0.0 110.77 -179.709 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 88' ' ' ALA . 32.4 m -84.47 -9.53 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.112 -0.992 . . . . 0.0 111.416 -179.296 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.712 ' HA ' HG21 ' A' ' 108' ' ' VAL . 21.9 m-85 -97.0 -14.04 21.91 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.955 -1.09 . . . . 0.0 110.772 -179.763 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -116.19 59.39 0.73 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.041 -1.037 . . . . 0.0 110.256 179.698 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 91' ' ' VAL . 19.4 mttt -94.91 20.09 9.35 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.228 -0.92 . . . . 0.0 110.559 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.456 ' OD2' ' CB ' ' A' ' 97' ' ' ASN . 9.6 p-10 -114.07 -28.39 7.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.183 -0.948 . . . . 0.0 110.398 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.89 -26.67 12.15 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.456 ' CB ' ' OD2' ' A' ' 95' ' ' ASP . 25.5 t-20 -44.79 -28.93 0.7 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.37 -1.076 . . . . 0.0 110.521 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 90.9 -42.6 2.87 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.45 ' CG ' ' OE1' ' A' ' 135' ' ' GLN . 12.1 m-30 -93.3 170.7 9.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.239 -1.153 . . . . 0.0 110.504 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.502 HD11 ' CE1' ' A' ' 89' ' ' PHE . 18.0 mt -104.18 119.71 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.301 -0.874 . . . . 0.0 109.432 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.4 t -102.65 174.89 5.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.232 -0.917 . . . . 0.0 109.855 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.7 -45.02 63.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.035 -1.041 . . . . 0.0 109.909 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.5 -45.57 91.33 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.253 -0.904 . . . . 0.0 110.056 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.647 ' O ' HG23 ' A' ' 108' ' ' VAL . 48.4 mt-10 -61.93 -48.3 81.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.175 179.749 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.581 HD22 HG13 ' A' ' 121' ' ' VAL . 6.8 tt -53.7 -31.77 49.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 0.0 110.164 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.0 ttt-85 -73.07 -41.33 64.23 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.21 -0.932 . . . . 0.0 110.08 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -73.07 -11.29 60.5 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.297 -0.877 . . . . 0.0 110.503 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.712 HG21 ' HA ' ' A' ' 92' ' ' PHE . 92.9 t -92.93 -49.69 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.236 -0.915 . . . . 0.0 110.062 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.2 mmt -50.29 -45.16 54.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.413 -0.804 . . . . 0.0 110.435 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.8 p -52.79 -44.87 66.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.304 -0.872 . . . . 0.0 110.377 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -63.6 -43.43 96.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.126 -0.984 . . . . 0.0 110.023 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 13.6 mt -55.34 -40.7 71.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 110.123 179.762 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 125.83 45.65 0.24 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.594 ' OE1' HD11 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -156.54 146.53 21.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.25 -1.147 . . . . 0.0 110.045 179.98 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.475 ' C ' HD12 ' A' ' 116' ' ' LEU . 24.6 tttt -123.25 138.07 54.72 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.192 -0.943 . . . . 0.0 110.284 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.916 HD23 ' OE1' ' A' ' 120' ' ' GLU . 4.7 mp -139.9 -163.66 1.55 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.26 -0.9 . . . . 0.0 110.145 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.422 HG22 ' N ' ' A' ' 118' ' ' ASP . 57.4 m -120.08 164.46 16.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.228 -0.92 . . . . 0.0 110.236 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.422 ' N ' HG22 ' A' ' 117' ' ' THR . 0.9 OUTLIER -58.4 -34.39 70.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.29 -0.881 . . . . 0.0 110.411 179.942 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -56.25 -61.16 2.59 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.302 -0.874 . . . . 0.0 110.758 -179.677 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.916 ' OE1' HD23 ' A' ' 116' ' ' LEU . 96.0 mt-10 -52.18 -55.1 23.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.073 -1.017 . . . . 0.0 110.433 -179.654 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.581 HG13 HD22 ' A' ' 105' ' ' LEU . 95.4 t -54.24 -27.91 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.277 -0.889 . . . . 0.0 110.752 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -75.4 -40.36 57.98 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.107 -0.996 . . . . 0.0 110.196 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -74.91 -18.07 60.47 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.197 -0.94 . . . . 0.0 109.688 179.51 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.418 ' HG3' ' O ' ' A' ' 120' ' ' GLU . 96.3 mtp -78.06 -50.28 12.37 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 109.949 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 29.1 mm -65.03 -39.86 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.361 -0.837 . . . . 0.0 110.165 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -61.43 -55.86 26.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 110.255 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -57.79 -37.92 74.58 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.255 -0.903 . . . . 0.0 110.534 -179.848 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.527 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -70.53 -24.41 62.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 110.167 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -69.18 92.18 0.54 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.307 -0.87 . . . . 0.0 110.21 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 66.1 mt -75.68 -48.51 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.285 -0.884 . . . . 0.0 110.169 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.2 p30 -64.26 -30.37 71.42 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.348 -0.845 . . . . 0.0 110.188 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 87.66 52.63 2.94 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.653 179.198 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -117.64 -32.86 4.73 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.954 -1.321 . . . . 0.0 109.923 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 118.95 24.2 3.1 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.45 ' O ' ' NE2' ' A' ' 135' ' ' GLN . 3.6 pp0? -159.61 149.02 18.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.203 -1.174 . . . . 0.0 110.143 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.4 t -109.0 125.95 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.244 -0.91 . . . . 0.0 110.721 -179.584 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -97.51 -165.6 1.28 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.879 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.75 ' O ' HG23 ' A' ' 142' ' ' VAL . 47.9 t80 -68.06 -48.42 65.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.11 -0.994 . . . . 0.0 110.537 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -63.52 -45.55 90.09 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.121 -0.987 . . . . 0.0 110.602 -179.683 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.414 ' OE2' ' OD2' ' A' ' 131' ' ' ASP . 37.0 mt-10 -58.6 -38.34 77.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.261 -0.899 . . . . 0.0 110.501 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.857 ' CE1' HG23 ' A' ' 85' ' ' ILE . 6.5 t80 -72.39 -26.87 62.04 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.183 -0.948 . . . . 0.0 110.418 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 138' ' ' TYR . 87.6 t -76.66 -24.46 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.078 -1.014 . . . . 0.0 110.676 -179.423 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -87.39 -51.17 6.09 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.142 -0.974 . . . . 0.0 110.452 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.54 ' CE ' ' CD2' ' A' ' 141' ' ' PHE . 21.5 ptt? -56.41 -32.86 65.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.903 . . . . 0.0 110.701 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.518 ' HE3' ' CZ ' ' A' ' 141' ' ' PHE . 28.2 tpp -72.83 -54.24 9.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.15 -0.969 . . . . 0.0 110.538 -179.526 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 146' ' ' THR . 5.2 t . . . . . 0 N--CA 1.496 1.836 0 O-C-N 121.08 -1.013 . . . . 0.0 110.42 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.424 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 52.2 mt-10 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.363 0.602 . . . . 0.0 109.83 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -57.34 -48.74 78.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.199 -0.938 . . . . 0.0 110.028 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.483 ' HG3' ' N ' ' A' ' 9' ' ' ILE . 19.3 pt20 -52.03 -38.19 56.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.719 179.711 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.483 ' N ' ' HG3' ' A' ' 8' ' ' GLN . 34.6 mt -62.24 -44.47 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.328 -0.857 . . . . 0.0 109.516 179.41 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.61 -37.18 70.33 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.281 -0.887 . . . . 0.0 109.486 179.373 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -62.78 -45.42 92.73 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.325 -0.859 . . . . 0.0 109.499 179.391 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -61.36 -33.1 73.08 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.429 -0.794 . . . . 0.0 109.849 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt -61.57 -49.51 76.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -0.915 . . . . 0.0 109.583 179.62 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -57.69 -39.62 77.6 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.451 -0.781 . . . . 0.0 109.627 179.537 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.462 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -60.21 -43.25 96.14 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.257 -0.902 . . . . 0.0 109.794 179.676 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -59.32 -39.13 82.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.161 -0.962 . . . . 0.0 109.29 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.3 t -70.16 -25.4 63.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.822 . . . . 0.0 109.181 178.984 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.842 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.4 tm? -71.41 -29.12 64.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.471 -0.768 . . . . 0.0 109.551 179.45 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.515 ' HA ' HG21 ' A' ' 35' ' ' VAL . 20.8 m-85 -87.54 -64.59 1.12 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.401 -0.812 . . . . 0.0 109.972 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -85.44 74.43 10.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.348 -0.845 . . . . 0.0 109.799 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.417 ' CE ' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -99.02 47.64 0.97 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.279 -0.888 . . . . 0.0 110.414 -179.641 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.403 ' OD1' ' OD2' ' A' ' 24' ' ' ASP . 4.1 p30 -127.91 -5.02 5.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.169 -0.957 . . . . 0.0 110.583 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.47 48.68 5.21 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.403 ' OD2' ' OD1' ' A' ' 22' ' ' ASP . 13.6 m-20 -117.9 -72.69 0.68 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -1.131 . . . . 0.0 110.26 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.21 -10.52 4.43 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.6 p -132.33 150.26 52.19 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.136 -1.214 . . . . 0.0 110.364 -179.827 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 70.8 mt -97.12 131.62 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.222 -0.923 . . . . 0.0 110.241 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.8 t -120.72 -174.07 2.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.344 -0.847 . . . . 0.0 110.18 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.7 p -75.27 -31.84 60.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.223 -0.923 . . . . 0.0 110.692 -179.68 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -65.8 -59.76 3.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.116 -0.99 . . . . 0.0 109.805 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -57.21 -56.27 23.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.388 -0.82 . . . . 0.0 109.484 179.526 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.963 HD22 HD11 ' A' ' 52' ' ' ILE . 10.9 tp -57.22 -22.56 41.82 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.231 -0.918 . . . . 0.0 109.297 179.085 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.85 -42.62 96.91 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.8 m -69.21 -25.16 64.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.512 -0.993 . . . . 0.0 109.712 179.287 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.515 HG21 ' HA ' ' A' ' 19' ' ' PHE . 37.3 t -76.74 -33.43 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.415 -0.803 . . . . 0.0 110.956 -179.768 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.7 tpp -90.07 -23.48 21.41 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.921 -1.112 . . . . 0.0 110.898 -179.318 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.7 ttm-85 -90.91 -32.55 15.96 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.09 -1.006 . . . . 0.0 110.629 -179.752 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 71.1 m -79.94 -21.71 43.52 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.116 -0.99 . . . . 0.0 110.404 -179.752 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 mp -135.35 80.12 1.82 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 110.438 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.89 -54.06 0.52 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 50.48 74.25 0.23 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.214 -1.168 . . . . 0.0 109.871 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.524 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 2.6 t30 -152.22 -66.27 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.222 -0.924 . . . . 0.0 110.376 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.524 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 43.7 Cg_endo -71.56 -160.75 0.09 OUTLIER 'Trans proline' 0 C--N 1.317 -1.086 0 O-C-N 123.241 1.127 . . . . 0.0 110.145 179.458 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 40.2 p -147.09 -178.46 6.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.205 -0.935 . . . . 0.0 109.85 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -65.47 -32.89 74.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 110.05 179.838 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.34 -62.68 1.29 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.124 -0.985 . . . . 0.0 109.537 179.448 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -51.85 -27.56 13.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.184 -0.947 . . . . 0.0 109.042 179.062 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.871 HD21 HD23 ' A' ' 32' ' ' LEU . 6.2 tt -68.88 -43.88 74.41 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.478 -0.764 . . . . 0.0 109.472 179.332 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -53.46 -42.77 67.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.38 -0.825 . . . . 0.0 109.021 179.104 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -65.47 -33.92 77.07 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.842 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.452 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 0.5 OUTLIER -68.45 -20.3 64.62 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.587 -0.696 . . . . 0.0 109.359 179.001 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.963 HD11 HD22 ' A' ' 32' ' ' LEU . 32.4 mm -87.09 -26.5 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.399 -0.813 . . . . 0.0 110.087 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -73.79 -30.47 62.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.0 110.537 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.659 ' HG3' HG23 ' A' ' 55' ' ' VAL . 8.4 pt-20 -71.64 -26.74 62.68 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.088 -1.008 . . . . 0.0 110.204 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.659 HG23 ' HG3' ' A' ' 54' ' ' GLU . 96.3 t -90.17 -30.46 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.163 -0.961 . . . . 0.0 109.717 179.608 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -76.48 115.92 16.68 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.438 -0.789 . . . . 0.0 110.206 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.69 18.88 21.46 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.256 -0.902 . . . . 0.0 110.239 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.433 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 61.6 m-20 -112.02 -65.72 1.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.354 -0.841 . . . . 0.0 109.968 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.16 -12.6 2.09 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -70.11 -36.7 75.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.971 -1.311 . . . . 0.0 110.534 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 119.73 -63.64 0.46 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 48.9 p -69.25 170.56 9.99 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.17 -1.194 . . . . 0.0 110.724 -179.437 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.602 HD13 HG11 ' A' ' 55' ' ' VAL . 89.1 mt -115.09 149.46 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.244 -0.91 . . . . 0.0 110.309 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.469 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 55.5 m-20 -98.37 -166.24 1.34 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 110.209 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.581 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 10.2 t80 -81.47 -38.26 0.93 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.162 -0.961 . . . . 0.0 112.118 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.6 Cg_endo -72.39 -25.9 17.77 Favored 'Trans proline' 0 C--O 1.209 -0.938 0 O-C-N 122.817 0.904 . . . . 0.0 111.269 -178.922 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.433 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 63.4 mt-10 -76.05 -33.61 59.61 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.827 -1.171 . . . . 0.0 109.524 179.421 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.479 ' CZ ' ' SD ' ' A' ' 72' ' ' MET . 12.6 t80 -75.38 -53.0 9.45 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.537 -0.727 . . . . 0.0 110.064 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.675 HD13 ' O ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -65.31 -20.83 66.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.509 -0.745 . . . . 0.0 110.408 -179.824 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.423 ' CB ' ' O ' ' A' ' 66' ' ' PRO . 50.6 m -91.38 -22.97 20.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.907 -1.12 . . . . 0.0 111.18 -179.595 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.634 ' SD ' HG13 ' A' ' 55' ' ' VAL . 60.0 ttp -86.99 -43.64 12.2 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.877 -1.139 . . . . 0.0 111.153 -179.241 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.479 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 43.2 mtt -82.84 -34.56 26.82 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.905 -1.122 . . . . 0.0 110.595 -179.473 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.141 -0.975 . . . . 0.0 110.66 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.282 0.563 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.4 mt -69.62 -40.68 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.367 -0.833 . . . . 0.0 110.309 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.6 ttp180 -67.96 -56.87 7.39 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.17 -0.957 . . . . 0.0 110.034 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -47.78 -47.81 30.55 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.256 -0.903 . . . . 0.0 110.111 179.765 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.718 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -54.82 -54.49 41.58 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.302 -0.874 . . . . 0.0 110.107 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -49.93 -28.7 7.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.291 -0.881 . . . . 0.0 110.259 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -71.97 -47.01 55.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.144 -0.973 . . . . 0.0 110.643 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 88' ' ' ALA . 35.9 m -70.9 -20.14 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.17 -0.956 . . . . 0.0 110.4 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.448 ' CD2' HG23 ' A' ' 91' ' ' VAL . 25.5 m-85 -95.35 -12.85 25.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.325 -0.859 . . . . 0.0 110.345 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -107.18 73.87 0.95 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.167 -0.958 . . . . 0.0 110.59 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -74.98 -36.46 62.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.171 -0.956 . . . . 0.0 109.995 179.639 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.8 p30 -74.54 -25.41 59.29 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.312 -0.867 . . . . 0.0 110.51 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 76.46 60.79 2.93 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.433 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 26.0 p-10 -124.33 -10.07 7.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.357 -1.084 . . . . 0.0 110.476 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.526 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 86.27 16.03 63.36 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.08 -1.057 . . . . 0.0 110.493 179.005 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 38.2 m-85 -142.1 138.31 31.6 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.188 -1.184 . . . . 0.0 110.26 179.875 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.43 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 25.6 mt -94.06 129.75 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.327 -0.858 . . . . 0.0 110.16 -179.748 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.7 t -114.91 166.09 12.16 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.285 -0.885 . . . . 0.0 109.977 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.46 -26.56 68.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.297 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.42 -69.83 0.27 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.282 -0.886 . . . . 0.0 110.266 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.483 ' O ' HG23 ' A' ' 108' ' ' VAL . 37.1 mt-10 -52.71 -38.78 61.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 110.212 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.625 HD22 HG13 ' A' ' 121' ' ' VAL . 4.0 tt -52.69 -46.21 67.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.094 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.785 ' O ' HG22 ' A' ' 110' ' ' THR . 2.6 ttm-85 -66.72 -37.85 85.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.362 -0.836 . . . . 0.0 110.045 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -61.4 -23.86 66.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.165 -0.959 . . . . 0.0 110.248 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 104' ' ' GLU . 50.0 t -87.28 -41.0 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.119 -0.988 . . . . 0.0 110.616 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.6 mmt -68.17 -57.79 5.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.137 -0.977 . . . . 0.0 110.521 -179.613 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.785 HG22 ' O ' ' A' ' 106' ' ' ARG . 9.8 t -50.13 -23.86 2.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.303 -0.873 . . . . 0.0 110.401 -179.772 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -79.43 -50.37 10.9 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.18 -0.95 . . . . 0.0 110.276 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.8 mt -60.75 -23.47 64.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.208 -0.933 . . . . 0.0 110.302 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.427 ' O ' ' HG2' ' A' ' 114' ' ' GLU . . . 102.88 90.97 2.17 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 1.3 mm-40 -155.3 -164.46 1.77 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.326 -1.102 . . . . 0.0 110.029 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.69 99.56 2.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.131 -0.981 . . . . 0.0 110.28 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.6 mp -137.52 135.62 36.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.326 -0.859 . . . . 0.0 110.204 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.608 HG22 ' OE2' ' A' ' 120' ' ' GLU . 13.1 t -75.78 172.18 13.09 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.228 -0.92 . . . . 0.0 109.949 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 53.7 m-20 -59.95 -41.58 92.17 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.241 -0.912 . . . . 0.0 110.299 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.456 ' OE1' ' N ' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -53.26 -47.72 68.88 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.164 -0.96 . . . . 0.0 110.811 -179.672 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.608 ' OE2' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -54.37 -56.22 20.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.99 -1.069 . . . . 0.0 110.897 -179.605 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.625 HG13 HD22 ' A' ' 105' ' ' LEU . 84.1 t -52.96 -44.74 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.913 -1.117 . . . . 0.0 110.675 -179.629 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 118' ' ' ASP . 1.5 m-20 -62.51 -30.8 71.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.145 -0.972 . . . . 0.0 110.611 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -72.48 -28.48 62.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.072 -1.018 . . . . 0.0 110.057 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.4 mtp -74.29 -45.77 45.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -0.874 . . . . 0.0 110.215 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.542 HD11 HD12 ' A' ' 105' ' ' LEU . 30.0 mm -64.65 -39.85 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.305 -0.872 . . . . 0.0 110.408 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.4 mtp180 -67.76 -51.0 54.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.158 -0.964 . . . . 0.0 110.115 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -55.41 -35.17 65.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.17 -0.956 . . . . 0.0 109.781 179.56 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -75.82 -28.72 58.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.361 -0.837 . . . . 0.0 109.812 179.685 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.401 ' OD2' ' HA2' ' A' ' 132' ' ' GLY . 16.0 t0 -71.92 91.93 1.23 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -0.871 . . . . 0.0 110.119 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 96.2 mt -73.14 -32.61 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.217 -0.927 . . . . 0.0 110.717 -179.615 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 23.4 p30 -99.59 -18.54 17.3 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.232 -0.918 . . . . 0.0 110.505 -179.776 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.467 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 77.0 72.11 1.14 Allowed Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.974 -1.108 . . . . 0.0 110.337 179.438 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.406 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 76.4 m-20 -113.93 6.1 16.44 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.072 -1.251 . . . . 0.0 110.118 179.175 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.32 16.3 69.45 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.42 ' HB2' ' HB3' ' A' ' 99' ' ' TYR . 3.7 pt20 -170.16 165.46 9.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.115 -1.226 . . . . 0.0 110.166 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.43 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 52.4 t -106.71 107.58 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.177 -0.952 . . . . 0.0 110.386 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -77.74 163.08 26.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.363 -0.836 . . . . 0.0 110.142 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.782 ' O ' HG23 ' A' ' 142' ' ' VAL . 33.0 t80 -51.47 -30.16 18.92 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.24 -0.913 . . . . 0.0 110.278 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -70.47 -59.29 2.93 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.2 -0.937 . . . . 0.0 110.474 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 56.3 mt-10 -54.16 -25.66 23.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 0.0 110.221 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.609 ' CZ ' ' HE2' ' A' ' 145' ' ' MET . 16.7 t80 -77.93 -35.39 50.54 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.312 -0.867 . . . . 0.0 110.137 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 138' ' ' TYR . 97.0 t -75.24 -22.83 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 110.364 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -83.31 -46.83 12.16 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.275 -0.89 . . . . 0.0 110.459 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.627 ' HE3' ' HG2' ' A' ' 145' ' ' MET . 0.2 OUTLIER -70.3 -13.22 62.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.027 -1.046 . . . . 0.0 110.293 -179.788 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.627 ' HG2' ' HE3' ' A' ' 144' ' ' MET . 13.4 mmt -89.28 -61.01 1.8 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.285 -0.884 . . . . 0.0 109.994 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 142' ' ' VAL . 9.5 t . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.188 -0.945 . . . . 0.0 110.105 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 121.423 0.63 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -76.78 -32.11 57.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.846 . . . . 0.0 109.728 179.633 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -65.38 -49.71 68.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.426 -0.796 . . . . 0.0 110.03 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.7 mt -68.48 -45.98 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.203 -0.936 . . . . 0.0 109.584 179.508 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 13' ' ' LYS . . . -59.32 -25.69 64.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.374 -0.828 . . . . 0.0 109.48 179.36 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.432 ' HA ' ' OE1' ' A' ' 11' ' ' GLU . 5.3 tp10 -69.59 -50.23 46.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.309 -0.87 . . . . 0.0 109.071 179.323 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -67.11 -17.24 64.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.368 -0.832 . . . . 0.0 109.58 179.075 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 25.6 mtpt -76.59 -49.49 16.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.153 -0.967 . . . . 0.0 109.796 179.596 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.9 -41.95 88.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.187 -0.946 . . . . 0.0 109.791 179.378 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.08 -49.99 67.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 109.791 179.636 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.454 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 40.3 t80 -54.68 -28.45 47.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.921 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.0 m -80.8 -32.73 35.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.342 -0.849 . . . . 0.0 109.497 179.63 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.636 ' O ' HD23 ' A' ' 18' ' ' LEU . 3.2 tt -69.57 -18.03 63.6 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.42 -0.8 . . . . 0.0 109.646 179.483 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 5.1 m-30 -96.7 -45.14 6.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.421 -0.799 . . . . 0.0 109.953 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.411 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 24.8 t0 -78.86 104.63 9.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.386 -0.821 . . . . 0.0 110.313 -179.741 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.425 ' HE2' ' O ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -110.4 64.68 0.61 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.161 -0.962 . . . . 0.0 110.837 -179.688 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.405 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 13.7 p-10 -170.89 -36.82 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.033 -1.042 . . . . 0.0 110.612 179.771 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.57 100.31 2.45 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 -179.293 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 24.7 p-10 -176.97 -29.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.242 -1.152 . . . . 0.0 111.014 -179.619 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.812 ' O ' HG23 ' A' ' 26' ' ' THR . . . 88.21 52.83 2.79 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.812 HG23 ' O ' ' A' ' 25' ' ' GLY . 0.3 OUTLIER -169.93 150.36 3.85 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.185 -1.186 . . . . 0.0 110.314 179.817 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.2 109.09 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.34 -0.85 . . . . 0.0 110.364 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.556 ' HA ' HG22 ' A' ' 62' ' ' THR . 65.6 p -93.24 -167.15 1.66 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.26 -0.9 . . . . 0.0 110.115 179.807 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.559 HG22 HD12 ' A' ' 52' ' ' ILE . 9.3 p -84.67 -20.7 30.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.23 -0.919 . . . . 0.0 110.207 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -72.69 -60.26 2.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.237 -0.914 . . . . 0.0 109.94 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.411 ' OE1' ' HA ' ' A' ' 20' ' ' ASP . 93.1 mt-10 -56.57 -49.29 75.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 109.624 179.5 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.445 ' O ' ' HB ' ' A' ' 35' ' ' VAL . 3.6 tp -60.73 -31.94 71.23 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.292 -0.88 . . . . 0.0 109.265 179.293 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.8 -42.33 94.46 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.709 -1.757 . . . . 0.0 108.709 179.298 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 66.9 m -71.58 -24.78 61.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -1.113 . . . . 0.0 109.477 179.311 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 51.1 t -70.96 -34.84 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.413 -0.805 . . . . 0.0 110.279 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 21.9 mmt -90.76 -23.14 20.74 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.214 -0.929 . . . . 0.0 110.439 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.408 ' NH2' ' HG2' ' A' ' 37' ' ' ARG . 6.7 ttp85 -80.49 -31.8 37.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 110.238 -179.771 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.2 m -92.38 -31.98 15.13 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.148 -0.97 . . . . 0.0 110.569 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.436 ' CG ' ' O ' ' A' ' 35' ' ' VAL . 66.9 mt -86.08 -71.98 0.52 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.141 -0.975 . . . . 0.0 110.496 -179.754 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -118.77 88.74 0.45 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -62.49 123.01 17.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.284 -1.127 . . . . 0.0 110.036 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.503 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.9 OUTLIER 179.47 -59.31 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.175 -0.953 . . . . 0.0 110.305 -179.906 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 42' ' ' ASN . 42.2 Cg_endo -68.41 158.43 57.65 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.593 1.312 . . . . 0.0 110.69 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 71.7 p -107.8 -138.21 0.37 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.368 -0.832 . . . . 0.0 109.619 179.826 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -99.16 -40.33 8.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.93 -1.106 . . . . 0.0 109.82 179.589 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.01 -59.42 2.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.306 -0.872 . . . . 0.0 109.915 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 37.2 tt0 -54.9 -30.59 58.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 109.792 179.587 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' A' ' 44' ' ' THR . 7.5 tt -64.17 -52.6 58.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.358 -0.839 . . . . 0.0 109.775 179.785 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -52.92 -35.54 58.54 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.269 -0.894 . . . . 0.0 109.053 179.352 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 8.5 t70 -61.64 -41.76 97.94 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.383 -0.823 . . . . 0.0 109.524 179.297 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.432 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 32.1 ttp -68.18 -19.77 64.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.383 -0.823 . . . . 0.0 109.565 179.538 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.559 HD12 HG22 ' A' ' 29' ' ' THR . 22.9 mt -83.57 -24.95 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.238 -0.914 . . . . 0.0 110.077 179.59 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -65.65 -46.18 80.15 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.162 -0.961 . . . . 0.0 110.07 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.59 ' HG3' HG23 ' A' ' 55' ' ' VAL . 21.3 pt-20 -59.45 -31.38 69.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.174 -0.954 . . . . 0.0 109.683 179.637 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.888 HG13 ' HE2' ' A' ' 71' ' ' MET . 75.8 t -87.0 -16.96 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.394 -0.816 . . . . 0.0 110.004 179.536 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.43 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 6.6 t0 -110.5 87.99 2.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.284 -0.885 . . . . 0.0 110.091 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.24 -12.65 61.85 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.253 -0.904 . . . . 0.0 110.752 -179.669 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -72.2 -59.3 2.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.14 -0.975 . . . . 0.0 110.439 -179.769 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.9 -1.35 21.35 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.349 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 20.2 p30 -69.96 -31.09 68.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.148 -1.207 . . . . 0.0 110.116 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.456 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 120.86 -59.8 0.55 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.556 HG22 ' HA ' ' A' ' 28' ' ' THR . 50.1 p -91.15 166.37 13.0 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.18 -1.188 . . . . 0.0 110.756 -179.447 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.8 mt -102.95 137.34 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.384 -0.822 . . . . 0.0 110.132 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.432 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 51.1 m-20 -92.62 178.44 5.8 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.273 -0.892 . . . . 0.0 110.305 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.584 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 25.2 t80 -71.66 -44.27 12.15 Favored Pre-proline 0 N--CA 1.486 1.357 0 O-C-N 121.166 -0.959 . . . . 0.0 111.069 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.3 Cg_endo -71.35 -21.6 26.29 Favored 'Trans proline' 0 C--N 1.324 -0.763 0 O-C-N 123.109 1.057 . . . . 0.0 109.874 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.43 ' OE2' ' HA ' ' A' ' 56' ' ' ASP . 84.7 tt0 -83.73 -30.51 26.65 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.38 -0.825 . . . . 0.0 109.265 178.977 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.454 ' CE2' ' HB2' ' A' ' 16' ' ' PHE . 43.2 t80 -70.81 -47.06 61.48 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.534 -0.729 . . . . 0.0 109.853 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.68 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 4.9 tt -74.28 -27.99 60.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.329 -0.857 . . . . 0.0 109.874 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.2 m -80.52 -16.67 53.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.224 -0.923 . . . . 0.0 110.142 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.888 ' HE2' HG13 ' A' ' 55' ' ' VAL . 14.3 tmm? -88.36 -46.8 8.87 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.304 -0.872 . . . . 0.0 110.856 -179.523 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.412 ' HE3' ' HE3' ' A' ' 71' ' ' MET . 58.0 mtt -90.85 -59.49 2.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.01 -1.056 . . . . 0.0 111.275 -179.219 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.496 1.855 0 O-C-N 121.258 -0.901 . . . . 0.0 111.121 -178.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 121.375 0.607 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.699 HG21 HG22 ' A' ' 142' ' ' VAL . 17.0 mt -52.13 -22.91 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.312 -0.868 . . . . 0.0 109.732 179.603 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.9 ttm-85 -69.09 -51.26 40.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.318 -0.864 . . . . 0.0 109.827 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -55.42 -43.03 74.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.067 -1.02 . . . . 0.0 109.764 179.528 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.747 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -58.04 -56.08 26.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.894 . . . . 0.0 109.978 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -48.91 -30.85 6.38 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.19 -0.944 . . . . 0.0 110.586 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.6 ttp85 -70.33 -48.77 55.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.22 -0.925 . . . . 0.0 111.15 -179.362 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.747 HG22 ' O ' ' A' ' 88' ' ' ALA . 27.5 m -64.78 -26.99 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.808 -1.183 . . . . 0.0 110.521 -179.54 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.679 ' HA ' HG21 ' A' ' 108' ' ' VAL . 38.6 m-85 -88.27 -14.95 37.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.256 -0.903 . . . . 0.0 110.24 179.687 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.25 77.16 1.77 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.0 109.893 179.512 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -94.56 -21.9 18.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.268 -0.895 . . . . 0.0 110.707 -179.477 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 2.0 p30 -71.11 -14.52 62.33 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.132 -0.98 . . . . 0.0 110.775 -179.297 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.86 30.36 23.71 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.598 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.456 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 1.7 t-20 -76.0 -78.12 0.12 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.246 -1.15 . . . . 0.0 109.939 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 145.28 -16.61 1.89 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.521 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -133.57 155.29 49.89 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.228 -1.16 . . . . 0.0 109.577 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.432 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 18.5 mt -94.74 118.6 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 120.988 -1.07 . . . . 0.0 109.541 179.784 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.8 m -102.37 168.8 9.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 110.128 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.28 -44.98 89.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.177 -0.952 . . . . 0.0 110.178 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.4 -58.15 9.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.125 -0.984 . . . . 0.0 110.011 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -49.88 -50.17 46.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.17 -0.956 . . . . 0.0 109.946 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -48.89 -40.31 29.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.44 -0.787 . . . . 0.0 110.151 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.1 tpt85 -64.02 -42.7 97.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.241 -0.912 . . . . 0.0 109.839 179.772 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -59.84 -27.05 66.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.301 -0.874 . . . . 0.0 110.209 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.679 HG21 ' HA ' ' A' ' 92' ' ' PHE . 92.4 t -84.35 -68.46 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.319 -0.863 . . . . 0.0 110.999 -179.275 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.405 ' HB3' HD13 ' A' ' 116' ' ' LEU . 20.2 mmt -50.19 -27.88 6.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.235 -0.916 . . . . 0.0 110.681 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.7 m -75.51 -42.22 53.28 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.238 -0.914 . . . . 0.0 110.653 -179.734 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -87.76 -2.15 58.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.153 -0.967 . . . . 0.0 110.775 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.642 HD12 HG12 ' A' ' 108' ' ' VAL . 14.2 mt -88.57 -68.7 0.75 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.964 -1.085 . . . . 0.0 110.176 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 166.6 37.94 0.02 OUTLIER Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -135.43 154.45 51.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.264 -1.139 . . . . 0.0 110.263 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -120.52 99.48 6.58 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.32 -0.863 . . . . 0.0 110.21 179.759 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 116' ' ' LEU . 4.8 mp -110.3 -166.77 1.12 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.167 -0.958 . . . . 0.0 110.423 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.501 HG22 ' HG3' ' A' ' 120' ' ' GLU . 12.1 t -135.19 -164.74 1.57 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.371 -0.831 . . . . 0.0 109.632 179.668 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 118' ' ' ASP . 1.2 m-20 -81.08 -45.74 16.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.022 -1.048 . . . . 0.0 110.653 -179.704 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -58.7 -39.52 81.0 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.417 -0.802 . . . . 0.0 110.819 -179.605 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.501 ' HG3' HG22 ' A' ' 117' ' ' THR . 43.7 mt-10 -62.63 -49.89 73.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.117 -0.99 . . . . 0.0 110.766 -179.704 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 76.0 t -58.63 -37.4 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.101 -0.999 . . . . 0.0 110.43 -179.76 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -64.81 -47.77 76.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.141 -0.974 . . . . 0.0 110.294 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.414 ' HG2' ' OE2' ' A' ' 127' ' ' GLU . 6.4 tm-20 -66.3 -21.86 66.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.229 -0.919 . . . . 0.0 109.843 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 28.8 mmm -73.88 -56.5 4.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.389 -0.819 . . . . 0.0 110.231 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 22.3 mm -66.72 -25.42 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.296 -0.878 . . . . 0.0 110.344 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -72.66 -57.98 3.71 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.194 -0.941 . . . . 0.0 110.225 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.445 ' CA ' ' OE1' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -63.05 -19.22 64.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 110.069 179.908 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.472 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -82.79 -34.2 27.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.256 -0.902 . . . . 0.0 110.013 179.674 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.87 90.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 110.114 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.673 HD12 ' HA ' ' A' ' 140' ' ' GLU . 92.5 mt -61.25 -18.9 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.895 . . . . 0.0 110.335 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.4 p30 -114.45 -30.34 6.58 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.217 -0.927 . . . . 0.0 110.195 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.458 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 89.39 80.62 1.32 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.432 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 33.0 p30 -139.1 13.76 2.63 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.334 -1.098 . . . . 0.0 110.565 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.25 24.6 76.13 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.159 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.432 ' HG3' ' OD1' ' A' ' 133' ' ' ASP . 0.3 OUTLIER -170.5 143.66 2.29 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.137 -1.214 . . . . 0.0 110.268 179.639 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.432 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 91.7 t -93.73 129.24 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 110.453 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -88.43 174.53 8.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.423 -0.798 . . . . 0.0 110.23 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.453 ' CD1' ' C ' ' A' ' 138' ' ' TYR . 8.0 t80 -68.03 -51.72 43.67 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.281 -0.887 . . . . 0.0 109.456 179.302 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -62.31 -40.99 98.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.331 -0.856 . . . . 0.0 109.789 179.646 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.673 ' HA ' HD12 ' A' ' 130' ' ' ILE . 31.5 mt-10 -65.25 -29.72 70.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 109.981 179.585 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.468 ' CD1' ' CE ' ' A' ' 144' ' ' MET . 78.6 t80 -74.12 -28.21 61.24 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.271 -0.893 . . . . 0.0 110.128 -179.827 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.699 HG22 HG21 ' A' ' 85' ' ' ILE . 60.3 t -88.46 -20.78 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.245 -0.909 . . . . 0.0 110.446 179.906 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -98.2 -17.35 19.04 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.356 -0.84 . . . . 0.0 110.904 -179.416 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.472 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 15.0 ptt? -81.32 -27.71 34.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.045 -1.034 . . . . 0.0 110.357 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.414 ' N ' ' HG3' ' A' ' 144' ' ' MET . 4.7 tpp -89.58 -68.56 0.77 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.9 . . . . 0.0 109.919 179.861 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 67.9 p . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.211 -0.931 . . . . 0.0 110.126 179.932 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.244 0.545 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -58.75 -44.0 90.44 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.192 -0.942 . . . . 0.0 110.789 -179.649 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -59.63 -48.0 83.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.077 -1.014 . . . . 0.0 109.986 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 61.8 mt -59.9 -30.07 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.155 -0.966 . . . . 0.0 109.665 179.545 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.97 -30.02 67.26 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.273 -0.892 . . . . 0.0 109.705 179.88 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 65.9 tt0 -69.77 -58.15 4.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.42 -0.8 . . . . 0.0 109.997 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -59.01 -36.26 74.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.175 -0.953 . . . . 0.0 109.439 179.426 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 9.6 tmtt? -65.36 -33.86 76.95 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.507 -0.746 . . . . 0.0 109.609 179.619 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 14.2 mm-40 -63.56 -42.67 98.33 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.358 -0.839 . . . . 0.0 109.634 179.421 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.432 ' HB1' ' CZ ' ' A' ' 19' ' ' PHE . . . -59.86 -48.22 82.58 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.329 -0.857 . . . . 0.0 110.041 179.695 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -55.43 -54.29 45.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.287 -0.883 . . . . 0.0 110.188 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.1 m -58.7 -27.75 65.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.154 -0.966 . . . . 0.0 109.827 179.653 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.753 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.4 tt -71.06 -32.23 68.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.441 -0.787 . . . . 0.0 110.05 -179.978 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.432 ' CZ ' ' HB1' ' A' ' 15' ' ' ALA . 6.1 m-85 -84.31 -62.82 1.46 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.264 -0.897 . . . . 0.0 110.889 -179.184 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -82.12 85.1 6.83 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.226 -0.921 . . . . 0.0 110.625 -179.329 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.423 ' HD3' ' O ' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -106.48 52.74 0.71 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.141 -0.974 . . . . 0.0 109.972 179.375 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 1.7 p30 -137.08 -35.41 0.7 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.21 -0.931 . . . . 0.0 110.695 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 113.09 39.83 1.11 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.835 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -101.61 -33.0 10.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.357 -1.084 . . . . 0.0 110.032 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.58 -15.14 63.15 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.902 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.8 p -139.97 160.66 39.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.972 -1.31 . . . . 0.0 110.502 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.8 mt -103.17 111.99 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.362 -0.836 . . . . 0.0 109.983 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.581 HG22 ' CG2' ' A' ' 62' ' ' THR . 49.8 p -101.93 -164.9 1.14 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.211 -0.93 . . . . 0.0 110.263 -179.934 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.517 ' HA ' HD21 ' A' ' 48' ' ' LEU . 42.4 p -78.11 -36.58 47.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.221 -0.924 . . . . 0.0 110.243 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.5 mttm -68.58 -56.62 7.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 0.0 109.706 179.592 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.652 ' O ' HG22 ' A' ' 34' ' ' THR . 98.9 mt-10 -58.1 -40.9 82.32 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.284 -0.885 . . . . 0.0 109.626 179.413 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.716 HD23 ' CG ' ' A' ' 48' ' ' LEU . 7.0 tp -66.81 -26.76 67.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.26 -0.9 . . . . 0.0 109.401 179.186 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.0 -43.99 95.09 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.662 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.652 HG22 ' O ' ' A' ' 31' ' ' GLU . 7.0 t -75.41 -21.6 58.08 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.058 -1.26 . . . . 0.0 110.123 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.5 t -78.21 -29.81 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.2 -0.938 . . . . 0.0 109.972 179.535 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.8 mmt -90.17 -28.0 19.21 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.185 -0.947 . . . . 0.0 110.288 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.4 mtm180 -89.61 -17.51 28.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.234 -0.916 . . . . 0.0 110.447 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 34' ' ' THR . 29.7 t -49.6 -52.86 27.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.17 -0.957 . . . . 0.0 110.249 -179.766 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.26 61.32 1.53 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 110.214 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . -171.58 -62.57 0.04 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.416 ' HB2' ' O ' ' A' ' 40' ' ' GLY . 82.4 mt-30 54.81 102.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.232 -1.158 . . . . 0.0 110.115 -179.808 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.509 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 t-20 -164.84 -63.03 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.343 -0.848 . . . . 0.0 110.077 179.839 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.509 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 45.2 Cg_endo -71.12 171.49 15.84 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.392 1.206 . . . . 0.0 109.9 179.608 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.432 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 81.1 p -120.27 -170.74 2.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.141 -0.974 . . . . 0.0 109.94 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -74.55 -29.03 61.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.127 -0.983 . . . . 0.0 110.197 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.07 -57.22 4.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.201 -0.937 . . . . 0.0 109.827 179.736 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -62.08 -24.72 67.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 0.0 109.889 179.616 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.716 ' CG ' HD23 ' A' ' 32' ' ' LEU . 4.8 tt -70.23 -52.99 18.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.312 -0.867 . . . . 0.0 109.677 179.506 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.467 ' N ' HD23 ' A' ' 48' ' ' LEU . 51.3 tt0 -54.33 -37.61 65.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.182 -0.949 . . . . 0.0 109.449 179.271 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -68.79 -35.55 77.17 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.356 -0.84 . . . . 0.0 109.296 179.386 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.442 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 54.5 ttp -68.51 -17.45 64.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.326 -0.859 . . . . 0.0 109.675 179.417 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.619 HD11 HD22 ' A' ' 32' ' ' LEU . 13.8 mt -88.25 -37.88 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.888 . . . . 0.0 109.769 179.43 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -53.49 -35.61 60.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.912 . . . . 0.0 110.022 179.603 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.483 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 7.4 pt-20 -71.22 -32.56 68.95 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.355 -0.841 . . . . 0.0 110.273 -179.824 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.73 HG13 ' SD ' ' A' ' 71' ' ' MET . 71.5 t -76.38 -67.94 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.121 -0.987 . . . . 0.0 109.588 179.544 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -46.01 125.55 6.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.506 -0.746 . . . . 0.0 110.176 179.787 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.83 -26.07 10.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.143 -0.973 . . . . 0.0 110.842 -179.589 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 2.8 p30 -70.03 -34.76 73.68 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.228 -0.92 . . . . 0.0 110.455 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.457 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 92.5 76.37 1.33 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.822 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.409 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 18.6 p-10 -142.9 -43.55 0.3 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.222 -1.163 . . . . 0.0 110.179 179.391 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.534 ' C ' HG23 ' A' ' 62' ' ' THR . . . 132.61 2.61 3.94 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.842 179.323 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.581 ' CG2' HG22 ' A' ' 28' ' ' THR . 49.5 p -154.24 167.17 30.79 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.803 -1.41 . . . . 0.0 111.093 -179.858 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.7 HD11 HG11 ' A' ' 55' ' ' VAL . 49.3 mt -104.98 146.25 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.385 -0.822 . . . . 0.0 109.775 179.662 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.443 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 48.7 m-20 -105.45 170.51 7.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.095 -1.003 . . . . 0.0 110.293 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.547 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 32.9 t80 -67.07 -42.3 40.3 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.877 . . . . 0.0 111.412 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 46.1 Cg_endo -74.73 -26.3 11.62 Favored 'Trans proline' 0 C--O 1.212 -0.782 0 O-C-N 123.087 1.046 . . . . 0.0 110.146 -179.587 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 71' ' ' MET . 35.1 tt0 -78.99 -27.95 43.41 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.289 -0.882 . . . . 0.0 109.369 179.378 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -74.57 -61.07 2.0 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.318 -0.864 . . . . 0.0 109.728 179.647 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.481 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 5.0 tt -56.92 -38.09 72.38 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.291 -0.88 . . . . 0.0 109.826 179.669 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.434 ' HB ' ' O ' ' A' ' 66' ' ' PRO . 52.1 m -73.77 -26.4 60.63 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.192 -0.943 . . . . 0.0 110.325 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.73 ' SD ' HG13 ' A' ' 55' ' ' VAL . 34.4 ttp -63.37 -50.18 70.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 110.208 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.473 ' CE ' ' CE ' ' A' ' 71' ' ' MET . 36.5 mtt -90.5 -15.2 31.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.286 -0.884 . . . . 0.0 111.188 -179.372 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.481 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.503 2.201 0 O-C-N 120.955 -1.091 . . . . 0.0 111.23 -179.664 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 121.339 0.59 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.6 mt -53.44 -46.54 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.077 -1.014 . . . . 0.0 110.02 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -55.49 -42.38 74.33 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.178 -0.951 . . . . 0.0 109.071 179.437 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -49.6 -50.68 41.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.398 -0.814 . . . . 0.0 109.39 179.259 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.726 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -52.54 -44.73 65.97 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.358 -0.838 . . . . 0.0 109.281 179.134 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.448 ' CD1' HD11 ' A' ' 100' ' ' ILE . 4.0 t80 -54.16 -39.6 66.7 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.166 -0.958 . . . . 0.0 109.987 179.782 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -59.07 -51.37 70.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.231 -0.918 . . . . 0.0 110.242 -179.874 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.726 HG22 ' O ' ' A' ' 88' ' ' ALA . 26.6 m -68.28 -18.49 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.125 -0.985 . . . . 0.0 109.745 179.817 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.467 ' CD1' HG21 ' A' ' 108' ' ' VAL . 29.0 m-85 -103.41 4.38 36.13 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.36 -0.837 . . . . 0.0 110.317 179.657 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.414 ' OD2' ' HA2' ' A' ' 98' ' ' GLY . 59.1 t0 -146.19 70.21 1.22 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -0.939 . . . . 0.0 109.749 179.748 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -107.3 59.01 0.62 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 110.708 -179.557 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.2 p30 -138.31 -40.0 0.52 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.128 -0.983 . . . . 0.0 110.309 179.567 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.469 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 135.56 17.81 0.83 Allowed Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.225 -1.464 . . . . 0.0 111.827 178.846 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.469 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 27.6 p30 -131.58 -122.16 0.2 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.352 -1.675 . . . . 0.0 109.89 179.192 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.469 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . -170.09 44.53 0.2 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 23.5 m-85 -131.95 128.52 38.64 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.39 -1.065 . . . . 0.0 110.294 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.45 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 24.0 mt -95.92 124.38 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.195 -0.941 . . . . 0.0 109.972 179.702 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.4 t -113.51 157.55 21.87 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.256 -0.903 . . . . 0.0 110.258 -179.844 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.25 -26.54 12.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 110.15 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 106' ' ' ARG . . . -69.72 -59.31 3.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.198 -0.939 . . . . 0.0 110.09 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -51.92 -38.92 58.14 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.064 -1.022 . . . . 0.0 110.264 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.938 HD22 HG13 ' A' ' 121' ' ' VAL . 6.5 tt -59.1 -48.98 79.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 110.488 -179.796 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.597 ' O ' HG23 ' A' ' 110' ' ' THR . 0.0 OUTLIER -65.81 -21.7 66.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.907 -1.121 . . . . 0.0 109.999 -179.905 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.472 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 21.1 t-160 -72.3 -34.63 68.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.416 -0.802 . . . . 0.0 110.035 -179.969 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.467 HG21 ' CD1' ' A' ' 92' ' ' PHE . 96.8 t -78.88 -42.12 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.319 -0.863 . . . . 0.0 110.434 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 4.7 mmt -66.52 -56.96 8.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.215 -179.67 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.597 HG23 ' O ' ' A' ' 106' ' ' ARG . 44.1 p -46.61 -48.97 19.66 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.447 -0.783 . . . . 0.0 110.714 -179.819 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -59.13 -55.67 32.08 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.179 -0.95 . . . . 0.0 110.258 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 112' ' ' LEU . 79.6 mt -52.36 -72.6 0.05 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.14 -0.975 . . . . 0.0 109.924 179.658 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.08 40.37 0.02 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.869 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.804 ' O ' HD12 ' A' ' 116' ' ' LEU . 35.9 mm-40 -121.71 93.24 3.94 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.233 -1.157 . . . . 0.0 110.089 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -74.63 111.4 9.78 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.269 -0.894 . . . . 0.0 110.208 -179.89 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 114' ' ' GLU . 0.9 OUTLIER -117.43 177.56 4.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -0.862 . . . . 0.0 110.285 -179.939 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 59.0 m -100.87 158.87 15.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.334 -0.854 . . . . 0.0 110.173 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -59.91 -41.98 92.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.289 -0.882 . . . . 0.0 110.6 -179.765 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -60.08 -50.64 72.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.291 -0.881 . . . . 0.0 110.716 -179.696 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -53.23 -52.79 57.82 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.144 -0.972 . . . . 0.0 110.877 -179.492 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.938 HG13 HD22 ' A' ' 105' ' ' LEU . 95.5 t -55.32 -55.81 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.144 -0.973 . . . . 0.0 110.371 -179.607 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -54.54 -26.66 33.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.303 -0.873 . . . . 0.0 110.35 -179.693 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 7.1 tt0 -76.3 -34.71 59.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 110.069 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 72.0 mtp -67.58 -47.08 70.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.214 -0.929 . . . . 0.0 110.122 -179.919 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 29.6 mm -64.11 -45.0 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 110.234 179.807 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.5 -33.7 75.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.192 -0.942 . . . . 0.0 110.041 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 41.2 mm-40 -67.93 -33.95 75.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.018 179.79 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.528 ' HB3' ' CG2' ' A' ' 136' ' ' VAL . . . -71.18 -42.13 69.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.284 -0.885 . . . . 0.0 110.464 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -56.92 92.39 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.159 -0.963 . . . . 0.0 110.385 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.417 HD11 ' CB ' ' A' ' 143' ' ' GLN . 76.3 mt -64.4 -31.89 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.194 -0.941 . . . . 0.0 110.236 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 22.4 p30 -101.99 -18.58 15.58 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.193 -0.942 . . . . 0.0 110.536 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.454 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 77.3 75.7 0.91 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.645 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 40.4 m-20 -109.8 -49.3 3.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.227 -1.161 . . . . 0.0 110.053 179.711 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 157.17 -23.59 0.45 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.708 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -143.74 155.91 44.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.329 -1.1 . . . . 0.0 110.115 179.727 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.528 ' CG2' ' HB3' ' A' ' 128' ' ' ALA . 77.7 t -91.6 108.51 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.203 -0.936 . . . . 0.0 110.315 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -82.63 165.55 19.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.948 . . . . 0.0 110.249 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.545 ' O ' HG23 ' A' ' 142' ' ' VAL . 35.5 t80 -44.68 -34.46 2.23 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.369 -0.832 . . . . 0.0 111.766 -178.823 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -65.22 -67.05 0.47 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.867 -1.145 . . . . 0.0 110.726 -179.223 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -52.86 -26.16 13.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.207 -0.933 . . . . 0.0 110.359 -179.589 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.714 ' CE1' ' HE3' ' A' ' 145' ' ' MET . 7.9 t80 -68.44 -40.43 81.14 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 109.985 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 138' ' ' TYR . 43.5 t -82.01 -20.25 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.294 -0.879 . . . . 0.0 110.554 179.975 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.417 ' CB ' HD11 ' A' ' 130' ' ' ILE . 81.4 mm-40 -80.5 -28.25 37.54 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.341 -0.849 . . . . 0.0 110.696 -179.534 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.403 ' HG3' ' N ' ' A' ' 145' ' ' MET . 4.3 ptt? -84.53 -21.68 30.43 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.053 -1.029 . . . . 0.0 110.462 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.714 ' HE3' ' CE1' ' A' ' 141' ' ' PHE . 46.4 mtt -89.02 -39.83 13.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.203 -0.936 . . . . 0.0 110.524 -179.801 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.207 -0.933 . . . . 0.0 110.383 -179.8 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.405 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 21.6 pt-20 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.084 0.469 . . . . 0.0 110.497 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -55.5 -54.61 41.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.167 -0.958 . . . . 0.0 109.969 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -50.97 -45.03 60.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.908 . . . . 0.0 109.788 179.581 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 31.3 mm -52.87 -40.92 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.884 . . . . 0.0 109.646 179.667 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -59.94 -44.4 94.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.361 -0.837 . . . . 0.0 109.89 179.615 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -53.29 -51.31 62.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 109.954 179.805 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -60.7 -33.87 73.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 109.896 179.737 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 72.1 mttt -66.07 -27.46 68.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.888 179.626 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -73.19 -53.05 11.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.35 -0.843 . . . . 0.0 109.913 179.763 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.444 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -58.89 -34.84 72.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.21 -0.931 . . . . 0.0 109.98 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -66.99 -54.25 23.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.883 . . . . 0.0 109.975 179.867 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.0 m -56.64 -21.39 26.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.238 -0.914 . . . . 0.0 110.021 179.654 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.814 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.1 tm? -78.6 -35.44 45.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.443 -0.786 . . . . 0.0 109.791 179.878 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.444 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 22.7 m-85 -70.46 -55.58 8.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.386 -0.821 . . . . 0.0 110.454 -179.889 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.442 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 0.5 OUTLIER -55.79 113.16 1.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.209 -0.932 . . . . 0.0 110.412 -179.897 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -109.96 54.58 0.66 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 110.143 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.456 ' OD2' ' HB2' ' A' ' 24' ' ' ASP . 10.2 p-10 -162.51 -37.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.111 -0.993 . . . . 0.0 110.598 -179.788 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.81 39.66 2.48 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.456 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 6.8 t70 -103.54 -67.67 0.88 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.369 -1.077 . . . . 0.0 110.101 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.531 ' C ' HG23 ' A' ' 26' ' ' THR . . . 135.92 23.47 0.55 Allowed Glycine 0 N--CA 1.499 2.842 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.621 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.531 HG23 ' C ' ' A' ' 25' ' ' GLY . 74.4 p -154.15 144.17 21.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.896 -1.355 . . . . 0.0 109.534 179.534 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.6 mt -96.37 107.18 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.109 -0.994 . . . . 0.0 110.328 -179.764 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.686 HG22 ' CG2' ' A' ' 62' ' ' THR . 72.4 p -103.28 -176.98 3.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.374 -0.829 . . . . 0.0 110.178 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.716 HG22 HD12 ' A' ' 52' ' ' ILE . 25.5 p -68.31 -26.68 65.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.277 -0.89 . . . . 0.0 110.14 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -68.67 -62.44 1.39 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.21 -0.931 . . . . 0.0 109.921 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.442 ' OE1' ' HA ' ' A' ' 20' ' ' ASP . 35.2 mt-10 -56.42 -55.36 34.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.325 -0.859 . . . . 0.0 109.458 179.602 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.817 HD23 HD21 ' A' ' 48' ' ' LEU . 6.6 tp -57.57 -23.77 52.49 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.177 -0.952 . . . . 0.0 109.296 179.144 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.487 ' HA2' ' CD1' ' A' ' 48' ' ' LEU . . . -62.85 -46.93 92.59 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.444 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.466 ' O ' ' CB ' ' A' ' 38' ' ' SER . 96.4 m -78.54 -14.45 59.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.332 -1.099 . . . . 0.0 109.934 179.636 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.445 ' HB ' ' HA ' ' A' ' 32' ' ' LEU . 50.5 t -78.77 -36.57 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.172 -0.955 . . . . 0.0 110.21 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.7 mmt -90.72 -38.09 13.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.352 -0.843 . . . . 0.0 110.756 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.7 mtm180 -75.74 -36.32 59.93 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.714 -179.497 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.645 ' O ' HD22 ' A' ' 39' ' ' LEU . 8.4 t -76.99 -23.93 52.24 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.876 -1.14 . . . . 0.0 110.054 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.645 HD22 ' O ' ' A' ' 38' ' ' SER . 3.9 mm? -119.85 56.61 0.95 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.314 -0.866 . . . . 0.0 110.169 179.8 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.49 56.95 0.07 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -48.43 104.92 0.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.178 -1.19 . . . . 0.0 110.479 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.539 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 5.9 m-20 -159.66 -63.61 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.318 -0.864 . . . . 0.0 110.329 179.314 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.539 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 46.6 Cg_endo -73.87 -179.32 4.49 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.332 1.175 . . . . 0.0 109.864 179.439 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 8.7 t -134.72 -175.64 3.96 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.108 -0.995 . . . . 0.0 110.102 -179.852 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.06 -42.0 93.58 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.034 -1.041 . . . . 0.0 110.333 -179.832 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.47 -68.46 0.38 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.22 -0.925 . . . . 0.0 110.411 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -47.14 -26.21 1.07 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.221 -0.924 . . . . 0.0 109.984 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.817 HD21 HD23 ' A' ' 32' ' ' LEU . 9.1 tt -70.56 -49.48 47.53 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.313 -0.867 . . . . 0.0 109.764 179.52 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -52.45 -41.18 63.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.118 -0.989 . . . . 0.0 109.222 179.224 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.78 -35.38 79.94 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.877 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.44 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 3.5 ttt -68.16 -15.05 63.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.646 -0.659 . . . . 0.0 109.573 179.007 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.716 HD12 HG22 ' A' ' 29' ' ' THR . 57.3 mt -88.56 -35.17 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.397 -0.814 . . . . 0.0 109.834 179.39 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -51.83 -45.38 63.93 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.274 -0.891 . . . . 0.0 110.657 -179.802 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.693 ' HG3' HG23 ' A' ' 55' ' ' VAL . 22.0 pt-20 -56.93 -34.27 67.81 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.177 -0.952 . . . . 0.0 110.476 -179.658 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.875 HG13 ' HE2' ' A' ' 71' ' ' MET . 95.3 t -84.49 -71.73 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.202 -0.936 . . . . 0.0 110.284 -179.696 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.433 ' HB2' ' CG1' ' A' ' 63' ' ' ILE . 24.2 t70 -56.53 124.33 17.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.335 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.34 5.29 21.48 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.23 -0.919 . . . . 0.0 110.702 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.83 -23.22 36.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.077 -1.015 . . . . 0.0 110.198 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.26 14.43 76.66 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.737 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -91.56 -37.39 13.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.014 -1.286 . . . . 0.0 110.165 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.14 -52.02 0.83 Allowed Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.231 179.567 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.686 ' CG2' HG22 ' A' ' 28' ' ' THR . 66.7 p -101.87 167.55 9.99 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.067 -1.255 . . . . 0.0 110.728 -179.379 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.446 HG23 ' CB ' ' A' ' 67' ' ' GLU . 48.7 mt -115.29 157.17 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.287 -0.883 . . . . 0.0 110.055 179.662 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.485 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 1.4 m-20 -112.6 -172.37 2.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.241 -0.912 . . . . 0.0 110.728 -179.648 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.572 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 50.3 t80 -65.3 -42.62 60.31 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.473 -0.767 . . . . 0.0 111.976 -179.686 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.5 Cg_endo -71.67 -33.35 10.56 Favored 'Trans proline' 0 C--N 1.323 -0.787 0 O-C-N 123.069 1.036 . . . . 0.0 110.893 -179.146 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.446 ' CB ' HG23 ' A' ' 63' ' ' ILE . 48.6 mt-10 -71.43 -30.16 65.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.021 -1.049 . . . . 0.0 108.844 179.169 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.491 ' CZ ' ' SD ' ' A' ' 72' ' ' MET . 64.9 t80 -73.46 -43.0 61.24 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.512 0.672 . . . . 0.0 109.654 179.738 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.49 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 15.5 tp -77.19 -12.12 59.91 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.49 -0.756 . . . . 0.0 110.344 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.7 m -90.68 -28.42 18.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.929 -1.107 . . . . 0.0 110.44 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.875 ' HE2' HG13 ' A' ' 55' ' ' VAL . 18.9 tmm? -90.61 -37.02 14.07 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.178 -0.951 . . . . 0.0 111.197 -179.488 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.491 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 48.9 mtt -91.3 -11.8 36.97 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.112 -0.993 . . . . 0.0 111.975 -178.646 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.5 2.03 0 O-C-N 120.772 -1.205 . . . . 0.0 111.126 -179.401 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.032 0.444 . . . . 0.0 110.314 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.732 HG12 HG22 ' A' ' 142' ' ' VAL . 3.8 tp -48.06 -34.87 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.168 -0.958 . . . . 0.0 109.536 179.834 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -59.95 -48.7 80.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.392 -0.818 . . . . 0.0 109.499 179.282 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.419 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 7.8 mm-40 -54.13 -41.6 68.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.255 -0.903 . . . . 0.0 109.563 179.39 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.15 -46.41 88.45 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.312 -0.867 . . . . 0.0 109.66 179.528 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.435 ' O ' ' HB3' ' A' ' 93' ' ' ASP . 0.4 OUTLIER -63.38 -20.82 65.86 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.179 179.736 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.419 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -74.05 -49.74 22.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.365 -0.834 . . . . 0.0 110.882 -179.489 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 92' ' ' PHE . 16.5 m -75.1 -41.04 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.133 -0.979 . . . . 0.0 111.416 -179.089 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 1.011 ' CE1' HD12 ' A' ' 105' ' ' LEU . 37.7 m-85 -72.78 -28.18 62.45 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.068 -1.02 . . . . 0.0 111.248 -179.141 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.435 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 10.4 t70 -111.15 51.6 0.77 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.859 -1.151 . . . . 0.0 110.348 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.74 2.63 32.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 110.49 179.882 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 3.0 p30 -85.96 -37.77 18.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.128 -0.983 . . . . 0.0 110.296 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 104.38 47.64 1.2 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.443 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 15.8 p-10 -122.77 -32.77 3.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.151 -1.205 . . . . 0.0 110.295 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.48 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 100.36 16.16 28.03 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.901 -1.142 . . . . 0.0 110.312 179.274 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 37.6 m-85 -144.79 161.44 39.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.051 -1.264 . . . . 0.0 110.303 179.762 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.548 HG23 ' HB3' ' A' ' 92' ' ' PHE . 23.0 mt -107.0 118.39 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.256 -0.903 . . . . 0.0 109.419 179.323 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.3 m -102.13 163.36 12.28 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.44 -0.788 . . . . 0.0 109.632 179.8 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.87 -49.76 76.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.063 -1.023 . . . . 0.0 110.167 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -50.43 -50.45 52.0 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.274 -0.891 . . . . 0.0 110.573 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -57.95 -45.73 86.19 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.356 -0.84 . . . . 0.0 110.136 -179.881 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.011 HD12 ' CE1' ' A' ' 92' ' ' PHE . 40.5 tp -59.15 -23.88 62.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.438 -0.789 . . . . 0.0 110.319 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.44 -43.3 27.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.307 -0.871 . . . . 0.0 110.403 -179.933 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.414 ' O ' ' OG1' ' A' ' 110' ' ' THR . 81.6 m-70 -68.18 -30.27 69.33 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.216 -0.927 . . . . 0.0 110.551 -179.927 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.706 HG11 ' CE1' ' A' ' 92' ' ' PHE . 48.1 t -75.17 -47.82 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.02 -1.05 . . . . 0.0 109.866 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.694 ' HE3' HD11 ' A' ' 105' ' ' LEU . 63.7 mtt -65.36 -10.42 33.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.174 -0.954 . . . . 0.0 110.509 179.911 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 107' ' ' HIS . 1.1 p -90.17 -26.41 20.16 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.018 -1.051 . . . . 0.0 109.858 179.245 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -88.47 -52.92 4.92 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.146 -0.971 . . . . 0.0 110.117 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.1 mt -47.73 -72.85 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.165 -0.959 . . . . 0.0 110.278 179.811 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 162.97 40.78 0.02 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.489 ' HB3' ' CD1' ' A' ' 116' ' ' LEU . 51.5 mt-10 -120.85 121.45 38.13 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.323 -1.104 . . . . 0.0 110.462 -179.786 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -106.81 66.03 0.68 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.206 -0.934 . . . . 0.0 110.109 179.702 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.489 ' CD1' ' HB3' ' A' ' 114' ' ' GLU . 3.4 mp -88.04 167.98 13.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.261 -0.899 . . . . 0.0 110.364 -179.895 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 22.9 m -86.24 163.21 17.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.334 -0.854 . . . . 0.0 109.969 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -60.77 -54.44 45.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.159 -0.963 . . . . 0.0 110.379 -179.805 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -47.07 -40.23 14.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.947 . . . . 0.0 110.276 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -56.76 -60.09 4.07 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.251 -0.906 . . . . 0.0 110.441 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.803 HG13 HD23 ' A' ' 105' ' ' LEU . 53.1 t -47.22 -39.72 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.143 -0.973 . . . . 0.0 110.371 -179.622 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -62.68 -44.07 97.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.135 -0.978 . . . . 0.0 109.99 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -69.11 -20.51 64.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.199 179.839 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 85.1 mtp -77.78 -46.52 21.41 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.126 -0.984 . . . . 0.0 109.993 179.977 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.483 HG23 HG23 ' A' ' 136' ' ' VAL . 26.0 mm -65.57 -29.38 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.158 -0.964 . . . . 0.0 110.007 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -75.91 -54.79 6.36 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.2 -0.938 . . . . 0.0 110.132 179.576 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -54.94 -33.52 62.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.226 -0.921 . . . . 0.0 109.995 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -75.13 -37.43 61.41 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.209 -0.932 . . . . 0.0 109.811 179.701 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -57.89 95.46 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.317 -0.864 . . . . 0.0 109.809 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.433 HD12 ' HG2' ' A' ' 140' ' ' GLU . 21.8 mt -62.07 -46.96 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.888 . . . . 0.0 110.402 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 21.6 p30 -86.6 -19.69 28.99 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.185 -0.947 . . . . 0.0 110.059 179.854 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.445 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 67.48 65.56 2.69 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 178.871 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.426 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 34.4 m-20 -98.28 -35.62 10.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.178 -1.19 . . . . 0.0 109.719 179.048 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.75 -28.62 1.04 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 -179.664 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.412 ' O ' ' OE1' ' A' ' 135' ' ' GLN . 0.0 OUTLIER -137.08 169.62 17.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.471 -1.017 . . . . 0.0 109.709 179.589 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.483 HG23 HG23 ' A' ' 125' ' ' ILE . 84.4 t -99.28 145.23 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 120.97 -1.081 . . . . 0.0 110.752 -179.447 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -106.67 178.79 4.46 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.365 -0.835 . . . . 0.0 110.193 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.537 ' O ' HG23 ' A' ' 142' ' ' VAL . 13.7 t80 -69.07 -44.7 72.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.231 -0.918 . . . . 0.0 110.441 -179.997 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.58 -33.32 73.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.242 -0.911 . . . . 0.0 110.27 -179.735 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.433 ' HG2' HD12 ' A' ' 130' ' ' ILE . 48.3 mt-10 -71.27 -35.6 71.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.146 -0.971 . . . . 0.0 110.085 179.818 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.477 ' CE2' HG13 ' A' ' 85' ' ' ILE . 57.4 t80 -71.13 -32.72 69.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.212 -0.93 . . . . 0.0 110.657 -179.847 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.732 HG22 HG12 ' A' ' 85' ' ' ILE . 59.4 t -78.7 -29.54 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.12 -0.987 . . . . 0.0 110.72 -179.734 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.424 ' OE1' ' N ' ' A' ' 143' ' ' GLN . 0.6 OUTLIER -97.06 -9.74 27.46 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.129 -0.982 . . . . 0.0 111.456 -179.068 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.47 ' HG2' ' HA ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -89.31 -31.56 17.77 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.705 -1.247 . . . . 0.0 110.372 -179.958 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 56.0 ttm -85.97 -48.77 8.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.938 179.907 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.5 p . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.351 -0.843 . . . . 0.0 110.091 179.682 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.098 0.475 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -62.08 -55.06 32.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.032 -1.042 . . . . 0.0 110.764 -179.661 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -59.76 -50.89 72.05 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.208 -0.932 . . . . 0.0 110.217 -179.544 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 12' ' ' PHE . 22.9 mt -48.91 -42.74 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.045 -1.034 . . . . 0.0 109.664 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.02 -43.1 99.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 109.571 179.301 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -58.65 -29.1 66.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 109.555 179.463 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 12.5 m-85 -72.91 -36.23 67.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.279 -0.888 . . . . 0.0 109.934 179.656 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -70.46 -27.1 63.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.917 . . . . 0.0 109.858 179.623 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.83 -43.83 52.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.352 -0.843 . . . . 0.0 109.845 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.56 -42.86 86.45 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.246 -0.909 . . . . 0.0 109.7 179.484 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -57.14 -44.62 83.54 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.269 -0.894 . . . . 0.0 109.651 179.685 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 98.3 p -64.12 -35.6 81.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -0.904 . . . . 0.0 109.337 179.388 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.676 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -58.69 -33.17 69.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.466 -0.771 . . . . 0.0 109.381 179.438 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.504 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 3.5 m-30 -87.09 -24.08 24.69 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.39 -0.819 . . . . 0.0 109.92 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.422 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 66.7 t0 -101.69 92.67 4.96 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.334 -0.854 . . . . 0.0 109.912 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.52 -14.29 15.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 110.59 -179.548 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -78.89 -37.34 40.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.184 -0.948 . . . . 0.0 110.299 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.72 83.13 1.71 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 23.5 p-10 -156.53 -32.41 0.09 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.122 -1.223 . . . . 0.0 111.207 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.451 ' C ' HG23 ' A' ' 26' ' ' THR . . . 101.81 22.85 9.76 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.56 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.451 HG23 ' C ' ' A' ' 25' ' ' GLY . 75.9 p -149.69 155.01 39.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.164 -1.198 . . . . 0.0 109.988 179.863 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.5 mt -109.43 124.93 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.069 -1.02 . . . . 0.0 110.218 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.801 HG22 HG21 ' A' ' 62' ' ' THR . 41.4 p -108.0 -159.01 0.67 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.426 -0.796 . . . . 0.0 110.189 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.794 HG22 HD12 ' A' ' 52' ' ' ILE . 32.0 p -90.23 -34.04 15.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.218 179.921 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.49 -58.88 6.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -0.906 . . . . 0.0 109.995 -179.952 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 19' ' ' PHE . 48.8 mt-10 -60.49 -54.64 43.03 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.32 -0.862 . . . . 0.0 109.709 179.831 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.646 HD23 HD11 ' A' ' 48' ' ' LEU . 2.8 tp -57.26 -20.18 26.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.269 -0.894 . . . . 0.0 109.713 179.533 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.35 -46.85 46.84 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 179.542 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.437 ' O ' ' CB ' ' A' ' 38' ' ' SER . 38.4 m -68.8 -20.22 64.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.447 -1.031 . . . . 0.0 109.805 179.349 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.857 ' O ' HD12 ' A' ' 39' ' ' LEU . 54.9 t -75.48 -58.1 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.385 -0.822 . . . . 0.0 110.332 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.506 ' CE ' ' CE ' ' A' ' 51' ' ' MET . 58.7 mtt -72.9 -18.8 61.38 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.279 -0.888 . . . . 0.0 110.785 -179.391 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -89.93 -29.33 18.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.021 -1.049 . . . . 0.0 110.09 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 34' ' ' THR . 40.5 t -82.41 -30.73 29.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.237 -0.915 . . . . 0.0 110.101 179.756 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.857 HD12 ' O ' ' A' ' 35' ' ' VAL . 1.3 mt -104.35 64.93 0.77 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.376 -0.828 . . . . 0.0 109.663 179.608 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.22 78.16 1.34 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.411 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -63.24 88.38 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.282 -1.128 . . . . 0.0 110.55 -179.459 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.534 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 3.2 m120 -114.28 -66.66 0.03 OUTLIER Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.375 -0.828 . . . . 0.0 110.689 179.72 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.534 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 47.1 Cg_endo -73.49 -169.44 0.54 Allowed 'Trans proline' 0 C--N 1.32 -0.934 0 O-C-N 123.092 1.048 . . . . 0.0 110.341 179.484 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 35.0 p -138.54 -175.3 4.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.321 -0.862 . . . . 0.0 110.07 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -66.56 -31.5 72.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.222 -0.923 . . . . 0.0 109.974 179.683 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.23 -67.28 0.5 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 0.0 109.953 179.73 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -50.6 -31.11 15.02 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.354 -0.841 . . . . 0.0 109.688 179.718 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.646 HD11 HD23 ' A' ' 32' ' ' LEU . 8.8 tt -65.63 -47.94 73.89 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.395 -0.815 . . . . 0.0 110.066 179.65 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.419 ' OE1' HG21 ' A' ' 29' ' ' THR . 4.6 tp-100 -54.46 -44.95 72.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 109.217 179.465 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 1.0 OUTLIER -67.87 -27.35 66.6 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.345 -0.847 . . . . 0.0 109.307 179.355 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.506 ' CE ' ' CE ' ' A' ' 36' ' ' MET . 20.2 ttp -76.15 -15.18 60.12 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.497 -0.752 . . . . 0.0 109.719 179.413 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.794 HD12 HG22 ' A' ' 29' ' ' THR . 6.4 mt -90.51 -38.45 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.132 -0.98 . . . . 0.0 109.823 179.378 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -52.99 -28.64 24.91 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.158 -0.964 . . . . 0.0 109.75 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.475 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 9.6 pt-20 -79.95 -33.84 39.27 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 109.541 179.245 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.475 ' N ' ' HG3' ' A' ' 54' ' ' GLU . 85.3 t -69.48 -65.76 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.192 -0.943 . . . . 0.0 109.202 178.973 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -56.35 101.51 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.435 -0.791 . . . . 0.0 109.845 179.419 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.43 58.36 0.8 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.128 -0.983 . . . . 0.0 110.711 -179.523 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.425 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 15.3 m-20 -141.81 -49.79 0.39 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.261 -0.899 . . . . 0.0 109.852 179.565 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.64 50.77 0.55 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.647 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.412 ' OD1' ' HB2' ' A' ' 58' ' ' ASP . 7.7 p-10 -129.14 -48.29 1.21 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.27 -1.135 . . . . 0.0 110.443 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.95 -86.66 0.13 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.3 -1.429 . . . . 0.0 110.8 179.6 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.801 HG21 HG22 ' A' ' 28' ' ' THR . 73.7 p -91.22 170.59 9.88 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.246 -1.149 . . . . 0.0 111.34 -178.662 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.423 ' CD1' HG11 ' A' ' 55' ' ' VAL . 33.1 mt -88.9 159.7 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.515 -0.741 . . . . 0.0 109.917 179.628 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.425 ' HB2' ' OE1' ' A' ' 67' ' ' GLU . 20.7 t0 -108.29 -176.93 3.19 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.276 -0.89 . . . . 0.0 110.417 -179.969 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.583 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 23.5 t80 -72.81 -43.79 8.49 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.406 -0.809 . . . . 0.0 111.174 179.86 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.7 Cg_endo -72.18 -19.08 26.45 Favored 'Trans proline' 0 C--O 1.213 -0.748 0 O-C-N 123.122 1.064 . . . . 0.0 110.562 -179.844 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.425 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 39.9 mt-10 -78.57 -27.81 45.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.021 -1.049 . . . . 0.0 108.919 179.029 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 7.5 t80 -76.88 -48.62 17.81 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.287 0.565 . . . . 0.0 110.419 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.739 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 17.0 tp -78.26 -17.39 56.73 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.193 -0.942 . . . . 0.0 111.236 -179.388 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.405 ' CB ' ' O ' ' A' ' 66' ' ' PRO . 43.1 m -87.77 -38.83 15.42 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.706 -1.246 . . . . 0.0 110.56 -179.797 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.518 ' HE2' ' CE ' ' A' ' 72' ' ' MET . 4.8 ptt? -78.38 -31.62 48.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.157 -0.964 . . . . 0.0 110.332 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.518 ' CE ' ' HE2' ' A' ' 71' ' ' MET . 48.2 mtt -89.79 -9.58 48.7 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.156 -0.965 . . . . 0.0 110.671 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.141 -0.974 . . . . 0.0 110.394 -179.808 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 121.183 0.516 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 26.1 mm -67.02 -29.93 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.449 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -56.52 10.03 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.158 -0.964 . . . . 0.0 109.838 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -55.08 -42.33 72.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.346 -0.846 . . . . 0.0 110.161 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.41 -39.3 92.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.9 . . . . 0.0 110.558 -179.667 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.44 ' O ' ' CB ' ' A' ' 93' ' ' ASP . 5.0 t80 -63.46 -33.26 75.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.914 -1.116 . . . . 0.0 110.387 -179.631 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -75.52 -55.04 6.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.086 -1.009 . . . . 0.0 111.003 -179.481 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.562 HG23 ' N ' ' A' ' 92' ' ' PHE . 19.2 m -56.26 -42.9 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.095 -1.003 . . . . 0.0 110.813 -179.35 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.752 ' CE1' HD12 ' A' ' 105' ' ' LEU . 30.3 m-85 -77.44 -20.77 54.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.135 -0.978 . . . . 0.0 110.211 179.88 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 89' ' ' PHE . 35.5 t0 -113.71 53.21 0.78 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.154 -0.966 . . . . 0.0 109.471 179.127 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -86.36 56.17 3.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.543 -0.723 . . . . 0.0 110.757 -179.419 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.462 ' OD2' ' HB2' ' A' ' 97' ' ' ASN . 26.3 p-10 -158.26 29.94 0.25 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.103 -0.998 . . . . 0.0 110.335 179.731 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.44 33.12 4.2 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.524 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.462 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 18.1 t-20 -91.93 -60.01 1.97 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.236 -1.155 . . . . 0.0 110.083 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.458 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 112.07 -5.49 27.14 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.742 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.458 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 37.3 m-85 -138.93 140.06 38.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.938 -1.331 . . . . 0.0 110.465 -179.826 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 39.5 mt -85.97 118.25 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.315 -0.866 . . . . 0.0 110.161 179.813 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.3 t -102.91 174.15 6.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.451 -0.781 . . . . 0.0 109.462 179.514 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.25 -41.21 73.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.039 -1.038 . . . . 0.0 109.988 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.42 -54.55 44.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.211 -0.931 . . . . 0.0 110.091 179.64 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.403 ' OE2' ' OD2' ' A' ' 95' ' ' ASP . 45.9 mt-10 -59.58 -45.34 92.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.224 -0.922 . . . . 0.0 110.043 179.765 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.857 HD23 HG13 ' A' ' 121' ' ' VAL . 32.5 tp -58.52 -21.12 51.26 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.429 -0.794 . . . . 0.0 110.534 -179.927 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.8 ttt-85 -83.52 -40.08 19.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.213 -0.929 . . . . 0.0 110.097 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -73.22 -22.65 60.39 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.28 -0.887 . . . . 0.0 110.125 179.88 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 97.3 t -89.92 -44.15 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -0.882 . . . . 0.0 110.068 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 4.7 mmt -49.5 -24.41 2.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.908 . . . . 0.0 110.163 179.852 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 64.6 p -82.34 -41.75 19.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 110.081 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -57.04 -45.18 83.36 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.234 -0.917 . . . . 0.0 110.177 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.421 ' HB2' ' OE1' ' A' ' 114' ' ' GLU . 80.4 mt -64.12 -55.91 18.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.317 -0.865 . . . . 0.0 110.31 -179.969 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 142.52 53.07 0.04 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.758 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.421 ' OE1' ' HB2' ' A' ' 112' ' ' LEU . 49.5 mp0 -139.11 -62.83 0.53 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.168 -1.195 . . . . 0.0 110.068 179.693 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 114' ' ' GLU . 70.3 tttt 55.78 104.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.299 -0.876 . . . . 0.0 110.417 179.751 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.58 -175.82 3.24 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.165 -0.959 . . . . 0.0 110.529 -179.948 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.428 HG23 ' H ' ' A' ' 120' ' ' GLU . 9.5 t -87.89 -177.8 5.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.361 -0.837 . . . . 0.0 110.184 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -68.96 -34.8 75.93 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.178 -0.951 . . . . 0.0 110.448 -179.875 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -65.47 -53.24 45.45 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.232 -0.917 . . . . 0.0 110.779 -179.767 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.428 ' H ' HG23 ' A' ' 117' ' ' THR . 5.7 mm-40 -54.32 -50.45 67.35 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.127 -0.983 . . . . 0.0 110.56 -179.54 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.857 HG13 HD23 ' A' ' 105' ' ' LEU . 56.1 t -56.44 -47.98 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.162 -0.961 . . . . 0.0 110.133 -179.978 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -62.68 -23.69 67.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.184 -0.948 . . . . 0.0 109.868 179.677 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.434 ' HG3' ' OE1' ' A' ' 127' ' ' GLU . 16.5 tp10 -75.07 -30.01 60.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.395 -0.816 . . . . 0.0 109.917 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.757 ' CE ' HD21 ' A' ' 105' ' ' LEU . 23.3 mtm -77.33 -46.24 23.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.368 -0.833 . . . . 0.0 110.1 -179.978 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 24.9 mm -68.7 -33.22 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.025 -1.047 . . . . 0.0 109.879 179.698 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -71.97 -55.86 6.69 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.392 -0.818 . . . . 0.0 110.636 -179.63 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.434 ' OE1' ' HG3' ' A' ' 123' ' ' GLU . 54.5 mt-10 -61.06 -36.4 79.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.176 -0.953 . . . . 0.0 110.116 -179.768 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.55 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -70.23 -26.98 64.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.814 179.799 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -63.3 94.69 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.867 . . . . 0.0 109.991 179.76 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 128' ' ' ALA . 97.8 mt -79.8 -43.94 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.218 -0.926 . . . . 0.0 110.854 -179.646 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 23.4 p30 -79.27 -19.51 50.4 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.016 -1.053 . . . . 0.0 110.791 -179.655 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 79.0 70.79 1.29 Allowed Glycine 0 N--CA 1.495 2.632 0 C-N-CA 120.031 -1.081 . . . . 0.0 110.53 179.344 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -125.5 -26.67 3.53 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.186 -1.185 . . . . 0.0 110.578 179.545 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 118.35 -37.43 3.24 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.689 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.417 ' OE1' ' CD1' ' A' ' 99' ' ' TYR . 3.2 pt20 -113.14 156.72 22.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.278 -1.13 . . . . 0.0 109.922 179.81 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.42 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 62.4 t -99.5 118.41 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.203 -0.935 . . . . 0.0 110.423 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 37.8 p30 -93.25 -163.93 1.11 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.244 -0.91 . . . . 0.0 110.131 179.669 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.554 ' O ' HG23 ' A' ' 142' ' ' VAL . 23.2 t80 -69.63 -62.55 1.34 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.095 -1.003 . . . . 0.0 111.127 -179.289 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -44.06 -59.48 2.29 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.275 -0.891 . . . . 0.0 111.191 -179.121 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 144' ' ' MET . 51.7 mt-10 -51.44 -51.37 55.48 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 121.198 -0.939 . . . . 0.0 110.538 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 137' ' ' ASN . 0.8 OUTLIER -54.08 -31.3 51.37 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.291 -0.88 . . . . 0.0 110.551 -179.582 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 138' ' ' TYR . 94.9 t -72.1 -62.86 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.285 -0.884 . . . . 0.0 110.691 -179.51 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -64.9 -9.66 22.84 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.222 -0.924 . . . . 0.0 110.87 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.55 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 49.3 ttp -59.46 -60.54 3.69 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.13 -0.981 . . . . 0.0 110.786 -179.704 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.453 ' HG3' ' HE3' ' A' ' 144' ' ' MET . 38.3 mtt -89.88 -44.3 10.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.448 -0.783 . . . . 0.0 110.857 -179.368 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.05 -1.031 . . . . 0.0 110.122 -179.901 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.355 0.598 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -66.49 -44.59 82.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.375 -0.828 . . . . 0.0 110.331 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.435 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 42.1 tt0 -55.67 -47.25 77.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 110.177 -179.856 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.0 mt -60.07 -40.6 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.052 -1.03 . . . . 0.0 109.482 179.427 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.79 -26.91 68.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.349 -0.844 . . . . 0.0 109.329 179.15 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 38.2 tt0 -67.64 -46.49 72.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.347 -0.846 . . . . 0.0 109.365 179.411 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -63.53 -32.11 73.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.908 . . . . 0.0 109.465 179.157 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.17 -40.44 82.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.5 -0.75 . . . . 0.0 110.165 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -63.14 -45.26 92.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.2 -0.937 . . . . 0.0 110.187 -179.835 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.33 -37.39 87.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.141 -0.974 . . . . 0.0 110.074 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -63.92 -37.38 87.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.189 -0.945 . . . . 0.0 109.945 179.862 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.9 m -65.9 -39.93 91.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.388 -0.82 . . . . 0.0 110.286 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.658 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.5 tm? -66.56 -35.96 81.49 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.183 -0.948 . . . . 0.0 110.13 -179.936 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.436 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 12.0 m-30 -69.65 -64.78 0.81 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.224 -0.923 . . . . 0.0 109.931 179.718 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -83.0 96.07 8.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.35 -0.844 . . . . 0.0 109.856 179.674 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.422 ' HD3' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -109.66 48.57 0.88 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.256 -0.902 . . . . 0.0 110.524 -179.758 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -131.22 -35.24 1.37 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.105 -0.997 . . . . 0.0 110.368 179.768 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.32 86.21 1.49 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 21.1 p-10 -178.13 -34.19 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.302 -1.117 . . . . 0.0 110.617 179.654 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.519 ' C ' HG23 ' A' ' 26' ' ' THR . . . 83.91 42.19 7.78 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.131 179.633 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.519 HG23 ' C ' ' A' ' 25' ' ' GLY . 59.3 p -151.28 107.47 3.44 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.095 -1.238 . . . . 0.0 110.389 179.875 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.4 mt -74.68 124.63 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.828 179.559 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.9 p -112.78 -157.21 0.61 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.332 -0.855 . . . . 0.0 110.08 -179.865 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.524 ' HA ' HD21 ' A' ' 48' ' ' LEU . 38.0 p -87.53 -27.06 22.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.212 -0.93 . . . . 0.0 110.253 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -70.72 -56.8 5.58 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.147 -0.97 . . . . 0.0 109.676 179.553 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.485 ' O ' HG23 ' A' ' 35' ' ' VAL . 50.8 mt-10 -57.27 -36.08 70.55 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.303 -0.873 . . . . 0.0 109.685 179.555 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.868 HD22 HD11 ' A' ' 52' ' ' ILE . 9.0 tp -68.87 -31.78 70.96 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.349 -0.845 . . . . 0.0 109.707 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.82 -41.6 98.77 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.413 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 66.1 m -72.42 -33.65 67.28 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.317 -1.108 . . . . 0.0 109.967 179.771 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 31' ' ' GLU . 53.7 t -71.15 -26.98 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.377 -0.827 . . . . 0.0 110.444 -179.958 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.1 mmt -86.91 -32.29 20.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 110.467 -179.619 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 -90.79 -11.07 40.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.228 -0.92 . . . . 0.0 110.775 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 97.3 p -97.41 -23.03 16.26 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.981 -1.074 . . . . 0.0 110.48 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.6 mt -107.79 -46.85 3.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.118 -0.989 . . . . 0.0 110.388 -179.871 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.65 84.01 0.1 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.987 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.3 tp60 -50.92 161.32 0.38 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.357 -1.084 . . . . 0.0 110.558 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.519 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.0 OUTLIER 177.03 -56.3 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.488 -0.758 . . . . 0.0 109.976 179.647 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 42' ' ' ASN . 54.6 Cg_endo -76.76 -163.2 0.19 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.483 1.254 . . . . 0.0 110.864 179.671 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.669 HG23 ' N ' ' A' ' 45' ' ' GLU . 11.1 t -137.18 -140.19 0.15 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.077 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.669 ' N ' HG23 ' A' ' 44' ' ' THR . 52.1 mt-10 -97.89 -45.22 6.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.818 -1.176 . . . . 0.0 110.031 179.593 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.51 -52.98 26.2 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.198 -0.939 . . . . 0.0 109.618 179.389 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -59.07 -20.91 57.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.364 -0.835 . . . . 0.0 109.723 179.639 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.753 ' HG ' HD23 ' A' ' 32' ' ' LEU . 7.9 tt -71.93 -53.43 13.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.895 . . . . 0.0 109.481 179.368 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -50.92 -42.76 59.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.219 179.253 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -63.92 -39.69 94.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.362 -0.837 . . . . 0.0 109.6 179.415 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.429 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 36.4 ttp -66.21 -19.42 65.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -0.878 . . . . 0.0 109.566 179.375 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.868 HD11 HD22 ' A' ' 32' ' ' LEU . 5.6 mm -84.26 -29.73 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.407 -0.808 . . . . 0.0 109.683 179.413 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -71.6 -46.42 59.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.398 -0.814 . . . . 0.0 110.888 -179.45 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.641 ' HG3' HG23 ' A' ' 55' ' ' VAL . 24.2 pt-20 -51.35 -33.96 31.83 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.101 -1.0 . . . . 0.0 110.379 -179.711 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.641 HG23 ' HG3' ' A' ' 54' ' ' GLU . 48.6 t -82.15 -39.77 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.247 -0.908 . . . . 0.0 110.147 179.943 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -78.31 111.72 14.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.395 -0.816 . . . . 0.0 110.562 -179.67 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.77 54.98 0.65 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.206 -0.934 . . . . 0.0 109.925 179.741 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -134.96 -53.91 0.81 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.401 -0.812 . . . . 0.0 109.891 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 128.45 60.54 0.12 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.662 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.491 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 6.8 p-10 -151.34 -52.78 0.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -1.115 . . . . 0.0 110.131 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.6 -5.89 9.87 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.785 179.032 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.5 p -120.96 141.69 50.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.79 -1.418 . . . . 0.0 110.573 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 77.1 mt -92.32 121.38 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -0.949 . . . . 0.0 110.11 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.421 ' OD2' ' HD2' ' A' ' 66' ' ' PRO . 9.7 t70 -84.2 -167.0 1.59 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.285 -0.885 . . . . 0.0 110.196 -179.778 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.59 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 40.5 t80 -78.32 -44.38 2.13 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.05 -1.031 . . . . 0.0 111.631 -179.674 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.0 Cg_endo -70.76 -21.56 28.68 Favored 'Trans proline' 0 N--CA 1.482 0.802 0 O-C-N 123.079 1.041 . . . . 0.0 110.505 -179.579 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 71' ' ' MET . 53.0 mt-10 -81.12 -27.78 35.4 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.191 -0.943 . . . . 0.0 109.174 179.227 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.542 ' CE2' ' CE ' ' A' ' 72' ' ' MET . 36.0 t80 -77.26 -36.38 54.48 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.492 -0.755 . . . . 0.0 109.813 179.612 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.549 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 13.7 tp -76.81 -32.49 57.66 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.404 -0.81 . . . . 0.0 110.235 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 97.1 m -80.88 -23.78 38.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.337 -0.852 . . . . 0.0 110.41 -179.853 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.616 ' HG3' HG13 ' A' ' 55' ' ' VAL . 13.8 tmm? -84.33 -45.3 12.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.256 -0.903 . . . . 0.0 110.372 -179.723 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.542 ' CE ' ' CE2' ' A' ' 68' ' ' PHE . 9.5 mtt -79.17 -16.42 56.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 110.671 -179.272 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.095 -1.003 . . . . 0.0 108.902 179.098 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.158 0.504 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.566 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 60.3 mt -55.76 -35.89 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.138 -0.976 . . . . 0.0 110.114 -179.781 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.0 tpt180 -64.4 -53.0 55.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.956 . . . . 0.0 109.358 179.346 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -57.29 -23.57 49.31 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.358 -0.839 . . . . 0.0 109.443 179.28 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 85' ' ' ILE . . . -67.92 -60.47 2.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.416 -0.802 . . . . 0.0 109.859 179.768 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -55.76 -24.17 33.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.175 -0.953 . . . . 0.0 110.16 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.496 ' NE ' ' HA ' ' A' ' 90' ' ' ARG . 8.6 tpm_? -73.0 -58.29 3.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.317 -0.864 . . . . 0.0 110.707 -179.723 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.2 m -70.36 -12.14 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.121 -0.987 . . . . 0.0 110.684 -179.592 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -101.05 -13.31 18.27 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.091 -1.006 . . . . 0.0 110.606 -179.8 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -132.71 44.44 2.86 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.094 -1.004 . . . . 0.0 110.329 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.71 3.57 22.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.118 -0.989 . . . . 0.0 110.769 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 3.0 p30 -70.58 -30.74 67.52 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.134 -0.979 . . . . 0.0 110.573 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.8 34.94 1.94 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -179.361 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.404 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 23.1 t-20 -110.16 -47.36 3.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.355 -1.085 . . . . 0.0 110.319 -179.679 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 125.24 -35.32 3.12 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.833 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 0.8 OUTLIER -132.8 169.56 16.55 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.075 -1.25 . . . . 0.0 109.663 -179.753 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 38.3 mt -80.63 129.19 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.112 -0.992 . . . . 0.0 109.62 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.9 t -118.56 174.02 6.5 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.333 -0.855 . . . . 0.0 109.814 179.714 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.19 -38.76 78.82 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.155 -0.966 . . . . 0.0 110.048 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.66 87.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.237 -0.915 . . . . 0.0 110.033 179.746 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.636 ' O ' HG23 ' A' ' 108' ' ' VAL . 33.1 mt-10 -62.03 -54.13 45.88 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.246 -0.909 . . . . 0.0 110.094 179.825 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.575 HD21 ' HE3' ' A' ' 109' ' ' MET . 4.3 tt -47.76 -34.36 8.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 110.1 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.8 ttt-85 -70.97 -44.05 66.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.293 -0.879 . . . . 0.0 110.329 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 48.1 m170 -69.94 -10.4 58.42 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.129 -0.982 . . . . 0.0 110.622 -179.824 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 104' ' ' GLU . 61.5 t -92.29 -57.06 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.124 -0.985 . . . . 0.0 110.538 -179.749 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.575 ' HE3' HD21 ' A' ' 105' ' ' LEU . 64.8 mtt -71.41 -26.81 62.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.194 -0.941 . . . . 0.0 110.584 -179.693 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.2 m -69.35 -42.32 75.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.201 -0.937 . . . . 0.0 110.29 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -75.02 -34.33 61.9 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.188 -0.945 . . . . 0.0 110.265 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.2 mt -60.62 -32.2 71.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.168 -0.958 . . . . 0.0 110.229 179.923 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.42 -13.7 4.28 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.64 134.55 34.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -1.175 . . . . 0.0 110.27 -179.961 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -101.61 120.23 40.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.945 . . . . 0.0 110.208 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.83 179.25 4.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.21 -0.931 . . . . 0.0 110.546 -179.766 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.527 HG22 ' H ' ' A' ' 118' ' ' ASP . 17.7 m -122.56 175.88 6.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.406 -0.809 . . . . 0.0 109.944 179.741 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.527 ' H ' HG22 ' A' ' 117' ' ' THR . 1.4 m-20 -65.54 -51.95 56.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.161 -0.962 . . . . 0.0 110.544 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -64.97 -34.82 79.35 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.084 -1.01 . . . . 0.0 110.446 -179.807 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.416 ' HA ' ' OE1' ' A' ' 120' ' ' GLU . 7.9 mm-40 -61.37 -46.04 91.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.108 -0.995 . . . . 0.0 110.079 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.4 t -64.06 -56.47 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 109.808 179.656 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -51.4 -26.3 7.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.975 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 30.5 tt0 -70.09 -52.97 19.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.18 179.982 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.477 ' HE2' HD21 ' A' ' 105' ' ' LEU . 42.4 mtp -58.21 -48.22 81.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.174 -0.954 . . . . 0.0 110.141 179.875 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 25.7 mm -60.89 -29.24 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.072 -1.018 . . . . 0.0 109.599 179.585 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.402 ' HB3' ' O ' ' A' ' 123' ' ' GLU . 22.6 ttm180 -66.74 -40.83 88.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.374 -0.829 . . . . 0.0 109.991 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -70.48 -28.37 64.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.285 -0.884 . . . . 0.0 110.237 179.919 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.411 ' O ' HG13 ' A' ' 130' ' ' ILE . . . -80.32 -25.05 39.52 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.311 -0.868 . . . . 0.0 110.469 -179.819 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -70.11 92.16 0.73 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.227 -0.921 . . . . 0.0 109.995 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 128' ' ' ALA . 74.4 mt -85.31 -34.54 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.3 -0.875 . . . . 0.0 110.594 -179.639 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 6.3 p30 -84.98 -25.79 27.54 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.073 -1.017 . . . . 0.0 110.299 179.845 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.455 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 89.94 71.56 1.25 Allowed Glycine 0 N--CA 1.494 2.562 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.316 179.337 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.411 ' OD2' ' OD1' ' A' ' 131' ' ' ASP . 73.1 m-20 -136.5 -38.69 0.66 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.205 -1.173 . . . . 0.0 110.021 179.294 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 121.96 -7.28 10.12 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.507 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -126.61 150.92 48.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.157 -1.202 . . . . 0.0 110.153 179.953 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.2 t -115.2 109.41 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.19 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -82.34 -167.73 1.7 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.18 -0.95 . . . . 0.0 110.195 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -62.18 -45.22 94.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.255 -0.903 . . . . 0.0 111.284 -179.134 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -62.69 -56.73 14.99 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.942 -1.099 . . . . 0.0 110.921 -179.248 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 144' ' ' MET . 50.5 mt-10 -57.1 -24.27 52.89 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.13 -0.981 . . . . 0.0 110.725 -179.591 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.474 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 89.2 t80 -78.66 -35.09 45.78 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.232 -0.917 . . . . 0.0 110.944 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 84.6 t -83.09 -22.96 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.108 -0.995 . . . . 0.0 110.869 -179.509 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -92.53 -23.42 19.09 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.18 -0.95 . . . . 0.0 110.882 -179.617 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.486 ' HE2' ' HE3' ' A' ' 145' ' ' MET . 1.0 OUTLIER -71.29 -20.26 62.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.003 -1.061 . . . . 0.0 110.496 -179.707 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.486 ' HE3' ' HE2' ' A' ' 144' ' ' MET . 63.5 mtt -84.85 -70.37 0.58 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.223 -0.923 . . . . 0.0 110.537 -179.694 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 59.0 p . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.2 -0.938 . . . . 0.0 110.183 -179.672 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.464 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.6 pt-20 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.102 0.477 . . . . 0.0 110.119 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -65.34 -64.9 0.75 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.104 -0.998 . . . . 0.0 109.985 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -55.13 -39.97 70.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.144 -0.973 . . . . 0.0 109.476 179.685 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 6' ' ' GLU . 55.3 mt -56.8 -37.73 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.389 -0.819 . . . . 0.0 109.478 179.315 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.97 -43.06 99.63 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.278 -0.889 . . . . 0.0 109.341 179.386 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.03 -36.73 82.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.486 -0.759 . . . . 0.0 109.837 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -76.03 -20.08 58.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.406 -0.808 . . . . 0.0 109.665 179.525 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -79.53 -33.53 41.88 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.289 -0.882 . . . . 0.0 109.416 179.183 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -74.27 -39.95 62.65 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.391 -0.818 . . . . 0.0 109.857 179.735 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.75 -48.31 39.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.2 -0.938 . . . . 0.0 109.599 179.54 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.555 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 1.2 t80 -58.68 -34.07 70.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.415 -0.803 . . . . 0.0 109.47 179.334 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.2 t -72.11 -38.49 69.31 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.465 -0.772 . . . . 0.0 109.817 179.806 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.854 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.2 tm? -65.92 -24.06 66.75 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.526 -0.734 . . . . 0.0 109.663 179.768 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.462 ' HA ' ' CG2' ' A' ' 35' ' ' VAL . 17.0 m-85 -82.15 -59.29 2.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.323 -0.861 . . . . 0.0 110.339 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.417 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 7.9 t0 -76.52 97.49 4.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 109.772 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.442 ' HD2' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -110.53 46.37 1.05 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.068 -1.02 . . . . 0.0 110.843 -179.644 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.404 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 12.0 p-10 -132.33 -33.31 1.29 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.236 -0.915 . . . . 0.0 110.513 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.38 76.32 1.05 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.89 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 15.3 p-10 -159.49 -45.26 0.05 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.02 -1.283 . . . . 0.0 110.579 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.9 -2.97 25.79 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.728 -1.225 . . . . 0.0 110.324 179.674 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 34.5 p -121.1 165.16 15.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.943 -1.328 . . . . 0.0 110.197 179.878 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.3 mt -112.64 130.24 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.187 -0.946 . . . . 0.0 110.094 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.6 p -114.5 177.05 4.78 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.429 -0.794 . . . . 0.0 109.895 -179.975 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.608 ' HA ' HD21 ' A' ' 48' ' ' LEU . 12.7 p -66.67 -28.67 68.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 0.0 110.112 179.877 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -57.66 6.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -0.933 . . . . 0.0 109.905 179.521 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.417 ' OE1' ' HA ' ' A' ' 20' ' ' ASP . 28.4 mt-10 -57.23 -56.01 27.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 0.0 110.123 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.061 HD22 HD11 ' A' ' 52' ' ' ILE . 1.4 tp -57.51 -24.71 57.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.855 179.665 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.408 ' HA2' ' CD1' ' A' ' 48' ' ' LEU . . . -65.74 -42.9 95.0 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.846 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.1 m -76.16 -23.14 54.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.3 -1.117 . . . . 0.0 110.04 179.835 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.462 ' CG2' ' HA ' ' A' ' 19' ' ' PHE . 54.9 t -72.57 -42.54 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.402 -0.811 . . . . 0.0 110.526 -179.727 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.404 ' O ' ' O ' ' A' ' 40' ' ' GLY . 22.5 mmt -90.13 -14.93 32.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.167 -0.958 . . . . 0.0 110.735 -179.692 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -90.65 -59.91 2.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.209 -0.932 . . . . 0.0 111.076 -179.348 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.0 m -59.76 -51.44 69.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.254 -0.904 . . . . 0.0 111.361 -178.958 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.9 mp -69.53 -30.45 68.29 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.1 -1.0 . . . . 0.0 111.207 -178.982 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 36' ' ' MET . . . -161.42 80.57 0.14 Allowed Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.229 -1.462 . . . . 0.0 110.422 -179.775 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -55.94 126.97 28.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.163 -1.198 . . . . 0.0 109.725 179.365 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.516 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.9 t-20 -171.53 -60.91 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.224 -0.923 . . . . 0.0 110.609 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.516 ' HD3' ' HB3' ' A' ' 42' ' ' ASN . 44.1 Cg_endo -70.01 -161.84 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.249 1.131 . . . . 0.0 110.117 179.801 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 7.9 t -150.96 -178.67 6.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.931 . . . . 0.0 110.282 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -59.89 -33.6 72.06 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.246 -0.909 . . . . 0.0 110.464 -179.798 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.1 -70.66 0.25 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.211 -0.93 . . . . 0.0 110.257 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -49.76 -25.05 2.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.104 -0.997 . . . . 0.0 109.713 179.762 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.716 ' HG ' HD23 ' A' ' 32' ' ' LEU . 3.6 tt -65.21 -60.01 3.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.465 -0.772 . . . . 0.0 109.719 179.466 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.402 ' O ' ' OD1' ' A' ' 53' ' ' ASN . 64.5 tt0 -50.5 -33.91 23.17 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.296 -0.878 . . . . 0.0 109.756 179.616 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -61.57 -46.43 89.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.191 -0.943 . . . . 0.0 109.967 179.809 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.428 ' HA ' ' HG2' ' A' ' 54' ' ' GLU . 21.8 mtm -65.58 -22.59 66.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.929 . . . . 0.0 109.82 179.667 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.061 HD11 HD22 ' A' ' 32' ' ' LEU . 39.7 mm -80.88 -23.26 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.251 -0.906 . . . . 0.0 109.969 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 49' ' ' GLN . 5.1 m120 -88.34 -26.62 22.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.303 -0.873 . . . . 0.0 110.2 179.885 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.531 ' HG3' HG23 ' A' ' 55' ' ' VAL . 10.7 pt-20 -77.69 -24.3 49.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.201 -0.937 . . . . 0.0 110.075 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.531 HG23 ' HG3' ' A' ' 54' ' ' GLU . 78.8 t -88.86 -54.53 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.673 179.454 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.413 ' OD2' ' OD1' ' A' ' 60' ' ' ASN . 12.8 t70 -67.09 120.32 13.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.405 -0.809 . . . . 0.0 110.051 179.82 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.6 30.94 5.83 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.16 -0.962 . . . . 0.0 110.663 -179.66 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -113.33 -60.87 1.82 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.116 -0.99 . . . . 0.0 110.088 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.52 -18.25 1.3 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.729 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.413 ' OD1' ' OD2' ' A' ' 56' ' ' ASP . 17.0 p30 -69.52 -29.48 67.1 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.175 -1.191 . . . . 0.0 110.295 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.623 ' O ' HG22 ' A' ' 52' ' ' ILE . . . 99.18 -52.61 1.08 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.754 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.406 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 66.0 p -72.11 146.49 47.46 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.183 -1.186 . . . . 0.0 110.38 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.412 ' O ' ' HB ' ' A' ' 26' ' ' THR . 64.3 mt -86.43 161.09 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 110.254 179.908 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -111.81 -173.35 2.23 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.371 -0.831 . . . . 0.0 109.898 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.562 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 5.0 t80 -75.6 -44.82 4.25 Favored Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.235 -0.915 . . . . 0.0 111.423 -179.882 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.0 Cg_endo -73.33 -23.89 17.18 Favored 'Trans proline' 0 C--N 1.322 -0.845 0 O-C-N 123.288 1.151 . . . . 0.0 110.255 -179.259 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -77.23 -29.09 53.96 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.252 -0.905 . . . . 0.0 109.1 179.094 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.644 ' CE2' ' HE2' ' A' ' 72' ' ' MET . 47.8 t80 -73.54 -50.74 19.81 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.545 -0.722 . . . . 0.0 110.309 179.826 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.96 -30.98 71.26 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.304 -0.873 . . . . 0.0 110.965 -179.527 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 78.9 m -71.1 -40.91 71.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.172 -0.955 . . . . 0.0 110.983 -179.388 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.454 ' HE1' ' HE1' ' A' ' 72' ' ' MET . 0.0 OUTLIER -89.94 -9.37 49.07 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.903 -1.123 . . . . 0.0 110.95 -179.51 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.644 ' HE2' ' CE2' ' A' ' 68' ' ' PHE . 15.6 mmt -90.26 -19.89 23.6 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.989 -1.07 . . . . 0.0 110.556 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.721 0 O-C-N 121.155 -0.966 . . . . 0.0 110.354 -179.874 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.071 0.463 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.48 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 38.9 mt -64.93 -60.23 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.141 -0.974 . . . . 0.0 110.263 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -51.57 -50.49 60.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.174 -0.954 . . . . 0.0 109.711 179.922 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 49.7 mt-10 -50.05 -41.6 48.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 0.0 109.79 179.52 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 85' ' ' ILE . . . -56.2 -50.27 71.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.34 -0.85 . . . . 0.0 110.032 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.475 ' CZ ' ' O ' ' A' ' 98' ' ' GLY . 2.3 t80 -57.34 -28.76 63.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.262 -0.899 . . . . 0.0 110.213 179.983 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.413 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 3.7 tpt180 -71.1 -45.88 62.83 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.342 -0.849 . . . . 0.0 111.185 -179.442 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 88' ' ' ALA . 34.4 m -77.17 -20.35 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.088 -1.007 . . . . 0.0 110.775 -179.33 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.432 ' HA ' HG21 ' A' ' 108' ' ' VAL . 10.0 m-85 -89.58 -17.04 29.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.169 -0.957 . . . . 0.0 109.904 179.631 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.408 ' OD1' HG12 ' A' ' 100' ' ' ILE . 4.4 m-20 -126.89 81.32 2.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.295 -0.878 . . . . 0.0 110.144 179.863 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -104.35 49.96 0.8 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.398 -0.814 . . . . 0.0 110.483 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 3.1 p30 -141.56 -43.58 0.36 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.089 -1.007 . . . . 0.0 110.705 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.486 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 147.97 -57.18 0.49 Allowed Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.28 -1.438 . . . . 0.0 110.995 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.473 ' ND2' ' OD1' ' A' ' 95' ' ' ASP . 22.6 p30 -43.56 -31.23 0.7 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.141 -1.211 . . . . 0.0 111.161 -178.738 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.475 ' O ' ' CZ ' ' A' ' 89' ' ' PHE . . . 80.14 -8.19 53.01 Favored Glycine 0 N--CA 1.495 2.6 0 C-N-CA 119.803 -1.189 . . . . 0.0 110.477 179.561 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -89.41 131.81 35.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.962 -1.316 . . . . 0.0 109.989 179.917 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.409 HD11 ' CE1' ' A' ' 89' ' ' PHE . 16.6 mt -78.99 112.32 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.185 -0.947 . . . . 0.0 109.796 -179.949 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 44.6 t -96.56 155.91 16.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.264 -0.897 . . . . 0.0 110.154 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.64 -44.74 77.43 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.141 -0.974 . . . . 0.0 110.063 -179.956 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.96 -58.7 6.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.827 . . . . 0.0 110.016 179.844 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.718 ' O ' HG23 ' A' ' 108' ' ' VAL . 47.2 mt-10 -51.51 -38.99 56.74 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.317 -0.865 . . . . 0.0 110.224 179.847 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.79 HD12 HD11 ' A' ' 125' ' ' ILE . 0.4 OUTLIER -58.81 -41.82 87.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.349 -0.844 . . . . 0.0 109.829 179.937 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.419 ' O ' ' HB ' ' A' ' 110' ' ' THR . 48.1 ttp180 -68.2 -25.51 65.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.384 -0.822 . . . . 0.0 109.942 179.807 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -90.95 -12.66 35.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.329 -0.857 . . . . 0.0 110.373 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 104' ' ' GLU . 77.2 t -91.17 -64.61 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.255 -0.903 . . . . 0.0 110.316 -179.939 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.621 ' HA ' HD12 ' A' ' 112' ' ' LEU . 57.8 mtt -61.13 -51.18 70.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.251 -0.906 . . . . 0.0 110.367 -179.693 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 106' ' ' ARG . 36.8 m -50.99 -29.52 12.56 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.266 -0.896 . . . . 0.0 110.304 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -78.69 -46.09 19.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.184 -0.948 . . . . 0.0 110.406 -179.944 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.621 HD12 ' HA ' ' A' ' 109' ' ' MET . 12.8 mt -48.83 -73.98 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.143 -0.973 . . . . 0.0 110.109 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.85 66.59 0.02 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.872 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -136.9 -176.37 4.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.313 -1.11 . . . . 0.0 110.068 179.714 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -130.18 87.96 2.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.948 . . . . 0.0 110.374 -179.943 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.8 mt -125.93 -171.88 2.48 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.284 -0.885 . . . . 0.0 110.137 179.857 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.6 t -143.91 -159.95 1.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.138 -0.976 . . . . 0.0 110.201 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.63 -42.16 25.45 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.077 -1.014 . . . . 0.0 110.917 -179.525 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -59.61 -55.49 33.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.942 . . . . 0.0 111.125 -179.469 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -51.72 -38.48 55.39 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.196 -0.94 . . . . 0.0 111.058 -179.445 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 73.9 t -67.7 -47.47 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.158 -0.963 . . . . 0.0 110.457 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.79 -36.38 72.11 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.333 -0.855 . . . . 0.0 110.137 -179.92 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 36.6 tt0 -72.5 -35.15 68.07 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.324 -0.86 . . . . 0.0 109.633 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.411 ' HB3' ' HE3' ' A' ' 124' ' ' MET . 5.7 mmm -59.03 -60.34 4.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.271 -0.893 . . . . 0.0 109.936 179.466 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.79 HD11 HD12 ' A' ' 105' ' ' LEU . 27.9 mm -56.69 -41.89 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.372 -0.83 . . . . 0.0 110.376 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 16.5 ttp180 -57.09 -36.81 71.03 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -0.907 . . . . 0.0 110.191 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 49.7 mt-10 -67.09 -49.65 64.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.197 -0.94 . . . . 0.0 110.087 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.54 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -80.03 -2.33 43.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.349 -0.844 . . . . 0.0 110.665 -179.811 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 59.6 t0 -90.29 71.75 7.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.947 -1.096 . . . . 0.0 110.299 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.488 HG13 ' N ' ' A' ' 131' ' ' ASP . 23.4 pt -70.52 -41.94 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -0.929 . . . . 0.0 111.171 -179.561 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.488 ' N ' HG13 ' A' ' 130' ' ' ILE . 50.6 p-10 -67.28 -19.42 65.49 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.963 -1.086 . . . . 0.0 111.264 -179.173 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 75.45 75.93 0.8 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.909 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -146.35 15.0 1.29 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.379 -1.071 . . . . 0.0 110.56 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 60.27 34.89 86.54 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.684 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -171.01 167.16 7.32 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.13 -1.217 . . . . 0.0 110.061 179.563 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 84.6 t -131.0 120.29 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.155 -0.966 . . . . 0.0 110.18 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -94.54 -165.07 1.25 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.209 -0.932 . . . . 0.0 110.9 -179.637 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -66.91 -58.58 4.72 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.356 -0.84 . . . . 0.0 111.307 -178.965 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -47.61 -51.74 20.25 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.845 -1.159 . . . . 0.0 110.381 -179.548 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -58.71 -34.91 71.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.103 -0.998 . . . . 0.0 109.97 179.62 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.421 ' HA ' ' SD ' ' A' ' 144' ' ' MET . 6.5 t80 -64.94 -32.72 74.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.514 -0.741 . . . . 0.0 110.623 -179.762 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.4 t -82.96 -23.92 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.261 -0.899 . . . . 0.0 110.586 -179.471 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -90.26 -17.47 27.4 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.133 -0.979 . . . . 0.0 110.422 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.54 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 17.0 ptt? -90.09 -27.82 19.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.145 -0.972 . . . . 0.0 110.376 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 27.7 tpp -88.9 -65.45 1.02 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.287 -0.883 . . . . 0.0 110.439 -179.607 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 146' ' ' THR . 5.1 t . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.151 -0.968 . . . . 0.0 110.438 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.237 0.542 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 4.4 m-20 -110.02 148.25 32.02 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.23 -0.919 . . . . 0.0 110.455 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.421 ' CD ' ' N ' ' A' ' 3' ' ' GLN . 1.9 mp0 -108.31 114.35 28.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.318 -0.864 . . . . 0.0 109.872 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.3 pp -68.45 149.21 49.57 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.203 -0.935 . . . . 0.0 110.144 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.9 p -122.06 146.66 46.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.28 -0.887 . . . . 0.0 110.218 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -57.18 -17.07 9.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.3 -0.875 . . . . 0.0 110.307 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -56.37 -42.6 78.11 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.932 . . . . 0.0 110.502 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -56.24 -52.52 64.15 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.211 -0.93 . . . . 0.0 110.196 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.3 mt -55.26 -40.95 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 109.941 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.29 -37.56 80.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.893 . . . . 0.0 109.613 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -61.17 -48.99 79.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.423 -0.798 . . . . 0.0 109.9 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -65.8 -25.21 67.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.411 -0.806 . . . . 0.0 109.992 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.6 mtpt -75.84 -30.68 59.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.33 -0.856 . . . . 0.0 109.705 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -71.08 -41.5 70.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 0.0 109.556 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.605 ' HB1' ' CZ ' ' A' ' 19' ' ' PHE . . . -68.27 -39.63 82.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.383 -0.823 . . . . 0.0 109.761 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -56.17 -55.07 37.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.377 -0.827 . . . . 0.0 110.088 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.2 m -60.65 -35.13 75.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.35 -0.844 . . . . 0.0 110.348 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.947 ' O ' HD23 ' A' ' 18' ' ' LEU . 4.9 tt -63.68 -29.42 70.66 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.191 -0.943 . . . . 0.0 110.202 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.605 ' CZ ' ' HB1' ' A' ' 15' ' ' ALA . 12.3 m-85 -79.37 -57.76 3.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 0.0 110.485 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -61.2 106.27 0.59 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.127 -0.983 . . . . 0.0 109.97 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -109.6 47.61 0.93 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.228 -0.92 . . . . 0.0 110.726 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -162.44 22.22 0.1 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.245 -0.91 . . . . 0.0 110.504 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 47.58 78.32 0.09 OUTLIER Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -134.91 -36.83 0.82 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.223 -1.163 . . . . 0.0 110.57 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.91 -23.43 35.64 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.5 p -118.05 143.44 46.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.407 -1.055 . . . . 0.0 109.971 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 44.3 mt -92.03 113.01 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.259 -0.9 . . . . 0.0 110.427 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.524 ' HA ' HG22 ' A' ' 62' ' ' THR . 80.9 p -97.11 -176.52 3.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 109.906 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.5 p -74.84 -28.49 60.7 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.253 -0.904 . . . . 0.0 110.07 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -70.81 -54.1 12.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 109.71 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.427 ' O ' HG23 ' A' ' 35' ' ' VAL . 91.5 mt-10 -56.1 -52.42 64.38 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.281 -0.887 . . . . 0.0 109.057 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.935 HD22 HD11 ' A' ' 52' ' ' ILE . 3.7 tp -55.05 -33.54 62.79 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.456 -0.778 . . . . 0.0 109.367 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.59 -49.78 67.5 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.2 m -69.17 -21.19 64.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.326 -1.102 . . . . 0.0 109.785 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 19' ' ' PHE . 54.8 t -73.47 -31.03 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.446 -0.784 . . . . 0.0 109.787 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.2 mmt -90.91 -24.27 20.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.894 . . . . 0.0 110.189 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -84.36 -20.86 31.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.253 -0.905 . . . . 0.0 110.448 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.6 m -88.07 -19.34 27.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.197 -0.939 . . . . 0.0 110.151 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.468 ' CD1' H141 ' A' ' 153' ' ' WW7 . 90.5 mt -89.16 -78.35 0.35 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.269 -0.894 . . . . 0.0 110.295 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.73 55.74 0.2 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -152.67 157.96 41.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.227 -1.16 . . . . 0.0 110.299 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.512 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 80.5 m-20 -143.04 48.6 1.01 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.157 -0.964 . . . . 0.0 110.58 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.512 ' CD ' ' N ' ' A' ' 42' ' ' ASN . 42.5 Cg_endo -68.8 -159.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.653 1.344 . . . . 0.0 110.082 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.512 HG22 ' H ' ' A' ' 45' ' ' GLU . 18.0 m -130.88 175.38 9.11 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.929 -1.107 . . . . 0.0 110.442 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.512 ' H ' HG22 ' A' ' 44' ' ' THR . 13.6 tp10 -67.38 -32.71 73.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.272 -0.893 . . . . 0.0 110.054 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.02 -64.8 0.84 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 110.184 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 2.3 mt-10 -50.03 -38.93 40.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -1.0 . . . . 0.0 109.668 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.523 HD11 HD23 ' A' ' 32' ' ' LEU . 10.1 tt -57.65 -50.28 73.67 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.373 -0.829 . . . . 0.0 109.459 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -50.18 -38.25 38.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -0.939 . . . . 0.0 109.408 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 47' ' ' GLU . 36.3 m-20 -62.63 -42.83 99.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.377 -0.827 . . . . 0.0 109.77 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.9 ttp -67.05 -15.87 63.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.266 -0.896 . . . . 0.0 109.645 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.935 HD11 HD22 ' A' ' 32' ' ' LEU . 45.9 mm -88.66 -25.67 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.178 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -58.36 -36.6 73.71 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.111 -0.993 . . . . 0.0 110.124 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.848 ' HG3' HG23 ' A' ' 55' ' ' VAL . 8.2 pt-20 -74.21 -23.78 59.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.92 . . . . 0.0 109.993 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.848 HG23 ' HG3' ' A' ' 54' ' ' GLU . 42.8 t -98.8 23.53 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.905 . . . . 0.0 110.051 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -135.4 112.92 10.71 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.342 -0.849 . . . . 0.0 109.92 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.94 34.42 3.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.176 -0.952 . . . . 0.0 110.211 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 2.6 p30 -141.54 -34.12 0.49 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.373 -0.829 . . . . 0.0 110.843 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 95.44 52.84 1.65 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.449 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 24.6 p-10 -122.34 -12.32 8.24 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.442 -1.034 . . . . 0.0 110.682 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.786 ' O ' HG23 ' A' ' 62' ' ' THR . . . 78.42 27.56 57.25 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.206 -1.157 . . . . 0.0 110.206 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 61' ' ' GLY . 0.9 OUTLIER -163.02 167.18 22.78 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.149 -1.206 . . . . 0.0 110.204 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.744 HD13 HG11 ' A' ' 55' ' ' VAL . 63.5 mt -117.39 150.6 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.12 -0.987 . . . . 0.0 110.127 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.445 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 1.5 m-20 -112.58 -162.97 0.82 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.316 -0.865 . . . . 0.0 110.425 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.609 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 7.0 t80 -81.55 -40.67 1.03 Allowed Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.411 -0.806 . . . . 0.0 111.914 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.4 Cg_endo -70.81 -21.4 28.65 Favored 'Trans proline' 0 N--CA 1.482 0.795 0 O-C-N 122.993 0.996 . . . . 0.0 110.974 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.425 ' OE1' ' OD1' ' A' ' 64' ' ' ASP . 57.2 mt-10 -86.12 -35.22 20.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.91 -1.119 . . . . 0.0 109.411 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.487 ' CZ ' ' SD ' ' A' ' 72' ' ' MET . 11.6 t80 -70.78 -38.49 73.41 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.419 -0.801 . . . . 0.0 110.417 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.484 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 1.1 tp -80.55 -37.14 31.98 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.203 -0.936 . . . . 0.0 110.709 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 88.9 m -71.35 -20.34 62.17 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.824 -1.173 . . . . 0.0 110.487 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 61.4 ttp -88.77 -42.33 11.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.139 -0.976 . . . . 0.0 110.86 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.487 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 59.0 mtt -90.51 -9.7 46.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.053 -1.03 . . . . 0.0 111.541 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -85.07 -9.95 57.41 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.845 -1.16 . . . . 0.0 110.519 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -84.14 -81.56 0.18 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.068 -1.02 . . . . 0.0 110.293 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.496 ' O ' ' CB ' ' A' ' 76' ' ' MET . 52.5 mttp -107.43 -87.11 0.49 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.273 -0.892 . . . . 0.0 110.656 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.496 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 19.4 ttt 80.14 -40.48 0.19 Allowed 'General case' 0 N--CA 1.525 3.28 0 O-C-N 121.904 -0.498 . . . . 0.0 111.077 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -157.11 -173.47 4.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.808 -1.182 . . . . 0.0 109.923 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -138.92 114.3 9.66 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.104 -0.998 . . . . 0.0 110.631 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.6 m -130.89 80.25 1.93 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.411 -0.805 . . . . 0.0 109.85 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -56.23 141.49 40.92 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.241 -0.912 . . . . 0.0 110.611 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.435 ' HA ' ' OH ' ' A' ' 138' ' ' TYR . 33.7 t -133.62 102.35 5.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.372 -0.83 . . . . 0.0 110.104 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 51.9 tt0 -119.4 160.48 22.23 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.254 -0.904 . . . . 0.0 110.106 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -65.55 -11.11 40.94 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.255 -0.903 . . . . 0.0 110.715 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.5 ' HA ' ' N2 ' ' A' ' 154' ' ' WW7 . 41.7 mm-40 -88.9 -65.17 1.05 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 110.389 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.741 HD12 ' HD1' ' A' ' 141' ' ' PHE . 38.8 mm -66.23 -10.23 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.224 -0.923 . . . . 0.0 110.339 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 2.5 ttt180 -73.48 -54.71 7.6 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.254 -0.904 . . . . 0.0 109.845 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.609 ' HB2' HN21 ' A' ' 154' ' ' WW7 . 49.9 mt-10 -66.35 -35.52 80.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.362 -0.836 . . . . 0.0 109.615 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.714 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -57.32 -54.16 49.94 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.499 -0.751 . . . . 0.0 110.356 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.35 -27.41 69.0 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.882 -1.136 . . . . 0.0 110.247 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.35 -25.82 62.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.147 -0.971 . . . . 0.0 110.503 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.714 HG22 ' O ' ' A' ' 88' ' ' ALA . 34.3 m -95.1 -21.34 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.074 -1.016 . . . . 0.0 110.669 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.534 ' CZ ' ' H2 ' ' A' ' 154' ' ' WW7 . 21.7 m-85 -93.58 -11.91 30.71 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.16 -0.963 . . . . 0.0 110.574 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.425 ' OD2' ' HA2' ' A' ' 98' ' ' GLY . 40.5 t0 -114.23 92.1 3.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.209 -0.932 . . . . 0.0 110.269 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.49 -6.52 14.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.124 -0.985 . . . . 0.0 110.709 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.43 ' OD2' ' ND2' ' A' ' 97' ' ' ASN . 2.7 p-10 -91.93 -39.77 11.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.954 -1.091 . . . . 0.0 110.213 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 128.52 -35.36 2.69 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.546 -1.311 . . . . 0.0 111.091 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.52 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 42.4 p30 -47.88 -22.82 0.62 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.81 -1.406 . . . . 0.0 111.18 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.45 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 75.56 42.76 26.09 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 97' ' ' ASN . 77.2 m-85 -152.5 146.32 25.16 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.223 -1.163 . . . . 0.0 109.909 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.435 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 26.5 mt -94.41 121.28 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.171 -0.956 . . . . 0.0 109.994 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 74.5 m -109.01 151.36 26.44 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.477 -0.764 . . . . 0.0 109.956 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.41 ' HA ' HG13 ' A' ' 125' ' ' ILE . . . -51.23 -36.26 40.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.13 -0.981 . . . . 0.0 110.3 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.19 -59.87 4.41 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.287 -0.883 . . . . 0.0 110.307 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -48.39 -51.23 27.49 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.189 -0.945 . . . . 0.0 110.161 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.872 HD23 HG13 ' A' ' 121' ' ' VAL . 13.0 tp -49.24 -40.58 34.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.917 . . . . 0.0 110.15 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -62.46 -41.41 98.74 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.224 -0.923 . . . . 0.0 110.492 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -77.21 -12.92 60.01 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.191 -0.943 . . . . 0.0 110.823 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 53.2 t -88.57 -37.06 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.97 -1.081 . . . . 0.0 110.366 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 26.5 mmt -69.52 -32.27 71.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.147 -0.971 . . . . 0.0 110.471 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.0 p -76.36 -28.66 56.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.088 -1.008 . . . . 0.0 110.156 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -75.05 -44.16 49.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.222 -0.924 . . . . 0.0 110.176 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.7 mt -54.26 -36.28 63.43 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.187 -0.946 . . . . 0.0 110.369 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.87 31.37 1.03 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -116.19 -156.2 0.61 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.195 -1.179 . . . . 0.0 109.929 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -161.03 84.05 0.66 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.218 -0.926 . . . . 0.0 110.332 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.409 ' HG ' ' OE1' ' A' ' 120' ' ' GLU . 4.9 mp -108.68 131.82 54.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.336 -0.852 . . . . 0.0 110.08 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 19.8 m -77.94 159.99 28.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.221 -0.925 . . . . 0.0 110.224 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.0 -33.12 16.97 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.202 -0.936 . . . . 0.0 110.522 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -61.26 -42.47 98.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.153 -0.967 . . . . 0.0 110.54 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.409 ' OE1' ' HG ' ' A' ' 116' ' ' LEU . 85.4 mt-10 -67.71 -45.23 75.66 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.309 -0.87 . . . . 0.0 111.1 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.872 HG13 HD23 ' A' ' 105' ' ' LEU . 41.2 t -61.71 -56.21 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.049 -1.032 . . . . 0.0 110.605 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -52.07 -46.18 65.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.285 -0.884 . . . . 0.0 110.441 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -63.02 -33.1 74.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.295 -0.878 . . . . 0.0 110.242 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.423 ' HB3' ' HE2' ' A' ' 124' ' ' MET . 80.6 mtp -65.24 -62.52 1.49 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.882 . . . . 0.0 109.873 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.851 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 21.9 mm -49.81 -30.38 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 110.148 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.0 ttt180 -70.24 -41.08 74.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.292 -0.88 . . . . 0.0 110.447 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.75 -28.7 68.62 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.215 -0.928 . . . . 0.0 110.485 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.656 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -93.58 -17.01 23.8 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.119 -0.988 . . . . 0.0 110.753 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.93 ' OD1' HG22 ' A' ' 136' ' ' VAL . 1.6 m-20 -81.25 82.63 7.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.026 -1.047 . . . . 0.0 110.942 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.486 HG13 ' N ' ' A' ' 131' ' ' ASP . 21.9 pt -89.47 -32.49 5.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-O 121.429 0.633 . . . . 0.0 110.169 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 51.6 p-10 -121.83 -13.13 8.32 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.502 -0.749 . . . . 0.0 111.432 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . -95.2 -63.51 0.99 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.593 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 1.2 m-20 59.96 100.49 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.515 -0.991 . . . . 0.0 108.48 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 105.11 -20.97 36.86 Favored Glycine 0 C--N 1.294 -1.777 0 N-CA-C 107.824 -2.11 . . . . 0.0 107.824 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -162.1 153.23 17.96 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.659 -0.906 . . . . 0.0 109.859 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.93 HG22 ' OD1' ' A' ' 129' ' ' ASP . 46.5 t -122.1 152.66 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.258 -0.902 . . . . 0.0 110.532 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -129.95 -168.77 2.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.874 . . . . 0.0 110.594 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.435 ' OH ' ' HA ' ' A' ' 81' ' ' SER . 1.7 t80 -59.57 -64.33 0.98 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.376 -0.828 . . . . 0.0 111.09 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -43.27 -55.46 4.01 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.4 -0.813 . . . . 0.0 111.146 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.479 ' OE2' ' HA ' ' A' ' 129' ' ' ASP . 5.9 mt-10 -48.44 -51.4 27.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.189 -0.945 . . . . 0.0 110.978 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.741 ' HD1' HD12 ' A' ' 85' ' ' ILE . 2.9 t80 -59.65 -32.96 70.94 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.061 -1.024 . . . . 0.0 110.967 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.693 HG22 HG21 ' A' ' 85' ' ' ILE . 57.9 t -76.42 -27.16 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.068 -1.02 . . . . 0.0 111.506 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 46.1 tp60 -98.27 -11.09 22.98 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.88 -1.138 . . . . 0.0 110.882 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.656 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 19.7 ptt? -91.33 -34.18 15.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.014 -1.054 . . . . 0.0 110.642 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.48 ' HE3' ' CE1' ' A' ' 141' ' ' PHE . 23.4 tpp -82.83 -40.14 20.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 110.41 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 68.2 p -92.0 130.38 37.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.086 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -175.16 128.4 0.28 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.181 -0.949 . . . . 0.0 110.395 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 28.2 mmtt . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.138 179.78 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 153' ' ' WW7 . . . . . 0.619 'CL1 ' HD13 ' A' ' 32' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' WW7 . . . . . 0.851 'CL1 ' HD13 ' A' ' 125' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.211 0.529 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.54 128.34 35.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 109.846 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -106.1 -12.77 15.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.098 -1.001 . . . . 0.0 110.76 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 54.0 mt -97.02 32.02 2.25 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.037 -1.039 . . . . 0.0 110.12 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.2 m -73.39 -56.54 4.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 110.148 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -81.82 -30.85 32.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 110.217 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -50.3 -34.5 23.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.263 -0.898 . . . . 0.0 109.874 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.538 ' HG2' ' CE2' ' A' ' 12' ' ' PHE . 45.0 tt0 -59.73 -48.29 82.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.395 -0.815 . . . . 0.0 109.95 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.7 mt -59.56 -45.1 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.033 -1.042 . . . . 0.0 109.597 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.33 -25.76 64.46 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.387 -0.821 . . . . 0.0 109.505 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 15.0 tp10 -69.02 -44.76 72.1 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.377 -0.827 . . . . 0.0 109.707 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.538 ' CE2' ' HG2' ' A' ' 8' ' ' GLN . 20.3 m-85 -62.28 -47.7 83.15 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.253 -0.904 . . . . 0.0 109.808 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -56.17 -46.67 79.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.353 -0.842 . . . . 0.0 109.964 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -52.96 -46.17 68.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.22 -0.925 . . . . 0.0 109.631 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.458 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -58.92 -44.25 91.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.376 -0.827 . . . . 0.0 110.044 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.456 ' CE1' ' CD1' ' A' ' 27' ' ' ILE . 37.8 t80 -51.31 -40.72 59.62 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.11 -0.994 . . . . 0.0 109.742 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.4 t -66.1 -38.29 87.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -0.888 . . . . 0.0 109.595 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.494 ' C ' HD23 ' A' ' 18' ' ' LEU . 10.5 tt -57.96 -31.78 67.2 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.325 -0.859 . . . . 0.0 109.956 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.512 ' HA ' HG21 ' A' ' 35' ' ' VAL . 32.1 m-85 -87.29 -25.59 23.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.313 -0.867 . . . . 0.0 110.287 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -100.92 114.47 28.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.313 -0.867 . . . . 0.0 109.925 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -103.7 -28.07 11.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.191 -0.943 . . . . 0.0 110.794 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.42 ' OD1' ' HB2' ' A' ' 24' ' ' ASP . 4.1 p30 -92.6 11.46 26.48 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.12 -0.988 . . . . 0.0 110.633 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 47.84 47.94 24.61 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.42 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 7.4 t70 -84.81 -27.45 26.8 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.263 -1.139 . . . . 0.0 110.501 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.09 -27.81 14.84 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.4 p -125.81 148.62 49.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.214 -1.168 . . . . 0.0 110.24 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.456 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 83.0 mt -96.03 126.84 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.293 -0.879 . . . . 0.0 110.114 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.7 p -108.8 -162.82 0.83 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.368 -0.832 . . . . 0.0 110.171 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.1 p -86.47 -28.36 23.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -0.987 . . . . 0.0 110.225 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -65.9 -58.36 5.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 109.698 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -54.95 -55.66 28.27 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.305 -0.872 . . . . 0.0 109.834 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.964 HD22 HD11 ' A' ' 52' ' ' ILE . 2.7 tp -54.16 -29.17 44.47 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.349 -0.845 . . . . 0.0 109.705 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.72 -49.68 73.83 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.0 m -68.81 -23.06 64.23 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.169 -1.195 . . . . 0.0 110.219 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.512 HG21 ' HA ' ' A' ' 19' ' ' PHE . 16.6 t -72.47 -37.77 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.275 -0.89 . . . . 0.0 109.881 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.4 mmt -90.28 -10.35 44.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 110.468 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -89.18 -36.66 15.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.134 -0.979 . . . . 0.0 110.658 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 72.8 p -79.33 -36.76 38.97 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.131 -0.981 . . . . 0.0 110.412 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.36 -11.19 55.14 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.268 -0.895 . . . . 0.0 110.482 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 151.07 89.6 0.07 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.69 143.8 57.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -1.118 . . . . 0.0 111.05 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.555 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 10.5 m-20 -159.85 -64.93 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.416 -0.803 . . . . 0.0 109.497 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.555 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 49.4 Cg_endo -74.47 150.22 40.6 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.423 1.222 . . . . 0.0 109.446 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 72.7 p -90.33 -137.79 0.14 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.054 -1.029 . . . . 0.0 109.415 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -100.9 -37.82 8.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.784 -1.198 . . . . 0.0 109.188 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -75.24 -58.1 3.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.409 -0.807 . . . . 0.0 109.236 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -51.81 -40.79 61.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.32 -0.862 . . . . 0.0 109.048 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.623 HD21 HD23 ' A' ' 32' ' ' LEU . 9.4 tt -58.01 -42.61 85.61 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.611 -0.681 . . . . 0.0 109.182 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.414 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 35.1 tt0 -53.04 -39.71 63.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.905 . . . . 0.0 108.901 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -65.32 -37.32 86.76 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.218 -0.926 . . . . 0.0 108.66 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.418 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 13.5 ttt -66.39 -18.52 65.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.465 -0.772 . . . . 0.0 109.309 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.964 HD11 HD22 ' A' ' 32' ' ' LEU . 33.3 mm -82.39 -31.69 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.372 -0.83 . . . . 0.0 109.802 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -59.33 -49.64 77.05 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.454 -0.779 . . . . 0.0 110.526 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.491 ' HG3' HG23 ' A' ' 55' ' ' VAL . 21.7 pt-20 -56.69 -19.16 15.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.079 -1.013 . . . . 0.0 110.124 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.798 HG21 ' C6 ' ' A' ' 153' ' ' WW7 . 56.0 t -94.48 -25.74 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.267 -0.895 . . . . 0.0 110.164 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -97.8 100.66 12.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.217 -0.927 . . . . 0.0 110.458 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -93.41 46.53 1.2 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.219 -0.925 . . . . 0.0 109.982 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -132.02 -66.49 0.7 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.218 -0.926 . . . . 0.0 110.484 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 135.84 53.94 0.06 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.439 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 12.4 p-10 -142.06 -46.41 0.35 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -1.139 . . . . 0.0 110.316 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.19 -72.55 0.48 Allowed Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.656 -1.259 . . . . 0.0 110.531 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.9 p -69.67 169.88 11.96 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.251 -1.147 . . . . 0.0 111.149 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.473 HD13 HG11 ' A' ' 55' ' ' VAL . 42.0 mt -115.83 143.89 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.309 -0.869 . . . . 0.0 110.258 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.42 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 57.3 m-20 -96.12 -168.23 1.71 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.255 -0.903 . . . . 0.0 110.227 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.563 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 57.7 t80 -82.77 -41.78 0.89 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 111.459 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.4 Cg_endo -74.55 -29.34 9.17 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 O-C-N 123.05 1.026 . . . . 0.0 109.968 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -74.12 -27.26 60.78 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.322 -0.861 . . . . 0.0 108.775 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -75.32 -47.43 27.79 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.621 -0.674 . . . . 0.0 110.04 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.892 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 1.8 tt -70.21 -20.76 63.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.297 -0.877 . . . . 0.0 110.167 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.0 m -78.6 -43.23 26.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 110.884 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.511 ' SD ' HG13 ' A' ' 55' ' ' VAL . 64.0 ttp -69.12 -48.18 63.17 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.1 -1.0 . . . . 0.0 110.93 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 28.7 mtt -78.68 -10.89 59.92 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.102 -0.998 . . . . 0.0 110.991 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.892 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . -66.54 -42.15 87.6 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.972 -1.08 . . . . 0.0 110.005 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -108.82 45.96 1.0 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.382 -0.824 . . . . 0.0 110.521 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.06 45.77 1.25 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.022 -1.049 . . . . 0.0 110.666 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 17.6 ptp -83.31 138.74 33.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.095 -1.003 . . . . 0.0 110.34 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -94.49 -20.31 19.78 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.303 -0.873 . . . . 0.0 110.081 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -163.25 157.84 20.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.889 . . . . 0.0 110.185 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 79' ' ' THR . 5.6 t -122.34 69.2 0.96 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.197 -0.939 . . . . 0.0 110.491 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -113.62 170.69 8.07 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.089 -1.007 . . . . 0.0 110.222 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.8 t -155.15 59.99 0.65 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.203 -0.936 . . . . 0.0 110.278 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -123.21 -178.01 3.86 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.244 -0.91 . . . . 0.0 110.196 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 46.13 85.34 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.168 -0.958 . . . . 0.0 110.606 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -90.86 -33.66 15.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.006 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.1 mt -51.53 -30.39 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.398 -0.814 . . . . 0.0 110.133 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -68.57 -42.09 78.8 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.231 -0.918 . . . . 0.0 109.846 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -62.38 -37.44 85.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.273 -0.892 . . . . 0.0 110.164 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.728 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -65.19 -62.44 1.54 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -0.9 . . . . 0.0 110.38 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.42 ' CE2' ' HA ' ' A' ' 138' ' ' TYR . 6.2 t80 -54.92 -28.0 47.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.18 -0.95 . . . . 0.0 110.211 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 -63.39 -53.26 55.25 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.255 -0.903 . . . . 0.0 110.559 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.701 HG23 ' CD1' ' A' ' 92' ' ' PHE . 31.0 m -70.68 -24.86 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.106 -0.996 . . . . 0.0 110.707 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.728 ' CE2' ' HB1' ' A' ' 88' ' ' ALA . 14.3 m-30 -73.41 -28.85 62.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.132 -0.98 . . . . 0.0 110.007 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -108.67 67.63 0.67 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 0.0 109.752 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -77.08 -30.33 55.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.348 -0.845 . . . . 0.0 110.485 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.445 ' OD2' ' HB2' ' A' ' 97' ' ' ASN . 30.8 p-10 -69.24 -7.13 33.89 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.171 -0.956 . . . . 0.0 110.491 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.52 28.57 70.91 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.445 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 1.8 t-20 -80.78 -75.87 0.26 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.296 -1.12 . . . . 0.0 110.01 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 151.18 -25.21 0.99 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.439 ' HB3' ' HB2' ' A' ' 135' ' ' GLN . 14.3 m-85 -118.88 131.69 56.07 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.193 -1.181 . . . . 0.0 110.092 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.447 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 83.3 mt -70.01 128.62 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.146 -0.971 . . . . 0.0 110.084 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 97.9 p -114.6 175.07 5.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.897 . . . . 0.0 110.226 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 105' ' ' LEU . . . -71.14 -53.02 15.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 110.228 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -47.08 -56.62 6.22 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.179 -0.95 . . . . 0.0 110.244 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.465 ' O ' HG23 ' A' ' 108' ' ' VAL . 94.4 mt-10 -58.69 -41.93 87.38 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 109.807 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.825 HD23 HG13 ' A' ' 121' ' ' VAL . 55.1 tp -54.86 -30.54 58.07 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.309 -0.869 . . . . 0.0 110.104 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -77.29 -42.72 35.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.92 . . . . 0.0 110.128 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -62.34 -19.44 63.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 110.312 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 104' ' ' GLU . 47.8 t -92.67 -45.08 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.175 -0.953 . . . . 0.0 110.42 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.491 ' HA ' HD12 ' A' ' 112' ' ' LEU . 26.4 mmt -70.02 -18.34 63.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.272 -0.892 . . . . 0.0 110.555 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.9 m -75.83 -25.27 56.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.155 -0.965 . . . . 0.0 110.033 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -88.38 -38.73 14.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.303 -0.873 . . . . 0.0 110.075 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.491 HD12 ' HA ' ' A' ' 109' ' ' MET . 50.6 mt -58.15 -42.6 86.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.369 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.09 0.83 7.51 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 2.4 mm-40 -72.85 -43.15 62.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.069 -1.253 . . . . 0.0 110.256 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 16.7 mmtp 55.74 106.99 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.42 -0.8 . . . . 0.0 110.414 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.4 HD12 ' HB3' ' A' ' 109' ' ' MET . 1.6 mt -131.87 161.46 32.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.261 -0.9 . . . . 0.0 110.21 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.479 HG22 ' N ' ' A' ' 118' ' ' ASP . 67.7 m -86.51 168.18 13.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 0.0 110.06 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.479 ' N ' HG22 ' A' ' 117' ' ' THR . 50.6 m-20 -57.1 -43.64 82.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.268 -0.895 . . . . 0.0 110.688 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -66.31 -33.34 75.51 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.051 -1.031 . . . . 0.0 110.472 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -65.35 -59.12 4.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.044 -1.035 . . . . 0.0 109.908 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.825 HG13 HD23 ' A' ' 105' ' ' LEU . 70.4 t -52.04 -45.4 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.172 -0.955 . . . . 0.0 109.665 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -54.71 -41.47 70.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 0.0 109.528 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -64.57 -33.13 75.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.368 -0.833 . . . . 0.0 109.544 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 26.4 mmm -63.88 -49.54 72.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.879 . . . . 0.0 110.127 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.421 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 34.7 mm -64.83 -26.89 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.352 -0.843 . . . . 0.0 110.245 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -69.76 -50.12 46.38 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.153 -0.967 . . . . 0.0 110.129 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -57.74 -39.3 77.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.166 -0.959 . . . . 0.0 109.733 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.496 ' HB2' ' SD ' ' A' ' 144' ' ' MET . . . -70.9 -30.59 66.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.319 -0.863 . . . . 0.0 109.939 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -70.27 91.12 0.71 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.393 -0.817 . . . . 0.0 110.166 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 65.2 mt -74.69 -50.8 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.201 -0.937 . . . . 0.0 110.817 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 29.1 p30 -69.39 -17.95 63.72 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.104 -0.997 . . . . 0.0 110.877 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 71.49 72.18 0.95 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.407 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 6.6 p30 -125.73 -24.91 3.75 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.236 -1.156 . . . . 0.0 111.237 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 132.59 -24.52 3.89 Favored Glycine 0 N--CA 1.496 2.688 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.33 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 99' ' ' TYR . 2.4 pp0? -140.25 167.51 21.96 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.055 -1.262 . . . . 0.0 110.558 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.447 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 57.9 t -102.86 144.25 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.21 -0.931 . . . . 0.0 110.68 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -106.93 166.22 10.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.363 -0.835 . . . . 0.0 109.476 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.498 ' O ' HG23 ' A' ' 142' ' ' VAL . 51.8 t80 -52.94 -38.67 62.22 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.039 -1.038 . . . . 0.0 110.1 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -67.77 -60.35 2.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.213 -0.93 . . . . 0.0 110.623 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -47.13 -36.45 8.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.208 -0.933 . . . . 0.0 110.745 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.496 ' CD2' ' HE1' ' A' ' 144' ' ' MET . 10.2 t80 -65.51 -46.29 80.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.138 -0.976 . . . . 0.0 110.182 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 138' ' ' TYR . 52.4 t -66.48 -22.61 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.225 -0.922 . . . . 0.0 110.101 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -84.33 -25.29 29.33 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.378 -0.826 . . . . 0.0 111.019 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.496 ' SD ' ' HB2' ' A' ' 128' ' ' ALA . 10.1 ptt? -89.54 -23.1 22.1 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.003 -1.06 . . . . 0.0 110.756 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.551 ' HE3' H121 ' A' ' 154' ' ' WW7 . 38.4 tpp -88.58 -9.76 51.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.257 -0.902 . . . . 0.0 110.815 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 142' ' ' VAL . 14.2 t -114.6 -30.22 6.57 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.077 -1.014 . . . . 0.0 110.719 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -94.81 130.15 41.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.029 -1.044 . . . . 0.0 110.516 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.137 179.895 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 153' ' ' WW7 . . . . . 0.798 ' C6 ' HG21 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' WW7 . . . . . 0.551 H121 ' HE3' ' A' ' 145' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.223 0.535 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.76 -6.04 48.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.261 -0.899 . . . . 0.0 110.446 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.405 ' O ' ' O ' ' A' ' 4' ' ' LEU . 8.5 pt20 -128.74 -177.03 4.03 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.137 -0.977 . . . . 0.0 110.5 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.405 ' O ' ' O ' ' A' ' 3' ' ' GLN . 0.8 OUTLIER -57.12 -162.54 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.319 -0.863 . . . . 0.0 110.396 -179.708 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.51 HG22 ' H ' ' A' ' 7' ' ' GLU . 15.4 m -138.52 149.52 45.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.253 -0.905 . . . . 0.0 109.945 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -76.09 -11.41 59.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.237 -0.914 . . . . 0.0 110.436 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.51 ' H ' HG22 ' A' ' 5' ' ' THR . 36.5 mt-10 -63.72 -26.24 68.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.149 -0.969 . . . . 0.0 110.334 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -68.13 -49.87 58.29 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.194 -0.941 . . . . 0.0 110.014 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.8 mt -61.88 -47.95 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.167 -0.958 . . . . 0.0 109.805 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 13' ' ' LYS . . . -55.24 -39.6 69.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.281 -0.887 . . . . 0.0 109.657 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -58.46 -43.92 89.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.42 -0.8 . . . . 0.0 109.619 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.476 ' CE1' ' HB3' ' A' ' 72' ' ' MET . 35.8 m-85 -63.18 -25.62 68.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.378 -0.826 . . . . 0.0 109.805 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 17.8 mtpt -77.47 -28.26 52.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.333 -0.855 . . . . 0.0 110.249 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 2.6 tt0 -73.05 -42.92 62.59 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.146 -0.972 . . . . 0.0 110.065 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.87 -50.68 16.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.178 -0.951 . . . . 0.0 109.48 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.544 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 77.9 t80 -49.93 -48.03 52.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 109.614 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.7 t -68.82 -35.83 77.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.553 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.917 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.4 tm? -59.34 -24.35 63.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.423 -0.798 . . . . 0.0 109.309 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.425 ' CD1' HG13 ' A' ' 35' ' ' VAL . 13.8 m-85 -87.31 -62.28 1.54 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.513 -0.742 . . . . 0.0 109.68 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -51.65 115.58 1.7 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.53 -0.732 . . . . 0.0 110.076 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -105.85 -36.68 6.93 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.024 -1.048 . . . . 0.0 110.708 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -69.46 -25.83 64.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.148 -0.97 . . . . 0.0 110.167 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.93 95.43 0.42 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.409 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 9.1 p-10 -158.01 -46.3 0.06 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.237 -1.155 . . . . 0.0 110.609 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.523 ' C ' HG23 ' A' ' 26' ' ' THR . . . 126.5 23.88 1.47 Allowed Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.852 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.523 HG23 ' C ' ' A' ' 25' ' ' GLY . 53.8 p -154.89 140.95 18.39 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.799 -1.413 . . . . 0.0 110.618 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 62.2 mt -99.63 112.72 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -0.918 . . . . 0.0 109.759 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.644 HG22 ' H ' ' A' ' 29' ' ' THR . 4.5 m -97.67 -177.87 3.93 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.313 -0.867 . . . . 0.0 110.186 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.923 HG22 HD12 ' A' ' 52' ' ' ILE . 16.8 p -72.9 -31.62 64.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.145 -0.972 . . . . 0.0 110.929 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -62.21 1.58 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.898 -1.126 . . . . 0.0 110.09 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.657 ' O ' HG23 ' A' ' 35' ' ' VAL . 50.8 mt-10 -55.18 -47.63 74.93 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.158 -0.964 . . . . 0.0 109.437 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.705 HD22 HD11 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -55.7 -32.3 63.19 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.281 -0.887 . . . . 0.0 109.608 179.4 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.91 -51.62 57.84 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.9 m -70.27 -12.76 61.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.264 -1.139 . . . . 0.0 110.136 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 31' ' ' GLU . 59.5 t -78.36 -32.08 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.22 -0.925 . . . . 0.0 110.109 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -87.34 -27.52 22.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.108 -0.995 . . . . 0.0 110.205 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.92 -46.2 15.55 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.128 -0.982 . . . . 0.0 109.946 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.6 t -57.08 -22.53 40.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.324 -0.86 . . . . 0.0 110.101 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.524 HD12 ' O ' ' A' ' 35' ' ' VAL . 75.7 mt -95.39 -69.72 0.74 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.341 -0.85 . . . . 0.0 109.997 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.16 88.96 0.07 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.405 ' O ' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -175.82 -56.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.229 -1.159 . . . . 0.0 110.275 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' A' ' 41' ' ' GLN . 41.9 t30 53.97 64.81 6.07 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.172 -0.955 . . . . 0.0 110.244 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -74.85 -163.04 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.765 1.403 . . . . 0.0 110.402 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 47' ' ' GLU . 89.2 m -109.3 151.19 26.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.359 -0.838 . . . . 0.0 109.941 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -59.67 -41.9 91.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 110.03 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.79 -62.14 1.5 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.319 -0.863 . . . . 0.0 110.25 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.435 ' HB3' ' HB ' ' A' ' 44' ' ' THR . 41.6 tt0 -50.07 -24.98 3.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.247 -0.908 . . . . 0.0 109.893 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 44' ' ' THR . 9.2 tt -70.74 -51.27 28.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.434 -0.791 . . . . 0.0 109.612 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -54.03 -30.1 46.31 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.292 -0.88 . . . . 0.0 109.085 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -75.96 -35.43 59.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.493 -0.755 . . . . 0.0 109.561 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.434 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 27.9 ttp -71.04 -19.93 62.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.469 -0.769 . . . . 0.0 110.081 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.923 HD12 HG22 ' A' ' 29' ' ' THR . 10.7 mt -88.15 -36.75 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -0.87 . . . . 0.0 109.684 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -55.0 -40.64 70.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.195 -0.94 . . . . 0.0 109.91 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.504 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 10.0 pt-20 -70.14 -30.58 67.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.256 -0.903 . . . . 0.0 110.131 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.702 HG21 ' C6 ' ' A' ' 153' ' ' WW7 . 59.0 t -74.35 -72.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.353 -0.842 . . . . 0.0 109.328 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -52.03 98.62 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.686 -0.634 . . . . 0.0 110.401 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -87.41 50.03 1.93 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.602 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -138.03 9.28 2.78 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.447 -0.783 . . . . 0.0 110.333 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 53.17 88.02 0.01 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -169.39 -60.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.217 -1.166 . . . . 0.0 110.077 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.404 ' O ' ' CG2' ' A' ' 52' ' ' ILE . . . 136.54 -57.83 0.67 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.436 HG22 HG23 ' A' ' 28' ' ' THR . 68.8 p -90.13 143.51 26.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.203 -1.175 . . . . 0.0 110.712 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.609 HD11 ' CG1' ' A' ' 55' ' ' VAL . 86.6 mt -93.86 151.11 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.453 -0.78 . . . . 0.0 109.68 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.411 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 47.8 m-20 -109.02 -162.79 0.83 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.237 -0.914 . . . . 0.0 110.531 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.547 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 28.1 t80 -79.39 -42.08 1.58 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.359 -0.838 . . . . 0.0 111.355 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 49.3 Cg_endo -75.73 -25.8 10.41 Favored 'Trans proline' 0 N--CA 1.481 0.75 0 O-C-N 123.124 1.065 . . . . 0.0 110.428 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -78.65 -28.06 45.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 0.0 109.188 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.629 ' CE1' ' HE3' ' A' ' 72' ' ' MET . 88.2 t80 -78.11 -44.73 25.31 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.635 -0.666 . . . . 0.0 110.118 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.56 -32.22 60.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 0.0 110.894 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 83.2 m -78.56 -31.44 47.35 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.991 -1.068 . . . . 0.0 110.88 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.43 ' HG3' ' HG3' ' A' ' 72' ' ' MET . 18.7 ptt? -79.93 -31.48 40.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.92 -1.113 . . . . 0.0 110.777 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.629 ' HE3' ' CE1' ' A' ' 68' ' ' PHE . 53.9 mtt -89.22 -10.45 46.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.008 -1.058 . . . . 0.0 110.932 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.02 -21.45 54.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.072 -1.017 . . . . 0.0 110.45 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.425 ' O ' ' O ' ' A' ' 75' ' ' LYS . 4.1 mmt85 -110.52 -28.56 8.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.105 -0.997 . . . . 0.0 110.761 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 74' ' ' ARG . 5.6 mttp 60.79 132.29 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.467 -0.771 . . . . 0.0 110.307 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 89.7 mtp -140.24 174.78 10.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.014 -1.054 . . . . 0.0 110.462 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -108.94 115.12 29.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 110.376 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.418 ' OD2' ' HB2' ' A' ' 54' ' ' GLU . 23.9 t70 -150.36 75.46 1.23 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.337 -0.852 . . . . 0.0 110.091 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.427 HG22 ' OD1' ' A' ' 80' ' ' ASP . 70.8 m -104.3 151.3 23.59 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.313 -0.867 . . . . 0.0 110.146 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.427 ' OD1' HG22 ' A' ' 79' ' ' THR . 0.7 OUTLIER 57.11 115.38 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.513 -0.742 . . . . 0.0 110.861 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.0 t -104.5 74.12 1.14 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.918 . . . . 0.0 109.988 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -99.61 -42.04 7.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.162 -0.961 . . . . 0.0 110.673 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -177.11 101.02 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.249 -0.907 . . . . 0.0 110.333 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -61.24 -43.13 99.38 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.261 -0.899 . . . . 0.0 110.203 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.6 mt -50.46 -23.77 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.146 -0.971 . . . . 0.0 110.255 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.23 -55.26 5.22 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.214 -0.929 . . . . 0.0 110.457 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 47.9 mt-10 -53.58 -38.55 64.01 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.221 -0.925 . . . . 0.0 110.147 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.746 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -65.25 -59.48 4.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.391 -0.818 . . . . 0.0 110.206 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.638 ' CD1' HD11 ' A' ' 100' ' ' ILE . 20.8 t80 -46.15 -28.74 1.31 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.358 -0.839 . . . . 0.0 110.267 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 71.6 mtp180 -71.13 -55.37 8.33 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.252 -0.905 . . . . 0.0 110.422 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.746 HG22 ' O ' ' A' ' 88' ' ' ALA . 32.7 m -61.36 -19.64 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.152 -0.968 . . . . 0.0 110.579 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.559 ' CE2' ' H2 ' ' A' ' 154' ' ' WW7 . 40.9 m-85 -92.12 -21.31 20.5 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.126 -0.984 . . . . 0.0 110.21 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -127.45 37.49 4.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 0.0 109.927 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -85.0 8.07 19.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.898 . . . . 0.0 110.658 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 3.0 p30 -81.92 -22.71 36.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.155 -0.966 . . . . 0.0 110.138 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.437 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 112.18 29.82 3.12 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.473 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 39.0 p-10 -127.09 -15.46 5.28 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.263 -1.139 . . . . 0.0 110.719 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 65.53 11.28 52.7 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.613 ' O ' 'CA ' ' A' ' 151' ' ' ' CA' . 49.8 m-85 -121.41 139.54 53.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.026 -1.279 . . . . 0.0 110.241 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.638 HD11 ' CD1' ' A' ' 89' ' ' PHE . 21.8 mt -91.23 113.37 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.137 -0.977 . . . . 0.0 110.273 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 76.3 p -103.85 156.46 17.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.412 -0.805 . . . . 0.0 109.915 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.77 -34.95 55.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.127 -0.983 . . . . 0.0 110.307 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.42 -62.32 1.48 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.181 -0.949 . . . . 0.0 110.498 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.415 ' OE1' ' OD2' ' A' ' 95' ' ' ASP . 51.4 mt-10 -46.95 -42.98 18.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.179 -0.95 . . . . 0.0 110.254 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.621 HD22 HG13 ' A' ' 121' ' ' VAL . 8.6 tt -55.07 -54.12 47.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.399 -0.813 . . . . 0.0 110.126 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.411 ' O ' ' HG3' ' A' ' 106' ' ' ARG . 3.1 tpt180 -63.1 -19.95 64.91 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.924 . . . . 0.0 109.986 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -77.89 -27.32 49.6 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.286 -0.884 . . . . 0.0 110.14 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.452 HG21 ' CD1' ' A' ' 92' ' ' PHE . 78.4 t -83.77 -40.1 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.315 -0.865 . . . . 0.0 109.903 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.42 ' HG2' ' CD1' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -59.87 -41.9 92.54 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.344 -0.848 . . . . 0.0 110.062 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.1 p -56.01 -44.68 78.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.33 -0.856 . . . . 0.0 110.335 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -61.28 -48.32 81.94 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.243 -0.911 . . . . 0.0 110.132 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.5 mt -64.48 -13.93 54.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.207 -0.933 . . . . 0.0 110.275 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.27 51.44 3.52 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -102.23 -177.47 3.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.129 -1.218 . . . . 0.0 110.015 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.15 47.6 0.99 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.166 -0.959 . . . . 0.0 110.577 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.815 HD23 ' OE1' ' A' ' 120' ' ' GLU . 7.0 mt -75.89 -175.73 3.12 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.264 -0.898 . . . . 0.0 110.158 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.531 HG22 ' N ' ' A' ' 118' ' ' ASP . 88.8 m -135.92 170.08 16.57 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.293 -0.879 . . . . 0.0 110.288 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.531 ' N ' HG22 ' A' ' 117' ' ' THR . 75.1 m-20 -52.87 -33.29 49.25 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.314 -0.866 . . . . 0.0 110.783 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -65.68 -53.1 45.71 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.127 -0.983 . . . . 0.0 110.613 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.815 ' OE1' HD23 ' A' ' 116' ' ' LEU . 74.2 mt-10 -60.57 -48.88 79.8 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.318 -0.864 . . . . 0.0 111.209 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.621 HG13 HD22 ' A' ' 105' ' ' LEU . 95.7 t -55.81 -53.31 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.231 -0.918 . . . . 0.0 110.833 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.75 -36.47 74.4 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.23 -0.919 . . . . 0.0 110.667 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.456 ' CG ' ' OE2' ' A' ' 127' ' ' GLU . 36.9 tt0 -71.63 -24.95 61.96 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.193 -0.942 . . . . 0.0 110.289 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.486 ' HE2' HD11 ' A' ' 105' ' ' LEU . 85.3 mtp -76.63 -49.18 16.87 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.183 -0.948 . . . . 0.0 110.068 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.702 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 19.2 mm -69.08 -26.53 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 110.326 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.43 -39.14 47.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.127 -0.983 . . . . 0.0 110.528 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.456 ' OE2' ' CG ' ' A' ' 123' ' ' GLU . 0.3 OUTLIER -69.78 -31.23 69.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.133 -0.979 . . . . 0.0 110.178 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.11 -27.91 24.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.208 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 56.8 t0 -68.29 93.58 0.48 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.374 -0.829 . . . . 0.0 110.224 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 55.6 mt -75.42 -47.9 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.287 -0.883 . . . . 0.0 110.739 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.409 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 47.7 p30 -73.19 -6.37 45.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.132 -0.98 . . . . 0.0 110.811 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.406 ' HA2' ' OD2' ' A' ' 129' ' ' ASP . . . 57.87 61.98 6.83 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -124.03 8.63 8.65 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.203 -1.175 . . . . 0.0 111.027 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.54 36.19 54.62 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.55 ' NE2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -170.96 137.36 1.19 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.354 -1.086 . . . . 0.0 109.964 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.437 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 46.8 t -110.35 118.16 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.157 -0.965 . . . . 0.0 110.318 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -87.37 177.2 7.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.163 -0.961 . . . . 0.0 110.022 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.538 ' O ' HG23 ' A' ' 142' ' ' VAL . 16.0 t80 -61.5 -45.05 95.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.111 -0.993 . . . . 0.0 110.286 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -53.08 -55.56 22.96 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.282 -0.886 . . . . 0.0 110.077 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.441 ' O ' ' HG2' ' A' ' 144' ' ' MET . 56.7 mt-10 -64.86 -23.36 67.21 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.224 -0.922 . . . . 0.0 109.785 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.542 ' CE1' ' HE2' ' A' ' 145' ' ' MET . 37.9 t80 -75.75 -22.86 56.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.551 -0.718 . . . . 0.0 109.757 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 138' ' ' TYR . 84.9 t -90.1 -24.19 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.369 -0.832 . . . . 0.0 109.928 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -80.43 -34.24 36.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.372 -0.83 . . . . 0.0 110.217 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.573 ' HE3' ' CE ' ' A' ' 145' ' ' MET . 0.1 OUTLIER -82.57 -13.67 56.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.286 -0.884 . . . . 0.0 110.257 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.573 ' CE ' ' HE3' ' A' ' 144' ' ' MET . 15.1 mmt -87.49 -46.66 9.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 110.394 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.3 p -92.97 -53.18 4.25 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.141 -0.974 . . . . 0.0 110.489 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -94.19 -164.72 1.21 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.149 -0.969 . . . . 0.0 110.583 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.6 mttp . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.236 -179.851 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . 0.613 'CA ' ' O ' ' A' ' 99' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 153' ' ' WW7 . . . . . 0.702 ' C6 ' HG21 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' WW7 . . . . . 0.702 'CL1 ' HD13 ' A' ' 125' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.345 0.593 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -135.68 175.28 9.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.365 -0.834 . . . . 0.0 109.985 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -122.35 -177.59 3.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 0.0 109.999 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.607 ' O ' HG23 ' A' ' 5' ' ' THR . 0.4 OUTLIER -151.94 126.67 9.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.173 -0.954 . . . . 0.0 110.262 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.607 HG23 ' O ' ' A' ' 4' ' ' LEU . 2.2 p -156.64 -66.39 0.1 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.171 -0.956 . . . . 0.0 110.313 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -80.21 -9.89 59.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 110.53 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.67 -60.28 3.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.121 -0.987 . . . . 0.0 110.426 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.526 ' HG2' ' CE2' ' A' ' 12' ' ' PHE . 51.2 tt0 -62.7 -43.35 99.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.327 -0.858 . . . . 0.0 110.415 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.8 mt -55.0 -42.23 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.081 -1.012 . . . . 0.0 109.839 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.97 -34.9 78.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.317 -0.865 . . . . 0.0 110.029 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.91 -48.87 78.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 109.779 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.526 ' CE2' ' HG2' ' A' ' 8' ' ' GLN . 24.1 m-85 -60.08 -47.87 84.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.016 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -49.04 -42.04 37.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.17 -0.956 . . . . 0.0 110.072 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -66.5 -37.7 85.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.875 . . . . 0.0 110.307 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.81 -47.87 83.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.142 -0.974 . . . . 0.0 109.971 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -60.27 -45.26 93.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 110.146 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.3 t -62.84 -21.22 65.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.924 . . . . 0.0 109.991 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.73 ' O ' HD23 ' A' ' 18' ' ' LEU . 4.7 tt -85.2 -25.18 27.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 109.939 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.564 ' HA ' HG21 ' A' ' 35' ' ' VAL . 8.3 m-85 -92.74 -67.98 0.83 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.219 -0.926 . . . . 0.0 110.412 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -70.99 86.78 0.72 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.382 -0.823 . . . . 0.0 110.235 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.39 42.54 1.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.342 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -125.18 -43.2 1.96 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.136 -0.977 . . . . 0.0 110.25 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.93 -37.42 1.66 Allowed Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.86 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 49.9 p-10 -55.67 -17.85 6.67 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.96 -1.318 . . . . 0.0 110.952 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.428 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 63.13 13.59 49.52 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 34.0 p -122.21 116.05 23.46 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.023 -1.281 . . . . 0.0 110.286 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 62' ' ' THR . 61.2 mt -69.54 109.25 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.173 -0.954 . . . . 0.0 110.254 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.534 HG22 HG22 ' A' ' 62' ' ' THR . 81.2 p -104.19 -157.85 0.63 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.881 . . . . 0.0 110.204 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.1 p -82.99 -36.85 24.73 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.198 -0.939 . . . . 0.0 110.636 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -64.94 -59.85 3.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.117 -0.99 . . . . 0.0 110.192 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -59.09 -52.5 65.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.166 -0.958 . . . . 0.0 109.805 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.717 HD23 HD21 ' A' ' 48' ' ' LEU . 2.6 tp -59.45 -21.82 60.6 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.241 -0.912 . . . . 0.0 109.682 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -68.23 -44.61 74.88 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 70.8 m -71.63 -34.14 69.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.349 -1.089 . . . . 0.0 110.176 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.564 HG21 ' HA ' ' A' ' 19' ' ' PHE . 63.6 t -69.6 -32.14 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.29 -0.881 . . . . 0.0 110.617 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 25.9 mmt -90.16 -18.47 25.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.221 -0.924 . . . . 0.0 110.241 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 10.7 tpt180 -79.06 -33.93 44.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 110.357 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.3 t -61.36 -21.07 63.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.289 -0.882 . . . . 0.0 110.383 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -144.98 76.38 1.49 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.175 -0.953 . . . . 0.0 110.255 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.24 -65.28 0.15 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 53.6 21.12 2.4 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.13 -1.218 . . . . 0.0 109.963 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.522 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.0 OUTLIER -105.56 -67.22 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.425 -0.797 . . . . 0.0 110.823 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 42' ' ' ASN . 46.8 Cg_endo -72.31 170.64 18.7 Favored 'Trans proline' 0 C--N 1.321 -0.911 0 O-C-N 123.063 1.033 . . . . 0.0 110.467 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.442 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.6 OUTLIER -118.76 -140.63 0.36 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -0.887 . . . . 0.0 109.629 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -90.74 -30.67 16.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.908 -1.12 . . . . 0.0 110.189 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.62 -66.44 0.66 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.206 -0.933 . . . . 0.0 109.805 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 41.8 mt-10 -50.58 -36.22 33.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 109.54 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.717 HD21 HD23 ' A' ' 32' ' ' LEU . 6.0 tt -60.35 -45.2 94.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.84 . . . . 0.0 109.587 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -53.16 -39.36 63.5 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.282 -0.886 . . . . 0.0 108.629 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 47' ' ' GLU . 57.4 m-20 -64.31 -38.08 89.78 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.434 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -60.75 -23.84 65.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.439 -0.788 . . . . 0.0 108.919 178.746 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.702 HD11 HD22 ' A' ' 32' ' ' LEU . 10.7 mt -85.34 -24.86 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.456 -0.778 . . . . 0.0 109.786 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -73.54 -35.67 65.55 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.263 -0.898 . . . . 0.0 110.243 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.478 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 24.2 pt-20 -72.74 -42.54 63.96 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.174 -0.953 . . . . 0.0 110.166 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.851 HG21 ' C6 ' ' A' ' 153' ' ' WW7 . 68.0 t -69.87 -57.61 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.036 -1.04 . . . . 0.0 109.593 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.404 ' OD1' ' OE1' ' A' ' 67' ' ' GLU . 45.3 t0 -68.3 133.58 49.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.467 -0.77 . . . . 0.0 110.07 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.93 50.85 0.78 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.17 -0.956 . . . . 0.0 110.376 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.401 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 55.4 m-20 -136.48 -74.72 0.43 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.193 -0.942 . . . . 0.0 110.466 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.38 47.57 0.05 OUTLIER Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -140.35 14.15 2.39 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.353 -1.086 . . . . 0.0 110.405 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 62' ' ' THR . . . 47.16 38.45 11.65 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.534 HG22 HG22 ' A' ' 28' ' ' THR . 20.6 p -152.58 136.7 16.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.999 -1.294 . . . . 0.0 110.576 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 75.4 mt -111.67 123.74 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.884 . . . . 0.0 110.082 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.447 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.4 m-20 -83.73 -174.19 5.14 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.148 -0.97 . . . . 0.0 110.546 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.563 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -67.25 -46.71 50.82 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.436 -0.79 . . . . 0.0 111.032 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.6 Cg_endo -73.73 -31.12 8.82 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 O-C-N 123.415 1.218 . . . . 0.0 110.427 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.404 ' OE1' ' OD1' ' A' ' 56' ' ' ASP . 27.5 mt-10 -73.78 -23.65 59.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.158 -0.964 . . . . 0.0 109.176 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.718 ' CE1' ' HE2' ' A' ' 72' ' ' MET . 65.4 t80 -76.01 -55.51 5.53 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.638 -0.664 . . . . 0.0 110.281 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.708 ' O ' HD23 ' A' ' 69' ' ' LEU . 5.4 tt -63.87 -28.86 70.13 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.349 -0.845 . . . . 0.0 110.297 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.4 m -68.52 -57.59 5.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.221 -0.924 . . . . 0.0 110.375 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.635 ' SD ' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -69.38 -12.67 61.85 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.167 -0.958 . . . . 0.0 110.673 -179.474 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.718 ' HE2' ' CE1' ' A' ' 68' ' ' PHE . 11.4 mmt -80.52 -24.93 39.01 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.05 -1.031 . . . . 0.0 110.085 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.53 -36.16 81.7 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.334 -0.854 . . . . 0.0 109.899 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.428 ' O ' ' CG ' ' A' ' 74' ' ' ARG . 1.8 ttp180 -110.85 65.11 0.61 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.408 -0.807 . . . . 0.0 110.839 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.83 134.62 47.66 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.913 -1.117 . . . . 0.0 110.041 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 36.9 ttp -125.89 128.64 47.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.223 -0.923 . . . . 0.0 110.384 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -82.69 165.14 20.23 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.301 -0.874 . . . . 0.0 109.853 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -135.5 136.91 41.62 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.127 -0.983 . . . . 0.0 110.692 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 77.9 p -81.29 164.35 22.28 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.355 -0.84 . . . . 0.0 110.418 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -122.57 -155.31 0.64 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.226 -0.921 . . . . 0.0 109.842 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.1 m -133.21 157.06 46.33 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.126 -0.984 . . . . 0.0 110.311 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -96.16 -149.05 0.31 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.285 -0.884 . . . . 0.0 110.356 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.413 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . 44.9 mm-40 52.01 87.76 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.256 -0.902 . . . . 0.0 110.187 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -69.99 -16.08 63.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 110.461 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 65.5 mt -55.21 -45.19 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.115 -0.991 . . . . 0.0 110.097 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -58.6 -56.4 22.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.168 -0.957 . . . . 0.0 109.979 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 10.8 mt-10 -46.29 -44.57 16.7 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.336 -0.852 . . . . 0.0 110.172 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.596 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -57.22 -57.64 11.72 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.378 -0.826 . . . . 0.0 109.467 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.49 ' CE1' HG13 ' A' ' 100' ' ' ILE . 29.9 t80 -49.8 -25.28 2.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.115 -0.991 . . . . 0.0 109.638 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.424 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 15.7 ttt180 -67.05 -59.33 3.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.51 -0.744 . . . . 0.0 110.464 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 88' ' ' ALA . 34.7 m -61.52 -31.66 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.208 -0.933 . . . . 0.0 110.583 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.821 ' CE1' HG11 ' A' ' 108' ' ' VAL . 31.1 m-85 -78.7 -15.96 57.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.084 -1.01 . . . . 0.0 110.663 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -114.61 73.21 0.82 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.965 -1.084 . . . . 0.0 110.463 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -99.42 54.91 0.97 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.259 -0.9 . . . . 0.0 110.761 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.3 p30 -140.04 -37.02 0.48 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.077 -1.014 . . . . 0.0 110.615 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.478 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 107.8 42.9 1.38 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.501 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 45.2 p-10 -135.46 -18.59 1.7 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.057 -1.261 . . . . 0.0 111.477 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.481 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 80.42 42.02 10.86 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.501 ' HB2' ' ND2' ' A' ' 97' ' ' ASN . 68.5 m-85 -152.33 145.39 24.55 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.335 -1.097 . . . . 0.0 110.093 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.49 HG13 ' CE1' ' A' ' 89' ' ' PHE . 31.9 mt -96.69 130.67 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.199 -0.938 . . . . 0.0 110.427 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.8 t -117.25 166.94 11.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.38 -0.825 . . . . 0.0 109.858 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.61 -32.21 73.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.181 -0.949 . . . . 0.0 110.678 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.6 -52.14 34.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.117 -0.99 . . . . 0.0 110.442 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.641 ' O ' HG23 ' A' ' 108' ' ' VAL . 53.8 mt-10 -60.19 -40.18 89.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.275 -0.89 . . . . 0.0 110.755 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.056 HD23 HG13 ' A' ' 121' ' ' VAL . 6.7 tp -64.09 -36.82 85.28 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.087 -1.008 . . . . 0.0 110.541 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 106' ' ' ARG . 1.6 ttp-105 -66.65 -39.25 88.13 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.099 -1.001 . . . . 0.0 110.293 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -73.48 -22.81 60.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 0.0 110.384 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.821 HG11 ' CE1' ' A' ' 92' ' ' PHE . 77.0 t -82.15 -32.83 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.336 -0.853 . . . . 0.0 110.487 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.408 ' HG2' ' O ' ' A' ' 105' ' ' LEU . 24.1 mmt -66.8 -28.78 68.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.129 -0.982 . . . . 0.0 110.272 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.4 p -63.3 -54.04 43.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.189 -0.945 . . . . 0.0 110.013 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -61.35 -40.38 94.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.253 -0.904 . . . . 0.0 110.153 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.7 mt -54.34 -30.24 50.78 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.188 -0.945 . . . . 0.0 110.232 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.39 26.0 7.11 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.49 ' O ' HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -127.35 107.4 9.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.272 -1.134 . . . . 0.0 110.041 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -86.09 109.23 18.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.915 . . . . 0.0 110.548 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.49 HD12 ' O ' ' A' ' 114' ' ' GLU . 1.6 mp -112.71 -169.23 1.44 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.259 -0.901 . . . . 0.0 109.924 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.48 HG22 ' N ' ' A' ' 118' ' ' ASP . 31.1 m -117.57 168.71 10.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.002 -1.061 . . . . 0.0 110.721 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.48 ' N ' HG22 ' A' ' 117' ' ' THR . 26.4 m-20 -59.15 -36.22 74.87 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.4 -0.812 . . . . 0.0 110.295 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -67.0 -36.58 82.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.225 -0.922 . . . . 0.0 110.295 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 124' ' ' MET . 1.7 mt-10 -63.66 -51.72 63.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.38 -0.825 . . . . 0.0 110.361 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 1.056 HG13 HD23 ' A' ' 105' ' ' LEU . 50.3 t -63.42 -58.12 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.165 -0.959 . . . . 0.0 110.395 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -46.57 -43.13 16.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.338 -0.851 . . . . 0.0 110.395 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -67.01 -37.58 84.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.219 -0.925 . . . . 0.0 110.349 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.405 ' HG3' ' O ' ' A' ' 120' ' ' GLU . 90.9 mtp -59.27 -55.11 38.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 110.288 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.74 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 35.7 mm -56.16 -39.06 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 110.125 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -58.29 -44.36 88.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 109.952 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -69.01 -24.61 64.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.076 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.45 ' CB ' HG21 ' A' ' 136' ' ' VAL . . . -81.43 -21.48 38.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.174 -0.953 . . . . 0.0 110.074 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -67.76 89.42 0.26 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.314 -0.866 . . . . 0.0 110.427 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 140' ' ' GLU . 47.7 mt -77.04 -29.74 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.791 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.7 p30 -99.37 -26.52 14.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.374 -0.829 . . . . 0.0 110.227 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 96.36 80.29 1.51 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 11.7 p-10 -144.68 -42.01 0.25 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -1.193 . . . . 0.0 110.358 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 126.51 -20.96 6.08 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.45 ' CG ' ' OD2' ' A' ' 133' ' ' ASP . 5.2 pt20 -119.16 158.91 24.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.095 -1.238 . . . . 0.0 110.524 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.45 HG21 ' CB ' ' A' ' 128' ' ' ALA . 59.5 t -119.42 113.14 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.269 -0.895 . . . . 0.0 110.055 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 12.4 p-10 -85.59 -157.98 0.36 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.125 -0.985 . . . . 0.0 110.321 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -68.93 -66.05 0.63 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.087 -1.008 . . . . 0.0 111.406 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -47.87 -47.42 31.74 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.143 -0.973 . . . . 0.0 110.854 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.414 ' HA ' HD12 ' A' ' 130' ' ' ILE . 33.1 mt-10 -66.29 -31.35 72.09 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.078 -1.014 . . . . 0.0 110.56 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' ' 137' ' ' ASN . 15.5 t80 -70.61 -27.48 64.12 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.139 -0.976 . . . . 0.0 109.831 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.427 ' O ' ' CB ' ' A' ' 146' ' ' THR . 53.8 t -90.43 -23.14 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.523 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -83.83 -34.15 24.73 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.218 -0.926 . . . . 0.0 110.929 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.614 ' HE2' ' HE3' ' A' ' 145' ' ' MET . 15.0 ptt? -64.17 -35.33 80.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.013 -1.054 . . . . 0.0 110.21 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.614 ' HE3' ' HE2' ' A' ' 144' ' ' MET . 12.4 mtt -90.19 -36.53 14.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 0.0 109.424 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.427 ' CB ' ' O ' ' A' ' 142' ' ' VAL . 22.7 m -86.11 85.39 7.36 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.538 -0.726 . . . . 0.0 110.109 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -116.93 98.58 6.56 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.233 -0.917 . . . . 0.0 110.117 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.2 tttp . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.269 -179.812 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 153' ' ' WW7 . . . . . 0.851 ' C6 ' HG21 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' WW7 . . . . . 0.74 'CL1 ' HD13 ' A' ' 125' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.178 0.513 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.406 ' O ' ' O ' ' A' ' 3' ' ' GLN . 50.7 m-20 -109.11 99.94 9.17 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.274 -0.891 . . . . 0.0 110.524 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.406 ' O ' ' O ' ' A' ' 2' ' ' ASP . 37.5 tt0 59.96 119.23 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.377 -0.827 . . . . 0.0 110.729 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 4' ' ' LEU . 32.3 mt -72.13 162.3 29.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.253 -0.904 . . . . 0.0 110.321 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.0 p -129.48 -178.48 4.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 110.206 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.547 ' OE1' HD12 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -74.16 -9.72 58.9 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.231 -0.918 . . . . 0.0 110.584 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -66.16 -51.11 60.97 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.039 -1.038 . . . . 0.0 110.458 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -64.35 -39.53 94.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -0.929 . . . . 0.0 110.083 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.547 HD12 ' OE1' ' A' ' 6' ' ' GLU . 32.5 mt -59.06 -42.69 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.143 -0.973 . . . . 0.0 109.604 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.14 95.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.353 -0.842 . . . . 0.0 109.545 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -60.03 -40.78 90.52 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.333 -0.855 . . . . 0.0 109.654 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -65.13 -31.54 72.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -0.841 . . . . 0.0 109.482 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.63 -50.59 68.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.852 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -60.79 -46.59 89.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.939 . . . . 0.0 109.839 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.505 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -48.82 -55.05 12.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.243 -0.911 . . . . 0.0 109.844 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -52.78 -52.47 56.58 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.399 -0.813 . . . . 0.0 110.347 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.0 m -53.58 -30.18 41.01 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.199 -0.938 . . . . 0.0 110.262 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.68 ' O ' HD23 ' A' ' 18' ' ' LEU . 6.7 tt -70.52 -37.98 74.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.873 . . . . 0.0 110.142 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 1.086 ' CD1' HG11 ' A' ' 35' ' ' VAL . 78.5 m-85 -71.66 -65.24 0.78 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.433 -0.792 . . . . 0.0 110.353 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.444 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -53.74 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.149 -0.969 . . . . 0.0 110.351 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -105.16 51.94 0.75 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.264 -0.898 . . . . 0.0 110.235 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.482 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 23.0 p-10 -169.4 -33.06 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.263 -0.898 . . . . 0.0 110.936 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.73 93.98 2.33 Favored Glycine 0 N--CA 1.498 2.806 0 C-N-CA 119.669 -1.253 . . . . 0.0 110.678 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.445 ' HB2' 'CA ' ' A' ' 149' ' ' ' CA' . 43.7 m-20 -158.91 -45.83 0.06 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.44 -1.035 . . . . 0.0 110.038 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.88 -9.57 23.33 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.1 p -126.89 156.0 42.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.17 -1.194 . . . . 0.0 110.312 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 56.9 mt -105.42 119.64 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.465 -0.772 . . . . 0.0 110.031 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.3 p -103.21 -162.73 0.93 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.196 -0.94 . . . . 0.0 110.223 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.518 HG21 ' HG2' ' A' ' 49' ' ' GLN . 12.7 p -83.85 -27.99 28.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.162 -0.961 . . . . 0.0 110.609 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 mttp -71.21 -58.68 3.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.174 -0.954 . . . . 0.0 109.954 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.735 ' O ' HG23 ' A' ' 35' ' ' VAL . 49.8 mt-10 -56.52 -42.78 79.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.47 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.89 HD22 HD11 ' A' ' 52' ' ' ILE . 2.6 tp -67.57 -26.82 66.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.246 -0.909 . . . . 0.0 109.766 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.437 ' HA2' ' CD1' ' A' ' 48' ' ' LEU . . . -65.6 -38.69 94.91 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.2 m -83.0 -20.61 34.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -1.115 . . . . 0.0 109.885 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.086 HG11 ' CD1' ' A' ' 19' ' ' PHE . 60.4 t -74.4 -34.64 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 109.567 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 9.6 mmt -90.18 -31.66 16.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.431 -0.793 . . . . 0.0 109.636 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.2 tpt85 -78.99 -20.99 47.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.453 -0.779 . . . . 0.0 110.135 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.1 m -106.61 -6.52 17.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.336 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.737 HD23 H152 ' A' ' 153' ' ' WW7 . 1.6 tp -166.05 94.13 0.55 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.128 -0.983 . . . . 0.0 110.271 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.99 -103.79 0.32 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -123.45 -159.32 0.84 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -1.114 . . . . 0.0 110.288 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -130.87 60.35 52.48 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.239 -0.913 . . . . 0.0 110.06 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.5 -165.48 0.17 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.819 1.431 . . . . 0.0 110.156 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.584 HG22 ' H ' ' A' ' 45' ' ' GLU . 5.9 m -125.39 -179.76 4.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.236 -0.915 . . . . 0.0 109.786 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.584 ' H ' HG22 ' A' ' 44' ' ' THR . 4.1 tp10 -69.04 -50.89 44.49 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.087 -1.008 . . . . 0.0 109.627 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.46 -57.15 11.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.196 -0.94 . . . . 0.0 109.876 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 3.4 tp10 -50.84 -39.74 54.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.915 . . . . 0.0 109.64 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.536 ' CG ' HD23 ' A' ' 32' ' ' LEU . 9.0 tt -54.79 -47.59 73.78 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.312 -0.868 . . . . 0.0 109.311 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.518 ' HG2' HG21 ' A' ' 29' ' ' THR . 1.6 mt-30 -54.32 -44.4 72.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.78 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 47' ' ' GLU . 1.6 m-20 -51.31 -43.9 61.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 109.536 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.445 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 54.6 mtp -64.01 -34.85 78.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.202 -0.936 . . . . 0.0 109.794 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.89 HD11 HD22 ' A' ' 32' ' ' LEU . 28.0 mm -64.72 -27.97 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.299 -0.876 . . . . 0.0 110.063 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -68.06 -38.34 82.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.334 -0.854 . . . . 0.0 110.407 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.589 ' HG3' HG23 ' A' ' 55' ' ' VAL . 16.7 pt-20 -82.32 -10.49 59.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.084 -1.01 . . . . 0.0 110.154 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.897 HG21 ' C6 ' ' A' ' 153' ' ' WW7 . 69.9 t -104.97 -9.99 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.189 -0.944 . . . . 0.0 110.155 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -98.52 102.43 14.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.115 -0.991 . . . . 0.0 110.299 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.54 -11.12 21.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.193 -0.942 . . . . 0.0 110.538 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -69.99 -59.48 2.89 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.111 -0.993 . . . . 0.0 110.15 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 131.75 -13.7 5.3 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -76.64 -42.12 43.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.053 -1.263 . . . . 0.0 110.106 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.17 -63.63 0.6 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 57.0 p -76.67 167.28 22.11 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.243 -1.151 . . . . 0.0 110.47 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.5 HG23 ' OE1' ' A' ' 67' ' ' GLU . 74.2 mt -96.19 152.29 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.208 -0.933 . . . . 0.0 109.98 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.404 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 22.7 m-20 -114.18 -157.58 0.63 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.905 . . . . 0.0 110.472 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.563 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 7.6 t80 -84.79 -42.63 0.69 Allowed Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.414 -0.804 . . . . 0.0 111.526 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.6 Cg_endo -73.52 -24.1 16.52 Favored 'Trans proline' 0 N--CA 1.481 0.786 0 O-C-N 122.994 0.997 . . . . 0.0 110.776 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.5 ' OE1' HG23 ' A' ' 63' ' ' ILE . 31.2 tt0 -79.24 -31.36 43.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.138 -0.976 . . . . 0.0 108.97 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.479 ' CE1' ' SD ' ' A' ' 72' ' ' MET . 16.4 t80 -70.68 -45.21 65.44 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.788 -0.57 . . . . 0.0 110.165 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.453 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 34.5 tp -75.75 -25.03 56.17 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.263 -0.898 . . . . 0.0 110.533 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.411 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 53.4 m -84.97 -18.22 35.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.091 -1.005 . . . . 0.0 110.567 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.7 tmm? -90.7 -38.19 13.23 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.045 -1.035 . . . . 0.0 110.876 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.479 ' SD ' ' CE1' ' A' ' 68' ' ' PHE . 66.5 mtt -90.0 -14.03 34.83 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.061 -1.024 . . . . 0.0 111.04 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -89.8 -10.41 45.58 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.02 -1.05 . . . . 0.0 110.781 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 70' ' ' THR . 60.9 mtp180 -67.12 -39.5 86.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.013 -1.055 . . . . 0.0 110.267 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -86.57 153.96 21.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.371 -0.83 . . . . 0.0 110.264 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 13.3 ptp -95.82 179.25 5.17 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.256 -0.903 . . . . 0.0 110.436 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.97 -154.05 0.45 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.347 -0.846 . . . . 0.0 109.806 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -102.32 120.91 41.28 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.225 -0.922 . . . . 0.0 109.934 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t -151.59 145.02 24.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.165 -0.96 . . . . 0.0 110.517 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -132.01 159.64 38.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.33 -0.856 . . . . 0.0 110.113 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 84.0 p -80.04 149.53 30.67 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.164 -0.96 . . . . 0.0 110.084 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.444 ' CG ' ' O ' ' A' ' 82' ' ' GLU . 21.8 pt-20 -73.28 120.55 19.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.261 -0.899 . . . . 0.0 110.423 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 21.8 pt-20 -172.77 65.68 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.26 -0.9 . . . . 0.0 110.149 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -92.04 -58.67 2.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.242 -0.911 . . . . 0.0 110.465 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.412 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 16.7 mt -47.91 -35.2 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.15 -0.969 . . . . 0.0 110.216 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -55.15 -54.54 42.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.179 -0.951 . . . . 0.0 109.712 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 55.5 mt-10 -54.62 -39.92 68.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.24 -0.912 . . . . 0.0 110.147 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.649 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -56.19 -56.24 23.36 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.269 -0.894 . . . . 0.0 110.107 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -48.27 -40.16 23.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.141 -0.975 . . . . 0.0 110.23 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 45.6 mtt-85 -61.42 -41.24 96.85 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.266 -0.896 . . . . 0.0 110.829 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.649 HG22 ' O ' ' A' ' 88' ' ' ALA . 29.5 m -83.24 -10.13 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.936 -1.103 . . . . 0.0 110.783 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.95 ' CE1' HG11 ' A' ' 108' ' ' VAL . 35.6 m-85 -105.32 -1.77 24.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.116 -0.99 . . . . 0.0 110.695 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -135.67 73.77 1.48 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.06 -1.025 . . . . 0.0 110.257 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -78.05 -24.63 47.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.237 -0.914 . . . . 0.0 110.545 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.618 ' OD2' 'CA ' ' A' ' 151' ' ' ' CA' . 2.5 p30 -70.16 -28.99 65.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.315 -0.865 . . . . 0.0 110.402 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.454 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 77.93 61.45 2.53 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.438 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 16.6 p-10 -125.24 -34.94 2.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.257 -1.143 . . . . 0.0 110.432 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.432 ' C ' ' CG ' ' A' ' 99' ' ' TYR . . . 108.06 16.71 11.94 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.779 -1.201 . . . . 0.0 110.374 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.432 ' CG ' ' C ' ' A' ' 98' ' ' GLY . 35.4 m-85 -147.48 134.57 20.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.985 -1.303 . . . . 0.0 110.002 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.497 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 17.9 mt -90.48 120.61 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.809 -1.182 . . . . 0.0 109.664 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.8 t -96.9 171.69 8.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.402 -0.812 . . . . 0.0 110.056 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.01 -46.84 61.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.87 . . . . 0.0 110.284 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.05 -55.15 22.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.298 -0.876 . . . . 0.0 110.439 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.615 ' O ' HG23 ' A' ' 108' ' ' VAL . 57.1 mt-10 -55.42 -50.06 70.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.259 -0.9 . . . . 0.0 110.613 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.683 ' O ' HD23 ' A' ' 105' ' ' LEU . 3.2 tt -49.92 -34.19 19.71 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.199 -0.938 . . . . 0.0 110.431 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.852 ' O ' HG23 ' A' ' 110' ' ' THR . 54.9 ttp180 -74.25 -36.76 63.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.153 -0.967 . . . . 0.0 110.001 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -74.49 -15.4 60.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.852 . . . . 0.0 110.075 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.95 HG11 ' CE1' ' A' ' 92' ' ' PHE . 77.1 t -85.91 -47.93 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.247 -0.908 . . . . 0.0 110.132 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.467 ' HG3' HD13 ' A' ' 116' ' ' LEU . 25.5 mmt -61.48 -32.72 72.74 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.965 . . . . 0.0 109.974 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.852 HG23 ' O ' ' A' ' 106' ' ' ARG . 66.7 p -59.93 -30.43 69.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.164 -0.96 . . . . 0.0 109.238 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -85.79 -31.08 22.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.555 -0.716 . . . . 0.0 109.974 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 77.5 mt -87.47 16.49 5.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 110.093 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 61.91 83.27 0.07 OUTLIER Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.49 ' HB3' HD12 ' A' ' 116' ' ' LEU . 1.3 mm-40 -158.31 133.42 8.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.187 -1.184 . . . . 0.0 110.464 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -95.38 104.19 16.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 110.028 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.49 HD12 ' HB3' ' A' ' 114' ' ' GLU . 1.7 mt -136.06 117.43 14.66 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.278 -0.888 . . . . 0.0 110.504 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.507 HG22 ' N ' ' A' ' 118' ' ' ASP . 38.2 m -71.44 172.81 8.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.314 -0.866 . . . . 0.0 109.91 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.507 ' N ' HG22 ' A' ' 117' ' ' THR . 4.6 m-20 -62.13 -31.8 72.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 110.222 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -69.59 -48.71 59.25 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.247 -0.908 . . . . 0.0 110.205 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.408 ' HB3' HD23 ' A' ' 116' ' ' LEU . 42.8 mt-10 -57.37 -50.81 71.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.127 -0.983 . . . . 0.0 109.935 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.402 HG13 ' HB3' ' A' ' 105' ' ' LEU . 89.3 t -55.35 -49.56 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.401 -0.812 . . . . 0.0 110.177 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.435 ' OD1' ' HD2' ' A' ' 126' ' ' ARG . 8.5 t70 -57.42 -31.87 66.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 110.066 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -70.05 -32.0 69.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.201 -0.937 . . . . 0.0 109.911 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.4 ' HE2' HD21 ' A' ' 105' ' ' LEU . 84.8 mtp -67.9 -44.71 76.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.31 -0.869 . . . . 0.0 109.646 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.464 HD11 HD12 ' A' ' 105' ' ' LEU . 30.1 mm -62.51 -37.57 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.412 -0.805 . . . . 0.0 110.345 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.435 ' HD2' ' OD1' ' A' ' 122' ' ' ASP . 65.8 mtp180 -70.4 -37.05 74.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.24 -0.913 . . . . 0.0 110.252 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -71.39 -27.26 63.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.185 -0.947 . . . . 0.0 109.895 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.518 ' HB2' ' H6 ' ' A' ' 154' ' ' WW7 . . . -83.66 -27.29 29.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.38 -0.825 . . . . 0.0 109.992 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.403 ' OD1' ' OD1' ' A' ' 131' ' ' ASP . 11.9 t0 -65.15 94.73 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.0 110.008 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 140' ' ' GLU . 68.7 mt -67.8 -31.42 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.225 -0.922 . . . . 0.0 110.231 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 19.5 p30 -100.84 -17.41 16.89 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.263 -0.898 . . . . 0.0 110.355 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 69.84 62.56 3.75 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.411 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 82.2 m-20 -101.56 -41.29 6.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.091 -1.241 . . . . 0.0 110.109 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.26 -22.06 1.09 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.57 162.75 34.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -1.148 . . . . 0.0 110.032 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.529 HG21 'CL1 ' ' A' ' 154' ' ' WW7 . 41.0 t -88.92 143.99 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.211 -0.93 . . . . 0.0 110.504 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -112.26 151.67 29.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 109.806 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.419 ' O ' HG23 ' A' ' 142' ' ' VAL . 55.4 t80 -46.18 -37.15 6.68 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.194 -0.941 . . . . 0.0 110.459 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -72.15 -45.25 61.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.232 -0.917 . . . . 0.0 110.495 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' A' ' 144' ' ' MET . 55.7 mt-10 -62.24 -23.31 66.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.127 -0.983 . . . . 0.0 110.438 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.56 ' CD1' ' CE ' ' A' ' 144' ' ' MET . 23.2 t80 -81.21 -39.78 24.87 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.321 -0.862 . . . . 0.0 110.544 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 138' ' ' TYR . 65.6 t -73.98 -21.83 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.239 -0.913 . . . . 0.0 110.564 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.863 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 68.9 mm-40 -88.27 -40.17 13.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.167 -0.958 . . . . 0.0 111.051 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.56 ' CE ' ' CD1' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -72.24 -20.47 61.54 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.865 -1.147 . . . . 0.0 110.943 -179.229 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.485 ' N ' ' HG3' ' A' ' 144' ' ' MET . 19.7 ttm -90.43 -68.07 0.81 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.098 -1.001 . . . . 0.0 110.547 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 68.7 p -58.9 -53.71 55.29 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.099 -1.0 . . . . 0.0 110.283 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.863 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -69.86 140.74 53.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.916 . . . . 0.0 110.372 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 91.9 mttt . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.196 179.928 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . 0.445 'CA ' ' HB2' ' A' ' 24' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . 0.618 'CA ' ' OD2' ' A' ' 95' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 153' ' ' WW7 . . . . . 0.897 ' C6 ' HG21 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' WW7 . . . . . 0.589 ' H3 ' ' CD2' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.289 0.566 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -138.57 69.81 1.38 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.881 . . . . 0.0 110.075 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -63.0 -75.1 0.08 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.309 -0.869 . . . . 0.0 110.399 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.6 mp -67.31 167.98 11.41 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.14 -0.975 . . . . 0.0 110.074 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.599 HG23 ' H ' ' A' ' 6' ' ' GLU . 1.4 t -167.43 -55.64 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.139 -0.976 . . . . 0.0 110.685 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.599 ' H ' HG23 ' A' ' 5' ' ' THR . 30.7 tt0 -90.97 -18.38 24.76 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.864 -1.147 . . . . 0.0 110.174 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -74.52 -40.49 61.73 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.451 -0.78 . . . . 0.0 110.701 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.417 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 54.0 mt-30 -67.66 -51.59 47.98 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.144 -0.972 . . . . 0.0 110.329 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.0 mt -57.72 -48.99 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.075 -1.016 . . . . 0.0 109.522 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.3 -32.11 68.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 109.74 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 37.0 tt0 -59.81 -51.19 70.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.914 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -58.66 -34.11 70.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.291 -0.881 . . . . 0.0 109.662 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.6 -46.73 86.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.377 -0.827 . . . . 0.0 110.466 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -59.49 -45.69 90.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.226 -0.921 . . . . 0.0 110.451 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.415 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -60.15 -41.55 92.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.957 . . . . 0.0 110.1 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -58.52 -56.21 25.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.276 -0.89 . . . . 0.0 110.141 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.2 m -53.36 -29.17 32.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.149 -0.969 . . . . 0.0 109.668 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.7 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.8 tt -66.43 -41.2 89.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.39 -0.819 . . . . 0.0 109.782 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.616 ' CD1' HG11 ' A' ' 35' ' ' VAL . 27.7 m-85 -77.61 -64.81 1.06 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.319 -0.863 . . . . 0.0 110.338 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.408 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 55.7 t0 -49.23 106.04 0.1 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.285 -0.884 . . . . 0.0 110.383 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -110.35 15.19 22.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.187 -0.946 . . . . 0.0 111.014 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.407 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 9.3 p-10 -126.19 -42.81 1.83 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.012 -1.055 . . . . 0.0 110.423 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.69 19.69 6.01 Favored Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.513 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.407 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 57.1 p-10 -91.39 -8.1 48.89 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.965 -1.314 . . . . 0.0 110.537 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.655 ' O ' HG23 ' A' ' 26' ' ' THR . . . 70.85 42.37 60.92 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.655 HG23 ' O ' ' A' ' 25' ' ' GLY . 9.3 p -158.34 148.8 20.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.242 -1.152 . . . . 0.0 109.943 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.6 mt -108.81 105.36 18.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.182 -0.949 . . . . 0.0 109.937 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.922 ' HA ' HG22 ' A' ' 62' ' ' THR . 3.5 m -96.65 -175.74 3.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.413 -0.804 . . . . 0.0 109.747 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.646 ' H ' HG22 ' A' ' 28' ' ' THR . 23.5 p -72.1 -29.32 63.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.0 110.539 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -65.4 -62.06 1.75 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 0.0 110.366 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.72 ' O ' HG23 ' A' ' 35' ' ' VAL . 49.5 mt-10 -57.12 -44.92 83.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.272 -0.893 . . . . 0.0 110.05 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.597 HD22 HD11 ' A' ' 52' ' ' ILE . 2.9 tp -63.85 -25.18 68.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -0.904 . . . . 0.0 109.665 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.14 -46.73 69.41 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.44 ' O ' ' CB ' ' A' ' 38' ' ' SER . 87.1 m -72.69 -21.77 61.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.311 -1.111 . . . . 0.0 109.498 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 31' ' ' GLU . 58.0 t -71.14 -42.45 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.431 -0.793 . . . . 0.0 109.811 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 26.0 mmt -75.46 -30.03 59.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 110.457 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -88.47 -9.38 52.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.156 -0.965 . . . . 0.0 110.301 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 34' ' ' THR . 47.7 t -101.09 8.84 42.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.09 -1.006 . . . . 0.0 110.542 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.534 HD13 H142 ' A' ' 153' ' ' WW7 . 90.9 mt -127.68 -81.37 0.6 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.139 -0.976 . . . . 0.0 110.207 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.48 36.73 0.59 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.46 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.2 mp0 -140.09 171.92 13.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.504 -0.998 . . . . 0.0 109.851 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.503 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -155.87 52.55 0.68 Allowed Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.023 -1.048 . . . . 0.0 111.048 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.478 ' HD3' ' N ' ' A' ' 42' ' ' ASN . 50.0 Cg_endo -77.68 160.81 31.19 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.671 1.353 . . . . 0.0 110.229 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.0 p -92.45 -142.22 0.2 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.276 -0.89 . . . . 0.0 109.883 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -105.59 -32.22 8.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.937 -1.102 . . . . 0.0 110.053 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.96 -67.7 0.54 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -0.938 . . . . 0.0 109.655 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -49.83 -38.7 36.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 109.441 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.497 HD11 HD23 ' A' ' 32' ' ' LEU . 6.4 tt -57.07 -48.88 77.48 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.45 -0.781 . . . . 0.0 109.342 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -51.51 -42.07 61.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.434 -0.791 . . . . 0.0 109.551 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.39 -42.78 99.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.871 . . . . 0.0 109.816 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.441 ' HA ' ' OE2' ' A' ' 54' ' ' GLU . 18.5 ttp -62.3 -19.8 63.66 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.283 -0.885 . . . . 0.0 109.353 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.597 HD11 HD22 ' A' ' 32' ' ' LEU . 25.4 mt -89.18 -24.52 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.426 -0.796 . . . . 0.0 109.887 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -67.97 -35.3 78.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.302 -0.874 . . . . 0.0 110.154 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.444 ' HG3' HG23 ' A' ' 55' ' ' VAL . 17.2 pt-20 -73.73 -33.75 64.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.224 -0.922 . . . . 0.0 110.04 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.787 HG21 ' C6 ' ' A' ' 153' ' ' WW7 . 99.9 t -77.1 -68.78 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.285 -0.885 . . . . 0.0 109.806 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.411 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 64.1 t0 -47.0 125.72 7.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.276 -0.89 . . . . 0.0 110.051 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.67 28.78 5.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.217 -0.927 . . . . 0.0 110.206 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.443 ' HB2' ' OD1' ' A' ' 60' ' ' ASN . 40.5 m-20 -122.76 -62.08 1.39 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.405 -0.809 . . . . 0.0 110.05 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.82 36.16 0.6 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.443 ' OD1' ' HB2' ' A' ' 58' ' ' ASP . 6.8 m120 -103.85 -40.67 6.15 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.176 -1.19 . . . . 0.0 110.107 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.413 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 123.87 -14.79 7.97 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.922 HG22 ' HA ' ' A' ' 28' ' ' THR . 75.2 p -130.97 164.47 25.28 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.147 -1.208 . . . . 0.0 110.446 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 80.1 mt -110.21 122.15 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.246 -0.909 . . . . 0.0 110.237 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.447 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 55.0 m-20 -81.38 -168.32 1.81 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.307 -0.871 . . . . 0.0 110.399 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.547 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 42.4 t80 -72.99 -42.46 7.31 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 111.246 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.8 Cg_endo -75.76 -28.19 8.18 Favored 'Trans proline' 0 C--N 1.325 -0.703 0 O-C-N 123.035 1.018 . . . . 0.0 109.821 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.413 ' OE1' ' OD2' ' A' ' 58' ' ' ASP . 40.7 tt0 -73.52 -24.03 60.1 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.446 ' O ' ' HG2' ' A' ' 71' ' ' MET . 10.3 t80 -84.73 -43.01 14.68 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.429 0.633 . . . . 0.0 110.145 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.627 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 3.7 tt -72.3 -18.28 61.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.193 -0.942 . . . . 0.0 110.128 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.411 ' O ' ' HG2' ' A' ' 74' ' ' ARG . 98.5 m -90.3 -43.04 10.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.125 -0.984 . . . . 0.0 110.493 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.488 ' HG3' ' N ' ' A' ' 72' ' ' MET . 6.5 ptt? -64.09 -40.99 97.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.145 -0.972 . . . . 0.0 110.518 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.488 ' N ' ' HG3' ' A' ' 71' ' ' MET . 32.7 mtt -84.32 -9.66 58.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.099 -1.001 . . . . 0.0 110.683 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.627 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . -90.6 -25.02 20.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.024 -1.047 . . . . 0.0 110.618 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -102.43 52.16 0.8 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.215 -0.928 . . . . 0.0 110.732 -179.486 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -94.73 -3.7 48.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.068 -1.02 . . . . 0.0 110.635 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 22.9 mmt -146.54 -49.51 0.2 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.065 -1.022 . . . . 0.0 110.434 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -109.42 -171.18 1.79 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.106 -0.996 . . . . 0.0 110.342 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -140.52 20.25 2.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 110.029 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.402 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 97.8 m -60.64 91.81 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.244 -0.91 . . . . 0.0 110.402 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 79' ' ' THR . 22.4 m-20 -152.73 125.62 8.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.118 -0.989 . . . . 0.0 110.62 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.1 m -89.57 -153.28 0.27 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.247 -0.908 . . . . 0.0 109.915 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 33.0 mt-10 -150.64 146.49 26.53 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.218 -0.926 . . . . 0.0 110.652 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 82' ' ' GLU . 11.5 mt-10 -154.61 87.37 1.16 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.558 -0.714 . . . . 0.0 109.863 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.8 -25.12 68.04 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.326 -0.859 . . . . 0.0 110.409 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.7 mt -68.0 -59.39 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.252 -0.905 . . . . 0.0 110.388 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.4 ttm-85 -53.02 -43.5 66.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.059 -1.025 . . . . 0.0 109.448 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -54.61 -43.83 72.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.361 -0.837 . . . . 0.0 109.629 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 92' ' ' PHE . . . -58.47 -37.73 76.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.35 -0.843 . . . . 0.0 109.667 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -65.03 -28.93 69.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.063 -1.023 . . . . 0.0 109.897 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -70.45 -58.95 3.16 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.494 -0.754 . . . . 0.0 111.118 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.557 HG23 ' N ' ' A' ' 92' ' ' PHE . 30.1 m -62.94 -43.33 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.14 -0.975 . . . . 0.0 110.981 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.695 ' HA ' HG21 ' A' ' 108' ' ' VAL . 18.0 m-85 -69.72 -22.42 63.4 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.973 -1.08 . . . . 0.0 110.263 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -147.28 81.96 1.54 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.963 . . . . 0.0 110.483 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.6 pttt -109.68 47.43 0.94 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.355 -0.841 . . . . 0.0 109.907 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 1.8 p30 -115.31 -31.69 5.88 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.273 -0.892 . . . . 0.0 110.618 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.46 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 138.33 -54.09 0.7 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.279 -1.438 . . . . 0.0 110.959 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -48.77 -34.46 12.29 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 120.947 -1.325 . . . . 0.0 110.846 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.469 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 80.28 33.01 33.27 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.963 -1.113 . . . . 0.0 110.406 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.483 ' HB3' ' CB ' ' A' ' 135' ' ' GLN . 20.7 m-85 -130.2 127.58 39.95 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.951 -1.323 . . . . 0.0 109.884 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.647 HD13 ' CE1' ' A' ' 141' ' ' PHE . 8.8 mt -76.01 110.39 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.962 -1.086 . . . . 0.0 110.167 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.1 t -93.6 165.59 12.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.065 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.51 -41.39 96.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.291 -0.88 . . . . 0.0 110.341 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.4 -53.36 49.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.186 -0.946 . . . . 0.0 110.037 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.427 ' O ' HG23 ' A' ' 108' ' ' VAL . 51.0 mt-10 -51.75 -37.73 52.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.426 -0.796 . . . . 0.0 110.103 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.0 tt -69.36 -35.2 75.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.4 -0.813 . . . . 0.0 110.121 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.785 ' O ' HG23 ' A' ' 110' ' ' THR . 58.0 ttp180 -66.36 -26.69 67.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.483 -0.76 . . . . 0.0 110.254 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -85.01 -31.54 23.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.281 -0.887 . . . . 0.0 110.514 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.695 HG21 ' HA ' ' A' ' 92' ' ' PHE . 98.2 t -76.37 -30.94 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.166 -0.959 . . . . 0.0 110.452 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.4 mmt -75.99 -26.57 56.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.104 -0.998 . . . . 0.0 110.18 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.785 HG23 ' O ' ' A' ' 106' ' ' ARG . 45.4 p -68.67 -40.61 80.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.27 -0.894 . . . . 0.0 110.146 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -80.01 -41.54 25.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.195 -0.94 . . . . 0.0 110.045 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.444 ' HA ' HD23 ' A' ' 112' ' ' LEU . 9.2 mt -47.63 -25.47 1.18 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.255 -0.903 . . . . 0.0 110.204 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.44 20.8 8.34 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -123.19 110.0 14.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.23 -1.159 . . . . 0.0 110.3 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.95 107.25 9.16 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.341 -0.85 . . . . 0.0 110.285 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.9 -174.85 2.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.184 -0.947 . . . . 0.0 110.19 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 118' ' ' ASP . 30.5 m -136.8 166.65 23.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 110.209 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.425 ' N ' HG22 ' A' ' 117' ' ' THR . 22.5 m-20 -55.07 -33.22 62.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -0.94 . . . . 0.0 110.359 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.18 -47.24 80.57 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.328 -0.857 . . . . 0.0 110.784 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -65.4 -58.39 5.98 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.118 -0.989 . . . . 0.0 110.613 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.2 t -49.64 -41.24 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.145 -0.972 . . . . 0.0 110.395 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -64.39 -39.08 93.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.167 -0.958 . . . . 0.0 110.163 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -66.91 -30.06 70.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.223 -0.923 . . . . 0.0 110.152 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 78.7 mtp -75.83 -62.99 1.41 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.178 -0.951 . . . . 0.0 110.66 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.504 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 26.0 mm -52.05 -29.23 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.156 -0.965 . . . . 0.0 110.67 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.1 mtp85 -71.75 -56.87 4.98 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.051 -1.031 . . . . 0.0 110.349 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -69.45 -8.28 45.4 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.197 -0.939 . . . . 0.0 110.361 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.427 ' HB2' ' H6 ' ' A' ' 154' ' ' WW7 . . . -98.83 -24.66 14.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -0.919 . . . . 0.0 110.104 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -83.51 83.65 7.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.075 -1.016 . . . . 0.0 109.915 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.519 HD12 ' HG2' ' A' ' 140' ' ' GLU . 18.5 mt -45.41 -69.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.33 -0.856 . . . . 0.0 110.688 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.8 p30 -60.91 -24.41 65.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.221 -0.924 . . . . 0.0 110.366 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.421 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 62.51 62.64 5.37 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -106.61 -31.51 8.45 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.24 -1.153 . . . . 0.0 110.205 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 161.96 -49.11 0.34 Allowed Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.13 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.483 ' CB ' ' HB3' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -123.42 170.43 10.36 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.033 -1.274 . . . . 0.0 110.107 -179.363 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.4 t -105.97 97.8 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.379 -0.826 . . . . 0.0 110.002 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.409 ' OD1' ' HB3' ' A' ' 139' ' ' GLU . 9.8 p30 -70.19 179.43 2.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.332 -0.855 . . . . 0.0 110.355 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.441 ' O ' HG23 ' A' ' 142' ' ' VAL . 18.9 t80 -61.65 -41.43 97.5 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.311 -0.868 . . . . 0.0 111.268 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.409 ' HB3' ' OD1' ' A' ' 137' ' ' ASN . 25.2 tt0 -53.15 -52.17 59.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.028 -1.045 . . . . 0.0 110.199 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.519 ' HG2' HD12 ' A' ' 130' ' ' ILE . 55.0 mt-10 -67.4 -21.25 65.6 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.275 -0.891 . . . . 0.0 109.879 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.647 ' CE1' HD13 ' A' ' 100' ' ' ILE . 1.9 t80 -77.54 -23.33 50.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.359 -0.838 . . . . 0.0 110.414 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 138' ' ' TYR . 80.4 t -88.43 -23.05 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.197 -0.939 . . . . 0.0 110.511 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -91.65 -39.02 12.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.296 -0.877 . . . . 0.0 110.799 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.496 ' HE3' ' HG3' ' A' ' 145' ' ' MET . 0.0 OUTLIER -67.44 -17.75 64.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.981 -1.074 . . . . 0.0 110.358 -179.651 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.496 ' HG3' ' HE3' ' A' ' 144' ' ' MET . 52.2 mtt -88.13 -55.06 3.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.118 -0.989 . . . . 0.0 109.887 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 146' ' ' THR . 2.7 t -116.55 117.09 28.91 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.508 -0.745 . . . . 0.0 110.069 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -117.13 114.8 24.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.163 -0.961 . . . . 0.0 110.441 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.217 179.947 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 153' ' ' WW7 . . . . . 0.787 ' C6 ' HG21 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' WW7 . . . . . 0.584 ' H3 ' ' CD2' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.288 0.566 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -83.62 131.55 34.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.163 -0.961 . . . . 0.0 110.209 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -97.46 133.22 42.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.22 -0.925 . . . . 0.0 110.234 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.42 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.5 OUTLIER -156.93 143.73 18.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 110.464 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.3 p -125.65 9.36 7.69 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.194 -0.941 . . . . 0.0 110.191 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -73.25 -34.84 66.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.08 -1.012 . . . . 0.0 109.522 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -77.22 -33.03 56.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.402 -0.812 . . . . 0.0 109.457 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -67.57 -59.13 3.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.448 -0.782 . . . . 0.0 110.285 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.4 mt -59.71 -34.72 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 109.587 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.28 -32.38 73.96 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.267 -0.896 . . . . 0.0 108.988 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -66.91 -51.75 51.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.459 -0.775 . . . . 0.0 109.426 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -59.46 -29.99 68.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.618 -0.676 . . . . 0.0 109.751 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -66.26 -55.99 13.44 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.4 -0.812 . . . . 0.0 110.191 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -51.01 -38.25 50.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.16 -0.962 . . . . 0.0 109.969 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.514 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -62.13 -54.31 42.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.026 -1.046 . . . . 0.0 109.886 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.453 ' CE1' HD11 ' A' ' 27' ' ' ILE . 18.5 t80 -56.7 -26.9 57.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.294 -0.879 . . . . 0.0 110.687 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.0 p -75.98 -35.06 59.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.179 -0.95 . . . . 0.0 109.888 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.642 ' O ' HD23 ' A' ' 18' ' ' LEU . 3.1 tt -69.51 -26.8 64.71 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.313 -0.867 . . . . 0.0 109.644 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.645 ' CD1' HG11 ' A' ' 35' ' ' VAL . 30.4 m-85 -86.08 -69.19 0.68 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.375 -0.828 . . . . 0.0 109.938 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -56.18 105.07 0.17 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.312 -0.868 . . . . 0.0 110.283 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -105.75 -38.06 6.51 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.312 -0.867 . . . . 0.0 110.665 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -70.27 -26.11 63.67 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.141 -0.975 . . . . 0.0 110.505 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.89 106.44 0.83 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 7.7 p-10 -169.64 -39.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -1.177 . . . . 0.0 110.263 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.72 12.57 12.59 Favored Glycine 0 N--CA 1.495 2.632 0 C-N-CA 119.93 -1.129 . . . . 0.0 110.37 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 54.8 p -139.96 164.97 28.59 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.044 -1.269 . . . . 0.0 110.267 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.468 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 40.8 mt -123.47 120.56 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.135 -0.978 . . . . 0.0 110.191 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.613 HG22 ' H ' ' A' ' 29' ' ' THR . 5.2 m -113.75 -179.08 3.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.35 -0.844 . . . . 0.0 110.292 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.613 ' H ' HG22 ' A' ' 28' ' ' THR . 56.1 p -68.84 -27.49 65.88 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.267 -0.896 . . . . 0.0 110.754 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.3 mtmm -66.31 -61.34 2.06 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.059 -1.026 . . . . 0.0 109.929 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -60.91 -58.83 6.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.056 -1.028 . . . . 0.0 109.541 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.991 HD23 HD11 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -52.1 -26.73 11.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 109.708 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.44 -52.42 46.69 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 97.2 m -65.77 -23.99 66.84 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.203 -1.174 . . . . 0.0 109.879 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.645 HG11 ' CD1' ' A' ' 19' ' ' PHE . 46.5 t -66.34 -42.83 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.442 -0.786 . . . . 0.0 109.904 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.466 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 61.5 mtt -89.17 -11.63 43.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.376 -0.828 . . . . 0.0 110.379 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -89.85 -21.24 22.65 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.163 -0.961 . . . . 0.0 110.186 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.9 m -109.52 -22.51 11.95 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.197 -0.939 . . . . 0.0 110.432 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.46 66.1 1.08 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.147 -0.971 . . . . 0.0 110.637 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.02 51.64 0.16 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -48.08 102.26 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.236 -1.155 . . . . 0.0 110.304 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.523 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 2.4 t30 -156.67 -65.93 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.885 . . . . 0.0 110.234 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.523 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 46.3 Cg_endo -72.23 170.42 19.16 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.316 1.166 . . . . 0.0 110.311 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.5 HG23 ' N ' ' A' ' 45' ' ' GLU . 10.8 t -119.39 -149.09 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.623 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.5 ' N ' HG23 ' A' ' 44' ' ' THR . 22.0 tt0 -95.81 -31.84 12.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.831 -1.168 . . . . 0.0 110.115 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.481 ' H ' HG23 ' A' ' 44' ' ' THR . . . -74.64 -67.65 0.61 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.23 -0.919 . . . . 0.0 110.089 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -49.0 -31.55 7.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.135 -0.978 . . . . 0.0 109.744 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.991 HD11 HD23 ' A' ' 32' ' ' LEU . 9.1 tt -63.96 -51.7 63.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.92 . . . . 0.0 109.209 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.7 tm0? -49.5 -41.47 40.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.459 -0.776 . . . . 0.0 109.605 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -64.71 -39.46 93.69 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.36 -0.837 . . . . 0.0 109.709 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.452 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 25.4 ttp -70.27 -13.18 62.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.158 -0.963 . . . . 0.0 109.85 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.978 HD11 HD22 ' A' ' 32' ' ' LEU . 29.7 mm -84.75 -35.31 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.218 -0.926 . . . . 0.0 109.537 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -60.7 -39.88 90.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.463 -0.773 . . . . 0.0 110.504 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.473 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 12.3 pt-20 -69.39 -35.95 76.3 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.128 -0.983 . . . . 0.0 110.596 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.858 HG21 ' C6 ' ' A' ' 153' ' ' WW7 . 79.6 t -71.39 -28.39 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.064 -1.023 . . . . 0.0 110.062 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -96.8 117.3 30.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.37 -0.832 . . . . 0.0 110.448 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.06 25.95 10.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -0.843 . . . . 0.0 109.773 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -106.61 -68.13 0.9 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.485 -0.759 . . . . 0.0 110.167 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.38 -14.27 2.06 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.421 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 27.7 p-10 -69.78 -14.11 62.61 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.15 -1.206 . . . . 0.0 110.287 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.642 ' O ' HG23 ' A' ' 62' ' ' THR . . . 79.24 23.86 62.42 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.011 -1.09 . . . . 0.0 110.545 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.642 HG23 ' O ' ' A' ' 61' ' ' GLY . 7.1 p -156.44 167.65 29.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.996 -1.296 . . . . 0.0 110.414 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.641 HD11 HG11 ' A' ' 55' ' ' VAL . 82.9 mt -108.31 169.74 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.182 -0.949 . . . . 0.0 110.596 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.546 ' N ' HG22 ' A' ' 63' ' ' ILE . 46.7 m-20 -131.44 -163.02 1.28 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.31 -0.869 . . . . 0.0 109.848 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.562 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 40.1 t80 -82.51 -43.26 0.95 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.068 -1.02 . . . . 0.0 111.357 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 47.2 Cg_endo -73.15 -28.53 12.62 Favored 'Trans proline' 0 N--CA 1.48 0.68 0 O-C-N 123.091 1.048 . . . . 0.0 110.304 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -78.34 -23.73 46.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.105 -0.997 . . . . 0.0 109.225 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.456 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 24.3 t80 -75.91 -48.64 20.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.624 -0.672 . . . . 0.0 110.201 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.589 ' O ' HD23 ' A' ' 69' ' ' LEU . 2.8 tt -75.71 -21.49 57.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.353 -0.842 . . . . 0.0 110.349 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.7 m -89.57 -21.86 22.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -0.964 . . . . 0.0 110.713 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.471 ' HG3' ' N ' ' A' ' 72' ' ' MET . 8.1 ptt? -88.86 -36.08 16.2 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.964 -1.085 . . . . 0.0 110.515 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.471 ' N ' ' HG3' ' A' ' 71' ' ' MET . 52.5 mtt -84.72 -23.55 29.26 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.188 -0.945 . . . . 0.0 110.0 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.83 -52.0 6.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.368 -0.832 . . . . 0.0 110.04 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.8 mpp_? -110.24 63.79 0.61 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.417 -0.802 . . . . 0.0 110.039 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -89.51 91.14 8.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.422 -0.799 . . . . 0.0 110.425 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.3 ttt -84.86 140.69 30.98 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.173 -0.954 . . . . 0.0 110.116 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.8 mtmt -86.52 107.21 18.0 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.184 -0.948 . . . . 0.0 110.44 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -153.26 128.38 9.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 0.0 110.21 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.1 m -126.96 148.12 50.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.218 -0.926 . . . . 0.0 110.2 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -167.31 99.01 0.51 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.286 -0.884 . . . . 0.0 110.02 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.5 t -138.26 178.15 7.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.131 -0.981 . . . . 0.0 110.394 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -151.11 99.3 2.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.259 -0.901 . . . . 0.0 110.206 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.401 ' OE2' ' OH ' ' A' ' 138' ' ' TYR . 23.4 tt0 -171.5 97.68 0.19 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.151 -0.968 . . . . 0.0 110.157 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.554 ' HB2' HN21 ' A' ' 154' ' ' WW7 . 33.1 mt-10 -60.28 -30.92 69.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.446 -0.784 . . . . 0.0 110.361 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 40.7 mt -51.71 -34.93 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.112 -0.993 . . . . 0.0 109.733 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -58.08 -43.89 87.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.944 . . . . 0.0 109.398 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -62.23 -33.59 74.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.424 -0.798 . . . . 0.0 109.784 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.783 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -65.92 -66.48 0.54 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.416 -0.802 . . . . 0.0 109.889 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -49.62 -26.62 3.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.927 . . . . 0.0 110.308 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.412 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 16.0 tpt180 -68.78 -45.23 71.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.148 -0.97 . . . . 0.0 110.255 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.783 HG22 ' O ' ' A' ' 88' ' ' ALA . 34.0 m -76.27 -15.79 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.283 -0.885 . . . . 0.0 110.443 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.757 ' HE2' ' HB1' ' A' ' 88' ' ' ALA . 23.0 m-85 -90.85 -18.38 24.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.132 -0.98 . . . . 0.0 110.491 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -128.82 44.32 2.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.099 -1.001 . . . . 0.0 110.077 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 20.4 ptmt -106.46 47.62 0.87 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 110.403 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.414 ' OD2' ' OE1' ' A' ' 104' ' ' GLU . 2.8 p30 -116.88 -22.57 8.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.237 -0.915 . . . . 0.0 110.043 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.23 29.33 4.03 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -105.78 -71.09 0.76 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.405 -1.056 . . . . 0.0 110.091 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 151.9 -36.48 0.84 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -134.12 169.59 16.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -1.16 . . . . 0.0 110.133 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.5 mt -73.1 131.29 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 109.858 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.425 ' HB3' ' OE2' ' A' ' 104' ' ' GLU . 36.5 t -113.83 172.26 7.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.47 -0.769 . . . . 0.0 110.023 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.455 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -68.65 -48.06 64.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -0.947 . . . . 0.0 110.144 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.89 -52.35 66.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.185 -0.947 . . . . 0.0 110.247 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.721 ' O ' HG23 ' A' ' 108' ' ' VAL . 46.2 mt-10 -48.97 -54.76 14.22 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.376 -0.827 . . . . 0.0 110.577 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 105' ' ' LEU . 5.2 tt -61.25 -30.33 70.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.379 -0.826 . . . . 0.0 110.763 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.528 ' HG3' HG21 ' A' ' 121' ' ' VAL . 17.0 ttp180 -67.24 -38.89 85.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.187 -0.945 . . . . 0.0 110.583 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -84.04 -14.2 51.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 110.472 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 104' ' ' GLU . 71.8 t -84.29 -29.15 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.236 -0.915 . . . . 0.0 110.527 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.598 ' HB3' HD12 ' A' ' 116' ' ' LEU . 26.4 mmt -81.81 -46.65 13.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.946 . . . . 0.0 110.529 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.2 p -50.44 -32.97 19.34 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 110.268 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -86.16 -48.81 8.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.128 -0.982 . . . . 0.0 110.372 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 112' ' ' LEU . 22.6 mt -47.07 -32.46 4.11 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.138 -0.976 . . . . 0.0 110.509 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.48 38.4 0.92 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -119.06 167.4 11.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.341 -1.094 . . . . 0.0 110.069 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -121.41 94.49 4.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.889 . . . . 0.0 110.061 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.598 HD12 ' HB3' ' A' ' 109' ' ' MET . 5.5 mt -128.58 151.94 48.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.281 -0.887 . . . . 0.0 110.228 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.536 HG22 ' N ' ' A' ' 118' ' ' ASP . 91.4 m -99.77 172.39 7.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.868 . . . . 0.0 110.002 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.536 ' N ' HG22 ' A' ' 117' ' ' THR . 1.4 m-20 -56.45 -62.89 1.41 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.242 -0.911 . . . . 0.0 110.636 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -52.54 -41.4 63.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.143 -0.973 . . . . 0.0 110.315 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.435 ' O ' ' HB3' ' A' ' 123' ' ' GLU . 6.4 mm-40 -52.08 -50.63 61.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.118 -0.989 . . . . 0.0 110.017 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.528 HG21 ' HG3' ' A' ' 106' ' ' ARG . 63.8 t -57.54 -43.9 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.16 -0.962 . . . . 0.0 109.821 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -59.58 -28.53 67.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.297 -0.877 . . . . 0.0 109.729 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 24.4 tt0 -73.27 -37.44 66.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.352 -0.842 . . . . 0.0 109.863 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 74.9 mtp -66.4 -39.92 89.3 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.274 -0.891 . . . . 0.0 109.821 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 31.8 mm -69.22 -38.61 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -0.906 . . . . 0.0 110.188 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -62.77 -46.33 88.52 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.257 -0.902 . . . . 0.0 110.228 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -62.47 -38.84 91.41 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.292 -0.88 . . . . 0.0 110.162 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.14 -16.0 61.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -0.861 . . . . 0.0 110.21 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.411 ' OD1' ' OD1' ' A' ' 131' ' ' ASP . 57.7 t0 -87.78 60.95 6.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.365 -0.835 . . . . 0.0 110.129 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.469 HG13 ' N ' ' A' ' 131' ' ' ASP . 18.0 pt -56.02 -42.26 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.435 -0.791 . . . . 0.0 111.409 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.469 ' N ' HG13 ' A' ' 130' ' ' ILE . 47.8 p-10 -72.74 -18.99 61.46 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.037 -1.039 . . . . 0.0 111.125 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.34 72.19 0.88 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.512 ' CG ' ' NE2' ' A' ' 135' ' ' GLN . 33.7 p30 -126.15 -16.99 5.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.406 -1.055 . . . . 0.0 110.873 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.465 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 122.96 -49.89 0.87 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.512 ' NE2' ' CG ' ' A' ' 133' ' ' ASP . 0.5 OUTLIER -119.18 164.7 15.19 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.086 -1.243 . . . . 0.0 110.772 -179.611 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.5 t -102.63 127.0 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.303 -0.873 . . . . 0.0 110.053 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -97.22 -172.12 2.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.953 -1.092 . . . . 0.0 110.459 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.401 ' OH ' ' OE2' ' A' ' 83' ' ' GLU . 31.0 t80 -64.4 -62.47 1.58 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.334 -0.854 . . . . 0.0 111.621 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -43.87 -53.53 5.99 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.239 -0.913 . . . . 0.0 111.141 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -56.77 -39.37 73.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.898 -1.126 . . . . 0.0 110.399 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.525 ' CZ ' ' HE1' ' A' ' 145' ' ' MET . 20.2 t80 -66.82 -27.09 67.27 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.391 -0.818 . . . . 0.0 111.133 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 57.6 t -90.06 -20.67 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.024 -1.047 . . . . 0.0 110.77 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.57 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 0.2 OUTLIER -83.81 -30.04 26.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.212 -0.93 . . . . 0.0 110.824 -179.369 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.47 ' CE ' ' CD1' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -90.01 -13.19 36.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.112 -0.993 . . . . 0.0 110.608 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.525 ' HE1' ' CZ ' ' A' ' 141' ' ' PHE . 30.0 ttm -89.98 -27.99 19.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.913 . . . . 0.0 110.537 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 60.0 p -121.77 -50.82 2.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.134 -0.979 . . . . 0.0 110.194 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -75.06 126.88 31.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.958 . . . . 0.0 110.042 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 90.6 mttt . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.252 -179.806 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 153' ' ' WW7 . . . . . 0.858 ' C6 ' HG21 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' WW7 . . . . . 0.554 HN21 ' HB2' ' A' ' 84' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.268 0.556 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -67.2 109.08 2.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.168 -0.957 . . . . 0.0 110.215 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -148.42 151.77 35.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.286 -0.884 . . . . 0.0 110.167 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 68.1 mt -57.93 129.76 43.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -0.943 . . . . 0.0 110.311 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 97.7 m -161.87 -45.32 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 109.798 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.586 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 1.0 OUTLIER -88.21 -15.73 35.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.329 -0.857 . . . . 0.0 109.931 179.555 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -74.24 -66.07 0.77 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.28 -0.888 . . . . 0.0 109.814 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -54.77 -58.75 6.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.23 -0.919 . . . . 0.0 109.997 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 9' ' ' ILE . 28.6 mt -47.73 -49.14 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.124 -0.985 . . . . 0.0 110.062 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 6' ' ' GLU . . . -52.83 -41.6 64.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.275 -0.89 . . . . 0.0 110.2 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -61.0 -41.44 96.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.879 . . . . 0.0 110.132 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -64.06 -30.17 71.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.279 -0.888 . . . . 0.0 109.734 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.478 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 30.1 mtpt -68.99 -38.97 79.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.535 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.31 -45.19 95.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.313 -0.867 . . . . 0.0 109.341 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.85 -44.8 86.77 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.317 -0.865 . . . . 0.0 109.452 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -56.22 -42.15 76.8 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.315 -0.865 . . . . 0.0 109.633 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.4 t -59.1 -42.63 90.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.428 -0.795 . . . . 0.0 109.641 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.582 ' O ' HD23 ' A' ' 18' ' ' LEU . 5.8 tt -59.79 -29.36 68.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.464 -0.772 . . . . 0.0 109.456 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.672 ' HA ' HG21 ' A' ' 35' ' ' VAL . 5.8 m-30 -88.24 -18.29 28.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.464 -0.772 . . . . 0.0 110.043 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -104.17 64.06 0.76 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.397 -0.814 . . . . 0.0 109.35 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.497 ' HE3' ' CG2' ' A' ' 34' ' ' THR . 53.0 mttm -44.73 -52.96 7.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.586 -0.696 . . . . 0.0 111.267 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.417 ' OD2' ' OD2' ' A' ' 24' ' ' ASP . 6.7 p-10 -69.7 -43.22 72.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.906 -1.121 . . . . 0.0 110.017 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.83 51.52 1.64 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 3.5 p30 -105.66 -24.53 12.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.058 -1.26 . . . . 0.0 109.878 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.549 ' C ' HG23 ' A' ' 26' ' ' THR . . . 111.86 30.38 3.02 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.549 HG23 ' C ' ' A' ' 25' ' ' GLY . 57.8 p -153.73 158.26 40.72 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.024 -1.28 . . . . 0.0 110.53 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.0 mt -124.22 109.21 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.317 -0.864 . . . . 0.0 109.934 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.601 HG22 ' CG2' ' A' ' 62' ' ' THR . 68.9 p -95.66 -164.51 1.17 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.239 -0.913 . . . . 0.0 110.301 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.455 HG22 HD12 ' A' ' 52' ' ' ILE . 35.8 p -85.41 -26.13 26.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.246 -0.908 . . . . 0.0 110.206 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.87 -62.8 1.24 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.24 -0.912 . . . . 0.0 110.025 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.74 ' O ' HG23 ' A' ' 35' ' ' VAL . 56.9 mt-10 -57.66 -46.06 84.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.137 -0.977 . . . . 0.0 109.763 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.872 HD22 HD11 ' A' ' 52' ' ' ILE . 0.8 OUTLIER -60.25 -32.04 70.78 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.269 -0.894 . . . . 0.0 109.676 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.54 -50.83 63.31 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.497 ' CG2' ' HE3' ' A' ' 21' ' ' LYS . 63.5 m -70.01 -22.3 63.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.105 -1.232 . . . . 0.0 109.611 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 31' ' ' GLU . 51.4 t -70.21 -32.2 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.472 -0.768 . . . . 0.0 109.55 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.425 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 26.2 mmt -86.97 -22.72 25.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.375 -0.828 . . . . 0.0 109.622 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.4 mmm-85 -68.16 -45.25 74.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 0.0 109.875 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.1 m -94.73 8.73 41.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.308 -0.87 . . . . 0.0 110.296 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.723 HD23 H142 ' A' ' 153' ' ' WW7 . 0.3 OUTLIER -164.09 74.78 0.31 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.102 -0.999 . . . . 0.0 110.19 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.31 -91.49 0.14 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -161.84 -145.37 0.11 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -1.145 . . . . 0.0 110.011 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -121.4 72.06 26.81 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.007 . . . . 0.0 110.299 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -76.18 135.97 17.55 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.874 1.46 . . . . 0.0 110.179 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 72.8 p -73.4 -149.83 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.209 -0.932 . . . . 0.0 110.282 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -104.39 -42.41 5.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 109.894 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.42 -63.72 1.01 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.241 -0.912 . . . . 0.0 109.744 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 38.4 tt0 -51.61 -41.32 61.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.914 . . . . 0.0 109.689 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.456 HD11 HD23 ' A' ' 32' ' ' LEU . 7.9 tt -55.27 -53.13 60.02 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.809 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -51.41 -37.56 49.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.364 -0.835 . . . . 0.0 109.767 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 7.4 t0 -63.11 -40.64 98.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.334 -0.854 . . . . 0.0 109.724 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.432 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 21.8 ttp -66.67 -19.24 65.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.329 -0.857 . . . . 0.0 109.636 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.872 HD11 HD22 ' A' ' 32' ' ' LEU . 26.3 mt -87.77 -25.48 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.252 -0.905 . . . . 0.0 110.479 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -62.5 -38.47 90.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.05 -1.031 . . . . 0.0 110.388 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.547 ' HG3' HG23 ' A' ' 55' ' ' VAL . 14.3 pt-20 -65.5 -18.76 65.56 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.123 -0.985 . . . . 0.0 110.343 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.547 HG23 ' HG3' ' A' ' 54' ' ' GLU . 79.6 t -95.9 -69.7 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.247 -0.908 . . . . 0.0 110.065 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -45.1 123.33 3.85 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.385 -0.822 . . . . 0.0 110.531 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.33 36.74 2.95 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.894 . . . . 0.0 110.363 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.414 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 48.6 m-20 -123.68 -52.22 1.81 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.24 -0.912 . . . . 0.0 110.371 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.31 16.17 7.88 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.45 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 24.6 p30 -93.62 -20.97 19.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.257 -1.143 . . . . 0.0 110.023 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.45 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 109.91 -44.77 1.43 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.601 ' CG2' HG22 ' A' ' 28' ' ' THR . 71.0 p -98.81 164.9 12.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.095 -1.238 . . . . 0.0 110.568 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.1 mt -101.88 158.59 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.148 -0.97 . . . . 0.0 110.132 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.43 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 32.4 m-20 -113.4 -167.82 1.25 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.372 -0.83 . . . . 0.0 110.797 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.563 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 41.8 t80 -76.37 -42.97 3.33 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.422 -0.799 . . . . 0.0 111.342 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.2 Cg_endo -72.6 -25.99 16.98 Favored 'Trans proline' 0 C--O 1.208 -1.02 0 O-C-N 123.033 1.017 . . . . 0.0 110.32 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.414 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 49.5 mt-10 -78.54 -24.32 45.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.038 -1.039 . . . . 0.0 109.351 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.484 ' CZ ' ' SD ' ' A' ' 72' ' ' MET . 55.7 t80 -78.12 -51.73 9.82 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.55 -0.719 . . . . 0.0 110.466 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.754 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 3.4 tt -75.1 -20.04 59.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.243 -0.911 . . . . 0.0 110.727 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.437 ' HB ' ' O ' ' A' ' 66' ' ' PRO . 18.9 m -82.21 -50.83 8.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.079 -1.013 . . . . 0.0 110.503 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.01 -29.66 67.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.093 -1.004 . . . . 0.0 109.867 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.484 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 52.8 mtt -86.5 -12.91 47.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.218 -0.926 . . . . 0.0 110.188 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . -74.96 -25.84 59.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.233 -0.917 . . . . 0.0 110.636 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -99.99 33.74 2.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.179 -0.951 . . . . 0.0 110.5 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -53.75 123.49 12.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.185 -0.947 . . . . 0.0 109.55 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.5 ttt -139.38 127.27 22.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.137 -0.977 . . . . 0.0 110.771 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -126.51 164.05 22.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.331 -0.856 . . . . 0.0 109.523 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -145.62 152.81 40.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.052 -1.03 . . . . 0.0 110.592 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.7 m -153.78 152.43 30.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 0.0 110.079 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -100.4 163.54 12.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 110.485 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 77.1 p -154.32 -173.72 4.69 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.366 -0.834 . . . . 0.0 110.105 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -137.46 164.24 29.15 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.195 -0.941 . . . . 0.0 110.221 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.419 ' CD ' ' N ' ' A' ' 83' ' ' GLU . 1.2 pm0 -162.45 72.23 0.34 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.135 -0.978 . . . . 0.0 110.532 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -106.46 -70.49 0.79 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.199 -0.938 . . . . 0.0 110.301 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 32.7 mt -58.86 -33.71 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.071 -1.018 . . . . 0.0 109.711 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -54.79 -44.92 74.18 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.273 -0.892 . . . . 0.0 109.408 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.43 ' HB2' HN21 ' A' ' 154' ' ' WW7 . 5.9 mm-40 -64.78 -36.32 83.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.304 -0.873 . . . . 0.0 110.072 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.682 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -60.43 -61.95 2.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.33 -0.857 . . . . 0.0 110.293 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.469 ' CE1' ' HA ' ' A' ' 138' ' ' TYR . 1.1 t80 -55.13 -28.26 51.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.452 -0.78 . . . . 0.0 110.54 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.65 -47.75 65.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.151 -0.968 . . . . 0.0 110.844 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.734 HG23 ' CD1' ' A' ' 92' ' ' PHE . 27.2 m -69.59 -24.64 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.069 -1.019 . . . . 0.0 110.477 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.734 ' CD1' HG23 ' A' ' 91' ' ' VAL . 13.4 m-85 -86.18 -16.89 36.4 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.239 -0.913 . . . . 0.0 110.239 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -109.22 97.12 6.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.274 -0.891 . . . . 0.0 110.245 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -103.41 12.43 35.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.904 . . . . 0.0 110.545 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 1.9 p30 -116.64 -41.74 3.05 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.988 -1.07 . . . . 0.0 110.501 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.468 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 111.91 36.66 1.65 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.438 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 41.0 p30 -117.11 -9.54 11.03 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.941 -1.329 . . . . 0.0 110.844 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 70.82 35.89 65.98 Favored Glycine 0 N--CA 1.498 2.822 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 28.1 m-85 -140.25 136.77 33.67 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.205 -1.174 . . . . 0.0 109.66 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.424 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 12.8 mt -92.11 119.59 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.938 -1.101 . . . . 0.0 109.797 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 77.6 p -109.75 151.66 26.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.166 -0.959 . . . . 0.0 110.226 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.1 -29.41 60.58 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.197 -0.939 . . . . 0.0 110.413 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.72 -52.91 61.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.204 -0.935 . . . . 0.0 110.235 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.841 ' O ' HG23 ' A' ' 108' ' ' VAL . 98.7 mt-10 -66.51 -55.82 13.76 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.243 -0.911 . . . . 0.0 110.28 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.611 HD23 HG13 ' A' ' 121' ' ' VAL . 17.2 tp -53.41 -25.35 15.41 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.109 -0.994 . . . . 0.0 110.35 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 47.2 ttt85 -71.45 -49.83 37.67 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.262 -0.899 . . . . 0.0 110.313 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -79.63 -9.33 59.62 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.27 -0.894 . . . . 0.0 110.792 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 104' ' ' GLU . 91.0 t -83.97 -46.37 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.059 -1.026 . . . . 0.0 110.47 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.405 ' O ' ' HB2' ' A' ' 114' ' ' GLU . 25.8 mtt -82.0 -32.81 30.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.041 -1.037 . . . . 0.0 110.585 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 55.8 m -67.23 -31.04 71.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.215 -0.928 . . . . 0.0 110.347 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -87.64 -42.13 12.9 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.177 -0.952 . . . . 0.0 110.322 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.434 HD12 ' O ' ' A' ' 108' ' ' VAL . 29.7 mt -46.13 -27.15 0.9 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.273 -0.892 . . . . 0.0 110.206 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.37 37.52 0.56 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 109' ' ' MET . 45.6 mt-10 -127.91 127.75 43.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.125 -1.221 . . . . 0.0 110.225 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -83.23 92.78 7.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 110.19 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.5 mt -118.83 -176.3 3.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.217 -0.927 . . . . 0.0 110.149 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.3 t -144.52 -178.41 5.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.25 -0.906 . . . . 0.0 110.45 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -61.85 -31.1 71.33 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.342 -0.848 . . . . 0.0 110.997 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.42 ' N ' ' CD ' ' A' ' 119' ' ' GLU . 6.2 mp0 -67.11 -41.1 86.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.26 -0.9 . . . . 0.0 110.708 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -67.72 -56.39 9.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.208 -0.932 . . . . 0.0 110.575 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.611 HG13 HD23 ' A' ' 105' ' ' LEU . 78.0 t -52.99 -49.3 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 0.0 110.412 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -57.54 -41.14 80.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.222 -0.924 . . . . 0.0 110.57 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -65.89 -32.74 74.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.22 -0.925 . . . . 0.0 110.796 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -73.11 -38.59 66.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.25 -0.906 . . . . 0.0 110.573 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 31.5 mm -70.11 -27.61 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.113 -0.992 . . . . 0.0 109.99 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -72.93 -45.79 56.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.396 -0.815 . . . . 0.0 110.223 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -70.54 -28.76 65.18 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.078 -1.014 . . . . 0.0 110.103 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.62 -24.95 36.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.354 -0.841 . . . . 0.0 110.402 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -86.76 77.07 9.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.051 -1.031 . . . . 0.0 110.174 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.72 HD12 ' HG2' ' A' ' 140' ' ' GLU . 5.6 mt -45.91 -60.18 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.387 -0.82 . . . . 0.0 110.482 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.9 p30 -66.24 -26.97 67.61 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.074 -1.016 . . . . 0.0 110.398 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 65.48 66.18 2.56 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 2.6 p30 -107.54 -35.39 6.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.281 -1.129 . . . . 0.0 110.674 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 167.77 -37.77 0.22 Allowed Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.021 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.409 ' HG3' ' HB3' ' A' ' 99' ' ' TYR . 2.7 pm0 -140.38 166.83 23.63 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.113 -1.228 . . . . 0.0 110.265 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.424 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 12.1 t -88.46 146.34 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.295 -0.878 . . . . 0.0 110.044 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -109.46 169.9 8.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 109.917 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.485 ' O ' HG23 ' A' ' 142' ' ' VAL . 9.0 t80 -61.66 -47.87 83.42 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.183 -0.948 . . . . 0.0 110.545 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -59.91 -41.46 91.73 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.007 -1.058 . . . . 0.0 110.152 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.72 ' HG2' HD12 ' A' ' 130' ' ' ILE . 52.2 mt-10 -69.41 -24.72 63.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.92 . . . . 0.0 110.014 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.518 ' CZ ' ' CE ' ' A' ' 145' ' ' MET . 8.0 t80 -77.51 -25.23 50.13 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.378 -0.826 . . . . 0.0 109.977 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 138' ' ' TYR . 90.0 t -80.34 -23.4 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.278 -0.889 . . . . 0.0 110.04 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -89.13 -31.74 17.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -0.9 . . . . 0.0 110.296 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.434 ' CE ' ' CD2' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -82.65 -22.51 34.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.153 -0.967 . . . . 0.0 110.243 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.518 ' CE ' ' CZ ' ' A' ' 141' ' ' PHE . 46.0 tpp -71.54 -29.95 65.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.337 -0.852 . . . . 0.0 109.97 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.1 p -117.71 54.15 0.91 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.363 -0.835 . . . . 0.0 110.306 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -96.91 -179.48 4.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 110.278 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.156 -179.963 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 153' ' ' WW7 . . . . . 0.723 H142 HD23 ' A' ' 39' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' WW7 . . . . . 0.623 H131 ' HB2' ' A' ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.252 0.548 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 15.0 p-10 -143.66 -162.44 1.46 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.257 -0.902 . . . . 0.0 110.133 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -71.49 143.49 49.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.138 -0.976 . . . . 0.0 110.376 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -104.72 -168.24 1.45 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -0.889 . . . . 0.0 110.201 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.8 p -133.42 -162.63 1.26 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.244 -0.91 . . . . 0.0 109.834 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.87 -15.39 30.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.142 -0.974 . . . . 0.0 110.262 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 2.5 tp10 -46.81 -48.29 20.81 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.272 -0.892 . . . . 0.0 110.145 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -53.97 -47.23 71.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.454 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.887 HG23 HD11 ' A' ' 69' ' ' LEU . 44.3 mt -56.38 -33.74 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.336 -0.852 . . . . 0.0 109.468 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -62.83 -37.44 86.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.39 -0.819 . . . . 0.0 109.373 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -63.09 -51.04 68.17 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.303 -0.873 . . . . 0.0 109.421 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -60.1 -28.11 67.56 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.471 -0.768 . . . . 0.0 109.891 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 2.4 mtpm? -64.25 -52.65 57.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 109.49 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -53.12 -38.07 62.32 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.348 -0.845 . . . . 0.0 109.304 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.04 -43.63 98.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.445 -0.784 . . . . 0.0 109.693 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -54.29 -39.65 67.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 109.377 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.7 t -73.03 -29.99 63.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.427 -0.796 . . . . 0.0 109.505 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.842 ' O ' HD23 ' A' ' 18' ' ' LEU . 5.1 tt -59.43 -35.97 75.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.447 -0.783 . . . . 0.0 109.388 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.566 ' CE2' ' H3 ' ' A' ' 153' ' ' WW7 . 9.8 m-85 -82.19 -56.7 3.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.436 -0.79 . . . . 0.0 109.874 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.457 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 9.8 t70 -52.96 106.2 0.15 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.452 -0.78 . . . . 0.0 110.214 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -110.31 41.72 1.69 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.264 -0.898 . . . . 0.0 110.983 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 5.6 p-10 -150.12 -50.77 0.14 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.037 -1.039 . . . . 0.0 110.387 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.91 57.61 0.33 Allowed Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.744 -1.217 . . . . 0.0 110.333 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 56.5 p-10 -135.75 0.62 2.71 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.135 -1.215 . . . . 0.0 110.737 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.555 ' C ' HG23 ' A' ' 26' ' ' THR . . . 64.09 40.27 97.96 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.555 HG23 ' C ' ' A' ' 25' ' ' GLY . 81.0 p -154.83 139.52 17.05 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.232 -1.158 . . . . 0.0 109.857 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 86.4 mt -105.12 132.36 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.125 -0.985 . . . . 0.0 110.205 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.515 HG22 ' H ' ' A' ' 29' ' ' THR . 10.0 m -125.21 174.79 7.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.227 -0.921 . . . . 0.0 110.563 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.515 ' H ' HG22 ' A' ' 28' ' ' THR . 43.5 p -64.01 -21.12 66.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.439 -0.788 . . . . 0.0 109.954 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -70.84 -69.32 0.37 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.278 -0.888 . . . . 0.0 110.071 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.457 ' OE1' ' HA ' ' A' ' 20' ' ' ASP . 21.8 mt-10 -53.02 -46.61 68.47 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.331 -0.856 . . . . 0.0 109.61 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.979 HD22 HD11 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -60.19 -32.85 71.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.886 . . . . 0.0 109.659 179.511 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.04 -42.19 98.31 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.9 m -72.08 -24.39 61.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -1.081 . . . . 0.0 109.612 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.416 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 42.3 t -69.37 -35.87 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.405 -0.809 . . . . 0.0 109.688 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.412 ' O ' ' O ' ' A' ' 40' ' ' GLY . 25.4 mmt -90.25 -20.46 22.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 110.368 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.6 mtt85 -89.48 -18.1 27.37 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.023 -1.048 . . . . 0.0 110.651 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 92.4 p -101.54 -16.96 16.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.02 -1.05 . . . . 0.0 110.231 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.84 55.91 1.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.202 -0.936 . . . . 0.0 110.02 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 36' ' ' MET . . . 104.92 86.23 1.91 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.417 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 66.3 tt0 -83.14 67.48 9.18 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.459 -1.024 . . . . 0.0 110.634 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.484 ' HB2' ' HD3' ' A' ' 43' ' ' PRO . 1.8 m120 -85.05 -58.39 0.35 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.124 -0.985 . . . . 0.0 111.157 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' A' ' 42' ' ' ASN . 44.4 Cg_endo -73.88 -169.01 0.5 Allowed 'Trans proline' 0 C--N 1.315 -1.202 0 O-C-N 123.564 1.297 . . . . 0.0 111.056 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 10.9 t -132.94 -174.21 3.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.433 -0.792 . . . . 0.0 109.892 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -66.32 -43.94 84.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.141 -0.974 . . . . 0.0 110.595 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.89 -67.45 0.44 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.174 -0.954 . . . . 0.0 110.434 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -47.39 -29.86 2.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 0.0 110.1 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.863 HD11 HD23 ' A' ' 32' ' ' LEU . 8.6 tt -66.7 -49.36 66.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.931 . . . . 0.0 109.343 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -49.22 -38.88 27.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 109.243 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -64.2 -42.18 96.74 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.399 -0.813 . . . . 0.0 109.411 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.451 ' HG3' ' OE2' ' A' ' 54' ' ' GLU . 2.5 ttp -65.58 -14.56 61.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.264 -0.897 . . . . 0.0 109.946 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.979 HD11 HD22 ' A' ' 32' ' ' LEU . 25.4 mm -88.47 -33.61 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.302 -0.874 . . . . 0.0 110.3 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -65.25 -33.33 75.74 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.419 -0.8 . . . . 0.0 110.697 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.555 ' HG3' HG23 ' A' ' 55' ' ' VAL . 22.7 pt-20 -71.3 -8.29 52.7 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.058 -1.026 . . . . 0.0 110.647 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.76 HG22 ' SD ' ' A' ' 71' ' ' MET . 79.3 t -108.51 -18.84 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.069 -1.019 . . . . 0.0 110.107 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.532 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 4.6 t70 -109.04 109.27 20.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 111.053 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.76 15.19 23.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 109.66 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.73 -45.19 17.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.417 -0.802 . . . . 0.0 109.985 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.0 15.87 8.87 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.78 HD21 ' H ' ' A' ' 60' ' ' ASN . 0.1 OUTLIER -105.21 -31.73 8.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.053 -1.263 . . . . 0.0 110.171 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.38 -47.43 1.02 Allowed Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.84 -1.172 . . . . 0.0 110.248 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.415 ' O ' ' OD2' ' A' ' 56' ' ' ASP . 10.1 p -96.99 166.78 11.44 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.186 -1.185 . . . . 0.0 110.81 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.48 HD13 HG11 ' A' ' 55' ' ' VAL . 17.2 mt -102.95 161.34 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.202 -0.936 . . . . 0.0 110.316 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -113.65 -160.91 0.74 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.336 -0.853 . . . . 0.0 110.502 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.57 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 21.9 t80 -82.09 -43.4 1.02 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.896 . . . . 0.0 111.837 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.6 Cg_endo -72.42 -24.15 19.58 Favored 'Trans proline' 0 C--N 1.321 -0.894 0 O-C-N 123.027 1.014 . . . . 0.0 110.656 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -76.83 -33.78 57.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.143 -0.973 . . . . 0.0 109.087 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.571 ' CE1' ' CE ' ' A' ' 72' ' ' MET . 77.5 t80 -72.03 -40.27 68.55 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.572 -0.705 . . . . 0.0 109.852 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.887 HD11 HG23 ' A' ' 9' ' ' ILE . 8.2 tp -78.71 -17.93 55.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.446 -0.784 . . . . 0.0 110.607 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 51.9 m -90.63 -23.34 20.83 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.022 -1.049 . . . . 0.0 110.651 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.76 ' SD ' HG22 ' A' ' 55' ' ' VAL . 48.6 ttp -90.8 -36.96 13.94 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.891 -1.131 . . . . 0.0 111.073 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.571 ' CE ' ' CE1' ' A' ' 68' ' ' PHE . 56.8 mtt -89.83 -53.25 4.59 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.054 -1.029 . . . . 0.0 111.496 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -65.89 -10.15 35.9 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.931 -1.105 . . . . 0.0 110.882 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 70' ' ' THR . 5.0 tpt180 -86.72 10.24 16.38 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.041 -1.037 . . . . 0.0 110.442 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.98 177.82 4.78 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.007 -1.058 . . . . 0.0 110.131 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 54.36 101.6 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.262 -0.899 . . . . 0.0 110.186 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -145.37 15.73 1.48 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.178 -0.951 . . . . 0.0 110.269 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -62.53 151.79 36.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 109.751 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.7 t -115.74 138.77 50.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.179 -0.95 . . . . 0.0 110.203 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 1.7 m-20 -108.71 117.54 34.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.185 -0.947 . . . . 0.0 109.921 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 81.0 p -122.79 112.55 18.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 110.819 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -121.35 -0.04 9.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.36 -0.837 . . . . 0.0 109.935 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -149.04 89.76 1.69 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.289 -0.882 . . . . 0.0 109.66 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 1.0 OUTLIER -44.0 -26.75 0.31 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.449 -0.782 . . . . 0.0 110.761 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 79.5 mt -66.51 -59.31 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.192 -0.942 . . . . 0.0 110.093 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -63.08 -57.18 11.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.356 -0.84 . . . . 0.0 110.337 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.583 ' O ' HG13 ' A' ' 91' ' ' VAL . 51.3 mm-40 -51.02 -32.02 20.15 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.244 -0.91 . . . . 0.0 110.451 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' A' ' 84' ' ' GLU . . . -72.98 -40.72 65.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.192 -0.942 . . . . 0.0 110.414 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -62.79 -29.51 70.76 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.968 -1.083 . . . . 0.0 110.554 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 66.6 mtt85 -80.9 -52.12 7.82 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.201 -0.937 . . . . 0.0 110.938 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 87' ' ' GLU . 19.6 m -59.09 -36.22 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.211 -0.931 . . . . 0.0 111.02 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.534 ' CD2' ' H3 ' ' A' ' 154' ' ' WW7 . 16.2 m-85 -78.85 -38.8 36.98 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.033 -1.042 . . . . 0.0 110.606 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -111.55 71.3 0.74 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.275 -0.891 . . . . 0.0 110.147 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.441 ' CD ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -108.06 42.59 1.34 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.146 -0.971 . . . . 0.0 110.499 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 2.7 p30 -125.77 -26.95 3.41 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.242 -0.912 . . . . 0.0 110.605 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.4 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 108.21 31.57 3.51 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.45 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 18.6 t-20 -93.12 -44.98 8.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -1.145 . . . . 0.0 110.135 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.476 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 111.24 -14.91 28.07 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 33.8 m-85 -144.28 147.27 33.32 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.218 -1.166 . . . . 0.0 110.108 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.45 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 26.0 mt -71.1 137.5 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.245 -0.909 . . . . 0.0 109.439 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.3 m -114.21 169.64 8.88 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.194 -0.941 . . . . 0.0 110.394 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.61 -46.01 56.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.236 -0.915 . . . . 0.0 110.115 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.91 -53.94 49.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -0.918 . . . . 0.0 109.986 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.774 ' O ' HG23 ' A' ' 108' ' ' VAL . 31.2 mt-10 -58.57 -38.66 78.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.238 -0.914 . . . . 0.0 109.783 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.836 HD12 HD11 ' A' ' 125' ' ' ILE . 1.4 tt -57.78 -36.83 72.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.32 -0.863 . . . . 0.0 110.105 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.68 ' O ' HG22 ' A' ' 110' ' ' THR . 6.6 ttt-85 -70.0 -44.44 69.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.343 -0.848 . . . . 0.0 110.304 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -70.64 -11.06 60.7 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.084 -1.01 . . . . 0.0 110.497 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 104' ' ' GLU . 85.1 t -91.8 -40.79 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.135 -0.978 . . . . 0.0 110.163 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.2 mmt -69.9 -52.77 21.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.257 -0.902 . . . . 0.0 110.558 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.68 HG22 ' O ' ' A' ' 106' ' ' ARG . 5.8 t -56.99 -24.33 52.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.229 -0.919 . . . . 0.0 110.689 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -85.31 -33.86 22.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.022 -1.049 . . . . 0.0 110.69 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 24.4 mt -73.58 -56.53 4.9 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.131 -0.981 . . . . 0.0 110.28 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 167.58 -32.1 0.19 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -70.96 140.31 50.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.322 -1.105 . . . . 0.0 110.203 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 3.4 pttp -114.77 101.57 9.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.169 -0.957 . . . . 0.0 110.392 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.3 mt -112.0 168.5 9.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.125 -0.985 . . . . 0.0 110.236 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.544 HG22 ' N ' ' A' ' 118' ' ' ASP . 85.3 m -115.58 170.32 8.52 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.223 -0.923 . . . . 0.0 110.45 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.544 ' N ' HG22 ' A' ' 117' ' ' THR . 0.9 OUTLIER -51.02 -35.44 34.16 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.339 -0.851 . . . . 0.0 110.962 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -62.36 -54.78 35.39 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.059 -1.026 . . . . 0.0 110.798 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -61.2 -54.6 42.26 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.221 -0.924 . . . . 0.0 110.702 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' A' ' 105' ' ' LEU . 79.6 t -50.65 -41.25 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.115 -0.991 . . . . 0.0 110.566 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.96 -40.62 91.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.118 -0.989 . . . . 0.0 110.214 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.443 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 12.4 mt-10 -71.1 -18.41 62.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.236 -0.915 . . . . 0.0 109.972 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.1 mmm -78.79 -48.67 14.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 110.155 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.836 HD11 HD12 ' A' ' 105' ' ' LEU . 30.4 mm -70.44 -36.4 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.312 -0.868 . . . . 0.0 110.334 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -72.11 -47.36 51.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.362 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.443 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 5.7 mm-40 -70.15 -23.85 63.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.207 -0.933 . . . . 0.0 110.186 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.79 -14.65 27.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.171 -0.956 . . . . 0.0 110.011 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.76 ' OD1' HG22 ' A' ' 136' ' ' VAL . 3.8 m-20 -79.92 88.33 5.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.098 -1.001 . . . . 0.0 110.922 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.478 HG22 ' O ' ' A' ' 130' ' ' ILE . 11.5 mm -67.24 -4.08 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.523 -0.736 . . . . 0.0 111.11 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 54.0 p30 -176.57 -19.71 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 O-C-N 120.709 -1.245 . . . . 0.0 112.223 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . -71.8 -52.06 13.27 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 1.2 m-20 56.48 96.32 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.468 -1.019 . . . . 0.0 108.418 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 105.28 -20.49 37.58 Favored Glycine 0 C--N 1.295 -1.748 0 N-CA-C 107.564 -2.214 . . . . 0.0 107.564 -177.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.469 ' HB2' ' CB ' ' A' ' 99' ' ' TYR . 2.5 pt20 -153.4 152.32 30.92 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.621 -0.929 . . . . 0.0 109.729 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.76 HG22 ' OD1' ' A' ' 129' ' ' ASP . 99.5 t -118.48 147.12 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.208 -0.933 . . . . 0.0 110.346 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.4 ' OD1' ' CD1' ' A' ' 99' ' ' TYR . 2.9 m120 -105.91 179.46 4.26 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.435 -0.791 . . . . 0.0 110.585 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -73.73 -49.54 25.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.312 -0.868 . . . . 0.0 108.884 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -59.29 -41.75 89.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.346 -0.846 . . . . 0.0 109.046 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.45 ' OE1' ' HA ' ' A' ' 136' ' ' VAL . 36.1 tt0 -64.98 -33.27 75.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.484 -0.76 . . . . 0.0 109.968 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.429 ' O ' ' HG2' ' A' ' 144' ' ' MET . 13.4 t80 -68.91 -25.62 64.68 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.315 -0.866 . . . . 0.0 110.31 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.8 t -81.44 -36.28 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.122 -0.986 . . . . 0.0 109.726 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.49 -29.95 64.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 110.8 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.504 ' HE3' ' HE1' ' A' ' 145' ' ' MET . 3.4 ptt? -74.59 -25.55 59.33 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.006 -1.059 . . . . 0.0 110.623 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.529 ' HE3' ' N1 ' ' A' ' 154' ' ' WW7 . 20.5 mmt -87.11 -67.69 0.8 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.117 -0.989 . . . . 0.0 110.504 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 65.6 p -64.58 127.46 31.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.071 -1.018 . . . . 0.0 110.411 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.74 -150.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.445 -0.785 . . . . 0.0 110.358 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.226 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 153' ' ' WW7 . . . . . 0.794 ' HN1' H141 ' A' ' 153' ' ' WW7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' WW7 . . . . . 0.534 ' H3 ' ' CD2' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.244 0.545 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -95.58 73.54 3.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.166 -0.959 . . . . 0.0 110.089 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -84.9 -68.33 0.73 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.405 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 4' ' ' LEU . 10.6 mt -51.39 167.34 0.09 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.229 -0.919 . . . . 0.0 110.25 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.6 p -92.99 175.07 6.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.246 -0.909 . . . . 0.0 110.228 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -88.49 -19.05 26.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.275 -0.891 . . . . 0.0 110.247 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.86 -55.94 28.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.274 -0.891 . . . . 0.0 110.252 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -56.65 -33.28 66.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.301 -0.874 . . . . 0.0 109.75 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.0 mm -65.71 -35.95 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.509 -0.745 . . . . 0.0 109.807 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.15 -33.52 73.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.882 . . . . 0.0 109.587 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.8 -51.08 68.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.393 -0.817 . . . . 0.0 109.575 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -58.83 -38.67 79.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.378 -0.826 . . . . 0.0 109.835 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -63.85 -31.11 72.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.354 -0.841 . . . . 0.0 109.911 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -68.47 -45.63 71.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -0.862 . . . . 0.0 110.292 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.44 -44.66 93.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.309 -0.869 . . . . 0.0 110.355 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -58.79 -43.68 90.55 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.21 -0.931 . . . . 0.0 110.298 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.4 m -66.48 -33.95 76.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 110.077 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.799 ' O ' HD23 ' A' ' 18' ' ' LEU . 2.8 tt -62.46 -37.47 86.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 109.788 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.581 ' HA ' HG21 ' A' ' 35' ' ' VAL . 9.3 m-30 -72.51 -64.33 0.97 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.331 -0.856 . . . . 0.0 109.893 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -51.0 120.15 4.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.412 -0.805 . . . . 0.0 109.862 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -104.85 -8.73 18.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.907 -1.121 . . . . 0.0 110.885 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.402 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 6.9 p-10 -101.55 -42.29 6.29 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.9 -1.125 . . . . 0.0 110.238 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.12 55.4 0.92 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 58.5 p30 -123.5 -11.47 7.84 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.166 -1.197 . . . . 0.0 110.503 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.643 ' O ' HG23 ' A' ' 26' ' ' THR . . . 89.12 36.89 7.41 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 25' ' ' GLY . 14.6 p -158.5 129.55 6.34 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.339 -1.095 . . . . 0.0 110.256 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 62' ' ' THR . 62.0 mt -93.19 118.32 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.315 -0.866 . . . . 0.0 109.993 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 t -104.24 -176.28 3.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.232 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.63 HG22 HD12 ' A' ' 52' ' ' ILE . 31.4 p -75.09 -35.08 61.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 110.475 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -62.37 -60.28 3.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.267 -0.896 . . . . 0.0 109.972 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -58.83 -53.11 62.12 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.212 -0.93 . . . . 0.0 109.623 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.739 HD22 HD11 ' A' ' 52' ' ' ILE . 0.5 OUTLIER -58.88 -19.45 42.17 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.235 -0.916 . . . . 0.0 109.572 179.535 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.493 ' HA2' ' CD1' ' A' ' 48' ' ' LEU . . . -67.35 -49.53 51.2 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 38' ' ' SER . 60.0 m -70.84 -19.12 62.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.298 -1.119 . . . . 0.0 109.862 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.581 HG21 ' HA ' ' A' ' 19' ' ' PHE . 24.4 t -76.58 -38.45 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.394 -0.816 . . . . 0.0 110.334 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.714 ' HA ' HD23 ' A' ' 39' ' ' LEU . 26.5 mmt -84.48 -22.96 30.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.121 -0.987 . . . . 0.0 110.163 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.452 ' HD3' ' HA ' ' A' ' 42' ' ' ASN . 3.7 tpp180 -90.68 -16.9 27.72 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.329 -0.857 . . . . 0.0 110.417 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 34' ' ' THR . 32.9 t -92.0 10.11 30.38 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.995 -1.065 . . . . 0.0 110.982 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.714 HD23 ' HA ' ' A' ' 36' ' ' MET . 3.8 pp -107.27 -26.7 10.92 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.015 -1.053 . . . . 0.0 110.65 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.55 -31.13 1.03 Allowed Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.065 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.603 ' HG3' HD11 ' A' ' 39' ' ' LEU . 67.3 mt-30 -81.01 158.75 25.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.101 -1.235 . . . . 0.0 110.323 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.452 ' HA ' ' HD3' ' A' ' 37' ' ' ARG . 77.1 m-20 -130.43 61.09 56.91 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.25 -0.906 . . . . 0.0 110.131 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.05 -163.15 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.771 1.406 . . . . 0.0 110.234 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.527 HG22 ' N ' ' A' ' 45' ' ' GLU . 58.4 m -135.55 171.98 13.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.253 -0.904 . . . . 0.0 110.119 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.527 ' N ' HG22 ' A' ' 44' ' ' THR . 69.3 mt-10 -59.56 -28.94 67.56 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.2 -0.937 . . . . 0.0 110.478 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.92 -67.48 0.49 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.153 -0.967 . . . . 0.0 110.064 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -53.42 -23.09 8.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -0.914 . . . . 0.0 109.512 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.508 HD11 HD23 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -67.85 -58.0 5.32 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.564 -0.71 . . . . 0.0 110.011 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -51.22 -38.09 50.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.322 -0.861 . . . . 0.0 109.527 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -65.17 -38.99 92.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.367 -0.833 . . . . 0.0 109.508 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.444 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 1.6 ttp -66.98 -26.26 66.72 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.426 -0.796 . . . . 0.0 109.784 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.739 HD11 HD22 ' A' ' 32' ' ' LEU . 56.9 mt -83.17 -27.33 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.319 -0.863 . . . . 0.0 109.818 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -58.58 -46.84 86.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.384 -0.823 . . . . 0.0 110.401 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.828 ' HG3' HG23 ' A' ' 55' ' ' VAL . 13.2 pt-20 -64.39 -27.2 68.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -0.918 . . . . 0.0 110.071 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.828 HG23 ' HG3' ' A' ' 54' ' ' GLU . 85.8 t -96.1 -3.97 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.344 -0.848 . . . . 0.0 110.338 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -126.11 105.86 9.17 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.028 -1.045 . . . . 0.0 110.159 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.24 33.66 4.34 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.111 -0.993 . . . . 0.0 110.465 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -104.82 -49.11 3.58 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.186 -0.946 . . . . 0.0 110.236 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 119.53 51.69 0.28 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.457 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 16.1 p-10 -148.02 -43.69 0.16 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -1.129 . . . . 0.0 110.15 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 116.76 -4.12 19.26 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.579 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 45.1 p -123.76 164.05 19.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.906 -1.349 . . . . 0.0 110.469 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.72 HD11 'CL1 ' ' A' ' 153' ' ' WW7 . 52.1 mt -114.05 130.82 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.257 -0.902 . . . . 0.0 110.165 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.428 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 56.0 m-20 -83.3 -173.68 4.85 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 110.112 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.559 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 66.4 t80 -80.73 -42.63 1.25 Allowed Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.324 -0.86 . . . . 0.0 111.35 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 46.5 Cg_endo -74.66 -26.81 11.27 Favored 'Trans proline' 0 N--CA 1.48 0.72 0 O-C-N 123.082 1.043 . . . . 0.0 110.092 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 71' ' ' MET . 78.7 tt0 -78.09 -25.31 47.5 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.358 -0.839 . . . . 0.0 109.002 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 8.0 t80 -79.21 -54.34 6.07 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.607 -0.683 . . . . 0.0 110.025 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.687 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 0.6 OUTLIER -60.0 -34.78 73.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.329 -0.857 . . . . 0.0 110.427 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.4 m -77.02 -32.37 57.01 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.195 -0.941 . . . . 0.0 110.236 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.526 ' HE3' ' HG3' ' A' ' 72' ' ' MET . 18.2 tmm? -61.9 -52.65 63.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.268 -0.895 . . . . 0.0 110.278 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.526 ' HG3' ' HE3' ' A' ' 71' ' ' MET . 47.5 mtt -81.55 -10.4 59.46 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.165 -0.96 . . . . 0.0 110.293 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . -81.36 -23.41 37.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.163 -0.961 . . . . 0.0 110.127 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' A' ' 74' ' ' ARG . 32.3 ttm180 -106.88 62.34 0.63 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.17 -0.956 . . . . 0.0 110.309 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -101.4 -47.24 4.75 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.069 -1.019 . . . . 0.0 109.734 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 4.2 tpp -124.18 122.07 36.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.453 -0.779 . . . . 0.0 109.93 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.81 164.67 14.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.179 -0.951 . . . . 0.0 110.167 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -60.0 -174.71 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 110.133 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.0 t -132.61 -175.4 3.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.925 . . . . 0.0 110.092 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -114.7 132.74 56.31 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.277 -0.889 . . . . 0.0 109.932 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.2 m -124.55 104.94 8.99 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.168 -0.958 . . . . 0.0 110.533 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -88.07 164.4 15.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.252 -0.905 . . . . 0.0 110.085 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.21 -53.04 42.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.198 -0.939 . . . . 0.0 110.379 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -56.03 -48.73 75.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 109.953 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.4 mt -52.07 -45.45 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.213 -0.929 . . . . 0.0 109.527 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -55.07 -44.41 74.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 110.179 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -57.41 -51.68 68.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.932 . . . . 0.0 110.245 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 92' ' ' PHE . . . -54.96 -29.58 57.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.131 -0.981 . . . . 0.0 110.557 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.433 ' O ' ' HB3' ' A' ' 93' ' ' ASP . 3.2 t80 -72.6 -35.98 68.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.003 -1.06 . . . . 0.0 110.838 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -76.32 -42.85 43.74 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.08 -1.013 . . . . 0.0 111.256 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.556 HG23 ' CD1' ' A' ' 92' ' ' PHE . 19.7 m -70.64 -41.23 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.047 -1.033 . . . . 0.0 110.859 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.562 ' CG ' ' H3 ' ' A' ' 154' ' ' WW7 . 25.9 m-85 -75.46 -25.07 57.12 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.877 -1.139 . . . . 0.0 110.028 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.447 ' OD2' ' N ' ' A' ' 99' ' ' TYR . 11.5 t70 -125.33 70.29 1.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.937 . . . . 0.0 110.09 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.11 65.98 0.62 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.429 -0.794 . . . . 0.0 110.284 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.461 ' OD2' ' HB2' ' A' ' 97' ' ' ASN . 21.6 p-10 -150.62 26.49 0.75 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.23 -0.919 . . . . 0.0 110.051 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.04 24.58 60.87 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.461 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 11.1 t-20 -95.49 -70.65 0.7 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.249 -1.147 . . . . 0.0 110.193 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.31 -9.98 10.05 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.447 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 55.0 m-85 -133.08 153.07 51.85 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.196 -1.179 . . . . 0.0 110.342 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.444 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 13.3 mt -91.84 116.26 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.336 -0.853 . . . . 0.0 109.499 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.0 t -95.06 176.04 6.39 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.318 -0.864 . . . . 0.0 110.115 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.468 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -71.84 -41.81 67.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 110.16 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.88 -50.45 62.44 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.181 -0.949 . . . . 0.0 110.27 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.865 ' O ' HG23 ' A' ' 108' ' ' VAL . 24.0 tt0 -59.52 -40.9 88.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.187 -0.945 . . . . 0.0 109.87 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 105' ' ' LEU . 30.6 tp -62.55 -33.83 75.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.381 -0.824 . . . . 0.0 110.046 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.59 ' O ' HG23 ' A' ' 110' ' ' THR . 6.7 ttp180 -69.16 -34.07 74.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.246 -0.909 . . . . 0.0 109.905 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 41.6 t60 -74.64 -24.18 58.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 110.276 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 104' ' ' GLU . 21.8 t -77.04 -39.92 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.258 -0.902 . . . . 0.0 110.187 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.6 mmt -61.84 -36.67 81.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.882 . . . . 0.0 110.136 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 106' ' ' ARG . 48.2 p -53.23 -43.48 67.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.155 -0.965 . . . . 0.0 109.71 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -60.14 -47.56 85.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.827 . . . . 0.0 110.219 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.5 mt -55.72 -36.3 67.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 110.124 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.07 41.88 2.74 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -119.87 133.59 55.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -1.168 . . . . 0.0 110.101 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.0 tttp -84.54 107.46 16.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.321 -0.862 . . . . 0.0 110.015 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.1 mt -126.29 164.21 21.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -0.869 . . . . 0.0 110.232 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 51.7 m -107.13 162.7 13.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 110.204 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.461 ' OD2' ' NH2' ' A' ' 106' ' ' ARG . 2.4 m-20 -58.2 -40.66 82.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 110.205 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -58.78 -35.55 72.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.312 -0.868 . . . . 0.0 110.526 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.02 -49.84 64.02 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.226 -0.921 . . . . 0.0 110.795 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.468 HG11 ' O ' ' A' ' 102' ' ' ALA . 59.3 t -59.36 -53.31 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.225 -0.922 . . . . 0.0 110.174 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -53.61 -42.56 67.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.189 -0.944 . . . . 0.0 110.004 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 27.1 tt0 -63.03 -33.2 74.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.346 -0.846 . . . . 0.0 110.054 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.406 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 5.5 mmm -65.19 -53.29 47.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.179 -0.951 . . . . 0.0 109.989 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 34.8 mm -54.94 -32.21 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.255 -0.903 . . . . 0.0 110.089 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 -70.65 -42.73 70.42 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.298 -0.876 . . . . 0.0 110.136 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 49.9 mt-10 -65.82 -23.95 66.8 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.292 -0.88 . . . . 0.0 110.219 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.63 -22.48 19.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.322 -0.862 . . . . 0.0 110.066 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -72.67 90.43 1.38 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 110.228 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 59.0 mt -89.34 -25.61 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.14 -0.975 . . . . 0.0 110.304 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 41.7 p30 -87.4 -16.44 34.92 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.244 -0.91 . . . . 0.0 110.496 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.455 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 75.1 70.35 1.27 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -130.62 -33.9 1.59 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.21 -1.171 . . . . 0.0 110.427 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 111.61 18.43 7.99 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.438 ' HB2' ' HB3' ' A' ' 99' ' ' TYR . 1.4 pt20 -160.56 147.4 15.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.371 -1.076 . . . . 0.0 109.949 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.444 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 60.7 t -91.09 132.18 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 110.377 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -106.39 171.4 7.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 109.82 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -53.83 -38.34 64.53 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.174 -0.954 . . . . 0.0 110.351 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -68.03 -62.88 1.2 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.185 -0.947 . . . . 0.0 110.647 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -46.83 -33.72 4.72 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.283 -0.886 . . . . 0.0 110.899 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.427 ' O ' ' HG3' ' A' ' 144' ' ' MET . 12.8 t80 -70.23 -40.94 74.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 111.133 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.632 ' O ' HG22 ' A' ' 146' ' ' THR . 99.2 t -77.48 -20.9 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.052 -1.03 . . . . 0.0 110.766 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -85.12 -28.11 25.79 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.257 -0.902 . . . . 0.0 110.959 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.455 ' CE ' ' HG3' ' A' ' 145' ' ' MET . 0.2 OUTLIER -83.05 -20.13 35.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.058 -1.026 . . . . 0.0 110.316 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.516 ' HE1' H121 ' A' ' 154' ' ' WW7 . 26.0 mtt -90.24 -59.12 2.27 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.303 -0.873 . . . . 0.0 110.256 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.632 HG22 ' O ' ' A' ' 142' ' ' VAL . 13.7 t -54.21 132.08 42.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 110.004 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -174.11 126.28 0.35 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 0.0 110.286 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.115 179.966 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 153' ' ' WW7 . . . . . 0.813 ' C6 ' HG21 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' WW7 . . . . . 0.562 ' H3 ' ' CG ' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.322 0.582 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -152.06 121.99 7.06 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.185 -0.947 . . . . 0.0 110.248 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -142.74 145.68 33.57 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.191 -0.943 . . . . 0.0 110.04 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.615 ' O ' HG23 ' A' ' 5' ' ' THR . 0.5 OUTLIER -124.79 -27.61 3.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -0.943 . . . . 0.0 110.591 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 4' ' ' LEU . 17.9 p -158.2 157.45 32.66 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.159 -0.963 . . . . 0.0 110.513 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -89.01 -8.95 53.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.263 -0.898 . . . . 0.0 110.03 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -64.54 -57.09 10.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.238 -0.914 . . . . 0.0 110.495 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.425 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 1.9 mp0 -47.16 -51.66 17.65 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.3 -0.875 . . . . 0.0 110.371 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 92.6 mt -57.41 -49.23 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.101 -0.999 . . . . 0.0 110.032 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.38 -26.08 39.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.398 -0.814 . . . . 0.0 109.804 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 16.0 tt0 -72.72 -57.82 3.81 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.366 -0.834 . . . . 0.0 109.636 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.438 ' O ' ' HB2' ' A' ' 16' ' ' PHE . 71.9 m-85 -56.4 -23.34 37.46 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.263 -0.898 . . . . 0.0 109.79 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.3 mttp -76.06 -40.35 53.43 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.283 -0.885 . . . . 0.0 110.033 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -62.66 -52.83 61.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 109.902 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.503 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.96 -47.19 85.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 109.998 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.507 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 14.3 t80 -47.76 -48.99 29.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.199 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.2 t -58.84 -42.76 90.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.904 . . . . 0.0 109.886 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.712 ' O ' HD23 ' A' ' 18' ' ' LEU . 3.6 tt -49.52 -44.41 46.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.287 -0.883 . . . . 0.0 110.171 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.83 ' CD1' HG11 ' A' ' 35' ' ' VAL . 37.3 m-85 -75.67 -30.28 59.35 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.175 -0.953 . . . . 0.0 110.401 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -80.35 107.52 13.21 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.108 -0.995 . . . . 0.0 110.43 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.402 ' HE3' ' CG2' ' A' ' 34' ' ' THR . 24.9 mttm -105.93 -35.36 7.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.0 110.436 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -74.07 -21.27 59.99 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.128 -0.982 . . . . 0.0 110.11 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.87 100.23 0.04 OUTLIER Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 35.1 p-10 -168.63 -26.21 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.354 -1.086 . . . . 0.0 111.41 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.52 ' C ' HG23 ' A' ' 26' ' ' THR . . . 111.09 27.56 4.2 Favored Glycine 0 N--CA 1.492 2.367 0 O-C-N 120.671 -1.268 . . . . 0.0 109.996 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.52 HG23 ' C ' ' A' ' 25' ' ' GLY . 72.2 p -153.36 170.21 21.22 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.052 -1.264 . . . . 0.0 110.337 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.441 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 12.2 mt -129.47 115.32 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.405 -0.81 . . . . 0.0 109.947 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.495 HG22 ' N ' ' A' ' 29' ' ' THR . 20.6 m -102.33 174.67 5.81 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.195 -0.941 . . . . 0.0 110.191 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.57 HG21 ' OE1' ' A' ' 49' ' ' GLN . 22.8 p -72.21 -21.41 61.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.146 -0.971 . . . . 0.0 110.059 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -70.73 -57.64 4.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.253 -0.905 . . . . 0.0 109.82 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -60.25 -57.62 12.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 0.0 109.71 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.738 HD22 HD11 ' A' ' 52' ' ' ILE . 2.0 tp -51.84 -35.43 44.57 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.279 -0.888 . . . . 0.0 109.584 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.26 -47.11 76.74 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.402 ' CG2' ' HE3' ' A' ' 21' ' ' LYS . 62.5 m -63.3 -31.21 72.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -1.139 . . . . 0.0 109.973 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.83 HG11 ' CD1' ' A' ' 19' ' ' PHE . 54.6 t -67.38 -31.48 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.195 -0.941 . . . . 0.0 109.833 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.4 mmt -90.55 -14.2 33.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.287 -0.883 . . . . 0.0 110.427 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.5 ttp180 -88.77 -31.5 18.36 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.153 -0.967 . . . . 0.0 110.435 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 88.7 p -91.44 -24.32 19.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.267 -0.896 . . . . 0.0 110.188 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -92.62 -67.31 0.86 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.247 -0.908 . . . . 0.0 109.932 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -129.32 89.33 0.31 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -59.68 116.5 4.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -1.119 . . . . 0.0 110.485 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.527 ' CB ' ' HD3' ' A' ' 43' ' ' PRO . 1.4 m120 -172.1 -61.03 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.301 -0.874 . . . . 0.0 110.477 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.527 ' HD3' ' CB ' ' A' ' 42' ' ' ASN . 47.7 Cg_endo -74.82 144.35 30.84 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.595 1.313 . . . . 0.0 110.105 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.698 HG23 ' H ' ' A' ' 46' ' ' ALA . 7.2 t -107.34 -141.37 0.38 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.106 -0.996 . . . . 0.0 109.897 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.672 ' N ' HG23 ' A' ' 44' ' ' THR . 44.4 mt-10 -88.23 -30.78 19.44 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.901 -1.124 . . . . 0.0 110.088 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.698 ' H ' HG23 ' A' ' 44' ' ' THR . . . -73.21 -64.75 0.91 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 109.702 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 55.4 mt-10 -52.31 -48.56 65.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.181 -0.949 . . . . 0.0 109.333 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.69 HD11 HD23 ' A' ' 32' ' ' LEU . 7.5 tt -52.1 -40.84 61.85 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.354 -0.841 . . . . 0.0 109.154 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.57 ' OE1' HG21 ' A' ' 29' ' ' THR . 62.8 tp60 -53.91 -44.63 70.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.508 -0.745 . . . . 0.0 109.578 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -57.91 -44.67 86.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.254 -0.904 . . . . 0.0 109.482 179.381 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.434 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 70.1 mtp -59.69 -26.61 65.72 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.319 -0.863 . . . . 0.0 109.842 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.738 HD11 HD22 ' A' ' 32' ' ' LEU . 29.9 mm -77.13 -29.53 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.898 . . . . 0.0 110.157 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -68.31 -43.26 78.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.336 -0.853 . . . . 0.0 110.454 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.519 ' HG3' HG23 ' A' ' 55' ' ' VAL . 22.7 pt-20 -68.0 -24.97 65.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.3 -0.875 . . . . 0.0 110.565 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.813 HG13 ' SD ' ' A' ' 71' ' ' MET . 75.9 t -89.33 -21.73 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.178 -0.951 . . . . 0.0 110.113 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -101.49 107.79 19.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.362 -0.836 . . . . 0.0 110.359 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -95.69 17.32 15.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.07 -1.019 . . . . 0.0 110.149 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.434 ' HB2' ' OD1' ' A' ' 60' ' ' ASN . 34.2 m-20 -107.4 -52.24 2.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.354 -0.842 . . . . 0.0 110.046 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.53 19.95 5.6 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.434 ' OD1' ' HB2' ' A' ' 58' ' ' ASP . 22.0 m120 -88.24 -9.23 53.62 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.239 -1.154 . . . . 0.0 110.44 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.25 -38.62 3.15 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.5 p -110.22 160.64 16.33 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.109 -1.23 . . . . 0.0 110.772 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.749 HD13 HG11 ' A' ' 55' ' ' VAL . 49.8 mt -95.8 158.32 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.56 -0.713 . . . . 0.0 109.968 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.432 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.1 m-20 -113.87 -170.67 1.75 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.279 -0.888 . . . . 0.0 110.411 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.563 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.8 t80 -77.23 -46.12 2.69 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.842 . . . . 0.0 111.124 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.1 Cg_endo -73.49 -16.15 24.45 Favored 'Trans proline' 0 C--N 1.318 -1.04 0 O-C-N 123.306 1.161 . . . . 0.0 110.403 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -84.46 -34.5 23.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -0.943 . . . . 0.0 109.043 178.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.488 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 5.5 t80 -70.04 -40.27 75.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.606 -0.684 . . . . 0.0 109.532 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.695 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 18.6 tp -76.61 -38.79 54.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.467 -0.771 . . . . 0.0 110.56 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.8 m -71.17 -22.05 62.09 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.163 -0.961 . . . . 0.0 110.656 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.813 ' SD ' HG13 ' A' ' 55' ' ' VAL . 62.4 ttp -82.3 -51.01 8.31 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.065 -1.022 . . . . 0.0 110.095 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.468 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 57.1 mtt -79.05 -9.69 59.62 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.405 -0.809 . . . . 0.0 110.674 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.695 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . -75.48 -22.09 57.51 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.103 -0.998 . . . . 0.0 110.31 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.5 ttm-85 -106.38 41.24 1.46 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.2 -0.938 . . . . 0.0 110.043 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -138.85 -178.49 5.34 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.221 -0.924 . . . . 0.0 110.163 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.56 164.91 2.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.12 -0.988 . . . . 0.0 109.962 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -129.43 -176.29 3.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.403 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -143.38 113.95 7.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.36 -0.837 . . . . 0.0 109.765 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 79' ' ' THR . 40.8 m -153.97 45.32 0.59 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.255 -0.903 . . . . 0.0 110.501 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -150.96 42.43 0.78 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.07 -1.019 . . . . 0.0 110.232 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.9 m -141.41 -177.4 5.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.246 -0.909 . . . . 0.0 110.354 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 86' ' ' ARG . 3.8 tp10 -91.24 -152.35 0.28 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.273 -0.892 . . . . 0.0 110.033 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -114.38 -92.81 0.49 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.286 -0.884 . . . . 0.0 110.129 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -101.55 -31.96 10.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.045 -1.035 . . . . 0.0 109.766 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 97.8 mt -52.87 -33.32 18.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.305 -0.872 . . . . 0.0 109.802 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.437 ' HD3' ' OE2' ' A' ' 87' ' ' GLU . 2.2 ttt180 -64.34 -46.81 81.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 109.353 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.437 ' OE2' ' HD3' ' A' ' 86' ' ' ARG . 4.7 mp0 -57.75 -29.09 64.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.35 -0.844 . . . . 0.0 109.66 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.597 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -65.92 -62.89 1.25 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.365 -0.834 . . . . 0.0 110.148 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.607 ' CD1' HD11 ' A' ' 100' ' ' ILE . 1.9 t80 -50.01 -29.35 8.47 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.357 -0.839 . . . . 0.0 110.416 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -68.44 -55.15 12.84 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.136 -0.977 . . . . 0.0 110.714 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 88' ' ' ALA . 29.7 m -63.72 -20.66 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.132 -0.98 . . . . 0.0 110.344 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.672 ' CE1' HG11 ' A' ' 108' ' ' VAL . 24.6 m-85 -92.52 -14.06 28.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 0.0 110.34 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -123.93 66.25 1.04 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.234 -0.916 . . . . 0.0 109.714 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -95.61 61.97 2.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.863 . . . . 0.0 110.552 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.8 p30 -164.34 -35.84 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.117 -0.989 . . . . 0.0 110.717 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.454 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 110.04 38.88 1.62 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.445 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 3.8 t-20 -92.81 -57.97 2.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.389 -1.066 . . . . 0.0 110.184 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.425 ' C ' ' CD1' ' A' ' 99' ' ' TYR . . . 121.59 -22.31 7.81 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.641 ' CD2' ' NE2' ' A' ' 135' ' ' GLN . 27.4 m-85 -131.72 158.69 40.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.152 -1.205 . . . . 0.0 110.306 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.607 HD11 ' CD1' ' A' ' 89' ' ' PHE . 70.9 mt -93.89 135.49 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.331 -0.856 . . . . 0.0 110.587 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.5 t -117.47 176.0 5.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.498 -0.751 . . . . 0.0 109.837 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.63 -37.59 76.86 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.204 -0.935 . . . . 0.0 110.515 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.33 -59.03 6.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.19 -0.944 . . . . 0.0 110.258 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -52.54 -48.51 66.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.266 -0.896 . . . . 0.0 110.086 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.0 HD23 HG13 ' A' ' 121' ' ' VAL . 14.7 tp -54.38 -34.63 61.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -0.89 . . . . 0.0 110.356 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.9 ttt-85 -69.79 -33.29 72.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.08 -1.013 . . . . 0.0 110.367 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 53.2 m170 -68.04 -38.53 82.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.27 -0.894 . . . . 0.0 110.49 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.672 HG11 ' CE1' ' A' ' 92' ' ' PHE . 97.0 t -73.91 -49.59 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.165 -0.96 . . . . 0.0 110.558 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.437 ' HG2' ' O ' ' A' ' 105' ' ' LEU . 22.9 mmt -51.68 -62.69 1.47 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.221 -0.925 . . . . 0.0 110.886 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.6 p -44.96 -27.8 0.59 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.34 -0.85 . . . . 0.0 111.018 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 4.5 m120 -81.3 -39.7 24.8 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.007 -1.058 . . . . 0.0 110.68 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 112' ' ' LEU . 80.5 mt -72.41 -15.54 61.84 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.29 -0.881 . . . . 0.0 110.383 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.48 53.12 1.08 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.609 ' OE1' HD11 ' A' ' 116' ' ' LEU . 13.5 mm-40 -128.49 100.44 5.77 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.341 -1.094 . . . . 0.0 110.098 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -87.88 106.8 18.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 110.213 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.609 HD11 ' OE1' ' A' ' 114' ' ' GLU . 4.3 mp -129.99 -178.37 4.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 0.0 109.998 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.8 m -102.77 155.94 17.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.135 -0.978 . . . . 0.0 110.224 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.408 ' O ' ' OD2' ' A' ' 122' ' ' ASP . 45.5 m-20 -49.16 -43.06 41.54 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.227 -0.921 . . . . 0.0 110.191 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -60.98 -42.59 98.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.187 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -52.37 -59.51 4.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.294 -0.879 . . . . 0.0 110.245 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 1.0 HG13 HD23 ' A' ' 105' ' ' LEU . 42.1 t -53.29 -45.51 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.099 -1.001 . . . . 0.0 110.051 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.408 ' OD2' ' O ' ' A' ' 118' ' ' ASP . 60.3 m-20 -52.49 -37.34 57.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.966 . . . . 0.0 109.77 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -70.67 -33.67 71.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.354 -0.842 . . . . 0.0 110.002 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 5.9 mmm -61.91 -55.35 30.48 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.279 -0.888 . . . . 0.0 110.066 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.654 HG23 HG23 ' A' ' 136' ' ' VAL . 22.8 mm -58.47 -38.86 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.272 -0.892 . . . . 0.0 110.1 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -71.24 -22.43 61.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.255 -0.903 . . . . 0.0 110.158 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.4 ' O ' ' OE1' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -76.28 -42.16 46.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 109.88 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.949 ' HB2' ' H6 ' ' A' ' 154' ' ' WW7 . . . -70.42 -33.68 71.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.025 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -59.58 97.64 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.147 -0.97 . . . . 0.0 109.895 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.8 mt -73.16 -44.12 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.396 -0.815 . . . . 0.0 111.421 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.5 p30 -85.62 -31.2 22.72 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.072 -1.018 . . . . 0.0 110.938 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 97.97 54.05 1.23 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -95.16 14.92 20.5 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.237 -1.155 . . . . 0.0 110.216 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 64.74 21.9 67.69 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.641 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -170.1 140.87 2.03 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.588 -0.948 . . . . 0.0 109.719 -179.715 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.654 HG23 HG23 ' A' ' 125' ' ' ILE . 70.8 t -86.11 149.39 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.154 -0.967 . . . . 0.0 110.307 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.614 ' ND2' ' CE2' ' A' ' 99' ' ' TYR . 15.6 t-20 -125.83 169.32 12.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.158 -0.964 . . . . 0.0 110.272 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 138' ' ' TYR . 8.1 t80 -58.26 -51.01 71.57 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.401 -0.812 . . . . 0.0 110.671 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -54.99 -54.74 39.12 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.158 -0.964 . . . . 0.0 110.354 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.45 ' O ' ' CG ' ' A' ' 144' ' ' MET . 46.5 mt-10 -61.29 -20.71 63.2 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.155 -0.965 . . . . 0.0 109.932 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.568 ' CD1' ' CD1' ' A' ' 100' ' ' ILE . 13.4 t80 -75.71 -28.74 58.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.351 -0.843 . . . . 0.0 110.53 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.9 t -87.46 -23.44 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.214 -0.928 . . . . 0.0 110.998 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.402 ' HA ' ' CG2' ' A' ' 146' ' ' THR . 76.0 mt-30 -101.78 -9.61 20.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.074 -1.016 . . . . 0.0 110.951 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.523 ' HE1' ' HE2' ' A' ' 145' ' ' MET . 0.1 OUTLIER -89.09 -28.31 20.18 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.022 -1.049 . . . . 0.0 110.132 179.706 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.523 ' HE2' ' HE1' ' A' ' 144' ' ' MET . 32.4 ttm -89.73 -43.11 10.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 110.284 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.402 ' CG2' ' HA ' ' A' ' 143' ' ' GLN . 8.9 t -54.63 -21.71 11.36 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.202 -0.936 . . . . 0.0 109.997 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -49.36 123.48 7.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.233 -0.917 . . . . 0.0 110.177 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 27.4 pttt . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.272 179.967 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 153' ' ' WW7 . . . . . 0.782 ' C6 ' HG21 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' WW7 . . . . . 0.949 ' H6 ' ' HB2' ' A' ' 128' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.389 0.614 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -76.59 -49.7 15.69 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.239 -0.913 . . . . 0.0 110.262 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -134.51 140.24 46.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.229 -0.919 . . . . 0.0 110.026 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.5 OUTLIER -120.0 137.38 54.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.096 -1.002 . . . . 0.0 110.371 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.65 HG23 ' H ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -161.64 -74.23 0.06 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.288 -0.883 . . . . 0.0 110.201 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.65 ' H ' HG23 ' A' ' 5' ' ' THR . 56.8 mt-10 -83.25 -22.78 32.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.039 -1.038 . . . . 0.0 109.661 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -55.9 -28.47 56.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.242 -0.911 . . . . 0.0 109.541 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -66.97 -41.99 85.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.424 -0.798 . . . . 0.0 109.606 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.3 mt -60.79 -45.14 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.413 -0.804 . . . . 0.0 109.832 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.9 -42.67 98.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.82 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -55.25 -45.17 76.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.313 -0.867 . . . . 0.0 109.773 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.492 ' CE2' ' HB2' ' A' ' 73' ' ' ALA . 12.6 m-85 -56.97 -51.76 67.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 0.0 109.81 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -51.54 -34.77 38.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.0 110.261 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -66.54 -41.77 88.18 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.134 -0.979 . . . . 0.0 110.02 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.445 ' HB1' ' CE2' ' A' ' 19' ' ' PHE . . . -63.87 -47.02 82.35 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.216 -0.928 . . . . 0.0 110.146 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -62.53 -33.08 74.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -0.903 . . . . 0.0 109.814 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.1 m -71.09 -32.64 69.31 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.277 -0.889 . . . . 0.0 109.468 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.943 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.4 tm? -78.22 -23.74 47.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.482 -0.761 . . . . 0.0 109.878 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.445 ' CE2' ' HB1' ' A' ' 15' ' ' ALA . 15.7 m-30 -83.25 -67.03 0.82 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.351 -0.843 . . . . 0.0 109.786 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -48.43 111.75 0.5 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.248 -0.907 . . . . 0.0 109.832 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -78.53 -58.41 3.27 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.209 -0.932 . . . . 0.0 110.824 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.413 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 8.6 p-10 -69.34 -41.75 76.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.147 -0.971 . . . . 0.0 109.978 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.69 46.18 2.16 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 2.6 p30 -95.07 -24.87 16.69 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.054 -1.263 . . . . 0.0 110.051 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.534 ' C ' HG23 ' A' ' 26' ' ' THR . . . 109.83 32.5 2.86 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.534 HG23 ' C ' ' A' ' 25' ' ' GLY . 69.5 p -153.98 150.51 28.36 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.165 -1.197 . . . . 0.0 110.242 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 95.2 mt -117.67 107.96 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.27 -0.894 . . . . 0.0 110.131 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.944 HG22 HG21 ' A' ' 62' ' ' THR . 73.1 p -101.0 -174.31 2.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.834 . . . . 0.0 110.097 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.635 HG22 HG13 ' A' ' 52' ' ' ILE . 43.5 p -74.87 -24.84 58.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 110.06 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -71.75 -62.46 1.41 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.09 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -56.88 -49.27 76.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.091 -1.006 . . . . 0.0 109.709 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.025 HD22 HD11 ' A' ' 52' ' ' ILE . 1.9 tp -60.36 -31.46 70.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.274 -0.891 . . . . 0.0 109.529 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.51 -43.12 96.17 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 38' ' ' SER . 30.7 m -73.74 -24.95 59.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.396 -1.061 . . . . 0.0 109.891 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.5 t -70.64 -33.65 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.356 -0.84 . . . . 0.0 110.253 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.2 mmt -89.24 -23.93 22.22 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.356 -0.84 . . . . 0.0 110.382 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.431 ' NH1' ' HG2' ' A' ' 37' ' ' ARG . 11.3 tpt180 -90.62 -11.24 40.5 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.226 -0.921 . . . . 0.0 110.738 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 34' ' ' THR . 23.8 t -67.8 -68.92 0.35 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.106 -0.996 . . . . 0.0 110.414 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.477 HD11 ' C16' ' A' ' 153' ' ' WW7 . 0.5 OUTLIER -139.42 68.39 1.37 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.301 -0.874 . . . . 0.0 110.179 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -158.89 -109.99 0.27 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -112.46 -164.54 0.92 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.319 -1.106 . . . . 0.0 110.05 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -124.82 64.53 42.58 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 110.453 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 152.49 51.71 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.862 1.454 . . . . 0.0 110.368 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.511 HG22 ' N ' ' A' ' 45' ' ' GLU . 35.6 m -100.73 173.47 6.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.183 -0.948 . . . . 0.0 109.826 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.511 ' N ' HG22 ' A' ' 44' ' ' THR . 1.8 mp0 -66.78 -22.73 66.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.143 -0.973 . . . . 0.0 110.353 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.15 -70.96 0.41 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.124 -0.985 . . . . 0.0 109.991 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -52.56 -30.54 31.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.287 -0.883 . . . . 0.0 109.251 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.538 HD11 HD23 ' A' ' 32' ' ' LEU . 5.5 tt -66.56 -46.52 75.78 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.462 -0.774 . . . . 0.0 109.361 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.408 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 2.0 tt0 -50.62 -39.25 49.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.293 -0.879 . . . . 0.0 108.812 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.98 -45.7 93.74 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.211 178.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.44 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 0.4 OUTLIER -57.24 -24.37 54.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.404 178.953 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.025 HD11 HD22 ' A' ' 32' ' ' LEU . 46.9 mm -83.3 -31.26 8.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.456 -0.778 . . . . 0.0 109.913 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -76.38 -24.3 54.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.284 -0.885 . . . . 0.0 110.243 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.485 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 24.0 pt-20 -84.72 -36.23 21.97 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.193 -0.942 . . . . 0.0 110.377 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.485 ' N ' ' HG3' ' A' ' 54' ' ' GLU . 71.2 t -77.18 -32.67 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.128 -0.982 . . . . 0.0 109.942 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -97.1 100.46 11.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.342 -0.848 . . . . 0.0 110.169 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -100.21 22.74 11.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.164 -0.96 . . . . 0.0 110.042 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.413 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 29.5 m-20 -92.8 -56.57 2.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 110.133 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.94 25.93 1.45 Allowed Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.244 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -110.18 -41.32 4.45 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.825 -1.397 . . . . 0.0 110.005 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.14 -81.89 0.28 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.514 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.944 HG21 HG22 ' A' ' 28' ' ' THR . 69.7 p -79.26 170.71 16.22 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.324 -1.104 . . . . 0.0 111.025 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.7 mt -97.01 153.93 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.301 -0.874 . . . . 0.0 110.337 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.458 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 0.8 OUTLIER -105.86 -171.55 1.92 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.241 -0.912 . . . . 0.0 110.258 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.558 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 33.6 t80 -82.43 -41.88 0.94 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.343 -0.848 . . . . 0.0 111.76 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.0 Cg_endo -74.61 -20.26 18.03 Favored 'Trans proline' 0 C--N 1.323 -0.768 0 O-C-N 123.006 1.003 . . . . 0.0 110.187 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.413 ' OE1' ' OD2' ' A' ' 58' ' ' ASP . 41.9 tt0 -83.71 -28.46 28.27 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.22 -0.925 . . . . 0.0 109.408 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 6.5 t80 -74.58 -46.59 37.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.625 -0.672 . . . . 0.0 110.118 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.687 ' O ' HD23 ' A' ' 69' ' ' LEU . 8.3 tt -74.03 -32.91 63.55 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.288 -0.883 . . . . 0.0 110.609 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.1 m -79.35 -22.4 44.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.245 -0.909 . . . . 0.0 110.892 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.666 ' HE2' ' HE3' ' A' ' 72' ' ' MET . 11.6 ptt? -89.65 -26.37 20.77 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.927 -1.108 . . . . 0.0 110.904 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.666 ' HE3' ' HE2' ' A' ' 71' ' ' MET . 52.5 mtt -90.72 -55.57 3.52 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.053 -1.029 . . . . 0.0 111.191 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.492 ' HB2' ' CE2' ' A' ' 12' ' ' PHE . . . -60.04 -57.88 10.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.259 -0.901 . . . . 0.0 110.772 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -110.81 65.04 0.61 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.246 -0.909 . . . . 0.0 110.692 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.459 ' HG3' ' N ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -58.6 -21.06 52.33 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.2 -0.938 . . . . 0.0 109.946 179.75 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.459 ' N ' ' HG3' ' A' ' 75' ' ' LYS . 31.4 ttm -89.12 95.97 10.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.314 -0.867 . . . . 0.0 110.326 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -103.97 153.89 20.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 110.125 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -174.97 99.68 0.08 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.106 -0.996 . . . . 0.0 110.383 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.614 HG22 ' H ' ' A' ' 80' ' ' ASP . 2.4 m -88.51 -176.71 5.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.157 -0.964 . . . . 0.0 109.839 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.614 ' H ' HG22 ' A' ' 79' ' ' THR . 61.6 t0 -116.18 122.74 45.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.126 -0.984 . . . . 0.0 110.39 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.4 p -109.89 -161.54 0.76 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.186 -0.946 . . . . 0.0 109.849 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -175.36 157.19 2.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -0.957 . . . . 0.0 110.278 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 56.75 21.75 6.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.864 . . . . 0.0 110.164 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -110.03 -44.93 3.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.37 -0.831 . . . . 0.0 109.911 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.544 HG23 ' CE1' ' A' ' 141' ' ' PHE . 13.7 mt -58.35 -17.17 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.895 . . . . 0.0 109.93 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -68.54 -52.27 33.88 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.154 -0.966 . . . . 0.0 109.533 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 38.8 mm-40 -61.66 -35.21 77.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 109.801 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.746 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -61.65 -61.14 2.73 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.221 -0.924 . . . . 0.0 109.737 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.427 ' CE2' ' HA ' ' A' ' 138' ' ' TYR . 31.9 t80 -54.44 -22.32 12.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.23 -0.919 . . . . 0.0 110.084 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 5.3 mtp180 -67.91 -44.98 75.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.097 -1.002 . . . . 0.0 109.817 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.746 HG22 ' O ' ' A' ' 88' ' ' ALA . 30.2 m -78.43 -21.59 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.344 -0.848 . . . . 0.0 110.576 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.845 ' CE1' HG11 ' A' ' 108' ' ' VAL . 38.4 m-85 -86.48 -15.5 39.95 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.129 -0.982 . . . . 0.0 110.587 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -124.44 47.78 2.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.219 -0.925 . . . . 0.0 110.223 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -106.49 40.4 1.63 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.324 -0.86 . . . . 0.0 110.163 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -124.35 -25.66 4.05 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.278 -0.888 . . . . 0.0 110.54 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 119.37 -32.02 5.21 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -47.34 -38.63 13.27 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.335 -1.097 . . . . 0.0 110.462 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.462 ' C ' ' CD1' ' A' ' 99' ' ' TYR . . . 97.19 -14.72 63.37 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.542 ' CD2' ' NE2' ' A' ' 135' ' ' GLN . 46.4 m-85 -135.03 168.47 19.06 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.114 -1.227 . . . . 0.0 110.118 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.446 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 37.1 mt -87.01 126.58 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.269 -0.895 . . . . 0.0 109.983 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.0 m -113.67 175.26 5.53 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.456 -0.777 . . . . 0.0 109.665 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.9 -43.68 78.69 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.136 -0.977 . . . . 0.0 110.279 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.67 -52.13 62.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.282 -0.886 . . . . 0.0 110.23 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -53.71 -53.3 54.07 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.221 -0.924 . . . . 0.0 110.126 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.5 tt -49.73 -39.43 37.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.268 -0.895 . . . . 0.0 110.247 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.436 ' O ' HG23 ' A' ' 110' ' ' THR . 44.0 ttt-85 -64.09 -38.84 92.51 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.22 -0.925 . . . . 0.0 110.41 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.405 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 54.2 t-80 -72.23 -19.19 61.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.255 -0.903 . . . . 0.0 110.524 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.845 HG11 ' CE1' ' A' ' 92' ' ' PHE . 90.1 t -84.4 -46.39 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.192 -0.943 . . . . 0.0 110.624 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.438 ' HB3' HD12 ' A' ' 116' ' ' LEU . 25.6 mmt -61.12 -48.17 82.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.141 -0.974 . . . . 0.0 110.668 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 106' ' ' ARG . 47.0 p -49.24 -37.44 23.35 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.207 -0.933 . . . . 0.0 110.56 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.405 ' ND2' ' O ' ' A' ' 107' ' ' HIS . 76.7 m-20 -73.39 -48.62 32.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.288 -0.882 . . . . 0.0 110.455 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.8 mt -59.14 -21.79 59.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 110.37 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.8 46.89 4.69 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 6.0 mm-40 -110.37 -29.5 8.09 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.26 -1.141 . . . . 0.0 110.197 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 114' ' ' GLU . 47.4 tttt 55.46 99.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.337 -0.852 . . . . 0.0 110.418 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.438 HD12 ' HB3' ' A' ' 109' ' ' MET . 0.5 OUTLIER -127.68 151.73 48.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.282 -0.886 . . . . 0.0 110.183 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.2 m -76.52 157.68 31.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 109.998 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -64.59 -42.91 95.28 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.229 -0.919 . . . . 0.0 110.354 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -56.63 -40.01 74.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.116 -0.99 . . . . 0.0 110.307 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 124' ' ' MET . 33.7 mt-10 -63.31 -46.37 87.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.162 -0.961 . . . . 0.0 110.159 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.418 ' O ' ' HB2' ' A' ' 124' ' ' MET . 95.1 t -55.27 -51.5 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.045 -1.034 . . . . 0.0 110.214 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -55.65 -46.99 77.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 110.229 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -62.9 -25.17 68.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -0.924 . . . . 0.0 110.237 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.418 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 73.7 mtp -73.84 -46.68 43.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.048 -1.032 . . . . 0.0 109.971 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 30.6 mm -61.29 -30.68 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.11 -0.994 . . . . 0.0 110.011 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.61 -43.46 47.98 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.246 -0.908 . . . . 0.0 110.265 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -67.43 -24.95 65.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.926 . . . . 0.0 110.071 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.75 -35.84 24.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.888 . . . . 0.0 110.204 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.4 ' OD2' ' HA2' ' A' ' 132' ' ' GLY . 23.1 t0 -61.32 96.09 0.05 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.922 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 140' ' ' GLU . 89.4 mt -67.77 -64.33 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.316 -0.865 . . . . 0.0 110.885 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.403 ' OD1' ' OE2' ' A' ' 140' ' ' GLU . 29.4 p30 -73.71 -19.79 60.71 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.234 -0.917 . . . . 0.0 110.906 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.4 ' HA2' ' OD2' ' A' ' 129' ' ' ASP . . . 80.66 75.4 1.08 Allowed Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.881 -1.152 . . . . 0.0 110.395 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 31.7 m-20 -111.35 -23.97 10.48 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.167 -1.196 . . . . 0.0 110.024 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 135.78 -39.3 1.68 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.542 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -132.76 170.71 14.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.567 -0.961 . . . . 0.0 109.69 179.633 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.446 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 91.1 t -95.28 133.83 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.972 -1.08 . . . . 0.0 110.231 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.506 ' ND2' ' CE2' ' A' ' 99' ' ' TYR . 17.1 t-20 -102.56 170.58 7.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.113 -0.992 . . . . 0.0 110.1 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.427 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 21.7 t80 -56.06 -47.18 78.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.23 -0.918 . . . . 0.0 110.462 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -55.73 -55.53 31.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -0.955 . . . . 0.0 110.273 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.419 ' HA ' HD12 ' A' ' 130' ' ' ILE . 52.6 mt-10 -58.35 -26.46 63.14 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.312 -0.867 . . . . 0.0 110.239 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.544 ' CE1' HG23 ' A' ' 85' ' ' ILE . 9.7 t80 -70.43 -32.1 69.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.253 -0.904 . . . . 0.0 110.151 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 87.0 t -82.33 -29.01 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.272 -0.892 . . . . 0.0 110.369 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -80.53 -23.79 39.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.275 -0.891 . . . . 0.0 110.424 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 54.7 ttp -80.51 -32.88 36.82 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.141 -0.975 . . . . 0.0 110.432 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.7 ttm -84.23 -11.47 56.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.246 -0.909 . . . . 0.0 110.803 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.497 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 44.7 p -118.4 133.46 55.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.092 -1.005 . . . . 0.0 110.214 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 146' ' ' THR . . . 58.57 157.82 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.251 -0.906 . . . . 0.0 110.674 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.177 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 153' ' ' WW7 . . . . . 0.557 'CL1 ' HD13 ' A' ' 32' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' WW7 . . . . . 0.513 ' H3 ' ' CD2' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.365 0.602 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -110.72 150.47 29.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.251 -0.906 . . . . 0.0 110.269 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.685 ' O ' HG23 ' A' ' 5' ' ' THR . 69.4 mt-30 -81.6 5.74 17.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.19 -0.944 . . . . 0.0 110.399 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 4' ' ' LEU . 7.6 mp 53.51 -88.8 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.283 -0.885 . . . . 0.0 110.533 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 3' ' ' GLN . 3.7 p 54.65 -168.87 0.07 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.318 -0.864 . . . . 0.0 110.45 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -58.68 -17.21 20.58 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.313 -0.867 . . . . 0.0 110.815 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -66.95 -37.81 84.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.024 -1.047 . . . . 0.0 109.93 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.484 ' HG3' ' CE2' ' A' ' 12' ' ' PHE . 21.6 tp60 -72.33 -55.39 7.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.352 -0.842 . . . . 0.0 110.18 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.441 HG22 ' HD2' ' A' ' 13' ' ' LYS . 64.1 mt -52.2 -38.92 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 109.884 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.455 ' HA ' ' HD3' ' A' ' 13' ' ' LYS . . . -65.87 -36.76 84.33 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.282 -0.886 . . . . 0.0 109.449 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -59.3 -50.05 75.48 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.388 -0.82 . . . . 0.0 109.832 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.484 ' CE2' ' HG3' ' A' ' 8' ' ' GLN . 23.0 m-85 -63.6 -32.66 74.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.279 -0.888 . . . . 0.0 109.918 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.455 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 31.7 mtpt -65.46 -36.62 84.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.27 -0.894 . . . . 0.0 110.163 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -69.63 -38.4 77.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 0.0 109.715 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.458 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -64.32 -39.46 93.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.289 -0.882 . . . . 0.0 109.999 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -62.52 -57.51 10.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.137 -0.977 . . . . 0.0 110.238 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.9 p -55.64 -26.53 44.88 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.264 -0.897 . . . . 0.0 109.516 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.562 HD13 ' C ' ' A' ' 18' ' ' LEU . 2.1 tm? -71.91 -36.88 70.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.407 -0.808 . . . . 0.0 109.978 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.458 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 15.4 m-85 -71.04 -56.49 6.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.062 -1.024 . . . . 0.0 109.538 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.79 101.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.425 -0.797 . . . . 0.0 109.997 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.6 mmtt -67.0 -42.79 84.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 109.979 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 53.0 p-10 -86.56 -15.18 40.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.334 -0.854 . . . . 0.0 110.598 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.426 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 67.8 37.67 88.77 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -79.85 -17.75 52.47 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.359 -1.083 . . . . 0.0 110.502 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.97 -21.79 22.18 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.374 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.4 p -119.72 158.08 27.23 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.923 -1.339 . . . . 0.0 110.786 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 96.3 mt -117.08 125.99 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.421 -0.799 . . . . 0.0 110.08 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.1 p -104.35 -162.49 0.9 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.0 110.121 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.673 HG22 HD12 ' A' ' 52' ' ' ILE . 20.1 p -87.81 -39.94 14.46 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.132 -0.98 . . . . 0.0 110.924 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -57.48 10.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.036 -1.04 . . . . 0.0 110.401 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -57.04 -42.1 79.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.949 . . . . 0.0 109.671 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.709 HD22 HD11 ' A' ' 52' ' ' ILE . 5.3 tp -63.37 -28.38 69.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.35 -0.843 . . . . 0.0 109.747 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.97 -47.71 79.47 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.5 m -66.74 -28.5 68.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.269 -1.136 . . . . 0.0 109.554 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.7 t -73.17 -28.28 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.48 -0.763 . . . . 0.0 110.102 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.416 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 25.7 mmt -83.4 -25.73 31.04 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.212 -0.93 . . . . 0.0 110.121 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -89.67 -16.7 29.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.888 . . . . 0.0 110.217 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.6 m -50.96 -54.56 23.24 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.319 -0.863 . . . . 0.0 110.232 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.8 39.93 1.83 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.306 -0.871 . . . . 0.0 110.337 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -131.39 -100.71 0.84 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -138.3 -155.79 0.63 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -1.157 . . . . 0.0 110.006 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -125.12 69.03 58.45 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.118 -0.989 . . . . 0.0 110.165 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 -160.95 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.906 1.477 . . . . 0.0 110.109 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.432 HG22 ' N ' ' A' ' 45' ' ' GLU . 35.4 m -134.73 166.5 22.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.127 -0.983 . . . . 0.0 110.266 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.432 ' N ' HG22 ' A' ' 44' ' ' THR . 5.9 mm-40 -63.24 -22.64 67.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.221 -0.924 . . . . 0.0 110.166 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.3 -70.03 0.39 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.102 -0.999 . . . . 0.0 110.043 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -50.57 -31.73 16.6 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.301 -0.875 . . . . 0.0 109.923 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.482 HD21 ' HA ' ' A' ' 29' ' ' THR . 5.6 tt -62.9 -50.88 69.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 110.066 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.419 ' O ' ' OD1' ' A' ' 53' ' ' ASN . 37.4 tt0 -53.3 -42.81 67.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.119 -0.988 . . . . 0.0 109.306 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -62.35 -34.75 77.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.631 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.441 ' HG2' ' H7 ' ' A' ' 153' ' ' WW7 . 4.7 ttp -68.94 -22.27 64.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.412 -0.805 . . . . 0.0 109.787 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.709 HD11 HD22 ' A' ' 32' ' ' LEU . 35.9 mt -87.38 -30.05 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.328 -0.857 . . . . 0.0 109.979 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 49' ' ' GLN . 3.6 m-20 -51.77 -42.93 62.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.171 -0.955 . . . . 0.0 110.079 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.438 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 13.3 pt-20 -68.57 -29.98 68.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.228 -0.92 . . . . 0.0 110.419 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.646 HG11 HD11 ' A' ' 63' ' ' ILE . 67.2 t -75.88 -69.87 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.208 -0.933 . . . . 0.0 110.166 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.428 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 54.2 t0 -43.17 94.15 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.541 -0.724 . . . . 0.0 110.881 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -109.89 61.4 0.6 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 109.773 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 1.7 p30 -164.0 -33.44 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.337 -0.852 . . . . 0.0 110.941 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.443 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 105.74 47.85 1.07 Allowed Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.098 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -117.73 -12.78 10.21 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.265 -1.138 . . . . 0.0 110.332 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.68 -56.59 4.14 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 59.4 p -109.31 170.3 8.14 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.255 -1.144 . . . . 0.0 110.248 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.646 HD11 HG11 ' A' ' 55' ' ' VAL . 39.6 mt -89.79 139.34 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.155 -0.966 . . . . 0.0 110.143 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.4 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 0.8 OUTLIER -103.56 179.68 4.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.219 -0.926 . . . . 0.0 110.176 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.569 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.2 t80 -73.56 -46.53 7.36 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 0.0 111.003 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.0 Cg_endo -71.66 -22.34 24.26 Favored 'Trans proline' 0 N--CA 1.482 0.807 0 O-C-N 123.186 1.098 . . . . 0.0 110.419 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.428 ' OE2' ' HA ' ' A' ' 56' ' ' ASP . 80.5 tt0 -81.37 -37.69 27.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.173 -0.954 . . . . 0.0 109.166 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.421 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 16.6 t80 -66.52 -38.73 87.82 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.525 -0.735 . . . . 0.0 109.867 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.497 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 1.1 tt -72.83 -36.35 67.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.354 -0.841 . . . . 0.0 110.059 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 92.7 m -76.22 -12.43 60.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.102 -0.999 . . . . 0.0 110.3 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.1 tmm? -89.09 -44.41 10.37 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.105 -0.997 . . . . 0.0 110.837 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.411 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 64.6 mtt -90.48 -37.76 13.69 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.028 -1.045 . . . . 0.0 111.135 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -57.4 -17.82 14.77 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.178 -0.951 . . . . 0.0 110.57 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -50.01 -29.39 8.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.208 -0.933 . . . . 0.0 110.648 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 76' ' ' MET . 14.5 tptt -60.66 97.69 0.06 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.221 -0.925 . . . . 0.0 110.729 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.41 ' O ' ' O ' ' A' ' 75' ' ' LYS . 56.9 mtm 48.3 -174.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.191 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.43 145.0 0.31 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.095 -1.003 . . . . 0.0 110.328 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -149.05 133.61 17.69 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.335 -0.853 . . . . 0.0 110.004 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 86.9 m -142.34 143.56 32.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.255 -0.903 . . . . 0.0 110.288 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -178.33 80.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.361 -0.837 . . . . 0.0 110.049 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 56.2 m -96.82 -173.52 2.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.316 -0.865 . . . . 0.0 110.296 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.461 ' OE1' ' N ' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -86.81 125.03 33.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.307 -0.871 . . . . 0.0 110.103 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -179.76 98.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -0.935 . . . . 0.0 110.336 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.78 -43.07 98.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.233 -0.917 . . . . 0.0 110.058 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 84.3 mt -53.42 -37.79 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.377 -0.827 . . . . 0.0 110.365 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.69 -55.44 23.37 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.136 -0.977 . . . . 0.0 109.777 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -49.46 -41.04 39.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.278 -0.889 . . . . 0.0 110.003 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.536 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -59.06 -59.9 4.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 110.028 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.428 ' O ' ' HB3' ' A' ' 93' ' ' ASP . 11.9 t80 -50.49 -22.58 1.99 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.314 -0.866 . . . . 0.0 110.134 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.3 ttt180 -72.26 -58.39 3.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 110.701 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 88' ' ' ALA . 30.3 m -60.19 -32.37 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.033 -1.042 . . . . 0.0 110.117 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.694 ' CE1' HG11 ' A' ' 108' ' ' VAL . 36.5 m-85 -80.47 -19.21 46.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.237 -0.914 . . . . 0.0 110.177 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 52.6 t0 -123.59 57.83 1.16 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.279 -0.888 . . . . 0.0 109.943 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.8 pttm -88.73 39.47 0.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.245 -0.91 . . . . 0.0 110.455 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.429 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 1.5 p30 -125.85 -30.64 2.99 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.31 -0.869 . . . . 0.0 110.316 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.93 38.78 3.06 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.721 -1.228 . . . . 0.0 111.006 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.507 ' O ' ' CE2' ' A' ' 99' ' ' TYR . 30.2 p30 -129.49 -21.84 3.11 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.75 -1.441 . . . . 0.0 110.99 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.507 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 79.93 48.65 6.44 Favored Glycine 0 N--CA 1.494 2.502 0 O-C-N 120.866 -1.146 . . . . 0.0 110.314 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 62.8 m-85 -151.19 142.53 23.36 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.172 -1.193 . . . . 0.0 110.323 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.485 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 21.2 mt -111.75 110.81 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.142 -0.974 . . . . 0.0 109.505 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.5 p -104.3 151.81 22.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.893 . . . . 0.0 110.181 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -46.84 -28.59 1.62 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.29 -0.881 . . . . 0.0 110.181 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.25 -56.01 10.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.281 -0.887 . . . . 0.0 110.241 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.85 ' O ' HG23 ' A' ' 108' ' ' VAL . 53.6 mt-10 -58.21 -31.13 67.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.206 -0.934 . . . . 0.0 110.182 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.001 HD23 HG13 ' A' ' 121' ' ' VAL . 39.5 tp -69.73 -34.59 74.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.973 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -77.79 -19.84 54.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.372 -0.83 . . . . 0.0 110.019 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -91.89 -20.29 21.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 0.0 110.167 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 104' ' ' GLU . 46.5 t -92.43 -50.83 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.165 -0.959 . . . . 0.0 110.1 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.616 ' HA ' HD12 ' A' ' 112' ' ' LEU . 17.1 mmt -46.96 -34.35 5.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.333 -0.854 . . . . 0.0 110.512 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.1 p -62.98 -51.89 65.11 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.236 -0.915 . . . . 0.0 109.708 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -53.67 -42.75 68.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.343 -0.848 . . . . 0.0 110.164 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.616 HD12 ' HA ' ' A' ' 109' ' ' MET . 17.4 mt -59.82 -37.7 79.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.282 -0.886 . . . . 0.0 110.152 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 125.03 -20.15 6.75 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -82.58 107.61 15.35 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.274 -1.133 . . . . 0.0 110.361 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -85.83 126.69 34.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.838 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 mt -130.38 156.95 43.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.204 -0.935 . . . . 0.0 110.287 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 91.7 m -91.37 155.44 18.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.28 -0.887 . . . . 0.0 110.393 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -46.42 -35.83 5.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.339 -0.851 . . . . 0.0 110.637 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -59.7 -64.38 0.97 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.155 -0.966 . . . . 0.0 110.669 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -50.24 -44.73 53.54 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.118 -0.989 . . . . 0.0 110.322 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 1.001 HG13 HD23 ' A' ' 105' ' ' LEU . 40.5 t -53.15 -48.23 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 110.056 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -61.22 -30.82 70.67 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.281 -0.887 . . . . 0.0 110.026 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -69.62 -36.92 76.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.337 -0.852 . . . . 0.0 110.168 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.1 mtp -71.98 -54.57 9.53 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.252 -0.905 . . . . 0.0 110.377 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.879 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 20.7 mm -52.42 -37.14 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.157 -0.964 . . . . 0.0 109.879 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 43.1 ttt-85 -66.84 -50.79 61.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.365 -0.835 . . . . 0.0 110.533 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -63.22 -21.0 65.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.177 -0.952 . . . . 0.0 110.492 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.494 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -92.57 -16.96 25.04 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.174 -0.954 . . . . 0.0 110.652 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -82.44 78.49 9.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.04 -1.038 . . . . 0.0 109.955 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.425 HD12 ' CB ' ' A' ' 140' ' ' GLU . 14.4 mt -48.95 -57.41 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.46 -0.775 . . . . 0.0 110.809 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 27.4 p30 -81.55 -19.12 42.71 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.035 -1.041 . . . . 0.0 110.903 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 76.5 69.24 1.42 Allowed Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.938 -1.125 . . . . 0.0 110.457 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.427 ' O ' ' HG2' ' A' ' 135' ' ' GLN . 53.8 m-20 -111.77 19.24 18.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.123 -1.222 . . . . 0.0 109.848 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 68.78 18.01 71.86 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 133' ' ' ASP . 2.1 pt20 -170.46 138.75 1.56 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.309 -1.113 . . . . 0.0 109.916 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.485 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 57.7 t -94.44 123.54 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.141 -0.974 . . . . 0.0 110.044 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -93.67 175.53 6.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.169 -0.957 . . . . 0.0 109.977 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.415 ' O ' HG23 ' A' ' 142' ' ' VAL . 23.5 t80 -59.06 -48.76 80.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.254 -0.904 . . . . 0.0 110.603 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.38 -50.83 64.28 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.103 -0.998 . . . . 0.0 110.665 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.425 ' CB ' HD12 ' A' ' 130' ' ' ILE . 54.4 mt-10 -64.03 -28.28 69.69 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.114 -0.991 . . . . 0.0 110.126 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.65 ' CZ ' ' HE3' ' A' ' 145' ' ' MET . 13.8 t80 -73.0 -20.9 60.92 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.335 -0.853 . . . . 0.0 110.03 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.64 ' O ' HG23 ' A' ' 146' ' ' THR . 79.0 t -87.39 -32.93 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.312 -0.868 . . . . 0.0 110.624 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.3 -20.1 32.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.133 -0.979 . . . . 0.0 111.272 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.494 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 19.9 ptt? -82.82 -32.6 27.53 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.864 -1.147 . . . . 0.0 110.964 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.65 ' HE3' ' CZ ' ' A' ' 141' ' ' PHE . 54.9 mtt -90.48 -27.36 19.27 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.922 -1.111 . . . . 0.0 110.671 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.64 HG23 ' O ' ' A' ' 142' ' ' VAL . 0.9 OUTLIER -51.25 -81.8 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.131 -0.981 . . . . 0.0 110.723 -179.682 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -138.14 153.48 49.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.17 -0.956 . . . . 0.0 110.472 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.195 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 153' ' ' WW7 . . . . . 0.441 ' H7 ' ' HG2' ' A' ' 51' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' WW7 . . . . . 0.879 'CL1 ' HD13 ' A' ' 125' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.293 0.568 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 2' ' ' ASP . 1.8 p30 -141.14 60.04 1.51 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.307 -0.871 . . . . 0.0 110.15 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -97.33 -60.98 1.47 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.38 -0.825 . . . . 0.0 110.384 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.1 mt -122.76 -133.05 0.28 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.218 -0.926 . . . . 0.0 110.257 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.46 HG22 ' N ' ' A' ' 6' ' ' GLU . 32.3 m -108.83 167.45 10.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.796 -1.19 . . . . 0.0 110.509 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.46 ' N ' HG22 ' A' ' 5' ' ' THR . 16.1 pt-20 -64.67 -14.3 57.72 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.282 -0.886 . . . . 0.0 110.222 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -66.15 -27.67 68.2 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.226 -0.921 . . . . 0.0 109.983 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -70.69 -44.92 65.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.308 -0.87 . . . . 0.0 109.73 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 86.5 mt -63.07 -48.13 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.751 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.59 -31.8 70.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.317 -0.864 . . . . 0.0 109.9 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.75 -51.93 62.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.355 -0.841 . . . . 0.0 109.888 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.427 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 10.7 m-30 -56.35 -46.73 79.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.354 -0.841 . . . . 0.0 110.09 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -62.39 -26.08 68.28 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.329 -0.857 . . . . 0.0 110.34 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -69.85 -66.29 0.61 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.112 -0.992 . . . . 0.0 110.13 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.418 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -48.59 -39.27 23.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -0.913 . . . . 0.0 109.966 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -62.19 -43.82 97.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -0.942 . . . . 0.0 109.963 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.5 m -65.04 -18.46 65.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 109.85 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.891 HD13 ' O ' ' A' ' 18' ' ' LEU . 2.9 tm? -87.75 -31.03 19.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 110.022 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.418 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 21.4 m-85 -74.46 -43.88 54.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.15 -0.968 . . . . 0.0 110.138 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -71.73 125.77 27.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.339 -0.85 . . . . 0.0 110.255 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.402 ' HD2' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -108.47 -51.93 2.83 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.205 -0.934 . . . . 0.0 110.795 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 3.0 p30 -70.6 -22.22 62.57 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.137 -0.977 . . . . 0.0 110.16 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.417 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 83.92 51.01 4.15 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.417 ' OD1' ' OG1' ' A' ' 26' ' ' THR . 7.0 p30 -104.72 18.62 21.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.109 -1.23 . . . . 0.0 110.335 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.812 ' O ' HG23 ' A' ' 26' ' ' THR . . . 49.6 41.67 34.43 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.812 HG23 ' O ' ' A' ' 25' ' ' GLY . 0.8 OUTLIER -166.56 160.47 15.25 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.306 -1.114 . . . . 0.0 110.291 179.803 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 55.3 mt -121.9 118.2 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.315 -0.865 . . . . 0.0 109.884 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.591 HG22 ' H ' ' A' ' 29' ' ' THR . 5.8 m -105.93 -179.82 4.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.495 -0.753 . . . . 0.0 110.034 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.591 ' H ' HG22 ' A' ' 28' ' ' THR . 13.5 p -71.58 -16.84 62.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.113 -0.992 . . . . 0.0 110.353 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -75.6 -67.72 0.64 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 109.846 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.402 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 50.6 mt-10 -53.71 -41.32 66.85 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.317 -0.865 . . . . 0.0 109.415 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.039 HD22 HD11 ' A' ' 52' ' ' ILE . 1.8 tp -63.88 -38.52 91.4 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.346 -0.846 . . . . 0.0 109.28 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.49 ' HA2' HD12 ' A' ' 48' ' ' LEU . . . -51.87 -42.31 53.18 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.5 m -70.4 -45.08 66.68 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.382 -1.069 . . . . 0.0 110.085 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.5 t -50.06 -43.4 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.357 -0.84 . . . . 0.0 110.735 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 21.8 mmt -85.34 -23.66 27.95 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.237 -0.914 . . . . 0.0 110.318 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 32.9 ttt180 -70.63 -16.7 62.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.381 -0.824 . . . . 0.0 110.139 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -102.61 -22.95 13.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 110.234 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.441 HD13 ' HA ' ' A' ' 39' ' ' LEU . 3.3 mm? -112.44 59.52 0.64 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.218 -0.926 . . . . 0.0 110.262 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.82 69.11 0.41 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.415 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 48.6 tt0 -58.17 106.72 0.4 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.241 -1.153 . . . . 0.0 110.114 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.557 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.9 m120 -155.54 -65.39 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.282 -0.886 . . . . 0.0 110.577 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.557 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 44.0 Cg_endo -70.15 166.08 29.26 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 123.429 1.226 . . . . 0.0 110.097 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.612 HG22 ' N ' ' A' ' 45' ' ' GLU . 41.8 m -132.32 -98.32 0.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.104 -0.997 . . . . 0.0 110.041 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.612 ' N ' HG22 ' A' ' 44' ' ' THR . 87.7 tt0 -110.77 -46.25 3.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.818 -1.176 . . . . 0.0 110.151 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.02 -63.25 1.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 109.971 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 29.1 mt-10 -50.24 -40.4 47.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.603 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.524 HD23 ' C ' ' A' ' 48' ' ' LEU . 10.6 tt -54.92 -53.45 55.35 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.295 -0.878 . . . . 0.0 109.412 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -48.74 -39.8 26.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.815 . . . . 0.0 109.821 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 39.0 t70 -57.92 -44.93 87.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.325 -0.859 . . . . 0.0 109.528 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.448 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 0.7 OUTLIER -62.78 -24.83 67.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.376 -0.828 . . . . 0.0 109.731 179.549 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.039 HD11 HD22 ' A' ' 32' ' ' LEU . 46.2 mm -80.02 -23.38 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.408 -0.808 . . . . 0.0 110.174 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -79.14 -30.99 43.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.151 -0.968 . . . . 0.0 110.094 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.565 ' HG3' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -76.3 -13.63 60.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 110.136 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.565 HG23 ' HG3' ' A' ' 54' ' ' GLU . 93.2 t -103.01 -60.76 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.89 . . . . 0.0 110.117 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -45.87 108.75 0.14 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.397 -0.815 . . . . 0.0 110.185 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.41 13.34 25.59 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.312 -0.868 . . . . 0.0 110.539 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -110.38 -60.27 1.83 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.11 -0.994 . . . . 0.0 109.87 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 132.56 47.0 0.11 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.466 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 19.4 p30 -126.22 -31.27 2.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.372 -1.075 . . . . 0.0 110.526 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.466 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 115.49 -60.2 0.41 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.42 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 81.5 p -89.59 170.27 10.62 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.07 -1.253 . . . . 0.0 110.566 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.493 ' CD1' HG11 ' A' ' 55' ' ' VAL . 81.7 mt -108.21 152.26 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.054 -1.029 . . . . 0.0 110.291 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.452 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.4 m-20 -101.15 179.54 4.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.358 -0.839 . . . . 0.0 110.242 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.542 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 7.5 t80 -73.08 -42.45 7.16 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 111.038 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 46.6 Cg_endo -76.87 -30.28 4.75 Favored 'Trans proline' 0 C--N 1.327 -0.567 0 O-C-N 123.125 1.066 . . . . 0.0 109.837 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -72.7 -20.76 61.16 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.425 -0.797 . . . . 0.0 109.147 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.514 ' CE2' ' CE ' ' A' ' 72' ' ' MET . 8.5 t80 -82.05 -49.47 10.18 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.589 -0.694 . . . . 0.0 110.048 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.87 -18.5 64.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.004 -1.06 . . . . 0.0 110.232 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 72.8 m -90.04 -33.82 16.18 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.168 -0.957 . . . . 0.0 110.47 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.49 ' SD ' HG13 ' A' ' 55' ' ' VAL . 4.9 ptm -77.52 -25.15 50.02 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.171 -0.956 . . . . 0.0 110.265 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.514 ' CE ' ' CE2' ' A' ' 68' ' ' PHE . 1.1 mmt -84.4 -33.57 23.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.231 -0.918 . . . . 0.0 110.257 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.09 -52.49 10.9 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.18 -0.95 . . . . 0.0 110.03 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 76' ' ' MET . 1.7 tpt180 -110.65 73.14 0.81 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.333 -0.855 . . . . 0.0 109.879 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.58 94.95 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.722 -0.611 . . . . 0.0 110.666 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.45 ' N ' ' O ' ' A' ' 74' ' ' ARG . 61.2 mtt -64.25 139.97 58.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.387 -0.821 . . . . 0.0 110.52 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.8 tttt -100.0 -40.18 7.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.381 -0.824 . . . . 0.0 110.192 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -174.84 -56.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.199 -0.938 . . . . 0.0 110.157 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.1 p -104.71 149.83 25.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 0.0 110.092 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -140.08 132.3 28.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.235 -0.916 . . . . 0.0 110.384 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 24.3 m -132.15 142.91 49.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.328 -0.858 . . . . 0.0 110.087 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -48.69 -33.18 9.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.924 . . . . 0.0 110.076 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 45.01 75.67 0.1 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.393 -0.817 . . . . 0.0 110.641 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.441 ' HG3' ' N ' ' A' ' 85' ' ' ILE . 15.8 pt-20 -73.01 -32.35 65.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.136 -0.977 . . . . 0.0 110.109 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.441 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 56.9 mt -53.43 -44.12 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.193 -0.942 . . . . 0.0 109.69 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -50.98 -49.65 59.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.354 -0.842 . . . . 0.0 110.039 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 4.7 mp0 -54.44 -41.84 69.87 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.234 -0.916 . . . . 0.0 110.145 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.81 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -61.45 -63.94 1.11 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.255 -0.903 . . . . 0.0 110.285 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.466 ' CZ ' ' OD2' ' A' ' 93' ' ' ASP . 9.2 t80 -45.62 -27.85 0.86 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.281 -0.887 . . . . 0.0 110.466 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.428 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 34.7 ttm-85 -66.62 -50.76 61.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.184 -0.948 . . . . 0.0 109.705 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.81 HG22 ' O ' ' A' ' 88' ' ' ALA . 33.2 m -70.04 -18.38 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.269 -0.895 . . . . 0.0 110.329 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.554 ' CD2' ' H3 ' ' A' ' 154' ' ' WW7 . 37.0 m-85 -94.52 -8.42 38.39 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.141 -0.974 . . . . 0.0 110.443 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.466 ' OD2' ' CZ ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -140.54 35.56 1.83 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.096 -1.002 . . . . 0.0 110.194 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.21 10.77 15.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 110.361 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 2.7 p30 -83.49 -19.61 35.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.082 -1.011 . . . . 0.0 110.196 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.68 29.21 5.39 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 17.9 t-20 -98.42 -72.49 0.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.332 -1.099 . . . . 0.0 110.102 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.494 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 135.83 -14.81 4.1 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.499 ' CE1' ' OD1' ' A' ' 137' ' ' ASN . 27.6 m-85 -139.18 152.07 47.1 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.018 -1.283 . . . . 0.0 109.971 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.439 HG23 ' HB3' ' A' ' 92' ' ' PHE . 37.9 mt -81.61 121.79 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.022 -1.049 . . . . 0.0 110.159 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.1 m -111.56 176.28 5.08 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.469 -0.769 . . . . 0.0 109.828 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.21 -56.24 10.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.155 -0.966 . . . . 0.0 110.194 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -49.78 -54.16 20.84 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.236 -0.915 . . . . 0.0 110.333 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.462 ' O ' HG23 ' A' ' 108' ' ' VAL . 50.7 mt-10 -53.47 -43.67 68.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 tt -59.09 -37.95 78.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.324 -0.86 . . . . 0.0 110.38 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.818 ' O ' HG23 ' A' ' 110' ' ' THR . 2.5 tmt_? -69.47 -28.44 66.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.05 -1.031 . . . . 0.0 109.632 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -71.55 -29.44 64.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.336 -0.853 . . . . 0.0 109.843 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.531 HG21 ' HA ' ' A' ' 92' ' ' PHE . 34.0 t -79.28 -50.2 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.316 -0.865 . . . . 0.0 110.073 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -49.95 -43.74 50.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.363 -0.836 . . . . 0.0 110.266 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.818 HG23 ' O ' ' A' ' 106' ' ' ARG . 69.1 p -50.7 -43.41 57.68 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.284 -0.885 . . . . 0.0 110.023 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -58.46 -41.22 84.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.311 -0.868 . . . . 0.0 110.243 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.3 mt -62.09 -53.52 54.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.263 -0.898 . . . . 0.0 110.365 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.66 40.07 0.34 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -111.3 -175.04 2.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.164 -1.198 . . . . 0.0 110.197 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -144.23 81.14 1.66 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.921 . . . . 0.0 110.147 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.97 161.03 15.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.304 -0.873 . . . . 0.0 110.089 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.431 HG22 ' HG2' ' A' ' 120' ' ' GLU . 11.0 t -98.6 -165.4 1.24 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.887 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -80.98 -43.97 18.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.117 -0.989 . . . . 0.0 110.362 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 122' ' ' ASP . 65.2 mm-40 -50.61 -54.35 23.49 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.26 -0.9 . . . . 0.0 110.719 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.431 ' HG2' HG22 ' A' ' 117' ' ' THR . 69.9 mm-40 -48.69 -61.93 1.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.12 -0.987 . . . . 0.0 110.698 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.2 t -47.73 -39.19 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.206 -0.933 . . . . 0.0 110.625 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.441 ' HB3' ' O ' ' A' ' 119' ' ' GLU . 38.7 t70 -56.57 -47.5 79.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.994 -1.066 . . . . 0.0 110.066 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.46 -25.68 66.84 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.248 -0.908 . . . . 0.0 110.286 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 24.4 mmm -70.27 -57.06 5.3 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.187 -0.945 . . . . 0.0 110.14 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.66 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 25.4 mm -57.34 -31.39 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.381 -0.825 . . . . 0.0 110.409 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -76.64 -32.95 58.32 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.135 -0.978 . . . . 0.0 110.235 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -69.97 -33.23 71.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 0.0 110.141 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.475 ' HA ' ' HB2' ' A' ' 144' ' ' MET . . . -79.81 -43.41 22.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.927 . . . . 0.0 110.336 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -60.21 98.35 0.06 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.135 -0.978 . . . . 0.0 109.943 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.442 ' CD1' ' HA ' ' A' ' 140' ' ' GLU . 5.4 mt -56.22 -42.97 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.294 -0.879 . . . . 0.0 110.333 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 53.5 p-10 -76.65 -15.92 59.68 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.042 -1.036 . . . . 0.0 110.231 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.456 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 55.68 55.18 30.14 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.425 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 2.5 p30 -97.53 -21.77 16.92 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.207 -1.172 . . . . 0.0 110.267 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 130.66 0.56 5.27 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.384 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.425 ' HG3' ' OD1' ' A' ' 133' ' ' ASP . 0.1 OUTLIER -154.95 151.01 28.01 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.862 -1.375 . . . . 0.0 110.6 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.589 HG23 HG23 ' A' ' 125' ' ' ILE . 71.8 t -100.25 142.14 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.202 -0.936 . . . . 0.0 110.305 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.499 ' OD1' ' CE1' ' A' ' 99' ' ' TYR . 2.5 t30 -111.2 -169.59 1.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.426 -0.796 . . . . 0.0 110.047 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.683 ' O ' HG23 ' A' ' 142' ' ' VAL . 49.3 t80 -75.37 -57.06 4.12 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.26 -0.9 . . . . 0.0 110.264 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -55.68 -52.02 65.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.86 . . . . 0.0 110.604 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.442 ' HA ' ' CD1' ' A' ' 130' ' ' ILE . 51.7 mt-10 -56.82 -46.88 81.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 110.526 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.557 ' CD1' ' HE2' ' A' ' 144' ' ' MET . 35.2 t80 -59.82 -25.36 64.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.094 -1.004 . . . . 0.0 110.322 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 138' ' ' TYR . 60.2 t -86.48 -22.25 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.247 -0.908 . . . . 0.0 110.383 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -98.82 -9.13 24.78 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.34 -0.85 . . . . 0.0 110.663 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.557 ' HE2' ' CD1' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -90.69 -30.93 16.82 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.002 -1.061 . . . . 0.0 110.806 -179.686 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.428 ' HE1' ' O2 ' ' A' ' 154' ' ' WW7 . 43.4 ttm -88.98 -45.65 9.49 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.071 -1.018 . . . . 0.0 109.609 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 65.6 p -74.28 122.66 23.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.445 -0.784 . . . . 0.0 109.86 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -174.08 85.98 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.116 -0.99 . . . . 0.0 110.412 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 7.5 mptt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.162 179.958 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 153' ' ' WW7 . . . . . 0.558 ' C6 ' HG21 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' WW7 . . . . . 0.664 H121 ' HB2' ' A' ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.254 0.549 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -134.33 112.39 10.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.905 . . . . 0.0 109.971 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -131.7 69.99 1.47 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.89 . . . . 0.0 110.029 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.44 175.78 9.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.835 . . . . 0.0 110.125 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.657 HG22 ' H ' ' A' ' 7' ' ' GLU . 50.4 m -117.64 137.02 52.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.944 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -74.68 -15.62 60.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.299 -0.876 . . . . 0.0 110.598 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.657 ' H ' HG22 ' A' ' 5' ' ' THR . 3.6 tp10 -63.37 -28.37 69.95 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.065 -1.022 . . . . 0.0 110.202 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -73.37 -53.7 10.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.18 -0.95 . . . . 0.0 110.278 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.3 mt -54.84 -44.49 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 110.103 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.32 -36.12 79.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.335 -0.853 . . . . 0.0 109.481 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -63.62 -36.98 85.6 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.301 -0.875 . . . . 0.0 109.766 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -73.61 -22.8 59.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.318 -0.864 . . . . 0.0 109.817 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -72.66 -39.62 66.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.8 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -70.85 -39.29 73.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.394 -0.816 . . . . 0.0 110.031 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.95 -53.06 52.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.186 -0.946 . . . . 0.0 109.996 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.519 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 26.5 t80 -55.5 -39.37 70.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 109.866 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.6 m -67.69 -30.8 70.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -0.876 . . . . 0.0 109.981 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.772 HD13 ' O ' ' A' ' 18' ' ' LEU . 1.9 tm? -65.07 -38.58 91.24 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.347 -0.846 . . . . 0.0 110.033 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.477 ' CE2' ' H3 ' ' A' ' 153' ' ' WW7 . 23.1 m-85 -75.87 -61.92 1.77 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.77 112.74 0.7 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 110.027 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -109.23 -42.13 4.47 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.227 -0.921 . . . . 0.0 110.69 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -71.34 -33.13 69.33 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.121 -0.987 . . . . 0.0 110.253 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.06 74.17 1.1 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -142.83 15.69 1.94 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.276 -1.132 . . . . 0.0 110.242 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.594 ' O ' HG23 ' A' ' 26' ' ' THR . . . 49.19 35.53 19.94 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 25' ' ' GLY . 20.3 p -156.86 149.29 23.28 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.228 -1.16 . . . . 0.0 110.119 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.3 mt -112.87 121.78 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.274 -0.892 . . . . 0.0 110.388 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.577 HG23 ' H ' ' A' ' 30' ' ' LYS . 8.8 t -122.39 -175.66 3.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -0.872 . . . . 0.0 109.779 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.532 HG21 ' OE1' ' A' ' 49' ' ' GLN . 29.0 p -62.16 -26.34 68.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.114 -0.991 . . . . 0.0 110.189 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.577 ' H ' HG23 ' A' ' 28' ' ' THR . 19.0 mtmt -69.87 -60.36 2.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -0.907 . . . . 0.0 110.018 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.449 ' O ' HG23 ' A' ' 35' ' ' VAL . 84.8 mt-10 -59.07 -61.2 2.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.11 -0.994 . . . . 0.0 109.778 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.04 HD22 HD11 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -51.53 -33.38 31.69 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.272 -0.892 . . . . 0.0 109.761 179.768 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.29 -44.91 94.81 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.446 ' O ' ' HB2' ' A' ' 38' ' ' SER . 90.8 m -76.62 -17.4 59.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -1.148 . . . . 0.0 109.781 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 31' ' ' GLU . 54.2 t -73.42 -39.3 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.291 -0.881 . . . . 0.0 110.135 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 21.4 mmt -90.33 -27.58 19.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -0.896 . . . . 0.0 110.466 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -82.61 -26.9 31.84 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.273 -0.892 . . . . 0.0 110.588 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.479 ' CB ' HD23 ' A' ' 39' ' ' LEU . 22.4 t -51.81 -32.69 32.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.995 . . . . 0.0 110.126 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.954 HD21 HN21 ' A' ' 153' ' ' WW7 . 0.5 OUTLIER -158.46 69.18 0.49 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.897 . . . . 0.0 110.153 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . 177.4 -64.84 0.09 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 40' ' ' GLY . 53.4 mt-30 55.14 19.62 2.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.256 -1.144 . . . . 0.0 110.314 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.506 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 2.6 m120 -72.35 -58.32 3.13 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.17 -0.956 . . . . 0.0 110.412 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.506 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 42.7 Cg_endo -70.66 -169.51 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.768 1.404 . . . . 0.0 110.299 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.626 HG22 ' H ' ' A' ' 45' ' ' GLU . 4.1 m -135.72 -177.31 4.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.288 -0.883 . . . . 0.0 109.832 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.626 ' H ' HG22 ' A' ' 44' ' ' THR . 45.2 mt-10 -67.24 -50.3 61.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.087 -1.008 . . . . 0.0 110.252 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.79 -56.65 15.58 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.197 -0.939 . . . . 0.0 110.04 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -52.01 -34.78 44.37 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.207 -0.933 . . . . 0.0 109.408 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.757 HD11 HD23 ' A' ' 32' ' ' LEU . 9.5 tt -63.68 -45.02 91.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.423 -0.798 . . . . 0.0 109.224 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.532 ' OE1' HG21 ' A' ' 29' ' ' THR . 1.5 tp-100 -49.47 -43.65 45.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.348 -0.845 . . . . 0.0 109.172 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -62.83 -45.21 93.68 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.412 -0.805 . . . . 0.0 109.342 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.438 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 3.7 ttp -59.36 -17.65 31.7 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.345 -0.847 . . . . 0.0 109.772 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.04 HD11 HD22 ' A' ' 32' ' ' LEU . 31.0 mm -90.46 -28.73 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 110.195 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -74.9 -27.18 60.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.323 -0.86 . . . . 0.0 110.552 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.637 ' HG3' HG23 ' A' ' 55' ' ' VAL . 25.3 pt-20 -74.35 -9.14 58.31 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.095 -1.003 . . . . 0.0 110.497 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.637 HG23 ' HG3' ' A' ' 54' ' ' GLU . 44.0 t -112.01 -23.18 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.043 -1.036 . . . . 0.0 110.523 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -91.26 109.05 20.32 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.13 -0.981 . . . . 0.0 110.333 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.25 16.15 21.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 110.329 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 40.1 m-20 -97.82 -69.83 0.74 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.274 -0.892 . . . . 0.0 110.42 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.65 -22.1 0.33 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -69.53 -21.48 63.65 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.08 -1.247 . . . . 0.0 110.123 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.54 -41.46 2.3 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.8 p -89.8 170.22 10.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.128 -1.219 . . . . 0.0 110.52 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.439 HD13 HG11 ' A' ' 55' ' ' VAL . 75.1 mt -104.55 151.43 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.367 -0.833 . . . . 0.0 109.892 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.425 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 1.6 m-20 -112.03 -167.28 1.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 110.255 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.552 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 23.5 t80 -73.97 -43.35 6.25 Favored Pre-proline 0 C--N 1.303 -1.422 0 O-C-N 121.284 -0.885 . . . . 0.0 111.099 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.3 Cg_endo -74.42 -30.04 8.67 Favored 'Trans proline' 0 C--O 1.211 -0.859 0 O-C-N 123.026 1.014 . . . . 0.0 110.006 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.435 ' HB3' HG23 ' A' ' 63' ' ' ILE . 1.3 tt0 -75.02 -26.02 59.19 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.098 -1.001 . . . . 0.0 108.918 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.562 ' CE1' ' CE ' ' A' ' 72' ' ' MET . 80.4 t80 -75.36 -43.56 49.76 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.62 -0.675 . . . . 0.0 110.405 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.406 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 4.2 tp -80.8 -16.73 52.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.341 -0.85 . . . . 0.0 110.363 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 34.6 m -84.28 -34.02 23.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.065 -1.022 . . . . 0.0 110.651 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.523 ' HE3' ' HG3' ' A' ' 72' ' ' MET . 0.0 OUTLIER -88.67 -30.11 19.39 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.94 -1.1 . . . . 0.0 110.52 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.562 ' CE ' ' CE1' ' A' ' 68' ' ' PHE . 25.3 mtt -81.56 -11.35 59.19 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.047 -1.033 . . . . 0.0 110.515 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.07 -22.1 66.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.125 -0.984 . . . . 0.0 110.042 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -110.25 61.61 0.6 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.219 -0.926 . . . . 0.0 110.505 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.33 147.97 22.94 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.228 -0.92 . . . . 0.0 110.069 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 51.6 mtt -117.31 166.18 12.59 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.143 -0.973 . . . . 0.0 110.923 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.9 mtmm -103.87 129.44 51.36 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.408 -0.807 . . . . 0.0 110.132 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -172.85 110.72 0.21 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.292 -0.88 . . . . 0.0 110.204 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -130.08 152.78 49.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.215 -0.928 . . . . 0.0 110.094 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -59.23 124.88 21.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.29 -0.881 . . . . 0.0 110.683 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.0 m -88.0 130.25 35.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.195 -0.94 . . . . 0.0 110.016 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -120.92 -26.02 5.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.211 -0.93 . . . . 0.0 110.358 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.404 ' O ' ' OE2' ' A' ' 87' ' ' GLU . 12.9 tt0 -156.37 75.96 0.88 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.281 -0.887 . . . . 0.0 109.793 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.418 ' OE2' H152 ' A' ' 154' ' ' WW7 . 29.1 tt0 -105.84 -46.26 4.17 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.288 -0.883 . . . . 0.0 110.61 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.915 HD11 HG21 ' A' ' 146' ' ' THR . 88.7 mt -59.8 -48.68 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.137 -0.977 . . . . 0.0 110.407 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -56.69 -53.4 58.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.185 -0.947 . . . . 0.0 110.112 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.404 ' OE2' ' O ' ' A' ' 83' ' ' GLU . 34.9 mt-10 -46.93 -41.78 16.6 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.288 -0.883 . . . . 0.0 110.339 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.517 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -59.61 -59.36 5.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.147 -0.971 . . . . 0.0 110.099 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -49.63 -23.88 1.93 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.16 -0.963 . . . . 0.0 110.461 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -76.42 -43.95 38.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.285 -0.885 . . . . 0.0 111.171 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 88' ' ' ALA . 16.6 m -79.42 -19.23 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.042 -1.036 . . . . 0.0 110.966 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.489 ' CD1' HG23 ' A' ' 91' ' ' VAL . 24.9 m-85 -89.36 -24.46 21.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.102 -0.999 . . . . 0.0 109.982 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -106.89 92.7 4.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.276 -0.89 . . . . 0.0 109.366 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -100.17 -33.55 10.4 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.167 -0.958 . . . . 0.0 111.402 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 3.1 p30 -69.61 -38.45 77.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.956 -1.09 . . . . 0.0 110.438 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 106.41 41.95 1.68 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.446 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 39.4 p-10 -110.96 -14.82 13.89 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.352 -1.087 . . . . 0.0 110.412 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.5 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 69.28 43.99 67.97 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.5 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 33.5 m-85 -157.8 116.51 3.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.448 -1.031 . . . . 0.0 110.15 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 24.2 mt -87.86 113.22 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.01 -1.056 . . . . 0.0 109.647 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 90.5 p -99.38 159.22 15.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.167 -0.958 . . . . 0.0 110.266 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.2 -18.26 24.76 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.139 -0.976 . . . . 0.0 110.098 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.75 -66.91 0.65 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.233 -0.917 . . . . 0.0 109.983 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.915 ' O ' HG23 ' A' ' 108' ' ' VAL . 92.0 mt-10 -51.65 -39.22 57.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.183 -0.948 . . . . 0.0 109.724 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.959 HD12 HD11 ' A' ' 125' ' ' ILE . 1.5 tt -64.27 -41.34 96.97 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.593 -0.692 . . . . 0.0 110.311 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 57.7 ttp85 -65.89 -23.15 66.58 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.221 -0.924 . . . . 0.0 110.027 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -94.52 -14.7 24.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.384 -0.822 . . . . 0.0 110.245 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.915 HG23 ' O ' ' A' ' 104' ' ' GLU . 72.2 t -82.45 -49.02 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.314 -0.866 . . . . 0.0 110.264 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.6 mmt -60.14 -55.48 33.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.165 -0.959 . . . . 0.0 110.387 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.3 p -49.67 -30.42 9.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.249 -0.907 . . . . 0.0 110.491 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -74.18 -58.48 3.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.218 -0.926 . . . . 0.0 110.293 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.3 mt -47.37 -76.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.257 -0.902 . . . . 0.0 110.326 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.35 43.09 0.06 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -125.3 159.61 31.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -1.208 . . . . 0.0 110.127 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.75 60.4 1.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 110.441 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.03 -174.22 4.35 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.253 -0.905 . . . . 0.0 109.88 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 121' ' ' VAL . 6.9 t -126.92 173.32 9.7 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.073 -1.017 . . . . 0.0 110.277 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 88.4 m-20 -58.48 -39.04 78.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -0.89 . . . . 0.0 110.283 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.03 -68.16 0.34 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.27 -0.894 . . . . 0.0 111.057 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.448 ' OE1' ' N ' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -47.78 -47.14 30.89 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.271 -0.893 . . . . 0.0 111.194 -179.181 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 117' ' ' THR . 78.9 t -54.89 -48.58 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.011 -1.056 . . . . 0.0 110.412 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -61.84 -30.56 70.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.106 -0.996 . . . . 0.0 109.938 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.11 -32.36 70.36 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.281 -0.887 . . . . 0.0 109.728 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' A' ' 120' ' ' GLU . 83.7 mtp -66.7 -53.7 30.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.359 -0.838 . . . . 0.0 109.75 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.959 HD11 HD12 ' A' ' 105' ' ' LEU . 44.0 mm -59.01 -29.25 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.303 -0.873 . . . . 0.0 110.114 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -77.9 -28.36 49.78 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.274 -0.892 . . . . 0.0 109.907 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.38 -29.26 62.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.441 -0.787 . . . . 0.0 110.06 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.492 ' HB1' ' HG2' ' A' ' 144' ' ' MET . . . -94.75 -24.13 17.24 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.344 -0.847 . . . . 0.0 110.401 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.522 ' OD1' HG22 ' A' ' 136' ' ' VAL . 3.7 m-20 -73.16 95.61 2.1 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.981 -1.074 . . . . 0.0 111.126 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 54.8 mt -92.04 -9.52 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.495 -0.753 . . . . 0.0 110.544 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 57.2 p-10 -149.7 -18.22 0.27 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.056 -1.028 . . . . 0.0 112.106 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.492 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . -95.1 -51.75 1.86 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 2.6 m-20 60.69 107.95 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.667 -0.902 . . . . 0.0 108.642 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 100.58 -26.37 24.86 Favored Glycine 0 C--N 1.292 -1.875 0 N-CA-C 107.059 -2.416 . . . . 0.0 107.059 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.407 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 0.2 OUTLIER -139.71 134.92 32.6 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.811 -0.817 . . . . 0.0 109.444 179.036 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.759 HG23 HG23 ' A' ' 125' ' ' ILE . 98.5 t -105.92 142.14 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.311 -0.868 . . . . 0.0 110.494 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -112.25 -176.06 2.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.302 -0.874 . . . . 0.0 109.83 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.57 ' O ' HG23 ' A' ' 142' ' ' VAL . 27.9 t80 -67.47 -36.47 81.21 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.075 -1.016 . . . . 0.0 110.224 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -71.82 -35.6 69.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.064 -1.023 . . . . 0.0 110.285 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.512 ' OE2' ' HA ' ' A' ' 129' ' ' ASP . 35.9 mt-10 -70.27 -31.78 69.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.203 -0.936 . . . . 0.0 110.497 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.617 ' HE2' HG23 ' A' ' 85' ' ' ILE . 65.6 t80 -79.34 -29.37 42.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.224 -0.923 . . . . 0.0 110.669 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 138' ' ' TYR . 96.2 t -80.24 -23.11 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.098 -1.001 . . . . 0.0 110.701 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -93.23 -31.04 14.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.164 -0.96 . . . . 0.0 110.697 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.492 ' HG2' ' HB1' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -79.07 -29.94 43.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.099 -1.001 . . . . 0.0 110.314 -179.82 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.486 ' HE3' ' N1 ' ' A' ' 154' ' ' WW7 . 59.0 tpp -89.12 -58.34 2.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 109.912 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.915 HG21 HD11 ' A' ' 85' ' ' ILE . 64.7 p -107.64 102.32 11.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.373 -0.829 . . . . 0.0 110.064 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -121.49 130.71 53.72 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.274 -0.891 . . . . 0.0 110.324 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.429 ' HD3' ' OXT' ' A' ' 148' ' ' LYS . 10.5 tmtt? . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.087 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 153' ' ' WW7 . . . . . 0.954 HN21 HD21 ' A' ' 39' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' WW7 . . . . . 0.507 'CL1 ' HD13 ' A' ' 125' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.283 0.563 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -153.82 -59.9 0.13 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.226 -0.921 . . . . 0.0 110.186 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -115.51 169.93 8.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.214 -0.929 . . . . 0.0 110.188 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.1 mt -77.94 -169.76 1.67 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.243 -0.91 . . . . 0.0 110.486 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 m -85.46 131.12 34.43 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.295 -0.878 . . . . 0.0 110.558 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -58.15 -20.51 41.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.179 -0.951 . . . . 0.0 109.654 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -74.05 -46.43 43.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.255 -0.903 . . . . 0.0 109.694 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -65.88 -55.07 18.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.431 -0.793 . . . . 0.0 109.593 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.63 HG23 HD11 ' A' ' 69' ' ' LEU . 65.6 mt -53.46 -42.41 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.368 -0.832 . . . . 0.0 109.695 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -59.59 -36.17 75.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -0.881 . . . . 0.0 109.894 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -61.95 -54.53 40.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.624 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -54.68 -36.28 64.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.748 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 17.5 mttt -60.13 -43.14 95.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.327 -0.858 . . . . 0.0 109.914 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -61.31 -38.48 86.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.914 . . . . 0.0 109.791 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.437 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.96 -45.58 93.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.238 -0.914 . . . . 0.0 109.968 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -59.75 -47.51 85.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.165 -0.959 . . . . 0.0 109.768 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.9 m -59.19 -27.31 65.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.929 . . . . 0.0 109.376 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.748 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.4 tm? -73.75 -34.32 64.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.478 -0.764 . . . . 0.0 109.613 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.437 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 15.4 m-85 -80.91 -68.08 0.72 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.43 -0.794 . . . . 0.0 109.998 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -58.88 115.24 2.98 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.243 -0.911 . . . . 0.0 110.05 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -104.19 -36.83 7.52 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.197 -0.94 . . . . 0.0 110.166 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -70.19 -11.01 60.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.234 -0.916 . . . . 0.0 110.366 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.57 97.54 0.01 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 10.7 p-10 -150.58 -42.91 0.12 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.376 -1.073 . . . . 0.0 110.108 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.578 ' O ' HG23 ' A' ' 26' ' ' THR . . . 120.02 15.88 5.05 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 25' ' ' GLY . 13.1 p -155.51 132.57 10.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.091 -1.241 . . . . 0.0 110.379 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.436 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 26.6 mt -90.46 127.7 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.282 -0.886 . . . . 0.0 110.109 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.7 p -107.28 -163.71 0.93 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 110.26 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.768 HG22 HD12 ' A' ' 52' ' ' ILE . 7.4 p -86.09 -38.06 18.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.295 -0.878 . . . . 0.0 110.557 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -60.76 -57.74 11.42 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.079 -1.013 . . . . 0.0 110.116 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -55.75 -53.63 54.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.37 -0.831 . . . . 0.0 109.999 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.59 HD13 'CL1 ' ' A' ' 153' ' ' WW7 . 4.5 tp -56.56 -24.93 50.53 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.095 -1.003 . . . . 0.0 109.549 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.21 -53.31 45.67 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.461 ' HA ' ' HB2' ' A' ' 37' ' ' ARG . 27.8 m -66.1 -35.83 81.56 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.251 -1.147 . . . . 0.0 109.793 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.5 t -56.11 -39.9 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.362 -0.836 . . . . 0.0 109.993 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.46 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 24.8 mmt -85.8 -15.31 42.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.353 -0.842 . . . . 0.0 109.954 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.461 ' HB2' ' HA ' ' A' ' 34' ' ' THR . 0.5 OUTLIER -83.05 -14.74 53.24 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.283 -0.886 . . . . 0.0 110.514 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.515 ' C ' HD22 ' A' ' 39' ' ' LEU . 56.3 m -95.92 -20.9 18.4 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.192 -0.942 . . . . 0.0 110.976 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 39' ' ' LEU . 4.5 mm? -99.75 50.08 0.92 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.03 -1.044 . . . . 0.0 110.474 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 48.38 93.32 0.01 OUTLIER Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.452 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -176.82 -41.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -1.151 . . . . 0.0 110.091 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.459 ' HA ' ' CD ' ' A' ' 37' ' ' ARG . 5.8 p-10 36.36 62.16 2.98 Favored Pre-proline 0 N--CA 1.508 2.44 0 O-C-N 121.948 -0.47 . . . . 0.0 111.191 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.46 ' HG3' ' HB3' ' A' ' 36' ' ' MET . 49.0 Cg_endo -76.2 -176.5 3.1 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.835 1.44 . . . . 0.0 110.183 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.406 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 72.4 p -113.32 161.19 17.55 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.356 -0.84 . . . . 0.0 110.057 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -64.47 -29.34 70.38 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.258 -0.901 . . . . 0.0 110.325 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.83 -69.48 0.44 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.179 -0.951 . . . . 0.0 110.101 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -49.15 -30.72 7.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.135 -0.978 . . . . 0.0 109.432 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.507 HD21 ' HA ' ' A' ' 29' ' ' THR . 5.5 tt -63.19 -47.5 82.31 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.48 -0.762 . . . . 0.0 109.719 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.454 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 37.3 tt0 -54.72 -47.32 73.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.192 -0.943 . . . . 0.0 109.621 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.05 -33.49 72.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -0.892 . . . . 0.0 109.581 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.453 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 56.1 ttp -68.95 -27.66 65.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 109.743 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.768 HD12 HG22 ' A' ' 29' ' ' THR . 38.4 mt -79.84 -23.66 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.355 -0.84 . . . . 0.0 109.602 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 49' ' ' GLN . 3.1 m-80 -60.77 -32.17 71.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.405 -0.809 . . . . 0.0 110.166 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.581 ' HG3' HG23 ' A' ' 55' ' ' VAL . 1.6 pt-20 -81.54 -22.46 37.86 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.197 -0.94 . . . . 0.0 110.21 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.776 HG13 ' SD ' ' A' ' 71' ' ' MET . 92.2 t -93.24 -11.08 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.129 -0.982 . . . . 0.0 110.325 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -118.43 113.98 22.2 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.046 -1.034 . . . . 0.0 110.549 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.21 9.7 28.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.41 -0.806 . . . . 0.0 109.814 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 0.9 OUTLIER -82.35 -54.77 4.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.292 -0.88 . . . . 0.0 110.13 -179.75 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.24 29.03 1.39 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -118.91 -22.97 7.09 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.247 -1.149 . . . . 0.0 110.221 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.39 -14.37 65.16 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 80.9 p -119.83 164.53 15.87 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.052 -1.263 . . . . 0.0 110.861 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.436 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 64.2 mt -106.86 158.08 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.354 -0.841 . . . . 0.0 110.401 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.424 ' OD2' ' HD2' ' A' ' 66' ' ' PRO . 8.5 t70 -113.44 -166.8 1.12 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.41 -0.807 . . . . 0.0 109.614 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.523 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.2 t80 -84.2 -44.86 0.75 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.075 -1.015 . . . . 0.0 111.389 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.7 Cg_endo -75.21 -21.02 15.89 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 O-C-N 123.191 1.101 . . . . 0.0 110.351 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -78.66 -32.94 47.4 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.281 -0.887 . . . . 0.0 108.735 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -70.93 -53.25 15.65 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.433 0.635 . . . . 0.0 110.198 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.708 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 7.8 tt -60.56 -40.16 90.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.308 -0.87 . . . . 0.0 110.168 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 89.8 m -73.77 -17.65 61.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.164 -0.96 . . . . 0.0 110.47 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.776 ' SD ' HG13 ' A' ' 55' ' ' VAL . 62.1 ttp -76.96 -50.75 12.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.069 -1.019 . . . . 0.0 110.771 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.588 ' HE3' ' CE ' ' A' ' 71' ' ' MET . 45.6 mtt -90.59 -43.86 9.92 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.101 -0.999 . . . . 0.0 111.317 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -61.11 -13.12 15.07 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.185 -0.947 . . . . 0.0 111.15 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 70' ' ' THR . 5.2 tpt180 -98.63 44.99 1.01 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.965 -1.084 . . . . 0.0 110.644 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -111.08 41.6 1.8 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.193 -0.942 . . . . 0.0 109.793 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 18.0 mmt -109.17 175.48 5.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.247 -0.908 . . . . 0.0 110.588 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -133.4 -153.52 0.55 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.349 -0.845 . . . . 0.0 109.68 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -142.21 125.4 16.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.107 -0.996 . . . . 0.0 110.017 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.4 p -107.87 121.73 45.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 110.315 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.66 177.08 5.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.34 -0.85 . . . . 0.0 109.848 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.9 p -175.15 171.66 2.93 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.104 -0.998 . . . . 0.0 110.745 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -174.93 -73.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.368 -0.832 . . . . 0.0 109.907 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 60.93 86.98 0.1 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.33 -0.856 . . . . 0.0 110.608 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -87.13 -15.01 39.68 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.181 -0.949 . . . . 0.0 110.258 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 12.4 mt -55.94 -35.03 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 110.292 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.8 ttm-85 -50.61 -49.5 56.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 109.553 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -61.54 -49.03 78.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.27 -0.893 . . . . 0.0 109.418 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.4 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -56.44 -19.44 15.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 109.852 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -82.42 -40.44 21.23 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.027 -1.045 . . . . 0.0 109.721 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -56.97 -40.86 77.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.527 -0.733 . . . . 0.0 109.835 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 92' ' ' PHE . 17.7 m -73.78 -42.86 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.127 -0.983 . . . . 0.0 110.602 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.94 ' CE1' HD12 ' A' ' 105' ' ' LEU . 15.8 m-85 -79.84 4.74 15.63 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.002 -1.061 . . . . 0.0 110.77 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -149.92 80.35 1.37 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.077 -1.014 . . . . 0.0 110.092 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -90.45 31.46 1.03 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -0.874 . . . . 0.0 110.249 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -127.88 -113.61 0.27 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -0.962 . . . . 0.0 110.057 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.54 32.13 0.18 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.455 ' HB2' ' CD2' ' A' ' 99' ' ' TYR . 14.2 p30 -111.26 -21.08 12.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.364 -1.08 . . . . 0.0 110.308 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 67.05 10.74 57.17 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.455 ' CD2' ' HB2' ' A' ' 97' ' ' ASN . 8.1 m-85 -107.49 105.15 14.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.155 -1.203 . . . . 0.0 109.88 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 31.0 mt -76.64 130.16 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.32 -0.862 . . . . 0.0 109.554 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.0 m -116.08 172.69 7.0 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.34 -0.85 . . . . 0.0 110.559 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.718 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -66.79 -37.79 85.27 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.557 -0.715 . . . . 0.0 110.275 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.41 -60.84 3.22 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.255 -0.903 . . . . 0.0 110.305 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.707 ' O ' HG23 ' A' ' 108' ' ' VAL . 50.0 mt-10 -56.43 -28.31 59.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.166 -0.959 . . . . 0.0 110.16 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.94 HD12 ' CE1' ' A' ' 92' ' ' PHE . 19.0 tp -66.12 -39.83 90.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.148 -0.97 . . . . 0.0 110.523 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.72 ' O ' HG23 ' A' ' 110' ' ' THR . 30.4 ttp180 -75.12 -29.81 60.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.062 -1.024 . . . . 0.0 110.078 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.62 -21.58 48.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.303 -0.873 . . . . 0.0 110.158 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 104' ' ' GLU . 54.0 t -83.74 -48.97 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 109.856 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.652 ' SD ' HD13 ' A' ' 116' ' ' LEU . 65.1 mtt -63.01 -32.45 73.82 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.385 -0.822 . . . . 0.0 109.985 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.72 HG23 ' O ' ' A' ' 106' ' ' ARG . 2.9 p -55.44 -41.28 72.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.341 -0.85 . . . . 0.0 109.64 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -73.76 -44.72 55.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.892 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.4 mt -58.78 -73.39 0.08 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.208 -0.933 . . . . 0.0 110.205 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 155.84 62.3 0.01 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.5 ' HB3' HD11 ' A' ' 116' ' ' LEU . 54.9 mm-40 -143.94 157.81 44.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.206 -1.173 . . . . 0.0 110.439 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.407 ' N ' ' CD ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -126.69 109.52 12.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.282 -0.886 . . . . 0.0 110.132 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.652 HD13 ' SD ' ' A' ' 109' ' ' MET . 4.2 mp -125.89 162.44 25.18 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.226 -0.921 . . . . 0.0 110.67 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.529 HG22 ' N ' ' A' ' 118' ' ' ASP . 64.3 m -114.05 173.14 6.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.389 -0.819 . . . . 0.0 109.951 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.529 ' N ' HG22 ' A' ' 117' ' ' THR . 43.1 m-20 -53.23 -38.44 62.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.148 -0.97 . . . . 0.0 110.855 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -66.4 -50.23 64.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.961 -1.087 . . . . 0.0 110.735 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.446 ' OE1' ' N ' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -55.62 -57.68 10.96 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.17 -0.956 . . . . 0.0 110.494 -179.739 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.718 ' CG1' ' HB1' ' A' ' 102' ' ' ALA . 21.0 t -51.7 -47.4 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.347 -0.845 . . . . 0.0 110.209 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -57.65 -34.01 68.89 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.055 -1.028 . . . . 0.0 109.916 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.437 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 32.8 tt0 -75.48 -25.3 57.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.89 . . . . 0.0 110.093 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.561 ' HE2' HD21 ' A' ' 105' ' ' LEU . 10.4 mmm -75.35 -47.29 28.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.204 -0.935 . . . . 0.0 110.133 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.516 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 26.8 mm -70.94 -27.08 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.218 -0.926 . . . . 0.0 109.869 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -75.1 -56.05 5.12 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.403 -0.811 . . . . 0.0 110.216 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.455 ' OE1' ' N ' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -57.35 -31.62 65.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.092 -1.005 . . . . 0.0 109.725 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.455 ' N ' ' OE1' ' A' ' 127' ' ' GLU . . . -79.11 -27.86 42.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 109.087 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 47.6 t0 -63.59 95.37 0.1 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.455 -0.778 . . . . 0.0 109.925 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.54 HD12 ' HG2' ' A' ' 140' ' ' GLU . 50.2 mt -80.21 -28.76 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.255 -0.903 . . . . 0.0 110.783 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 2.8 p30 -86.11 -28.39 24.06 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.192 -0.942 . . . . 0.0 110.848 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 88.95 51.91 2.9 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 36.9 p-10 -118.91 -21.57 7.69 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.3 -1.118 . . . . 0.0 110.459 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.59 -25.99 7.45 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.263 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.403 ' CG ' ' OD2' ' A' ' 133' ' ' ASP . 9.0 pt20 -114.7 165.67 12.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.14 -1.212 . . . . 0.0 110.915 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.412 ' CG2' ' HB3' ' A' ' 128' ' ' ALA . 56.1 t -109.82 131.04 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.416 -0.803 . . . . 0.0 109.36 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 10.7 t30 -94.78 -175.13 3.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.065 -1.022 . . . . 0.0 110.675 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.42 ' CD1' ' C ' ' A' ' 138' ' ' TYR . 17.3 t80 -70.87 -59.69 2.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.383 -0.823 . . . . 0.0 110.65 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -52.2 -43.06 64.0 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.162 -0.961 . . . . 0.0 110.293 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.54 ' HG2' HD12 ' A' ' 130' ' ' ILE . 52.1 mt-10 -66.58 -33.31 75.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.022 -1.049 . . . . 0.0 109.896 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.657 ' CZ ' ' HE3' ' A' ' 145' ' ' MET . 25.5 t80 -68.79 -20.13 64.33 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.41 -0.806 . . . . 0.0 109.625 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 138' ' ' TYR . 65.2 t -90.34 -41.76 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.304 -0.872 . . . . 0.0 110.891 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.55 -14.66 59.6 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.13 -0.982 . . . . 0.0 110.855 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.511 ' CE ' ' CD1' ' A' ' 141' ' ' PHE . 4.9 ptt? -85.35 -27.06 26.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.018 -1.051 . . . . 0.0 109.83 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.657 ' HE3' ' CZ ' ' A' ' 141' ' ' PHE . 52.5 mtt -84.82 -68.56 0.71 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.486 -0.759 . . . . 0.0 110.317 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.7 p -45.28 123.94 4.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.607 -0.683 . . . . 0.0 110.177 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 148' ' ' LYS . . . -97.21 -150.89 0.35 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.342 -0.849 . . . . 0.0 110.793 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 147' ' ' ALA . 18.1 tptt . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 117.888 -1.053 . . . . 0.0 110.105 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 153' ' ' WW7 . . . . . 0.693 ' C6 ' HG21 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' WW7 . . . . . 0.65 H111 ' HE1' ' A' ' 145' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.223 0.535 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -76.14 90.74 3.1 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.227 -0.92 . . . . 0.0 110.22 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -83.87 152.58 24.49 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.265 -0.897 . . . . 0.0 110.328 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.511 ' HA ' HD23 ' A' ' 4' ' ' LEU . 2.9 mt -84.48 168.44 15.46 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.265 -0.897 . . . . 0.0 110.324 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.523 HG23 ' H ' ' A' ' 7' ' ' GLU . 8.8 t -139.01 -175.77 4.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.265 -0.897 . . . . 0.0 110.048 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -81.06 -9.61 59.8 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.194 -0.942 . . . . 0.0 110.885 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.523 ' H ' HG23 ' A' ' 5' ' ' THR . 3.9 mt-10 -66.82 -69.63 0.3 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.968 -1.083 . . . . 0.0 110.426 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.46 ' OE1' HD21 ' A' ' 4' ' ' LEU . 49.5 mt-30 -49.18 -55.13 13.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.907 . . . . 0.0 110.083 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 9' ' ' ILE . 65.9 mt -49.65 -40.41 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.166 -0.959 . . . . 0.0 109.896 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -61.35 -40.53 94.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 110.0 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.32 -41.09 96.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 110.209 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -61.65 -52.82 62.77 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.253 -0.904 . . . . 0.0 110.002 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -49.64 -46.15 49.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.146 -0.971 . . . . 0.0 109.667 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -52.87 -50.58 63.53 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.305 -0.872 . . . . 0.0 109.736 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.66 -37.8 59.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.399 -0.813 . . . . 0.0 109.834 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.507 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 18.8 t80 -58.25 -49.87 75.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.432 -0.793 . . . . 0.0 109.831 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.2 t -60.49 -32.2 71.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.296 -0.878 . . . . 0.0 110.147 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.696 ' O ' HD23 ' A' ' 18' ' ' LEU . 5.4 tt -61.51 -44.57 96.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.264 -0.897 . . . . 0.0 110.065 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -70.48 -57.9 4.29 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.168 -0.957 . . . . 0.0 110.214 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -58.64 107.41 0.51 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.278 -0.888 . . . . 0.0 110.252 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -110.8 52.87 0.72 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.163 -0.961 . . . . 0.0 110.989 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.423 ' OD2' ' OD2' ' A' ' 24' ' ' ASP . 6.2 p-10 -151.72 -42.9 0.11 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.046 -1.034 . . . . 0.0 109.959 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.5 64.94 0.57 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 1.4 p30 -144.07 -44.56 0.26 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.049 -1.266 . . . . 0.0 110.207 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.466 ' C ' HG23 ' A' ' 26' ' ' THR . . . 113.22 32.89 2.07 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.388 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.466 HG23 ' C ' ' A' ' 25' ' ' GLY . 43.6 p -148.95 145.0 27.17 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.938 -1.331 . . . . 0.0 110.336 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.401 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 63.3 mt -107.53 117.31 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.302 -0.874 . . . . 0.0 110.171 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.413 ' HA ' HG22 ' A' ' 62' ' ' THR . 76.2 p -102.16 -167.15 1.37 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.246 -0.909 . . . . 0.0 109.99 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.546 HG22 HD12 ' A' ' 52' ' ' ILE . 25.0 p -83.21 -31.75 26.89 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.184 -0.947 . . . . 0.0 110.515 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.7 mtmt -65.18 -62.95 1.24 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.217 -0.927 . . . . 0.0 110.194 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -56.47 -58.7 6.88 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.168 -0.957 . . . . 0.0 109.385 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.737 HD23 HD21 ' A' ' 48' ' ' LEU . 6.0 tp -54.36 -22.6 12.66 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.268 -0.895 . . . . 0.0 109.195 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.537 ' HA2' HD13 ' A' ' 48' ' ' LEU . . . -63.58 -46.61 91.87 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.46 ' O ' ' CB ' ' A' ' 38' ' ' SER . 71.3 m -72.79 -21.58 60.96 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.252 -1.146 . . . . 0.0 110.272 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.42 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 53.0 t -72.78 -63.77 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.204 -0.935 . . . . 0.0 110.274 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 12.4 tpp -67.35 -41.01 85.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 110.521 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.463 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 48.1 ttp180 -65.25 -32.59 74.34 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.174 -0.953 . . . . 0.0 110.739 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 34' ' ' THR . 10.8 t -86.97 10.42 16.4 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.938 -1.101 . . . . 0.0 110.635 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 38' ' ' SER . 36.6 mt -136.33 63.54 1.58 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.002 -1.061 . . . . 0.0 110.403 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . 121.13 -34.14 4.11 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.453 ' CG ' ' O ' ' A' ' 37' ' ' ARG . 67.3 mt-30 54.86 40.08 31.8 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.215 -1.168 . . . . 0.0 110.846 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.538 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 2.4 t30 -86.26 -48.17 0.54 Allowed Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.986 -1.071 . . . . 0.0 110.217 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 42' ' ' ASN . 51.8 Cg_endo -84.85 -171.55 1.0 Allowed 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.696 1.366 . . . . 0.0 110.098 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.658 HG22 ' HB3' ' A' ' 47' ' ' GLU . 12.7 t -138.64 -174.27 3.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.176 -0.953 . . . . 0.0 109.666 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.56 -49.91 71.55 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.967 -1.083 . . . . 0.0 110.108 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.37 -66.11 0.59 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.187 -0.946 . . . . 0.0 110.451 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.658 ' HB3' HG22 ' A' ' 44' ' ' THR . 39.4 tt0 -45.93 -34.26 3.8 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.339 -0.85 . . . . 0.0 110.273 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.737 HD21 HD23 ' A' ' 32' ' ' LEU . 5.0 tt -60.67 -50.25 74.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.28 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.635 ' N ' HD23 ' A' ' 48' ' ' LEU . 5.4 tt0 -52.45 -40.17 61.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.389 -0.819 . . . . 0.0 109.257 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -62.97 -37.45 87.18 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.53 -0.731 . . . . 0.0 109.496 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.442 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 33.9 ttp -71.19 -16.78 62.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.411 -0.806 . . . . 0.0 109.94 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.546 HD12 HG22 ' A' ' 29' ' ' THR . 22.6 mt -83.37 -33.53 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.186 -0.946 . . . . 0.0 109.98 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -52.4 -47.78 66.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.262 -0.899 . . . . 0.0 110.011 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.56 ' HG3' HG23 ' A' ' 55' ' ' VAL . 14.8 pt-20 -64.49 -29.11 70.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.269 -0.894 . . . . 0.0 109.875 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.84 HG21 ' C6 ' ' A' ' 153' ' ' WW7 . 76.7 t -85.0 -10.69 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.372 -0.83 . . . . 0.0 110.196 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -107.53 112.1 24.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.111 -0.993 . . . . 0.0 110.23 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -101.86 34.02 2.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.256 -0.902 . . . . 0.0 110.128 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.404 ' OD1' ' OE2' ' A' ' 67' ' ' GLU . 7.1 m-20 -116.33 -36.26 4.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -0.941 . . . . 0.0 110.316 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.91 56.56 2.06 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.626 ' N ' HD21 ' A' ' 60' ' ' ASN . 0.1 OUTLIER -138.41 -41.88 0.5 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.249 -1.148 . . . . 0.0 110.325 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.798 ' O ' HG23 ' A' ' 62' ' ' THR . . . 126.19 20.7 1.97 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.797 -1.192 . . . . 0.0 110.571 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.798 HG23 ' O ' ' A' ' 61' ' ' GLY . 0.8 OUTLIER -164.72 161.65 20.79 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.009 -1.289 . . . . 0.0 110.356 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.505 ' CD1' ' CG1' ' A' ' 55' ' ' VAL . 78.9 mt -103.79 161.08 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 110.228 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.419 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 35.0 m-20 -125.84 -155.07 0.66 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.185 -0.947 . . . . 0.0 110.779 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.557 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 13.3 t80 -87.15 -41.34 0.53 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.399 -0.813 . . . . 0.0 112.21 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.0 Cg_endo -72.52 -19.02 25.31 Favored 'Trans proline' 0 C--O 1.211 -0.855 0 O-C-N 123.038 1.02 . . . . 0.0 110.621 -179.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.419 ' OE1' ' OD2' ' A' ' 64' ' ' ASP . 49.9 mt-10 -87.69 -31.64 19.62 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.078 -1.013 . . . . 0.0 109.383 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.507 ' CE2' ' HB2' ' A' ' 16' ' ' PHE . 81.3 t80 -73.35 -41.0 63.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.717 -0.614 . . . . 0.0 110.242 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.915 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 0.6 OUTLIER -83.28 -37.73 23.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.37 -0.832 . . . . 0.0 110.767 -179.436 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 66' ' ' PRO . 60.8 m -68.5 -31.07 70.08 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.985 -1.072 . . . . 0.0 110.309 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.403 ' SD ' HG13 ' A' ' 55' ' ' VAL . 57.4 ttp -81.1 -59.31 2.7 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.242 -0.911 . . . . 0.0 110.472 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.411 ' HE1' ' C2 ' ' A' ' 153' ' ' WW7 . 61.3 mtt -68.99 -9.46 52.46 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.355 -0.841 . . . . 0.0 110.642 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.915 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . -54.85 -55.66 27.9 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.134 -0.979 . . . . 0.0 110.444 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.41 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 4.1 ptp85 -110.18 50.85 0.78 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.355 -0.841 . . . . 0.0 110.627 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -146.12 99.84 3.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.131 -0.981 . . . . 0.0 110.637 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 64.3 mtt -104.32 174.76 5.74 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.335 -0.853 . . . . 0.0 109.657 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -173.2 88.61 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.148 -0.97 . . . . 0.0 110.232 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 17.5 p-10 -168.1 153.11 6.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 110.183 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t -93.99 167.05 11.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.262 -0.899 . . . . 0.0 110.492 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -150.64 60.58 0.94 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.302 -0.873 . . . . 0.0 110.425 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.2 t -166.33 137.38 3.52 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.201 -0.937 . . . . 0.0 110.027 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 34.6 tt0 -58.22 129.52 42.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 110.4 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 88.8 tt0 -177.13 -34.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.41 -0.806 . . . . 0.0 110.218 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.481 ' OE1' ' N2 ' ' A' ' 154' ' ' WW7 . 45.9 mt-10 -107.62 -13.9 14.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.925 . . . . 0.0 110.611 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.7 mm -65.55 -51.86 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.067 -1.02 . . . . 0.0 110.134 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -62.65 -52.71 62.24 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.35 -0.844 . . . . 0.0 110.177 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.441 ' O ' HG13 ' A' ' 91' ' ' VAL . 55.5 mt-10 -57.34 -28.75 63.4 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.228 -0.92 . . . . 0.0 110.305 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.643 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -67.04 -65.28 0.7 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.917 . . . . 0.0 110.274 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -52.15 -24.23 6.72 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.183 -0.948 . . . . 0.0 110.353 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.1 ttt-85 -74.57 -39.65 62.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.211 -0.931 . . . . 0.0 110.288 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 88' ' ' ALA . 23.2 m -84.91 -11.04 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 110.545 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.529 ' CZ ' ' H2 ' ' A' ' 154' ' ' WW7 . 24.2 m-85 -101.41 -14.68 17.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.031 -1.043 . . . . 0.0 110.509 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 99' ' ' TYR . 83.8 m-20 -132.17 83.03 2.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.017 -1.052 . . . . 0.0 110.619 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -104.53 27.12 8.21 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.141 -0.975 . . . . 0.0 109.994 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.8 p30 -106.69 -24.12 12.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.273 -0.892 . . . . 0.0 109.914 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.441 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 99.49 43.1 2.58 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.504 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 30.6 p-10 -128.81 -24.45 2.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.335 -1.097 . . . . 0.0 110.877 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.452 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 75.2 35.07 49.91 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.504 ' CD2' ' O ' ' A' ' 97' ' ' ASN . 61.3 m-85 -147.46 144.86 28.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.319 -1.107 . . . . 0.0 109.654 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.435 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 23.9 mt -100.24 141.72 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.078 -1.014 . . . . 0.0 109.743 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.4 t -126.54 167.55 15.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.169 -0.957 . . . . 0.0 110.409 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.92 -52.02 53.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.366 -0.834 . . . . 0.0 110.039 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.3 -56.46 16.47 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.385 -0.822 . . . . 0.0 110.235 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.479 ' O ' HG23 ' A' ' 108' ' ' VAL . 97.3 mt-10 -50.86 -45.01 59.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 110.039 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.713 HD12 HD11 ' A' ' 125' ' ' ILE . 2.6 tt -57.18 -38.37 73.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.384 -0.822 . . . . 0.0 110.018 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.415 ' O ' ' HB ' ' A' ' 110' ' ' THR . 66.4 ttt180 -69.27 -26.09 64.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.159 -0.963 . . . . 0.0 109.765 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -83.72 -14.36 51.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.348 -0.845 . . . . 0.0 109.993 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 104' ' ' GLU . 79.1 t -88.37 -62.06 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.147 -0.971 . . . . 0.0 110.825 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 60.9 mtt -65.46 -53.65 39.7 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.159 -0.963 . . . . 0.0 110.72 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.415 ' HB ' ' O ' ' A' ' 106' ' ' ARG . 28.8 m -47.32 -34.28 6.65 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.32 -0.863 . . . . 0.0 110.271 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -77.12 -41.28 42.61 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 110.402 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.437 ' HA ' HD23 ' A' ' 112' ' ' LEU . 16.2 mt -51.32 -49.05 62.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.147 -0.97 . . . . 0.0 110.273 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 139.7 48.06 0.06 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -135.22 149.26 49.85 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.213 -1.169 . . . . 0.0 110.098 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -95.79 104.27 16.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.273 -0.892 . . . . 0.0 110.454 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.0 mt -124.09 164.5 19.29 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.177 -0.952 . . . . 0.0 110.181 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 56.8 m -122.51 153.3 39.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.166 -0.959 . . . . 0.0 110.194 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -45.53 -30.06 1.34 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.277 -0.889 . . . . 0.0 110.549 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -65.08 -61.03 2.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.871 . . . . 0.0 110.457 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -49.81 -51.51 39.12 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.216 -0.927 . . . . 0.0 110.517 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 75.2 t -53.84 -45.69 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.251 -0.906 . . . . 0.0 110.501 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.15 -27.93 69.42 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.21 -0.931 . . . . 0.0 110.394 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -71.98 -31.75 66.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 0.0 110.107 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.5 mtp -77.87 -45.67 23.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.336 -0.853 . . . . 0.0 110.36 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.713 HD11 HD12 ' A' ' 105' ' ' LEU . 19.3 mm -61.96 -41.44 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 110.212 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -63.95 -52.18 60.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.005 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -55.04 -36.44 65.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.202 -0.936 . . . . 0.0 110.23 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.558 ' HB2' ' H6 ' ' A' ' 154' ' ' WW7 . . . -71.16 -29.79 65.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.225 -0.922 . . . . 0.0 110.31 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -73.53 91.39 1.81 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.157 -0.964 . . . . 0.0 110.365 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 130' ' ' ILE . 63.3 mt -84.5 1.3 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.243 -0.911 . . . . 0.0 110.767 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.602 ' OD2' 'CA ' ' A' ' 152' ' ' ' CA' . 2.4 p30 -112.03 -35.47 5.66 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.976 -1.077 . . . . 0.0 110.296 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.442 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 102.44 42.46 2.17 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 58.7 p30 -109.91 -12.7 14.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.161 -1.2 . . . . 0.0 110.541 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.467 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 98.74 -47.01 1.44 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -94.34 164.49 13.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.193 -1.181 . . . . 0.0 110.577 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.435 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 58.2 t -112.61 152.99 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.353 -0.842 . . . . 0.0 109.878 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.401 ' ND2' ' HB3' ' A' ' 139' ' ' GLU . 5.2 p-10 -128.66 -168.88 1.98 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.038 -1.039 . . . . 0.0 110.843 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.841 ' O ' HG23 ' A' ' 142' ' ' VAL . 4.3 t80 -64.64 -44.39 90.61 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.51 -0.744 . . . . 0.0 111.006 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.401 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 35.4 tt0 -61.63 -61.05 2.79 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.232 -0.917 . . . . 0.0 111.219 -179.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.4 ' OE2' ' OD2' ' A' ' 131' ' ' ASP . 53.8 mt-10 -56.59 -28.9 61.39 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.112 -0.992 . . . . 0.0 111.032 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.409 ' CZ ' ' HB1' ' A' ' 88' ' ' ALA . 23.2 t80 -78.86 -27.35 44.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.084 -1.01 . . . . 0.0 110.401 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 138' ' ' TYR . 86.3 t -83.6 -24.72 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.259 -0.901 . . . . 0.0 110.484 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.554 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 85.2 mt-30 -95.29 -22.28 17.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.137 -0.977 . . . . 0.0 110.738 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.0 -12.49 41.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.879 -1.138 . . . . 0.0 110.321 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.465 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 53.1 tpp -90.25 -48.04 7.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.187 -0.946 . . . . 0.0 110.311 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.7 p -85.04 -56.61 3.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.323 -0.861 . . . . 0.0 110.588 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -72.71 144.87 47.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.172 -0.955 . . . . 0.0 109.967 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.279 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . 0.602 'CA ' ' OD2' ' A' ' 131' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' WW7 . . . . . 0.84 ' C6 ' HG21 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' WW7 . . . . . 0.558 ' H6 ' ' HB2' ' A' ' 128' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 121.199 0.523 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.464 ' HB3' HD21 ' A' ' 4' ' ' LEU . 1.3 m-20 -117.23 113.07 21.68 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 0.0 110.228 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -113.26 81.9 1.58 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.334 -0.854 . . . . 0.0 110.011 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.618 ' N ' HD23 ' A' ' 4' ' ' LEU . 0.6 OUTLIER -136.75 150.25 48.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.309 -0.869 . . . . 0.0 110.427 -179.608 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.7 m -55.09 166.97 0.46 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.111 -0.993 . . . . 0.0 109.308 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -89.98 -23.51 21.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.042 -1.036 . . . . 0.0 110.7 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.506 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 52.4 mt-10 -50.01 -46.84 53.13 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.126 -0.984 . . . . 0.0 110.348 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -59.67 -57.19 14.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.309 -0.869 . . . . 0.0 110.307 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 1.025 HG22 ' HE3' ' A' ' 13' ' ' LYS . 83.5 mt -49.97 -28.95 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.257 -0.902 . . . . 0.0 109.614 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -71.47 -42.15 68.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.329 -0.857 . . . . 0.0 110.045 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.34 -42.11 81.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 0.0 109.97 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -64.39 -47.07 80.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.294 -0.878 . . . . 0.0 110.194 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.025 ' HE3' HG22 ' A' ' 9' ' ' ILE . 87.5 mttt -50.84 -51.75 48.09 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.23 -0.919 . . . . 0.0 109.813 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 17' ' ' SER . 40.6 tt0 -53.35 -43.09 67.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.383 -0.823 . . . . 0.0 109.998 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.568 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -57.32 -44.34 84.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.944 . . . . 0.0 109.767 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.43 ' O ' ' HB2' ' A' ' 19' ' ' PHE . 3.2 t80 -63.49 -32.71 74.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.193 -0.942 . . . . 0.0 109.773 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 38.2 t -58.79 -61.58 2.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 110.325 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.568 HD21 ' HA ' ' A' ' 15' ' ' ALA . 1.2 pp -67.3 -15.38 63.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.1 -1.0 . . . . 0.0 110.372 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.523 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 8.1 m-30 -69.29 -63.81 0.99 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.131 -0.98 . . . . 0.0 109.706 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -70.67 107.81 4.1 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.355 -0.84 . . . . 0.0 109.995 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -107.37 -29.67 9.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.117 -0.989 . . . . 0.0 110.375 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 38.0 p30 -69.86 -11.2 60.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.185 -0.947 . . . . 0.0 110.485 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.452 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 66.24 99.03 0.02 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -155.21 -51.74 0.09 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.263 -1.14 . . . . 0.0 110.377 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.0 -5.12 5.04 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 77.4 p -145.37 152.05 39.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.001 -1.294 . . . . 0.0 110.207 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.8 mt -87.37 101.23 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.259 -0.901 . . . . 0.0 110.071 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.2 p -95.37 -177.59 4.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.381 -0.824 . . . . 0.0 109.909 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.64 HG22 HD12 ' A' ' 52' ' ' ILE . 12.0 p -63.1 -30.07 71.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.077 -1.015 . . . . 0.0 110.227 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -63.69 -56.94 11.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.131 -0.981 . . . . 0.0 110.203 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.553 ' O ' HG23 ' A' ' 35' ' ' VAL . 32.0 mt-10 -57.31 -46.45 83.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.868 . . . . 0.0 110.023 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.706 HD13 'CL1 ' ' A' ' 153' ' ' WW7 . 11.0 tp -64.02 -23.25 67.26 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.19 -0.944 . . . . 0.0 109.774 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.04 -42.99 74.97 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.436 ' O ' ' CB ' ' A' ' 38' ' ' SER . 91.6 m -81.5 -18.77 43.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -1.131 . . . . 0.0 109.892 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.751 ' O ' HD12 ' A' ' 39' ' ' LEU . 51.6 t -79.59 -31.89 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.032 -1.043 . . . . 0.0 109.777 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.423 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 26.3 mmt -89.93 -25.4 20.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.297 -0.877 . . . . 0.0 110.163 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.463 ' HD2' ' HA ' ' A' ' 42' ' ' ASN . 3.3 tpt180 -89.37 -25.7 21.43 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.219 -0.926 . . . . 0.0 110.127 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 34' ' ' THR . 62.2 m -85.4 -14.2 47.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -0.926 . . . . 0.0 110.3 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.751 HD12 ' O ' ' A' ' 35' ' ' VAL . 30.5 mt -89.82 -88.03 0.17 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.234 -0.916 . . . . 0.0 110.334 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 41' ' ' GLN . . . -152.22 51.99 0.49 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.444 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 36.8 mt-30 -158.02 169.19 25.13 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.262 -1.14 . . . . 0.0 110.09 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.463 ' HA ' ' HD2' ' A' ' 37' ' ' ARG . 77.5 m-20 -144.4 58.24 5.53 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.496 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 42' ' ' ASN . 48.5 Cg_endo -79.19 -177.8 4.16 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.792 1.417 . . . . 0.0 110.369 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.455 HG22 ' N ' ' A' ' 45' ' ' GLU . 32.3 m -112.68 169.42 8.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.25 -0.906 . . . . 0.0 110.159 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.455 ' N ' HG22 ' A' ' 44' ' ' THR . 37.9 tt0 -66.84 -35.2 79.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.164 -0.96 . . . . 0.0 110.034 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.84 -66.72 0.6 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.266 -0.896 . . . . 0.0 109.88 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -47.25 -35.89 8.29 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.311 -0.868 . . . . 0.0 109.618 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.594 ' CG ' HD23 ' A' ' 32' ' ' LEU . 6.2 tt -61.99 -47.35 85.19 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.509 -0.744 . . . . 0.0 109.805 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.445 ' N ' HD23 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -52.52 -43.54 65.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.929 . . . . 0.0 109.659 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -65.13 -33.02 75.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.923 . . . . 0.0 109.4 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.458 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 31.6 ttp -71.17 -17.69 62.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.341 -0.85 . . . . 0.0 109.481 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.64 HD12 HG22 ' A' ' 29' ' ' THR . 44.9 mt -86.17 -27.39 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.353 -0.842 . . . . 0.0 109.85 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 -59.03 -23.64 62.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 110.123 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.458 ' CG ' ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -83.88 -24.97 30.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.283 -0.886 . . . . 0.0 110.128 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.833 HG21 ' C6 ' ' A' ' 153' ' ' WW7 . 80.2 t -85.57 -65.5 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.225 -0.922 . . . . 0.0 109.991 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.402 ' OD2' ' OD1' ' A' ' 60' ' ' ASN . 46.6 t0 -50.31 135.74 21.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.377 -0.827 . . . . 0.0 110.285 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -103.66 -27.04 12.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.279 -0.888 . . . . 0.0 109.789 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -69.97 -30.71 68.12 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.367 -0.833 . . . . 0.0 109.812 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.06 24.51 61.51 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.402 ' OD1' ' OD2' ' A' ' 56' ' ' ASP . 14.2 p-10 -81.55 -32.7 32.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.164 -1.198 . . . . 0.0 110.219 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 129.28 -18.35 5.52 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.756 -1.212 . . . . 0.0 110.094 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 41.3 p -144.74 170.09 16.77 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.103 -1.233 . . . . 0.0 110.366 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.511 HD11 ' CG1' ' A' ' 55' ' ' VAL . 45.7 mt -112.48 163.46 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.106 -0.997 . . . . 0.0 110.163 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.464 ' N ' HG22 ' A' ' 63' ' ' ILE . 73.8 m-20 -125.01 -164.74 1.31 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.19 -0.944 . . . . 0.0 110.531 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.564 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 57.1 t80 -78.81 -43.89 1.85 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.344 -0.847 . . . . 0.0 111.386 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.2 Cg_endo -72.51 -32.54 9.75 Favored 'Trans proline' 0 C--N 1.324 -0.739 0 O-C-N 123.001 1.001 . . . . 0.0 110.176 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.43 ' OE1' ' HA ' ' A' ' 63' ' ' ILE . 35.0 tt0 -76.55 -20.84 56.43 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.226 -0.921 . . . . 0.0 109.277 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.531 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 8.7 t80 -80.96 -44.35 18.33 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.501 -0.749 . . . . 0.0 109.703 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.579 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -71.47 -22.76 61.77 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.324 -0.86 . . . . 0.0 109.613 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.0 m -85.2 -41.28 15.78 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.419 -0.801 . . . . 0.0 110.242 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.491 ' HG3' ' N ' ' A' ' 72' ' ' MET . 19.5 ptm -66.11 -33.2 75.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.135 -0.978 . . . . 0.0 110.169 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.531 ' CE ' ' CZ ' ' A' ' 68' ' ' PHE . 20.6 mtt -90.15 -10.78 43.27 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.237 -0.914 . . . . 0.0 110.269 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.579 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . -72.8 -13.26 61.27 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.129 -0.982 . . . . 0.0 110.349 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -53.31 -69.41 0.12 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.212 -0.93 . . . . 0.0 110.264 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -49.76 131.08 21.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.36 -0.838 . . . . 0.0 110.378 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 32.0 mtt -105.82 128.94 54.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.24 -0.912 . . . . 0.0 110.25 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -108.62 -23.97 11.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.103 -0.998 . . . . 0.0 109.913 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -139.94 149.69 43.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -0.881 . . . . 0.0 110.033 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 79' ' ' THR . 94.6 m -150.09 65.48 0.97 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.241 -0.912 . . . . 0.0 110.015 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -62.67 -160.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.224 -0.922 . . . . 0.0 110.128 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 48.3 t -162.99 -55.33 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.343 -0.848 . . . . 0.0 109.743 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 81' ' ' SER . 2.8 mt-10 -167.07 77.29 0.18 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.361 -0.837 . . . . 0.0 110.059 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -162.34 53.44 0.22 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 110.232 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -77.0 -64.57 1.1 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.232 -0.917 . . . . 0.0 110.941 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 54.0 mt -46.72 -32.85 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.105 -0.997 . . . . 0.0 109.947 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.413 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 35.0 ttt180 -66.2 -47.21 74.61 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.421 -0.799 . . . . 0.0 109.354 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 2.8 tt0 -49.27 -48.48 45.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.437 -0.789 . . . . 0.0 109.983 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.737 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -62.9 -61.47 2.38 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.385 -0.822 . . . . 0.0 110.19 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -44.69 -26.98 0.44 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.428 -0.795 . . . . 0.0 110.644 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 86' ' ' ARG . 4.9 mmp_? -75.53 -47.66 25.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.273 -0.892 . . . . 0.0 110.469 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.737 HG22 ' O ' ' A' ' 88' ' ' ALA . 35.8 m -70.65 -9.75 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.201 -0.937 . . . . 0.0 110.864 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.754 ' CE1' HG11 ' A' ' 108' ' ' VAL . 42.7 m-85 -103.02 -22.89 13.73 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.099 -1.001 . . . . 0.0 110.77 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -114.23 77.67 1.08 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.078 -1.013 . . . . 0.0 110.306 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.9 ptpt -109.69 -7.28 15.1 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.251 -0.905 . . . . 0.0 110.55 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.418 ' OD2' ' OD1' ' A' ' 97' ' ' ASN . 10.8 p-10 -73.28 -37.78 66.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.033 -1.042 . . . . 0.0 110.121 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 121.62 -24.14 7.28 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.196 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.463 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 15.0 p-10 -58.71 -30.01 67.11 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.704 -1.469 . . . . 0.0 110.863 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.471 ' C ' ' CD1' ' A' ' 99' ' ' TYR . . . 94.0 16.25 45.36 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.576 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.626 ' O ' 'CA ' ' A' ' 151' ' ' ' CA' . 86.4 m-85 -142.09 151.54 42.44 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.95 -1.323 . . . . 0.0 110.188 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.418 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 24.0 mt -91.97 130.69 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.11 -0.994 . . . . 0.0 109.729 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 44.4 t -114.98 165.67 12.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.292 -0.88 . . . . 0.0 110.113 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.07 -29.45 67.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.279 -0.888 . . . . 0.0 110.343 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.12 -54.5 7.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.189 -0.944 . . . . 0.0 110.414 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.838 ' O ' HG23 ' A' ' 108' ' ' VAL . 43.7 mt-10 -53.51 -40.65 65.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.216 -0.927 . . . . 0.0 110.282 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.759 HD22 HG13 ' A' ' 121' ' ' VAL . 8.7 tt -71.19 -32.94 69.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.146 -0.971 . . . . 0.0 110.492 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -71.36 -21.35 62.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.07 -1.019 . . . . 0.0 109.898 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -95.68 -20.27 19.05 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.247 -0.908 . . . . 0.0 109.729 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.838 HG23 ' O ' ' A' ' 104' ' ' GLU . 93.2 t -84.14 -38.12 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.321 -0.862 . . . . 0.0 110.307 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.5 mmt -63.67 -30.45 71.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.867 . . . . 0.0 110.152 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.1 p -69.06 -39.16 79.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 109.965 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -66.6 -42.91 86.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.189 -0.944 . . . . 0.0 110.224 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.4 ' HB3' ' OE1' ' A' ' 114' ' ' GLU . 89.9 mt -66.54 -33.57 75.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.898 . . . . 0.0 110.125 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.51 -16.72 11.41 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.431 ' CD ' ' N ' ' A' ' 114' ' ' GLU . 5.6 mp0 -69.01 114.11 6.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -1.131 . . . . 0.0 110.288 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.29 121.39 32.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 110.384 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.59 169.82 12.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 110.104 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 27.9 m -98.25 159.49 14.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.105 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -54.35 -44.01 71.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.217 -0.927 . . . . 0.0 110.186 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -65.35 -43.31 91.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 110.409 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -55.76 -46.97 77.76 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.169 -0.957 . . . . 0.0 110.603 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.759 HG13 HD22 ' A' ' 105' ' ' LEU . 77.9 t -59.49 -55.41 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 110.254 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.44 -24.99 49.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.159 -0.963 . . . . 0.0 109.928 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -76.33 -33.99 59.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.356 -0.84 . . . . 0.0 110.064 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.426 ' HE2' HD11 ' A' ' 105' ' ' LEU . 54.5 mtp -71.51 -42.28 68.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 0.0 110.007 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.767 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 31.5 mm -66.71 -36.76 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.255 -0.903 . . . . 0.0 110.08 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.57 -57.37 7.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.278 -0.889 . . . . 0.0 110.129 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.403 ' HA ' ' OE1' ' A' ' 127' ' ' GLU . 3.1 mm-40 -51.2 -42.18 60.74 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.4 -0.812 . . . . 0.0 110.641 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -70.24 -30.61 67.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.203 -0.936 . . . . 0.0 110.449 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 6.8 t0 -74.62 84.09 2.07 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.282 -0.886 . . . . 0.0 110.267 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.4 mt -58.57 -37.91 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.215 -0.928 . . . . 0.0 110.034 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.9 p30 -77.13 -32.3 56.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.268 -0.895 . . . . 0.0 109.991 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.453 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 81.03 60.03 2.34 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 135' ' ' GLN . 56.3 p30 -117.21 8.12 13.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.161 -1.199 . . . . 0.0 110.442 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.61 -40.48 3.04 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.401 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 2.3 pt20 -98.17 158.03 15.8 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.062 -1.258 . . . . 0.0 110.485 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.418 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 76.2 t -114.3 134.05 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.384 -0.823 . . . . 0.0 110.232 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.454 ' OD1' ' CG ' ' A' ' 140' ' ' GLU . 24.2 p-10 -105.19 171.83 7.11 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.124 -0.985 . . . . 0.0 109.997 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -52.83 -60.59 3.08 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.228 -0.92 . . . . 0.0 111.471 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -44.3 -51.84 8.06 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.134 -0.979 . . . . 0.0 111.375 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.46 ' O ' ' CG ' ' A' ' 144' ' ' MET . 58.3 mt-10 -59.89 -37.25 78.85 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.985 -1.072 . . . . 0.0 110.459 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.645 ' CZ ' ' HE3' ' A' ' 145' ' ' MET . 87.4 t80 -66.38 -22.17 66.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.311 -0.868 . . . . 0.0 110.782 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 98.1 t -90.5 -42.18 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.026 -1.046 . . . . 0.0 111.231 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.932 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 75.5 mt-30 -78.61 -13.37 59.86 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.955 -1.091 . . . . 0.0 110.62 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.482 ' HE3' ' HG3' ' A' ' 145' ' ' MET . 0.0 OUTLIER -90.72 -9.91 44.98 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.064 -1.023 . . . . 0.0 110.582 -179.883 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.645 ' HE3' ' CZ ' ' A' ' 141' ' ' PHE . 18.9 mtt -90.68 -70.85 0.66 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.037 -1.04 . . . . 0.0 111.669 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.9 t -118.23 37.88 3.87 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.955 -1.091 . . . . 0.0 111.024 -178.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.932 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -110.16 143.83 39.69 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.153 -0.967 . . . . 0.0 109.778 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.406 ' OXT' ' O ' ' A' ' 147' ' ' ALA . 18.9 tttm . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.123 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . 0.626 'CA ' ' O ' ' A' ' 99' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 153' ' ' WW7 . . . . . 0.833 ' C6 ' HG21 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' WW7 . . . . . 0.767 'CL1 ' HD13 ' A' ' 125' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.213 0.53 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -98.66 100.79 12.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.298 -0.876 . . . . 0.0 110.345 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -109.98 96.25 6.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.325 -0.859 . . . . 0.0 110.206 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.528 HD11 ' O ' ' A' ' 73' ' ' ALA . 31.2 mt -56.71 173.86 0.18 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.265 -0.897 . . . . 0.0 110.298 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.6 p -79.32 151.67 30.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.304 -0.873 . . . . 0.0 109.951 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -63.22 -16.0 58.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.33 -0.857 . . . . 0.0 110.275 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -69.14 -62.54 1.34 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.18 -0.95 . . . . 0.0 110.373 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.46 ' HG2' ' CE2' ' A' ' 12' ' ' PHE . 11.7 tt0 -58.76 -41.13 85.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 110.14 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.2 mt -58.38 -37.81 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.194 -0.941 . . . . 0.0 109.906 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -69.28 -33.24 72.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.295 -0.878 . . . . 0.0 109.963 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -61.2 -51.37 69.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 109.597 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.46 ' CE2' ' HG2' ' A' ' 8' ' ' GLN . 21.4 m-85 -58.64 -39.03 79.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.469 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -54.14 -42.5 69.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 109.554 179.463 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 17' ' ' SER . 35.1 mt-10 -61.34 -45.04 96.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -0.895 . . . . 0.0 109.786 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.501 ' O ' ' CG ' ' A' ' 19' ' ' PHE . . . -53.49 -48.89 68.54 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.302 -0.873 . . . . 0.0 109.523 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.513 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 28.8 t80 -65.35 -26.67 68.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.383 -0.823 . . . . 0.0 109.797 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -59.91 -63.65 1.23 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.313 -0.867 . . . . 0.0 110.001 179.722 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.465 HD21 ' HA ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -64.37 -19.64 65.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.257 -0.902 . . . . 0.0 109.748 179.683 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.501 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 10.5 m-30 -69.61 -32.2 70.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.361 -0.837 . . . . 0.0 109.444 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -97.96 97.23 8.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -87.52 49.92 1.9 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 110.253 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 2.7 p30 -170.77 -32.45 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.384 -0.822 . . . . 0.0 110.583 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 77.08 60.87 2.78 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -108.03 -39.6 5.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -1.18 . . . . 0.0 110.816 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.521 ' C ' HG23 ' A' ' 26' ' ' THR . . . 135.83 -10.05 4.24 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.23 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.521 HG23 ' C ' ' A' ' 25' ' ' GLY . 68.1 p -151.06 168.28 25.1 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.1 -1.235 . . . . 0.0 110.425 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 65.6 mt -102.59 123.26 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.369 -0.832 . . . . 0.0 110.294 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.1 p -92.97 -163.78 1.09 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.332 -0.855 . . . . 0.0 110.179 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.462 HG22 HD12 ' A' ' 52' ' ' ILE . 4.5 p -90.31 -45.25 9.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.243 -0.911 . . . . 0.0 110.781 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.441 ' HG3' ' HG3' ' A' ' 31' ' ' GLU . 6.1 pttt -56.47 -45.83 80.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.987 -1.071 . . . . 0.0 110.16 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.441 ' HG3' ' HG3' ' A' ' 30' ' ' LYS . 49.6 mt-10 -63.76 -48.75 75.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.98 -1.075 . . . . 0.0 109.34 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.45 ' C ' HD11 ' A' ' 48' ' ' LEU . 13.1 tp -62.61 -15.68 52.82 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.45 -0.781 . . . . 0.0 109.753 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.469 ' HA2' ' CD1' ' A' ' 48' ' ' LEU . . . -75.89 -46.17 14.57 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 57.7 m -71.27 -20.18 62.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -1.094 . . . . 0.0 109.653 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.3 t -83.33 -33.12 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.33 -0.856 . . . . 0.0 109.968 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.435 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 26.0 mmt -88.38 -18.34 28.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.155 -0.965 . . . . 0.0 109.899 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -90.83 -36.05 14.45 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.0 110.249 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.6 m -80.9 -45.08 17.33 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.243 -0.911 . . . . 0.0 110.045 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.403 HD13 H151 ' A' ' 153' ' ' WW7 . 12.7 mt -92.47 -36.49 13.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 110.079 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 36' ' ' MET . . . -68.64 -112.65 0.02 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -148.67 -70.29 0.21 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.254 -1.145 . . . . 0.0 110.351 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.508 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 51.6 t30 -163.39 49.7 0.24 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 0.0 110.463 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 42' ' ' ASN . 45.3 Cg_endo -71.52 -166.26 0.23 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.747 1.393 . . . . 0.0 110.127 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.61 HG23 ' H ' ' A' ' 47' ' ' GLU . 4.9 t -141.31 173.15 11.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.132 -0.98 . . . . 0.0 110.277 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -68.21 -25.73 65.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.188 -0.945 . . . . 0.0 109.973 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.99 -65.62 0.82 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.294 -0.879 . . . . 0.0 109.606 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.61 ' H ' HG23 ' A' ' 44' ' ' THR . 6.0 tp10 -52.9 -23.55 7.37 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.419 -0.801 . . . . 0.0 109.406 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.469 ' CD1' ' HA2' ' A' ' 33' ' ' GLY . 3.6 tt -68.72 -56.44 8.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.439 -0.788 . . . . 0.0 109.244 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -47.69 -44.01 27.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 109.411 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -63.0 -40.21 97.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.518 -0.739 . . . . 0.0 109.597 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.439 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 6.3 ttp -66.02 -17.81 64.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.339 -0.851 . . . . 0.0 109.779 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.462 HD12 HG22 ' A' ' 29' ' ' THR . 33.8 mt -89.79 -24.97 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 109.608 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -66.0 -36.66 83.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 110.277 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.536 ' HG3' HG23 ' A' ' 55' ' ' VAL . 16.3 pt-20 -68.19 -36.8 80.16 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.099 -1.0 . . . . 0.0 110.251 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.82 HG13 ' SD ' ' A' ' 71' ' ' MET . 99.4 t -76.2 -67.96 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.115 -0.991 . . . . 0.0 110.293 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -43.91 105.9 0.06 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.591 -0.693 . . . . 0.0 110.491 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.12 33.2 4.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.909 . . . . 0.0 110.356 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.3 p30 -122.9 -40.49 2.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.919 . . . . 0.0 110.235 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 103.49 45.99 1.48 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.434 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 19.8 p-10 -122.73 -27.71 4.28 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.089 -1.242 . . . . 0.0 110.397 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.62 -74.54 0.41 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.674 -1.251 . . . . 0.0 110.268 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.8 p -86.1 170.1 12.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.207 -1.172 . . . . 0.0 110.575 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.563 HD13 HG11 ' A' ' 55' ' ' VAL . 20.5 mt -90.13 159.28 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.296 -0.878 . . . . 0.0 109.719 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.435 ' OD2' ' HD2' ' A' ' 66' ' ' PRO . 10.4 t0 -115.41 -179.48 3.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.243 -0.911 . . . . 0.0 110.489 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.591 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 10.6 t80 -74.98 -41.94 4.28 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.333 -0.855 . . . . 0.0 111.752 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.7 Cg_endo -72.07 -17.03 28.57 Favored 'Trans proline' 0 C--O 1.212 -0.823 0 O-C-N 123.105 1.055 . . . . 0.0 110.583 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 71' ' ' MET . 51.2 mt-10 -84.67 -37.52 20.9 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.006 -1.059 . . . . 0.0 108.916 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.513 ' CE2' ' HB2' ' A' ' 16' ' ' PHE . 73.1 t80 -63.67 -48.33 77.65 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.542 -0.723 . . . . 0.0 110.217 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.469 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 1.8 tp -74.4 -37.01 63.5 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.29 -0.881 . . . . 0.0 110.446 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.498 ' O ' ' HB3' ' A' ' 74' ' ' ARG . 71.4 m -74.63 -10.2 59.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.135 -0.978 . . . . 0.0 110.441 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.82 ' SD ' HG13 ' A' ' 55' ' ' VAL . 63.6 ttp -91.44 -49.89 6.09 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.885 -1.135 . . . . 0.0 109.746 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.481 ' HE1' ' CE1' ' A' ' 68' ' ' PHE . 39.4 mtt -91.75 -63.58 1.23 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.338 -0.851 . . . . 0.0 111.645 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.528 ' O ' HD11 ' A' ' 4' ' ' LEU . . . -56.78 -14.18 3.17 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.267 -0.896 . . . . 0.0 111.749 -178.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.498 ' HB3' ' O ' ' A' ' 70' ' ' THR . 11.7 ttt180 -110.12 53.67 0.69 Allowed 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.799 -1.188 . . . . 0.0 110.773 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 33.9 tttt -93.75 138.76 31.61 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.167 -0.958 . . . . 0.0 109.962 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 13.2 ptp -146.17 -179.41 6.71 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.974 -1.078 . . . . 0.0 110.942 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -159.27 128.88 5.51 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.544 -0.723 . . . . 0.0 109.516 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -118.12 15.86 14.11 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.066 -1.021 . . . . 0.0 110.925 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 31.2 p -78.07 84.47 4.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.99 -1.069 . . . . 0.0 109.837 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -168.36 153.71 6.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.411 -0.805 . . . . 0.0 109.921 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.8 m -72.07 -169.51 0.49 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.173 -0.955 . . . . 0.0 110.213 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -132.93 55.37 1.9 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.22 -0.925 . . . . 0.0 110.203 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 37.5 tt0 -150.59 17.99 0.81 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 110.067 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -58.4 -27.42 64.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.076 -1.015 . . . . 0.0 110.343 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.5 mt -52.31 -40.1 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.232 -0.918 . . . . 0.0 110.121 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 20.1 ttt85 -55.12 -49.38 71.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.418 -0.801 . . . . 0.0 110.269 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.59 ' O ' HG13 ' A' ' 91' ' ' VAL . 48.5 mt-10 -64.59 -37.13 86.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.342 -0.849 . . . . 0.0 110.429 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 92' ' ' PHE . . . -64.94 -22.52 67.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 110.302 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.561 ' CD1' HD11 ' A' ' 100' ' ' ILE . 22.4 t80 -83.48 -38.86 21.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.091 -1.006 . . . . 0.0 110.201 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -70.66 -31.44 68.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.381 -0.824 . . . . 0.0 110.777 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.59 HG13 ' O ' ' A' ' 87' ' ' GLU . 7.2 m -83.56 -41.42 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.077 -1.014 . . . . 0.0 110.488 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.516 ' N ' HG23 ' A' ' 91' ' ' VAL . 9.5 m-85 -67.67 -23.48 65.32 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.971 -1.081 . . . . 0.0 110.012 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -108.6 81.03 1.4 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.219 -0.926 . . . . 0.0 109.935 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 91' ' ' VAL . 13.4 mtpt -97.26 1.55 49.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 0.0 110.89 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.699 ' OD2' 'CA ' ' A' ' 151' ' ' ' CA' . 2.3 p30 -79.39 -27.77 41.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.931 -1.106 . . . . 0.0 109.784 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.402 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 94.63 44.16 3.48 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.463 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 23.9 p-10 -128.57 -14.28 4.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.185 -1.185 . . . . 0.0 110.984 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.98 -5.88 84.32 Favored Glycine 0 N--CA 1.504 3.197 0 O-C-N 120.974 -1.079 . . . . 0.0 110.876 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.463 ' HB2' ' ND2' ' A' ' 97' ' ' ASN . 9.5 m-85 -116.61 139.03 50.97 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.954 -1.321 . . . . 0.0 110.309 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.561 HD11 ' CD1' ' A' ' 89' ' ' PHE . 22.0 mt -91.3 115.74 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.222 -0.924 . . . . 0.0 109.916 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.9 t -100.01 172.59 7.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 109.956 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.67 -41.85 71.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.196 -0.94 . . . . 0.0 110.215 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -55.08 -53.78 51.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.316 -0.865 . . . . 0.0 110.122 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.726 ' O ' HG23 ' A' ' 108' ' ' VAL . 51.1 mt-10 -56.74 -49.84 74.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 110.047 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.593 HD12 HD11 ' A' ' 125' ' ' ILE . 1.5 tt -51.1 -34.7 31.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.892 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.432 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 9.5 ttm180 -66.72 -41.55 87.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.241 -0.912 . . . . 0.0 109.814 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -75.45 -10.08 59.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.312 -0.867 . . . . 0.0 110.283 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 104' ' ' GLU . 97.4 t -86.64 -52.13 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.02 -1.05 . . . . 0.0 110.196 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 14.3 mmt -73.4 -60.43 2.25 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.203 -0.935 . . . . 0.0 110.434 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.1 m -46.66 -35.56 6.12 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.401 -0.812 . . . . 0.0 110.552 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -73.73 -45.13 53.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.175 -0.953 . . . . 0.0 110.415 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 41.4 mt -50.04 -52.25 35.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.204 -0.935 . . . . 0.0 110.285 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 157.04 -38.12 0.56 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -57.57 139.5 53.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.292 -1.122 . . . . 0.0 110.242 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -106.89 79.61 1.35 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -0.875 . . . . 0.0 110.335 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.61 -179.1 7.06 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.279 -0.888 . . . . 0.0 110.048 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 66.9 m -108.4 153.79 22.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.247 -0.908 . . . . 0.0 110.252 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.96 -40.87 64.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.321 -0.862 . . . . 0.0 110.466 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -59.04 -41.4 87.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.202 -0.936 . . . . 0.0 110.374 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -56.14 -56.91 15.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.333 -0.854 . . . . 0.0 110.496 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.431 HG13 HD13 ' A' ' 105' ' ' LEU . 97.6 t -54.5 -48.38 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 110.444 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -56.22 -33.37 65.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 0.0 110.225 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -74.4 -28.4 61.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 110.067 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 95.5 mtp -71.65 -53.2 14.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.262 -0.899 . . . . 0.0 109.933 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.593 HD11 HD12 ' A' ' 105' ' ' LEU . 29.3 mm -61.51 -32.06 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 109.993 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 54.2 ttt-85 -64.91 -53.95 38.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.327 -0.858 . . . . 0.0 110.18 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -60.61 -32.47 71.6 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.128 -0.982 . . . . 0.0 110.131 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.18 -27.69 64.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.277 -0.889 . . . . 0.0 110.189 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -70.33 87.96 0.63 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.939 . . . . 0.0 110.178 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 68.7 mt -65.91 -43.01 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.232 -0.917 . . . . 0.0 110.111 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -79.38 -42.39 25.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -0.95 . . . . 0.0 110.115 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.86 84.63 1.81 Allowed Glycine 0 N--CA 1.485 1.964 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.479 ' OD2' ' CG ' ' A' ' 135' ' ' GLN . 18.1 p-10 -147.96 -46.49 0.16 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.254 -1.145 . . . . 0.0 110.598 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 134.3 31.61 0.36 Allowed Glycine 0 N--CA 1.498 2.772 0 C-N-CA 119.491 -1.337 . . . . 0.0 110.889 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.479 ' CG ' ' OD2' ' A' ' 133' ' ' ASP . 8.8 pt20 -169.98 135.82 1.43 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.971 -1.311 . . . . 0.0 110.134 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.2 t -100.09 113.06 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -0.975 . . . . 0.0 110.283 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.433 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 13.8 p30 -89.3 -169.87 2.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.013 -1.054 . . . . 0.0 109.987 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.401 ' O ' HG23 ' A' ' 142' ' ' VAL . 2.4 t80 -62.32 -48.03 81.63 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.078 -1.014 . . . . 0.0 111.095 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -56.05 -55.9 27.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.072 -1.017 . . . . 0.0 110.617 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.422 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 56.2 mt-10 -61.55 -22.69 65.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.275 -0.891 . . . . 0.0 110.748 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.447 ' CE1' ' CD1' ' A' ' 100' ' ' ILE . 9.8 t80 -79.83 -26.56 40.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.176 -0.952 . . . . 0.0 110.104 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.433 ' O ' ' HB ' ' A' ' 146' ' ' THR . 85.9 t -90.32 -24.21 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.255 -0.903 . . . . 0.0 110.287 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -83.29 -42.27 17.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.185 -0.947 . . . . 0.0 110.654 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.484 ' HG3' ' N ' ' A' ' 145' ' ' MET . 5.2 ptt? -59.73 -38.92 83.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.146 -0.971 . . . . 0.0 110.195 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.484 ' N ' ' HG3' ' A' ' 144' ' ' MET . 14.3 ttm -91.35 -9.33 45.29 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.248 -0.908 . . . . 0.0 110.343 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 142' ' ' VAL . 1.3 m -142.4 94.55 2.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.046 -1.034 . . . . 0.0 110.887 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -106.08 -171.42 1.9 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.155 -0.965 . . . . 0.0 109.829 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 6.8 tttp . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.334 179.955 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . 0.699 'CA ' ' OD2' ' A' ' 95' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 153' ' ' WW7 . . . . . 0.53 H122 H162 ' A' ' 153' ' ' WW7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' WW7 . . . . . 0.477 ' H3 ' ' CD1' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.229 0.537 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.58 123.77 33.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 110.198 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -141.42 119.53 12.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 110.296 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.8 pp -156.2 125.22 6.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 110.276 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.6 m -138.18 -58.81 0.65 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.288 -0.883 . . . . 0.0 110.1 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -69.73 -32.03 70.35 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.325 -0.859 . . . . 0.0 109.784 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -59.94 -40.99 90.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.374 -0.828 . . . . 0.0 109.771 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.425 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 34.9 tp60 -58.98 -44.4 91.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.689 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 57.1 mt -58.47 -45.96 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.9 . . . . 0.0 109.65 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.18 -27.04 68.69 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.317 -0.864 . . . . 0.0 109.657 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 5.9 tp10 -67.62 -44.52 77.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.33 -0.856 . . . . 0.0 109.848 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -61.82 -52.62 63.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 0.0 109.641 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.443 ' HE3' HD13 ' A' ' 69' ' ' LEU . 82.4 mttt -51.93 -43.38 63.42 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.24 -0.913 . . . . 0.0 109.389 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -56.27 -42.21 77.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 0.0 109.555 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.44 -39.66 88.31 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.39 -0.819 . . . . 0.0 109.749 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -56.51 -49.88 73.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.66 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 64.8 m -59.93 -31.0 69.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 109.642 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.806 ' O ' HD23 ' A' ' 18' ' ' LEU . 2.5 tt -65.49 -32.79 74.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.419 -0.801 . . . . 0.0 109.853 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.473 ' O ' ' HD2' ' A' ' 21' ' ' LYS . 5.2 m-85 -87.11 -67.06 0.85 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.395 -0.816 . . . . 0.0 109.999 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -48.24 95.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.957 -1.089 . . . . 0.0 109.988 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.473 ' HD2' ' O ' ' A' ' 19' ' ' PHE . 0.7 OUTLIER -84.33 -47.84 10.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.91 . . . . 0.0 110.455 -179.659 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 3.9 p30 -70.0 -20.89 63.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.108 -0.995 . . . . 0.0 110.025 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.463 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 74.83 72.84 0.99 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.406 ' OD2' ' OD1' ' A' ' 22' ' ' ASP . 65.1 m-20 -112.77 -23.4 10.18 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.145 -1.209 . . . . 0.0 109.932 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.44 -11.96 47.29 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.9 p -132.75 148.02 52.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.184 -1.186 . . . . 0.0 110.298 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.6 mt -102.86 124.77 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.97 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.5 p -114.55 -161.85 0.79 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.339 -0.85 . . . . 0.0 110.599 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.883 HG22 HG13 ' A' ' 52' ' ' ILE . 52.0 p -82.31 -21.04 36.27 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.376 -0.828 . . . . 0.0 110.48 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -74.66 -59.17 2.86 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.231 -0.918 . . . . 0.0 110.032 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.449 ' O ' HG23 ' A' ' 35' ' ' VAL . 43.7 mt-10 -62.19 -45.92 91.25 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.314 -0.866 . . . . 0.0 109.874 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.953 HD22 HD11 ' A' ' 52' ' ' ILE . 3.5 tp -62.73 -36.58 83.46 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.193 -0.942 . . . . 0.0 109.74 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.06 -41.86 86.11 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 65.5 m -80.53 -23.37 40.06 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.128 -1.219 . . . . 0.0 110.503 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 31' ' ' GLU . 38.1 t -72.59 -29.86 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.228 -0.92 . . . . 0.0 110.002 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -89.87 -30.23 18.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -0.882 . . . . 0.0 109.452 179.409 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -62.46 -58.15 8.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.475 -0.766 . . . . 0.0 110.236 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.2 t -95.13 10.36 36.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -0.891 . . . . 0.0 110.384 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.62 59.88 0.17 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.059 -1.025 . . . . 0.0 110.319 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.488 ' HA2' ' N2 ' ' A' ' 153' ' ' WW7 . . . 163.07 -97.89 0.15 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.423 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -148.46 175.62 10.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -1.136 . . . . 0.0 110.099 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -107.71 73.77 0.42 Allowed Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.307 -0.871 . . . . 0.0 110.407 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 41' ' ' GLN . 46.9 Cg_endo -72.07 -178.56 3.27 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.719 1.378 . . . . 0.0 110.205 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 9.3 m -105.42 167.01 10.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.894 . . . . 0.0 109.542 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.423 ' O ' ' HB3' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -54.71 -52.99 60.7 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.928 -1.108 . . . . 0.0 110.159 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.11 -62.72 1.28 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.185 -0.947 . . . . 0.0 110.645 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -45.23 -26.78 0.54 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.238 -0.914 . . . . 0.0 109.982 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.564 HD23 ' C ' ' A' ' 48' ' ' LEU . 9.2 tt -70.44 -51.5 28.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.374 -0.829 . . . . 0.0 109.293 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.449 ' HA ' ' OE1' ' A' ' 49' ' ' GLN . 4.1 tp-100 -50.37 -38.26 41.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.201 -0.937 . . . . 0.0 109.349 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -61.65 -43.93 97.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.277 -0.89 . . . . 0.0 109.104 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.45 ' HA ' ' HG2' ' A' ' 54' ' ' GLU . 2.2 ttp -60.25 -22.93 63.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.446 -0.784 . . . . 0.0 109.353 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.953 HD11 HD22 ' A' ' 32' ' ' LEU . 35.8 mm -81.68 -27.53 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.536 -0.727 . . . . 0.0 110.279 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -81.57 -15.18 55.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.207 -0.933 . . . . 0.0 110.825 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.74 ' HG3' HG23 ' A' ' 55' ' ' VAL . 2.8 pt-20 -88.47 -16.42 32.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.95 -1.094 . . . . 0.0 110.628 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.854 HG21 ' C6 ' ' A' ' 153' ' ' WW7 . 64.0 t -104.23 -36.88 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.097 -1.002 . . . . 0.0 110.403 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -84.9 103.23 13.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.959 . . . . 0.0 110.039 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.98 41.72 1.56 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.288 -0.882 . . . . 0.0 109.986 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -115.29 18.48 16.1 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.371 -0.831 . . . . 0.0 109.674 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.42 29.24 30.47 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -108.07 -63.97 1.26 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.256 -1.143 . . . . 0.0 110.409 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.28 -65.2 0.43 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 81.1 p -96.07 161.31 14.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -1.148 . . . . 0.0 109.709 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 78.6 mt -84.05 142.15 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.117 -0.989 . . . . 0.0 110.427 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.448 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 56.3 m-20 -101.83 -176.69 3.2 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.319 -0.863 . . . . 0.0 109.945 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.577 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -72.61 -47.24 9.51 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 111.089 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.6 Cg_endo -72.28 -24.4 19.77 Favored 'Trans proline' 0 C--N 1.321 -0.892 0 O-C-N 123.336 1.177 . . . . 0.0 110.408 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -77.34 -28.08 52.95 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.173 -0.955 . . . . 0.0 108.714 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.537 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 7.9 t80 -76.8 -38.07 54.61 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.639 -0.663 . . . . 0.0 109.976 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.537 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 27.5 tp -75.23 -26.42 58.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.359 -0.838 . . . . 0.0 110.271 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.0 m -79.95 -32.33 39.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.178 -0.951 . . . . 0.0 110.076 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.442 ' HG3' ' N ' ' A' ' 72' ' ' MET . 16.8 ptm -84.5 -29.09 26.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.333 -0.854 . . . . 0.0 110.634 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.537 ' CE ' ' CZ ' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -90.58 -29.53 17.77 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.198 -0.939 . . . . 0.0 110.74 -179.658 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -84.53 -37.11 21.66 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.207 -0.933 . . . . 0.0 110.473 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.45 ' C ' ' CG ' ' A' ' 75' ' ' LYS . 16.4 ttt-85 -102.9 -28.7 11.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.934 . . . . 0.0 110.184 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.45 ' CG ' ' C ' ' A' ' 74' ' ' ARG . 15.7 ptpt 36.87 -161.07 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.692 0 O-C-N 121.953 -0.467 . . . . 0.0 111.012 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.454 ' O ' ' HG3' ' A' ' 76' ' ' MET . 22.5 ptp -133.12 55.08 1.92 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.815 -1.178 . . . . 0.0 110.768 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.32 -47.95 3.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.071 -1.018 . . . . 0.0 110.423 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.59 127.99 53.47 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.091 -1.005 . . . . 0.0 110.565 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.5 p -60.0 161.88 6.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.198 -0.939 . . . . 0.0 109.816 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 9.8 t70 -156.62 48.89 0.47 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.118 -0.989 . . . . 0.0 110.0 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 79.4 p -68.96 159.04 33.48 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.151 -0.968 . . . . 0.0 110.218 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.436 ' HG2' ' HG2' ' A' ' 83' ' ' GLU . 7.9 pm0 -64.23 -139.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.873 . . . . 0.0 110.101 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.436 ' HG2' ' HG2' ' A' ' 82' ' ' GLU . 64.5 mm-40 47.93 87.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.092 -1.005 . . . . 0.0 110.673 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -68.07 -17.56 64.42 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.21 -0.931 . . . . 0.0 109.963 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.527 ' CG2' HG22 ' A' ' 142' ' ' VAL . 47.3 mm -67.71 -41.8 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 110.341 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -71.45 -43.81 65.98 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.27 -0.894 . . . . 0.0 110.267 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 66.2 mt-10 -58.71 -43.92 90.2 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.18 -0.95 . . . . 0.0 110.212 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.507 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -59.8 -60.29 4.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 0.0 109.751 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CZ ' ' O ' ' A' ' 98' ' ' GLY . 6.2 t80 -48.95 -25.72 2.1 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.323 -0.86 . . . . 0.0 109.805 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 21.9 ttt180 -69.29 -64.45 0.87 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.426 -0.796 . . . . 0.0 110.858 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 88' ' ' ALA . 32.9 m -56.59 -35.2 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.333 -0.854 . . . . 0.0 111.545 -178.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.868 ' CE1' HD12 ' A' ' 105' ' ' LEU . 44.4 m-85 -77.93 -21.81 50.55 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.824 -1.173 . . . . 0.0 110.932 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 89' ' ' PHE . 97.0 m-20 -128.03 40.76 3.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.053 -1.03 . . . . 0.0 109.944 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 21.2 pttp -91.85 25.19 2.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 110.022 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.437 ' OD1' ' HB2' ' A' ' 97' ' ' ASN . 2.8 p30 -107.19 0.58 23.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.368 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.04 16.82 36.97 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.437 ' HB2' ' OD1' ' A' ' 95' ' ' ASP . 21.4 t-20 -95.53 -62.13 1.35 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.097 -1.237 . . . . 0.0 110.287 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.504 ' O ' ' CZ ' ' A' ' 89' ' ' PHE . . . 121.46 -57.82 0.59 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.443 ' CE1' ' OD1' ' A' ' 137' ' ' ASN . 12.7 m-85 -91.5 159.76 15.77 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.267 -1.137 . . . . 0.0 110.138 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.569 HG23 ' HB3' ' A' ' 92' ' ' PHE . 17.5 mt -87.17 154.89 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.106 -0.996 . . . . 0.0 109.467 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 105' ' ' LEU . 23.3 t -140.57 -177.43 5.05 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.137 -0.977 . . . . 0.0 110.611 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.74 -34.18 40.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.366 -0.833 . . . . 0.0 109.953 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.06 -54.91 9.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -0.963 . . . . 0.0 109.928 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -59.14 -43.76 92.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.251 -0.906 . . . . 0.0 109.846 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.966 HD23 HG13 ' A' ' 121' ' ' VAL . 56.8 tp -52.22 -50.41 62.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 110.28 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -67.55 -26.26 66.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -0.883 . . . . 0.0 110.471 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.418 ' ND1' ' O ' ' A' ' 107' ' ' HIS . 31.9 t-80 -75.85 -16.82 60.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.131 -0.981 . . . . 0.0 110.12 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 72.8 t -88.68 -50.56 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.359 -0.838 . . . . 0.0 110.267 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 55.6 mtt -68.57 -44.29 74.73 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.359 -0.838 . . . . 0.0 110.532 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 91.0 m -58.83 -44.49 90.9 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.271 -0.893 . . . . 0.0 110.457 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -64.84 -53.36 47.98 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.252 -0.905 . . . . 0.0 110.689 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.432 ' HA ' HD23 ' A' ' 112' ' ' LEU . 27.6 mt -46.86 -86.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.236 -0.915 . . . . 0.0 110.307 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -179.97 33.67 0.06 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -122.98 143.19 50.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -1.194 . . . . 0.0 110.156 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 39.4 pttt -113.8 117.55 31.77 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.265 -0.897 . . . . 0.0 109.942 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.8 mt -124.72 149.77 46.91 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.109 -0.994 . . . . 0.0 110.646 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.401 ' HB ' ' HG3' ' A' ' 120' ' ' GLU . 39.7 m -71.63 136.79 47.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.283 -0.886 . . . . 0.0 110.052 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -47.87 -44.06 29.01 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.186 -0.946 . . . . 0.0 110.218 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -55.44 -43.01 75.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.836 . . . . 0.0 110.579 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 124' ' ' MET . 45.9 mt-10 -60.37 -51.93 67.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.209 -0.932 . . . . 0.0 110.583 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.966 HG13 HD23 ' A' ' 105' ' ' LEU . 54.1 t -53.43 -48.22 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.074 -1.017 . . . . 0.0 110.339 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -58.43 -41.23 84.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.174 -0.954 . . . . 0.0 110.246 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -70.54 -20.64 62.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.913 . . . . 0.0 110.195 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.423 ' O ' ' H6 ' ' A' ' 154' ' ' WW7 . 85.2 mtp -76.94 -43.67 34.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.175 -0.953 . . . . 0.0 109.615 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.627 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 14.4 mm -67.7 -30.3 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.886 . . . . 0.0 109.926 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.8 ttp85 -75.91 -52.26 10.68 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.113 -0.992 . . . . 0.0 110.217 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -54.17 -38.5 65.62 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.214 -0.928 . . . . 0.0 110.151 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.41 ' HB2' ' H6 ' ' A' ' 154' ' ' WW7 . . . -73.22 -41.56 63.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.877 . . . . 0.0 109.802 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -69.22 92.99 0.59 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.383 -0.823 . . . . 0.0 109.771 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 75.9 mt -63.23 -44.14 99.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.368 -0.833 . . . . 0.0 110.777 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.9 p30 -74.31 -29.41 61.61 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.113 -0.992 . . . . 0.0 110.274 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.453 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 75.19 57.94 4.15 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.444 ' OD1' ' CG ' ' A' ' 135' ' ' GLN . 57.1 p-10 -106.82 0.98 24.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.127 -1.219 . . . . 0.0 110.6 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.14 26.47 12.37 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.444 ' CG ' ' OD1' ' A' ' 133' ' ' ASP . 7.6 pt20 -169.38 164.69 10.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.194 -1.18 . . . . 0.0 110.101 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.479 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 55.2 t -123.06 115.73 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.21 -0.931 . . . . 0.0 109.921 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.443 ' OD1' ' CE1' ' A' ' 99' ' ' TYR . 15.6 t30 -84.16 -174.89 5.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.293 -0.879 . . . . 0.0 110.62 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.682 ' O ' HG23 ' A' ' 142' ' ' VAL . 12.0 t80 -69.74 -42.65 73.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.4 -0.813 . . . . 0.0 110.682 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -61.55 -58.46 8.05 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.276 -0.89 . . . . 0.0 110.659 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -56.07 -36.82 68.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.089 -1.007 . . . . 0.0 110.362 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.583 ' CZ ' ' HE1' ' A' ' 145' ' ' MET . 13.5 t80 -67.08 -27.72 67.59 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.265 -0.897 . . . . 0.0 110.689 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 138' ' ' TYR . 98.5 t -89.93 -22.65 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.34 -0.85 . . . . 0.0 111.078 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -81.61 -36.48 28.89 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.08 -1.013 . . . . 0.0 110.991 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.622 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 4.7 ptt? -64.58 -28.91 69.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.939 -1.1 . . . . 0.0 110.093 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.622 ' CE ' ' HE2' ' A' ' 144' ' ' MET . 61.2 mtt -82.71 -23.26 34.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.879 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.654 HG23 ' O ' ' A' ' 142' ' ' VAL . 47.2 p -84.34 136.68 33.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.339 -0.851 . . . . 0.0 109.915 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 146' ' ' THR . . . 60.73 150.94 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.179 -0.951 . . . . 0.0 110.235 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 34.8 mttt . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.139 179.954 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 153' ' ' WW7 . . . . . 0.854 ' C6 ' HG21 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' WW7 . . . . . 0.627 'CL1 ' HD13 ' A' ' 125' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.199 0.523 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -99.39 56.11 1.0 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.255 -0.903 . . . . 0.0 110.001 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -135.05 163.12 30.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.31 -0.869 . . . . 0.0 110.012 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.5 mt -66.13 -83.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.237 -0.914 . . . . 0.0 110.445 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.516 HG23 ' HB2' ' A' ' 7' ' ' GLU . 10.0 t -166.86 174.9 8.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.195 -0.941 . . . . 0.0 110.199 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -70.92 -26.05 63.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 110.218 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.516 ' HB2' HG23 ' A' ' 5' ' ' THR . 16.7 mm-40 -48.32 -43.41 33.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.201 -0.937 . . . . 0.0 110.238 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.503 ' HG3' ' CE2' ' A' ' 12' ' ' PHE . 2.9 tp-100 -59.5 -42.06 91.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.913 . . . . 0.0 109.786 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.1 mm -61.59 -36.79 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.387 -0.82 . . . . 0.0 109.6 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.28 -30.06 66.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.324 -0.86 . . . . 0.0 109.815 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -64.74 -47.23 79.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.87 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.503 ' CE2' ' HG3' ' A' ' 8' ' ' GLN . 24.0 m-85 -65.26 -49.64 68.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.326 -0.859 . . . . 0.0 110.224 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -53.4 -40.14 64.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.198 -0.939 . . . . 0.0 110.105 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -59.32 -53.26 60.31 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.313 -0.867 . . . . 0.0 110.006 179.816 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.489 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -51.19 -36.92 43.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.201 -0.937 . . . . 0.0 109.668 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.525 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 60.3 t80 -65.95 -39.57 90.55 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.382 -0.824 . . . . 0.0 109.84 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.8 t -65.62 -21.59 66.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.879 179.639 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.694 ' C ' HD23 ' A' ' 18' ' ' LEU . 7.9 tt -79.78 -41.5 26.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.398 -0.814 . . . . 0.0 110.048 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.519 ' CE2' ' H3 ' ' A' ' 153' ' ' WW7 . 16.3 m-85 -69.27 -42.09 75.99 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.344 -0.847 . . . . 0.0 110.385 -179.525 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -78.3 100.97 6.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.427 -0.795 . . . . 0.0 110.131 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -101.43 -20.73 15.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 110.491 -179.636 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -86.25 -32.45 21.12 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.151 -0.968 . . . . 0.0 110.748 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.36 79.81 1.47 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.795 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 39.3 p-10 -146.09 -22.86 0.45 Allowed 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.223 -1.163 . . . . 0.0 111.898 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.529 ' C ' HG23 ' A' ' 26' ' ' THR . . . 90.24 22.99 33.23 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.529 HG23 ' C ' ' A' ' 25' ' ' GLY . 71.1 p -152.68 132.34 13.11 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.215 -1.168 . . . . 0.0 110.177 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 55.7 mt -95.55 111.91 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 110.114 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.589 HG23 ' H ' ' A' ' 30' ' ' LYS . 10.6 t -106.62 -173.68 2.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.463 -0.773 . . . . 0.0 109.767 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.673 HG22 HD12 ' A' ' 52' ' ' ILE . 40.7 p -70.98 -22.45 62.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.142 -0.974 . . . . 0.0 110.408 179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.589 ' H ' HG23 ' A' ' 28' ' ' THR . 19.8 mtmt -67.91 -60.13 2.75 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.269 -0.894 . . . . 0.0 110.138 179.669 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -59.7 -58.53 8.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.251 -0.905 . . . . 0.0 109.762 179.549 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.732 HD23 HD11 ' A' ' 48' ' ' LEU . 1.8 tp -52.28 -30.96 30.49 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.312 -0.868 . . . . 0.0 109.818 179.686 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.86 -49.14 81.17 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 92.1 m -70.57 -23.58 62.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.2 -1.176 . . . . 0.0 110.104 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.0 t -71.35 -33.54 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.408 -0.808 . . . . 0.0 110.186 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.404 ' O ' ' O ' ' A' ' 40' ' ' GLY . 23.2 mmt -90.81 -24.24 20.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.221 -0.924 . . . . 0.0 110.365 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -89.92 -15.46 32.02 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.124 -0.985 . . . . 0.0 110.313 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.553 ' HB3' HD12 ' A' ' 39' ' ' LEU . 37.4 t -97.19 -44.03 7.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.193 -0.942 . . . . 0.0 110.18 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.553 HD12 ' HB3' ' A' ' 38' ' ' SER . 3.5 mp -117.51 64.93 0.73 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.12 -0.987 . . . . 0.0 110.054 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 36' ' ' MET . . . 127.92 58.89 0.12 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.407 ' OE1' ' N ' ' A' ' 42' ' ' ASN . 0.7 OUTLIER -58.66 132.95 55.37 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.316 -1.108 . . . . 0.0 110.695 -179.733 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.533 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.3 m-80 179.29 -59.96 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.4 -0.812 . . . . 0.0 110.001 179.726 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 46.2 Cg_endo -72.23 -163.84 0.16 Allowed 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.749 1.394 . . . . 0.0 110.252 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.632 HG23 ' N ' ' A' ' 45' ' ' GLU . 14.1 t -152.91 -136.52 0.06 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.593 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.632 ' N ' HG23 ' A' ' 44' ' ' THR . 30.8 mt-10 -101.5 -40.18 7.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.733 -1.229 . . . . 0.0 109.796 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.47 -67.11 0.66 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.884 . . . . 0.0 109.586 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -49.01 -44.09 40.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.308 -0.87 . . . . 0.0 109.468 179.321 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.732 HD11 HD23 ' A' ' 32' ' ' LEU . 5.7 tt -55.35 -46.31 76.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.425 -0.797 . . . . 0.0 109.459 179.206 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.527 ' N ' HD23 ' A' ' 48' ' ' LEU . 43.5 tt0 -51.01 -41.87 60.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.299 -0.876 . . . . 0.0 109.361 179.306 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.447 ' HA ' ' OD1' ' A' ' 53' ' ' ASN . 33.9 t70 -62.48 -43.33 99.08 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.459 -0.776 . . . . 0.0 109.63 179.344 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.432 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 21.5 ttp -61.18 -22.83 65.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.308 -0.87 . . . . 0.0 109.713 179.629 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.673 HD12 HG22 ' A' ' 29' ' ' THR . 37.0 mt -84.13 -26.65 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -0.859 . . . . 0.0 109.863 179.635 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.447 ' OD1' ' HA ' ' A' ' 50' ' ' ASP . 33.3 m120 -65.22 -19.7 66.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.174 -0.954 . . . . 0.0 110.441 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -84.33 -23.84 30.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 110.037 179.763 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.709 HG21 ' C6 ' ' A' ' 153' ' ' WW7 . 85.1 t -93.0 -63.74 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.335 -0.853 . . . . 0.0 109.69 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -55.22 113.07 1.24 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.376 -0.828 . . . . 0.0 110.378 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -101.82 45.45 0.97 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.36 -0.837 . . . . 0.0 109.928 179.849 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.59 -47.41 1.56 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.351 -0.843 . . . . 0.0 110.395 -179.516 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.31 38.56 2.42 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.607 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.446 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 18.6 p-10 -125.38 -19.16 5.12 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.171 -1.194 . . . . 0.0 110.66 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.508 ' C ' HG23 ' A' ' 62' ' ' THR . . . 102.22 4.58 50.4 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.718 -1.229 . . . . 0.0 111.27 178.559 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.508 HG23 ' C ' ' A' ' 61' ' ' GLY . 47.5 p -149.87 152.36 34.97 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.557 -1.555 . . . . 0.0 110.833 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.581 HD11 ' CG1' ' A' ' 55' ' ' VAL . 72.7 mt -100.6 130.94 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.339 -0.851 . . . . 0.0 109.987 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.456 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -77.35 -169.06 1.28 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.137 -0.977 . . . . 0.0 110.327 -179.927 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.56 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 4.1 t80 -80.14 -44.27 1.44 Allowed Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.221 -0.924 . . . . 0.0 111.294 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.3 Cg_endo -74.09 -27.01 12.27 Favored 'Trans proline' 0 C--N 1.322 -0.838 0 O-C-N 123.138 1.073 . . . . 0.0 109.984 -179.384 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -73.01 -30.81 64.05 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.355 -0.841 . . . . 0.0 108.811 179.197 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.525 ' CE2' ' HB2' ' A' ' 16' ' ' PHE . 84.9 t80 -72.01 -45.18 61.87 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.54 0.686 . . . . 0.0 109.618 179.271 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.545 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 9.1 tp -77.54 -15.41 59.28 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.367 -0.833 . . . . 0.0 109.719 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.473 ' O ' ' HB3' ' A' ' 74' ' ' ARG . 7.5 m -86.87 -22.52 25.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 110.216 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.481 ' HE2' ' HE3' ' A' ' 72' ' ' MET . 9.2 ptt? -90.61 -37.46 13.78 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.958 -1.089 . . . . 0.0 110.237 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.481 ' HE3' ' HE2' ' A' ' 71' ' ' MET . 59.8 mtt -90.15 -65.62 1.0 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.259 -0.901 . . . . 0.0 111.443 -179.208 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -60.77 -11.62 8.14 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.467 -0.771 . . . . 0.0 111.708 -178.612 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.473 ' HB3' ' O ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -96.43 35.53 1.47 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.712 -1.242 . . . . 0.0 110.899 -179.501 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.39 104.8 0.1 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.059 -1.026 . . . . 0.0 109.9 179.686 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.0 ttt -144.2 89.43 2.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.267 -0.896 . . . . 0.0 110.138 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.6 tttt -110.57 -108.53 0.35 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 110.059 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -136.2 57.84 1.76 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.672 -1.267 . . . . 0.0 110.034 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 47.6 p -120.54 -48.0 2.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 110.429 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -147.62 -56.31 0.24 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.159 -0.963 . . . . 0.0 110.29 -179.771 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 79.6 p -66.64 120.54 13.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.25 -0.906 . . . . 0.0 110.357 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -174.07 -146.63 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.22 -0.925 . . . . 0.0 110.501 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -159.96 93.88 1.09 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.883 . . . . 0.0 109.865 -179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -76.62 -35.08 58.29 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.318 -0.864 . . . . 0.0 110.541 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.1 mt -50.39 -43.89 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.206 -0.934 . . . . 0.0 110.577 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -57.23 -43.17 82.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.91 . . . . 0.0 110.609 -179.767 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -63.5 -37.41 87.2 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.303 -0.873 . . . . 0.0 111.305 -179.378 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.707 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -64.55 -60.01 3.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.106 -0.996 . . . . 0.0 110.593 -179.421 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -51.36 -34.31 33.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.23 -0.918 . . . . 0.0 110.615 -179.492 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -45.36 88.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.106 -0.996 . . . . 0.0 110.557 -179.669 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.707 HG22 ' O ' ' A' ' 88' ' ' ALA . 33.0 m -77.38 -14.7 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.051 -1.031 . . . . 0.0 110.538 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.684 ' HE2' ' HB1' ' A' ' 88' ' ' ALA . 22.4 m-85 -93.82 -13.96 26.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.195 -0.941 . . . . 0.0 110.406 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -107.46 59.24 0.62 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.932 . . . . 0.0 109.837 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -63.54 -43.86 95.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.376 -0.827 . . . . 0.0 110.646 -179.686 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.429 ' OD2' ' HB3' ' A' ' 97' ' ' ASN . 18.1 p-10 -69.04 -26.8 65.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.194 -0.941 . . . . 0.0 110.106 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.18 8.33 71.98 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.168 178.614 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.429 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 20.6 p-10 -62.5 -30.09 71.02 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.599 -1.53 . . . . 0.0 110.105 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.497 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 107.69 7.73 31.31 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.497 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 30.1 m-85 -140.49 163.27 33.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.124 -1.221 . . . . 0.0 109.874 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.461 ' CD1' ' CD1' ' A' ' 141' ' ' PHE . 40.0 mt -100.08 129.31 50.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.198 -0.939 . . . . 0.0 109.876 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.6 t -110.37 147.21 34.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.445 -0.784 . . . . 0.0 109.721 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -51.26 -45.36 62.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.121 -0.987 . . . . 0.0 110.248 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -49.88 -55.52 14.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.154 -0.966 . . . . 0.0 110.293 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -61.35 -30.63 70.64 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.174 -0.954 . . . . 0.0 110.592 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.755 HD23 HG13 ' A' ' 121' ' ' VAL . 21.7 tp -58.42 -44.01 88.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.26 -0.9 . . . . 0.0 110.285 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.08 -28.04 48.69 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.322 -0.861 . . . . 0.0 110.192 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -70.34 -19.46 63.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.2 -0.937 . . . . 0.0 110.151 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 70.2 t -101.78 -26.63 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.153 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.657 ' HB3' HD13 ' A' ' 116' ' ' LEU . 23.0 mmt -77.89 -24.57 48.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.159 -0.963 . . . . 0.0 110.248 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.6 m -90.61 -15.38 30.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -0.923 . . . . 0.0 110.431 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -90.21 -43.41 10.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.093 -1.004 . . . . 0.0 110.463 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 46.8 mt -59.83 -45.28 92.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 109.975 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 136.66 50.18 0.07 OUTLIER Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.451 ' HB3' HD11 ' A' ' 116' ' ' LEU . 65.6 mm-40 -136.94 126.91 25.88 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.208 -1.172 . . . . 0.0 110.095 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.36 112.98 25.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.2 -0.937 . . . . 0.0 110.448 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.657 HD13 ' HB3' ' A' ' 109' ' ' MET . 3.5 mp -127.67 -169.5 2.06 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.342 -0.849 . . . . 0.0 109.905 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.2 t -144.53 164.9 29.53 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.144 -0.972 . . . . 0.0 110.607 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -53.81 -28.79 37.37 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.393 -0.817 . . . . 0.0 111.004 -179.552 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.29 -51.54 43.77 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.145 -0.972 . . . . 0.0 110.957 -179.317 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -64.1 -51.58 63.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.189 -0.945 . . . . 0.0 110.782 -179.426 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.755 HG13 HD23 ' A' ' 105' ' ' LEU . 77.9 t -57.19 -45.89 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.236 -0.915 . . . . 0.0 110.728 -179.373 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -58.82 -53.56 57.03 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.061 -1.024 . . . . 0.0 110.505 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -62.64 -22.96 66.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -0.931 . . . . 0.0 110.418 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 5.8 mmm -71.56 -49.66 38.49 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.153 -0.967 . . . . 0.0 110.113 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 23.6 mm -69.4 -28.53 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.193 -0.942 . . . . 0.0 109.953 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -70.63 -43.36 69.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.964 . . . . 0.0 109.983 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -71.16 -27.59 63.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.211 -0.931 . . . . 0.0 109.816 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.753 ' HB2' ' H6 ' ' A' ' 154' ' ' WW7 . . . -78.29 -25.2 46.57 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.341 -0.849 . . . . 0.0 109.769 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -74.83 86.61 2.23 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.303 -0.873 . . . . 0.0 110.201 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 70.5 mt -69.08 -48.13 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.282 -0.886 . . . . 0.0 110.433 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 3.0 p30 -73.77 -21.97 60.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.229 -0.92 . . . . 0.0 110.278 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 68.79 68.15 1.74 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 36.8 p30 -118.35 -16.92 9.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.438 -1.037 . . . . 0.0 111.032 -179.309 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.466 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 124.71 -46.8 1.06 Allowed Glycine 0 N--CA 1.498 2.779 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.406 ' O ' ' OE1' ' A' ' 135' ' ' GLN . 0.0 OUTLIER -119.31 170.57 9.0 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.242 -1.152 . . . . 0.0 109.909 179.846 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.424 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 75.6 t -103.3 151.61 6.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.041 -1.037 . . . . 0.0 110.672 -179.345 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.494 ' OD1' ' CD1' ' A' ' 99' ' ' TYR . 72.6 m-20 -122.73 -172.74 2.54 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.494 -0.754 . . . . 0.0 109.82 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.722 ' O ' HG23 ' A' ' 142' ' ' VAL . 3.9 t80 -72.93 -19.91 61.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.195 -0.941 . . . . 0.0 109.727 179.595 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.41 -56.58 4.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.136 -0.978 . . . . 0.0 109.837 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -64.76 -25.37 67.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.146 -0.971 . . . . 0.0 109.691 179.561 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.493 ' CE2' ' HE3' ' A' ' 145' ' ' MET . 19.1 t80 -75.29 -29.16 60.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.399 -0.813 . . . . 0.0 109.967 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 138' ' ' TYR . 70.5 t -84.83 -27.85 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.233 -0.917 . . . . 0.0 110.27 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.83 -34.15 34.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.837 . . . . 0.0 110.646 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.446 ' HE3' ' HE3' ' A' ' 145' ' ' MET . 0.1 OUTLIER -82.6 -25.54 33.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 110.47 -179.46 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.493 ' HE3' ' CE2' ' A' ' 141' ' ' PHE . 26.0 ttm -89.86 -57.36 2.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.277 -0.889 . . . . 0.0 110.104 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.0 p 42.96 94.47 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.427 -0.796 . . . . 0.0 110.924 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -109.46 45.65 1.06 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.343 -0.848 . . . . 0.0 110.077 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.249 -179.855 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 153' ' ' WW7 . . . . . 0.709 ' C6 ' HG21 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' WW7 . . . . . 0.753 ' H6 ' ' HB2' ' A' ' 128' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.263 0.554 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -53.18 110.36 0.53 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.902 . . . . 0.0 110.26 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -100.13 153.74 19.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.236 -0.915 . . . . 0.0 110.154 179.882 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 48.7 mt -129.22 121.73 28.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.237 -0.914 . . . . 0.0 110.211 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.8 p -134.59 -55.46 0.84 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.243 -0.911 . . . . 0.0 110.097 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -81.85 -41.34 21.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.306 -0.871 . . . . 0.0 110.295 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.417 ' OE1' ' CA ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -52.65 -35.65 55.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 110.775 -179.594 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -56.57 -54.05 50.46 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.06 -1.025 . . . . 0.0 109.817 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 78.8 mt -58.95 -34.2 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.658 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.75 -28.07 67.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.256 -0.902 . . . . 0.0 110.073 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -72.45 -53.51 11.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.337 -0.852 . . . . 0.0 109.725 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -56.37 -45.7 80.39 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.327 -0.858 . . . . 0.0 109.819 179.616 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.85 -41.37 74.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 109.758 179.433 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -54.44 -52.53 61.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.402 -0.811 . . . . 0.0 109.953 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.23 -50.09 62.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.38 -0.825 . . . . 0.0 110.253 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -51.26 -45.56 62.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.186 -0.946 . . . . 0.0 109.828 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.9 m -55.14 -41.95 72.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.241 -0.912 . . . . 0.0 109.761 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.718 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.1 tt -59.0 -34.32 71.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.375 -0.828 . . . . 0.0 109.647 179.575 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.622 ' CZ ' HG11 ' A' ' 35' ' ' VAL . 10.5 m-85 -74.5 -69.97 0.43 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.325 -0.859 . . . . 0.0 110.541 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.28 91.49 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.367 -0.833 . . . . 0.0 110.089 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 19' ' ' PHE . 2.3 mttm -81.42 -28.29 34.33 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.341 -0.849 . . . . 0.0 109.943 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.403 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 5.0 p30 -104.89 -9.81 17.74 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.282 -0.886 . . . . 0.0 110.487 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 61.56 63.23 5.01 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.642 ' OD2' 'CA ' ' A' ' 149' ' ' ' CA' . 1.8 p30 -92.02 -15.68 27.53 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.184 -1.186 . . . . 0.0 110.012 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.551 ' C ' HG23 ' A' ' 26' ' ' THR . . . 114.88 -9.85 21.16 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.551 HG23 ' C ' ' A' ' 25' ' ' GLY . 82.3 p -156.07 169.8 23.64 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.161 -1.199 . . . . 0.0 110.497 -179.818 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.4 mt -105.14 125.39 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.44 -0.788 . . . . 0.0 109.49 179.229 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 49.3 p -110.45 -171.98 1.94 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.198 -0.938 . . . . 0.0 110.437 -179.547 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.61 HG21 ' HG2' ' A' ' 49' ' ' GLN . 55.3 p -79.05 -25.49 43.18 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.328 -0.857 . . . . 0.0 110.422 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -70.26 -56.81 5.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.29 -0.881 . . . . 0.0 109.766 179.606 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.403 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 88.8 mt-10 -59.43 -48.34 82.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.311 -0.868 . . . . 0.0 109.318 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.068 HD22 HD11 ' A' ' 52' ' ' ILE . 1.3 tp -61.94 -26.73 68.37 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.468 -0.77 . . . . 0.0 109.426 179.428 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.52 -44.38 97.67 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.545 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.3 m -71.3 -27.2 63.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -1.116 . . . . 0.0 109.938 179.569 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.622 HG11 ' CZ ' ' A' ' 19' ' ' PHE . 8.1 t -67.05 -38.7 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.291 -0.88 . . . . 0.0 109.99 179.761 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 20.8 mmt -89.56 -20.15 24.13 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.069 -1.019 . . . . 0.0 110.37 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -90.25 -13.28 35.72 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.22 -0.925 . . . . 0.0 110.721 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.664 ' OG ' HD23 ' A' ' 39' ' ' LEU . 14.9 p -65.59 -59.55 3.84 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.219 -0.925 . . . . 0.0 110.463 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.664 HD23 ' OG ' ' A' ' 38' ' ' SER . 0.5 OUTLIER -132.85 47.25 2.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.098 -1.001 . . . . 0.0 110.125 179.975 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -166.98 43.69 0.25 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.44 ' OE1' ' N ' ' A' ' 42' ' ' ASN . 0.9 OUTLIER -49.38 115.08 1.19 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.217 -1.166 . . . . 0.0 110.162 -179.818 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.501 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 0.6 OUTLIER -174.81 -61.75 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.402 -0.811 . . . . 0.0 109.931 179.743 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.501 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 43.4 Cg_endo -70.67 165.73 31.05 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.549 1.289 . . . . 0.0 110.266 179.453 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.484 HG22 ' H ' ' A' ' 45' ' ' GLU . 0.8 OUTLIER -119.93 -146.87 0.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.158 -0.964 . . . . 0.0 109.782 179.913 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.484 ' H ' HG22 ' A' ' 44' ' ' THR . 20.9 pt-20 -92.37 -41.34 10.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.133 -0.98 . . . . 0.0 109.694 179.54 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.469 ' N ' ' HG3' ' A' ' 45' ' ' GLU . . . -71.12 -60.72 2.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.292 -0.88 . . . . 0.0 110.051 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -49.05 -30.5 6.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.068 -1.02 . . . . 0.0 109.477 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.592 HD11 HD23 ' A' ' 32' ' ' LEU . 8.0 tt -65.2 -52.19 56.36 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.556 -0.715 . . . . 0.0 109.5 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.61 ' HG2' HG21 ' A' ' 29' ' ' THR . 70.3 mt-30 -49.67 -39.04 35.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.943 . . . . 0.0 109.356 179.242 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.88 -46.22 91.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.429 -0.794 . . . . 0.0 109.703 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.415 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 18.0 ttp -65.2 -17.92 64.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.903 . . . . 0.0 109.738 179.527 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.068 HD11 HD22 ' A' ' 32' ' ' LEU . 36.3 mm -85.84 -28.75 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.395 -0.815 . . . . 0.0 110.133 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -62.54 -41.89 99.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.259 -0.901 . . . . 0.0 110.244 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.608 ' HG3' HG23 ' A' ' 55' ' ' VAL . 12.0 pt-20 -67.8 -24.44 65.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.273 -0.892 . . . . 0.0 109.898 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.896 HG13 ' SD ' ' A' ' 71' ' ' MET . 74.0 t -92.65 -7.26 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.293 -0.879 . . . . 0.0 110.297 179.562 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.461 ' OD2' ' CA ' ' A' ' 61' ' ' GLY . 22.8 t0 -113.21 98.73 7.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.028 -1.045 . . . . 0.0 110.853 -179.564 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.91 25.53 9.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 0.0 109.146 178.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.413 ' OD2' ' OD1' ' A' ' 60' ' ' ASN . 8.8 t70 -98.55 -49.1 4.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.602 -0.686 . . . . 0.0 110.419 -179.705 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.47 -26.55 5.45 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.434 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 16.5 p-10 -70.46 -33.84 71.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.032 -1.276 . . . . 0.0 110.339 -179.833 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.461 ' CA ' ' OD2' ' A' ' 56' ' ' ASP . . . 119.38 -61.24 0.49 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.434 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 81.7 p -70.09 165.38 22.08 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.302 -1.117 . . . . 0.0 110.254 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.471 HG12 HG12 ' A' ' 55' ' ' VAL . 9.9 mt -100.21 157.71 3.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.272 -0.893 . . . . 0.0 109.768 179.629 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.439 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 46.0 m-20 -111.7 -169.96 1.56 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.512 -179.538 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.575 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 9.8 t80 -78.19 -44.86 2.21 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.256 -0.902 . . . . 0.0 111.44 -179.549 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.3 Cg_endo -71.64 -17.66 29.56 Favored 'Trans proline' 0 C--O 1.205 -1.14 0 O-C-N 123.127 1.067 . . . . 0.0 110.252 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -84.71 -30.91 24.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.185 -0.947 . . . . 0.0 109.372 179.123 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 9.0 t80 -71.45 -49.21 43.74 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.591 -0.693 . . . . 0.0 110.231 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.834 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 0.6 OUTLIER -76.64 -29.7 56.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.197 -0.939 . . . . 0.0 110.725 -179.661 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 66' ' ' PRO . 54.8 m -78.51 -19.57 52.68 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.774 -1.204 . . . . 0.0 110.334 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.896 ' SD ' HG13 ' A' ' 55' ' ' VAL . 61.1 ttp -86.34 -49.8 7.39 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.135 -0.978 . . . . 0.0 110.573 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.2 mtt -83.1 -59.69 2.39 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.223 -0.923 . . . . 0.0 110.786 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.834 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -47.11 -35.28 6.93 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.046 -1.034 . . . . 0.0 110.558 -179.492 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.46 ' NH1' ' OG1' ' A' ' 79' ' ' THR . 52.1 mtt180 -108.97 62.63 0.6 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.227 -0.921 . . . . 0.0 110.196 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.96 -28.84 60.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -0.888 . . . . 0.0 110.181 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 9.7 ptm -142.02 14.36 2.07 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.231 -0.918 . . . . 0.0 110.43 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.04 93.26 3.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.159 -0.963 . . . . 0.0 109.984 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -77.67 169.26 18.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.915 . . . . 0.0 110.39 -179.67 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.46 ' OG1' ' NH1' ' A' ' 74' ' ' ARG . 55.1 m -93.99 -34.95 12.85 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.291 -0.881 . . . . 0.0 110.432 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 65.3 t0 54.31 55.06 8.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 109.951 -179.584 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.453 ' OG ' HG22 ' A' ' 79' ' ' THR . 49.5 m -136.43 -46.62 0.62 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.199 -0.938 . . . . 0.0 110.138 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 25.8 tt0 55.36 29.98 14.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.912 . . . . 0.0 110.301 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -89.0 53.47 2.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.922 . . . . 0.0 110.197 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.684 ' HB2' HN21 ' A' ' 154' ' ' WW7 . 48.2 mt-10 -93.96 -25.77 17.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.234 -0.916 . . . . 0.0 110.331 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.9 mm -51.99 -46.27 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 110.451 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -62.43 -44.43 96.45 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.125 -0.984 . . . . 0.0 109.868 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -54.24 -37.14 64.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.352 -0.843 . . . . 0.0 110.118 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.792 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -68.28 -63.91 0.97 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.305 -0.872 . . . . 0.0 110.438 -179.787 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -45.33 -27.73 0.72 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.239 -0.913 . . . . 0.0 110.612 -179.647 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.82 -54.6 9.63 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.23 -0.919 . . . . 0.0 110.408 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.792 HG22 ' O ' ' A' ' 88' ' ' ALA . 33.9 m -61.85 -21.22 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.23 -0.919 . . . . 0.0 110.26 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.643 ' CE1' HG11 ' A' ' 108' ' ' VAL . 46.5 m-85 -93.23 -16.27 24.98 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.243 -0.911 . . . . 0.0 110.313 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.424 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 49.3 t0 -124.94 67.12 1.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.862 . . . . 0.0 109.863 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -95.22 2.06 54.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 110.855 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 2.7 p30 -95.81 -13.21 24.23 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.094 -1.004 . . . . 0.0 110.347 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.36 36.18 8.28 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.451 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 6.4 t-20 -93.25 -61.39 1.58 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.22 -1.165 . . . . 0.0 110.183 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.479 ' C ' ' CD1' ' A' ' 99' ' ' TYR . . . 128.59 -14.4 6.1 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 33.6 m-85 -136.73 146.91 46.38 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.129 -1.218 . . . . 0.0 110.225 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 100' ' ' ILE . 39.8 mt -74.71 143.37 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.173 -0.954 . . . . 0.0 110.403 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.5 p -129.2 158.93 37.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.369 -0.832 . . . . 0.0 109.748 179.617 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.88 -25.14 56.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.148 -0.97 . . . . 0.0 110.545 -179.58 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.12 -64.5 1.04 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.181 -0.949 . . . . 0.0 110.507 -179.731 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.566 ' O ' HG23 ' A' ' 108' ' ' VAL . 41.3 mt-10 -48.95 -40.95 32.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.231 -0.918 . . . . 0.0 110.068 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.46 ' O ' HD23 ' A' ' 105' ' ' LEU . 6.4 tt -63.74 -40.12 95.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.0 110.156 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.753 ' O ' HG23 ' A' ' 110' ' ' THR . 2.5 tpm_? -58.71 -35.37 72.56 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.206 -0.934 . . . . 0.0 109.982 179.775 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.4 ' O ' ' OG1' ' A' ' 110' ' ' THR . 73.6 m-70 -77.32 -24.85 50.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.87 . . . . 0.0 110.619 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.643 HG11 ' CE1' ' A' ' 92' ' ' PHE . 90.4 t -77.16 -37.98 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.131 -0.98 . . . . 0.0 110.545 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.768 ' HA ' HD12 ' A' ' 112' ' ' LEU . 24.7 mmt -72.66 -26.07 61.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.23 -0.918 . . . . 0.0 110.562 -179.52 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.753 HG23 ' O ' ' A' ' 106' ' ' ARG . 39.4 p -64.6 -45.22 87.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.164 -0.96 . . . . 0.0 110.125 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -72.19 -42.9 65.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.19 -0.944 . . . . 0.0 110.021 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.768 HD12 ' HA ' ' A' ' 109' ' ' MET . 39.7 mt -47.0 -25.85 0.89 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.255 -0.903 . . . . 0.0 110.403 179.785 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.2 43.96 3.64 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -132.95 136.28 46.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.29 -1.124 . . . . 0.0 110.033 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.01 109.11 21.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.241 -0.912 . . . . 0.0 110.618 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.7 mp -123.69 -177.94 3.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.345 -0.847 . . . . 0.0 109.745 179.507 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 57.8 m -129.03 155.53 45.26 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.122 -0.986 . . . . 0.0 110.256 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.419 ' O ' ' OD2' ' A' ' 122' ' ' ASP . 36.8 m-20 -49.07 -40.82 33.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.253 -0.905 . . . . 0.0 110.05 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -61.36 -50.74 71.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.231 -0.918 . . . . 0.0 110.268 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 123' ' ' GLU . 6.0 mm-40 -52.82 -48.01 67.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.298 -0.876 . . . . 0.0 110.331 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 75.3 t -54.52 -50.31 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.192 -0.942 . . . . 0.0 110.255 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 118' ' ' ASP . 61.4 m-20 -53.61 -34.77 59.61 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 110.191 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -62.88 -47.62 82.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.194 -0.941 . . . . 0.0 109.971 179.957 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.43 ' HB3' ' HE2' ' A' ' 124' ' ' MET . 60.4 mtp -63.13 -59.08 5.26 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.29 -0.881 . . . . 0.0 110.226 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.936 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 28.7 mm -50.89 -24.56 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.314 -0.866 . . . . 0.0 110.429 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -77.14 -49.15 15.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.207 -0.933 . . . . 0.0 110.071 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -63.02 -19.74 64.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -0.936 . . . . 0.0 110.017 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.467 ' HB2' ' SD ' ' A' ' 144' ' ' MET . . . -87.73 -40.98 13.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.358 -0.839 . . . . 0.0 110.088 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -64.54 88.07 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.297 -0.877 . . . . 0.0 110.243 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 43.4 mt -63.28 -57.16 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.305 -0.872 . . . . 0.0 110.304 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.8 p30 -63.3 -30.43 71.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.193 -0.942 . . . . 0.0 110.167 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.446 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 72.35 68.65 1.55 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.421 ' OD1' ' HG2' ' A' ' 135' ' ' GLN . 2.9 p30 -116.42 -25.98 7.29 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.21 -1.171 . . . . 0.0 110.538 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 137.83 -6.42 3.48 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.28 179.822 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.421 ' HG2' ' OD1' ' A' ' 133' ' ' ASP . 0.8 OUTLIER -150.63 160.46 43.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.988 -1.301 . . . . 0.0 110.324 -179.883 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 66.4 t -105.61 137.61 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 109.995 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.4 ' ND2' ' HB2' ' A' ' 139' ' ' GLU . 6.7 p-10 -108.12 -170.26 1.65 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.056 -1.028 . . . . 0.0 110.279 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.583 ' CE1' HG21 ' A' ' 142' ' ' VAL . 11.2 t80 -66.56 -62.66 1.34 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.355 -0.841 . . . . 0.0 111.201 -179.063 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.4 ' HB2' ' ND2' ' A' ' 137' ' ' ASN . 32.8 mt-10 -44.9 -48.81 11.22 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.195 -0.941 . . . . 0.0 111.614 -179.106 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -58.84 -47.62 84.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.031 -1.043 . . . . 0.0 110.796 -179.174 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -64.58 -23.18 67.18 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 110.643 -179.698 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.583 HG21 ' CE1' ' A' ' 138' ' ' TYR . 76.5 t -90.63 -20.25 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.19 -0.944 . . . . 0.0 111.146 -179.533 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -89.36 -24.77 21.88 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.114 -0.991 . . . . 0.0 110.899 -179.105 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.467 ' SD ' ' HB2' ' A' ' 128' ' ' ALA . 20.4 ptt? -88.86 -31.81 18.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.021 -1.049 . . . . 0.0 110.442 -179.932 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.432 ' N ' ' HG3' ' A' ' 144' ' ' MET . 18.8 tpp -86.48 -9.49 56.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.215 -0.928 . . . . 0.0 110.3 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 142' ' ' VAL . 12.0 t -95.75 6.7 48.27 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.16 -0.962 . . . . 0.0 110.681 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -143.85 153.75 42.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.128 -0.982 . . . . 0.0 110.288 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.7 mttp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.31 -179.952 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . 0.642 'CA ' ' OD2' ' A' ' 24' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 153' ' ' WW7 . . . . . 0.896 ' C6 ' HG21 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 154' ' ' WW7 . . . . . 0.936 'CL1 ' HD13 ' A' ' 125' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.228 0.537 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.8 74.32 1.19 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.243 -0.911 . . . . 0.0 110.131 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -151.52 122.78 7.75 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.323 -0.861 . . . . 0.0 110.297 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 pp -72.94 -171.36 0.86 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.016 -1.053 . . . . 0.0 109.416 179.336 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.8 t -140.73 150.56 43.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.081 -1.012 . . . . 0.0 110.637 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -86.9 -11.98 49.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.445 -0.784 . . . . 0.0 109.896 179.301 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.66 -36.24 34.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.167 -0.958 . . . . 0.0 109.912 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.82 -47.19 86.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -0.86 . . . . 0.0 109.706 179.682 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.5 mm -61.24 -39.38 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.517 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.29 -33.65 75.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.411 -0.806 . . . . 0.0 109.869 179.469 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.26 -53.08 54.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.673 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -53.1 -36.69 60.99 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.132 -0.98 . . . . 0.0 109.172 179.224 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -65.63 -37.45 86.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.546 -0.721 . . . . 0.0 109.651 179.266 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -57.23 -47.12 82.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.459 -0.776 . . . . 0.0 109.967 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.18 -54.58 44.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.145 -0.972 . . . . 0.0 110.22 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -47.01 -48.53 21.85 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.241 -0.912 . . . . 0.0 110.331 179.94 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.7 m -60.71 -37.77 82.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.421 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.87 ' O ' HD23 ' A' ' 18' ' ' LEU . 6.8 tt -65.16 -22.74 66.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 110.026 -179.861 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.494 ' CE2' ' H3 ' ' A' ' 153' ' ' WW7 . 10.0 m-85 -90.72 -69.32 0.74 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.308 -0.87 . . . . 0.0 110.028 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -56.69 120.48 7.88 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.117 -0.989 . . . . 0.0 109.585 179.716 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.6 mttt -110.33 -29.76 7.99 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.034 -1.041 . . . . 0.0 111.844 -178.935 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.436 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 10.4 p-10 -68.61 -44.91 73.28 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.801 -1.187 . . . . 0.0 110.144 -179.416 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.42 27.04 3.75 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.798 -1.192 . . . . 0.0 110.613 178.922 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.436 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 8.3 p-10 -95.69 -43.62 7.82 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.989 -1.3 . . . . 0.0 110.27 179.57 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.26 31.14 2.91 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.39 179.351 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.0 p -146.89 135.25 21.8 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.952 -1.323 . . . . 0.0 110.098 179.466 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 80.4 mt -106.53 98.91 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.345 -0.847 . . . . 0.0 110.034 179.787 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.802 HG23 HG22 ' A' ' 62' ' ' THR . 1.0 OUTLIER -81.83 -164.78 0.84 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.883 . . . . 0.0 110.064 -179.925 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.628 ' H ' HG22 ' A' ' 28' ' ' THR . 5.1 p -83.76 -41.57 17.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.102 -0.999 . . . . 0.0 110.586 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.515 ' HG3' ' N ' ' A' ' 31' ' ' GLU . 6.3 ptpt -69.68 -41.63 75.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.937 -1.102 . . . . 0.0 109.414 179.664 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.515 ' N ' ' HG3' ' A' ' 30' ' ' LYS . 60.1 mt-10 -61.78 -45.0 95.77 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.143 -0.973 . . . . 0.0 108.717 178.849 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.831 HD23 HD11 ' A' ' 48' ' ' LEU . 2.0 tp -64.21 -29.21 70.33 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.096 -0.641 . . . . 0.0 109.294 179.219 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.96 -40.2 96.61 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 179.292 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.5 m -69.74 -41.99 74.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.489 -1.006 . . . . 0.0 109.948 179.427 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.0 t -57.93 -34.2 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.298 -0.876 . . . . 0.0 109.994 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.3 mmt -89.73 -18.41 26.44 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.358 -0.839 . . . . 0.0 109.815 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -88.29 -13.31 41.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.389 -0.82 . . . . 0.0 110.578 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.409 ' HB3' HD23 ' A' ' 39' ' ' LEU . 44.0 t -68.2 -12.91 61.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.954 -1.091 . . . . 0.0 109.946 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.446 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 0.7 OUTLIER -169.21 88.2 0.18 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.173 -0.954 . . . . 0.0 110.207 -179.987 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.75 -52.0 0.84 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 51.56 31.85 8.2 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.22 -1.165 . . . . 0.0 109.972 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.495 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -76.5 -55.4 1.64 Allowed Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.412 -0.805 . . . . 0.0 110.957 -179.768 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 42' ' ' ASN . 45.1 Cg_endo -73.99 135.23 20.83 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.77 1.405 . . . . 0.0 110.534 -179.611 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.451 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 29.1 p -102.25 -130.75 0.26 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.308 -0.87 . . . . 0.0 109.569 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -100.88 -33.89 10.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.804 -1.185 . . . . 0.0 109.95 179.649 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.65 -66.23 0.77 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.337 -0.852 . . . . 0.0 110.077 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -51.21 -32.0 22.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 109.659 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.831 HD11 HD23 ' A' ' 32' ' ' LEU . 9.4 tt -64.26 -53.1 54.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.322 -0.861 . . . . 0.0 109.988 179.746 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -51.39 -39.0 56.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 109.827 179.614 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -66.03 -37.04 84.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.243 -0.911 . . . . 0.0 109.639 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.411 ' HG2' ' H6 ' ' A' ' 153' ' ' WW7 . 10.9 ttp -69.85 -20.08 63.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.323 -0.861 . . . . 0.0 109.735 179.57 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.83 HD11 HD22 ' A' ' 32' ' ' LEU . 32.7 mm -86.6 -24.65 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.391 -0.818 . . . . 0.0 109.899 179.644 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -70.58 -37.36 73.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.259 -0.901 . . . . 0.0 110.259 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.82 -19.36 48.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 110.485 -179.761 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.561 ' CG1' HD11 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -99.76 -14.09 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.098 -1.001 . . . . 0.0 110.11 -179.615 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 2.8 t70 -84.3 128.06 34.35 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.179 -0.951 . . . . 0.0 110.203 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -96.58 -12.86 23.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.202 -0.936 . . . . 0.0 110.402 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.402 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 61.1 m-20 -97.5 -73.46 0.61 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.124 -0.985 . . . . 0.0 110.486 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.429 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 134.94 41.49 0.14 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 62' ' ' THR . 16.6 p30 -116.02 -16.68 11.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.339 -1.094 . . . . 0.0 110.293 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.663 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 106.87 -40.99 2.3 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.719 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.802 HG22 HG23 ' A' ' 28' ' ' THR . 69.1 p -98.54 162.45 13.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.147 -1.207 . . . . 0.0 110.517 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.561 HD11 ' CG1' ' A' ' 55' ' ' VAL . 70.0 mt -115.04 144.87 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.4 -0.813 . . . . 0.0 110.081 179.817 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -101.69 -165.28 1.18 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.988 -1.07 . . . . 0.0 110.137 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.543 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 27.2 t80 -77.52 -44.32 2.56 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 111.276 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.0 Cg_endo -74.25 -27.86 11.15 Favored 'Trans proline' 0 C--N 1.324 -0.761 0 O-C-N 123.112 1.059 . . . . 0.0 110.02 -179.627 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.402 ' OE1' ' OD2' ' A' ' 58' ' ' ASP . 45.9 tt0 -77.21 -22.98 51.49 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.356 -0.84 . . . . 0.0 109.236 179.253 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.435 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 14.2 t80 -77.9 -44.5 26.87 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.506 -0.746 . . . . 0.0 110.252 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.4 -26.51 61.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 110.32 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 88.2 m -80.9 -29.76 35.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 0.0 110.497 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.423 ' HG2' ' O ' ' A' ' 68' ' ' PHE . 6.7 ptt? -86.13 -24.6 26.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.036 -1.04 . . . . 0.0 110.386 -179.828 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.462 ' HE3' ' C2 ' ' A' ' 153' ' ' WW7 . 19.2 mmt -83.03 -27.53 30.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.281 -0.887 . . . . 0.0 110.403 -179.716 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.99 -42.81 10.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.917 . . . . 0.0 110.778 -179.51 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 -101.05 -25.36 14.08 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.241 -0.912 . . . . 0.0 110.656 -179.482 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt 49.19 83.34 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.115 -0.99 . . . . 0.0 110.282 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 89.9 mtp -72.28 160.21 32.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.259 -0.901 . . . . 0.0 110.169 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.07 156.72 44.72 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.084 -1.01 . . . . 0.0 110.201 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -169.06 126.13 0.95 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.185 -0.947 . . . . 0.0 110.463 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.11 131.87 52.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.317 -0.864 . . . . 0.0 109.77 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -144.7 -42.04 0.25 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.076 -1.015 . . . . 0.0 110.553 -179.635 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.1 m -160.07 136.46 8.86 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.148 -0.97 . . . . 0.0 110.14 -179.857 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.445 ' OE1' ' N ' ' A' ' 82' ' ' GLU . 0.4 OUTLIER -89.17 -171.66 3.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.239 -0.913 . . . . 0.0 110.164 179.955 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.41 ' HB3' ' OE1' ' A' ' 84' ' ' GLU . 5.1 tt0 -177.87 -51.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.245 -0.909 . . . . 0.0 110.449 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.41 ' OE1' ' HB3' ' A' ' 83' ' ' GLU . 0.4 OUTLIER -79.55 -35.35 40.0 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.111 -0.993 . . . . 0.0 110.473 179.955 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.857 HG23 ' CE1' ' A' ' 141' ' ' PHE . 54.8 mt -57.54 -52.45 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.181 -0.949 . . . . 0.0 110.526 -179.632 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.0 ttm-85 -56.87 -50.55 72.11 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.221 -0.924 . . . . 0.0 110.378 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -54.01 -36.56 63.12 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.223 -0.923 . . . . 0.0 110.412 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.561 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -61.28 -63.93 1.12 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.195 -0.94 . . . . 0.0 110.163 -179.697 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.502 ' CE1' HD11 ' A' ' 100' ' ' ILE . 1.1 t80 -45.76 -33.32 2.97 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.435 -0.79 . . . . 0.0 110.485 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.4 ttt85 -63.98 -45.86 87.15 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.31 -0.869 . . . . 0.0 110.77 -179.709 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 88' ' ' ALA . 32.4 m -84.47 -9.53 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.112 -0.992 . . . . 0.0 111.416 -179.296 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.712 ' HA ' HG21 ' A' ' 108' ' ' VAL . 21.9 m-85 -97.0 -14.04 21.91 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.955 -1.09 . . . . 0.0 110.772 -179.763 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -116.19 59.39 0.73 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.041 -1.037 . . . . 0.0 110.256 179.698 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 91' ' ' VAL . 19.4 mttt -94.91 20.09 9.35 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.228 -0.92 . . . . 0.0 110.559 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.456 ' OD2' ' CB ' ' A' ' 97' ' ' ASN . 9.6 p-10 -114.07 -28.39 7.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.183 -0.948 . . . . 0.0 110.398 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.89 -26.67 12.15 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.456 ' CB ' ' OD2' ' A' ' 95' ' ' ASP . 25.5 t-20 -44.79 -28.93 0.7 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.37 -1.076 . . . . 0.0 110.521 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 90.9 -42.6 2.87 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.45 ' CG ' ' OE1' ' A' ' 135' ' ' GLN . 12.1 m-30 -93.3 170.7 9.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.239 -1.153 . . . . 0.0 110.504 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.502 HD11 ' CE1' ' A' ' 89' ' ' PHE . 18.0 mt -104.18 119.71 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.301 -0.874 . . . . 0.0 109.432 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.4 t -102.65 174.89 5.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.232 -0.917 . . . . 0.0 109.855 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.7 -45.02 63.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.035 -1.041 . . . . 0.0 109.909 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.5 -45.57 91.33 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.253 -0.904 . . . . 0.0 110.056 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.647 ' O ' HG23 ' A' ' 108' ' ' VAL . 48.4 mt-10 -61.93 -48.3 81.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.175 179.749 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.581 HD22 HG13 ' A' ' 121' ' ' VAL . 6.8 tt -53.7 -31.77 49.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 0.0 110.164 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.0 ttt-85 -73.07 -41.33 64.23 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.21 -0.932 . . . . 0.0 110.08 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -73.07 -11.29 60.5 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.297 -0.877 . . . . 0.0 110.503 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.712 HG21 ' HA ' ' A' ' 92' ' ' PHE . 92.9 t -92.93 -49.69 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.236 -0.915 . . . . 0.0 110.062 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.2 mmt -50.29 -45.16 54.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.413 -0.804 . . . . 0.0 110.435 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.8 p -52.79 -44.87 66.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.304 -0.872 . . . . 0.0 110.377 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -63.6 -43.43 96.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.126 -0.984 . . . . 0.0 110.023 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 13.6 mt -55.34 -40.7 71.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 110.123 179.762 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 125.83 45.65 0.24 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.594 ' OE1' HD11 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -156.54 146.53 21.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.25 -1.147 . . . . 0.0 110.045 179.98 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.475 ' C ' HD12 ' A' ' 116' ' ' LEU . 24.6 tttt -123.25 138.07 54.72 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.192 -0.943 . . . . 0.0 110.284 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.916 HD23 ' OE1' ' A' ' 120' ' ' GLU . 4.7 mp -139.9 -163.66 1.55 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.26 -0.9 . . . . 0.0 110.145 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.422 HG22 ' N ' ' A' ' 118' ' ' ASP . 57.4 m -120.08 164.46 16.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.228 -0.92 . . . . 0.0 110.236 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.422 ' N ' HG22 ' A' ' 117' ' ' THR . 0.9 OUTLIER -58.4 -34.39 70.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.29 -0.881 . . . . 0.0 110.411 179.942 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -56.25 -61.16 2.59 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.302 -0.874 . . . . 0.0 110.758 -179.677 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.916 ' OE1' HD23 ' A' ' 116' ' ' LEU . 96.0 mt-10 -52.18 -55.1 23.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.073 -1.017 . . . . 0.0 110.433 -179.654 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.581 HG13 HD22 ' A' ' 105' ' ' LEU . 95.4 t -54.24 -27.91 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.277 -0.889 . . . . 0.0 110.752 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -75.4 -40.36 57.98 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.107 -0.996 . . . . 0.0 110.196 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -74.91 -18.07 60.47 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.197 -0.94 . . . . 0.0 109.688 179.51 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.418 ' HG3' ' O ' ' A' ' 120' ' ' GLU . 96.3 mtp -78.06 -50.28 12.37 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 109.949 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.71 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 29.1 mm -65.03 -39.86 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.361 -0.837 . . . . 0.0 110.165 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -61.43 -55.86 26.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 110.255 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -57.79 -37.92 74.58 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.255 -0.903 . . . . 0.0 110.534 -179.848 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.527 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -70.53 -24.41 62.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 110.167 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -69.18 92.18 0.54 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.307 -0.87 . . . . 0.0 110.21 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 66.1 mt -75.68 -48.51 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.285 -0.884 . . . . 0.0 110.169 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.2 p30 -64.26 -30.37 71.42 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.348 -0.845 . . . . 0.0 110.188 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 87.66 52.63 2.94 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.653 179.198 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -117.64 -32.86 4.73 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.954 -1.321 . . . . 0.0 109.923 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 118.95 24.2 3.1 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.45 ' O ' ' NE2' ' A' ' 135' ' ' GLN . 3.6 pp0? -159.61 149.02 18.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.203 -1.174 . . . . 0.0 110.143 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.69 HG21 'CL1 ' ' A' ' 154' ' ' WW7 . 45.4 t -109.0 125.95 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.244 -0.91 . . . . 0.0 110.721 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -97.51 -165.6 1.28 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.879 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.75 ' O ' HG23 ' A' ' 142' ' ' VAL . 47.9 t80 -68.06 -48.42 65.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.11 -0.994 . . . . 0.0 110.537 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -63.52 -45.55 90.09 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.121 -0.987 . . . . 0.0 110.602 -179.683 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.414 ' OE2' ' OD2' ' A' ' 131' ' ' ASP . 37.0 mt-10 -58.6 -38.34 77.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.261 -0.899 . . . . 0.0 110.501 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.857 ' CE1' HG23 ' A' ' 85' ' ' ILE . 6.5 t80 -72.39 -26.87 62.04 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.183 -0.948 . . . . 0.0 110.418 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 138' ' ' TYR . 87.6 t -76.66 -24.46 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.078 -1.014 . . . . 0.0 110.676 -179.423 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -87.39 -51.17 6.09 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.142 -0.974 . . . . 0.0 110.452 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.54 ' CE ' ' CD2' ' A' ' 141' ' ' PHE . 21.5 ptt? -56.41 -32.86 65.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.903 . . . . 0.0 110.701 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.506 ' HE3' ' CZ ' ' A' ' 141' ' ' PHE . 28.2 tpp -72.83 -54.24 9.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.15 -0.969 . . . . 0.0 110.538 -179.526 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 146' ' ' THR . 5.2 t -118.11 105.08 11.46 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.08 -1.013 . . . . 0.0 110.42 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.71 150.12 45.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.145 -0.972 . . . . 0.0 110.284 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.188 179.903 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 153' ' ' WW7 . . . . . 0.52 H161 ' C12' ' A' ' 153' ' ' WW7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 154' ' ' WW7 . . . . . 0.71 'CL1 ' HD13 ' A' ' 125' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.201 0.524 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -123.15 141.52 51.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.157 -0.964 . . . . 0.0 110.468 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -136.48 55.52 1.84 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.322 -0.862 . . . . 0.0 110.149 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.6 mt -91.01 104.12 16.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.233 -0.917 . . . . 0.0 110.517 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.422 ' O ' ' HG2' ' A' ' 8' ' ' GLN . 57.4 m -108.42 -69.72 0.84 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.29 -0.881 . . . . 0.0 109.607 179.47 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.424 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 52.2 mt-10 -90.46 -29.22 18.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.394 -0.816 . . . . 0.0 109.83 179.316 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -57.34 -48.74 78.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.199 -0.938 . . . . 0.0 110.028 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.483 ' HG3' ' N ' ' A' ' 9' ' ' ILE . 3.5 pt20 -52.03 -38.19 56.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.719 179.711 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.483 ' N ' ' HG3' ' A' ' 8' ' ' GLN . 34.6 mt -62.24 -44.47 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.328 -0.857 . . . . 0.0 109.516 179.41 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.61 -37.18 70.33 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.281 -0.887 . . . . 0.0 109.486 179.373 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -62.78 -45.42 92.73 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.325 -0.859 . . . . 0.0 109.499 179.391 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -61.36 -33.1 73.08 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.429 -0.794 . . . . 0.0 109.849 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt -61.57 -49.51 76.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -0.915 . . . . 0.0 109.583 179.62 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -57.69 -39.62 77.6 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.451 -0.781 . . . . 0.0 109.627 179.537 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.462 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -60.21 -43.25 96.14 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.257 -0.902 . . . . 0.0 109.794 179.676 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -59.32 -39.13 82.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.161 -0.962 . . . . 0.0 109.29 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.3 t -70.16 -25.4 63.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.822 . . . . 0.0 109.181 178.984 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.842 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.4 tm? -71.41 -29.12 64.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.471 -0.768 . . . . 0.0 109.551 179.45 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.516 ' CZ ' ' H3 ' ' A' ' 153' ' ' WW7 . 20.8 m-85 -87.54 -64.59 1.12 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.401 -0.812 . . . . 0.0 109.972 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -85.44 74.43 10.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.348 -0.845 . . . . 0.0 109.799 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.417 ' CE ' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -99.02 47.64 0.97 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.279 -0.888 . . . . 0.0 110.414 -179.641 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.403 ' OD1' ' OD2' ' A' ' 24' ' ' ASP . 4.1 p30 -127.91 -5.02 5.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.169 -0.957 . . . . 0.0 110.583 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.47 48.68 5.21 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.403 ' OD2' ' OD1' ' A' ' 22' ' ' ASP . 13.6 m-20 -117.9 -72.69 0.68 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -1.131 . . . . 0.0 110.26 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.21 -10.52 4.43 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.6 p -132.33 150.26 52.19 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.136 -1.214 . . . . 0.0 110.364 -179.827 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 70.8 mt -97.12 131.62 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.222 -0.923 . . . . 0.0 110.241 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.8 t -120.72 -174.07 2.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.344 -0.847 . . . . 0.0 110.18 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.7 p -75.27 -31.84 60.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.223 -0.923 . . . . 0.0 110.692 -179.68 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -65.8 -59.76 3.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.116 -0.99 . . . . 0.0 109.805 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -57.21 -56.27 23.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.388 -0.82 . . . . 0.0 109.484 179.526 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.963 HD22 HD11 ' A' ' 52' ' ' ILE . 10.9 tp -57.22 -22.56 41.82 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.231 -0.918 . . . . 0.0 109.297 179.085 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.85 -42.62 96.91 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.8 m -69.21 -25.16 64.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.512 -0.993 . . . . 0.0 109.712 179.287 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.515 HG21 ' HA ' ' A' ' 19' ' ' PHE . 37.3 t -76.74 -33.43 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.415 -0.803 . . . . 0.0 110.956 -179.768 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.7 tpp -90.07 -23.48 21.41 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.921 -1.112 . . . . 0.0 110.898 -179.318 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.7 ttm-85 -90.91 -32.55 15.96 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.09 -1.006 . . . . 0.0 110.629 -179.752 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 71.1 m -79.94 -21.71 43.52 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.116 -0.99 . . . . 0.0 110.404 -179.752 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 mp -135.35 80.12 1.82 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 110.438 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.89 -54.06 0.52 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 50.48 74.25 0.23 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.214 -1.168 . . . . 0.0 109.871 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.524 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 2.6 t30 -152.22 -66.27 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.222 -0.924 . . . . 0.0 110.376 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.524 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 43.7 Cg_endo -71.56 -160.75 0.09 OUTLIER 'Trans proline' 0 C--N 1.317 -1.086 0 O-C-N 123.241 1.127 . . . . 0.0 110.145 179.458 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 40.2 p -147.09 -178.46 6.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.205 -0.935 . . . . 0.0 109.85 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -65.47 -32.89 74.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 110.05 179.838 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.34 -62.68 1.29 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.124 -0.985 . . . . 0.0 109.537 179.448 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -51.85 -27.56 13.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.184 -0.947 . . . . 0.0 109.042 179.062 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.871 HD21 HD23 ' A' ' 32' ' ' LEU . 6.2 tt -68.88 -43.88 74.41 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.478 -0.764 . . . . 0.0 109.472 179.332 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -53.46 -42.77 67.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.38 -0.825 . . . . 0.0 109.021 179.104 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -65.47 -33.92 77.07 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.842 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.452 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 0.5 OUTLIER -68.45 -20.3 64.62 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.587 -0.696 . . . . 0.0 109.359 179.001 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.963 HD11 HD22 ' A' ' 32' ' ' LEU . 32.4 mm -87.09 -26.5 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.399 -0.813 . . . . 0.0 110.087 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -73.79 -30.47 62.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.0 110.537 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.659 ' HG3' HG23 ' A' ' 55' ' ' VAL . 8.4 pt-20 -71.64 -26.74 62.68 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.088 -1.008 . . . . 0.0 110.204 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.659 HG23 ' HG3' ' A' ' 54' ' ' GLU . 96.3 t -90.17 -30.46 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.163 -0.961 . . . . 0.0 109.717 179.608 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -76.48 115.92 16.68 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.438 -0.789 . . . . 0.0 110.206 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.69 18.88 21.46 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.256 -0.902 . . . . 0.0 110.239 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.433 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 61.6 m-20 -112.02 -65.72 1.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.354 -0.841 . . . . 0.0 109.968 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.16 -12.6 2.09 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -70.11 -36.7 75.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.971 -1.311 . . . . 0.0 110.534 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 119.73 -63.64 0.46 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 48.9 p -69.25 170.56 9.99 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.17 -1.194 . . . . 0.0 110.724 -179.437 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.602 HD13 HG11 ' A' ' 55' ' ' VAL . 89.1 mt -115.09 149.46 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.244 -0.91 . . . . 0.0 110.309 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.469 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 55.5 m-20 -98.37 -166.24 1.34 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 110.209 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.581 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 10.2 t80 -81.47 -38.26 0.93 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.162 -0.961 . . . . 0.0 112.118 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.6 Cg_endo -72.39 -25.9 17.77 Favored 'Trans proline' 0 C--O 1.209 -0.938 0 O-C-N 122.817 0.904 . . . . 0.0 111.269 -178.922 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.433 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 63.4 mt-10 -76.05 -33.61 59.61 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.827 -1.171 . . . . 0.0 109.524 179.421 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.479 ' CZ ' ' SD ' ' A' ' 72' ' ' MET . 12.6 t80 -75.38 -53.0 9.45 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.537 -0.727 . . . . 0.0 110.064 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.675 HD13 ' O ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -65.31 -20.83 66.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.509 -0.745 . . . . 0.0 110.408 -179.824 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.423 ' CB ' ' O ' ' A' ' 66' ' ' PRO . 50.6 m -91.38 -22.97 20.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.907 -1.12 . . . . 0.0 111.18 -179.595 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.634 ' SD ' HG13 ' A' ' 55' ' ' VAL . 60.0 ttp -86.99 -43.64 12.2 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.877 -1.139 . . . . 0.0 111.153 -179.241 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.479 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 43.2 mtt -82.84 -34.56 26.82 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.905 -1.122 . . . . 0.0 110.595 -179.473 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -69.0 -8.58 46.15 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.141 -0.975 . . . . 0.0 110.66 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.4 tpt85 -40.16 -36.9 0.55 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.551 -0.718 . . . . 0.0 110.77 -179.566 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -73.4 88.14 1.57 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.296 -0.877 . . . . 0.0 109.586 179.395 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 50.7 ttp -105.2 131.85 52.15 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.259 -0.901 . . . . 0.0 110.812 -179.243 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -141.29 112.92 7.64 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.291 -0.881 . . . . 0.0 109.682 179.424 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.435 ' O ' HG23 ' A' ' 79' ' ' THR . 27.1 m-20 -113.75 134.17 54.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.18 -0.95 . . . . 0.0 110.712 -179.459 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 78' ' ' ASP . 0.6 OUTLIER -155.58 153.38 30.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.425 -0.797 . . . . 0.0 109.894 179.593 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 51.5 p-10 -150.58 153.44 35.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.301 -0.874 . . . . 0.0 110.248 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.7 t -122.9 -55.23 1.8 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.336 -0.852 . . . . 0.0 109.852 179.892 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -96.88 88.26 4.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 109.855 179.708 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -159.12 77.52 0.73 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.169 -0.957 . . . . 0.0 110.345 -179.768 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -90.7 -24.49 20.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 110.142 179.831 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.4 mt -69.62 -40.68 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.367 -0.833 . . . . 0.0 110.309 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.6 ttp180 -67.96 -56.87 7.39 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.17 -0.957 . . . . 0.0 110.034 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -47.78 -47.81 30.55 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.256 -0.903 . . . . 0.0 110.111 179.765 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.718 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -54.82 -54.49 41.58 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.302 -0.874 . . . . 0.0 110.107 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -49.93 -28.7 7.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.291 -0.881 . . . . 0.0 110.259 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -71.97 -47.01 55.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.144 -0.973 . . . . 0.0 110.643 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 88' ' ' ALA . 35.9 m -70.9 -20.14 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.17 -0.956 . . . . 0.0 110.4 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.555 ' CE2' ' H2 ' ' A' ' 154' ' ' WW7 . 25.5 m-85 -95.35 -12.85 25.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.325 -0.859 . . . . 0.0 110.345 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -107.18 73.87 0.95 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.167 -0.958 . . . . 0.0 110.59 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -74.98 -36.46 62.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.171 -0.956 . . . . 0.0 109.995 179.639 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.8 p30 -74.54 -25.41 59.29 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.312 -0.867 . . . . 0.0 110.51 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 76.46 60.79 2.93 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.433 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 26.0 p-10 -124.33 -10.07 7.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.357 -1.084 . . . . 0.0 110.476 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.526 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 86.27 16.03 63.36 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.08 -1.057 . . . . 0.0 110.493 179.005 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 38.2 m-85 -142.1 138.31 31.6 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.188 -1.184 . . . . 0.0 110.26 179.875 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.43 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 25.6 mt -94.06 129.75 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.327 -0.858 . . . . 0.0 110.16 -179.748 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.7 t -114.91 166.09 12.16 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.285 -0.885 . . . . 0.0 109.977 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.46 -26.56 68.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.297 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.42 -69.83 0.27 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.282 -0.886 . . . . 0.0 110.266 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.483 ' O ' HG23 ' A' ' 108' ' ' VAL . 37.1 mt-10 -52.71 -38.78 61.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 110.212 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.625 HD22 HG13 ' A' ' 121' ' ' VAL . 4.0 tt -52.69 -46.21 67.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.094 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.785 ' O ' HG22 ' A' ' 110' ' ' THR . 2.6 ttm-85 -66.72 -37.85 85.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.362 -0.836 . . . . 0.0 110.045 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -61.4 -23.86 66.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.165 -0.959 . . . . 0.0 110.248 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 104' ' ' GLU . 50.0 t -87.28 -41.0 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.119 -0.988 . . . . 0.0 110.616 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.6 mmt -68.17 -57.79 5.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.137 -0.977 . . . . 0.0 110.521 -179.613 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.785 HG22 ' O ' ' A' ' 106' ' ' ARG . 9.8 t -50.13 -23.86 2.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.303 -0.873 . . . . 0.0 110.401 -179.772 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -79.43 -50.37 10.9 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.18 -0.95 . . . . 0.0 110.276 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.8 mt -60.75 -23.47 64.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.208 -0.933 . . . . 0.0 110.302 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.427 ' O ' ' HG2' ' A' ' 114' ' ' GLU . . . 102.88 90.97 2.17 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 1.3 mm-40 -155.3 -164.46 1.77 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.326 -1.102 . . . . 0.0 110.029 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.69 99.56 2.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.131 -0.981 . . . . 0.0 110.28 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.6 mp -137.52 135.62 36.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.326 -0.859 . . . . 0.0 110.204 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.608 HG22 ' OE2' ' A' ' 120' ' ' GLU . 13.1 t -75.78 172.18 13.09 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.228 -0.92 . . . . 0.0 109.949 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 53.7 m-20 -59.95 -41.58 92.17 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.241 -0.912 . . . . 0.0 110.299 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.456 ' OE1' ' N ' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -53.26 -47.72 68.88 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.164 -0.96 . . . . 0.0 110.811 -179.672 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.608 ' OE2' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -54.37 -56.22 20.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.99 -1.069 . . . . 0.0 110.897 -179.605 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.625 HG13 HD22 ' A' ' 105' ' ' LEU . 84.1 t -52.96 -44.74 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.913 -1.117 . . . . 0.0 110.675 -179.629 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 118' ' ' ASP . 1.5 m-20 -62.51 -30.8 71.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.145 -0.972 . . . . 0.0 110.611 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -72.48 -28.48 62.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.072 -1.018 . . . . 0.0 110.057 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.4 mtp -74.29 -45.77 45.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -0.874 . . . . 0.0 110.215 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.682 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 30.0 mm -64.65 -39.85 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.305 -0.872 . . . . 0.0 110.408 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.4 mtp180 -67.76 -51.0 54.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.158 -0.964 . . . . 0.0 110.115 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -55.41 -35.17 65.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.17 -0.956 . . . . 0.0 109.781 179.56 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -75.82 -28.72 58.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.361 -0.837 . . . . 0.0 109.812 179.685 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.401 ' OD2' ' HA2' ' A' ' 132' ' ' GLY . 16.0 t0 -71.92 91.93 1.23 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -0.871 . . . . 0.0 110.119 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 96.2 mt -73.14 -32.61 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.217 -0.927 . . . . 0.0 110.717 -179.615 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 23.4 p30 -99.59 -18.54 17.3 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.232 -0.918 . . . . 0.0 110.505 -179.776 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.467 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 77.0 72.11 1.14 Allowed Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.974 -1.108 . . . . 0.0 110.337 179.438 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.406 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 76.4 m-20 -113.93 6.1 16.44 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.072 -1.251 . . . . 0.0 110.118 179.175 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.32 16.3 69.45 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.42 ' HB2' ' HB3' ' A' ' 99' ' ' TYR . 3.7 pt20 -170.16 165.46 9.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.115 -1.226 . . . . 0.0 110.166 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.43 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 52.4 t -106.71 107.58 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.177 -0.952 . . . . 0.0 110.386 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -77.74 163.08 26.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.363 -0.836 . . . . 0.0 110.142 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.782 ' O ' HG23 ' A' ' 142' ' ' VAL . 33.0 t80 -51.47 -30.16 18.92 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.24 -0.913 . . . . 0.0 110.278 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -70.47 -59.29 2.93 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.2 -0.937 . . . . 0.0 110.474 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 56.3 mt-10 -54.16 -25.66 23.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 0.0 110.221 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.548 ' CZ ' ' HE2' ' A' ' 145' ' ' MET . 16.7 t80 -77.93 -35.39 50.54 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.312 -0.867 . . . . 0.0 110.137 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 138' ' ' TYR . 97.0 t -75.24 -22.83 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 110.364 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -83.31 -46.83 12.16 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.275 -0.89 . . . . 0.0 110.459 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.627 ' HE3' ' HG2' ' A' ' 145' ' ' MET . 0.2 OUTLIER -70.3 -13.22 62.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.027 -1.046 . . . . 0.0 110.293 -179.788 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.921 ' HE3' ' HN1' ' A' ' 154' ' ' WW7 . 13.4 mmt -89.28 -61.01 1.8 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.285 -0.884 . . . . 0.0 109.994 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.478 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 9.5 t -111.33 -17.16 13.21 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.188 -0.945 . . . . 0.0 110.105 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 146' ' ' THR . . . 58.01 108.7 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.324 -0.86 . . . . 0.0 110.273 179.821 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.9 tptt . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.2 179.974 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 153' ' ' WW7 . . . . . 0.516 ' H3 ' ' CZ ' ' A' ' 19' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 154' ' ' WW7 . . . . . 0.921 ' HN1' ' HE3' ' A' ' 145' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.293 0.568 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -77.65 130.54 36.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.258 -0.901 . . . . 0.0 110.168 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.7 tm0? -168.42 76.75 0.13 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.276 -0.89 . . . . 0.0 110.121 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.6 mt -105.26 177.36 4.87 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.312 -0.868 . . . . 0.0 110.203 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.5 t -109.4 -30.39 7.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 109.796 179.69 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -78.49 -28.21 46.31 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.222 -0.924 . . . . 0.0 109.719 179.378 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -76.78 -32.11 57.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.846 . . . . 0.0 109.728 179.633 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -65.38 -49.71 68.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.426 -0.796 . . . . 0.0 110.03 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.7 mt -68.48 -45.98 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.203 -0.936 . . . . 0.0 109.584 179.508 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 13' ' ' LYS . . . -59.32 -25.69 64.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.374 -0.828 . . . . 0.0 109.48 179.36 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.432 ' HA ' ' OE1' ' A' ' 11' ' ' GLU . 5.3 tp10 -69.59 -50.23 46.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.309 -0.87 . . . . 0.0 109.071 179.323 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -67.11 -17.24 64.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.368 -0.832 . . . . 0.0 109.58 179.075 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 25.6 mtpt -76.59 -49.49 16.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.153 -0.967 . . . . 0.0 109.796 179.596 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.9 -41.95 88.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.187 -0.946 . . . . 0.0 109.791 179.378 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.08 -49.99 67.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 109.791 179.636 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.454 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 40.3 t80 -54.68 -28.45 47.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.921 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.0 m -80.8 -32.73 35.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.342 -0.849 . . . . 0.0 109.497 179.63 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.636 ' O ' HD23 ' A' ' 18' ' ' LEU . 3.2 tt -69.57 -18.03 63.6 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.42 -0.8 . . . . 0.0 109.646 179.483 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.538 ' CE2' ' H3 ' ' A' ' 153' ' ' WW7 . 5.1 m-30 -96.7 -45.14 6.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.421 -0.799 . . . . 0.0 109.953 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.623 ' OD1' 'CA ' ' A' ' 149' ' ' ' CA' . 24.8 t0 -78.86 104.63 9.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.386 -0.821 . . . . 0.0 110.313 -179.741 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.425 ' HE2' ' O ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -110.4 64.68 0.61 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.161 -0.962 . . . . 0.0 110.837 -179.688 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.405 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 13.7 p-10 -170.89 -36.82 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.033 -1.042 . . . . 0.0 110.612 179.771 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.57 100.31 2.45 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 -179.293 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 24.7 p-10 -176.97 -29.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.242 -1.152 . . . . 0.0 111.014 -179.619 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.812 ' O ' HG23 ' A' ' 26' ' ' THR . . . 88.21 52.83 2.79 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.812 HG23 ' O ' ' A' ' 25' ' ' GLY . 0.3 OUTLIER -169.93 150.36 3.85 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.185 -1.186 . . . . 0.0 110.314 179.817 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.2 109.09 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.34 -0.85 . . . . 0.0 110.364 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.556 ' HA ' HG22 ' A' ' 62' ' ' THR . 65.6 p -93.24 -167.15 1.66 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.26 -0.9 . . . . 0.0 110.115 179.807 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.559 HG22 HD12 ' A' ' 52' ' ' ILE . 9.3 p -84.67 -20.7 30.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.23 -0.919 . . . . 0.0 110.207 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -72.69 -60.26 2.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.237 -0.914 . . . . 0.0 109.94 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.411 ' OE1' ' HA ' ' A' ' 20' ' ' ASP . 93.1 mt-10 -56.57 -49.29 75.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 109.624 179.5 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.445 ' O ' ' HB ' ' A' ' 35' ' ' VAL . 3.6 tp -60.73 -31.94 71.23 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.292 -0.88 . . . . 0.0 109.265 179.293 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.8 -42.33 94.46 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.709 -1.757 . . . . 0.0 108.709 179.298 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 66.9 m -71.58 -24.78 61.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -1.113 . . . . 0.0 109.477 179.311 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 51.1 t -70.96 -34.84 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.413 -0.805 . . . . 0.0 110.279 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 21.9 mmt -90.76 -23.14 20.74 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.214 -0.929 . . . . 0.0 110.439 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.408 ' NH2' ' HG2' ' A' ' 37' ' ' ARG . 6.7 ttp85 -80.49 -31.8 37.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 110.238 -179.771 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.2 m -92.38 -31.98 15.13 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.148 -0.97 . . . . 0.0 110.569 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.436 ' CG ' ' O ' ' A' ' 35' ' ' VAL . 66.9 mt -86.08 -71.98 0.52 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.141 -0.975 . . . . 0.0 110.496 -179.754 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -118.77 88.74 0.45 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -62.49 123.01 17.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.284 -1.127 . . . . 0.0 110.036 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.503 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.9 OUTLIER 179.47 -59.31 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.175 -0.953 . . . . 0.0 110.305 -179.906 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 42' ' ' ASN . 42.2 Cg_endo -68.41 158.43 57.65 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.593 1.312 . . . . 0.0 110.69 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 71.7 p -107.8 -138.21 0.37 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.368 -0.832 . . . . 0.0 109.619 179.826 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -99.16 -40.33 8.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.93 -1.106 . . . . 0.0 109.82 179.589 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.01 -59.42 2.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.306 -0.872 . . . . 0.0 109.915 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 37.2 tt0 -54.9 -30.59 58.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 109.792 179.587 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' A' ' 44' ' ' THR . 7.5 tt -64.17 -52.6 58.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.358 -0.839 . . . . 0.0 109.775 179.785 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -52.92 -35.54 58.54 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.269 -0.894 . . . . 0.0 109.053 179.352 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 8.5 t70 -61.64 -41.76 97.94 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.383 -0.823 . . . . 0.0 109.524 179.297 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.432 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 32.1 ttp -68.18 -19.77 64.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.383 -0.823 . . . . 0.0 109.565 179.538 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.559 HD12 HG22 ' A' ' 29' ' ' THR . 22.9 mt -83.57 -24.95 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.238 -0.914 . . . . 0.0 110.077 179.59 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -65.65 -46.18 80.15 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.162 -0.961 . . . . 0.0 110.07 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.59 ' HG3' HG23 ' A' ' 55' ' ' VAL . 21.3 pt-20 -59.45 -31.38 69.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.174 -0.954 . . . . 0.0 109.683 179.637 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.888 HG13 ' HE2' ' A' ' 71' ' ' MET . 75.8 t -87.0 -16.96 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.394 -0.816 . . . . 0.0 110.004 179.536 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.43 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 6.6 t0 -110.5 87.99 2.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.284 -0.885 . . . . 0.0 110.091 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.24 -12.65 61.85 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.253 -0.904 . . . . 0.0 110.752 -179.669 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -72.2 -59.3 2.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.14 -0.975 . . . . 0.0 110.439 -179.769 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.9 -1.35 21.35 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.349 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 20.2 p30 -69.96 -31.09 68.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.148 -1.207 . . . . 0.0 110.116 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.456 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 120.86 -59.8 0.55 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.556 HG22 ' HA ' ' A' ' 28' ' ' THR . 50.1 p -91.15 166.37 13.0 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.18 -1.188 . . . . 0.0 110.756 -179.447 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.8 mt -102.95 137.34 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.384 -0.822 . . . . 0.0 110.132 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.432 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 51.1 m-20 -92.62 178.44 5.8 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.273 -0.892 . . . . 0.0 110.305 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.584 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 25.2 t80 -71.66 -44.27 12.15 Favored Pre-proline 0 N--CA 1.486 1.357 0 O-C-N 121.166 -0.959 . . . . 0.0 111.069 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.3 Cg_endo -71.35 -21.6 26.29 Favored 'Trans proline' 0 C--N 1.324 -0.763 0 O-C-N 123.109 1.057 . . . . 0.0 109.874 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.43 ' OE2' ' HA ' ' A' ' 56' ' ' ASP . 84.7 tt0 -83.73 -30.51 26.65 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.38 -0.825 . . . . 0.0 109.265 178.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.454 ' CE2' ' HB2' ' A' ' 16' ' ' PHE . 43.2 t80 -70.81 -47.06 61.48 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.534 -0.729 . . . . 0.0 109.853 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.68 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 4.9 tt -74.28 -27.99 60.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.329 -0.857 . . . . 0.0 109.874 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.508 ' HA ' ' HB2' ' A' ' 74' ' ' ARG . 18.2 m -80.52 -16.67 53.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.224 -0.923 . . . . 0.0 110.142 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.888 ' HE2' HG13 ' A' ' 55' ' ' VAL . 14.3 tmm? -88.36 -46.8 8.87 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.304 -0.872 . . . . 0.0 110.856 -179.523 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.412 ' HE3' ' HE3' ' A' ' 71' ' ' MET . 58.0 mtt -90.85 -59.49 2.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.01 -1.056 . . . . 0.0 111.275 -179.219 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -57.34 -50.99 71.17 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.258 -0.901 . . . . 0.0 111.121 -178.952 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.508 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 0.7 OUTLIER -60.62 -69.3 0.23 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.154 -0.966 . . . . 0.0 110.816 -179.178 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 74' ' ' ARG . 6.6 tptp 55.32 102.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.319 -0.863 . . . . 0.0 110.289 -179.426 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -90.18 -165.31 1.32 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.291 -0.881 . . . . 0.0 110.221 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.9 pttt -141.08 156.12 46.04 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -0.834 . . . . 0.0 109.948 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -123.6 171.34 9.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.934 . . . . 0.0 110.482 -179.759 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.55 HG23 ' OD1' ' A' ' 80' ' ' ASP . 5.5 t -118.54 -16.83 9.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.307 -0.87 . . . . 0.0 110.348 -179.821 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.55 ' OD1' HG23 ' A' ' 79' ' ' THR . 31.3 m-20 -81.2 125.58 30.46 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.155 -0.966 . . . . 0.0 110.288 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' A' ' 82' ' ' GLU . 64.1 m -111.65 -38.09 5.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.2 -0.938 . . . . 0.0 110.21 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 81' ' ' SER . 28.7 tt0 59.81 167.71 0.07 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.288 -0.882 . . . . 0.0 110.181 -179.809 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -99.91 39.54 1.32 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.268 -0.895 . . . . 0.0 110.493 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -80.53 -47.13 14.69 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.208 -0.932 . . . . 0.0 109.809 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.699 HG21 HG22 ' A' ' 142' ' ' VAL . 17.0 mt -52.13 -22.91 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.312 -0.868 . . . . 0.0 109.732 179.603 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.9 ttm-85 -69.09 -51.26 40.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.318 -0.864 . . . . 0.0 109.827 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -55.42 -43.03 74.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.067 -1.02 . . . . 0.0 109.764 179.528 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.747 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -58.04 -56.08 26.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.894 . . . . 0.0 109.978 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -48.91 -30.85 6.38 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.19 -0.944 . . . . 0.0 110.586 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.6 ttp85 -70.33 -48.77 55.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.22 -0.925 . . . . 0.0 111.15 -179.362 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.747 HG22 ' O ' ' A' ' 88' ' ' ALA . 27.5 m -64.78 -26.99 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.808 -1.183 . . . . 0.0 110.521 -179.54 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.679 ' HA ' HG21 ' A' ' 108' ' ' VAL . 38.6 m-85 -88.27 -14.95 37.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.256 -0.903 . . . . 0.0 110.24 179.687 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.25 77.16 1.77 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.0 109.893 179.512 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -94.56 -21.9 18.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.268 -0.895 . . . . 0.0 110.707 -179.477 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 2.0 p30 -71.11 -14.52 62.33 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.132 -0.98 . . . . 0.0 110.775 -179.297 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.86 30.36 23.71 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.598 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.456 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 1.7 t-20 -76.0 -78.12 0.12 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.246 -1.15 . . . . 0.0 109.939 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 145.28 -16.61 1.89 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.521 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -133.57 155.29 49.89 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.228 -1.16 . . . . 0.0 109.577 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.432 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 18.5 mt -94.74 118.6 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 120.988 -1.07 . . . . 0.0 109.541 179.784 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.8 m -102.37 168.8 9.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 110.128 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.28 -44.98 89.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.177 -0.952 . . . . 0.0 110.178 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.4 -58.15 9.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.125 -0.984 . . . . 0.0 110.011 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -49.88 -50.17 46.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.17 -0.956 . . . . 0.0 109.946 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -48.89 -40.31 29.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.44 -0.787 . . . . 0.0 110.151 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.1 tpt85 -64.02 -42.7 97.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.241 -0.912 . . . . 0.0 109.839 179.772 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -59.84 -27.05 66.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.301 -0.874 . . . . 0.0 110.209 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.679 HG21 ' HA ' ' A' ' 92' ' ' PHE . 92.4 t -84.35 -68.46 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.319 -0.863 . . . . 0.0 110.999 -179.275 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.405 ' HB3' HD13 ' A' ' 116' ' ' LEU . 20.2 mmt -50.19 -27.88 6.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.235 -0.916 . . . . 0.0 110.681 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.7 m -75.51 -42.22 53.28 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.238 -0.914 . . . . 0.0 110.653 -179.734 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -87.76 -2.15 58.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.153 -0.967 . . . . 0.0 110.775 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.642 HD12 HG12 ' A' ' 108' ' ' VAL . 14.2 mt -88.57 -68.7 0.75 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.964 -1.085 . . . . 0.0 110.176 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 166.6 37.94 0.02 OUTLIER Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -135.43 154.45 51.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.264 -1.139 . . . . 0.0 110.263 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -120.52 99.48 6.58 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.32 -0.863 . . . . 0.0 110.21 179.759 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 116' ' ' LEU . 4.8 mp -110.3 -166.77 1.12 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.167 -0.958 . . . . 0.0 110.423 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.501 HG22 ' HG3' ' A' ' 120' ' ' GLU . 12.1 t -135.19 -164.74 1.57 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.371 -0.831 . . . . 0.0 109.632 179.668 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 118' ' ' ASP . 1.2 m-20 -81.08 -45.74 16.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.022 -1.048 . . . . 0.0 110.653 -179.704 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -58.7 -39.52 81.0 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.417 -0.802 . . . . 0.0 110.819 -179.605 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.501 ' HG3' HG22 ' A' ' 117' ' ' THR . 43.7 mt-10 -62.63 -49.89 73.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.117 -0.99 . . . . 0.0 110.766 -179.704 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 76.0 t -58.63 -37.4 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.101 -0.999 . . . . 0.0 110.43 -179.76 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -64.81 -47.77 76.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.141 -0.974 . . . . 0.0 110.294 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.414 ' HG2' ' OE2' ' A' ' 127' ' ' GLU . 6.4 tm-20 -66.3 -21.86 66.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.229 -0.919 . . . . 0.0 109.843 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 28.8 mmm -73.88 -56.5 4.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.389 -0.819 . . . . 0.0 110.231 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.697 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 22.3 mm -66.72 -25.42 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.296 -0.878 . . . . 0.0 110.344 -179.91 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -72.66 -57.98 3.71 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.194 -0.941 . . . . 0.0 110.225 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.445 ' CA ' ' OE1' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -63.05 -19.22 64.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 110.069 179.908 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.505 ' HB2' ' H6 ' ' A' ' 154' ' ' WW7 . . . -82.79 -34.2 27.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.256 -0.902 . . . . 0.0 110.013 179.674 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.87 90.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 110.114 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.673 HD12 ' HA ' ' A' ' 140' ' ' GLU . 92.5 mt -61.25 -18.9 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.895 . . . . 0.0 110.335 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.4 p30 -114.45 -30.34 6.58 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.217 -0.927 . . . . 0.0 110.195 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.458 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 89.39 80.62 1.32 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.432 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 33.0 p30 -139.1 13.76 2.63 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.334 -1.098 . . . . 0.0 110.565 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.25 24.6 76.13 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.159 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.432 ' HG3' ' OD1' ' A' ' 133' ' ' ASP . 0.3 OUTLIER -170.5 143.66 2.29 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.137 -1.214 . . . . 0.0 110.268 179.639 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.432 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 91.7 t -93.73 129.24 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 110.453 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -88.43 174.53 8.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.423 -0.798 . . . . 0.0 110.23 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.453 ' CD1' ' C ' ' A' ' 138' ' ' TYR . 8.0 t80 -68.03 -51.72 43.67 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.281 -0.887 . . . . 0.0 109.456 179.302 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -62.31 -40.99 98.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.331 -0.856 . . . . 0.0 109.789 179.646 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.673 ' HA ' HD12 ' A' ' 130' ' ' ILE . 31.5 mt-10 -65.25 -29.72 70.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 109.981 179.585 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.468 ' CD1' ' CE ' ' A' ' 144' ' ' MET . 78.6 t80 -74.12 -28.21 61.24 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.271 -0.893 . . . . 0.0 110.128 -179.827 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.699 HG22 HG21 ' A' ' 85' ' ' ILE . 60.3 t -88.46 -20.78 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.245 -0.909 . . . . 0.0 110.446 179.906 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -98.2 -17.35 19.04 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.356 -0.84 . . . . 0.0 110.904 -179.416 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.472 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 15.0 ptt? -81.32 -27.71 34.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.045 -1.034 . . . . 0.0 110.357 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.414 ' N ' ' HG3' ' A' ' 144' ' ' MET . 4.7 tpp -89.58 -68.56 0.77 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.9 . . . . 0.0 109.919 179.861 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 67.9 p -73.24 103.43 3.95 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.211 -0.931 . . . . 0.0 110.126 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -111.75 144.38 41.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 0.0 110.363 -179.854 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.218 179.971 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . 0.623 'CA ' ' OD1' ' A' ' 20' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 153' ' ' WW7 . . . . . 0.538 ' H3 ' ' CE2' ' A' ' 19' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 154' ' ' WW7 . . . . . 0.697 'CL1 ' HD13 ' A' ' 125' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.29 0.566 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -115.15 -161.76 0.79 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.161 -0.962 . . . . 0.0 109.95 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -138.34 -168.13 2.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.068 -1.02 . . . . 0.0 110.36 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.2 mt -94.95 -154.32 0.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.438 -0.788 . . . . 0.0 109.999 179.948 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.7 m -163.63 -63.17 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.319 -0.863 . . . . 0.0 110.014 179.948 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.0 -38.33 85.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.437 -0.789 . . . . 0.0 110.489 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -58.75 -44.0 90.44 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.192 -0.942 . . . . 0.0 110.789 -179.649 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -59.63 -48.0 83.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.077 -1.014 . . . . 0.0 109.986 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 61.8 mt -59.9 -30.07 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.155 -0.966 . . . . 0.0 109.665 179.545 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.97 -30.02 67.26 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.273 -0.892 . . . . 0.0 109.705 179.88 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 65.9 tt0 -69.77 -58.15 4.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.42 -0.8 . . . . 0.0 109.997 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -59.01 -36.26 74.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.175 -0.953 . . . . 0.0 109.439 179.426 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 9.6 tmtt? -65.36 -33.86 76.95 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.507 -0.746 . . . . 0.0 109.609 179.619 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 14.2 mm-40 -63.56 -42.67 98.33 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.358 -0.839 . . . . 0.0 109.634 179.421 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.432 ' HB1' ' CZ ' ' A' ' 19' ' ' PHE . . . -59.86 -48.22 82.58 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.329 -0.857 . . . . 0.0 110.041 179.695 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -55.43 -54.29 45.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.287 -0.883 . . . . 0.0 110.188 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.1 m -58.7 -27.75 65.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.154 -0.966 . . . . 0.0 109.827 179.653 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.753 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.4 tt -71.06 -32.23 68.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.441 -0.787 . . . . 0.0 110.05 -179.978 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.559 ' CD2' ' H3 ' ' A' ' 153' ' ' WW7 . 6.1 m-85 -84.31 -62.82 1.46 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.264 -0.897 . . . . 0.0 110.889 -179.184 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -82.12 85.1 6.83 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.226 -0.921 . . . . 0.0 110.625 -179.329 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' HD3' ' O ' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -106.48 52.74 0.71 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.141 -0.974 . . . . 0.0 109.972 179.375 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 1.7 p30 -137.08 -35.41 0.7 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.21 -0.931 . . . . 0.0 110.695 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 113.09 39.83 1.11 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.835 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -101.61 -33.0 10.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.357 -1.084 . . . . 0.0 110.032 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.58 -15.14 63.15 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.902 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.8 p -139.97 160.66 39.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.972 -1.31 . . . . 0.0 110.502 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.8 mt -103.17 111.99 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.362 -0.836 . . . . 0.0 109.983 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.581 HG22 ' CG2' ' A' ' 62' ' ' THR . 49.8 p -101.93 -164.9 1.14 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.211 -0.93 . . . . 0.0 110.263 -179.934 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.517 ' HA ' HD21 ' A' ' 48' ' ' LEU . 42.4 p -78.11 -36.58 47.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.221 -0.924 . . . . 0.0 110.243 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.5 mttm -68.58 -56.62 7.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 0.0 109.706 179.592 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.652 ' O ' HG22 ' A' ' 34' ' ' THR . 98.9 mt-10 -58.1 -40.9 82.32 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.284 -0.885 . . . . 0.0 109.626 179.413 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.716 HD23 ' CG ' ' A' ' 48' ' ' LEU . 7.0 tp -66.81 -26.76 67.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.26 -0.9 . . . . 0.0 109.401 179.186 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.0 -43.99 95.09 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.662 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.652 HG22 ' O ' ' A' ' 31' ' ' GLU . 7.0 t -75.41 -21.6 58.08 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.058 -1.26 . . . . 0.0 110.123 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.5 t -78.21 -29.81 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.2 -0.938 . . . . 0.0 109.972 179.535 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.8 mmt -90.17 -28.0 19.21 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.185 -0.947 . . . . 0.0 110.288 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.4 mtm180 -89.61 -17.51 28.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.234 -0.916 . . . . 0.0 110.447 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 34' ' ' THR . 29.7 t -49.6 -52.86 27.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.17 -0.957 . . . . 0.0 110.249 -179.766 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.26 61.32 1.53 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 110.214 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . -171.58 -62.57 0.04 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.416 ' HB2' ' O ' ' A' ' 40' ' ' GLY . 82.4 mt-30 54.81 102.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.232 -1.158 . . . . 0.0 110.115 -179.808 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.509 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.2 t-20 -164.84 -63.03 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.343 -0.848 . . . . 0.0 110.077 179.839 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.509 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 45.2 Cg_endo -71.12 171.49 15.84 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.392 1.206 . . . . 0.0 109.9 179.608 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.432 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 81.1 p -120.27 -170.74 2.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.141 -0.974 . . . . 0.0 109.94 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -74.55 -29.03 61.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.127 -0.983 . . . . 0.0 110.197 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.07 -57.22 4.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.201 -0.937 . . . . 0.0 109.827 179.736 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -62.08 -24.72 67.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 0.0 109.889 179.616 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.716 ' CG ' HD23 ' A' ' 32' ' ' LEU . 4.8 tt -70.23 -52.99 18.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.312 -0.867 . . . . 0.0 109.677 179.506 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.467 ' N ' HD23 ' A' ' 48' ' ' LEU . 51.3 tt0 -54.33 -37.61 65.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.182 -0.949 . . . . 0.0 109.449 179.271 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -68.79 -35.55 77.17 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.356 -0.84 . . . . 0.0 109.296 179.386 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.442 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 54.5 ttp -68.51 -17.45 64.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.326 -0.859 . . . . 0.0 109.675 179.417 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.619 HD11 HD22 ' A' ' 32' ' ' LEU . 13.8 mt -88.25 -37.88 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.888 . . . . 0.0 109.769 179.43 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -53.49 -35.61 60.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.912 . . . . 0.0 110.022 179.603 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.483 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 7.4 pt-20 -71.22 -32.56 68.95 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.355 -0.841 . . . . 0.0 110.273 -179.824 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.73 HG13 ' SD ' ' A' ' 71' ' ' MET . 71.5 t -76.38 -67.94 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.121 -0.987 . . . . 0.0 109.588 179.544 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.698 ' OD1' 'CA ' ' A' ' 150' ' ' ' CA' . 20.3 t70 -46.01 125.55 6.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.506 -0.746 . . . . 0.0 110.176 179.787 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.83 -26.07 10.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.143 -0.973 . . . . 0.0 110.842 -179.589 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.609 ' OD2' 'CA ' ' A' ' 150' ' ' ' CA' . 2.8 p30 -70.03 -34.76 73.68 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.228 -0.92 . . . . 0.0 110.455 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.457 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 92.5 76.37 1.33 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.822 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.409 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 18.6 p-10 -142.9 -43.55 0.3 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.222 -1.163 . . . . 0.0 110.179 179.391 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.534 ' C ' HG23 ' A' ' 62' ' ' THR . . . 132.61 2.61 3.94 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.842 179.323 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.581 ' CG2' HG22 ' A' ' 28' ' ' THR . 49.5 p -154.24 167.17 30.79 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.803 -1.41 . . . . 0.0 111.093 -179.858 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.7 HD11 HG11 ' A' ' 55' ' ' VAL . 49.3 mt -104.98 146.25 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.385 -0.822 . . . . 0.0 109.775 179.662 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.443 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 48.7 m-20 -105.45 170.51 7.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.095 -1.003 . . . . 0.0 110.293 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.547 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 32.9 t80 -67.07 -42.3 40.3 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.877 . . . . 0.0 111.412 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 46.1 Cg_endo -74.73 -26.3 11.62 Favored 'Trans proline' 0 C--O 1.212 -0.782 0 O-C-N 123.087 1.046 . . . . 0.0 110.146 -179.587 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 71' ' ' MET . 35.1 tt0 -78.99 -27.95 43.41 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.289 -0.882 . . . . 0.0 109.369 179.378 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -74.57 -61.07 2.0 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.318 -0.864 . . . . 0.0 109.728 179.647 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.481 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 5.0 tt -56.92 -38.09 72.38 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.291 -0.88 . . . . 0.0 109.826 179.669 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.434 ' HB ' ' O ' ' A' ' 66' ' ' PRO . 52.1 m -73.77 -26.4 60.63 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.192 -0.943 . . . . 0.0 110.325 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.73 ' SD ' HG13 ' A' ' 55' ' ' VAL . 34.4 ttp -63.37 -50.18 70.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 110.208 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.473 ' CE ' ' CE ' ' A' ' 71' ' ' MET . 36.5 mtt -90.5 -15.2 31.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.286 -0.884 . . . . 0.0 111.188 -179.372 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.481 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -91.27 -9.68 44.25 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.955 -1.091 . . . . 0.0 111.23 -179.664 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.68 27.08 1.18 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.064 -1.022 . . . . 0.0 111.454 -178.765 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -89.19 116.55 27.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.888 -1.132 . . . . 0.0 110.047 179.316 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.407 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -155.05 169.5 23.96 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.186 -0.946 . . . . 0.0 110.188 -179.816 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.41 ' O ' ' C ' ' A' ' 78' ' ' ASP . 21.7 tttm -120.62 6.96 10.51 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.162 -0.961 . . . . 0.0 110.811 -179.84 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 77' ' ' LYS . 3.0 p30 37.05 -153.47 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.576 0 O-C-N 121.673 -0.642 . . . . 0.0 111.251 179.781 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.409 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 9.0 t -123.49 155.72 36.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -0.878 . . . . 0.0 110.501 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.55 138.25 52.67 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.37 -0.831 . . . . 0.0 110.128 179.921 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 71.1 m -146.34 -81.61 0.14 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.186 -0.947 . . . . 0.0 110.394 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -134.64 97.44 3.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 0.0 109.89 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.487 ' HB2' ' HB3' ' A' ' 86' ' ' ARG . 8.6 pt-20 -167.33 75.38 0.15 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.236 -0.915 . . . . 0.0 110.601 -179.323 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -71.89 -67.79 0.51 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.125 -0.985 . . . . 0.0 110.339 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.6 mt -53.44 -46.54 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.077 -1.014 . . . . 0.0 110.02 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.487 ' HB3' ' HB2' ' A' ' 83' ' ' GLU . 27.1 ttt180 -55.49 -42.38 74.33 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.178 -0.951 . . . . 0.0 109.071 179.437 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -49.6 -50.68 41.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.398 -0.814 . . . . 0.0 109.39 179.259 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.726 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -52.54 -44.73 65.97 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.358 -0.838 . . . . 0.0 109.281 179.134 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.448 ' CD1' HD11 ' A' ' 100' ' ' ILE . 4.0 t80 -54.16 -39.6 66.7 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.166 -0.958 . . . . 0.0 109.987 179.782 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -59.07 -51.37 70.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.231 -0.918 . . . . 0.0 110.242 -179.874 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.726 HG22 ' O ' ' A' ' 88' ' ' ALA . 26.6 m -68.28 -18.49 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.125 -0.985 . . . . 0.0 109.745 179.817 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.547 ' CE2' ' H3 ' ' A' ' 154' ' ' WW7 . 29.0 m-85 -103.41 4.38 36.13 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.36 -0.837 . . . . 0.0 110.317 179.657 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.414 ' OD2' ' HA2' ' A' ' 98' ' ' GLY . 59.1 t0 -146.19 70.21 1.22 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -0.939 . . . . 0.0 109.749 179.748 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -107.3 59.01 0.62 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 110.708 -179.557 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.2 p30 -138.31 -40.0 0.52 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.128 -0.983 . . . . 0.0 110.309 179.567 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.469 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 135.56 17.81 0.83 Allowed Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.225 -1.464 . . . . 0.0 111.827 178.846 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.469 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 27.6 p30 -131.58 -122.16 0.2 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.352 -1.675 . . . . 0.0 109.89 179.192 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.469 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . -170.09 44.53 0.2 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 23.5 m-85 -131.95 128.52 38.64 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.39 -1.065 . . . . 0.0 110.294 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.45 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 24.0 mt -95.92 124.38 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.195 -0.941 . . . . 0.0 109.972 179.702 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.4 t -113.51 157.55 21.87 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.256 -0.903 . . . . 0.0 110.258 -179.844 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.25 -26.54 12.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 110.15 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 106' ' ' ARG . . . -69.72 -59.31 3.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.198 -0.939 . . . . 0.0 110.09 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -51.92 -38.92 58.14 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.064 -1.022 . . . . 0.0 110.264 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.938 HD22 HG13 ' A' ' 121' ' ' VAL . 6.5 tt -59.1 -48.98 79.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 110.488 -179.796 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.597 ' O ' HG23 ' A' ' 110' ' ' THR . 0.0 OUTLIER -65.81 -21.7 66.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.907 -1.121 . . . . 0.0 109.999 -179.905 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.472 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 21.1 t-160 -72.3 -34.63 68.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.416 -0.802 . . . . 0.0 110.035 -179.969 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.467 HG21 ' CD1' ' A' ' 92' ' ' PHE . 96.8 t -78.88 -42.12 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.319 -0.863 . . . . 0.0 110.434 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 4.7 mmt -66.52 -56.96 8.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.215 -179.67 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.597 HG23 ' O ' ' A' ' 106' ' ' ARG . 44.1 p -46.61 -48.97 19.66 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.447 -0.783 . . . . 0.0 110.714 -179.819 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -59.13 -55.67 32.08 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.179 -0.95 . . . . 0.0 110.258 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 112' ' ' LEU . 79.6 mt -52.36 -72.6 0.05 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.14 -0.975 . . . . 0.0 109.924 179.658 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.08 40.37 0.02 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.869 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.804 ' O ' HD12 ' A' ' 116' ' ' LEU . 35.9 mm-40 -121.71 93.24 3.94 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.233 -1.157 . . . . 0.0 110.089 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -74.63 111.4 9.78 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.269 -0.894 . . . . 0.0 110.208 -179.89 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 114' ' ' GLU . 0.9 OUTLIER -117.43 177.56 4.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -0.862 . . . . 0.0 110.285 -179.939 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 59.0 m -100.87 158.87 15.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.334 -0.854 . . . . 0.0 110.173 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -59.91 -41.98 92.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.289 -0.882 . . . . 0.0 110.6 -179.765 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -60.08 -50.64 72.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.291 -0.881 . . . . 0.0 110.716 -179.696 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -53.23 -52.79 57.82 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.144 -0.972 . . . . 0.0 110.877 -179.492 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.938 HG13 HD22 ' A' ' 105' ' ' LEU . 95.5 t -55.32 -55.81 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.144 -0.973 . . . . 0.0 110.371 -179.607 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -54.54 -26.66 33.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.303 -0.873 . . . . 0.0 110.35 -179.693 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 7.1 tt0 -76.3 -34.71 59.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 110.069 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 72.0 mtp -67.58 -47.08 70.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.214 -0.929 . . . . 0.0 110.122 -179.919 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.91 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 29.6 mm -64.11 -45.0 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 110.234 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.5 -33.7 75.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.192 -0.942 . . . . 0.0 110.041 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 41.2 mm-40 -67.93 -33.95 75.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.018 179.79 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.528 ' HB3' ' CG2' ' A' ' 136' ' ' VAL . . . -71.18 -42.13 69.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.284 -0.885 . . . . 0.0 110.464 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -56.92 92.39 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.159 -0.963 . . . . 0.0 110.385 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.417 HD11 ' CB ' ' A' ' 143' ' ' GLN . 76.3 mt -64.4 -31.89 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.194 -0.941 . . . . 0.0 110.236 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 22.4 p30 -101.99 -18.58 15.58 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.193 -0.942 . . . . 0.0 110.536 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.454 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 77.3 75.7 0.91 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.645 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 40.4 m-20 -109.8 -49.3 3.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.227 -1.161 . . . . 0.0 110.053 179.711 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 157.17 -23.59 0.45 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.708 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -143.74 155.91 44.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.329 -1.1 . . . . 0.0 110.115 179.727 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.528 ' CG2' ' HB3' ' A' ' 128' ' ' ALA . 77.7 t -91.6 108.51 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.203 -0.936 . . . . 0.0 110.315 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -82.63 165.55 19.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.948 . . . . 0.0 110.249 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.545 ' O ' HG23 ' A' ' 142' ' ' VAL . 35.5 t80 -44.68 -34.46 2.23 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.369 -0.832 . . . . 0.0 111.766 -178.823 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -65.22 -67.05 0.47 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.867 -1.145 . . . . 0.0 110.726 -179.223 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -52.86 -26.16 13.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.207 -0.933 . . . . 0.0 110.359 -179.589 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.657 ' CE1' ' HE3' ' A' ' 145' ' ' MET . 7.9 t80 -68.44 -40.43 81.14 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 109.985 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 138' ' ' TYR . 43.5 t -82.01 -20.25 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.294 -0.879 . . . . 0.0 110.554 179.975 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.417 ' CB ' HD11 ' A' ' 130' ' ' ILE . 81.4 mm-40 -80.5 -28.25 37.54 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.341 -0.849 . . . . 0.0 110.696 -179.534 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.403 ' HG3' ' N ' ' A' ' 145' ' ' MET . 4.3 ptt? -84.53 -21.68 30.43 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.053 -1.029 . . . . 0.0 110.462 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.657 ' HE3' ' CE1' ' A' ' 141' ' ' PHE . 46.4 mtt -89.02 -39.83 13.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.203 -0.936 . . . . 0.0 110.524 -179.801 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.1 p -63.23 -68.12 0.37 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.207 -0.933 . . . . 0.0 110.383 -179.8 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -171.61 -178.95 2.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.221 -0.924 . . . . 0.0 110.152 179.944 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.154 -0.966 . . . . 0.0 110.179 -179.934 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . 0.698 'CA ' ' OD1' ' A' ' 56' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 153' ' ' WW7 . . . . . 0.57 ' C6 ' HG21 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 154' ' ' WW7 . . . . . 0.91 'CL1 ' HD13 ' A' ' 125' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 121.201 0.524 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -116.99 89.92 3.22 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.162 -0.961 . . . . 0.0 110.354 179.932 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -171.36 -44.66 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.184 -0.948 . . . . 0.0 110.024 179.915 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.821 ' O ' HG23 ' A' ' 5' ' ' THR . 7.1 mt -134.73 131.51 37.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.298 -0.876 . . . . 0.0 110.077 179.813 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.821 HG23 ' O ' ' A' ' 4' ' ' LEU . 0.4 OUTLIER -170.54 -61.29 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.287 -0.883 . . . . 0.0 110.307 -179.959 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.405 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 21.6 pt-20 -89.19 -23.65 22.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.352 -0.843 . . . . 0.0 110.497 -179.629 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -55.5 -54.61 41.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.167 -0.958 . . . . 0.0 109.969 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -50.97 -45.03 60.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.908 . . . . 0.0 109.788 179.581 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 31.3 mm -52.87 -40.92 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.884 . . . . 0.0 109.646 179.667 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -59.94 -44.4 94.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.361 -0.837 . . . . 0.0 109.89 179.615 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -53.29 -51.31 62.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 109.954 179.805 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -60.7 -33.87 73.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 109.896 179.737 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 72.1 mttt -66.07 -27.46 68.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.888 179.626 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -73.19 -53.05 11.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.35 -0.843 . . . . 0.0 109.913 179.763 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.444 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -58.89 -34.84 72.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.21 -0.931 . . . . 0.0 109.98 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -66.99 -54.25 23.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.883 . . . . 0.0 109.975 179.867 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.0 m -56.64 -21.39 26.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.238 -0.914 . . . . 0.0 110.021 179.654 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.814 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.1 tm? -78.6 -35.44 45.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.443 -0.786 . . . . 0.0 109.791 179.878 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.448 ' CE2' ' H3 ' ' A' ' 153' ' ' WW7 . 22.7 m-85 -70.46 -55.58 8.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.386 -0.821 . . . . 0.0 110.454 -179.889 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.442 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 0.5 OUTLIER -55.79 113.16 1.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.209 -0.932 . . . . 0.0 110.412 -179.897 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -109.96 54.58 0.66 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 110.143 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.456 ' OD2' ' HB2' ' A' ' 24' ' ' ASP . 10.2 p-10 -162.51 -37.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.111 -0.993 . . . . 0.0 110.598 -179.788 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.81 39.66 2.48 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.456 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 6.8 t70 -103.54 -67.67 0.88 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.369 -1.077 . . . . 0.0 110.101 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.531 ' C ' HG23 ' A' ' 26' ' ' THR . . . 135.92 23.47 0.55 Allowed Glycine 0 N--CA 1.499 2.842 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.621 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.531 HG23 ' C ' ' A' ' 25' ' ' GLY . 74.4 p -154.15 144.17 21.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.896 -1.355 . . . . 0.0 109.534 179.534 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.6 mt -96.37 107.18 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.109 -0.994 . . . . 0.0 110.328 -179.764 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.686 HG22 ' CG2' ' A' ' 62' ' ' THR . 72.4 p -103.28 -176.98 3.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.374 -0.829 . . . . 0.0 110.178 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.716 HG22 HD12 ' A' ' 52' ' ' ILE . 25.5 p -68.31 -26.68 65.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.277 -0.89 . . . . 0.0 110.14 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -68.67 -62.44 1.39 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.21 -0.931 . . . . 0.0 109.921 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.442 ' OE1' ' HA ' ' A' ' 20' ' ' ASP . 35.2 mt-10 -56.42 -55.36 34.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.325 -0.859 . . . . 0.0 109.458 179.602 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.817 HD23 HD21 ' A' ' 48' ' ' LEU . 6.6 tp -57.57 -23.77 52.49 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.177 -0.952 . . . . 0.0 109.296 179.144 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.487 ' HA2' ' CD1' ' A' ' 48' ' ' LEU . . . -62.85 -46.93 92.59 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.444 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.466 ' O ' ' CB ' ' A' ' 38' ' ' SER . 96.4 m -78.54 -14.45 59.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.332 -1.099 . . . . 0.0 109.934 179.636 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.445 ' HB ' ' HA ' ' A' ' 32' ' ' LEU . 50.5 t -78.77 -36.57 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.172 -0.955 . . . . 0.0 110.21 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.7 mmt -90.72 -38.09 13.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.352 -0.843 . . . . 0.0 110.756 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.7 mtm180 -75.74 -36.32 59.93 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.714 -179.497 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.645 ' O ' HD22 ' A' ' 39' ' ' LEU . 8.4 t -76.99 -23.93 52.24 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.876 -1.14 . . . . 0.0 110.054 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.645 HD22 ' O ' ' A' ' 38' ' ' SER . 3.9 mm? -119.85 56.61 0.95 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.314 -0.866 . . . . 0.0 110.169 179.8 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.49 56.95 0.07 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -48.43 104.92 0.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.178 -1.19 . . . . 0.0 110.479 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.539 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 5.9 m-20 -159.66 -63.61 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.318 -0.864 . . . . 0.0 110.329 179.314 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.539 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 46.6 Cg_endo -73.87 -179.32 4.49 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.332 1.175 . . . . 0.0 109.864 179.439 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 8.7 t -134.72 -175.64 3.96 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.108 -0.995 . . . . 0.0 110.102 -179.852 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.06 -42.0 93.58 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.034 -1.041 . . . . 0.0 110.333 -179.832 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.47 -68.46 0.38 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.22 -0.925 . . . . 0.0 110.411 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -47.14 -26.21 1.07 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.221 -0.924 . . . . 0.0 109.984 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.817 HD21 HD23 ' A' ' 32' ' ' LEU . 9.1 tt -70.56 -49.48 47.53 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.313 -0.867 . . . . 0.0 109.764 179.52 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -52.45 -41.18 63.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.118 -0.989 . . . . 0.0 109.222 179.224 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.78 -35.38 79.94 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.877 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.44 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 3.5 ttt -68.16 -15.05 63.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.646 -0.659 . . . . 0.0 109.573 179.007 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.716 HD12 HG22 ' A' ' 29' ' ' THR . 57.3 mt -88.56 -35.17 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.397 -0.814 . . . . 0.0 109.834 179.39 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -51.83 -45.38 63.93 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.274 -0.891 . . . . 0.0 110.657 -179.802 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.693 ' HG3' HG23 ' A' ' 55' ' ' VAL . 22.0 pt-20 -56.93 -34.27 67.81 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.177 -0.952 . . . . 0.0 110.476 -179.658 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.844 HG13 ' HE2' ' A' ' 71' ' ' MET . 95.3 t -84.49 -71.73 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.202 -0.936 . . . . 0.0 110.284 -179.696 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.433 ' HB2' ' CG1' ' A' ' 63' ' ' ILE . 24.2 t70 -56.53 124.33 17.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.335 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.34 5.29 21.48 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.23 -0.919 . . . . 0.0 110.702 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.83 -23.22 36.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.077 -1.015 . . . . 0.0 110.198 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.26 14.43 76.66 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.737 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -91.56 -37.39 13.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.014 -1.286 . . . . 0.0 110.165 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.14 -52.02 0.83 Allowed Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.231 179.567 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.686 ' CG2' HG22 ' A' ' 28' ' ' THR . 66.7 p -101.87 167.55 9.99 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.067 -1.255 . . . . 0.0 110.728 -179.379 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.446 HG23 ' CB ' ' A' ' 67' ' ' GLU . 48.7 mt -115.29 157.17 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.287 -0.883 . . . . 0.0 110.055 179.662 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.485 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 1.4 m-20 -112.6 -172.37 2.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.241 -0.912 . . . . 0.0 110.728 -179.648 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.572 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 50.3 t80 -65.3 -42.62 60.31 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.473 -0.767 . . . . 0.0 111.976 -179.686 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.5 Cg_endo -71.67 -33.35 10.56 Favored 'Trans proline' 0 C--N 1.323 -0.787 0 O-C-N 123.069 1.036 . . . . 0.0 110.893 -179.146 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.446 ' CB ' HG23 ' A' ' 63' ' ' ILE . 48.6 mt-10 -71.43 -30.16 65.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.021 -1.049 . . . . 0.0 108.844 179.169 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.491 ' CZ ' ' SD ' ' A' ' 72' ' ' MET . 64.9 t80 -73.46 -43.0 61.24 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.512 0.672 . . . . 0.0 109.654 179.738 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.49 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 15.5 tp -77.19 -12.12 59.91 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.49 -0.756 . . . . 0.0 110.344 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.7 m -90.68 -28.42 18.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.929 -1.107 . . . . 0.0 110.44 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.844 ' HE2' HG13 ' A' ' 55' ' ' VAL . 18.9 tmm? -90.61 -37.02 14.07 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.178 -0.951 . . . . 0.0 111.197 -179.488 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.491 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 48.9 mtt -91.3 -11.8 36.97 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.112 -0.993 . . . . 0.0 111.975 -178.646 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -85.13 -23.5 28.4 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.772 -1.205 . . . . 0.0 111.126 -179.401 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.21 -51.95 13.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.983 -1.073 . . . . 0.0 110.513 -179.441 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.82 138.04 39.59 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.167 -0.958 . . . . 0.0 110.291 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 13.2 tpt -174.46 135.08 0.41 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.255 -0.903 . . . . 0.0 110.29 179.861 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.75 -165.53 1.37 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.312 -0.867 . . . . 0.0 110.512 -179.963 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -163.8 -62.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.429 -0.794 . . . . 0.0 109.912 179.882 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.65 119.22 38.47 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.333 -0.854 . . . . 0.0 109.755 179.664 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -112.21 66.43 0.64 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.2 -0.938 . . . . 0.0 110.391 -179.622 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.5 t -135.84 158.85 43.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 109.861 179.656 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -168.38 149.75 4.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.187 -0.946 . . . . 0.0 110.077 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 33.4 tt0 -131.17 24.05 4.88 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.332 -0.855 . . . . 0.0 109.882 179.887 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -77.36 -25.14 50.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.366 -0.834 . . . . 0.0 110.314 -179.848 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.732 HG12 HG22 ' A' ' 142' ' ' VAL . 3.8 tp -48.06 -34.87 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.168 -0.958 . . . . 0.0 109.536 179.834 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -59.95 -48.7 80.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.392 -0.818 . . . . 0.0 109.499 179.282 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.419 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 7.8 mm-40 -54.13 -41.6 68.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.255 -0.903 . . . . 0.0 109.563 179.39 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.15 -46.41 88.45 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.312 -0.867 . . . . 0.0 109.66 179.528 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.435 ' O ' ' HB3' ' A' ' 93' ' ' ASP . 0.4 OUTLIER -63.38 -20.82 65.86 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.179 179.736 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.419 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -74.05 -49.74 22.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.365 -0.834 . . . . 0.0 110.882 -179.489 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 92' ' ' PHE . 16.5 m -75.1 -41.04 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.133 -0.979 . . . . 0.0 111.416 -179.089 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 1.011 ' CE1' HD12 ' A' ' 105' ' ' LEU . 37.7 m-85 -72.78 -28.18 62.45 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.068 -1.02 . . . . 0.0 111.248 -179.141 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.435 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 10.4 t70 -111.15 51.6 0.77 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.859 -1.151 . . . . 0.0 110.348 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.74 2.63 32.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 110.49 179.882 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 3.0 p30 -85.96 -37.77 18.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.128 -0.983 . . . . 0.0 110.296 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 104.38 47.64 1.2 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.443 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 15.8 p-10 -122.77 -32.77 3.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.151 -1.205 . . . . 0.0 110.295 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.48 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 100.36 16.16 28.03 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.901 -1.142 . . . . 0.0 110.312 179.274 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 37.6 m-85 -144.79 161.44 39.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.051 -1.264 . . . . 0.0 110.303 179.762 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.548 HG23 ' HB3' ' A' ' 92' ' ' PHE . 23.0 mt -107.0 118.39 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.256 -0.903 . . . . 0.0 109.419 179.323 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.3 m -102.13 163.36 12.28 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.44 -0.788 . . . . 0.0 109.632 179.8 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.87 -49.76 76.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.063 -1.023 . . . . 0.0 110.167 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -50.43 -50.45 52.0 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.274 -0.891 . . . . 0.0 110.573 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -57.95 -45.73 86.19 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.356 -0.84 . . . . 0.0 110.136 -179.881 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.011 HD12 ' CE1' ' A' ' 92' ' ' PHE . 40.5 tp -59.15 -23.88 62.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.438 -0.789 . . . . 0.0 110.319 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.44 -43.3 27.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.307 -0.871 . . . . 0.0 110.403 -179.933 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.414 ' O ' ' OG1' ' A' ' 110' ' ' THR . 81.6 m-70 -68.18 -30.27 69.33 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.216 -0.927 . . . . 0.0 110.551 -179.927 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.706 HG11 ' CE1' ' A' ' 92' ' ' PHE . 48.1 t -75.17 -47.82 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.02 -1.05 . . . . 0.0 109.866 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.694 ' HE3' HD11 ' A' ' 105' ' ' LEU . 63.7 mtt -65.36 -10.42 33.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.174 -0.954 . . . . 0.0 110.509 179.911 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 107' ' ' HIS . 1.1 p -90.17 -26.41 20.16 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.018 -1.051 . . . . 0.0 109.858 179.245 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -88.47 -52.92 4.92 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.146 -0.971 . . . . 0.0 110.117 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.1 mt -47.73 -72.85 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.165 -0.959 . . . . 0.0 110.278 179.811 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 162.97 40.78 0.02 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.489 ' HB3' ' CD1' ' A' ' 116' ' ' LEU . 51.5 mt-10 -120.85 121.45 38.13 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.323 -1.104 . . . . 0.0 110.462 -179.786 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -106.81 66.03 0.68 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.206 -0.934 . . . . 0.0 110.109 179.702 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.489 ' CD1' ' HB3' ' A' ' 114' ' ' GLU . 3.4 mp -88.04 167.98 13.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.261 -0.899 . . . . 0.0 110.364 -179.895 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 22.9 m -86.24 163.21 17.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.334 -0.854 . . . . 0.0 109.969 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -60.77 -54.44 45.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.159 -0.963 . . . . 0.0 110.379 -179.805 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -47.07 -40.23 14.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.947 . . . . 0.0 110.276 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -56.76 -60.09 4.07 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.251 -0.906 . . . . 0.0 110.441 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.803 HG13 HD23 ' A' ' 105' ' ' LEU . 53.1 t -47.22 -39.72 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.143 -0.973 . . . . 0.0 110.371 -179.622 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -62.68 -44.07 97.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.135 -0.978 . . . . 0.0 109.99 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -69.11 -20.51 64.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.199 179.839 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.419 ' O ' ' H6 ' ' A' ' 154' ' ' WW7 . 85.1 mtp -77.78 -46.52 21.41 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.126 -0.984 . . . . 0.0 109.993 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.519 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 26.0 mm -65.57 -29.38 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.158 -0.964 . . . . 0.0 110.007 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -75.91 -54.79 6.36 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.2 -0.938 . . . . 0.0 110.132 179.576 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -54.94 -33.52 62.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.226 -0.921 . . . . 0.0 109.995 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.766 ' HB2' ' H6 ' ' A' ' 154' ' ' WW7 . . . -75.13 -37.43 61.41 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.209 -0.932 . . . . 0.0 109.811 179.701 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -57.89 95.46 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.317 -0.864 . . . . 0.0 109.809 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.433 HD12 ' HG2' ' A' ' 140' ' ' GLU . 21.8 mt -62.07 -46.96 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.888 . . . . 0.0 110.402 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 21.6 p30 -86.6 -19.69 28.99 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.185 -0.947 . . . . 0.0 110.059 179.854 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.445 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 67.48 65.56 2.69 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 178.871 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.426 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 34.4 m-20 -98.28 -35.62 10.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.178 -1.19 . . . . 0.0 109.719 179.048 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.75 -28.62 1.04 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 -179.664 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.412 ' O ' ' OE1' ' A' ' 135' ' ' GLN . 0.0 OUTLIER -137.08 169.62 17.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.471 -1.017 . . . . 0.0 109.709 179.589 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.777 HG21 'CL1 ' ' A' ' 154' ' ' WW7 . 84.4 t -99.28 145.23 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 120.97 -1.081 . . . . 0.0 110.752 -179.447 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -106.67 178.79 4.46 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.365 -0.835 . . . . 0.0 110.193 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.537 ' O ' HG23 ' A' ' 142' ' ' VAL . 13.7 t80 -69.07 -44.7 72.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.231 -0.918 . . . . 0.0 110.441 -179.997 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.58 -33.32 73.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.242 -0.911 . . . . 0.0 110.27 -179.735 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.433 ' HG2' HD12 ' A' ' 130' ' ' ILE . 48.3 mt-10 -71.27 -35.6 71.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.146 -0.971 . . . . 0.0 110.085 179.818 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.477 ' CE2' HG13 ' A' ' 85' ' ' ILE . 57.4 t80 -71.13 -32.72 69.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.212 -0.93 . . . . 0.0 110.657 -179.847 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.732 HG22 HG12 ' A' ' 85' ' ' ILE . 59.4 t -78.7 -29.54 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.12 -0.987 . . . . 0.0 110.72 -179.734 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.424 ' OE1' ' N ' ' A' ' 143' ' ' GLN . 0.6 OUTLIER -97.06 -9.74 27.46 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.129 -0.982 . . . . 0.0 111.456 -179.068 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.47 ' HG2' ' HA ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -89.31 -31.56 17.77 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.705 -1.247 . . . . 0.0 110.372 -179.958 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 56.0 ttm -85.97 -48.77 8.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.938 179.907 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.5 p -61.43 126.07 26.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.351 -0.843 . . . . 0.0 110.091 179.682 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -140.14 43.63 1.91 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.195 -0.941 . . . . 0.0 110.433 -179.895 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.2 mttm . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.282 179.725 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 153' ' ' WW7 . . . . . 0.486 ' O1 ' ' H8 ' ' A' ' 153' ' ' WW7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 154' ' ' WW7 . . . . . 0.777 'CL1 ' HG21 ' A' ' 136' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.168 0.509 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -96.1 -169.81 1.99 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.233 -0.917 . . . . 0.0 110.238 -179.986 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -168.97 115.74 0.62 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.311 -0.868 . . . . 0.0 109.946 179.685 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 80.7 mt -75.62 -158.06 0.08 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.414 -0.804 . . . . 0.0 110.613 -179.535 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.3 p -138.15 -178.97 5.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.452 -0.78 . . . . 0.0 110.072 179.833 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -82.63 -9.6 59.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.227 -0.92 . . . . 0.0 110.586 -179.88 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -62.08 -55.06 32.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.032 -1.042 . . . . 0.0 110.764 -179.661 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -59.76 -50.89 72.05 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.208 -0.932 . . . . 0.0 110.217 -179.544 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 12' ' ' PHE . 22.9 mt -48.91 -42.74 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.045 -1.034 . . . . 0.0 109.664 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.02 -43.1 99.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 109.571 179.301 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -58.65 -29.1 66.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 109.555 179.463 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 12.5 m-85 -72.91 -36.23 67.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.279 -0.888 . . . . 0.0 109.934 179.656 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -70.46 -27.1 63.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.917 . . . . 0.0 109.858 179.623 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.83 -43.83 52.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.352 -0.843 . . . . 0.0 109.845 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.56 -42.86 86.45 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.246 -0.909 . . . . 0.0 109.7 179.484 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -57.14 -44.62 83.54 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.269 -0.894 . . . . 0.0 109.651 179.685 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 98.3 p -64.12 -35.6 81.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -0.904 . . . . 0.0 109.337 179.388 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.676 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -58.69 -33.17 69.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.466 -0.771 . . . . 0.0 109.381 179.438 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.542 ' CE2' ' H3 ' ' A' ' 153' ' ' WW7 . 3.5 m-30 -87.09 -24.08 24.69 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.39 -0.819 . . . . 0.0 109.92 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.422 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 66.7 t0 -101.69 92.67 4.96 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.334 -0.854 . . . . 0.0 109.912 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.52 -14.29 15.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 110.59 -179.548 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -78.89 -37.34 40.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.184 -0.948 . . . . 0.0 110.299 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.72 83.13 1.71 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 23.5 p-10 -156.53 -32.41 0.09 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.122 -1.223 . . . . 0.0 111.207 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.451 ' C ' HG23 ' A' ' 26' ' ' THR . . . 101.81 22.85 9.76 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.56 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.451 HG23 ' C ' ' A' ' 25' ' ' GLY . 75.9 p -149.69 155.01 39.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.164 -1.198 . . . . 0.0 109.988 179.863 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.5 mt -109.43 124.93 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.069 -1.02 . . . . 0.0 110.218 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.801 HG22 HG21 ' A' ' 62' ' ' THR . 41.4 p -108.0 -159.01 0.67 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.426 -0.796 . . . . 0.0 110.189 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.794 HG22 HD12 ' A' ' 52' ' ' ILE . 32.0 p -90.23 -34.04 15.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.218 179.921 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.49 -58.88 6.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -0.906 . . . . 0.0 109.995 -179.952 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 19' ' ' PHE . 48.8 mt-10 -60.49 -54.64 43.03 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.32 -0.862 . . . . 0.0 109.709 179.831 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.646 HD23 HD11 ' A' ' 48' ' ' LEU . 2.8 tp -57.26 -20.18 26.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.269 -0.894 . . . . 0.0 109.713 179.533 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.35 -46.85 46.84 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 179.542 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.437 ' O ' ' CB ' ' A' ' 38' ' ' SER . 38.4 m -68.8 -20.22 64.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.447 -1.031 . . . . 0.0 109.805 179.349 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.857 ' O ' HD12 ' A' ' 39' ' ' LEU . 54.9 t -75.48 -58.1 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.385 -0.822 . . . . 0.0 110.332 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.506 ' CE ' ' CE ' ' A' ' 51' ' ' MET . 58.7 mtt -72.9 -18.8 61.38 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.279 -0.888 . . . . 0.0 110.785 -179.391 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -89.93 -29.33 18.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.021 -1.049 . . . . 0.0 110.09 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 34' ' ' THR . 40.5 t -82.41 -30.73 29.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.237 -0.915 . . . . 0.0 110.101 179.756 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.857 HD12 ' O ' ' A' ' 35' ' ' VAL . 1.3 mt -104.35 64.93 0.77 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.376 -0.828 . . . . 0.0 109.663 179.608 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.22 78.16 1.34 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.411 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -63.24 88.38 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.282 -1.128 . . . . 0.0 110.55 -179.459 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.534 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 3.2 m120 -114.28 -66.66 0.03 OUTLIER Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.375 -0.828 . . . . 0.0 110.689 179.72 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.534 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 47.1 Cg_endo -73.49 -169.44 0.54 Allowed 'Trans proline' 0 C--N 1.32 -0.934 0 O-C-N 123.092 1.048 . . . . 0.0 110.341 179.484 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 35.0 p -138.54 -175.3 4.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.321 -0.862 . . . . 0.0 110.07 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -66.56 -31.5 72.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.222 -0.923 . . . . 0.0 109.974 179.683 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.23 -67.28 0.5 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 0.0 109.953 179.73 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -50.6 -31.11 15.02 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.354 -0.841 . . . . 0.0 109.688 179.718 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.646 HD11 HD23 ' A' ' 32' ' ' LEU . 8.8 tt -65.63 -47.94 73.89 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.395 -0.815 . . . . 0.0 110.066 179.65 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.419 ' OE1' HG21 ' A' ' 29' ' ' THR . 4.6 tp-100 -54.46 -44.95 72.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 109.217 179.465 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 1.0 OUTLIER -67.87 -27.35 66.6 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.345 -0.847 . . . . 0.0 109.307 179.355 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.506 ' CE ' ' CE ' ' A' ' 36' ' ' MET . 20.2 ttp -76.15 -15.18 60.12 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.497 -0.752 . . . . 0.0 109.719 179.413 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.794 HD12 HG22 ' A' ' 29' ' ' THR . 6.4 mt -90.51 -38.45 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.132 -0.98 . . . . 0.0 109.823 179.378 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -52.99 -28.64 24.91 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.158 -0.964 . . . . 0.0 109.75 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.475 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 9.6 pt-20 -79.95 -33.84 39.27 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 109.541 179.245 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.475 ' N ' ' HG3' ' A' ' 54' ' ' GLU . 85.3 t -69.48 -65.76 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.192 -0.943 . . . . 0.0 109.202 178.973 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -56.35 101.51 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.435 -0.791 . . . . 0.0 109.845 179.419 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.43 58.36 0.8 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.128 -0.983 . . . . 0.0 110.711 -179.523 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.425 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 15.3 m-20 -141.81 -49.79 0.39 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.261 -0.899 . . . . 0.0 109.852 179.565 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.64 50.77 0.55 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.647 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.412 ' OD1' ' HB2' ' A' ' 58' ' ' ASP . 7.7 p-10 -129.14 -48.29 1.21 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.27 -1.135 . . . . 0.0 110.443 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.95 -86.66 0.13 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.3 -1.429 . . . . 0.0 110.8 179.6 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.801 HG21 HG22 ' A' ' 28' ' ' THR . 73.7 p -91.22 170.59 9.88 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.246 -1.149 . . . . 0.0 111.34 -178.662 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.423 ' CD1' HG11 ' A' ' 55' ' ' VAL . 33.1 mt -88.9 159.7 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.515 -0.741 . . . . 0.0 109.917 179.628 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.425 ' HB2' ' OE1' ' A' ' 67' ' ' GLU . 20.7 t0 -108.29 -176.93 3.19 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.276 -0.89 . . . . 0.0 110.417 -179.969 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.583 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 23.5 t80 -72.81 -43.79 8.49 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.406 -0.809 . . . . 0.0 111.174 179.86 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.7 Cg_endo -72.18 -19.08 26.45 Favored 'Trans proline' 0 C--O 1.213 -0.748 0 O-C-N 123.122 1.064 . . . . 0.0 110.562 -179.844 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.425 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 39.9 mt-10 -78.57 -27.81 45.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.021 -1.049 . . . . 0.0 108.919 179.029 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 7.5 t80 -76.88 -48.62 17.81 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.287 0.565 . . . . 0.0 110.419 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.739 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 17.0 tp -78.26 -17.39 56.73 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.193 -0.942 . . . . 0.0 111.236 -179.388 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.405 ' CB ' ' O ' ' A' ' 66' ' ' PRO . 43.1 m -87.77 -38.83 15.42 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.706 -1.246 . . . . 0.0 110.56 -179.797 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.525 ' CE ' ' HE3' ' A' ' 72' ' ' MET . 4.8 ptt? -78.38 -31.62 48.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.157 -0.964 . . . . 0.0 110.332 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.525 ' HE3' ' CE ' ' A' ' 71' ' ' MET . 48.2 mtt -89.79 -9.58 48.7 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.156 -0.965 . . . . 0.0 110.671 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . -83.53 -34.52 25.25 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.141 -0.974 . . . . 0.0 110.394 -179.808 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.98 59.65 1.19 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.38 -0.825 . . . . 0.0 110.161 -179.595 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.0 tttt -131.22 85.38 2.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 0.0 110.308 179.994 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 11.0 tpt -121.7 129.12 52.51 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.231 -0.918 . . . . 0.0 109.873 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -78.25 134.89 37.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.286 -0.884 . . . . 0.0 110.423 -179.764 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.414 ' O ' ' HB ' ' A' ' 79' ' ' THR . 33.4 t70 -152.08 79.94 1.25 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.304 -0.873 . . . . 0.0 110.359 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 78' ' ' ASP . 9.7 t -176.51 163.5 2.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.273 -0.892 . . . . 0.0 110.063 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -103.3 -171.26 1.91 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.163 -0.961 . . . . 0.0 110.245 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.6 t -50.62 -72.62 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.876 . . . . 0.0 110.359 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.484 ' HG2' ' HG3' ' A' ' 84' ' ' GLU . 44.5 tt0 -153.15 -71.23 0.14 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.196 -0.94 . . . . 0.0 110.187 -179.728 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 46.48 86.64 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.215 -0.928 . . . . 0.0 110.506 179.713 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.484 ' HG3' ' HG2' ' A' ' 82' ' ' GLU . 42.3 mt-10 -98.18 -34.61 10.67 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.116 -0.99 . . . . 0.0 110.322 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.4 HD11 HN22 ' A' ' 154' ' ' WW7 . 26.1 mm -67.02 -29.93 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.449 -179.913 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -56.52 10.03 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.158 -0.964 . . . . 0.0 109.838 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -55.08 -42.33 72.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.346 -0.846 . . . . 0.0 110.161 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.41 -39.3 92.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.9 . . . . 0.0 110.558 -179.667 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.44 ' O ' ' CB ' ' A' ' 93' ' ' ASP . 5.0 t80 -63.46 -33.26 75.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.914 -1.116 . . . . 0.0 110.387 -179.631 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -75.52 -55.04 6.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.086 -1.009 . . . . 0.0 111.003 -179.481 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.562 HG23 ' N ' ' A' ' 92' ' ' PHE . 19.2 m -56.26 -42.9 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.095 -1.003 . . . . 0.0 110.813 -179.35 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.752 ' CE1' HD12 ' A' ' 105' ' ' LEU . 30.3 m-85 -77.44 -20.77 54.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.135 -0.978 . . . . 0.0 110.211 179.88 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 89' ' ' PHE . 35.5 t0 -113.71 53.21 0.78 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.154 -0.966 . . . . 0.0 109.471 179.127 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -86.36 56.17 3.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.543 -0.723 . . . . 0.0 110.757 -179.419 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.462 ' OD2' ' HB2' ' A' ' 97' ' ' ASN . 26.3 p-10 -158.26 29.94 0.25 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.103 -0.998 . . . . 0.0 110.335 179.731 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.44 33.12 4.2 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.524 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.462 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 18.1 t-20 -91.93 -60.01 1.97 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.236 -1.155 . . . . 0.0 110.083 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.458 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 112.07 -5.49 27.14 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.742 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.458 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 37.3 m-85 -138.93 140.06 38.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.938 -1.331 . . . . 0.0 110.465 -179.826 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 39.5 mt -85.97 118.25 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.315 -0.866 . . . . 0.0 110.161 179.813 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.3 t -102.91 174.15 6.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.451 -0.781 . . . . 0.0 109.462 179.514 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.25 -41.21 73.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.039 -1.038 . . . . 0.0 109.988 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.42 -54.55 44.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.211 -0.931 . . . . 0.0 110.091 179.64 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.403 ' OE2' ' OD2' ' A' ' 95' ' ' ASP . 45.9 mt-10 -59.58 -45.34 92.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.224 -0.922 . . . . 0.0 110.043 179.765 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.857 HD23 HG13 ' A' ' 121' ' ' VAL . 32.5 tp -58.52 -21.12 51.26 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.429 -0.794 . . . . 0.0 110.534 -179.927 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.8 ttt-85 -83.52 -40.08 19.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.213 -0.929 . . . . 0.0 110.097 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -73.22 -22.65 60.39 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.28 -0.887 . . . . 0.0 110.125 179.88 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 97.3 t -89.92 -44.15 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -0.882 . . . . 0.0 110.068 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 4.7 mmt -49.5 -24.41 2.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.908 . . . . 0.0 110.163 179.852 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 64.6 p -82.34 -41.75 19.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 110.081 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -57.04 -45.18 83.36 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.234 -0.917 . . . . 0.0 110.177 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.421 ' HB2' ' OE1' ' A' ' 114' ' ' GLU . 80.4 mt -64.12 -55.91 18.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.317 -0.865 . . . . 0.0 110.31 -179.969 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 142.52 53.07 0.04 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.758 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.421 ' OE1' ' HB2' ' A' ' 112' ' ' LEU . 49.5 mp0 -139.11 -62.83 0.53 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.168 -1.195 . . . . 0.0 110.068 179.693 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 114' ' ' GLU . 70.3 tttt 55.78 104.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.299 -0.876 . . . . 0.0 110.417 179.751 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.58 -175.82 3.24 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.165 -0.959 . . . . 0.0 110.529 -179.948 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.428 HG23 ' H ' ' A' ' 120' ' ' GLU . 9.5 t -87.89 -177.8 5.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.361 -0.837 . . . . 0.0 110.184 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -68.96 -34.8 75.93 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.178 -0.951 . . . . 0.0 110.448 -179.875 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -65.47 -53.24 45.45 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.232 -0.917 . . . . 0.0 110.779 -179.767 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.428 ' H ' HG23 ' A' ' 117' ' ' THR . 5.7 mm-40 -54.32 -50.45 67.35 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.127 -0.983 . . . . 0.0 110.56 -179.54 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.857 HG13 HD23 ' A' ' 105' ' ' LEU . 56.1 t -56.44 -47.98 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.162 -0.961 . . . . 0.0 110.133 -179.978 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -62.68 -23.69 67.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.184 -0.948 . . . . 0.0 109.868 179.677 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.434 ' HG3' ' OE1' ' A' ' 127' ' ' GLU . 16.5 tp10 -75.07 -30.01 60.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.395 -0.816 . . . . 0.0 109.917 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.757 ' CE ' HD21 ' A' ' 105' ' ' LEU . 23.3 mtm -77.33 -46.24 23.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.368 -0.833 . . . . 0.0 110.1 -179.978 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.83 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 24.9 mm -68.7 -33.22 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.025 -1.047 . . . . 0.0 109.879 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -71.97 -55.86 6.69 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.392 -0.818 . . . . 0.0 110.636 -179.63 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.434 ' OE1' ' HG3' ' A' ' 123' ' ' GLU . 54.5 mt-10 -61.06 -36.4 79.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.176 -0.953 . . . . 0.0 110.116 -179.768 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.55 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -70.23 -26.98 64.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.814 179.799 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -63.3 94.69 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.867 . . . . 0.0 109.991 179.76 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 128' ' ' ALA . 97.8 mt -79.8 -43.94 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.218 -0.926 . . . . 0.0 110.854 -179.646 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 23.4 p30 -79.27 -19.51 50.4 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.016 -1.053 . . . . 0.0 110.791 -179.655 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 79.0 70.79 1.29 Allowed Glycine 0 N--CA 1.495 2.632 0 C-N-CA 120.031 -1.081 . . . . 0.0 110.53 179.344 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -125.5 -26.67 3.53 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.186 -1.185 . . . . 0.0 110.578 179.545 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 118.35 -37.43 3.24 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.689 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.417 ' OE1' ' CD1' ' A' ' 99' ' ' TYR . 3.2 pt20 -113.14 156.72 22.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.278 -1.13 . . . . 0.0 109.922 179.81 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.42 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 62.4 t -99.5 118.41 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.203 -0.935 . . . . 0.0 110.423 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 37.8 p30 -93.25 -163.93 1.11 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.244 -0.91 . . . . 0.0 110.131 179.669 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.554 ' O ' HG23 ' A' ' 142' ' ' VAL . 23.2 t80 -69.63 -62.55 1.34 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.095 -1.003 . . . . 0.0 111.127 -179.289 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -44.06 -59.48 2.29 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.275 -0.891 . . . . 0.0 111.191 -179.121 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 144' ' ' MET . 51.7 mt-10 -51.44 -51.37 55.48 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 121.198 -0.939 . . . . 0.0 110.538 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 137' ' ' ASN . 0.8 OUTLIER -54.08 -31.3 51.37 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.291 -0.88 . . . . 0.0 110.551 -179.582 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 138' ' ' TYR . 94.9 t -72.1 -62.86 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.285 -0.884 . . . . 0.0 110.691 -179.51 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -64.9 -9.66 22.84 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.222 -0.924 . . . . 0.0 110.87 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.55 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 49.3 ttp -59.46 -60.54 3.69 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.13 -0.981 . . . . 0.0 110.786 -179.704 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.453 ' HG3' ' HE3' ' A' ' 144' ' ' MET . 38.3 mtt -89.88 -44.3 10.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.448 -0.783 . . . . 0.0 110.857 -179.368 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.571 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 66.6 p -70.64 138.07 50.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.05 -1.031 . . . . 0.0 110.122 -179.901 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 146' ' ' THR . . . 62.57 164.06 0.1 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.273 -0.892 . . . . 0.0 110.298 -179.912 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.423 ' C ' ' CD ' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.251 -179.957 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 153' ' ' WW7 . . . . . 0.542 ' H3 ' ' CE2' ' A' ' 19' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 154' ' ' WW7 . . . . . 0.83 'CL1 ' HD13 ' A' ' 125' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.286 0.565 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -154.6 143.51 20.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.228 -0.92 . . . . 0.0 110.161 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.402 ' O ' ' OH ' ' A' ' 99' ' ' TYR . 47.2 mt-30 -133.22 87.87 2.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.281 -0.887 . . . . 0.0 110.365 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.26 -177.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.134 -0.979 . . . . 0.0 110.168 179.835 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.4 t -99.74 -28.1 13.33 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.148 -0.97 . . . . 0.0 110.468 -179.786 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -89.97 -34.35 16.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.183 -0.948 . . . . 0.0 110.08 179.9 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -66.49 -44.59 82.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.375 -0.828 . . . . 0.0 110.331 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.435 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 42.1 tt0 -55.67 -47.25 77.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 110.177 -179.856 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.0 mt -60.07 -40.6 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.052 -1.03 . . . . 0.0 109.482 179.427 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.79 -26.91 68.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.349 -0.844 . . . . 0.0 109.329 179.15 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 38.2 tt0 -67.64 -46.49 72.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.347 -0.846 . . . . 0.0 109.365 179.411 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -63.53 -32.11 73.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.908 . . . . 0.0 109.465 179.157 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.17 -40.44 82.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.5 -0.75 . . . . 0.0 110.165 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -63.14 -45.26 92.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.2 -0.937 . . . . 0.0 110.187 -179.835 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.33 -37.39 87.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.141 -0.974 . . . . 0.0 110.074 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -63.92 -37.38 87.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.189 -0.945 . . . . 0.0 109.945 179.862 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.9 m -65.9 -39.93 91.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.388 -0.82 . . . . 0.0 110.286 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.658 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.5 tm? -66.56 -35.96 81.49 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.183 -0.948 . . . . 0.0 110.13 -179.936 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.48 ' CE2' ' H3 ' ' A' ' 153' ' ' WW7 . 12.0 m-30 -69.65 -64.78 0.81 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.224 -0.923 . . . . 0.0 109.931 179.718 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -83.0 96.07 8.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.35 -0.844 . . . . 0.0 109.856 179.674 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.422 ' HD3' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -109.66 48.57 0.88 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.256 -0.902 . . . . 0.0 110.524 -179.758 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -131.22 -35.24 1.37 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.105 -0.997 . . . . 0.0 110.368 179.768 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.32 86.21 1.49 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 21.1 p-10 -178.13 -34.19 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.302 -1.117 . . . . 0.0 110.617 179.654 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.519 ' C ' HG23 ' A' ' 26' ' ' THR . . . 83.91 42.19 7.78 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.131 179.633 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.519 HG23 ' C ' ' A' ' 25' ' ' GLY . 59.3 p -151.28 107.47 3.44 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.095 -1.238 . . . . 0.0 110.389 179.875 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.4 mt -74.68 124.63 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.828 179.559 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.9 p -112.78 -157.21 0.61 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.332 -0.855 . . . . 0.0 110.08 -179.865 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.524 ' HA ' HD21 ' A' ' 48' ' ' LEU . 38.0 p -87.53 -27.06 22.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.212 -0.93 . . . . 0.0 110.253 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -70.72 -56.8 5.58 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.147 -0.97 . . . . 0.0 109.676 179.553 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.485 ' O ' HG23 ' A' ' 35' ' ' VAL . 50.8 mt-10 -57.27 -36.08 70.55 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.303 -0.873 . . . . 0.0 109.685 179.555 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.868 HD22 HD11 ' A' ' 52' ' ' ILE . 9.0 tp -68.87 -31.78 70.96 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.349 -0.845 . . . . 0.0 109.707 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.82 -41.6 98.77 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.413 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 66.1 m -72.42 -33.65 67.28 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.317 -1.108 . . . . 0.0 109.967 179.771 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 31' ' ' GLU . 53.7 t -71.15 -26.98 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.377 -0.827 . . . . 0.0 110.444 -179.958 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.1 mmt -86.91 -32.29 20.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 110.467 -179.619 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 -90.79 -11.07 40.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.228 -0.92 . . . . 0.0 110.775 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 97.3 p -97.41 -23.03 16.26 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.981 -1.074 . . . . 0.0 110.48 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.6 mt -107.79 -46.85 3.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.118 -0.989 . . . . 0.0 110.388 -179.871 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.65 84.01 0.1 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.987 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.3 tp60 -50.92 161.32 0.38 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.357 -1.084 . . . . 0.0 110.558 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.519 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.0 OUTLIER 177.03 -56.3 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.488 -0.758 . . . . 0.0 109.976 179.647 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 42' ' ' ASN . 54.6 Cg_endo -76.76 -163.2 0.19 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.483 1.254 . . . . 0.0 110.864 179.671 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.669 HG23 ' N ' ' A' ' 45' ' ' GLU . 11.1 t -137.18 -140.19 0.15 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.077 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.669 ' N ' HG23 ' A' ' 44' ' ' THR . 52.1 mt-10 -97.89 -45.22 6.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.818 -1.176 . . . . 0.0 110.031 179.593 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.51 -52.98 26.2 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.198 -0.939 . . . . 0.0 109.618 179.389 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -59.07 -20.91 57.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.364 -0.835 . . . . 0.0 109.723 179.639 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.753 ' HG ' HD23 ' A' ' 32' ' ' LEU . 7.9 tt -71.93 -53.43 13.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.895 . . . . 0.0 109.481 179.368 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -50.92 -42.76 59.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.219 179.253 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -63.92 -39.69 94.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.362 -0.837 . . . . 0.0 109.6 179.415 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.429 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 36.4 ttp -66.21 -19.42 65.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -0.878 . . . . 0.0 109.566 179.375 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.868 HD11 HD22 ' A' ' 32' ' ' LEU . 5.6 mm -84.26 -29.73 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.407 -0.808 . . . . 0.0 109.683 179.413 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -71.6 -46.42 59.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.398 -0.814 . . . . 0.0 110.888 -179.45 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.641 ' HG3' HG23 ' A' ' 55' ' ' VAL . 24.2 pt-20 -51.35 -33.96 31.83 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.101 -1.0 . . . . 0.0 110.379 -179.711 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.641 HG23 ' HG3' ' A' ' 54' ' ' GLU . 48.6 t -82.15 -39.77 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.247 -0.908 . . . . 0.0 110.147 179.943 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -78.31 111.72 14.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.395 -0.816 . . . . 0.0 110.562 -179.67 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.77 54.98 0.65 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.206 -0.934 . . . . 0.0 109.925 179.741 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -134.96 -53.91 0.81 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.401 -0.812 . . . . 0.0 109.891 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 128.45 60.54 0.12 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.662 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.491 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 6.8 p-10 -151.34 -52.78 0.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -1.115 . . . . 0.0 110.131 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.6 -5.89 9.87 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.785 179.032 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.5 p -120.96 141.69 50.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.79 -1.418 . . . . 0.0 110.573 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 77.1 mt -92.32 121.38 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -0.949 . . . . 0.0 110.11 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.421 ' OD2' ' HD2' ' A' ' 66' ' ' PRO . 9.7 t70 -84.2 -167.0 1.59 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.285 -0.885 . . . . 0.0 110.196 -179.778 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.59 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 40.5 t80 -78.32 -44.38 2.13 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.05 -1.031 . . . . 0.0 111.631 -179.674 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.0 Cg_endo -70.76 -21.56 28.68 Favored 'Trans proline' 0 N--CA 1.482 0.802 0 O-C-N 123.079 1.041 . . . . 0.0 110.505 -179.579 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 71' ' ' MET . 53.0 mt-10 -81.12 -27.78 35.4 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.191 -0.943 . . . . 0.0 109.174 179.227 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.554 ' CE2' ' HE1' ' A' ' 72' ' ' MET . 36.0 t80 -77.26 -36.38 54.48 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.492 -0.755 . . . . 0.0 109.813 179.612 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.549 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 13.7 tp -76.81 -32.49 57.66 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.404 -0.81 . . . . 0.0 110.235 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 97.1 m -80.88 -23.78 38.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.337 -0.852 . . . . 0.0 110.41 -179.853 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.616 ' HG3' HG13 ' A' ' 55' ' ' VAL . 13.8 tmm? -84.33 -45.3 12.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.256 -0.903 . . . . 0.0 110.372 -179.723 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.554 ' HE1' ' CE2' ' A' ' 68' ' ' PHE . 9.5 mtt -79.17 -16.42 56.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 110.671 -179.272 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . -54.2 -57.24 11.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.095 -1.003 . . . . 0.0 108.902 179.098 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -110.71 61.15 0.61 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.561 -0.712 . . . . 0.0 109.158 178.871 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.01 111.04 0.25 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.46 -0.775 . . . . 0.0 110.891 -179.13 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 13.9 mmt -88.56 96.15 10.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -0.889 . . . . 0.0 109.801 179.626 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -127.37 77.56 1.75 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.301 -0.875 . . . . 0.0 110.237 -179.589 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -149.49 176.21 10.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.353 -0.842 . . . . 0.0 110.132 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 70.9 p -111.41 -162.01 0.78 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -0.897 . . . . 0.0 110.039 179.82 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -100.06 97.48 8.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.333 -0.854 . . . . 0.0 110.124 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 75.4 m -152.52 -59.9 0.15 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.431 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -124.57 109.05 12.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.132 -0.98 . . . . 0.0 110.548 -179.824 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -103.35 -1.74 28.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.36 -0.838 . . . . 0.0 110.52 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -80.67 -36.71 32.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.119 -0.988 . . . . 0.0 110.64 -179.71 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.566 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 60.3 mt -55.76 -35.89 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.138 -0.976 . . . . 0.0 110.114 -179.781 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.0 tpt180 -64.4 -53.0 55.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.956 . . . . 0.0 109.358 179.346 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -57.29 -23.57 49.31 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.358 -0.839 . . . . 0.0 109.443 179.28 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 85' ' ' ILE . . . -67.92 -60.47 2.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.416 -0.802 . . . . 0.0 109.859 179.768 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -55.76 -24.17 33.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.175 -0.953 . . . . 0.0 110.16 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.496 ' NE ' ' HA ' ' A' ' 90' ' ' ARG . 8.6 tpm_? -73.0 -58.29 3.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.317 -0.864 . . . . 0.0 110.707 -179.723 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.2 m -70.36 -12.14 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.121 -0.987 . . . . 0.0 110.684 -179.592 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.543 ' CD2' ' H3 ' ' A' ' 154' ' ' WW7 . 10.6 m-85 -101.05 -13.31 18.27 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.091 -1.006 . . . . 0.0 110.606 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -132.71 44.44 2.86 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.094 -1.004 . . . . 0.0 110.329 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.71 3.57 22.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.118 -0.989 . . . . 0.0 110.769 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 3.0 p30 -70.58 -30.74 67.52 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.134 -0.979 . . . . 0.0 110.573 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.8 34.94 1.94 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -179.361 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.404 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 23.1 t-20 -110.16 -47.36 3.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.355 -1.085 . . . . 0.0 110.319 -179.679 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 125.24 -35.32 3.12 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.833 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 0.8 OUTLIER -132.8 169.56 16.55 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.075 -1.25 . . . . 0.0 109.663 -179.753 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 38.3 mt -80.63 129.19 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.112 -0.992 . . . . 0.0 109.62 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.9 t -118.56 174.02 6.5 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.333 -0.855 . . . . 0.0 109.814 179.714 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.19 -38.76 78.82 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.155 -0.966 . . . . 0.0 110.048 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.66 87.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.237 -0.915 . . . . 0.0 110.033 179.746 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.636 ' O ' HG23 ' A' ' 108' ' ' VAL . 33.1 mt-10 -62.03 -54.13 45.88 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.246 -0.909 . . . . 0.0 110.094 179.825 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.459 ' O ' HD23 ' A' ' 105' ' ' LEU . 4.3 tt -47.76 -34.36 8.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 110.1 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.8 ttt-85 -70.97 -44.05 66.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.293 -0.879 . . . . 0.0 110.329 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 48.1 m170 -69.94 -10.4 58.42 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.129 -0.982 . . . . 0.0 110.622 -179.824 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 104' ' ' GLU . 61.5 t -92.29 -57.06 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.124 -0.985 . . . . 0.0 110.538 -179.749 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.459 ' HE3' HD21 ' A' ' 105' ' ' LEU . 64.8 mtt -71.41 -26.81 62.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.194 -0.941 . . . . 0.0 110.584 -179.693 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.2 m -69.35 -42.32 75.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.201 -0.937 . . . . 0.0 110.29 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -75.02 -34.33 61.9 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.188 -0.945 . . . . 0.0 110.265 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.2 mt -60.62 -32.2 71.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.168 -0.958 . . . . 0.0 110.229 179.923 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.42 -13.7 4.28 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.64 134.55 34.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -1.175 . . . . 0.0 110.27 -179.961 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -101.61 120.23 40.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.945 . . . . 0.0 110.208 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.83 179.25 4.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.21 -0.931 . . . . 0.0 110.546 -179.766 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.527 HG22 ' H ' ' A' ' 118' ' ' ASP . 17.7 m -122.56 175.88 6.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.406 -0.809 . . . . 0.0 109.944 179.741 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.527 ' H ' HG22 ' A' ' 117' ' ' THR . 1.4 m-20 -65.54 -51.95 56.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.161 -0.962 . . . . 0.0 110.544 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -64.97 -34.82 79.35 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.084 -1.01 . . . . 0.0 110.446 -179.807 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.416 ' HA ' ' OE1' ' A' ' 120' ' ' GLU . 7.9 mm-40 -61.37 -46.04 91.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.108 -0.995 . . . . 0.0 110.079 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.4 t -64.06 -56.47 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 109.808 179.656 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -51.4 -26.3 7.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.975 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 30.5 tt0 -70.09 -52.97 19.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.18 179.982 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 42.4 mtp -58.21 -48.22 81.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.174 -0.954 . . . . 0.0 110.141 179.875 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.705 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 25.7 mm -60.89 -29.24 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.072 -1.018 . . . . 0.0 109.599 179.585 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.402 ' HB3' ' O ' ' A' ' 123' ' ' GLU . 22.6 ttm180 -66.74 -40.83 88.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.374 -0.829 . . . . 0.0 109.991 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -70.48 -28.37 64.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.285 -0.884 . . . . 0.0 110.237 179.919 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.411 ' O ' HG13 ' A' ' 130' ' ' ILE . . . -80.32 -25.05 39.52 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.311 -0.868 . . . . 0.0 110.469 -179.819 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -70.11 92.16 0.73 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.227 -0.921 . . . . 0.0 109.995 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 128' ' ' ALA . 74.4 mt -85.31 -34.54 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.3 -0.875 . . . . 0.0 110.594 -179.639 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 6.3 p30 -84.98 -25.79 27.54 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.073 -1.017 . . . . 0.0 110.299 179.845 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.455 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 89.94 71.56 1.25 Allowed Glycine 0 N--CA 1.494 2.562 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.316 179.337 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.411 ' OD2' ' OD1' ' A' ' 131' ' ' ASP . 73.1 m-20 -136.5 -38.69 0.66 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.205 -1.173 . . . . 0.0 110.021 179.294 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 121.96 -7.28 10.12 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.507 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -126.61 150.92 48.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.157 -1.202 . . . . 0.0 110.153 179.953 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.2 t -115.2 109.41 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.19 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -82.34 -167.73 1.7 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.18 -0.95 . . . . 0.0 110.195 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -62.18 -45.22 94.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.255 -0.903 . . . . 0.0 111.284 -179.134 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -62.69 -56.73 14.99 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.942 -1.099 . . . . 0.0 110.921 -179.248 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 144' ' ' MET . 50.5 mt-10 -57.1 -24.27 52.89 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.13 -0.981 . . . . 0.0 110.725 -179.591 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.474 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 89.2 t80 -78.66 -35.09 45.78 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.232 -0.917 . . . . 0.0 110.944 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 84.6 t -83.09 -22.96 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.108 -0.995 . . . . 0.0 110.869 -179.509 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -92.53 -23.42 19.09 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.18 -0.95 . . . . 0.0 110.882 -179.617 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.493 ' HE2' ' HE3' ' A' ' 145' ' ' MET . 1.0 OUTLIER -71.29 -20.26 62.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.003 -1.061 . . . . 0.0 110.496 -179.707 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.493 ' HE3' ' HE2' ' A' ' 144' ' ' MET . 63.5 mtt -84.85 -70.37 0.58 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.223 -0.923 . . . . 0.0 110.537 -179.694 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 59.0 p -51.65 -28.43 14.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.2 -0.938 . . . . 0.0 110.183 -179.672 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 49.76 39.64 18.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.319 -0.863 . . . . 0.0 110.575 179.833 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.182 179.87 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 153' ' ' WW7 . . . . . 0.533 'CL1 ' HD13 ' A' ' 32' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 154' ' ' WW7 . . . . . 0.705 'CL1 ' HD13 ' A' ' 125' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 121.228 0.537 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -151.84 110.95 3.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.226 -0.921 . . . . 0.0 109.86 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -112.1 -58.3 2.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.179 -0.951 . . . . 0.0 110.47 -179.805 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.66 HD12 HG22 ' A' ' 5' ' ' THR . 0.6 OUTLIER -114.3 -155.45 0.57 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.899 . . . . 0.0 110.419 -179.574 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.66 HG22 HD12 ' A' ' 4' ' ' LEU . 8.2 t -64.73 168.83 5.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.859 . . . . 0.0 110.177 179.86 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.464 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.6 pt-20 -88.54 -9.72 51.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.203 -0.936 . . . . 0.0 110.119 179.673 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -65.34 -64.9 0.75 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.104 -0.998 . . . . 0.0 109.985 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.635 ' HB2' HD11 ' A' ' 4' ' ' LEU . 72.3 mt-30 -55.13 -39.97 70.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.144 -0.973 . . . . 0.0 109.476 179.685 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 6' ' ' GLU . 55.3 mt -56.8 -37.73 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.389 -0.819 . . . . 0.0 109.478 179.315 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.97 -43.06 99.63 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.278 -0.889 . . . . 0.0 109.341 179.386 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.03 -36.73 82.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.486 -0.759 . . . . 0.0 109.837 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -76.03 -20.08 58.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.406 -0.808 . . . . 0.0 109.665 179.525 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -79.53 -33.53 41.88 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.289 -0.882 . . . . 0.0 109.416 179.183 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -74.27 -39.95 62.65 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.391 -0.818 . . . . 0.0 109.857 179.735 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.75 -48.31 39.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.2 -0.938 . . . . 0.0 109.599 179.54 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.555 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 1.2 t80 -58.68 -34.07 70.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.415 -0.803 . . . . 0.0 109.47 179.334 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.2 t -72.11 -38.49 69.31 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.465 -0.772 . . . . 0.0 109.817 179.806 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.854 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.2 tm? -65.92 -24.06 66.75 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.526 -0.734 . . . . 0.0 109.663 179.768 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.462 ' HA ' ' CG2' ' A' ' 35' ' ' VAL . 17.0 m-85 -82.15 -59.29 2.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.323 -0.861 . . . . 0.0 110.339 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.417 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 7.9 t0 -76.52 97.49 4.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 109.772 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.442 ' HD2' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -110.53 46.37 1.05 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.068 -1.02 . . . . 0.0 110.843 -179.644 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.404 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 12.0 p-10 -132.33 -33.31 1.29 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.236 -0.915 . . . . 0.0 110.513 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.38 76.32 1.05 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.89 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 15.3 p-10 -159.49 -45.26 0.05 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.02 -1.283 . . . . 0.0 110.579 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.9 -2.97 25.79 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.728 -1.225 . . . . 0.0 110.324 179.674 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 34.5 p -121.1 165.16 15.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.943 -1.328 . . . . 0.0 110.197 179.878 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.3 mt -112.64 130.24 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.187 -0.946 . . . . 0.0 110.094 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.6 p -114.5 177.05 4.78 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.429 -0.794 . . . . 0.0 109.895 -179.975 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.608 ' HA ' HD21 ' A' ' 48' ' ' LEU . 12.7 p -66.67 -28.67 68.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 0.0 110.112 179.877 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -57.66 6.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -0.933 . . . . 0.0 109.905 179.521 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.417 ' OE1' ' HA ' ' A' ' 20' ' ' ASP . 28.4 mt-10 -57.23 -56.01 27.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 0.0 110.123 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.061 HD22 HD11 ' A' ' 52' ' ' ILE . 1.4 tp -57.51 -24.71 57.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.855 179.665 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.408 ' HA2' ' CD1' ' A' ' 48' ' ' LEU . . . -65.74 -42.9 95.0 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.846 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.1 m -76.16 -23.14 54.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.3 -1.117 . . . . 0.0 110.04 179.835 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.462 ' CG2' ' HA ' ' A' ' 19' ' ' PHE . 54.9 t -72.57 -42.54 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.402 -0.811 . . . . 0.0 110.526 -179.727 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.408 ' SD ' H132 ' A' ' 153' ' ' WW7 . 22.5 mmt -90.13 -14.93 32.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.167 -0.958 . . . . 0.0 110.735 -179.692 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -90.65 -59.91 2.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.209 -0.932 . . . . 0.0 111.076 -179.348 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.0 m -59.76 -51.44 69.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.254 -0.904 . . . . 0.0 111.361 -178.958 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.9 mp -69.53 -30.45 68.29 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.1 -1.0 . . . . 0.0 111.207 -178.982 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 36' ' ' MET . . . -161.42 80.57 0.14 Allowed Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.229 -1.462 . . . . 0.0 110.422 -179.775 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -55.94 126.97 28.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.163 -1.198 . . . . 0.0 109.725 179.365 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.516 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.9 t-20 -171.53 -60.91 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.224 -0.923 . . . . 0.0 110.609 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.516 ' HD3' ' HB3' ' A' ' 42' ' ' ASN . 44.1 Cg_endo -70.01 -161.84 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.249 1.131 . . . . 0.0 110.117 179.801 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 7.9 t -150.96 -178.67 6.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.931 . . . . 0.0 110.282 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -59.89 -33.6 72.06 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.246 -0.909 . . . . 0.0 110.464 -179.798 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.1 -70.66 0.25 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.211 -0.93 . . . . 0.0 110.257 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -49.76 -25.05 2.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.104 -0.997 . . . . 0.0 109.713 179.762 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.716 ' HG ' HD23 ' A' ' 32' ' ' LEU . 3.6 tt -65.21 -60.01 3.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.465 -0.772 . . . . 0.0 109.719 179.466 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.402 ' O ' ' OD1' ' A' ' 53' ' ' ASN . 64.5 tt0 -50.5 -33.91 23.17 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.296 -0.878 . . . . 0.0 109.756 179.616 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -61.57 -46.43 89.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.191 -0.943 . . . . 0.0 109.967 179.809 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.428 ' HA ' ' HG2' ' A' ' 54' ' ' GLU . 21.8 mtm -65.58 -22.59 66.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.929 . . . . 0.0 109.82 179.667 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.061 HD11 HD22 ' A' ' 32' ' ' LEU . 39.7 mm -80.88 -23.26 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.251 -0.906 . . . . 0.0 109.969 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 49' ' ' GLN . 5.1 m120 -88.34 -26.62 22.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.303 -0.873 . . . . 0.0 110.2 179.885 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.531 ' HG3' HG23 ' A' ' 55' ' ' VAL . 10.7 pt-20 -77.69 -24.3 49.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.201 -0.937 . . . . 0.0 110.075 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.531 HG23 ' HG3' ' A' ' 54' ' ' GLU . 78.8 t -88.86 -54.53 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.673 179.454 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.413 ' OD2' ' OD1' ' A' ' 60' ' ' ASN . 12.8 t70 -67.09 120.32 13.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.405 -0.809 . . . . 0.0 110.051 179.82 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.6 30.94 5.83 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.16 -0.962 . . . . 0.0 110.663 -179.66 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -113.33 -60.87 1.82 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.116 -0.99 . . . . 0.0 110.088 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.52 -18.25 1.3 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.729 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.413 ' OD1' ' OD2' ' A' ' 56' ' ' ASP . 17.0 p30 -69.52 -29.48 67.1 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.175 -1.191 . . . . 0.0 110.295 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.623 ' O ' HG22 ' A' ' 52' ' ' ILE . . . 99.18 -52.61 1.08 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.754 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.406 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 66.0 p -72.11 146.49 47.46 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.183 -1.186 . . . . 0.0 110.38 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.577 HD11 'CL1 ' ' A' ' 153' ' ' WW7 . 64.3 mt -86.43 161.09 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 110.254 179.908 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -111.81 -173.35 2.23 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.371 -0.831 . . . . 0.0 109.898 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.562 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 5.0 t80 -75.6 -44.82 4.25 Favored Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.235 -0.915 . . . . 0.0 111.423 -179.882 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.0 Cg_endo -73.33 -23.89 17.18 Favored 'Trans proline' 0 C--N 1.322 -0.845 0 O-C-N 123.288 1.151 . . . . 0.0 110.255 -179.259 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -77.23 -29.09 53.96 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.252 -0.905 . . . . 0.0 109.1 179.094 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.644 ' CE2' ' HE2' ' A' ' 72' ' ' MET . 47.8 t80 -73.54 -50.74 19.81 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.545 -0.722 . . . . 0.0 110.309 179.826 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.96 -30.98 71.26 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.304 -0.873 . . . . 0.0 110.965 -179.527 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 78.9 m -71.1 -40.91 71.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.172 -0.955 . . . . 0.0 110.983 -179.388 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.454 ' HE1' ' HE1' ' A' ' 72' ' ' MET . 0.0 OUTLIER -89.94 -9.37 49.07 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.903 -1.123 . . . . 0.0 110.95 -179.51 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.644 ' HE2' ' CE2' ' A' ' 68' ' ' PHE . 15.6 mmt -90.26 -19.89 23.6 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.989 -1.07 . . . . 0.0 110.556 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.62 -15.38 59.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.155 -0.966 . . . . 0.0 110.354 -179.874 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -97.02 46.81 1.04 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.094 -1.004 . . . . 0.0 110.303 -179.956 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.1 tttm -123.2 154.69 38.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.951 . . . . 0.0 109.93 179.885 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 39.1 ttp -107.46 107.88 18.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.04 -1.037 . . . . 0.0 110.397 -179.835 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -100.61 27.76 5.6 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.311 -0.868 . . . . 0.0 110.151 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -115.72 25.0 11.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -0.887 . . . . 0.0 110.214 -179.764 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 93.6 m -48.9 105.12 0.07 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.219 -0.926 . . . . 0.0 110.042 179.906 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -108.0 88.17 2.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.902 . . . . 0.0 110.169 -179.869 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.4 t -60.43 -176.94 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.216 -0.927 . . . . 0.0 110.247 -179.951 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -159.29 124.26 4.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.244 -0.91 . . . . 0.0 110.271 179.833 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -131.49 78.93 1.85 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.295 -0.878 . . . . 0.0 109.732 179.519 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -53.59 -30.97 44.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.46 -0.775 . . . . 0.0 110.883 -179.491 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.48 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 38.9 mt -64.93 -60.23 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.141 -0.974 . . . . 0.0 110.263 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -51.57 -50.49 60.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.174 -0.954 . . . . 0.0 109.711 179.922 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 49.7 mt-10 -50.05 -41.6 48.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 0.0 109.79 179.52 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 85' ' ' ILE . . . -56.2 -50.27 71.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.34 -0.85 . . . . 0.0 110.032 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.475 ' CZ ' ' O ' ' A' ' 98' ' ' GLY . 2.3 t80 -57.34 -28.76 63.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.262 -0.899 . . . . 0.0 110.213 179.983 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.413 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 3.7 tpt180 -71.1 -45.88 62.83 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.342 -0.849 . . . . 0.0 111.185 -179.442 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 88' ' ' ALA . 34.4 m -77.17 -20.35 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.088 -1.007 . . . . 0.0 110.775 -179.33 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.432 ' HA ' HG21 ' A' ' 108' ' ' VAL . 10.0 m-85 -89.58 -17.04 29.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.169 -0.957 . . . . 0.0 109.904 179.631 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.408 ' OD1' HG12 ' A' ' 100' ' ' ILE . 4.4 m-20 -126.89 81.32 2.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.295 -0.878 . . . . 0.0 110.144 179.863 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -104.35 49.96 0.8 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.398 -0.814 . . . . 0.0 110.483 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 3.1 p30 -141.56 -43.58 0.36 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.089 -1.007 . . . . 0.0 110.705 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.486 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 147.97 -57.18 0.49 Allowed Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.28 -1.438 . . . . 0.0 110.995 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.473 ' ND2' ' OD1' ' A' ' 95' ' ' ASP . 22.6 p30 -43.56 -31.23 0.7 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.141 -1.211 . . . . 0.0 111.161 -178.738 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.475 ' O ' ' CZ ' ' A' ' 89' ' ' PHE . . . 80.14 -8.19 53.01 Favored Glycine 0 N--CA 1.495 2.6 0 C-N-CA 119.803 -1.189 . . . . 0.0 110.477 179.561 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -89.41 131.81 35.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.962 -1.316 . . . . 0.0 109.989 179.917 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.409 HD11 ' CE1' ' A' ' 89' ' ' PHE . 16.6 mt -78.99 112.32 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.185 -0.947 . . . . 0.0 109.796 -179.949 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 44.6 t -96.56 155.91 16.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.264 -0.897 . . . . 0.0 110.154 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.64 -44.74 77.43 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.141 -0.974 . . . . 0.0 110.063 -179.956 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.96 -58.7 6.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.827 . . . . 0.0 110.016 179.844 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.718 ' O ' HG23 ' A' ' 108' ' ' VAL . 47.2 mt-10 -51.51 -38.99 56.74 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.317 -0.865 . . . . 0.0 110.224 179.847 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.79 HD12 HD11 ' A' ' 125' ' ' ILE . 0.4 OUTLIER -58.81 -41.82 87.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.349 -0.844 . . . . 0.0 109.829 179.937 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.419 ' O ' ' HB ' ' A' ' 110' ' ' THR . 48.1 ttp180 -68.2 -25.51 65.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.384 -0.822 . . . . 0.0 109.942 179.807 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -90.95 -12.66 35.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.329 -0.857 . . . . 0.0 110.373 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 104' ' ' GLU . 77.2 t -91.17 -64.61 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.255 -0.903 . . . . 0.0 110.316 -179.939 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.621 ' HA ' HD12 ' A' ' 112' ' ' LEU . 57.8 mtt -61.13 -51.18 70.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.251 -0.906 . . . . 0.0 110.367 -179.693 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 106' ' ' ARG . 36.8 m -50.99 -29.52 12.56 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.266 -0.896 . . . . 0.0 110.304 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -78.69 -46.09 19.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.184 -0.948 . . . . 0.0 110.406 -179.944 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.621 HD12 ' HA ' ' A' ' 109' ' ' MET . 12.8 mt -48.83 -73.98 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.143 -0.973 . . . . 0.0 110.109 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.85 66.59 0.02 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.872 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -136.9 -176.37 4.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.313 -1.11 . . . . 0.0 110.068 179.714 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -130.18 87.96 2.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.948 . . . . 0.0 110.374 -179.943 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.8 mt -125.93 -171.88 2.48 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.284 -0.885 . . . . 0.0 110.137 179.857 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.6 t -143.91 -159.95 1.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.138 -0.976 . . . . 0.0 110.201 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.63 -42.16 25.45 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.077 -1.014 . . . . 0.0 110.917 -179.525 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -59.61 -55.49 33.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.942 . . . . 0.0 111.125 -179.469 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -51.72 -38.48 55.39 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.196 -0.94 . . . . 0.0 111.058 -179.445 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 73.9 t -67.7 -47.47 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.158 -0.963 . . . . 0.0 110.457 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.79 -36.38 72.11 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.333 -0.855 . . . . 0.0 110.137 -179.92 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 36.6 tt0 -72.5 -35.15 68.07 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.324 -0.86 . . . . 0.0 109.633 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.411 ' HB3' ' HE3' ' A' ' 124' ' ' MET . 5.7 mmm -59.03 -60.34 4.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.271 -0.893 . . . . 0.0 109.936 179.466 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.79 HD11 HD12 ' A' ' 105' ' ' LEU . 27.9 mm -56.69 -41.89 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.372 -0.83 . . . . 0.0 110.376 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 16.5 ttp180 -57.09 -36.81 71.03 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -0.907 . . . . 0.0 110.191 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 49.7 mt-10 -67.09 -49.65 64.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.197 -0.94 . . . . 0.0 110.087 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.54 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -80.03 -2.33 43.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.349 -0.844 . . . . 0.0 110.665 -179.811 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 59.6 t0 -90.29 71.75 7.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.947 -1.096 . . . . 0.0 110.299 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.488 HG13 ' N ' ' A' ' 131' ' ' ASP . 23.4 pt -70.52 -41.94 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -0.929 . . . . 0.0 111.171 -179.561 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.488 ' N ' HG13 ' A' ' 130' ' ' ILE . 50.6 p-10 -67.28 -19.42 65.49 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.963 -1.086 . . . . 0.0 111.264 -179.173 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 75.45 75.93 0.8 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.909 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -146.35 15.0 1.29 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.379 -1.071 . . . . 0.0 110.56 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 60.27 34.89 86.54 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.684 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -171.01 167.16 7.32 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.13 -1.217 . . . . 0.0 110.061 179.563 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 84.6 t -131.0 120.29 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.155 -0.966 . . . . 0.0 110.18 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -94.54 -165.07 1.25 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.209 -0.932 . . . . 0.0 110.9 -179.637 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -66.91 -58.58 4.72 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.356 -0.84 . . . . 0.0 111.307 -178.965 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -47.61 -51.74 20.25 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.845 -1.159 . . . . 0.0 110.381 -179.548 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -58.71 -34.91 71.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.103 -0.998 . . . . 0.0 109.97 179.62 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.421 ' HA ' ' SD ' ' A' ' 144' ' ' MET . 6.5 t80 -64.94 -32.72 74.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.514 -0.741 . . . . 0.0 110.623 -179.762 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.4 t -82.96 -23.92 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.261 -0.899 . . . . 0.0 110.586 -179.471 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -90.26 -17.47 27.4 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.133 -0.979 . . . . 0.0 110.422 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.54 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 17.0 ptt? -90.09 -27.82 19.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.145 -0.972 . . . . 0.0 110.376 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 27.7 tpp -88.9 -65.45 1.02 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.287 -0.883 . . . . 0.0 110.439 -179.607 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 146' ' ' THR . 5.1 t -124.97 116.77 22.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.151 -0.968 . . . . 0.0 110.438 -179.771 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' A' ' 148' ' ' LYS . . . -135.56 -160.36 1.05 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.276 -0.89 . . . . 0.0 110.116 179.726 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 147' ' ' ALA . 42.7 tttp . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.346 179.898 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 153' ' ' WW7 . . . . . 0.577 'CL1 ' HD11 ' A' ' 63' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 154' ' ' WW7 . . . . . 0.43 ' H3 ' ' CD2' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.242 0.544 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -56.37 -42.6 78.11 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.932 . . . . 0.0 110.502 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -56.24 -52.52 64.15 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.211 -0.93 . . . . 0.0 110.196 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.3 mt -55.26 -40.95 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 109.941 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.29 -37.56 80.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.893 . . . . 0.0 109.613 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -61.17 -48.99 79.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.423 -0.798 . . . . 0.0 109.9 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -65.8 -25.21 67.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.411 -0.806 . . . . 0.0 109.992 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.6 mtpt -75.84 -30.68 59.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.33 -0.856 . . . . 0.0 109.705 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -71.08 -41.5 70.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 0.0 109.556 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.605 ' HB1' ' CZ ' ' A' ' 19' ' ' PHE . . . -68.27 -39.63 82.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.383 -0.823 . . . . 0.0 109.761 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -56.17 -55.07 37.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.377 -0.827 . . . . 0.0 110.088 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.2 m -60.65 -35.13 75.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.35 -0.844 . . . . 0.0 110.348 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.947 ' O ' HD23 ' A' ' 18' ' ' LEU . 4.9 tt -63.68 -29.42 70.66 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.191 -0.943 . . . . 0.0 110.202 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.605 ' CZ ' ' HB1' ' A' ' 15' ' ' ALA . 12.3 m-85 -79.37 -57.76 3.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 0.0 110.485 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -61.2 106.27 0.59 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.127 -0.983 . . . . 0.0 109.97 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -109.6 47.61 0.93 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.228 -0.92 . . . . 0.0 110.726 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -162.44 22.22 0.1 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.245 -0.91 . . . . 0.0 110.504 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 47.58 78.32 0.09 OUTLIER Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -134.91 -36.83 0.82 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.223 -1.163 . . . . 0.0 110.57 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.91 -23.43 35.64 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.5 p -118.05 143.44 46.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.407 -1.055 . . . . 0.0 109.971 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 44.3 mt -92.03 113.01 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.259 -0.9 . . . . 0.0 110.427 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.524 ' HA ' HG22 ' A' ' 62' ' ' THR . 80.9 p -97.11 -176.52 3.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 109.906 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.5 p -74.84 -28.49 60.7 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.253 -0.904 . . . . 0.0 110.07 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -70.81 -54.1 12.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 109.71 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.427 ' O ' HG23 ' A' ' 35' ' ' VAL . 91.5 mt-10 -56.1 -52.42 64.38 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.281 -0.887 . . . . 0.0 109.057 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.935 HD22 HD11 ' A' ' 52' ' ' ILE . 3.7 tp -55.05 -33.54 62.79 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.456 -0.778 . . . . 0.0 109.367 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.59 -49.78 67.5 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.2 m -69.17 -21.19 64.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.326 -1.102 . . . . 0.0 109.785 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 19' ' ' PHE . 54.8 t -73.47 -31.03 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.446 -0.784 . . . . 0.0 109.787 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.2 mmt -90.91 -24.27 20.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.894 . . . . 0.0 110.189 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -84.36 -20.86 31.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.253 -0.905 . . . . 0.0 110.448 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.6 m -88.07 -19.34 27.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.197 -0.939 . . . . 0.0 110.151 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.5 mt -89.16 -78.35 0.35 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.269 -0.894 . . . . 0.0 110.295 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.73 55.74 0.2 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -152.67 157.96 41.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.227 -1.16 . . . . 0.0 110.299 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.512 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 80.5 m-20 -143.04 48.6 1.01 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.157 -0.964 . . . . 0.0 110.58 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.512 ' CD ' ' N ' ' A' ' 42' ' ' ASN . 42.5 Cg_endo -68.8 -159.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.653 1.344 . . . . 0.0 110.082 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.512 HG22 ' H ' ' A' ' 45' ' ' GLU . 18.0 m -130.88 175.38 9.11 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.929 -1.107 . . . . 0.0 110.442 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.512 ' H ' HG22 ' A' ' 44' ' ' THR . 13.6 tp10 -67.38 -32.71 73.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.272 -0.893 . . . . 0.0 110.054 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.02 -64.8 0.84 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 110.184 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 2.3 mt-10 -50.03 -38.93 40.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -1.0 . . . . 0.0 109.668 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.523 HD11 HD23 ' A' ' 32' ' ' LEU . 10.1 tt -57.65 -50.28 73.67 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.373 -0.829 . . . . 0.0 109.459 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -50.18 -38.25 38.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -0.939 . . . . 0.0 109.408 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 47' ' ' GLU . 36.3 m-20 -62.63 -42.83 99.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.377 -0.827 . . . . 0.0 109.77 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.9 ttp -67.05 -15.87 63.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.266 -0.896 . . . . 0.0 109.645 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.935 HD11 HD22 ' A' ' 32' ' ' LEU . 45.9 mm -88.66 -25.67 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.178 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -58.36 -36.6 73.71 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.111 -0.993 . . . . 0.0 110.124 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.848 ' HG3' HG23 ' A' ' 55' ' ' VAL . 8.2 pt-20 -74.21 -23.78 59.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.92 . . . . 0.0 109.993 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.848 HG23 ' HG3' ' A' ' 54' ' ' GLU . 42.8 t -98.8 23.53 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.905 . . . . 0.0 110.051 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -135.4 112.92 10.71 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.342 -0.849 . . . . 0.0 109.92 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.94 34.42 3.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.176 -0.952 . . . . 0.0 110.211 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 2.6 p30 -141.54 -34.12 0.49 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.373 -0.829 . . . . 0.0 110.843 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 95.44 52.84 1.65 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.449 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 24.6 p-10 -122.34 -12.32 8.24 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.442 -1.034 . . . . 0.0 110.682 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.786 ' O ' HG23 ' A' ' 62' ' ' THR . . . 78.42 27.56 57.25 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.206 -1.157 . . . . 0.0 110.206 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 61' ' ' GLY . 0.9 OUTLIER -163.02 167.18 22.78 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.149 -1.206 . . . . 0.0 110.204 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.744 HD13 HG11 ' A' ' 55' ' ' VAL . 63.5 mt -117.39 150.6 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.12 -0.987 . . . . 0.0 110.127 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.445 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 1.5 m-20 -112.58 -162.97 0.82 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.316 -0.865 . . . . 0.0 110.425 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.609 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 7.0 t80 -81.55 -40.67 1.03 Allowed Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.411 -0.806 . . . . 0.0 111.914 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.4 Cg_endo -70.81 -21.4 28.65 Favored 'Trans proline' 0 N--CA 1.482 0.795 0 O-C-N 122.993 0.996 . . . . 0.0 110.974 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.425 ' OE1' ' OD1' ' A' ' 64' ' ' ASP . 57.2 mt-10 -86.12 -35.22 20.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.91 -1.119 . . . . 0.0 109.411 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.487 ' CZ ' ' SD ' ' A' ' 72' ' ' MET . 11.6 t80 -70.78 -38.49 73.41 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.419 -0.801 . . . . 0.0 110.417 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.484 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 1.1 tp -80.55 -37.14 31.98 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.203 -0.936 . . . . 0.0 110.709 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 88.9 m -71.35 -20.34 62.17 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.824 -1.173 . . . . 0.0 110.487 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 61.4 ttp -88.77 -42.33 11.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.139 -0.976 . . . . 0.0 110.86 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.487 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 59.0 mtt -90.51 -9.7 46.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.053 -1.03 . . . . 0.0 111.541 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.499 2.019 0 O-C-N 120.845 -1.16 . . . . 0.0 110.519 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.253 0.549 . . . . 0.0 110.389 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.741 HD12 ' HD1' ' A' ' 141' ' ' PHE . 38.8 mm -66.23 -10.23 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.224 -0.923 . . . . 0.0 110.339 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -73.48 -54.71 7.6 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.254 -0.904 . . . . 0.0 109.845 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -66.35 -35.52 80.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.362 -0.836 . . . . 0.0 109.615 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.714 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -57.32 -54.16 49.94 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.499 -0.751 . . . . 0.0 110.356 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.35 -27.41 69.0 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.882 -1.136 . . . . 0.0 110.247 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.35 -25.82 62.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.147 -0.971 . . . . 0.0 110.503 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.714 HG22 ' O ' ' A' ' 88' ' ' ALA . 34.3 m -95.1 -21.34 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.074 -1.016 . . . . 0.0 110.669 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.513 ' CD2' ' O ' ' A' ' 88' ' ' ALA . 21.7 m-85 -93.58 -11.91 30.71 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.16 -0.963 . . . . 0.0 110.574 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.425 ' OD2' ' HA2' ' A' ' 98' ' ' GLY . 40.5 t0 -114.23 92.1 3.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.209 -0.932 . . . . 0.0 110.269 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.49 -6.52 14.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.124 -0.985 . . . . 0.0 110.709 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.43 ' OD2' ' ND2' ' A' ' 97' ' ' ASN . 2.7 p-10 -91.93 -39.77 11.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.954 -1.091 . . . . 0.0 110.213 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 128.52 -35.36 2.69 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.546 -1.311 . . . . 0.0 111.091 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.52 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 42.4 p30 -47.88 -22.82 0.62 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.81 -1.406 . . . . 0.0 111.18 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.45 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 75.56 42.76 26.09 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 97' ' ' ASN . 77.2 m-85 -152.5 146.32 25.16 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.223 -1.163 . . . . 0.0 109.909 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.435 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 26.5 mt -94.41 121.28 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.171 -0.956 . . . . 0.0 109.994 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 74.5 m -109.01 151.36 26.44 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.477 -0.764 . . . . 0.0 109.956 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.41 ' HA ' HG13 ' A' ' 125' ' ' ILE . . . -51.23 -36.26 40.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.13 -0.981 . . . . 0.0 110.3 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.19 -59.87 4.41 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.287 -0.883 . . . . 0.0 110.307 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -48.39 -51.23 27.49 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.189 -0.945 . . . . 0.0 110.161 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.872 HD23 HG13 ' A' ' 121' ' ' VAL . 13.0 tp -49.24 -40.58 34.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.917 . . . . 0.0 110.15 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -62.46 -41.41 98.74 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.224 -0.923 . . . . 0.0 110.492 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -77.21 -12.92 60.01 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.191 -0.943 . . . . 0.0 110.823 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 53.2 t -88.57 -37.06 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.97 -1.081 . . . . 0.0 110.366 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 26.5 mmt -69.52 -32.27 71.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.147 -0.971 . . . . 0.0 110.471 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.0 p -76.36 -28.66 56.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.088 -1.008 . . . . 0.0 110.156 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -75.05 -44.16 49.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.222 -0.924 . . . . 0.0 110.176 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.7 mt -54.26 -36.28 63.43 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.187 -0.946 . . . . 0.0 110.369 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.87 31.37 1.03 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -116.19 -156.2 0.61 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.195 -1.179 . . . . 0.0 109.929 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -161.03 84.05 0.66 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.218 -0.926 . . . . 0.0 110.332 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.409 ' HG ' ' OE1' ' A' ' 120' ' ' GLU . 4.9 mp -108.68 131.82 54.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.336 -0.852 . . . . 0.0 110.08 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 19.8 m -77.94 159.99 28.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.221 -0.925 . . . . 0.0 110.224 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.0 -33.12 16.97 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.202 -0.936 . . . . 0.0 110.522 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -61.26 -42.47 98.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.153 -0.967 . . . . 0.0 110.54 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.409 ' OE1' ' HG ' ' A' ' 116' ' ' LEU . 85.4 mt-10 -67.71 -45.23 75.66 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.309 -0.87 . . . . 0.0 111.1 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.872 HG13 HD23 ' A' ' 105' ' ' LEU . 41.2 t -61.71 -56.21 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.049 -1.032 . . . . 0.0 110.605 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -52.07 -46.18 65.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.285 -0.884 . . . . 0.0 110.441 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -63.02 -33.1 74.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.295 -0.878 . . . . 0.0 110.242 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.423 ' HB3' ' HE2' ' A' ' 124' ' ' MET . 80.6 mtp -65.24 -62.52 1.49 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.882 . . . . 0.0 109.873 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 21.9 mm -49.81 -30.38 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 110.148 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.0 ttt180 -70.24 -41.08 74.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.292 -0.88 . . . . 0.0 110.447 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.75 -28.7 68.62 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.215 -0.928 . . . . 0.0 110.485 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.656 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -93.58 -17.01 23.8 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.119 -0.988 . . . . 0.0 110.753 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.93 ' OD1' HG22 ' A' ' 136' ' ' VAL . 1.6 m-20 -81.25 82.63 7.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.026 -1.047 . . . . 0.0 110.942 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.486 HG13 ' N ' ' A' ' 131' ' ' ASP . 21.9 pt -89.47 -32.49 5.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-O 121.429 0.633 . . . . 0.0 110.169 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 51.6 p-10 -121.83 -13.13 8.32 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.502 -0.749 . . . . 0.0 111.432 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . -95.2 -63.51 0.99 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.593 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 1.2 m-20 59.96 100.49 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.515 -0.991 . . . . 0.0 108.48 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 105.11 -20.97 36.86 Favored Glycine 0 C--N 1.294 -1.777 0 N-CA-C 107.824 -2.11 . . . . 0.0 107.824 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -162.1 153.23 17.96 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.659 -0.906 . . . . 0.0 109.859 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.93 HG22 ' OD1' ' A' ' 129' ' ' ASP . 46.5 t -122.1 152.66 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.258 -0.902 . . . . 0.0 110.532 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -129.95 -168.77 2.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.874 . . . . 0.0 110.594 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -59.57 -64.33 0.98 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.376 -0.828 . . . . 0.0 111.09 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -43.27 -55.46 4.01 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.4 -0.813 . . . . 0.0 111.146 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.479 ' OE2' ' HA ' ' A' ' 129' ' ' ASP . 5.9 mt-10 -48.44 -51.4 27.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.189 -0.945 . . . . 0.0 110.978 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.741 ' HD1' HD12 ' A' ' 85' ' ' ILE . 2.9 t80 -59.65 -32.96 70.94 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.061 -1.024 . . . . 0.0 110.967 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.693 HG22 HG21 ' A' ' 85' ' ' ILE . 57.9 t -76.42 -27.16 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.068 -1.02 . . . . 0.0 111.506 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 46.1 tp60 -98.27 -11.09 22.98 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.88 -1.138 . . . . 0.0 110.882 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.656 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 19.7 ptt? -91.33 -34.18 15.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.014 -1.054 . . . . 0.0 110.642 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.461 ' N ' ' HG3' ' A' ' 144' ' ' MET . 23.4 tpp -82.83 -40.14 20.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 110.41 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 68.2 p . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.086 179.807 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.154 0.502 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -50.3 -34.5 23.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.263 -0.898 . . . . 0.0 109.874 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.538 ' HG2' ' CE2' ' A' ' 12' ' ' PHE . 45.0 tt0 -59.73 -48.29 82.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.395 -0.815 . . . . 0.0 109.95 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.7 mt -59.56 -45.1 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.033 -1.042 . . . . 0.0 109.597 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.33 -25.76 64.46 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.387 -0.821 . . . . 0.0 109.505 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 15.0 tp10 -69.02 -44.76 72.1 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.377 -0.827 . . . . 0.0 109.707 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.538 ' CE2' ' HG2' ' A' ' 8' ' ' GLN . 20.3 m-85 -62.28 -47.7 83.15 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.253 -0.904 . . . . 0.0 109.808 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -56.17 -46.67 79.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.353 -0.842 . . . . 0.0 109.964 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -52.96 -46.17 68.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.22 -0.925 . . . . 0.0 109.631 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.458 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -58.92 -44.25 91.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.376 -0.827 . . . . 0.0 110.044 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.456 ' CE1' ' CD1' ' A' ' 27' ' ' ILE . 37.8 t80 -51.31 -40.72 59.62 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.11 -0.994 . . . . 0.0 109.742 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.4 t -66.1 -38.29 87.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -0.888 . . . . 0.0 109.595 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.494 ' C ' HD23 ' A' ' 18' ' ' LEU . 10.5 tt -57.96 -31.78 67.2 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.325 -0.859 . . . . 0.0 109.956 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.512 ' HA ' HG21 ' A' ' 35' ' ' VAL . 32.1 m-85 -87.29 -25.59 23.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.313 -0.867 . . . . 0.0 110.287 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -100.92 114.47 28.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.313 -0.867 . . . . 0.0 109.925 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -103.7 -28.07 11.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.191 -0.943 . . . . 0.0 110.794 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.42 ' OD1' ' HB2' ' A' ' 24' ' ' ASP . 4.1 p30 -92.6 11.46 26.48 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.12 -0.988 . . . . 0.0 110.633 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 47.84 47.94 24.61 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.42 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 7.4 t70 -84.81 -27.45 26.8 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.263 -1.139 . . . . 0.0 110.501 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.09 -27.81 14.84 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.4 p -125.81 148.62 49.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.214 -1.168 . . . . 0.0 110.24 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.456 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 83.0 mt -96.03 126.84 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.293 -0.879 . . . . 0.0 110.114 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.7 p -108.8 -162.82 0.83 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.368 -0.832 . . . . 0.0 110.171 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.1 p -86.47 -28.36 23.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -0.987 . . . . 0.0 110.225 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -65.9 -58.36 5.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 109.698 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -54.95 -55.66 28.27 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.305 -0.872 . . . . 0.0 109.834 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.964 HD22 HD11 ' A' ' 52' ' ' ILE . 2.7 tp -54.16 -29.17 44.47 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.349 -0.845 . . . . 0.0 109.705 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.72 -49.68 73.83 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.0 m -68.81 -23.06 64.23 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.169 -1.195 . . . . 0.0 110.219 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.512 HG21 ' HA ' ' A' ' 19' ' ' PHE . 16.6 t -72.47 -37.77 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.275 -0.89 . . . . 0.0 109.881 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.4 mmt -90.28 -10.35 44.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 110.468 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -89.18 -36.66 15.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.134 -0.979 . . . . 0.0 110.658 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 72.8 p -79.33 -36.76 38.97 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.131 -0.981 . . . . 0.0 110.412 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.36 -11.19 55.14 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.268 -0.895 . . . . 0.0 110.482 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 151.07 89.6 0.07 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.69 143.8 57.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -1.118 . . . . 0.0 111.05 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.555 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 10.5 m-20 -159.85 -64.93 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.416 -0.803 . . . . 0.0 109.497 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.555 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 49.4 Cg_endo -74.47 150.22 40.6 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.423 1.222 . . . . 0.0 109.446 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 72.7 p -90.33 -137.79 0.14 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.054 -1.029 . . . . 0.0 109.415 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -100.9 -37.82 8.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.784 -1.198 . . . . 0.0 109.188 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -75.24 -58.1 3.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.409 -0.807 . . . . 0.0 109.236 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -51.81 -40.79 61.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.32 -0.862 . . . . 0.0 109.048 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.623 HD21 HD23 ' A' ' 32' ' ' LEU . 9.4 tt -58.01 -42.61 85.61 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.611 -0.681 . . . . 0.0 109.182 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.414 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 35.1 tt0 -53.04 -39.71 63.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.905 . . . . 0.0 108.901 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -65.32 -37.32 86.76 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.218 -0.926 . . . . 0.0 108.66 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.418 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 13.5 ttt -66.39 -18.52 65.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.465 -0.772 . . . . 0.0 109.309 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.964 HD11 HD22 ' A' ' 32' ' ' LEU . 33.3 mm -82.39 -31.69 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.372 -0.83 . . . . 0.0 109.802 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -59.33 -49.64 77.05 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.454 -0.779 . . . . 0.0 110.526 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.491 ' HG3' HG23 ' A' ' 55' ' ' VAL . 21.7 pt-20 -56.69 -19.16 15.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.079 -1.013 . . . . 0.0 110.124 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.511 HG13 ' SD ' ' A' ' 71' ' ' MET . 56.0 t -94.48 -25.74 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.267 -0.895 . . . . 0.0 110.164 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -97.8 100.66 12.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.217 -0.927 . . . . 0.0 110.458 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -93.41 46.53 1.2 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.219 -0.925 . . . . 0.0 109.982 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -132.02 -66.49 0.7 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.218 -0.926 . . . . 0.0 110.484 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 135.84 53.94 0.06 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.439 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 12.4 p-10 -142.06 -46.41 0.35 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -1.139 . . . . 0.0 110.316 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.19 -72.55 0.48 Allowed Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.656 -1.259 . . . . 0.0 110.531 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.9 p -69.67 169.88 11.96 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.251 -1.147 . . . . 0.0 111.149 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.473 HD13 HG11 ' A' ' 55' ' ' VAL . 42.0 mt -115.83 143.89 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.309 -0.869 . . . . 0.0 110.258 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.42 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 57.3 m-20 -96.12 -168.23 1.71 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.255 -0.903 . . . . 0.0 110.227 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.563 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 57.7 t80 -82.77 -41.78 0.89 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 111.459 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.4 Cg_endo -74.55 -29.34 9.17 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 O-C-N 123.05 1.026 . . . . 0.0 109.968 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -74.12 -27.26 60.78 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.322 -0.861 . . . . 0.0 108.775 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -75.32 -47.43 27.79 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.621 -0.674 . . . . 0.0 110.04 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.892 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 1.8 tt -70.21 -20.76 63.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.297 -0.877 . . . . 0.0 110.167 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.0 m -78.6 -43.23 26.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 110.884 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.511 ' SD ' HG13 ' A' ' 55' ' ' VAL . 64.0 ttp -69.12 -48.18 63.17 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.1 -1.0 . . . . 0.0 110.93 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 28.7 mtt -78.68 -10.89 59.92 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.102 -0.998 . . . . 0.0 110.991 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.892 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.497 1.882 0 O-C-N 120.972 -1.08 . . . . 0.0 110.005 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.294 0.569 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.1 mt -51.53 -30.39 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.398 -0.814 . . . . 0.0 110.133 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -68.57 -42.09 78.8 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.231 -0.918 . . . . 0.0 109.846 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -62.38 -37.44 85.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.273 -0.892 . . . . 0.0 110.164 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.728 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -65.19 -62.44 1.54 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -0.9 . . . . 0.0 110.38 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.42 ' CE2' ' HA ' ' A' ' 138' ' ' TYR . 6.2 t80 -54.92 -28.0 47.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.18 -0.95 . . . . 0.0 110.211 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 -63.39 -53.26 55.25 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.255 -0.903 . . . . 0.0 110.559 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.701 HG23 ' CD1' ' A' ' 92' ' ' PHE . 31.0 m -70.68 -24.86 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.106 -0.996 . . . . 0.0 110.707 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.728 ' CE2' ' HB1' ' A' ' 88' ' ' ALA . 14.3 m-30 -73.41 -28.85 62.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.132 -0.98 . . . . 0.0 110.007 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -108.67 67.63 0.67 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 0.0 109.752 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -77.08 -30.33 55.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.348 -0.845 . . . . 0.0 110.485 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.445 ' OD2' ' HB2' ' A' ' 97' ' ' ASN . 30.8 p-10 -69.24 -7.13 33.89 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.171 -0.956 . . . . 0.0 110.491 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.52 28.57 70.91 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.445 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 1.8 t-20 -80.78 -75.87 0.26 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.296 -1.12 . . . . 0.0 110.01 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 151.18 -25.21 0.99 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.439 ' HB3' ' HB2' ' A' ' 135' ' ' GLN . 14.3 m-85 -118.88 131.69 56.07 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.193 -1.181 . . . . 0.0 110.092 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.447 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 83.3 mt -70.01 128.62 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.146 -0.971 . . . . 0.0 110.084 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 97.9 p -114.6 175.07 5.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.897 . . . . 0.0 110.226 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 105' ' ' LEU . . . -71.14 -53.02 15.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 110.228 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -47.08 -56.62 6.22 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.179 -0.95 . . . . 0.0 110.244 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.465 ' O ' HG23 ' A' ' 108' ' ' VAL . 94.4 mt-10 -58.69 -41.93 87.38 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 109.807 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.825 HD23 HG13 ' A' ' 121' ' ' VAL . 55.1 tp -54.86 -30.54 58.07 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.309 -0.869 . . . . 0.0 110.104 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -77.29 -42.72 35.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.92 . . . . 0.0 110.128 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -62.34 -19.44 63.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 110.312 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 104' ' ' GLU . 47.8 t -92.67 -45.08 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.175 -0.953 . . . . 0.0 110.42 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.491 ' HA ' HD12 ' A' ' 112' ' ' LEU . 26.4 mmt -70.02 -18.34 63.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.272 -0.892 . . . . 0.0 110.555 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.9 m -75.83 -25.27 56.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.155 -0.965 . . . . 0.0 110.033 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -88.38 -38.73 14.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.303 -0.873 . . . . 0.0 110.075 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.491 HD12 ' HA ' ' A' ' 109' ' ' MET . 50.6 mt -58.15 -42.6 86.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.369 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.09 0.83 7.51 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 2.4 mm-40 -72.85 -43.15 62.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.069 -1.253 . . . . 0.0 110.256 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 16.7 mmtp 55.74 106.99 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.42 -0.8 . . . . 0.0 110.414 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.4 HD12 ' HB3' ' A' ' 109' ' ' MET . 1.6 mt -131.87 161.46 32.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.261 -0.9 . . . . 0.0 110.21 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.479 HG22 ' N ' ' A' ' 118' ' ' ASP . 67.7 m -86.51 168.18 13.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 0.0 110.06 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.479 ' N ' HG22 ' A' ' 117' ' ' THR . 50.6 m-20 -57.1 -43.64 82.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.268 -0.895 . . . . 0.0 110.688 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -66.31 -33.34 75.51 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.051 -1.031 . . . . 0.0 110.472 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -65.35 -59.12 4.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.044 -1.035 . . . . 0.0 109.908 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.825 HG13 HD23 ' A' ' 105' ' ' LEU . 70.4 t -52.04 -45.4 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.172 -0.955 . . . . 0.0 109.665 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -54.71 -41.47 70.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 0.0 109.528 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -64.57 -33.13 75.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.368 -0.833 . . . . 0.0 109.544 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 26.4 mmm -63.88 -49.54 72.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.879 . . . . 0.0 110.127 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.414 HG23 HG23 ' A' ' 136' ' ' VAL . 34.7 mm -64.83 -26.89 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.352 -0.843 . . . . 0.0 110.245 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -69.76 -50.12 46.38 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.153 -0.967 . . . . 0.0 110.129 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -57.74 -39.3 77.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.166 -0.959 . . . . 0.0 109.733 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.496 ' HB2' ' SD ' ' A' ' 144' ' ' MET . . . -70.9 -30.59 66.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.319 -0.863 . . . . 0.0 109.939 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -70.27 91.12 0.71 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.393 -0.817 . . . . 0.0 110.166 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 65.2 mt -74.69 -50.8 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.201 -0.937 . . . . 0.0 110.817 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 29.1 p30 -69.39 -17.95 63.72 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.104 -0.997 . . . . 0.0 110.877 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 71.49 72.18 0.95 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.407 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 6.6 p30 -125.73 -24.91 3.75 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.236 -1.156 . . . . 0.0 111.237 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 132.59 -24.52 3.89 Favored Glycine 0 N--CA 1.496 2.688 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.33 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 99' ' ' TYR . 2.4 pp0? -140.25 167.51 21.96 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.055 -1.262 . . . . 0.0 110.558 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.447 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 57.9 t -102.86 144.25 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.21 -0.931 . . . . 0.0 110.68 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -106.93 166.22 10.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.363 -0.835 . . . . 0.0 109.476 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.498 ' O ' HG23 ' A' ' 142' ' ' VAL . 51.8 t80 -52.94 -38.67 62.22 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.039 -1.038 . . . . 0.0 110.1 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -67.77 -60.35 2.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.213 -0.93 . . . . 0.0 110.623 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -47.13 -36.45 8.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.208 -0.933 . . . . 0.0 110.745 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.565 ' CD2' ' HE1' ' A' ' 144' ' ' MET . 10.2 t80 -65.51 -46.29 80.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.138 -0.976 . . . . 0.0 110.182 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 138' ' ' TYR . 52.4 t -66.48 -22.61 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.225 -0.922 . . . . 0.0 110.101 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -84.33 -25.29 29.33 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.378 -0.826 . . . . 0.0 111.019 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.565 ' HE1' ' CD2' ' A' ' 141' ' ' PHE . 10.1 ptt? -89.54 -23.1 22.1 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.003 -1.06 . . . . 0.0 110.756 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.508 ' HE2' ' HB2' ' A' ' 145' ' ' MET . 38.4 tpp -88.58 -9.76 51.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.257 -0.902 . . . . 0.0 110.815 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 142' ' ' VAL . 14.2 t . . . . . 0 N--CA 1.497 1.886 0 O-C-N 121.077 -1.014 . . . . 0.0 110.719 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.089 0.471 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -63.72 -26.24 68.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.149 -0.969 . . . . 0.0 110.334 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -68.13 -49.87 58.29 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.194 -0.941 . . . . 0.0 110.014 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.8 mt -61.88 -47.95 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.167 -0.958 . . . . 0.0 109.805 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 13' ' ' LYS . . . -55.24 -39.6 69.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.281 -0.887 . . . . 0.0 109.657 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -58.46 -43.92 89.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.42 -0.8 . . . . 0.0 109.619 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.476 ' CE1' ' HB3' ' A' ' 72' ' ' MET . 35.8 m-85 -63.18 -25.62 68.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.378 -0.826 . . . . 0.0 109.805 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 17.8 mtpt -77.47 -28.26 52.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.333 -0.855 . . . . 0.0 110.249 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 2.6 tt0 -73.05 -42.92 62.59 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.146 -0.972 . . . . 0.0 110.065 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.87 -50.68 16.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.178 -0.951 . . . . 0.0 109.48 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.544 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 77.9 t80 -49.93 -48.03 52.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 109.614 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.7 t -68.82 -35.83 77.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.553 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.917 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.4 tm? -59.34 -24.35 63.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.423 -0.798 . . . . 0.0 109.309 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.425 ' CD1' HG13 ' A' ' 35' ' ' VAL . 13.8 m-85 -87.31 -62.28 1.54 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.513 -0.742 . . . . 0.0 109.68 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -51.65 115.58 1.7 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.53 -0.732 . . . . 0.0 110.076 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -105.85 -36.68 6.93 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.024 -1.048 . . . . 0.0 110.708 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -69.46 -25.83 64.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.148 -0.97 . . . . 0.0 110.167 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.93 95.43 0.42 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.409 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 9.1 p-10 -158.01 -46.3 0.06 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.237 -1.155 . . . . 0.0 110.609 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.523 ' C ' HG23 ' A' ' 26' ' ' THR . . . 126.5 23.88 1.47 Allowed Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.852 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.523 HG23 ' C ' ' A' ' 25' ' ' GLY . 53.8 p -154.89 140.95 18.39 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.799 -1.413 . . . . 0.0 110.618 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 62.2 mt -99.63 112.72 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -0.918 . . . . 0.0 109.759 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.644 HG22 ' H ' ' A' ' 29' ' ' THR . 4.5 m -97.67 -177.87 3.93 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.313 -0.867 . . . . 0.0 110.186 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.923 HG22 HD12 ' A' ' 52' ' ' ILE . 16.8 p -72.9 -31.62 64.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.145 -0.972 . . . . 0.0 110.929 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -62.21 1.58 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.898 -1.126 . . . . 0.0 110.09 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.657 ' O ' HG23 ' A' ' 35' ' ' VAL . 50.8 mt-10 -55.18 -47.63 74.93 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.158 -0.964 . . . . 0.0 109.437 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.705 HD22 HD11 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -55.7 -32.3 63.19 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.281 -0.887 . . . . 0.0 109.608 179.4 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.91 -51.62 57.84 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.9 m -70.27 -12.76 61.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.264 -1.139 . . . . 0.0 110.136 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 31' ' ' GLU . 59.5 t -78.36 -32.08 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.22 -0.925 . . . . 0.0 110.109 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -87.34 -27.52 22.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.108 -0.995 . . . . 0.0 110.205 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.92 -46.2 15.55 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.128 -0.982 . . . . 0.0 109.946 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.6 t -57.08 -22.53 40.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.324 -0.86 . . . . 0.0 110.101 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.524 HD12 ' O ' ' A' ' 35' ' ' VAL . 75.7 mt -95.39 -69.72 0.74 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.341 -0.85 . . . . 0.0 109.997 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.16 88.96 0.07 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.405 ' O ' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -175.82 -56.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.229 -1.159 . . . . 0.0 110.275 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' A' ' 41' ' ' GLN . 41.9 t30 53.97 64.81 6.07 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.172 -0.955 . . . . 0.0 110.244 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -74.85 -163.04 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.765 1.403 . . . . 0.0 110.402 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 47' ' ' GLU . 89.2 m -109.3 151.19 26.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.359 -0.838 . . . . 0.0 109.941 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -59.67 -41.9 91.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 110.03 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.79 -62.14 1.5 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.319 -0.863 . . . . 0.0 110.25 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.435 ' HB3' ' HB ' ' A' ' 44' ' ' THR . 41.6 tt0 -50.07 -24.98 3.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.247 -0.908 . . . . 0.0 109.893 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 44' ' ' THR . 9.2 tt -70.74 -51.27 28.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.434 -0.791 . . . . 0.0 109.612 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -54.03 -30.1 46.31 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.292 -0.88 . . . . 0.0 109.085 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -75.96 -35.43 59.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.493 -0.755 . . . . 0.0 109.561 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.434 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 27.9 ttp -71.04 -19.93 62.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.469 -0.769 . . . . 0.0 110.081 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.923 HD12 HG22 ' A' ' 29' ' ' THR . 10.7 mt -88.15 -36.75 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -0.87 . . . . 0.0 109.684 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -55.0 -40.64 70.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.195 -0.94 . . . . 0.0 109.91 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.504 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 10.0 pt-20 -70.14 -30.58 67.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.256 -0.903 . . . . 0.0 110.131 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.609 ' CG1' HD11 ' A' ' 63' ' ' ILE . 59.0 t -74.35 -72.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.353 -0.842 . . . . 0.0 109.328 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -52.03 98.62 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.686 -0.634 . . . . 0.0 110.401 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -87.41 50.03 1.93 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.602 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -138.03 9.28 2.78 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.447 -0.783 . . . . 0.0 110.333 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 53.17 88.02 0.01 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -169.39 -60.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.217 -1.166 . . . . 0.0 110.077 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.404 ' O ' ' CG2' ' A' ' 52' ' ' ILE . . . 136.54 -57.83 0.67 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.436 HG22 HG23 ' A' ' 28' ' ' THR . 68.8 p -90.13 143.51 26.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.203 -1.175 . . . . 0.0 110.712 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.609 HD11 ' CG1' ' A' ' 55' ' ' VAL . 86.6 mt -93.86 151.11 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.453 -0.78 . . . . 0.0 109.68 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.411 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 47.8 m-20 -109.02 -162.79 0.83 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.237 -0.914 . . . . 0.0 110.531 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.547 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 28.1 t80 -79.39 -42.08 1.58 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.359 -0.838 . . . . 0.0 111.355 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 49.3 Cg_endo -75.73 -25.8 10.41 Favored 'Trans proline' 0 N--CA 1.481 0.75 0 O-C-N 123.124 1.065 . . . . 0.0 110.428 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -78.65 -28.06 45.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 0.0 109.188 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.629 ' CE1' ' HE3' ' A' ' 72' ' ' MET . 88.2 t80 -78.11 -44.73 25.31 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.635 -0.666 . . . . 0.0 110.118 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.56 -32.22 60.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 0.0 110.894 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 83.2 m -78.56 -31.44 47.35 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.991 -1.068 . . . . 0.0 110.88 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.43 ' HG3' ' HG3' ' A' ' 72' ' ' MET . 18.7 ptt? -79.93 -31.48 40.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.92 -1.113 . . . . 0.0 110.777 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.629 ' HE3' ' CE1' ' A' ' 68' ' ' PHE . 53.9 mtt -89.22 -10.45 46.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.008 -1.058 . . . . 0.0 110.932 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.746 0 O-C-N 121.072 -1.017 . . . . 0.0 110.45 -179.719 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 121.202 0.525 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.6 mt -50.46 -23.77 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.146 -0.971 . . . . 0.0 110.255 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.23 -55.26 5.22 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.214 -0.929 . . . . 0.0 110.457 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 47.9 mt-10 -53.58 -38.55 64.01 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.221 -0.925 . . . . 0.0 110.147 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.746 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -65.25 -59.48 4.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.391 -0.818 . . . . 0.0 110.206 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.638 ' CD1' HD11 ' A' ' 100' ' ' ILE . 20.8 t80 -46.15 -28.74 1.31 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.358 -0.839 . . . . 0.0 110.267 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 71.6 mtp180 -71.13 -55.37 8.33 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.252 -0.905 . . . . 0.0 110.422 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.746 HG22 ' O ' ' A' ' 88' ' ' ALA . 32.7 m -61.36 -19.64 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.152 -0.968 . . . . 0.0 110.579 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.525 ' HB3' HG23 ' A' ' 100' ' ' ILE . 40.9 m-85 -92.12 -21.31 20.5 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.126 -0.984 . . . . 0.0 110.21 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -127.45 37.49 4.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 0.0 109.927 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -85.0 8.07 19.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.898 . . . . 0.0 110.658 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 3.0 p30 -81.92 -22.71 36.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.155 -0.966 . . . . 0.0 110.138 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.437 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 112.18 29.82 3.12 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.473 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 39.0 p-10 -127.09 -15.46 5.28 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.263 -1.139 . . . . 0.0 110.719 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 65.53 11.28 52.7 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.55 ' CD1' ' NE2' ' A' ' 135' ' ' GLN . 49.8 m-85 -121.41 139.54 53.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.026 -1.279 . . . . 0.0 110.241 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.638 HD11 ' CD1' ' A' ' 89' ' ' PHE . 21.8 mt -91.23 113.37 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.137 -0.977 . . . . 0.0 110.273 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 76.3 p -103.85 156.46 17.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.412 -0.805 . . . . 0.0 109.915 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.77 -34.95 55.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.127 -0.983 . . . . 0.0 110.307 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.42 -62.32 1.48 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.181 -0.949 . . . . 0.0 110.498 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.415 ' OE1' ' OD2' ' A' ' 95' ' ' ASP . 51.4 mt-10 -46.95 -42.98 18.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.179 -0.95 . . . . 0.0 110.254 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.621 HD22 HG13 ' A' ' 121' ' ' VAL . 8.6 tt -55.07 -54.12 47.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.399 -0.813 . . . . 0.0 110.126 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.411 ' O ' ' HG3' ' A' ' 106' ' ' ARG . 3.1 tpt180 -63.1 -19.95 64.91 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.924 . . . . 0.0 109.986 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -77.89 -27.32 49.6 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.286 -0.884 . . . . 0.0 110.14 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.452 HG21 ' CD1' ' A' ' 92' ' ' PHE . 78.4 t -83.77 -40.1 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.315 -0.865 . . . . 0.0 109.903 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.42 ' HG2' ' CD1' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -59.87 -41.9 92.54 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.344 -0.848 . . . . 0.0 110.062 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.1 p -56.01 -44.68 78.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.33 -0.856 . . . . 0.0 110.335 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -61.28 -48.32 81.94 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.243 -0.911 . . . . 0.0 110.132 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.5 mt -64.48 -13.93 54.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.207 -0.933 . . . . 0.0 110.275 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.27 51.44 3.52 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -102.23 -177.47 3.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.129 -1.218 . . . . 0.0 110.015 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.15 47.6 0.99 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.166 -0.959 . . . . 0.0 110.577 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.815 HD23 ' OE1' ' A' ' 120' ' ' GLU . 7.0 mt -75.89 -175.73 3.12 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.264 -0.898 . . . . 0.0 110.158 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.531 HG22 ' N ' ' A' ' 118' ' ' ASP . 88.8 m -135.92 170.08 16.57 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.293 -0.879 . . . . 0.0 110.288 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.531 ' N ' HG22 ' A' ' 117' ' ' THR . 75.1 m-20 -52.87 -33.29 49.25 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.314 -0.866 . . . . 0.0 110.783 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -65.68 -53.1 45.71 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.127 -0.983 . . . . 0.0 110.613 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.815 ' OE1' HD23 ' A' ' 116' ' ' LEU . 74.2 mt-10 -60.57 -48.88 79.8 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.318 -0.864 . . . . 0.0 111.209 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.621 HG13 HD22 ' A' ' 105' ' ' LEU . 95.7 t -55.81 -53.31 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.231 -0.918 . . . . 0.0 110.833 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.75 -36.47 74.4 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.23 -0.919 . . . . 0.0 110.667 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.456 ' CG ' ' OE2' ' A' ' 127' ' ' GLU . 36.9 tt0 -71.63 -24.95 61.96 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.193 -0.942 . . . . 0.0 110.289 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.486 ' HE2' HD11 ' A' ' 105' ' ' LEU . 85.3 mtp -76.63 -49.18 16.87 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.183 -0.948 . . . . 0.0 110.068 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.44 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 19.2 mm -69.08 -26.53 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 110.326 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.43 -39.14 47.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.127 -0.983 . . . . 0.0 110.528 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.456 ' OE2' ' CG ' ' A' ' 123' ' ' GLU . 0.3 OUTLIER -69.78 -31.23 69.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.133 -0.979 . . . . 0.0 110.178 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.11 -27.91 24.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.208 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 56.8 t0 -68.29 93.58 0.48 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.374 -0.829 . . . . 0.0 110.224 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 55.6 mt -75.42 -47.9 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.287 -0.883 . . . . 0.0 110.739 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.409 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 47.7 p30 -73.19 -6.37 45.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.132 -0.98 . . . . 0.0 110.811 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.406 ' HA2' ' OD2' ' A' ' 129' ' ' ASP . . . 57.87 61.98 6.83 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -124.03 8.63 8.65 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.203 -1.175 . . . . 0.0 111.027 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.54 36.19 54.62 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.55 ' NE2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -170.96 137.36 1.19 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.354 -1.086 . . . . 0.0 109.964 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.437 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 46.8 t -110.35 118.16 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.157 -0.965 . . . . 0.0 110.318 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -87.37 177.2 7.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.163 -0.961 . . . . 0.0 110.022 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.538 ' O ' HG23 ' A' ' 142' ' ' VAL . 16.0 t80 -61.5 -45.05 95.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.111 -0.993 . . . . 0.0 110.286 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -53.08 -55.56 22.96 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.282 -0.886 . . . . 0.0 110.077 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.441 ' O ' ' HG2' ' A' ' 144' ' ' MET . 56.7 mt-10 -64.86 -23.36 67.21 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.224 -0.922 . . . . 0.0 109.785 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.517 ' CE1' ' HE2' ' A' ' 145' ' ' MET . 37.9 t80 -75.75 -22.86 56.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.551 -0.718 . . . . 0.0 109.757 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 138' ' ' TYR . 84.9 t -90.1 -24.19 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.369 -0.832 . . . . 0.0 109.928 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -80.43 -34.24 36.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.372 -0.83 . . . . 0.0 110.217 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.573 ' HE3' ' CE ' ' A' ' 145' ' ' MET . 0.1 OUTLIER -82.57 -13.67 56.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.286 -0.884 . . . . 0.0 110.257 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.573 ' CE ' ' HE3' ' A' ' 144' ' ' MET . 15.1 mmt -87.49 -46.66 9.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 110.394 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.3 p . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.141 -0.974 . . . . 0.0 110.489 -179.769 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.117 0.484 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.67 -60.28 3.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.121 -0.987 . . . . 0.0 110.426 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.526 ' HG2' ' CE2' ' A' ' 12' ' ' PHE . 7.9 tt0 -62.7 -43.35 99.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.327 -0.858 . . . . 0.0 110.415 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.8 mt -55.0 -42.23 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.081 -1.012 . . . . 0.0 109.839 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.97 -34.9 78.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.317 -0.865 . . . . 0.0 110.029 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.91 -48.87 78.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 109.779 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.526 ' CE2' ' HG2' ' A' ' 8' ' ' GLN . 24.1 m-85 -60.08 -47.87 84.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.016 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -49.04 -42.04 37.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.17 -0.956 . . . . 0.0 110.072 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -66.5 -37.7 85.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.875 . . . . 0.0 110.307 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.81 -47.87 83.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.142 -0.974 . . . . 0.0 109.971 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -60.27 -45.26 93.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 110.146 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.3 t -62.84 -21.22 65.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.924 . . . . 0.0 109.991 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.73 ' O ' HD23 ' A' ' 18' ' ' LEU . 4.7 tt -85.2 -25.18 27.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 109.939 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.564 ' HA ' HG21 ' A' ' 35' ' ' VAL . 8.3 m-85 -92.74 -67.98 0.83 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.219 -0.926 . . . . 0.0 110.412 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -70.99 86.78 0.72 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.382 -0.823 . . . . 0.0 110.235 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.39 42.54 1.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.342 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -125.18 -43.2 1.96 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.136 -0.977 . . . . 0.0 110.25 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.93 -37.42 1.66 Allowed Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.86 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 49.9 p-10 -55.67 -17.85 6.67 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.96 -1.318 . . . . 0.0 110.952 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.428 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 63.13 13.59 49.52 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 34.0 p -122.21 116.05 23.46 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.023 -1.281 . . . . 0.0 110.286 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 62' ' ' THR . 61.2 mt -69.54 109.25 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.173 -0.954 . . . . 0.0 110.254 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.534 HG22 HG22 ' A' ' 62' ' ' THR . 81.2 p -104.19 -157.85 0.63 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.881 . . . . 0.0 110.204 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.1 p -82.99 -36.85 24.73 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.198 -0.939 . . . . 0.0 110.636 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -64.94 -59.85 3.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.117 -0.99 . . . . 0.0 110.192 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -59.09 -52.5 65.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.166 -0.958 . . . . 0.0 109.805 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.717 HD23 HD21 ' A' ' 48' ' ' LEU . 2.6 tp -59.45 -21.82 60.6 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.241 -0.912 . . . . 0.0 109.682 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -68.23 -44.61 74.88 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 70.8 m -71.63 -34.14 69.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.349 -1.089 . . . . 0.0 110.176 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.564 HG21 ' HA ' ' A' ' 19' ' ' PHE . 63.6 t -69.6 -32.14 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.29 -0.881 . . . . 0.0 110.617 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 25.9 mmt -90.16 -18.47 25.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.221 -0.924 . . . . 0.0 110.241 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 10.7 tpt180 -79.06 -33.93 44.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 110.357 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.3 t -61.36 -21.07 63.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.289 -0.882 . . . . 0.0 110.383 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -144.98 76.38 1.49 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.175 -0.953 . . . . 0.0 110.255 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.24 -65.28 0.15 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 53.6 21.12 2.4 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.13 -1.218 . . . . 0.0 109.963 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.522 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.0 OUTLIER -105.56 -67.22 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.425 -0.797 . . . . 0.0 110.823 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 42' ' ' ASN . 46.8 Cg_endo -72.31 170.64 18.7 Favored 'Trans proline' 0 C--N 1.321 -0.911 0 O-C-N 123.063 1.033 . . . . 0.0 110.467 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.442 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.6 OUTLIER -118.76 -140.63 0.36 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -0.887 . . . . 0.0 109.629 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -90.74 -30.67 16.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.908 -1.12 . . . . 0.0 110.189 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.62 -66.44 0.66 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.206 -0.933 . . . . 0.0 109.805 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 41.8 mt-10 -50.58 -36.22 33.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 109.54 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.717 HD21 HD23 ' A' ' 32' ' ' LEU . 6.0 tt -60.35 -45.2 94.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.84 . . . . 0.0 109.587 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -53.16 -39.36 63.5 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.282 -0.886 . . . . 0.0 108.629 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 47' ' ' GLU . 57.4 m-20 -64.31 -38.08 89.78 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.434 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -60.75 -23.84 65.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.439 -0.788 . . . . 0.0 108.919 178.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.702 HD11 HD22 ' A' ' 32' ' ' LEU . 10.7 mt -85.34 -24.86 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.456 -0.778 . . . . 0.0 109.786 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -73.54 -35.67 65.55 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.263 -0.898 . . . . 0.0 110.243 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.478 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 24.2 pt-20 -72.74 -42.54 63.96 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.174 -0.953 . . . . 0.0 110.166 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.635 HG13 ' SD ' ' A' ' 71' ' ' MET . 68.0 t -69.87 -57.61 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.036 -1.04 . . . . 0.0 109.593 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.404 ' OD1' ' OE1' ' A' ' 67' ' ' GLU . 45.3 t0 -68.3 133.58 49.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.467 -0.77 . . . . 0.0 110.07 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.93 50.85 0.78 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.17 -0.956 . . . . 0.0 110.376 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.401 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 55.4 m-20 -136.48 -74.72 0.43 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.193 -0.942 . . . . 0.0 110.466 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.38 47.57 0.05 OUTLIER Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -140.35 14.15 2.39 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.353 -1.086 . . . . 0.0 110.405 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 62' ' ' THR . . . 47.16 38.45 11.65 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.534 HG22 HG22 ' A' ' 28' ' ' THR . 20.6 p -152.58 136.7 16.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.999 -1.294 . . . . 0.0 110.576 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 75.4 mt -111.67 123.74 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.884 . . . . 0.0 110.082 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.447 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.4 m-20 -83.73 -174.19 5.14 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.148 -0.97 . . . . 0.0 110.546 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.563 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -67.25 -46.71 50.82 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.436 -0.79 . . . . 0.0 111.032 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.6 Cg_endo -73.73 -31.12 8.82 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 O-C-N 123.415 1.218 . . . . 0.0 110.427 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.404 ' OE1' ' OD1' ' A' ' 56' ' ' ASP . 27.5 mt-10 -73.78 -23.65 59.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.158 -0.964 . . . . 0.0 109.176 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.785 ' CE1' ' HE2' ' A' ' 72' ' ' MET . 65.4 t80 -76.01 -55.51 5.53 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.638 -0.664 . . . . 0.0 110.281 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.708 ' O ' HD23 ' A' ' 69' ' ' LEU . 5.4 tt -63.87 -28.86 70.13 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.349 -0.845 . . . . 0.0 110.297 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.4 m -68.52 -57.59 5.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.221 -0.924 . . . . 0.0 110.375 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.635 ' SD ' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -69.38 -12.67 61.85 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.167 -0.958 . . . . 0.0 110.673 -179.474 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.785 ' HE2' ' CE1' ' A' ' 68' ' ' PHE . 11.4 mmt -80.52 -24.93 39.01 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.05 -1.031 . . . . 0.0 110.085 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.475 0 O-C-N 121.334 -0.854 . . . . 0.0 109.899 179.618 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.149 0.5 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 65.5 mt -55.21 -45.19 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.115 -0.991 . . . . 0.0 110.097 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -58.6 -56.4 22.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.168 -0.957 . . . . 0.0 109.979 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 10.8 mt-10 -46.29 -44.57 16.7 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.336 -0.852 . . . . 0.0 110.172 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.596 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -57.22 -57.64 11.72 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.378 -0.826 . . . . 0.0 109.467 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.49 ' CE1' HG13 ' A' ' 100' ' ' ILE . 29.9 t80 -49.8 -25.28 2.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.115 -0.991 . . . . 0.0 109.638 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.424 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 15.7 ttt180 -67.05 -59.33 3.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.51 -0.744 . . . . 0.0 110.464 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 88' ' ' ALA . 34.7 m -61.52 -31.66 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.208 -0.933 . . . . 0.0 110.583 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.821 ' CE1' HG11 ' A' ' 108' ' ' VAL . 31.1 m-85 -78.7 -15.96 57.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.084 -1.01 . . . . 0.0 110.663 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -114.61 73.21 0.82 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.965 -1.084 . . . . 0.0 110.463 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -99.42 54.91 0.97 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.259 -0.9 . . . . 0.0 110.761 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.3 p30 -140.04 -37.02 0.48 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.077 -1.014 . . . . 0.0 110.615 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.478 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 107.8 42.9 1.38 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.501 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 45.2 p-10 -135.46 -18.59 1.7 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.057 -1.261 . . . . 0.0 111.477 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.481 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 80.42 42.02 10.86 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.534 ' CD1' ' NE2' ' A' ' 135' ' ' GLN . 68.5 m-85 -152.33 145.39 24.55 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.335 -1.097 . . . . 0.0 110.093 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.49 HG13 ' CE1' ' A' ' 89' ' ' PHE . 31.9 mt -96.69 130.67 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.199 -0.938 . . . . 0.0 110.427 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.8 t -117.25 166.94 11.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.38 -0.825 . . . . 0.0 109.858 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.61 -32.21 73.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.181 -0.949 . . . . 0.0 110.678 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.6 -52.14 34.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.117 -0.99 . . . . 0.0 110.442 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.641 ' O ' HG23 ' A' ' 108' ' ' VAL . 53.8 mt-10 -60.19 -40.18 89.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.275 -0.89 . . . . 0.0 110.755 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.056 HD23 HG13 ' A' ' 121' ' ' VAL . 6.7 tp -64.09 -36.82 85.28 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.087 -1.008 . . . . 0.0 110.541 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 106' ' ' ARG . 1.6 ttp-105 -66.65 -39.25 88.13 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.099 -1.001 . . . . 0.0 110.293 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -73.48 -22.81 60.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 0.0 110.384 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.821 HG11 ' CE1' ' A' ' 92' ' ' PHE . 77.0 t -82.15 -32.83 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.336 -0.853 . . . . 0.0 110.487 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.408 ' HG2' ' O ' ' A' ' 105' ' ' LEU . 24.1 mmt -66.8 -28.78 68.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.129 -0.982 . . . . 0.0 110.272 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.4 p -63.3 -54.04 43.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.189 -0.945 . . . . 0.0 110.013 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -61.35 -40.38 94.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.253 -0.904 . . . . 0.0 110.153 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.7 mt -54.34 -30.24 50.78 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.188 -0.945 . . . . 0.0 110.232 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.39 26.0 7.11 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.49 ' O ' HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -127.35 107.4 9.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.272 -1.134 . . . . 0.0 110.041 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -86.09 109.23 18.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.915 . . . . 0.0 110.548 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.49 HD12 ' O ' ' A' ' 114' ' ' GLU . 1.6 mp -112.71 -169.23 1.44 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.259 -0.901 . . . . 0.0 109.924 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.48 HG22 ' N ' ' A' ' 118' ' ' ASP . 31.1 m -117.57 168.71 10.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.002 -1.061 . . . . 0.0 110.721 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.48 ' N ' HG22 ' A' ' 117' ' ' THR . 26.4 m-20 -59.15 -36.22 74.87 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.4 -0.812 . . . . 0.0 110.295 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -67.0 -36.58 82.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.225 -0.922 . . . . 0.0 110.295 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 124' ' ' MET . 1.7 mt-10 -63.66 -51.72 63.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.38 -0.825 . . . . 0.0 110.361 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 1.056 HG13 HD23 ' A' ' 105' ' ' LEU . 50.3 t -63.42 -58.12 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.165 -0.959 . . . . 0.0 110.395 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -46.57 -43.13 16.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.338 -0.851 . . . . 0.0 110.395 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -67.01 -37.58 84.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.219 -0.925 . . . . 0.0 110.349 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.405 ' HG3' ' O ' ' A' ' 120' ' ' GLU . 90.9 mtp -59.27 -55.11 38.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 110.288 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 35.7 mm -56.16 -39.06 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 110.125 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -58.29 -44.36 88.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 109.952 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -69.01 -24.61 64.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.076 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.45 ' CB ' HG21 ' A' ' 136' ' ' VAL . . . -81.43 -21.48 38.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.174 -0.953 . . . . 0.0 110.074 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -67.76 89.42 0.26 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.314 -0.866 . . . . 0.0 110.427 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 140' ' ' GLU . 47.7 mt -77.04 -29.74 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.791 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.7 p30 -99.37 -26.52 14.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.374 -0.829 . . . . 0.0 110.227 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 96.36 80.29 1.51 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 11.7 p-10 -144.68 -42.01 0.25 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -1.193 . . . . 0.0 110.358 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 126.51 -20.96 6.08 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.534 ' NE2' ' CD1' ' A' ' 99' ' ' TYR . 16.5 pt20 -119.16 158.91 24.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.095 -1.238 . . . . 0.0 110.524 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.45 HG21 ' CB ' ' A' ' 128' ' ' ALA . 59.5 t -119.42 113.14 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.269 -0.895 . . . . 0.0 110.055 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 12.4 p-10 -85.59 -157.98 0.36 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.125 -0.985 . . . . 0.0 110.321 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -68.93 -66.05 0.63 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.087 -1.008 . . . . 0.0 111.406 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -47.87 -47.42 31.74 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.143 -0.973 . . . . 0.0 110.854 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.414 ' HA ' HD12 ' A' ' 130' ' ' ILE . 33.1 mt-10 -66.29 -31.35 72.09 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.078 -1.014 . . . . 0.0 110.56 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' ' 137' ' ' ASN . 15.5 t80 -70.61 -27.48 64.12 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.139 -0.976 . . . . 0.0 109.831 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.427 ' O ' ' CB ' ' A' ' 146' ' ' THR . 53.8 t -90.43 -23.14 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.523 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -83.83 -34.15 24.73 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.218 -0.926 . . . . 0.0 110.929 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.613 ' HE2' ' HE3' ' A' ' 145' ' ' MET . 15.0 ptt? -64.17 -35.33 80.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.013 -1.054 . . . . 0.0 110.21 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.613 ' HE3' ' HE2' ' A' ' 144' ' ' MET . 12.4 mtt -90.19 -36.53 14.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 0.0 109.424 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.427 ' CB ' ' O ' ' A' ' 142' ' ' VAL . 22.7 m . . . . . 0 C--N 1.302 -1.487 0 O-C-N 121.538 -0.726 . . . . 0.0 110.109 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.547 ' OE1' HD12 ' A' ' 9' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.066 0.46 . . . . 0.0 110.584 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -66.16 -51.11 60.97 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.039 -1.038 . . . . 0.0 110.458 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -64.35 -39.53 94.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -0.929 . . . . 0.0 110.083 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.547 HD12 ' OE1' ' A' ' 6' ' ' GLU . 32.5 mt -59.06 -42.69 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.143 -0.973 . . . . 0.0 109.604 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.14 95.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.353 -0.842 . . . . 0.0 109.545 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -60.03 -40.78 90.52 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.333 -0.855 . . . . 0.0 109.654 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -65.13 -31.54 72.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -0.841 . . . . 0.0 109.482 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.63 -50.59 68.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.852 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -60.79 -46.59 89.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.939 . . . . 0.0 109.839 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.505 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -48.82 -55.05 12.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.243 -0.911 . . . . 0.0 109.844 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -52.78 -52.47 56.58 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.399 -0.813 . . . . 0.0 110.347 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.0 m -53.58 -30.18 41.01 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.199 -0.938 . . . . 0.0 110.262 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.68 ' O ' HD23 ' A' ' 18' ' ' LEU . 6.7 tt -70.52 -37.98 74.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.873 . . . . 0.0 110.142 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 1.086 ' CD1' HG11 ' A' ' 35' ' ' VAL . 78.5 m-85 -71.66 -65.24 0.78 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.433 -0.792 . . . . 0.0 110.353 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.444 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -53.74 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.149 -0.969 . . . . 0.0 110.351 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -105.16 51.94 0.75 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.264 -0.898 . . . . 0.0 110.235 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.482 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 23.0 p-10 -169.4 -33.06 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.263 -0.898 . . . . 0.0 110.936 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.73 93.98 2.33 Favored Glycine 0 N--CA 1.498 2.806 0 C-N-CA 119.669 -1.253 . . . . 0.0 110.678 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.43 ' OD2' ' OD2' ' A' ' 22' ' ' ASP . 43.7 m-20 -158.91 -45.83 0.06 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.44 -1.035 . . . . 0.0 110.038 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.88 -9.57 23.33 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.1 p -126.89 156.0 42.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.17 -1.194 . . . . 0.0 110.312 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 56.9 mt -105.42 119.64 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.465 -0.772 . . . . 0.0 110.031 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.3 p -103.21 -162.73 0.93 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.196 -0.94 . . . . 0.0 110.223 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.518 HG21 ' HG2' ' A' ' 49' ' ' GLN . 12.7 p -83.85 -27.99 28.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.162 -0.961 . . . . 0.0 110.609 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 mttp -71.21 -58.68 3.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.174 -0.954 . . . . 0.0 109.954 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.735 ' O ' HG23 ' A' ' 35' ' ' VAL . 49.8 mt-10 -56.52 -42.78 79.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.47 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.89 HD22 HD11 ' A' ' 52' ' ' ILE . 2.6 tp -67.57 -26.82 66.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.246 -0.909 . . . . 0.0 109.766 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.437 ' HA2' ' CD1' ' A' ' 48' ' ' LEU . . . -65.6 -38.69 94.91 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.2 m -83.0 -20.61 34.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -1.115 . . . . 0.0 109.885 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 1.086 HG11 ' CD1' ' A' ' 19' ' ' PHE . 60.4 t -74.4 -34.64 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 109.567 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 9.6 mmt -90.18 -31.66 16.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.431 -0.793 . . . . 0.0 109.636 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.2 tpt85 -78.99 -20.99 47.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.453 -0.779 . . . . 0.0 110.135 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.1 m -106.61 -6.52 17.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.336 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.6 tp -166.05 94.13 0.55 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.128 -0.983 . . . . 0.0 110.271 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.99 -103.79 0.32 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -123.45 -159.32 0.84 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -1.114 . . . . 0.0 110.288 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -130.87 60.35 52.48 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.239 -0.913 . . . . 0.0 110.06 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.5 -165.48 0.17 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.819 1.431 . . . . 0.0 110.156 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.584 HG22 ' H ' ' A' ' 45' ' ' GLU . 5.9 m -125.39 -179.76 4.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.236 -0.915 . . . . 0.0 109.786 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.584 ' H ' HG22 ' A' ' 44' ' ' THR . 4.1 tp10 -69.04 -50.89 44.49 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.087 -1.008 . . . . 0.0 109.627 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.46 -57.15 11.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.196 -0.94 . . . . 0.0 109.876 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 3.4 tp10 -50.84 -39.74 54.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.915 . . . . 0.0 109.64 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.536 ' CG ' HD23 ' A' ' 32' ' ' LEU . 9.0 tt -54.79 -47.59 73.78 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.312 -0.868 . . . . 0.0 109.311 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.518 ' HG2' HG21 ' A' ' 29' ' ' THR . 1.6 mt-30 -54.32 -44.4 72.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.78 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 47' ' ' GLU . 1.6 m-20 -51.31 -43.9 61.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 109.536 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.445 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 54.6 mtp -64.01 -34.85 78.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.202 -0.936 . . . . 0.0 109.794 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.89 HD11 HD22 ' A' ' 32' ' ' LEU . 28.0 mm -64.72 -27.97 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.299 -0.876 . . . . 0.0 110.063 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -68.06 -38.34 82.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.334 -0.854 . . . . 0.0 110.407 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.589 ' HG3' HG23 ' A' ' 55' ' ' VAL . 16.7 pt-20 -82.32 -10.49 59.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.084 -1.01 . . . . 0.0 110.154 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.589 HG23 ' HG3' ' A' ' 54' ' ' GLU . 69.9 t -104.97 -9.99 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.189 -0.944 . . . . 0.0 110.155 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -98.52 102.43 14.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.115 -0.991 . . . . 0.0 110.299 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.54 -11.12 21.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.193 -0.942 . . . . 0.0 110.538 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -69.99 -59.48 2.89 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.111 -0.993 . . . . 0.0 110.15 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 131.75 -13.7 5.3 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -76.64 -42.12 43.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.053 -1.263 . . . . 0.0 110.106 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.17 -63.63 0.6 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 57.0 p -76.67 167.28 22.11 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.243 -1.151 . . . . 0.0 110.47 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.5 HG23 ' OE1' ' A' ' 67' ' ' GLU . 74.2 mt -96.19 152.29 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.208 -0.933 . . . . 0.0 109.98 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.404 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 22.7 m-20 -114.18 -157.58 0.63 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.905 . . . . 0.0 110.472 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.563 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 7.6 t80 -84.79 -42.63 0.69 Allowed Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.414 -0.804 . . . . 0.0 111.526 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.6 Cg_endo -73.52 -24.1 16.52 Favored 'Trans proline' 0 N--CA 1.481 0.786 0 O-C-N 122.994 0.997 . . . . 0.0 110.776 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.5 ' OE1' HG23 ' A' ' 63' ' ' ILE . 31.2 tt0 -79.24 -31.36 43.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.138 -0.976 . . . . 0.0 108.97 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.479 ' CE1' ' SD ' ' A' ' 72' ' ' MET . 16.4 t80 -70.68 -45.21 65.44 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.788 -0.57 . . . . 0.0 110.165 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.453 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 34.5 tp -75.75 -25.03 56.17 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.263 -0.898 . . . . 0.0 110.533 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 53.4 m -84.97 -18.22 35.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.091 -1.005 . . . . 0.0 110.567 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.7 tmm? -90.7 -38.19 13.23 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.045 -1.035 . . . . 0.0 110.876 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.479 ' SD ' ' CE1' ' A' ' 68' ' ' PHE . 66.5 mtt -90.0 -14.03 34.83 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.061 -1.024 . . . . 0.0 111.04 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.495 1.805 0 O-C-N 121.02 -1.05 . . . . 0.0 110.781 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.173 0.511 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.412 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 16.7 mt -47.91 -35.2 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.15 -0.969 . . . . 0.0 110.216 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -55.15 -54.54 42.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.179 -0.951 . . . . 0.0 109.712 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 55.5 mt-10 -54.62 -39.92 68.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.24 -0.912 . . . . 0.0 110.147 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.649 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -56.19 -56.24 23.36 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.269 -0.894 . . . . 0.0 110.107 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -48.27 -40.16 23.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.141 -0.975 . . . . 0.0 110.23 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 45.6 mtt-85 -61.42 -41.24 96.85 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.266 -0.896 . . . . 0.0 110.829 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.649 HG22 ' O ' ' A' ' 88' ' ' ALA . 29.5 m -83.24 -10.13 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.936 -1.103 . . . . 0.0 110.783 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.95 ' CE1' HG11 ' A' ' 108' ' ' VAL . 35.6 m-85 -105.32 -1.77 24.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.116 -0.99 . . . . 0.0 110.695 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -135.67 73.77 1.48 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.06 -1.025 . . . . 0.0 110.257 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -78.05 -24.63 47.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.237 -0.914 . . . . 0.0 110.545 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.5 p30 -70.16 -28.99 65.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.315 -0.865 . . . . 0.0 110.402 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.454 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 77.93 61.45 2.53 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.438 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 16.6 p-10 -125.24 -34.94 2.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.257 -1.143 . . . . 0.0 110.432 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.432 ' C ' ' CG ' ' A' ' 99' ' ' TYR . . . 108.06 16.71 11.94 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.779 -1.201 . . . . 0.0 110.374 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.432 ' CG ' ' C ' ' A' ' 98' ' ' GLY . 35.4 m-85 -147.48 134.57 20.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.985 -1.303 . . . . 0.0 110.002 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.497 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 17.9 mt -90.48 120.61 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.809 -1.182 . . . . 0.0 109.664 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.8 t -96.9 171.69 8.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.402 -0.812 . . . . 0.0 110.056 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.01 -46.84 61.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.87 . . . . 0.0 110.284 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.05 -55.15 22.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.298 -0.876 . . . . 0.0 110.439 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.615 ' O ' HG23 ' A' ' 108' ' ' VAL . 57.1 mt-10 -55.42 -50.06 70.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.259 -0.9 . . . . 0.0 110.613 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.683 ' O ' HD23 ' A' ' 105' ' ' LEU . 3.2 tt -49.92 -34.19 19.71 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.199 -0.938 . . . . 0.0 110.431 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.852 ' O ' HG23 ' A' ' 110' ' ' THR . 54.9 ttp180 -74.25 -36.76 63.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.153 -0.967 . . . . 0.0 110.001 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -74.49 -15.4 60.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.852 . . . . 0.0 110.075 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.95 HG11 ' CE1' ' A' ' 92' ' ' PHE . 77.1 t -85.91 -47.93 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.247 -0.908 . . . . 0.0 110.132 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.467 ' HG3' HD13 ' A' ' 116' ' ' LEU . 25.5 mmt -61.48 -32.72 72.74 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.965 . . . . 0.0 109.974 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.852 HG23 ' O ' ' A' ' 106' ' ' ARG . 66.7 p -59.93 -30.43 69.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.164 -0.96 . . . . 0.0 109.238 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -85.79 -31.08 22.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.555 -0.716 . . . . 0.0 109.974 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 77.5 mt -87.47 16.49 5.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 110.093 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 61.91 83.27 0.07 OUTLIER Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.49 ' HB3' HD12 ' A' ' 116' ' ' LEU . 1.3 mm-40 -158.31 133.42 8.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.187 -1.184 . . . . 0.0 110.464 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -95.38 104.19 16.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 110.028 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.49 HD12 ' HB3' ' A' ' 114' ' ' GLU . 1.7 mt -136.06 117.43 14.66 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.278 -0.888 . . . . 0.0 110.504 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.507 HG22 ' N ' ' A' ' 118' ' ' ASP . 38.2 m -71.44 172.81 8.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.314 -0.866 . . . . 0.0 109.91 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.507 ' N ' HG22 ' A' ' 117' ' ' THR . 4.6 m-20 -62.13 -31.8 72.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 110.222 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -69.59 -48.71 59.25 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.247 -0.908 . . . . 0.0 110.205 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.408 ' HB3' HD23 ' A' ' 116' ' ' LEU . 42.8 mt-10 -57.37 -50.81 71.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.127 -0.983 . . . . 0.0 109.935 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.402 HG13 ' HB3' ' A' ' 105' ' ' LEU . 89.3 t -55.35 -49.56 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.401 -0.812 . . . . 0.0 110.177 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.435 ' OD1' ' HD2' ' A' ' 126' ' ' ARG . 8.5 t70 -57.42 -31.87 66.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 110.066 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -70.05 -32.0 69.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.201 -0.937 . . . . 0.0 109.911 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 84.8 mtp -67.9 -44.71 76.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.31 -0.869 . . . . 0.0 109.646 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.464 HD11 HD12 ' A' ' 105' ' ' LEU . 30.1 mm -62.51 -37.57 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.412 -0.805 . . . . 0.0 110.345 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.435 ' HD2' ' OD1' ' A' ' 122' ' ' ASP . 65.8 mtp180 -70.4 -37.05 74.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.24 -0.913 . . . . 0.0 110.252 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -71.39 -27.26 63.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.185 -0.947 . . . . 0.0 109.895 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.66 -27.29 29.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.38 -0.825 . . . . 0.0 109.992 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.403 ' OD1' ' OD1' ' A' ' 131' ' ' ASP . 11.9 t0 -65.15 94.73 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.0 110.008 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 140' ' ' GLU . 68.7 mt -67.8 -31.42 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.225 -0.922 . . . . 0.0 110.231 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 19.5 p30 -100.84 -17.41 16.89 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.263 -0.898 . . . . 0.0 110.355 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 69.84 62.56 3.75 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.411 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 82.2 m-20 -101.56 -41.29 6.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.091 -1.241 . . . . 0.0 110.109 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.26 -22.06 1.09 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -142.57 162.75 34.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -1.148 . . . . 0.0 110.032 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 41.0 t -88.92 143.99 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.211 -0.93 . . . . 0.0 110.504 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -112.26 151.67 29.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 109.806 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.419 ' O ' HG23 ' A' ' 142' ' ' VAL . 55.4 t80 -46.18 -37.15 6.68 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.194 -0.941 . . . . 0.0 110.459 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -72.15 -45.25 61.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.232 -0.917 . . . . 0.0 110.495 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' A' ' 144' ' ' MET . 55.7 mt-10 -62.24 -23.31 66.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.127 -0.983 . . . . 0.0 110.438 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.56 ' CD1' ' CE ' ' A' ' 144' ' ' MET . 23.2 t80 -81.21 -39.78 24.87 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.321 -0.862 . . . . 0.0 110.544 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 138' ' ' TYR . 65.6 t -73.98 -21.83 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.239 -0.913 . . . . 0.0 110.564 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 68.9 mm-40 -88.27 -40.17 13.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.167 -0.958 . . . . 0.0 111.051 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.56 ' CE ' ' CD1' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -72.24 -20.47 61.54 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.865 -1.147 . . . . 0.0 110.943 -179.229 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.485 ' N ' ' HG3' ' A' ' 144' ' ' MET . 19.7 ttm -90.43 -68.07 0.81 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.098 -1.001 . . . . 0.0 110.547 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.099 -1.0 . . . . 0.0 110.283 -179.866 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.139 0.495 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -74.52 -40.49 61.73 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.451 -0.78 . . . . 0.0 110.701 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.417 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 54.0 mt-30 -67.66 -51.59 47.98 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.144 -0.972 . . . . 0.0 110.329 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.0 mt -57.72 -48.99 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.075 -1.016 . . . . 0.0 109.522 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.3 -32.11 68.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 109.74 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 37.0 tt0 -59.81 -51.19 70.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.914 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -58.66 -34.11 70.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.291 -0.881 . . . . 0.0 109.662 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.6 -46.73 86.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.377 -0.827 . . . . 0.0 110.466 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -59.49 -45.69 90.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.226 -0.921 . . . . 0.0 110.451 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.415 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -60.15 -41.55 92.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.957 . . . . 0.0 110.1 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -58.52 -56.21 25.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.276 -0.89 . . . . 0.0 110.141 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.2 m -53.36 -29.17 32.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.149 -0.969 . . . . 0.0 109.668 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.7 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.8 tt -66.43 -41.2 89.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.39 -0.819 . . . . 0.0 109.782 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.616 ' CD1' HG11 ' A' ' 35' ' ' VAL . 27.7 m-85 -77.61 -64.81 1.06 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.319 -0.863 . . . . 0.0 110.338 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.408 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 55.7 t0 -49.23 106.04 0.1 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.285 -0.884 . . . . 0.0 110.383 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -110.35 15.19 22.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.187 -0.946 . . . . 0.0 111.014 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.407 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 9.3 p-10 -126.19 -42.81 1.83 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.012 -1.055 . . . . 0.0 110.423 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.69 19.69 6.01 Favored Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.513 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.407 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 57.1 p-10 -91.39 -8.1 48.89 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.965 -1.314 . . . . 0.0 110.537 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.655 ' O ' HG23 ' A' ' 26' ' ' THR . . . 70.85 42.37 60.92 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.655 HG23 ' O ' ' A' ' 25' ' ' GLY . 9.3 p -158.34 148.8 20.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.242 -1.152 . . . . 0.0 109.943 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.6 mt -108.81 105.36 18.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.182 -0.949 . . . . 0.0 109.937 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.922 ' HA ' HG22 ' A' ' 62' ' ' THR . 3.5 m -96.65 -175.74 3.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.413 -0.804 . . . . 0.0 109.747 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.646 ' H ' HG22 ' A' ' 28' ' ' THR . 23.5 p -72.1 -29.32 63.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.0 110.539 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -65.4 -62.06 1.75 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 0.0 110.366 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.72 ' O ' HG23 ' A' ' 35' ' ' VAL . 49.5 mt-10 -57.12 -44.92 83.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.272 -0.893 . . . . 0.0 110.05 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.597 HD22 HD11 ' A' ' 52' ' ' ILE . 2.9 tp -63.85 -25.18 68.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -0.904 . . . . 0.0 109.665 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.14 -46.73 69.41 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.44 ' O ' ' CB ' ' A' ' 38' ' ' SER . 87.1 m -72.69 -21.77 61.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.311 -1.111 . . . . 0.0 109.498 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 31' ' ' GLU . 58.0 t -71.14 -42.45 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.431 -0.793 . . . . 0.0 109.811 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 26.0 mmt -75.46 -30.03 59.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 110.457 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -88.47 -9.38 52.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.156 -0.965 . . . . 0.0 110.301 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 34' ' ' THR . 47.7 t -101.09 8.84 42.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.09 -1.006 . . . . 0.0 110.542 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.9 mt -127.68 -81.37 0.6 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.139 -0.976 . . . . 0.0 110.207 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.466 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . -156.48 36.73 0.59 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.466 ' NE2' ' O ' ' A' ' 40' ' ' GLY . 4.9 mp0 -140.09 171.92 13.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.504 -0.998 . . . . 0.0 109.851 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.478 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 23.8 p30 -155.87 52.55 0.68 Allowed Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.023 -1.048 . . . . 0.0 111.048 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.478 ' HD3' ' N ' ' A' ' 42' ' ' ASN . 50.0 Cg_endo -77.68 160.81 31.19 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.671 1.353 . . . . 0.0 110.229 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.0 p -92.45 -142.22 0.2 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.276 -0.89 . . . . 0.0 109.883 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -105.59 -32.22 8.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.937 -1.102 . . . . 0.0 110.053 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.96 -67.7 0.54 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -0.938 . . . . 0.0 109.655 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -49.83 -38.7 36.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 109.441 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.497 HD11 HD23 ' A' ' 32' ' ' LEU . 6.4 tt -57.07 -48.88 77.48 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.45 -0.781 . . . . 0.0 109.342 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -51.51 -42.07 61.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.434 -0.791 . . . . 0.0 109.551 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.39 -42.78 99.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.871 . . . . 0.0 109.816 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.441 ' HA ' ' OE2' ' A' ' 54' ' ' GLU . 18.5 ttp -62.3 -19.8 63.66 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.283 -0.885 . . . . 0.0 109.353 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.597 HD11 HD22 ' A' ' 32' ' ' LEU . 25.4 mt -89.18 -24.52 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.426 -0.796 . . . . 0.0 109.887 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -67.97 -35.3 78.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.302 -0.874 . . . . 0.0 110.154 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.444 ' HG3' HG23 ' A' ' 55' ' ' VAL . 17.2 pt-20 -73.73 -33.75 64.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.224 -0.922 . . . . 0.0 110.04 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.444 HG23 ' HG3' ' A' ' 54' ' ' GLU . 99.9 t -77.1 -68.78 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.285 -0.885 . . . . 0.0 109.806 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.411 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 64.1 t0 -47.0 125.72 7.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.276 -0.89 . . . . 0.0 110.051 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.67 28.78 5.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.217 -0.927 . . . . 0.0 110.206 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.443 ' HB2' ' OD1' ' A' ' 60' ' ' ASN . 40.5 m-20 -122.76 -62.08 1.39 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.405 -0.809 . . . . 0.0 110.05 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.82 36.16 0.6 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.443 ' OD1' ' HB2' ' A' ' 58' ' ' ASP . 6.8 m120 -103.85 -40.67 6.15 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.176 -1.19 . . . . 0.0 110.107 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.413 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 123.87 -14.79 7.97 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.922 HG22 ' HA ' ' A' ' 28' ' ' THR . 75.2 p -130.97 164.47 25.28 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.147 -1.208 . . . . 0.0 110.446 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 80.1 mt -110.21 122.15 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.246 -0.909 . . . . 0.0 110.237 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.447 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 55.0 m-20 -81.38 -168.32 1.81 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.307 -0.871 . . . . 0.0 110.399 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.547 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 42.4 t80 -72.99 -42.46 7.31 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 111.246 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.8 Cg_endo -75.76 -28.19 8.18 Favored 'Trans proline' 0 C--N 1.325 -0.703 0 O-C-N 123.035 1.018 . . . . 0.0 109.821 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.413 ' OE1' ' OD2' ' A' ' 58' ' ' ASP . 40.7 tt0 -73.52 -24.03 60.1 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.446 ' O ' ' HG2' ' A' ' 71' ' ' MET . 10.3 t80 -84.73 -43.01 14.68 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.429 0.633 . . . . 0.0 110.145 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.627 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 3.7 tt -72.3 -18.28 61.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.193 -0.942 . . . . 0.0 110.128 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.5 m -90.3 -43.04 10.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.125 -0.984 . . . . 0.0 110.493 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.488 ' HG3' ' N ' ' A' ' 72' ' ' MET . 6.5 ptt? -64.09 -40.99 97.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.145 -0.972 . . . . 0.0 110.518 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.488 ' N ' ' HG3' ' A' ' 71' ' ' MET . 32.7 mtt -84.32 -9.66 58.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.099 -1.001 . . . . 0.0 110.683 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.627 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.495 1.798 0 O-C-N 121.024 -1.047 . . . . 0.0 110.618 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 121.147 0.499 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.7 mt -68.0 -59.39 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.252 -0.905 . . . . 0.0 110.388 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.4 ttm-85 -53.02 -43.5 66.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.059 -1.025 . . . . 0.0 109.448 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -54.61 -43.83 72.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.361 -0.837 . . . . 0.0 109.629 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 92' ' ' PHE . . . -58.47 -37.73 76.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.35 -0.843 . . . . 0.0 109.667 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -65.03 -28.93 69.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.063 -1.023 . . . . 0.0 109.897 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -70.45 -58.95 3.16 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.494 -0.754 . . . . 0.0 111.118 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.557 HG23 ' N ' ' A' ' 92' ' ' PHE . 30.1 m -62.94 -43.33 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.14 -0.975 . . . . 0.0 110.981 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.695 ' HA ' HG21 ' A' ' 108' ' ' VAL . 18.0 m-85 -69.72 -22.42 63.4 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.973 -1.08 . . . . 0.0 110.263 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.409 ' OD2' ' O ' ' A' ' 99' ' ' TYR . 11.9 t70 -147.28 81.96 1.54 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.963 . . . . 0.0 110.483 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.6 pttt -109.68 47.43 0.94 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.355 -0.841 . . . . 0.0 109.907 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 1.8 p30 -115.31 -31.69 5.88 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.273 -0.892 . . . . 0.0 110.618 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.46 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 138.33 -54.09 0.7 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.279 -1.438 . . . . 0.0 110.959 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -48.77 -34.46 12.29 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 120.947 -1.325 . . . . 0.0 110.846 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.469 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 80.28 33.01 33.27 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.963 -1.113 . . . . 0.0 110.406 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.483 ' HB3' ' CB ' ' A' ' 135' ' ' GLN . 20.7 m-85 -130.2 127.58 39.95 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.951 -1.323 . . . . 0.0 109.884 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.647 HD13 ' CE1' ' A' ' 141' ' ' PHE . 8.8 mt -76.01 110.39 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.962 -1.086 . . . . 0.0 110.167 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.1 t -93.6 165.59 12.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.065 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.51 -41.39 96.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.291 -0.88 . . . . 0.0 110.341 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.4 -53.36 49.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.186 -0.946 . . . . 0.0 110.037 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.427 ' O ' HG23 ' A' ' 108' ' ' VAL . 51.0 mt-10 -51.75 -37.73 52.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.426 -0.796 . . . . 0.0 110.103 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.0 tt -69.36 -35.2 75.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.4 -0.813 . . . . 0.0 110.121 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.785 ' O ' HG23 ' A' ' 110' ' ' THR . 58.0 ttp180 -66.36 -26.69 67.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.483 -0.76 . . . . 0.0 110.254 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -85.01 -31.54 23.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.281 -0.887 . . . . 0.0 110.514 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.695 HG21 ' HA ' ' A' ' 92' ' ' PHE . 98.2 t -76.37 -30.94 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.166 -0.959 . . . . 0.0 110.452 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.4 mmt -75.99 -26.57 56.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.104 -0.998 . . . . 0.0 110.18 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.785 HG23 ' O ' ' A' ' 106' ' ' ARG . 45.4 p -68.67 -40.61 80.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.27 -0.894 . . . . 0.0 110.146 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -80.01 -41.54 25.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.195 -0.94 . . . . 0.0 110.045 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.444 ' HA ' HD23 ' A' ' 112' ' ' LEU . 9.2 mt -47.63 -25.47 1.18 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.255 -0.903 . . . . 0.0 110.204 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.44 20.8 8.34 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -123.19 110.0 14.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.23 -1.159 . . . . 0.0 110.3 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.95 107.25 9.16 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.341 -0.85 . . . . 0.0 110.285 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.9 -174.85 2.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.184 -0.947 . . . . 0.0 110.19 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 118' ' ' ASP . 30.5 m -136.8 166.65 23.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 110.209 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.425 ' N ' HG22 ' A' ' 117' ' ' THR . 22.5 m-20 -55.07 -33.22 62.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -0.94 . . . . 0.0 110.359 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.18 -47.24 80.57 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.328 -0.857 . . . . 0.0 110.784 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -65.4 -58.39 5.98 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.118 -0.989 . . . . 0.0 110.613 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.2 t -49.64 -41.24 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.145 -0.972 . . . . 0.0 110.395 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -64.39 -39.08 93.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.167 -0.958 . . . . 0.0 110.163 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -66.91 -30.06 70.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.223 -0.923 . . . . 0.0 110.152 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 78.7 mtp -75.83 -62.99 1.41 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.178 -0.951 . . . . 0.0 110.66 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 26.0 mm -52.05 -29.23 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.156 -0.965 . . . . 0.0 110.67 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.1 mtp85 -71.75 -56.87 4.98 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.051 -1.031 . . . . 0.0 110.349 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -69.45 -8.28 45.4 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.197 -0.939 . . . . 0.0 110.361 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -98.83 -24.66 14.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -0.919 . . . . 0.0 110.104 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -83.51 83.65 7.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.075 -1.016 . . . . 0.0 109.915 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.519 HD12 ' HG2' ' A' ' 140' ' ' GLU . 18.5 mt -45.41 -69.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.33 -0.856 . . . . 0.0 110.688 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.8 p30 -60.91 -24.41 65.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.221 -0.924 . . . . 0.0 110.366 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.421 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 62.51 62.64 5.37 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -106.61 -31.51 8.45 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.24 -1.153 . . . . 0.0 110.205 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 161.96 -49.11 0.34 Allowed Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.13 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.483 ' CB ' ' HB3' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -123.42 170.43 10.36 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.033 -1.274 . . . . 0.0 110.107 -179.363 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.4 t -105.97 97.8 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.379 -0.826 . . . . 0.0 110.002 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.409 ' OD1' ' HB3' ' A' ' 139' ' ' GLU . 9.8 p30 -70.19 179.43 2.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.332 -0.855 . . . . 0.0 110.355 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.441 ' O ' HG23 ' A' ' 142' ' ' VAL . 18.9 t80 -61.65 -41.43 97.5 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.311 -0.868 . . . . 0.0 111.268 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.409 ' HB3' ' OD1' ' A' ' 137' ' ' ASN . 25.2 tt0 -53.15 -52.17 59.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.028 -1.045 . . . . 0.0 110.199 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.519 ' HG2' HD12 ' A' ' 130' ' ' ILE . 55.0 mt-10 -67.4 -21.25 65.6 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.275 -0.891 . . . . 0.0 109.879 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.647 ' CE1' HD13 ' A' ' 100' ' ' ILE . 1.9 t80 -77.54 -23.33 50.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.359 -0.838 . . . . 0.0 110.414 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 138' ' ' TYR . 80.4 t -88.43 -23.05 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.197 -0.939 . . . . 0.0 110.511 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -91.65 -39.02 12.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.296 -0.877 . . . . 0.0 110.799 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.496 ' HE3' ' HG3' ' A' ' 145' ' ' MET . 0.0 OUTLIER -67.44 -17.75 64.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.981 -1.074 . . . . 0.0 110.358 -179.651 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.496 ' HG3' ' HE3' ' A' ' 144' ' ' MET . 52.2 mtt -88.13 -55.06 3.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.118 -0.989 . . . . 0.0 109.887 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 146' ' ' THR . 2.7 t . . . . . 0 N--CA 1.495 1.788 0 O-C-N 121.508 -0.745 . . . . 0.0 110.069 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.336 0.588 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -77.22 -33.03 56.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.402 -0.812 . . . . 0.0 109.457 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -67.57 -59.13 3.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.448 -0.782 . . . . 0.0 110.285 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.4 mt -59.71 -34.72 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 109.587 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.28 -32.38 73.96 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.267 -0.896 . . . . 0.0 108.988 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -66.91 -51.75 51.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.459 -0.775 . . . . 0.0 109.426 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -59.46 -29.99 68.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.618 -0.676 . . . . 0.0 109.751 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -66.26 -55.99 13.44 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.4 -0.812 . . . . 0.0 110.191 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -51.01 -38.25 50.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.16 -0.962 . . . . 0.0 109.969 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.514 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -62.13 -54.31 42.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.026 -1.046 . . . . 0.0 109.886 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.453 ' CE1' HD11 ' A' ' 27' ' ' ILE . 18.5 t80 -56.7 -26.9 57.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.294 -0.879 . . . . 0.0 110.687 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.0 p -75.98 -35.06 59.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.179 -0.95 . . . . 0.0 109.888 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.642 ' O ' HD23 ' A' ' 18' ' ' LEU . 3.1 tt -69.51 -26.8 64.71 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.313 -0.867 . . . . 0.0 109.644 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.645 ' CD1' HG11 ' A' ' 35' ' ' VAL . 30.4 m-85 -86.08 -69.19 0.68 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.375 -0.828 . . . . 0.0 109.938 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -56.18 105.07 0.17 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.312 -0.868 . . . . 0.0 110.283 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -105.75 -38.06 6.51 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.312 -0.867 . . . . 0.0 110.665 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -70.27 -26.11 63.67 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.141 -0.975 . . . . 0.0 110.505 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.89 106.44 0.83 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 7.7 p-10 -169.64 -39.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -1.177 . . . . 0.0 110.263 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.72 12.57 12.59 Favored Glycine 0 N--CA 1.495 2.632 0 C-N-CA 119.93 -1.129 . . . . 0.0 110.37 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 54.8 p -139.96 164.97 28.59 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.044 -1.269 . . . . 0.0 110.267 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.468 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 40.8 mt -123.47 120.56 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.135 -0.978 . . . . 0.0 110.191 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.613 HG22 ' H ' ' A' ' 29' ' ' THR . 5.2 m -113.75 -179.08 3.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.35 -0.844 . . . . 0.0 110.292 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.613 ' H ' HG22 ' A' ' 28' ' ' THR . 56.1 p -68.84 -27.49 65.88 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.267 -0.896 . . . . 0.0 110.754 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.3 mtmm -66.31 -61.34 2.06 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.059 -1.026 . . . . 0.0 109.929 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -60.91 -58.83 6.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.056 -1.028 . . . . 0.0 109.541 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.991 HD23 HD11 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -52.1 -26.73 11.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 109.708 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.44 -52.42 46.69 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 97.2 m -65.77 -23.99 66.84 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.203 -1.174 . . . . 0.0 109.879 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.645 HG11 ' CD1' ' A' ' 19' ' ' PHE . 46.5 t -66.34 -42.83 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.442 -0.786 . . . . 0.0 109.904 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.466 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 61.5 mtt -89.17 -11.63 43.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.376 -0.828 . . . . 0.0 110.379 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -89.85 -21.24 22.65 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.163 -0.961 . . . . 0.0 110.186 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.9 m -109.52 -22.51 11.95 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.197 -0.939 . . . . 0.0 110.432 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.46 66.1 1.08 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.147 -0.971 . . . . 0.0 110.637 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.02 51.64 0.16 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -48.08 102.26 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.236 -1.155 . . . . 0.0 110.304 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.523 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 2.4 t30 -156.67 -65.93 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.885 . . . . 0.0 110.234 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.523 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 46.3 Cg_endo -72.23 170.42 19.16 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.316 1.166 . . . . 0.0 110.311 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.5 HG23 ' N ' ' A' ' 45' ' ' GLU . 10.8 t -119.39 -149.09 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.623 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.5 ' N ' HG23 ' A' ' 44' ' ' THR . 22.0 tt0 -95.81 -31.84 12.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.831 -1.168 . . . . 0.0 110.115 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.481 ' H ' HG23 ' A' ' 44' ' ' THR . . . -74.64 -67.65 0.61 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.23 -0.919 . . . . 0.0 110.089 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -49.0 -31.55 7.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.135 -0.978 . . . . 0.0 109.744 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.991 HD11 HD23 ' A' ' 32' ' ' LEU . 9.1 tt -63.96 -51.7 63.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.92 . . . . 0.0 109.209 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.7 tm0? -49.5 -41.47 40.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.459 -0.776 . . . . 0.0 109.605 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -64.71 -39.46 93.69 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.36 -0.837 . . . . 0.0 109.709 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.452 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 25.4 ttp -70.27 -13.18 62.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.158 -0.963 . . . . 0.0 109.85 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.978 HD11 HD22 ' A' ' 32' ' ' LEU . 29.7 mm -84.75 -35.31 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.218 -0.926 . . . . 0.0 109.537 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -60.7 -39.88 90.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.463 -0.773 . . . . 0.0 110.504 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.473 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 12.3 pt-20 -69.39 -35.95 76.3 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.128 -0.983 . . . . 0.0 110.596 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.641 HG11 HD11 ' A' ' 63' ' ' ILE . 79.6 t -71.39 -28.39 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.064 -1.023 . . . . 0.0 110.062 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -96.8 117.3 30.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.37 -0.832 . . . . 0.0 110.448 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.06 25.95 10.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -0.843 . . . . 0.0 109.773 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -106.61 -68.13 0.9 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.485 -0.759 . . . . 0.0 110.167 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.38 -14.27 2.06 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.421 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 27.7 p-10 -69.78 -14.11 62.61 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.15 -1.206 . . . . 0.0 110.287 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.642 ' O ' HG23 ' A' ' 62' ' ' THR . . . 79.24 23.86 62.42 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.011 -1.09 . . . . 0.0 110.545 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.642 HG23 ' O ' ' A' ' 61' ' ' GLY . 7.1 p -156.44 167.65 29.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.996 -1.296 . . . . 0.0 110.414 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.641 HD11 HG11 ' A' ' 55' ' ' VAL . 82.9 mt -108.31 169.74 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.182 -0.949 . . . . 0.0 110.596 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.546 ' N ' HG22 ' A' ' 63' ' ' ILE . 46.7 m-20 -131.44 -163.02 1.28 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.31 -0.869 . . . . 0.0 109.848 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.562 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 40.1 t80 -82.51 -43.26 0.95 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.068 -1.02 . . . . 0.0 111.357 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 47.2 Cg_endo -73.15 -28.53 12.62 Favored 'Trans proline' 0 N--CA 1.48 0.68 0 O-C-N 123.091 1.048 . . . . 0.0 110.304 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -78.34 -23.73 46.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.105 -0.997 . . . . 0.0 109.225 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.456 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 24.3 t80 -75.91 -48.64 20.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.624 -0.672 . . . . 0.0 110.201 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.589 ' O ' HD23 ' A' ' 69' ' ' LEU . 2.8 tt -75.71 -21.49 57.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.353 -0.842 . . . . 0.0 110.349 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.7 m -89.57 -21.86 22.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -0.964 . . . . 0.0 110.713 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.471 ' HG3' ' N ' ' A' ' 72' ' ' MET . 8.1 ptt? -88.86 -36.08 16.2 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.964 -1.085 . . . . 0.0 110.515 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.471 ' N ' ' HG3' ' A' ' 71' ' ' MET . 52.5 mtt -84.72 -23.55 29.26 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.188 -0.945 . . . . 0.0 110.0 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.368 -0.832 . . . . 0.0 110.04 179.827 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.304 0.573 . . . . 0.0 110.361 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 40.7 mt -51.71 -34.93 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.112 -0.993 . . . . 0.0 109.733 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -58.08 -43.89 87.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.944 . . . . 0.0 109.398 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -62.23 -33.59 74.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.424 -0.798 . . . . 0.0 109.784 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.783 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -65.92 -66.48 0.54 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.416 -0.802 . . . . 0.0 109.889 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -49.62 -26.62 3.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.927 . . . . 0.0 110.308 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.412 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 16.0 tpt180 -68.78 -45.23 71.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.148 -0.97 . . . . 0.0 110.255 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.783 HG22 ' O ' ' A' ' 88' ' ' ALA . 34.0 m -76.27 -15.79 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.283 -0.885 . . . . 0.0 110.443 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.757 ' HE2' ' HB1' ' A' ' 88' ' ' ALA . 23.0 m-85 -90.85 -18.38 24.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.132 -0.98 . . . . 0.0 110.491 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -128.82 44.32 2.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.099 -1.001 . . . . 0.0 110.077 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 20.4 ptmt -106.46 47.62 0.87 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 110.403 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.414 ' OD2' ' OE1' ' A' ' 104' ' ' GLU . 2.8 p30 -116.88 -22.57 8.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.237 -0.915 . . . . 0.0 110.043 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.23 29.33 4.03 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -105.78 -71.09 0.76 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.405 -1.056 . . . . 0.0 110.091 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 151.9 -36.48 0.84 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -134.12 169.59 16.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -1.16 . . . . 0.0 110.133 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.5 mt -73.1 131.29 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 109.858 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.425 ' HB3' ' OE2' ' A' ' 104' ' ' GLU . 36.5 t -113.83 172.26 7.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.47 -0.769 . . . . 0.0 110.023 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.455 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -68.65 -48.06 64.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -0.947 . . . . 0.0 110.144 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.89 -52.35 66.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.185 -0.947 . . . . 0.0 110.247 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.721 ' O ' HG23 ' A' ' 108' ' ' VAL . 46.2 mt-10 -48.97 -54.76 14.22 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.376 -0.827 . . . . 0.0 110.577 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 105' ' ' LEU . 5.2 tt -61.25 -30.33 70.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.379 -0.826 . . . . 0.0 110.763 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.528 ' HG3' HG21 ' A' ' 121' ' ' VAL . 17.0 ttp180 -67.24 -38.89 85.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.187 -0.945 . . . . 0.0 110.583 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -84.04 -14.2 51.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 110.472 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 104' ' ' GLU . 71.8 t -84.29 -29.15 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.236 -0.915 . . . . 0.0 110.527 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.598 ' HB3' HD12 ' A' ' 116' ' ' LEU . 26.4 mmt -81.81 -46.65 13.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.946 . . . . 0.0 110.529 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.2 p -50.44 -32.97 19.34 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 110.268 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -86.16 -48.81 8.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.128 -0.982 . . . . 0.0 110.372 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 112' ' ' LEU . 22.6 mt -47.07 -32.46 4.11 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.138 -0.976 . . . . 0.0 110.509 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.48 38.4 0.92 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -119.06 167.4 11.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.341 -1.094 . . . . 0.0 110.069 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -121.41 94.49 4.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.889 . . . . 0.0 110.061 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.598 HD12 ' HB3' ' A' ' 109' ' ' MET . 5.5 mt -128.58 151.94 48.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.281 -0.887 . . . . 0.0 110.228 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.536 HG22 ' N ' ' A' ' 118' ' ' ASP . 91.4 m -99.77 172.39 7.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.868 . . . . 0.0 110.002 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.536 ' N ' HG22 ' A' ' 117' ' ' THR . 1.4 m-20 -56.45 -62.89 1.41 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.242 -0.911 . . . . 0.0 110.636 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -52.54 -41.4 63.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.143 -0.973 . . . . 0.0 110.315 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.435 ' O ' ' HB3' ' A' ' 123' ' ' GLU . 6.4 mm-40 -52.08 -50.63 61.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.118 -0.989 . . . . 0.0 110.017 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.528 HG21 ' HG3' ' A' ' 106' ' ' ARG . 63.8 t -57.54 -43.9 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.16 -0.962 . . . . 0.0 109.821 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -59.58 -28.53 67.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.297 -0.877 . . . . 0.0 109.729 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 24.4 tt0 -73.27 -37.44 66.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.352 -0.842 . . . . 0.0 109.863 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 74.9 mtp -66.4 -39.92 89.3 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.274 -0.891 . . . . 0.0 109.821 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 31.8 mm -69.22 -38.61 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -0.906 . . . . 0.0 110.188 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -62.77 -46.33 88.52 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.257 -0.902 . . . . 0.0 110.228 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -62.47 -38.84 91.41 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.292 -0.88 . . . . 0.0 110.162 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.14 -16.0 61.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -0.861 . . . . 0.0 110.21 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.411 ' OD1' ' OD1' ' A' ' 131' ' ' ASP . 57.7 t0 -87.78 60.95 6.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.365 -0.835 . . . . 0.0 110.129 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.469 HG13 ' N ' ' A' ' 131' ' ' ASP . 18.0 pt -56.02 -42.26 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.435 -0.791 . . . . 0.0 111.409 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.469 ' N ' HG13 ' A' ' 130' ' ' ILE . 47.8 p-10 -72.74 -18.99 61.46 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.037 -1.039 . . . . 0.0 111.125 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.34 72.19 0.88 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 33.7 p30 -126.15 -16.99 5.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.406 -1.055 . . . . 0.0 110.873 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.465 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 122.96 -49.89 0.87 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.409 ' NE2' ' C ' ' A' ' 135' ' ' GLN . 0.0 OUTLIER -119.18 164.7 15.19 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.086 -1.243 . . . . 0.0 110.772 -179.611 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.5 t -102.63 127.0 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.303 -0.873 . . . . 0.0 110.053 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -97.22 -172.12 2.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.953 -1.092 . . . . 0.0 110.459 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -64.4 -62.47 1.58 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.334 -0.854 . . . . 0.0 111.621 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -43.87 -53.53 5.99 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.239 -0.913 . . . . 0.0 111.141 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -56.77 -39.37 73.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.898 -1.126 . . . . 0.0 110.399 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.525 ' CZ ' ' HE1' ' A' ' 145' ' ' MET . 20.2 t80 -66.82 -27.09 67.27 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.391 -0.818 . . . . 0.0 111.133 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 57.6 t -90.06 -20.67 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.024 -1.047 . . . . 0.0 110.77 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -83.81 -30.04 26.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.212 -0.93 . . . . 0.0 110.824 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.47 ' CE ' ' CD1' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -90.01 -13.19 36.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.112 -0.993 . . . . 0.0 110.608 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.525 ' HE1' ' CZ ' ' A' ' 141' ' ' PHE . 30.0 ttm -89.98 -27.99 19.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.913 . . . . 0.0 110.537 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 60.0 p . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.134 -0.979 . . . . 0.0 110.194 179.847 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.586 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.331 0.586 . . . . 0.0 109.931 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -74.24 -66.07 0.77 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.28 -0.888 . . . . 0.0 109.814 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -54.77 -58.75 6.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.23 -0.919 . . . . 0.0 109.997 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 9' ' ' ILE . 28.6 mt -47.73 -49.14 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.124 -0.985 . . . . 0.0 110.062 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 6' ' ' GLU . . . -52.83 -41.6 64.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.275 -0.89 . . . . 0.0 110.2 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -61.0 -41.44 96.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.879 . . . . 0.0 110.132 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -64.06 -30.17 71.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.279 -0.888 . . . . 0.0 109.734 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.478 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 30.1 mtpt -68.99 -38.97 79.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.535 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.31 -45.19 95.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.313 -0.867 . . . . 0.0 109.341 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.85 -44.8 86.77 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.317 -0.865 . . . . 0.0 109.452 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -56.22 -42.15 76.8 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.315 -0.865 . . . . 0.0 109.633 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.4 t -59.1 -42.63 90.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.428 -0.795 . . . . 0.0 109.641 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.582 ' O ' HD23 ' A' ' 18' ' ' LEU . 5.8 tt -59.79 -29.36 68.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.464 -0.772 . . . . 0.0 109.456 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.672 ' HA ' HG21 ' A' ' 35' ' ' VAL . 5.8 m-30 -88.24 -18.29 28.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.464 -0.772 . . . . 0.0 110.043 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -104.17 64.06 0.76 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.397 -0.814 . . . . 0.0 109.35 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.497 ' HE3' ' CG2' ' A' ' 34' ' ' THR . 53.0 mttm -44.73 -52.96 7.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.586 -0.696 . . . . 0.0 111.267 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.417 ' OD2' ' OD2' ' A' ' 24' ' ' ASP . 6.7 p-10 -69.7 -43.22 72.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.906 -1.121 . . . . 0.0 110.017 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.83 51.52 1.64 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 3.5 p30 -105.66 -24.53 12.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.058 -1.26 . . . . 0.0 109.878 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.549 ' C ' HG23 ' A' ' 26' ' ' THR . . . 111.86 30.38 3.02 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.549 HG23 ' C ' ' A' ' 25' ' ' GLY . 57.8 p -153.73 158.26 40.72 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.024 -1.28 . . . . 0.0 110.53 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.0 mt -124.22 109.21 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.317 -0.864 . . . . 0.0 109.934 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.601 HG22 ' CG2' ' A' ' 62' ' ' THR . 68.9 p -95.66 -164.51 1.17 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.239 -0.913 . . . . 0.0 110.301 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.455 HG22 HD12 ' A' ' 52' ' ' ILE . 35.8 p -85.41 -26.13 26.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.246 -0.908 . . . . 0.0 110.206 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.87 -62.8 1.24 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.24 -0.912 . . . . 0.0 110.025 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.74 ' O ' HG23 ' A' ' 35' ' ' VAL . 56.9 mt-10 -57.66 -46.06 84.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.137 -0.977 . . . . 0.0 109.763 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.872 HD22 HD11 ' A' ' 52' ' ' ILE . 0.8 OUTLIER -60.25 -32.04 70.78 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.269 -0.894 . . . . 0.0 109.676 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.54 -50.83 63.31 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.497 ' CG2' ' HE3' ' A' ' 21' ' ' LYS . 63.5 m -70.01 -22.3 63.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.105 -1.232 . . . . 0.0 109.611 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 31' ' ' GLU . 51.4 t -70.21 -32.2 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.472 -0.768 . . . . 0.0 109.55 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.425 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 26.2 mmt -86.97 -22.72 25.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.375 -0.828 . . . . 0.0 109.622 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.4 mmm-85 -68.16 -45.25 74.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 0.0 109.875 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.1 m -94.73 8.73 41.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.308 -0.87 . . . . 0.0 110.296 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -164.09 74.78 0.31 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.102 -0.999 . . . . 0.0 110.19 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.31 -91.49 0.14 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -161.84 -145.37 0.11 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -1.145 . . . . 0.0 110.011 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -121.4 72.06 26.81 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.007 . . . . 0.0 110.299 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -76.18 135.97 17.55 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.874 1.46 . . . . 0.0 110.179 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 72.8 p -73.4 -149.83 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.209 -0.932 . . . . 0.0 110.282 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -104.39 -42.41 5.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 109.894 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.42 -63.72 1.01 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.241 -0.912 . . . . 0.0 109.744 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 38.4 tt0 -51.61 -41.32 61.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.914 . . . . 0.0 109.689 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.456 HD11 HD23 ' A' ' 32' ' ' LEU . 7.9 tt -55.27 -53.13 60.02 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.809 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -51.41 -37.56 49.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.364 -0.835 . . . . 0.0 109.767 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 7.4 t0 -63.11 -40.64 98.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.334 -0.854 . . . . 0.0 109.724 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.432 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 21.8 ttp -66.67 -19.24 65.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.329 -0.857 . . . . 0.0 109.636 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.872 HD11 HD22 ' A' ' 32' ' ' LEU . 26.3 mt -87.77 -25.48 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.252 -0.905 . . . . 0.0 110.479 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -62.5 -38.47 90.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.05 -1.031 . . . . 0.0 110.388 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.547 ' HG3' HG23 ' A' ' 55' ' ' VAL . 14.3 pt-20 -65.5 -18.76 65.56 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.123 -0.985 . . . . 0.0 110.343 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.547 HG23 ' HG3' ' A' ' 54' ' ' GLU . 79.6 t -95.9 -69.7 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.247 -0.908 . . . . 0.0 110.065 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -45.1 123.33 3.85 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.385 -0.822 . . . . 0.0 110.531 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.33 36.74 2.95 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.894 . . . . 0.0 110.363 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.414 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 48.6 m-20 -123.68 -52.22 1.81 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.24 -0.912 . . . . 0.0 110.371 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.31 16.17 7.88 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.45 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 24.6 p30 -93.62 -20.97 19.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.257 -1.143 . . . . 0.0 110.023 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.45 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 109.91 -44.77 1.43 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.601 ' CG2' HG22 ' A' ' 28' ' ' THR . 71.0 p -98.81 164.9 12.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.095 -1.238 . . . . 0.0 110.568 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.1 mt -101.88 158.59 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.148 -0.97 . . . . 0.0 110.132 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.43 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 32.4 m-20 -113.4 -167.82 1.25 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.372 -0.83 . . . . 0.0 110.797 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.563 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 41.8 t80 -76.37 -42.97 3.33 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.422 -0.799 . . . . 0.0 111.342 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.2 Cg_endo -72.6 -25.99 16.98 Favored 'Trans proline' 0 C--O 1.208 -1.02 0 O-C-N 123.033 1.017 . . . . 0.0 110.32 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.414 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 49.5 mt-10 -78.54 -24.32 45.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.038 -1.039 . . . . 0.0 109.351 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.484 ' CZ ' ' SD ' ' A' ' 72' ' ' MET . 55.7 t80 -78.12 -51.73 9.82 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.55 -0.719 . . . . 0.0 110.466 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.754 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 3.4 tt -75.1 -20.04 59.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.243 -0.911 . . . . 0.0 110.727 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.437 ' HB ' ' O ' ' A' ' 66' ' ' PRO . 18.9 m -82.21 -50.83 8.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.079 -1.013 . . . . 0.0 110.503 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.01 -29.66 67.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.093 -1.004 . . . . 0.0 109.867 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.484 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 52.8 mtt -86.5 -12.91 47.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.218 -0.926 . . . . 0.0 110.188 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.233 -0.917 . . . . 0.0 110.636 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 . . . . . 0 N--CA 1.496 1.846 0 CA-C-O 121.342 0.591 . . . . 0.0 110.301 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 32.7 mt -58.86 -33.71 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.071 -1.018 . . . . 0.0 109.711 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -54.79 -44.92 74.18 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.273 -0.892 . . . . 0.0 109.408 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -64.78 -36.32 83.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.304 -0.873 . . . . 0.0 110.072 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.682 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -60.43 -61.95 2.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.33 -0.857 . . . . 0.0 110.293 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.469 ' CE1' ' HA ' ' A' ' 138' ' ' TYR . 1.1 t80 -55.13 -28.26 51.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.452 -0.78 . . . . 0.0 110.54 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.65 -47.75 65.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.151 -0.968 . . . . 0.0 110.844 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.734 HG23 ' CD1' ' A' ' 92' ' ' PHE . 27.2 m -69.59 -24.64 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.069 -1.019 . . . . 0.0 110.477 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.734 ' CD1' HG23 ' A' ' 91' ' ' VAL . 13.4 m-85 -86.18 -16.89 36.4 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.239 -0.913 . . . . 0.0 110.239 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -109.22 97.12 6.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.274 -0.891 . . . . 0.0 110.245 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -103.41 12.43 35.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.904 . . . . 0.0 110.545 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 1.9 p30 -116.64 -41.74 3.05 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.988 -1.07 . . . . 0.0 110.501 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.468 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 111.91 36.66 1.65 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.438 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 41.0 p30 -117.11 -9.54 11.03 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.941 -1.329 . . . . 0.0 110.844 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 70.82 35.89 65.98 Favored Glycine 0 N--CA 1.498 2.822 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 28.1 m-85 -140.25 136.77 33.67 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.205 -1.174 . . . . 0.0 109.66 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.424 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 12.8 mt -92.11 119.59 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.938 -1.101 . . . . 0.0 109.797 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 77.6 p -109.75 151.66 26.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.166 -0.959 . . . . 0.0 110.226 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.1 -29.41 60.58 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.197 -0.939 . . . . 0.0 110.413 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.72 -52.91 61.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.204 -0.935 . . . . 0.0 110.235 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.841 ' O ' HG23 ' A' ' 108' ' ' VAL . 98.7 mt-10 -66.51 -55.82 13.76 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.243 -0.911 . . . . 0.0 110.28 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.611 HD23 HG13 ' A' ' 121' ' ' VAL . 17.2 tp -53.41 -25.35 15.41 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.109 -0.994 . . . . 0.0 110.35 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 47.2 ttt85 -71.45 -49.83 37.67 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.262 -0.899 . . . . 0.0 110.313 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -79.63 -9.33 59.62 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.27 -0.894 . . . . 0.0 110.792 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 104' ' ' GLU . 91.0 t -83.97 -46.37 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.059 -1.026 . . . . 0.0 110.47 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.405 ' O ' ' HB2' ' A' ' 114' ' ' GLU . 25.8 mtt -82.0 -32.81 30.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.041 -1.037 . . . . 0.0 110.585 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 55.8 m -67.23 -31.04 71.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.215 -0.928 . . . . 0.0 110.347 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -87.64 -42.13 12.9 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.177 -0.952 . . . . 0.0 110.322 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.434 HD12 ' O ' ' A' ' 108' ' ' VAL . 29.7 mt -46.13 -27.15 0.9 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.273 -0.892 . . . . 0.0 110.206 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.37 37.52 0.56 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 109' ' ' MET . 45.6 mt-10 -127.91 127.75 43.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.125 -1.221 . . . . 0.0 110.225 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -83.23 92.78 7.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 110.19 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.5 mt -118.83 -176.3 3.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.217 -0.927 . . . . 0.0 110.149 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.3 t -144.52 -178.41 5.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.25 -0.906 . . . . 0.0 110.45 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -61.85 -31.1 71.33 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.342 -0.848 . . . . 0.0 110.997 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.42 ' N ' ' CD ' ' A' ' 119' ' ' GLU . 6.2 mp0 -67.11 -41.1 86.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.26 -0.9 . . . . 0.0 110.708 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -67.72 -56.39 9.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.208 -0.932 . . . . 0.0 110.575 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.611 HG13 HD23 ' A' ' 105' ' ' LEU . 78.0 t -52.99 -49.3 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 0.0 110.412 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -57.54 -41.14 80.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.222 -0.924 . . . . 0.0 110.57 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -65.89 -32.74 74.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.22 -0.925 . . . . 0.0 110.796 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -73.11 -38.59 66.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.25 -0.906 . . . . 0.0 110.573 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 31.5 mm -70.11 -27.61 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.113 -0.992 . . . . 0.0 109.99 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -72.93 -45.79 56.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.396 -0.815 . . . . 0.0 110.223 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -70.54 -28.76 65.18 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.078 -1.014 . . . . 0.0 110.103 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.62 -24.95 36.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.354 -0.841 . . . . 0.0 110.402 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -86.76 77.07 9.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.051 -1.031 . . . . 0.0 110.174 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.72 HD12 ' HG2' ' A' ' 140' ' ' GLU . 5.6 mt -45.91 -60.18 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.387 -0.82 . . . . 0.0 110.482 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.9 p30 -66.24 -26.97 67.61 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.074 -1.016 . . . . 0.0 110.398 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 65.48 66.18 2.56 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 2.6 p30 -107.54 -35.39 6.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.281 -1.129 . . . . 0.0 110.674 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 167.77 -37.77 0.22 Allowed Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.021 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.409 ' HG3' ' HB3' ' A' ' 99' ' ' TYR . 2.7 pm0 -140.38 166.83 23.63 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.113 -1.228 . . . . 0.0 110.265 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.424 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 12.1 t -88.46 146.34 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.295 -0.878 . . . . 0.0 110.044 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -109.46 169.9 8.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 109.917 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.485 ' O ' HG23 ' A' ' 142' ' ' VAL . 9.0 t80 -61.66 -47.87 83.42 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.183 -0.948 . . . . 0.0 110.545 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -59.91 -41.46 91.73 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.007 -1.058 . . . . 0.0 110.152 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.72 ' HG2' HD12 ' A' ' 130' ' ' ILE . 52.2 mt-10 -69.41 -24.72 63.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.92 . . . . 0.0 110.014 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.518 ' CZ ' ' CE ' ' A' ' 145' ' ' MET . 8.0 t80 -77.51 -25.23 50.13 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.378 -0.826 . . . . 0.0 109.977 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 138' ' ' TYR . 90.0 t -80.34 -23.4 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.278 -0.889 . . . . 0.0 110.04 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -89.13 -31.74 17.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -0.9 . . . . 0.0 110.296 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.434 ' CE ' ' CD2' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -82.65 -22.51 34.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.153 -0.967 . . . . 0.0 110.243 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.518 ' CE ' ' CZ ' ' A' ' 141' ' ' PHE . 46.0 tpp -71.54 -29.95 65.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.337 -0.852 . . . . 0.0 109.97 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.1 p . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.363 -0.835 . . . . 0.0 110.306 -179.89 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.204 0.526 . . . . 0.0 110.262 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 2.5 tp10 -46.81 -48.29 20.81 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.272 -0.892 . . . . 0.0 110.145 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -53.97 -47.23 71.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.454 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.887 HG23 HD11 ' A' ' 69' ' ' LEU . 44.3 mt -56.38 -33.74 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.336 -0.852 . . . . 0.0 109.468 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -62.83 -37.44 86.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.39 -0.819 . . . . 0.0 109.373 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -63.09 -51.04 68.17 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.303 -0.873 . . . . 0.0 109.421 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -60.1 -28.11 67.56 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.471 -0.768 . . . . 0.0 109.891 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 2.4 mtpm? -64.25 -52.65 57.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 109.49 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -53.12 -38.07 62.32 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.348 -0.845 . . . . 0.0 109.304 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.04 -43.63 98.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.445 -0.784 . . . . 0.0 109.693 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -54.29 -39.65 67.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 109.377 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.7 t -73.03 -29.99 63.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.427 -0.796 . . . . 0.0 109.505 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.842 ' O ' HD23 ' A' ' 18' ' ' LEU . 5.1 tt -59.43 -35.97 75.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.447 -0.783 . . . . 0.0 109.388 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -82.19 -56.7 3.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.436 -0.79 . . . . 0.0 109.874 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.457 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 9.8 t70 -52.96 106.2 0.15 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.452 -0.78 . . . . 0.0 110.214 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -110.31 41.72 1.69 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.264 -0.898 . . . . 0.0 110.983 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 5.6 p-10 -150.12 -50.77 0.14 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.037 -1.039 . . . . 0.0 110.387 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.91 57.61 0.33 Allowed Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.744 -1.217 . . . . 0.0 110.333 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 56.5 p-10 -135.75 0.62 2.71 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.135 -1.215 . . . . 0.0 110.737 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.555 ' C ' HG23 ' A' ' 26' ' ' THR . . . 64.09 40.27 97.96 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.555 HG23 ' C ' ' A' ' 25' ' ' GLY . 81.0 p -154.83 139.52 17.05 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.232 -1.158 . . . . 0.0 109.857 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 86.4 mt -105.12 132.36 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.125 -0.985 . . . . 0.0 110.205 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.515 HG22 ' H ' ' A' ' 29' ' ' THR . 10.0 m -125.21 174.79 7.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.227 -0.921 . . . . 0.0 110.563 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.515 ' H ' HG22 ' A' ' 28' ' ' THR . 43.5 p -64.01 -21.12 66.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.439 -0.788 . . . . 0.0 109.954 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -70.84 -69.32 0.37 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.278 -0.888 . . . . 0.0 110.071 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.457 ' OE1' ' HA ' ' A' ' 20' ' ' ASP . 21.8 mt-10 -53.02 -46.61 68.47 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.331 -0.856 . . . . 0.0 109.61 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.979 HD22 HD11 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -60.19 -32.85 71.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.886 . . . . 0.0 109.659 179.511 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.04 -42.19 98.31 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.9 m -72.08 -24.39 61.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -1.081 . . . . 0.0 109.612 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.416 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 42.3 t -69.37 -35.87 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.405 -0.809 . . . . 0.0 109.688 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.412 ' O ' ' O ' ' A' ' 40' ' ' GLY . 25.4 mmt -90.25 -20.46 22.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 110.368 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.6 mtt85 -89.48 -18.1 27.37 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.023 -1.048 . . . . 0.0 110.651 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 92.4 p -101.54 -16.96 16.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.02 -1.05 . . . . 0.0 110.231 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.84 55.91 1.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.202 -0.936 . . . . 0.0 110.02 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 36' ' ' MET . . . 104.92 86.23 1.91 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.417 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 9.8 tt0 -83.14 67.48 9.18 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.459 -1.024 . . . . 0.0 110.634 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.484 ' HB2' ' HD3' ' A' ' 43' ' ' PRO . 1.8 m120 -85.05 -58.39 0.35 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.124 -0.985 . . . . 0.0 111.157 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' A' ' 42' ' ' ASN . 44.4 Cg_endo -73.88 -169.01 0.5 Allowed 'Trans proline' 0 C--N 1.315 -1.202 0 O-C-N 123.564 1.297 . . . . 0.0 111.056 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 10.9 t -132.94 -174.21 3.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.433 -0.792 . . . . 0.0 109.892 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -66.32 -43.94 84.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.141 -0.974 . . . . 0.0 110.595 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.89 -67.45 0.44 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.174 -0.954 . . . . 0.0 110.434 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -47.39 -29.86 2.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 0.0 110.1 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.863 HD11 HD23 ' A' ' 32' ' ' LEU . 8.6 tt -66.7 -49.36 66.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.931 . . . . 0.0 109.343 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -49.22 -38.88 27.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 109.243 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -64.2 -42.18 96.74 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.399 -0.813 . . . . 0.0 109.411 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.451 ' HG3' ' OE2' ' A' ' 54' ' ' GLU . 2.5 ttp -65.58 -14.56 61.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.264 -0.897 . . . . 0.0 109.946 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.979 HD11 HD22 ' A' ' 32' ' ' LEU . 25.4 mm -88.47 -33.61 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.302 -0.874 . . . . 0.0 110.3 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -65.25 -33.33 75.74 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.419 -0.8 . . . . 0.0 110.697 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.555 ' HG3' HG23 ' A' ' 55' ' ' VAL . 22.7 pt-20 -71.3 -8.29 52.7 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.058 -1.026 . . . . 0.0 110.647 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.76 HG22 ' SD ' ' A' ' 71' ' ' MET . 79.3 t -108.51 -18.84 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.069 -1.019 . . . . 0.0 110.107 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.415 ' OD2' ' O ' ' A' ' 62' ' ' THR . 4.6 t70 -109.04 109.27 20.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 111.053 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.76 15.19 23.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 109.66 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.73 -45.19 17.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.417 -0.802 . . . . 0.0 109.985 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.0 15.87 8.87 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -105.21 -31.73 8.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.053 -1.263 . . . . 0.0 110.171 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.38 -47.43 1.02 Allowed Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.84 -1.172 . . . . 0.0 110.248 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.415 ' O ' ' OD2' ' A' ' 56' ' ' ASP . 10.1 p -96.99 166.78 11.44 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.186 -1.185 . . . . 0.0 110.81 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.48 HD13 HG11 ' A' ' 55' ' ' VAL . 17.2 mt -102.95 161.34 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.202 -0.936 . . . . 0.0 110.316 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -113.65 -160.91 0.74 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.336 -0.853 . . . . 0.0 110.502 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.57 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 21.9 t80 -82.09 -43.4 1.02 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.896 . . . . 0.0 111.837 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.6 Cg_endo -72.42 -24.15 19.58 Favored 'Trans proline' 0 C--N 1.321 -0.894 0 O-C-N 123.027 1.014 . . . . 0.0 110.656 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -76.83 -33.78 57.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.143 -0.973 . . . . 0.0 109.087 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.571 ' CE1' ' CE ' ' A' ' 72' ' ' MET . 77.5 t80 -72.03 -40.27 68.55 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.572 -0.705 . . . . 0.0 109.852 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.887 HD11 HG23 ' A' ' 9' ' ' ILE . 8.2 tp -78.71 -17.93 55.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.446 -0.784 . . . . 0.0 110.607 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.9 m -90.63 -23.34 20.83 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.022 -1.049 . . . . 0.0 110.651 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.76 ' SD ' HG22 ' A' ' 55' ' ' VAL . 48.6 ttp -90.8 -36.96 13.94 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.891 -1.131 . . . . 0.0 111.073 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.571 ' CE ' ' CE1' ' A' ' 68' ' ' PHE . 56.8 mtt -89.83 -53.25 4.59 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.054 -1.029 . . . . 0.0 111.496 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.498 1.974 0 O-C-N 120.931 -1.105 . . . . 0.0 110.882 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 1.0 OUTLIER . . . . . 0 N--CA 1.498 1.952 0 CA-C-O 121.123 0.487 . . . . 0.0 110.761 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 79.5 mt -66.51 -59.31 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.192 -0.942 . . . . 0.0 110.093 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -63.08 -57.18 11.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.356 -0.84 . . . . 0.0 110.337 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.583 ' O ' HG13 ' A' ' 91' ' ' VAL . 51.3 mm-40 -51.02 -32.02 20.15 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.244 -0.91 . . . . 0.0 110.451 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' A' ' 84' ' ' GLU . . . -72.98 -40.72 65.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.192 -0.942 . . . . 0.0 110.414 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -62.79 -29.51 70.76 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.968 -1.083 . . . . 0.0 110.554 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 66.6 mtt85 -80.9 -52.12 7.82 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.201 -0.937 . . . . 0.0 110.938 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 87' ' ' GLU . 19.6 m -59.09 -36.22 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.211 -0.931 . . . . 0.0 111.02 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.507 ' CD2' HG23 ' A' ' 91' ' ' VAL . 16.2 m-85 -78.85 -38.8 36.98 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.033 -1.042 . . . . 0.0 110.606 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -111.55 71.3 0.74 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.275 -0.891 . . . . 0.0 110.147 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.441 ' CD ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -108.06 42.59 1.34 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.146 -0.971 . . . . 0.0 110.499 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 2.7 p30 -125.77 -26.95 3.41 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.242 -0.912 . . . . 0.0 110.605 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.4 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 108.21 31.57 3.51 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.45 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 18.6 t-20 -93.12 -44.98 8.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -1.145 . . . . 0.0 110.135 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.476 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 111.24 -14.91 28.07 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 33.8 m-85 -144.28 147.27 33.32 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.218 -1.166 . . . . 0.0 110.108 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.45 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 26.0 mt -71.1 137.5 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.245 -0.909 . . . . 0.0 109.439 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.3 m -114.21 169.64 8.88 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.194 -0.941 . . . . 0.0 110.394 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.61 -46.01 56.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.236 -0.915 . . . . 0.0 110.115 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.91 -53.94 49.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -0.918 . . . . 0.0 109.986 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.774 ' O ' HG23 ' A' ' 108' ' ' VAL . 31.2 mt-10 -58.57 -38.66 78.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.238 -0.914 . . . . 0.0 109.783 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.836 HD12 HD11 ' A' ' 125' ' ' ILE . 1.4 tt -57.78 -36.83 72.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.32 -0.863 . . . . 0.0 110.105 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.68 ' O ' HG22 ' A' ' 110' ' ' THR . 6.6 ttt-85 -70.0 -44.44 69.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.343 -0.848 . . . . 0.0 110.304 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -70.64 -11.06 60.7 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.084 -1.01 . . . . 0.0 110.497 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 104' ' ' GLU . 85.1 t -91.8 -40.79 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.135 -0.978 . . . . 0.0 110.163 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.2 mmt -69.9 -52.77 21.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.257 -0.902 . . . . 0.0 110.558 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.68 HG22 ' O ' ' A' ' 106' ' ' ARG . 5.8 t -56.99 -24.33 52.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.229 -0.919 . . . . 0.0 110.689 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -85.31 -33.86 22.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.022 -1.049 . . . . 0.0 110.69 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 24.4 mt -73.58 -56.53 4.9 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.131 -0.981 . . . . 0.0 110.28 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 167.58 -32.1 0.19 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -70.96 140.31 50.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.322 -1.105 . . . . 0.0 110.203 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 3.4 pttp -114.77 101.57 9.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.169 -0.957 . . . . 0.0 110.392 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.3 mt -112.0 168.5 9.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.125 -0.985 . . . . 0.0 110.236 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.544 HG22 ' N ' ' A' ' 118' ' ' ASP . 85.3 m -115.58 170.32 8.52 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.223 -0.923 . . . . 0.0 110.45 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.544 ' N ' HG22 ' A' ' 117' ' ' THR . 0.9 OUTLIER -51.02 -35.44 34.16 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.339 -0.851 . . . . 0.0 110.962 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -62.36 -54.78 35.39 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.059 -1.026 . . . . 0.0 110.798 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -61.2 -54.6 42.26 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.221 -0.924 . . . . 0.0 110.702 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' A' ' 105' ' ' LEU . 79.6 t -50.65 -41.25 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.115 -0.991 . . . . 0.0 110.566 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.96 -40.62 91.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.118 -0.989 . . . . 0.0 110.214 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.443 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 12.4 mt-10 -71.1 -18.41 62.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.236 -0.915 . . . . 0.0 109.972 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.1 mmm -78.79 -48.67 14.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 110.155 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.836 HD11 HD12 ' A' ' 105' ' ' LEU . 30.4 mm -70.44 -36.4 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.312 -0.868 . . . . 0.0 110.334 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -72.11 -47.36 51.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.362 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.443 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 5.7 mm-40 -70.15 -23.85 63.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.207 -0.933 . . . . 0.0 110.186 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.79 -14.65 27.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.171 -0.956 . . . . 0.0 110.011 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.76 ' OD1' HG22 ' A' ' 136' ' ' VAL . 3.8 m-20 -79.92 88.33 5.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.098 -1.001 . . . . 0.0 110.922 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.478 HG22 ' O ' ' A' ' 130' ' ' ILE . 11.5 mm -67.24 -4.08 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.523 -0.736 . . . . 0.0 111.11 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 54.0 p30 -176.57 -19.71 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 O-C-N 120.709 -1.245 . . . . 0.0 112.223 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . -71.8 -52.06 13.27 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 1.2 m-20 56.48 96.32 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.468 -1.019 . . . . 0.0 108.418 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 105.28 -20.49 37.58 Favored Glycine 0 C--N 1.295 -1.748 0 N-CA-C 107.564 -2.214 . . . . 0.0 107.564 -177.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.469 ' HB2' ' CB ' ' A' ' 99' ' ' TYR . 2.5 pt20 -153.4 152.32 30.92 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.621 -0.929 . . . . 0.0 109.729 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.76 HG22 ' OD1' ' A' ' 129' ' ' ASP . 99.5 t -118.48 147.12 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.208 -0.933 . . . . 0.0 110.346 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.4 ' OD1' ' CD1' ' A' ' 99' ' ' TYR . 2.9 m120 -105.91 179.46 4.26 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.435 -0.791 . . . . 0.0 110.585 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -73.73 -49.54 25.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.312 -0.868 . . . . 0.0 108.884 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -59.29 -41.75 89.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.346 -0.846 . . . . 0.0 109.046 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.45 ' OE1' ' HA ' ' A' ' 136' ' ' VAL . 36.1 tt0 -64.98 -33.27 75.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.484 -0.76 . . . . 0.0 109.968 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.429 ' O ' ' HG2' ' A' ' 144' ' ' MET . 13.4 t80 -68.91 -25.62 64.68 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.315 -0.866 . . . . 0.0 110.31 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.8 t -81.44 -36.28 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.122 -0.986 . . . . 0.0 109.726 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.49 -29.95 64.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 110.8 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.48 ' HE3' ' CE ' ' A' ' 145' ' ' MET . 3.4 ptt? -74.59 -25.55 59.33 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.006 -1.059 . . . . 0.0 110.623 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.48 ' CE ' ' HE3' ' A' ' 144' ' ' MET . 20.5 mmt -87.11 -67.69 0.8 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.117 -0.989 . . . . 0.0 110.504 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 65.6 p . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.071 -1.018 . . . . 0.0 110.411 -179.72 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.105 0.479 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.86 -55.94 28.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.274 -0.891 . . . . 0.0 110.252 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -56.65 -33.28 66.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.301 -0.874 . . . . 0.0 109.75 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.0 mm -65.71 -35.95 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.509 -0.745 . . . . 0.0 109.807 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.15 -33.52 73.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.882 . . . . 0.0 109.587 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.8 -51.08 68.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.393 -0.817 . . . . 0.0 109.575 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -58.83 -38.67 79.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.378 -0.826 . . . . 0.0 109.835 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -63.85 -31.11 72.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.354 -0.841 . . . . 0.0 109.911 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -68.47 -45.63 71.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -0.862 . . . . 0.0 110.292 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.44 -44.66 93.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.309 -0.869 . . . . 0.0 110.355 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -58.79 -43.68 90.55 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.21 -0.931 . . . . 0.0 110.298 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.4 m -66.48 -33.95 76.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 110.077 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.799 ' O ' HD23 ' A' ' 18' ' ' LEU . 2.8 tt -62.46 -37.47 86.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 109.788 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.581 ' HA ' HG21 ' A' ' 35' ' ' VAL . 9.3 m-30 -72.51 -64.33 0.97 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.331 -0.856 . . . . 0.0 109.893 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -51.0 120.15 4.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.412 -0.805 . . . . 0.0 109.862 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -104.85 -8.73 18.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.907 -1.121 . . . . 0.0 110.885 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.402 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 6.9 p-10 -101.55 -42.29 6.29 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.9 -1.125 . . . . 0.0 110.238 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.12 55.4 0.92 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 58.5 p30 -123.5 -11.47 7.84 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.166 -1.197 . . . . 0.0 110.503 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.643 ' O ' HG23 ' A' ' 26' ' ' THR . . . 89.12 36.89 7.41 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 25' ' ' GLY . 14.6 p -158.5 129.55 6.34 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.339 -1.095 . . . . 0.0 110.256 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 62' ' ' THR . 62.0 mt -93.19 118.32 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.315 -0.866 . . . . 0.0 109.993 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 t -104.24 -176.28 3.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.232 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.63 HG22 HD12 ' A' ' 52' ' ' ILE . 31.4 p -75.09 -35.08 61.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 110.475 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -62.37 -60.28 3.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.267 -0.896 . . . . 0.0 109.972 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -58.83 -53.11 62.12 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.212 -0.93 . . . . 0.0 109.623 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.739 HD22 HD11 ' A' ' 52' ' ' ILE . 0.5 OUTLIER -58.88 -19.45 42.17 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.235 -0.916 . . . . 0.0 109.572 179.535 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.493 ' HA2' ' CD1' ' A' ' 48' ' ' LEU . . . -67.35 -49.53 51.2 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 38' ' ' SER . 60.0 m -70.84 -19.12 62.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.298 -1.119 . . . . 0.0 109.862 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.581 HG21 ' HA ' ' A' ' 19' ' ' PHE . 24.4 t -76.58 -38.45 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.394 -0.816 . . . . 0.0 110.334 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.714 ' HA ' HD23 ' A' ' 39' ' ' LEU . 26.5 mmt -84.48 -22.96 30.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.121 -0.987 . . . . 0.0 110.163 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.452 ' HD3' ' HA ' ' A' ' 42' ' ' ASN . 3.7 tpp180 -90.68 -16.9 27.72 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.329 -0.857 . . . . 0.0 110.417 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 34' ' ' THR . 32.9 t -92.0 10.11 30.38 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.995 -1.065 . . . . 0.0 110.982 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.714 HD23 ' HA ' ' A' ' 36' ' ' MET . 3.8 pp -107.27 -26.7 10.92 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.015 -1.053 . . . . 0.0 110.65 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.55 -31.13 1.03 Allowed Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.065 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.603 ' HG3' HD11 ' A' ' 39' ' ' LEU . 67.3 mt-30 -81.01 158.75 25.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.101 -1.235 . . . . 0.0 110.323 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.452 ' HA ' ' HD3' ' A' ' 37' ' ' ARG . 77.1 m-20 -130.43 61.09 56.91 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.25 -0.906 . . . . 0.0 110.131 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.05 -163.15 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.771 1.406 . . . . 0.0 110.234 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.527 HG22 ' N ' ' A' ' 45' ' ' GLU . 58.4 m -135.55 171.98 13.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.253 -0.904 . . . . 0.0 110.119 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.527 ' N ' HG22 ' A' ' 44' ' ' THR . 69.3 mt-10 -59.56 -28.94 67.56 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.2 -0.937 . . . . 0.0 110.478 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.92 -67.48 0.49 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.153 -0.967 . . . . 0.0 110.064 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -53.42 -23.09 8.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -0.914 . . . . 0.0 109.512 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.508 HD11 HD23 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -67.85 -58.0 5.32 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.564 -0.71 . . . . 0.0 110.011 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -51.22 -38.09 50.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.322 -0.861 . . . . 0.0 109.527 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -65.17 -38.99 92.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.367 -0.833 . . . . 0.0 109.508 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.444 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 1.6 ttp -66.98 -26.26 66.72 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.426 -0.796 . . . . 0.0 109.784 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.739 HD11 HD22 ' A' ' 32' ' ' LEU . 56.9 mt -83.17 -27.33 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.319 -0.863 . . . . 0.0 109.818 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -58.58 -46.84 86.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.384 -0.823 . . . . 0.0 110.401 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.828 ' HG3' HG23 ' A' ' 55' ' ' VAL . 13.2 pt-20 -64.39 -27.2 68.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -0.918 . . . . 0.0 110.071 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.828 HG23 ' HG3' ' A' ' 54' ' ' GLU . 85.8 t -96.1 -3.97 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.344 -0.848 . . . . 0.0 110.338 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -126.11 105.86 9.17 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.028 -1.045 . . . . 0.0 110.159 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.24 33.66 4.34 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.111 -0.993 . . . . 0.0 110.465 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -104.82 -49.11 3.58 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.186 -0.946 . . . . 0.0 110.236 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 119.53 51.69 0.28 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.457 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 16.1 p-10 -148.02 -43.69 0.16 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -1.129 . . . . 0.0 110.15 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 116.76 -4.12 19.26 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.579 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 45.1 p -123.76 164.05 19.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.906 -1.349 . . . . 0.0 110.469 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 52.1 mt -114.05 130.82 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.257 -0.902 . . . . 0.0 110.165 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.428 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 56.0 m-20 -83.3 -173.68 4.85 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 110.112 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.559 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 66.4 t80 -80.73 -42.63 1.25 Allowed Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.324 -0.86 . . . . 0.0 111.35 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 46.5 Cg_endo -74.66 -26.81 11.27 Favored 'Trans proline' 0 N--CA 1.48 0.72 0 O-C-N 123.082 1.043 . . . . 0.0 110.092 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 71' ' ' MET . 78.7 tt0 -78.09 -25.31 47.5 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.358 -0.839 . . . . 0.0 109.002 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 8.0 t80 -79.21 -54.34 6.07 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.607 -0.683 . . . . 0.0 110.025 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.687 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 0.6 OUTLIER -60.0 -34.78 73.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.329 -0.857 . . . . 0.0 110.427 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.4 m -77.02 -32.37 57.01 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.195 -0.941 . . . . 0.0 110.236 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.526 ' HE3' ' HG3' ' A' ' 72' ' ' MET . 18.2 tmm? -61.9 -52.65 63.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.268 -0.895 . . . . 0.0 110.278 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.526 ' HG3' ' HE3' ' A' ' 71' ' ' MET . 47.5 mtt -81.55 -10.4 59.46 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.165 -0.96 . . . . 0.0 110.293 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.163 -0.961 . . . . 0.0 110.127 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.215 0.531 . . . . 0.0 109.953 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.4 mt -52.07 -45.45 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.213 -0.929 . . . . 0.0 109.527 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -55.07 -44.41 74.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 110.179 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -57.41 -51.68 68.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.932 . . . . 0.0 110.245 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 92' ' ' PHE . . . -54.96 -29.58 57.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.131 -0.981 . . . . 0.0 110.557 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.433 ' O ' ' HB3' ' A' ' 93' ' ' ASP . 3.2 t80 -72.6 -35.98 68.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.003 -1.06 . . . . 0.0 110.838 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -76.32 -42.85 43.74 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.08 -1.013 . . . . 0.0 111.256 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.556 HG23 ' CD1' ' A' ' 92' ' ' PHE . 19.7 m -70.64 -41.23 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.047 -1.033 . . . . 0.0 110.859 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.556 ' CD1' HG23 ' A' ' 91' ' ' VAL . 25.9 m-85 -75.46 -25.07 57.12 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.877 -1.139 . . . . 0.0 110.028 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.447 ' OD2' ' N ' ' A' ' 99' ' ' TYR . 11.5 t70 -125.33 70.29 1.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.937 . . . . 0.0 110.09 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.11 65.98 0.62 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.429 -0.794 . . . . 0.0 110.284 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.461 ' OD2' ' HB2' ' A' ' 97' ' ' ASN . 21.6 p-10 -150.62 26.49 0.75 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.23 -0.919 . . . . 0.0 110.051 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.04 24.58 60.87 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.461 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 11.1 t-20 -95.49 -70.65 0.7 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.249 -1.147 . . . . 0.0 110.193 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.31 -9.98 10.05 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.456 ' CD1' ' NE2' ' A' ' 135' ' ' GLN . 55.0 m-85 -133.08 153.07 51.85 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.196 -1.179 . . . . 0.0 110.342 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.444 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 13.3 mt -91.84 116.26 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.336 -0.853 . . . . 0.0 109.499 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.0 t -95.06 176.04 6.39 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.318 -0.864 . . . . 0.0 110.115 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.468 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -71.84 -41.81 67.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 110.16 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.88 -50.45 62.44 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.181 -0.949 . . . . 0.0 110.27 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.865 ' O ' HG23 ' A' ' 108' ' ' VAL . 24.0 tt0 -59.52 -40.9 88.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.187 -0.945 . . . . 0.0 109.87 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 105' ' ' LEU . 30.6 tp -62.55 -33.83 75.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.381 -0.824 . . . . 0.0 110.046 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.59 ' O ' HG23 ' A' ' 110' ' ' THR . 6.7 ttp180 -69.16 -34.07 74.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.246 -0.909 . . . . 0.0 109.905 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 41.6 t60 -74.64 -24.18 58.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 110.276 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 104' ' ' GLU . 21.8 t -77.04 -39.92 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.258 -0.902 . . . . 0.0 110.187 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.6 mmt -61.84 -36.67 81.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.882 . . . . 0.0 110.136 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 106' ' ' ARG . 48.2 p -53.23 -43.48 67.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.155 -0.965 . . . . 0.0 109.71 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -60.14 -47.56 85.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.827 . . . . 0.0 110.219 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.5 mt -55.72 -36.3 67.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 110.124 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.07 41.88 2.74 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -119.87 133.59 55.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -1.168 . . . . 0.0 110.101 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.0 tttp -84.54 107.46 16.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.321 -0.862 . . . . 0.0 110.015 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.1 mt -126.29 164.21 21.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -0.869 . . . . 0.0 110.232 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 51.7 m -107.13 162.7 13.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 110.204 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.461 ' OD2' ' NH2' ' A' ' 106' ' ' ARG . 2.4 m-20 -58.2 -40.66 82.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 110.205 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -58.78 -35.55 72.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.312 -0.868 . . . . 0.0 110.526 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.02 -49.84 64.02 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.226 -0.921 . . . . 0.0 110.795 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.468 HG11 ' O ' ' A' ' 102' ' ' ALA . 59.3 t -59.36 -53.31 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.225 -0.922 . . . . 0.0 110.174 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -53.61 -42.56 67.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.189 -0.944 . . . . 0.0 110.004 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 27.1 tt0 -63.03 -33.2 74.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.346 -0.846 . . . . 0.0 110.054 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.406 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 5.5 mmm -65.19 -53.29 47.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.179 -0.951 . . . . 0.0 109.989 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 34.8 mm -54.94 -32.21 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.255 -0.903 . . . . 0.0 110.089 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 -70.65 -42.73 70.42 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.298 -0.876 . . . . 0.0 110.136 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 49.9 mt-10 -65.82 -23.95 66.8 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.292 -0.88 . . . . 0.0 110.219 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.63 -22.48 19.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.322 -0.862 . . . . 0.0 110.066 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -72.67 90.43 1.38 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 110.228 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 59.0 mt -89.34 -25.61 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.14 -0.975 . . . . 0.0 110.304 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 41.7 p30 -87.4 -16.44 34.92 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.244 -0.91 . . . . 0.0 110.496 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.455 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 75.1 70.35 1.27 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -130.62 -33.9 1.59 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.21 -1.171 . . . . 0.0 110.427 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 111.61 18.43 7.99 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.456 ' NE2' ' CD1' ' A' ' 99' ' ' TYR . 4.0 pt20 -160.56 147.4 15.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.371 -1.076 . . . . 0.0 109.949 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.444 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 60.7 t -91.09 132.18 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 110.377 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -106.39 171.4 7.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 109.82 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -53.83 -38.34 64.53 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.174 -0.954 . . . . 0.0 110.351 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -68.03 -62.88 1.2 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.185 -0.947 . . . . 0.0 110.647 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -46.83 -33.72 4.72 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.283 -0.886 . . . . 0.0 110.899 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.427 ' O ' ' HG3' ' A' ' 144' ' ' MET . 12.8 t80 -70.23 -40.94 74.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 111.133 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.632 ' O ' HG22 ' A' ' 146' ' ' THR . 99.2 t -77.48 -20.9 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.052 -1.03 . . . . 0.0 110.766 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -85.12 -28.11 25.79 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.257 -0.902 . . . . 0.0 110.959 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.455 ' CE ' ' HG3' ' A' ' 145' ' ' MET . 0.2 OUTLIER -83.05 -20.13 35.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.058 -1.026 . . . . 0.0 110.316 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.455 ' HG3' ' CE ' ' A' ' 144' ' ' MET . 26.0 mtt -90.24 -59.12 2.27 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.303 -0.873 . . . . 0.0 110.256 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.632 HG22 ' O ' ' A' ' 142' ' ' VAL . 13.7 t . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 110.004 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.039 0.447 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -64.54 -57.09 10.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.238 -0.914 . . . . 0.0 110.495 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.425 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 1.9 mp0 -47.16 -51.66 17.65 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.3 -0.875 . . . . 0.0 110.371 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 92.6 mt -57.41 -49.23 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.101 -0.999 . . . . 0.0 110.032 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.38 -26.08 39.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.398 -0.814 . . . . 0.0 109.804 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 16.0 tt0 -72.72 -57.82 3.81 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.366 -0.834 . . . . 0.0 109.636 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.438 ' O ' ' HB2' ' A' ' 16' ' ' PHE . 71.9 m-85 -56.4 -23.34 37.46 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.263 -0.898 . . . . 0.0 109.79 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.3 mttp -76.06 -40.35 53.43 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.283 -0.885 . . . . 0.0 110.033 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -62.66 -52.83 61.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 109.902 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.503 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.96 -47.19 85.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 109.998 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.507 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 14.3 t80 -47.76 -48.99 29.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.199 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.2 t -58.84 -42.76 90.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.904 . . . . 0.0 109.886 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.712 ' O ' HD23 ' A' ' 18' ' ' LEU . 3.6 tt -49.52 -44.41 46.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.287 -0.883 . . . . 0.0 110.171 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.83 ' CD1' HG11 ' A' ' 35' ' ' VAL . 37.3 m-85 -75.67 -30.28 59.35 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.175 -0.953 . . . . 0.0 110.401 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -80.35 107.52 13.21 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.108 -0.995 . . . . 0.0 110.43 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.402 ' HE3' ' CG2' ' A' ' 34' ' ' THR . 24.9 mttm -105.93 -35.36 7.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.0 110.436 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -74.07 -21.27 59.99 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.128 -0.982 . . . . 0.0 110.11 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.87 100.23 0.04 OUTLIER Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 35.1 p-10 -168.63 -26.21 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.354 -1.086 . . . . 0.0 111.41 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.52 ' C ' HG23 ' A' ' 26' ' ' THR . . . 111.09 27.56 4.2 Favored Glycine 0 N--CA 1.492 2.367 0 O-C-N 120.671 -1.268 . . . . 0.0 109.996 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.52 HG23 ' C ' ' A' ' 25' ' ' GLY . 72.2 p -153.36 170.21 21.22 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.052 -1.264 . . . . 0.0 110.337 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.441 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 12.2 mt -129.47 115.32 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.405 -0.81 . . . . 0.0 109.947 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.495 HG22 ' N ' ' A' ' 29' ' ' THR . 20.6 m -102.33 174.67 5.81 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.195 -0.941 . . . . 0.0 110.191 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.57 HG21 ' OE1' ' A' ' 49' ' ' GLN . 22.8 p -72.21 -21.41 61.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.146 -0.971 . . . . 0.0 110.059 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -70.73 -57.64 4.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.253 -0.905 . . . . 0.0 109.82 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -60.25 -57.62 12.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 0.0 109.71 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.738 HD22 HD11 ' A' ' 52' ' ' ILE . 2.0 tp -51.84 -35.43 44.57 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.279 -0.888 . . . . 0.0 109.584 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.26 -47.11 76.74 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.402 ' CG2' ' HE3' ' A' ' 21' ' ' LYS . 62.5 m -63.3 -31.21 72.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -1.139 . . . . 0.0 109.973 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.83 HG11 ' CD1' ' A' ' 19' ' ' PHE . 54.6 t -67.38 -31.48 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.195 -0.941 . . . . 0.0 109.833 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.4 mmt -90.55 -14.2 33.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.287 -0.883 . . . . 0.0 110.427 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.5 ttp180 -88.77 -31.5 18.36 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.153 -0.967 . . . . 0.0 110.435 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 88.7 p -91.44 -24.32 19.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.267 -0.896 . . . . 0.0 110.188 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -92.62 -67.31 0.86 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.247 -0.908 . . . . 0.0 109.932 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -129.32 89.33 0.31 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -59.68 116.5 4.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -1.119 . . . . 0.0 110.485 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.527 ' CB ' ' HD3' ' A' ' 43' ' ' PRO . 5.4 m-80 -172.1 -61.03 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.301 -0.874 . . . . 0.0 110.477 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.527 ' HD3' ' CB ' ' A' ' 42' ' ' ASN . 47.7 Cg_endo -74.82 144.35 30.84 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.595 1.313 . . . . 0.0 110.105 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.698 HG23 ' H ' ' A' ' 46' ' ' ALA . 7.2 t -107.34 -141.37 0.38 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.106 -0.996 . . . . 0.0 109.897 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.672 ' N ' HG23 ' A' ' 44' ' ' THR . 44.4 mt-10 -88.23 -30.78 19.44 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.901 -1.124 . . . . 0.0 110.088 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.698 ' H ' HG23 ' A' ' 44' ' ' THR . . . -73.21 -64.75 0.91 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 109.702 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 55.4 mt-10 -52.31 -48.56 65.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.181 -0.949 . . . . 0.0 109.333 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.69 HD11 HD23 ' A' ' 32' ' ' LEU . 7.5 tt -52.1 -40.84 61.85 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.354 -0.841 . . . . 0.0 109.154 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.57 ' OE1' HG21 ' A' ' 29' ' ' THR . 62.8 tp60 -53.91 -44.63 70.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.508 -0.745 . . . . 0.0 109.578 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -57.91 -44.67 86.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.254 -0.904 . . . . 0.0 109.482 179.381 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.434 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 70.1 mtp -59.69 -26.61 65.72 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.319 -0.863 . . . . 0.0 109.842 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.738 HD11 HD22 ' A' ' 32' ' ' LEU . 29.9 mm -77.13 -29.53 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.898 . . . . 0.0 110.157 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -68.31 -43.26 78.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.336 -0.853 . . . . 0.0 110.454 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.519 ' HG3' HG23 ' A' ' 55' ' ' VAL . 22.7 pt-20 -68.0 -24.97 65.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.3 -0.875 . . . . 0.0 110.565 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.813 HG13 ' SD ' ' A' ' 71' ' ' MET . 75.9 t -89.33 -21.73 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.178 -0.951 . . . . 0.0 110.113 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -101.49 107.79 19.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.362 -0.836 . . . . 0.0 110.359 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -95.69 17.32 15.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.07 -1.019 . . . . 0.0 110.149 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.434 ' HB2' ' OD1' ' A' ' 60' ' ' ASN . 34.2 m-20 -107.4 -52.24 2.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.354 -0.842 . . . . 0.0 110.046 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.53 19.95 5.6 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.434 ' OD1' ' HB2' ' A' ' 58' ' ' ASP . 22.0 m120 -88.24 -9.23 53.62 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.239 -1.154 . . . . 0.0 110.44 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.25 -38.62 3.15 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.5 p -110.22 160.64 16.33 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.109 -1.23 . . . . 0.0 110.772 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.749 HD13 HG11 ' A' ' 55' ' ' VAL . 49.8 mt -95.8 158.32 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.56 -0.713 . . . . 0.0 109.968 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.432 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.1 m-20 -113.87 -170.67 1.75 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.279 -0.888 . . . . 0.0 110.411 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.563 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.8 t80 -77.23 -46.12 2.69 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.842 . . . . 0.0 111.124 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.1 Cg_endo -73.49 -16.15 24.45 Favored 'Trans proline' 0 C--N 1.318 -1.04 0 O-C-N 123.306 1.161 . . . . 0.0 110.403 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -84.46 -34.5 23.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -0.943 . . . . 0.0 109.043 178.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.488 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 5.5 t80 -70.04 -40.27 75.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.606 -0.684 . . . . 0.0 109.532 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.695 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 18.6 tp -76.61 -38.79 54.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.467 -0.771 . . . . 0.0 110.56 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.8 m -71.17 -22.05 62.09 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.163 -0.961 . . . . 0.0 110.656 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.813 ' SD ' HG13 ' A' ' 55' ' ' VAL . 62.4 ttp -82.3 -51.01 8.31 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.065 -1.022 . . . . 0.0 110.095 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.468 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 57.1 mtt -79.05 -9.69 59.62 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.405 -0.809 . . . . 0.0 110.674 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.695 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.495 1.811 0 O-C-N 121.103 -0.998 . . . . 0.0 110.31 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.43 0.633 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 97.8 mt -52.87 -33.32 18.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.305 -0.872 . . . . 0.0 109.802 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.437 ' HD3' ' OE2' ' A' ' 87' ' ' GLU . 2.2 ttt180 -64.34 -46.81 81.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 109.353 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.437 ' OE2' ' HD3' ' A' ' 86' ' ' ARG . 4.7 mp0 -57.75 -29.09 64.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.35 -0.844 . . . . 0.0 109.66 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.597 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -65.92 -62.89 1.25 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.365 -0.834 . . . . 0.0 110.148 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.607 ' CD1' HD11 ' A' ' 100' ' ' ILE . 1.9 t80 -50.01 -29.35 8.47 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.357 -0.839 . . . . 0.0 110.416 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -68.44 -55.15 12.84 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.136 -0.977 . . . . 0.0 110.714 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 88' ' ' ALA . 29.7 m -63.72 -20.66 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.132 -0.98 . . . . 0.0 110.344 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.672 ' CE1' HG11 ' A' ' 108' ' ' VAL . 24.6 m-85 -92.52 -14.06 28.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 0.0 110.34 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -123.93 66.25 1.04 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.234 -0.916 . . . . 0.0 109.714 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -95.61 61.97 2.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.863 . . . . 0.0 110.552 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.8 p30 -164.34 -35.84 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.117 -0.989 . . . . 0.0 110.717 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.454 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 110.04 38.88 1.62 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.445 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 3.8 t-20 -92.81 -57.97 2.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.389 -1.066 . . . . 0.0 110.184 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.425 ' C ' ' CD1' ' A' ' 99' ' ' TYR . . . 121.59 -22.31 7.81 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 27.4 m-85 -131.72 158.69 40.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.152 -1.205 . . . . 0.0 110.306 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.607 HD11 ' CD1' ' A' ' 89' ' ' PHE . 70.9 mt -93.89 135.49 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.331 -0.856 . . . . 0.0 110.587 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.5 t -117.47 176.0 5.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.498 -0.751 . . . . 0.0 109.837 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.63 -37.59 76.86 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.204 -0.935 . . . . 0.0 110.515 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.33 -59.03 6.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.19 -0.944 . . . . 0.0 110.258 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -52.54 -48.51 66.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.266 -0.896 . . . . 0.0 110.086 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.0 HD23 HG13 ' A' ' 121' ' ' VAL . 14.7 tp -54.38 -34.63 61.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -0.89 . . . . 0.0 110.356 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.9 ttt-85 -69.79 -33.29 72.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.08 -1.013 . . . . 0.0 110.367 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 53.2 m170 -68.04 -38.53 82.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.27 -0.894 . . . . 0.0 110.49 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.672 HG11 ' CE1' ' A' ' 92' ' ' PHE . 97.0 t -73.91 -49.59 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.165 -0.96 . . . . 0.0 110.558 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.437 ' HG2' ' O ' ' A' ' 105' ' ' LEU . 22.9 mmt -51.68 -62.69 1.47 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.221 -0.925 . . . . 0.0 110.886 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.6 p -44.96 -27.8 0.59 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.34 -0.85 . . . . 0.0 111.018 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 4.5 m120 -81.3 -39.7 24.8 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.007 -1.058 . . . . 0.0 110.68 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 112' ' ' LEU . 80.5 mt -72.41 -15.54 61.84 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.29 -0.881 . . . . 0.0 110.383 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.48 53.12 1.08 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.609 ' OE1' HD11 ' A' ' 116' ' ' LEU . 13.5 mm-40 -128.49 100.44 5.77 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.341 -1.094 . . . . 0.0 110.098 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -87.88 106.8 18.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 110.213 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.609 HD11 ' OE1' ' A' ' 114' ' ' GLU . 4.3 mp -129.99 -178.37 4.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 0.0 109.998 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.8 m -102.77 155.94 17.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.135 -0.978 . . . . 0.0 110.224 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.408 ' O ' ' OD2' ' A' ' 122' ' ' ASP . 45.5 m-20 -49.16 -43.06 41.54 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.227 -0.921 . . . . 0.0 110.191 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -60.98 -42.59 98.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.187 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -52.37 -59.51 4.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.294 -0.879 . . . . 0.0 110.245 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 1.0 HG13 HD23 ' A' ' 105' ' ' LEU . 42.1 t -53.29 -45.51 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.099 -1.001 . . . . 0.0 110.051 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.408 ' OD2' ' O ' ' A' ' 118' ' ' ASP . 60.3 m-20 -52.49 -37.34 57.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.966 . . . . 0.0 109.77 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -70.67 -33.67 71.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.354 -0.842 . . . . 0.0 110.002 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 5.9 mmm -61.91 -55.35 30.48 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.279 -0.888 . . . . 0.0 110.066 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.654 HG23 HG23 ' A' ' 136' ' ' VAL . 22.8 mm -58.47 -38.86 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.272 -0.892 . . . . 0.0 110.1 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -71.24 -22.43 61.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.255 -0.903 . . . . 0.0 110.158 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.4 ' O ' ' OE1' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -76.28 -42.16 46.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 109.88 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.42 -33.68 71.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.025 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -59.58 97.64 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.147 -0.97 . . . . 0.0 109.895 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.8 mt -73.16 -44.12 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.396 -0.815 . . . . 0.0 111.421 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.5 p30 -85.62 -31.2 22.72 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.072 -1.018 . . . . 0.0 110.938 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 97.97 54.05 1.23 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -95.16 14.92 20.5 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.237 -1.155 . . . . 0.0 110.216 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 64.74 21.9 67.69 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.496 ' OE1' ' CD2' ' A' ' 99' ' ' TYR . 1.1 pp0? -170.1 140.87 2.03 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.588 -0.948 . . . . 0.0 109.719 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.654 HG23 HG23 ' A' ' 125' ' ' ILE . 70.8 t -86.11 149.39 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.154 -0.967 . . . . 0.0 110.307 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.462 ' OD1' ' CE2' ' A' ' 99' ' ' TYR . 48.3 t30 -125.83 169.32 12.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.158 -0.964 . . . . 0.0 110.272 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 138' ' ' TYR . 8.1 t80 -58.26 -51.01 71.57 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.401 -0.812 . . . . 0.0 110.671 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -54.99 -54.74 39.12 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.158 -0.964 . . . . 0.0 110.354 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.45 ' O ' ' CG ' ' A' ' 144' ' ' MET . 46.5 mt-10 -61.29 -20.71 63.2 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.155 -0.965 . . . . 0.0 109.932 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.568 ' CD1' ' CD1' ' A' ' 100' ' ' ILE . 13.4 t80 -75.71 -28.74 58.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.351 -0.843 . . . . 0.0 110.53 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.9 t -87.46 -23.44 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.214 -0.928 . . . . 0.0 110.998 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.402 ' HA ' ' CG2' ' A' ' 146' ' ' THR . 76.0 mt-30 -101.78 -9.61 20.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.074 -1.016 . . . . 0.0 110.951 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.45 ' CG ' ' O ' ' A' ' 140' ' ' GLU . 0.1 OUTLIER -89.09 -28.31 20.18 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.022 -1.049 . . . . 0.0 110.132 179.706 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 32.4 ttm -89.73 -43.11 10.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 110.284 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.402 ' CG2' ' HA ' ' A' ' 143' ' ' GLN . 8.9 t . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.202 -0.936 . . . . 0.0 109.997 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.458 0.647 . . . . 0.0 109.661 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -55.9 -28.47 56.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.242 -0.911 . . . . 0.0 109.541 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -66.97 -41.99 85.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.424 -0.798 . . . . 0.0 109.606 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.3 mt -60.79 -45.14 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.413 -0.804 . . . . 0.0 109.832 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.9 -42.67 98.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.82 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -55.25 -45.17 76.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.313 -0.867 . . . . 0.0 109.773 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.492 ' CE2' ' HB2' ' A' ' 73' ' ' ALA . 12.6 m-85 -56.97 -51.76 67.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 0.0 109.81 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -51.54 -34.77 38.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.0 110.261 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -66.54 -41.77 88.18 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.134 -0.979 . . . . 0.0 110.02 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.445 ' HB1' ' CE2' ' A' ' 19' ' ' PHE . . . -63.87 -47.02 82.35 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.216 -0.928 . . . . 0.0 110.146 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -62.53 -33.08 74.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -0.903 . . . . 0.0 109.814 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.1 m -71.09 -32.64 69.31 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.277 -0.889 . . . . 0.0 109.468 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.943 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.4 tm? -78.22 -23.74 47.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.482 -0.761 . . . . 0.0 109.878 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.445 ' CE2' ' HB1' ' A' ' 15' ' ' ALA . 15.7 m-30 -83.25 -67.03 0.82 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.351 -0.843 . . . . 0.0 109.786 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -48.43 111.75 0.5 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.248 -0.907 . . . . 0.0 109.832 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -78.53 -58.41 3.27 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.209 -0.932 . . . . 0.0 110.824 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.413 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 8.6 p-10 -69.34 -41.75 76.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.147 -0.971 . . . . 0.0 109.978 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.69 46.18 2.16 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 2.6 p30 -95.07 -24.87 16.69 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.054 -1.263 . . . . 0.0 110.051 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.534 ' C ' HG23 ' A' ' 26' ' ' THR . . . 109.83 32.5 2.86 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.534 HG23 ' C ' ' A' ' 25' ' ' GLY . 69.5 p -153.98 150.51 28.36 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.165 -1.197 . . . . 0.0 110.242 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 95.2 mt -117.67 107.96 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.27 -0.894 . . . . 0.0 110.131 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.944 HG22 HG21 ' A' ' 62' ' ' THR . 73.1 p -101.0 -174.31 2.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.834 . . . . 0.0 110.097 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.635 HG22 HG13 ' A' ' 52' ' ' ILE . 43.5 p -74.87 -24.84 58.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 110.06 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -71.75 -62.46 1.41 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.09 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -56.88 -49.27 76.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.091 -1.006 . . . . 0.0 109.709 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.025 HD22 HD11 ' A' ' 52' ' ' ILE . 1.9 tp -60.36 -31.46 70.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.274 -0.891 . . . . 0.0 109.529 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.51 -43.12 96.17 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 38' ' ' SER . 30.7 m -73.74 -24.95 59.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.396 -1.061 . . . . 0.0 109.891 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.5 t -70.64 -33.65 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.356 -0.84 . . . . 0.0 110.253 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.2 mmt -89.24 -23.93 22.22 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.356 -0.84 . . . . 0.0 110.382 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.431 ' NH1' ' HG2' ' A' ' 37' ' ' ARG . 11.3 tpt180 -90.62 -11.24 40.5 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.226 -0.921 . . . . 0.0 110.738 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 34' ' ' THR . 23.8 t -67.8 -68.92 0.35 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.106 -0.996 . . . . 0.0 110.414 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.42 68.39 1.37 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.301 -0.874 . . . . 0.0 110.179 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -158.89 -109.99 0.27 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -112.46 -164.54 0.92 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.319 -1.106 . . . . 0.0 110.05 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -124.82 64.53 42.58 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 110.453 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 152.49 51.71 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.862 1.454 . . . . 0.0 110.368 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.511 HG22 ' N ' ' A' ' 45' ' ' GLU . 35.6 m -100.73 173.47 6.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.183 -0.948 . . . . 0.0 109.826 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.511 ' N ' HG22 ' A' ' 44' ' ' THR . 1.8 mp0 -66.78 -22.73 66.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.143 -0.973 . . . . 0.0 110.353 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.15 -70.96 0.41 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.124 -0.985 . . . . 0.0 109.991 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -52.56 -30.54 31.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.287 -0.883 . . . . 0.0 109.251 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.538 HD11 HD23 ' A' ' 32' ' ' LEU . 5.5 tt -66.56 -46.52 75.78 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.462 -0.774 . . . . 0.0 109.361 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.408 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 2.0 tt0 -50.62 -39.25 49.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.293 -0.879 . . . . 0.0 108.812 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.98 -45.7 93.74 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.211 178.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.44 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 0.4 OUTLIER -57.24 -24.37 54.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.404 178.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.025 HD11 HD22 ' A' ' 32' ' ' LEU . 46.9 mm -83.3 -31.26 8.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.456 -0.778 . . . . 0.0 109.913 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -76.38 -24.3 54.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.284 -0.885 . . . . 0.0 110.243 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.485 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 24.0 pt-20 -84.72 -36.23 21.97 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.193 -0.942 . . . . 0.0 110.377 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.485 ' N ' ' HG3' ' A' ' 54' ' ' GLU . 71.2 t -77.18 -32.67 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.128 -0.982 . . . . 0.0 109.942 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -97.1 100.46 11.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.342 -0.848 . . . . 0.0 110.169 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -100.21 22.74 11.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.164 -0.96 . . . . 0.0 110.042 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.413 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 29.5 m-20 -92.8 -56.57 2.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 110.133 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.94 25.93 1.45 Allowed Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.244 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -110.18 -41.32 4.45 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.825 -1.397 . . . . 0.0 110.005 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.14 -81.89 0.28 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.514 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.944 HG21 HG22 ' A' ' 28' ' ' THR . 69.7 p -79.26 170.71 16.22 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.324 -1.104 . . . . 0.0 111.025 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.7 mt -97.01 153.93 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.301 -0.874 . . . . 0.0 110.337 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.458 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 0.8 OUTLIER -105.86 -171.55 1.92 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.241 -0.912 . . . . 0.0 110.258 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.558 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 33.6 t80 -82.43 -41.88 0.94 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.343 -0.848 . . . . 0.0 111.76 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.0 Cg_endo -74.61 -20.26 18.03 Favored 'Trans proline' 0 C--N 1.323 -0.768 0 O-C-N 123.006 1.003 . . . . 0.0 110.187 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.413 ' OE1' ' OD2' ' A' ' 58' ' ' ASP . 41.9 tt0 -83.71 -28.46 28.27 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.22 -0.925 . . . . 0.0 109.408 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 6.5 t80 -74.58 -46.59 37.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.625 -0.672 . . . . 0.0 110.118 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.687 ' O ' HD23 ' A' ' 69' ' ' LEU . 8.3 tt -74.03 -32.91 63.55 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.288 -0.883 . . . . 0.0 110.609 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.1 m -79.35 -22.4 44.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.245 -0.909 . . . . 0.0 110.892 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.666 ' HE2' ' HE3' ' A' ' 72' ' ' MET . 11.6 ptt? -89.65 -26.37 20.77 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.927 -1.108 . . . . 0.0 110.904 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.666 ' HE3' ' HE2' ' A' ' 71' ' ' MET . 52.5 mtt -90.72 -55.57 3.52 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.053 -1.029 . . . . 0.0 111.191 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.492 ' HB2' ' CE2' ' A' ' 12' ' ' PHE . . . . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.259 -0.901 . . . . 0.0 110.772 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.473 0.654 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.544 HG23 ' CE1' ' A' ' 141' ' ' PHE . 13.7 mt -58.35 -17.17 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.895 . . . . 0.0 109.93 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -68.54 -52.27 33.88 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.154 -0.966 . . . . 0.0 109.533 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 38.8 mm-40 -61.66 -35.21 77.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 109.801 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.746 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -61.65 -61.14 2.73 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.221 -0.924 . . . . 0.0 109.737 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.427 ' CE2' ' HA ' ' A' ' 138' ' ' TYR . 31.9 t80 -54.44 -22.32 12.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.23 -0.919 . . . . 0.0 110.084 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 5.3 mtp180 -67.91 -44.98 75.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.097 -1.002 . . . . 0.0 109.817 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.746 HG22 ' O ' ' A' ' 88' ' ' ALA . 30.2 m -78.43 -21.59 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.344 -0.848 . . . . 0.0 110.576 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.845 ' CE1' HG11 ' A' ' 108' ' ' VAL . 38.4 m-85 -86.48 -15.5 39.95 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.129 -0.982 . . . . 0.0 110.587 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -124.44 47.78 2.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.219 -0.925 . . . . 0.0 110.223 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -106.49 40.4 1.63 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.324 -0.86 . . . . 0.0 110.163 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -124.35 -25.66 4.05 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.278 -0.888 . . . . 0.0 110.54 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 119.37 -32.02 5.21 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -47.34 -38.63 13.27 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.335 -1.097 . . . . 0.0 110.462 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.462 ' C ' ' CD1' ' A' ' 99' ' ' TYR . . . 97.19 -14.72 63.37 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.542 ' CD2' ' NE2' ' A' ' 135' ' ' GLN . 46.4 m-85 -135.03 168.47 19.06 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.114 -1.227 . . . . 0.0 110.118 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.446 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 37.1 mt -87.01 126.58 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.269 -0.895 . . . . 0.0 109.983 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.0 m -113.67 175.26 5.53 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.456 -0.777 . . . . 0.0 109.665 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.9 -43.68 78.69 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.136 -0.977 . . . . 0.0 110.279 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.67 -52.13 62.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.282 -0.886 . . . . 0.0 110.23 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -53.71 -53.3 54.07 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.221 -0.924 . . . . 0.0 110.126 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.5 tt -49.73 -39.43 37.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.268 -0.895 . . . . 0.0 110.247 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.436 ' O ' HG23 ' A' ' 110' ' ' THR . 44.0 ttt-85 -64.09 -38.84 92.51 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.22 -0.925 . . . . 0.0 110.41 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.405 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 54.2 t-80 -72.23 -19.19 61.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.255 -0.903 . . . . 0.0 110.524 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.845 HG11 ' CE1' ' A' ' 92' ' ' PHE . 90.1 t -84.4 -46.39 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.192 -0.943 . . . . 0.0 110.624 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.438 ' HB3' HD12 ' A' ' 116' ' ' LEU . 25.6 mmt -61.12 -48.17 82.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.141 -0.974 . . . . 0.0 110.668 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 106' ' ' ARG . 47.0 p -49.24 -37.44 23.35 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.207 -0.933 . . . . 0.0 110.56 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.405 ' ND2' ' O ' ' A' ' 107' ' ' HIS . 76.7 m-20 -73.39 -48.62 32.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.288 -0.882 . . . . 0.0 110.455 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.8 mt -59.14 -21.79 59.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 110.37 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.8 46.89 4.69 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 6.0 mm-40 -110.37 -29.5 8.09 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.26 -1.141 . . . . 0.0 110.197 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 114' ' ' GLU . 47.4 tttt 55.46 99.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.337 -0.852 . . . . 0.0 110.418 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.438 HD12 ' HB3' ' A' ' 109' ' ' MET . 0.5 OUTLIER -127.68 151.73 48.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.282 -0.886 . . . . 0.0 110.183 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.2 m -76.52 157.68 31.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 109.998 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -64.59 -42.91 95.28 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.229 -0.919 . . . . 0.0 110.354 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -56.63 -40.01 74.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.116 -0.99 . . . . 0.0 110.307 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 124' ' ' MET . 33.7 mt-10 -63.31 -46.37 87.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.162 -0.961 . . . . 0.0 110.159 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.418 ' O ' ' HB2' ' A' ' 124' ' ' MET . 95.1 t -55.27 -51.5 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.045 -1.034 . . . . 0.0 110.214 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -55.65 -46.99 77.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 110.229 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -62.9 -25.17 68.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -0.924 . . . . 0.0 110.237 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.418 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 73.7 mtp -73.84 -46.68 43.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.048 -1.032 . . . . 0.0 109.971 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 30.6 mm -61.29 -30.68 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.11 -0.994 . . . . 0.0 110.011 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.61 -43.46 47.98 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.246 -0.908 . . . . 0.0 110.265 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -67.43 -24.95 65.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.926 . . . . 0.0 110.071 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.75 -35.84 24.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.888 . . . . 0.0 110.204 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.4 ' OD2' ' HA2' ' A' ' 132' ' ' GLY . 23.1 t0 -61.32 96.09 0.05 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.922 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 140' ' ' GLU . 89.4 mt -67.77 -64.33 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.316 -0.865 . . . . 0.0 110.885 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.403 ' OD1' ' OE2' ' A' ' 140' ' ' GLU . 29.4 p30 -73.71 -19.79 60.71 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.234 -0.917 . . . . 0.0 110.906 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.4 ' HA2' ' OD2' ' A' ' 129' ' ' ASP . . . 80.66 75.4 1.08 Allowed Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.881 -1.152 . . . . 0.0 110.395 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 31.7 m-20 -111.35 -23.97 10.48 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.167 -1.196 . . . . 0.0 110.024 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 135.78 -39.3 1.68 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.542 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -132.76 170.71 14.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.567 -0.961 . . . . 0.0 109.69 179.633 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.446 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 91.1 t -95.28 133.83 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.972 -1.08 . . . . 0.0 110.231 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -102.56 170.58 7.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.113 -0.992 . . . . 0.0 110.1 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.427 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 21.7 t80 -56.06 -47.18 78.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.23 -0.918 . . . . 0.0 110.462 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -55.73 -55.53 31.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -0.955 . . . . 0.0 110.273 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.419 ' HA ' HD12 ' A' ' 130' ' ' ILE . 52.6 mt-10 -58.35 -26.46 63.14 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.312 -0.867 . . . . 0.0 110.239 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.544 ' CE1' HG23 ' A' ' 85' ' ' ILE . 9.7 t80 -70.43 -32.1 69.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.253 -0.904 . . . . 0.0 110.151 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 87.0 t -82.33 -29.01 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.272 -0.892 . . . . 0.0 110.369 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -80.53 -23.79 39.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.275 -0.891 . . . . 0.0 110.424 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 54.7 ttp -80.51 -32.88 36.82 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.141 -0.975 . . . . 0.0 110.432 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.7 ttm -84.23 -11.47 56.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.246 -0.909 . . . . 0.0 110.803 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.7 p . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.092 -1.005 . . . . 0.0 110.214 179.805 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.035 0.445 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -66.95 -37.81 84.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.024 -1.047 . . . . 0.0 109.93 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.484 ' HG3' ' CE2' ' A' ' 12' ' ' PHE . 21.6 tp60 -72.33 -55.39 7.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.352 -0.842 . . . . 0.0 110.18 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.441 HG22 ' HD2' ' A' ' 13' ' ' LYS . 64.1 mt -52.2 -38.92 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 109.884 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.455 ' HA ' ' HD3' ' A' ' 13' ' ' LYS . . . -65.87 -36.76 84.33 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.282 -0.886 . . . . 0.0 109.449 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -59.3 -50.05 75.48 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.388 -0.82 . . . . 0.0 109.832 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.484 ' CE2' ' HG3' ' A' ' 8' ' ' GLN . 23.0 m-85 -63.6 -32.66 74.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.279 -0.888 . . . . 0.0 109.918 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.455 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 31.7 mtpt -65.46 -36.62 84.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.27 -0.894 . . . . 0.0 110.163 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -69.63 -38.4 77.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 0.0 109.715 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.458 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -64.32 -39.46 93.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.289 -0.882 . . . . 0.0 109.999 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -62.52 -57.51 10.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.137 -0.977 . . . . 0.0 110.238 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.9 p -55.64 -26.53 44.88 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.264 -0.897 . . . . 0.0 109.516 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.562 HD13 ' C ' ' A' ' 18' ' ' LEU . 2.1 tm? -71.91 -36.88 70.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.407 -0.808 . . . . 0.0 109.978 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.458 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 15.4 m-85 -71.04 -56.49 6.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.062 -1.024 . . . . 0.0 109.538 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.79 101.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.425 -0.797 . . . . 0.0 109.997 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.6 mmtt -67.0 -42.79 84.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 109.979 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 53.0 p-10 -86.56 -15.18 40.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.334 -0.854 . . . . 0.0 110.598 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.426 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 67.8 37.67 88.77 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -79.85 -17.75 52.47 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.359 -1.083 . . . . 0.0 110.502 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.97 -21.79 22.18 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.374 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.4 p -119.72 158.08 27.23 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.923 -1.339 . . . . 0.0 110.786 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 96.3 mt -117.08 125.99 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.421 -0.799 . . . . 0.0 110.08 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.1 p -104.35 -162.49 0.9 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.0 110.121 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.673 HG22 HD12 ' A' ' 52' ' ' ILE . 20.1 p -87.81 -39.94 14.46 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.132 -0.98 . . . . 0.0 110.924 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -57.48 10.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.036 -1.04 . . . . 0.0 110.401 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -57.04 -42.1 79.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.949 . . . . 0.0 109.671 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.709 HD22 HD11 ' A' ' 52' ' ' ILE . 5.3 tp -63.37 -28.38 69.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.35 -0.843 . . . . 0.0 109.747 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.97 -47.71 79.47 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.5 m -66.74 -28.5 68.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.269 -1.136 . . . . 0.0 109.554 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.7 t -73.17 -28.28 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.48 -0.763 . . . . 0.0 110.102 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.416 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 25.7 mmt -83.4 -25.73 31.04 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.212 -0.93 . . . . 0.0 110.121 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -89.67 -16.7 29.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.888 . . . . 0.0 110.217 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.6 m -50.96 -54.56 23.24 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.319 -0.863 . . . . 0.0 110.232 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.8 39.93 1.83 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.306 -0.871 . . . . 0.0 110.337 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -131.39 -100.71 0.84 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -138.3 -155.79 0.63 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -1.157 . . . . 0.0 110.006 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -125.12 69.03 58.45 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.118 -0.989 . . . . 0.0 110.165 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 -160.95 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.906 1.477 . . . . 0.0 110.109 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.432 HG22 ' N ' ' A' ' 45' ' ' GLU . 35.4 m -134.73 166.5 22.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.127 -0.983 . . . . 0.0 110.266 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.432 ' N ' HG22 ' A' ' 44' ' ' THR . 5.9 mm-40 -63.24 -22.64 67.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.221 -0.924 . . . . 0.0 110.166 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.3 -70.03 0.39 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.102 -0.999 . . . . 0.0 110.043 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -50.57 -31.73 16.6 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.301 -0.875 . . . . 0.0 109.923 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.482 HD21 ' HA ' ' A' ' 29' ' ' THR . 5.6 tt -62.9 -50.88 69.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 110.066 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.419 ' O ' ' OD1' ' A' ' 53' ' ' ASN . 37.4 tt0 -53.3 -42.81 67.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.119 -0.988 . . . . 0.0 109.306 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -62.35 -34.75 77.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.631 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.418 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 4.7 ttp -68.94 -22.27 64.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.412 -0.805 . . . . 0.0 109.787 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.709 HD11 HD22 ' A' ' 32' ' ' LEU . 35.9 mt -87.38 -30.05 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.328 -0.857 . . . . 0.0 109.979 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 49' ' ' GLN . 3.6 m-20 -51.77 -42.93 62.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.171 -0.955 . . . . 0.0 110.079 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.438 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 13.3 pt-20 -68.57 -29.98 68.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.228 -0.92 . . . . 0.0 110.419 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.646 HG11 HD11 ' A' ' 63' ' ' ILE . 67.2 t -75.88 -69.87 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.208 -0.933 . . . . 0.0 110.166 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.428 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 54.2 t0 -43.17 94.15 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.541 -0.724 . . . . 0.0 110.881 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -109.89 61.4 0.6 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 109.773 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 1.7 p30 -164.0 -33.44 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.337 -0.852 . . . . 0.0 110.941 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.443 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 105.74 47.85 1.07 Allowed Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.098 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -117.73 -12.78 10.21 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.265 -1.138 . . . . 0.0 110.332 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.68 -56.59 4.14 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 59.4 p -109.31 170.3 8.14 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.255 -1.144 . . . . 0.0 110.248 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.646 HD11 HG11 ' A' ' 55' ' ' VAL . 39.6 mt -89.79 139.34 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.155 -0.966 . . . . 0.0 110.143 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.4 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 0.8 OUTLIER -103.56 179.68 4.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.219 -0.926 . . . . 0.0 110.176 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.569 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.2 t80 -73.56 -46.53 7.36 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 0.0 111.003 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.0 Cg_endo -71.66 -22.34 24.26 Favored 'Trans proline' 0 N--CA 1.482 0.807 0 O-C-N 123.186 1.098 . . . . 0.0 110.419 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.428 ' OE2' ' HA ' ' A' ' 56' ' ' ASP . 80.5 tt0 -81.37 -37.69 27.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.173 -0.954 . . . . 0.0 109.166 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.421 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 16.6 t80 -66.52 -38.73 87.82 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.525 -0.735 . . . . 0.0 109.867 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.497 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 1.1 tt -72.83 -36.35 67.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.354 -0.841 . . . . 0.0 110.059 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 92.7 m -76.22 -12.43 60.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.102 -0.999 . . . . 0.0 110.3 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.1 tmm? -89.09 -44.41 10.37 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.105 -0.997 . . . . 0.0 110.837 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.411 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 64.6 mtt -90.48 -37.76 13.69 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.028 -1.045 . . . . 0.0 111.135 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.498 1.971 0 O-C-N 121.178 -0.951 . . . . 0.0 110.57 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.236 0.541 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 84.3 mt -53.42 -37.79 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.377 -0.827 . . . . 0.0 110.365 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.69 -55.44 23.37 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.136 -0.977 . . . . 0.0 109.777 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -49.46 -41.04 39.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.278 -0.889 . . . . 0.0 110.003 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.536 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -59.06 -59.9 4.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 110.028 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.428 ' O ' ' HB3' ' A' ' 93' ' ' ASP . 11.9 t80 -50.49 -22.58 1.99 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.314 -0.866 . . . . 0.0 110.134 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.3 ttt180 -72.26 -58.39 3.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 110.701 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 88' ' ' ALA . 30.3 m -60.19 -32.37 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.033 -1.042 . . . . 0.0 110.117 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.694 ' CE1' HG11 ' A' ' 108' ' ' VAL . 36.5 m-85 -80.47 -19.21 46.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.237 -0.914 . . . . 0.0 110.177 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 52.6 t0 -123.59 57.83 1.16 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.279 -0.888 . . . . 0.0 109.943 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.8 pttm -88.73 39.47 0.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.245 -0.91 . . . . 0.0 110.455 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.429 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 1.5 p30 -125.85 -30.64 2.99 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.31 -0.869 . . . . 0.0 110.316 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.93 38.78 3.06 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.721 -1.228 . . . . 0.0 111.006 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.507 ' O ' ' CE2' ' A' ' 99' ' ' TYR . 30.2 p30 -129.49 -21.84 3.11 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.75 -1.441 . . . . 0.0 110.99 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.507 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 79.93 48.65 6.44 Favored Glycine 0 N--CA 1.494 2.502 0 O-C-N 120.866 -1.146 . . . . 0.0 110.314 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 62.8 m-85 -151.19 142.53 23.36 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.172 -1.193 . . . . 0.0 110.323 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.485 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 21.2 mt -111.75 110.81 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.142 -0.974 . . . . 0.0 109.505 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.5 p -104.3 151.81 22.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.893 . . . . 0.0 110.181 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -46.84 -28.59 1.62 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.29 -0.881 . . . . 0.0 110.181 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.25 -56.01 10.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.281 -0.887 . . . . 0.0 110.241 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.85 ' O ' HG23 ' A' ' 108' ' ' VAL . 53.6 mt-10 -58.21 -31.13 67.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.206 -0.934 . . . . 0.0 110.182 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.001 HD23 HG13 ' A' ' 121' ' ' VAL . 39.5 tp -69.73 -34.59 74.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.973 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -77.79 -19.84 54.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.372 -0.83 . . . . 0.0 110.019 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -91.89 -20.29 21.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 0.0 110.167 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 104' ' ' GLU . 46.5 t -92.43 -50.83 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.165 -0.959 . . . . 0.0 110.1 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.616 ' HA ' HD12 ' A' ' 112' ' ' LEU . 17.1 mmt -46.96 -34.35 5.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.333 -0.854 . . . . 0.0 110.512 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.1 p -62.98 -51.89 65.11 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.236 -0.915 . . . . 0.0 109.708 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -53.67 -42.75 68.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.343 -0.848 . . . . 0.0 110.164 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.616 HD12 ' HA ' ' A' ' 109' ' ' MET . 17.4 mt -59.82 -37.7 79.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.282 -0.886 . . . . 0.0 110.152 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 125.03 -20.15 6.75 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -82.58 107.61 15.35 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.274 -1.133 . . . . 0.0 110.361 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -85.83 126.69 34.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.838 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 mt -130.38 156.95 43.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.204 -0.935 . . . . 0.0 110.287 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 91.7 m -91.37 155.44 18.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.28 -0.887 . . . . 0.0 110.393 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -46.42 -35.83 5.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.339 -0.851 . . . . 0.0 110.637 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -59.7 -64.38 0.97 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.155 -0.966 . . . . 0.0 110.669 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -50.24 -44.73 53.54 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.118 -0.989 . . . . 0.0 110.322 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 1.001 HG13 HD23 ' A' ' 105' ' ' LEU . 40.5 t -53.15 -48.23 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 110.056 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -61.22 -30.82 70.67 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.281 -0.887 . . . . 0.0 110.026 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -69.62 -36.92 76.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.337 -0.852 . . . . 0.0 110.168 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.1 mtp -71.98 -54.57 9.53 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.252 -0.905 . . . . 0.0 110.377 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 20.7 mm -52.42 -37.14 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.157 -0.964 . . . . 0.0 109.879 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 43.1 ttt-85 -66.84 -50.79 61.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.365 -0.835 . . . . 0.0 110.533 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -63.22 -21.0 65.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.177 -0.952 . . . . 0.0 110.492 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.494 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -92.57 -16.96 25.04 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.174 -0.954 . . . . 0.0 110.652 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -82.44 78.49 9.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.04 -1.038 . . . . 0.0 109.955 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.425 HD12 ' CB ' ' A' ' 140' ' ' GLU . 14.4 mt -48.95 -57.41 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.46 -0.775 . . . . 0.0 110.809 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 27.4 p30 -81.55 -19.12 42.71 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.035 -1.041 . . . . 0.0 110.903 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 76.5 69.24 1.42 Allowed Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.938 -1.125 . . . . 0.0 110.457 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.427 ' O ' ' HG2' ' A' ' 135' ' ' GLN . 53.8 m-20 -111.77 19.24 18.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.123 -1.222 . . . . 0.0 109.848 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 68.78 18.01 71.86 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 133' ' ' ASP . 2.1 pt20 -170.46 138.75 1.56 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.309 -1.113 . . . . 0.0 109.916 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.485 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 57.7 t -94.44 123.54 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.141 -0.974 . . . . 0.0 110.044 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -93.67 175.53 6.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.169 -0.957 . . . . 0.0 109.977 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.415 ' O ' HG23 ' A' ' 142' ' ' VAL . 23.5 t80 -59.06 -48.76 80.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.254 -0.904 . . . . 0.0 110.603 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.38 -50.83 64.28 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.103 -0.998 . . . . 0.0 110.665 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.425 ' CB ' HD12 ' A' ' 130' ' ' ILE . 54.4 mt-10 -64.03 -28.28 69.69 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.114 -0.991 . . . . 0.0 110.126 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.71 ' CZ ' ' HE3' ' A' ' 145' ' ' MET . 13.8 t80 -73.0 -20.9 60.92 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.335 -0.853 . . . . 0.0 110.03 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.64 ' O ' HG23 ' A' ' 146' ' ' THR . 79.0 t -87.39 -32.93 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.312 -0.868 . . . . 0.0 110.624 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.3 -20.1 32.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.133 -0.979 . . . . 0.0 111.272 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.494 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 19.9 ptt? -82.82 -32.6 27.53 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.864 -1.147 . . . . 0.0 110.964 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.71 ' HE3' ' CZ ' ' A' ' 141' ' ' PHE . 54.9 mtt -90.48 -27.36 19.27 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.922 -1.111 . . . . 0.0 110.671 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.64 HG23 ' O ' ' A' ' 142' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.131 -0.981 . . . . 0.0 110.723 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.186 0.517 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -66.15 -27.67 68.2 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.226 -0.921 . . . . 0.0 109.983 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -70.69 -44.92 65.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.308 -0.87 . . . . 0.0 109.73 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 86.5 mt -63.07 -48.13 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.751 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.59 -31.8 70.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.317 -0.864 . . . . 0.0 109.9 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.75 -51.93 62.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.355 -0.841 . . . . 0.0 109.888 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.427 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 10.7 m-30 -56.35 -46.73 79.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.354 -0.841 . . . . 0.0 110.09 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -62.39 -26.08 68.28 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.329 -0.857 . . . . 0.0 110.34 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -69.85 -66.29 0.61 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.112 -0.992 . . . . 0.0 110.13 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.418 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -48.59 -39.27 23.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -0.913 . . . . 0.0 109.966 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -62.19 -43.82 97.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -0.942 . . . . 0.0 109.963 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.5 m -65.04 -18.46 65.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 109.85 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.891 HD13 ' O ' ' A' ' 18' ' ' LEU . 2.9 tm? -87.75 -31.03 19.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 110.022 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.418 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 21.4 m-85 -74.46 -43.88 54.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.15 -0.968 . . . . 0.0 110.138 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -71.73 125.77 27.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.339 -0.85 . . . . 0.0 110.255 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.402 ' HD2' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -108.47 -51.93 2.83 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.205 -0.934 . . . . 0.0 110.795 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 3.0 p30 -70.6 -22.22 62.57 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.137 -0.977 . . . . 0.0 110.16 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.417 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 83.92 51.01 4.15 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.417 ' OD1' ' OG1' ' A' ' 26' ' ' THR . 7.0 p30 -104.72 18.62 21.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.109 -1.23 . . . . 0.0 110.335 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.812 ' O ' HG23 ' A' ' 26' ' ' THR . . . 49.6 41.67 34.43 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.812 HG23 ' O ' ' A' ' 25' ' ' GLY . 0.8 OUTLIER -166.56 160.47 15.25 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.306 -1.114 . . . . 0.0 110.291 179.803 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 55.3 mt -121.9 118.2 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.315 -0.865 . . . . 0.0 109.884 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.591 HG22 ' H ' ' A' ' 29' ' ' THR . 5.8 m -105.93 -179.82 4.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.495 -0.753 . . . . 0.0 110.034 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.591 ' H ' HG22 ' A' ' 28' ' ' THR . 13.5 p -71.58 -16.84 62.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.113 -0.992 . . . . 0.0 110.353 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -75.6 -67.72 0.64 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 109.846 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.402 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 50.6 mt-10 -53.71 -41.32 66.85 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.317 -0.865 . . . . 0.0 109.415 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.039 HD22 HD11 ' A' ' 52' ' ' ILE . 1.8 tp -63.88 -38.52 91.4 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.346 -0.846 . . . . 0.0 109.28 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.49 ' HA2' HD12 ' A' ' 48' ' ' LEU . . . -51.87 -42.31 53.18 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.5 m -70.4 -45.08 66.68 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.382 -1.069 . . . . 0.0 110.085 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.5 t -50.06 -43.4 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.357 -0.84 . . . . 0.0 110.735 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 21.8 mmt -85.34 -23.66 27.95 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.237 -0.914 . . . . 0.0 110.318 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 32.9 ttt180 -70.63 -16.7 62.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.381 -0.824 . . . . 0.0 110.139 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -102.61 -22.95 13.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 110.234 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.441 HD13 ' HA ' ' A' ' 39' ' ' LEU . 3.3 mm? -112.44 59.52 0.64 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.218 -0.926 . . . . 0.0 110.262 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.82 69.11 0.41 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.415 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 48.6 tt0 -58.17 106.72 0.4 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.241 -1.153 . . . . 0.0 110.114 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.557 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.9 m120 -155.54 -65.39 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.282 -0.886 . . . . 0.0 110.577 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.557 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 44.0 Cg_endo -70.15 166.08 29.26 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 123.429 1.226 . . . . 0.0 110.097 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.612 HG22 ' N ' ' A' ' 45' ' ' GLU . 41.8 m -132.32 -98.32 0.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.104 -0.997 . . . . 0.0 110.041 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.612 ' N ' HG22 ' A' ' 44' ' ' THR . 87.7 tt0 -110.77 -46.25 3.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.818 -1.176 . . . . 0.0 110.151 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.02 -63.25 1.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 109.971 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 29.1 mt-10 -50.24 -40.4 47.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.603 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.524 HD23 ' C ' ' A' ' 48' ' ' LEU . 10.6 tt -54.92 -53.45 55.35 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.295 -0.878 . . . . 0.0 109.412 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -48.74 -39.8 26.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.815 . . . . 0.0 109.821 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 39.0 t70 -57.92 -44.93 87.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.325 -0.859 . . . . 0.0 109.528 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.448 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 0.7 OUTLIER -62.78 -24.83 67.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.376 -0.828 . . . . 0.0 109.731 179.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.039 HD11 HD22 ' A' ' 32' ' ' LEU . 46.2 mm -80.02 -23.38 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.408 -0.808 . . . . 0.0 110.174 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -79.14 -30.99 43.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.151 -0.968 . . . . 0.0 110.094 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.565 ' HG3' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -76.3 -13.63 60.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 110.136 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.565 HG23 ' HG3' ' A' ' 54' ' ' GLU . 93.2 t -103.01 -60.76 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.89 . . . . 0.0 110.117 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -45.87 108.75 0.14 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.397 -0.815 . . . . 0.0 110.185 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.41 13.34 25.59 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.312 -0.868 . . . . 0.0 110.539 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -110.38 -60.27 1.83 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.11 -0.994 . . . . 0.0 109.87 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 132.56 47.0 0.11 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.466 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 19.4 p30 -126.22 -31.27 2.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.372 -1.075 . . . . 0.0 110.526 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.466 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 115.49 -60.2 0.41 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.42 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 81.5 p -89.59 170.27 10.62 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.07 -1.253 . . . . 0.0 110.566 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.493 ' CD1' HG11 ' A' ' 55' ' ' VAL . 81.7 mt -108.21 152.26 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.054 -1.029 . . . . 0.0 110.291 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.452 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.4 m-20 -101.15 179.54 4.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.358 -0.839 . . . . 0.0 110.242 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.542 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 7.5 t80 -73.08 -42.45 7.16 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 111.038 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 46.6 Cg_endo -76.87 -30.28 4.75 Favored 'Trans proline' 0 C--N 1.327 -0.567 0 O-C-N 123.125 1.066 . . . . 0.0 109.837 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -72.7 -20.76 61.16 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.425 -0.797 . . . . 0.0 109.147 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.546 ' CE2' ' HE3' ' A' ' 72' ' ' MET . 8.5 t80 -82.05 -49.47 10.18 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.589 -0.694 . . . . 0.0 110.048 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.87 -18.5 64.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.004 -1.06 . . . . 0.0 110.232 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 72.8 m -90.04 -33.82 16.18 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.168 -0.957 . . . . 0.0 110.47 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.49 ' SD ' HG13 ' A' ' 55' ' ' VAL . 4.9 ptm -77.52 -25.15 50.02 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.171 -0.956 . . . . 0.0 110.265 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.546 ' HE3' ' CE2' ' A' ' 68' ' ' PHE . 1.1 mmt -84.4 -33.57 23.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.231 -0.918 . . . . 0.0 110.257 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.18 -0.95 . . . . 0.0 110.03 179.946 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.441 ' HG3' ' N ' ' A' ' 85' ' ' ILE . 15.8 pt-20 . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 121.404 0.621 . . . . 0.0 110.109 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.441 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 56.9 mt -53.43 -44.12 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.193 -0.942 . . . . 0.0 109.69 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -50.98 -49.65 59.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.354 -0.842 . . . . 0.0 110.039 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 4.7 mp0 -54.44 -41.84 69.87 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.234 -0.916 . . . . 0.0 110.145 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.81 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -61.45 -63.94 1.11 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.255 -0.903 . . . . 0.0 110.285 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.466 ' CZ ' ' OD2' ' A' ' 93' ' ' ASP . 9.2 t80 -45.62 -27.85 0.86 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.281 -0.887 . . . . 0.0 110.466 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.428 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 34.7 ttm-85 -66.62 -50.76 61.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.184 -0.948 . . . . 0.0 109.705 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.81 HG22 ' O ' ' A' ' 88' ' ' ALA . 33.2 m -70.04 -18.38 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.269 -0.895 . . . . 0.0 110.329 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.531 ' HA ' HG21 ' A' ' 108' ' ' VAL . 37.0 m-85 -94.52 -8.42 38.39 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.141 -0.974 . . . . 0.0 110.443 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.466 ' OD2' ' CZ ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -140.54 35.56 1.83 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.096 -1.002 . . . . 0.0 110.194 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.21 10.77 15.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 110.361 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 2.7 p30 -83.49 -19.61 35.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.082 -1.011 . . . . 0.0 110.196 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.68 29.21 5.39 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 17.9 t-20 -98.42 -72.49 0.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.332 -1.099 . . . . 0.0 110.102 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.494 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 135.83 -14.81 4.1 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.499 ' CE1' ' OD1' ' A' ' 137' ' ' ASN . 27.6 m-85 -139.18 152.07 47.1 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.018 -1.283 . . . . 0.0 109.971 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.439 HG23 ' HB3' ' A' ' 92' ' ' PHE . 37.9 mt -81.61 121.79 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.022 -1.049 . . . . 0.0 110.159 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.1 m -111.56 176.28 5.08 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.469 -0.769 . . . . 0.0 109.828 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.21 -56.24 10.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.155 -0.966 . . . . 0.0 110.194 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -49.78 -54.16 20.84 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.236 -0.915 . . . . 0.0 110.333 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.462 ' O ' HG23 ' A' ' 108' ' ' VAL . 50.7 mt-10 -53.47 -43.67 68.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 tt -59.09 -37.95 78.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.324 -0.86 . . . . 0.0 110.38 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.818 ' O ' HG23 ' A' ' 110' ' ' THR . 2.5 tmt_? -69.47 -28.44 66.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.05 -1.031 . . . . 0.0 109.632 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.439 ' CD2' ' N ' ' A' ' 107' ' ' HIS . 35.0 m170 -71.55 -29.44 64.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.336 -0.853 . . . . 0.0 109.843 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.531 HG21 ' HA ' ' A' ' 92' ' ' PHE . 34.0 t -79.28 -50.2 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.316 -0.865 . . . . 0.0 110.073 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -49.95 -43.74 50.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.363 -0.836 . . . . 0.0 110.266 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.818 HG23 ' O ' ' A' ' 106' ' ' ARG . 69.1 p -50.7 -43.41 57.68 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.284 -0.885 . . . . 0.0 110.023 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -58.46 -41.22 84.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.311 -0.868 . . . . 0.0 110.243 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.3 mt -62.09 -53.52 54.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.263 -0.898 . . . . 0.0 110.365 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.66 40.07 0.34 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -111.3 -175.04 2.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.164 -1.198 . . . . 0.0 110.197 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -144.23 81.14 1.66 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.921 . . . . 0.0 110.147 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.97 161.03 15.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.304 -0.873 . . . . 0.0 110.089 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.431 HG22 ' HG2' ' A' ' 120' ' ' GLU . 11.0 t -98.6 -165.4 1.24 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.887 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -80.98 -43.97 18.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.117 -0.989 . . . . 0.0 110.362 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 122' ' ' ASP . 65.2 mm-40 -50.61 -54.35 23.49 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.26 -0.9 . . . . 0.0 110.719 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.431 ' HG2' HG22 ' A' ' 117' ' ' THR . 69.9 mm-40 -48.69 -61.93 1.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.12 -0.987 . . . . 0.0 110.698 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.2 t -47.73 -39.19 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.206 -0.933 . . . . 0.0 110.625 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.441 ' HB3' ' O ' ' A' ' 119' ' ' GLU . 38.7 t70 -56.57 -47.5 79.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.994 -1.066 . . . . 0.0 110.066 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.46 -25.68 66.84 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.248 -0.908 . . . . 0.0 110.286 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 24.4 mmm -70.27 -57.06 5.3 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.187 -0.945 . . . . 0.0 110.14 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.589 HG23 HG23 ' A' ' 136' ' ' VAL . 25.4 mm -57.34 -31.39 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.381 -0.825 . . . . 0.0 110.409 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -76.64 -32.95 58.32 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.135 -0.978 . . . . 0.0 110.235 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -69.97 -33.23 71.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 0.0 110.141 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.475 ' HA ' ' HB2' ' A' ' 144' ' ' MET . . . -79.81 -43.41 22.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.927 . . . . 0.0 110.336 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -60.21 98.35 0.06 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.135 -0.978 . . . . 0.0 109.943 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.442 ' CD1' ' HA ' ' A' ' 140' ' ' GLU . 5.4 mt -56.22 -42.97 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.294 -0.879 . . . . 0.0 110.333 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 53.5 p-10 -76.65 -15.92 59.68 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.042 -1.036 . . . . 0.0 110.231 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.456 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 55.68 55.18 30.14 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.425 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 2.5 p30 -97.53 -21.77 16.92 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.207 -1.172 . . . . 0.0 110.267 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 130.66 0.56 5.27 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.384 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.425 ' HG3' ' OD1' ' A' ' 133' ' ' ASP . 0.1 OUTLIER -154.95 151.01 28.01 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.862 -1.375 . . . . 0.0 110.6 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.589 HG23 HG23 ' A' ' 125' ' ' ILE . 71.8 t -100.25 142.14 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.202 -0.936 . . . . 0.0 110.305 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.499 ' OD1' ' CE1' ' A' ' 99' ' ' TYR . 2.5 t30 -111.2 -169.59 1.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.426 -0.796 . . . . 0.0 110.047 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.683 ' O ' HG23 ' A' ' 142' ' ' VAL . 49.3 t80 -75.37 -57.06 4.12 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.26 -0.9 . . . . 0.0 110.264 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -55.68 -52.02 65.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.86 . . . . 0.0 110.604 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.442 ' HA ' ' CD1' ' A' ' 130' ' ' ILE . 51.7 mt-10 -56.82 -46.88 81.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 110.526 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.588 ' CD1' ' HE2' ' A' ' 144' ' ' MET . 35.2 t80 -59.82 -25.36 64.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.094 -1.004 . . . . 0.0 110.322 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 138' ' ' TYR . 60.2 t -86.48 -22.25 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.247 -0.908 . . . . 0.0 110.383 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -98.82 -9.13 24.78 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.34 -0.85 . . . . 0.0 110.663 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.588 ' HE2' ' CD1' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -90.69 -30.93 16.82 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.002 -1.061 . . . . 0.0 110.806 -179.686 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.415 ' HE2' ' HE1' ' A' ' 144' ' ' MET . 43.4 ttm -88.98 -45.65 9.49 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.071 -1.018 . . . . 0.0 109.609 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 65.6 p . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.445 -0.784 . . . . 0.0 109.86 179.449 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.162 0.506 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -63.37 -28.37 69.95 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.065 -1.022 . . . . 0.0 110.202 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -73.37 -53.7 10.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.18 -0.95 . . . . 0.0 110.278 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.3 mt -54.84 -44.49 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 110.103 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.32 -36.12 79.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.335 -0.853 . . . . 0.0 109.481 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -63.62 -36.98 85.6 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.301 -0.875 . . . . 0.0 109.766 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -73.61 -22.8 59.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.318 -0.864 . . . . 0.0 109.817 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -72.66 -39.62 66.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.8 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -70.85 -39.29 73.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.394 -0.816 . . . . 0.0 110.031 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.95 -53.06 52.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.186 -0.946 . . . . 0.0 109.996 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.519 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 26.5 t80 -55.5 -39.37 70.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 109.866 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.6 m -67.69 -30.8 70.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -0.876 . . . . 0.0 109.981 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.772 HD13 ' O ' ' A' ' 18' ' ' LEU . 1.9 tm? -65.07 -38.58 91.24 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.347 -0.846 . . . . 0.0 110.033 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -75.87 -61.92 1.77 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.77 112.74 0.7 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 110.027 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -109.23 -42.13 4.47 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.227 -0.921 . . . . 0.0 110.69 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.404 ' OD1' ' OE2' ' A' ' 31' ' ' GLU . 11.0 p-10 -71.34 -33.13 69.33 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.121 -0.987 . . . . 0.0 110.253 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.06 74.17 1.1 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -142.83 15.69 1.94 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.276 -1.132 . . . . 0.0 110.242 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.594 ' O ' HG23 ' A' ' 26' ' ' THR . . . 49.19 35.53 19.94 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 25' ' ' GLY . 20.3 p -156.86 149.29 23.28 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.228 -1.16 . . . . 0.0 110.119 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.3 mt -112.87 121.78 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.274 -0.892 . . . . 0.0 110.388 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.577 HG23 ' H ' ' A' ' 30' ' ' LYS . 8.8 t -122.39 -175.66 3.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -0.872 . . . . 0.0 109.779 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.532 HG21 ' OE1' ' A' ' 49' ' ' GLN . 29.0 p -62.16 -26.34 68.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.114 -0.991 . . . . 0.0 110.189 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.577 ' H ' HG23 ' A' ' 28' ' ' THR . 19.0 mtmt -69.87 -60.36 2.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -0.907 . . . . 0.0 110.018 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.449 ' O ' HG23 ' A' ' 35' ' ' VAL . 84.8 mt-10 -59.07 -61.2 2.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.11 -0.994 . . . . 0.0 109.778 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.04 HD22 HD11 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -51.53 -33.38 31.69 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.272 -0.892 . . . . 0.0 109.761 179.768 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.29 -44.91 94.81 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.446 ' O ' ' HB2' ' A' ' 38' ' ' SER . 90.8 m -76.62 -17.4 59.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -1.148 . . . . 0.0 109.781 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 31' ' ' GLU . 54.2 t -73.42 -39.3 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.291 -0.881 . . . . 0.0 110.135 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 21.4 mmt -90.33 -27.58 19.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -0.896 . . . . 0.0 110.466 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -82.61 -26.9 31.84 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.273 -0.892 . . . . 0.0 110.588 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.479 ' CB ' HD23 ' A' ' 39' ' ' LEU . 22.4 t -51.81 -32.69 32.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.995 . . . . 0.0 110.126 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.479 HD23 ' CB ' ' A' ' 38' ' ' SER . 0.5 OUTLIER -158.46 69.18 0.49 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.897 . . . . 0.0 110.153 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . 177.4 -64.84 0.09 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 40' ' ' GLY . 53.4 mt-30 55.14 19.62 2.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.256 -1.144 . . . . 0.0 110.314 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.506 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 2.6 m120 -72.35 -58.32 3.13 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.17 -0.956 . . . . 0.0 110.412 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.506 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 42.7 Cg_endo -70.66 -169.51 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.768 1.404 . . . . 0.0 110.299 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.626 HG22 ' H ' ' A' ' 45' ' ' GLU . 4.1 m -135.72 -177.31 4.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.288 -0.883 . . . . 0.0 109.832 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.626 ' H ' HG22 ' A' ' 44' ' ' THR . 45.2 mt-10 -67.24 -50.3 61.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.087 -1.008 . . . . 0.0 110.252 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.79 -56.65 15.58 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.197 -0.939 . . . . 0.0 110.04 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -52.01 -34.78 44.37 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.207 -0.933 . . . . 0.0 109.408 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.757 HD11 HD23 ' A' ' 32' ' ' LEU . 9.5 tt -63.68 -45.02 91.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.423 -0.798 . . . . 0.0 109.224 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.532 ' OE1' HG21 ' A' ' 29' ' ' THR . 1.5 tp-100 -49.47 -43.65 45.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.348 -0.845 . . . . 0.0 109.172 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -62.83 -45.21 93.68 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.412 -0.805 . . . . 0.0 109.342 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.438 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 3.7 ttp -59.36 -17.65 31.7 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.345 -0.847 . . . . 0.0 109.772 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.04 HD11 HD22 ' A' ' 32' ' ' LEU . 31.0 mm -90.46 -28.73 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 110.195 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -74.9 -27.18 60.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.323 -0.86 . . . . 0.0 110.552 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.637 ' HG3' HG23 ' A' ' 55' ' ' VAL . 25.3 pt-20 -74.35 -9.14 58.31 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.095 -1.003 . . . . 0.0 110.497 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.637 HG23 ' HG3' ' A' ' 54' ' ' GLU . 44.0 t -112.01 -23.18 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.043 -1.036 . . . . 0.0 110.523 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -91.26 109.05 20.32 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.13 -0.981 . . . . 0.0 110.333 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.25 16.15 21.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 110.329 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 40.1 m-20 -97.82 -69.83 0.74 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.274 -0.892 . . . . 0.0 110.42 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.65 -22.1 0.33 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -69.53 -21.48 63.65 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.08 -1.247 . . . . 0.0 110.123 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.54 -41.46 2.3 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.8 p -89.8 170.22 10.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.128 -1.219 . . . . 0.0 110.52 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.439 HD13 HG11 ' A' ' 55' ' ' VAL . 75.1 mt -104.55 151.43 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.367 -0.833 . . . . 0.0 109.892 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.425 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 1.6 m-20 -112.03 -167.28 1.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 110.255 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.552 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 23.5 t80 -73.97 -43.35 6.25 Favored Pre-proline 0 C--N 1.303 -1.422 0 O-C-N 121.284 -0.885 . . . . 0.0 111.099 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.3 Cg_endo -74.42 -30.04 8.67 Favored 'Trans proline' 0 C--O 1.211 -0.859 0 O-C-N 123.026 1.014 . . . . 0.0 110.006 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.435 ' HB3' HG23 ' A' ' 63' ' ' ILE . 1.3 tt0 -75.02 -26.02 59.19 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.098 -1.001 . . . . 0.0 108.918 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.562 ' CE1' ' CE ' ' A' ' 72' ' ' MET . 80.4 t80 -75.36 -43.56 49.76 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.62 -0.675 . . . . 0.0 110.405 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.406 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 4.2 tp -80.8 -16.73 52.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.341 -0.85 . . . . 0.0 110.363 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 34.6 m -84.28 -34.02 23.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.065 -1.022 . . . . 0.0 110.651 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.523 ' HE3' ' HG3' ' A' ' 72' ' ' MET . 0.0 OUTLIER -88.67 -30.11 19.39 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.94 -1.1 . . . . 0.0 110.52 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.562 ' CE ' ' CE1' ' A' ' 68' ' ' PHE . 25.3 mtt -81.56 -11.35 59.19 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.047 -1.033 . . . . 0.0 110.515 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.125 -0.984 . . . . 0.0 110.042 179.715 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.137 0.494 . . . . 0.0 110.61 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.915 HD11 HG21 ' A' ' 146' ' ' THR . 88.7 mt -59.8 -48.68 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.137 -0.977 . . . . 0.0 110.407 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -56.69 -53.4 58.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.185 -0.947 . . . . 0.0 110.112 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -46.93 -41.78 16.6 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.288 -0.883 . . . . 0.0 110.339 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.517 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -59.61 -59.36 5.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.147 -0.971 . . . . 0.0 110.099 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -49.63 -23.88 1.93 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.16 -0.963 . . . . 0.0 110.461 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -76.42 -43.95 38.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.285 -0.885 . . . . 0.0 111.171 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 88' ' ' ALA . 16.6 m -79.42 -19.23 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.042 -1.036 . . . . 0.0 110.966 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.489 ' CD1' HG23 ' A' ' 91' ' ' VAL . 24.9 m-85 -89.36 -24.46 21.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.102 -0.999 . . . . 0.0 109.982 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -106.89 92.7 4.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.276 -0.89 . . . . 0.0 109.366 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -100.17 -33.55 10.4 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.167 -0.958 . . . . 0.0 111.402 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 3.1 p30 -69.61 -38.45 77.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.956 -1.09 . . . . 0.0 110.438 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 106.41 41.95 1.68 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.446 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 39.4 p-10 -110.96 -14.82 13.89 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.352 -1.087 . . . . 0.0 110.412 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.5 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 69.28 43.99 67.97 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.5 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 33.5 m-85 -157.8 116.51 3.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.448 -1.031 . . . . 0.0 110.15 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 24.2 mt -87.86 113.22 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.01 -1.056 . . . . 0.0 109.647 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 90.5 p -99.38 159.22 15.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.167 -0.958 . . . . 0.0 110.266 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.2 -18.26 24.76 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.139 -0.976 . . . . 0.0 110.098 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.75 -66.91 0.65 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.233 -0.917 . . . . 0.0 109.983 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.915 ' O ' HG23 ' A' ' 108' ' ' VAL . 92.0 mt-10 -51.65 -39.22 57.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.183 -0.948 . . . . 0.0 109.724 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.959 HD12 HD11 ' A' ' 125' ' ' ILE . 1.5 tt -64.27 -41.34 96.97 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.593 -0.692 . . . . 0.0 110.311 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 57.7 ttp85 -65.89 -23.15 66.58 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.221 -0.924 . . . . 0.0 110.027 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -94.52 -14.7 24.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.384 -0.822 . . . . 0.0 110.245 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.915 HG23 ' O ' ' A' ' 104' ' ' GLU . 72.2 t -82.45 -49.02 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.314 -0.866 . . . . 0.0 110.264 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.6 mmt -60.14 -55.48 33.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.165 -0.959 . . . . 0.0 110.387 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.3 p -49.67 -30.42 9.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.249 -0.907 . . . . 0.0 110.491 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -74.18 -58.48 3.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.218 -0.926 . . . . 0.0 110.293 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.3 mt -47.37 -76.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.257 -0.902 . . . . 0.0 110.326 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.35 43.09 0.06 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -125.3 159.61 31.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -1.208 . . . . 0.0 110.127 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.75 60.4 1.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 110.441 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.03 -174.22 4.35 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.253 -0.905 . . . . 0.0 109.88 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 121' ' ' VAL . 6.9 t -126.92 173.32 9.7 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.073 -1.017 . . . . 0.0 110.277 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 88.4 m-20 -58.48 -39.04 78.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -0.89 . . . . 0.0 110.283 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.03 -68.16 0.34 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.27 -0.894 . . . . 0.0 111.057 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.448 ' OE1' ' N ' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -47.78 -47.14 30.89 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.271 -0.893 . . . . 0.0 111.194 -179.181 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 117' ' ' THR . 78.9 t -54.89 -48.58 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.011 -1.056 . . . . 0.0 110.412 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -61.84 -30.56 70.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.106 -0.996 . . . . 0.0 109.938 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.11 -32.36 70.36 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.281 -0.887 . . . . 0.0 109.728 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' A' ' 120' ' ' GLU . 83.7 mtp -66.7 -53.7 30.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.359 -0.838 . . . . 0.0 109.75 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.959 HD11 HD12 ' A' ' 105' ' ' LEU . 44.0 mm -59.01 -29.25 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.303 -0.873 . . . . 0.0 110.114 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -77.9 -28.36 49.78 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.274 -0.892 . . . . 0.0 109.907 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.38 -29.26 62.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.441 -0.787 . . . . 0.0 110.06 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.492 ' HB1' ' HG2' ' A' ' 144' ' ' MET . . . -94.75 -24.13 17.24 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.344 -0.847 . . . . 0.0 110.401 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.522 ' OD1' HG22 ' A' ' 136' ' ' VAL . 3.7 m-20 -73.16 95.61 2.1 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.981 -1.074 . . . . 0.0 111.126 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 54.8 mt -92.04 -9.52 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.495 -0.753 . . . . 0.0 110.544 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 57.2 p-10 -149.7 -18.22 0.27 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.056 -1.028 . . . . 0.0 112.106 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.492 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . -95.1 -51.75 1.86 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 2.6 m-20 60.69 107.95 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.667 -0.902 . . . . 0.0 108.642 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 100.58 -26.37 24.86 Favored Glycine 0 C--N 1.292 -1.875 0 N-CA-C 107.059 -2.416 . . . . 0.0 107.059 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.407 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 0.2 OUTLIER -139.71 134.92 32.6 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.811 -0.817 . . . . 0.0 109.444 179.036 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.759 HG23 HG23 ' A' ' 125' ' ' ILE . 98.5 t -105.92 142.14 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.311 -0.868 . . . . 0.0 110.494 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -112.25 -176.06 2.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.302 -0.874 . . . . 0.0 109.83 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.57 ' O ' HG23 ' A' ' 142' ' ' VAL . 27.9 t80 -67.47 -36.47 81.21 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.075 -1.016 . . . . 0.0 110.224 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -71.82 -35.6 69.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.064 -1.023 . . . . 0.0 110.285 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.512 ' OE2' ' HA ' ' A' ' 129' ' ' ASP . 35.9 mt-10 -70.27 -31.78 69.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.203 -0.936 . . . . 0.0 110.497 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.617 ' HE2' HG23 ' A' ' 85' ' ' ILE . 65.6 t80 -79.34 -29.37 42.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.224 -0.923 . . . . 0.0 110.669 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 138' ' ' TYR . 96.2 t -80.24 -23.11 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.098 -1.001 . . . . 0.0 110.701 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -93.23 -31.04 14.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.164 -0.96 . . . . 0.0 110.697 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.492 ' HG2' ' HB1' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -79.07 -29.94 43.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.099 -1.001 . . . . 0.0 110.314 -179.82 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 59.0 tpp -89.12 -58.34 2.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 109.912 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.915 HG21 HD11 ' A' ' 85' ' ' ILE . 64.7 p . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.373 -0.829 . . . . 0.0 110.064 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.347 0.594 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -74.05 -46.43 43.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.255 -0.903 . . . . 0.0 109.694 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -65.88 -55.07 18.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.431 -0.793 . . . . 0.0 109.593 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.63 HG23 HD11 ' A' ' 69' ' ' LEU . 65.6 mt -53.46 -42.41 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.368 -0.832 . . . . 0.0 109.695 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -59.59 -36.17 75.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -0.881 . . . . 0.0 109.894 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -61.95 -54.53 40.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.624 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -54.68 -36.28 64.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.748 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 17.5 mttt -60.13 -43.14 95.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.327 -0.858 . . . . 0.0 109.914 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -61.31 -38.48 86.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.914 . . . . 0.0 109.791 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.437 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.96 -45.58 93.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.238 -0.914 . . . . 0.0 109.968 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -59.75 -47.51 85.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.165 -0.959 . . . . 0.0 109.768 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.9 m -59.19 -27.31 65.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.929 . . . . 0.0 109.376 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.748 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.4 tm? -73.75 -34.32 64.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.478 -0.764 . . . . 0.0 109.613 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.437 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 15.4 m-85 -80.91 -68.08 0.72 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.43 -0.794 . . . . 0.0 109.998 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.404 ' OD1' ' OD1' ' A' ' 24' ' ' ASP . 46.1 t0 -58.88 115.24 2.98 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.243 -0.911 . . . . 0.0 110.05 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -104.19 -36.83 7.52 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.197 -0.94 . . . . 0.0 110.166 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -70.19 -11.01 60.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.234 -0.916 . . . . 0.0 110.366 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.57 97.54 0.01 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 10.7 p-10 -150.58 -42.91 0.12 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.376 -1.073 . . . . 0.0 110.108 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.578 ' O ' HG23 ' A' ' 26' ' ' THR . . . 120.02 15.88 5.05 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 25' ' ' GLY . 13.1 p -155.51 132.57 10.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.091 -1.241 . . . . 0.0 110.379 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.436 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 26.6 mt -90.46 127.7 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.282 -0.886 . . . . 0.0 110.109 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.7 p -107.28 -163.71 0.93 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 110.26 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.768 HG22 HD12 ' A' ' 52' ' ' ILE . 7.4 p -86.09 -38.06 18.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.295 -0.878 . . . . 0.0 110.557 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -60.76 -57.74 11.42 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.079 -1.013 . . . . 0.0 110.116 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -55.75 -53.63 54.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.37 -0.831 . . . . 0.0 109.999 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.5 tp -56.56 -24.93 50.53 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.095 -1.003 . . . . 0.0 109.549 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.21 -53.31 45.67 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.461 ' HA ' ' HB2' ' A' ' 37' ' ' ARG . 27.8 m -66.1 -35.83 81.56 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.251 -1.147 . . . . 0.0 109.793 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.5 t -56.11 -39.9 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.362 -0.836 . . . . 0.0 109.993 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.46 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 24.8 mmt -85.8 -15.31 42.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.353 -0.842 . . . . 0.0 109.954 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.461 ' HB2' ' HA ' ' A' ' 34' ' ' THR . 0.5 OUTLIER -83.05 -14.74 53.24 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.283 -0.886 . . . . 0.0 110.514 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.515 ' C ' HD22 ' A' ' 39' ' ' LEU . 56.3 m -95.92 -20.9 18.4 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.192 -0.942 . . . . 0.0 110.976 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 39' ' ' LEU . 4.5 mm? -99.75 50.08 0.92 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.03 -1.044 . . . . 0.0 110.474 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 48.38 93.32 0.01 OUTLIER Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.452 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -176.82 -41.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -1.151 . . . . 0.0 110.091 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.459 ' HA ' ' CD ' ' A' ' 37' ' ' ARG . 5.8 p-10 36.36 62.16 2.98 Favored Pre-proline 0 N--CA 1.508 2.44 0 O-C-N 121.948 -0.47 . . . . 0.0 111.191 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.46 ' HG3' ' HB3' ' A' ' 36' ' ' MET . 49.0 Cg_endo -76.2 -176.5 3.1 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.835 1.44 . . . . 0.0 110.183 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.406 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 72.4 p -113.32 161.19 17.55 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.356 -0.84 . . . . 0.0 110.057 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -64.47 -29.34 70.38 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.258 -0.901 . . . . 0.0 110.325 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.83 -69.48 0.44 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.179 -0.951 . . . . 0.0 110.101 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -49.15 -30.72 7.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.135 -0.978 . . . . 0.0 109.432 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.507 HD21 ' HA ' ' A' ' 29' ' ' THR . 5.5 tt -63.19 -47.5 82.31 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.48 -0.762 . . . . 0.0 109.719 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -54.72 -47.32 73.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.192 -0.943 . . . . 0.0 109.621 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.05 -33.49 72.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -0.892 . . . . 0.0 109.581 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.453 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 56.1 ttp -68.95 -27.66 65.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 109.743 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.768 HD12 HG22 ' A' ' 29' ' ' THR . 38.4 mt -79.84 -23.66 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.355 -0.84 . . . . 0.0 109.602 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -60.77 -32.17 71.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.405 -0.809 . . . . 0.0 110.166 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.581 ' HG3' HG23 ' A' ' 55' ' ' VAL . 1.6 pt-20 -81.54 -22.46 37.86 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.197 -0.94 . . . . 0.0 110.21 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.776 HG13 ' SD ' ' A' ' 71' ' ' MET . 92.2 t -93.24 -11.08 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.129 -0.982 . . . . 0.0 110.325 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -118.43 113.98 22.2 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.046 -1.034 . . . . 0.0 110.549 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.21 9.7 28.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.41 -0.806 . . . . 0.0 109.814 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 0.9 OUTLIER -82.35 -54.77 4.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.292 -0.88 . . . . 0.0 110.13 -179.75 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.24 29.03 1.39 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -118.91 -22.97 7.09 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.247 -1.149 . . . . 0.0 110.221 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.39 -14.37 65.16 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 80.9 p -119.83 164.53 15.87 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.052 -1.263 . . . . 0.0 110.861 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.436 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 64.2 mt -106.86 158.08 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.354 -0.841 . . . . 0.0 110.401 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.424 ' OD2' ' HD2' ' A' ' 66' ' ' PRO . 8.5 t70 -113.44 -166.8 1.12 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.41 -0.807 . . . . 0.0 109.614 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.523 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.2 t80 -84.2 -44.86 0.75 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.075 -1.015 . . . . 0.0 111.389 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.7 Cg_endo -75.21 -21.02 15.89 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 O-C-N 123.191 1.101 . . . . 0.0 110.351 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -78.66 -32.94 47.4 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.281 -0.887 . . . . 0.0 108.735 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -70.93 -53.25 15.65 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.433 0.635 . . . . 0.0 110.198 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.708 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 7.8 tt -60.56 -40.16 90.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.308 -0.87 . . . . 0.0 110.168 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.8 m -73.77 -17.65 61.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.164 -0.96 . . . . 0.0 110.47 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.776 ' SD ' HG13 ' A' ' 55' ' ' VAL . 62.1 ttp -76.96 -50.75 12.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.069 -1.019 . . . . 0.0 110.771 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.588 ' HE3' ' CE ' ' A' ' 71' ' ' MET . 45.6 mtt -90.59 -43.86 9.92 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.101 -0.999 . . . . 0.0 111.317 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.497 1.916 0 O-C-N 121.185 -0.947 . . . . 0.0 111.15 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 121.35 0.595 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 12.4 mt -55.94 -35.03 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 110.292 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.8 ttm-85 -50.61 -49.5 56.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 109.553 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -61.54 -49.03 78.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.27 -0.893 . . . . 0.0 109.418 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.4 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -56.44 -19.44 15.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 109.852 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -82.42 -40.44 21.23 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.027 -1.045 . . . . 0.0 109.721 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -56.97 -40.86 77.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.527 -0.733 . . . . 0.0 109.835 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 92' ' ' PHE . 17.7 m -73.78 -42.86 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.127 -0.983 . . . . 0.0 110.602 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.94 ' CE1' HD12 ' A' ' 105' ' ' LEU . 15.8 m-85 -79.84 4.74 15.63 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.002 -1.061 . . . . 0.0 110.77 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -149.92 80.35 1.37 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.077 -1.014 . . . . 0.0 110.092 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -90.45 31.46 1.03 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -0.874 . . . . 0.0 110.249 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -127.88 -113.61 0.27 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -0.962 . . . . 0.0 110.057 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.54 32.13 0.18 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.455 ' HB2' ' CD2' ' A' ' 99' ' ' TYR . 14.2 p30 -111.26 -21.08 12.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.364 -1.08 . . . . 0.0 110.308 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 67.05 10.74 57.17 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.455 ' CD2' ' HB2' ' A' ' 97' ' ' ASN . 8.1 m-85 -107.49 105.15 14.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.155 -1.203 . . . . 0.0 109.88 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 31.0 mt -76.64 130.16 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.32 -0.862 . . . . 0.0 109.554 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.0 m -116.08 172.69 7.0 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.34 -0.85 . . . . 0.0 110.559 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.718 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -66.79 -37.79 85.27 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.557 -0.715 . . . . 0.0 110.275 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.41 -60.84 3.22 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.255 -0.903 . . . . 0.0 110.305 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.707 ' O ' HG23 ' A' ' 108' ' ' VAL . 50.0 mt-10 -56.43 -28.31 59.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.166 -0.959 . . . . 0.0 110.16 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.94 HD12 ' CE1' ' A' ' 92' ' ' PHE . 19.0 tp -66.12 -39.83 90.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.148 -0.97 . . . . 0.0 110.523 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.72 ' O ' HG23 ' A' ' 110' ' ' THR . 30.4 ttp180 -75.12 -29.81 60.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.062 -1.024 . . . . 0.0 110.078 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.62 -21.58 48.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.303 -0.873 . . . . 0.0 110.158 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 104' ' ' GLU . 54.0 t -83.74 -48.97 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 109.856 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.652 ' SD ' HD13 ' A' ' 116' ' ' LEU . 65.1 mtt -63.01 -32.45 73.82 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.385 -0.822 . . . . 0.0 109.985 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.72 HG23 ' O ' ' A' ' 106' ' ' ARG . 2.9 p -55.44 -41.28 72.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.341 -0.85 . . . . 0.0 109.64 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -73.76 -44.72 55.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.892 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.4 mt -58.78 -73.39 0.08 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.208 -0.933 . . . . 0.0 110.205 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 155.84 62.3 0.01 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.5 ' HB3' HD11 ' A' ' 116' ' ' LEU . 54.9 mm-40 -143.94 157.81 44.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.206 -1.173 . . . . 0.0 110.439 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.407 ' N ' ' CD ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -126.69 109.52 12.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.282 -0.886 . . . . 0.0 110.132 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.652 HD13 ' SD ' ' A' ' 109' ' ' MET . 4.2 mp -125.89 162.44 25.18 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.226 -0.921 . . . . 0.0 110.67 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.529 HG22 ' N ' ' A' ' 118' ' ' ASP . 64.3 m -114.05 173.14 6.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.389 -0.819 . . . . 0.0 109.951 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.529 ' N ' HG22 ' A' ' 117' ' ' THR . 43.1 m-20 -53.23 -38.44 62.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.148 -0.97 . . . . 0.0 110.855 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -66.4 -50.23 64.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.961 -1.087 . . . . 0.0 110.735 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.446 ' OE1' ' N ' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -55.62 -57.68 10.96 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.17 -0.956 . . . . 0.0 110.494 -179.739 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.718 ' CG1' ' HB1' ' A' ' 102' ' ' ALA . 21.0 t -51.7 -47.4 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.347 -0.845 . . . . 0.0 110.209 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -57.65 -34.01 68.89 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.055 -1.028 . . . . 0.0 109.916 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.437 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 32.8 tt0 -75.48 -25.3 57.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.89 . . . . 0.0 110.093 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.561 ' HE2' HD21 ' A' ' 105' ' ' LEU . 10.4 mmm -75.35 -47.29 28.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.204 -0.935 . . . . 0.0 110.133 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.447 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 26.8 mm -70.94 -27.08 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.218 -0.926 . . . . 0.0 109.869 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -75.1 -56.05 5.12 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.403 -0.811 . . . . 0.0 110.216 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.455 ' OE1' ' N ' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -57.35 -31.62 65.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.092 -1.005 . . . . 0.0 109.725 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.455 ' N ' ' OE1' ' A' ' 127' ' ' GLU . . . -79.11 -27.86 42.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 109.087 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 47.6 t0 -63.59 95.37 0.1 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.455 -0.778 . . . . 0.0 109.925 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.54 HD12 ' HG2' ' A' ' 140' ' ' GLU . 50.2 mt -80.21 -28.76 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.255 -0.903 . . . . 0.0 110.783 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 2.8 p30 -86.11 -28.39 24.06 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.192 -0.942 . . . . 0.0 110.848 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 88.95 51.91 2.9 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 36.9 p-10 -118.91 -21.57 7.69 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.3 -1.118 . . . . 0.0 110.459 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.59 -25.99 7.45 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.263 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.403 ' CG ' ' OD2' ' A' ' 133' ' ' ASP . 9.0 pt20 -114.7 165.67 12.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.14 -1.212 . . . . 0.0 110.915 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.412 ' CG2' ' HB3' ' A' ' 128' ' ' ALA . 56.1 t -109.82 131.04 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.416 -0.803 . . . . 0.0 109.36 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 10.7 t30 -94.78 -175.13 3.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.065 -1.022 . . . . 0.0 110.675 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.42 ' CD1' ' C ' ' A' ' 138' ' ' TYR . 17.3 t80 -70.87 -59.69 2.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.383 -0.823 . . . . 0.0 110.65 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -52.2 -43.06 64.0 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.162 -0.961 . . . . 0.0 110.293 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.54 ' HG2' HD12 ' A' ' 130' ' ' ILE . 52.1 mt-10 -66.58 -33.31 75.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.022 -1.049 . . . . 0.0 109.896 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.742 ' CZ ' ' HE3' ' A' ' 145' ' ' MET . 25.5 t80 -68.79 -20.13 64.33 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.41 -0.806 . . . . 0.0 109.625 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 138' ' ' TYR . 65.2 t -90.34 -41.76 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.304 -0.872 . . . . 0.0 110.891 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.55 -14.66 59.6 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.13 -0.982 . . . . 0.0 110.855 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.511 ' CE ' ' CD1' ' A' ' 141' ' ' PHE . 4.9 ptt? -85.35 -27.06 26.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.018 -1.051 . . . . 0.0 109.83 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.742 ' HE3' ' CZ ' ' A' ' 141' ' ' PHE . 52.5 mtt -84.82 -68.56 0.71 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.486 -0.759 . . . . 0.0 110.317 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.7 p . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.607 -0.683 . . . . 0.0 110.177 -179.946 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 121.047 0.451 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 3.9 mt-10 -66.82 -69.63 0.3 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.968 -1.083 . . . . 0.0 110.426 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -49.18 -55.13 13.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.907 . . . . 0.0 110.083 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 9' ' ' ILE . 65.9 mt -49.65 -40.41 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.166 -0.959 . . . . 0.0 109.896 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -61.35 -40.53 94.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 110.0 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.32 -41.09 96.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 110.209 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -61.65 -52.82 62.77 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.253 -0.904 . . . . 0.0 110.002 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -49.64 -46.15 49.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.146 -0.971 . . . . 0.0 109.667 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -52.87 -50.58 63.53 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.305 -0.872 . . . . 0.0 109.736 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.66 -37.8 59.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.399 -0.813 . . . . 0.0 109.834 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.507 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 18.8 t80 -58.25 -49.87 75.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.432 -0.793 . . . . 0.0 109.831 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.2 t -60.49 -32.2 71.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.296 -0.878 . . . . 0.0 110.147 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.696 ' O ' HD23 ' A' ' 18' ' ' LEU . 5.4 tt -61.51 -44.57 96.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.264 -0.897 . . . . 0.0 110.065 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -70.48 -57.9 4.29 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.168 -0.957 . . . . 0.0 110.214 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -58.64 107.41 0.51 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.278 -0.888 . . . . 0.0 110.252 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -110.8 52.87 0.72 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.163 -0.961 . . . . 0.0 110.989 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.423 ' OD2' ' OD2' ' A' ' 24' ' ' ASP . 6.2 p-10 -151.72 -42.9 0.11 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.046 -1.034 . . . . 0.0 109.959 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.5 64.94 0.57 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 1.4 p30 -144.07 -44.56 0.26 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.049 -1.266 . . . . 0.0 110.207 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.466 ' C ' HG23 ' A' ' 26' ' ' THR . . . 113.22 32.89 2.07 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.388 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.466 HG23 ' C ' ' A' ' 25' ' ' GLY . 43.6 p -148.95 145.0 27.17 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.938 -1.331 . . . . 0.0 110.336 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.401 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 63.3 mt -107.53 117.31 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.302 -0.874 . . . . 0.0 110.171 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.413 ' HA ' HG22 ' A' ' 62' ' ' THR . 76.2 p -102.16 -167.15 1.37 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.246 -0.909 . . . . 0.0 109.99 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.546 HG22 HD12 ' A' ' 52' ' ' ILE . 25.0 p -83.21 -31.75 26.89 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.184 -0.947 . . . . 0.0 110.515 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.7 mtmt -65.18 -62.95 1.24 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.217 -0.927 . . . . 0.0 110.194 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -56.47 -58.7 6.88 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.168 -0.957 . . . . 0.0 109.385 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.737 HD23 HD21 ' A' ' 48' ' ' LEU . 6.0 tp -54.36 -22.6 12.66 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.268 -0.895 . . . . 0.0 109.195 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.537 ' HA2' HD13 ' A' ' 48' ' ' LEU . . . -63.58 -46.61 91.87 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.46 ' O ' ' CB ' ' A' ' 38' ' ' SER . 71.3 m -72.79 -21.58 60.96 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.252 -1.146 . . . . 0.0 110.272 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.42 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 53.0 t -72.78 -63.77 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.204 -0.935 . . . . 0.0 110.274 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 12.4 tpp -67.35 -41.01 85.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 110.521 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.463 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 48.1 ttp180 -65.25 -32.59 74.34 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.174 -0.953 . . . . 0.0 110.739 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 34' ' ' THR . 10.8 t -86.97 10.42 16.4 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.938 -1.101 . . . . 0.0 110.635 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 38' ' ' SER . 36.6 mt -136.33 63.54 1.58 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.002 -1.061 . . . . 0.0 110.403 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . 121.13 -34.14 4.11 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.453 ' CG ' ' O ' ' A' ' 37' ' ' ARG . 67.3 mt-30 54.86 40.08 31.8 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.215 -1.168 . . . . 0.0 110.846 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.538 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 2.4 t30 -86.26 -48.17 0.54 Allowed Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.986 -1.071 . . . . 0.0 110.217 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 42' ' ' ASN . 51.8 Cg_endo -84.85 -171.55 1.0 Allowed 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.696 1.366 . . . . 0.0 110.098 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.658 HG22 ' HB3' ' A' ' 47' ' ' GLU . 12.7 t -138.64 -174.27 3.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.176 -0.953 . . . . 0.0 109.666 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.56 -49.91 71.55 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.967 -1.083 . . . . 0.0 110.108 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.37 -66.11 0.59 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.187 -0.946 . . . . 0.0 110.451 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.658 ' HB3' HG22 ' A' ' 44' ' ' THR . 39.4 tt0 -45.93 -34.26 3.8 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.339 -0.85 . . . . 0.0 110.273 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.737 HD21 HD23 ' A' ' 32' ' ' LEU . 5.0 tt -60.67 -50.25 74.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.28 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.635 ' N ' HD23 ' A' ' 48' ' ' LEU . 5.4 tt0 -52.45 -40.17 61.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.389 -0.819 . . . . 0.0 109.257 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -62.97 -37.45 87.18 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.53 -0.731 . . . . 0.0 109.496 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.442 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 33.9 ttp -71.19 -16.78 62.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.411 -0.806 . . . . 0.0 109.94 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.546 HD12 HG22 ' A' ' 29' ' ' THR . 22.6 mt -83.37 -33.53 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.186 -0.946 . . . . 0.0 109.98 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -52.4 -47.78 66.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.262 -0.899 . . . . 0.0 110.011 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.56 ' HG3' HG23 ' A' ' 55' ' ' VAL . 14.8 pt-20 -64.49 -29.11 70.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.269 -0.894 . . . . 0.0 109.875 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.56 HG23 ' HG3' ' A' ' 54' ' ' GLU . 76.7 t -85.0 -10.69 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.372 -0.83 . . . . 0.0 110.196 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -107.53 112.1 24.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.111 -0.993 . . . . 0.0 110.23 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -101.86 34.02 2.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.256 -0.902 . . . . 0.0 110.128 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.404 ' OD1' ' OE2' ' A' ' 67' ' ' GLU . 7.1 m-20 -116.33 -36.26 4.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -0.941 . . . . 0.0 110.316 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.91 56.56 2.06 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.441 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 14.5 p-10 -138.41 -41.88 0.5 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.249 -1.148 . . . . 0.0 110.325 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.798 ' O ' HG23 ' A' ' 62' ' ' THR . . . 126.19 20.7 1.97 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.797 -1.192 . . . . 0.0 110.571 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.798 HG23 ' O ' ' A' ' 61' ' ' GLY . 0.8 OUTLIER -164.72 161.65 20.79 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.009 -1.289 . . . . 0.0 110.356 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.505 ' CD1' ' CG1' ' A' ' 55' ' ' VAL . 78.9 mt -103.79 161.08 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 110.228 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.419 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 35.0 m-20 -125.84 -155.07 0.66 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.185 -0.947 . . . . 0.0 110.779 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.557 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 13.3 t80 -87.15 -41.34 0.53 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.399 -0.813 . . . . 0.0 112.21 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.0 Cg_endo -72.52 -19.02 25.31 Favored 'Trans proline' 0 C--O 1.211 -0.855 0 O-C-N 123.038 1.02 . . . . 0.0 110.621 -179.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.419 ' OE1' ' OD2' ' A' ' 64' ' ' ASP . 49.9 mt-10 -87.69 -31.64 19.62 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.078 -1.013 . . . . 0.0 109.383 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.507 ' CE2' ' HB2' ' A' ' 16' ' ' PHE . 81.3 t80 -73.35 -41.0 63.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.717 -0.614 . . . . 0.0 110.242 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.915 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 0.6 OUTLIER -83.28 -37.73 23.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.37 -0.832 . . . . 0.0 110.767 -179.436 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 66' ' ' PRO . 60.8 m -68.5 -31.07 70.08 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.985 -1.072 . . . . 0.0 110.309 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.403 ' SD ' HG13 ' A' ' 55' ' ' VAL . 57.4 ttp -81.1 -59.31 2.7 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.242 -0.911 . . . . 0.0 110.472 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.3 mtt -68.99 -9.46 52.46 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.355 -0.841 . . . . 0.0 110.642 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.915 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.134 -0.979 . . . . 0.0 110.444 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.115 0.483 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.7 mm -65.55 -51.86 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.067 -1.02 . . . . 0.0 110.134 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -62.65 -52.71 62.24 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.35 -0.844 . . . . 0.0 110.177 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.441 ' O ' HG13 ' A' ' 91' ' ' VAL . 55.5 mt-10 -57.34 -28.75 63.4 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.228 -0.92 . . . . 0.0 110.305 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.643 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -67.04 -65.28 0.7 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.917 . . . . 0.0 110.274 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -52.15 -24.23 6.72 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.183 -0.948 . . . . 0.0 110.353 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.1 ttt-85 -74.57 -39.65 62.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.211 -0.931 . . . . 0.0 110.288 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 88' ' ' ALA . 23.2 m -84.91 -11.04 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 110.545 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.501 ' CD2' ' O ' ' A' ' 88' ' ' ALA . 24.2 m-85 -101.41 -14.68 17.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.031 -1.043 . . . . 0.0 110.509 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 99' ' ' TYR . 83.8 m-20 -132.17 83.03 2.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.017 -1.052 . . . . 0.0 110.619 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -104.53 27.12 8.21 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.141 -0.975 . . . . 0.0 109.994 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.8 p30 -106.69 -24.12 12.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.273 -0.892 . . . . 0.0 109.914 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.441 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 99.49 43.1 2.58 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.504 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 30.6 p-10 -128.81 -24.45 2.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.335 -1.097 . . . . 0.0 110.877 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.452 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 75.2 35.07 49.91 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.504 ' CD2' ' O ' ' A' ' 97' ' ' ASN . 61.3 m-85 -147.46 144.86 28.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.319 -1.107 . . . . 0.0 109.654 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.435 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 23.9 mt -100.24 141.72 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.078 -1.014 . . . . 0.0 109.743 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.4 t -126.54 167.55 15.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.169 -0.957 . . . . 0.0 110.409 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.92 -52.02 53.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.366 -0.834 . . . . 0.0 110.039 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.3 -56.46 16.47 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.385 -0.822 . . . . 0.0 110.235 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.479 ' O ' HG23 ' A' ' 108' ' ' VAL . 97.3 mt-10 -50.86 -45.01 59.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 110.039 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.713 HD12 HD11 ' A' ' 125' ' ' ILE . 2.6 tt -57.18 -38.37 73.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.384 -0.822 . . . . 0.0 110.018 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.415 ' O ' ' HB ' ' A' ' 110' ' ' THR . 66.4 ttt180 -69.27 -26.09 64.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.159 -0.963 . . . . 0.0 109.765 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -83.72 -14.36 51.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.348 -0.845 . . . . 0.0 109.993 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 104' ' ' GLU . 79.1 t -88.37 -62.06 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.147 -0.971 . . . . 0.0 110.825 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 60.9 mtt -65.46 -53.65 39.7 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.159 -0.963 . . . . 0.0 110.72 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.415 ' HB ' ' O ' ' A' ' 106' ' ' ARG . 28.8 m -47.32 -34.28 6.65 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.32 -0.863 . . . . 0.0 110.271 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -77.12 -41.28 42.61 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 110.402 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.437 ' HA ' HD23 ' A' ' 112' ' ' LEU . 16.2 mt -51.32 -49.05 62.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.147 -0.97 . . . . 0.0 110.273 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 139.7 48.06 0.06 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -135.22 149.26 49.85 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.213 -1.169 . . . . 0.0 110.098 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -95.79 104.27 16.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.273 -0.892 . . . . 0.0 110.454 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.0 mt -124.09 164.5 19.29 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.177 -0.952 . . . . 0.0 110.181 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 56.8 m -122.51 153.3 39.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.166 -0.959 . . . . 0.0 110.194 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -45.53 -30.06 1.34 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.277 -0.889 . . . . 0.0 110.549 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -65.08 -61.03 2.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.871 . . . . 0.0 110.457 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -49.81 -51.51 39.12 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.216 -0.927 . . . . 0.0 110.517 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 75.2 t -53.84 -45.69 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.251 -0.906 . . . . 0.0 110.501 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.15 -27.93 69.42 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.21 -0.931 . . . . 0.0 110.394 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -71.98 -31.75 66.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 0.0 110.107 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.5 mtp -77.87 -45.67 23.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.336 -0.853 . . . . 0.0 110.36 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.713 HD11 HD12 ' A' ' 105' ' ' LEU . 19.3 mm -61.96 -41.44 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 110.212 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -63.95 -52.18 60.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.005 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -55.04 -36.44 65.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.202 -0.936 . . . . 0.0 110.23 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.16 -29.79 65.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.225 -0.922 . . . . 0.0 110.31 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -73.53 91.39 1.81 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.157 -0.964 . . . . 0.0 110.365 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 130' ' ' ILE . 63.3 mt -84.5 1.3 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.243 -0.911 . . . . 0.0 110.767 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 2.4 p30 -112.03 -35.47 5.66 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.976 -1.077 . . . . 0.0 110.296 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.442 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 102.44 42.46 2.17 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 58.7 p30 -109.91 -12.7 14.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.161 -1.2 . . . . 0.0 110.541 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.467 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 98.74 -47.01 1.44 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -94.34 164.49 13.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.193 -1.181 . . . . 0.0 110.577 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.435 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 58.2 t -112.61 152.99 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.353 -0.842 . . . . 0.0 109.878 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.401 ' ND2' ' HB3' ' A' ' 139' ' ' GLU . 5.2 p-10 -128.66 -168.88 1.98 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.038 -1.039 . . . . 0.0 110.843 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.841 ' O ' HG23 ' A' ' 142' ' ' VAL . 4.3 t80 -64.64 -44.39 90.61 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.51 -0.744 . . . . 0.0 111.006 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.401 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 35.4 tt0 -61.63 -61.05 2.79 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.232 -0.917 . . . . 0.0 111.219 -179.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.4 ' OE2' ' OD2' ' A' ' 131' ' ' ASP . 53.8 mt-10 -56.59 -28.9 61.39 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.112 -0.992 . . . . 0.0 111.032 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.409 ' CZ ' ' HB1' ' A' ' 88' ' ' ALA . 23.2 t80 -78.86 -27.35 44.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.084 -1.01 . . . . 0.0 110.401 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 138' ' ' TYR . 86.3 t -83.6 -24.72 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.259 -0.901 . . . . 0.0 110.484 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -95.29 -22.28 17.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.137 -0.977 . . . . 0.0 110.738 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.0 -12.49 41.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.879 -1.138 . . . . 0.0 110.321 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.465 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 53.1 tpp -90.25 -48.04 7.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.187 -0.946 . . . . 0.0 110.311 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.323 -0.861 . . . . 0.0 110.588 -179.746 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.026 0.441 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.506 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 52.4 mt-10 -50.01 -46.84 53.13 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.126 -0.984 . . . . 0.0 110.348 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -59.67 -57.19 14.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.309 -0.869 . . . . 0.0 110.307 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 1.025 HG22 ' HE3' ' A' ' 13' ' ' LYS . 83.5 mt -49.97 -28.95 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.257 -0.902 . . . . 0.0 109.614 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -71.47 -42.15 68.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.329 -0.857 . . . . 0.0 110.045 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.34 -42.11 81.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 0.0 109.97 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -64.39 -47.07 80.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.294 -0.878 . . . . 0.0 110.194 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 1.025 ' HE3' HG22 ' A' ' 9' ' ' ILE . 87.5 mttt -50.84 -51.75 48.09 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.23 -0.919 . . . . 0.0 109.813 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 17' ' ' SER . 40.6 tt0 -53.35 -43.09 67.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.383 -0.823 . . . . 0.0 109.998 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.568 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -57.32 -44.34 84.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.944 . . . . 0.0 109.767 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.43 ' O ' ' HB2' ' A' ' 19' ' ' PHE . 3.2 t80 -63.49 -32.71 74.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.193 -0.942 . . . . 0.0 109.773 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 38.2 t -58.79 -61.58 2.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 110.325 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.568 HD21 ' HA ' ' A' ' 15' ' ' ALA . 1.2 pp -67.3 -15.38 63.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.1 -1.0 . . . . 0.0 110.372 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.523 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 8.1 m-30 -69.29 -63.81 0.99 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.131 -0.98 . . . . 0.0 109.706 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -70.67 107.81 4.1 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.355 -0.84 . . . . 0.0 109.995 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -107.37 -29.67 9.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.117 -0.989 . . . . 0.0 110.375 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 38.0 p30 -69.86 -11.2 60.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.185 -0.947 . . . . 0.0 110.485 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.452 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 66.24 99.03 0.02 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -155.21 -51.74 0.09 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.263 -1.14 . . . . 0.0 110.377 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.0 -5.12 5.04 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 77.4 p -145.37 152.05 39.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.001 -1.294 . . . . 0.0 110.207 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.8 mt -87.37 101.23 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.259 -0.901 . . . . 0.0 110.071 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.2 p -95.37 -177.59 4.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.381 -0.824 . . . . 0.0 109.909 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.64 HG22 HD12 ' A' ' 52' ' ' ILE . 12.0 p -63.1 -30.07 71.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.077 -1.015 . . . . 0.0 110.227 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -63.69 -56.94 11.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.131 -0.981 . . . . 0.0 110.203 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.553 ' O ' HG23 ' A' ' 35' ' ' VAL . 32.0 mt-10 -57.31 -46.45 83.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.868 . . . . 0.0 110.023 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.594 HD23 ' CG ' ' A' ' 48' ' ' LEU . 11.0 tp -64.02 -23.25 67.26 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.19 -0.944 . . . . 0.0 109.774 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.04 -42.99 74.97 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.436 ' O ' ' CB ' ' A' ' 38' ' ' SER . 91.6 m -81.5 -18.77 43.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -1.131 . . . . 0.0 109.892 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.751 ' O ' HD12 ' A' ' 39' ' ' LEU . 51.6 t -79.59 -31.89 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.032 -1.043 . . . . 0.0 109.777 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.423 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 26.3 mmt -89.93 -25.4 20.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.297 -0.877 . . . . 0.0 110.163 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.463 ' HD2' ' HA ' ' A' ' 42' ' ' ASN . 3.3 tpt180 -89.37 -25.7 21.43 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.219 -0.926 . . . . 0.0 110.127 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 34' ' ' THR . 62.2 m -85.4 -14.2 47.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -0.926 . . . . 0.0 110.3 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.751 HD12 ' O ' ' A' ' 35' ' ' VAL . 30.5 mt -89.82 -88.03 0.17 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.234 -0.916 . . . . 0.0 110.334 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 41' ' ' GLN . . . -152.22 51.99 0.49 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.444 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 36.8 mt-30 -158.02 169.19 25.13 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.262 -1.14 . . . . 0.0 110.09 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.463 ' HA ' ' HD2' ' A' ' 37' ' ' ARG . 77.5 m-20 -144.4 58.24 5.53 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.496 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 42' ' ' ASN . 48.5 Cg_endo -79.19 -177.8 4.16 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.792 1.417 . . . . 0.0 110.369 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.455 HG22 ' N ' ' A' ' 45' ' ' GLU . 32.3 m -112.68 169.42 8.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.25 -0.906 . . . . 0.0 110.159 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.455 ' N ' HG22 ' A' ' 44' ' ' THR . 37.9 tt0 -66.84 -35.2 79.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.164 -0.96 . . . . 0.0 110.034 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.84 -66.72 0.6 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.266 -0.896 . . . . 0.0 109.88 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -47.25 -35.89 8.29 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.311 -0.868 . . . . 0.0 109.618 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.594 ' CG ' HD23 ' A' ' 32' ' ' LEU . 6.2 tt -61.99 -47.35 85.19 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.509 -0.744 . . . . 0.0 109.805 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.445 ' N ' HD23 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -52.52 -43.54 65.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.929 . . . . 0.0 109.659 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -65.13 -33.02 75.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.923 . . . . 0.0 109.4 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.458 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 31.6 ttp -71.17 -17.69 62.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.341 -0.85 . . . . 0.0 109.481 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.64 HD12 HG22 ' A' ' 29' ' ' THR . 44.9 mt -86.17 -27.39 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.353 -0.842 . . . . 0.0 109.85 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -59.03 -23.64 62.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 110.123 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.458 ' CG ' ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -83.88 -24.97 30.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.283 -0.886 . . . . 0.0 110.128 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.511 ' CG1' HD11 ' A' ' 63' ' ' ILE . 80.2 t -85.57 -65.5 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.225 -0.922 . . . . 0.0 109.991 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.402 ' OD2' ' OD1' ' A' ' 60' ' ' ASN . 46.6 t0 -50.31 135.74 21.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.377 -0.827 . . . . 0.0 110.285 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -103.66 -27.04 12.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.279 -0.888 . . . . 0.0 109.789 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -69.97 -30.71 68.12 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.367 -0.833 . . . . 0.0 109.812 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.06 24.51 61.51 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.402 ' OD1' ' OD2' ' A' ' 56' ' ' ASP . 14.2 p-10 -81.55 -32.7 32.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.164 -1.198 . . . . 0.0 110.219 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 129.28 -18.35 5.52 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.756 -1.212 . . . . 0.0 110.094 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 41.3 p -144.74 170.09 16.77 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.103 -1.233 . . . . 0.0 110.366 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.511 HD11 ' CG1' ' A' ' 55' ' ' VAL . 45.7 mt -112.48 163.46 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.106 -0.997 . . . . 0.0 110.163 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.464 ' N ' HG22 ' A' ' 63' ' ' ILE . 73.8 m-20 -125.01 -164.74 1.31 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.19 -0.944 . . . . 0.0 110.531 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.564 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 57.1 t80 -78.81 -43.89 1.85 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.344 -0.847 . . . . 0.0 111.386 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.2 Cg_endo -72.51 -32.54 9.75 Favored 'Trans proline' 0 C--N 1.324 -0.739 0 O-C-N 123.001 1.001 . . . . 0.0 110.176 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.43 ' OE1' ' HA ' ' A' ' 63' ' ' ILE . 35.0 tt0 -76.55 -20.84 56.43 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.226 -0.921 . . . . 0.0 109.277 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.531 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 8.7 t80 -80.96 -44.35 18.33 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.501 -0.749 . . . . 0.0 109.703 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.579 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -71.47 -22.76 61.77 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.324 -0.86 . . . . 0.0 109.613 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.0 m -85.2 -41.28 15.78 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.419 -0.801 . . . . 0.0 110.242 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.491 ' HG3' ' N ' ' A' ' 72' ' ' MET . 19.5 ptm -66.11 -33.2 75.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.135 -0.978 . . . . 0.0 110.169 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.531 ' CE ' ' CZ ' ' A' ' 68' ' ' PHE . 20.6 mtt -90.15 -10.78 43.27 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.237 -0.914 . . . . 0.0 110.269 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.579 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.129 -0.982 . . . . 0.0 110.349 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 121.143 0.497 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 54.0 mt -46.72 -32.85 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.105 -0.997 . . . . 0.0 109.947 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.413 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 35.0 ttt180 -66.2 -47.21 74.61 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.421 -0.799 . . . . 0.0 109.354 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 2.8 tt0 -49.27 -48.48 45.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.437 -0.789 . . . . 0.0 109.983 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.737 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -62.9 -61.47 2.38 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.385 -0.822 . . . . 0.0 110.19 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -44.69 -26.98 0.44 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.428 -0.795 . . . . 0.0 110.644 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 86' ' ' ARG . 4.9 mmp_? -75.53 -47.66 25.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.273 -0.892 . . . . 0.0 110.469 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.737 HG22 ' O ' ' A' ' 88' ' ' ALA . 35.8 m -70.65 -9.75 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.201 -0.937 . . . . 0.0 110.864 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.754 ' CE1' HG11 ' A' ' 108' ' ' VAL . 42.7 m-85 -103.02 -22.89 13.73 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.099 -1.001 . . . . 0.0 110.77 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -114.23 77.67 1.08 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.078 -1.013 . . . . 0.0 110.306 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.9 ptpt -109.69 -7.28 15.1 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.251 -0.905 . . . . 0.0 110.55 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.418 ' OD2' ' OD1' ' A' ' 97' ' ' ASN . 10.8 p-10 -73.28 -37.78 66.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.033 -1.042 . . . . 0.0 110.121 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 121.62 -24.14 7.28 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.196 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.463 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 15.0 p-10 -58.71 -30.01 67.11 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.704 -1.469 . . . . 0.0 110.863 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.471 ' C ' ' CD1' ' A' ' 99' ' ' TYR . . . 94.0 16.25 45.36 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.576 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.481 ' CD2' ' NE2' ' A' ' 135' ' ' GLN . 86.4 m-85 -142.09 151.54 42.44 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.95 -1.323 . . . . 0.0 110.188 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.418 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 24.0 mt -91.97 130.69 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.11 -0.994 . . . . 0.0 109.729 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 44.4 t -114.98 165.67 12.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.292 -0.88 . . . . 0.0 110.113 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.07 -29.45 67.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.279 -0.888 . . . . 0.0 110.343 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.12 -54.5 7.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.189 -0.944 . . . . 0.0 110.414 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.838 ' O ' HG23 ' A' ' 108' ' ' VAL . 43.7 mt-10 -53.51 -40.65 65.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.216 -0.927 . . . . 0.0 110.282 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.759 HD22 HG13 ' A' ' 121' ' ' VAL . 8.7 tt -71.19 -32.94 69.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.146 -0.971 . . . . 0.0 110.492 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -71.36 -21.35 62.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.07 -1.019 . . . . 0.0 109.898 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.469 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 54.9 t60 -95.68 -20.27 19.05 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.247 -0.908 . . . . 0.0 109.729 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.838 HG23 ' O ' ' A' ' 104' ' ' GLU . 93.2 t -84.14 -38.12 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.321 -0.862 . . . . 0.0 110.307 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.5 mmt -63.67 -30.45 71.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.867 . . . . 0.0 110.152 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.1 p -69.06 -39.16 79.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 109.965 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 107' ' ' HIS . 76.4 m-20 -66.6 -42.91 86.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.189 -0.944 . . . . 0.0 110.224 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.4 ' HB3' ' OE1' ' A' ' 114' ' ' GLU . 89.9 mt -66.54 -33.57 75.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.898 . . . . 0.0 110.125 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.51 -16.72 11.41 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.431 ' CD ' ' N ' ' A' ' 114' ' ' GLU . 5.6 mp0 -69.01 114.11 6.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -1.131 . . . . 0.0 110.288 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.29 121.39 32.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 110.384 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.59 169.82 12.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 110.104 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 27.9 m -98.25 159.49 14.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.105 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -54.35 -44.01 71.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.217 -0.927 . . . . 0.0 110.186 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -65.35 -43.31 91.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 110.409 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -55.76 -46.97 77.76 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.169 -0.957 . . . . 0.0 110.603 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.759 HG13 HD22 ' A' ' 105' ' ' LEU . 77.9 t -59.49 -55.41 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 110.254 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.44 -24.99 49.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.159 -0.963 . . . . 0.0 109.928 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -76.33 -33.99 59.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.356 -0.84 . . . . 0.0 110.064 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.426 ' HE2' HD11 ' A' ' 105' ' ' LEU . 54.5 mtp -71.51 -42.28 68.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 0.0 110.007 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 31.5 mm -66.71 -36.76 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.255 -0.903 . . . . 0.0 110.08 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.57 -57.37 7.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.278 -0.889 . . . . 0.0 110.129 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.403 ' HA ' ' OE1' ' A' ' 127' ' ' GLU . 3.1 mm-40 -51.2 -42.18 60.74 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.4 -0.812 . . . . 0.0 110.641 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -70.24 -30.61 67.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.203 -0.936 . . . . 0.0 110.449 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 6.8 t0 -74.62 84.09 2.07 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.282 -0.886 . . . . 0.0 110.267 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.4 mt -58.57 -37.91 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.215 -0.928 . . . . 0.0 110.034 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.9 p30 -77.13 -32.3 56.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.268 -0.895 . . . . 0.0 109.991 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.453 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 81.03 60.03 2.34 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 135' ' ' GLN . 56.3 p30 -117.21 8.12 13.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.161 -1.199 . . . . 0.0 110.442 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.61 -40.48 3.04 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.481 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 7.0 pt20 -98.17 158.03 15.8 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.062 -1.258 . . . . 0.0 110.485 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.418 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 76.2 t -114.3 134.05 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.384 -0.823 . . . . 0.0 110.232 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.454 ' OD1' ' CG ' ' A' ' 140' ' ' GLU . 24.2 p-10 -105.19 171.83 7.11 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.124 -0.985 . . . . 0.0 109.997 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -52.83 -60.59 3.08 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.228 -0.92 . . . . 0.0 111.471 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -44.3 -51.84 8.06 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.134 -0.979 . . . . 0.0 111.375 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.46 ' O ' ' CG ' ' A' ' 144' ' ' MET . 58.3 mt-10 -59.89 -37.25 78.85 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.985 -1.072 . . . . 0.0 110.459 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.645 ' CZ ' ' HE3' ' A' ' 145' ' ' MET . 87.4 t80 -66.38 -22.17 66.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.311 -0.868 . . . . 0.0 110.782 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 98.1 t -90.5 -42.18 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.026 -1.046 . . . . 0.0 111.231 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -78.61 -13.37 59.86 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.955 -1.091 . . . . 0.0 110.62 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.482 ' HE3' ' HG3' ' A' ' 145' ' ' MET . 0.0 OUTLIER -90.72 -9.91 44.98 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.064 -1.023 . . . . 0.0 110.582 -179.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.645 ' HE3' ' CZ ' ' A' ' 141' ' ' PHE . 18.9 mtt -90.68 -70.85 0.66 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.037 -1.04 . . . . 0.0 111.669 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.497 1.906 0 O-C-N 120.955 -1.091 . . . . 0.0 111.024 -178.966 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.16 0.505 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -69.14 -62.54 1.34 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.18 -0.95 . . . . 0.0 110.373 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.46 ' HG2' ' CE2' ' A' ' 12' ' ' PHE . 11.7 tt0 -58.76 -41.13 85.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 110.14 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.2 mt -58.38 -37.81 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.194 -0.941 . . . . 0.0 109.906 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -69.28 -33.24 72.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.295 -0.878 . . . . 0.0 109.963 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -61.2 -51.37 69.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 109.597 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.46 ' CE2' ' HG2' ' A' ' 8' ' ' GLN . 21.4 m-85 -58.64 -39.03 79.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.469 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -54.14 -42.5 69.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 109.554 179.463 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 17' ' ' SER . 35.1 mt-10 -61.34 -45.04 96.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -0.895 . . . . 0.0 109.786 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.501 ' O ' ' CG ' ' A' ' 19' ' ' PHE . . . -53.49 -48.89 68.54 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.302 -0.873 . . . . 0.0 109.523 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.513 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 28.8 t80 -65.35 -26.67 68.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.383 -0.823 . . . . 0.0 109.797 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -59.91 -63.65 1.23 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.313 -0.867 . . . . 0.0 110.001 179.722 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.465 HD21 ' HA ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -64.37 -19.64 65.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.257 -0.902 . . . . 0.0 109.748 179.683 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.501 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 10.5 m-30 -69.61 -32.2 70.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.361 -0.837 . . . . 0.0 109.444 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -97.96 97.23 8.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -87.52 49.92 1.9 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 110.253 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 2.7 p30 -170.77 -32.45 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.384 -0.822 . . . . 0.0 110.583 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 77.08 60.87 2.78 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -108.03 -39.6 5.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -1.18 . . . . 0.0 110.816 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.521 ' C ' HG23 ' A' ' 26' ' ' THR . . . 135.83 -10.05 4.24 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.23 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.521 HG23 ' C ' ' A' ' 25' ' ' GLY . 68.1 p -151.06 168.28 25.1 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.1 -1.235 . . . . 0.0 110.425 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 65.6 mt -102.59 123.26 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.369 -0.832 . . . . 0.0 110.294 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.1 p -92.97 -163.78 1.09 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.332 -0.855 . . . . 0.0 110.179 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.462 HG22 HD12 ' A' ' 52' ' ' ILE . 4.5 p -90.31 -45.25 9.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.243 -0.911 . . . . 0.0 110.781 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.441 ' HG3' ' HG3' ' A' ' 31' ' ' GLU . 6.1 pttt -56.47 -45.83 80.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.987 -1.071 . . . . 0.0 110.16 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.441 ' HG3' ' HG3' ' A' ' 30' ' ' LYS . 49.6 mt-10 -63.76 -48.75 75.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.98 -1.075 . . . . 0.0 109.34 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.45 ' C ' HD11 ' A' ' 48' ' ' LEU . 13.1 tp -62.61 -15.68 52.82 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.45 -0.781 . . . . 0.0 109.753 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.469 ' HA2' ' CD1' ' A' ' 48' ' ' LEU . . . -75.89 -46.17 14.57 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 57.7 m -71.27 -20.18 62.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -1.094 . . . . 0.0 109.653 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.3 t -83.33 -33.12 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.33 -0.856 . . . . 0.0 109.968 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.435 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 26.0 mmt -88.38 -18.34 28.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.155 -0.965 . . . . 0.0 109.899 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -90.83 -36.05 14.45 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.0 110.249 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.6 m -80.9 -45.08 17.33 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.243 -0.911 . . . . 0.0 110.045 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.7 mt -92.47 -36.49 13.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 110.079 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 36' ' ' MET . . . -68.64 -112.65 0.02 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -148.67 -70.29 0.21 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.254 -1.145 . . . . 0.0 110.351 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.508 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 51.6 t30 -163.39 49.7 0.24 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 0.0 110.463 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 42' ' ' ASN . 45.3 Cg_endo -71.52 -166.26 0.23 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.747 1.393 . . . . 0.0 110.127 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.61 HG23 ' H ' ' A' ' 47' ' ' GLU . 4.9 t -141.31 173.15 11.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.132 -0.98 . . . . 0.0 110.277 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -68.21 -25.73 65.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.188 -0.945 . . . . 0.0 109.973 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.99 -65.62 0.82 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.294 -0.879 . . . . 0.0 109.606 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.61 ' H ' HG23 ' A' ' 44' ' ' THR . 6.0 tp10 -52.9 -23.55 7.37 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.419 -0.801 . . . . 0.0 109.406 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.469 ' CD1' ' HA2' ' A' ' 33' ' ' GLY . 3.6 tt -68.72 -56.44 8.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.439 -0.788 . . . . 0.0 109.244 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -47.69 -44.01 27.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 109.411 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -63.0 -40.21 97.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.518 -0.739 . . . . 0.0 109.597 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.439 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 6.3 ttp -66.02 -17.81 64.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.339 -0.851 . . . . 0.0 109.779 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.462 HD12 HG22 ' A' ' 29' ' ' THR . 33.8 mt -89.79 -24.97 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 109.608 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -66.0 -36.66 83.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 110.277 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.536 ' HG3' HG23 ' A' ' 55' ' ' VAL . 16.3 pt-20 -68.19 -36.8 80.16 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.099 -1.0 . . . . 0.0 110.251 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.82 HG13 ' SD ' ' A' ' 71' ' ' MET . 99.4 t -76.2 -67.96 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.115 -0.991 . . . . 0.0 110.293 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -43.91 105.9 0.06 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.591 -0.693 . . . . 0.0 110.491 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.12 33.2 4.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.909 . . . . 0.0 110.356 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.3 p30 -122.9 -40.49 2.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.919 . . . . 0.0 110.235 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 103.49 45.99 1.48 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.434 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 19.8 p-10 -122.73 -27.71 4.28 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.089 -1.242 . . . . 0.0 110.397 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.62 -74.54 0.41 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.674 -1.251 . . . . 0.0 110.268 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.8 p -86.1 170.1 12.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.207 -1.172 . . . . 0.0 110.575 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.563 HD13 HG11 ' A' ' 55' ' ' VAL . 20.5 mt -90.13 159.28 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.296 -0.878 . . . . 0.0 109.719 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.435 ' OD2' ' HD2' ' A' ' 66' ' ' PRO . 10.4 t0 -115.41 -179.48 3.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.243 -0.911 . . . . 0.0 110.489 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.591 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 10.6 t80 -74.98 -41.94 4.28 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.333 -0.855 . . . . 0.0 111.752 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.7 Cg_endo -72.07 -17.03 28.57 Favored 'Trans proline' 0 C--O 1.212 -0.823 0 O-C-N 123.105 1.055 . . . . 0.0 110.583 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 71' ' ' MET . 51.2 mt-10 -84.67 -37.52 20.9 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.006 -1.059 . . . . 0.0 108.916 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.513 ' CE2' ' HB2' ' A' ' 16' ' ' PHE . 73.1 t80 -63.67 -48.33 77.65 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.542 -0.723 . . . . 0.0 110.217 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.469 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 1.8 tp -74.4 -37.01 63.5 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.29 -0.881 . . . . 0.0 110.446 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.424 ' HB ' ' O ' ' A' ' 66' ' ' PRO . 71.4 m -74.63 -10.2 59.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.135 -0.978 . . . . 0.0 110.441 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.82 ' SD ' HG13 ' A' ' 55' ' ' VAL . 63.6 ttp -91.44 -49.89 6.09 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.885 -1.135 . . . . 0.0 109.746 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.481 ' HE1' ' CE1' ' A' ' 68' ' ' PHE . 39.4 mtt -91.75 -63.58 1.23 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.338 -0.851 . . . . 0.0 111.645 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.501 2.094 0 O-C-N 121.267 -0.896 . . . . 0.0 111.749 -178.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.123 0.487 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.5 mt -52.31 -40.1 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.232 -0.918 . . . . 0.0 110.121 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 20.1 ttt85 -55.12 -49.38 71.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.418 -0.801 . . . . 0.0 110.269 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.59 ' O ' HG13 ' A' ' 91' ' ' VAL . 48.5 mt-10 -64.59 -37.13 86.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.342 -0.849 . . . . 0.0 110.429 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 92' ' ' PHE . . . -64.94 -22.52 67.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 110.302 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.561 ' CD1' HD11 ' A' ' 100' ' ' ILE . 22.4 t80 -83.48 -38.86 21.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.091 -1.006 . . . . 0.0 110.201 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -70.66 -31.44 68.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.381 -0.824 . . . . 0.0 110.777 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.59 HG13 ' O ' ' A' ' 87' ' ' GLU . 7.2 m -83.56 -41.42 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.077 -1.014 . . . . 0.0 110.488 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.516 ' N ' HG23 ' A' ' 91' ' ' VAL . 9.5 m-85 -67.67 -23.48 65.32 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.971 -1.081 . . . . 0.0 110.012 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -108.6 81.03 1.4 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.219 -0.926 . . . . 0.0 109.935 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 91' ' ' VAL . 13.4 mtpt -97.26 1.55 49.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 0.0 110.89 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 2.3 p30 -79.39 -27.77 41.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.931 -1.106 . . . . 0.0 109.784 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.402 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 94.63 44.16 3.48 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.463 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 23.9 p-10 -128.57 -14.28 4.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.185 -1.185 . . . . 0.0 110.984 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.98 -5.88 84.32 Favored Glycine 0 N--CA 1.504 3.197 0 O-C-N 120.974 -1.079 . . . . 0.0 110.876 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.463 ' HB2' ' ND2' ' A' ' 97' ' ' ASN . 9.5 m-85 -116.61 139.03 50.97 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.954 -1.321 . . . . 0.0 110.309 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.561 HD11 ' CD1' ' A' ' 89' ' ' PHE . 22.0 mt -91.3 115.74 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.222 -0.924 . . . . 0.0 109.916 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.9 t -100.01 172.59 7.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 109.956 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.67 -41.85 71.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.196 -0.94 . . . . 0.0 110.215 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -55.08 -53.78 51.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.316 -0.865 . . . . 0.0 110.122 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.726 ' O ' HG23 ' A' ' 108' ' ' VAL . 51.1 mt-10 -56.74 -49.84 74.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 110.047 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.593 HD12 HD11 ' A' ' 125' ' ' ILE . 1.5 tt -51.1 -34.7 31.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.892 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.432 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 9.5 ttm180 -66.72 -41.55 87.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.241 -0.912 . . . . 0.0 109.814 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -75.45 -10.08 59.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.312 -0.867 . . . . 0.0 110.283 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 104' ' ' GLU . 97.4 t -86.64 -52.13 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.02 -1.05 . . . . 0.0 110.196 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 14.3 mmt -73.4 -60.43 2.25 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.203 -0.935 . . . . 0.0 110.434 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.1 m -46.66 -35.56 6.12 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.401 -0.812 . . . . 0.0 110.552 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -73.73 -45.13 53.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.175 -0.953 . . . . 0.0 110.415 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 41.4 mt -50.04 -52.25 35.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.204 -0.935 . . . . 0.0 110.285 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 157.04 -38.12 0.56 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -57.57 139.5 53.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.292 -1.122 . . . . 0.0 110.242 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -106.89 79.61 1.35 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -0.875 . . . . 0.0 110.335 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.61 -179.1 7.06 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.279 -0.888 . . . . 0.0 110.048 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 66.9 m -108.4 153.79 22.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.247 -0.908 . . . . 0.0 110.252 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.96 -40.87 64.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.321 -0.862 . . . . 0.0 110.466 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -59.04 -41.4 87.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.202 -0.936 . . . . 0.0 110.374 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -56.14 -56.91 15.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.333 -0.854 . . . . 0.0 110.496 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.431 HG13 HD13 ' A' ' 105' ' ' LEU . 97.6 t -54.5 -48.38 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 110.444 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -56.22 -33.37 65.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 0.0 110.225 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -74.4 -28.4 61.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 110.067 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 95.5 mtp -71.65 -53.2 14.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.262 -0.899 . . . . 0.0 109.933 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.593 HD11 HD12 ' A' ' 105' ' ' LEU . 29.3 mm -61.51 -32.06 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 109.993 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 54.2 ttt-85 -64.91 -53.95 38.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.327 -0.858 . . . . 0.0 110.18 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -60.61 -32.47 71.6 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.128 -0.982 . . . . 0.0 110.131 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.18 -27.69 64.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.277 -0.889 . . . . 0.0 110.189 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -70.33 87.96 0.63 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.939 . . . . 0.0 110.178 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 68.7 mt -65.91 -43.01 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.232 -0.917 . . . . 0.0 110.111 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.402 ' OD1' ' OE2' ' A' ' 140' ' ' GLU . 5.4 p-10 -79.38 -42.39 25.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -0.95 . . . . 0.0 110.115 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.86 84.63 1.81 Allowed Glycine 0 N--CA 1.485 1.964 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.479 ' OD2' ' CG ' ' A' ' 135' ' ' GLN . 18.1 p-10 -147.96 -46.49 0.16 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.254 -1.145 . . . . 0.0 110.598 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 134.3 31.61 0.36 Allowed Glycine 0 N--CA 1.498 2.772 0 C-N-CA 119.491 -1.337 . . . . 0.0 110.889 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.479 ' CG ' ' OD2' ' A' ' 133' ' ' ASP . 8.8 pt20 -169.98 135.82 1.43 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.971 -1.311 . . . . 0.0 110.134 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.2 t -100.09 113.06 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -0.975 . . . . 0.0 110.283 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.433 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 13.8 p30 -89.3 -169.87 2.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.013 -1.054 . . . . 0.0 109.987 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.401 ' O ' HG23 ' A' ' 142' ' ' VAL . 2.4 t80 -62.32 -48.03 81.63 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.078 -1.014 . . . . 0.0 111.095 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -56.05 -55.9 27.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.072 -1.017 . . . . 0.0 110.617 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.422 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 56.2 mt-10 -61.55 -22.69 65.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.275 -0.891 . . . . 0.0 110.748 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.447 ' CE1' ' CD1' ' A' ' 100' ' ' ILE . 9.8 t80 -79.83 -26.56 40.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.176 -0.952 . . . . 0.0 110.104 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.433 ' O ' ' HB ' ' A' ' 146' ' ' THR . 85.9 t -90.32 -24.21 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.255 -0.903 . . . . 0.0 110.287 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -83.29 -42.27 17.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.185 -0.947 . . . . 0.0 110.654 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.484 ' HG3' ' N ' ' A' ' 145' ' ' MET . 5.2 ptt? -59.73 -38.92 83.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.146 -0.971 . . . . 0.0 110.195 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.484 ' N ' ' HG3' ' A' ' 144' ' ' MET . 14.3 ttm -91.35 -9.33 45.29 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.248 -0.908 . . . . 0.0 110.343 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 142' ' ' VAL . 1.3 m . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.046 -1.034 . . . . 0.0 110.887 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 121.271 0.558 . . . . 0.0 109.784 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -59.94 -40.99 90.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.374 -0.828 . . . . 0.0 109.771 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.425 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 34.9 tp60 -58.98 -44.4 91.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.689 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 57.1 mt -58.47 -45.96 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.9 . . . . 0.0 109.65 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.18 -27.04 68.69 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.317 -0.864 . . . . 0.0 109.657 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 5.9 tp10 -67.62 -44.52 77.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.33 -0.856 . . . . 0.0 109.848 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -61.82 -52.62 63.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 0.0 109.641 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.443 ' HE3' HD13 ' A' ' 69' ' ' LEU . 82.4 mttt -51.93 -43.38 63.42 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.24 -0.913 . . . . 0.0 109.389 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -56.27 -42.21 77.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 0.0 109.555 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.44 -39.66 88.31 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.39 -0.819 . . . . 0.0 109.749 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -56.51 -49.88 73.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.66 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 64.8 m -59.93 -31.0 69.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 109.642 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.806 ' O ' HD23 ' A' ' 18' ' ' LEU . 2.5 tt -65.49 -32.79 74.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.419 -0.801 . . . . 0.0 109.853 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.473 ' O ' ' HD2' ' A' ' 21' ' ' LYS . 5.2 m-85 -87.11 -67.06 0.85 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.395 -0.816 . . . . 0.0 109.999 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -48.24 95.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.957 -1.089 . . . . 0.0 109.988 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.473 ' HD2' ' O ' ' A' ' 19' ' ' PHE . 0.7 OUTLIER -84.33 -47.84 10.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.91 . . . . 0.0 110.455 -179.659 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 3.9 p30 -70.0 -20.89 63.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.108 -0.995 . . . . 0.0 110.025 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.463 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 74.83 72.84 0.99 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.406 ' OD2' ' OD1' ' A' ' 22' ' ' ASP . 65.1 m-20 -112.77 -23.4 10.18 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.145 -1.209 . . . . 0.0 109.932 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.44 -11.96 47.29 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.9 p -132.75 148.02 52.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.184 -1.186 . . . . 0.0 110.298 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.6 mt -102.86 124.77 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.97 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.5 p -114.55 -161.85 0.79 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.339 -0.85 . . . . 0.0 110.599 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.883 HG22 HG13 ' A' ' 52' ' ' ILE . 52.0 p -82.31 -21.04 36.27 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.376 -0.828 . . . . 0.0 110.48 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -74.66 -59.17 2.86 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.231 -0.918 . . . . 0.0 110.032 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.449 ' O ' HG23 ' A' ' 35' ' ' VAL . 43.7 mt-10 -62.19 -45.92 91.25 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.314 -0.866 . . . . 0.0 109.874 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.953 HD22 HD11 ' A' ' 52' ' ' ILE . 3.5 tp -62.73 -36.58 83.46 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.193 -0.942 . . . . 0.0 109.74 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.06 -41.86 86.11 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 65.5 m -80.53 -23.37 40.06 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.128 -1.219 . . . . 0.0 110.503 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 31' ' ' GLU . 38.1 t -72.59 -29.86 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.228 -0.92 . . . . 0.0 110.002 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -89.87 -30.23 18.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -0.882 . . . . 0.0 109.452 179.409 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.499 ' HD3' ' ND2' ' A' ' 42' ' ' ASN . 22.8 tpp180 -62.46 -58.15 8.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.475 -0.766 . . . . 0.0 110.236 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.2 t -95.13 10.36 36.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -0.891 . . . . 0.0 110.384 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.62 59.88 0.17 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.059 -1.025 . . . . 0.0 110.319 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 163.07 -97.89 0.15 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.423 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -148.46 175.62 10.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -1.136 . . . . 0.0 110.099 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.499 ' ND2' ' HD3' ' A' ' 37' ' ' ARG . 1.7 m120 -107.71 73.77 0.42 Allowed Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.307 -0.871 . . . . 0.0 110.407 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 41' ' ' GLN . 46.9 Cg_endo -72.07 -178.56 3.27 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.719 1.378 . . . . 0.0 110.205 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 9.3 m -105.42 167.01 10.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.894 . . . . 0.0 109.542 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.423 ' O ' ' HB3' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -54.71 -52.99 60.7 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.928 -1.108 . . . . 0.0 110.159 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.11 -62.72 1.28 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.185 -0.947 . . . . 0.0 110.645 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -45.23 -26.78 0.54 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.238 -0.914 . . . . 0.0 109.982 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.564 HD23 ' C ' ' A' ' 48' ' ' LEU . 9.2 tt -70.44 -51.5 28.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.374 -0.829 . . . . 0.0 109.293 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.449 ' HA ' ' OE1' ' A' ' 49' ' ' GLN . 4.1 tp-100 -50.37 -38.26 41.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.201 -0.937 . . . . 0.0 109.349 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -61.65 -43.93 97.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.277 -0.89 . . . . 0.0 109.104 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.45 ' HA ' ' HG2' ' A' ' 54' ' ' GLU . 2.2 ttp -60.25 -22.93 63.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.446 -0.784 . . . . 0.0 109.353 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.953 HD11 HD22 ' A' ' 32' ' ' LEU . 35.8 mm -81.68 -27.53 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.536 -0.727 . . . . 0.0 110.279 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -81.57 -15.18 55.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.207 -0.933 . . . . 0.0 110.825 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.74 ' HG3' HG23 ' A' ' 55' ' ' VAL . 2.8 pt-20 -88.47 -16.42 32.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.95 -1.094 . . . . 0.0 110.628 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.74 HG23 ' HG3' ' A' ' 54' ' ' GLU . 64.0 t -104.23 -36.88 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.097 -1.002 . . . . 0.0 110.403 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -84.9 103.23 13.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.959 . . . . 0.0 110.039 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.98 41.72 1.56 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.288 -0.882 . . . . 0.0 109.986 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -115.29 18.48 16.1 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.371 -0.831 . . . . 0.0 109.674 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.42 29.24 30.47 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -108.07 -63.97 1.26 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.256 -1.143 . . . . 0.0 110.409 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.28 -65.2 0.43 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 81.1 p -96.07 161.31 14.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -1.148 . . . . 0.0 109.709 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 78.6 mt -84.05 142.15 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.117 -0.989 . . . . 0.0 110.427 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.448 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 56.3 m-20 -101.83 -176.69 3.2 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.319 -0.863 . . . . 0.0 109.945 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.577 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -72.61 -47.24 9.51 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 111.089 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.6 Cg_endo -72.28 -24.4 19.77 Favored 'Trans proline' 0 C--N 1.321 -0.892 0 O-C-N 123.336 1.177 . . . . 0.0 110.408 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -77.34 -28.08 52.95 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.173 -0.955 . . . . 0.0 108.714 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.537 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 7.9 t80 -76.8 -38.07 54.61 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.639 -0.663 . . . . 0.0 109.976 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.537 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 27.5 tp -75.23 -26.42 58.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.359 -0.838 . . . . 0.0 110.271 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.0 m -79.95 -32.33 39.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.178 -0.951 . . . . 0.0 110.076 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.442 ' HG3' ' N ' ' A' ' 72' ' ' MET . 16.8 ptm -84.5 -29.09 26.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.333 -0.854 . . . . 0.0 110.634 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.537 ' CE ' ' CZ ' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -90.58 -29.53 17.77 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.198 -0.939 . . . . 0.0 110.74 -179.658 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.761 0 O-C-N 121.207 -0.933 . . . . 0.0 110.473 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.303 0.573 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.527 ' CG2' HG22 ' A' ' 142' ' ' VAL . 47.3 mm -67.71 -41.8 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 110.341 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -71.45 -43.81 65.98 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.27 -0.894 . . . . 0.0 110.267 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 66.2 mt-10 -58.71 -43.92 90.2 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.18 -0.95 . . . . 0.0 110.212 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.507 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -59.8 -60.29 4.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 0.0 109.751 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CZ ' ' O ' ' A' ' 98' ' ' GLY . 6.2 t80 -48.95 -25.72 2.1 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.323 -0.86 . . . . 0.0 109.805 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 21.9 ttt180 -69.29 -64.45 0.87 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.426 -0.796 . . . . 0.0 110.858 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 88' ' ' ALA . 32.9 m -56.59 -35.2 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.333 -0.854 . . . . 0.0 111.545 -178.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.868 ' CE1' HD12 ' A' ' 105' ' ' LEU . 44.4 m-85 -77.93 -21.81 50.55 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.824 -1.173 . . . . 0.0 110.932 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 89' ' ' PHE . 97.0 m-20 -128.03 40.76 3.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.053 -1.03 . . . . 0.0 109.944 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 21.2 pttp -91.85 25.19 2.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 110.022 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.437 ' OD1' ' HB2' ' A' ' 97' ' ' ASN . 2.8 p30 -107.19 0.58 23.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.368 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.04 16.82 36.97 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.437 ' HB2' ' OD1' ' A' ' 95' ' ' ASP . 21.4 t-20 -95.53 -62.13 1.35 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.097 -1.237 . . . . 0.0 110.287 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.504 ' O ' ' CZ ' ' A' ' 89' ' ' PHE . . . 121.46 -57.82 0.59 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.443 ' CE1' ' OD1' ' A' ' 137' ' ' ASN . 12.7 m-85 -91.5 159.76 15.77 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.267 -1.137 . . . . 0.0 110.138 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.569 HG23 ' HB3' ' A' ' 92' ' ' PHE . 17.5 mt -87.17 154.89 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.106 -0.996 . . . . 0.0 109.467 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 105' ' ' LEU . 23.3 t -140.57 -177.43 5.05 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.137 -0.977 . . . . 0.0 110.611 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.74 -34.18 40.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.366 -0.833 . . . . 0.0 109.953 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.06 -54.91 9.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -0.963 . . . . 0.0 109.928 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -59.14 -43.76 92.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.251 -0.906 . . . . 0.0 109.846 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.966 HD23 HG13 ' A' ' 121' ' ' VAL . 56.8 tp -52.22 -50.41 62.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 110.28 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -67.55 -26.26 66.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -0.883 . . . . 0.0 110.471 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.418 ' ND1' ' O ' ' A' ' 107' ' ' HIS . 31.9 t-80 -75.85 -16.82 60.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.131 -0.981 . . . . 0.0 110.12 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 72.8 t -88.68 -50.56 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.359 -0.838 . . . . 0.0 110.267 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 55.6 mtt -68.57 -44.29 74.73 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.359 -0.838 . . . . 0.0 110.532 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 91.0 m -58.83 -44.49 90.9 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.271 -0.893 . . . . 0.0 110.457 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -64.84 -53.36 47.98 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.252 -0.905 . . . . 0.0 110.689 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.432 ' HA ' HD23 ' A' ' 112' ' ' LEU . 27.6 mt -46.86 -86.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.236 -0.915 . . . . 0.0 110.307 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -179.97 33.67 0.06 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -122.98 143.19 50.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -1.194 . . . . 0.0 110.156 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 39.4 pttt -113.8 117.55 31.77 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.265 -0.897 . . . . 0.0 109.942 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.8 mt -124.72 149.77 46.91 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.109 -0.994 . . . . 0.0 110.646 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.401 ' HB ' ' HG3' ' A' ' 120' ' ' GLU . 39.7 m -71.63 136.79 47.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.283 -0.886 . . . . 0.0 110.052 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -47.87 -44.06 29.01 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.186 -0.946 . . . . 0.0 110.218 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -55.44 -43.01 75.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.836 . . . . 0.0 110.579 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 124' ' ' MET . 45.9 mt-10 -60.37 -51.93 67.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.209 -0.932 . . . . 0.0 110.583 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.966 HG13 HD23 ' A' ' 105' ' ' LEU . 54.1 t -53.43 -48.22 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.074 -1.017 . . . . 0.0 110.339 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -58.43 -41.23 84.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.174 -0.954 . . . . 0.0 110.246 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -70.54 -20.64 62.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.913 . . . . 0.0 110.195 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.419 ' HG3' ' O ' ' A' ' 120' ' ' GLU . 85.2 mtp -76.94 -43.67 34.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.175 -0.953 . . . . 0.0 109.615 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 14.4 mm -67.7 -30.3 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.886 . . . . 0.0 109.926 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.8 ttp85 -75.91 -52.26 10.68 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.113 -0.992 . . . . 0.0 110.217 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -54.17 -38.5 65.62 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.214 -0.928 . . . . 0.0 110.151 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.22 -41.56 63.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.877 . . . . 0.0 109.802 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -69.22 92.99 0.59 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.383 -0.823 . . . . 0.0 109.771 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 75.9 mt -63.23 -44.14 99.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.368 -0.833 . . . . 0.0 110.777 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.9 p30 -74.31 -29.41 61.61 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.113 -0.992 . . . . 0.0 110.274 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.453 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 75.19 57.94 4.15 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.444 ' OD1' ' CG ' ' A' ' 135' ' ' GLN . 57.1 p-10 -106.82 0.98 24.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.127 -1.219 . . . . 0.0 110.6 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.14 26.47 12.37 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.444 ' CG ' ' OD1' ' A' ' 133' ' ' ASP . 7.6 pt20 -169.38 164.69 10.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.194 -1.18 . . . . 0.0 110.101 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.479 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 55.2 t -123.06 115.73 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.21 -0.931 . . . . 0.0 109.921 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.443 ' OD1' ' CE1' ' A' ' 99' ' ' TYR . 15.6 t30 -84.16 -174.89 5.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.293 -0.879 . . . . 0.0 110.62 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.682 ' O ' HG23 ' A' ' 142' ' ' VAL . 12.0 t80 -69.74 -42.65 73.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.4 -0.813 . . . . 0.0 110.682 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -61.55 -58.46 8.05 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.276 -0.89 . . . . 0.0 110.659 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -56.07 -36.82 68.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.089 -1.007 . . . . 0.0 110.362 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.583 ' CZ ' ' HE1' ' A' ' 145' ' ' MET . 13.5 t80 -67.08 -27.72 67.59 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.265 -0.897 . . . . 0.0 110.689 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 138' ' ' TYR . 98.5 t -89.93 -22.65 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.34 -0.85 . . . . 0.0 111.078 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -81.61 -36.48 28.89 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.08 -1.013 . . . . 0.0 110.991 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.622 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 4.7 ptt? -64.58 -28.91 69.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.939 -1.1 . . . . 0.0 110.093 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.622 ' CE ' ' HE2' ' A' ' 144' ' ' MET . 61.2 mtt -82.71 -23.26 34.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.879 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.654 HG23 ' O ' ' A' ' 142' ' ' VAL . 47.2 p . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.339 -0.851 . . . . 0.0 109.915 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.144 0.497 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -48.32 -43.41 33.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.201 -0.937 . . . . 0.0 110.238 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.503 ' HG3' ' CE2' ' A' ' 12' ' ' PHE . 2.9 tp-100 -59.5 -42.06 91.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.913 . . . . 0.0 109.786 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.1 mm -61.59 -36.79 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.387 -0.82 . . . . 0.0 109.6 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.28 -30.06 66.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.324 -0.86 . . . . 0.0 109.815 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -64.74 -47.23 79.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.87 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.503 ' CE2' ' HG3' ' A' ' 8' ' ' GLN . 24.0 m-85 -65.26 -49.64 68.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.326 -0.859 . . . . 0.0 110.224 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -53.4 -40.14 64.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.198 -0.939 . . . . 0.0 110.105 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -59.32 -53.26 60.31 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.313 -0.867 . . . . 0.0 110.006 179.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.489 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -51.19 -36.92 43.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.201 -0.937 . . . . 0.0 109.668 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.525 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 60.3 t80 -65.95 -39.57 90.55 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.382 -0.824 . . . . 0.0 109.84 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.8 t -65.62 -21.59 66.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.879 179.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.694 ' C ' HD23 ' A' ' 18' ' ' LEU . 7.9 tt -79.78 -41.5 26.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.398 -0.814 . . . . 0.0 110.048 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.489 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 16.3 m-85 -69.27 -42.09 75.99 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.344 -0.847 . . . . 0.0 110.385 -179.525 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -78.3 100.97 6.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.427 -0.795 . . . . 0.0 110.131 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -101.43 -20.73 15.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 110.491 -179.636 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.408 ' OD1' ' OE2' ' A' ' 31' ' ' GLU . 8.3 p-10 -86.25 -32.45 21.12 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.151 -0.968 . . . . 0.0 110.748 -179.478 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.36 79.81 1.47 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 39.3 p-10 -146.09 -22.86 0.45 Allowed 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.223 -1.163 . . . . 0.0 111.898 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.529 ' C ' HG23 ' A' ' 26' ' ' THR . . . 90.24 22.99 33.23 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.529 HG23 ' C ' ' A' ' 25' ' ' GLY . 71.1 p -152.68 132.34 13.11 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.215 -1.168 . . . . 0.0 110.177 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 55.7 mt -95.55 111.91 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 110.114 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.589 HG23 ' H ' ' A' ' 30' ' ' LYS . 10.6 t -106.62 -173.68 2.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.463 -0.773 . . . . 0.0 109.767 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.673 HG22 HD12 ' A' ' 52' ' ' ILE . 40.7 p -70.98 -22.45 62.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.142 -0.974 . . . . 0.0 110.408 179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.589 ' H ' HG23 ' A' ' 28' ' ' THR . 19.8 mtmt -67.91 -60.13 2.75 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.269 -0.894 . . . . 0.0 110.138 179.669 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.408 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 79.6 mt-10 -59.7 -58.53 8.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.251 -0.905 . . . . 0.0 109.762 179.549 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.732 HD23 HD11 ' A' ' 48' ' ' LEU . 1.8 tp -52.28 -30.96 30.49 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.312 -0.868 . . . . 0.0 109.818 179.686 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.86 -49.14 81.17 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 92.1 m -70.57 -23.58 62.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.2 -1.176 . . . . 0.0 110.104 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.0 t -71.35 -33.54 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.408 -0.808 . . . . 0.0 110.186 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.404 ' O ' ' O ' ' A' ' 40' ' ' GLY . 23.2 mmt -90.81 -24.24 20.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.221 -0.924 . . . . 0.0 110.365 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -89.92 -15.46 32.02 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.124 -0.985 . . . . 0.0 110.313 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.553 ' HB3' HD12 ' A' ' 39' ' ' LEU . 37.4 t -97.19 -44.03 7.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.193 -0.942 . . . . 0.0 110.18 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.553 HD12 ' HB3' ' A' ' 38' ' ' SER . 3.5 mp -117.51 64.93 0.73 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.12 -0.987 . . . . 0.0 110.054 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 36' ' ' MET . . . 127.92 58.89 0.12 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.407 ' OE1' ' N ' ' A' ' 42' ' ' ASN . 0.7 OUTLIER -58.66 132.95 55.37 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.316 -1.108 . . . . 0.0 110.695 -179.733 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.533 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.3 m-80 179.29 -59.96 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.4 -0.812 . . . . 0.0 110.001 179.726 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 46.2 Cg_endo -72.23 -163.84 0.16 Allowed 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.749 1.394 . . . . 0.0 110.252 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.632 HG23 ' N ' ' A' ' 45' ' ' GLU . 14.1 t -152.91 -136.52 0.06 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.593 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.632 ' N ' HG23 ' A' ' 44' ' ' THR . 30.8 mt-10 -101.5 -40.18 7.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.733 -1.229 . . . . 0.0 109.796 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.47 -67.11 0.66 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.884 . . . . 0.0 109.586 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -49.01 -44.09 40.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.308 -0.87 . . . . 0.0 109.468 179.321 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.732 HD11 HD23 ' A' ' 32' ' ' LEU . 5.7 tt -55.35 -46.31 76.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.425 -0.797 . . . . 0.0 109.459 179.206 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.527 ' N ' HD23 ' A' ' 48' ' ' LEU . 43.5 tt0 -51.01 -41.87 60.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.299 -0.876 . . . . 0.0 109.361 179.306 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.447 ' HA ' ' OD1' ' A' ' 53' ' ' ASN . 33.9 t70 -62.48 -43.33 99.08 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.459 -0.776 . . . . 0.0 109.63 179.344 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.432 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 21.5 ttp -61.18 -22.83 65.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.308 -0.87 . . . . 0.0 109.713 179.629 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.673 HD12 HG22 ' A' ' 29' ' ' THR . 37.0 mt -84.13 -26.65 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -0.859 . . . . 0.0 109.863 179.635 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.447 ' OD1' ' HA ' ' A' ' 50' ' ' ASP . 33.3 m120 -65.22 -19.7 66.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.174 -0.954 . . . . 0.0 110.441 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -84.33 -23.84 30.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 110.037 179.763 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.581 ' CG1' HD11 ' A' ' 63' ' ' ILE . 85.1 t -93.0 -63.74 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.335 -0.853 . . . . 0.0 109.69 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -55.22 113.07 1.24 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.376 -0.828 . . . . 0.0 110.378 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -101.82 45.45 0.97 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.36 -0.837 . . . . 0.0 109.928 179.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.59 -47.41 1.56 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.351 -0.843 . . . . 0.0 110.395 -179.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.31 38.56 2.42 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.607 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.446 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 18.6 p-10 -125.38 -19.16 5.12 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.171 -1.194 . . . . 0.0 110.66 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.508 ' C ' HG23 ' A' ' 62' ' ' THR . . . 102.22 4.58 50.4 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.718 -1.229 . . . . 0.0 111.27 178.559 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.508 HG23 ' C ' ' A' ' 61' ' ' GLY . 47.5 p -149.87 152.36 34.97 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.557 -1.555 . . . . 0.0 110.833 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.581 HD11 ' CG1' ' A' ' 55' ' ' VAL . 72.7 mt -100.6 130.94 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.339 -0.851 . . . . 0.0 109.987 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.456 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -77.35 -169.06 1.28 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.137 -0.977 . . . . 0.0 110.327 -179.927 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.56 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 4.1 t80 -80.14 -44.27 1.44 Allowed Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.221 -0.924 . . . . 0.0 111.294 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.3 Cg_endo -74.09 -27.01 12.27 Favored 'Trans proline' 0 C--N 1.322 -0.838 0 O-C-N 123.138 1.073 . . . . 0.0 109.984 -179.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -73.01 -30.81 64.05 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.355 -0.841 . . . . 0.0 108.811 179.197 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.525 ' CE2' ' HB2' ' A' ' 16' ' ' PHE . 84.9 t80 -72.01 -45.18 61.87 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.54 0.686 . . . . 0.0 109.618 179.271 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.545 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 9.1 tp -77.54 -15.41 59.28 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.367 -0.833 . . . . 0.0 109.719 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.5 m -86.87 -22.52 25.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 110.216 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.481 ' HE2' ' HE3' ' A' ' 72' ' ' MET . 9.2 ptt? -90.61 -37.46 13.78 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.958 -1.089 . . . . 0.0 110.237 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.481 ' HE3' ' HE2' ' A' ' 71' ' ' MET . 59.8 mtt -90.15 -65.62 1.0 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.259 -0.901 . . . . 0.0 111.443 -179.208 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.498 1.951 0 O-C-N 121.467 -0.771 . . . . 0.0 111.708 -178.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 121.213 0.53 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.1 mt -50.39 -43.89 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.206 -0.934 . . . . 0.0 110.577 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -57.23 -43.17 82.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.91 . . . . 0.0 110.609 -179.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -63.5 -37.41 87.2 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.303 -0.873 . . . . 0.0 111.305 -179.378 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.707 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -64.55 -60.01 3.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.106 -0.996 . . . . 0.0 110.593 -179.421 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -51.36 -34.31 33.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.23 -0.918 . . . . 0.0 110.615 -179.492 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -45.36 88.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.106 -0.996 . . . . 0.0 110.557 -179.669 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.707 HG22 ' O ' ' A' ' 88' ' ' ALA . 33.0 m -77.38 -14.7 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.051 -1.031 . . . . 0.0 110.538 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.684 ' HE2' ' HB1' ' A' ' 88' ' ' ALA . 22.4 m-85 -93.82 -13.96 26.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.195 -0.941 . . . . 0.0 110.406 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -107.46 59.24 0.62 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.932 . . . . 0.0 109.837 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -63.54 -43.86 95.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.376 -0.827 . . . . 0.0 110.646 -179.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.429 ' OD2' ' HB3' ' A' ' 97' ' ' ASN . 18.1 p-10 -69.04 -26.8 65.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.194 -0.941 . . . . 0.0 110.106 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.18 8.33 71.98 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.168 178.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.429 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 20.6 p-10 -62.5 -30.09 71.02 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.599 -1.53 . . . . 0.0 110.105 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.497 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 107.69 7.73 31.31 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.497 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 30.1 m-85 -140.49 163.27 33.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.124 -1.221 . . . . 0.0 109.874 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.461 ' CD1' ' CD1' ' A' ' 141' ' ' PHE . 40.0 mt -100.08 129.31 50.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.198 -0.939 . . . . 0.0 109.876 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.6 t -110.37 147.21 34.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.445 -0.784 . . . . 0.0 109.721 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -51.26 -45.36 62.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.121 -0.987 . . . . 0.0 110.248 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -49.88 -55.52 14.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.154 -0.966 . . . . 0.0 110.293 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -61.35 -30.63 70.64 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.174 -0.954 . . . . 0.0 110.592 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.755 HD23 HG13 ' A' ' 121' ' ' VAL . 21.7 tp -58.42 -44.01 88.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.26 -0.9 . . . . 0.0 110.285 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.08 -28.04 48.69 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.322 -0.861 . . . . 0.0 110.192 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -70.34 -19.46 63.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.2 -0.937 . . . . 0.0 110.151 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 70.2 t -101.78 -26.63 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.153 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.657 ' HB3' HD13 ' A' ' 116' ' ' LEU . 23.0 mmt -77.89 -24.57 48.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.159 -0.963 . . . . 0.0 110.248 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.6 m -90.61 -15.38 30.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -0.923 . . . . 0.0 110.431 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -90.21 -43.41 10.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.093 -1.004 . . . . 0.0 110.463 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 46.8 mt -59.83 -45.28 92.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 109.975 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 136.66 50.18 0.07 OUTLIER Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.451 ' HB3' HD11 ' A' ' 116' ' ' LEU . 65.6 mm-40 -136.94 126.91 25.88 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.208 -1.172 . . . . 0.0 110.095 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.36 112.98 25.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.2 -0.937 . . . . 0.0 110.448 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.657 HD13 ' HB3' ' A' ' 109' ' ' MET . 3.5 mp -127.67 -169.5 2.06 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.342 -0.849 . . . . 0.0 109.905 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.2 t -144.53 164.9 29.53 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.144 -0.972 . . . . 0.0 110.607 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -53.81 -28.79 37.37 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.393 -0.817 . . . . 0.0 111.004 -179.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.29 -51.54 43.77 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.145 -0.972 . . . . 0.0 110.957 -179.317 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -64.1 -51.58 63.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.189 -0.945 . . . . 0.0 110.782 -179.426 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.755 HG13 HD23 ' A' ' 105' ' ' LEU . 77.9 t -57.19 -45.89 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.236 -0.915 . . . . 0.0 110.728 -179.373 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -58.82 -53.56 57.03 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.061 -1.024 . . . . 0.0 110.505 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -62.64 -22.96 66.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -0.931 . . . . 0.0 110.418 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 5.8 mmm -71.56 -49.66 38.49 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.153 -0.967 . . . . 0.0 110.113 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 23.6 mm -69.4 -28.53 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.193 -0.942 . . . . 0.0 109.953 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -70.63 -43.36 69.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.964 . . . . 0.0 109.983 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -71.16 -27.59 63.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.211 -0.931 . . . . 0.0 109.816 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -78.29 -25.2 46.57 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.341 -0.849 . . . . 0.0 109.769 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -74.83 86.61 2.23 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.303 -0.873 . . . . 0.0 110.201 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 70.5 mt -69.08 -48.13 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.282 -0.886 . . . . 0.0 110.433 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 3.0 p30 -73.77 -21.97 60.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.229 -0.92 . . . . 0.0 110.278 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 68.79 68.15 1.74 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 36.8 p30 -118.35 -16.92 9.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.438 -1.037 . . . . 0.0 111.032 -179.309 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.466 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 124.71 -46.8 1.06 Allowed Glycine 0 N--CA 1.498 2.779 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.406 ' O ' ' OE1' ' A' ' 135' ' ' GLN . 0.0 OUTLIER -119.31 170.57 9.0 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.242 -1.152 . . . . 0.0 109.909 179.846 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.424 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 75.6 t -103.3 151.61 6.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.041 -1.037 . . . . 0.0 110.672 -179.345 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.494 ' OD1' ' CD1' ' A' ' 99' ' ' TYR . 72.6 m-20 -122.73 -172.74 2.54 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.494 -0.754 . . . . 0.0 109.82 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.722 ' O ' HG23 ' A' ' 142' ' ' VAL . 3.9 t80 -72.93 -19.91 61.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.195 -0.941 . . . . 0.0 109.727 179.595 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.41 -56.58 4.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.136 -0.978 . . . . 0.0 109.837 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -64.76 -25.37 67.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.146 -0.971 . . . . 0.0 109.691 179.561 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.493 ' CE2' ' HE3' ' A' ' 145' ' ' MET . 19.1 t80 -75.29 -29.16 60.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.399 -0.813 . . . . 0.0 109.967 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 138' ' ' TYR . 70.5 t -84.83 -27.85 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.233 -0.917 . . . . 0.0 110.27 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.83 -34.15 34.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.837 . . . . 0.0 110.646 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -82.6 -25.54 33.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 110.47 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.493 ' HE3' ' CE2' ' A' ' 141' ' ' PHE . 26.0 ttm -89.86 -57.36 2.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.277 -0.889 . . . . 0.0 110.104 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.5 2.051 0 O-C-N 121.427 -0.796 . . . . 0.0 110.924 179.826 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.305 0.574 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.417 ' OE1' ' CA ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -52.65 -35.65 55.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 110.775 -179.594 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -56.57 -54.05 50.46 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.06 -1.025 . . . . 0.0 109.817 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 78.8 mt -58.95 -34.2 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.658 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.75 -28.07 67.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.256 -0.902 . . . . 0.0 110.073 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -72.45 -53.51 11.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.337 -0.852 . . . . 0.0 109.725 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -56.37 -45.7 80.39 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.327 -0.858 . . . . 0.0 109.819 179.616 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.85 -41.37 74.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 109.758 179.433 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -54.44 -52.53 61.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.402 -0.811 . . . . 0.0 109.953 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.23 -50.09 62.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.38 -0.825 . . . . 0.0 110.253 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -51.26 -45.56 62.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.186 -0.946 . . . . 0.0 109.828 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.9 m -55.14 -41.95 72.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.241 -0.912 . . . . 0.0 109.761 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.718 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.1 tt -59.0 -34.32 71.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.375 -0.828 . . . . 0.0 109.647 179.575 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.622 ' CZ ' HG11 ' A' ' 35' ' ' VAL . 10.5 m-85 -74.5 -69.97 0.43 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.325 -0.859 . . . . 0.0 110.541 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.28 91.49 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.367 -0.833 . . . . 0.0 110.089 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 19' ' ' PHE . 2.3 mttm -81.42 -28.29 34.33 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.341 -0.849 . . . . 0.0 109.943 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.403 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 5.0 p30 -104.89 -9.81 17.74 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.282 -0.886 . . . . 0.0 110.487 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 61.56 63.23 5.01 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -92.02 -15.68 27.53 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.184 -1.186 . . . . 0.0 110.012 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.551 ' C ' HG23 ' A' ' 26' ' ' THR . . . 114.88 -9.85 21.16 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.551 HG23 ' C ' ' A' ' 25' ' ' GLY . 82.3 p -156.07 169.8 23.64 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.161 -1.199 . . . . 0.0 110.497 -179.818 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.4 mt -105.14 125.39 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.44 -0.788 . . . . 0.0 109.49 179.229 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 49.3 p -110.45 -171.98 1.94 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.198 -0.938 . . . . 0.0 110.437 -179.547 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.61 HG21 ' HG2' ' A' ' 49' ' ' GLN . 55.3 p -79.05 -25.49 43.18 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.328 -0.857 . . . . 0.0 110.422 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -70.26 -56.81 5.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.29 -0.881 . . . . 0.0 109.766 179.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.403 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 88.8 mt-10 -59.43 -48.34 82.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.311 -0.868 . . . . 0.0 109.318 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.068 HD22 HD11 ' A' ' 52' ' ' ILE . 1.3 tp -61.94 -26.73 68.37 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.468 -0.77 . . . . 0.0 109.426 179.428 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.52 -44.38 97.67 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.545 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.3 m -71.3 -27.2 63.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -1.116 . . . . 0.0 109.938 179.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.622 HG11 ' CZ ' ' A' ' 19' ' ' PHE . 8.1 t -67.05 -38.7 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.291 -0.88 . . . . 0.0 109.99 179.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 20.8 mmt -89.56 -20.15 24.13 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.069 -1.019 . . . . 0.0 110.37 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -90.25 -13.28 35.72 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.22 -0.925 . . . . 0.0 110.721 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.664 ' OG ' HD23 ' A' ' 39' ' ' LEU . 14.9 p -65.59 -59.55 3.84 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.219 -0.925 . . . . 0.0 110.463 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.664 HD23 ' OG ' ' A' ' 38' ' ' SER . 0.5 OUTLIER -132.85 47.25 2.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.098 -1.001 . . . . 0.0 110.125 179.975 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -166.98 43.69 0.25 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.44 ' OE1' ' N ' ' A' ' 42' ' ' ASN . 0.9 OUTLIER -49.38 115.08 1.19 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.217 -1.166 . . . . 0.0 110.162 -179.818 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.501 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 0.6 OUTLIER -174.81 -61.75 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.402 -0.811 . . . . 0.0 109.931 179.743 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.501 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 43.4 Cg_endo -70.67 165.73 31.05 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.549 1.289 . . . . 0.0 110.266 179.453 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.484 HG22 ' H ' ' A' ' 45' ' ' GLU . 0.8 OUTLIER -119.93 -146.87 0.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.158 -0.964 . . . . 0.0 109.782 179.913 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.484 ' H ' HG22 ' A' ' 44' ' ' THR . 20.9 pt-20 -92.37 -41.34 10.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.133 -0.98 . . . . 0.0 109.694 179.54 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.469 ' N ' ' HG3' ' A' ' 45' ' ' GLU . . . -71.12 -60.72 2.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.292 -0.88 . . . . 0.0 110.051 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -49.05 -30.5 6.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.068 -1.02 . . . . 0.0 109.477 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.592 HD11 HD23 ' A' ' 32' ' ' LEU . 8.0 tt -65.2 -52.19 56.36 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.556 -0.715 . . . . 0.0 109.5 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.61 ' HG2' HG21 ' A' ' 29' ' ' THR . 70.3 mt-30 -49.67 -39.04 35.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.943 . . . . 0.0 109.356 179.242 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.88 -46.22 91.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.429 -0.794 . . . . 0.0 109.703 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.415 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 18.0 ttp -65.2 -17.92 64.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.903 . . . . 0.0 109.738 179.527 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.068 HD11 HD22 ' A' ' 32' ' ' LEU . 36.3 mm -85.84 -28.75 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.395 -0.815 . . . . 0.0 110.133 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -62.54 -41.89 99.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.259 -0.901 . . . . 0.0 110.244 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.608 ' HG3' HG23 ' A' ' 55' ' ' VAL . 12.0 pt-20 -67.8 -24.44 65.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.273 -0.892 . . . . 0.0 109.898 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.896 HG13 ' SD ' ' A' ' 71' ' ' MET . 74.0 t -92.65 -7.26 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.293 -0.879 . . . . 0.0 110.297 179.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.461 ' OD2' ' CA ' ' A' ' 61' ' ' GLY . 22.8 t0 -113.21 98.73 7.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.028 -1.045 . . . . 0.0 110.853 -179.564 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.91 25.53 9.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 0.0 109.146 178.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.413 ' OD2' ' OD1' ' A' ' 60' ' ' ASN . 8.8 t70 -98.55 -49.1 4.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.602 -0.686 . . . . 0.0 110.419 -179.705 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.47 -26.55 5.45 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.434 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 16.5 p-10 -70.46 -33.84 71.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.032 -1.276 . . . . 0.0 110.339 -179.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.461 ' CA ' ' OD2' ' A' ' 56' ' ' ASP . . . 119.38 -61.24 0.49 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.434 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 81.7 p -70.09 165.38 22.08 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.302 -1.117 . . . . 0.0 110.254 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.471 HG12 HG12 ' A' ' 55' ' ' VAL . 9.9 mt -100.21 157.71 3.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.272 -0.893 . . . . 0.0 109.768 179.629 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.439 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 46.0 m-20 -111.7 -169.96 1.56 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.512 -179.538 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.575 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 9.8 t80 -78.19 -44.86 2.21 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.256 -0.902 . . . . 0.0 111.44 -179.549 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.3 Cg_endo -71.64 -17.66 29.56 Favored 'Trans proline' 0 C--O 1.205 -1.14 0 O-C-N 123.127 1.067 . . . . 0.0 110.252 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -84.71 -30.91 24.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.185 -0.947 . . . . 0.0 109.372 179.123 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 9.0 t80 -71.45 -49.21 43.74 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.591 -0.693 . . . . 0.0 110.231 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.834 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 0.6 OUTLIER -76.64 -29.7 56.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.197 -0.939 . . . . 0.0 110.725 -179.661 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 66' ' ' PRO . 54.8 m -78.51 -19.57 52.68 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.774 -1.204 . . . . 0.0 110.334 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.896 ' SD ' HG13 ' A' ' 55' ' ' VAL . 61.1 ttp -86.34 -49.8 7.39 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.135 -0.978 . . . . 0.0 110.573 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.446 ' HE2' ' CE ' ' A' ' 71' ' ' MET . 38.2 mtt -83.1 -59.69 2.39 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.223 -0.923 . . . . 0.0 110.786 -179.43 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.834 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.497 1.896 0 O-C-N 121.046 -1.034 . . . . 0.0 110.558 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.258 0.552 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.9 mm -51.99 -46.27 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 110.451 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -62.43 -44.43 96.45 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.125 -0.984 . . . . 0.0 109.868 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -54.24 -37.14 64.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.352 -0.843 . . . . 0.0 110.118 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.792 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -68.28 -63.91 0.97 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.305 -0.872 . . . . 0.0 110.438 -179.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -45.33 -27.73 0.72 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.239 -0.913 . . . . 0.0 110.612 -179.647 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.82 -54.6 9.63 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.23 -0.919 . . . . 0.0 110.408 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.792 HG22 ' O ' ' A' ' 88' ' ' ALA . 33.9 m -61.85 -21.22 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.23 -0.919 . . . . 0.0 110.26 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.643 ' CE1' HG11 ' A' ' 108' ' ' VAL . 46.5 m-85 -93.23 -16.27 24.98 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.243 -0.911 . . . . 0.0 110.313 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.424 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 49.3 t0 -124.94 67.12 1.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.862 . . . . 0.0 109.863 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -95.22 2.06 54.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 110.855 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 2.7 p30 -95.81 -13.21 24.23 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.094 -1.004 . . . . 0.0 110.347 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.36 36.18 8.28 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.451 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 6.4 t-20 -93.25 -61.39 1.58 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.22 -1.165 . . . . 0.0 110.183 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.479 ' C ' ' CD1' ' A' ' 99' ' ' TYR . . . 128.59 -14.4 6.1 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 33.6 m-85 -136.73 146.91 46.38 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.129 -1.218 . . . . 0.0 110.225 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 100' ' ' ILE . 39.8 mt -74.71 143.37 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.173 -0.954 . . . . 0.0 110.403 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.5 p -129.2 158.93 37.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.369 -0.832 . . . . 0.0 109.748 179.617 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.88 -25.14 56.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.148 -0.97 . . . . 0.0 110.545 -179.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.12 -64.5 1.04 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.181 -0.949 . . . . 0.0 110.507 -179.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.566 ' O ' HG23 ' A' ' 108' ' ' VAL . 41.3 mt-10 -48.95 -40.95 32.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.231 -0.918 . . . . 0.0 110.068 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.46 ' O ' HD23 ' A' ' 105' ' ' LEU . 6.4 tt -63.74 -40.12 95.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.0 110.156 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.753 ' O ' HG23 ' A' ' 110' ' ' THR . 2.5 tpm_? -58.71 -35.37 72.56 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.206 -0.934 . . . . 0.0 109.982 179.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.4 ' O ' ' OG1' ' A' ' 110' ' ' THR . 73.6 m-70 -77.32 -24.85 50.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.87 . . . . 0.0 110.619 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.643 HG11 ' CE1' ' A' ' 92' ' ' PHE . 90.4 t -77.16 -37.98 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.131 -0.98 . . . . 0.0 110.545 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.768 ' HA ' HD12 ' A' ' 112' ' ' LEU . 24.7 mmt -72.66 -26.07 61.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.23 -0.918 . . . . 0.0 110.562 -179.52 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.753 HG23 ' O ' ' A' ' 106' ' ' ARG . 39.4 p -64.6 -45.22 87.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.164 -0.96 . . . . 0.0 110.125 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -72.19 -42.9 65.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.19 -0.944 . . . . 0.0 110.021 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.768 HD12 ' HA ' ' A' ' 109' ' ' MET . 39.7 mt -47.0 -25.85 0.89 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.255 -0.903 . . . . 0.0 110.403 179.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.2 43.96 3.64 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -132.95 136.28 46.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.29 -1.124 . . . . 0.0 110.033 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.01 109.11 21.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.241 -0.912 . . . . 0.0 110.618 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.7 mp -123.69 -177.94 3.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.345 -0.847 . . . . 0.0 109.745 179.507 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 57.8 m -129.03 155.53 45.26 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.122 -0.986 . . . . 0.0 110.256 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.419 ' O ' ' OD2' ' A' ' 122' ' ' ASP . 36.8 m-20 -49.07 -40.82 33.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.253 -0.905 . . . . 0.0 110.05 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -61.36 -50.74 71.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.231 -0.918 . . . . 0.0 110.268 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 123' ' ' GLU . 6.0 mm-40 -52.82 -48.01 67.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.298 -0.876 . . . . 0.0 110.331 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 75.3 t -54.52 -50.31 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.192 -0.942 . . . . 0.0 110.255 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 118' ' ' ASP . 61.4 m-20 -53.61 -34.77 59.61 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 110.191 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -62.88 -47.62 82.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.194 -0.941 . . . . 0.0 109.971 179.957 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.43 ' HB3' ' HE2' ' A' ' 124' ' ' MET . 60.4 mtp -63.13 -59.08 5.26 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.29 -0.881 . . . . 0.0 110.226 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.7 mm -50.89 -24.56 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.314 -0.866 . . . . 0.0 110.429 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -77.14 -49.15 15.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.207 -0.933 . . . . 0.0 110.071 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -63.02 -19.74 64.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -0.936 . . . . 0.0 110.017 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.467 ' HB2' ' SD ' ' A' ' 144' ' ' MET . . . -87.73 -40.98 13.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.358 -0.839 . . . . 0.0 110.088 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -64.54 88.07 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.297 -0.877 . . . . 0.0 110.243 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 43.4 mt -63.28 -57.16 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.305 -0.872 . . . . 0.0 110.304 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.8 p30 -63.3 -30.43 71.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.193 -0.942 . . . . 0.0 110.167 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.446 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 72.35 68.65 1.55 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.421 ' OD1' ' HG2' ' A' ' 135' ' ' GLN . 2.9 p30 -116.42 -25.98 7.29 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.21 -1.171 . . . . 0.0 110.538 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 137.83 -6.42 3.48 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.28 179.822 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.439 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 2.6 pt20 -150.63 160.46 43.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.988 -1.301 . . . . 0.0 110.324 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 66.4 t -105.61 137.61 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 109.995 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.4 ' ND2' ' HB2' ' A' ' 139' ' ' GLU . 6.7 p-10 -108.12 -170.26 1.65 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.056 -1.028 . . . . 0.0 110.279 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.583 ' CE1' HG21 ' A' ' 142' ' ' VAL . 11.2 t80 -66.56 -62.66 1.34 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.355 -0.841 . . . . 0.0 111.201 -179.063 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.4 ' HB2' ' ND2' ' A' ' 137' ' ' ASN . 32.8 mt-10 -44.9 -48.81 11.22 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.195 -0.941 . . . . 0.0 111.614 -179.106 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -58.84 -47.62 84.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.031 -1.043 . . . . 0.0 110.796 -179.174 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -64.58 -23.18 67.18 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 110.643 -179.698 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.583 HG21 ' CE1' ' A' ' 138' ' ' TYR . 76.5 t -90.63 -20.25 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.19 -0.944 . . . . 0.0 111.146 -179.533 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -89.36 -24.77 21.88 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.114 -0.991 . . . . 0.0 110.899 -179.105 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.467 ' SD ' ' HB2' ' A' ' 128' ' ' ALA . 20.4 ptt? -88.86 -31.81 18.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.021 -1.049 . . . . 0.0 110.442 -179.932 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.432 ' N ' ' HG3' ' A' ' 144' ' ' MET . 18.8 tpp -86.48 -9.49 56.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.215 -0.928 . . . . 0.0 110.3 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 142' ' ' VAL . 12.0 t . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.16 -0.962 . . . . 0.0 110.681 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.192 0.52 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.66 -36.24 34.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.167 -0.958 . . . . 0.0 109.912 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.82 -47.19 86.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -0.86 . . . . 0.0 109.706 179.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.5 mm -61.24 -39.38 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.517 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.29 -33.65 75.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.411 -0.806 . . . . 0.0 109.869 179.469 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.26 -53.08 54.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.673 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -53.1 -36.69 60.99 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.132 -0.98 . . . . 0.0 109.172 179.224 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -65.63 -37.45 86.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.546 -0.721 . . . . 0.0 109.651 179.266 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -57.23 -47.12 82.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.459 -0.776 . . . . 0.0 109.967 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.18 -54.58 44.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.145 -0.972 . . . . 0.0 110.22 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -47.01 -48.53 21.85 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.241 -0.912 . . . . 0.0 110.331 179.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.7 m -60.71 -37.77 82.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.421 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.87 ' O ' HD23 ' A' ' 18' ' ' LEU . 6.8 tt -65.16 -22.74 66.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 110.026 -179.861 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -90.72 -69.32 0.74 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.308 -0.87 . . . . 0.0 110.028 179.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -56.69 120.48 7.88 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.117 -0.989 . . . . 0.0 109.585 179.716 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.6 mttt -110.33 -29.76 7.99 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.034 -1.041 . . . . 0.0 111.844 -178.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.436 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 10.4 p-10 -68.61 -44.91 73.28 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.801 -1.187 . . . . 0.0 110.144 -179.416 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.42 27.04 3.75 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.798 -1.192 . . . . 0.0 110.613 178.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.436 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 8.3 p-10 -95.69 -43.62 7.82 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.989 -1.3 . . . . 0.0 110.27 179.57 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.26 31.14 2.91 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.39 179.351 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.0 p -146.89 135.25 21.8 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.952 -1.323 . . . . 0.0 110.098 179.466 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 80.4 mt -106.53 98.91 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.345 -0.847 . . . . 0.0 110.034 179.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.802 HG23 HG22 ' A' ' 62' ' ' THR . 1.0 OUTLIER -81.83 -164.78 0.84 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.883 . . . . 0.0 110.064 -179.925 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.628 ' H ' HG22 ' A' ' 28' ' ' THR . 5.1 p -83.76 -41.57 17.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.102 -0.999 . . . . 0.0 110.586 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.515 ' HG3' ' N ' ' A' ' 31' ' ' GLU . 6.3 ptpt -69.68 -41.63 75.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.937 -1.102 . . . . 0.0 109.414 179.664 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.515 ' N ' ' HG3' ' A' ' 30' ' ' LYS . 60.1 mt-10 -61.78 -45.0 95.77 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.143 -0.973 . . . . 0.0 108.717 178.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.831 HD23 HD11 ' A' ' 48' ' ' LEU . 2.0 tp -64.21 -29.21 70.33 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.096 -0.641 . . . . 0.0 109.294 179.219 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.96 -40.2 96.61 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 179.292 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.5 m -69.74 -41.99 74.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.489 -1.006 . . . . 0.0 109.948 179.427 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.0 t -57.93 -34.2 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.298 -0.876 . . . . 0.0 109.994 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.3 mmt -89.73 -18.41 26.44 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.358 -0.839 . . . . 0.0 109.815 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -88.29 -13.31 41.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.389 -0.82 . . . . 0.0 110.578 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.409 ' HB3' HD23 ' A' ' 39' ' ' LEU . 44.0 t -68.2 -12.91 61.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.954 -1.091 . . . . 0.0 109.946 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.446 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 0.7 OUTLIER -169.21 88.2 0.18 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.173 -0.954 . . . . 0.0 110.207 -179.987 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.75 -52.0 0.84 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 51.56 31.85 8.2 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.22 -1.165 . . . . 0.0 109.972 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.495 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -76.5 -55.4 1.64 Allowed Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.412 -0.805 . . . . 0.0 110.957 -179.768 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 42' ' ' ASN . 45.1 Cg_endo -73.99 135.23 20.83 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.77 1.405 . . . . 0.0 110.534 -179.611 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.451 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 29.1 p -102.25 -130.75 0.26 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.308 -0.87 . . . . 0.0 109.569 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -100.88 -33.89 10.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.804 -1.185 . . . . 0.0 109.95 179.649 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.65 -66.23 0.77 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.337 -0.852 . . . . 0.0 110.077 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -51.21 -32.0 22.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 109.659 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.831 HD11 HD23 ' A' ' 32' ' ' LEU . 9.4 tt -64.26 -53.1 54.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.322 -0.861 . . . . 0.0 109.988 179.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -51.39 -39.0 56.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 109.827 179.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -66.03 -37.04 84.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.243 -0.911 . . . . 0.0 109.639 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.9 ttp -69.85 -20.08 63.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.323 -0.861 . . . . 0.0 109.735 179.57 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.83 HD11 HD22 ' A' ' 32' ' ' LEU . 32.7 mm -86.6 -24.65 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.391 -0.818 . . . . 0.0 109.899 179.644 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -70.58 -37.36 73.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.259 -0.901 . . . . 0.0 110.259 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.82 -19.36 48.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 110.485 -179.761 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.561 ' CG1' HD11 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -99.76 -14.09 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.098 -1.001 . . . . 0.0 110.11 -179.615 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 2.8 t70 -84.3 128.06 34.35 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.179 -0.951 . . . . 0.0 110.203 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -96.58 -12.86 23.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.202 -0.936 . . . . 0.0 110.402 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.402 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 61.1 m-20 -97.5 -73.46 0.61 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.124 -0.985 . . . . 0.0 110.486 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.429 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 134.94 41.49 0.14 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 62' ' ' THR . 16.6 p30 -116.02 -16.68 11.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.339 -1.094 . . . . 0.0 110.293 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.663 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 106.87 -40.99 2.3 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.802 HG22 HG23 ' A' ' 28' ' ' THR . 69.1 p -98.54 162.45 13.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.147 -1.207 . . . . 0.0 110.517 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.561 HD11 ' CG1' ' A' ' 55' ' ' VAL . 70.0 mt -115.04 144.87 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.4 -0.813 . . . . 0.0 110.081 179.817 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -101.69 -165.28 1.18 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.988 -1.07 . . . . 0.0 110.137 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.543 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 27.2 t80 -77.52 -44.32 2.56 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 111.276 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.0 Cg_endo -74.25 -27.86 11.15 Favored 'Trans proline' 0 C--N 1.324 -0.761 0 O-C-N 123.112 1.059 . . . . 0.0 110.02 -179.627 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.402 ' OE1' ' OD2' ' A' ' 58' ' ' ASP . 45.9 tt0 -77.21 -22.98 51.49 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.356 -0.84 . . . . 0.0 109.236 179.253 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.435 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 14.2 t80 -77.9 -44.5 26.87 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.506 -0.746 . . . . 0.0 110.252 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.4 -26.51 61.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 110.32 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 88.2 m -80.9 -29.76 35.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 0.0 110.497 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.423 ' HG2' ' O ' ' A' ' 68' ' ' PHE . 6.7 ptt? -86.13 -24.6 26.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.036 -1.04 . . . . 0.0 110.386 -179.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 68' ' ' PHE . 19.2 mmt -83.03 -27.53 30.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.281 -0.887 . . . . 0.0 110.403 -179.716 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.917 . . . . 0.0 110.778 -179.51 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.929 0 CA-C-O 121.177 0.513 . . . . 0.0 110.473 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.857 HG23 ' CE1' ' A' ' 141' ' ' PHE . 54.8 mt -57.54 -52.45 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.181 -0.949 . . . . 0.0 110.526 -179.632 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.0 ttm-85 -56.87 -50.55 72.11 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.221 -0.924 . . . . 0.0 110.378 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -54.01 -36.56 63.12 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.223 -0.923 . . . . 0.0 110.412 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.561 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -61.28 -63.93 1.12 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.195 -0.94 . . . . 0.0 110.163 -179.697 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.502 ' CE1' HD11 ' A' ' 100' ' ' ILE . 1.1 t80 -45.76 -33.32 2.97 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.435 -0.79 . . . . 0.0 110.485 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.4 ttt85 -63.98 -45.86 87.15 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.31 -0.869 . . . . 0.0 110.77 -179.709 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 88' ' ' ALA . 32.4 m -84.47 -9.53 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.112 -0.992 . . . . 0.0 111.416 -179.296 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.712 ' HA ' HG21 ' A' ' 108' ' ' VAL . 21.9 m-85 -97.0 -14.04 21.91 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.955 -1.09 . . . . 0.0 110.772 -179.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -116.19 59.39 0.73 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.041 -1.037 . . . . 0.0 110.256 179.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 91' ' ' VAL . 19.4 mttt -94.91 20.09 9.35 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.228 -0.92 . . . . 0.0 110.559 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.456 ' OD2' ' CB ' ' A' ' 97' ' ' ASN . 9.6 p-10 -114.07 -28.39 7.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.183 -0.948 . . . . 0.0 110.398 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.89 -26.67 12.15 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.456 ' CB ' ' OD2' ' A' ' 95' ' ' ASP . 25.5 t-20 -44.79 -28.93 0.7 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.37 -1.076 . . . . 0.0 110.521 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 90.9 -42.6 2.87 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.45 ' CG ' ' OE1' ' A' ' 135' ' ' GLN . 12.1 m-30 -93.3 170.7 9.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.239 -1.153 . . . . 0.0 110.504 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.502 HD11 ' CE1' ' A' ' 89' ' ' PHE . 18.0 mt -104.18 119.71 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.301 -0.874 . . . . 0.0 109.432 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.4 t -102.65 174.89 5.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.232 -0.917 . . . . 0.0 109.855 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.7 -45.02 63.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.035 -1.041 . . . . 0.0 109.909 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.5 -45.57 91.33 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.253 -0.904 . . . . 0.0 110.056 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.647 ' O ' HG23 ' A' ' 108' ' ' VAL . 48.4 mt-10 -61.93 -48.3 81.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.175 179.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.581 HD22 HG13 ' A' ' 121' ' ' VAL . 6.8 tt -53.7 -31.77 49.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 0.0 110.164 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.0 ttt-85 -73.07 -41.33 64.23 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.21 -0.932 . . . . 0.0 110.08 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -73.07 -11.29 60.5 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.297 -0.877 . . . . 0.0 110.503 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.712 HG21 ' HA ' ' A' ' 92' ' ' PHE . 92.9 t -92.93 -49.69 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.236 -0.915 . . . . 0.0 110.062 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.2 mmt -50.29 -45.16 54.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.413 -0.804 . . . . 0.0 110.435 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.8 p -52.79 -44.87 66.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.304 -0.872 . . . . 0.0 110.377 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -63.6 -43.43 96.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.126 -0.984 . . . . 0.0 110.023 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 13.6 mt -55.34 -40.7 71.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 110.123 179.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 125.83 45.65 0.24 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.594 ' OE1' HD11 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -156.54 146.53 21.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.25 -1.147 . . . . 0.0 110.045 179.98 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.475 ' C ' HD12 ' A' ' 116' ' ' LEU . 24.6 tttt -123.25 138.07 54.72 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.192 -0.943 . . . . 0.0 110.284 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.916 HD23 ' OE1' ' A' ' 120' ' ' GLU . 4.7 mp -139.9 -163.66 1.55 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.26 -0.9 . . . . 0.0 110.145 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.422 HG22 ' N ' ' A' ' 118' ' ' ASP . 57.4 m -120.08 164.46 16.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.228 -0.92 . . . . 0.0 110.236 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.422 ' N ' HG22 ' A' ' 117' ' ' THR . 0.9 OUTLIER -58.4 -34.39 70.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.29 -0.881 . . . . 0.0 110.411 179.942 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -56.25 -61.16 2.59 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.302 -0.874 . . . . 0.0 110.758 -179.677 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.916 ' OE1' HD23 ' A' ' 116' ' ' LEU . 96.0 mt-10 -52.18 -55.1 23.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.073 -1.017 . . . . 0.0 110.433 -179.654 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.581 HG13 HD22 ' A' ' 105' ' ' LEU . 95.4 t -54.24 -27.91 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.277 -0.889 . . . . 0.0 110.752 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -75.4 -40.36 57.98 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.107 -0.996 . . . . 0.0 110.196 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -74.91 -18.07 60.47 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.197 -0.94 . . . . 0.0 109.688 179.51 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.418 ' HG3' ' O ' ' A' ' 120' ' ' GLU . 96.3 mtp -78.06 -50.28 12.37 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 109.949 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 29.1 mm -65.03 -39.86 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.361 -0.837 . . . . 0.0 110.165 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -61.43 -55.86 26.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 110.255 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -57.79 -37.92 74.58 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.255 -0.903 . . . . 0.0 110.534 -179.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.527 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -70.53 -24.41 62.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 110.167 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -69.18 92.18 0.54 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.307 -0.87 . . . . 0.0 110.21 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 66.1 mt -75.68 -48.51 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.285 -0.884 . . . . 0.0 110.169 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.2 p30 -64.26 -30.37 71.42 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.348 -0.845 . . . . 0.0 110.188 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 87.66 52.63 2.94 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.653 179.198 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -117.64 -32.86 4.73 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.954 -1.321 . . . . 0.0 109.923 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 118.95 24.2 3.1 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.45 ' O ' ' NE2' ' A' ' 135' ' ' GLN . 3.6 pp0? -159.61 149.02 18.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.203 -1.174 . . . . 0.0 110.143 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.4 t -109.0 125.95 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.244 -0.91 . . . . 0.0 110.721 -179.584 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -97.51 -165.6 1.28 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.879 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.75 ' O ' HG23 ' A' ' 142' ' ' VAL . 47.9 t80 -68.06 -48.42 65.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.11 -0.994 . . . . 0.0 110.537 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -63.52 -45.55 90.09 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.121 -0.987 . . . . 0.0 110.602 -179.683 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.414 ' OE2' ' OD2' ' A' ' 131' ' ' ASP . 37.0 mt-10 -58.6 -38.34 77.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.261 -0.899 . . . . 0.0 110.501 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.857 ' CE1' HG23 ' A' ' 85' ' ' ILE . 6.5 t80 -72.39 -26.87 62.04 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.183 -0.948 . . . . 0.0 110.418 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 138' ' ' TYR . 87.6 t -76.66 -24.46 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.078 -1.014 . . . . 0.0 110.676 -179.423 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -87.39 -51.17 6.09 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.142 -0.974 . . . . 0.0 110.452 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.54 ' CE ' ' CD2' ' A' ' 141' ' ' PHE . 21.5 ptt? -56.41 -32.86 65.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.903 . . . . 0.0 110.701 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.518 ' HE3' ' CZ ' ' A' ' 141' ' ' PHE . 28.2 tpp -72.83 -54.24 9.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.15 -0.969 . . . . 0.0 110.538 -179.526 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 146' ' ' THR . 5.2 t . . . . . 0 N--CA 1.496 1.836 0 O-C-N 121.08 -1.013 . . . . 0.0 110.42 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.424 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 52.2 mt-10 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.363 0.602 . . . . 0.0 109.83 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -57.34 -48.74 78.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.199 -0.938 . . . . 0.0 110.028 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.483 ' HG3' ' N ' ' A' ' 9' ' ' ILE . 3.5 pt20 -52.03 -38.19 56.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.719 179.711 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.483 ' N ' ' HG3' ' A' ' 8' ' ' GLN . 34.6 mt -62.24 -44.47 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.328 -0.857 . . . . 0.0 109.516 179.41 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.61 -37.18 70.33 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.281 -0.887 . . . . 0.0 109.486 179.373 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -62.78 -45.42 92.73 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.325 -0.859 . . . . 0.0 109.499 179.391 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -61.36 -33.1 73.08 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.429 -0.794 . . . . 0.0 109.849 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt -61.57 -49.51 76.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -0.915 . . . . 0.0 109.583 179.62 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -57.69 -39.62 77.6 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.451 -0.781 . . . . 0.0 109.627 179.537 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.462 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -60.21 -43.25 96.14 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.257 -0.902 . . . . 0.0 109.794 179.676 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -59.32 -39.13 82.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.161 -0.962 . . . . 0.0 109.29 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.3 t -70.16 -25.4 63.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.822 . . . . 0.0 109.181 178.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.842 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.4 tm? -71.41 -29.12 64.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.471 -0.768 . . . . 0.0 109.551 179.45 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.515 ' HA ' HG21 ' A' ' 35' ' ' VAL . 20.8 m-85 -87.54 -64.59 1.12 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.401 -0.812 . . . . 0.0 109.972 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -85.44 74.43 10.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.348 -0.845 . . . . 0.0 109.799 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.417 ' CE ' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -99.02 47.64 0.97 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.279 -0.888 . . . . 0.0 110.414 -179.641 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.403 ' OD1' ' OD2' ' A' ' 24' ' ' ASP . 4.1 p30 -127.91 -5.02 5.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.169 -0.957 . . . . 0.0 110.583 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.47 48.68 5.21 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.403 ' OD2' ' OD1' ' A' ' 22' ' ' ASP . 13.6 m-20 -117.9 -72.69 0.68 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -1.131 . . . . 0.0 110.26 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.21 -10.52 4.43 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.6 p -132.33 150.26 52.19 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.136 -1.214 . . . . 0.0 110.364 -179.827 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 70.8 mt -97.12 131.62 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.222 -0.923 . . . . 0.0 110.241 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.8 t -120.72 -174.07 2.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.344 -0.847 . . . . 0.0 110.18 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.7 p -75.27 -31.84 60.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.223 -0.923 . . . . 0.0 110.692 -179.68 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -65.8 -59.76 3.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.116 -0.99 . . . . 0.0 109.805 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -57.21 -56.27 23.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.388 -0.82 . . . . 0.0 109.484 179.526 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.963 HD22 HD11 ' A' ' 52' ' ' ILE . 10.9 tp -57.22 -22.56 41.82 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.231 -0.918 . . . . 0.0 109.297 179.085 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.85 -42.62 96.91 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.8 m -69.21 -25.16 64.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.512 -0.993 . . . . 0.0 109.712 179.287 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.515 HG21 ' HA ' ' A' ' 19' ' ' PHE . 37.3 t -76.74 -33.43 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.415 -0.803 . . . . 0.0 110.956 -179.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.7 tpp -90.07 -23.48 21.41 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.921 -1.112 . . . . 0.0 110.898 -179.318 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.7 ttm-85 -90.91 -32.55 15.96 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.09 -1.006 . . . . 0.0 110.629 -179.752 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 71.1 m -79.94 -21.71 43.52 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.116 -0.99 . . . . 0.0 110.404 -179.752 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 mp -135.35 80.12 1.82 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 110.438 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.89 -54.06 0.52 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 50.48 74.25 0.23 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.214 -1.168 . . . . 0.0 109.871 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.524 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 2.6 t30 -152.22 -66.27 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.222 -0.924 . . . . 0.0 110.376 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.524 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 43.7 Cg_endo -71.56 -160.75 0.09 OUTLIER 'Trans proline' 0 C--N 1.317 -1.086 0 O-C-N 123.241 1.127 . . . . 0.0 110.145 179.458 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 40.2 p -147.09 -178.46 6.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.205 -0.935 . . . . 0.0 109.85 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -65.47 -32.89 74.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 110.05 179.838 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.34 -62.68 1.29 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.124 -0.985 . . . . 0.0 109.537 179.448 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -51.85 -27.56 13.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.184 -0.947 . . . . 0.0 109.042 179.062 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.871 HD21 HD23 ' A' ' 32' ' ' LEU . 6.2 tt -68.88 -43.88 74.41 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.478 -0.764 . . . . 0.0 109.472 179.332 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -53.46 -42.77 67.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.38 -0.825 . . . . 0.0 109.021 179.104 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -65.47 -33.92 77.07 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.452 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 0.5 OUTLIER -68.45 -20.3 64.62 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.587 -0.696 . . . . 0.0 109.359 179.001 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.963 HD11 HD22 ' A' ' 32' ' ' LEU . 32.4 mm -87.09 -26.5 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.399 -0.813 . . . . 0.0 110.087 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -73.79 -30.47 62.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.0 110.537 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.659 ' HG3' HG23 ' A' ' 55' ' ' VAL . 8.4 pt-20 -71.64 -26.74 62.68 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.088 -1.008 . . . . 0.0 110.204 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.659 HG23 ' HG3' ' A' ' 54' ' ' GLU . 96.3 t -90.17 -30.46 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.163 -0.961 . . . . 0.0 109.717 179.608 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -76.48 115.92 16.68 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.438 -0.789 . . . . 0.0 110.206 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.69 18.88 21.46 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.256 -0.902 . . . . 0.0 110.239 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.433 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 61.6 m-20 -112.02 -65.72 1.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.354 -0.841 . . . . 0.0 109.968 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.16 -12.6 2.09 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -70.11 -36.7 75.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.971 -1.311 . . . . 0.0 110.534 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 119.73 -63.64 0.46 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 48.9 p -69.25 170.56 9.99 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.17 -1.194 . . . . 0.0 110.724 -179.437 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.602 HD13 HG11 ' A' ' 55' ' ' VAL . 89.1 mt -115.09 149.46 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.244 -0.91 . . . . 0.0 110.309 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.469 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 55.5 m-20 -98.37 -166.24 1.34 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 110.209 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.581 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 10.2 t80 -81.47 -38.26 0.93 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.162 -0.961 . . . . 0.0 112.118 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.6 Cg_endo -72.39 -25.9 17.77 Favored 'Trans proline' 0 C--O 1.209 -0.938 0 O-C-N 122.817 0.904 . . . . 0.0 111.269 -178.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.433 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 63.4 mt-10 -76.05 -33.61 59.61 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.827 -1.171 . . . . 0.0 109.524 179.421 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.479 ' CZ ' ' SD ' ' A' ' 72' ' ' MET . 12.6 t80 -75.38 -53.0 9.45 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.537 -0.727 . . . . 0.0 110.064 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.675 HD13 ' O ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -65.31 -20.83 66.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.509 -0.745 . . . . 0.0 110.408 -179.824 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.423 ' CB ' ' O ' ' A' ' 66' ' ' PRO . 50.6 m -91.38 -22.97 20.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.907 -1.12 . . . . 0.0 111.18 -179.595 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.634 ' SD ' HG13 ' A' ' 55' ' ' VAL . 60.0 ttp -86.99 -43.64 12.2 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.877 -1.139 . . . . 0.0 111.153 -179.241 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.479 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 43.2 mtt -82.84 -34.56 26.82 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.905 -1.122 . . . . 0.0 110.595 -179.473 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.141 -0.975 . . . . 0.0 110.66 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.282 0.563 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.4 mt -69.62 -40.68 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.367 -0.833 . . . . 0.0 110.309 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.6 ttp180 -67.96 -56.87 7.39 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.17 -0.957 . . . . 0.0 110.034 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -47.78 -47.81 30.55 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.256 -0.903 . . . . 0.0 110.111 179.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.718 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -54.82 -54.49 41.58 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.302 -0.874 . . . . 0.0 110.107 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -49.93 -28.7 7.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.291 -0.881 . . . . 0.0 110.259 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -71.97 -47.01 55.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.144 -0.973 . . . . 0.0 110.643 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 88' ' ' ALA . 35.9 m -70.9 -20.14 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.17 -0.956 . . . . 0.0 110.4 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.448 ' CD2' HG23 ' A' ' 91' ' ' VAL . 25.5 m-85 -95.35 -12.85 25.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.325 -0.859 . . . . 0.0 110.345 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -107.18 73.87 0.95 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.167 -0.958 . . . . 0.0 110.59 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -74.98 -36.46 62.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.171 -0.956 . . . . 0.0 109.995 179.639 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.8 p30 -74.54 -25.41 59.29 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.312 -0.867 . . . . 0.0 110.51 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 76.46 60.79 2.93 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.433 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 26.0 p-10 -124.33 -10.07 7.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.357 -1.084 . . . . 0.0 110.476 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.526 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 86.27 16.03 63.36 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.08 -1.057 . . . . 0.0 110.493 179.005 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.557 ' CD1' ' NE2' ' A' ' 135' ' ' GLN . 38.2 m-85 -142.1 138.31 31.6 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.188 -1.184 . . . . 0.0 110.26 179.875 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.43 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 25.6 mt -94.06 129.75 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.327 -0.858 . . . . 0.0 110.16 -179.748 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.7 t -114.91 166.09 12.16 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.285 -0.885 . . . . 0.0 109.977 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.46 -26.56 68.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.297 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.42 -69.83 0.27 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.282 -0.886 . . . . 0.0 110.266 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.483 ' O ' HG23 ' A' ' 108' ' ' VAL . 37.1 mt-10 -52.71 -38.78 61.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 110.212 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.625 HD22 HG13 ' A' ' 121' ' ' VAL . 4.0 tt -52.69 -46.21 67.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.094 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.785 ' O ' HG22 ' A' ' 110' ' ' THR . 2.6 ttm-85 -66.72 -37.85 85.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.362 -0.836 . . . . 0.0 110.045 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -61.4 -23.86 66.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.165 -0.959 . . . . 0.0 110.248 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 104' ' ' GLU . 50.0 t -87.28 -41.0 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.119 -0.988 . . . . 0.0 110.616 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.6 mmt -68.17 -57.79 5.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.137 -0.977 . . . . 0.0 110.521 -179.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.785 HG22 ' O ' ' A' ' 106' ' ' ARG . 9.8 t -50.13 -23.86 2.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.303 -0.873 . . . . 0.0 110.401 -179.772 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -79.43 -50.37 10.9 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.18 -0.95 . . . . 0.0 110.276 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.8 mt -60.75 -23.47 64.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.208 -0.933 . . . . 0.0 110.302 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.427 ' O ' ' HG2' ' A' ' 114' ' ' GLU . . . 102.88 90.97 2.17 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 1.3 mm-40 -155.3 -164.46 1.77 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.326 -1.102 . . . . 0.0 110.029 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.69 99.56 2.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.131 -0.981 . . . . 0.0 110.28 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.6 mp -137.52 135.62 36.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.326 -0.859 . . . . 0.0 110.204 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.608 HG22 ' OE2' ' A' ' 120' ' ' GLU . 13.1 t -75.78 172.18 13.09 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.228 -0.92 . . . . 0.0 109.949 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 53.7 m-20 -59.95 -41.58 92.17 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.241 -0.912 . . . . 0.0 110.299 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.456 ' OE1' ' N ' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -53.26 -47.72 68.88 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.164 -0.96 . . . . 0.0 110.811 -179.672 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.608 ' OE2' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -54.37 -56.22 20.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.99 -1.069 . . . . 0.0 110.897 -179.605 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.625 HG13 HD22 ' A' ' 105' ' ' LEU . 84.1 t -52.96 -44.74 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.913 -1.117 . . . . 0.0 110.675 -179.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 118' ' ' ASP . 1.5 m-20 -62.51 -30.8 71.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.145 -0.972 . . . . 0.0 110.611 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -72.48 -28.48 62.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.072 -1.018 . . . . 0.0 110.057 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.4 mtp -74.29 -45.77 45.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -0.874 . . . . 0.0 110.215 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.542 HD11 HD12 ' A' ' 105' ' ' LEU . 30.0 mm -64.65 -39.85 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.305 -0.872 . . . . 0.0 110.408 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.4 mtp180 -67.76 -51.0 54.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.158 -0.964 . . . . 0.0 110.115 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -55.41 -35.17 65.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.17 -0.956 . . . . 0.0 109.781 179.56 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -75.82 -28.72 58.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.361 -0.837 . . . . 0.0 109.812 179.685 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.401 ' OD2' ' HA2' ' A' ' 132' ' ' GLY . 16.0 t0 -71.92 91.93 1.23 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -0.871 . . . . 0.0 110.119 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 96.2 mt -73.14 -32.61 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.217 -0.927 . . . . 0.0 110.717 -179.615 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 23.4 p30 -99.59 -18.54 17.3 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.232 -0.918 . . . . 0.0 110.505 -179.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.467 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 77.0 72.11 1.14 Allowed Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.974 -1.108 . . . . 0.0 110.337 179.438 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.406 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 76.4 m-20 -113.93 6.1 16.44 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.072 -1.251 . . . . 0.0 110.118 179.175 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.32 16.3 69.45 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.557 ' NE2' ' CD1' ' A' ' 99' ' ' TYR . 11.2 pt20 -170.16 165.46 9.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.115 -1.226 . . . . 0.0 110.166 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.43 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 52.4 t -106.71 107.58 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.177 -0.952 . . . . 0.0 110.386 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -77.74 163.08 26.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.363 -0.836 . . . . 0.0 110.142 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.782 ' O ' HG23 ' A' ' 142' ' ' VAL . 33.0 t80 -51.47 -30.16 18.92 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.24 -0.913 . . . . 0.0 110.278 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -70.47 -59.29 2.93 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.2 -0.937 . . . . 0.0 110.474 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 56.3 mt-10 -54.16 -25.66 23.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 0.0 110.221 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.609 ' CZ ' ' HE2' ' A' ' 145' ' ' MET . 16.7 t80 -77.93 -35.39 50.54 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.312 -0.867 . . . . 0.0 110.137 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 138' ' ' TYR . 97.0 t -75.24 -22.83 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 110.364 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -83.31 -46.83 12.16 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.275 -0.89 . . . . 0.0 110.459 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.627 ' HE3' ' HG2' ' A' ' 145' ' ' MET . 0.2 OUTLIER -70.3 -13.22 62.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.027 -1.046 . . . . 0.0 110.293 -179.788 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.627 ' HG2' ' HE3' ' A' ' 144' ' ' MET . 13.4 mmt -89.28 -61.01 1.8 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.285 -0.884 . . . . 0.0 109.994 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 142' ' ' VAL . 9.5 t . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.188 -0.945 . . . . 0.0 110.105 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 121.423 0.63 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -76.78 -32.11 57.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.846 . . . . 0.0 109.728 179.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -65.38 -49.71 68.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.426 -0.796 . . . . 0.0 110.03 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.7 mt -68.48 -45.98 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.203 -0.936 . . . . 0.0 109.584 179.508 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 13' ' ' LYS . . . -59.32 -25.69 64.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.374 -0.828 . . . . 0.0 109.48 179.36 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.432 ' HA ' ' OE1' ' A' ' 11' ' ' GLU . 5.3 tp10 -69.59 -50.23 46.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.309 -0.87 . . . . 0.0 109.071 179.323 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -67.11 -17.24 64.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.368 -0.832 . . . . 0.0 109.58 179.075 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 25.6 mtpt -76.59 -49.49 16.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.153 -0.967 . . . . 0.0 109.796 179.596 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.9 -41.95 88.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.187 -0.946 . . . . 0.0 109.791 179.378 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.08 -49.99 67.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 109.791 179.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.454 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 40.3 t80 -54.68 -28.45 47.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.921 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.0 m -80.8 -32.73 35.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.342 -0.849 . . . . 0.0 109.497 179.63 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.636 ' O ' HD23 ' A' ' 18' ' ' LEU . 3.2 tt -69.57 -18.03 63.6 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.42 -0.8 . . . . 0.0 109.646 179.483 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 5.1 m-30 -96.7 -45.14 6.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.421 -0.799 . . . . 0.0 109.953 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.411 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 24.8 t0 -78.86 104.63 9.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.386 -0.821 . . . . 0.0 110.313 -179.741 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.425 ' HE2' ' O ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -110.4 64.68 0.61 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.161 -0.962 . . . . 0.0 110.837 -179.688 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.405 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 13.7 p-10 -170.89 -36.82 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.033 -1.042 . . . . 0.0 110.612 179.771 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.57 100.31 2.45 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 -179.293 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 24.7 p-10 -176.97 -29.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.242 -1.152 . . . . 0.0 111.014 -179.619 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.812 ' O ' HG23 ' A' ' 26' ' ' THR . . . 88.21 52.83 2.79 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.812 HG23 ' O ' ' A' ' 25' ' ' GLY . 0.3 OUTLIER -169.93 150.36 3.85 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.185 -1.186 . . . . 0.0 110.314 179.817 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.2 109.09 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.34 -0.85 . . . . 0.0 110.364 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.556 ' HA ' HG22 ' A' ' 62' ' ' THR . 65.6 p -93.24 -167.15 1.66 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.26 -0.9 . . . . 0.0 110.115 179.807 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.559 HG22 HD12 ' A' ' 52' ' ' ILE . 9.3 p -84.67 -20.7 30.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.23 -0.919 . . . . 0.0 110.207 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -72.69 -60.26 2.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.237 -0.914 . . . . 0.0 109.94 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.411 ' OE1' ' HA ' ' A' ' 20' ' ' ASP . 93.1 mt-10 -56.57 -49.29 75.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 109.624 179.5 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.445 ' O ' ' HB ' ' A' ' 35' ' ' VAL . 3.6 tp -60.73 -31.94 71.23 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.292 -0.88 . . . . 0.0 109.265 179.293 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.8 -42.33 94.46 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.709 -1.757 . . . . 0.0 108.709 179.298 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 66.9 m -71.58 -24.78 61.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -1.113 . . . . 0.0 109.477 179.311 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 51.1 t -70.96 -34.84 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.413 -0.805 . . . . 0.0 110.279 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 21.9 mmt -90.76 -23.14 20.74 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.214 -0.929 . . . . 0.0 110.439 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.408 ' NH2' ' HG2' ' A' ' 37' ' ' ARG . 6.7 ttp85 -80.49 -31.8 37.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 110.238 -179.771 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.2 m -92.38 -31.98 15.13 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.148 -0.97 . . . . 0.0 110.569 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.436 ' CG ' ' O ' ' A' ' 35' ' ' VAL . 66.9 mt -86.08 -71.98 0.52 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.141 -0.975 . . . . 0.0 110.496 -179.754 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -118.77 88.74 0.45 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -62.49 123.01 17.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.284 -1.127 . . . . 0.0 110.036 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.503 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.9 OUTLIER 179.47 -59.31 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.175 -0.953 . . . . 0.0 110.305 -179.906 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 42' ' ' ASN . 42.2 Cg_endo -68.41 158.43 57.65 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.593 1.312 . . . . 0.0 110.69 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 71.7 p -107.8 -138.21 0.37 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.368 -0.832 . . . . 0.0 109.619 179.826 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -99.16 -40.33 8.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.93 -1.106 . . . . 0.0 109.82 179.589 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.01 -59.42 2.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.306 -0.872 . . . . 0.0 109.915 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 37.2 tt0 -54.9 -30.59 58.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 109.792 179.587 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' A' ' 44' ' ' THR . 7.5 tt -64.17 -52.6 58.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.358 -0.839 . . . . 0.0 109.775 179.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -52.92 -35.54 58.54 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.269 -0.894 . . . . 0.0 109.053 179.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 8.5 t70 -61.64 -41.76 97.94 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.383 -0.823 . . . . 0.0 109.524 179.297 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.432 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 32.1 ttp -68.18 -19.77 64.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.383 -0.823 . . . . 0.0 109.565 179.538 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.559 HD12 HG22 ' A' ' 29' ' ' THR . 22.9 mt -83.57 -24.95 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.238 -0.914 . . . . 0.0 110.077 179.59 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -65.65 -46.18 80.15 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.162 -0.961 . . . . 0.0 110.07 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.59 ' HG3' HG23 ' A' ' 55' ' ' VAL . 21.3 pt-20 -59.45 -31.38 69.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.174 -0.954 . . . . 0.0 109.683 179.637 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.888 HG13 ' HE2' ' A' ' 71' ' ' MET . 75.8 t -87.0 -16.96 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.394 -0.816 . . . . 0.0 110.004 179.536 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.43 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 6.6 t0 -110.5 87.99 2.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.284 -0.885 . . . . 0.0 110.091 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.24 -12.65 61.85 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.253 -0.904 . . . . 0.0 110.752 -179.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -72.2 -59.3 2.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.14 -0.975 . . . . 0.0 110.439 -179.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.9 -1.35 21.35 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.349 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 20.2 p30 -69.96 -31.09 68.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.148 -1.207 . . . . 0.0 110.116 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.456 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 120.86 -59.8 0.55 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.556 HG22 ' HA ' ' A' ' 28' ' ' THR . 50.1 p -91.15 166.37 13.0 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.18 -1.188 . . . . 0.0 110.756 -179.447 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.8 mt -102.95 137.34 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.384 -0.822 . . . . 0.0 110.132 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.432 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 51.1 m-20 -92.62 178.44 5.8 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.273 -0.892 . . . . 0.0 110.305 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.584 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 25.2 t80 -71.66 -44.27 12.15 Favored Pre-proline 0 N--CA 1.486 1.357 0 O-C-N 121.166 -0.959 . . . . 0.0 111.069 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.3 Cg_endo -71.35 -21.6 26.29 Favored 'Trans proline' 0 C--N 1.324 -0.763 0 O-C-N 123.109 1.057 . . . . 0.0 109.874 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.43 ' OE2' ' HA ' ' A' ' 56' ' ' ASP . 84.7 tt0 -83.73 -30.51 26.65 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.38 -0.825 . . . . 0.0 109.265 178.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.454 ' CE2' ' HB2' ' A' ' 16' ' ' PHE . 43.2 t80 -70.81 -47.06 61.48 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.534 -0.729 . . . . 0.0 109.853 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.68 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 4.9 tt -74.28 -27.99 60.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.329 -0.857 . . . . 0.0 109.874 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.2 m -80.52 -16.67 53.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.224 -0.923 . . . . 0.0 110.142 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.888 ' HE2' HG13 ' A' ' 55' ' ' VAL . 14.3 tmm? -88.36 -46.8 8.87 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.304 -0.872 . . . . 0.0 110.856 -179.523 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.412 ' HE3' ' HE3' ' A' ' 71' ' ' MET . 58.0 mtt -90.85 -59.49 2.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.01 -1.056 . . . . 0.0 111.275 -179.219 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.496 1.855 0 O-C-N 121.258 -0.901 . . . . 0.0 111.121 -178.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 121.375 0.607 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.699 HG21 HG22 ' A' ' 142' ' ' VAL . 17.0 mt -52.13 -22.91 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.312 -0.868 . . . . 0.0 109.732 179.603 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.9 ttm-85 -69.09 -51.26 40.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.318 -0.864 . . . . 0.0 109.827 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -55.42 -43.03 74.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.067 -1.02 . . . . 0.0 109.764 179.528 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.747 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -58.04 -56.08 26.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.894 . . . . 0.0 109.978 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -48.91 -30.85 6.38 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.19 -0.944 . . . . 0.0 110.586 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.6 ttp85 -70.33 -48.77 55.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.22 -0.925 . . . . 0.0 111.15 -179.362 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.747 HG22 ' O ' ' A' ' 88' ' ' ALA . 27.5 m -64.78 -26.99 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.808 -1.183 . . . . 0.0 110.521 -179.54 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.679 ' HA ' HG21 ' A' ' 108' ' ' VAL . 38.6 m-85 -88.27 -14.95 37.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.256 -0.903 . . . . 0.0 110.24 179.687 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.25 77.16 1.77 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.0 109.893 179.512 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -94.56 -21.9 18.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.268 -0.895 . . . . 0.0 110.707 -179.477 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 2.0 p30 -71.11 -14.52 62.33 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.132 -0.98 . . . . 0.0 110.775 -179.297 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.86 30.36 23.71 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.598 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.456 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 1.7 t-20 -76.0 -78.12 0.12 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.246 -1.15 . . . . 0.0 109.939 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 145.28 -16.61 1.89 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.521 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -133.57 155.29 49.89 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.228 -1.16 . . . . 0.0 109.577 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.432 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 18.5 mt -94.74 118.6 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 120.988 -1.07 . . . . 0.0 109.541 179.784 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.8 m -102.37 168.8 9.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 110.128 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.28 -44.98 89.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.177 -0.952 . . . . 0.0 110.178 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.4 -58.15 9.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.125 -0.984 . . . . 0.0 110.011 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -49.88 -50.17 46.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.17 -0.956 . . . . 0.0 109.946 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -48.89 -40.31 29.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.44 -0.787 . . . . 0.0 110.151 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.1 tpt85 -64.02 -42.7 97.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.241 -0.912 . . . . 0.0 109.839 179.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -59.84 -27.05 66.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.301 -0.874 . . . . 0.0 110.209 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.679 HG21 ' HA ' ' A' ' 92' ' ' PHE . 92.4 t -84.35 -68.46 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.319 -0.863 . . . . 0.0 110.999 -179.275 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.405 ' HB3' HD13 ' A' ' 116' ' ' LEU . 20.2 mmt -50.19 -27.88 6.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.235 -0.916 . . . . 0.0 110.681 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.7 m -75.51 -42.22 53.28 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.238 -0.914 . . . . 0.0 110.653 -179.734 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -87.76 -2.15 58.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.153 -0.967 . . . . 0.0 110.775 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.642 HD12 HG12 ' A' ' 108' ' ' VAL . 14.2 mt -88.57 -68.7 0.75 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.964 -1.085 . . . . 0.0 110.176 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 166.6 37.94 0.02 OUTLIER Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -135.43 154.45 51.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.264 -1.139 . . . . 0.0 110.263 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -120.52 99.48 6.58 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.32 -0.863 . . . . 0.0 110.21 179.759 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 116' ' ' LEU . 4.8 mp -110.3 -166.77 1.12 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.167 -0.958 . . . . 0.0 110.423 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.501 HG22 ' HG3' ' A' ' 120' ' ' GLU . 12.1 t -135.19 -164.74 1.57 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.371 -0.831 . . . . 0.0 109.632 179.668 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 118' ' ' ASP . 1.2 m-20 -81.08 -45.74 16.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.022 -1.048 . . . . 0.0 110.653 -179.704 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -58.7 -39.52 81.0 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.417 -0.802 . . . . 0.0 110.819 -179.605 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.501 ' HG3' HG22 ' A' ' 117' ' ' THR . 43.7 mt-10 -62.63 -49.89 73.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.117 -0.99 . . . . 0.0 110.766 -179.704 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 76.0 t -58.63 -37.4 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.101 -0.999 . . . . 0.0 110.43 -179.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -64.81 -47.77 76.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.141 -0.974 . . . . 0.0 110.294 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.414 ' HG2' ' OE2' ' A' ' 127' ' ' GLU . 6.4 tm-20 -66.3 -21.86 66.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.229 -0.919 . . . . 0.0 109.843 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 28.8 mmm -73.88 -56.5 4.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.389 -0.819 . . . . 0.0 110.231 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 22.3 mm -66.72 -25.42 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.296 -0.878 . . . . 0.0 110.344 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -72.66 -57.98 3.71 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.194 -0.941 . . . . 0.0 110.225 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.445 ' CA ' ' OE1' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -63.05 -19.22 64.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 110.069 179.908 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.472 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -82.79 -34.2 27.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.256 -0.902 . . . . 0.0 110.013 179.674 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.87 90.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 110.114 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.673 HD12 ' HA ' ' A' ' 140' ' ' GLU . 92.5 mt -61.25 -18.9 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.895 . . . . 0.0 110.335 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.4 p30 -114.45 -30.34 6.58 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.217 -0.927 . . . . 0.0 110.195 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.458 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 89.39 80.62 1.32 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.432 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 33.0 p30 -139.1 13.76 2.63 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.334 -1.098 . . . . 0.0 110.565 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.25 24.6 76.13 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.159 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.432 ' HG3' ' OD1' ' A' ' 133' ' ' ASP . 0.3 OUTLIER -170.5 143.66 2.29 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.137 -1.214 . . . . 0.0 110.268 179.639 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.432 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 91.7 t -93.73 129.24 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 110.453 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -88.43 174.53 8.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.423 -0.798 . . . . 0.0 110.23 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.453 ' CD1' ' C ' ' A' ' 138' ' ' TYR . 8.0 t80 -68.03 -51.72 43.67 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.281 -0.887 . . . . 0.0 109.456 179.302 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -62.31 -40.99 98.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.331 -0.856 . . . . 0.0 109.789 179.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.673 ' HA ' HD12 ' A' ' 130' ' ' ILE . 31.5 mt-10 -65.25 -29.72 70.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 109.981 179.585 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.468 ' CD1' ' CE ' ' A' ' 144' ' ' MET . 78.6 t80 -74.12 -28.21 61.24 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.271 -0.893 . . . . 0.0 110.128 -179.827 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.699 HG22 HG21 ' A' ' 85' ' ' ILE . 60.3 t -88.46 -20.78 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.245 -0.909 . . . . 0.0 110.446 179.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -98.2 -17.35 19.04 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.356 -0.84 . . . . 0.0 110.904 -179.416 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.472 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 15.0 ptt? -81.32 -27.71 34.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.045 -1.034 . . . . 0.0 110.357 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.414 ' N ' ' HG3' ' A' ' 144' ' ' MET . 4.7 tpp -89.58 -68.56 0.77 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.9 . . . . 0.0 109.919 179.861 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 67.9 p . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.211 -0.931 . . . . 0.0 110.126 179.932 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.244 0.545 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -58.75 -44.0 90.44 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.192 -0.942 . . . . 0.0 110.789 -179.649 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -59.63 -48.0 83.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.077 -1.014 . . . . 0.0 109.986 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 61.8 mt -59.9 -30.07 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.155 -0.966 . . . . 0.0 109.665 179.545 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.97 -30.02 67.26 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.273 -0.892 . . . . 0.0 109.705 179.88 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 65.9 tt0 -69.77 -58.15 4.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.42 -0.8 . . . . 0.0 109.997 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -59.01 -36.26 74.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.175 -0.953 . . . . 0.0 109.439 179.426 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 9.6 tmtt? -65.36 -33.86 76.95 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.507 -0.746 . . . . 0.0 109.609 179.619 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 14.2 mm-40 -63.56 -42.67 98.33 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.358 -0.839 . . . . 0.0 109.634 179.421 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.432 ' HB1' ' CZ ' ' A' ' 19' ' ' PHE . . . -59.86 -48.22 82.58 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.329 -0.857 . . . . 0.0 110.041 179.695 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -55.43 -54.29 45.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.287 -0.883 . . . . 0.0 110.188 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.1 m -58.7 -27.75 65.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.154 -0.966 . . . . 0.0 109.827 179.653 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.753 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.4 tt -71.06 -32.23 68.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.441 -0.787 . . . . 0.0 110.05 -179.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.432 ' CZ ' ' HB1' ' A' ' 15' ' ' ALA . 6.1 m-85 -84.31 -62.82 1.46 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.264 -0.897 . . . . 0.0 110.889 -179.184 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -82.12 85.1 6.83 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.226 -0.921 . . . . 0.0 110.625 -179.329 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.423 ' HD3' ' O ' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -106.48 52.74 0.71 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.141 -0.974 . . . . 0.0 109.972 179.375 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 1.7 p30 -137.08 -35.41 0.7 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.21 -0.931 . . . . 0.0 110.695 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 113.09 39.83 1.11 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.835 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -101.61 -33.0 10.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.357 -1.084 . . . . 0.0 110.032 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.58 -15.14 63.15 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.8 p -139.97 160.66 39.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.972 -1.31 . . . . 0.0 110.502 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.8 mt -103.17 111.99 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.362 -0.836 . . . . 0.0 109.983 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.581 HG22 ' CG2' ' A' ' 62' ' ' THR . 49.8 p -101.93 -164.9 1.14 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.211 -0.93 . . . . 0.0 110.263 -179.934 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.517 ' HA ' HD21 ' A' ' 48' ' ' LEU . 42.4 p -78.11 -36.58 47.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.221 -0.924 . . . . 0.0 110.243 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.5 mttm -68.58 -56.62 7.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 0.0 109.706 179.592 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.652 ' O ' HG22 ' A' ' 34' ' ' THR . 98.9 mt-10 -58.1 -40.9 82.32 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.284 -0.885 . . . . 0.0 109.626 179.413 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.716 HD23 ' CG ' ' A' ' 48' ' ' LEU . 7.0 tp -66.81 -26.76 67.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.26 -0.9 . . . . 0.0 109.401 179.186 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.0 -43.99 95.09 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.662 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.652 HG22 ' O ' ' A' ' 31' ' ' GLU . 7.0 t -75.41 -21.6 58.08 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.058 -1.26 . . . . 0.0 110.123 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.5 t -78.21 -29.81 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.2 -0.938 . . . . 0.0 109.972 179.535 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.8 mmt -90.17 -28.0 19.21 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.185 -0.947 . . . . 0.0 110.288 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.4 mtm180 -89.61 -17.51 28.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.234 -0.916 . . . . 0.0 110.447 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 34' ' ' THR . 29.7 t -49.6 -52.86 27.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.17 -0.957 . . . . 0.0 110.249 -179.766 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.26 61.32 1.53 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 110.214 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . -171.58 -62.57 0.04 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.416 ' HB2' ' O ' ' A' ' 40' ' ' GLY . 25.6 mt-30 54.81 102.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.232 -1.158 . . . . 0.0 110.115 -179.808 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.509 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.8 t30 -164.84 -63.03 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.343 -0.848 . . . . 0.0 110.077 179.839 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.509 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 45.2 Cg_endo -71.12 171.49 15.84 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.392 1.206 . . . . 0.0 109.9 179.608 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.432 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 81.1 p -120.27 -170.74 2.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.141 -0.974 . . . . 0.0 109.94 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -74.55 -29.03 61.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.127 -0.983 . . . . 0.0 110.197 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.07 -57.22 4.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.201 -0.937 . . . . 0.0 109.827 179.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -62.08 -24.72 67.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 0.0 109.889 179.616 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.716 ' CG ' HD23 ' A' ' 32' ' ' LEU . 4.8 tt -70.23 -52.99 18.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.312 -0.867 . . . . 0.0 109.677 179.506 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.467 ' N ' HD23 ' A' ' 48' ' ' LEU . 51.3 tt0 -54.33 -37.61 65.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.182 -0.949 . . . . 0.0 109.449 179.271 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -68.79 -35.55 77.17 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.356 -0.84 . . . . 0.0 109.296 179.386 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.442 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 54.5 ttp -68.51 -17.45 64.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.326 -0.859 . . . . 0.0 109.675 179.417 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.619 HD11 HD22 ' A' ' 32' ' ' LEU . 13.8 mt -88.25 -37.88 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.888 . . . . 0.0 109.769 179.43 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -53.49 -35.61 60.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.912 . . . . 0.0 110.022 179.603 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.483 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 7.4 pt-20 -71.22 -32.56 68.95 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.355 -0.841 . . . . 0.0 110.273 -179.824 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.73 HG13 ' SD ' ' A' ' 71' ' ' MET . 71.5 t -76.38 -67.94 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.121 -0.987 . . . . 0.0 109.588 179.544 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -46.01 125.55 6.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.506 -0.746 . . . . 0.0 110.176 179.787 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.83 -26.07 10.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.143 -0.973 . . . . 0.0 110.842 -179.589 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 2.8 p30 -70.03 -34.76 73.68 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.228 -0.92 . . . . 0.0 110.455 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.457 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 92.5 76.37 1.33 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.822 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.409 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 18.6 p-10 -142.9 -43.55 0.3 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.222 -1.163 . . . . 0.0 110.179 179.391 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.534 ' C ' HG23 ' A' ' 62' ' ' THR . . . 132.61 2.61 3.94 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.842 179.323 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.581 ' CG2' HG22 ' A' ' 28' ' ' THR . 49.5 p -154.24 167.17 30.79 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.803 -1.41 . . . . 0.0 111.093 -179.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.7 HD11 HG11 ' A' ' 55' ' ' VAL . 49.3 mt -104.98 146.25 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.385 -0.822 . . . . 0.0 109.775 179.662 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.443 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 48.7 m-20 -105.45 170.51 7.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.095 -1.003 . . . . 0.0 110.293 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.547 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 32.9 t80 -67.07 -42.3 40.3 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.877 . . . . 0.0 111.412 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 46.1 Cg_endo -74.73 -26.3 11.62 Favored 'Trans proline' 0 C--O 1.212 -0.782 0 O-C-N 123.087 1.046 . . . . 0.0 110.146 -179.587 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 71' ' ' MET . 35.1 tt0 -78.99 -27.95 43.41 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.289 -0.882 . . . . 0.0 109.369 179.378 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -74.57 -61.07 2.0 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.318 -0.864 . . . . 0.0 109.728 179.647 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.481 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 5.0 tt -56.92 -38.09 72.38 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.291 -0.88 . . . . 0.0 109.826 179.669 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.434 ' HB ' ' O ' ' A' ' 66' ' ' PRO . 52.1 m -73.77 -26.4 60.63 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.192 -0.943 . . . . 0.0 110.325 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.73 ' SD ' HG13 ' A' ' 55' ' ' VAL . 34.4 ttp -63.37 -50.18 70.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 110.208 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.473 ' CE ' ' CE ' ' A' ' 71' ' ' MET . 36.5 mtt -90.5 -15.2 31.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.286 -0.884 . . . . 0.0 111.188 -179.372 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.481 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.503 2.201 0 O-C-N 120.955 -1.091 . . . . 0.0 111.23 -179.664 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 121.339 0.59 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.6 mt -53.44 -46.54 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.077 -1.014 . . . . 0.0 110.02 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -55.49 -42.38 74.33 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.178 -0.951 . . . . 0.0 109.071 179.437 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -49.6 -50.68 41.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.398 -0.814 . . . . 0.0 109.39 179.259 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.726 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -52.54 -44.73 65.97 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.358 -0.838 . . . . 0.0 109.281 179.134 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.448 ' CD1' HD11 ' A' ' 100' ' ' ILE . 4.0 t80 -54.16 -39.6 66.7 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.166 -0.958 . . . . 0.0 109.987 179.782 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -59.07 -51.37 70.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.231 -0.918 . . . . 0.0 110.242 -179.874 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.726 HG22 ' O ' ' A' ' 88' ' ' ALA . 26.6 m -68.28 -18.49 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.125 -0.985 . . . . 0.0 109.745 179.817 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.467 ' CD1' HG21 ' A' ' 108' ' ' VAL . 29.0 m-85 -103.41 4.38 36.13 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.36 -0.837 . . . . 0.0 110.317 179.657 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.414 ' OD2' ' HA2' ' A' ' 98' ' ' GLY . 59.1 t0 -146.19 70.21 1.22 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -0.939 . . . . 0.0 109.749 179.748 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -107.3 59.01 0.62 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 110.708 -179.557 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.2 p30 -138.31 -40.0 0.52 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.128 -0.983 . . . . 0.0 110.309 179.567 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.469 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 135.56 17.81 0.83 Allowed Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.225 -1.464 . . . . 0.0 111.827 178.846 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.469 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 27.6 p30 -131.58 -122.16 0.2 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.352 -1.675 . . . . 0.0 109.89 179.192 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.469 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . -170.09 44.53 0.2 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 23.5 m-85 -131.95 128.52 38.64 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.39 -1.065 . . . . 0.0 110.294 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.45 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 24.0 mt -95.92 124.38 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.195 -0.941 . . . . 0.0 109.972 179.702 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.4 t -113.51 157.55 21.87 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.256 -0.903 . . . . 0.0 110.258 -179.844 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.25 -26.54 12.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 110.15 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 106' ' ' ARG . . . -69.72 -59.31 3.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.198 -0.939 . . . . 0.0 110.09 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -51.92 -38.92 58.14 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.064 -1.022 . . . . 0.0 110.264 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.938 HD22 HG13 ' A' ' 121' ' ' VAL . 6.5 tt -59.1 -48.98 79.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 110.488 -179.796 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.597 ' O ' HG23 ' A' ' 110' ' ' THR . 0.0 OUTLIER -65.81 -21.7 66.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.907 -1.121 . . . . 0.0 109.999 -179.905 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.472 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 21.1 t-160 -72.3 -34.63 68.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.416 -0.802 . . . . 0.0 110.035 -179.969 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.467 HG21 ' CD1' ' A' ' 92' ' ' PHE . 96.8 t -78.88 -42.12 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.319 -0.863 . . . . 0.0 110.434 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 4.7 mmt -66.52 -56.96 8.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.215 -179.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.597 HG23 ' O ' ' A' ' 106' ' ' ARG . 44.1 p -46.61 -48.97 19.66 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.447 -0.783 . . . . 0.0 110.714 -179.819 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -59.13 -55.67 32.08 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.179 -0.95 . . . . 0.0 110.258 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 112' ' ' LEU . 79.6 mt -52.36 -72.6 0.05 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.14 -0.975 . . . . 0.0 109.924 179.658 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.08 40.37 0.02 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.869 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.804 ' O ' HD12 ' A' ' 116' ' ' LEU . 35.9 mm-40 -121.71 93.24 3.94 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.233 -1.157 . . . . 0.0 110.089 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -74.63 111.4 9.78 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.269 -0.894 . . . . 0.0 110.208 -179.89 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 114' ' ' GLU . 0.9 OUTLIER -117.43 177.56 4.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -0.862 . . . . 0.0 110.285 -179.939 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 59.0 m -100.87 158.87 15.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.334 -0.854 . . . . 0.0 110.173 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -59.91 -41.98 92.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.289 -0.882 . . . . 0.0 110.6 -179.765 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -60.08 -50.64 72.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.291 -0.881 . . . . 0.0 110.716 -179.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -53.23 -52.79 57.82 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.144 -0.972 . . . . 0.0 110.877 -179.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.938 HG13 HD22 ' A' ' 105' ' ' LEU . 95.5 t -55.32 -55.81 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.144 -0.973 . . . . 0.0 110.371 -179.607 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -54.54 -26.66 33.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.303 -0.873 . . . . 0.0 110.35 -179.693 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 7.1 tt0 -76.3 -34.71 59.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 110.069 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 72.0 mtp -67.58 -47.08 70.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.214 -0.929 . . . . 0.0 110.122 -179.919 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 29.6 mm -64.11 -45.0 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 110.234 179.807 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.5 -33.7 75.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.192 -0.942 . . . . 0.0 110.041 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 41.2 mm-40 -67.93 -33.95 75.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.018 179.79 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.528 ' HB3' ' CG2' ' A' ' 136' ' ' VAL . . . -71.18 -42.13 69.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.284 -0.885 . . . . 0.0 110.464 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -56.92 92.39 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.159 -0.963 . . . . 0.0 110.385 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.417 HD11 ' CB ' ' A' ' 143' ' ' GLN . 76.3 mt -64.4 -31.89 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.194 -0.941 . . . . 0.0 110.236 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 22.4 p30 -101.99 -18.58 15.58 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.193 -0.942 . . . . 0.0 110.536 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.454 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 77.3 75.7 0.91 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.645 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 40.4 m-20 -109.8 -49.3 3.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.227 -1.161 . . . . 0.0 110.053 179.711 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 157.17 -23.59 0.45 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.708 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -143.74 155.91 44.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.329 -1.1 . . . . 0.0 110.115 179.727 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.528 ' CG2' ' HB3' ' A' ' 128' ' ' ALA . 77.7 t -91.6 108.51 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.203 -0.936 . . . . 0.0 110.315 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -82.63 165.55 19.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.948 . . . . 0.0 110.249 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.545 ' O ' HG23 ' A' ' 142' ' ' VAL . 35.5 t80 -44.68 -34.46 2.23 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.369 -0.832 . . . . 0.0 111.766 -178.823 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -65.22 -67.05 0.47 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.867 -1.145 . . . . 0.0 110.726 -179.223 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -52.86 -26.16 13.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.207 -0.933 . . . . 0.0 110.359 -179.589 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.714 ' CE1' ' HE3' ' A' ' 145' ' ' MET . 7.9 t80 -68.44 -40.43 81.14 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 109.985 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 138' ' ' TYR . 43.5 t -82.01 -20.25 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.294 -0.879 . . . . 0.0 110.554 179.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.417 ' CB ' HD11 ' A' ' 130' ' ' ILE . 81.4 mm-40 -80.5 -28.25 37.54 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.341 -0.849 . . . . 0.0 110.696 -179.534 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.403 ' HG3' ' N ' ' A' ' 145' ' ' MET . 4.3 ptt? -84.53 -21.68 30.43 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.053 -1.029 . . . . 0.0 110.462 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.714 ' HE3' ' CE1' ' A' ' 141' ' ' PHE . 46.4 mtt -89.02 -39.83 13.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.203 -0.936 . . . . 0.0 110.524 -179.801 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.207 -0.933 . . . . 0.0 110.383 -179.8 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.405 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 21.6 pt-20 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.084 0.469 . . . . 0.0 110.497 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -55.5 -54.61 41.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.167 -0.958 . . . . 0.0 109.969 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -50.97 -45.03 60.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.908 . . . . 0.0 109.788 179.581 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 31.3 mm -52.87 -40.92 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.884 . . . . 0.0 109.646 179.667 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -59.94 -44.4 94.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.361 -0.837 . . . . 0.0 109.89 179.615 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -53.29 -51.31 62.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 109.954 179.805 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -60.7 -33.87 73.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 109.896 179.737 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 72.1 mttt -66.07 -27.46 68.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.888 179.626 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -73.19 -53.05 11.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.35 -0.843 . . . . 0.0 109.913 179.763 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.444 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -58.89 -34.84 72.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.21 -0.931 . . . . 0.0 109.98 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -66.99 -54.25 23.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.883 . . . . 0.0 109.975 179.867 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.0 m -56.64 -21.39 26.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.238 -0.914 . . . . 0.0 110.021 179.654 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.814 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.1 tm? -78.6 -35.44 45.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.443 -0.786 . . . . 0.0 109.791 179.878 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.444 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 22.7 m-85 -70.46 -55.58 8.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.386 -0.821 . . . . 0.0 110.454 -179.889 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.442 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 0.5 OUTLIER -55.79 113.16 1.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.209 -0.932 . . . . 0.0 110.412 -179.897 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -109.96 54.58 0.66 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 110.143 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.456 ' OD2' ' HB2' ' A' ' 24' ' ' ASP . 10.2 p-10 -162.51 -37.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.111 -0.993 . . . . 0.0 110.598 -179.788 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.81 39.66 2.48 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.456 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 6.8 t70 -103.54 -67.67 0.88 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.369 -1.077 . . . . 0.0 110.101 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.531 ' C ' HG23 ' A' ' 26' ' ' THR . . . 135.92 23.47 0.55 Allowed Glycine 0 N--CA 1.499 2.842 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.621 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.531 HG23 ' C ' ' A' ' 25' ' ' GLY . 74.4 p -154.15 144.17 21.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.896 -1.355 . . . . 0.0 109.534 179.534 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.6 mt -96.37 107.18 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.109 -0.994 . . . . 0.0 110.328 -179.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.686 HG22 ' CG2' ' A' ' 62' ' ' THR . 72.4 p -103.28 -176.98 3.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.374 -0.829 . . . . 0.0 110.178 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.716 HG22 HD12 ' A' ' 52' ' ' ILE . 25.5 p -68.31 -26.68 65.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.277 -0.89 . . . . 0.0 110.14 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -68.67 -62.44 1.39 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.21 -0.931 . . . . 0.0 109.921 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.442 ' OE1' ' HA ' ' A' ' 20' ' ' ASP . 35.2 mt-10 -56.42 -55.36 34.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.325 -0.859 . . . . 0.0 109.458 179.602 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.817 HD23 HD21 ' A' ' 48' ' ' LEU . 6.6 tp -57.57 -23.77 52.49 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.177 -0.952 . . . . 0.0 109.296 179.144 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.487 ' HA2' ' CD1' ' A' ' 48' ' ' LEU . . . -62.85 -46.93 92.59 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.444 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.466 ' O ' ' CB ' ' A' ' 38' ' ' SER . 96.4 m -78.54 -14.45 59.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.332 -1.099 . . . . 0.0 109.934 179.636 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.445 ' HB ' ' HA ' ' A' ' 32' ' ' LEU . 50.5 t -78.77 -36.57 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.172 -0.955 . . . . 0.0 110.21 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.7 mmt -90.72 -38.09 13.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.352 -0.843 . . . . 0.0 110.756 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.7 mtm180 -75.74 -36.32 59.93 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.714 -179.497 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.645 ' O ' HD22 ' A' ' 39' ' ' LEU . 8.4 t -76.99 -23.93 52.24 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.876 -1.14 . . . . 0.0 110.054 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.645 HD22 ' O ' ' A' ' 38' ' ' SER . 3.9 mm? -119.85 56.61 0.95 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.314 -0.866 . . . . 0.0 110.169 179.8 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.49 56.95 0.07 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -48.43 104.92 0.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.178 -1.19 . . . . 0.0 110.479 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.539 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 5.9 m-20 -159.66 -63.61 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.318 -0.864 . . . . 0.0 110.329 179.314 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.539 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 46.6 Cg_endo -73.87 -179.32 4.49 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.332 1.175 . . . . 0.0 109.864 179.439 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 8.7 t -134.72 -175.64 3.96 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.108 -0.995 . . . . 0.0 110.102 -179.852 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.06 -42.0 93.58 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.034 -1.041 . . . . 0.0 110.333 -179.832 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.47 -68.46 0.38 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.22 -0.925 . . . . 0.0 110.411 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -47.14 -26.21 1.07 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.221 -0.924 . . . . 0.0 109.984 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.817 HD21 HD23 ' A' ' 32' ' ' LEU . 9.1 tt -70.56 -49.48 47.53 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.313 -0.867 . . . . 0.0 109.764 179.52 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -52.45 -41.18 63.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.118 -0.989 . . . . 0.0 109.222 179.224 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.78 -35.38 79.94 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.44 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 3.5 ttt -68.16 -15.05 63.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.646 -0.659 . . . . 0.0 109.573 179.007 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.716 HD12 HG22 ' A' ' 29' ' ' THR . 57.3 mt -88.56 -35.17 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.397 -0.814 . . . . 0.0 109.834 179.39 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -51.83 -45.38 63.93 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.274 -0.891 . . . . 0.0 110.657 -179.802 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.693 ' HG3' HG23 ' A' ' 55' ' ' VAL . 22.0 pt-20 -56.93 -34.27 67.81 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.177 -0.952 . . . . 0.0 110.476 -179.658 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.875 HG13 ' HE2' ' A' ' 71' ' ' MET . 95.3 t -84.49 -71.73 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.202 -0.936 . . . . 0.0 110.284 -179.696 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.433 ' HB2' ' CG1' ' A' ' 63' ' ' ILE . 24.2 t70 -56.53 124.33 17.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.335 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.34 5.29 21.48 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.23 -0.919 . . . . 0.0 110.702 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.83 -23.22 36.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.077 -1.015 . . . . 0.0 110.198 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.26 14.43 76.66 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.737 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -91.56 -37.39 13.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.014 -1.286 . . . . 0.0 110.165 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.14 -52.02 0.83 Allowed Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.231 179.567 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.686 ' CG2' HG22 ' A' ' 28' ' ' THR . 66.7 p -101.87 167.55 9.99 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.067 -1.255 . . . . 0.0 110.728 -179.379 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.446 HG23 ' CB ' ' A' ' 67' ' ' GLU . 48.7 mt -115.29 157.17 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.287 -0.883 . . . . 0.0 110.055 179.662 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.485 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 1.4 m-20 -112.6 -172.37 2.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.241 -0.912 . . . . 0.0 110.728 -179.648 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.572 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 50.3 t80 -65.3 -42.62 60.31 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.473 -0.767 . . . . 0.0 111.976 -179.686 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.5 Cg_endo -71.67 -33.35 10.56 Favored 'Trans proline' 0 C--N 1.323 -0.787 0 O-C-N 123.069 1.036 . . . . 0.0 110.893 -179.146 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.446 ' CB ' HG23 ' A' ' 63' ' ' ILE . 48.6 mt-10 -71.43 -30.16 65.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.021 -1.049 . . . . 0.0 108.844 179.169 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.491 ' CZ ' ' SD ' ' A' ' 72' ' ' MET . 64.9 t80 -73.46 -43.0 61.24 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.512 0.672 . . . . 0.0 109.654 179.738 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.49 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 15.5 tp -77.19 -12.12 59.91 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.49 -0.756 . . . . 0.0 110.344 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.7 m -90.68 -28.42 18.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.929 -1.107 . . . . 0.0 110.44 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.875 ' HE2' HG13 ' A' ' 55' ' ' VAL . 18.9 tmm? -90.61 -37.02 14.07 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.178 -0.951 . . . . 0.0 111.197 -179.488 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.491 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 48.9 mtt -91.3 -11.8 36.97 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.112 -0.993 . . . . 0.0 111.975 -178.646 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.5 2.03 0 O-C-N 120.772 -1.205 . . . . 0.0 111.126 -179.401 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.032 0.444 . . . . 0.0 110.314 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.732 HG12 HG22 ' A' ' 142' ' ' VAL . 3.8 tp -48.06 -34.87 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.168 -0.958 . . . . 0.0 109.536 179.834 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -59.95 -48.7 80.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.392 -0.818 . . . . 0.0 109.499 179.282 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.419 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 7.8 mm-40 -54.13 -41.6 68.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.255 -0.903 . . . . 0.0 109.563 179.39 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.15 -46.41 88.45 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.312 -0.867 . . . . 0.0 109.66 179.528 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.435 ' O ' ' HB3' ' A' ' 93' ' ' ASP . 0.4 OUTLIER -63.38 -20.82 65.86 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.179 179.736 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.419 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -74.05 -49.74 22.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.365 -0.834 . . . . 0.0 110.882 -179.489 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 92' ' ' PHE . 16.5 m -75.1 -41.04 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.133 -0.979 . . . . 0.0 111.416 -179.089 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 1.011 ' CE1' HD12 ' A' ' 105' ' ' LEU . 37.7 m-85 -72.78 -28.18 62.45 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.068 -1.02 . . . . 0.0 111.248 -179.141 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.435 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 10.4 t70 -111.15 51.6 0.77 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.859 -1.151 . . . . 0.0 110.348 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.74 2.63 32.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 110.49 179.882 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 3.0 p30 -85.96 -37.77 18.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.128 -0.983 . . . . 0.0 110.296 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 104.38 47.64 1.2 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.443 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 15.8 p-10 -122.77 -32.77 3.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.151 -1.205 . . . . 0.0 110.295 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.48 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 100.36 16.16 28.03 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.901 -1.142 . . . . 0.0 110.312 179.274 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 37.6 m-85 -144.79 161.44 39.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.051 -1.264 . . . . 0.0 110.303 179.762 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.548 HG23 ' HB3' ' A' ' 92' ' ' PHE . 23.0 mt -107.0 118.39 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.256 -0.903 . . . . 0.0 109.419 179.323 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.3 m -102.13 163.36 12.28 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.44 -0.788 . . . . 0.0 109.632 179.8 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.87 -49.76 76.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.063 -1.023 . . . . 0.0 110.167 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -50.43 -50.45 52.0 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.274 -0.891 . . . . 0.0 110.573 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -57.95 -45.73 86.19 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.356 -0.84 . . . . 0.0 110.136 -179.881 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.011 HD12 ' CE1' ' A' ' 92' ' ' PHE . 40.5 tp -59.15 -23.88 62.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.438 -0.789 . . . . 0.0 110.319 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.44 -43.3 27.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.307 -0.871 . . . . 0.0 110.403 -179.933 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.414 ' O ' ' OG1' ' A' ' 110' ' ' THR . 81.6 m-70 -68.18 -30.27 69.33 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.216 -0.927 . . . . 0.0 110.551 -179.927 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.706 HG11 ' CE1' ' A' ' 92' ' ' PHE . 48.1 t -75.17 -47.82 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.02 -1.05 . . . . 0.0 109.866 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.694 ' HE3' HD11 ' A' ' 105' ' ' LEU . 63.7 mtt -65.36 -10.42 33.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.174 -0.954 . . . . 0.0 110.509 179.911 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 107' ' ' HIS . 1.1 p -90.17 -26.41 20.16 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.018 -1.051 . . . . 0.0 109.858 179.245 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -88.47 -52.92 4.92 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.146 -0.971 . . . . 0.0 110.117 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.1 mt -47.73 -72.85 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.165 -0.959 . . . . 0.0 110.278 179.811 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 162.97 40.78 0.02 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.489 ' HB3' ' CD1' ' A' ' 116' ' ' LEU . 51.5 mt-10 -120.85 121.45 38.13 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.323 -1.104 . . . . 0.0 110.462 -179.786 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -106.81 66.03 0.68 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.206 -0.934 . . . . 0.0 110.109 179.702 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.489 ' CD1' ' HB3' ' A' ' 114' ' ' GLU . 3.4 mp -88.04 167.98 13.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.261 -0.899 . . . . 0.0 110.364 -179.895 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 22.9 m -86.24 163.21 17.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.334 -0.854 . . . . 0.0 109.969 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -60.77 -54.44 45.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.159 -0.963 . . . . 0.0 110.379 -179.805 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -47.07 -40.23 14.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.947 . . . . 0.0 110.276 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -56.76 -60.09 4.07 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.251 -0.906 . . . . 0.0 110.441 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.803 HG13 HD23 ' A' ' 105' ' ' LEU . 53.1 t -47.22 -39.72 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.143 -0.973 . . . . 0.0 110.371 -179.622 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -62.68 -44.07 97.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.135 -0.978 . . . . 0.0 109.99 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -69.11 -20.51 64.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.199 179.839 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 85.1 mtp -77.78 -46.52 21.41 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.126 -0.984 . . . . 0.0 109.993 179.977 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.483 HG23 HG23 ' A' ' 136' ' ' VAL . 26.0 mm -65.57 -29.38 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.158 -0.964 . . . . 0.0 110.007 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -75.91 -54.79 6.36 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.2 -0.938 . . . . 0.0 110.132 179.576 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -54.94 -33.52 62.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.226 -0.921 . . . . 0.0 109.995 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -75.13 -37.43 61.41 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.209 -0.932 . . . . 0.0 109.811 179.701 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -57.89 95.46 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.317 -0.864 . . . . 0.0 109.809 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.433 HD12 ' HG2' ' A' ' 140' ' ' GLU . 21.8 mt -62.07 -46.96 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.888 . . . . 0.0 110.402 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 21.6 p30 -86.6 -19.69 28.99 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.185 -0.947 . . . . 0.0 110.059 179.854 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.445 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 67.48 65.56 2.69 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 178.871 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.426 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 34.4 m-20 -98.28 -35.62 10.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.178 -1.19 . . . . 0.0 109.719 179.048 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.75 -28.62 1.04 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 -179.664 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.412 ' O ' ' OE1' ' A' ' 135' ' ' GLN . 0.0 OUTLIER -137.08 169.62 17.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.471 -1.017 . . . . 0.0 109.709 179.589 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.483 HG23 HG23 ' A' ' 125' ' ' ILE . 84.4 t -99.28 145.23 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 120.97 -1.081 . . . . 0.0 110.752 -179.447 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -106.67 178.79 4.46 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.365 -0.835 . . . . 0.0 110.193 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.537 ' O ' HG23 ' A' ' 142' ' ' VAL . 13.7 t80 -69.07 -44.7 72.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.231 -0.918 . . . . 0.0 110.441 -179.997 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.58 -33.32 73.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.242 -0.911 . . . . 0.0 110.27 -179.735 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.433 ' HG2' HD12 ' A' ' 130' ' ' ILE . 48.3 mt-10 -71.27 -35.6 71.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.146 -0.971 . . . . 0.0 110.085 179.818 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.477 ' CE2' HG13 ' A' ' 85' ' ' ILE . 57.4 t80 -71.13 -32.72 69.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.212 -0.93 . . . . 0.0 110.657 -179.847 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.732 HG22 HG12 ' A' ' 85' ' ' ILE . 59.4 t -78.7 -29.54 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.12 -0.987 . . . . 0.0 110.72 -179.734 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.424 ' OE1' ' N ' ' A' ' 143' ' ' GLN . 0.6 OUTLIER -97.06 -9.74 27.46 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.129 -0.982 . . . . 0.0 111.456 -179.068 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.47 ' HG2' ' HA ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -89.31 -31.56 17.77 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.705 -1.247 . . . . 0.0 110.372 -179.958 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 56.0 ttm -85.97 -48.77 8.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.938 179.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.5 p . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.351 -0.843 . . . . 0.0 110.091 179.682 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.098 0.475 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -62.08 -55.06 32.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.032 -1.042 . . . . 0.0 110.764 -179.661 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -59.76 -50.89 72.05 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.208 -0.932 . . . . 0.0 110.217 -179.544 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 12' ' ' PHE . 22.9 mt -48.91 -42.74 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.045 -1.034 . . . . 0.0 109.664 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.02 -43.1 99.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 109.571 179.301 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -58.65 -29.1 66.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 109.555 179.463 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 12.5 m-85 -72.91 -36.23 67.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.279 -0.888 . . . . 0.0 109.934 179.656 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -70.46 -27.1 63.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.917 . . . . 0.0 109.858 179.623 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.83 -43.83 52.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.352 -0.843 . . . . 0.0 109.845 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.56 -42.86 86.45 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.246 -0.909 . . . . 0.0 109.7 179.484 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -57.14 -44.62 83.54 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.269 -0.894 . . . . 0.0 109.651 179.685 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 98.3 p -64.12 -35.6 81.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -0.904 . . . . 0.0 109.337 179.388 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.676 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -58.69 -33.17 69.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.466 -0.771 . . . . 0.0 109.381 179.438 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.504 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 3.5 m-30 -87.09 -24.08 24.69 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.39 -0.819 . . . . 0.0 109.92 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.422 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 66.7 t0 -101.69 92.67 4.96 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.334 -0.854 . . . . 0.0 109.912 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.52 -14.29 15.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 110.59 -179.548 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -78.89 -37.34 40.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.184 -0.948 . . . . 0.0 110.299 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.72 83.13 1.71 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 23.5 p-10 -156.53 -32.41 0.09 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.122 -1.223 . . . . 0.0 111.207 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.451 ' C ' HG23 ' A' ' 26' ' ' THR . . . 101.81 22.85 9.76 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.56 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.451 HG23 ' C ' ' A' ' 25' ' ' GLY . 75.9 p -149.69 155.01 39.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.164 -1.198 . . . . 0.0 109.988 179.863 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.5 mt -109.43 124.93 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.069 -1.02 . . . . 0.0 110.218 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.801 HG22 HG21 ' A' ' 62' ' ' THR . 41.4 p -108.0 -159.01 0.67 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.426 -0.796 . . . . 0.0 110.189 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.794 HG22 HD12 ' A' ' 52' ' ' ILE . 32.0 p -90.23 -34.04 15.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.218 179.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.49 -58.88 6.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -0.906 . . . . 0.0 109.995 -179.952 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 19' ' ' PHE . 48.8 mt-10 -60.49 -54.64 43.03 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.32 -0.862 . . . . 0.0 109.709 179.831 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.646 HD23 HD11 ' A' ' 48' ' ' LEU . 2.8 tp -57.26 -20.18 26.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.269 -0.894 . . . . 0.0 109.713 179.533 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.35 -46.85 46.84 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 179.542 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.437 ' O ' ' CB ' ' A' ' 38' ' ' SER . 38.4 m -68.8 -20.22 64.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.447 -1.031 . . . . 0.0 109.805 179.349 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.857 ' O ' HD12 ' A' ' 39' ' ' LEU . 54.9 t -75.48 -58.1 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.385 -0.822 . . . . 0.0 110.332 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.506 ' CE ' ' CE ' ' A' ' 51' ' ' MET . 58.7 mtt -72.9 -18.8 61.38 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.279 -0.888 . . . . 0.0 110.785 -179.391 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -89.93 -29.33 18.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.021 -1.049 . . . . 0.0 110.09 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 34' ' ' THR . 40.5 t -82.41 -30.73 29.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.237 -0.915 . . . . 0.0 110.101 179.756 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.857 HD12 ' O ' ' A' ' 35' ' ' VAL . 1.3 mt -104.35 64.93 0.77 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.376 -0.828 . . . . 0.0 109.663 179.608 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.22 78.16 1.34 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.411 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -63.24 88.38 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.282 -1.128 . . . . 0.0 110.55 -179.459 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.534 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 3.2 m120 -114.28 -66.66 0.03 OUTLIER Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.375 -0.828 . . . . 0.0 110.689 179.72 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.534 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 47.1 Cg_endo -73.49 -169.44 0.54 Allowed 'Trans proline' 0 C--N 1.32 -0.934 0 O-C-N 123.092 1.048 . . . . 0.0 110.341 179.484 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 35.0 p -138.54 -175.3 4.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.321 -0.862 . . . . 0.0 110.07 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -66.56 -31.5 72.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.222 -0.923 . . . . 0.0 109.974 179.683 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.23 -67.28 0.5 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 0.0 109.953 179.73 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -50.6 -31.11 15.02 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.354 -0.841 . . . . 0.0 109.688 179.718 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.646 HD11 HD23 ' A' ' 32' ' ' LEU . 8.8 tt -65.63 -47.94 73.89 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.395 -0.815 . . . . 0.0 110.066 179.65 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.419 ' OE1' HG21 ' A' ' 29' ' ' THR . 4.6 tp-100 -54.46 -44.95 72.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 109.217 179.465 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 1.0 OUTLIER -67.87 -27.35 66.6 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.345 -0.847 . . . . 0.0 109.307 179.355 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.506 ' CE ' ' CE ' ' A' ' 36' ' ' MET . 20.2 ttp -76.15 -15.18 60.12 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.497 -0.752 . . . . 0.0 109.719 179.413 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.794 HD12 HG22 ' A' ' 29' ' ' THR . 6.4 mt -90.51 -38.45 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.132 -0.98 . . . . 0.0 109.823 179.378 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -52.99 -28.64 24.91 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.158 -0.964 . . . . 0.0 109.75 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.475 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 9.6 pt-20 -79.95 -33.84 39.27 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 109.541 179.245 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.475 ' N ' ' HG3' ' A' ' 54' ' ' GLU . 85.3 t -69.48 -65.76 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.192 -0.943 . . . . 0.0 109.202 178.973 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -56.35 101.51 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.435 -0.791 . . . . 0.0 109.845 179.419 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.43 58.36 0.8 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.128 -0.983 . . . . 0.0 110.711 -179.523 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.425 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 15.3 m-20 -141.81 -49.79 0.39 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.261 -0.899 . . . . 0.0 109.852 179.565 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.64 50.77 0.55 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.647 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.412 ' OD1' ' HB2' ' A' ' 58' ' ' ASP . 7.7 p-10 -129.14 -48.29 1.21 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.27 -1.135 . . . . 0.0 110.443 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.95 -86.66 0.13 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.3 -1.429 . . . . 0.0 110.8 179.6 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.801 HG21 HG22 ' A' ' 28' ' ' THR . 73.7 p -91.22 170.59 9.88 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.246 -1.149 . . . . 0.0 111.34 -178.662 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.423 ' CD1' HG11 ' A' ' 55' ' ' VAL . 33.1 mt -88.9 159.7 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.515 -0.741 . . . . 0.0 109.917 179.628 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.425 ' HB2' ' OE1' ' A' ' 67' ' ' GLU . 20.7 t0 -108.29 -176.93 3.19 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.276 -0.89 . . . . 0.0 110.417 -179.969 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.583 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 23.5 t80 -72.81 -43.79 8.49 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.406 -0.809 . . . . 0.0 111.174 179.86 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.7 Cg_endo -72.18 -19.08 26.45 Favored 'Trans proline' 0 C--O 1.213 -0.748 0 O-C-N 123.122 1.064 . . . . 0.0 110.562 -179.844 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.425 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 39.9 mt-10 -78.57 -27.81 45.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.021 -1.049 . . . . 0.0 108.919 179.029 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 7.5 t80 -76.88 -48.62 17.81 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.287 0.565 . . . . 0.0 110.419 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.739 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 17.0 tp -78.26 -17.39 56.73 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.193 -0.942 . . . . 0.0 111.236 -179.388 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.405 ' CB ' ' O ' ' A' ' 66' ' ' PRO . 43.1 m -87.77 -38.83 15.42 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.706 -1.246 . . . . 0.0 110.56 -179.797 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.518 ' HE2' ' CE ' ' A' ' 72' ' ' MET . 4.8 ptt? -78.38 -31.62 48.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.157 -0.964 . . . . 0.0 110.332 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.518 ' CE ' ' HE2' ' A' ' 71' ' ' MET . 48.2 mtt -89.79 -9.58 48.7 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.156 -0.965 . . . . 0.0 110.671 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.141 -0.974 . . . . 0.0 110.394 -179.808 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 121.183 0.516 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 26.1 mm -67.02 -29.93 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.449 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -56.52 10.03 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.158 -0.964 . . . . 0.0 109.838 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -55.08 -42.33 72.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.346 -0.846 . . . . 0.0 110.161 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.41 -39.3 92.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.9 . . . . 0.0 110.558 -179.667 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.44 ' O ' ' CB ' ' A' ' 93' ' ' ASP . 5.0 t80 -63.46 -33.26 75.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.914 -1.116 . . . . 0.0 110.387 -179.631 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -75.52 -55.04 6.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.086 -1.009 . . . . 0.0 111.003 -179.481 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.562 HG23 ' N ' ' A' ' 92' ' ' PHE . 19.2 m -56.26 -42.9 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.095 -1.003 . . . . 0.0 110.813 -179.35 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.752 ' CE1' HD12 ' A' ' 105' ' ' LEU . 30.3 m-85 -77.44 -20.77 54.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.135 -0.978 . . . . 0.0 110.211 179.88 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 89' ' ' PHE . 35.5 t0 -113.71 53.21 0.78 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.154 -0.966 . . . . 0.0 109.471 179.127 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -86.36 56.17 3.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.543 -0.723 . . . . 0.0 110.757 -179.419 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.462 ' OD2' ' HB2' ' A' ' 97' ' ' ASN . 26.3 p-10 -158.26 29.94 0.25 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.103 -0.998 . . . . 0.0 110.335 179.731 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.44 33.12 4.2 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.524 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.462 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 18.1 t-20 -91.93 -60.01 1.97 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.236 -1.155 . . . . 0.0 110.083 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.458 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 112.07 -5.49 27.14 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.742 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.559 ' CD1' ' NE2' ' A' ' 135' ' ' GLN . 37.3 m-85 -138.93 140.06 38.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.938 -1.331 . . . . 0.0 110.465 -179.826 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 39.5 mt -85.97 118.25 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.315 -0.866 . . . . 0.0 110.161 179.813 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.3 t -102.91 174.15 6.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.451 -0.781 . . . . 0.0 109.462 179.514 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.25 -41.21 73.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.039 -1.038 . . . . 0.0 109.988 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.42 -54.55 44.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.211 -0.931 . . . . 0.0 110.091 179.64 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.403 ' OE2' ' OD2' ' A' ' 95' ' ' ASP . 45.9 mt-10 -59.58 -45.34 92.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.224 -0.922 . . . . 0.0 110.043 179.765 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.857 HD23 HG13 ' A' ' 121' ' ' VAL . 32.5 tp -58.52 -21.12 51.26 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.429 -0.794 . . . . 0.0 110.534 -179.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.8 ttt-85 -83.52 -40.08 19.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.213 -0.929 . . . . 0.0 110.097 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -73.22 -22.65 60.39 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.28 -0.887 . . . . 0.0 110.125 179.88 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 97.3 t -89.92 -44.15 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -0.882 . . . . 0.0 110.068 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 4.7 mmt -49.5 -24.41 2.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.908 . . . . 0.0 110.163 179.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 64.6 p -82.34 -41.75 19.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 110.081 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -57.04 -45.18 83.36 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.234 -0.917 . . . . 0.0 110.177 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.421 ' HB2' ' OE1' ' A' ' 114' ' ' GLU . 80.4 mt -64.12 -55.91 18.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.317 -0.865 . . . . 0.0 110.31 -179.969 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 142.52 53.07 0.04 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.758 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.421 ' OE1' ' HB2' ' A' ' 112' ' ' LEU . 49.5 mp0 -139.11 -62.83 0.53 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.168 -1.195 . . . . 0.0 110.068 179.693 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 114' ' ' GLU . 70.3 tttt 55.78 104.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.299 -0.876 . . . . 0.0 110.417 179.751 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.58 -175.82 3.24 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.165 -0.959 . . . . 0.0 110.529 -179.948 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.428 HG23 ' H ' ' A' ' 120' ' ' GLU . 9.5 t -87.89 -177.8 5.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.361 -0.837 . . . . 0.0 110.184 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -68.96 -34.8 75.93 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.178 -0.951 . . . . 0.0 110.448 -179.875 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -65.47 -53.24 45.45 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.232 -0.917 . . . . 0.0 110.779 -179.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.428 ' H ' HG23 ' A' ' 117' ' ' THR . 5.7 mm-40 -54.32 -50.45 67.35 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.127 -0.983 . . . . 0.0 110.56 -179.54 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.857 HG13 HD23 ' A' ' 105' ' ' LEU . 56.1 t -56.44 -47.98 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.162 -0.961 . . . . 0.0 110.133 -179.978 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -62.68 -23.69 67.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.184 -0.948 . . . . 0.0 109.868 179.677 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.434 ' HG3' ' OE1' ' A' ' 127' ' ' GLU . 16.5 tp10 -75.07 -30.01 60.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.395 -0.816 . . . . 0.0 109.917 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.757 ' CE ' HD21 ' A' ' 105' ' ' LEU . 23.3 mtm -77.33 -46.24 23.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.368 -0.833 . . . . 0.0 110.1 -179.978 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 24.9 mm -68.7 -33.22 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.025 -1.047 . . . . 0.0 109.879 179.698 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -71.97 -55.86 6.69 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.392 -0.818 . . . . 0.0 110.636 -179.63 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.434 ' OE1' ' HG3' ' A' ' 123' ' ' GLU . 54.5 mt-10 -61.06 -36.4 79.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.176 -0.953 . . . . 0.0 110.116 -179.768 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.55 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -70.23 -26.98 64.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.814 179.799 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -63.3 94.69 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.867 . . . . 0.0 109.991 179.76 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 128' ' ' ALA . 97.8 mt -79.8 -43.94 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.218 -0.926 . . . . 0.0 110.854 -179.646 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 23.4 p30 -79.27 -19.51 50.4 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.016 -1.053 . . . . 0.0 110.791 -179.655 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 79.0 70.79 1.29 Allowed Glycine 0 N--CA 1.495 2.632 0 C-N-CA 120.031 -1.081 . . . . 0.0 110.53 179.344 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -125.5 -26.67 3.53 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.186 -1.185 . . . . 0.0 110.578 179.545 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 118.35 -37.43 3.24 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.689 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.559 ' NE2' ' CD1' ' A' ' 99' ' ' TYR . 9.0 pt20 -113.14 156.72 22.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.278 -1.13 . . . . 0.0 109.922 179.81 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.42 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 62.4 t -99.5 118.41 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.203 -0.935 . . . . 0.0 110.423 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 37.8 p30 -93.25 -163.93 1.11 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.244 -0.91 . . . . 0.0 110.131 179.669 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.554 ' O ' HG23 ' A' ' 142' ' ' VAL . 23.2 t80 -69.63 -62.55 1.34 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.095 -1.003 . . . . 0.0 111.127 -179.289 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -44.06 -59.48 2.29 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.275 -0.891 . . . . 0.0 111.191 -179.121 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 144' ' ' MET . 51.7 mt-10 -51.44 -51.37 55.48 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 121.198 -0.939 . . . . 0.0 110.538 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 137' ' ' ASN . 0.8 OUTLIER -54.08 -31.3 51.37 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.291 -0.88 . . . . 0.0 110.551 -179.582 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 138' ' ' TYR . 94.9 t -72.1 -62.86 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.285 -0.884 . . . . 0.0 110.691 -179.51 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -64.9 -9.66 22.84 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.222 -0.924 . . . . 0.0 110.87 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.55 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 49.3 ttp -59.46 -60.54 3.69 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.13 -0.981 . . . . 0.0 110.786 -179.704 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.453 ' HG3' ' HE3' ' A' ' 144' ' ' MET . 38.3 mtt -89.88 -44.3 10.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.448 -0.783 . . . . 0.0 110.857 -179.368 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.05 -1.031 . . . . 0.0 110.122 -179.901 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.355 0.598 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -66.49 -44.59 82.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.375 -0.828 . . . . 0.0 110.331 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.435 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 7.3 tt0 -55.67 -47.25 77.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 110.177 -179.856 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.0 mt -60.07 -40.6 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.052 -1.03 . . . . 0.0 109.482 179.427 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.79 -26.91 68.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.349 -0.844 . . . . 0.0 109.329 179.15 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 38.2 tt0 -67.64 -46.49 72.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.347 -0.846 . . . . 0.0 109.365 179.411 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -63.53 -32.11 73.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.908 . . . . 0.0 109.465 179.157 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.17 -40.44 82.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.5 -0.75 . . . . 0.0 110.165 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -63.14 -45.26 92.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.2 -0.937 . . . . 0.0 110.187 -179.835 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.33 -37.39 87.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.141 -0.974 . . . . 0.0 110.074 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -63.92 -37.38 87.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.189 -0.945 . . . . 0.0 109.945 179.862 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.9 m -65.9 -39.93 91.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.388 -0.82 . . . . 0.0 110.286 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.658 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.5 tm? -66.56 -35.96 81.49 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.183 -0.948 . . . . 0.0 110.13 -179.936 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.436 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 12.0 m-30 -69.65 -64.78 0.81 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.224 -0.923 . . . . 0.0 109.931 179.718 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -83.0 96.07 8.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.35 -0.844 . . . . 0.0 109.856 179.674 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.422 ' HD3' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -109.66 48.57 0.88 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.256 -0.902 . . . . 0.0 110.524 -179.758 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -131.22 -35.24 1.37 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.105 -0.997 . . . . 0.0 110.368 179.768 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.32 86.21 1.49 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 21.1 p-10 -178.13 -34.19 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.302 -1.117 . . . . 0.0 110.617 179.654 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.519 ' C ' HG23 ' A' ' 26' ' ' THR . . . 83.91 42.19 7.78 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.131 179.633 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.519 HG23 ' C ' ' A' ' 25' ' ' GLY . 59.3 p -151.28 107.47 3.44 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.095 -1.238 . . . . 0.0 110.389 179.875 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.4 mt -74.68 124.63 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.828 179.559 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.9 p -112.78 -157.21 0.61 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.332 -0.855 . . . . 0.0 110.08 -179.865 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.524 ' HA ' HD21 ' A' ' 48' ' ' LEU . 38.0 p -87.53 -27.06 22.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.212 -0.93 . . . . 0.0 110.253 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -70.72 -56.8 5.58 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.147 -0.97 . . . . 0.0 109.676 179.553 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.485 ' O ' HG23 ' A' ' 35' ' ' VAL . 50.8 mt-10 -57.27 -36.08 70.55 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.303 -0.873 . . . . 0.0 109.685 179.555 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.868 HD22 HD11 ' A' ' 52' ' ' ILE . 9.0 tp -68.87 -31.78 70.96 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.349 -0.845 . . . . 0.0 109.707 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.82 -41.6 98.77 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.413 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 66.1 m -72.42 -33.65 67.28 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.317 -1.108 . . . . 0.0 109.967 179.771 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 31' ' ' GLU . 53.7 t -71.15 -26.98 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.377 -0.827 . . . . 0.0 110.444 -179.958 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.1 mmt -86.91 -32.29 20.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 110.467 -179.619 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 -90.79 -11.07 40.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.228 -0.92 . . . . 0.0 110.775 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 97.3 p -97.41 -23.03 16.26 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.981 -1.074 . . . . 0.0 110.48 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.6 mt -107.79 -46.85 3.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.118 -0.989 . . . . 0.0 110.388 -179.871 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.65 84.01 0.1 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.3 tp60 -50.92 161.32 0.38 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.357 -1.084 . . . . 0.0 110.558 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.519 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.3 t30 177.03 -56.3 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.488 -0.758 . . . . 0.0 109.976 179.647 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 42' ' ' ASN . 54.6 Cg_endo -76.76 -163.2 0.19 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.483 1.254 . . . . 0.0 110.864 179.671 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.669 HG23 ' N ' ' A' ' 45' ' ' GLU . 11.1 t -137.18 -140.19 0.15 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.077 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.669 ' N ' HG23 ' A' ' 44' ' ' THR . 52.1 mt-10 -97.89 -45.22 6.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.818 -1.176 . . . . 0.0 110.031 179.593 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.51 -52.98 26.2 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.198 -0.939 . . . . 0.0 109.618 179.389 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -59.07 -20.91 57.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.364 -0.835 . . . . 0.0 109.723 179.639 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.753 ' HG ' HD23 ' A' ' 32' ' ' LEU . 7.9 tt -71.93 -53.43 13.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.895 . . . . 0.0 109.481 179.368 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -50.92 -42.76 59.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.219 179.253 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -63.92 -39.69 94.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.362 -0.837 . . . . 0.0 109.6 179.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.429 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 36.4 ttp -66.21 -19.42 65.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -0.878 . . . . 0.0 109.566 179.375 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.868 HD11 HD22 ' A' ' 32' ' ' LEU . 5.6 mm -84.26 -29.73 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.407 -0.808 . . . . 0.0 109.683 179.413 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -71.6 -46.42 59.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.398 -0.814 . . . . 0.0 110.888 -179.45 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.641 ' HG3' HG23 ' A' ' 55' ' ' VAL . 24.2 pt-20 -51.35 -33.96 31.83 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.101 -1.0 . . . . 0.0 110.379 -179.711 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.641 HG23 ' HG3' ' A' ' 54' ' ' GLU . 48.6 t -82.15 -39.77 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.247 -0.908 . . . . 0.0 110.147 179.943 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -78.31 111.72 14.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.395 -0.816 . . . . 0.0 110.562 -179.67 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.77 54.98 0.65 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.206 -0.934 . . . . 0.0 109.925 179.741 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -134.96 -53.91 0.81 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.401 -0.812 . . . . 0.0 109.891 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 128.45 60.54 0.12 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.662 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.491 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 6.8 p-10 -151.34 -52.78 0.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -1.115 . . . . 0.0 110.131 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.6 -5.89 9.87 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.785 179.032 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.5 p -120.96 141.69 50.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.79 -1.418 . . . . 0.0 110.573 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 77.1 mt -92.32 121.38 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -0.949 . . . . 0.0 110.11 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.421 ' OD2' ' HD2' ' A' ' 66' ' ' PRO . 9.7 t70 -84.2 -167.0 1.59 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.285 -0.885 . . . . 0.0 110.196 -179.778 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.59 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 40.5 t80 -78.32 -44.38 2.13 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.05 -1.031 . . . . 0.0 111.631 -179.674 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.0 Cg_endo -70.76 -21.56 28.68 Favored 'Trans proline' 0 N--CA 1.482 0.802 0 O-C-N 123.079 1.041 . . . . 0.0 110.505 -179.579 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 71' ' ' MET . 53.0 mt-10 -81.12 -27.78 35.4 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.191 -0.943 . . . . 0.0 109.174 179.227 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.542 ' CE2' ' CE ' ' A' ' 72' ' ' MET . 36.0 t80 -77.26 -36.38 54.48 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.492 -0.755 . . . . 0.0 109.813 179.612 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.549 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 13.7 tp -76.81 -32.49 57.66 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.404 -0.81 . . . . 0.0 110.235 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 97.1 m -80.88 -23.78 38.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.337 -0.852 . . . . 0.0 110.41 -179.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.616 ' HG3' HG13 ' A' ' 55' ' ' VAL . 13.8 tmm? -84.33 -45.3 12.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.256 -0.903 . . . . 0.0 110.372 -179.723 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.542 ' CE ' ' CE2' ' A' ' 68' ' ' PHE . 9.5 mtt -79.17 -16.42 56.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 110.671 -179.272 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.095 -1.003 . . . . 0.0 108.902 179.098 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.158 0.504 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.566 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 60.3 mt -55.76 -35.89 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.138 -0.976 . . . . 0.0 110.114 -179.781 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.0 tpt180 -64.4 -53.0 55.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.956 . . . . 0.0 109.358 179.346 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -57.29 -23.57 49.31 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.358 -0.839 . . . . 0.0 109.443 179.28 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 85' ' ' ILE . . . -67.92 -60.47 2.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.416 -0.802 . . . . 0.0 109.859 179.768 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -55.76 -24.17 33.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.175 -0.953 . . . . 0.0 110.16 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.496 ' NE ' ' HA ' ' A' ' 90' ' ' ARG . 8.6 tpm_? -73.0 -58.29 3.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.317 -0.864 . . . . 0.0 110.707 -179.723 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.2 m -70.36 -12.14 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.121 -0.987 . . . . 0.0 110.684 -179.592 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -101.05 -13.31 18.27 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.091 -1.006 . . . . 0.0 110.606 -179.8 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -132.71 44.44 2.86 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.094 -1.004 . . . . 0.0 110.329 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.71 3.57 22.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.118 -0.989 . . . . 0.0 110.769 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 3.0 p30 -70.58 -30.74 67.52 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.134 -0.979 . . . . 0.0 110.573 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.8 34.94 1.94 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -179.361 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.404 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 23.1 t-20 -110.16 -47.36 3.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.355 -1.085 . . . . 0.0 110.319 -179.679 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 125.24 -35.32 3.12 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.833 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 0.8 OUTLIER -132.8 169.56 16.55 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.075 -1.25 . . . . 0.0 109.663 -179.753 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 38.3 mt -80.63 129.19 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.112 -0.992 . . . . 0.0 109.62 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.9 t -118.56 174.02 6.5 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.333 -0.855 . . . . 0.0 109.814 179.714 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.19 -38.76 78.82 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.155 -0.966 . . . . 0.0 110.048 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.66 87.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.237 -0.915 . . . . 0.0 110.033 179.746 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.636 ' O ' HG23 ' A' ' 108' ' ' VAL . 33.1 mt-10 -62.03 -54.13 45.88 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.246 -0.909 . . . . 0.0 110.094 179.825 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.575 HD21 ' HE3' ' A' ' 109' ' ' MET . 4.3 tt -47.76 -34.36 8.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 110.1 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.8 ttt-85 -70.97 -44.05 66.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.293 -0.879 . . . . 0.0 110.329 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 48.1 m170 -69.94 -10.4 58.42 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.129 -0.982 . . . . 0.0 110.622 -179.824 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 104' ' ' GLU . 61.5 t -92.29 -57.06 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.124 -0.985 . . . . 0.0 110.538 -179.749 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.575 ' HE3' HD21 ' A' ' 105' ' ' LEU . 64.8 mtt -71.41 -26.81 62.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.194 -0.941 . . . . 0.0 110.584 -179.693 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.2 m -69.35 -42.32 75.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.201 -0.937 . . . . 0.0 110.29 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -75.02 -34.33 61.9 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.188 -0.945 . . . . 0.0 110.265 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.2 mt -60.62 -32.2 71.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.168 -0.958 . . . . 0.0 110.229 179.923 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.42 -13.7 4.28 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.64 134.55 34.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -1.175 . . . . 0.0 110.27 -179.961 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -101.61 120.23 40.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.945 . . . . 0.0 110.208 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.83 179.25 4.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.21 -0.931 . . . . 0.0 110.546 -179.766 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.527 HG22 ' H ' ' A' ' 118' ' ' ASP . 17.7 m -122.56 175.88 6.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.406 -0.809 . . . . 0.0 109.944 179.741 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.527 ' H ' HG22 ' A' ' 117' ' ' THR . 1.4 m-20 -65.54 -51.95 56.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.161 -0.962 . . . . 0.0 110.544 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -64.97 -34.82 79.35 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.084 -1.01 . . . . 0.0 110.446 -179.807 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.416 ' HA ' ' OE1' ' A' ' 120' ' ' GLU . 7.9 mm-40 -61.37 -46.04 91.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.108 -0.995 . . . . 0.0 110.079 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.4 t -64.06 -56.47 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 109.808 179.656 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -51.4 -26.3 7.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.975 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 30.5 tt0 -70.09 -52.97 19.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.18 179.982 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.477 ' HE2' HD21 ' A' ' 105' ' ' LEU . 42.4 mtp -58.21 -48.22 81.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.174 -0.954 . . . . 0.0 110.141 179.875 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 25.7 mm -60.89 -29.24 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.072 -1.018 . . . . 0.0 109.599 179.585 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.402 ' HB3' ' O ' ' A' ' 123' ' ' GLU . 22.6 ttm180 -66.74 -40.83 88.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.374 -0.829 . . . . 0.0 109.991 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -70.48 -28.37 64.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.285 -0.884 . . . . 0.0 110.237 179.919 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.411 ' O ' HG13 ' A' ' 130' ' ' ILE . . . -80.32 -25.05 39.52 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.311 -0.868 . . . . 0.0 110.469 -179.819 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -70.11 92.16 0.73 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.227 -0.921 . . . . 0.0 109.995 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 128' ' ' ALA . 74.4 mt -85.31 -34.54 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.3 -0.875 . . . . 0.0 110.594 -179.639 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 6.3 p30 -84.98 -25.79 27.54 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.073 -1.017 . . . . 0.0 110.299 179.845 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.455 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 89.94 71.56 1.25 Allowed Glycine 0 N--CA 1.494 2.562 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.316 179.337 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.411 ' OD2' ' OD1' ' A' ' 131' ' ' ASP . 73.1 m-20 -136.5 -38.69 0.66 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.205 -1.173 . . . . 0.0 110.021 179.294 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 121.96 -7.28 10.12 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.507 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -126.61 150.92 48.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.157 -1.202 . . . . 0.0 110.153 179.953 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.2 t -115.2 109.41 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.19 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -82.34 -167.73 1.7 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.18 -0.95 . . . . 0.0 110.195 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -62.18 -45.22 94.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.255 -0.903 . . . . 0.0 111.284 -179.134 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -62.69 -56.73 14.99 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.942 -1.099 . . . . 0.0 110.921 -179.248 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 144' ' ' MET . 50.5 mt-10 -57.1 -24.27 52.89 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.13 -0.981 . . . . 0.0 110.725 -179.591 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.474 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 89.2 t80 -78.66 -35.09 45.78 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.232 -0.917 . . . . 0.0 110.944 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 84.6 t -83.09 -22.96 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.108 -0.995 . . . . 0.0 110.869 -179.509 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -92.53 -23.42 19.09 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.18 -0.95 . . . . 0.0 110.882 -179.617 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.486 ' HE2' ' HE3' ' A' ' 145' ' ' MET . 1.0 OUTLIER -71.29 -20.26 62.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.003 -1.061 . . . . 0.0 110.496 -179.707 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.486 ' HE3' ' HE2' ' A' ' 144' ' ' MET . 63.5 mtt -84.85 -70.37 0.58 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.223 -0.923 . . . . 0.0 110.537 -179.694 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 59.0 p . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.2 -0.938 . . . . 0.0 110.183 -179.672 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.464 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.6 pt-20 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.102 0.477 . . . . 0.0 110.119 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -65.34 -64.9 0.75 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.104 -0.998 . . . . 0.0 109.985 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -55.13 -39.97 70.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.144 -0.973 . . . . 0.0 109.476 179.685 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 6' ' ' GLU . 55.3 mt -56.8 -37.73 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.389 -0.819 . . . . 0.0 109.478 179.315 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.97 -43.06 99.63 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.278 -0.889 . . . . 0.0 109.341 179.386 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.03 -36.73 82.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.486 -0.759 . . . . 0.0 109.837 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -76.03 -20.08 58.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.406 -0.808 . . . . 0.0 109.665 179.525 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -79.53 -33.53 41.88 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.289 -0.882 . . . . 0.0 109.416 179.183 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -74.27 -39.95 62.65 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.391 -0.818 . . . . 0.0 109.857 179.735 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.75 -48.31 39.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.2 -0.938 . . . . 0.0 109.599 179.54 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.555 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 1.2 t80 -58.68 -34.07 70.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.415 -0.803 . . . . 0.0 109.47 179.334 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.2 t -72.11 -38.49 69.31 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.465 -0.772 . . . . 0.0 109.817 179.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.854 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.2 tm? -65.92 -24.06 66.75 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.526 -0.734 . . . . 0.0 109.663 179.768 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.462 ' HA ' ' CG2' ' A' ' 35' ' ' VAL . 17.0 m-85 -82.15 -59.29 2.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.323 -0.861 . . . . 0.0 110.339 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.417 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 7.9 t0 -76.52 97.49 4.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 109.772 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.442 ' HD2' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -110.53 46.37 1.05 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.068 -1.02 . . . . 0.0 110.843 -179.644 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.404 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 12.0 p-10 -132.33 -33.31 1.29 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.236 -0.915 . . . . 0.0 110.513 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.38 76.32 1.05 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.89 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 15.3 p-10 -159.49 -45.26 0.05 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.02 -1.283 . . . . 0.0 110.579 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.9 -2.97 25.79 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.728 -1.225 . . . . 0.0 110.324 179.674 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 34.5 p -121.1 165.16 15.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.943 -1.328 . . . . 0.0 110.197 179.878 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.3 mt -112.64 130.24 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.187 -0.946 . . . . 0.0 110.094 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.6 p -114.5 177.05 4.78 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.429 -0.794 . . . . 0.0 109.895 -179.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.608 ' HA ' HD21 ' A' ' 48' ' ' LEU . 12.7 p -66.67 -28.67 68.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 0.0 110.112 179.877 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -57.66 6.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -0.933 . . . . 0.0 109.905 179.521 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.417 ' OE1' ' HA ' ' A' ' 20' ' ' ASP . 28.4 mt-10 -57.23 -56.01 27.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 0.0 110.123 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.061 HD22 HD11 ' A' ' 52' ' ' ILE . 1.4 tp -57.51 -24.71 57.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.855 179.665 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.408 ' HA2' ' CD1' ' A' ' 48' ' ' LEU . . . -65.74 -42.9 95.0 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.846 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.1 m -76.16 -23.14 54.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.3 -1.117 . . . . 0.0 110.04 179.835 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.462 ' CG2' ' HA ' ' A' ' 19' ' ' PHE . 54.9 t -72.57 -42.54 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.402 -0.811 . . . . 0.0 110.526 -179.727 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.404 ' O ' ' O ' ' A' ' 40' ' ' GLY . 22.5 mmt -90.13 -14.93 32.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.167 -0.958 . . . . 0.0 110.735 -179.692 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -90.65 -59.91 2.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.209 -0.932 . . . . 0.0 111.076 -179.348 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.0 m -59.76 -51.44 69.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.254 -0.904 . . . . 0.0 111.361 -178.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.9 mp -69.53 -30.45 68.29 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.1 -1.0 . . . . 0.0 111.207 -178.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 36' ' ' MET . . . -161.42 80.57 0.14 Allowed Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.229 -1.462 . . . . 0.0 110.422 -179.775 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -55.94 126.97 28.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.163 -1.198 . . . . 0.0 109.725 179.365 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.516 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 3.0 t30 -171.53 -60.91 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.224 -0.923 . . . . 0.0 110.609 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.516 ' HD3' ' HB3' ' A' ' 42' ' ' ASN . 44.1 Cg_endo -70.01 -161.84 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.249 1.131 . . . . 0.0 110.117 179.801 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 7.9 t -150.96 -178.67 6.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.931 . . . . 0.0 110.282 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -59.89 -33.6 72.06 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.246 -0.909 . . . . 0.0 110.464 -179.798 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.1 -70.66 0.25 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.211 -0.93 . . . . 0.0 110.257 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -49.76 -25.05 2.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.104 -0.997 . . . . 0.0 109.713 179.762 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.716 ' HG ' HD23 ' A' ' 32' ' ' LEU . 3.6 tt -65.21 -60.01 3.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.465 -0.772 . . . . 0.0 109.719 179.466 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.402 ' O ' ' OD1' ' A' ' 53' ' ' ASN . 8.9 tt0 -50.5 -33.91 23.17 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.296 -0.878 . . . . 0.0 109.756 179.616 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -61.57 -46.43 89.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.191 -0.943 . . . . 0.0 109.967 179.809 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.428 ' HA ' ' HG2' ' A' ' 54' ' ' GLU . 21.8 mtm -65.58 -22.59 66.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.929 . . . . 0.0 109.82 179.667 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.061 HD11 HD22 ' A' ' 32' ' ' LEU . 39.7 mm -80.88 -23.26 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.251 -0.906 . . . . 0.0 109.969 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 49' ' ' GLN . 5.1 m120 -88.34 -26.62 22.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.303 -0.873 . . . . 0.0 110.2 179.885 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.531 ' HG3' HG23 ' A' ' 55' ' ' VAL . 10.7 pt-20 -77.69 -24.3 49.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.201 -0.937 . . . . 0.0 110.075 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.531 HG23 ' HG3' ' A' ' 54' ' ' GLU . 78.8 t -88.86 -54.53 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.673 179.454 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.413 ' OD2' ' OD1' ' A' ' 60' ' ' ASN . 12.8 t70 -67.09 120.32 13.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.405 -0.809 . . . . 0.0 110.051 179.82 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.6 30.94 5.83 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.16 -0.962 . . . . 0.0 110.663 -179.66 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -113.33 -60.87 1.82 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.116 -0.99 . . . . 0.0 110.088 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.52 -18.25 1.3 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.729 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.413 ' OD1' ' OD2' ' A' ' 56' ' ' ASP . 17.0 p30 -69.52 -29.48 67.1 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.175 -1.191 . . . . 0.0 110.295 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.623 ' O ' HG22 ' A' ' 52' ' ' ILE . . . 99.18 -52.61 1.08 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.754 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.406 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 66.0 p -72.11 146.49 47.46 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.183 -1.186 . . . . 0.0 110.38 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.412 ' O ' ' HB ' ' A' ' 26' ' ' THR . 64.3 mt -86.43 161.09 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 110.254 179.908 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -111.81 -173.35 2.23 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.371 -0.831 . . . . 0.0 109.898 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.562 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 5.0 t80 -75.6 -44.82 4.25 Favored Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.235 -0.915 . . . . 0.0 111.423 -179.882 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.0 Cg_endo -73.33 -23.89 17.18 Favored 'Trans proline' 0 C--N 1.322 -0.845 0 O-C-N 123.288 1.151 . . . . 0.0 110.255 -179.259 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -77.23 -29.09 53.96 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.252 -0.905 . . . . 0.0 109.1 179.094 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.644 ' CE2' ' HE2' ' A' ' 72' ' ' MET . 47.8 t80 -73.54 -50.74 19.81 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.545 -0.722 . . . . 0.0 110.309 179.826 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.96 -30.98 71.26 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.304 -0.873 . . . . 0.0 110.965 -179.527 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 78.9 m -71.1 -40.91 71.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.172 -0.955 . . . . 0.0 110.983 -179.388 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.454 ' HE1' ' HE1' ' A' ' 72' ' ' MET . 0.0 OUTLIER -89.94 -9.37 49.07 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.903 -1.123 . . . . 0.0 110.95 -179.51 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.644 ' HE2' ' CE2' ' A' ' 68' ' ' PHE . 15.6 mmt -90.26 -19.89 23.6 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.989 -1.07 . . . . 0.0 110.556 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.721 0 O-C-N 121.155 -0.966 . . . . 0.0 110.354 -179.874 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.071 0.463 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.48 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 38.9 mt -64.93 -60.23 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.141 -0.974 . . . . 0.0 110.263 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -51.57 -50.49 60.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.174 -0.954 . . . . 0.0 109.711 179.922 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 49.7 mt-10 -50.05 -41.6 48.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 0.0 109.79 179.52 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 85' ' ' ILE . . . -56.2 -50.27 71.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.34 -0.85 . . . . 0.0 110.032 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.475 ' CZ ' ' O ' ' A' ' 98' ' ' GLY . 2.3 t80 -57.34 -28.76 63.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.262 -0.899 . . . . 0.0 110.213 179.983 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.413 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 3.7 tpt180 -71.1 -45.88 62.83 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.342 -0.849 . . . . 0.0 111.185 -179.442 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 88' ' ' ALA . 34.4 m -77.17 -20.35 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.088 -1.007 . . . . 0.0 110.775 -179.33 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.432 ' HA ' HG21 ' A' ' 108' ' ' VAL . 10.0 m-85 -89.58 -17.04 29.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.169 -0.957 . . . . 0.0 109.904 179.631 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.408 ' OD1' HG12 ' A' ' 100' ' ' ILE . 4.4 m-20 -126.89 81.32 2.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.295 -0.878 . . . . 0.0 110.144 179.863 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -104.35 49.96 0.8 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.398 -0.814 . . . . 0.0 110.483 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 3.1 p30 -141.56 -43.58 0.36 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.089 -1.007 . . . . 0.0 110.705 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.486 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 147.97 -57.18 0.49 Allowed Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.28 -1.438 . . . . 0.0 110.995 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.473 ' ND2' ' OD1' ' A' ' 95' ' ' ASP . 22.6 p30 -43.56 -31.23 0.7 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.141 -1.211 . . . . 0.0 111.161 -178.738 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.475 ' O ' ' CZ ' ' A' ' 89' ' ' PHE . . . 80.14 -8.19 53.01 Favored Glycine 0 N--CA 1.495 2.6 0 C-N-CA 119.803 -1.189 . . . . 0.0 110.477 179.561 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -89.41 131.81 35.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.962 -1.316 . . . . 0.0 109.989 179.917 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.409 HD11 ' CE1' ' A' ' 89' ' ' PHE . 16.6 mt -78.99 112.32 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.185 -0.947 . . . . 0.0 109.796 -179.949 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 44.6 t -96.56 155.91 16.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.264 -0.897 . . . . 0.0 110.154 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.64 -44.74 77.43 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.141 -0.974 . . . . 0.0 110.063 -179.956 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.96 -58.7 6.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.827 . . . . 0.0 110.016 179.844 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.718 ' O ' HG23 ' A' ' 108' ' ' VAL . 47.2 mt-10 -51.51 -38.99 56.74 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.317 -0.865 . . . . 0.0 110.224 179.847 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.79 HD12 HD11 ' A' ' 125' ' ' ILE . 0.4 OUTLIER -58.81 -41.82 87.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.349 -0.844 . . . . 0.0 109.829 179.937 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.419 ' O ' ' HB ' ' A' ' 110' ' ' THR . 48.1 ttp180 -68.2 -25.51 65.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.384 -0.822 . . . . 0.0 109.942 179.807 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -90.95 -12.66 35.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.329 -0.857 . . . . 0.0 110.373 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 104' ' ' GLU . 77.2 t -91.17 -64.61 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.255 -0.903 . . . . 0.0 110.316 -179.939 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.621 ' HA ' HD12 ' A' ' 112' ' ' LEU . 57.8 mtt -61.13 -51.18 70.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.251 -0.906 . . . . 0.0 110.367 -179.693 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 106' ' ' ARG . 36.8 m -50.99 -29.52 12.56 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.266 -0.896 . . . . 0.0 110.304 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -78.69 -46.09 19.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.184 -0.948 . . . . 0.0 110.406 -179.944 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.621 HD12 ' HA ' ' A' ' 109' ' ' MET . 12.8 mt -48.83 -73.98 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.143 -0.973 . . . . 0.0 110.109 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.85 66.59 0.02 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.872 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -136.9 -176.37 4.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.313 -1.11 . . . . 0.0 110.068 179.714 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -130.18 87.96 2.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.948 . . . . 0.0 110.374 -179.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.8 mt -125.93 -171.88 2.48 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.284 -0.885 . . . . 0.0 110.137 179.857 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.6 t -143.91 -159.95 1.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.138 -0.976 . . . . 0.0 110.201 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.63 -42.16 25.45 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.077 -1.014 . . . . 0.0 110.917 -179.525 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -59.61 -55.49 33.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.942 . . . . 0.0 111.125 -179.469 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -51.72 -38.48 55.39 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.196 -0.94 . . . . 0.0 111.058 -179.445 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 73.9 t -67.7 -47.47 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.158 -0.963 . . . . 0.0 110.457 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.79 -36.38 72.11 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.333 -0.855 . . . . 0.0 110.137 -179.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 36.6 tt0 -72.5 -35.15 68.07 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.324 -0.86 . . . . 0.0 109.633 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.411 ' HB3' ' HE3' ' A' ' 124' ' ' MET . 5.7 mmm -59.03 -60.34 4.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.271 -0.893 . . . . 0.0 109.936 179.466 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.79 HD11 HD12 ' A' ' 105' ' ' LEU . 27.9 mm -56.69 -41.89 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.372 -0.83 . . . . 0.0 110.376 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 16.5 ttp180 -57.09 -36.81 71.03 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -0.907 . . . . 0.0 110.191 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 49.7 mt-10 -67.09 -49.65 64.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.197 -0.94 . . . . 0.0 110.087 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.54 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -80.03 -2.33 43.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.349 -0.844 . . . . 0.0 110.665 -179.811 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 59.6 t0 -90.29 71.75 7.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.947 -1.096 . . . . 0.0 110.299 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.488 HG13 ' N ' ' A' ' 131' ' ' ASP . 23.4 pt -70.52 -41.94 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -0.929 . . . . 0.0 111.171 -179.561 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.488 ' N ' HG13 ' A' ' 130' ' ' ILE . 50.6 p-10 -67.28 -19.42 65.49 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.963 -1.086 . . . . 0.0 111.264 -179.173 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 75.45 75.93 0.8 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.909 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -146.35 15.0 1.29 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.379 -1.071 . . . . 0.0 110.56 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 60.27 34.89 86.54 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.684 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -171.01 167.16 7.32 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.13 -1.217 . . . . 0.0 110.061 179.563 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 84.6 t -131.0 120.29 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.155 -0.966 . . . . 0.0 110.18 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -94.54 -165.07 1.25 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.209 -0.932 . . . . 0.0 110.9 -179.637 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -66.91 -58.58 4.72 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.356 -0.84 . . . . 0.0 111.307 -178.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -47.61 -51.74 20.25 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.845 -1.159 . . . . 0.0 110.381 -179.548 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -58.71 -34.91 71.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.103 -0.998 . . . . 0.0 109.97 179.62 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.421 ' HA ' ' SD ' ' A' ' 144' ' ' MET . 6.5 t80 -64.94 -32.72 74.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.514 -0.741 . . . . 0.0 110.623 -179.762 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.4 t -82.96 -23.92 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.261 -0.899 . . . . 0.0 110.586 -179.471 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -90.26 -17.47 27.4 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.133 -0.979 . . . . 0.0 110.422 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.54 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 17.0 ptt? -90.09 -27.82 19.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.145 -0.972 . . . . 0.0 110.376 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 27.7 tpp -88.9 -65.45 1.02 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.287 -0.883 . . . . 0.0 110.439 -179.607 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 146' ' ' THR . 5.1 t . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.151 -0.968 . . . . 0.0 110.438 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.237 0.542 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 4.4 m-20 -110.02 148.25 32.02 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.23 -0.919 . . . . 0.0 110.455 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.421 ' CD ' ' N ' ' A' ' 3' ' ' GLN . 1.9 mp0 -108.31 114.35 28.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.318 -0.864 . . . . 0.0 109.872 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.3 pp -68.45 149.21 49.57 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.203 -0.935 . . . . 0.0 110.144 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.9 p -122.06 146.66 46.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.28 -0.887 . . . . 0.0 110.218 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -57.18 -17.07 9.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.3 -0.875 . . . . 0.0 110.307 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -56.37 -42.6 78.11 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.932 . . . . 0.0 110.502 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -56.24 -52.52 64.15 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.211 -0.93 . . . . 0.0 110.196 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.3 mt -55.26 -40.95 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 109.941 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.29 -37.56 80.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.893 . . . . 0.0 109.613 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -61.17 -48.99 79.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.423 -0.798 . . . . 0.0 109.9 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -65.8 -25.21 67.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.411 -0.806 . . . . 0.0 109.992 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.6 mtpt -75.84 -30.68 59.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.33 -0.856 . . . . 0.0 109.705 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -71.08 -41.5 70.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 0.0 109.556 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.605 ' HB1' ' CZ ' ' A' ' 19' ' ' PHE . . . -68.27 -39.63 82.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.383 -0.823 . . . . 0.0 109.761 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -56.17 -55.07 37.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.377 -0.827 . . . . 0.0 110.088 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.2 m -60.65 -35.13 75.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.35 -0.844 . . . . 0.0 110.348 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.947 ' O ' HD23 ' A' ' 18' ' ' LEU . 4.9 tt -63.68 -29.42 70.66 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.191 -0.943 . . . . 0.0 110.202 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.605 ' CZ ' ' HB1' ' A' ' 15' ' ' ALA . 12.3 m-85 -79.37 -57.76 3.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 0.0 110.485 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -61.2 106.27 0.59 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.127 -0.983 . . . . 0.0 109.97 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -109.6 47.61 0.93 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.228 -0.92 . . . . 0.0 110.726 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -162.44 22.22 0.1 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.245 -0.91 . . . . 0.0 110.504 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 47.58 78.32 0.09 OUTLIER Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -134.91 -36.83 0.82 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.223 -1.163 . . . . 0.0 110.57 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.91 -23.43 35.64 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.5 p -118.05 143.44 46.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.407 -1.055 . . . . 0.0 109.971 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 44.3 mt -92.03 113.01 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.259 -0.9 . . . . 0.0 110.427 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.524 ' HA ' HG22 ' A' ' 62' ' ' THR . 80.9 p -97.11 -176.52 3.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 109.906 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.5 p -74.84 -28.49 60.7 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.253 -0.904 . . . . 0.0 110.07 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -70.81 -54.1 12.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 109.71 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.427 ' O ' HG23 ' A' ' 35' ' ' VAL . 91.5 mt-10 -56.1 -52.42 64.38 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.281 -0.887 . . . . 0.0 109.057 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.935 HD22 HD11 ' A' ' 52' ' ' ILE . 3.7 tp -55.05 -33.54 62.79 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.456 -0.778 . . . . 0.0 109.367 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.59 -49.78 67.5 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.2 m -69.17 -21.19 64.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.326 -1.102 . . . . 0.0 109.785 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 19' ' ' PHE . 54.8 t -73.47 -31.03 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.446 -0.784 . . . . 0.0 109.787 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.2 mmt -90.91 -24.27 20.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.894 . . . . 0.0 110.189 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -84.36 -20.86 31.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.253 -0.905 . . . . 0.0 110.448 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.6 m -88.07 -19.34 27.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.197 -0.939 . . . . 0.0 110.151 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.468 ' CD1' H141 ' A' ' 153' ' ' WW7 . 90.5 mt -89.16 -78.35 0.35 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.269 -0.894 . . . . 0.0 110.295 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.73 55.74 0.2 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -152.67 157.96 41.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.227 -1.16 . . . . 0.0 110.299 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.512 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 80.5 m-20 -143.04 48.6 1.01 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.157 -0.964 . . . . 0.0 110.58 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.512 ' CD ' ' N ' ' A' ' 42' ' ' ASN . 42.5 Cg_endo -68.8 -159.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.653 1.344 . . . . 0.0 110.082 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.512 HG22 ' H ' ' A' ' 45' ' ' GLU . 18.0 m -130.88 175.38 9.11 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.929 -1.107 . . . . 0.0 110.442 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.512 ' H ' HG22 ' A' ' 44' ' ' THR . 13.6 tp10 -67.38 -32.71 73.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.272 -0.893 . . . . 0.0 110.054 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.02 -64.8 0.84 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 110.184 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 2.3 mt-10 -50.03 -38.93 40.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -1.0 . . . . 0.0 109.668 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.523 HD11 HD23 ' A' ' 32' ' ' LEU . 10.1 tt -57.65 -50.28 73.67 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.373 -0.829 . . . . 0.0 109.459 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -50.18 -38.25 38.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -0.939 . . . . 0.0 109.408 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 47' ' ' GLU . 36.3 m-20 -62.63 -42.83 99.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.377 -0.827 . . . . 0.0 109.77 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.9 ttp -67.05 -15.87 63.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.266 -0.896 . . . . 0.0 109.645 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.935 HD11 HD22 ' A' ' 32' ' ' LEU . 45.9 mm -88.66 -25.67 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.178 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -58.36 -36.6 73.71 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.111 -0.993 . . . . 0.0 110.124 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.848 ' HG3' HG23 ' A' ' 55' ' ' VAL . 8.2 pt-20 -74.21 -23.78 59.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.92 . . . . 0.0 109.993 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.848 HG23 ' HG3' ' A' ' 54' ' ' GLU . 42.8 t -98.8 23.53 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.905 . . . . 0.0 110.051 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -135.4 112.92 10.71 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.342 -0.849 . . . . 0.0 109.92 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.94 34.42 3.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.176 -0.952 . . . . 0.0 110.211 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 2.6 p30 -141.54 -34.12 0.49 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.373 -0.829 . . . . 0.0 110.843 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 95.44 52.84 1.65 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.449 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 24.6 p-10 -122.34 -12.32 8.24 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.442 -1.034 . . . . 0.0 110.682 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.786 ' O ' HG23 ' A' ' 62' ' ' THR . . . 78.42 27.56 57.25 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.206 -1.157 . . . . 0.0 110.206 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 61' ' ' GLY . 0.9 OUTLIER -163.02 167.18 22.78 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.149 -1.206 . . . . 0.0 110.204 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.744 HD13 HG11 ' A' ' 55' ' ' VAL . 63.5 mt -117.39 150.6 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.12 -0.987 . . . . 0.0 110.127 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.445 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 1.5 m-20 -112.58 -162.97 0.82 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.316 -0.865 . . . . 0.0 110.425 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.609 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 7.0 t80 -81.55 -40.67 1.03 Allowed Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.411 -0.806 . . . . 0.0 111.914 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.4 Cg_endo -70.81 -21.4 28.65 Favored 'Trans proline' 0 N--CA 1.482 0.795 0 O-C-N 122.993 0.996 . . . . 0.0 110.974 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.425 ' OE1' ' OD1' ' A' ' 64' ' ' ASP . 57.2 mt-10 -86.12 -35.22 20.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.91 -1.119 . . . . 0.0 109.411 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.487 ' CZ ' ' SD ' ' A' ' 72' ' ' MET . 11.6 t80 -70.78 -38.49 73.41 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.419 -0.801 . . . . 0.0 110.417 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.484 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 1.1 tp -80.55 -37.14 31.98 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.203 -0.936 . . . . 0.0 110.709 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 88.9 m -71.35 -20.34 62.17 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.824 -1.173 . . . . 0.0 110.487 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 61.4 ttp -88.77 -42.33 11.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.139 -0.976 . . . . 0.0 110.86 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.487 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 59.0 mtt -90.51 -9.7 46.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.053 -1.03 . . . . 0.0 111.541 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -85.07 -9.95 57.41 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.845 -1.16 . . . . 0.0 110.519 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -84.14 -81.56 0.18 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.068 -1.02 . . . . 0.0 110.293 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.496 ' O ' ' CB ' ' A' ' 76' ' ' MET . 52.5 mttp -107.43 -87.11 0.49 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.273 -0.892 . . . . 0.0 110.656 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.496 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 19.4 ttt 80.14 -40.48 0.19 Allowed 'General case' 0 N--CA 1.525 3.28 0 O-C-N 121.904 -0.498 . . . . 0.0 111.077 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -157.11 -173.47 4.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.808 -1.182 . . . . 0.0 109.923 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -138.92 114.3 9.66 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.104 -0.998 . . . . 0.0 110.631 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.6 m -130.89 80.25 1.93 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.411 -0.805 . . . . 0.0 109.85 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -56.23 141.49 40.92 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.241 -0.912 . . . . 0.0 110.611 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.435 ' HA ' ' OH ' ' A' ' 138' ' ' TYR . 33.7 t -133.62 102.35 5.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.372 -0.83 . . . . 0.0 110.104 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 51.9 tt0 -119.4 160.48 22.23 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.254 -0.904 . . . . 0.0 110.106 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -65.55 -11.11 40.94 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.255 -0.903 . . . . 0.0 110.715 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.5 ' HA ' ' N2 ' ' A' ' 154' ' ' WW7 . 41.7 mm-40 -88.9 -65.17 1.05 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 110.389 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.741 HD12 ' HD1' ' A' ' 141' ' ' PHE . 38.8 mm -66.23 -10.23 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.224 -0.923 . . . . 0.0 110.339 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 2.5 ttt180 -73.48 -54.71 7.6 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.254 -0.904 . . . . 0.0 109.845 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.609 ' HB2' HN21 ' A' ' 154' ' ' WW7 . 49.9 mt-10 -66.35 -35.52 80.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.362 -0.836 . . . . 0.0 109.615 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.714 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -57.32 -54.16 49.94 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.499 -0.751 . . . . 0.0 110.356 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.35 -27.41 69.0 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.882 -1.136 . . . . 0.0 110.247 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.35 -25.82 62.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.147 -0.971 . . . . 0.0 110.503 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.714 HG22 ' O ' ' A' ' 88' ' ' ALA . 34.3 m -95.1 -21.34 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.074 -1.016 . . . . 0.0 110.669 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.534 ' CZ ' ' H2 ' ' A' ' 154' ' ' WW7 . 21.7 m-85 -93.58 -11.91 30.71 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.16 -0.963 . . . . 0.0 110.574 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.425 ' OD2' ' HA2' ' A' ' 98' ' ' GLY . 40.5 t0 -114.23 92.1 3.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.209 -0.932 . . . . 0.0 110.269 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.49 -6.52 14.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.124 -0.985 . . . . 0.0 110.709 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.43 ' OD2' ' ND2' ' A' ' 97' ' ' ASN . 2.7 p-10 -91.93 -39.77 11.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.954 -1.091 . . . . 0.0 110.213 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 128.52 -35.36 2.69 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.546 -1.311 . . . . 0.0 111.091 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.52 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 42.4 p30 -47.88 -22.82 0.62 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.81 -1.406 . . . . 0.0 111.18 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.45 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 75.56 42.76 26.09 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 97' ' ' ASN . 77.2 m-85 -152.5 146.32 25.16 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.223 -1.163 . . . . 0.0 109.909 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.435 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 26.5 mt -94.41 121.28 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.171 -0.956 . . . . 0.0 109.994 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 74.5 m -109.01 151.36 26.44 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.477 -0.764 . . . . 0.0 109.956 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.41 ' HA ' HG13 ' A' ' 125' ' ' ILE . . . -51.23 -36.26 40.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.13 -0.981 . . . . 0.0 110.3 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.19 -59.87 4.41 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.287 -0.883 . . . . 0.0 110.307 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -48.39 -51.23 27.49 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.189 -0.945 . . . . 0.0 110.161 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.872 HD23 HG13 ' A' ' 121' ' ' VAL . 13.0 tp -49.24 -40.58 34.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.917 . . . . 0.0 110.15 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -62.46 -41.41 98.74 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.224 -0.923 . . . . 0.0 110.492 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -77.21 -12.92 60.01 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.191 -0.943 . . . . 0.0 110.823 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 53.2 t -88.57 -37.06 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.97 -1.081 . . . . 0.0 110.366 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 26.5 mmt -69.52 -32.27 71.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.147 -0.971 . . . . 0.0 110.471 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.0 p -76.36 -28.66 56.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.088 -1.008 . . . . 0.0 110.156 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -75.05 -44.16 49.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.222 -0.924 . . . . 0.0 110.176 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.7 mt -54.26 -36.28 63.43 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.187 -0.946 . . . . 0.0 110.369 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 122.87 31.37 1.03 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -116.19 -156.2 0.61 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.195 -1.179 . . . . 0.0 109.929 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -161.03 84.05 0.66 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.218 -0.926 . . . . 0.0 110.332 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.409 ' HG ' ' OE1' ' A' ' 120' ' ' GLU . 4.9 mp -108.68 131.82 54.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.336 -0.852 . . . . 0.0 110.08 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 19.8 m -77.94 159.99 28.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.221 -0.925 . . . . 0.0 110.224 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.0 -33.12 16.97 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.202 -0.936 . . . . 0.0 110.522 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -61.26 -42.47 98.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.153 -0.967 . . . . 0.0 110.54 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.409 ' OE1' ' HG ' ' A' ' 116' ' ' LEU . 85.4 mt-10 -67.71 -45.23 75.66 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.309 -0.87 . . . . 0.0 111.1 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.872 HG13 HD23 ' A' ' 105' ' ' LEU . 41.2 t -61.71 -56.21 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.049 -1.032 . . . . 0.0 110.605 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -52.07 -46.18 65.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.285 -0.884 . . . . 0.0 110.441 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -63.02 -33.1 74.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.295 -0.878 . . . . 0.0 110.242 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.423 ' HB3' ' HE2' ' A' ' 124' ' ' MET . 80.6 mtp -65.24 -62.52 1.49 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.882 . . . . 0.0 109.873 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.851 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 21.9 mm -49.81 -30.38 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 110.148 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.0 ttt180 -70.24 -41.08 74.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.292 -0.88 . . . . 0.0 110.447 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.75 -28.7 68.62 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.215 -0.928 . . . . 0.0 110.485 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.656 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -93.58 -17.01 23.8 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.119 -0.988 . . . . 0.0 110.753 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.93 ' OD1' HG22 ' A' ' 136' ' ' VAL . 1.6 m-20 -81.25 82.63 7.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.026 -1.047 . . . . 0.0 110.942 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.486 HG13 ' N ' ' A' ' 131' ' ' ASP . 21.9 pt -89.47 -32.49 5.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-O 121.429 0.633 . . . . 0.0 110.169 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 51.6 p-10 -121.83 -13.13 8.32 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.502 -0.749 . . . . 0.0 111.432 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . -95.2 -63.51 0.99 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.593 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 1.2 m-20 59.96 100.49 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.515 -0.991 . . . . 0.0 108.48 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 105.11 -20.97 36.86 Favored Glycine 0 C--N 1.294 -1.777 0 N-CA-C 107.824 -2.11 . . . . 0.0 107.824 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -162.1 153.23 17.96 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.659 -0.906 . . . . 0.0 109.859 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.93 HG22 ' OD1' ' A' ' 129' ' ' ASP . 46.5 t -122.1 152.66 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.258 -0.902 . . . . 0.0 110.532 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -129.95 -168.77 2.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.874 . . . . 0.0 110.594 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.435 ' OH ' ' HA ' ' A' ' 81' ' ' SER . 1.7 t80 -59.57 -64.33 0.98 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.376 -0.828 . . . . 0.0 111.09 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -43.27 -55.46 4.01 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.4 -0.813 . . . . 0.0 111.146 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.479 ' OE2' ' HA ' ' A' ' 129' ' ' ASP . 5.9 mt-10 -48.44 -51.4 27.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.189 -0.945 . . . . 0.0 110.978 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.741 ' HD1' HD12 ' A' ' 85' ' ' ILE . 2.9 t80 -59.65 -32.96 70.94 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.061 -1.024 . . . . 0.0 110.967 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.693 HG22 HG21 ' A' ' 85' ' ' ILE . 57.9 t -76.42 -27.16 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.068 -1.02 . . . . 0.0 111.506 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 46.1 tp60 -98.27 -11.09 22.98 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.88 -1.138 . . . . 0.0 110.882 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.656 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 19.7 ptt? -91.33 -34.18 15.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.014 -1.054 . . . . 0.0 110.642 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.48 ' HE3' ' CE1' ' A' ' 141' ' ' PHE . 23.4 tpp -82.83 -40.14 20.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 110.41 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 68.2 p -92.0 130.38 37.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.086 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -175.16 128.4 0.28 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.181 -0.949 . . . . 0.0 110.395 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 28.2 mmtt . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.138 179.78 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' WW7 . . . . . 0.619 'CL1 ' HD13 ' A' ' 32' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' WW7 . . . . . 0.851 'CL1 ' HD13 ' A' ' 125' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.211 0.529 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.54 128.34 35.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 109.846 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -106.1 -12.77 15.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.098 -1.001 . . . . 0.0 110.76 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 54.0 mt -97.02 32.02 2.25 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.037 -1.039 . . . . 0.0 110.12 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.2 m -73.39 -56.54 4.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 110.148 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -81.82 -30.85 32.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 110.217 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -50.3 -34.5 23.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.263 -0.898 . . . . 0.0 109.874 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.538 ' HG2' ' CE2' ' A' ' 12' ' ' PHE . 45.0 tt0 -59.73 -48.29 82.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.395 -0.815 . . . . 0.0 109.95 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.7 mt -59.56 -45.1 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.033 -1.042 . . . . 0.0 109.597 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.33 -25.76 64.46 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.387 -0.821 . . . . 0.0 109.505 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 15.0 tp10 -69.02 -44.76 72.1 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.377 -0.827 . . . . 0.0 109.707 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.538 ' CE2' ' HG2' ' A' ' 8' ' ' GLN . 20.3 m-85 -62.28 -47.7 83.15 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.253 -0.904 . . . . 0.0 109.808 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -56.17 -46.67 79.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.353 -0.842 . . . . 0.0 109.964 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -52.96 -46.17 68.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.22 -0.925 . . . . 0.0 109.631 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.458 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -58.92 -44.25 91.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.376 -0.827 . . . . 0.0 110.044 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.456 ' CE1' ' CD1' ' A' ' 27' ' ' ILE . 37.8 t80 -51.31 -40.72 59.62 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.11 -0.994 . . . . 0.0 109.742 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.4 t -66.1 -38.29 87.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -0.888 . . . . 0.0 109.595 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.494 ' C ' HD23 ' A' ' 18' ' ' LEU . 10.5 tt -57.96 -31.78 67.2 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.325 -0.859 . . . . 0.0 109.956 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.512 ' HA ' HG21 ' A' ' 35' ' ' VAL . 32.1 m-85 -87.29 -25.59 23.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.313 -0.867 . . . . 0.0 110.287 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -100.92 114.47 28.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.313 -0.867 . . . . 0.0 109.925 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -103.7 -28.07 11.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.191 -0.943 . . . . 0.0 110.794 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.42 ' OD1' ' HB2' ' A' ' 24' ' ' ASP . 4.1 p30 -92.6 11.46 26.48 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.12 -0.988 . . . . 0.0 110.633 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 47.84 47.94 24.61 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.42 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 7.4 t70 -84.81 -27.45 26.8 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.263 -1.139 . . . . 0.0 110.501 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.09 -27.81 14.84 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.4 p -125.81 148.62 49.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.214 -1.168 . . . . 0.0 110.24 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.456 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 83.0 mt -96.03 126.84 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.293 -0.879 . . . . 0.0 110.114 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.7 p -108.8 -162.82 0.83 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.368 -0.832 . . . . 0.0 110.171 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.1 p -86.47 -28.36 23.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -0.987 . . . . 0.0 110.225 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -65.9 -58.36 5.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 109.698 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -54.95 -55.66 28.27 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.305 -0.872 . . . . 0.0 109.834 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.964 HD22 HD11 ' A' ' 52' ' ' ILE . 2.7 tp -54.16 -29.17 44.47 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.349 -0.845 . . . . 0.0 109.705 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.72 -49.68 73.83 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.0 m -68.81 -23.06 64.23 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.169 -1.195 . . . . 0.0 110.219 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.512 HG21 ' HA ' ' A' ' 19' ' ' PHE . 16.6 t -72.47 -37.77 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.275 -0.89 . . . . 0.0 109.881 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.4 mmt -90.28 -10.35 44.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 110.468 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -89.18 -36.66 15.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.134 -0.979 . . . . 0.0 110.658 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 72.8 p -79.33 -36.76 38.97 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.131 -0.981 . . . . 0.0 110.412 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.36 -11.19 55.14 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.268 -0.895 . . . . 0.0 110.482 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 151.07 89.6 0.07 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.69 143.8 57.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -1.118 . . . . 0.0 111.05 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.555 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 10.5 m-20 -159.85 -64.93 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.416 -0.803 . . . . 0.0 109.497 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.555 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 49.4 Cg_endo -74.47 150.22 40.6 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.423 1.222 . . . . 0.0 109.446 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 72.7 p -90.33 -137.79 0.14 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.054 -1.029 . . . . 0.0 109.415 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -100.9 -37.82 8.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.784 -1.198 . . . . 0.0 109.188 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 49' ' ' GLN . . . -75.24 -58.1 3.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.409 -0.807 . . . . 0.0 109.236 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -51.81 -40.79 61.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.32 -0.862 . . . . 0.0 109.048 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.623 HD21 HD23 ' A' ' 32' ' ' LEU . 9.4 tt -58.01 -42.61 85.61 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.611 -0.681 . . . . 0.0 109.182 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.414 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 35.1 tt0 -53.04 -39.71 63.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.905 . . . . 0.0 108.901 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -65.32 -37.32 86.76 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.218 -0.926 . . . . 0.0 108.66 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.418 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 13.5 ttt -66.39 -18.52 65.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.465 -0.772 . . . . 0.0 109.309 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.964 HD11 HD22 ' A' ' 32' ' ' LEU . 33.3 mm -82.39 -31.69 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.372 -0.83 . . . . 0.0 109.802 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -59.33 -49.64 77.05 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.454 -0.779 . . . . 0.0 110.526 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.491 ' HG3' HG23 ' A' ' 55' ' ' VAL . 21.7 pt-20 -56.69 -19.16 15.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.079 -1.013 . . . . 0.0 110.124 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.798 HG21 ' C6 ' ' A' ' 153' ' ' WW7 . 56.0 t -94.48 -25.74 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.267 -0.895 . . . . 0.0 110.164 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -97.8 100.66 12.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.217 -0.927 . . . . 0.0 110.458 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -93.41 46.53 1.2 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.219 -0.925 . . . . 0.0 109.982 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -132.02 -66.49 0.7 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.218 -0.926 . . . . 0.0 110.484 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 135.84 53.94 0.06 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.439 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 12.4 p-10 -142.06 -46.41 0.35 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -1.139 . . . . 0.0 110.316 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.19 -72.55 0.48 Allowed Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.656 -1.259 . . . . 0.0 110.531 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.9 p -69.67 169.88 11.96 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.251 -1.147 . . . . 0.0 111.149 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.473 HD13 HG11 ' A' ' 55' ' ' VAL . 42.0 mt -115.83 143.89 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.309 -0.869 . . . . 0.0 110.258 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.42 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 57.3 m-20 -96.12 -168.23 1.71 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.255 -0.903 . . . . 0.0 110.227 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.563 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 57.7 t80 -82.77 -41.78 0.89 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 111.459 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.4 Cg_endo -74.55 -29.34 9.17 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 O-C-N 123.05 1.026 . . . . 0.0 109.968 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -74.12 -27.26 60.78 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.322 -0.861 . . . . 0.0 108.775 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -75.32 -47.43 27.79 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.621 -0.674 . . . . 0.0 110.04 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.892 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 1.8 tt -70.21 -20.76 63.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.297 -0.877 . . . . 0.0 110.167 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.0 m -78.6 -43.23 26.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 110.884 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.511 ' SD ' HG13 ' A' ' 55' ' ' VAL . 64.0 ttp -69.12 -48.18 63.17 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.1 -1.0 . . . . 0.0 110.93 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 28.7 mtt -78.68 -10.89 59.92 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.102 -0.998 . . . . 0.0 110.991 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.892 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . -66.54 -42.15 87.6 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.972 -1.08 . . . . 0.0 110.005 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -108.82 45.96 1.0 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.382 -0.824 . . . . 0.0 110.521 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.06 45.77 1.25 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.022 -1.049 . . . . 0.0 110.666 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 17.6 ptp -83.31 138.74 33.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.095 -1.003 . . . . 0.0 110.34 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -94.49 -20.31 19.78 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.303 -0.873 . . . . 0.0 110.081 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -163.25 157.84 20.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.889 . . . . 0.0 110.185 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 79' ' ' THR . 5.6 t -122.34 69.2 0.96 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.197 -0.939 . . . . 0.0 110.491 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -113.62 170.69 8.07 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.089 -1.007 . . . . 0.0 110.222 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.8 t -155.15 59.99 0.65 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.203 -0.936 . . . . 0.0 110.278 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -123.21 -178.01 3.86 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.244 -0.91 . . . . 0.0 110.196 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 46.13 85.34 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.168 -0.958 . . . . 0.0 110.606 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -90.86 -33.66 15.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.006 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.1 mt -51.53 -30.39 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.398 -0.814 . . . . 0.0 110.133 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -68.57 -42.09 78.8 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.231 -0.918 . . . . 0.0 109.846 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -62.38 -37.44 85.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.273 -0.892 . . . . 0.0 110.164 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.728 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -65.19 -62.44 1.54 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -0.9 . . . . 0.0 110.38 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.42 ' CE2' ' HA ' ' A' ' 138' ' ' TYR . 6.2 t80 -54.92 -28.0 47.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.18 -0.95 . . . . 0.0 110.211 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 -63.39 -53.26 55.25 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.255 -0.903 . . . . 0.0 110.559 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.701 HG23 ' CD1' ' A' ' 92' ' ' PHE . 31.0 m -70.68 -24.86 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.106 -0.996 . . . . 0.0 110.707 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.728 ' CE2' ' HB1' ' A' ' 88' ' ' ALA . 14.3 m-30 -73.41 -28.85 62.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.132 -0.98 . . . . 0.0 110.007 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -108.67 67.63 0.67 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 0.0 109.752 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -77.08 -30.33 55.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.348 -0.845 . . . . 0.0 110.485 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.445 ' OD2' ' HB2' ' A' ' 97' ' ' ASN . 30.8 p-10 -69.24 -7.13 33.89 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.171 -0.956 . . . . 0.0 110.491 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.52 28.57 70.91 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.445 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 1.8 t-20 -80.78 -75.87 0.26 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.296 -1.12 . . . . 0.0 110.01 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 151.18 -25.21 0.99 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.439 ' HB3' ' HB2' ' A' ' 135' ' ' GLN . 14.3 m-85 -118.88 131.69 56.07 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.193 -1.181 . . . . 0.0 110.092 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.447 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 83.3 mt -70.01 128.62 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.146 -0.971 . . . . 0.0 110.084 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 97.9 p -114.6 175.07 5.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.897 . . . . 0.0 110.226 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 105' ' ' LEU . . . -71.14 -53.02 15.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 110.228 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -47.08 -56.62 6.22 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.179 -0.95 . . . . 0.0 110.244 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.465 ' O ' HG23 ' A' ' 108' ' ' VAL . 94.4 mt-10 -58.69 -41.93 87.38 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 109.807 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.825 HD23 HG13 ' A' ' 121' ' ' VAL . 55.1 tp -54.86 -30.54 58.07 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.309 -0.869 . . . . 0.0 110.104 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -77.29 -42.72 35.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.92 . . . . 0.0 110.128 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -62.34 -19.44 63.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 110.312 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 104' ' ' GLU . 47.8 t -92.67 -45.08 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.175 -0.953 . . . . 0.0 110.42 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.491 ' HA ' HD12 ' A' ' 112' ' ' LEU . 26.4 mmt -70.02 -18.34 63.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.272 -0.892 . . . . 0.0 110.555 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.9 m -75.83 -25.27 56.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.155 -0.965 . . . . 0.0 110.033 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -88.38 -38.73 14.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.303 -0.873 . . . . 0.0 110.075 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.491 HD12 ' HA ' ' A' ' 109' ' ' MET . 50.6 mt -58.15 -42.6 86.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.369 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.09 0.83 7.51 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 2.4 mm-40 -72.85 -43.15 62.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.069 -1.253 . . . . 0.0 110.256 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 114' ' ' GLU . 16.7 mmtp 55.74 106.99 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.42 -0.8 . . . . 0.0 110.414 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.4 HD12 ' HB3' ' A' ' 109' ' ' MET . 1.6 mt -131.87 161.46 32.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.261 -0.9 . . . . 0.0 110.21 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.479 HG22 ' N ' ' A' ' 118' ' ' ASP . 67.7 m -86.51 168.18 13.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 0.0 110.06 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.479 ' N ' HG22 ' A' ' 117' ' ' THR . 50.6 m-20 -57.1 -43.64 82.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.268 -0.895 . . . . 0.0 110.688 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -66.31 -33.34 75.51 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.051 -1.031 . . . . 0.0 110.472 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -65.35 -59.12 4.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.044 -1.035 . . . . 0.0 109.908 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.825 HG13 HD23 ' A' ' 105' ' ' LEU . 70.4 t -52.04 -45.4 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.172 -0.955 . . . . 0.0 109.665 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -54.71 -41.47 70.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 0.0 109.528 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -64.57 -33.13 75.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.368 -0.833 . . . . 0.0 109.544 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 26.4 mmm -63.88 -49.54 72.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.879 . . . . 0.0 110.127 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.421 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 34.7 mm -64.83 -26.89 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.352 -0.843 . . . . 0.0 110.245 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -69.76 -50.12 46.38 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.153 -0.967 . . . . 0.0 110.129 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -57.74 -39.3 77.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.166 -0.959 . . . . 0.0 109.733 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.496 ' HB2' ' SD ' ' A' ' 144' ' ' MET . . . -70.9 -30.59 66.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.319 -0.863 . . . . 0.0 109.939 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -70.27 91.12 0.71 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.393 -0.817 . . . . 0.0 110.166 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 65.2 mt -74.69 -50.8 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.201 -0.937 . . . . 0.0 110.817 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 29.1 p30 -69.39 -17.95 63.72 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.104 -0.997 . . . . 0.0 110.877 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 71.49 72.18 0.95 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.407 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 6.6 p30 -125.73 -24.91 3.75 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.236 -1.156 . . . . 0.0 111.237 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 132.59 -24.52 3.89 Favored Glycine 0 N--CA 1.496 2.688 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.33 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 99' ' ' TYR . 2.4 pp0? -140.25 167.51 21.96 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.055 -1.262 . . . . 0.0 110.558 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.447 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 57.9 t -102.86 144.25 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.21 -0.931 . . . . 0.0 110.68 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -106.93 166.22 10.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.363 -0.835 . . . . 0.0 109.476 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.498 ' O ' HG23 ' A' ' 142' ' ' VAL . 51.8 t80 -52.94 -38.67 62.22 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.039 -1.038 . . . . 0.0 110.1 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -67.77 -60.35 2.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.213 -0.93 . . . . 0.0 110.623 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -47.13 -36.45 8.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.208 -0.933 . . . . 0.0 110.745 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.496 ' CD2' ' HE1' ' A' ' 144' ' ' MET . 10.2 t80 -65.51 -46.29 80.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.138 -0.976 . . . . 0.0 110.182 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 138' ' ' TYR . 52.4 t -66.48 -22.61 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.225 -0.922 . . . . 0.0 110.101 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -84.33 -25.29 29.33 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.378 -0.826 . . . . 0.0 111.019 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.496 ' SD ' ' HB2' ' A' ' 128' ' ' ALA . 10.1 ptt? -89.54 -23.1 22.1 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.003 -1.06 . . . . 0.0 110.756 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.551 ' HE3' H121 ' A' ' 154' ' ' WW7 . 38.4 tpp -88.58 -9.76 51.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.257 -0.902 . . . . 0.0 110.815 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 142' ' ' VAL . 14.2 t -114.6 -30.22 6.57 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.077 -1.014 . . . . 0.0 110.719 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -94.81 130.15 41.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.029 -1.044 . . . . 0.0 110.516 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.137 179.895 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' WW7 . . . . . 0.798 ' C6 ' HG21 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' WW7 . . . . . 0.551 H121 ' HE3' ' A' ' 145' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.223 0.535 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.76 -6.04 48.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.261 -0.899 . . . . 0.0 110.446 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.405 ' O ' ' O ' ' A' ' 4' ' ' LEU . 8.5 pt20 -128.74 -177.03 4.03 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.137 -0.977 . . . . 0.0 110.5 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.405 ' O ' ' O ' ' A' ' 3' ' ' GLN . 0.8 OUTLIER -57.12 -162.54 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.319 -0.863 . . . . 0.0 110.396 -179.708 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.51 HG22 ' H ' ' A' ' 7' ' ' GLU . 15.4 m -138.52 149.52 45.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.253 -0.905 . . . . 0.0 109.945 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -76.09 -11.41 59.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.237 -0.914 . . . . 0.0 110.436 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.51 ' H ' HG22 ' A' ' 5' ' ' THR . 36.5 mt-10 -63.72 -26.24 68.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.149 -0.969 . . . . 0.0 110.334 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -68.13 -49.87 58.29 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.194 -0.941 . . . . 0.0 110.014 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.8 mt -61.88 -47.95 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.167 -0.958 . . . . 0.0 109.805 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 13' ' ' LYS . . . -55.24 -39.6 69.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.281 -0.887 . . . . 0.0 109.657 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -58.46 -43.92 89.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.42 -0.8 . . . . 0.0 109.619 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.476 ' CE1' ' HB3' ' A' ' 72' ' ' MET . 35.8 m-85 -63.18 -25.62 68.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.378 -0.826 . . . . 0.0 109.805 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 17.8 mtpt -77.47 -28.26 52.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.333 -0.855 . . . . 0.0 110.249 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 2.6 tt0 -73.05 -42.92 62.59 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.146 -0.972 . . . . 0.0 110.065 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.87 -50.68 16.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.178 -0.951 . . . . 0.0 109.48 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.544 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 77.9 t80 -49.93 -48.03 52.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 109.614 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.7 t -68.82 -35.83 77.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.553 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.917 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.4 tm? -59.34 -24.35 63.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.423 -0.798 . . . . 0.0 109.309 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.425 ' CD1' HG13 ' A' ' 35' ' ' VAL . 13.8 m-85 -87.31 -62.28 1.54 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.513 -0.742 . . . . 0.0 109.68 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -51.65 115.58 1.7 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.53 -0.732 . . . . 0.0 110.076 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -105.85 -36.68 6.93 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.024 -1.048 . . . . 0.0 110.708 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -69.46 -25.83 64.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.148 -0.97 . . . . 0.0 110.167 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.93 95.43 0.42 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.409 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 9.1 p-10 -158.01 -46.3 0.06 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.237 -1.155 . . . . 0.0 110.609 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.523 ' C ' HG23 ' A' ' 26' ' ' THR . . . 126.5 23.88 1.47 Allowed Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.852 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.523 HG23 ' C ' ' A' ' 25' ' ' GLY . 53.8 p -154.89 140.95 18.39 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.799 -1.413 . . . . 0.0 110.618 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 62.2 mt -99.63 112.72 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -0.918 . . . . 0.0 109.759 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.644 HG22 ' H ' ' A' ' 29' ' ' THR . 4.5 m -97.67 -177.87 3.93 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.313 -0.867 . . . . 0.0 110.186 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.923 HG22 HD12 ' A' ' 52' ' ' ILE . 16.8 p -72.9 -31.62 64.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.145 -0.972 . . . . 0.0 110.929 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -62.21 1.58 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.898 -1.126 . . . . 0.0 110.09 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.657 ' O ' HG23 ' A' ' 35' ' ' VAL . 50.8 mt-10 -55.18 -47.63 74.93 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.158 -0.964 . . . . 0.0 109.437 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.705 HD22 HD11 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -55.7 -32.3 63.19 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.281 -0.887 . . . . 0.0 109.608 179.4 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.91 -51.62 57.84 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.9 m -70.27 -12.76 61.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.264 -1.139 . . . . 0.0 110.136 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 31' ' ' GLU . 59.5 t -78.36 -32.08 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.22 -0.925 . . . . 0.0 110.109 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -87.34 -27.52 22.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.108 -0.995 . . . . 0.0 110.205 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.92 -46.2 15.55 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.128 -0.982 . . . . 0.0 109.946 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.6 t -57.08 -22.53 40.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.324 -0.86 . . . . 0.0 110.101 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.524 HD12 ' O ' ' A' ' 35' ' ' VAL . 75.7 mt -95.39 -69.72 0.74 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.341 -0.85 . . . . 0.0 109.997 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.16 88.96 0.07 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.405 ' O ' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -175.82 -56.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.229 -1.159 . . . . 0.0 110.275 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' A' ' 41' ' ' GLN . 41.9 t30 53.97 64.81 6.07 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.172 -0.955 . . . . 0.0 110.244 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -74.85 -163.04 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.765 1.403 . . . . 0.0 110.402 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 47' ' ' GLU . 89.2 m -109.3 151.19 26.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.359 -0.838 . . . . 0.0 109.941 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -59.67 -41.9 91.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 110.03 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.79 -62.14 1.5 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.319 -0.863 . . . . 0.0 110.25 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.435 ' HB3' ' HB ' ' A' ' 44' ' ' THR . 41.6 tt0 -50.07 -24.98 3.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.247 -0.908 . . . . 0.0 109.893 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 44' ' ' THR . 9.2 tt -70.74 -51.27 28.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.434 -0.791 . . . . 0.0 109.612 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -54.03 -30.1 46.31 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.292 -0.88 . . . . 0.0 109.085 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -75.96 -35.43 59.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.493 -0.755 . . . . 0.0 109.561 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.434 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 27.9 ttp -71.04 -19.93 62.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.469 -0.769 . . . . 0.0 110.081 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.923 HD12 HG22 ' A' ' 29' ' ' THR . 10.7 mt -88.15 -36.75 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -0.87 . . . . 0.0 109.684 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -55.0 -40.64 70.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.195 -0.94 . . . . 0.0 109.91 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.504 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 10.0 pt-20 -70.14 -30.58 67.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.256 -0.903 . . . . 0.0 110.131 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.702 HG21 ' C6 ' ' A' ' 153' ' ' WW7 . 59.0 t -74.35 -72.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.353 -0.842 . . . . 0.0 109.328 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -52.03 98.62 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.686 -0.634 . . . . 0.0 110.401 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -87.41 50.03 1.93 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.602 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -138.03 9.28 2.78 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.447 -0.783 . . . . 0.0 110.333 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 53.17 88.02 0.01 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -169.39 -60.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.217 -1.166 . . . . 0.0 110.077 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.404 ' O ' ' CG2' ' A' ' 52' ' ' ILE . . . 136.54 -57.83 0.67 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.436 HG22 HG23 ' A' ' 28' ' ' THR . 68.8 p -90.13 143.51 26.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.203 -1.175 . . . . 0.0 110.712 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.609 HD11 ' CG1' ' A' ' 55' ' ' VAL . 86.6 mt -93.86 151.11 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.453 -0.78 . . . . 0.0 109.68 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.411 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 47.8 m-20 -109.02 -162.79 0.83 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.237 -0.914 . . . . 0.0 110.531 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.547 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 28.1 t80 -79.39 -42.08 1.58 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.359 -0.838 . . . . 0.0 111.355 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 49.3 Cg_endo -75.73 -25.8 10.41 Favored 'Trans proline' 0 N--CA 1.481 0.75 0 O-C-N 123.124 1.065 . . . . 0.0 110.428 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -78.65 -28.06 45.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 0.0 109.188 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.629 ' CE1' ' HE3' ' A' ' 72' ' ' MET . 88.2 t80 -78.11 -44.73 25.31 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.635 -0.666 . . . . 0.0 110.118 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.56 -32.22 60.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 0.0 110.894 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 83.2 m -78.56 -31.44 47.35 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.991 -1.068 . . . . 0.0 110.88 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.43 ' HG3' ' HG3' ' A' ' 72' ' ' MET . 18.7 ptt? -79.93 -31.48 40.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.92 -1.113 . . . . 0.0 110.777 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.629 ' HE3' ' CE1' ' A' ' 68' ' ' PHE . 53.9 mtt -89.22 -10.45 46.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.008 -1.058 . . . . 0.0 110.932 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.02 -21.45 54.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.072 -1.017 . . . . 0.0 110.45 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.425 ' O ' ' O ' ' A' ' 75' ' ' LYS . 4.1 mmt85 -110.52 -28.56 8.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.105 -0.997 . . . . 0.0 110.761 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 74' ' ' ARG . 5.6 mttp 60.79 132.29 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.467 -0.771 . . . . 0.0 110.307 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 89.7 mtp -140.24 174.78 10.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.014 -1.054 . . . . 0.0 110.462 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -108.94 115.12 29.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 110.376 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.418 ' OD2' ' HB2' ' A' ' 54' ' ' GLU . 23.9 t70 -150.36 75.46 1.23 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.337 -0.852 . . . . 0.0 110.091 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.427 HG22 ' OD1' ' A' ' 80' ' ' ASP . 70.8 m -104.3 151.3 23.59 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.313 -0.867 . . . . 0.0 110.146 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.427 ' OD1' HG22 ' A' ' 79' ' ' THR . 0.7 OUTLIER 57.11 115.38 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.513 -0.742 . . . . 0.0 110.861 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.0 t -104.5 74.12 1.14 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.918 . . . . 0.0 109.988 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -99.61 -42.04 7.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.162 -0.961 . . . . 0.0 110.673 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -177.11 101.02 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.249 -0.907 . . . . 0.0 110.333 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -61.24 -43.13 99.38 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.261 -0.899 . . . . 0.0 110.203 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.6 mt -50.46 -23.77 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.146 -0.971 . . . . 0.0 110.255 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.23 -55.26 5.22 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.214 -0.929 . . . . 0.0 110.457 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 47.9 mt-10 -53.58 -38.55 64.01 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.221 -0.925 . . . . 0.0 110.147 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.746 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -65.25 -59.48 4.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.391 -0.818 . . . . 0.0 110.206 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.638 ' CD1' HD11 ' A' ' 100' ' ' ILE . 20.8 t80 -46.15 -28.74 1.31 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.358 -0.839 . . . . 0.0 110.267 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 71.6 mtp180 -71.13 -55.37 8.33 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.252 -0.905 . . . . 0.0 110.422 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.746 HG22 ' O ' ' A' ' 88' ' ' ALA . 32.7 m -61.36 -19.64 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.152 -0.968 . . . . 0.0 110.579 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.559 ' CE2' ' H2 ' ' A' ' 154' ' ' WW7 . 40.9 m-85 -92.12 -21.31 20.5 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.126 -0.984 . . . . 0.0 110.21 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -127.45 37.49 4.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 0.0 109.927 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -85.0 8.07 19.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.898 . . . . 0.0 110.658 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 3.0 p30 -81.92 -22.71 36.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.155 -0.966 . . . . 0.0 110.138 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.437 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 112.18 29.82 3.12 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.473 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 39.0 p-10 -127.09 -15.46 5.28 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.263 -1.139 . . . . 0.0 110.719 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 65.53 11.28 52.7 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.613 ' O ' 'CA ' ' A' ' 151' ' ' ' CA' . 49.8 m-85 -121.41 139.54 53.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.026 -1.279 . . . . 0.0 110.241 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.638 HD11 ' CD1' ' A' ' 89' ' ' PHE . 21.8 mt -91.23 113.37 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.137 -0.977 . . . . 0.0 110.273 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 76.3 p -103.85 156.46 17.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.412 -0.805 . . . . 0.0 109.915 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.77 -34.95 55.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.127 -0.983 . . . . 0.0 110.307 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.42 -62.32 1.48 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.181 -0.949 . . . . 0.0 110.498 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.415 ' OE1' ' OD2' ' A' ' 95' ' ' ASP . 51.4 mt-10 -46.95 -42.98 18.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.179 -0.95 . . . . 0.0 110.254 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.621 HD22 HG13 ' A' ' 121' ' ' VAL . 8.6 tt -55.07 -54.12 47.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.399 -0.813 . . . . 0.0 110.126 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.411 ' O ' ' HG3' ' A' ' 106' ' ' ARG . 3.1 tpt180 -63.1 -19.95 64.91 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.924 . . . . 0.0 109.986 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -77.89 -27.32 49.6 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.286 -0.884 . . . . 0.0 110.14 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.452 HG21 ' CD1' ' A' ' 92' ' ' PHE . 78.4 t -83.77 -40.1 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.315 -0.865 . . . . 0.0 109.903 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.42 ' HG2' ' CD1' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -59.87 -41.9 92.54 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.344 -0.848 . . . . 0.0 110.062 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.1 p -56.01 -44.68 78.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.33 -0.856 . . . . 0.0 110.335 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -61.28 -48.32 81.94 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.243 -0.911 . . . . 0.0 110.132 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.5 mt -64.48 -13.93 54.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.207 -0.933 . . . . 0.0 110.275 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.27 51.44 3.52 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -102.23 -177.47 3.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.129 -1.218 . . . . 0.0 110.015 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.15 47.6 0.99 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.166 -0.959 . . . . 0.0 110.577 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.815 HD23 ' OE1' ' A' ' 120' ' ' GLU . 7.0 mt -75.89 -175.73 3.12 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.264 -0.898 . . . . 0.0 110.158 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.531 HG22 ' N ' ' A' ' 118' ' ' ASP . 88.8 m -135.92 170.08 16.57 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.293 -0.879 . . . . 0.0 110.288 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.531 ' N ' HG22 ' A' ' 117' ' ' THR . 75.1 m-20 -52.87 -33.29 49.25 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.314 -0.866 . . . . 0.0 110.783 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -65.68 -53.1 45.71 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.127 -0.983 . . . . 0.0 110.613 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.815 ' OE1' HD23 ' A' ' 116' ' ' LEU . 74.2 mt-10 -60.57 -48.88 79.8 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.318 -0.864 . . . . 0.0 111.209 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.621 HG13 HD22 ' A' ' 105' ' ' LEU . 95.7 t -55.81 -53.31 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.231 -0.918 . . . . 0.0 110.833 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.75 -36.47 74.4 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.23 -0.919 . . . . 0.0 110.667 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.456 ' CG ' ' OE2' ' A' ' 127' ' ' GLU . 36.9 tt0 -71.63 -24.95 61.96 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.193 -0.942 . . . . 0.0 110.289 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.486 ' HE2' HD11 ' A' ' 105' ' ' LEU . 85.3 mtp -76.63 -49.18 16.87 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.183 -0.948 . . . . 0.0 110.068 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.702 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 19.2 mm -69.08 -26.53 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 110.326 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.43 -39.14 47.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.127 -0.983 . . . . 0.0 110.528 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.456 ' OE2' ' CG ' ' A' ' 123' ' ' GLU . 0.3 OUTLIER -69.78 -31.23 69.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.133 -0.979 . . . . 0.0 110.178 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.11 -27.91 24.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.208 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 56.8 t0 -68.29 93.58 0.48 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.374 -0.829 . . . . 0.0 110.224 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 55.6 mt -75.42 -47.9 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.287 -0.883 . . . . 0.0 110.739 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.409 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 47.7 p30 -73.19 -6.37 45.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.132 -0.98 . . . . 0.0 110.811 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.406 ' HA2' ' OD2' ' A' ' 129' ' ' ASP . . . 57.87 61.98 6.83 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -124.03 8.63 8.65 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.203 -1.175 . . . . 0.0 111.027 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.54 36.19 54.62 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.55 ' NE2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -170.96 137.36 1.19 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.354 -1.086 . . . . 0.0 109.964 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.437 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 46.8 t -110.35 118.16 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.157 -0.965 . . . . 0.0 110.318 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -87.37 177.2 7.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.163 -0.961 . . . . 0.0 110.022 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.538 ' O ' HG23 ' A' ' 142' ' ' VAL . 16.0 t80 -61.5 -45.05 95.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.111 -0.993 . . . . 0.0 110.286 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -53.08 -55.56 22.96 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.282 -0.886 . . . . 0.0 110.077 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.441 ' O ' ' HG2' ' A' ' 144' ' ' MET . 56.7 mt-10 -64.86 -23.36 67.21 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.224 -0.922 . . . . 0.0 109.785 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.542 ' CE1' ' HE2' ' A' ' 145' ' ' MET . 37.9 t80 -75.75 -22.86 56.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.551 -0.718 . . . . 0.0 109.757 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 138' ' ' TYR . 84.9 t -90.1 -24.19 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.369 -0.832 . . . . 0.0 109.928 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -80.43 -34.24 36.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.372 -0.83 . . . . 0.0 110.217 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.573 ' HE3' ' CE ' ' A' ' 145' ' ' MET . 0.1 OUTLIER -82.57 -13.67 56.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.286 -0.884 . . . . 0.0 110.257 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.573 ' CE ' ' HE3' ' A' ' 144' ' ' MET . 15.1 mmt -87.49 -46.66 9.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 110.394 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.3 p -92.97 -53.18 4.25 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.141 -0.974 . . . . 0.0 110.489 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -94.19 -164.72 1.21 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.149 -0.969 . . . . 0.0 110.583 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.6 mttp . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.236 -179.851 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . 0.613 'CA ' ' O ' ' A' ' 99' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' WW7 . . . . . 0.702 ' C6 ' HG21 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' WW7 . . . . . 0.702 'CL1 ' HD13 ' A' ' 125' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.345 0.593 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -135.68 175.28 9.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.365 -0.834 . . . . 0.0 109.985 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -122.35 -177.59 3.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 0.0 109.999 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.607 ' O ' HG23 ' A' ' 5' ' ' THR . 0.4 OUTLIER -151.94 126.67 9.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.173 -0.954 . . . . 0.0 110.262 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.607 HG23 ' O ' ' A' ' 4' ' ' LEU . 2.2 p -156.64 -66.39 0.1 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.171 -0.956 . . . . 0.0 110.313 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -80.21 -9.89 59.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 110.53 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.67 -60.28 3.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.121 -0.987 . . . . 0.0 110.426 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.526 ' HG2' ' CE2' ' A' ' 12' ' ' PHE . 7.9 tt0 -62.7 -43.35 99.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.327 -0.858 . . . . 0.0 110.415 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.8 mt -55.0 -42.23 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.081 -1.012 . . . . 0.0 109.839 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.97 -34.9 78.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.317 -0.865 . . . . 0.0 110.029 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.91 -48.87 78.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 109.779 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.526 ' CE2' ' HG2' ' A' ' 8' ' ' GLN . 24.1 m-85 -60.08 -47.87 84.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.016 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -49.04 -42.04 37.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.17 -0.956 . . . . 0.0 110.072 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -66.5 -37.7 85.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.875 . . . . 0.0 110.307 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.81 -47.87 83.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.142 -0.974 . . . . 0.0 109.971 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -60.27 -45.26 93.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 110.146 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.3 t -62.84 -21.22 65.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.924 . . . . 0.0 109.991 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.73 ' O ' HD23 ' A' ' 18' ' ' LEU . 4.7 tt -85.2 -25.18 27.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 109.939 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.564 ' HA ' HG21 ' A' ' 35' ' ' VAL . 8.3 m-85 -92.74 -67.98 0.83 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.219 -0.926 . . . . 0.0 110.412 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -70.99 86.78 0.72 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.382 -0.823 . . . . 0.0 110.235 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.39 42.54 1.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.342 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -125.18 -43.2 1.96 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.136 -0.977 . . . . 0.0 110.25 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.93 -37.42 1.66 Allowed Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.86 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 49.9 p-10 -55.67 -17.85 6.67 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.96 -1.318 . . . . 0.0 110.952 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.428 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 63.13 13.59 49.52 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 34.0 p -122.21 116.05 23.46 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.023 -1.281 . . . . 0.0 110.286 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 62' ' ' THR . 61.2 mt -69.54 109.25 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.173 -0.954 . . . . 0.0 110.254 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.534 HG22 HG22 ' A' ' 62' ' ' THR . 81.2 p -104.19 -157.85 0.63 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.881 . . . . 0.0 110.204 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.1 p -82.99 -36.85 24.73 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.198 -0.939 . . . . 0.0 110.636 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -64.94 -59.85 3.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.117 -0.99 . . . . 0.0 110.192 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -59.09 -52.5 65.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.166 -0.958 . . . . 0.0 109.805 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.717 HD23 HD21 ' A' ' 48' ' ' LEU . 2.6 tp -59.45 -21.82 60.6 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.241 -0.912 . . . . 0.0 109.682 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -68.23 -44.61 74.88 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 70.8 m -71.63 -34.14 69.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.349 -1.089 . . . . 0.0 110.176 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.564 HG21 ' HA ' ' A' ' 19' ' ' PHE . 63.6 t -69.6 -32.14 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.29 -0.881 . . . . 0.0 110.617 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 25.9 mmt -90.16 -18.47 25.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.221 -0.924 . . . . 0.0 110.241 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 10.7 tpt180 -79.06 -33.93 44.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 110.357 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.3 t -61.36 -21.07 63.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.289 -0.882 . . . . 0.0 110.383 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -144.98 76.38 1.49 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.175 -0.953 . . . . 0.0 110.255 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.24 -65.28 0.15 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 53.6 21.12 2.4 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.13 -1.218 . . . . 0.0 109.963 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.522 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.0 OUTLIER -105.56 -67.22 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.425 -0.797 . . . . 0.0 110.823 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 42' ' ' ASN . 46.8 Cg_endo -72.31 170.64 18.7 Favored 'Trans proline' 0 C--N 1.321 -0.911 0 O-C-N 123.063 1.033 . . . . 0.0 110.467 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.442 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.6 OUTLIER -118.76 -140.63 0.36 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -0.887 . . . . 0.0 109.629 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -90.74 -30.67 16.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.908 -1.12 . . . . 0.0 110.189 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.62 -66.44 0.66 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.206 -0.933 . . . . 0.0 109.805 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 41.8 mt-10 -50.58 -36.22 33.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 109.54 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.717 HD21 HD23 ' A' ' 32' ' ' LEU . 6.0 tt -60.35 -45.2 94.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.84 . . . . 0.0 109.587 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -53.16 -39.36 63.5 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.282 -0.886 . . . . 0.0 108.629 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 47' ' ' GLU . 57.4 m-20 -64.31 -38.08 89.78 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.434 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -60.75 -23.84 65.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.439 -0.788 . . . . 0.0 108.919 178.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.702 HD11 HD22 ' A' ' 32' ' ' LEU . 10.7 mt -85.34 -24.86 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.456 -0.778 . . . . 0.0 109.786 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -73.54 -35.67 65.55 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.263 -0.898 . . . . 0.0 110.243 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.478 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 24.2 pt-20 -72.74 -42.54 63.96 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.174 -0.953 . . . . 0.0 110.166 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.851 HG21 ' C6 ' ' A' ' 153' ' ' WW7 . 68.0 t -69.87 -57.61 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.036 -1.04 . . . . 0.0 109.593 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.404 ' OD1' ' OE1' ' A' ' 67' ' ' GLU . 45.3 t0 -68.3 133.58 49.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.467 -0.77 . . . . 0.0 110.07 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.93 50.85 0.78 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.17 -0.956 . . . . 0.0 110.376 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.401 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 55.4 m-20 -136.48 -74.72 0.43 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.193 -0.942 . . . . 0.0 110.466 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.38 47.57 0.05 OUTLIER Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -140.35 14.15 2.39 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.353 -1.086 . . . . 0.0 110.405 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 62' ' ' THR . . . 47.16 38.45 11.65 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.534 HG22 HG22 ' A' ' 28' ' ' THR . 20.6 p -152.58 136.7 16.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.999 -1.294 . . . . 0.0 110.576 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 75.4 mt -111.67 123.74 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.884 . . . . 0.0 110.082 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.447 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.4 m-20 -83.73 -174.19 5.14 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.148 -0.97 . . . . 0.0 110.546 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.563 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -67.25 -46.71 50.82 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.436 -0.79 . . . . 0.0 111.032 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.6 Cg_endo -73.73 -31.12 8.82 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 O-C-N 123.415 1.218 . . . . 0.0 110.427 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.404 ' OE1' ' OD1' ' A' ' 56' ' ' ASP . 27.5 mt-10 -73.78 -23.65 59.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.158 -0.964 . . . . 0.0 109.176 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.718 ' CE1' ' HE2' ' A' ' 72' ' ' MET . 65.4 t80 -76.01 -55.51 5.53 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.638 -0.664 . . . . 0.0 110.281 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.708 ' O ' HD23 ' A' ' 69' ' ' LEU . 5.4 tt -63.87 -28.86 70.13 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.349 -0.845 . . . . 0.0 110.297 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.4 m -68.52 -57.59 5.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.221 -0.924 . . . . 0.0 110.375 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.635 ' SD ' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -69.38 -12.67 61.85 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.167 -0.958 . . . . 0.0 110.673 -179.474 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.718 ' HE2' ' CE1' ' A' ' 68' ' ' PHE . 11.4 mmt -80.52 -24.93 39.01 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.05 -1.031 . . . . 0.0 110.085 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.53 -36.16 81.7 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.334 -0.854 . . . . 0.0 109.899 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.428 ' O ' ' CG ' ' A' ' 74' ' ' ARG . 1.8 ttp180 -110.85 65.11 0.61 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.408 -0.807 . . . . 0.0 110.839 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.83 134.62 47.66 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.913 -1.117 . . . . 0.0 110.041 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 36.9 ttp -125.89 128.64 47.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.223 -0.923 . . . . 0.0 110.384 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -82.69 165.14 20.23 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.301 -0.874 . . . . 0.0 109.853 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -135.5 136.91 41.62 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.127 -0.983 . . . . 0.0 110.692 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 77.9 p -81.29 164.35 22.28 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.355 -0.84 . . . . 0.0 110.418 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -122.57 -155.31 0.64 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.226 -0.921 . . . . 0.0 109.842 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.1 m -133.21 157.06 46.33 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.126 -0.984 . . . . 0.0 110.311 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -96.16 -149.05 0.31 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.285 -0.884 . . . . 0.0 110.356 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.413 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . 44.9 mm-40 52.01 87.76 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.256 -0.902 . . . . 0.0 110.187 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -69.99 -16.08 63.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 110.461 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 65.5 mt -55.21 -45.19 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.115 -0.991 . . . . 0.0 110.097 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -58.6 -56.4 22.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.168 -0.957 . . . . 0.0 109.979 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 10.8 mt-10 -46.29 -44.57 16.7 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.336 -0.852 . . . . 0.0 110.172 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.596 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -57.22 -57.64 11.72 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.378 -0.826 . . . . 0.0 109.467 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.49 ' CE1' HG13 ' A' ' 100' ' ' ILE . 29.9 t80 -49.8 -25.28 2.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.115 -0.991 . . . . 0.0 109.638 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.424 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 15.7 ttt180 -67.05 -59.33 3.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.51 -0.744 . . . . 0.0 110.464 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 88' ' ' ALA . 34.7 m -61.52 -31.66 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.208 -0.933 . . . . 0.0 110.583 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.821 ' CE1' HG11 ' A' ' 108' ' ' VAL . 31.1 m-85 -78.7 -15.96 57.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.084 -1.01 . . . . 0.0 110.663 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -114.61 73.21 0.82 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.965 -1.084 . . . . 0.0 110.463 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -99.42 54.91 0.97 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.259 -0.9 . . . . 0.0 110.761 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.3 p30 -140.04 -37.02 0.48 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.077 -1.014 . . . . 0.0 110.615 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.478 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 107.8 42.9 1.38 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.501 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 45.2 p-10 -135.46 -18.59 1.7 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.057 -1.261 . . . . 0.0 111.477 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.481 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 80.42 42.02 10.86 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.534 ' CD1' ' NE2' ' A' ' 135' ' ' GLN . 68.5 m-85 -152.33 145.39 24.55 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.335 -1.097 . . . . 0.0 110.093 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.49 HG13 ' CE1' ' A' ' 89' ' ' PHE . 31.9 mt -96.69 130.67 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.199 -0.938 . . . . 0.0 110.427 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.8 t -117.25 166.94 11.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.38 -0.825 . . . . 0.0 109.858 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.61 -32.21 73.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.181 -0.949 . . . . 0.0 110.678 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.6 -52.14 34.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.117 -0.99 . . . . 0.0 110.442 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.641 ' O ' HG23 ' A' ' 108' ' ' VAL . 53.8 mt-10 -60.19 -40.18 89.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.275 -0.89 . . . . 0.0 110.755 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.056 HD23 HG13 ' A' ' 121' ' ' VAL . 6.7 tp -64.09 -36.82 85.28 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.087 -1.008 . . . . 0.0 110.541 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 106' ' ' ARG . 1.6 ttp-105 -66.65 -39.25 88.13 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.099 -1.001 . . . . 0.0 110.293 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -73.48 -22.81 60.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 0.0 110.384 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.821 HG11 ' CE1' ' A' ' 92' ' ' PHE . 77.0 t -82.15 -32.83 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.336 -0.853 . . . . 0.0 110.487 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.408 ' HG2' ' O ' ' A' ' 105' ' ' LEU . 24.1 mmt -66.8 -28.78 68.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.129 -0.982 . . . . 0.0 110.272 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.4 p -63.3 -54.04 43.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.189 -0.945 . . . . 0.0 110.013 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -61.35 -40.38 94.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.253 -0.904 . . . . 0.0 110.153 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.7 mt -54.34 -30.24 50.78 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.188 -0.945 . . . . 0.0 110.232 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.39 26.0 7.11 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.49 ' O ' HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -127.35 107.4 9.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.272 -1.134 . . . . 0.0 110.041 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -86.09 109.23 18.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.915 . . . . 0.0 110.548 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.49 HD12 ' O ' ' A' ' 114' ' ' GLU . 1.6 mp -112.71 -169.23 1.44 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.259 -0.901 . . . . 0.0 109.924 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.48 HG22 ' N ' ' A' ' 118' ' ' ASP . 31.1 m -117.57 168.71 10.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.002 -1.061 . . . . 0.0 110.721 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.48 ' N ' HG22 ' A' ' 117' ' ' THR . 26.4 m-20 -59.15 -36.22 74.87 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.4 -0.812 . . . . 0.0 110.295 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -67.0 -36.58 82.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.225 -0.922 . . . . 0.0 110.295 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 124' ' ' MET . 1.7 mt-10 -63.66 -51.72 63.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.38 -0.825 . . . . 0.0 110.361 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 1.056 HG13 HD23 ' A' ' 105' ' ' LEU . 50.3 t -63.42 -58.12 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.165 -0.959 . . . . 0.0 110.395 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -46.57 -43.13 16.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.338 -0.851 . . . . 0.0 110.395 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -67.01 -37.58 84.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.219 -0.925 . . . . 0.0 110.349 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.405 ' HG3' ' O ' ' A' ' 120' ' ' GLU . 90.9 mtp -59.27 -55.11 38.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 110.288 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.74 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 35.7 mm -56.16 -39.06 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 110.125 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -58.29 -44.36 88.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 109.952 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -69.01 -24.61 64.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.076 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.45 ' CB ' HG21 ' A' ' 136' ' ' VAL . . . -81.43 -21.48 38.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.174 -0.953 . . . . 0.0 110.074 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -67.76 89.42 0.26 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.314 -0.866 . . . . 0.0 110.427 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 140' ' ' GLU . 47.7 mt -77.04 -29.74 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.791 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.7 p30 -99.37 -26.52 14.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.374 -0.829 . . . . 0.0 110.227 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 96.36 80.29 1.51 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 11.7 p-10 -144.68 -42.01 0.25 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -1.193 . . . . 0.0 110.358 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 126.51 -20.96 6.08 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.534 ' NE2' ' CD1' ' A' ' 99' ' ' TYR . 16.5 pt20 -119.16 158.91 24.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.095 -1.238 . . . . 0.0 110.524 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.45 HG21 ' CB ' ' A' ' 128' ' ' ALA . 59.5 t -119.42 113.14 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.269 -0.895 . . . . 0.0 110.055 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 12.4 p-10 -85.59 -157.98 0.36 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.125 -0.985 . . . . 0.0 110.321 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -68.93 -66.05 0.63 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.087 -1.008 . . . . 0.0 111.406 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -47.87 -47.42 31.74 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.143 -0.973 . . . . 0.0 110.854 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.414 ' HA ' HD12 ' A' ' 130' ' ' ILE . 33.1 mt-10 -66.29 -31.35 72.09 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.078 -1.014 . . . . 0.0 110.56 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' ' 137' ' ' ASN . 15.5 t80 -70.61 -27.48 64.12 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.139 -0.976 . . . . 0.0 109.831 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.427 ' O ' ' CB ' ' A' ' 146' ' ' THR . 53.8 t -90.43 -23.14 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.523 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -83.83 -34.15 24.73 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.218 -0.926 . . . . 0.0 110.929 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.614 ' HE2' ' HE3' ' A' ' 145' ' ' MET . 15.0 ptt? -64.17 -35.33 80.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.013 -1.054 . . . . 0.0 110.21 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.614 ' HE3' ' HE2' ' A' ' 144' ' ' MET . 12.4 mtt -90.19 -36.53 14.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 0.0 109.424 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.427 ' CB ' ' O ' ' A' ' 142' ' ' VAL . 22.7 m -86.11 85.39 7.36 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.538 -0.726 . . . . 0.0 110.109 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -116.93 98.58 6.56 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.233 -0.917 . . . . 0.0 110.117 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.2 tttp . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.269 -179.812 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' WW7 . . . . . 0.851 ' C6 ' HG21 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' WW7 . . . . . 0.74 'CL1 ' HD13 ' A' ' 125' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.178 0.513 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.406 ' O ' ' O ' ' A' ' 3' ' ' GLN . 50.7 m-20 -109.11 99.94 9.17 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.274 -0.891 . . . . 0.0 110.524 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.406 ' O ' ' O ' ' A' ' 2' ' ' ASP . 37.5 tt0 59.96 119.23 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.377 -0.827 . . . . 0.0 110.729 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 4' ' ' LEU . 32.3 mt -72.13 162.3 29.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.253 -0.904 . . . . 0.0 110.321 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.0 p -129.48 -178.48 4.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 110.206 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.547 ' OE1' HD12 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -74.16 -9.72 58.9 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.231 -0.918 . . . . 0.0 110.584 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -66.16 -51.11 60.97 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.039 -1.038 . . . . 0.0 110.458 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -64.35 -39.53 94.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -0.929 . . . . 0.0 110.083 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.547 HD12 ' OE1' ' A' ' 6' ' ' GLU . 32.5 mt -59.06 -42.69 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.143 -0.973 . . . . 0.0 109.604 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.14 95.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.353 -0.842 . . . . 0.0 109.545 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -60.03 -40.78 90.52 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.333 -0.855 . . . . 0.0 109.654 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -65.13 -31.54 72.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -0.841 . . . . 0.0 109.482 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.63 -50.59 68.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.852 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -60.79 -46.59 89.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.939 . . . . 0.0 109.839 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.505 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -48.82 -55.05 12.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.243 -0.911 . . . . 0.0 109.844 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -52.78 -52.47 56.58 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.399 -0.813 . . . . 0.0 110.347 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.0 m -53.58 -30.18 41.01 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.199 -0.938 . . . . 0.0 110.262 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.68 ' O ' HD23 ' A' ' 18' ' ' LEU . 6.7 tt -70.52 -37.98 74.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.873 . . . . 0.0 110.142 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 1.086 ' CD1' HG11 ' A' ' 35' ' ' VAL . 78.5 m-85 -71.66 -65.24 0.78 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.433 -0.792 . . . . 0.0 110.353 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.444 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -53.74 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.149 -0.969 . . . . 0.0 110.351 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -105.16 51.94 0.75 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.264 -0.898 . . . . 0.0 110.235 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.482 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 23.0 p-10 -169.4 -33.06 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.263 -0.898 . . . . 0.0 110.936 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.73 93.98 2.33 Favored Glycine 0 N--CA 1.498 2.806 0 C-N-CA 119.669 -1.253 . . . . 0.0 110.678 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.445 ' HB2' 'CA ' ' A' ' 149' ' ' ' CA' . 43.7 m-20 -158.91 -45.83 0.06 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.44 -1.035 . . . . 0.0 110.038 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.88 -9.57 23.33 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.1 p -126.89 156.0 42.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.17 -1.194 . . . . 0.0 110.312 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 56.9 mt -105.42 119.64 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.465 -0.772 . . . . 0.0 110.031 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.3 p -103.21 -162.73 0.93 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.196 -0.94 . . . . 0.0 110.223 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.518 HG21 ' HG2' ' A' ' 49' ' ' GLN . 12.7 p -83.85 -27.99 28.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.162 -0.961 . . . . 0.0 110.609 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 mttp -71.21 -58.68 3.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.174 -0.954 . . . . 0.0 109.954 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.735 ' O ' HG23 ' A' ' 35' ' ' VAL . 49.8 mt-10 -56.52 -42.78 79.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.47 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.89 HD22 HD11 ' A' ' 52' ' ' ILE . 2.6 tp -67.57 -26.82 66.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.246 -0.909 . . . . 0.0 109.766 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.437 ' HA2' ' CD1' ' A' ' 48' ' ' LEU . . . -65.6 -38.69 94.91 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.2 m -83.0 -20.61 34.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -1.115 . . . . 0.0 109.885 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.086 HG11 ' CD1' ' A' ' 19' ' ' PHE . 60.4 t -74.4 -34.64 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 109.567 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 9.6 mmt -90.18 -31.66 16.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.431 -0.793 . . . . 0.0 109.636 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.2 tpt85 -78.99 -20.99 47.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.453 -0.779 . . . . 0.0 110.135 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.1 m -106.61 -6.52 17.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.336 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.737 HD23 H152 ' A' ' 153' ' ' WW7 . 1.6 tp -166.05 94.13 0.55 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.128 -0.983 . . . . 0.0 110.271 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.99 -103.79 0.32 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -123.45 -159.32 0.84 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -1.114 . . . . 0.0 110.288 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -130.87 60.35 52.48 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.239 -0.913 . . . . 0.0 110.06 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.5 -165.48 0.17 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.819 1.431 . . . . 0.0 110.156 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.584 HG22 ' H ' ' A' ' 45' ' ' GLU . 5.9 m -125.39 -179.76 4.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.236 -0.915 . . . . 0.0 109.786 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.584 ' H ' HG22 ' A' ' 44' ' ' THR . 4.1 tp10 -69.04 -50.89 44.49 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.087 -1.008 . . . . 0.0 109.627 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.46 -57.15 11.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.196 -0.94 . . . . 0.0 109.876 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 3.4 tp10 -50.84 -39.74 54.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.915 . . . . 0.0 109.64 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.536 ' CG ' HD23 ' A' ' 32' ' ' LEU . 9.0 tt -54.79 -47.59 73.78 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.312 -0.868 . . . . 0.0 109.311 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.518 ' HG2' HG21 ' A' ' 29' ' ' THR . 1.6 mt-30 -54.32 -44.4 72.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.78 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 47' ' ' GLU . 1.6 m-20 -51.31 -43.9 61.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 109.536 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.445 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 54.6 mtp -64.01 -34.85 78.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.202 -0.936 . . . . 0.0 109.794 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.89 HD11 HD22 ' A' ' 32' ' ' LEU . 28.0 mm -64.72 -27.97 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.299 -0.876 . . . . 0.0 110.063 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -68.06 -38.34 82.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.334 -0.854 . . . . 0.0 110.407 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.589 ' HG3' HG23 ' A' ' 55' ' ' VAL . 16.7 pt-20 -82.32 -10.49 59.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.084 -1.01 . . . . 0.0 110.154 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.897 HG21 ' C6 ' ' A' ' 153' ' ' WW7 . 69.9 t -104.97 -9.99 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.189 -0.944 . . . . 0.0 110.155 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -98.52 102.43 14.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.115 -0.991 . . . . 0.0 110.299 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.54 -11.12 21.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.193 -0.942 . . . . 0.0 110.538 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -69.99 -59.48 2.89 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.111 -0.993 . . . . 0.0 110.15 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 131.75 -13.7 5.3 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -76.64 -42.12 43.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.053 -1.263 . . . . 0.0 110.106 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.17 -63.63 0.6 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 57.0 p -76.67 167.28 22.11 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.243 -1.151 . . . . 0.0 110.47 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.5 HG23 ' OE1' ' A' ' 67' ' ' GLU . 74.2 mt -96.19 152.29 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.208 -0.933 . . . . 0.0 109.98 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.404 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 22.7 m-20 -114.18 -157.58 0.63 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.905 . . . . 0.0 110.472 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.563 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 7.6 t80 -84.79 -42.63 0.69 Allowed Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.414 -0.804 . . . . 0.0 111.526 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.6 Cg_endo -73.52 -24.1 16.52 Favored 'Trans proline' 0 N--CA 1.481 0.786 0 O-C-N 122.994 0.997 . . . . 0.0 110.776 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.5 ' OE1' HG23 ' A' ' 63' ' ' ILE . 31.2 tt0 -79.24 -31.36 43.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.138 -0.976 . . . . 0.0 108.97 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.479 ' CE1' ' SD ' ' A' ' 72' ' ' MET . 16.4 t80 -70.68 -45.21 65.44 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.788 -0.57 . . . . 0.0 110.165 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.453 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 34.5 tp -75.75 -25.03 56.17 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.263 -0.898 . . . . 0.0 110.533 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.411 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 53.4 m -84.97 -18.22 35.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.091 -1.005 . . . . 0.0 110.567 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.7 tmm? -90.7 -38.19 13.23 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.045 -1.035 . . . . 0.0 110.876 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.479 ' SD ' ' CE1' ' A' ' 68' ' ' PHE . 66.5 mtt -90.0 -14.03 34.83 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.061 -1.024 . . . . 0.0 111.04 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -89.8 -10.41 45.58 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.02 -1.05 . . . . 0.0 110.781 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 70' ' ' THR . 60.9 mtp180 -67.12 -39.5 86.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.013 -1.055 . . . . 0.0 110.267 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -86.57 153.96 21.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.371 -0.83 . . . . 0.0 110.264 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 13.3 ptp -95.82 179.25 5.17 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.256 -0.903 . . . . 0.0 110.436 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.97 -154.05 0.45 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.347 -0.846 . . . . 0.0 109.806 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -102.32 120.91 41.28 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.225 -0.922 . . . . 0.0 109.934 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t -151.59 145.02 24.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.165 -0.96 . . . . 0.0 110.517 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -132.01 159.64 38.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.33 -0.856 . . . . 0.0 110.113 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 84.0 p -80.04 149.53 30.67 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.164 -0.96 . . . . 0.0 110.084 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.444 ' CG ' ' O ' ' A' ' 82' ' ' GLU . 21.8 pt-20 -73.28 120.55 19.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.261 -0.899 . . . . 0.0 110.423 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 21.8 pt-20 -172.77 65.68 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.26 -0.9 . . . . 0.0 110.149 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -92.04 -58.67 2.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.242 -0.911 . . . . 0.0 110.465 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.412 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 16.7 mt -47.91 -35.2 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.15 -0.969 . . . . 0.0 110.216 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -55.15 -54.54 42.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.179 -0.951 . . . . 0.0 109.712 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 55.5 mt-10 -54.62 -39.92 68.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.24 -0.912 . . . . 0.0 110.147 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.649 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -56.19 -56.24 23.36 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.269 -0.894 . . . . 0.0 110.107 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -48.27 -40.16 23.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.141 -0.975 . . . . 0.0 110.23 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 45.6 mtt-85 -61.42 -41.24 96.85 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.266 -0.896 . . . . 0.0 110.829 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.649 HG22 ' O ' ' A' ' 88' ' ' ALA . 29.5 m -83.24 -10.13 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.936 -1.103 . . . . 0.0 110.783 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.95 ' CE1' HG11 ' A' ' 108' ' ' VAL . 35.6 m-85 -105.32 -1.77 24.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.116 -0.99 . . . . 0.0 110.695 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -135.67 73.77 1.48 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.06 -1.025 . . . . 0.0 110.257 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -78.05 -24.63 47.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.237 -0.914 . . . . 0.0 110.545 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.618 ' OD2' 'CA ' ' A' ' 151' ' ' ' CA' . 2.5 p30 -70.16 -28.99 65.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.315 -0.865 . . . . 0.0 110.402 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.454 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 77.93 61.45 2.53 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.438 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 16.6 p-10 -125.24 -34.94 2.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.257 -1.143 . . . . 0.0 110.432 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.432 ' C ' ' CG ' ' A' ' 99' ' ' TYR . . . 108.06 16.71 11.94 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.779 -1.201 . . . . 0.0 110.374 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.432 ' CG ' ' C ' ' A' ' 98' ' ' GLY . 35.4 m-85 -147.48 134.57 20.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.985 -1.303 . . . . 0.0 110.002 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.497 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 17.9 mt -90.48 120.61 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.809 -1.182 . . . . 0.0 109.664 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.8 t -96.9 171.69 8.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.402 -0.812 . . . . 0.0 110.056 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.01 -46.84 61.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.87 . . . . 0.0 110.284 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.05 -55.15 22.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.298 -0.876 . . . . 0.0 110.439 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.615 ' O ' HG23 ' A' ' 108' ' ' VAL . 57.1 mt-10 -55.42 -50.06 70.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.259 -0.9 . . . . 0.0 110.613 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.683 ' O ' HD23 ' A' ' 105' ' ' LEU . 3.2 tt -49.92 -34.19 19.71 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.199 -0.938 . . . . 0.0 110.431 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.852 ' O ' HG23 ' A' ' 110' ' ' THR . 54.9 ttp180 -74.25 -36.76 63.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.153 -0.967 . . . . 0.0 110.001 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -74.49 -15.4 60.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.852 . . . . 0.0 110.075 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.95 HG11 ' CE1' ' A' ' 92' ' ' PHE . 77.1 t -85.91 -47.93 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.247 -0.908 . . . . 0.0 110.132 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.467 ' HG3' HD13 ' A' ' 116' ' ' LEU . 25.5 mmt -61.48 -32.72 72.74 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.965 . . . . 0.0 109.974 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.852 HG23 ' O ' ' A' ' 106' ' ' ARG . 66.7 p -59.93 -30.43 69.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.164 -0.96 . . . . 0.0 109.238 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -85.79 -31.08 22.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.555 -0.716 . . . . 0.0 109.974 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 77.5 mt -87.47 16.49 5.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 110.093 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 61.91 83.27 0.07 OUTLIER Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.49 ' HB3' HD12 ' A' ' 116' ' ' LEU . 1.3 mm-40 -158.31 133.42 8.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.187 -1.184 . . . . 0.0 110.464 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -95.38 104.19 16.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 110.028 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.49 HD12 ' HB3' ' A' ' 114' ' ' GLU . 1.7 mt -136.06 117.43 14.66 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.278 -0.888 . . . . 0.0 110.504 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.507 HG22 ' N ' ' A' ' 118' ' ' ASP . 38.2 m -71.44 172.81 8.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.314 -0.866 . . . . 0.0 109.91 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.507 ' N ' HG22 ' A' ' 117' ' ' THR . 4.6 m-20 -62.13 -31.8 72.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 110.222 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -69.59 -48.71 59.25 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.247 -0.908 . . . . 0.0 110.205 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.408 ' HB3' HD23 ' A' ' 116' ' ' LEU . 42.8 mt-10 -57.37 -50.81 71.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.127 -0.983 . . . . 0.0 109.935 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.402 HG13 ' HB3' ' A' ' 105' ' ' LEU . 89.3 t -55.35 -49.56 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.401 -0.812 . . . . 0.0 110.177 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.435 ' OD1' ' HD2' ' A' ' 126' ' ' ARG . 8.5 t70 -57.42 -31.87 66.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 110.066 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -70.05 -32.0 69.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.201 -0.937 . . . . 0.0 109.911 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.4 ' HE2' HD21 ' A' ' 105' ' ' LEU . 84.8 mtp -67.9 -44.71 76.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.31 -0.869 . . . . 0.0 109.646 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.464 HD11 HD12 ' A' ' 105' ' ' LEU . 30.1 mm -62.51 -37.57 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.412 -0.805 . . . . 0.0 110.345 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.435 ' HD2' ' OD1' ' A' ' 122' ' ' ASP . 65.8 mtp180 -70.4 -37.05 74.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.24 -0.913 . . . . 0.0 110.252 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -71.39 -27.26 63.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.185 -0.947 . . . . 0.0 109.895 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.518 ' HB2' ' H6 ' ' A' ' 154' ' ' WW7 . . . -83.66 -27.29 29.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.38 -0.825 . . . . 0.0 109.992 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.403 ' OD1' ' OD1' ' A' ' 131' ' ' ASP . 11.9 t0 -65.15 94.73 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.0 110.008 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 140' ' ' GLU . 68.7 mt -67.8 -31.42 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.225 -0.922 . . . . 0.0 110.231 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 19.5 p30 -100.84 -17.41 16.89 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.263 -0.898 . . . . 0.0 110.355 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 69.84 62.56 3.75 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.411 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 82.2 m-20 -101.56 -41.29 6.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.091 -1.241 . . . . 0.0 110.109 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.26 -22.06 1.09 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -142.57 162.75 34.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -1.148 . . . . 0.0 110.032 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.529 HG21 'CL1 ' ' A' ' 154' ' ' WW7 . 41.0 t -88.92 143.99 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.211 -0.93 . . . . 0.0 110.504 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -112.26 151.67 29.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 109.806 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.419 ' O ' HG23 ' A' ' 142' ' ' VAL . 55.4 t80 -46.18 -37.15 6.68 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.194 -0.941 . . . . 0.0 110.459 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -72.15 -45.25 61.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.232 -0.917 . . . . 0.0 110.495 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' A' ' 144' ' ' MET . 55.7 mt-10 -62.24 -23.31 66.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.127 -0.983 . . . . 0.0 110.438 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.56 ' CD1' ' CE ' ' A' ' 144' ' ' MET . 23.2 t80 -81.21 -39.78 24.87 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.321 -0.862 . . . . 0.0 110.544 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 138' ' ' TYR . 65.6 t -73.98 -21.83 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.239 -0.913 . . . . 0.0 110.564 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.863 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 68.9 mm-40 -88.27 -40.17 13.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.167 -0.958 . . . . 0.0 111.051 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.56 ' CE ' ' CD1' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -72.24 -20.47 61.54 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.865 -1.147 . . . . 0.0 110.943 -179.229 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.485 ' N ' ' HG3' ' A' ' 144' ' ' MET . 19.7 ttm -90.43 -68.07 0.81 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.098 -1.001 . . . . 0.0 110.547 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 68.7 p -58.9 -53.71 55.29 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.099 -1.0 . . . . 0.0 110.283 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.863 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -69.86 140.74 53.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.916 . . . . 0.0 110.372 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 91.9 mttt . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.196 179.928 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . 0.445 'CA ' ' HB2' ' A' ' 24' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . 0.618 'CA ' ' OD2' ' A' ' 95' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' WW7 . . . . . 0.897 ' C6 ' HG21 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' WW7 . . . . . 0.589 ' H3 ' ' CD2' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.289 0.566 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -138.57 69.81 1.38 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.881 . . . . 0.0 110.075 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -63.0 -75.1 0.08 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.309 -0.869 . . . . 0.0 110.399 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.6 mp -67.31 167.98 11.41 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.14 -0.975 . . . . 0.0 110.074 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.599 HG23 ' H ' ' A' ' 6' ' ' GLU . 1.4 t -167.43 -55.64 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.139 -0.976 . . . . 0.0 110.685 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.599 ' H ' HG23 ' A' ' 5' ' ' THR . 30.7 tt0 -90.97 -18.38 24.76 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.864 -1.147 . . . . 0.0 110.174 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -74.52 -40.49 61.73 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.451 -0.78 . . . . 0.0 110.701 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.417 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 54.0 mt-30 -67.66 -51.59 47.98 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.144 -0.972 . . . . 0.0 110.329 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.0 mt -57.72 -48.99 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.075 -1.016 . . . . 0.0 109.522 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.3 -32.11 68.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 109.74 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 37.0 tt0 -59.81 -51.19 70.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.914 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -58.66 -34.11 70.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.291 -0.881 . . . . 0.0 109.662 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.6 -46.73 86.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.377 -0.827 . . . . 0.0 110.466 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -59.49 -45.69 90.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.226 -0.921 . . . . 0.0 110.451 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.415 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -60.15 -41.55 92.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.957 . . . . 0.0 110.1 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -58.52 -56.21 25.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.276 -0.89 . . . . 0.0 110.141 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.2 m -53.36 -29.17 32.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.149 -0.969 . . . . 0.0 109.668 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.7 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.8 tt -66.43 -41.2 89.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.39 -0.819 . . . . 0.0 109.782 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.616 ' CD1' HG11 ' A' ' 35' ' ' VAL . 27.7 m-85 -77.61 -64.81 1.06 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.319 -0.863 . . . . 0.0 110.338 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.408 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 55.7 t0 -49.23 106.04 0.1 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.285 -0.884 . . . . 0.0 110.383 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -110.35 15.19 22.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.187 -0.946 . . . . 0.0 111.014 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.407 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 9.3 p-10 -126.19 -42.81 1.83 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.012 -1.055 . . . . 0.0 110.423 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.69 19.69 6.01 Favored Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.513 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.407 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 57.1 p-10 -91.39 -8.1 48.89 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.965 -1.314 . . . . 0.0 110.537 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.655 ' O ' HG23 ' A' ' 26' ' ' THR . . . 70.85 42.37 60.92 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.655 HG23 ' O ' ' A' ' 25' ' ' GLY . 9.3 p -158.34 148.8 20.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.242 -1.152 . . . . 0.0 109.943 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.6 mt -108.81 105.36 18.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.182 -0.949 . . . . 0.0 109.937 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.922 ' HA ' HG22 ' A' ' 62' ' ' THR . 3.5 m -96.65 -175.74 3.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.413 -0.804 . . . . 0.0 109.747 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.646 ' H ' HG22 ' A' ' 28' ' ' THR . 23.5 p -72.1 -29.32 63.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.0 110.539 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -65.4 -62.06 1.75 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 0.0 110.366 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.72 ' O ' HG23 ' A' ' 35' ' ' VAL . 49.5 mt-10 -57.12 -44.92 83.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.272 -0.893 . . . . 0.0 110.05 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.597 HD22 HD11 ' A' ' 52' ' ' ILE . 2.9 tp -63.85 -25.18 68.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -0.904 . . . . 0.0 109.665 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.14 -46.73 69.41 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.44 ' O ' ' CB ' ' A' ' 38' ' ' SER . 87.1 m -72.69 -21.77 61.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.311 -1.111 . . . . 0.0 109.498 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 31' ' ' GLU . 58.0 t -71.14 -42.45 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.431 -0.793 . . . . 0.0 109.811 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 26.0 mmt -75.46 -30.03 59.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 110.457 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -88.47 -9.38 52.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.156 -0.965 . . . . 0.0 110.301 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 34' ' ' THR . 47.7 t -101.09 8.84 42.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.09 -1.006 . . . . 0.0 110.542 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.534 HD13 H142 ' A' ' 153' ' ' WW7 . 90.9 mt -127.68 -81.37 0.6 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.139 -0.976 . . . . 0.0 110.207 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.466 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . -156.48 36.73 0.59 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.466 ' NE2' ' O ' ' A' ' 40' ' ' GLY . 4.9 mp0 -140.09 171.92 13.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.504 -0.998 . . . . 0.0 109.851 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.478 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 23.8 p30 -155.87 52.55 0.68 Allowed Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.023 -1.048 . . . . 0.0 111.048 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.478 ' HD3' ' N ' ' A' ' 42' ' ' ASN . 50.0 Cg_endo -77.68 160.81 31.19 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.671 1.353 . . . . 0.0 110.229 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.0 p -92.45 -142.22 0.2 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.276 -0.89 . . . . 0.0 109.883 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -105.59 -32.22 8.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.937 -1.102 . . . . 0.0 110.053 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.96 -67.7 0.54 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -0.938 . . . . 0.0 109.655 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -49.83 -38.7 36.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 109.441 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.497 HD11 HD23 ' A' ' 32' ' ' LEU . 6.4 tt -57.07 -48.88 77.48 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.45 -0.781 . . . . 0.0 109.342 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -51.51 -42.07 61.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.434 -0.791 . . . . 0.0 109.551 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.39 -42.78 99.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.871 . . . . 0.0 109.816 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.441 ' HA ' ' OE2' ' A' ' 54' ' ' GLU . 18.5 ttp -62.3 -19.8 63.66 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.283 -0.885 . . . . 0.0 109.353 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.597 HD11 HD22 ' A' ' 32' ' ' LEU . 25.4 mt -89.18 -24.52 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.426 -0.796 . . . . 0.0 109.887 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -67.97 -35.3 78.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.302 -0.874 . . . . 0.0 110.154 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.444 ' HG3' HG23 ' A' ' 55' ' ' VAL . 17.2 pt-20 -73.73 -33.75 64.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.224 -0.922 . . . . 0.0 110.04 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.787 HG21 ' C6 ' ' A' ' 153' ' ' WW7 . 99.9 t -77.1 -68.78 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.285 -0.885 . . . . 0.0 109.806 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.411 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 64.1 t0 -47.0 125.72 7.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.276 -0.89 . . . . 0.0 110.051 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.67 28.78 5.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.217 -0.927 . . . . 0.0 110.206 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.443 ' HB2' ' OD1' ' A' ' 60' ' ' ASN . 40.5 m-20 -122.76 -62.08 1.39 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.405 -0.809 . . . . 0.0 110.05 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.82 36.16 0.6 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.443 ' OD1' ' HB2' ' A' ' 58' ' ' ASP . 6.8 m120 -103.85 -40.67 6.15 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.176 -1.19 . . . . 0.0 110.107 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.413 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 123.87 -14.79 7.97 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.922 HG22 ' HA ' ' A' ' 28' ' ' THR . 75.2 p -130.97 164.47 25.28 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.147 -1.208 . . . . 0.0 110.446 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 80.1 mt -110.21 122.15 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.246 -0.909 . . . . 0.0 110.237 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.447 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 55.0 m-20 -81.38 -168.32 1.81 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.307 -0.871 . . . . 0.0 110.399 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.547 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 42.4 t80 -72.99 -42.46 7.31 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 111.246 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.8 Cg_endo -75.76 -28.19 8.18 Favored 'Trans proline' 0 C--N 1.325 -0.703 0 O-C-N 123.035 1.018 . . . . 0.0 109.821 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.413 ' OE1' ' OD2' ' A' ' 58' ' ' ASP . 40.7 tt0 -73.52 -24.03 60.1 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.446 ' O ' ' HG2' ' A' ' 71' ' ' MET . 10.3 t80 -84.73 -43.01 14.68 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.429 0.633 . . . . 0.0 110.145 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.627 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 3.7 tt -72.3 -18.28 61.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.193 -0.942 . . . . 0.0 110.128 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.411 ' O ' ' HG2' ' A' ' 74' ' ' ARG . 98.5 m -90.3 -43.04 10.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.125 -0.984 . . . . 0.0 110.493 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.488 ' HG3' ' N ' ' A' ' 72' ' ' MET . 6.5 ptt? -64.09 -40.99 97.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.145 -0.972 . . . . 0.0 110.518 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.488 ' N ' ' HG3' ' A' ' 71' ' ' MET . 32.7 mtt -84.32 -9.66 58.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.099 -1.001 . . . . 0.0 110.683 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.627 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . -90.6 -25.02 20.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.024 -1.047 . . . . 0.0 110.618 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -102.43 52.16 0.8 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.215 -0.928 . . . . 0.0 110.732 -179.486 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -94.73 -3.7 48.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.068 -1.02 . . . . 0.0 110.635 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 22.9 mmt -146.54 -49.51 0.2 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.065 -1.022 . . . . 0.0 110.434 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -109.42 -171.18 1.79 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.106 -0.996 . . . . 0.0 110.342 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -140.52 20.25 2.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 110.029 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.402 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 97.8 m -60.64 91.81 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.244 -0.91 . . . . 0.0 110.402 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 79' ' ' THR . 22.4 m-20 -152.73 125.62 8.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.118 -0.989 . . . . 0.0 110.62 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.1 m -89.57 -153.28 0.27 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.247 -0.908 . . . . 0.0 109.915 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 33.0 mt-10 -150.64 146.49 26.53 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.218 -0.926 . . . . 0.0 110.652 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 82' ' ' GLU . 11.5 mt-10 -154.61 87.37 1.16 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.558 -0.714 . . . . 0.0 109.863 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.8 -25.12 68.04 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.326 -0.859 . . . . 0.0 110.409 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.7 mt -68.0 -59.39 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.252 -0.905 . . . . 0.0 110.388 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.4 ttm-85 -53.02 -43.5 66.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.059 -1.025 . . . . 0.0 109.448 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -54.61 -43.83 72.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.361 -0.837 . . . . 0.0 109.629 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 92' ' ' PHE . . . -58.47 -37.73 76.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.35 -0.843 . . . . 0.0 109.667 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -65.03 -28.93 69.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.063 -1.023 . . . . 0.0 109.897 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -70.45 -58.95 3.16 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.494 -0.754 . . . . 0.0 111.118 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.557 HG23 ' N ' ' A' ' 92' ' ' PHE . 30.1 m -62.94 -43.33 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.14 -0.975 . . . . 0.0 110.981 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.695 ' HA ' HG21 ' A' ' 108' ' ' VAL . 18.0 m-85 -69.72 -22.42 63.4 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.973 -1.08 . . . . 0.0 110.263 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -147.28 81.96 1.54 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.963 . . . . 0.0 110.483 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.6 pttt -109.68 47.43 0.94 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.355 -0.841 . . . . 0.0 109.907 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 1.8 p30 -115.31 -31.69 5.88 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.273 -0.892 . . . . 0.0 110.618 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.46 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 138.33 -54.09 0.7 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.279 -1.438 . . . . 0.0 110.959 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -48.77 -34.46 12.29 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 120.947 -1.325 . . . . 0.0 110.846 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.469 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 80.28 33.01 33.27 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.963 -1.113 . . . . 0.0 110.406 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.483 ' HB3' ' CB ' ' A' ' 135' ' ' GLN . 20.7 m-85 -130.2 127.58 39.95 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.951 -1.323 . . . . 0.0 109.884 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.647 HD13 ' CE1' ' A' ' 141' ' ' PHE . 8.8 mt -76.01 110.39 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.962 -1.086 . . . . 0.0 110.167 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.1 t -93.6 165.59 12.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.065 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.51 -41.39 96.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.291 -0.88 . . . . 0.0 110.341 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.4 -53.36 49.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.186 -0.946 . . . . 0.0 110.037 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.427 ' O ' HG23 ' A' ' 108' ' ' VAL . 51.0 mt-10 -51.75 -37.73 52.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.426 -0.796 . . . . 0.0 110.103 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.0 tt -69.36 -35.2 75.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.4 -0.813 . . . . 0.0 110.121 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.785 ' O ' HG23 ' A' ' 110' ' ' THR . 58.0 ttp180 -66.36 -26.69 67.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.483 -0.76 . . . . 0.0 110.254 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -85.01 -31.54 23.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.281 -0.887 . . . . 0.0 110.514 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.695 HG21 ' HA ' ' A' ' 92' ' ' PHE . 98.2 t -76.37 -30.94 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.166 -0.959 . . . . 0.0 110.452 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.4 mmt -75.99 -26.57 56.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.104 -0.998 . . . . 0.0 110.18 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.785 HG23 ' O ' ' A' ' 106' ' ' ARG . 45.4 p -68.67 -40.61 80.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.27 -0.894 . . . . 0.0 110.146 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -80.01 -41.54 25.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.195 -0.94 . . . . 0.0 110.045 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.444 ' HA ' HD23 ' A' ' 112' ' ' LEU . 9.2 mt -47.63 -25.47 1.18 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.255 -0.903 . . . . 0.0 110.204 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.44 20.8 8.34 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -123.19 110.0 14.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.23 -1.159 . . . . 0.0 110.3 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.95 107.25 9.16 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.341 -0.85 . . . . 0.0 110.285 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.9 -174.85 2.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.184 -0.947 . . . . 0.0 110.19 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 118' ' ' ASP . 30.5 m -136.8 166.65 23.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 110.209 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.425 ' N ' HG22 ' A' ' 117' ' ' THR . 22.5 m-20 -55.07 -33.22 62.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -0.94 . . . . 0.0 110.359 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.18 -47.24 80.57 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.328 -0.857 . . . . 0.0 110.784 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -65.4 -58.39 5.98 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.118 -0.989 . . . . 0.0 110.613 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.2 t -49.64 -41.24 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.145 -0.972 . . . . 0.0 110.395 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -64.39 -39.08 93.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.167 -0.958 . . . . 0.0 110.163 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -66.91 -30.06 70.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.223 -0.923 . . . . 0.0 110.152 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 78.7 mtp -75.83 -62.99 1.41 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.178 -0.951 . . . . 0.0 110.66 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.504 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 26.0 mm -52.05 -29.23 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.156 -0.965 . . . . 0.0 110.67 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.1 mtp85 -71.75 -56.87 4.98 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.051 -1.031 . . . . 0.0 110.349 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -69.45 -8.28 45.4 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.197 -0.939 . . . . 0.0 110.361 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.427 ' HB2' ' H6 ' ' A' ' 154' ' ' WW7 . . . -98.83 -24.66 14.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -0.919 . . . . 0.0 110.104 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -83.51 83.65 7.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.075 -1.016 . . . . 0.0 109.915 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.519 HD12 ' HG2' ' A' ' 140' ' ' GLU . 18.5 mt -45.41 -69.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.33 -0.856 . . . . 0.0 110.688 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.8 p30 -60.91 -24.41 65.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.221 -0.924 . . . . 0.0 110.366 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.421 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 62.51 62.64 5.37 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -106.61 -31.51 8.45 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.24 -1.153 . . . . 0.0 110.205 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 161.96 -49.11 0.34 Allowed Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.13 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.483 ' CB ' ' HB3' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -123.42 170.43 10.36 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.033 -1.274 . . . . 0.0 110.107 -179.363 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.4 t -105.97 97.8 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.379 -0.826 . . . . 0.0 110.002 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.409 ' OD1' ' HB3' ' A' ' 139' ' ' GLU . 9.8 p30 -70.19 179.43 2.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.332 -0.855 . . . . 0.0 110.355 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.441 ' O ' HG23 ' A' ' 142' ' ' VAL . 18.9 t80 -61.65 -41.43 97.5 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.311 -0.868 . . . . 0.0 111.268 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.409 ' HB3' ' OD1' ' A' ' 137' ' ' ASN . 25.2 tt0 -53.15 -52.17 59.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.028 -1.045 . . . . 0.0 110.199 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.519 ' HG2' HD12 ' A' ' 130' ' ' ILE . 55.0 mt-10 -67.4 -21.25 65.6 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.275 -0.891 . . . . 0.0 109.879 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.647 ' CE1' HD13 ' A' ' 100' ' ' ILE . 1.9 t80 -77.54 -23.33 50.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.359 -0.838 . . . . 0.0 110.414 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 138' ' ' TYR . 80.4 t -88.43 -23.05 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.197 -0.939 . . . . 0.0 110.511 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -91.65 -39.02 12.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.296 -0.877 . . . . 0.0 110.799 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.496 ' HE3' ' HG3' ' A' ' 145' ' ' MET . 0.0 OUTLIER -67.44 -17.75 64.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.981 -1.074 . . . . 0.0 110.358 -179.651 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.496 ' HG3' ' HE3' ' A' ' 144' ' ' MET . 52.2 mtt -88.13 -55.06 3.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.118 -0.989 . . . . 0.0 109.887 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 146' ' ' THR . 2.7 t -116.55 117.09 28.91 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.508 -0.745 . . . . 0.0 110.069 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -117.13 114.8 24.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.163 -0.961 . . . . 0.0 110.441 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.217 179.947 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' WW7 . . . . . 0.787 ' C6 ' HG21 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' WW7 . . . . . 0.584 ' H3 ' ' CD2' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.288 0.566 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -83.62 131.55 34.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.163 -0.961 . . . . 0.0 110.209 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -97.46 133.22 42.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.22 -0.925 . . . . 0.0 110.234 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.42 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.5 OUTLIER -156.93 143.73 18.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 110.464 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.3 p -125.65 9.36 7.69 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.194 -0.941 . . . . 0.0 110.191 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -73.25 -34.84 66.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.08 -1.012 . . . . 0.0 109.522 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -77.22 -33.03 56.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.402 -0.812 . . . . 0.0 109.457 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -67.57 -59.13 3.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.448 -0.782 . . . . 0.0 110.285 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.4 mt -59.71 -34.72 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 109.587 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.28 -32.38 73.96 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.267 -0.896 . . . . 0.0 108.988 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -66.91 -51.75 51.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.459 -0.775 . . . . 0.0 109.426 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -59.46 -29.99 68.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.618 -0.676 . . . . 0.0 109.751 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -66.26 -55.99 13.44 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.4 -0.812 . . . . 0.0 110.191 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -51.01 -38.25 50.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.16 -0.962 . . . . 0.0 109.969 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.514 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -62.13 -54.31 42.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.026 -1.046 . . . . 0.0 109.886 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.453 ' CE1' HD11 ' A' ' 27' ' ' ILE . 18.5 t80 -56.7 -26.9 57.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.294 -0.879 . . . . 0.0 110.687 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.0 p -75.98 -35.06 59.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.179 -0.95 . . . . 0.0 109.888 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.642 ' O ' HD23 ' A' ' 18' ' ' LEU . 3.1 tt -69.51 -26.8 64.71 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.313 -0.867 . . . . 0.0 109.644 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.645 ' CD1' HG11 ' A' ' 35' ' ' VAL . 30.4 m-85 -86.08 -69.19 0.68 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.375 -0.828 . . . . 0.0 109.938 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -56.18 105.07 0.17 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.312 -0.868 . . . . 0.0 110.283 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -105.75 -38.06 6.51 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.312 -0.867 . . . . 0.0 110.665 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -70.27 -26.11 63.67 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.141 -0.975 . . . . 0.0 110.505 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.89 106.44 0.83 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 7.7 p-10 -169.64 -39.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -1.177 . . . . 0.0 110.263 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.72 12.57 12.59 Favored Glycine 0 N--CA 1.495 2.632 0 C-N-CA 119.93 -1.129 . . . . 0.0 110.37 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 54.8 p -139.96 164.97 28.59 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.044 -1.269 . . . . 0.0 110.267 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.468 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 40.8 mt -123.47 120.56 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.135 -0.978 . . . . 0.0 110.191 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.613 HG22 ' H ' ' A' ' 29' ' ' THR . 5.2 m -113.75 -179.08 3.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.35 -0.844 . . . . 0.0 110.292 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.613 ' H ' HG22 ' A' ' 28' ' ' THR . 56.1 p -68.84 -27.49 65.88 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.267 -0.896 . . . . 0.0 110.754 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.3 mtmm -66.31 -61.34 2.06 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.059 -1.026 . . . . 0.0 109.929 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -60.91 -58.83 6.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.056 -1.028 . . . . 0.0 109.541 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.991 HD23 HD11 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -52.1 -26.73 11.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 109.708 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.44 -52.42 46.69 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 97.2 m -65.77 -23.99 66.84 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.203 -1.174 . . . . 0.0 109.879 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.645 HG11 ' CD1' ' A' ' 19' ' ' PHE . 46.5 t -66.34 -42.83 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.442 -0.786 . . . . 0.0 109.904 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.466 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 61.5 mtt -89.17 -11.63 43.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.376 -0.828 . . . . 0.0 110.379 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -89.85 -21.24 22.65 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.163 -0.961 . . . . 0.0 110.186 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.9 m -109.52 -22.51 11.95 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.197 -0.939 . . . . 0.0 110.432 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.46 66.1 1.08 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.147 -0.971 . . . . 0.0 110.637 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.02 51.64 0.16 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -48.08 102.26 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.236 -1.155 . . . . 0.0 110.304 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.523 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 2.4 t30 -156.67 -65.93 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.885 . . . . 0.0 110.234 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.523 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 46.3 Cg_endo -72.23 170.42 19.16 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.316 1.166 . . . . 0.0 110.311 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.5 HG23 ' N ' ' A' ' 45' ' ' GLU . 10.8 t -119.39 -149.09 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.623 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.5 ' N ' HG23 ' A' ' 44' ' ' THR . 22.0 tt0 -95.81 -31.84 12.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.831 -1.168 . . . . 0.0 110.115 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.481 ' H ' HG23 ' A' ' 44' ' ' THR . . . -74.64 -67.65 0.61 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.23 -0.919 . . . . 0.0 110.089 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -49.0 -31.55 7.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.135 -0.978 . . . . 0.0 109.744 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.991 HD11 HD23 ' A' ' 32' ' ' LEU . 9.1 tt -63.96 -51.7 63.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.92 . . . . 0.0 109.209 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.7 tm0? -49.5 -41.47 40.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.459 -0.776 . . . . 0.0 109.605 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -64.71 -39.46 93.69 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.36 -0.837 . . . . 0.0 109.709 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.452 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 25.4 ttp -70.27 -13.18 62.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.158 -0.963 . . . . 0.0 109.85 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.978 HD11 HD22 ' A' ' 32' ' ' LEU . 29.7 mm -84.75 -35.31 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.218 -0.926 . . . . 0.0 109.537 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -60.7 -39.88 90.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.463 -0.773 . . . . 0.0 110.504 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.473 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 12.3 pt-20 -69.39 -35.95 76.3 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.128 -0.983 . . . . 0.0 110.596 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.858 HG21 ' C6 ' ' A' ' 153' ' ' WW7 . 79.6 t -71.39 -28.39 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.064 -1.023 . . . . 0.0 110.062 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -96.8 117.3 30.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.37 -0.832 . . . . 0.0 110.448 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.06 25.95 10.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -0.843 . . . . 0.0 109.773 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -106.61 -68.13 0.9 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.485 -0.759 . . . . 0.0 110.167 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.38 -14.27 2.06 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.421 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 27.7 p-10 -69.78 -14.11 62.61 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.15 -1.206 . . . . 0.0 110.287 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.642 ' O ' HG23 ' A' ' 62' ' ' THR . . . 79.24 23.86 62.42 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.011 -1.09 . . . . 0.0 110.545 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.642 HG23 ' O ' ' A' ' 61' ' ' GLY . 7.1 p -156.44 167.65 29.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.996 -1.296 . . . . 0.0 110.414 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.641 HD11 HG11 ' A' ' 55' ' ' VAL . 82.9 mt -108.31 169.74 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.182 -0.949 . . . . 0.0 110.596 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.546 ' N ' HG22 ' A' ' 63' ' ' ILE . 46.7 m-20 -131.44 -163.02 1.28 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.31 -0.869 . . . . 0.0 109.848 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.562 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 40.1 t80 -82.51 -43.26 0.95 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.068 -1.02 . . . . 0.0 111.357 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 47.2 Cg_endo -73.15 -28.53 12.62 Favored 'Trans proline' 0 N--CA 1.48 0.68 0 O-C-N 123.091 1.048 . . . . 0.0 110.304 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -78.34 -23.73 46.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.105 -0.997 . . . . 0.0 109.225 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.456 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 24.3 t80 -75.91 -48.64 20.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.624 -0.672 . . . . 0.0 110.201 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.589 ' O ' HD23 ' A' ' 69' ' ' LEU . 2.8 tt -75.71 -21.49 57.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.353 -0.842 . . . . 0.0 110.349 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.7 m -89.57 -21.86 22.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -0.964 . . . . 0.0 110.713 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.471 ' HG3' ' N ' ' A' ' 72' ' ' MET . 8.1 ptt? -88.86 -36.08 16.2 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.964 -1.085 . . . . 0.0 110.515 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.471 ' N ' ' HG3' ' A' ' 71' ' ' MET . 52.5 mtt -84.72 -23.55 29.26 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.188 -0.945 . . . . 0.0 110.0 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.83 -52.0 6.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.368 -0.832 . . . . 0.0 110.04 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.8 mpp_? -110.24 63.79 0.61 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.417 -0.802 . . . . 0.0 110.039 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -89.51 91.14 8.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.422 -0.799 . . . . 0.0 110.425 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.3 ttt -84.86 140.69 30.98 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.173 -0.954 . . . . 0.0 110.116 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.8 mtmt -86.52 107.21 18.0 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.184 -0.948 . . . . 0.0 110.44 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -153.26 128.38 9.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 0.0 110.21 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.1 m -126.96 148.12 50.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.218 -0.926 . . . . 0.0 110.2 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -167.31 99.01 0.51 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.286 -0.884 . . . . 0.0 110.02 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.5 t -138.26 178.15 7.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.131 -0.981 . . . . 0.0 110.394 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -151.11 99.3 2.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.259 -0.901 . . . . 0.0 110.206 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.401 ' OE2' ' OH ' ' A' ' 138' ' ' TYR . 23.4 tt0 -171.5 97.68 0.19 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.151 -0.968 . . . . 0.0 110.157 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.554 ' HB2' HN21 ' A' ' 154' ' ' WW7 . 33.1 mt-10 -60.28 -30.92 69.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.446 -0.784 . . . . 0.0 110.361 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 40.7 mt -51.71 -34.93 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.112 -0.993 . . . . 0.0 109.733 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -58.08 -43.89 87.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.944 . . . . 0.0 109.398 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -62.23 -33.59 74.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.424 -0.798 . . . . 0.0 109.784 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.783 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -65.92 -66.48 0.54 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.416 -0.802 . . . . 0.0 109.889 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -49.62 -26.62 3.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.927 . . . . 0.0 110.308 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.412 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 16.0 tpt180 -68.78 -45.23 71.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.148 -0.97 . . . . 0.0 110.255 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.783 HG22 ' O ' ' A' ' 88' ' ' ALA . 34.0 m -76.27 -15.79 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.283 -0.885 . . . . 0.0 110.443 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.757 ' HE2' ' HB1' ' A' ' 88' ' ' ALA . 23.0 m-85 -90.85 -18.38 24.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.132 -0.98 . . . . 0.0 110.491 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -128.82 44.32 2.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.099 -1.001 . . . . 0.0 110.077 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 20.4 ptmt -106.46 47.62 0.87 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 110.403 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.414 ' OD2' ' OE1' ' A' ' 104' ' ' GLU . 2.8 p30 -116.88 -22.57 8.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.237 -0.915 . . . . 0.0 110.043 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.23 29.33 4.03 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -105.78 -71.09 0.76 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.405 -1.056 . . . . 0.0 110.091 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 151.9 -36.48 0.84 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -134.12 169.59 16.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -1.16 . . . . 0.0 110.133 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.5 mt -73.1 131.29 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 109.858 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.425 ' HB3' ' OE2' ' A' ' 104' ' ' GLU . 36.5 t -113.83 172.26 7.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.47 -0.769 . . . . 0.0 110.023 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.455 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -68.65 -48.06 64.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -0.947 . . . . 0.0 110.144 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.89 -52.35 66.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.185 -0.947 . . . . 0.0 110.247 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.721 ' O ' HG23 ' A' ' 108' ' ' VAL . 46.2 mt-10 -48.97 -54.76 14.22 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.376 -0.827 . . . . 0.0 110.577 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 105' ' ' LEU . 5.2 tt -61.25 -30.33 70.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.379 -0.826 . . . . 0.0 110.763 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.528 ' HG3' HG21 ' A' ' 121' ' ' VAL . 17.0 ttp180 -67.24 -38.89 85.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.187 -0.945 . . . . 0.0 110.583 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -84.04 -14.2 51.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 110.472 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 104' ' ' GLU . 71.8 t -84.29 -29.15 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.236 -0.915 . . . . 0.0 110.527 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.598 ' HB3' HD12 ' A' ' 116' ' ' LEU . 26.4 mmt -81.81 -46.65 13.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.946 . . . . 0.0 110.529 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.2 p -50.44 -32.97 19.34 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 110.268 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -86.16 -48.81 8.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.128 -0.982 . . . . 0.0 110.372 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 112' ' ' LEU . 22.6 mt -47.07 -32.46 4.11 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.138 -0.976 . . . . 0.0 110.509 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 116.48 38.4 0.92 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -119.06 167.4 11.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.341 -1.094 . . . . 0.0 110.069 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -121.41 94.49 4.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.889 . . . . 0.0 110.061 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.598 HD12 ' HB3' ' A' ' 109' ' ' MET . 5.5 mt -128.58 151.94 48.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.281 -0.887 . . . . 0.0 110.228 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.536 HG22 ' N ' ' A' ' 118' ' ' ASP . 91.4 m -99.77 172.39 7.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.868 . . . . 0.0 110.002 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.536 ' N ' HG22 ' A' ' 117' ' ' THR . 1.4 m-20 -56.45 -62.89 1.41 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.242 -0.911 . . . . 0.0 110.636 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -52.54 -41.4 63.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.143 -0.973 . . . . 0.0 110.315 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.435 ' O ' ' HB3' ' A' ' 123' ' ' GLU . 6.4 mm-40 -52.08 -50.63 61.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.118 -0.989 . . . . 0.0 110.017 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.528 HG21 ' HG3' ' A' ' 106' ' ' ARG . 63.8 t -57.54 -43.9 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.16 -0.962 . . . . 0.0 109.821 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -59.58 -28.53 67.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.297 -0.877 . . . . 0.0 109.729 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 24.4 tt0 -73.27 -37.44 66.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.352 -0.842 . . . . 0.0 109.863 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 74.9 mtp -66.4 -39.92 89.3 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.274 -0.891 . . . . 0.0 109.821 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 31.8 mm -69.22 -38.61 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -0.906 . . . . 0.0 110.188 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -62.77 -46.33 88.52 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.257 -0.902 . . . . 0.0 110.228 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -62.47 -38.84 91.41 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.292 -0.88 . . . . 0.0 110.162 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.14 -16.0 61.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -0.861 . . . . 0.0 110.21 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.411 ' OD1' ' OD1' ' A' ' 131' ' ' ASP . 57.7 t0 -87.78 60.95 6.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.365 -0.835 . . . . 0.0 110.129 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.469 HG13 ' N ' ' A' ' 131' ' ' ASP . 18.0 pt -56.02 -42.26 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.435 -0.791 . . . . 0.0 111.409 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.469 ' N ' HG13 ' A' ' 130' ' ' ILE . 47.8 p-10 -72.74 -18.99 61.46 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.037 -1.039 . . . . 0.0 111.125 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.34 72.19 0.88 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 33.7 p30 -126.15 -16.99 5.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.406 -1.055 . . . . 0.0 110.873 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.465 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 122.96 -49.89 0.87 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.409 ' NE2' ' C ' ' A' ' 135' ' ' GLN . 0.0 OUTLIER -119.18 164.7 15.19 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.086 -1.243 . . . . 0.0 110.772 -179.611 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.5 t -102.63 127.0 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.303 -0.873 . . . . 0.0 110.053 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -97.22 -172.12 2.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.953 -1.092 . . . . 0.0 110.459 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.401 ' OH ' ' OE2' ' A' ' 83' ' ' GLU . 31.0 t80 -64.4 -62.47 1.58 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.334 -0.854 . . . . 0.0 111.621 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -43.87 -53.53 5.99 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.239 -0.913 . . . . 0.0 111.141 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -56.77 -39.37 73.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.898 -1.126 . . . . 0.0 110.399 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.525 ' CZ ' ' HE1' ' A' ' 145' ' ' MET . 20.2 t80 -66.82 -27.09 67.27 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.391 -0.818 . . . . 0.0 111.133 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 57.6 t -90.06 -20.67 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.024 -1.047 . . . . 0.0 110.77 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.57 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 1.4 mm-40 -83.81 -30.04 26.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.212 -0.93 . . . . 0.0 110.824 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.47 ' CE ' ' CD1' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -90.01 -13.19 36.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.112 -0.993 . . . . 0.0 110.608 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.525 ' HE1' ' CZ ' ' A' ' 141' ' ' PHE . 30.0 ttm -89.98 -27.99 19.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.913 . . . . 0.0 110.537 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 60.0 p -121.77 -50.82 2.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.134 -0.979 . . . . 0.0 110.194 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -75.06 126.88 31.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.958 . . . . 0.0 110.042 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 90.6 mttt . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.252 -179.806 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' WW7 . . . . . 0.858 ' C6 ' HG21 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' WW7 . . . . . 0.554 HN21 ' HB2' ' A' ' 84' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.268 0.556 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -67.2 109.08 2.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.168 -0.957 . . . . 0.0 110.215 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -148.42 151.77 35.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.286 -0.884 . . . . 0.0 110.167 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 68.1 mt -57.93 129.76 43.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -0.943 . . . . 0.0 110.311 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 97.7 m -161.87 -45.32 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 109.798 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.586 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 1.0 OUTLIER -88.21 -15.73 35.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.329 -0.857 . . . . 0.0 109.931 179.555 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -74.24 -66.07 0.77 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.28 -0.888 . . . . 0.0 109.814 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -54.77 -58.75 6.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.23 -0.919 . . . . 0.0 109.997 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 9' ' ' ILE . 28.6 mt -47.73 -49.14 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.124 -0.985 . . . . 0.0 110.062 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 6' ' ' GLU . . . -52.83 -41.6 64.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.275 -0.89 . . . . 0.0 110.2 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -61.0 -41.44 96.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.879 . . . . 0.0 110.132 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -64.06 -30.17 71.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.279 -0.888 . . . . 0.0 109.734 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.478 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 30.1 mtpt -68.99 -38.97 79.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.535 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.31 -45.19 95.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.313 -0.867 . . . . 0.0 109.341 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.85 -44.8 86.77 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.317 -0.865 . . . . 0.0 109.452 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -56.22 -42.15 76.8 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.315 -0.865 . . . . 0.0 109.633 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.4 t -59.1 -42.63 90.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.428 -0.795 . . . . 0.0 109.641 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.582 ' O ' HD23 ' A' ' 18' ' ' LEU . 5.8 tt -59.79 -29.36 68.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.464 -0.772 . . . . 0.0 109.456 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.672 ' HA ' HG21 ' A' ' 35' ' ' VAL . 5.8 m-30 -88.24 -18.29 28.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.464 -0.772 . . . . 0.0 110.043 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -104.17 64.06 0.76 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.397 -0.814 . . . . 0.0 109.35 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.497 ' HE3' ' CG2' ' A' ' 34' ' ' THR . 53.0 mttm -44.73 -52.96 7.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.586 -0.696 . . . . 0.0 111.267 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.417 ' OD2' ' OD2' ' A' ' 24' ' ' ASP . 6.7 p-10 -69.7 -43.22 72.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.906 -1.121 . . . . 0.0 110.017 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.83 51.52 1.64 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 3.5 p30 -105.66 -24.53 12.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.058 -1.26 . . . . 0.0 109.878 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.549 ' C ' HG23 ' A' ' 26' ' ' THR . . . 111.86 30.38 3.02 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.549 HG23 ' C ' ' A' ' 25' ' ' GLY . 57.8 p -153.73 158.26 40.72 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.024 -1.28 . . . . 0.0 110.53 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.0 mt -124.22 109.21 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.317 -0.864 . . . . 0.0 109.934 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.601 HG22 ' CG2' ' A' ' 62' ' ' THR . 68.9 p -95.66 -164.51 1.17 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.239 -0.913 . . . . 0.0 110.301 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.455 HG22 HD12 ' A' ' 52' ' ' ILE . 35.8 p -85.41 -26.13 26.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.246 -0.908 . . . . 0.0 110.206 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.87 -62.8 1.24 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.24 -0.912 . . . . 0.0 110.025 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.74 ' O ' HG23 ' A' ' 35' ' ' VAL . 56.9 mt-10 -57.66 -46.06 84.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.137 -0.977 . . . . 0.0 109.763 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.872 HD22 HD11 ' A' ' 52' ' ' ILE . 0.8 OUTLIER -60.25 -32.04 70.78 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.269 -0.894 . . . . 0.0 109.676 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.54 -50.83 63.31 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.497 ' CG2' ' HE3' ' A' ' 21' ' ' LYS . 63.5 m -70.01 -22.3 63.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.105 -1.232 . . . . 0.0 109.611 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 31' ' ' GLU . 51.4 t -70.21 -32.2 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.472 -0.768 . . . . 0.0 109.55 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.425 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 26.2 mmt -86.97 -22.72 25.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.375 -0.828 . . . . 0.0 109.622 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.4 mmm-85 -68.16 -45.25 74.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 0.0 109.875 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.1 m -94.73 8.73 41.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.308 -0.87 . . . . 0.0 110.296 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.723 HD23 H142 ' A' ' 153' ' ' WW7 . 0.3 OUTLIER -164.09 74.78 0.31 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.102 -0.999 . . . . 0.0 110.19 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.31 -91.49 0.14 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -161.84 -145.37 0.11 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -1.145 . . . . 0.0 110.011 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -121.4 72.06 26.81 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.007 . . . . 0.0 110.299 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -76.18 135.97 17.55 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.874 1.46 . . . . 0.0 110.179 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 72.8 p -73.4 -149.83 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.209 -0.932 . . . . 0.0 110.282 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -104.39 -42.41 5.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 109.894 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.42 -63.72 1.01 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.241 -0.912 . . . . 0.0 109.744 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 38.4 tt0 -51.61 -41.32 61.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.914 . . . . 0.0 109.689 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.456 HD11 HD23 ' A' ' 32' ' ' LEU . 7.9 tt -55.27 -53.13 60.02 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.809 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -51.41 -37.56 49.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.364 -0.835 . . . . 0.0 109.767 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 7.4 t0 -63.11 -40.64 98.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.334 -0.854 . . . . 0.0 109.724 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.432 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 21.8 ttp -66.67 -19.24 65.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.329 -0.857 . . . . 0.0 109.636 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.872 HD11 HD22 ' A' ' 32' ' ' LEU . 26.3 mt -87.77 -25.48 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.252 -0.905 . . . . 0.0 110.479 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -62.5 -38.47 90.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.05 -1.031 . . . . 0.0 110.388 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.547 ' HG3' HG23 ' A' ' 55' ' ' VAL . 14.3 pt-20 -65.5 -18.76 65.56 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.123 -0.985 . . . . 0.0 110.343 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.547 HG23 ' HG3' ' A' ' 54' ' ' GLU . 79.6 t -95.9 -69.7 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.247 -0.908 . . . . 0.0 110.065 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -45.1 123.33 3.85 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.385 -0.822 . . . . 0.0 110.531 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.33 36.74 2.95 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.894 . . . . 0.0 110.363 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.414 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 48.6 m-20 -123.68 -52.22 1.81 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.24 -0.912 . . . . 0.0 110.371 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.31 16.17 7.88 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.45 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 24.6 p30 -93.62 -20.97 19.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.257 -1.143 . . . . 0.0 110.023 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.45 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 109.91 -44.77 1.43 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.601 ' CG2' HG22 ' A' ' 28' ' ' THR . 71.0 p -98.81 164.9 12.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.095 -1.238 . . . . 0.0 110.568 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.1 mt -101.88 158.59 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.148 -0.97 . . . . 0.0 110.132 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.43 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 32.4 m-20 -113.4 -167.82 1.25 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.372 -0.83 . . . . 0.0 110.797 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.563 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 41.8 t80 -76.37 -42.97 3.33 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.422 -0.799 . . . . 0.0 111.342 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.2 Cg_endo -72.6 -25.99 16.98 Favored 'Trans proline' 0 C--O 1.208 -1.02 0 O-C-N 123.033 1.017 . . . . 0.0 110.32 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.414 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 49.5 mt-10 -78.54 -24.32 45.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.038 -1.039 . . . . 0.0 109.351 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.484 ' CZ ' ' SD ' ' A' ' 72' ' ' MET . 55.7 t80 -78.12 -51.73 9.82 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.55 -0.719 . . . . 0.0 110.466 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.754 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 3.4 tt -75.1 -20.04 59.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.243 -0.911 . . . . 0.0 110.727 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.437 ' HB ' ' O ' ' A' ' 66' ' ' PRO . 18.9 m -82.21 -50.83 8.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.079 -1.013 . . . . 0.0 110.503 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.01 -29.66 67.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.093 -1.004 . . . . 0.0 109.867 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.484 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 52.8 mtt -86.5 -12.91 47.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.218 -0.926 . . . . 0.0 110.188 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . -74.96 -25.84 59.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.233 -0.917 . . . . 0.0 110.636 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -99.99 33.74 2.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.179 -0.951 . . . . 0.0 110.5 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -53.75 123.49 12.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.185 -0.947 . . . . 0.0 109.55 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.5 ttt -139.38 127.27 22.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.137 -0.977 . . . . 0.0 110.771 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -126.51 164.05 22.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.331 -0.856 . . . . 0.0 109.523 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -145.62 152.81 40.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.052 -1.03 . . . . 0.0 110.592 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.7 m -153.78 152.43 30.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 0.0 110.079 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -100.4 163.54 12.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 110.485 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 77.1 p -154.32 -173.72 4.69 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.366 -0.834 . . . . 0.0 110.105 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -137.46 164.24 29.15 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.195 -0.941 . . . . 0.0 110.221 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.419 ' CD ' ' N ' ' A' ' 83' ' ' GLU . 1.2 pm0 -162.45 72.23 0.34 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.135 -0.978 . . . . 0.0 110.532 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -106.46 -70.49 0.79 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.199 -0.938 . . . . 0.0 110.301 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 32.7 mt -58.86 -33.71 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.071 -1.018 . . . . 0.0 109.711 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -54.79 -44.92 74.18 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.273 -0.892 . . . . 0.0 109.408 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.43 ' HB2' HN21 ' A' ' 154' ' ' WW7 . 5.9 mm-40 -64.78 -36.32 83.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.304 -0.873 . . . . 0.0 110.072 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.682 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -60.43 -61.95 2.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.33 -0.857 . . . . 0.0 110.293 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.469 ' CE1' ' HA ' ' A' ' 138' ' ' TYR . 1.1 t80 -55.13 -28.26 51.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.452 -0.78 . . . . 0.0 110.54 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.65 -47.75 65.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.151 -0.968 . . . . 0.0 110.844 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.734 HG23 ' CD1' ' A' ' 92' ' ' PHE . 27.2 m -69.59 -24.64 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.069 -1.019 . . . . 0.0 110.477 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.734 ' CD1' HG23 ' A' ' 91' ' ' VAL . 13.4 m-85 -86.18 -16.89 36.4 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.239 -0.913 . . . . 0.0 110.239 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -109.22 97.12 6.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.274 -0.891 . . . . 0.0 110.245 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -103.41 12.43 35.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.904 . . . . 0.0 110.545 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 1.9 p30 -116.64 -41.74 3.05 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.988 -1.07 . . . . 0.0 110.501 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.468 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 111.91 36.66 1.65 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.438 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 41.0 p30 -117.11 -9.54 11.03 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.941 -1.329 . . . . 0.0 110.844 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 70.82 35.89 65.98 Favored Glycine 0 N--CA 1.498 2.822 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 28.1 m-85 -140.25 136.77 33.67 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.205 -1.174 . . . . 0.0 109.66 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.424 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 12.8 mt -92.11 119.59 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.938 -1.101 . . . . 0.0 109.797 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 77.6 p -109.75 151.66 26.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.166 -0.959 . . . . 0.0 110.226 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.1 -29.41 60.58 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.197 -0.939 . . . . 0.0 110.413 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.72 -52.91 61.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.204 -0.935 . . . . 0.0 110.235 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.841 ' O ' HG23 ' A' ' 108' ' ' VAL . 98.7 mt-10 -66.51 -55.82 13.76 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.243 -0.911 . . . . 0.0 110.28 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.611 HD23 HG13 ' A' ' 121' ' ' VAL . 17.2 tp -53.41 -25.35 15.41 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.109 -0.994 . . . . 0.0 110.35 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 47.2 ttt85 -71.45 -49.83 37.67 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.262 -0.899 . . . . 0.0 110.313 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -79.63 -9.33 59.62 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.27 -0.894 . . . . 0.0 110.792 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 104' ' ' GLU . 91.0 t -83.97 -46.37 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.059 -1.026 . . . . 0.0 110.47 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.405 ' O ' ' HB2' ' A' ' 114' ' ' GLU . 25.8 mtt -82.0 -32.81 30.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.041 -1.037 . . . . 0.0 110.585 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 55.8 m -67.23 -31.04 71.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.215 -0.928 . . . . 0.0 110.347 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -87.64 -42.13 12.9 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.177 -0.952 . . . . 0.0 110.322 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.434 HD12 ' O ' ' A' ' 108' ' ' VAL . 29.7 mt -46.13 -27.15 0.9 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.273 -0.892 . . . . 0.0 110.206 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.37 37.52 0.56 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 109' ' ' MET . 45.6 mt-10 -127.91 127.75 43.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.125 -1.221 . . . . 0.0 110.225 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -83.23 92.78 7.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 110.19 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.5 mt -118.83 -176.3 3.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.217 -0.927 . . . . 0.0 110.149 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.3 t -144.52 -178.41 5.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.25 -0.906 . . . . 0.0 110.45 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -61.85 -31.1 71.33 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.342 -0.848 . . . . 0.0 110.997 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.42 ' N ' ' CD ' ' A' ' 119' ' ' GLU . 6.2 mp0 -67.11 -41.1 86.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.26 -0.9 . . . . 0.0 110.708 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -67.72 -56.39 9.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.208 -0.932 . . . . 0.0 110.575 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.611 HG13 HD23 ' A' ' 105' ' ' LEU . 78.0 t -52.99 -49.3 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 0.0 110.412 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -57.54 -41.14 80.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.222 -0.924 . . . . 0.0 110.57 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -65.89 -32.74 74.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.22 -0.925 . . . . 0.0 110.796 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -73.11 -38.59 66.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.25 -0.906 . . . . 0.0 110.573 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 31.5 mm -70.11 -27.61 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.113 -0.992 . . . . 0.0 109.99 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -72.93 -45.79 56.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.396 -0.815 . . . . 0.0 110.223 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -70.54 -28.76 65.18 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.078 -1.014 . . . . 0.0 110.103 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.62 -24.95 36.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.354 -0.841 . . . . 0.0 110.402 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -86.76 77.07 9.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.051 -1.031 . . . . 0.0 110.174 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.72 HD12 ' HG2' ' A' ' 140' ' ' GLU . 5.6 mt -45.91 -60.18 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.387 -0.82 . . . . 0.0 110.482 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.9 p30 -66.24 -26.97 67.61 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.074 -1.016 . . . . 0.0 110.398 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 65.48 66.18 2.56 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 2.6 p30 -107.54 -35.39 6.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.281 -1.129 . . . . 0.0 110.674 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 167.77 -37.77 0.22 Allowed Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.021 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.409 ' HG3' ' HB3' ' A' ' 99' ' ' TYR . 2.7 pm0 -140.38 166.83 23.63 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.113 -1.228 . . . . 0.0 110.265 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.424 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 12.1 t -88.46 146.34 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.295 -0.878 . . . . 0.0 110.044 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -109.46 169.9 8.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 109.917 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.485 ' O ' HG23 ' A' ' 142' ' ' VAL . 9.0 t80 -61.66 -47.87 83.42 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.183 -0.948 . . . . 0.0 110.545 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -59.91 -41.46 91.73 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.007 -1.058 . . . . 0.0 110.152 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.72 ' HG2' HD12 ' A' ' 130' ' ' ILE . 52.2 mt-10 -69.41 -24.72 63.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.92 . . . . 0.0 110.014 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.518 ' CZ ' ' CE ' ' A' ' 145' ' ' MET . 8.0 t80 -77.51 -25.23 50.13 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.378 -0.826 . . . . 0.0 109.977 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 138' ' ' TYR . 90.0 t -80.34 -23.4 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.278 -0.889 . . . . 0.0 110.04 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -89.13 -31.74 17.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -0.9 . . . . 0.0 110.296 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.434 ' CE ' ' CD2' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -82.65 -22.51 34.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.153 -0.967 . . . . 0.0 110.243 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.518 ' CE ' ' CZ ' ' A' ' 141' ' ' PHE . 46.0 tpp -71.54 -29.95 65.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.337 -0.852 . . . . 0.0 109.97 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.1 p -117.71 54.15 0.91 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.363 -0.835 . . . . 0.0 110.306 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -96.91 -179.48 4.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 110.278 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.156 -179.963 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' WW7 . . . . . 0.723 H142 HD23 ' A' ' 39' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' WW7 . . . . . 0.623 H131 ' HB2' ' A' ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.252 0.548 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 15.0 p-10 -143.66 -162.44 1.46 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.257 -0.902 . . . . 0.0 110.133 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -71.49 143.49 49.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.138 -0.976 . . . . 0.0 110.376 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -104.72 -168.24 1.45 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -0.889 . . . . 0.0 110.201 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.8 p -133.42 -162.63 1.26 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.244 -0.91 . . . . 0.0 109.834 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.87 -15.39 30.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.142 -0.974 . . . . 0.0 110.262 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 2.5 tp10 -46.81 -48.29 20.81 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.272 -0.892 . . . . 0.0 110.145 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -53.97 -47.23 71.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.454 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.887 HG23 HD11 ' A' ' 69' ' ' LEU . 44.3 mt -56.38 -33.74 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.336 -0.852 . . . . 0.0 109.468 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -62.83 -37.44 86.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.39 -0.819 . . . . 0.0 109.373 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -63.09 -51.04 68.17 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.303 -0.873 . . . . 0.0 109.421 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -60.1 -28.11 67.56 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.471 -0.768 . . . . 0.0 109.891 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 2.4 mtpm? -64.25 -52.65 57.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 109.49 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -53.12 -38.07 62.32 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.348 -0.845 . . . . 0.0 109.304 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.04 -43.63 98.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.445 -0.784 . . . . 0.0 109.693 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -54.29 -39.65 67.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 109.377 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.7 t -73.03 -29.99 63.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.427 -0.796 . . . . 0.0 109.505 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.842 ' O ' HD23 ' A' ' 18' ' ' LEU . 5.1 tt -59.43 -35.97 75.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.447 -0.783 . . . . 0.0 109.388 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.566 ' CE2' ' H3 ' ' A' ' 153' ' ' WW7 . 9.8 m-85 -82.19 -56.7 3.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.436 -0.79 . . . . 0.0 109.874 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.457 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 9.8 t70 -52.96 106.2 0.15 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.452 -0.78 . . . . 0.0 110.214 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -110.31 41.72 1.69 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.264 -0.898 . . . . 0.0 110.983 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 5.6 p-10 -150.12 -50.77 0.14 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.037 -1.039 . . . . 0.0 110.387 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.91 57.61 0.33 Allowed Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.744 -1.217 . . . . 0.0 110.333 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 56.5 p-10 -135.75 0.62 2.71 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.135 -1.215 . . . . 0.0 110.737 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.555 ' C ' HG23 ' A' ' 26' ' ' THR . . . 64.09 40.27 97.96 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.555 HG23 ' C ' ' A' ' 25' ' ' GLY . 81.0 p -154.83 139.52 17.05 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.232 -1.158 . . . . 0.0 109.857 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 86.4 mt -105.12 132.36 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.125 -0.985 . . . . 0.0 110.205 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.515 HG22 ' H ' ' A' ' 29' ' ' THR . 10.0 m -125.21 174.79 7.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.227 -0.921 . . . . 0.0 110.563 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.515 ' H ' HG22 ' A' ' 28' ' ' THR . 43.5 p -64.01 -21.12 66.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.439 -0.788 . . . . 0.0 109.954 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -70.84 -69.32 0.37 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.278 -0.888 . . . . 0.0 110.071 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.457 ' OE1' ' HA ' ' A' ' 20' ' ' ASP . 21.8 mt-10 -53.02 -46.61 68.47 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.331 -0.856 . . . . 0.0 109.61 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.979 HD22 HD11 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -60.19 -32.85 71.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.886 . . . . 0.0 109.659 179.511 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.04 -42.19 98.31 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.9 m -72.08 -24.39 61.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -1.081 . . . . 0.0 109.612 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.416 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 42.3 t -69.37 -35.87 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.405 -0.809 . . . . 0.0 109.688 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.412 ' O ' ' O ' ' A' ' 40' ' ' GLY . 25.4 mmt -90.25 -20.46 22.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 110.368 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.6 mtt85 -89.48 -18.1 27.37 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.023 -1.048 . . . . 0.0 110.651 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 92.4 p -101.54 -16.96 16.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.02 -1.05 . . . . 0.0 110.231 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.84 55.91 1.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.202 -0.936 . . . . 0.0 110.02 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 36' ' ' MET . . . 104.92 86.23 1.91 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.417 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 9.8 tt0 -83.14 67.48 9.18 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.459 -1.024 . . . . 0.0 110.634 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.484 ' HB2' ' HD3' ' A' ' 43' ' ' PRO . 1.8 m120 -85.05 -58.39 0.35 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.124 -0.985 . . . . 0.0 111.157 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' A' ' 42' ' ' ASN . 44.4 Cg_endo -73.88 -169.01 0.5 Allowed 'Trans proline' 0 C--N 1.315 -1.202 0 O-C-N 123.564 1.297 . . . . 0.0 111.056 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 10.9 t -132.94 -174.21 3.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.433 -0.792 . . . . 0.0 109.892 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -66.32 -43.94 84.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.141 -0.974 . . . . 0.0 110.595 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.89 -67.45 0.44 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.174 -0.954 . . . . 0.0 110.434 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -47.39 -29.86 2.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 0.0 110.1 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.863 HD11 HD23 ' A' ' 32' ' ' LEU . 8.6 tt -66.7 -49.36 66.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.931 . . . . 0.0 109.343 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -49.22 -38.88 27.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 109.243 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -64.2 -42.18 96.74 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.399 -0.813 . . . . 0.0 109.411 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.451 ' HG3' ' OE2' ' A' ' 54' ' ' GLU . 2.5 ttp -65.58 -14.56 61.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.264 -0.897 . . . . 0.0 109.946 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.979 HD11 HD22 ' A' ' 32' ' ' LEU . 25.4 mm -88.47 -33.61 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.302 -0.874 . . . . 0.0 110.3 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -65.25 -33.33 75.74 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.419 -0.8 . . . . 0.0 110.697 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.555 ' HG3' HG23 ' A' ' 55' ' ' VAL . 22.7 pt-20 -71.3 -8.29 52.7 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.058 -1.026 . . . . 0.0 110.647 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.76 HG22 ' SD ' ' A' ' 71' ' ' MET . 79.3 t -108.51 -18.84 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.069 -1.019 . . . . 0.0 110.107 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.415 ' OD2' ' O ' ' A' ' 62' ' ' THR . 4.6 t70 -109.04 109.27 20.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 111.053 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.76 15.19 23.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 109.66 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.73 -45.19 17.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.417 -0.802 . . . . 0.0 109.985 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.0 15.87 8.87 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -105.21 -31.73 8.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.053 -1.263 . . . . 0.0 110.171 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.38 -47.43 1.02 Allowed Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.84 -1.172 . . . . 0.0 110.248 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.415 ' O ' ' OD2' ' A' ' 56' ' ' ASP . 10.1 p -96.99 166.78 11.44 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.186 -1.185 . . . . 0.0 110.81 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.48 HD13 HG11 ' A' ' 55' ' ' VAL . 17.2 mt -102.95 161.34 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.202 -0.936 . . . . 0.0 110.316 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -113.65 -160.91 0.74 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.336 -0.853 . . . . 0.0 110.502 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.57 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 21.9 t80 -82.09 -43.4 1.02 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.896 . . . . 0.0 111.837 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.6 Cg_endo -72.42 -24.15 19.58 Favored 'Trans proline' 0 C--N 1.321 -0.894 0 O-C-N 123.027 1.014 . . . . 0.0 110.656 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -76.83 -33.78 57.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.143 -0.973 . . . . 0.0 109.087 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.571 ' CE1' ' CE ' ' A' ' 72' ' ' MET . 77.5 t80 -72.03 -40.27 68.55 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.572 -0.705 . . . . 0.0 109.852 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.887 HD11 HG23 ' A' ' 9' ' ' ILE . 8.2 tp -78.71 -17.93 55.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.446 -0.784 . . . . 0.0 110.607 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 51.9 m -90.63 -23.34 20.83 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.022 -1.049 . . . . 0.0 110.651 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.76 ' SD ' HG22 ' A' ' 55' ' ' VAL . 48.6 ttp -90.8 -36.96 13.94 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.891 -1.131 . . . . 0.0 111.073 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.571 ' CE ' ' CE1' ' A' ' 68' ' ' PHE . 56.8 mtt -89.83 -53.25 4.59 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.054 -1.029 . . . . 0.0 111.496 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -65.89 -10.15 35.9 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.931 -1.105 . . . . 0.0 110.882 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 70' ' ' THR . 5.0 tpt180 -86.72 10.24 16.38 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.041 -1.037 . . . . 0.0 110.442 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.98 177.82 4.78 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.007 -1.058 . . . . 0.0 110.131 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 54.36 101.6 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.262 -0.899 . . . . 0.0 110.186 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -145.37 15.73 1.48 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.178 -0.951 . . . . 0.0 110.269 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -62.53 151.79 36.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 109.751 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.7 t -115.74 138.77 50.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.179 -0.95 . . . . 0.0 110.203 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 1.7 m-20 -108.71 117.54 34.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.185 -0.947 . . . . 0.0 109.921 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 81.0 p -122.79 112.55 18.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 110.819 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -121.35 -0.04 9.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.36 -0.837 . . . . 0.0 109.935 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -149.04 89.76 1.69 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.289 -0.882 . . . . 0.0 109.66 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 1.0 OUTLIER -44.0 -26.75 0.31 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.449 -0.782 . . . . 0.0 110.761 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 79.5 mt -66.51 -59.31 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.192 -0.942 . . . . 0.0 110.093 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -63.08 -57.18 11.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.356 -0.84 . . . . 0.0 110.337 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.583 ' O ' HG13 ' A' ' 91' ' ' VAL . 51.3 mm-40 -51.02 -32.02 20.15 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.244 -0.91 . . . . 0.0 110.451 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' A' ' 84' ' ' GLU . . . -72.98 -40.72 65.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.192 -0.942 . . . . 0.0 110.414 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -62.79 -29.51 70.76 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.968 -1.083 . . . . 0.0 110.554 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 66.6 mtt85 -80.9 -52.12 7.82 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.201 -0.937 . . . . 0.0 110.938 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 87' ' ' GLU . 19.6 m -59.09 -36.22 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.211 -0.931 . . . . 0.0 111.02 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.534 ' CD2' ' H3 ' ' A' ' 154' ' ' WW7 . 16.2 m-85 -78.85 -38.8 36.98 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.033 -1.042 . . . . 0.0 110.606 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -111.55 71.3 0.74 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.275 -0.891 . . . . 0.0 110.147 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.441 ' CD ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -108.06 42.59 1.34 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.146 -0.971 . . . . 0.0 110.499 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 2.7 p30 -125.77 -26.95 3.41 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.242 -0.912 . . . . 0.0 110.605 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.4 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 108.21 31.57 3.51 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.45 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 18.6 t-20 -93.12 -44.98 8.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -1.145 . . . . 0.0 110.135 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.476 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 111.24 -14.91 28.07 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 33.8 m-85 -144.28 147.27 33.32 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.218 -1.166 . . . . 0.0 110.108 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.45 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 26.0 mt -71.1 137.5 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.245 -0.909 . . . . 0.0 109.439 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.3 m -114.21 169.64 8.88 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.194 -0.941 . . . . 0.0 110.394 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.61 -46.01 56.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.236 -0.915 . . . . 0.0 110.115 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.91 -53.94 49.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -0.918 . . . . 0.0 109.986 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.774 ' O ' HG23 ' A' ' 108' ' ' VAL . 31.2 mt-10 -58.57 -38.66 78.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.238 -0.914 . . . . 0.0 109.783 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.836 HD12 HD11 ' A' ' 125' ' ' ILE . 1.4 tt -57.78 -36.83 72.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.32 -0.863 . . . . 0.0 110.105 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.68 ' O ' HG22 ' A' ' 110' ' ' THR . 6.6 ttt-85 -70.0 -44.44 69.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.343 -0.848 . . . . 0.0 110.304 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -70.64 -11.06 60.7 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.084 -1.01 . . . . 0.0 110.497 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 104' ' ' GLU . 85.1 t -91.8 -40.79 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.135 -0.978 . . . . 0.0 110.163 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.2 mmt -69.9 -52.77 21.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.257 -0.902 . . . . 0.0 110.558 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.68 HG22 ' O ' ' A' ' 106' ' ' ARG . 5.8 t -56.99 -24.33 52.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.229 -0.919 . . . . 0.0 110.689 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -85.31 -33.86 22.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.022 -1.049 . . . . 0.0 110.69 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 24.4 mt -73.58 -56.53 4.9 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.131 -0.981 . . . . 0.0 110.28 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 167.58 -32.1 0.19 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -70.96 140.31 50.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.322 -1.105 . . . . 0.0 110.203 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 3.4 pttp -114.77 101.57 9.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.169 -0.957 . . . . 0.0 110.392 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.3 mt -112.0 168.5 9.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.125 -0.985 . . . . 0.0 110.236 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.544 HG22 ' N ' ' A' ' 118' ' ' ASP . 85.3 m -115.58 170.32 8.52 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.223 -0.923 . . . . 0.0 110.45 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.544 ' N ' HG22 ' A' ' 117' ' ' THR . 0.9 OUTLIER -51.02 -35.44 34.16 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.339 -0.851 . . . . 0.0 110.962 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -62.36 -54.78 35.39 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.059 -1.026 . . . . 0.0 110.798 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -61.2 -54.6 42.26 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.221 -0.924 . . . . 0.0 110.702 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' A' ' 105' ' ' LEU . 79.6 t -50.65 -41.25 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.115 -0.991 . . . . 0.0 110.566 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.96 -40.62 91.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.118 -0.989 . . . . 0.0 110.214 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.443 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 12.4 mt-10 -71.1 -18.41 62.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.236 -0.915 . . . . 0.0 109.972 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 9.1 mmm -78.79 -48.67 14.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 110.155 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.836 HD11 HD12 ' A' ' 105' ' ' LEU . 30.4 mm -70.44 -36.4 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.312 -0.868 . . . . 0.0 110.334 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -72.11 -47.36 51.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.362 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.443 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 5.7 mm-40 -70.15 -23.85 63.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.207 -0.933 . . . . 0.0 110.186 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.79 -14.65 27.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.171 -0.956 . . . . 0.0 110.011 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.76 ' OD1' HG22 ' A' ' 136' ' ' VAL . 3.8 m-20 -79.92 88.33 5.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.098 -1.001 . . . . 0.0 110.922 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.478 HG22 ' O ' ' A' ' 130' ' ' ILE . 11.5 mm -67.24 -4.08 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.523 -0.736 . . . . 0.0 111.11 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 54.0 p30 -176.57 -19.71 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 O-C-N 120.709 -1.245 . . . . 0.0 112.223 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . -71.8 -52.06 13.27 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 1.2 m-20 56.48 96.32 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.468 -1.019 . . . . 0.0 108.418 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 105.28 -20.49 37.58 Favored Glycine 0 C--N 1.295 -1.748 0 N-CA-C 107.564 -2.214 . . . . 0.0 107.564 -177.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.469 ' HB2' ' CB ' ' A' ' 99' ' ' TYR . 2.5 pt20 -153.4 152.32 30.92 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.621 -0.929 . . . . 0.0 109.729 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.76 HG22 ' OD1' ' A' ' 129' ' ' ASP . 99.5 t -118.48 147.12 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.208 -0.933 . . . . 0.0 110.346 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.4 ' OD1' ' CD1' ' A' ' 99' ' ' TYR . 2.9 m120 -105.91 179.46 4.26 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.435 -0.791 . . . . 0.0 110.585 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -73.73 -49.54 25.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.312 -0.868 . . . . 0.0 108.884 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -59.29 -41.75 89.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.346 -0.846 . . . . 0.0 109.046 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.45 ' OE1' ' HA ' ' A' ' 136' ' ' VAL . 36.1 tt0 -64.98 -33.27 75.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.484 -0.76 . . . . 0.0 109.968 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.429 ' O ' ' HG2' ' A' ' 144' ' ' MET . 13.4 t80 -68.91 -25.62 64.68 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.315 -0.866 . . . . 0.0 110.31 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.8 t -81.44 -36.28 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.122 -0.986 . . . . 0.0 109.726 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.49 -29.95 64.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 110.8 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.504 ' HE3' ' HE1' ' A' ' 145' ' ' MET . 3.4 ptt? -74.59 -25.55 59.33 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.006 -1.059 . . . . 0.0 110.623 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.529 ' HE3' ' N1 ' ' A' ' 154' ' ' WW7 . 20.5 mmt -87.11 -67.69 0.8 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.117 -0.989 . . . . 0.0 110.504 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 65.6 p -64.58 127.46 31.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.071 -1.018 . . . . 0.0 110.411 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.74 -150.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.445 -0.785 . . . . 0.0 110.358 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.226 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' WW7 . . . . . 0.794 ' HN1' H141 ' A' ' 153' ' ' WW7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' WW7 . . . . . 0.534 ' H3 ' ' CD2' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.244 0.545 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -95.58 73.54 3.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.166 -0.959 . . . . 0.0 110.089 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -84.9 -68.33 0.73 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.405 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 4' ' ' LEU . 10.6 mt -51.39 167.34 0.09 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.229 -0.919 . . . . 0.0 110.25 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.6 p -92.99 175.07 6.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.246 -0.909 . . . . 0.0 110.228 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -88.49 -19.05 26.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.275 -0.891 . . . . 0.0 110.247 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.86 -55.94 28.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.274 -0.891 . . . . 0.0 110.252 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -56.65 -33.28 66.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.301 -0.874 . . . . 0.0 109.75 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.0 mm -65.71 -35.95 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.509 -0.745 . . . . 0.0 109.807 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.15 -33.52 73.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.882 . . . . 0.0 109.587 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.8 -51.08 68.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.393 -0.817 . . . . 0.0 109.575 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -58.83 -38.67 79.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.378 -0.826 . . . . 0.0 109.835 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -63.85 -31.11 72.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.354 -0.841 . . . . 0.0 109.911 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -68.47 -45.63 71.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -0.862 . . . . 0.0 110.292 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.44 -44.66 93.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.309 -0.869 . . . . 0.0 110.355 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -58.79 -43.68 90.55 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.21 -0.931 . . . . 0.0 110.298 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.4 m -66.48 -33.95 76.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 110.077 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.799 ' O ' HD23 ' A' ' 18' ' ' LEU . 2.8 tt -62.46 -37.47 86.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 109.788 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.581 ' HA ' HG21 ' A' ' 35' ' ' VAL . 9.3 m-30 -72.51 -64.33 0.97 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.331 -0.856 . . . . 0.0 109.893 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -51.0 120.15 4.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.412 -0.805 . . . . 0.0 109.862 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -104.85 -8.73 18.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.907 -1.121 . . . . 0.0 110.885 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.402 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 6.9 p-10 -101.55 -42.29 6.29 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.9 -1.125 . . . . 0.0 110.238 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.12 55.4 0.92 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 58.5 p30 -123.5 -11.47 7.84 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.166 -1.197 . . . . 0.0 110.503 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.643 ' O ' HG23 ' A' ' 26' ' ' THR . . . 89.12 36.89 7.41 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 25' ' ' GLY . 14.6 p -158.5 129.55 6.34 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.339 -1.095 . . . . 0.0 110.256 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 62' ' ' THR . 62.0 mt -93.19 118.32 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.315 -0.866 . . . . 0.0 109.993 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 t -104.24 -176.28 3.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.232 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.63 HG22 HD12 ' A' ' 52' ' ' ILE . 31.4 p -75.09 -35.08 61.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 110.475 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -62.37 -60.28 3.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.267 -0.896 . . . . 0.0 109.972 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -58.83 -53.11 62.12 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.212 -0.93 . . . . 0.0 109.623 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.739 HD22 HD11 ' A' ' 52' ' ' ILE . 0.5 OUTLIER -58.88 -19.45 42.17 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.235 -0.916 . . . . 0.0 109.572 179.535 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.493 ' HA2' ' CD1' ' A' ' 48' ' ' LEU . . . -67.35 -49.53 51.2 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 38' ' ' SER . 60.0 m -70.84 -19.12 62.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.298 -1.119 . . . . 0.0 109.862 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.581 HG21 ' HA ' ' A' ' 19' ' ' PHE . 24.4 t -76.58 -38.45 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.394 -0.816 . . . . 0.0 110.334 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.714 ' HA ' HD23 ' A' ' 39' ' ' LEU . 26.5 mmt -84.48 -22.96 30.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.121 -0.987 . . . . 0.0 110.163 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.452 ' HD3' ' HA ' ' A' ' 42' ' ' ASN . 3.7 tpp180 -90.68 -16.9 27.72 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.329 -0.857 . . . . 0.0 110.417 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 34' ' ' THR . 32.9 t -92.0 10.11 30.38 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.995 -1.065 . . . . 0.0 110.982 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.714 HD23 ' HA ' ' A' ' 36' ' ' MET . 3.8 pp -107.27 -26.7 10.92 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.015 -1.053 . . . . 0.0 110.65 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.55 -31.13 1.03 Allowed Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.065 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.603 ' HG3' HD11 ' A' ' 39' ' ' LEU . 67.3 mt-30 -81.01 158.75 25.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.101 -1.235 . . . . 0.0 110.323 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.452 ' HA ' ' HD3' ' A' ' 37' ' ' ARG . 77.1 m-20 -130.43 61.09 56.91 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.25 -0.906 . . . . 0.0 110.131 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.05 -163.15 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.771 1.406 . . . . 0.0 110.234 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.527 HG22 ' N ' ' A' ' 45' ' ' GLU . 58.4 m -135.55 171.98 13.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.253 -0.904 . . . . 0.0 110.119 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.527 ' N ' HG22 ' A' ' 44' ' ' THR . 69.3 mt-10 -59.56 -28.94 67.56 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.2 -0.937 . . . . 0.0 110.478 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.92 -67.48 0.49 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.153 -0.967 . . . . 0.0 110.064 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -53.42 -23.09 8.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -0.914 . . . . 0.0 109.512 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.508 HD11 HD23 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -67.85 -58.0 5.32 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.564 -0.71 . . . . 0.0 110.011 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -51.22 -38.09 50.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.322 -0.861 . . . . 0.0 109.527 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -65.17 -38.99 92.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.367 -0.833 . . . . 0.0 109.508 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.444 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 1.6 ttp -66.98 -26.26 66.72 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.426 -0.796 . . . . 0.0 109.784 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.739 HD11 HD22 ' A' ' 32' ' ' LEU . 56.9 mt -83.17 -27.33 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.319 -0.863 . . . . 0.0 109.818 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -58.58 -46.84 86.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.384 -0.823 . . . . 0.0 110.401 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.828 ' HG3' HG23 ' A' ' 55' ' ' VAL . 13.2 pt-20 -64.39 -27.2 68.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -0.918 . . . . 0.0 110.071 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.828 HG23 ' HG3' ' A' ' 54' ' ' GLU . 85.8 t -96.1 -3.97 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.344 -0.848 . . . . 0.0 110.338 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -126.11 105.86 9.17 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.028 -1.045 . . . . 0.0 110.159 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.24 33.66 4.34 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.111 -0.993 . . . . 0.0 110.465 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -104.82 -49.11 3.58 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.186 -0.946 . . . . 0.0 110.236 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 119.53 51.69 0.28 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.457 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 16.1 p-10 -148.02 -43.69 0.16 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -1.129 . . . . 0.0 110.15 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 116.76 -4.12 19.26 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.579 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 45.1 p -123.76 164.05 19.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.906 -1.349 . . . . 0.0 110.469 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.72 HD11 'CL1 ' ' A' ' 153' ' ' WW7 . 52.1 mt -114.05 130.82 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.257 -0.902 . . . . 0.0 110.165 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.428 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 56.0 m-20 -83.3 -173.68 4.85 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 110.112 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.559 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 66.4 t80 -80.73 -42.63 1.25 Allowed Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.324 -0.86 . . . . 0.0 111.35 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 46.5 Cg_endo -74.66 -26.81 11.27 Favored 'Trans proline' 0 N--CA 1.48 0.72 0 O-C-N 123.082 1.043 . . . . 0.0 110.092 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 71' ' ' MET . 78.7 tt0 -78.09 -25.31 47.5 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.358 -0.839 . . . . 0.0 109.002 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 8.0 t80 -79.21 -54.34 6.07 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.607 -0.683 . . . . 0.0 110.025 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.687 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 0.6 OUTLIER -60.0 -34.78 73.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.329 -0.857 . . . . 0.0 110.427 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.4 m -77.02 -32.37 57.01 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.195 -0.941 . . . . 0.0 110.236 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.526 ' HE3' ' HG3' ' A' ' 72' ' ' MET . 18.2 tmm? -61.9 -52.65 63.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.268 -0.895 . . . . 0.0 110.278 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.526 ' HG3' ' HE3' ' A' ' 71' ' ' MET . 47.5 mtt -81.55 -10.4 59.46 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.165 -0.96 . . . . 0.0 110.293 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . -81.36 -23.41 37.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.163 -0.961 . . . . 0.0 110.127 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' A' ' 74' ' ' ARG . 32.3 ttm180 -106.88 62.34 0.63 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.17 -0.956 . . . . 0.0 110.309 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -101.4 -47.24 4.75 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.069 -1.019 . . . . 0.0 109.734 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 4.2 tpp -124.18 122.07 36.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.453 -0.779 . . . . 0.0 109.93 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.81 164.67 14.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.179 -0.951 . . . . 0.0 110.167 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -60.0 -174.71 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 110.133 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.0 t -132.61 -175.4 3.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.925 . . . . 0.0 110.092 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -114.7 132.74 56.31 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.277 -0.889 . . . . 0.0 109.932 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.2 m -124.55 104.94 8.99 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.168 -0.958 . . . . 0.0 110.533 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -88.07 164.4 15.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.252 -0.905 . . . . 0.0 110.085 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.21 -53.04 42.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.198 -0.939 . . . . 0.0 110.379 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -56.03 -48.73 75.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 109.953 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.4 mt -52.07 -45.45 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.213 -0.929 . . . . 0.0 109.527 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -55.07 -44.41 74.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 110.179 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -57.41 -51.68 68.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.932 . . . . 0.0 110.245 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 92' ' ' PHE . . . -54.96 -29.58 57.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.131 -0.981 . . . . 0.0 110.557 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.433 ' O ' ' HB3' ' A' ' 93' ' ' ASP . 3.2 t80 -72.6 -35.98 68.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.003 -1.06 . . . . 0.0 110.838 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -76.32 -42.85 43.74 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.08 -1.013 . . . . 0.0 111.256 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.556 HG23 ' CD1' ' A' ' 92' ' ' PHE . 19.7 m -70.64 -41.23 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.047 -1.033 . . . . 0.0 110.859 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.562 ' CG ' ' H3 ' ' A' ' 154' ' ' WW7 . 25.9 m-85 -75.46 -25.07 57.12 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.877 -1.139 . . . . 0.0 110.028 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.447 ' OD2' ' N ' ' A' ' 99' ' ' TYR . 11.5 t70 -125.33 70.29 1.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.937 . . . . 0.0 110.09 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.11 65.98 0.62 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.429 -0.794 . . . . 0.0 110.284 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.461 ' OD2' ' HB2' ' A' ' 97' ' ' ASN . 21.6 p-10 -150.62 26.49 0.75 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.23 -0.919 . . . . 0.0 110.051 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.04 24.58 60.87 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.461 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 11.1 t-20 -95.49 -70.65 0.7 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.249 -1.147 . . . . 0.0 110.193 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.31 -9.98 10.05 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.456 ' CD1' ' NE2' ' A' ' 135' ' ' GLN . 55.0 m-85 -133.08 153.07 51.85 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.196 -1.179 . . . . 0.0 110.342 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.444 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 13.3 mt -91.84 116.26 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.336 -0.853 . . . . 0.0 109.499 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.0 t -95.06 176.04 6.39 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.318 -0.864 . . . . 0.0 110.115 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.468 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -71.84 -41.81 67.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 110.16 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.88 -50.45 62.44 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.181 -0.949 . . . . 0.0 110.27 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.865 ' O ' HG23 ' A' ' 108' ' ' VAL . 24.0 tt0 -59.52 -40.9 88.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.187 -0.945 . . . . 0.0 109.87 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 105' ' ' LEU . 30.6 tp -62.55 -33.83 75.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.381 -0.824 . . . . 0.0 110.046 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.59 ' O ' HG23 ' A' ' 110' ' ' THR . 6.7 ttp180 -69.16 -34.07 74.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.246 -0.909 . . . . 0.0 109.905 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 41.6 t60 -74.64 -24.18 58.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 110.276 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 104' ' ' GLU . 21.8 t -77.04 -39.92 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.258 -0.902 . . . . 0.0 110.187 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.6 mmt -61.84 -36.67 81.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.882 . . . . 0.0 110.136 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 106' ' ' ARG . 48.2 p -53.23 -43.48 67.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.155 -0.965 . . . . 0.0 109.71 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -60.14 -47.56 85.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.827 . . . . 0.0 110.219 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.5 mt -55.72 -36.3 67.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 110.124 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.07 41.88 2.74 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -119.87 133.59 55.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -1.168 . . . . 0.0 110.101 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.0 tttp -84.54 107.46 16.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.321 -0.862 . . . . 0.0 110.015 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.1 mt -126.29 164.21 21.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -0.869 . . . . 0.0 110.232 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 51.7 m -107.13 162.7 13.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 110.204 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.461 ' OD2' ' NH2' ' A' ' 106' ' ' ARG . 2.4 m-20 -58.2 -40.66 82.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 110.205 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -58.78 -35.55 72.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.312 -0.868 . . . . 0.0 110.526 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.02 -49.84 64.02 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.226 -0.921 . . . . 0.0 110.795 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.468 HG11 ' O ' ' A' ' 102' ' ' ALA . 59.3 t -59.36 -53.31 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.225 -0.922 . . . . 0.0 110.174 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -53.61 -42.56 67.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.189 -0.944 . . . . 0.0 110.004 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 27.1 tt0 -63.03 -33.2 74.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.346 -0.846 . . . . 0.0 110.054 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.406 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 5.5 mmm -65.19 -53.29 47.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.179 -0.951 . . . . 0.0 109.989 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 34.8 mm -54.94 -32.21 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.255 -0.903 . . . . 0.0 110.089 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 -70.65 -42.73 70.42 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.298 -0.876 . . . . 0.0 110.136 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 49.9 mt-10 -65.82 -23.95 66.8 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.292 -0.88 . . . . 0.0 110.219 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.63 -22.48 19.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.322 -0.862 . . . . 0.0 110.066 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -72.67 90.43 1.38 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 110.228 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 59.0 mt -89.34 -25.61 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.14 -0.975 . . . . 0.0 110.304 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 41.7 p30 -87.4 -16.44 34.92 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.244 -0.91 . . . . 0.0 110.496 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.455 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 75.1 70.35 1.27 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -130.62 -33.9 1.59 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.21 -1.171 . . . . 0.0 110.427 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 111.61 18.43 7.99 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.456 ' NE2' ' CD1' ' A' ' 99' ' ' TYR . 4.0 pt20 -160.56 147.4 15.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.371 -1.076 . . . . 0.0 109.949 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.444 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 60.7 t -91.09 132.18 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 110.377 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -106.39 171.4 7.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 109.82 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -53.83 -38.34 64.53 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.174 -0.954 . . . . 0.0 110.351 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -68.03 -62.88 1.2 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.185 -0.947 . . . . 0.0 110.647 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -46.83 -33.72 4.72 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.283 -0.886 . . . . 0.0 110.899 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.427 ' O ' ' HG3' ' A' ' 144' ' ' MET . 12.8 t80 -70.23 -40.94 74.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 111.133 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.632 ' O ' HG22 ' A' ' 146' ' ' THR . 99.2 t -77.48 -20.9 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.052 -1.03 . . . . 0.0 110.766 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -85.12 -28.11 25.79 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.257 -0.902 . . . . 0.0 110.959 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.455 ' CE ' ' HG3' ' A' ' 145' ' ' MET . 0.2 OUTLIER -83.05 -20.13 35.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.058 -1.026 . . . . 0.0 110.316 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.516 ' HE1' H121 ' A' ' 154' ' ' WW7 . 26.0 mtt -90.24 -59.12 2.27 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.303 -0.873 . . . . 0.0 110.256 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.632 HG22 ' O ' ' A' ' 142' ' ' VAL . 13.7 t -54.21 132.08 42.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 110.004 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -174.11 126.28 0.35 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 0.0 110.286 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.115 179.966 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' WW7 . . . . . 0.813 ' C6 ' HG21 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' WW7 . . . . . 0.562 ' H3 ' ' CG ' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.322 0.582 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -152.06 121.99 7.06 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.185 -0.947 . . . . 0.0 110.248 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -142.74 145.68 33.57 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.191 -0.943 . . . . 0.0 110.04 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.615 ' O ' HG23 ' A' ' 5' ' ' THR . 0.5 OUTLIER -124.79 -27.61 3.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -0.943 . . . . 0.0 110.591 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 4' ' ' LEU . 17.9 p -158.2 157.45 32.66 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.159 -0.963 . . . . 0.0 110.513 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -89.01 -8.95 53.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.263 -0.898 . . . . 0.0 110.03 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -64.54 -57.09 10.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.238 -0.914 . . . . 0.0 110.495 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.425 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 1.9 mp0 -47.16 -51.66 17.65 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.3 -0.875 . . . . 0.0 110.371 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 92.6 mt -57.41 -49.23 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.101 -0.999 . . . . 0.0 110.032 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.38 -26.08 39.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.398 -0.814 . . . . 0.0 109.804 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 16.0 tt0 -72.72 -57.82 3.81 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.366 -0.834 . . . . 0.0 109.636 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.438 ' O ' ' HB2' ' A' ' 16' ' ' PHE . 71.9 m-85 -56.4 -23.34 37.46 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.263 -0.898 . . . . 0.0 109.79 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.3 mttp -76.06 -40.35 53.43 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.283 -0.885 . . . . 0.0 110.033 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -62.66 -52.83 61.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 109.902 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.503 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.96 -47.19 85.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 109.998 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.507 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 14.3 t80 -47.76 -48.99 29.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 110.199 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.2 t -58.84 -42.76 90.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.904 . . . . 0.0 109.886 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.712 ' O ' HD23 ' A' ' 18' ' ' LEU . 3.6 tt -49.52 -44.41 46.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.287 -0.883 . . . . 0.0 110.171 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.83 ' CD1' HG11 ' A' ' 35' ' ' VAL . 37.3 m-85 -75.67 -30.28 59.35 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.175 -0.953 . . . . 0.0 110.401 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -80.35 107.52 13.21 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.108 -0.995 . . . . 0.0 110.43 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.402 ' HE3' ' CG2' ' A' ' 34' ' ' THR . 24.9 mttm -105.93 -35.36 7.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.0 110.436 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -74.07 -21.27 59.99 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.128 -0.982 . . . . 0.0 110.11 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.87 100.23 0.04 OUTLIER Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 35.1 p-10 -168.63 -26.21 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.354 -1.086 . . . . 0.0 111.41 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.52 ' C ' HG23 ' A' ' 26' ' ' THR . . . 111.09 27.56 4.2 Favored Glycine 0 N--CA 1.492 2.367 0 O-C-N 120.671 -1.268 . . . . 0.0 109.996 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.52 HG23 ' C ' ' A' ' 25' ' ' GLY . 72.2 p -153.36 170.21 21.22 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.052 -1.264 . . . . 0.0 110.337 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.441 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 12.2 mt -129.47 115.32 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.405 -0.81 . . . . 0.0 109.947 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.495 HG22 ' N ' ' A' ' 29' ' ' THR . 20.6 m -102.33 174.67 5.81 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.195 -0.941 . . . . 0.0 110.191 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.57 HG21 ' OE1' ' A' ' 49' ' ' GLN . 22.8 p -72.21 -21.41 61.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.146 -0.971 . . . . 0.0 110.059 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -70.73 -57.64 4.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.253 -0.905 . . . . 0.0 109.82 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -60.25 -57.62 12.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 0.0 109.71 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.738 HD22 HD11 ' A' ' 52' ' ' ILE . 2.0 tp -51.84 -35.43 44.57 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.279 -0.888 . . . . 0.0 109.584 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.26 -47.11 76.74 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.402 ' CG2' ' HE3' ' A' ' 21' ' ' LYS . 62.5 m -63.3 -31.21 72.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -1.139 . . . . 0.0 109.973 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.83 HG11 ' CD1' ' A' ' 19' ' ' PHE . 54.6 t -67.38 -31.48 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.195 -0.941 . . . . 0.0 109.833 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.4 mmt -90.55 -14.2 33.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.287 -0.883 . . . . 0.0 110.427 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.5 ttp180 -88.77 -31.5 18.36 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.153 -0.967 . . . . 0.0 110.435 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 88.7 p -91.44 -24.32 19.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.267 -0.896 . . . . 0.0 110.188 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -92.62 -67.31 0.86 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.247 -0.908 . . . . 0.0 109.932 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -129.32 89.33 0.31 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -59.68 116.5 4.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -1.119 . . . . 0.0 110.485 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.527 ' CB ' ' HD3' ' A' ' 43' ' ' PRO . 5.4 m-80 -172.1 -61.03 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.301 -0.874 . . . . 0.0 110.477 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.527 ' HD3' ' CB ' ' A' ' 42' ' ' ASN . 47.7 Cg_endo -74.82 144.35 30.84 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.595 1.313 . . . . 0.0 110.105 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.698 HG23 ' H ' ' A' ' 46' ' ' ALA . 7.2 t -107.34 -141.37 0.38 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.106 -0.996 . . . . 0.0 109.897 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.672 ' N ' HG23 ' A' ' 44' ' ' THR . 44.4 mt-10 -88.23 -30.78 19.44 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.901 -1.124 . . . . 0.0 110.088 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.698 ' H ' HG23 ' A' ' 44' ' ' THR . . . -73.21 -64.75 0.91 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 109.702 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 55.4 mt-10 -52.31 -48.56 65.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.181 -0.949 . . . . 0.0 109.333 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.69 HD11 HD23 ' A' ' 32' ' ' LEU . 7.5 tt -52.1 -40.84 61.85 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.354 -0.841 . . . . 0.0 109.154 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.57 ' OE1' HG21 ' A' ' 29' ' ' THR . 62.8 tp60 -53.91 -44.63 70.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.508 -0.745 . . . . 0.0 109.578 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -57.91 -44.67 86.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.254 -0.904 . . . . 0.0 109.482 179.381 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.434 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 70.1 mtp -59.69 -26.61 65.72 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.319 -0.863 . . . . 0.0 109.842 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.738 HD11 HD22 ' A' ' 32' ' ' LEU . 29.9 mm -77.13 -29.53 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.898 . . . . 0.0 110.157 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -68.31 -43.26 78.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.336 -0.853 . . . . 0.0 110.454 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.519 ' HG3' HG23 ' A' ' 55' ' ' VAL . 22.7 pt-20 -68.0 -24.97 65.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.3 -0.875 . . . . 0.0 110.565 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.813 HG13 ' SD ' ' A' ' 71' ' ' MET . 75.9 t -89.33 -21.73 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.178 -0.951 . . . . 0.0 110.113 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -101.49 107.79 19.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.362 -0.836 . . . . 0.0 110.359 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -95.69 17.32 15.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.07 -1.019 . . . . 0.0 110.149 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.434 ' HB2' ' OD1' ' A' ' 60' ' ' ASN . 34.2 m-20 -107.4 -52.24 2.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.354 -0.842 . . . . 0.0 110.046 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.53 19.95 5.6 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.434 ' OD1' ' HB2' ' A' ' 58' ' ' ASP . 22.0 m120 -88.24 -9.23 53.62 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.239 -1.154 . . . . 0.0 110.44 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.25 -38.62 3.15 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.5 p -110.22 160.64 16.33 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.109 -1.23 . . . . 0.0 110.772 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.749 HD13 HG11 ' A' ' 55' ' ' VAL . 49.8 mt -95.8 158.32 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.56 -0.713 . . . . 0.0 109.968 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.432 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.1 m-20 -113.87 -170.67 1.75 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.279 -0.888 . . . . 0.0 110.411 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.563 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.8 t80 -77.23 -46.12 2.69 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.842 . . . . 0.0 111.124 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.1 Cg_endo -73.49 -16.15 24.45 Favored 'Trans proline' 0 C--N 1.318 -1.04 0 O-C-N 123.306 1.161 . . . . 0.0 110.403 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -84.46 -34.5 23.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -0.943 . . . . 0.0 109.043 178.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.488 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 5.5 t80 -70.04 -40.27 75.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.606 -0.684 . . . . 0.0 109.532 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.695 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 18.6 tp -76.61 -38.79 54.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.467 -0.771 . . . . 0.0 110.56 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.8 m -71.17 -22.05 62.09 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.163 -0.961 . . . . 0.0 110.656 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.813 ' SD ' HG13 ' A' ' 55' ' ' VAL . 62.4 ttp -82.3 -51.01 8.31 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.065 -1.022 . . . . 0.0 110.095 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.468 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 57.1 mtt -79.05 -9.69 59.62 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.405 -0.809 . . . . 0.0 110.674 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.695 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . -75.48 -22.09 57.51 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.103 -0.998 . . . . 0.0 110.31 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.5 ttm-85 -106.38 41.24 1.46 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.2 -0.938 . . . . 0.0 110.043 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -138.85 -178.49 5.34 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.221 -0.924 . . . . 0.0 110.163 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.56 164.91 2.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.12 -0.988 . . . . 0.0 109.962 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -129.43 -176.29 3.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.403 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -143.38 113.95 7.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.36 -0.837 . . . . 0.0 109.765 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 79' ' ' THR . 40.8 m -153.97 45.32 0.59 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.255 -0.903 . . . . 0.0 110.501 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -150.96 42.43 0.78 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.07 -1.019 . . . . 0.0 110.232 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.9 m -141.41 -177.4 5.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.246 -0.909 . . . . 0.0 110.354 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 86' ' ' ARG . 3.8 tp10 -91.24 -152.35 0.28 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.273 -0.892 . . . . 0.0 110.033 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -114.38 -92.81 0.49 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.286 -0.884 . . . . 0.0 110.129 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -101.55 -31.96 10.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.045 -1.035 . . . . 0.0 109.766 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 97.8 mt -52.87 -33.32 18.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.305 -0.872 . . . . 0.0 109.802 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.437 ' HD3' ' OE2' ' A' ' 87' ' ' GLU . 2.2 ttt180 -64.34 -46.81 81.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 109.353 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.437 ' OE2' ' HD3' ' A' ' 86' ' ' ARG . 4.7 mp0 -57.75 -29.09 64.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.35 -0.844 . . . . 0.0 109.66 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.597 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -65.92 -62.89 1.25 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.365 -0.834 . . . . 0.0 110.148 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.607 ' CD1' HD11 ' A' ' 100' ' ' ILE . 1.9 t80 -50.01 -29.35 8.47 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.357 -0.839 . . . . 0.0 110.416 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -68.44 -55.15 12.84 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.136 -0.977 . . . . 0.0 110.714 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 88' ' ' ALA . 29.7 m -63.72 -20.66 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.132 -0.98 . . . . 0.0 110.344 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.672 ' CE1' HG11 ' A' ' 108' ' ' VAL . 24.6 m-85 -92.52 -14.06 28.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 0.0 110.34 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -123.93 66.25 1.04 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.234 -0.916 . . . . 0.0 109.714 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -95.61 61.97 2.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.863 . . . . 0.0 110.552 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.8 p30 -164.34 -35.84 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.117 -0.989 . . . . 0.0 110.717 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.454 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 110.04 38.88 1.62 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.445 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 3.8 t-20 -92.81 -57.97 2.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.389 -1.066 . . . . 0.0 110.184 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.425 ' C ' ' CD1' ' A' ' 99' ' ' TYR . . . 121.59 -22.31 7.81 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 27.4 m-85 -131.72 158.69 40.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.152 -1.205 . . . . 0.0 110.306 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.607 HD11 ' CD1' ' A' ' 89' ' ' PHE . 70.9 mt -93.89 135.49 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.331 -0.856 . . . . 0.0 110.587 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.5 t -117.47 176.0 5.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.498 -0.751 . . . . 0.0 109.837 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.63 -37.59 76.86 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.204 -0.935 . . . . 0.0 110.515 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.33 -59.03 6.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.19 -0.944 . . . . 0.0 110.258 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -52.54 -48.51 66.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.266 -0.896 . . . . 0.0 110.086 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.0 HD23 HG13 ' A' ' 121' ' ' VAL . 14.7 tp -54.38 -34.63 61.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -0.89 . . . . 0.0 110.356 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.9 ttt-85 -69.79 -33.29 72.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.08 -1.013 . . . . 0.0 110.367 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 53.2 m170 -68.04 -38.53 82.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.27 -0.894 . . . . 0.0 110.49 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.672 HG11 ' CE1' ' A' ' 92' ' ' PHE . 97.0 t -73.91 -49.59 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.165 -0.96 . . . . 0.0 110.558 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.437 ' HG2' ' O ' ' A' ' 105' ' ' LEU . 22.9 mmt -51.68 -62.69 1.47 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.221 -0.925 . . . . 0.0 110.886 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.6 p -44.96 -27.8 0.59 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.34 -0.85 . . . . 0.0 111.018 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 4.5 m120 -81.3 -39.7 24.8 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.007 -1.058 . . . . 0.0 110.68 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 112' ' ' LEU . 80.5 mt -72.41 -15.54 61.84 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.29 -0.881 . . . . 0.0 110.383 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.48 53.12 1.08 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.609 ' OE1' HD11 ' A' ' 116' ' ' LEU . 13.5 mm-40 -128.49 100.44 5.77 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.341 -1.094 . . . . 0.0 110.098 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -87.88 106.8 18.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 110.213 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.609 HD11 ' OE1' ' A' ' 114' ' ' GLU . 4.3 mp -129.99 -178.37 4.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 0.0 109.998 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.8 m -102.77 155.94 17.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.135 -0.978 . . . . 0.0 110.224 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.408 ' O ' ' OD2' ' A' ' 122' ' ' ASP . 45.5 m-20 -49.16 -43.06 41.54 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.227 -0.921 . . . . 0.0 110.191 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -60.98 -42.59 98.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.187 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -52.37 -59.51 4.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.294 -0.879 . . . . 0.0 110.245 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 1.0 HG13 HD23 ' A' ' 105' ' ' LEU . 42.1 t -53.29 -45.51 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.099 -1.001 . . . . 0.0 110.051 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.408 ' OD2' ' O ' ' A' ' 118' ' ' ASP . 60.3 m-20 -52.49 -37.34 57.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.966 . . . . 0.0 109.77 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -70.67 -33.67 71.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.354 -0.842 . . . . 0.0 110.002 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 5.9 mmm -61.91 -55.35 30.48 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.279 -0.888 . . . . 0.0 110.066 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.654 HG23 HG23 ' A' ' 136' ' ' VAL . 22.8 mm -58.47 -38.86 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.272 -0.892 . . . . 0.0 110.1 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -71.24 -22.43 61.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.255 -0.903 . . . . 0.0 110.158 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.4 ' O ' ' OE1' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -76.28 -42.16 46.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 109.88 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.949 ' HB2' ' H6 ' ' A' ' 154' ' ' WW7 . . . -70.42 -33.68 71.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.025 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -59.58 97.64 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.147 -0.97 . . . . 0.0 109.895 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.8 mt -73.16 -44.12 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.396 -0.815 . . . . 0.0 111.421 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.5 p30 -85.62 -31.2 22.72 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.072 -1.018 . . . . 0.0 110.938 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 97.97 54.05 1.23 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -95.16 14.92 20.5 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.237 -1.155 . . . . 0.0 110.216 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 64.74 21.9 67.69 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.496 ' OE1' ' CD2' ' A' ' 99' ' ' TYR . 1.1 pp0? -170.1 140.87 2.03 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.588 -0.948 . . . . 0.0 109.719 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.654 HG23 HG23 ' A' ' 125' ' ' ILE . 70.8 t -86.11 149.39 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.154 -0.967 . . . . 0.0 110.307 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.462 ' OD1' ' CE2' ' A' ' 99' ' ' TYR . 48.3 t30 -125.83 169.32 12.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.158 -0.964 . . . . 0.0 110.272 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 138' ' ' TYR . 8.1 t80 -58.26 -51.01 71.57 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.401 -0.812 . . . . 0.0 110.671 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -54.99 -54.74 39.12 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.158 -0.964 . . . . 0.0 110.354 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.45 ' O ' ' CG ' ' A' ' 144' ' ' MET . 46.5 mt-10 -61.29 -20.71 63.2 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.155 -0.965 . . . . 0.0 109.932 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.568 ' CD1' ' CD1' ' A' ' 100' ' ' ILE . 13.4 t80 -75.71 -28.74 58.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.351 -0.843 . . . . 0.0 110.53 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.9 t -87.46 -23.44 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.214 -0.928 . . . . 0.0 110.998 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.402 ' HA ' ' CG2' ' A' ' 146' ' ' THR . 76.0 mt-30 -101.78 -9.61 20.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.074 -1.016 . . . . 0.0 110.951 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.523 ' HE1' ' HE2' ' A' ' 145' ' ' MET . 0.1 OUTLIER -89.09 -28.31 20.18 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.022 -1.049 . . . . 0.0 110.132 179.706 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.523 ' HE2' ' HE1' ' A' ' 144' ' ' MET . 32.4 ttm -89.73 -43.11 10.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 110.284 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.402 ' CG2' ' HA ' ' A' ' 143' ' ' GLN . 8.9 t -54.63 -21.71 11.36 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.202 -0.936 . . . . 0.0 109.997 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -49.36 123.48 7.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.233 -0.917 . . . . 0.0 110.177 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 27.4 pttt . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.272 179.967 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' WW7 . . . . . 0.782 ' C6 ' HG21 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' WW7 . . . . . 0.949 ' H6 ' ' HB2' ' A' ' 128' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.389 0.614 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -76.59 -49.7 15.69 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.239 -0.913 . . . . 0.0 110.262 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -134.51 140.24 46.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.229 -0.919 . . . . 0.0 110.026 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.5 OUTLIER -120.0 137.38 54.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.096 -1.002 . . . . 0.0 110.371 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.65 HG23 ' H ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -161.64 -74.23 0.06 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.288 -0.883 . . . . 0.0 110.201 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.65 ' H ' HG23 ' A' ' 5' ' ' THR . 56.8 mt-10 -83.25 -22.78 32.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.039 -1.038 . . . . 0.0 109.661 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -55.9 -28.47 56.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.242 -0.911 . . . . 0.0 109.541 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -66.97 -41.99 85.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.424 -0.798 . . . . 0.0 109.606 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.3 mt -60.79 -45.14 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.413 -0.804 . . . . 0.0 109.832 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.9 -42.67 98.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.82 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -55.25 -45.17 76.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.313 -0.867 . . . . 0.0 109.773 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.492 ' CE2' ' HB2' ' A' ' 73' ' ' ALA . 12.6 m-85 -56.97 -51.76 67.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 0.0 109.81 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -51.54 -34.77 38.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.0 110.261 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -66.54 -41.77 88.18 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.134 -0.979 . . . . 0.0 110.02 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.445 ' HB1' ' CE2' ' A' ' 19' ' ' PHE . . . -63.87 -47.02 82.35 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.216 -0.928 . . . . 0.0 110.146 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -62.53 -33.08 74.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -0.903 . . . . 0.0 109.814 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.1 m -71.09 -32.64 69.31 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.277 -0.889 . . . . 0.0 109.468 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.943 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.4 tm? -78.22 -23.74 47.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.482 -0.761 . . . . 0.0 109.878 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.445 ' CE2' ' HB1' ' A' ' 15' ' ' ALA . 15.7 m-30 -83.25 -67.03 0.82 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.351 -0.843 . . . . 0.0 109.786 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -48.43 111.75 0.5 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.248 -0.907 . . . . 0.0 109.832 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -78.53 -58.41 3.27 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.209 -0.932 . . . . 0.0 110.824 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.413 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 8.6 p-10 -69.34 -41.75 76.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.147 -0.971 . . . . 0.0 109.978 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.69 46.18 2.16 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 2.6 p30 -95.07 -24.87 16.69 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.054 -1.263 . . . . 0.0 110.051 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.534 ' C ' HG23 ' A' ' 26' ' ' THR . . . 109.83 32.5 2.86 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.534 HG23 ' C ' ' A' ' 25' ' ' GLY . 69.5 p -153.98 150.51 28.36 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.165 -1.197 . . . . 0.0 110.242 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 95.2 mt -117.67 107.96 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.27 -0.894 . . . . 0.0 110.131 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.944 HG22 HG21 ' A' ' 62' ' ' THR . 73.1 p -101.0 -174.31 2.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.834 . . . . 0.0 110.097 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.635 HG22 HG13 ' A' ' 52' ' ' ILE . 43.5 p -74.87 -24.84 58.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 110.06 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -71.75 -62.46 1.41 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.09 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -56.88 -49.27 76.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.091 -1.006 . . . . 0.0 109.709 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.025 HD22 HD11 ' A' ' 52' ' ' ILE . 1.9 tp -60.36 -31.46 70.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.274 -0.891 . . . . 0.0 109.529 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.51 -43.12 96.17 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 38' ' ' SER . 30.7 m -73.74 -24.95 59.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.396 -1.061 . . . . 0.0 109.891 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.5 t -70.64 -33.65 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.356 -0.84 . . . . 0.0 110.253 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.2 mmt -89.24 -23.93 22.22 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.356 -0.84 . . . . 0.0 110.382 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.431 ' NH1' ' HG2' ' A' ' 37' ' ' ARG . 11.3 tpt180 -90.62 -11.24 40.5 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.226 -0.921 . . . . 0.0 110.738 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 34' ' ' THR . 23.8 t -67.8 -68.92 0.35 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.106 -0.996 . . . . 0.0 110.414 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.477 HD11 ' C16' ' A' ' 153' ' ' WW7 . 0.5 OUTLIER -139.42 68.39 1.37 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.301 -0.874 . . . . 0.0 110.179 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -158.89 -109.99 0.27 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -112.46 -164.54 0.92 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.319 -1.106 . . . . 0.0 110.05 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -124.82 64.53 42.58 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 110.453 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 152.49 51.71 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.862 1.454 . . . . 0.0 110.368 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.511 HG22 ' N ' ' A' ' 45' ' ' GLU . 35.6 m -100.73 173.47 6.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.183 -0.948 . . . . 0.0 109.826 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.511 ' N ' HG22 ' A' ' 44' ' ' THR . 1.8 mp0 -66.78 -22.73 66.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.143 -0.973 . . . . 0.0 110.353 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.15 -70.96 0.41 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.124 -0.985 . . . . 0.0 109.991 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -52.56 -30.54 31.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.287 -0.883 . . . . 0.0 109.251 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.538 HD11 HD23 ' A' ' 32' ' ' LEU . 5.5 tt -66.56 -46.52 75.78 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.462 -0.774 . . . . 0.0 109.361 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.408 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 2.0 tt0 -50.62 -39.25 49.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.293 -0.879 . . . . 0.0 108.812 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.98 -45.7 93.74 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.211 178.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.44 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 0.4 OUTLIER -57.24 -24.37 54.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.404 178.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.025 HD11 HD22 ' A' ' 32' ' ' LEU . 46.9 mm -83.3 -31.26 8.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.456 -0.778 . . . . 0.0 109.913 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -76.38 -24.3 54.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.284 -0.885 . . . . 0.0 110.243 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.485 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 24.0 pt-20 -84.72 -36.23 21.97 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.193 -0.942 . . . . 0.0 110.377 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.485 ' N ' ' HG3' ' A' ' 54' ' ' GLU . 71.2 t -77.18 -32.67 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.128 -0.982 . . . . 0.0 109.942 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -97.1 100.46 11.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.342 -0.848 . . . . 0.0 110.169 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -100.21 22.74 11.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.164 -0.96 . . . . 0.0 110.042 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.413 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 29.5 m-20 -92.8 -56.57 2.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 110.133 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.94 25.93 1.45 Allowed Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.244 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -110.18 -41.32 4.45 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.825 -1.397 . . . . 0.0 110.005 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.14 -81.89 0.28 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.514 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.944 HG21 HG22 ' A' ' 28' ' ' THR . 69.7 p -79.26 170.71 16.22 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.324 -1.104 . . . . 0.0 111.025 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.7 mt -97.01 153.93 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.301 -0.874 . . . . 0.0 110.337 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.458 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 0.8 OUTLIER -105.86 -171.55 1.92 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.241 -0.912 . . . . 0.0 110.258 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.558 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 33.6 t80 -82.43 -41.88 0.94 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.343 -0.848 . . . . 0.0 111.76 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.0 Cg_endo -74.61 -20.26 18.03 Favored 'Trans proline' 0 C--N 1.323 -0.768 0 O-C-N 123.006 1.003 . . . . 0.0 110.187 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.413 ' OE1' ' OD2' ' A' ' 58' ' ' ASP . 41.9 tt0 -83.71 -28.46 28.27 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.22 -0.925 . . . . 0.0 109.408 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 6.5 t80 -74.58 -46.59 37.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.625 -0.672 . . . . 0.0 110.118 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.687 ' O ' HD23 ' A' ' 69' ' ' LEU . 8.3 tt -74.03 -32.91 63.55 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.288 -0.883 . . . . 0.0 110.609 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.1 m -79.35 -22.4 44.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.245 -0.909 . . . . 0.0 110.892 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.666 ' HE2' ' HE3' ' A' ' 72' ' ' MET . 11.6 ptt? -89.65 -26.37 20.77 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.927 -1.108 . . . . 0.0 110.904 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.666 ' HE3' ' HE2' ' A' ' 71' ' ' MET . 52.5 mtt -90.72 -55.57 3.52 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.053 -1.029 . . . . 0.0 111.191 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.492 ' HB2' ' CE2' ' A' ' 12' ' ' PHE . . . -60.04 -57.88 10.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.259 -0.901 . . . . 0.0 110.772 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -110.81 65.04 0.61 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.246 -0.909 . . . . 0.0 110.692 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.459 ' HG3' ' N ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -58.6 -21.06 52.33 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.2 -0.938 . . . . 0.0 109.946 179.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.459 ' N ' ' HG3' ' A' ' 75' ' ' LYS . 31.4 ttm -89.12 95.97 10.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.314 -0.867 . . . . 0.0 110.326 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -103.97 153.89 20.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 110.125 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -174.97 99.68 0.08 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.106 -0.996 . . . . 0.0 110.383 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.614 HG22 ' H ' ' A' ' 80' ' ' ASP . 2.4 m -88.51 -176.71 5.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.157 -0.964 . . . . 0.0 109.839 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.614 ' H ' HG22 ' A' ' 79' ' ' THR . 61.6 t0 -116.18 122.74 45.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.126 -0.984 . . . . 0.0 110.39 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.4 p -109.89 -161.54 0.76 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.186 -0.946 . . . . 0.0 109.849 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -175.36 157.19 2.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -0.957 . . . . 0.0 110.278 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 56.75 21.75 6.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.864 . . . . 0.0 110.164 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -110.03 -44.93 3.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.37 -0.831 . . . . 0.0 109.911 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.544 HG23 ' CE1' ' A' ' 141' ' ' PHE . 13.7 mt -58.35 -17.17 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.895 . . . . 0.0 109.93 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -68.54 -52.27 33.88 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.154 -0.966 . . . . 0.0 109.533 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 38.8 mm-40 -61.66 -35.21 77.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 109.801 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.746 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -61.65 -61.14 2.73 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.221 -0.924 . . . . 0.0 109.737 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.427 ' CE2' ' HA ' ' A' ' 138' ' ' TYR . 31.9 t80 -54.44 -22.32 12.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.23 -0.919 . . . . 0.0 110.084 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 5.3 mtp180 -67.91 -44.98 75.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.097 -1.002 . . . . 0.0 109.817 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.746 HG22 ' O ' ' A' ' 88' ' ' ALA . 30.2 m -78.43 -21.59 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.344 -0.848 . . . . 0.0 110.576 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.845 ' CE1' HG11 ' A' ' 108' ' ' VAL . 38.4 m-85 -86.48 -15.5 39.95 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.129 -0.982 . . . . 0.0 110.587 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -124.44 47.78 2.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.219 -0.925 . . . . 0.0 110.223 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -106.49 40.4 1.63 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.324 -0.86 . . . . 0.0 110.163 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -124.35 -25.66 4.05 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.278 -0.888 . . . . 0.0 110.54 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 119.37 -32.02 5.21 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -47.34 -38.63 13.27 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.335 -1.097 . . . . 0.0 110.462 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.462 ' C ' ' CD1' ' A' ' 99' ' ' TYR . . . 97.19 -14.72 63.37 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.542 ' CD2' ' NE2' ' A' ' 135' ' ' GLN . 46.4 m-85 -135.03 168.47 19.06 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.114 -1.227 . . . . 0.0 110.118 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.446 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 37.1 mt -87.01 126.58 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.269 -0.895 . . . . 0.0 109.983 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.0 m -113.67 175.26 5.53 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.456 -0.777 . . . . 0.0 109.665 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.9 -43.68 78.69 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.136 -0.977 . . . . 0.0 110.279 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.67 -52.13 62.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.282 -0.886 . . . . 0.0 110.23 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -53.71 -53.3 54.07 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.221 -0.924 . . . . 0.0 110.126 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.5 tt -49.73 -39.43 37.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.268 -0.895 . . . . 0.0 110.247 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.436 ' O ' HG23 ' A' ' 110' ' ' THR . 44.0 ttt-85 -64.09 -38.84 92.51 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.22 -0.925 . . . . 0.0 110.41 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.405 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 54.2 t-80 -72.23 -19.19 61.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.255 -0.903 . . . . 0.0 110.524 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.845 HG11 ' CE1' ' A' ' 92' ' ' PHE . 90.1 t -84.4 -46.39 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.192 -0.943 . . . . 0.0 110.624 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.438 ' HB3' HD12 ' A' ' 116' ' ' LEU . 25.6 mmt -61.12 -48.17 82.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.141 -0.974 . . . . 0.0 110.668 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 106' ' ' ARG . 47.0 p -49.24 -37.44 23.35 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.207 -0.933 . . . . 0.0 110.56 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.405 ' ND2' ' O ' ' A' ' 107' ' ' HIS . 76.7 m-20 -73.39 -48.62 32.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.288 -0.882 . . . . 0.0 110.455 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.8 mt -59.14 -21.79 59.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 110.37 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.8 46.89 4.69 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 6.0 mm-40 -110.37 -29.5 8.09 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.26 -1.141 . . . . 0.0 110.197 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 114' ' ' GLU . 47.4 tttt 55.46 99.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.337 -0.852 . . . . 0.0 110.418 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.438 HD12 ' HB3' ' A' ' 109' ' ' MET . 0.5 OUTLIER -127.68 151.73 48.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.282 -0.886 . . . . 0.0 110.183 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.2 m -76.52 157.68 31.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 109.998 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -64.59 -42.91 95.28 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.229 -0.919 . . . . 0.0 110.354 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -56.63 -40.01 74.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.116 -0.99 . . . . 0.0 110.307 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 124' ' ' MET . 33.7 mt-10 -63.31 -46.37 87.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.162 -0.961 . . . . 0.0 110.159 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.418 ' O ' ' HB2' ' A' ' 124' ' ' MET . 95.1 t -55.27 -51.5 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.045 -1.034 . . . . 0.0 110.214 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -55.65 -46.99 77.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 110.229 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -62.9 -25.17 68.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -0.924 . . . . 0.0 110.237 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.418 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 73.7 mtp -73.84 -46.68 43.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.048 -1.032 . . . . 0.0 109.971 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 30.6 mm -61.29 -30.68 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.11 -0.994 . . . . 0.0 110.011 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.61 -43.46 47.98 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.246 -0.908 . . . . 0.0 110.265 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -67.43 -24.95 65.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.926 . . . . 0.0 110.071 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.75 -35.84 24.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.888 . . . . 0.0 110.204 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.4 ' OD2' ' HA2' ' A' ' 132' ' ' GLY . 23.1 t0 -61.32 96.09 0.05 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.922 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 140' ' ' GLU . 89.4 mt -67.77 -64.33 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.316 -0.865 . . . . 0.0 110.885 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.403 ' OD1' ' OE2' ' A' ' 140' ' ' GLU . 29.4 p30 -73.71 -19.79 60.71 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.234 -0.917 . . . . 0.0 110.906 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.4 ' HA2' ' OD2' ' A' ' 129' ' ' ASP . . . 80.66 75.4 1.08 Allowed Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.881 -1.152 . . . . 0.0 110.395 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 31.7 m-20 -111.35 -23.97 10.48 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.167 -1.196 . . . . 0.0 110.024 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 135.78 -39.3 1.68 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.542 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -132.76 170.71 14.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.567 -0.961 . . . . 0.0 109.69 179.633 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.446 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 91.1 t -95.28 133.83 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.972 -1.08 . . . . 0.0 110.231 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -102.56 170.58 7.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.113 -0.992 . . . . 0.0 110.1 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.427 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 21.7 t80 -56.06 -47.18 78.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.23 -0.918 . . . . 0.0 110.462 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -55.73 -55.53 31.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -0.955 . . . . 0.0 110.273 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.419 ' HA ' HD12 ' A' ' 130' ' ' ILE . 52.6 mt-10 -58.35 -26.46 63.14 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.312 -0.867 . . . . 0.0 110.239 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.544 ' CE1' HG23 ' A' ' 85' ' ' ILE . 9.7 t80 -70.43 -32.1 69.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.253 -0.904 . . . . 0.0 110.151 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 87.0 t -82.33 -29.01 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.272 -0.892 . . . . 0.0 110.369 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -80.53 -23.79 39.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.275 -0.891 . . . . 0.0 110.424 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 54.7 ttp -80.51 -32.88 36.82 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.141 -0.975 . . . . 0.0 110.432 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.7 ttm -84.23 -11.47 56.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.246 -0.909 . . . . 0.0 110.803 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.497 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 44.7 p -118.4 133.46 55.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.092 -1.005 . . . . 0.0 110.214 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 146' ' ' THR . . . 58.57 157.82 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.251 -0.906 . . . . 0.0 110.674 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.177 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' WW7 . . . . . 0.557 'CL1 ' HD13 ' A' ' 32' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' WW7 . . . . . 0.513 ' H3 ' ' CD2' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.365 0.602 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -110.72 150.47 29.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.251 -0.906 . . . . 0.0 110.269 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.685 ' O ' HG23 ' A' ' 5' ' ' THR . 69.4 mt-30 -81.6 5.74 17.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.19 -0.944 . . . . 0.0 110.399 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 4' ' ' LEU . 7.6 mp 53.51 -88.8 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.283 -0.885 . . . . 0.0 110.533 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 3' ' ' GLN . 3.7 p 54.65 -168.87 0.07 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.318 -0.864 . . . . 0.0 110.45 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -58.68 -17.21 20.58 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.313 -0.867 . . . . 0.0 110.815 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -66.95 -37.81 84.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.024 -1.047 . . . . 0.0 109.93 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.484 ' HG3' ' CE2' ' A' ' 12' ' ' PHE . 21.6 tp60 -72.33 -55.39 7.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.352 -0.842 . . . . 0.0 110.18 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.441 HG22 ' HD2' ' A' ' 13' ' ' LYS . 64.1 mt -52.2 -38.92 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 109.884 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.455 ' HA ' ' HD3' ' A' ' 13' ' ' LYS . . . -65.87 -36.76 84.33 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.282 -0.886 . . . . 0.0 109.449 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -59.3 -50.05 75.48 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.388 -0.82 . . . . 0.0 109.832 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.484 ' CE2' ' HG3' ' A' ' 8' ' ' GLN . 23.0 m-85 -63.6 -32.66 74.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.279 -0.888 . . . . 0.0 109.918 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.455 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 31.7 mtpt -65.46 -36.62 84.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.27 -0.894 . . . . 0.0 110.163 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -69.63 -38.4 77.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 0.0 109.715 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.458 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -64.32 -39.46 93.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.289 -0.882 . . . . 0.0 109.999 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -62.52 -57.51 10.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.137 -0.977 . . . . 0.0 110.238 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.9 p -55.64 -26.53 44.88 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.264 -0.897 . . . . 0.0 109.516 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.562 HD13 ' C ' ' A' ' 18' ' ' LEU . 2.1 tm? -71.91 -36.88 70.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.407 -0.808 . . . . 0.0 109.978 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.458 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 15.4 m-85 -71.04 -56.49 6.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.062 -1.024 . . . . 0.0 109.538 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.79 101.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.425 -0.797 . . . . 0.0 109.997 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.6 mmtt -67.0 -42.79 84.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 109.979 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 53.0 p-10 -86.56 -15.18 40.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.334 -0.854 . . . . 0.0 110.598 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.426 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 67.8 37.67 88.77 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -79.85 -17.75 52.47 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.359 -1.083 . . . . 0.0 110.502 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.97 -21.79 22.18 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.374 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.4 p -119.72 158.08 27.23 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.923 -1.339 . . . . 0.0 110.786 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 96.3 mt -117.08 125.99 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.421 -0.799 . . . . 0.0 110.08 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.1 p -104.35 -162.49 0.9 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.0 110.121 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.673 HG22 HD12 ' A' ' 52' ' ' ILE . 20.1 p -87.81 -39.94 14.46 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.132 -0.98 . . . . 0.0 110.924 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -57.48 10.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.036 -1.04 . . . . 0.0 110.401 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -57.04 -42.1 79.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.949 . . . . 0.0 109.671 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.709 HD22 HD11 ' A' ' 52' ' ' ILE . 5.3 tp -63.37 -28.38 69.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.35 -0.843 . . . . 0.0 109.747 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.97 -47.71 79.47 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.5 m -66.74 -28.5 68.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.269 -1.136 . . . . 0.0 109.554 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.7 t -73.17 -28.28 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.48 -0.763 . . . . 0.0 110.102 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.416 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 25.7 mmt -83.4 -25.73 31.04 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.212 -0.93 . . . . 0.0 110.121 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -89.67 -16.7 29.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.888 . . . . 0.0 110.217 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.6 m -50.96 -54.56 23.24 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.319 -0.863 . . . . 0.0 110.232 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.8 39.93 1.83 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.306 -0.871 . . . . 0.0 110.337 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -131.39 -100.71 0.84 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -138.3 -155.79 0.63 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -1.157 . . . . 0.0 110.006 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -125.12 69.03 58.45 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.118 -0.989 . . . . 0.0 110.165 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 -160.95 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.906 1.477 . . . . 0.0 110.109 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.432 HG22 ' N ' ' A' ' 45' ' ' GLU . 35.4 m -134.73 166.5 22.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.127 -0.983 . . . . 0.0 110.266 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.432 ' N ' HG22 ' A' ' 44' ' ' THR . 5.9 mm-40 -63.24 -22.64 67.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.221 -0.924 . . . . 0.0 110.166 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.3 -70.03 0.39 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.102 -0.999 . . . . 0.0 110.043 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -50.57 -31.73 16.6 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.301 -0.875 . . . . 0.0 109.923 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.482 HD21 ' HA ' ' A' ' 29' ' ' THR . 5.6 tt -62.9 -50.88 69.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 110.066 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.419 ' O ' ' OD1' ' A' ' 53' ' ' ASN . 37.4 tt0 -53.3 -42.81 67.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.119 -0.988 . . . . 0.0 109.306 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -62.35 -34.75 77.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.631 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.441 ' HG2' ' H7 ' ' A' ' 153' ' ' WW7 . 4.7 ttp -68.94 -22.27 64.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.412 -0.805 . . . . 0.0 109.787 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.709 HD11 HD22 ' A' ' 32' ' ' LEU . 35.9 mt -87.38 -30.05 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.328 -0.857 . . . . 0.0 109.979 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 49' ' ' GLN . 3.6 m-20 -51.77 -42.93 62.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.171 -0.955 . . . . 0.0 110.079 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.438 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 13.3 pt-20 -68.57 -29.98 68.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.228 -0.92 . . . . 0.0 110.419 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.646 HG11 HD11 ' A' ' 63' ' ' ILE . 67.2 t -75.88 -69.87 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.208 -0.933 . . . . 0.0 110.166 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.428 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 54.2 t0 -43.17 94.15 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.541 -0.724 . . . . 0.0 110.881 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -109.89 61.4 0.6 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 109.773 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 1.7 p30 -164.0 -33.44 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.337 -0.852 . . . . 0.0 110.941 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.443 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 105.74 47.85 1.07 Allowed Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.098 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -117.73 -12.78 10.21 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.265 -1.138 . . . . 0.0 110.332 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.68 -56.59 4.14 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 59.4 p -109.31 170.3 8.14 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.255 -1.144 . . . . 0.0 110.248 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.646 HD11 HG11 ' A' ' 55' ' ' VAL . 39.6 mt -89.79 139.34 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.155 -0.966 . . . . 0.0 110.143 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.4 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 0.8 OUTLIER -103.56 179.68 4.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.219 -0.926 . . . . 0.0 110.176 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.569 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.2 t80 -73.56 -46.53 7.36 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 0.0 111.003 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.0 Cg_endo -71.66 -22.34 24.26 Favored 'Trans proline' 0 N--CA 1.482 0.807 0 O-C-N 123.186 1.098 . . . . 0.0 110.419 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.428 ' OE2' ' HA ' ' A' ' 56' ' ' ASP . 80.5 tt0 -81.37 -37.69 27.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.173 -0.954 . . . . 0.0 109.166 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.421 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 16.6 t80 -66.52 -38.73 87.82 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.525 -0.735 . . . . 0.0 109.867 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.497 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 1.1 tt -72.83 -36.35 67.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.354 -0.841 . . . . 0.0 110.059 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 92.7 m -76.22 -12.43 60.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.102 -0.999 . . . . 0.0 110.3 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.1 tmm? -89.09 -44.41 10.37 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.105 -0.997 . . . . 0.0 110.837 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.411 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 64.6 mtt -90.48 -37.76 13.69 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.028 -1.045 . . . . 0.0 111.135 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -57.4 -17.82 14.77 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.178 -0.951 . . . . 0.0 110.57 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -50.01 -29.39 8.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.208 -0.933 . . . . 0.0 110.648 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 76' ' ' MET . 14.5 tptt -60.66 97.69 0.06 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.221 -0.925 . . . . 0.0 110.729 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.41 ' O ' ' O ' ' A' ' 75' ' ' LYS . 56.9 mtm 48.3 -174.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.191 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.43 145.0 0.31 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.095 -1.003 . . . . 0.0 110.328 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -149.05 133.61 17.69 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.335 -0.853 . . . . 0.0 110.004 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 86.9 m -142.34 143.56 32.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.255 -0.903 . . . . 0.0 110.288 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -178.33 80.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.361 -0.837 . . . . 0.0 110.049 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 56.2 m -96.82 -173.52 2.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.316 -0.865 . . . . 0.0 110.296 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.461 ' OE1' ' N ' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -86.81 125.03 33.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.307 -0.871 . . . . 0.0 110.103 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -179.76 98.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -0.935 . . . . 0.0 110.336 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.78 -43.07 98.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.233 -0.917 . . . . 0.0 110.058 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 84.3 mt -53.42 -37.79 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.377 -0.827 . . . . 0.0 110.365 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.69 -55.44 23.37 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.136 -0.977 . . . . 0.0 109.777 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -49.46 -41.04 39.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.278 -0.889 . . . . 0.0 110.003 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.536 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -59.06 -59.9 4.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 110.028 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.428 ' O ' ' HB3' ' A' ' 93' ' ' ASP . 11.9 t80 -50.49 -22.58 1.99 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.314 -0.866 . . . . 0.0 110.134 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.3 ttt180 -72.26 -58.39 3.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 110.701 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 88' ' ' ALA . 30.3 m -60.19 -32.37 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.033 -1.042 . . . . 0.0 110.117 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.694 ' CE1' HG11 ' A' ' 108' ' ' VAL . 36.5 m-85 -80.47 -19.21 46.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.237 -0.914 . . . . 0.0 110.177 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 52.6 t0 -123.59 57.83 1.16 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.279 -0.888 . . . . 0.0 109.943 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.8 pttm -88.73 39.47 0.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.245 -0.91 . . . . 0.0 110.455 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.429 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 1.5 p30 -125.85 -30.64 2.99 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.31 -0.869 . . . . 0.0 110.316 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.93 38.78 3.06 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.721 -1.228 . . . . 0.0 111.006 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.507 ' O ' ' CE2' ' A' ' 99' ' ' TYR . 30.2 p30 -129.49 -21.84 3.11 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.75 -1.441 . . . . 0.0 110.99 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.507 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 79.93 48.65 6.44 Favored Glycine 0 N--CA 1.494 2.502 0 O-C-N 120.866 -1.146 . . . . 0.0 110.314 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 62.8 m-85 -151.19 142.53 23.36 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.172 -1.193 . . . . 0.0 110.323 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.485 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 21.2 mt -111.75 110.81 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.142 -0.974 . . . . 0.0 109.505 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.5 p -104.3 151.81 22.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.893 . . . . 0.0 110.181 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -46.84 -28.59 1.62 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.29 -0.881 . . . . 0.0 110.181 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.25 -56.01 10.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.281 -0.887 . . . . 0.0 110.241 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.85 ' O ' HG23 ' A' ' 108' ' ' VAL . 53.6 mt-10 -58.21 -31.13 67.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.206 -0.934 . . . . 0.0 110.182 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.001 HD23 HG13 ' A' ' 121' ' ' VAL . 39.5 tp -69.73 -34.59 74.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.973 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -77.79 -19.84 54.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.372 -0.83 . . . . 0.0 110.019 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -91.89 -20.29 21.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 0.0 110.167 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 104' ' ' GLU . 46.5 t -92.43 -50.83 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.165 -0.959 . . . . 0.0 110.1 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.616 ' HA ' HD12 ' A' ' 112' ' ' LEU . 17.1 mmt -46.96 -34.35 5.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.333 -0.854 . . . . 0.0 110.512 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.1 p -62.98 -51.89 65.11 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.236 -0.915 . . . . 0.0 109.708 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -53.67 -42.75 68.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.343 -0.848 . . . . 0.0 110.164 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.616 HD12 ' HA ' ' A' ' 109' ' ' MET . 17.4 mt -59.82 -37.7 79.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.282 -0.886 . . . . 0.0 110.152 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 125.03 -20.15 6.75 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -82.58 107.61 15.35 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.274 -1.133 . . . . 0.0 110.361 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -85.83 126.69 34.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.838 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 mt -130.38 156.95 43.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.204 -0.935 . . . . 0.0 110.287 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 91.7 m -91.37 155.44 18.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.28 -0.887 . . . . 0.0 110.393 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -46.42 -35.83 5.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.339 -0.851 . . . . 0.0 110.637 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -59.7 -64.38 0.97 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.155 -0.966 . . . . 0.0 110.669 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -50.24 -44.73 53.54 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.118 -0.989 . . . . 0.0 110.322 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 1.001 HG13 HD23 ' A' ' 105' ' ' LEU . 40.5 t -53.15 -48.23 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 110.056 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -61.22 -30.82 70.67 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.281 -0.887 . . . . 0.0 110.026 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -69.62 -36.92 76.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.337 -0.852 . . . . 0.0 110.168 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.1 mtp -71.98 -54.57 9.53 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.252 -0.905 . . . . 0.0 110.377 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.879 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 20.7 mm -52.42 -37.14 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.157 -0.964 . . . . 0.0 109.879 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 43.1 ttt-85 -66.84 -50.79 61.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.365 -0.835 . . . . 0.0 110.533 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -63.22 -21.0 65.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.177 -0.952 . . . . 0.0 110.492 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.494 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -92.57 -16.96 25.04 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.174 -0.954 . . . . 0.0 110.652 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -82.44 78.49 9.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.04 -1.038 . . . . 0.0 109.955 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.425 HD12 ' CB ' ' A' ' 140' ' ' GLU . 14.4 mt -48.95 -57.41 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.46 -0.775 . . . . 0.0 110.809 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 27.4 p30 -81.55 -19.12 42.71 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.035 -1.041 . . . . 0.0 110.903 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 76.5 69.24 1.42 Allowed Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.938 -1.125 . . . . 0.0 110.457 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.427 ' O ' ' HG2' ' A' ' 135' ' ' GLN . 53.8 m-20 -111.77 19.24 18.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.123 -1.222 . . . . 0.0 109.848 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 68.78 18.01 71.86 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 133' ' ' ASP . 2.1 pt20 -170.46 138.75 1.56 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.309 -1.113 . . . . 0.0 109.916 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.485 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 57.7 t -94.44 123.54 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.141 -0.974 . . . . 0.0 110.044 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -93.67 175.53 6.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.169 -0.957 . . . . 0.0 109.977 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.415 ' O ' HG23 ' A' ' 142' ' ' VAL . 23.5 t80 -59.06 -48.76 80.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.254 -0.904 . . . . 0.0 110.603 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.38 -50.83 64.28 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.103 -0.998 . . . . 0.0 110.665 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.425 ' CB ' HD12 ' A' ' 130' ' ' ILE . 54.4 mt-10 -64.03 -28.28 69.69 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.114 -0.991 . . . . 0.0 110.126 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.65 ' CZ ' ' HE3' ' A' ' 145' ' ' MET . 13.8 t80 -73.0 -20.9 60.92 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.335 -0.853 . . . . 0.0 110.03 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.64 ' O ' HG23 ' A' ' 146' ' ' THR . 79.0 t -87.39 -32.93 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.312 -0.868 . . . . 0.0 110.624 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.3 -20.1 32.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.133 -0.979 . . . . 0.0 111.272 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.494 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 19.9 ptt? -82.82 -32.6 27.53 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.864 -1.147 . . . . 0.0 110.964 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.65 ' HE3' ' CZ ' ' A' ' 141' ' ' PHE . 54.9 mtt -90.48 -27.36 19.27 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.922 -1.111 . . . . 0.0 110.671 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.64 HG23 ' O ' ' A' ' 142' ' ' VAL . 0.9 OUTLIER -51.25 -81.8 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.131 -0.981 . . . . 0.0 110.723 -179.682 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -138.14 153.48 49.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.17 -0.956 . . . . 0.0 110.472 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.195 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' WW7 . . . . . 0.441 ' H7 ' ' HG2' ' A' ' 51' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' WW7 . . . . . 0.879 'CL1 ' HD13 ' A' ' 125' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.293 0.568 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 2' ' ' ASP . 1.8 p30 -141.14 60.04 1.51 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.307 -0.871 . . . . 0.0 110.15 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -97.33 -60.98 1.47 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.38 -0.825 . . . . 0.0 110.384 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.1 mt -122.76 -133.05 0.28 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.218 -0.926 . . . . 0.0 110.257 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.46 HG22 ' N ' ' A' ' 6' ' ' GLU . 32.3 m -108.83 167.45 10.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.796 -1.19 . . . . 0.0 110.509 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.46 ' N ' HG22 ' A' ' 5' ' ' THR . 16.1 pt-20 -64.67 -14.3 57.72 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.282 -0.886 . . . . 0.0 110.222 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -66.15 -27.67 68.2 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.226 -0.921 . . . . 0.0 109.983 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -70.69 -44.92 65.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.308 -0.87 . . . . 0.0 109.73 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 86.5 mt -63.07 -48.13 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.751 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.59 -31.8 70.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.317 -0.864 . . . . 0.0 109.9 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.75 -51.93 62.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.355 -0.841 . . . . 0.0 109.888 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.427 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 10.7 m-30 -56.35 -46.73 79.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.354 -0.841 . . . . 0.0 110.09 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -62.39 -26.08 68.28 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.329 -0.857 . . . . 0.0 110.34 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -69.85 -66.29 0.61 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.112 -0.992 . . . . 0.0 110.13 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.418 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -48.59 -39.27 23.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -0.913 . . . . 0.0 109.966 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -62.19 -43.82 97.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -0.942 . . . . 0.0 109.963 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.5 m -65.04 -18.46 65.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 109.85 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.891 HD13 ' O ' ' A' ' 18' ' ' LEU . 2.9 tm? -87.75 -31.03 19.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 110.022 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.418 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 21.4 m-85 -74.46 -43.88 54.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.15 -0.968 . . . . 0.0 110.138 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -71.73 125.77 27.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.339 -0.85 . . . . 0.0 110.255 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.402 ' HD2' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -108.47 -51.93 2.83 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.205 -0.934 . . . . 0.0 110.795 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 3.0 p30 -70.6 -22.22 62.57 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.137 -0.977 . . . . 0.0 110.16 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.417 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 83.92 51.01 4.15 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.417 ' OD1' ' OG1' ' A' ' 26' ' ' THR . 7.0 p30 -104.72 18.62 21.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.109 -1.23 . . . . 0.0 110.335 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.812 ' O ' HG23 ' A' ' 26' ' ' THR . . . 49.6 41.67 34.43 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.812 HG23 ' O ' ' A' ' 25' ' ' GLY . 0.8 OUTLIER -166.56 160.47 15.25 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.306 -1.114 . . . . 0.0 110.291 179.803 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 55.3 mt -121.9 118.2 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.315 -0.865 . . . . 0.0 109.884 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.591 HG22 ' H ' ' A' ' 29' ' ' THR . 5.8 m -105.93 -179.82 4.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.495 -0.753 . . . . 0.0 110.034 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.591 ' H ' HG22 ' A' ' 28' ' ' THR . 13.5 p -71.58 -16.84 62.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.113 -0.992 . . . . 0.0 110.353 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -75.6 -67.72 0.64 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 109.846 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.402 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 50.6 mt-10 -53.71 -41.32 66.85 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.317 -0.865 . . . . 0.0 109.415 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.039 HD22 HD11 ' A' ' 52' ' ' ILE . 1.8 tp -63.88 -38.52 91.4 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.346 -0.846 . . . . 0.0 109.28 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.49 ' HA2' HD12 ' A' ' 48' ' ' LEU . . . -51.87 -42.31 53.18 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.5 m -70.4 -45.08 66.68 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.382 -1.069 . . . . 0.0 110.085 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.5 t -50.06 -43.4 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.357 -0.84 . . . . 0.0 110.735 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 21.8 mmt -85.34 -23.66 27.95 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.237 -0.914 . . . . 0.0 110.318 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 32.9 ttt180 -70.63 -16.7 62.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.381 -0.824 . . . . 0.0 110.139 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -102.61 -22.95 13.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 110.234 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.441 HD13 ' HA ' ' A' ' 39' ' ' LEU . 3.3 mm? -112.44 59.52 0.64 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.218 -0.926 . . . . 0.0 110.262 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.82 69.11 0.41 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.415 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 48.6 tt0 -58.17 106.72 0.4 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.241 -1.153 . . . . 0.0 110.114 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.557 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.9 m120 -155.54 -65.39 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.282 -0.886 . . . . 0.0 110.577 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.557 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 44.0 Cg_endo -70.15 166.08 29.26 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 123.429 1.226 . . . . 0.0 110.097 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.612 HG22 ' N ' ' A' ' 45' ' ' GLU . 41.8 m -132.32 -98.32 0.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.104 -0.997 . . . . 0.0 110.041 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.612 ' N ' HG22 ' A' ' 44' ' ' THR . 87.7 tt0 -110.77 -46.25 3.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.818 -1.176 . . . . 0.0 110.151 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.02 -63.25 1.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 109.971 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 29.1 mt-10 -50.24 -40.4 47.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.603 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.524 HD23 ' C ' ' A' ' 48' ' ' LEU . 10.6 tt -54.92 -53.45 55.35 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.295 -0.878 . . . . 0.0 109.412 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -48.74 -39.8 26.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.815 . . . . 0.0 109.821 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 39.0 t70 -57.92 -44.93 87.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.325 -0.859 . . . . 0.0 109.528 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.448 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 0.7 OUTLIER -62.78 -24.83 67.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.376 -0.828 . . . . 0.0 109.731 179.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.039 HD11 HD22 ' A' ' 32' ' ' LEU . 46.2 mm -80.02 -23.38 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.408 -0.808 . . . . 0.0 110.174 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -79.14 -30.99 43.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.151 -0.968 . . . . 0.0 110.094 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.565 ' HG3' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -76.3 -13.63 60.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 110.136 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.565 HG23 ' HG3' ' A' ' 54' ' ' GLU . 93.2 t -103.01 -60.76 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.89 . . . . 0.0 110.117 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -45.87 108.75 0.14 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.397 -0.815 . . . . 0.0 110.185 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.41 13.34 25.59 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.312 -0.868 . . . . 0.0 110.539 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -110.38 -60.27 1.83 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.11 -0.994 . . . . 0.0 109.87 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 132.56 47.0 0.11 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.466 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 19.4 p30 -126.22 -31.27 2.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.372 -1.075 . . . . 0.0 110.526 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.466 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 115.49 -60.2 0.41 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.42 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 81.5 p -89.59 170.27 10.62 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.07 -1.253 . . . . 0.0 110.566 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.493 ' CD1' HG11 ' A' ' 55' ' ' VAL . 81.7 mt -108.21 152.26 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.054 -1.029 . . . . 0.0 110.291 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.452 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.4 m-20 -101.15 179.54 4.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.358 -0.839 . . . . 0.0 110.242 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.542 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 7.5 t80 -73.08 -42.45 7.16 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 111.038 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 46.6 Cg_endo -76.87 -30.28 4.75 Favored 'Trans proline' 0 C--N 1.327 -0.567 0 O-C-N 123.125 1.066 . . . . 0.0 109.837 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -72.7 -20.76 61.16 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.425 -0.797 . . . . 0.0 109.147 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.514 ' CE2' ' CE ' ' A' ' 72' ' ' MET . 8.5 t80 -82.05 -49.47 10.18 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.589 -0.694 . . . . 0.0 110.048 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.87 -18.5 64.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.004 -1.06 . . . . 0.0 110.232 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 72.8 m -90.04 -33.82 16.18 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.168 -0.957 . . . . 0.0 110.47 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.49 ' SD ' HG13 ' A' ' 55' ' ' VAL . 4.9 ptm -77.52 -25.15 50.02 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.171 -0.956 . . . . 0.0 110.265 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.514 ' CE ' ' CE2' ' A' ' 68' ' ' PHE . 1.1 mmt -84.4 -33.57 23.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.231 -0.918 . . . . 0.0 110.257 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.09 -52.49 10.9 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.18 -0.95 . . . . 0.0 110.03 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 76' ' ' MET . 1.7 tpt180 -110.65 73.14 0.81 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.333 -0.855 . . . . 0.0 109.879 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.58 94.95 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.722 -0.611 . . . . 0.0 110.666 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.45 ' N ' ' O ' ' A' ' 74' ' ' ARG . 61.2 mtt -64.25 139.97 58.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.387 -0.821 . . . . 0.0 110.52 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.8 tttt -100.0 -40.18 7.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.381 -0.824 . . . . 0.0 110.192 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -174.84 -56.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.199 -0.938 . . . . 0.0 110.157 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.1 p -104.71 149.83 25.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 0.0 110.092 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -140.08 132.3 28.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.235 -0.916 . . . . 0.0 110.384 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 24.3 m -132.15 142.91 49.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.328 -0.858 . . . . 0.0 110.087 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -48.69 -33.18 9.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.924 . . . . 0.0 110.076 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 45.01 75.67 0.1 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.393 -0.817 . . . . 0.0 110.641 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.441 ' HG3' ' N ' ' A' ' 85' ' ' ILE . 15.8 pt-20 -73.01 -32.35 65.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.136 -0.977 . . . . 0.0 110.109 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.441 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 56.9 mt -53.43 -44.12 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.193 -0.942 . . . . 0.0 109.69 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -50.98 -49.65 59.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.354 -0.842 . . . . 0.0 110.039 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 4.7 mp0 -54.44 -41.84 69.87 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.234 -0.916 . . . . 0.0 110.145 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.81 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -61.45 -63.94 1.11 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.255 -0.903 . . . . 0.0 110.285 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.466 ' CZ ' ' OD2' ' A' ' 93' ' ' ASP . 9.2 t80 -45.62 -27.85 0.86 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.281 -0.887 . . . . 0.0 110.466 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.428 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 34.7 ttm-85 -66.62 -50.76 61.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.184 -0.948 . . . . 0.0 109.705 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.81 HG22 ' O ' ' A' ' 88' ' ' ALA . 33.2 m -70.04 -18.38 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.269 -0.895 . . . . 0.0 110.329 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.554 ' CD2' ' H3 ' ' A' ' 154' ' ' WW7 . 37.0 m-85 -94.52 -8.42 38.39 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.141 -0.974 . . . . 0.0 110.443 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.466 ' OD2' ' CZ ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -140.54 35.56 1.83 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.096 -1.002 . . . . 0.0 110.194 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.21 10.77 15.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 110.361 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 2.7 p30 -83.49 -19.61 35.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.082 -1.011 . . . . 0.0 110.196 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.68 29.21 5.39 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 17.9 t-20 -98.42 -72.49 0.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.332 -1.099 . . . . 0.0 110.102 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.494 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 135.83 -14.81 4.1 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.499 ' CE1' ' OD1' ' A' ' 137' ' ' ASN . 27.6 m-85 -139.18 152.07 47.1 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.018 -1.283 . . . . 0.0 109.971 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.439 HG23 ' HB3' ' A' ' 92' ' ' PHE . 37.9 mt -81.61 121.79 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.022 -1.049 . . . . 0.0 110.159 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.1 m -111.56 176.28 5.08 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.469 -0.769 . . . . 0.0 109.828 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.21 -56.24 10.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.155 -0.966 . . . . 0.0 110.194 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -49.78 -54.16 20.84 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.236 -0.915 . . . . 0.0 110.333 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.462 ' O ' HG23 ' A' ' 108' ' ' VAL . 50.7 mt-10 -53.47 -43.67 68.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 tt -59.09 -37.95 78.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.324 -0.86 . . . . 0.0 110.38 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.818 ' O ' HG23 ' A' ' 110' ' ' THR . 2.5 tmt_? -69.47 -28.44 66.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.05 -1.031 . . . . 0.0 109.632 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.439 ' CD2' ' N ' ' A' ' 107' ' ' HIS . 35.0 m170 -71.55 -29.44 64.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.336 -0.853 . . . . 0.0 109.843 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.531 HG21 ' HA ' ' A' ' 92' ' ' PHE . 34.0 t -79.28 -50.2 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.316 -0.865 . . . . 0.0 110.073 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -49.95 -43.74 50.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.363 -0.836 . . . . 0.0 110.266 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.818 HG23 ' O ' ' A' ' 106' ' ' ARG . 69.1 p -50.7 -43.41 57.68 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.284 -0.885 . . . . 0.0 110.023 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -58.46 -41.22 84.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.311 -0.868 . . . . 0.0 110.243 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.3 mt -62.09 -53.52 54.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.263 -0.898 . . . . 0.0 110.365 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.66 40.07 0.34 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -111.3 -175.04 2.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.164 -1.198 . . . . 0.0 110.197 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -144.23 81.14 1.66 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.921 . . . . 0.0 110.147 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.97 161.03 15.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.304 -0.873 . . . . 0.0 110.089 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.431 HG22 ' HG2' ' A' ' 120' ' ' GLU . 11.0 t -98.6 -165.4 1.24 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.887 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -80.98 -43.97 18.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.117 -0.989 . . . . 0.0 110.362 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 122' ' ' ASP . 65.2 mm-40 -50.61 -54.35 23.49 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.26 -0.9 . . . . 0.0 110.719 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.431 ' HG2' HG22 ' A' ' 117' ' ' THR . 69.9 mm-40 -48.69 -61.93 1.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.12 -0.987 . . . . 0.0 110.698 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.2 t -47.73 -39.19 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.206 -0.933 . . . . 0.0 110.625 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.441 ' HB3' ' O ' ' A' ' 119' ' ' GLU . 38.7 t70 -56.57 -47.5 79.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.994 -1.066 . . . . 0.0 110.066 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.46 -25.68 66.84 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.248 -0.908 . . . . 0.0 110.286 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 24.4 mmm -70.27 -57.06 5.3 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.187 -0.945 . . . . 0.0 110.14 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.66 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 25.4 mm -57.34 -31.39 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.381 -0.825 . . . . 0.0 110.409 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -76.64 -32.95 58.32 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.135 -0.978 . . . . 0.0 110.235 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -69.97 -33.23 71.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 0.0 110.141 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.475 ' HA ' ' HB2' ' A' ' 144' ' ' MET . . . -79.81 -43.41 22.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.927 . . . . 0.0 110.336 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -60.21 98.35 0.06 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.135 -0.978 . . . . 0.0 109.943 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.442 ' CD1' ' HA ' ' A' ' 140' ' ' GLU . 5.4 mt -56.22 -42.97 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.294 -0.879 . . . . 0.0 110.333 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 53.5 p-10 -76.65 -15.92 59.68 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.042 -1.036 . . . . 0.0 110.231 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.456 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 55.68 55.18 30.14 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.425 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 2.5 p30 -97.53 -21.77 16.92 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.207 -1.172 . . . . 0.0 110.267 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 130.66 0.56 5.27 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.384 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.425 ' HG3' ' OD1' ' A' ' 133' ' ' ASP . 0.1 OUTLIER -154.95 151.01 28.01 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.862 -1.375 . . . . 0.0 110.6 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.589 HG23 HG23 ' A' ' 125' ' ' ILE . 71.8 t -100.25 142.14 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.202 -0.936 . . . . 0.0 110.305 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.499 ' OD1' ' CE1' ' A' ' 99' ' ' TYR . 2.5 t30 -111.2 -169.59 1.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.426 -0.796 . . . . 0.0 110.047 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.683 ' O ' HG23 ' A' ' 142' ' ' VAL . 49.3 t80 -75.37 -57.06 4.12 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.26 -0.9 . . . . 0.0 110.264 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -55.68 -52.02 65.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.86 . . . . 0.0 110.604 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.442 ' HA ' ' CD1' ' A' ' 130' ' ' ILE . 51.7 mt-10 -56.82 -46.88 81.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 110.526 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.557 ' CD1' ' HE2' ' A' ' 144' ' ' MET . 35.2 t80 -59.82 -25.36 64.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.094 -1.004 . . . . 0.0 110.322 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 138' ' ' TYR . 60.2 t -86.48 -22.25 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.247 -0.908 . . . . 0.0 110.383 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -98.82 -9.13 24.78 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.34 -0.85 . . . . 0.0 110.663 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.557 ' HE2' ' CD1' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -90.69 -30.93 16.82 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.002 -1.061 . . . . 0.0 110.806 -179.686 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.428 ' HE1' ' O2 ' ' A' ' 154' ' ' WW7 . 43.4 ttm -88.98 -45.65 9.49 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.071 -1.018 . . . . 0.0 109.609 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 65.6 p -74.28 122.66 23.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.445 -0.784 . . . . 0.0 109.86 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -174.08 85.98 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.116 -0.99 . . . . 0.0 110.412 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 7.5 mptt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.162 179.958 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' WW7 . . . . . 0.558 ' C6 ' HG21 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' WW7 . . . . . 0.664 H121 ' HB2' ' A' ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.254 0.549 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -134.33 112.39 10.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.905 . . . . 0.0 109.971 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -131.7 69.99 1.47 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.89 . . . . 0.0 110.029 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.44 175.78 9.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.835 . . . . 0.0 110.125 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.657 HG22 ' H ' ' A' ' 7' ' ' GLU . 50.4 m -117.64 137.02 52.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.944 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -74.68 -15.62 60.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.299 -0.876 . . . . 0.0 110.598 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.657 ' H ' HG22 ' A' ' 5' ' ' THR . 3.6 tp10 -63.37 -28.37 69.95 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.065 -1.022 . . . . 0.0 110.202 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -73.37 -53.7 10.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.18 -0.95 . . . . 0.0 110.278 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.3 mt -54.84 -44.49 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 110.103 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.32 -36.12 79.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.335 -0.853 . . . . 0.0 109.481 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -63.62 -36.98 85.6 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.301 -0.875 . . . . 0.0 109.766 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -73.61 -22.8 59.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.318 -0.864 . . . . 0.0 109.817 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -72.66 -39.62 66.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.8 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -70.85 -39.29 73.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.394 -0.816 . . . . 0.0 110.031 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.95 -53.06 52.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.186 -0.946 . . . . 0.0 109.996 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.519 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 26.5 t80 -55.5 -39.37 70.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 109.866 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.6 m -67.69 -30.8 70.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -0.876 . . . . 0.0 109.981 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.772 HD13 ' O ' ' A' ' 18' ' ' LEU . 1.9 tm? -65.07 -38.58 91.24 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.347 -0.846 . . . . 0.0 110.033 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.477 ' CE2' ' H3 ' ' A' ' 153' ' ' WW7 . 23.1 m-85 -75.87 -61.92 1.77 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.77 112.74 0.7 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 110.027 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -109.23 -42.13 4.47 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.227 -0.921 . . . . 0.0 110.69 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -71.34 -33.13 69.33 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.121 -0.987 . . . . 0.0 110.253 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.06 74.17 1.1 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -142.83 15.69 1.94 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.276 -1.132 . . . . 0.0 110.242 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.594 ' O ' HG23 ' A' ' 26' ' ' THR . . . 49.19 35.53 19.94 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 25' ' ' GLY . 20.3 p -156.86 149.29 23.28 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.228 -1.16 . . . . 0.0 110.119 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.3 mt -112.87 121.78 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.274 -0.892 . . . . 0.0 110.388 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.577 HG23 ' H ' ' A' ' 30' ' ' LYS . 8.8 t -122.39 -175.66 3.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -0.872 . . . . 0.0 109.779 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.532 HG21 ' OE1' ' A' ' 49' ' ' GLN . 29.0 p -62.16 -26.34 68.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.114 -0.991 . . . . 0.0 110.189 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.577 ' H ' HG23 ' A' ' 28' ' ' THR . 19.0 mtmt -69.87 -60.36 2.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -0.907 . . . . 0.0 110.018 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.449 ' O ' HG23 ' A' ' 35' ' ' VAL . 84.8 mt-10 -59.07 -61.2 2.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.11 -0.994 . . . . 0.0 109.778 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.04 HD22 HD11 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -51.53 -33.38 31.69 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.272 -0.892 . . . . 0.0 109.761 179.768 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.29 -44.91 94.81 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.446 ' O ' ' HB2' ' A' ' 38' ' ' SER . 90.8 m -76.62 -17.4 59.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -1.148 . . . . 0.0 109.781 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 31' ' ' GLU . 54.2 t -73.42 -39.3 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.291 -0.881 . . . . 0.0 110.135 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 21.4 mmt -90.33 -27.58 19.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -0.896 . . . . 0.0 110.466 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -82.61 -26.9 31.84 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.273 -0.892 . . . . 0.0 110.588 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.479 ' CB ' HD23 ' A' ' 39' ' ' LEU . 22.4 t -51.81 -32.69 32.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.995 . . . . 0.0 110.126 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.954 HD21 HN21 ' A' ' 153' ' ' WW7 . 0.5 OUTLIER -158.46 69.18 0.49 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.897 . . . . 0.0 110.153 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . 177.4 -64.84 0.09 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 40' ' ' GLY . 53.4 mt-30 55.14 19.62 2.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.256 -1.144 . . . . 0.0 110.314 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.506 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 2.6 m120 -72.35 -58.32 3.13 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.17 -0.956 . . . . 0.0 110.412 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.506 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 42.7 Cg_endo -70.66 -169.51 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.768 1.404 . . . . 0.0 110.299 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.626 HG22 ' H ' ' A' ' 45' ' ' GLU . 4.1 m -135.72 -177.31 4.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.288 -0.883 . . . . 0.0 109.832 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.626 ' H ' HG22 ' A' ' 44' ' ' THR . 45.2 mt-10 -67.24 -50.3 61.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.087 -1.008 . . . . 0.0 110.252 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.79 -56.65 15.58 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.197 -0.939 . . . . 0.0 110.04 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -52.01 -34.78 44.37 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.207 -0.933 . . . . 0.0 109.408 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.757 HD11 HD23 ' A' ' 32' ' ' LEU . 9.5 tt -63.68 -45.02 91.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.423 -0.798 . . . . 0.0 109.224 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.532 ' OE1' HG21 ' A' ' 29' ' ' THR . 1.5 tp-100 -49.47 -43.65 45.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.348 -0.845 . . . . 0.0 109.172 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -62.83 -45.21 93.68 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.412 -0.805 . . . . 0.0 109.342 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.438 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 3.7 ttp -59.36 -17.65 31.7 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.345 -0.847 . . . . 0.0 109.772 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.04 HD11 HD22 ' A' ' 32' ' ' LEU . 31.0 mm -90.46 -28.73 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 110.195 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -74.9 -27.18 60.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.323 -0.86 . . . . 0.0 110.552 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.637 ' HG3' HG23 ' A' ' 55' ' ' VAL . 25.3 pt-20 -74.35 -9.14 58.31 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.095 -1.003 . . . . 0.0 110.497 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.637 HG23 ' HG3' ' A' ' 54' ' ' GLU . 44.0 t -112.01 -23.18 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.043 -1.036 . . . . 0.0 110.523 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -91.26 109.05 20.32 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.13 -0.981 . . . . 0.0 110.333 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.25 16.15 21.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 110.329 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 40.1 m-20 -97.82 -69.83 0.74 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.274 -0.892 . . . . 0.0 110.42 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.65 -22.1 0.33 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -69.53 -21.48 63.65 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.08 -1.247 . . . . 0.0 110.123 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.54 -41.46 2.3 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.8 p -89.8 170.22 10.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.128 -1.219 . . . . 0.0 110.52 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.439 HD13 HG11 ' A' ' 55' ' ' VAL . 75.1 mt -104.55 151.43 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.367 -0.833 . . . . 0.0 109.892 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.425 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 1.6 m-20 -112.03 -167.28 1.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 110.255 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.552 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 23.5 t80 -73.97 -43.35 6.25 Favored Pre-proline 0 C--N 1.303 -1.422 0 O-C-N 121.284 -0.885 . . . . 0.0 111.099 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.3 Cg_endo -74.42 -30.04 8.67 Favored 'Trans proline' 0 C--O 1.211 -0.859 0 O-C-N 123.026 1.014 . . . . 0.0 110.006 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.435 ' HB3' HG23 ' A' ' 63' ' ' ILE . 1.3 tt0 -75.02 -26.02 59.19 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.098 -1.001 . . . . 0.0 108.918 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.562 ' CE1' ' CE ' ' A' ' 72' ' ' MET . 80.4 t80 -75.36 -43.56 49.76 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.62 -0.675 . . . . 0.0 110.405 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.406 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 4.2 tp -80.8 -16.73 52.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.341 -0.85 . . . . 0.0 110.363 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 34.6 m -84.28 -34.02 23.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.065 -1.022 . . . . 0.0 110.651 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.523 ' HE3' ' HG3' ' A' ' 72' ' ' MET . 0.0 OUTLIER -88.67 -30.11 19.39 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.94 -1.1 . . . . 0.0 110.52 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.562 ' CE ' ' CE1' ' A' ' 68' ' ' PHE . 25.3 mtt -81.56 -11.35 59.19 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.047 -1.033 . . . . 0.0 110.515 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.07 -22.1 66.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.125 -0.984 . . . . 0.0 110.042 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -110.25 61.61 0.6 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.219 -0.926 . . . . 0.0 110.505 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.33 147.97 22.94 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.228 -0.92 . . . . 0.0 110.069 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 51.6 mtt -117.31 166.18 12.59 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.143 -0.973 . . . . 0.0 110.923 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.9 mtmm -103.87 129.44 51.36 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.408 -0.807 . . . . 0.0 110.132 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -172.85 110.72 0.21 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.292 -0.88 . . . . 0.0 110.204 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -130.08 152.78 49.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.215 -0.928 . . . . 0.0 110.094 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -59.23 124.88 21.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.29 -0.881 . . . . 0.0 110.683 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.0 m -88.0 130.25 35.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.195 -0.94 . . . . 0.0 110.016 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -120.92 -26.02 5.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.211 -0.93 . . . . 0.0 110.358 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.404 ' O ' ' OE2' ' A' ' 87' ' ' GLU . 12.9 tt0 -156.37 75.96 0.88 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.281 -0.887 . . . . 0.0 109.793 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.418 ' OE2' H152 ' A' ' 154' ' ' WW7 . 29.1 tt0 -105.84 -46.26 4.17 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.288 -0.883 . . . . 0.0 110.61 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.915 HD11 HG21 ' A' ' 146' ' ' THR . 88.7 mt -59.8 -48.68 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.137 -0.977 . . . . 0.0 110.407 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -56.69 -53.4 58.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.185 -0.947 . . . . 0.0 110.112 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.404 ' OE2' ' O ' ' A' ' 83' ' ' GLU . 34.9 mt-10 -46.93 -41.78 16.6 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.288 -0.883 . . . . 0.0 110.339 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.517 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -59.61 -59.36 5.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.147 -0.971 . . . . 0.0 110.099 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -49.63 -23.88 1.93 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.16 -0.963 . . . . 0.0 110.461 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -76.42 -43.95 38.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.285 -0.885 . . . . 0.0 111.171 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 88' ' ' ALA . 16.6 m -79.42 -19.23 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.042 -1.036 . . . . 0.0 110.966 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.489 ' CD1' HG23 ' A' ' 91' ' ' VAL . 24.9 m-85 -89.36 -24.46 21.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.102 -0.999 . . . . 0.0 109.982 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -106.89 92.7 4.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.276 -0.89 . . . . 0.0 109.366 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -100.17 -33.55 10.4 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.167 -0.958 . . . . 0.0 111.402 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 3.1 p30 -69.61 -38.45 77.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.956 -1.09 . . . . 0.0 110.438 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 106.41 41.95 1.68 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.446 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 39.4 p-10 -110.96 -14.82 13.89 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.352 -1.087 . . . . 0.0 110.412 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.5 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 69.28 43.99 67.97 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.5 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 33.5 m-85 -157.8 116.51 3.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.448 -1.031 . . . . 0.0 110.15 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 24.2 mt -87.86 113.22 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.01 -1.056 . . . . 0.0 109.647 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 90.5 p -99.38 159.22 15.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.167 -0.958 . . . . 0.0 110.266 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.2 -18.26 24.76 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.139 -0.976 . . . . 0.0 110.098 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.75 -66.91 0.65 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.233 -0.917 . . . . 0.0 109.983 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.915 ' O ' HG23 ' A' ' 108' ' ' VAL . 92.0 mt-10 -51.65 -39.22 57.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.183 -0.948 . . . . 0.0 109.724 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.959 HD12 HD11 ' A' ' 125' ' ' ILE . 1.5 tt -64.27 -41.34 96.97 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.593 -0.692 . . . . 0.0 110.311 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 57.7 ttp85 -65.89 -23.15 66.58 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.221 -0.924 . . . . 0.0 110.027 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -94.52 -14.7 24.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.384 -0.822 . . . . 0.0 110.245 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.915 HG23 ' O ' ' A' ' 104' ' ' GLU . 72.2 t -82.45 -49.02 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.314 -0.866 . . . . 0.0 110.264 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.6 mmt -60.14 -55.48 33.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.165 -0.959 . . . . 0.0 110.387 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.3 p -49.67 -30.42 9.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.249 -0.907 . . . . 0.0 110.491 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -74.18 -58.48 3.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.218 -0.926 . . . . 0.0 110.293 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.3 mt -47.37 -76.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.257 -0.902 . . . . 0.0 110.326 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.35 43.09 0.06 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -125.3 159.61 31.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -1.208 . . . . 0.0 110.127 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.75 60.4 1.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 110.441 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.03 -174.22 4.35 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.253 -0.905 . . . . 0.0 109.88 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 121' ' ' VAL . 6.9 t -126.92 173.32 9.7 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.073 -1.017 . . . . 0.0 110.277 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 88.4 m-20 -58.48 -39.04 78.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -0.89 . . . . 0.0 110.283 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.03 -68.16 0.34 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.27 -0.894 . . . . 0.0 111.057 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.448 ' OE1' ' N ' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -47.78 -47.14 30.89 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.271 -0.893 . . . . 0.0 111.194 -179.181 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 117' ' ' THR . 78.9 t -54.89 -48.58 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.011 -1.056 . . . . 0.0 110.412 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -61.84 -30.56 70.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.106 -0.996 . . . . 0.0 109.938 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.11 -32.36 70.36 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.281 -0.887 . . . . 0.0 109.728 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' A' ' 120' ' ' GLU . 83.7 mtp -66.7 -53.7 30.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.359 -0.838 . . . . 0.0 109.75 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.959 HD11 HD12 ' A' ' 105' ' ' LEU . 44.0 mm -59.01 -29.25 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.303 -0.873 . . . . 0.0 110.114 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -77.9 -28.36 49.78 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.274 -0.892 . . . . 0.0 109.907 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.38 -29.26 62.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.441 -0.787 . . . . 0.0 110.06 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.492 ' HB1' ' HG2' ' A' ' 144' ' ' MET . . . -94.75 -24.13 17.24 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.344 -0.847 . . . . 0.0 110.401 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.522 ' OD1' HG22 ' A' ' 136' ' ' VAL . 3.7 m-20 -73.16 95.61 2.1 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.981 -1.074 . . . . 0.0 111.126 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 54.8 mt -92.04 -9.52 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.495 -0.753 . . . . 0.0 110.544 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 57.2 p-10 -149.7 -18.22 0.27 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.056 -1.028 . . . . 0.0 112.106 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.492 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . -95.1 -51.75 1.86 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 2.6 m-20 60.69 107.95 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.667 -0.902 . . . . 0.0 108.642 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 100.58 -26.37 24.86 Favored Glycine 0 C--N 1.292 -1.875 0 N-CA-C 107.059 -2.416 . . . . 0.0 107.059 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.407 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 0.2 OUTLIER -139.71 134.92 32.6 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.811 -0.817 . . . . 0.0 109.444 179.036 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.759 HG23 HG23 ' A' ' 125' ' ' ILE . 98.5 t -105.92 142.14 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.311 -0.868 . . . . 0.0 110.494 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -112.25 -176.06 2.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.302 -0.874 . . . . 0.0 109.83 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.57 ' O ' HG23 ' A' ' 142' ' ' VAL . 27.9 t80 -67.47 -36.47 81.21 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.075 -1.016 . . . . 0.0 110.224 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -71.82 -35.6 69.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.064 -1.023 . . . . 0.0 110.285 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.512 ' OE2' ' HA ' ' A' ' 129' ' ' ASP . 35.9 mt-10 -70.27 -31.78 69.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.203 -0.936 . . . . 0.0 110.497 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.617 ' HE2' HG23 ' A' ' 85' ' ' ILE . 65.6 t80 -79.34 -29.37 42.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.224 -0.923 . . . . 0.0 110.669 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 138' ' ' TYR . 96.2 t -80.24 -23.11 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.098 -1.001 . . . . 0.0 110.701 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -93.23 -31.04 14.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.164 -0.96 . . . . 0.0 110.697 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.492 ' HG2' ' HB1' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -79.07 -29.94 43.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.099 -1.001 . . . . 0.0 110.314 -179.82 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.486 ' HE3' ' N1 ' ' A' ' 154' ' ' WW7 . 59.0 tpp -89.12 -58.34 2.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 109.912 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.915 HG21 HD11 ' A' ' 85' ' ' ILE . 64.7 p -107.64 102.32 11.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.373 -0.829 . . . . 0.0 110.064 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -121.49 130.71 53.72 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.274 -0.891 . . . . 0.0 110.324 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.429 ' HD3' ' OXT' ' A' ' 148' ' ' LYS . 10.5 tmtt? . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.087 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' WW7 . . . . . 0.954 HN21 HD21 ' A' ' 39' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' WW7 . . . . . 0.507 'CL1 ' HD13 ' A' ' 125' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.283 0.563 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -153.82 -59.9 0.13 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.226 -0.921 . . . . 0.0 110.186 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -115.51 169.93 8.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.214 -0.929 . . . . 0.0 110.188 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.1 mt -77.94 -169.76 1.67 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.243 -0.91 . . . . 0.0 110.486 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 m -85.46 131.12 34.43 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.295 -0.878 . . . . 0.0 110.558 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -58.15 -20.51 41.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.179 -0.951 . . . . 0.0 109.654 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -74.05 -46.43 43.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.255 -0.903 . . . . 0.0 109.694 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -65.88 -55.07 18.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.431 -0.793 . . . . 0.0 109.593 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.63 HG23 HD11 ' A' ' 69' ' ' LEU . 65.6 mt -53.46 -42.41 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.368 -0.832 . . . . 0.0 109.695 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -59.59 -36.17 75.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -0.881 . . . . 0.0 109.894 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -61.95 -54.53 40.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.624 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -54.68 -36.28 64.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.748 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 17.5 mttt -60.13 -43.14 95.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.327 -0.858 . . . . 0.0 109.914 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -61.31 -38.48 86.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.914 . . . . 0.0 109.791 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.437 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -61.96 -45.58 93.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.238 -0.914 . . . . 0.0 109.968 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -59.75 -47.51 85.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.165 -0.959 . . . . 0.0 109.768 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.9 m -59.19 -27.31 65.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.929 . . . . 0.0 109.376 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.748 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.4 tm? -73.75 -34.32 64.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.478 -0.764 . . . . 0.0 109.613 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.437 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 15.4 m-85 -80.91 -68.08 0.72 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.43 -0.794 . . . . 0.0 109.998 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -58.88 115.24 2.98 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.243 -0.911 . . . . 0.0 110.05 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -104.19 -36.83 7.52 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.197 -0.94 . . . . 0.0 110.166 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -70.19 -11.01 60.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.234 -0.916 . . . . 0.0 110.366 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.57 97.54 0.01 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 10.7 p-10 -150.58 -42.91 0.12 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.376 -1.073 . . . . 0.0 110.108 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.578 ' O ' HG23 ' A' ' 26' ' ' THR . . . 120.02 15.88 5.05 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 25' ' ' GLY . 13.1 p -155.51 132.57 10.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.091 -1.241 . . . . 0.0 110.379 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.436 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 26.6 mt -90.46 127.7 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.282 -0.886 . . . . 0.0 110.109 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.7 p -107.28 -163.71 0.93 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 110.26 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.768 HG22 HD12 ' A' ' 52' ' ' ILE . 7.4 p -86.09 -38.06 18.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.295 -0.878 . . . . 0.0 110.557 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -60.76 -57.74 11.42 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.079 -1.013 . . . . 0.0 110.116 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -55.75 -53.63 54.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.37 -0.831 . . . . 0.0 109.999 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.59 HD13 'CL1 ' ' A' ' 153' ' ' WW7 . 4.5 tp -56.56 -24.93 50.53 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.095 -1.003 . . . . 0.0 109.549 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.21 -53.31 45.67 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.461 ' HA ' ' HB2' ' A' ' 37' ' ' ARG . 27.8 m -66.1 -35.83 81.56 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.251 -1.147 . . . . 0.0 109.793 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.5 t -56.11 -39.9 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.362 -0.836 . . . . 0.0 109.993 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.46 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 24.8 mmt -85.8 -15.31 42.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.353 -0.842 . . . . 0.0 109.954 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.461 ' HB2' ' HA ' ' A' ' 34' ' ' THR . 0.5 OUTLIER -83.05 -14.74 53.24 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.283 -0.886 . . . . 0.0 110.514 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.515 ' C ' HD22 ' A' ' 39' ' ' LEU . 56.3 m -95.92 -20.9 18.4 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.192 -0.942 . . . . 0.0 110.976 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 39' ' ' LEU . 4.5 mm? -99.75 50.08 0.92 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.03 -1.044 . . . . 0.0 110.474 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 48.38 93.32 0.01 OUTLIER Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.452 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -176.82 -41.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -1.151 . . . . 0.0 110.091 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.459 ' HA ' ' CD ' ' A' ' 37' ' ' ARG . 5.8 p-10 36.36 62.16 2.98 Favored Pre-proline 0 N--CA 1.508 2.44 0 O-C-N 121.948 -0.47 . . . . 0.0 111.191 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.46 ' HG3' ' HB3' ' A' ' 36' ' ' MET . 49.0 Cg_endo -76.2 -176.5 3.1 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.835 1.44 . . . . 0.0 110.183 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.406 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 72.4 p -113.32 161.19 17.55 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.356 -0.84 . . . . 0.0 110.057 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -64.47 -29.34 70.38 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.258 -0.901 . . . . 0.0 110.325 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.83 -69.48 0.44 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.179 -0.951 . . . . 0.0 110.101 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -49.15 -30.72 7.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.135 -0.978 . . . . 0.0 109.432 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.507 HD21 ' HA ' ' A' ' 29' ' ' THR . 5.5 tt -63.19 -47.5 82.31 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.48 -0.762 . . . . 0.0 109.719 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -54.72 -47.32 73.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.192 -0.943 . . . . 0.0 109.621 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.05 -33.49 72.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -0.892 . . . . 0.0 109.581 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.453 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 56.1 ttp -68.95 -27.66 65.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 109.743 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.768 HD12 HG22 ' A' ' 29' ' ' THR . 38.4 mt -79.84 -23.66 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.355 -0.84 . . . . 0.0 109.602 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -60.77 -32.17 71.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.405 -0.809 . . . . 0.0 110.166 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.581 ' HG3' HG23 ' A' ' 55' ' ' VAL . 1.6 pt-20 -81.54 -22.46 37.86 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.197 -0.94 . . . . 0.0 110.21 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.776 HG13 ' SD ' ' A' ' 71' ' ' MET . 92.2 t -93.24 -11.08 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.129 -0.982 . . . . 0.0 110.325 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -118.43 113.98 22.2 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.046 -1.034 . . . . 0.0 110.549 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.21 9.7 28.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.41 -0.806 . . . . 0.0 109.814 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 0.9 OUTLIER -82.35 -54.77 4.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.292 -0.88 . . . . 0.0 110.13 -179.75 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.24 29.03 1.39 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -118.91 -22.97 7.09 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.247 -1.149 . . . . 0.0 110.221 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.39 -14.37 65.16 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 80.9 p -119.83 164.53 15.87 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.052 -1.263 . . . . 0.0 110.861 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.436 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 64.2 mt -106.86 158.08 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.354 -0.841 . . . . 0.0 110.401 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.424 ' OD2' ' HD2' ' A' ' 66' ' ' PRO . 8.5 t70 -113.44 -166.8 1.12 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.41 -0.807 . . . . 0.0 109.614 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.523 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.2 t80 -84.2 -44.86 0.75 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.075 -1.015 . . . . 0.0 111.389 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.7 Cg_endo -75.21 -21.02 15.89 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 O-C-N 123.191 1.101 . . . . 0.0 110.351 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -78.66 -32.94 47.4 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.281 -0.887 . . . . 0.0 108.735 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -70.93 -53.25 15.65 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.433 0.635 . . . . 0.0 110.198 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.708 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 7.8 tt -60.56 -40.16 90.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.308 -0.87 . . . . 0.0 110.168 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 89.8 m -73.77 -17.65 61.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.164 -0.96 . . . . 0.0 110.47 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.776 ' SD ' HG13 ' A' ' 55' ' ' VAL . 62.1 ttp -76.96 -50.75 12.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.069 -1.019 . . . . 0.0 110.771 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.588 ' HE3' ' CE ' ' A' ' 71' ' ' MET . 45.6 mtt -90.59 -43.86 9.92 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.101 -0.999 . . . . 0.0 111.317 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -61.11 -13.12 15.07 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.185 -0.947 . . . . 0.0 111.15 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 70' ' ' THR . 5.2 tpt180 -98.63 44.99 1.01 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.965 -1.084 . . . . 0.0 110.644 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -111.08 41.6 1.8 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.193 -0.942 . . . . 0.0 109.793 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 18.0 mmt -109.17 175.48 5.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.247 -0.908 . . . . 0.0 110.588 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -133.4 -153.52 0.55 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.349 -0.845 . . . . 0.0 109.68 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -142.21 125.4 16.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.107 -0.996 . . . . 0.0 110.017 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.4 p -107.87 121.73 45.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 110.315 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.66 177.08 5.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.34 -0.85 . . . . 0.0 109.848 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.9 p -175.15 171.66 2.93 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.104 -0.998 . . . . 0.0 110.745 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -174.93 -73.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.368 -0.832 . . . . 0.0 109.907 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 60.93 86.98 0.1 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.33 -0.856 . . . . 0.0 110.608 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -87.13 -15.01 39.68 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.181 -0.949 . . . . 0.0 110.258 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 12.4 mt -55.94 -35.03 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 110.292 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.8 ttm-85 -50.61 -49.5 56.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 109.553 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -61.54 -49.03 78.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.27 -0.893 . . . . 0.0 109.418 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.4 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -56.44 -19.44 15.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 109.852 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -82.42 -40.44 21.23 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.027 -1.045 . . . . 0.0 109.721 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -56.97 -40.86 77.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.527 -0.733 . . . . 0.0 109.835 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 92' ' ' PHE . 17.7 m -73.78 -42.86 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.127 -0.983 . . . . 0.0 110.602 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.94 ' CE1' HD12 ' A' ' 105' ' ' LEU . 15.8 m-85 -79.84 4.74 15.63 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.002 -1.061 . . . . 0.0 110.77 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -149.92 80.35 1.37 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.077 -1.014 . . . . 0.0 110.092 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -90.45 31.46 1.03 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -0.874 . . . . 0.0 110.249 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -127.88 -113.61 0.27 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -0.962 . . . . 0.0 110.057 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.54 32.13 0.18 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.455 ' HB2' ' CD2' ' A' ' 99' ' ' TYR . 14.2 p30 -111.26 -21.08 12.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.364 -1.08 . . . . 0.0 110.308 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 67.05 10.74 57.17 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.455 ' CD2' ' HB2' ' A' ' 97' ' ' ASN . 8.1 m-85 -107.49 105.15 14.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.155 -1.203 . . . . 0.0 109.88 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 31.0 mt -76.64 130.16 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.32 -0.862 . . . . 0.0 109.554 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.0 m -116.08 172.69 7.0 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.34 -0.85 . . . . 0.0 110.559 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.718 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -66.79 -37.79 85.27 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.557 -0.715 . . . . 0.0 110.275 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.41 -60.84 3.22 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.255 -0.903 . . . . 0.0 110.305 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.707 ' O ' HG23 ' A' ' 108' ' ' VAL . 50.0 mt-10 -56.43 -28.31 59.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.166 -0.959 . . . . 0.0 110.16 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.94 HD12 ' CE1' ' A' ' 92' ' ' PHE . 19.0 tp -66.12 -39.83 90.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.148 -0.97 . . . . 0.0 110.523 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.72 ' O ' HG23 ' A' ' 110' ' ' THR . 30.4 ttp180 -75.12 -29.81 60.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.062 -1.024 . . . . 0.0 110.078 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.62 -21.58 48.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.303 -0.873 . . . . 0.0 110.158 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 104' ' ' GLU . 54.0 t -83.74 -48.97 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 109.856 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.652 ' SD ' HD13 ' A' ' 116' ' ' LEU . 65.1 mtt -63.01 -32.45 73.82 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.385 -0.822 . . . . 0.0 109.985 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.72 HG23 ' O ' ' A' ' 106' ' ' ARG . 2.9 p -55.44 -41.28 72.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.341 -0.85 . . . . 0.0 109.64 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -73.76 -44.72 55.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.892 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.4 mt -58.78 -73.39 0.08 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.208 -0.933 . . . . 0.0 110.205 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 155.84 62.3 0.01 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.5 ' HB3' HD11 ' A' ' 116' ' ' LEU . 54.9 mm-40 -143.94 157.81 44.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.206 -1.173 . . . . 0.0 110.439 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.407 ' N ' ' CD ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -126.69 109.52 12.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.282 -0.886 . . . . 0.0 110.132 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.652 HD13 ' SD ' ' A' ' 109' ' ' MET . 4.2 mp -125.89 162.44 25.18 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.226 -0.921 . . . . 0.0 110.67 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.529 HG22 ' N ' ' A' ' 118' ' ' ASP . 64.3 m -114.05 173.14 6.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.389 -0.819 . . . . 0.0 109.951 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.529 ' N ' HG22 ' A' ' 117' ' ' THR . 43.1 m-20 -53.23 -38.44 62.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.148 -0.97 . . . . 0.0 110.855 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -66.4 -50.23 64.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.961 -1.087 . . . . 0.0 110.735 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.446 ' OE1' ' N ' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -55.62 -57.68 10.96 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.17 -0.956 . . . . 0.0 110.494 -179.739 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.718 ' CG1' ' HB1' ' A' ' 102' ' ' ALA . 21.0 t -51.7 -47.4 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.347 -0.845 . . . . 0.0 110.209 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -57.65 -34.01 68.89 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.055 -1.028 . . . . 0.0 109.916 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.437 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 32.8 tt0 -75.48 -25.3 57.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.89 . . . . 0.0 110.093 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.561 ' HE2' HD21 ' A' ' 105' ' ' LEU . 10.4 mmm -75.35 -47.29 28.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.204 -0.935 . . . . 0.0 110.133 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.516 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 26.8 mm -70.94 -27.08 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.218 -0.926 . . . . 0.0 109.869 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -75.1 -56.05 5.12 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.403 -0.811 . . . . 0.0 110.216 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.455 ' OE1' ' N ' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -57.35 -31.62 65.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.092 -1.005 . . . . 0.0 109.725 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.455 ' N ' ' OE1' ' A' ' 127' ' ' GLU . . . -79.11 -27.86 42.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 109.087 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 47.6 t0 -63.59 95.37 0.1 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.455 -0.778 . . . . 0.0 109.925 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.54 HD12 ' HG2' ' A' ' 140' ' ' GLU . 50.2 mt -80.21 -28.76 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.255 -0.903 . . . . 0.0 110.783 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 2.8 p30 -86.11 -28.39 24.06 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.192 -0.942 . . . . 0.0 110.848 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 88.95 51.91 2.9 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 36.9 p-10 -118.91 -21.57 7.69 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.3 -1.118 . . . . 0.0 110.459 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.59 -25.99 7.45 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.263 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.403 ' CG ' ' OD2' ' A' ' 133' ' ' ASP . 9.0 pt20 -114.7 165.67 12.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.14 -1.212 . . . . 0.0 110.915 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.412 ' CG2' ' HB3' ' A' ' 128' ' ' ALA . 56.1 t -109.82 131.04 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.416 -0.803 . . . . 0.0 109.36 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 10.7 t30 -94.78 -175.13 3.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.065 -1.022 . . . . 0.0 110.675 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.42 ' CD1' ' C ' ' A' ' 138' ' ' TYR . 17.3 t80 -70.87 -59.69 2.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.383 -0.823 . . . . 0.0 110.65 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -52.2 -43.06 64.0 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.162 -0.961 . . . . 0.0 110.293 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.54 ' HG2' HD12 ' A' ' 130' ' ' ILE . 52.1 mt-10 -66.58 -33.31 75.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.022 -1.049 . . . . 0.0 109.896 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.657 ' CZ ' ' HE3' ' A' ' 145' ' ' MET . 25.5 t80 -68.79 -20.13 64.33 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.41 -0.806 . . . . 0.0 109.625 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 138' ' ' TYR . 65.2 t -90.34 -41.76 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.304 -0.872 . . . . 0.0 110.891 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.55 -14.66 59.6 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.13 -0.982 . . . . 0.0 110.855 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.511 ' CE ' ' CD1' ' A' ' 141' ' ' PHE . 4.9 ptt? -85.35 -27.06 26.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.018 -1.051 . . . . 0.0 109.83 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.657 ' HE3' ' CZ ' ' A' ' 141' ' ' PHE . 52.5 mtt -84.82 -68.56 0.71 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.486 -0.759 . . . . 0.0 110.317 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.7 p -45.28 123.94 4.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.607 -0.683 . . . . 0.0 110.177 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 148' ' ' LYS . . . -97.21 -150.89 0.35 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.342 -0.849 . . . . 0.0 110.793 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 147' ' ' ALA . 18.1 tptt . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 117.888 -1.053 . . . . 0.0 110.105 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' WW7 . . . . . 0.693 ' C6 ' HG21 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' WW7 . . . . . 0.65 H111 ' HE1' ' A' ' 145' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.223 0.535 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -76.14 90.74 3.1 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.227 -0.92 . . . . 0.0 110.22 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -83.87 152.58 24.49 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.265 -0.897 . . . . 0.0 110.328 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.511 ' HA ' HD23 ' A' ' 4' ' ' LEU . 2.9 mt -84.48 168.44 15.46 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.265 -0.897 . . . . 0.0 110.324 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.523 HG23 ' H ' ' A' ' 7' ' ' GLU . 8.8 t -139.01 -175.77 4.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.265 -0.897 . . . . 0.0 110.048 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -81.06 -9.61 59.8 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.194 -0.942 . . . . 0.0 110.885 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.523 ' H ' HG23 ' A' ' 5' ' ' THR . 3.9 mt-10 -66.82 -69.63 0.3 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.968 -1.083 . . . . 0.0 110.426 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.46 ' OE1' HD21 ' A' ' 4' ' ' LEU . 49.5 mt-30 -49.18 -55.13 13.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.907 . . . . 0.0 110.083 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 9' ' ' ILE . 65.9 mt -49.65 -40.41 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.166 -0.959 . . . . 0.0 109.896 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -61.35 -40.53 94.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 110.0 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.32 -41.09 96.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 110.209 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -61.65 -52.82 62.77 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.253 -0.904 . . . . 0.0 110.002 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -49.64 -46.15 49.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.146 -0.971 . . . . 0.0 109.667 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -52.87 -50.58 63.53 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.305 -0.872 . . . . 0.0 109.736 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.66 -37.8 59.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.399 -0.813 . . . . 0.0 109.834 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.507 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 18.8 t80 -58.25 -49.87 75.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.432 -0.793 . . . . 0.0 109.831 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.2 t -60.49 -32.2 71.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.296 -0.878 . . . . 0.0 110.147 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.696 ' O ' HD23 ' A' ' 18' ' ' LEU . 5.4 tt -61.51 -44.57 96.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.264 -0.897 . . . . 0.0 110.065 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -70.48 -57.9 4.29 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.168 -0.957 . . . . 0.0 110.214 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -58.64 107.41 0.51 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.278 -0.888 . . . . 0.0 110.252 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -110.8 52.87 0.72 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.163 -0.961 . . . . 0.0 110.989 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.423 ' OD2' ' OD2' ' A' ' 24' ' ' ASP . 6.2 p-10 -151.72 -42.9 0.11 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.046 -1.034 . . . . 0.0 109.959 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.5 64.94 0.57 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 1.4 p30 -144.07 -44.56 0.26 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.049 -1.266 . . . . 0.0 110.207 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.466 ' C ' HG23 ' A' ' 26' ' ' THR . . . 113.22 32.89 2.07 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.388 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.466 HG23 ' C ' ' A' ' 25' ' ' GLY . 43.6 p -148.95 145.0 27.17 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.938 -1.331 . . . . 0.0 110.336 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.401 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 63.3 mt -107.53 117.31 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.302 -0.874 . . . . 0.0 110.171 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.413 ' HA ' HG22 ' A' ' 62' ' ' THR . 76.2 p -102.16 -167.15 1.37 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.246 -0.909 . . . . 0.0 109.99 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.546 HG22 HD12 ' A' ' 52' ' ' ILE . 25.0 p -83.21 -31.75 26.89 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.184 -0.947 . . . . 0.0 110.515 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.7 mtmt -65.18 -62.95 1.24 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.217 -0.927 . . . . 0.0 110.194 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -56.47 -58.7 6.88 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.168 -0.957 . . . . 0.0 109.385 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.737 HD23 HD21 ' A' ' 48' ' ' LEU . 6.0 tp -54.36 -22.6 12.66 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.268 -0.895 . . . . 0.0 109.195 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.537 ' HA2' HD13 ' A' ' 48' ' ' LEU . . . -63.58 -46.61 91.87 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.46 ' O ' ' CB ' ' A' ' 38' ' ' SER . 71.3 m -72.79 -21.58 60.96 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.252 -1.146 . . . . 0.0 110.272 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.42 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 53.0 t -72.78 -63.77 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.204 -0.935 . . . . 0.0 110.274 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 12.4 tpp -67.35 -41.01 85.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 110.521 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.463 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 48.1 ttp180 -65.25 -32.59 74.34 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.174 -0.953 . . . . 0.0 110.739 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 34' ' ' THR . 10.8 t -86.97 10.42 16.4 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.938 -1.101 . . . . 0.0 110.635 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 38' ' ' SER . 36.6 mt -136.33 63.54 1.58 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.002 -1.061 . . . . 0.0 110.403 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . 121.13 -34.14 4.11 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.453 ' CG ' ' O ' ' A' ' 37' ' ' ARG . 67.3 mt-30 54.86 40.08 31.8 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.215 -1.168 . . . . 0.0 110.846 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.538 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 2.4 t30 -86.26 -48.17 0.54 Allowed Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.986 -1.071 . . . . 0.0 110.217 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 42' ' ' ASN . 51.8 Cg_endo -84.85 -171.55 1.0 Allowed 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.696 1.366 . . . . 0.0 110.098 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.658 HG22 ' HB3' ' A' ' 47' ' ' GLU . 12.7 t -138.64 -174.27 3.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.176 -0.953 . . . . 0.0 109.666 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.56 -49.91 71.55 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.967 -1.083 . . . . 0.0 110.108 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.37 -66.11 0.59 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.187 -0.946 . . . . 0.0 110.451 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.658 ' HB3' HG22 ' A' ' 44' ' ' THR . 39.4 tt0 -45.93 -34.26 3.8 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.339 -0.85 . . . . 0.0 110.273 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.737 HD21 HD23 ' A' ' 32' ' ' LEU . 5.0 tt -60.67 -50.25 74.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.28 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.635 ' N ' HD23 ' A' ' 48' ' ' LEU . 5.4 tt0 -52.45 -40.17 61.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.389 -0.819 . . . . 0.0 109.257 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -62.97 -37.45 87.18 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.53 -0.731 . . . . 0.0 109.496 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.442 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 33.9 ttp -71.19 -16.78 62.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.411 -0.806 . . . . 0.0 109.94 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.546 HD12 HG22 ' A' ' 29' ' ' THR . 22.6 mt -83.37 -33.53 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.186 -0.946 . . . . 0.0 109.98 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -52.4 -47.78 66.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.262 -0.899 . . . . 0.0 110.011 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.56 ' HG3' HG23 ' A' ' 55' ' ' VAL . 14.8 pt-20 -64.49 -29.11 70.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.269 -0.894 . . . . 0.0 109.875 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.84 HG21 ' C6 ' ' A' ' 153' ' ' WW7 . 76.7 t -85.0 -10.69 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.372 -0.83 . . . . 0.0 110.196 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -107.53 112.1 24.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.111 -0.993 . . . . 0.0 110.23 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -101.86 34.02 2.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.256 -0.902 . . . . 0.0 110.128 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.404 ' OD1' ' OE2' ' A' ' 67' ' ' GLU . 7.1 m-20 -116.33 -36.26 4.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -0.941 . . . . 0.0 110.316 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.91 56.56 2.06 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.441 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 14.5 p-10 -138.41 -41.88 0.5 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.249 -1.148 . . . . 0.0 110.325 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.798 ' O ' HG23 ' A' ' 62' ' ' THR . . . 126.19 20.7 1.97 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.797 -1.192 . . . . 0.0 110.571 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.798 HG23 ' O ' ' A' ' 61' ' ' GLY . 0.8 OUTLIER -164.72 161.65 20.79 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.009 -1.289 . . . . 0.0 110.356 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.505 ' CD1' ' CG1' ' A' ' 55' ' ' VAL . 78.9 mt -103.79 161.08 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 110.228 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.419 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 35.0 m-20 -125.84 -155.07 0.66 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.185 -0.947 . . . . 0.0 110.779 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.557 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 13.3 t80 -87.15 -41.34 0.53 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.399 -0.813 . . . . 0.0 112.21 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.0 Cg_endo -72.52 -19.02 25.31 Favored 'Trans proline' 0 C--O 1.211 -0.855 0 O-C-N 123.038 1.02 . . . . 0.0 110.621 -179.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.419 ' OE1' ' OD2' ' A' ' 64' ' ' ASP . 49.9 mt-10 -87.69 -31.64 19.62 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.078 -1.013 . . . . 0.0 109.383 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.507 ' CE2' ' HB2' ' A' ' 16' ' ' PHE . 81.3 t80 -73.35 -41.0 63.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.717 -0.614 . . . . 0.0 110.242 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.915 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 0.6 OUTLIER -83.28 -37.73 23.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.37 -0.832 . . . . 0.0 110.767 -179.436 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 66' ' ' PRO . 60.8 m -68.5 -31.07 70.08 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.985 -1.072 . . . . 0.0 110.309 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.403 ' SD ' HG13 ' A' ' 55' ' ' VAL . 57.4 ttp -81.1 -59.31 2.7 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.242 -0.911 . . . . 0.0 110.472 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.411 ' HE1' ' C2 ' ' A' ' 153' ' ' WW7 . 61.3 mtt -68.99 -9.46 52.46 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.355 -0.841 . . . . 0.0 110.642 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.915 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . -54.85 -55.66 27.9 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.134 -0.979 . . . . 0.0 110.444 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.41 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 4.1 ptp85 -110.18 50.85 0.78 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.355 -0.841 . . . . 0.0 110.627 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -146.12 99.84 3.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.131 -0.981 . . . . 0.0 110.637 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 64.3 mtt -104.32 174.76 5.74 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.335 -0.853 . . . . 0.0 109.657 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -173.2 88.61 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.148 -0.97 . . . . 0.0 110.232 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 17.5 p-10 -168.1 153.11 6.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 110.183 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t -93.99 167.05 11.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.262 -0.899 . . . . 0.0 110.492 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -150.64 60.58 0.94 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.302 -0.873 . . . . 0.0 110.425 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.2 t -166.33 137.38 3.52 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.201 -0.937 . . . . 0.0 110.027 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 83' ' ' GLU . 34.6 tt0 -58.22 129.52 42.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 110.4 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 88.8 tt0 -177.13 -34.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.41 -0.806 . . . . 0.0 110.218 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.481 ' OE1' ' N2 ' ' A' ' 154' ' ' WW7 . 45.9 mt-10 -107.62 -13.9 14.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.925 . . . . 0.0 110.611 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.7 mm -65.55 -51.86 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.067 -1.02 . . . . 0.0 110.134 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -62.65 -52.71 62.24 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.35 -0.844 . . . . 0.0 110.177 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.441 ' O ' HG13 ' A' ' 91' ' ' VAL . 55.5 mt-10 -57.34 -28.75 63.4 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.228 -0.92 . . . . 0.0 110.305 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.643 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -67.04 -65.28 0.7 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.917 . . . . 0.0 110.274 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -52.15 -24.23 6.72 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.183 -0.948 . . . . 0.0 110.353 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.1 ttt-85 -74.57 -39.65 62.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.211 -0.931 . . . . 0.0 110.288 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 88' ' ' ALA . 23.2 m -84.91 -11.04 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 110.545 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.529 ' CZ ' ' H2 ' ' A' ' 154' ' ' WW7 . 24.2 m-85 -101.41 -14.68 17.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.031 -1.043 . . . . 0.0 110.509 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 99' ' ' TYR . 83.8 m-20 -132.17 83.03 2.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.017 -1.052 . . . . 0.0 110.619 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -104.53 27.12 8.21 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.141 -0.975 . . . . 0.0 109.994 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.8 p30 -106.69 -24.12 12.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.273 -0.892 . . . . 0.0 109.914 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.441 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 99.49 43.1 2.58 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.504 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 30.6 p-10 -128.81 -24.45 2.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.335 -1.097 . . . . 0.0 110.877 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.452 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 75.2 35.07 49.91 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.504 ' CD2' ' O ' ' A' ' 97' ' ' ASN . 61.3 m-85 -147.46 144.86 28.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.319 -1.107 . . . . 0.0 109.654 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.435 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 23.9 mt -100.24 141.72 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.078 -1.014 . . . . 0.0 109.743 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.4 t -126.54 167.55 15.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.169 -0.957 . . . . 0.0 110.409 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.92 -52.02 53.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.366 -0.834 . . . . 0.0 110.039 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.3 -56.46 16.47 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.385 -0.822 . . . . 0.0 110.235 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.479 ' O ' HG23 ' A' ' 108' ' ' VAL . 97.3 mt-10 -50.86 -45.01 59.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 110.039 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.713 HD12 HD11 ' A' ' 125' ' ' ILE . 2.6 tt -57.18 -38.37 73.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.384 -0.822 . . . . 0.0 110.018 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.415 ' O ' ' HB ' ' A' ' 110' ' ' THR . 66.4 ttt180 -69.27 -26.09 64.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.159 -0.963 . . . . 0.0 109.765 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -83.72 -14.36 51.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.348 -0.845 . . . . 0.0 109.993 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 104' ' ' GLU . 79.1 t -88.37 -62.06 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.147 -0.971 . . . . 0.0 110.825 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 60.9 mtt -65.46 -53.65 39.7 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.159 -0.963 . . . . 0.0 110.72 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.415 ' HB ' ' O ' ' A' ' 106' ' ' ARG . 28.8 m -47.32 -34.28 6.65 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.32 -0.863 . . . . 0.0 110.271 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -77.12 -41.28 42.61 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 110.402 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.437 ' HA ' HD23 ' A' ' 112' ' ' LEU . 16.2 mt -51.32 -49.05 62.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.147 -0.97 . . . . 0.0 110.273 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 139.7 48.06 0.06 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -135.22 149.26 49.85 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.213 -1.169 . . . . 0.0 110.098 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -95.79 104.27 16.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.273 -0.892 . . . . 0.0 110.454 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.0 mt -124.09 164.5 19.29 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.177 -0.952 . . . . 0.0 110.181 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 56.8 m -122.51 153.3 39.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.166 -0.959 . . . . 0.0 110.194 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -45.53 -30.06 1.34 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.277 -0.889 . . . . 0.0 110.549 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -65.08 -61.03 2.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.871 . . . . 0.0 110.457 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -49.81 -51.51 39.12 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.216 -0.927 . . . . 0.0 110.517 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 75.2 t -53.84 -45.69 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.251 -0.906 . . . . 0.0 110.501 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.15 -27.93 69.42 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.21 -0.931 . . . . 0.0 110.394 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -71.98 -31.75 66.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 0.0 110.107 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.5 mtp -77.87 -45.67 23.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.336 -0.853 . . . . 0.0 110.36 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.713 HD11 HD12 ' A' ' 105' ' ' LEU . 19.3 mm -61.96 -41.44 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 110.212 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -63.95 -52.18 60.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.005 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -55.04 -36.44 65.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.202 -0.936 . . . . 0.0 110.23 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.558 ' HB2' ' H6 ' ' A' ' 154' ' ' WW7 . . . -71.16 -29.79 65.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.225 -0.922 . . . . 0.0 110.31 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -73.53 91.39 1.81 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.157 -0.964 . . . . 0.0 110.365 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 130' ' ' ILE . 63.3 mt -84.5 1.3 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.243 -0.911 . . . . 0.0 110.767 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.602 ' OD2' 'CA ' ' A' ' 152' ' ' ' CA' . 2.4 p30 -112.03 -35.47 5.66 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.976 -1.077 . . . . 0.0 110.296 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.442 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 102.44 42.46 2.17 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 58.7 p30 -109.91 -12.7 14.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.161 -1.2 . . . . 0.0 110.541 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.467 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 98.74 -47.01 1.44 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -94.34 164.49 13.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.193 -1.181 . . . . 0.0 110.577 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.435 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 58.2 t -112.61 152.99 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.353 -0.842 . . . . 0.0 109.878 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.401 ' ND2' ' HB3' ' A' ' 139' ' ' GLU . 5.2 p-10 -128.66 -168.88 1.98 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.038 -1.039 . . . . 0.0 110.843 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.841 ' O ' HG23 ' A' ' 142' ' ' VAL . 4.3 t80 -64.64 -44.39 90.61 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.51 -0.744 . . . . 0.0 111.006 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.401 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 35.4 tt0 -61.63 -61.05 2.79 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.232 -0.917 . . . . 0.0 111.219 -179.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.4 ' OE2' ' OD2' ' A' ' 131' ' ' ASP . 53.8 mt-10 -56.59 -28.9 61.39 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.112 -0.992 . . . . 0.0 111.032 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.409 ' CZ ' ' HB1' ' A' ' 88' ' ' ALA . 23.2 t80 -78.86 -27.35 44.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.084 -1.01 . . . . 0.0 110.401 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 138' ' ' TYR . 86.3 t -83.6 -24.72 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.259 -0.901 . . . . 0.0 110.484 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.554 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 85.2 mt-30 -95.29 -22.28 17.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.137 -0.977 . . . . 0.0 110.738 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.0 -12.49 41.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.879 -1.138 . . . . 0.0 110.321 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.465 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 53.1 tpp -90.25 -48.04 7.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.187 -0.946 . . . . 0.0 110.311 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.7 p -85.04 -56.61 3.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.323 -0.861 . . . . 0.0 110.588 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -72.71 144.87 47.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.172 -0.955 . . . . 0.0 109.967 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.279 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . 0.602 'CA ' ' OD2' ' A' ' 131' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' WW7 . . . . . 0.84 ' C6 ' HG21 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' WW7 . . . . . 0.558 ' H6 ' ' HB2' ' A' ' 128' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 121.199 0.523 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.464 ' HB3' HD21 ' A' ' 4' ' ' LEU . 1.3 m-20 -117.23 113.07 21.68 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 0.0 110.228 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -113.26 81.9 1.58 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.334 -0.854 . . . . 0.0 110.011 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.618 ' N ' HD23 ' A' ' 4' ' ' LEU . 0.6 OUTLIER -136.75 150.25 48.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.309 -0.869 . . . . 0.0 110.427 -179.608 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.7 m -55.09 166.97 0.46 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.111 -0.993 . . . . 0.0 109.308 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -89.98 -23.51 21.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.042 -1.036 . . . . 0.0 110.7 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.506 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 52.4 mt-10 -50.01 -46.84 53.13 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.126 -0.984 . . . . 0.0 110.348 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -59.67 -57.19 14.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.309 -0.869 . . . . 0.0 110.307 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 1.025 HG22 ' HE3' ' A' ' 13' ' ' LYS . 83.5 mt -49.97 -28.95 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.257 -0.902 . . . . 0.0 109.614 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -71.47 -42.15 68.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.329 -0.857 . . . . 0.0 110.045 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.34 -42.11 81.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 0.0 109.97 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -64.39 -47.07 80.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.294 -0.878 . . . . 0.0 110.194 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.025 ' HE3' HG22 ' A' ' 9' ' ' ILE . 87.5 mttt -50.84 -51.75 48.09 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.23 -0.919 . . . . 0.0 109.813 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 17' ' ' SER . 40.6 tt0 -53.35 -43.09 67.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.383 -0.823 . . . . 0.0 109.998 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.568 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -57.32 -44.34 84.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.944 . . . . 0.0 109.767 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.43 ' O ' ' HB2' ' A' ' 19' ' ' PHE . 3.2 t80 -63.49 -32.71 74.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.193 -0.942 . . . . 0.0 109.773 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 38.2 t -58.79 -61.58 2.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 110.325 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.568 HD21 ' HA ' ' A' ' 15' ' ' ALA . 1.2 pp -67.3 -15.38 63.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.1 -1.0 . . . . 0.0 110.372 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.523 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 8.1 m-30 -69.29 -63.81 0.99 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.131 -0.98 . . . . 0.0 109.706 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -70.67 107.81 4.1 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.355 -0.84 . . . . 0.0 109.995 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -107.37 -29.67 9.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.117 -0.989 . . . . 0.0 110.375 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 38.0 p30 -69.86 -11.2 60.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.185 -0.947 . . . . 0.0 110.485 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.452 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 66.24 99.03 0.02 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -155.21 -51.74 0.09 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.263 -1.14 . . . . 0.0 110.377 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.0 -5.12 5.04 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 77.4 p -145.37 152.05 39.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.001 -1.294 . . . . 0.0 110.207 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.8 mt -87.37 101.23 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.259 -0.901 . . . . 0.0 110.071 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.2 p -95.37 -177.59 4.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.381 -0.824 . . . . 0.0 109.909 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.64 HG22 HD12 ' A' ' 52' ' ' ILE . 12.0 p -63.1 -30.07 71.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.077 -1.015 . . . . 0.0 110.227 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -63.69 -56.94 11.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.131 -0.981 . . . . 0.0 110.203 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.553 ' O ' HG23 ' A' ' 35' ' ' VAL . 32.0 mt-10 -57.31 -46.45 83.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.868 . . . . 0.0 110.023 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.706 HD13 'CL1 ' ' A' ' 153' ' ' WW7 . 11.0 tp -64.02 -23.25 67.26 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.19 -0.944 . . . . 0.0 109.774 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.04 -42.99 74.97 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.436 ' O ' ' CB ' ' A' ' 38' ' ' SER . 91.6 m -81.5 -18.77 43.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -1.131 . . . . 0.0 109.892 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.751 ' O ' HD12 ' A' ' 39' ' ' LEU . 51.6 t -79.59 -31.89 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.032 -1.043 . . . . 0.0 109.777 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.423 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 26.3 mmt -89.93 -25.4 20.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.297 -0.877 . . . . 0.0 110.163 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.463 ' HD2' ' HA ' ' A' ' 42' ' ' ASN . 3.3 tpt180 -89.37 -25.7 21.43 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.219 -0.926 . . . . 0.0 110.127 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 34' ' ' THR . 62.2 m -85.4 -14.2 47.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -0.926 . . . . 0.0 110.3 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.751 HD12 ' O ' ' A' ' 35' ' ' VAL . 30.5 mt -89.82 -88.03 0.17 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.234 -0.916 . . . . 0.0 110.334 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 41' ' ' GLN . . . -152.22 51.99 0.49 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.444 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 36.8 mt-30 -158.02 169.19 25.13 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.262 -1.14 . . . . 0.0 110.09 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.463 ' HA ' ' HD2' ' A' ' 37' ' ' ARG . 77.5 m-20 -144.4 58.24 5.53 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.496 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 42' ' ' ASN . 48.5 Cg_endo -79.19 -177.8 4.16 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.792 1.417 . . . . 0.0 110.369 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.455 HG22 ' N ' ' A' ' 45' ' ' GLU . 32.3 m -112.68 169.42 8.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.25 -0.906 . . . . 0.0 110.159 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.455 ' N ' HG22 ' A' ' 44' ' ' THR . 37.9 tt0 -66.84 -35.2 79.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.164 -0.96 . . . . 0.0 110.034 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.84 -66.72 0.6 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.266 -0.896 . . . . 0.0 109.88 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -47.25 -35.89 8.29 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.311 -0.868 . . . . 0.0 109.618 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.594 ' CG ' HD23 ' A' ' 32' ' ' LEU . 6.2 tt -61.99 -47.35 85.19 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.509 -0.744 . . . . 0.0 109.805 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.445 ' N ' HD23 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -52.52 -43.54 65.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.929 . . . . 0.0 109.659 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -65.13 -33.02 75.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.923 . . . . 0.0 109.4 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.458 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 31.6 ttp -71.17 -17.69 62.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.341 -0.85 . . . . 0.0 109.481 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.64 HD12 HG22 ' A' ' 29' ' ' THR . 44.9 mt -86.17 -27.39 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.353 -0.842 . . . . 0.0 109.85 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -59.03 -23.64 62.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 110.123 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.458 ' CG ' ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -83.88 -24.97 30.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.283 -0.886 . . . . 0.0 110.128 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.833 HG21 ' C6 ' ' A' ' 153' ' ' WW7 . 80.2 t -85.57 -65.5 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.225 -0.922 . . . . 0.0 109.991 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.402 ' OD2' ' OD1' ' A' ' 60' ' ' ASN . 46.6 t0 -50.31 135.74 21.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.377 -0.827 . . . . 0.0 110.285 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -103.66 -27.04 12.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.279 -0.888 . . . . 0.0 109.789 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -69.97 -30.71 68.12 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.367 -0.833 . . . . 0.0 109.812 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.06 24.51 61.51 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.402 ' OD1' ' OD2' ' A' ' 56' ' ' ASP . 14.2 p-10 -81.55 -32.7 32.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.164 -1.198 . . . . 0.0 110.219 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 129.28 -18.35 5.52 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.756 -1.212 . . . . 0.0 110.094 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 41.3 p -144.74 170.09 16.77 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.103 -1.233 . . . . 0.0 110.366 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.511 HD11 ' CG1' ' A' ' 55' ' ' VAL . 45.7 mt -112.48 163.46 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.106 -0.997 . . . . 0.0 110.163 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.464 ' N ' HG22 ' A' ' 63' ' ' ILE . 73.8 m-20 -125.01 -164.74 1.31 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.19 -0.944 . . . . 0.0 110.531 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.564 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 57.1 t80 -78.81 -43.89 1.85 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.344 -0.847 . . . . 0.0 111.386 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.2 Cg_endo -72.51 -32.54 9.75 Favored 'Trans proline' 0 C--N 1.324 -0.739 0 O-C-N 123.001 1.001 . . . . 0.0 110.176 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.43 ' OE1' ' HA ' ' A' ' 63' ' ' ILE . 35.0 tt0 -76.55 -20.84 56.43 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.226 -0.921 . . . . 0.0 109.277 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.531 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 8.7 t80 -80.96 -44.35 18.33 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.501 -0.749 . . . . 0.0 109.703 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.579 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -71.47 -22.76 61.77 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.324 -0.86 . . . . 0.0 109.613 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.0 m -85.2 -41.28 15.78 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.419 -0.801 . . . . 0.0 110.242 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.491 ' HG3' ' N ' ' A' ' 72' ' ' MET . 19.5 ptm -66.11 -33.2 75.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.135 -0.978 . . . . 0.0 110.169 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.531 ' CE ' ' CZ ' ' A' ' 68' ' ' PHE . 20.6 mtt -90.15 -10.78 43.27 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.237 -0.914 . . . . 0.0 110.269 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.579 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . -72.8 -13.26 61.27 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.129 -0.982 . . . . 0.0 110.349 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -53.31 -69.41 0.12 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.212 -0.93 . . . . 0.0 110.264 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -49.76 131.08 21.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.36 -0.838 . . . . 0.0 110.378 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 32.0 mtt -105.82 128.94 54.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.24 -0.912 . . . . 0.0 110.25 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -108.62 -23.97 11.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.103 -0.998 . . . . 0.0 109.913 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -139.94 149.69 43.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -0.881 . . . . 0.0 110.033 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 79' ' ' THR . 94.6 m -150.09 65.48 0.97 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.241 -0.912 . . . . 0.0 110.015 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -62.67 -160.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.224 -0.922 . . . . 0.0 110.128 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 48.3 t -162.99 -55.33 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.343 -0.848 . . . . 0.0 109.743 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 81' ' ' SER . 2.8 mt-10 -167.07 77.29 0.18 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.361 -0.837 . . . . 0.0 110.059 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -162.34 53.44 0.22 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 110.232 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -77.0 -64.57 1.1 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.232 -0.917 . . . . 0.0 110.941 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 54.0 mt -46.72 -32.85 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.105 -0.997 . . . . 0.0 109.947 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.413 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 35.0 ttt180 -66.2 -47.21 74.61 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.421 -0.799 . . . . 0.0 109.354 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 2.8 tt0 -49.27 -48.48 45.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.437 -0.789 . . . . 0.0 109.983 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.737 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -62.9 -61.47 2.38 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.385 -0.822 . . . . 0.0 110.19 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -44.69 -26.98 0.44 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.428 -0.795 . . . . 0.0 110.644 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 86' ' ' ARG . 4.9 mmp_? -75.53 -47.66 25.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.273 -0.892 . . . . 0.0 110.469 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.737 HG22 ' O ' ' A' ' 88' ' ' ALA . 35.8 m -70.65 -9.75 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.201 -0.937 . . . . 0.0 110.864 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.754 ' CE1' HG11 ' A' ' 108' ' ' VAL . 42.7 m-85 -103.02 -22.89 13.73 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.099 -1.001 . . . . 0.0 110.77 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -114.23 77.67 1.08 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.078 -1.013 . . . . 0.0 110.306 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.9 ptpt -109.69 -7.28 15.1 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.251 -0.905 . . . . 0.0 110.55 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.418 ' OD2' ' OD1' ' A' ' 97' ' ' ASN . 10.8 p-10 -73.28 -37.78 66.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.033 -1.042 . . . . 0.0 110.121 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 121.62 -24.14 7.28 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.196 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.463 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 15.0 p-10 -58.71 -30.01 67.11 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.704 -1.469 . . . . 0.0 110.863 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.471 ' C ' ' CD1' ' A' ' 99' ' ' TYR . . . 94.0 16.25 45.36 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.576 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.626 ' O ' 'CA ' ' A' ' 151' ' ' ' CA' . 86.4 m-85 -142.09 151.54 42.44 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.95 -1.323 . . . . 0.0 110.188 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.418 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 24.0 mt -91.97 130.69 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.11 -0.994 . . . . 0.0 109.729 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 44.4 t -114.98 165.67 12.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.292 -0.88 . . . . 0.0 110.113 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.07 -29.45 67.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.279 -0.888 . . . . 0.0 110.343 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.12 -54.5 7.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.189 -0.944 . . . . 0.0 110.414 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.838 ' O ' HG23 ' A' ' 108' ' ' VAL . 43.7 mt-10 -53.51 -40.65 65.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.216 -0.927 . . . . 0.0 110.282 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.759 HD22 HG13 ' A' ' 121' ' ' VAL . 8.7 tt -71.19 -32.94 69.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.146 -0.971 . . . . 0.0 110.492 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -71.36 -21.35 62.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.07 -1.019 . . . . 0.0 109.898 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.469 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 54.9 t60 -95.68 -20.27 19.05 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.247 -0.908 . . . . 0.0 109.729 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.838 HG23 ' O ' ' A' ' 104' ' ' GLU . 93.2 t -84.14 -38.12 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.321 -0.862 . . . . 0.0 110.307 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.5 mmt -63.67 -30.45 71.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.867 . . . . 0.0 110.152 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.1 p -69.06 -39.16 79.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 109.965 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 107' ' ' HIS . 76.4 m-20 -66.6 -42.91 86.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.189 -0.944 . . . . 0.0 110.224 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.4 ' HB3' ' OE1' ' A' ' 114' ' ' GLU . 89.9 mt -66.54 -33.57 75.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.898 . . . . 0.0 110.125 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.51 -16.72 11.41 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.431 ' CD ' ' N ' ' A' ' 114' ' ' GLU . 5.6 mp0 -69.01 114.11 6.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -1.131 . . . . 0.0 110.288 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.29 121.39 32.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 110.384 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.59 169.82 12.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 110.104 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 27.9 m -98.25 159.49 14.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.105 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -54.35 -44.01 71.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.217 -0.927 . . . . 0.0 110.186 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -65.35 -43.31 91.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 110.409 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -55.76 -46.97 77.76 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.169 -0.957 . . . . 0.0 110.603 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.759 HG13 HD22 ' A' ' 105' ' ' LEU . 77.9 t -59.49 -55.41 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 110.254 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.44 -24.99 49.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.159 -0.963 . . . . 0.0 109.928 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -76.33 -33.99 59.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.356 -0.84 . . . . 0.0 110.064 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.426 ' HE2' HD11 ' A' ' 105' ' ' LEU . 54.5 mtp -71.51 -42.28 68.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 0.0 110.007 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.767 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 31.5 mm -66.71 -36.76 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.255 -0.903 . . . . 0.0 110.08 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.57 -57.37 7.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.278 -0.889 . . . . 0.0 110.129 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.403 ' HA ' ' OE1' ' A' ' 127' ' ' GLU . 3.1 mm-40 -51.2 -42.18 60.74 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.4 -0.812 . . . . 0.0 110.641 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -70.24 -30.61 67.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.203 -0.936 . . . . 0.0 110.449 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 6.8 t0 -74.62 84.09 2.07 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.282 -0.886 . . . . 0.0 110.267 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.4 mt -58.57 -37.91 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.215 -0.928 . . . . 0.0 110.034 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.9 p30 -77.13 -32.3 56.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.268 -0.895 . . . . 0.0 109.991 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.453 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 81.03 60.03 2.34 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 135' ' ' GLN . 56.3 p30 -117.21 8.12 13.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.161 -1.199 . . . . 0.0 110.442 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.61 -40.48 3.04 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.481 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 7.0 pt20 -98.17 158.03 15.8 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.062 -1.258 . . . . 0.0 110.485 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.418 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 76.2 t -114.3 134.05 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.384 -0.823 . . . . 0.0 110.232 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.454 ' OD1' ' CG ' ' A' ' 140' ' ' GLU . 24.2 p-10 -105.19 171.83 7.11 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.124 -0.985 . . . . 0.0 109.997 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -52.83 -60.59 3.08 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.228 -0.92 . . . . 0.0 111.471 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -44.3 -51.84 8.06 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.134 -0.979 . . . . 0.0 111.375 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.46 ' O ' ' CG ' ' A' ' 144' ' ' MET . 58.3 mt-10 -59.89 -37.25 78.85 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.985 -1.072 . . . . 0.0 110.459 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.645 ' CZ ' ' HE3' ' A' ' 145' ' ' MET . 87.4 t80 -66.38 -22.17 66.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.311 -0.868 . . . . 0.0 110.782 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 98.1 t -90.5 -42.18 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.026 -1.046 . . . . 0.0 111.231 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.932 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 75.5 mt-30 -78.61 -13.37 59.86 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.955 -1.091 . . . . 0.0 110.62 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.482 ' HE3' ' HG3' ' A' ' 145' ' ' MET . 0.0 OUTLIER -90.72 -9.91 44.98 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.064 -1.023 . . . . 0.0 110.582 -179.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.645 ' HE3' ' CZ ' ' A' ' 141' ' ' PHE . 18.9 mtt -90.68 -70.85 0.66 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.037 -1.04 . . . . 0.0 111.669 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.9 t -118.23 37.88 3.87 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.955 -1.091 . . . . 0.0 111.024 -178.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.932 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -110.16 143.83 39.69 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.153 -0.967 . . . . 0.0 109.778 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.406 ' OXT' ' O ' ' A' ' 147' ' ' ALA . 18.9 tttm . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.123 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . 0.626 'CA ' ' O ' ' A' ' 99' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' WW7 . . . . . 0.833 ' C6 ' HG21 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' WW7 . . . . . 0.767 'CL1 ' HD13 ' A' ' 125' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.213 0.53 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -98.66 100.79 12.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.298 -0.876 . . . . 0.0 110.345 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -109.98 96.25 6.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.325 -0.859 . . . . 0.0 110.206 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.528 HD11 ' O ' ' A' ' 73' ' ' ALA . 31.2 mt -56.71 173.86 0.18 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.265 -0.897 . . . . 0.0 110.298 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.6 p -79.32 151.67 30.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.304 -0.873 . . . . 0.0 109.951 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -63.22 -16.0 58.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.33 -0.857 . . . . 0.0 110.275 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -69.14 -62.54 1.34 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.18 -0.95 . . . . 0.0 110.373 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.46 ' HG2' ' CE2' ' A' ' 12' ' ' PHE . 11.7 tt0 -58.76 -41.13 85.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 110.14 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.2 mt -58.38 -37.81 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.194 -0.941 . . . . 0.0 109.906 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -69.28 -33.24 72.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.295 -0.878 . . . . 0.0 109.963 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -61.2 -51.37 69.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 109.597 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.46 ' CE2' ' HG2' ' A' ' 8' ' ' GLN . 21.4 m-85 -58.64 -39.03 79.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.469 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -54.14 -42.5 69.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 109.554 179.463 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 17' ' ' SER . 35.1 mt-10 -61.34 -45.04 96.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -0.895 . . . . 0.0 109.786 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.501 ' O ' ' CG ' ' A' ' 19' ' ' PHE . . . -53.49 -48.89 68.54 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.302 -0.873 . . . . 0.0 109.523 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.513 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 28.8 t80 -65.35 -26.67 68.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.383 -0.823 . . . . 0.0 109.797 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -59.91 -63.65 1.23 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.313 -0.867 . . . . 0.0 110.001 179.722 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.465 HD21 ' HA ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -64.37 -19.64 65.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.257 -0.902 . . . . 0.0 109.748 179.683 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.501 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 10.5 m-30 -69.61 -32.2 70.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.361 -0.837 . . . . 0.0 109.444 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -97.96 97.23 8.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.436 -0.79 . . . . 0.0 109.787 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -87.52 49.92 1.9 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 110.253 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 2.7 p30 -170.77 -32.45 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.384 -0.822 . . . . 0.0 110.583 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 77.08 60.87 2.78 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -108.03 -39.6 5.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -1.18 . . . . 0.0 110.816 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.521 ' C ' HG23 ' A' ' 26' ' ' THR . . . 135.83 -10.05 4.24 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.23 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.521 HG23 ' C ' ' A' ' 25' ' ' GLY . 68.1 p -151.06 168.28 25.1 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.1 -1.235 . . . . 0.0 110.425 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 65.6 mt -102.59 123.26 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.369 -0.832 . . . . 0.0 110.294 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.1 p -92.97 -163.78 1.09 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.332 -0.855 . . . . 0.0 110.179 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.462 HG22 HD12 ' A' ' 52' ' ' ILE . 4.5 p -90.31 -45.25 9.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.243 -0.911 . . . . 0.0 110.781 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.441 ' HG3' ' HG3' ' A' ' 31' ' ' GLU . 6.1 pttt -56.47 -45.83 80.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.987 -1.071 . . . . 0.0 110.16 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.441 ' HG3' ' HG3' ' A' ' 30' ' ' LYS . 49.6 mt-10 -63.76 -48.75 75.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.98 -1.075 . . . . 0.0 109.34 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.45 ' C ' HD11 ' A' ' 48' ' ' LEU . 13.1 tp -62.61 -15.68 52.82 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.45 -0.781 . . . . 0.0 109.753 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.469 ' HA2' ' CD1' ' A' ' 48' ' ' LEU . . . -75.89 -46.17 14.57 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 57.7 m -71.27 -20.18 62.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -1.094 . . . . 0.0 109.653 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.3 t -83.33 -33.12 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.33 -0.856 . . . . 0.0 109.968 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.435 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 26.0 mmt -88.38 -18.34 28.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.155 -0.965 . . . . 0.0 109.899 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -90.83 -36.05 14.45 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.0 110.249 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.6 m -80.9 -45.08 17.33 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.243 -0.911 . . . . 0.0 110.045 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.403 HD13 H151 ' A' ' 153' ' ' WW7 . 12.7 mt -92.47 -36.49 13.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 110.079 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 36' ' ' MET . . . -68.64 -112.65 0.02 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -148.67 -70.29 0.21 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.254 -1.145 . . . . 0.0 110.351 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.508 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 51.6 t30 -163.39 49.7 0.24 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 0.0 110.463 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 42' ' ' ASN . 45.3 Cg_endo -71.52 -166.26 0.23 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.747 1.393 . . . . 0.0 110.127 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.61 HG23 ' H ' ' A' ' 47' ' ' GLU . 4.9 t -141.31 173.15 11.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.132 -0.98 . . . . 0.0 110.277 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -68.21 -25.73 65.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.188 -0.945 . . . . 0.0 109.973 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.99 -65.62 0.82 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.294 -0.879 . . . . 0.0 109.606 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.61 ' H ' HG23 ' A' ' 44' ' ' THR . 6.0 tp10 -52.9 -23.55 7.37 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.419 -0.801 . . . . 0.0 109.406 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.469 ' CD1' ' HA2' ' A' ' 33' ' ' GLY . 3.6 tt -68.72 -56.44 8.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.439 -0.788 . . . . 0.0 109.244 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -47.69 -44.01 27.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 109.411 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -63.0 -40.21 97.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.518 -0.739 . . . . 0.0 109.597 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.439 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 6.3 ttp -66.02 -17.81 64.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.339 -0.851 . . . . 0.0 109.779 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.462 HD12 HG22 ' A' ' 29' ' ' THR . 33.8 mt -89.79 -24.97 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 109.608 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -66.0 -36.66 83.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 110.277 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.536 ' HG3' HG23 ' A' ' 55' ' ' VAL . 16.3 pt-20 -68.19 -36.8 80.16 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.099 -1.0 . . . . 0.0 110.251 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.82 HG13 ' SD ' ' A' ' 71' ' ' MET . 99.4 t -76.2 -67.96 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.115 -0.991 . . . . 0.0 110.293 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -43.91 105.9 0.06 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.591 -0.693 . . . . 0.0 110.491 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.12 33.2 4.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.909 . . . . 0.0 110.356 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.3 p30 -122.9 -40.49 2.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.919 . . . . 0.0 110.235 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 103.49 45.99 1.48 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.434 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 19.8 p-10 -122.73 -27.71 4.28 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.089 -1.242 . . . . 0.0 110.397 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.62 -74.54 0.41 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.674 -1.251 . . . . 0.0 110.268 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.8 p -86.1 170.1 12.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.207 -1.172 . . . . 0.0 110.575 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.563 HD13 HG11 ' A' ' 55' ' ' VAL . 20.5 mt -90.13 159.28 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.296 -0.878 . . . . 0.0 109.719 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.435 ' OD2' ' HD2' ' A' ' 66' ' ' PRO . 10.4 t0 -115.41 -179.48 3.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.243 -0.911 . . . . 0.0 110.489 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.591 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 10.6 t80 -74.98 -41.94 4.28 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.333 -0.855 . . . . 0.0 111.752 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.7 Cg_endo -72.07 -17.03 28.57 Favored 'Trans proline' 0 C--O 1.212 -0.823 0 O-C-N 123.105 1.055 . . . . 0.0 110.583 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 71' ' ' MET . 51.2 mt-10 -84.67 -37.52 20.9 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.006 -1.059 . . . . 0.0 108.916 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.513 ' CE2' ' HB2' ' A' ' 16' ' ' PHE . 73.1 t80 -63.67 -48.33 77.65 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.542 -0.723 . . . . 0.0 110.217 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.469 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 1.8 tp -74.4 -37.01 63.5 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.29 -0.881 . . . . 0.0 110.446 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.498 ' O ' ' HB3' ' A' ' 74' ' ' ARG . 71.4 m -74.63 -10.2 59.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.135 -0.978 . . . . 0.0 110.441 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.82 ' SD ' HG13 ' A' ' 55' ' ' VAL . 63.6 ttp -91.44 -49.89 6.09 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.885 -1.135 . . . . 0.0 109.746 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.481 ' HE1' ' CE1' ' A' ' 68' ' ' PHE . 39.4 mtt -91.75 -63.58 1.23 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.338 -0.851 . . . . 0.0 111.645 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.528 ' O ' HD11 ' A' ' 4' ' ' LEU . . . -56.78 -14.18 3.17 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.267 -0.896 . . . . 0.0 111.749 -178.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.498 ' HB3' ' O ' ' A' ' 70' ' ' THR . 11.7 ttt180 -110.12 53.67 0.69 Allowed 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.799 -1.188 . . . . 0.0 110.773 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 33.9 tttt -93.75 138.76 31.61 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.167 -0.958 . . . . 0.0 109.962 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 13.2 ptp -146.17 -179.41 6.71 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.974 -1.078 . . . . 0.0 110.942 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -159.27 128.88 5.51 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.544 -0.723 . . . . 0.0 109.516 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -118.12 15.86 14.11 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.066 -1.021 . . . . 0.0 110.925 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 31.2 p -78.07 84.47 4.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.99 -1.069 . . . . 0.0 109.837 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -168.36 153.71 6.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.411 -0.805 . . . . 0.0 109.921 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.8 m -72.07 -169.51 0.49 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.173 -0.955 . . . . 0.0 110.213 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -132.93 55.37 1.9 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.22 -0.925 . . . . 0.0 110.203 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 37.5 tt0 -150.59 17.99 0.81 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 110.067 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -58.4 -27.42 64.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.076 -1.015 . . . . 0.0 110.343 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.5 mt -52.31 -40.1 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.232 -0.918 . . . . 0.0 110.121 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 20.1 ttt85 -55.12 -49.38 71.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.418 -0.801 . . . . 0.0 110.269 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.59 ' O ' HG13 ' A' ' 91' ' ' VAL . 48.5 mt-10 -64.59 -37.13 86.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.342 -0.849 . . . . 0.0 110.429 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 92' ' ' PHE . . . -64.94 -22.52 67.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 110.302 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.561 ' CD1' HD11 ' A' ' 100' ' ' ILE . 22.4 t80 -83.48 -38.86 21.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.091 -1.006 . . . . 0.0 110.201 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -70.66 -31.44 68.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.381 -0.824 . . . . 0.0 110.777 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.59 HG13 ' O ' ' A' ' 87' ' ' GLU . 7.2 m -83.56 -41.42 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.077 -1.014 . . . . 0.0 110.488 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.516 ' N ' HG23 ' A' ' 91' ' ' VAL . 9.5 m-85 -67.67 -23.48 65.32 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.971 -1.081 . . . . 0.0 110.012 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -108.6 81.03 1.4 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.219 -0.926 . . . . 0.0 109.935 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 91' ' ' VAL . 13.4 mtpt -97.26 1.55 49.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 0.0 110.89 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.699 ' OD2' 'CA ' ' A' ' 151' ' ' ' CA' . 2.3 p30 -79.39 -27.77 41.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.931 -1.106 . . . . 0.0 109.784 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.402 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 94.63 44.16 3.48 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.463 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 23.9 p-10 -128.57 -14.28 4.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.185 -1.185 . . . . 0.0 110.984 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.98 -5.88 84.32 Favored Glycine 0 N--CA 1.504 3.197 0 O-C-N 120.974 -1.079 . . . . 0.0 110.876 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.463 ' HB2' ' ND2' ' A' ' 97' ' ' ASN . 9.5 m-85 -116.61 139.03 50.97 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.954 -1.321 . . . . 0.0 110.309 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.561 HD11 ' CD1' ' A' ' 89' ' ' PHE . 22.0 mt -91.3 115.74 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.222 -0.924 . . . . 0.0 109.916 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.9 t -100.01 172.59 7.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 109.956 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.67 -41.85 71.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.196 -0.94 . . . . 0.0 110.215 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -55.08 -53.78 51.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.316 -0.865 . . . . 0.0 110.122 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.726 ' O ' HG23 ' A' ' 108' ' ' VAL . 51.1 mt-10 -56.74 -49.84 74.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 110.047 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.593 HD12 HD11 ' A' ' 125' ' ' ILE . 1.5 tt -51.1 -34.7 31.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.892 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.432 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 9.5 ttm180 -66.72 -41.55 87.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.241 -0.912 . . . . 0.0 109.814 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -75.45 -10.08 59.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.312 -0.867 . . . . 0.0 110.283 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 104' ' ' GLU . 97.4 t -86.64 -52.13 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.02 -1.05 . . . . 0.0 110.196 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 14.3 mmt -73.4 -60.43 2.25 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.203 -0.935 . . . . 0.0 110.434 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.1 m -46.66 -35.56 6.12 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.401 -0.812 . . . . 0.0 110.552 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -73.73 -45.13 53.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.175 -0.953 . . . . 0.0 110.415 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 41.4 mt -50.04 -52.25 35.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.204 -0.935 . . . . 0.0 110.285 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 157.04 -38.12 0.56 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -57.57 139.5 53.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.292 -1.122 . . . . 0.0 110.242 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -106.89 79.61 1.35 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -0.875 . . . . 0.0 110.335 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.61 -179.1 7.06 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.279 -0.888 . . . . 0.0 110.048 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 66.9 m -108.4 153.79 22.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.247 -0.908 . . . . 0.0 110.252 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.96 -40.87 64.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.321 -0.862 . . . . 0.0 110.466 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -59.04 -41.4 87.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.202 -0.936 . . . . 0.0 110.374 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -56.14 -56.91 15.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.333 -0.854 . . . . 0.0 110.496 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.431 HG13 HD13 ' A' ' 105' ' ' LEU . 97.6 t -54.5 -48.38 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 110.444 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -56.22 -33.37 65.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 0.0 110.225 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -74.4 -28.4 61.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 110.067 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 95.5 mtp -71.65 -53.2 14.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.262 -0.899 . . . . 0.0 109.933 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.593 HD11 HD12 ' A' ' 105' ' ' LEU . 29.3 mm -61.51 -32.06 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 109.993 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 54.2 ttt-85 -64.91 -53.95 38.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.327 -0.858 . . . . 0.0 110.18 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -60.61 -32.47 71.6 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.128 -0.982 . . . . 0.0 110.131 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.18 -27.69 64.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.277 -0.889 . . . . 0.0 110.189 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -70.33 87.96 0.63 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.939 . . . . 0.0 110.178 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 68.7 mt -65.91 -43.01 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.232 -0.917 . . . . 0.0 110.111 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -79.38 -42.39 25.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -0.95 . . . . 0.0 110.115 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.86 84.63 1.81 Allowed Glycine 0 N--CA 1.485 1.964 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.479 ' OD2' ' CG ' ' A' ' 135' ' ' GLN . 18.1 p-10 -147.96 -46.49 0.16 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.254 -1.145 . . . . 0.0 110.598 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 134.3 31.61 0.36 Allowed Glycine 0 N--CA 1.498 2.772 0 C-N-CA 119.491 -1.337 . . . . 0.0 110.889 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.479 ' CG ' ' OD2' ' A' ' 133' ' ' ASP . 8.8 pt20 -169.98 135.82 1.43 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.971 -1.311 . . . . 0.0 110.134 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.2 t -100.09 113.06 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -0.975 . . . . 0.0 110.283 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.433 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 13.8 p30 -89.3 -169.87 2.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.013 -1.054 . . . . 0.0 109.987 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.401 ' O ' HG23 ' A' ' 142' ' ' VAL . 2.4 t80 -62.32 -48.03 81.63 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.078 -1.014 . . . . 0.0 111.095 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -56.05 -55.9 27.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.072 -1.017 . . . . 0.0 110.617 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.422 ' OE1' ' ND2' ' A' ' 137' ' ' ASN . 56.2 mt-10 -61.55 -22.69 65.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.275 -0.891 . . . . 0.0 110.748 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.447 ' CE1' ' CD1' ' A' ' 100' ' ' ILE . 9.8 t80 -79.83 -26.56 40.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.176 -0.952 . . . . 0.0 110.104 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.433 ' O ' ' HB ' ' A' ' 146' ' ' THR . 85.9 t -90.32 -24.21 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.255 -0.903 . . . . 0.0 110.287 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -83.29 -42.27 17.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.185 -0.947 . . . . 0.0 110.654 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.484 ' HG3' ' N ' ' A' ' 145' ' ' MET . 5.2 ptt? -59.73 -38.92 83.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.146 -0.971 . . . . 0.0 110.195 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.484 ' N ' ' HG3' ' A' ' 144' ' ' MET . 14.3 ttm -91.35 -9.33 45.29 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.248 -0.908 . . . . 0.0 110.343 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 142' ' ' VAL . 1.3 m -142.4 94.55 2.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.046 -1.034 . . . . 0.0 110.887 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -106.08 -171.42 1.9 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.155 -0.965 . . . . 0.0 109.829 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 6.8 tttp . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.334 179.955 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . 0.699 'CA ' ' OD2' ' A' ' 95' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' WW7 . . . . . 0.53 H122 H162 ' A' ' 153' ' ' WW7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' WW7 . . . . . 0.477 ' H3 ' ' CD1' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.229 0.537 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.58 123.77 33.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 110.198 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -141.42 119.53 12.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 110.296 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.8 pp -156.2 125.22 6.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 110.276 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.6 m -138.18 -58.81 0.65 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.288 -0.883 . . . . 0.0 110.1 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -69.73 -32.03 70.35 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.325 -0.859 . . . . 0.0 109.784 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -59.94 -40.99 90.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.374 -0.828 . . . . 0.0 109.771 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.425 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 34.9 tp60 -58.98 -44.4 91.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.689 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 57.1 mt -58.47 -45.96 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.9 . . . . 0.0 109.65 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.18 -27.04 68.69 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.317 -0.864 . . . . 0.0 109.657 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 5.9 tp10 -67.62 -44.52 77.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.33 -0.856 . . . . 0.0 109.848 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -61.82 -52.62 63.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 0.0 109.641 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.443 ' HE3' HD13 ' A' ' 69' ' ' LEU . 82.4 mttt -51.93 -43.38 63.42 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.24 -0.913 . . . . 0.0 109.389 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -56.27 -42.21 77.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 0.0 109.555 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.44 -39.66 88.31 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.39 -0.819 . . . . 0.0 109.749 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -56.51 -49.88 73.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.66 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 64.8 m -59.93 -31.0 69.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 109.642 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.806 ' O ' HD23 ' A' ' 18' ' ' LEU . 2.5 tt -65.49 -32.79 74.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.419 -0.801 . . . . 0.0 109.853 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.473 ' O ' ' HD2' ' A' ' 21' ' ' LYS . 5.2 m-85 -87.11 -67.06 0.85 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.395 -0.816 . . . . 0.0 109.999 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -48.24 95.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.957 -1.089 . . . . 0.0 109.988 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.473 ' HD2' ' O ' ' A' ' 19' ' ' PHE . 0.7 OUTLIER -84.33 -47.84 10.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.91 . . . . 0.0 110.455 -179.659 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 3.9 p30 -70.0 -20.89 63.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.108 -0.995 . . . . 0.0 110.025 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.463 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 74.83 72.84 0.99 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.406 ' OD2' ' OD1' ' A' ' 22' ' ' ASP . 65.1 m-20 -112.77 -23.4 10.18 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.145 -1.209 . . . . 0.0 109.932 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.44 -11.96 47.29 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.9 p -132.75 148.02 52.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.184 -1.186 . . . . 0.0 110.298 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.6 mt -102.86 124.77 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.97 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.5 p -114.55 -161.85 0.79 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.339 -0.85 . . . . 0.0 110.599 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.883 HG22 HG13 ' A' ' 52' ' ' ILE . 52.0 p -82.31 -21.04 36.27 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.376 -0.828 . . . . 0.0 110.48 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -74.66 -59.17 2.86 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.231 -0.918 . . . . 0.0 110.032 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.449 ' O ' HG23 ' A' ' 35' ' ' VAL . 43.7 mt-10 -62.19 -45.92 91.25 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.314 -0.866 . . . . 0.0 109.874 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.953 HD22 HD11 ' A' ' 52' ' ' ILE . 3.5 tp -62.73 -36.58 83.46 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.193 -0.942 . . . . 0.0 109.74 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.06 -41.86 86.11 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 65.5 m -80.53 -23.37 40.06 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.128 -1.219 . . . . 0.0 110.503 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 31' ' ' GLU . 38.1 t -72.59 -29.86 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.228 -0.92 . . . . 0.0 110.002 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -89.87 -30.23 18.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -0.882 . . . . 0.0 109.452 179.409 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.499 ' HD3' ' ND2' ' A' ' 42' ' ' ASN . 22.8 tpp180 -62.46 -58.15 8.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.475 -0.766 . . . . 0.0 110.236 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.2 t -95.13 10.36 36.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -0.891 . . . . 0.0 110.384 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.62 59.88 0.17 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.059 -1.025 . . . . 0.0 110.319 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.488 ' HA2' ' N2 ' ' A' ' 153' ' ' WW7 . . . 163.07 -97.89 0.15 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.423 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -148.46 175.62 10.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -1.136 . . . . 0.0 110.099 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.499 ' ND2' ' HD3' ' A' ' 37' ' ' ARG . 1.7 m120 -107.71 73.77 0.42 Allowed Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.307 -0.871 . . . . 0.0 110.407 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 41' ' ' GLN . 46.9 Cg_endo -72.07 -178.56 3.27 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.719 1.378 . . . . 0.0 110.205 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 9.3 m -105.42 167.01 10.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.894 . . . . 0.0 109.542 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.423 ' O ' ' HB3' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -54.71 -52.99 60.7 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.928 -1.108 . . . . 0.0 110.159 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.11 -62.72 1.28 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.185 -0.947 . . . . 0.0 110.645 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -45.23 -26.78 0.54 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.238 -0.914 . . . . 0.0 109.982 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.564 HD23 ' C ' ' A' ' 48' ' ' LEU . 9.2 tt -70.44 -51.5 28.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.374 -0.829 . . . . 0.0 109.293 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.449 ' HA ' ' OE1' ' A' ' 49' ' ' GLN . 4.1 tp-100 -50.37 -38.26 41.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.201 -0.937 . . . . 0.0 109.349 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -61.65 -43.93 97.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.277 -0.89 . . . . 0.0 109.104 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.45 ' HA ' ' HG2' ' A' ' 54' ' ' GLU . 2.2 ttp -60.25 -22.93 63.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.446 -0.784 . . . . 0.0 109.353 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.953 HD11 HD22 ' A' ' 32' ' ' LEU . 35.8 mm -81.68 -27.53 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.536 -0.727 . . . . 0.0 110.279 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -81.57 -15.18 55.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.207 -0.933 . . . . 0.0 110.825 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.74 ' HG3' HG23 ' A' ' 55' ' ' VAL . 2.8 pt-20 -88.47 -16.42 32.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.95 -1.094 . . . . 0.0 110.628 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.854 HG21 ' C6 ' ' A' ' 153' ' ' WW7 . 64.0 t -104.23 -36.88 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.097 -1.002 . . . . 0.0 110.403 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -84.9 103.23 13.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.959 . . . . 0.0 110.039 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.98 41.72 1.56 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.288 -0.882 . . . . 0.0 109.986 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -115.29 18.48 16.1 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.371 -0.831 . . . . 0.0 109.674 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.42 29.24 30.47 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -108.07 -63.97 1.26 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.256 -1.143 . . . . 0.0 110.409 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.28 -65.2 0.43 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 81.1 p -96.07 161.31 14.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -1.148 . . . . 0.0 109.709 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 78.6 mt -84.05 142.15 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.117 -0.989 . . . . 0.0 110.427 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.448 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 56.3 m-20 -101.83 -176.69 3.2 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.319 -0.863 . . . . 0.0 109.945 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.577 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -72.61 -47.24 9.51 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 111.089 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.6 Cg_endo -72.28 -24.4 19.77 Favored 'Trans proline' 0 C--N 1.321 -0.892 0 O-C-N 123.336 1.177 . . . . 0.0 110.408 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -77.34 -28.08 52.95 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.173 -0.955 . . . . 0.0 108.714 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.537 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 7.9 t80 -76.8 -38.07 54.61 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.639 -0.663 . . . . 0.0 109.976 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.537 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 27.5 tp -75.23 -26.42 58.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.359 -0.838 . . . . 0.0 110.271 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.0 m -79.95 -32.33 39.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.178 -0.951 . . . . 0.0 110.076 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.442 ' HG3' ' N ' ' A' ' 72' ' ' MET . 16.8 ptm -84.5 -29.09 26.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.333 -0.854 . . . . 0.0 110.634 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.537 ' CE ' ' CZ ' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -90.58 -29.53 17.77 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.198 -0.939 . . . . 0.0 110.74 -179.658 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -84.53 -37.11 21.66 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.207 -0.933 . . . . 0.0 110.473 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.45 ' C ' ' CG ' ' A' ' 75' ' ' LYS . 16.4 ttt-85 -102.9 -28.7 11.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.934 . . . . 0.0 110.184 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.45 ' CG ' ' C ' ' A' ' 74' ' ' ARG . 15.7 ptpt 36.87 -161.07 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.692 0 O-C-N 121.953 -0.467 . . . . 0.0 111.012 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.454 ' O ' ' HG3' ' A' ' 76' ' ' MET . 22.5 ptp -133.12 55.08 1.92 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.815 -1.178 . . . . 0.0 110.768 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.32 -47.95 3.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.071 -1.018 . . . . 0.0 110.423 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.59 127.99 53.47 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.091 -1.005 . . . . 0.0 110.565 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.5 p -60.0 161.88 6.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.198 -0.939 . . . . 0.0 109.816 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 9.8 t70 -156.62 48.89 0.47 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.118 -0.989 . . . . 0.0 110.0 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 79.4 p -68.96 159.04 33.48 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.151 -0.968 . . . . 0.0 110.218 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.436 ' HG2' ' HG2' ' A' ' 83' ' ' GLU . 7.9 pm0 -64.23 -139.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.873 . . . . 0.0 110.101 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.436 ' HG2' ' HG2' ' A' ' 82' ' ' GLU . 64.5 mm-40 47.93 87.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.092 -1.005 . . . . 0.0 110.673 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -68.07 -17.56 64.42 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.21 -0.931 . . . . 0.0 109.963 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.527 ' CG2' HG22 ' A' ' 142' ' ' VAL . 47.3 mm -67.71 -41.8 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 110.341 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -71.45 -43.81 65.98 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.27 -0.894 . . . . 0.0 110.267 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 66.2 mt-10 -58.71 -43.92 90.2 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.18 -0.95 . . . . 0.0 110.212 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.507 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -59.8 -60.29 4.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 0.0 109.751 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CZ ' ' O ' ' A' ' 98' ' ' GLY . 6.2 t80 -48.95 -25.72 2.1 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.323 -0.86 . . . . 0.0 109.805 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 21.9 ttt180 -69.29 -64.45 0.87 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.426 -0.796 . . . . 0.0 110.858 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 88' ' ' ALA . 32.9 m -56.59 -35.2 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.333 -0.854 . . . . 0.0 111.545 -178.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.868 ' CE1' HD12 ' A' ' 105' ' ' LEU . 44.4 m-85 -77.93 -21.81 50.55 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.824 -1.173 . . . . 0.0 110.932 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 89' ' ' PHE . 97.0 m-20 -128.03 40.76 3.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.053 -1.03 . . . . 0.0 109.944 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 90' ' ' ARG . 21.2 pttp -91.85 25.19 2.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 110.022 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.437 ' OD1' ' HB2' ' A' ' 97' ' ' ASN . 2.8 p30 -107.19 0.58 23.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.368 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.04 16.82 36.97 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.437 ' HB2' ' OD1' ' A' ' 95' ' ' ASP . 21.4 t-20 -95.53 -62.13 1.35 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.097 -1.237 . . . . 0.0 110.287 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.504 ' O ' ' CZ ' ' A' ' 89' ' ' PHE . . . 121.46 -57.82 0.59 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.443 ' CE1' ' OD1' ' A' ' 137' ' ' ASN . 12.7 m-85 -91.5 159.76 15.77 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.267 -1.137 . . . . 0.0 110.138 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.569 HG23 ' HB3' ' A' ' 92' ' ' PHE . 17.5 mt -87.17 154.89 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.106 -0.996 . . . . 0.0 109.467 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 105' ' ' LEU . 23.3 t -140.57 -177.43 5.05 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.137 -0.977 . . . . 0.0 110.611 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.74 -34.18 40.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.366 -0.833 . . . . 0.0 109.953 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.06 -54.91 9.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -0.963 . . . . 0.0 109.928 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -59.14 -43.76 92.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.251 -0.906 . . . . 0.0 109.846 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.966 HD23 HG13 ' A' ' 121' ' ' VAL . 56.8 tp -52.22 -50.41 62.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 110.28 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -67.55 -26.26 66.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -0.883 . . . . 0.0 110.471 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.418 ' ND1' ' O ' ' A' ' 107' ' ' HIS . 31.9 t-80 -75.85 -16.82 60.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.131 -0.981 . . . . 0.0 110.12 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 72.8 t -88.68 -50.56 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.359 -0.838 . . . . 0.0 110.267 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 55.6 mtt -68.57 -44.29 74.73 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.359 -0.838 . . . . 0.0 110.532 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 91.0 m -58.83 -44.49 90.9 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.271 -0.893 . . . . 0.0 110.457 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -64.84 -53.36 47.98 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.252 -0.905 . . . . 0.0 110.689 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.432 ' HA ' HD23 ' A' ' 112' ' ' LEU . 27.6 mt -46.86 -86.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.236 -0.915 . . . . 0.0 110.307 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -179.97 33.67 0.06 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -122.98 143.19 50.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -1.194 . . . . 0.0 110.156 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 39.4 pttt -113.8 117.55 31.77 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.265 -0.897 . . . . 0.0 109.942 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.8 mt -124.72 149.77 46.91 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.109 -0.994 . . . . 0.0 110.646 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.401 ' HB ' ' HG3' ' A' ' 120' ' ' GLU . 39.7 m -71.63 136.79 47.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.283 -0.886 . . . . 0.0 110.052 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -47.87 -44.06 29.01 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.186 -0.946 . . . . 0.0 110.218 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -55.44 -43.01 75.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.836 . . . . 0.0 110.579 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 124' ' ' MET . 45.9 mt-10 -60.37 -51.93 67.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.209 -0.932 . . . . 0.0 110.583 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.966 HG13 HD23 ' A' ' 105' ' ' LEU . 54.1 t -53.43 -48.22 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.074 -1.017 . . . . 0.0 110.339 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -58.43 -41.23 84.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.174 -0.954 . . . . 0.0 110.246 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -70.54 -20.64 62.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.913 . . . . 0.0 110.195 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.423 ' O ' ' H6 ' ' A' ' 154' ' ' WW7 . 85.2 mtp -76.94 -43.67 34.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.175 -0.953 . . . . 0.0 109.615 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.627 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 14.4 mm -67.7 -30.3 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.886 . . . . 0.0 109.926 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.8 ttp85 -75.91 -52.26 10.68 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.113 -0.992 . . . . 0.0 110.217 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -54.17 -38.5 65.62 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.214 -0.928 . . . . 0.0 110.151 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.41 ' HB2' ' H6 ' ' A' ' 154' ' ' WW7 . . . -73.22 -41.56 63.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.877 . . . . 0.0 109.802 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -69.22 92.99 0.59 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.383 -0.823 . . . . 0.0 109.771 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 75.9 mt -63.23 -44.14 99.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.368 -0.833 . . . . 0.0 110.777 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.9 p30 -74.31 -29.41 61.61 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.113 -0.992 . . . . 0.0 110.274 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.453 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 75.19 57.94 4.15 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.444 ' OD1' ' CG ' ' A' ' 135' ' ' GLN . 57.1 p-10 -106.82 0.98 24.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.127 -1.219 . . . . 0.0 110.6 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.14 26.47 12.37 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.444 ' CG ' ' OD1' ' A' ' 133' ' ' ASP . 7.6 pt20 -169.38 164.69 10.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.194 -1.18 . . . . 0.0 110.101 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.479 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 55.2 t -123.06 115.73 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.21 -0.931 . . . . 0.0 109.921 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.443 ' OD1' ' CE1' ' A' ' 99' ' ' TYR . 15.6 t30 -84.16 -174.89 5.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.293 -0.879 . . . . 0.0 110.62 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.682 ' O ' HG23 ' A' ' 142' ' ' VAL . 12.0 t80 -69.74 -42.65 73.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.4 -0.813 . . . . 0.0 110.682 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -61.55 -58.46 8.05 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.276 -0.89 . . . . 0.0 110.659 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -56.07 -36.82 68.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.089 -1.007 . . . . 0.0 110.362 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.583 ' CZ ' ' HE1' ' A' ' 145' ' ' MET . 13.5 t80 -67.08 -27.72 67.59 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.265 -0.897 . . . . 0.0 110.689 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 138' ' ' TYR . 98.5 t -89.93 -22.65 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.34 -0.85 . . . . 0.0 111.078 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -81.61 -36.48 28.89 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.08 -1.013 . . . . 0.0 110.991 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.622 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 4.7 ptt? -64.58 -28.91 69.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.939 -1.1 . . . . 0.0 110.093 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.622 ' CE ' ' HE2' ' A' ' 144' ' ' MET . 61.2 mtt -82.71 -23.26 34.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.879 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.654 HG23 ' O ' ' A' ' 142' ' ' VAL . 47.2 p -84.34 136.68 33.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.339 -0.851 . . . . 0.0 109.915 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 146' ' ' THR . . . 60.73 150.94 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.179 -0.951 . . . . 0.0 110.235 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 34.8 mttt . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.139 179.954 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' WW7 . . . . . 0.854 ' C6 ' HG21 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' WW7 . . . . . 0.627 'CL1 ' HD13 ' A' ' 125' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.199 0.523 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -99.39 56.11 1.0 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.255 -0.903 . . . . 0.0 110.001 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -135.05 163.12 30.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.31 -0.869 . . . . 0.0 110.012 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.5 mt -66.13 -83.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.237 -0.914 . . . . 0.0 110.445 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.516 HG23 ' HB2' ' A' ' 7' ' ' GLU . 10.0 t -166.86 174.9 8.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.195 -0.941 . . . . 0.0 110.199 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -70.92 -26.05 63.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 110.218 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.516 ' HB2' HG23 ' A' ' 5' ' ' THR . 16.7 mm-40 -48.32 -43.41 33.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.201 -0.937 . . . . 0.0 110.238 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.503 ' HG3' ' CE2' ' A' ' 12' ' ' PHE . 2.9 tp-100 -59.5 -42.06 91.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.913 . . . . 0.0 109.786 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.1 mm -61.59 -36.79 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.387 -0.82 . . . . 0.0 109.6 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.28 -30.06 66.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.324 -0.86 . . . . 0.0 109.815 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -64.74 -47.23 79.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.87 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.503 ' CE2' ' HG3' ' A' ' 8' ' ' GLN . 24.0 m-85 -65.26 -49.64 68.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.326 -0.859 . . . . 0.0 110.224 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -53.4 -40.14 64.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.198 -0.939 . . . . 0.0 110.105 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -59.32 -53.26 60.31 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.313 -0.867 . . . . 0.0 110.006 179.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.489 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -51.19 -36.92 43.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.201 -0.937 . . . . 0.0 109.668 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.525 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 60.3 t80 -65.95 -39.57 90.55 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.382 -0.824 . . . . 0.0 109.84 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.8 t -65.62 -21.59 66.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.879 179.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.694 ' C ' HD23 ' A' ' 18' ' ' LEU . 7.9 tt -79.78 -41.5 26.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.398 -0.814 . . . . 0.0 110.048 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.519 ' CE2' ' H3 ' ' A' ' 153' ' ' WW7 . 16.3 m-85 -69.27 -42.09 75.99 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.344 -0.847 . . . . 0.0 110.385 -179.525 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -78.3 100.97 6.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.427 -0.795 . . . . 0.0 110.131 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -101.43 -20.73 15.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 110.491 -179.636 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -86.25 -32.45 21.12 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.151 -0.968 . . . . 0.0 110.748 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.36 79.81 1.47 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 39.3 p-10 -146.09 -22.86 0.45 Allowed 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.223 -1.163 . . . . 0.0 111.898 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.529 ' C ' HG23 ' A' ' 26' ' ' THR . . . 90.24 22.99 33.23 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.529 HG23 ' C ' ' A' ' 25' ' ' GLY . 71.1 p -152.68 132.34 13.11 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.215 -1.168 . . . . 0.0 110.177 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 55.7 mt -95.55 111.91 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 110.114 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.589 HG23 ' H ' ' A' ' 30' ' ' LYS . 10.6 t -106.62 -173.68 2.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.463 -0.773 . . . . 0.0 109.767 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.673 HG22 HD12 ' A' ' 52' ' ' ILE . 40.7 p -70.98 -22.45 62.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.142 -0.974 . . . . 0.0 110.408 179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.589 ' H ' HG23 ' A' ' 28' ' ' THR . 19.8 mtmt -67.91 -60.13 2.75 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.269 -0.894 . . . . 0.0 110.138 179.669 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -59.7 -58.53 8.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.251 -0.905 . . . . 0.0 109.762 179.549 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.732 HD23 HD11 ' A' ' 48' ' ' LEU . 1.8 tp -52.28 -30.96 30.49 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.312 -0.868 . . . . 0.0 109.818 179.686 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.86 -49.14 81.17 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 92.1 m -70.57 -23.58 62.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.2 -1.176 . . . . 0.0 110.104 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.0 t -71.35 -33.54 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.408 -0.808 . . . . 0.0 110.186 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.404 ' O ' ' O ' ' A' ' 40' ' ' GLY . 23.2 mmt -90.81 -24.24 20.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.221 -0.924 . . . . 0.0 110.365 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -89.92 -15.46 32.02 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.124 -0.985 . . . . 0.0 110.313 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.553 ' HB3' HD12 ' A' ' 39' ' ' LEU . 37.4 t -97.19 -44.03 7.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.193 -0.942 . . . . 0.0 110.18 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.553 HD12 ' HB3' ' A' ' 38' ' ' SER . 3.5 mp -117.51 64.93 0.73 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.12 -0.987 . . . . 0.0 110.054 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 36' ' ' MET . . . 127.92 58.89 0.12 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.407 ' OE1' ' N ' ' A' ' 42' ' ' ASN . 0.7 OUTLIER -58.66 132.95 55.37 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.316 -1.108 . . . . 0.0 110.695 -179.733 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.533 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.3 m-80 179.29 -59.96 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.4 -0.812 . . . . 0.0 110.001 179.726 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 46.2 Cg_endo -72.23 -163.84 0.16 Allowed 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.749 1.394 . . . . 0.0 110.252 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.632 HG23 ' N ' ' A' ' 45' ' ' GLU . 14.1 t -152.91 -136.52 0.06 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.593 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.632 ' N ' HG23 ' A' ' 44' ' ' THR . 30.8 mt-10 -101.5 -40.18 7.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.733 -1.229 . . . . 0.0 109.796 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.47 -67.11 0.66 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.884 . . . . 0.0 109.586 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -49.01 -44.09 40.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.308 -0.87 . . . . 0.0 109.468 179.321 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.732 HD11 HD23 ' A' ' 32' ' ' LEU . 5.7 tt -55.35 -46.31 76.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.425 -0.797 . . . . 0.0 109.459 179.206 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.527 ' N ' HD23 ' A' ' 48' ' ' LEU . 43.5 tt0 -51.01 -41.87 60.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.299 -0.876 . . . . 0.0 109.361 179.306 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.447 ' HA ' ' OD1' ' A' ' 53' ' ' ASN . 33.9 t70 -62.48 -43.33 99.08 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.459 -0.776 . . . . 0.0 109.63 179.344 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.432 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 21.5 ttp -61.18 -22.83 65.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.308 -0.87 . . . . 0.0 109.713 179.629 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.673 HD12 HG22 ' A' ' 29' ' ' THR . 37.0 mt -84.13 -26.65 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -0.859 . . . . 0.0 109.863 179.635 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.447 ' OD1' ' HA ' ' A' ' 50' ' ' ASP . 33.3 m120 -65.22 -19.7 66.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.174 -0.954 . . . . 0.0 110.441 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -84.33 -23.84 30.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 110.037 179.763 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.709 HG21 ' C6 ' ' A' ' 153' ' ' WW7 . 85.1 t -93.0 -63.74 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.335 -0.853 . . . . 0.0 109.69 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -55.22 113.07 1.24 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.376 -0.828 . . . . 0.0 110.378 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -101.82 45.45 0.97 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.36 -0.837 . . . . 0.0 109.928 179.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.59 -47.41 1.56 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.351 -0.843 . . . . 0.0 110.395 -179.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 105.31 38.56 2.42 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.607 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.446 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 18.6 p-10 -125.38 -19.16 5.12 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.171 -1.194 . . . . 0.0 110.66 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.508 ' C ' HG23 ' A' ' 62' ' ' THR . . . 102.22 4.58 50.4 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.718 -1.229 . . . . 0.0 111.27 178.559 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.508 HG23 ' C ' ' A' ' 61' ' ' GLY . 47.5 p -149.87 152.36 34.97 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.557 -1.555 . . . . 0.0 110.833 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.581 HD11 ' CG1' ' A' ' 55' ' ' VAL . 72.7 mt -100.6 130.94 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.339 -0.851 . . . . 0.0 109.987 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.456 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -77.35 -169.06 1.28 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.137 -0.977 . . . . 0.0 110.327 -179.927 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.56 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 4.1 t80 -80.14 -44.27 1.44 Allowed Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.221 -0.924 . . . . 0.0 111.294 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.3 Cg_endo -74.09 -27.01 12.27 Favored 'Trans proline' 0 C--N 1.322 -0.838 0 O-C-N 123.138 1.073 . . . . 0.0 109.984 -179.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -73.01 -30.81 64.05 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.355 -0.841 . . . . 0.0 108.811 179.197 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.525 ' CE2' ' HB2' ' A' ' 16' ' ' PHE . 84.9 t80 -72.01 -45.18 61.87 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.54 0.686 . . . . 0.0 109.618 179.271 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.545 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 9.1 tp -77.54 -15.41 59.28 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.367 -0.833 . . . . 0.0 109.719 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.473 ' O ' ' HB3' ' A' ' 74' ' ' ARG . 7.5 m -86.87 -22.52 25.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 110.216 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.481 ' HE2' ' HE3' ' A' ' 72' ' ' MET . 9.2 ptt? -90.61 -37.46 13.78 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.958 -1.089 . . . . 0.0 110.237 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.481 ' HE3' ' HE2' ' A' ' 71' ' ' MET . 59.8 mtt -90.15 -65.62 1.0 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.259 -0.901 . . . . 0.0 111.443 -179.208 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -60.77 -11.62 8.14 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.467 -0.771 . . . . 0.0 111.708 -178.612 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.473 ' HB3' ' O ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -96.43 35.53 1.47 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.712 -1.242 . . . . 0.0 110.899 -179.501 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.39 104.8 0.1 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.059 -1.026 . . . . 0.0 109.9 179.686 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.0 ttt -144.2 89.43 2.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.267 -0.896 . . . . 0.0 110.138 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.6 tttt -110.57 -108.53 0.35 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 110.059 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -136.2 57.84 1.76 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.672 -1.267 . . . . 0.0 110.034 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 47.6 p -120.54 -48.0 2.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 110.429 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -147.62 -56.31 0.24 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.159 -0.963 . . . . 0.0 110.29 -179.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 79.6 p -66.64 120.54 13.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.25 -0.906 . . . . 0.0 110.357 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -174.07 -146.63 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.22 -0.925 . . . . 0.0 110.501 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -159.96 93.88 1.09 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.883 . . . . 0.0 109.865 -179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -76.62 -35.08 58.29 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.318 -0.864 . . . . 0.0 110.541 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.1 mt -50.39 -43.89 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.206 -0.934 . . . . 0.0 110.577 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -57.23 -43.17 82.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.91 . . . . 0.0 110.609 -179.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -63.5 -37.41 87.2 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.303 -0.873 . . . . 0.0 111.305 -179.378 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.707 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -64.55 -60.01 3.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.106 -0.996 . . . . 0.0 110.593 -179.421 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -51.36 -34.31 33.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.23 -0.918 . . . . 0.0 110.615 -179.492 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -45.36 88.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.106 -0.996 . . . . 0.0 110.557 -179.669 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.707 HG22 ' O ' ' A' ' 88' ' ' ALA . 33.0 m -77.38 -14.7 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.051 -1.031 . . . . 0.0 110.538 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.684 ' HE2' ' HB1' ' A' ' 88' ' ' ALA . 22.4 m-85 -93.82 -13.96 26.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.195 -0.941 . . . . 0.0 110.406 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -107.46 59.24 0.62 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.932 . . . . 0.0 109.837 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -63.54 -43.86 95.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.376 -0.827 . . . . 0.0 110.646 -179.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.429 ' OD2' ' HB3' ' A' ' 97' ' ' ASN . 18.1 p-10 -69.04 -26.8 65.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.194 -0.941 . . . . 0.0 110.106 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.18 8.33 71.98 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.168 178.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.429 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 20.6 p-10 -62.5 -30.09 71.02 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.599 -1.53 . . . . 0.0 110.105 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.497 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 107.69 7.73 31.31 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.497 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 30.1 m-85 -140.49 163.27 33.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.124 -1.221 . . . . 0.0 109.874 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.461 ' CD1' ' CD1' ' A' ' 141' ' ' PHE . 40.0 mt -100.08 129.31 50.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.198 -0.939 . . . . 0.0 109.876 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.6 t -110.37 147.21 34.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.445 -0.784 . . . . 0.0 109.721 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -51.26 -45.36 62.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.121 -0.987 . . . . 0.0 110.248 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -49.88 -55.52 14.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.154 -0.966 . . . . 0.0 110.293 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -61.35 -30.63 70.64 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.174 -0.954 . . . . 0.0 110.592 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.755 HD23 HG13 ' A' ' 121' ' ' VAL . 21.7 tp -58.42 -44.01 88.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.26 -0.9 . . . . 0.0 110.285 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.08 -28.04 48.69 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.322 -0.861 . . . . 0.0 110.192 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -70.34 -19.46 63.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.2 -0.937 . . . . 0.0 110.151 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 70.2 t -101.78 -26.63 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.153 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.657 ' HB3' HD13 ' A' ' 116' ' ' LEU . 23.0 mmt -77.89 -24.57 48.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.159 -0.963 . . . . 0.0 110.248 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.6 m -90.61 -15.38 30.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -0.923 . . . . 0.0 110.431 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -90.21 -43.41 10.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.093 -1.004 . . . . 0.0 110.463 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 46.8 mt -59.83 -45.28 92.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 109.975 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 136.66 50.18 0.07 OUTLIER Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.451 ' HB3' HD11 ' A' ' 116' ' ' LEU . 65.6 mm-40 -136.94 126.91 25.88 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.208 -1.172 . . . . 0.0 110.095 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.36 112.98 25.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.2 -0.937 . . . . 0.0 110.448 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.657 HD13 ' HB3' ' A' ' 109' ' ' MET . 3.5 mp -127.67 -169.5 2.06 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.342 -0.849 . . . . 0.0 109.905 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.2 t -144.53 164.9 29.53 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.144 -0.972 . . . . 0.0 110.607 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -53.81 -28.79 37.37 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.393 -0.817 . . . . 0.0 111.004 -179.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.29 -51.54 43.77 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.145 -0.972 . . . . 0.0 110.957 -179.317 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -64.1 -51.58 63.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.189 -0.945 . . . . 0.0 110.782 -179.426 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.755 HG13 HD23 ' A' ' 105' ' ' LEU . 77.9 t -57.19 -45.89 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.236 -0.915 . . . . 0.0 110.728 -179.373 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -58.82 -53.56 57.03 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.061 -1.024 . . . . 0.0 110.505 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -62.64 -22.96 66.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -0.931 . . . . 0.0 110.418 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 5.8 mmm -71.56 -49.66 38.49 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.153 -0.967 . . . . 0.0 110.113 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 23.6 mm -69.4 -28.53 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.193 -0.942 . . . . 0.0 109.953 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -70.63 -43.36 69.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.964 . . . . 0.0 109.983 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -71.16 -27.59 63.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.211 -0.931 . . . . 0.0 109.816 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.753 ' HB2' ' H6 ' ' A' ' 154' ' ' WW7 . . . -78.29 -25.2 46.57 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.341 -0.849 . . . . 0.0 109.769 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -74.83 86.61 2.23 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.303 -0.873 . . . . 0.0 110.201 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 70.5 mt -69.08 -48.13 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.282 -0.886 . . . . 0.0 110.433 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 3.0 p30 -73.77 -21.97 60.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.229 -0.92 . . . . 0.0 110.278 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 68.79 68.15 1.74 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 36.8 p30 -118.35 -16.92 9.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.438 -1.037 . . . . 0.0 111.032 -179.309 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.466 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 124.71 -46.8 1.06 Allowed Glycine 0 N--CA 1.498 2.779 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.406 ' O ' ' OE1' ' A' ' 135' ' ' GLN . 0.0 OUTLIER -119.31 170.57 9.0 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.242 -1.152 . . . . 0.0 109.909 179.846 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.424 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 75.6 t -103.3 151.61 6.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.041 -1.037 . . . . 0.0 110.672 -179.345 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.494 ' OD1' ' CD1' ' A' ' 99' ' ' TYR . 72.6 m-20 -122.73 -172.74 2.54 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.494 -0.754 . . . . 0.0 109.82 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.722 ' O ' HG23 ' A' ' 142' ' ' VAL . 3.9 t80 -72.93 -19.91 61.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.195 -0.941 . . . . 0.0 109.727 179.595 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.41 -56.58 4.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.136 -0.978 . . . . 0.0 109.837 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -64.76 -25.37 67.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.146 -0.971 . . . . 0.0 109.691 179.561 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.493 ' CE2' ' HE3' ' A' ' 145' ' ' MET . 19.1 t80 -75.29 -29.16 60.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.399 -0.813 . . . . 0.0 109.967 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 138' ' ' TYR . 70.5 t -84.83 -27.85 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.233 -0.917 . . . . 0.0 110.27 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.83 -34.15 34.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.837 . . . . 0.0 110.646 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.446 ' HE3' ' HE3' ' A' ' 145' ' ' MET . 0.1 OUTLIER -82.6 -25.54 33.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 110.47 -179.46 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.493 ' HE3' ' CE2' ' A' ' 141' ' ' PHE . 26.0 ttm -89.86 -57.36 2.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.277 -0.889 . . . . 0.0 110.104 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.0 p 42.96 94.47 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.427 -0.796 . . . . 0.0 110.924 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -109.46 45.65 1.06 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.343 -0.848 . . . . 0.0 110.077 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.249 -179.855 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' WW7 . . . . . 0.709 ' C6 ' HG21 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' WW7 . . . . . 0.753 ' H6 ' ' HB2' ' A' ' 128' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.263 0.554 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -53.18 110.36 0.53 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.902 . . . . 0.0 110.26 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -100.13 153.74 19.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.236 -0.915 . . . . 0.0 110.154 179.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 48.7 mt -129.22 121.73 28.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.237 -0.914 . . . . 0.0 110.211 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.8 p -134.59 -55.46 0.84 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.243 -0.911 . . . . 0.0 110.097 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -81.85 -41.34 21.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.306 -0.871 . . . . 0.0 110.295 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.417 ' OE1' ' CA ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -52.65 -35.65 55.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 110.775 -179.594 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -56.57 -54.05 50.46 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.06 -1.025 . . . . 0.0 109.817 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 78.8 mt -58.95 -34.2 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.658 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.75 -28.07 67.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.256 -0.902 . . . . 0.0 110.073 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -72.45 -53.51 11.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.337 -0.852 . . . . 0.0 109.725 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -56.37 -45.7 80.39 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.327 -0.858 . . . . 0.0 109.819 179.616 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.85 -41.37 74.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 109.758 179.433 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -54.44 -52.53 61.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.402 -0.811 . . . . 0.0 109.953 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.23 -50.09 62.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.38 -0.825 . . . . 0.0 110.253 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -51.26 -45.56 62.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.186 -0.946 . . . . 0.0 109.828 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.9 m -55.14 -41.95 72.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.241 -0.912 . . . . 0.0 109.761 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.718 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.1 tt -59.0 -34.32 71.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.375 -0.828 . . . . 0.0 109.647 179.575 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.622 ' CZ ' HG11 ' A' ' 35' ' ' VAL . 10.5 m-85 -74.5 -69.97 0.43 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.325 -0.859 . . . . 0.0 110.541 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.28 91.49 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.367 -0.833 . . . . 0.0 110.089 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 19' ' ' PHE . 2.3 mttm -81.42 -28.29 34.33 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.341 -0.849 . . . . 0.0 109.943 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.403 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 5.0 p30 -104.89 -9.81 17.74 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.282 -0.886 . . . . 0.0 110.487 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 61.56 63.23 5.01 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.642 ' OD2' 'CA ' ' A' ' 149' ' ' ' CA' . 1.8 p30 -92.02 -15.68 27.53 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.184 -1.186 . . . . 0.0 110.012 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.551 ' C ' HG23 ' A' ' 26' ' ' THR . . . 114.88 -9.85 21.16 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.551 HG23 ' C ' ' A' ' 25' ' ' GLY . 82.3 p -156.07 169.8 23.64 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.161 -1.199 . . . . 0.0 110.497 -179.818 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.4 mt -105.14 125.39 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.44 -0.788 . . . . 0.0 109.49 179.229 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 49.3 p -110.45 -171.98 1.94 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.198 -0.938 . . . . 0.0 110.437 -179.547 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.61 HG21 ' HG2' ' A' ' 49' ' ' GLN . 55.3 p -79.05 -25.49 43.18 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.328 -0.857 . . . . 0.0 110.422 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -70.26 -56.81 5.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.29 -0.881 . . . . 0.0 109.766 179.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.403 ' OE2' ' OD2' ' A' ' 22' ' ' ASP . 88.8 mt-10 -59.43 -48.34 82.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.311 -0.868 . . . . 0.0 109.318 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.068 HD22 HD11 ' A' ' 52' ' ' ILE . 1.3 tp -61.94 -26.73 68.37 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.468 -0.77 . . . . 0.0 109.426 179.428 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.52 -44.38 97.67 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.545 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.3 m -71.3 -27.2 63.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -1.116 . . . . 0.0 109.938 179.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.622 HG11 ' CZ ' ' A' ' 19' ' ' PHE . 8.1 t -67.05 -38.7 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.291 -0.88 . . . . 0.0 109.99 179.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 20.8 mmt -89.56 -20.15 24.13 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.069 -1.019 . . . . 0.0 110.37 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -90.25 -13.28 35.72 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.22 -0.925 . . . . 0.0 110.721 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.664 ' OG ' HD23 ' A' ' 39' ' ' LEU . 14.9 p -65.59 -59.55 3.84 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.219 -0.925 . . . . 0.0 110.463 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.664 HD23 ' OG ' ' A' ' 38' ' ' SER . 0.5 OUTLIER -132.85 47.25 2.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.098 -1.001 . . . . 0.0 110.125 179.975 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -166.98 43.69 0.25 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.44 ' OE1' ' N ' ' A' ' 42' ' ' ASN . 0.9 OUTLIER -49.38 115.08 1.19 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.217 -1.166 . . . . 0.0 110.162 -179.818 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.501 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 0.6 OUTLIER -174.81 -61.75 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.402 -0.811 . . . . 0.0 109.931 179.743 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.501 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 43.4 Cg_endo -70.67 165.73 31.05 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.549 1.289 . . . . 0.0 110.266 179.453 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.484 HG22 ' H ' ' A' ' 45' ' ' GLU . 0.8 OUTLIER -119.93 -146.87 0.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.158 -0.964 . . . . 0.0 109.782 179.913 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.484 ' H ' HG22 ' A' ' 44' ' ' THR . 20.9 pt-20 -92.37 -41.34 10.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.133 -0.98 . . . . 0.0 109.694 179.54 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.469 ' N ' ' HG3' ' A' ' 45' ' ' GLU . . . -71.12 -60.72 2.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.292 -0.88 . . . . 0.0 110.051 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -49.05 -30.5 6.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.068 -1.02 . . . . 0.0 109.477 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.592 HD11 HD23 ' A' ' 32' ' ' LEU . 8.0 tt -65.2 -52.19 56.36 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.556 -0.715 . . . . 0.0 109.5 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.61 ' HG2' HG21 ' A' ' 29' ' ' THR . 70.3 mt-30 -49.67 -39.04 35.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.943 . . . . 0.0 109.356 179.242 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.88 -46.22 91.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.429 -0.794 . . . . 0.0 109.703 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.415 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 18.0 ttp -65.2 -17.92 64.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.903 . . . . 0.0 109.738 179.527 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.068 HD11 HD22 ' A' ' 32' ' ' LEU . 36.3 mm -85.84 -28.75 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.395 -0.815 . . . . 0.0 110.133 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -62.54 -41.89 99.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.259 -0.901 . . . . 0.0 110.244 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.608 ' HG3' HG23 ' A' ' 55' ' ' VAL . 12.0 pt-20 -67.8 -24.44 65.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.273 -0.892 . . . . 0.0 109.898 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.896 HG13 ' SD ' ' A' ' 71' ' ' MET . 74.0 t -92.65 -7.26 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.293 -0.879 . . . . 0.0 110.297 179.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.461 ' OD2' ' CA ' ' A' ' 61' ' ' GLY . 22.8 t0 -113.21 98.73 7.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.028 -1.045 . . . . 0.0 110.853 -179.564 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.91 25.53 9.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 0.0 109.146 178.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.413 ' OD2' ' OD1' ' A' ' 60' ' ' ASN . 8.8 t70 -98.55 -49.1 4.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.602 -0.686 . . . . 0.0 110.419 -179.705 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.47 -26.55 5.45 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.434 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 16.5 p-10 -70.46 -33.84 71.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.032 -1.276 . . . . 0.0 110.339 -179.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.461 ' CA ' ' OD2' ' A' ' 56' ' ' ASP . . . 119.38 -61.24 0.49 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.434 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 81.7 p -70.09 165.38 22.08 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.302 -1.117 . . . . 0.0 110.254 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.471 HG12 HG12 ' A' ' 55' ' ' VAL . 9.9 mt -100.21 157.71 3.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.272 -0.893 . . . . 0.0 109.768 179.629 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.439 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 46.0 m-20 -111.7 -169.96 1.56 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.512 -179.538 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.575 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 9.8 t80 -78.19 -44.86 2.21 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.256 -0.902 . . . . 0.0 111.44 -179.549 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.3 Cg_endo -71.64 -17.66 29.56 Favored 'Trans proline' 0 C--O 1.205 -1.14 0 O-C-N 123.127 1.067 . . . . 0.0 110.252 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -84.71 -30.91 24.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.185 -0.947 . . . . 0.0 109.372 179.123 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 9.0 t80 -71.45 -49.21 43.74 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.591 -0.693 . . . . 0.0 110.231 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.834 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 0.6 OUTLIER -76.64 -29.7 56.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.197 -0.939 . . . . 0.0 110.725 -179.661 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 66' ' ' PRO . 54.8 m -78.51 -19.57 52.68 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.774 -1.204 . . . . 0.0 110.334 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.896 ' SD ' HG13 ' A' ' 55' ' ' VAL . 61.1 ttp -86.34 -49.8 7.39 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.135 -0.978 . . . . 0.0 110.573 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.2 mtt -83.1 -59.69 2.39 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.223 -0.923 . . . . 0.0 110.786 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.834 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -47.11 -35.28 6.93 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.046 -1.034 . . . . 0.0 110.558 -179.492 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.46 ' NH1' ' OG1' ' A' ' 79' ' ' THR . 52.1 mtt180 -108.97 62.63 0.6 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.227 -0.921 . . . . 0.0 110.196 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.96 -28.84 60.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -0.888 . . . . 0.0 110.181 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 9.7 ptm -142.02 14.36 2.07 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.231 -0.918 . . . . 0.0 110.43 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.04 93.26 3.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.159 -0.963 . . . . 0.0 109.984 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -77.67 169.26 18.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.915 . . . . 0.0 110.39 -179.67 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.46 ' OG1' ' NH1' ' A' ' 74' ' ' ARG . 55.1 m -93.99 -34.95 12.85 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.291 -0.881 . . . . 0.0 110.432 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 65.3 t0 54.31 55.06 8.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 109.951 -179.584 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.453 ' OG ' HG22 ' A' ' 79' ' ' THR . 49.5 m -136.43 -46.62 0.62 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.199 -0.938 . . . . 0.0 110.138 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 25.8 tt0 55.36 29.98 14.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.912 . . . . 0.0 110.301 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -89.0 53.47 2.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.922 . . . . 0.0 110.197 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.684 ' HB2' HN21 ' A' ' 154' ' ' WW7 . 48.2 mt-10 -93.96 -25.77 17.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.234 -0.916 . . . . 0.0 110.331 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.9 mm -51.99 -46.27 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 110.451 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -62.43 -44.43 96.45 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.125 -0.984 . . . . 0.0 109.868 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -54.24 -37.14 64.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.352 -0.843 . . . . 0.0 110.118 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.792 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -68.28 -63.91 0.97 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.305 -0.872 . . . . 0.0 110.438 -179.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -45.33 -27.73 0.72 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.239 -0.913 . . . . 0.0 110.612 -179.647 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.82 -54.6 9.63 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.23 -0.919 . . . . 0.0 110.408 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.792 HG22 ' O ' ' A' ' 88' ' ' ALA . 33.9 m -61.85 -21.22 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.23 -0.919 . . . . 0.0 110.26 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.643 ' CE1' HG11 ' A' ' 108' ' ' VAL . 46.5 m-85 -93.23 -16.27 24.98 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.243 -0.911 . . . . 0.0 110.313 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.424 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 49.3 t0 -124.94 67.12 1.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.862 . . . . 0.0 109.863 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -95.22 2.06 54.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 110.855 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 2.7 p30 -95.81 -13.21 24.23 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.094 -1.004 . . . . 0.0 110.347 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.36 36.18 8.28 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.451 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 6.4 t-20 -93.25 -61.39 1.58 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.22 -1.165 . . . . 0.0 110.183 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.479 ' C ' ' CD1' ' A' ' 99' ' ' TYR . . . 128.59 -14.4 6.1 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 33.6 m-85 -136.73 146.91 46.38 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.129 -1.218 . . . . 0.0 110.225 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 100' ' ' ILE . 39.8 mt -74.71 143.37 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.173 -0.954 . . . . 0.0 110.403 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.5 p -129.2 158.93 37.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.369 -0.832 . . . . 0.0 109.748 179.617 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.88 -25.14 56.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.148 -0.97 . . . . 0.0 110.545 -179.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.12 -64.5 1.04 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.181 -0.949 . . . . 0.0 110.507 -179.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.566 ' O ' HG23 ' A' ' 108' ' ' VAL . 41.3 mt-10 -48.95 -40.95 32.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.231 -0.918 . . . . 0.0 110.068 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.46 ' O ' HD23 ' A' ' 105' ' ' LEU . 6.4 tt -63.74 -40.12 95.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.0 110.156 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.753 ' O ' HG23 ' A' ' 110' ' ' THR . 2.5 tpm_? -58.71 -35.37 72.56 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.206 -0.934 . . . . 0.0 109.982 179.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.4 ' O ' ' OG1' ' A' ' 110' ' ' THR . 73.6 m-70 -77.32 -24.85 50.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.87 . . . . 0.0 110.619 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.643 HG11 ' CE1' ' A' ' 92' ' ' PHE . 90.4 t -77.16 -37.98 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.131 -0.98 . . . . 0.0 110.545 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.768 ' HA ' HD12 ' A' ' 112' ' ' LEU . 24.7 mmt -72.66 -26.07 61.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.23 -0.918 . . . . 0.0 110.562 -179.52 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.753 HG23 ' O ' ' A' ' 106' ' ' ARG . 39.4 p -64.6 -45.22 87.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.164 -0.96 . . . . 0.0 110.125 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -72.19 -42.9 65.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.19 -0.944 . . . . 0.0 110.021 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.768 HD12 ' HA ' ' A' ' 109' ' ' MET . 39.7 mt -47.0 -25.85 0.89 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.255 -0.903 . . . . 0.0 110.403 179.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.2 43.96 3.64 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -132.95 136.28 46.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.29 -1.124 . . . . 0.0 110.033 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.01 109.11 21.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.241 -0.912 . . . . 0.0 110.618 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.7 mp -123.69 -177.94 3.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.345 -0.847 . . . . 0.0 109.745 179.507 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 57.8 m -129.03 155.53 45.26 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.122 -0.986 . . . . 0.0 110.256 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.419 ' O ' ' OD2' ' A' ' 122' ' ' ASP . 36.8 m-20 -49.07 -40.82 33.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.253 -0.905 . . . . 0.0 110.05 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -61.36 -50.74 71.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.231 -0.918 . . . . 0.0 110.268 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 123' ' ' GLU . 6.0 mm-40 -52.82 -48.01 67.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.298 -0.876 . . . . 0.0 110.331 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 75.3 t -54.52 -50.31 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.192 -0.942 . . . . 0.0 110.255 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 118' ' ' ASP . 61.4 m-20 -53.61 -34.77 59.61 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 110.191 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -62.88 -47.62 82.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.194 -0.941 . . . . 0.0 109.971 179.957 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.43 ' HB3' ' HE2' ' A' ' 124' ' ' MET . 60.4 mtp -63.13 -59.08 5.26 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.29 -0.881 . . . . 0.0 110.226 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.936 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 28.7 mm -50.89 -24.56 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.314 -0.866 . . . . 0.0 110.429 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -77.14 -49.15 15.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.207 -0.933 . . . . 0.0 110.071 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -63.02 -19.74 64.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -0.936 . . . . 0.0 110.017 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.467 ' HB2' ' SD ' ' A' ' 144' ' ' MET . . . -87.73 -40.98 13.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.358 -0.839 . . . . 0.0 110.088 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -64.54 88.07 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.297 -0.877 . . . . 0.0 110.243 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 43.4 mt -63.28 -57.16 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.305 -0.872 . . . . 0.0 110.304 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.8 p30 -63.3 -30.43 71.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.193 -0.942 . . . . 0.0 110.167 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.446 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 72.35 68.65 1.55 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.421 ' OD1' ' HG2' ' A' ' 135' ' ' GLN . 2.9 p30 -116.42 -25.98 7.29 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.21 -1.171 . . . . 0.0 110.538 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 137.83 -6.42 3.48 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.28 179.822 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.439 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 2.6 pt20 -150.63 160.46 43.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.988 -1.301 . . . . 0.0 110.324 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 66.4 t -105.61 137.61 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 109.995 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.4 ' ND2' ' HB2' ' A' ' 139' ' ' GLU . 6.7 p-10 -108.12 -170.26 1.65 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.056 -1.028 . . . . 0.0 110.279 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.583 ' CE1' HG21 ' A' ' 142' ' ' VAL . 11.2 t80 -66.56 -62.66 1.34 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.355 -0.841 . . . . 0.0 111.201 -179.063 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.4 ' HB2' ' ND2' ' A' ' 137' ' ' ASN . 32.8 mt-10 -44.9 -48.81 11.22 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.195 -0.941 . . . . 0.0 111.614 -179.106 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -58.84 -47.62 84.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.031 -1.043 . . . . 0.0 110.796 -179.174 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -64.58 -23.18 67.18 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 110.643 -179.698 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.583 HG21 ' CE1' ' A' ' 138' ' ' TYR . 76.5 t -90.63 -20.25 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.19 -0.944 . . . . 0.0 111.146 -179.533 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -89.36 -24.77 21.88 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.114 -0.991 . . . . 0.0 110.899 -179.105 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.467 ' SD ' ' HB2' ' A' ' 128' ' ' ALA . 20.4 ptt? -88.86 -31.81 18.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.021 -1.049 . . . . 0.0 110.442 -179.932 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.432 ' N ' ' HG3' ' A' ' 144' ' ' MET . 18.8 tpp -86.48 -9.49 56.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.215 -0.928 . . . . 0.0 110.3 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 142' ' ' VAL . 12.0 t -95.75 6.7 48.27 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.16 -0.962 . . . . 0.0 110.681 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -143.85 153.75 42.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.128 -0.982 . . . . 0.0 110.288 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.7 mttp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.31 -179.952 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . 0.642 'CA ' ' OD2' ' A' ' 24' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' WW7 . . . . . 0.896 ' C6 ' HG21 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' WW7 . . . . . 0.936 'CL1 ' HD13 ' A' ' 125' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.228 0.537 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.8 74.32 1.19 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.243 -0.911 . . . . 0.0 110.131 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -151.52 122.78 7.75 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.323 -0.861 . . . . 0.0 110.297 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 pp -72.94 -171.36 0.86 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.016 -1.053 . . . . 0.0 109.416 179.336 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.8 t -140.73 150.56 43.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.081 -1.012 . . . . 0.0 110.637 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -86.9 -11.98 49.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.445 -0.784 . . . . 0.0 109.896 179.301 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.66 -36.24 34.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.167 -0.958 . . . . 0.0 109.912 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.82 -47.19 86.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -0.86 . . . . 0.0 109.706 179.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.5 mm -61.24 -39.38 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.517 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.29 -33.65 75.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.411 -0.806 . . . . 0.0 109.869 179.469 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.26 -53.08 54.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.673 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -53.1 -36.69 60.99 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.132 -0.98 . . . . 0.0 109.172 179.224 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -65.63 -37.45 86.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.546 -0.721 . . . . 0.0 109.651 179.266 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -57.23 -47.12 82.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.459 -0.776 . . . . 0.0 109.967 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.18 -54.58 44.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.145 -0.972 . . . . 0.0 110.22 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -47.01 -48.53 21.85 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.241 -0.912 . . . . 0.0 110.331 179.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.7 m -60.71 -37.77 82.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.421 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.87 ' O ' HD23 ' A' ' 18' ' ' LEU . 6.8 tt -65.16 -22.74 66.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 110.026 -179.861 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.494 ' CE2' ' H3 ' ' A' ' 153' ' ' WW7 . 10.0 m-85 -90.72 -69.32 0.74 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.308 -0.87 . . . . 0.0 110.028 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -56.69 120.48 7.88 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.117 -0.989 . . . . 0.0 109.585 179.716 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.6 mttt -110.33 -29.76 7.99 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.034 -1.041 . . . . 0.0 111.844 -178.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.436 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 10.4 p-10 -68.61 -44.91 73.28 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.801 -1.187 . . . . 0.0 110.144 -179.416 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.42 27.04 3.75 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.798 -1.192 . . . . 0.0 110.613 178.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.436 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 8.3 p-10 -95.69 -43.62 7.82 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.989 -1.3 . . . . 0.0 110.27 179.57 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.26 31.14 2.91 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.39 179.351 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.0 p -146.89 135.25 21.8 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.952 -1.323 . . . . 0.0 110.098 179.466 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 80.4 mt -106.53 98.91 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.345 -0.847 . . . . 0.0 110.034 179.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.802 HG23 HG22 ' A' ' 62' ' ' THR . 1.0 OUTLIER -81.83 -164.78 0.84 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.883 . . . . 0.0 110.064 -179.925 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.628 ' H ' HG22 ' A' ' 28' ' ' THR . 5.1 p -83.76 -41.57 17.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.102 -0.999 . . . . 0.0 110.586 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.515 ' HG3' ' N ' ' A' ' 31' ' ' GLU . 6.3 ptpt -69.68 -41.63 75.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.937 -1.102 . . . . 0.0 109.414 179.664 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.515 ' N ' ' HG3' ' A' ' 30' ' ' LYS . 60.1 mt-10 -61.78 -45.0 95.77 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.143 -0.973 . . . . 0.0 108.717 178.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.831 HD23 HD11 ' A' ' 48' ' ' LEU . 2.0 tp -64.21 -29.21 70.33 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.096 -0.641 . . . . 0.0 109.294 179.219 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.96 -40.2 96.61 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 179.292 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.5 m -69.74 -41.99 74.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.489 -1.006 . . . . 0.0 109.948 179.427 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.0 t -57.93 -34.2 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.298 -0.876 . . . . 0.0 109.994 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.3 mmt -89.73 -18.41 26.44 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.358 -0.839 . . . . 0.0 109.815 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -88.29 -13.31 41.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.389 -0.82 . . . . 0.0 110.578 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.409 ' HB3' HD23 ' A' ' 39' ' ' LEU . 44.0 t -68.2 -12.91 61.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.954 -1.091 . . . . 0.0 109.946 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.446 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 0.7 OUTLIER -169.21 88.2 0.18 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.173 -0.954 . . . . 0.0 110.207 -179.987 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.75 -52.0 0.84 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 51.56 31.85 8.2 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.22 -1.165 . . . . 0.0 109.972 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.495 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -76.5 -55.4 1.64 Allowed Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.412 -0.805 . . . . 0.0 110.957 -179.768 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 42' ' ' ASN . 45.1 Cg_endo -73.99 135.23 20.83 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.77 1.405 . . . . 0.0 110.534 -179.611 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.451 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 29.1 p -102.25 -130.75 0.26 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.308 -0.87 . . . . 0.0 109.569 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -100.88 -33.89 10.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.804 -1.185 . . . . 0.0 109.95 179.649 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.65 -66.23 0.77 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.337 -0.852 . . . . 0.0 110.077 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -51.21 -32.0 22.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 109.659 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.831 HD11 HD23 ' A' ' 32' ' ' LEU . 9.4 tt -64.26 -53.1 54.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.322 -0.861 . . . . 0.0 109.988 179.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -51.39 -39.0 56.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 109.827 179.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -66.03 -37.04 84.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.243 -0.911 . . . . 0.0 109.639 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.411 ' HG2' ' H6 ' ' A' ' 153' ' ' WW7 . 10.9 ttp -69.85 -20.08 63.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.323 -0.861 . . . . 0.0 109.735 179.57 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.83 HD11 HD22 ' A' ' 32' ' ' LEU . 32.7 mm -86.6 -24.65 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.391 -0.818 . . . . 0.0 109.899 179.644 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -70.58 -37.36 73.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.259 -0.901 . . . . 0.0 110.259 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.82 -19.36 48.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 110.485 -179.761 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.561 ' CG1' HD11 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -99.76 -14.09 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.098 -1.001 . . . . 0.0 110.11 -179.615 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 2.8 t70 -84.3 128.06 34.35 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.179 -0.951 . . . . 0.0 110.203 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -96.58 -12.86 23.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.202 -0.936 . . . . 0.0 110.402 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.402 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 61.1 m-20 -97.5 -73.46 0.61 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.124 -0.985 . . . . 0.0 110.486 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.429 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 134.94 41.49 0.14 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 62' ' ' THR . 16.6 p30 -116.02 -16.68 11.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.339 -1.094 . . . . 0.0 110.293 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.663 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 106.87 -40.99 2.3 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.802 HG22 HG23 ' A' ' 28' ' ' THR . 69.1 p -98.54 162.45 13.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.147 -1.207 . . . . 0.0 110.517 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.561 HD11 ' CG1' ' A' ' 55' ' ' VAL . 70.0 mt -115.04 144.87 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.4 -0.813 . . . . 0.0 110.081 179.817 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -101.69 -165.28 1.18 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.988 -1.07 . . . . 0.0 110.137 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.543 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 27.2 t80 -77.52 -44.32 2.56 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 111.276 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.0 Cg_endo -74.25 -27.86 11.15 Favored 'Trans proline' 0 C--N 1.324 -0.761 0 O-C-N 123.112 1.059 . . . . 0.0 110.02 -179.627 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.402 ' OE1' ' OD2' ' A' ' 58' ' ' ASP . 45.9 tt0 -77.21 -22.98 51.49 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.356 -0.84 . . . . 0.0 109.236 179.253 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.435 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 14.2 t80 -77.9 -44.5 26.87 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.506 -0.746 . . . . 0.0 110.252 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.4 -26.51 61.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 110.32 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 88.2 m -80.9 -29.76 35.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 0.0 110.497 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.423 ' HG2' ' O ' ' A' ' 68' ' ' PHE . 6.7 ptt? -86.13 -24.6 26.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.036 -1.04 . . . . 0.0 110.386 -179.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.462 ' HE3' ' C2 ' ' A' ' 153' ' ' WW7 . 19.2 mmt -83.03 -27.53 30.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.281 -0.887 . . . . 0.0 110.403 -179.716 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.99 -42.81 10.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.917 . . . . 0.0 110.778 -179.51 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 -101.05 -25.36 14.08 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.241 -0.912 . . . . 0.0 110.656 -179.482 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt 49.19 83.34 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.115 -0.99 . . . . 0.0 110.282 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 89.9 mtp -72.28 160.21 32.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.259 -0.901 . . . . 0.0 110.169 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.07 156.72 44.72 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.084 -1.01 . . . . 0.0 110.201 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -169.06 126.13 0.95 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.185 -0.947 . . . . 0.0 110.463 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.11 131.87 52.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.317 -0.864 . . . . 0.0 109.77 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -144.7 -42.04 0.25 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.076 -1.015 . . . . 0.0 110.553 -179.635 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.1 m -160.07 136.46 8.86 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.148 -0.97 . . . . 0.0 110.14 -179.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.445 ' OE1' ' N ' ' A' ' 82' ' ' GLU . 0.4 OUTLIER -89.17 -171.66 3.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.239 -0.913 . . . . 0.0 110.164 179.955 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.41 ' HB3' ' OE1' ' A' ' 84' ' ' GLU . 5.1 tt0 -177.87 -51.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.245 -0.909 . . . . 0.0 110.449 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.41 ' OE1' ' HB3' ' A' ' 83' ' ' GLU . 0.4 OUTLIER -79.55 -35.35 40.0 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.111 -0.993 . . . . 0.0 110.473 179.955 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.857 HG23 ' CE1' ' A' ' 141' ' ' PHE . 54.8 mt -57.54 -52.45 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.181 -0.949 . . . . 0.0 110.526 -179.632 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.0 ttm-85 -56.87 -50.55 72.11 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.221 -0.924 . . . . 0.0 110.378 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -54.01 -36.56 63.12 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.223 -0.923 . . . . 0.0 110.412 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.561 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -61.28 -63.93 1.12 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.195 -0.94 . . . . 0.0 110.163 -179.697 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.502 ' CE1' HD11 ' A' ' 100' ' ' ILE . 1.1 t80 -45.76 -33.32 2.97 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.435 -0.79 . . . . 0.0 110.485 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.4 ttt85 -63.98 -45.86 87.15 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.31 -0.869 . . . . 0.0 110.77 -179.709 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 88' ' ' ALA . 32.4 m -84.47 -9.53 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.112 -0.992 . . . . 0.0 111.416 -179.296 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.712 ' HA ' HG21 ' A' ' 108' ' ' VAL . 21.9 m-85 -97.0 -14.04 21.91 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.955 -1.09 . . . . 0.0 110.772 -179.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -116.19 59.39 0.73 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.041 -1.037 . . . . 0.0 110.256 179.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 91' ' ' VAL . 19.4 mttt -94.91 20.09 9.35 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.228 -0.92 . . . . 0.0 110.559 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.456 ' OD2' ' CB ' ' A' ' 97' ' ' ASN . 9.6 p-10 -114.07 -28.39 7.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.183 -0.948 . . . . 0.0 110.398 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.89 -26.67 12.15 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.456 ' CB ' ' OD2' ' A' ' 95' ' ' ASP . 25.5 t-20 -44.79 -28.93 0.7 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.37 -1.076 . . . . 0.0 110.521 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 90.9 -42.6 2.87 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.45 ' CG ' ' OE1' ' A' ' 135' ' ' GLN . 12.1 m-30 -93.3 170.7 9.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.239 -1.153 . . . . 0.0 110.504 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.502 HD11 ' CE1' ' A' ' 89' ' ' PHE . 18.0 mt -104.18 119.71 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.301 -0.874 . . . . 0.0 109.432 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.4 t -102.65 174.89 5.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.232 -0.917 . . . . 0.0 109.855 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.7 -45.02 63.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.035 -1.041 . . . . 0.0 109.909 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.5 -45.57 91.33 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.253 -0.904 . . . . 0.0 110.056 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.647 ' O ' HG23 ' A' ' 108' ' ' VAL . 48.4 mt-10 -61.93 -48.3 81.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.175 179.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.581 HD22 HG13 ' A' ' 121' ' ' VAL . 6.8 tt -53.7 -31.77 49.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 0.0 110.164 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.0 ttt-85 -73.07 -41.33 64.23 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.21 -0.932 . . . . 0.0 110.08 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -73.07 -11.29 60.5 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.297 -0.877 . . . . 0.0 110.503 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.712 HG21 ' HA ' ' A' ' 92' ' ' PHE . 92.9 t -92.93 -49.69 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.236 -0.915 . . . . 0.0 110.062 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.2 mmt -50.29 -45.16 54.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.413 -0.804 . . . . 0.0 110.435 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.8 p -52.79 -44.87 66.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.304 -0.872 . . . . 0.0 110.377 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -63.6 -43.43 96.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.126 -0.984 . . . . 0.0 110.023 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 13.6 mt -55.34 -40.7 71.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 110.123 179.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 125.83 45.65 0.24 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.594 ' OE1' HD11 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -156.54 146.53 21.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.25 -1.147 . . . . 0.0 110.045 179.98 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.475 ' C ' HD12 ' A' ' 116' ' ' LEU . 24.6 tttt -123.25 138.07 54.72 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.192 -0.943 . . . . 0.0 110.284 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.916 HD23 ' OE1' ' A' ' 120' ' ' GLU . 4.7 mp -139.9 -163.66 1.55 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.26 -0.9 . . . . 0.0 110.145 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.422 HG22 ' N ' ' A' ' 118' ' ' ASP . 57.4 m -120.08 164.46 16.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.228 -0.92 . . . . 0.0 110.236 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.422 ' N ' HG22 ' A' ' 117' ' ' THR . 0.9 OUTLIER -58.4 -34.39 70.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.29 -0.881 . . . . 0.0 110.411 179.942 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -56.25 -61.16 2.59 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.302 -0.874 . . . . 0.0 110.758 -179.677 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.916 ' OE1' HD23 ' A' ' 116' ' ' LEU . 96.0 mt-10 -52.18 -55.1 23.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.073 -1.017 . . . . 0.0 110.433 -179.654 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.581 HG13 HD22 ' A' ' 105' ' ' LEU . 95.4 t -54.24 -27.91 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.277 -0.889 . . . . 0.0 110.752 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -75.4 -40.36 57.98 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.107 -0.996 . . . . 0.0 110.196 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -74.91 -18.07 60.47 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.197 -0.94 . . . . 0.0 109.688 179.51 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.418 ' HG3' ' O ' ' A' ' 120' ' ' GLU . 96.3 mtp -78.06 -50.28 12.37 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 109.949 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.71 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 29.1 mm -65.03 -39.86 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.361 -0.837 . . . . 0.0 110.165 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -61.43 -55.86 26.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 110.255 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -57.79 -37.92 74.58 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.255 -0.903 . . . . 0.0 110.534 -179.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.527 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -70.53 -24.41 62.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 110.167 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -69.18 92.18 0.54 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.307 -0.87 . . . . 0.0 110.21 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 66.1 mt -75.68 -48.51 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.285 -0.884 . . . . 0.0 110.169 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.2 p30 -64.26 -30.37 71.42 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.348 -0.845 . . . . 0.0 110.188 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 87.66 52.63 2.94 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.653 179.198 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -117.64 -32.86 4.73 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.954 -1.321 . . . . 0.0 109.923 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 118.95 24.2 3.1 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.45 ' O ' ' NE2' ' A' ' 135' ' ' GLN . 3.6 pp0? -159.61 149.02 18.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.203 -1.174 . . . . 0.0 110.143 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.69 HG21 'CL1 ' ' A' ' 154' ' ' WW7 . 45.4 t -109.0 125.95 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.244 -0.91 . . . . 0.0 110.721 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -97.51 -165.6 1.28 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.879 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.75 ' O ' HG23 ' A' ' 142' ' ' VAL . 47.9 t80 -68.06 -48.42 65.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.11 -0.994 . . . . 0.0 110.537 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -63.52 -45.55 90.09 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.121 -0.987 . . . . 0.0 110.602 -179.683 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.414 ' OE2' ' OD2' ' A' ' 131' ' ' ASP . 37.0 mt-10 -58.6 -38.34 77.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.261 -0.899 . . . . 0.0 110.501 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.857 ' CE1' HG23 ' A' ' 85' ' ' ILE . 6.5 t80 -72.39 -26.87 62.04 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.183 -0.948 . . . . 0.0 110.418 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 138' ' ' TYR . 87.6 t -76.66 -24.46 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.078 -1.014 . . . . 0.0 110.676 -179.423 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -87.39 -51.17 6.09 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.142 -0.974 . . . . 0.0 110.452 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.54 ' CE ' ' CD2' ' A' ' 141' ' ' PHE . 21.5 ptt? -56.41 -32.86 65.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.903 . . . . 0.0 110.701 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.506 ' HE3' ' CZ ' ' A' ' 141' ' ' PHE . 28.2 tpp -72.83 -54.24 9.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.15 -0.969 . . . . 0.0 110.538 -179.526 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 146' ' ' THR . 5.2 t -118.11 105.08 11.46 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.08 -1.013 . . . . 0.0 110.42 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.71 150.12 45.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.145 -0.972 . . . . 0.0 110.284 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.188 179.903 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' WW7 . . . . . 0.52 H161 ' C12' ' A' ' 153' ' ' WW7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' WW7 . . . . . 0.71 'CL1 ' HD13 ' A' ' 125' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.201 0.524 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -123.15 141.52 51.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.157 -0.964 . . . . 0.0 110.468 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -136.48 55.52 1.84 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.322 -0.862 . . . . 0.0 110.149 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.6 mt -91.01 104.12 16.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.233 -0.917 . . . . 0.0 110.517 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.422 ' O ' ' HG2' ' A' ' 8' ' ' GLN . 57.4 m -108.42 -69.72 0.84 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.29 -0.881 . . . . 0.0 109.607 179.47 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.424 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 52.2 mt-10 -90.46 -29.22 18.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.394 -0.816 . . . . 0.0 109.83 179.316 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -57.34 -48.74 78.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.199 -0.938 . . . . 0.0 110.028 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.483 ' HG3' ' N ' ' A' ' 9' ' ' ILE . 3.5 pt20 -52.03 -38.19 56.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.719 179.711 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.483 ' N ' ' HG3' ' A' ' 8' ' ' GLN . 34.6 mt -62.24 -44.47 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.328 -0.857 . . . . 0.0 109.516 179.41 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.61 -37.18 70.33 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.281 -0.887 . . . . 0.0 109.486 179.373 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -62.78 -45.42 92.73 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.325 -0.859 . . . . 0.0 109.499 179.391 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -61.36 -33.1 73.08 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.429 -0.794 . . . . 0.0 109.849 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt -61.57 -49.51 76.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -0.915 . . . . 0.0 109.583 179.62 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -57.69 -39.62 77.6 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.451 -0.781 . . . . 0.0 109.627 179.537 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.462 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -60.21 -43.25 96.14 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.257 -0.902 . . . . 0.0 109.794 179.676 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -59.32 -39.13 82.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.161 -0.962 . . . . 0.0 109.29 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.3 t -70.16 -25.4 63.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.822 . . . . 0.0 109.181 178.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.842 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.4 tm? -71.41 -29.12 64.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.471 -0.768 . . . . 0.0 109.551 179.45 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.516 ' CZ ' ' H3 ' ' A' ' 153' ' ' WW7 . 20.8 m-85 -87.54 -64.59 1.12 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.401 -0.812 . . . . 0.0 109.972 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -85.44 74.43 10.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.348 -0.845 . . . . 0.0 109.799 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.417 ' CE ' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -99.02 47.64 0.97 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.279 -0.888 . . . . 0.0 110.414 -179.641 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.403 ' OD1' ' OD2' ' A' ' 24' ' ' ASP . 4.1 p30 -127.91 -5.02 5.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.169 -0.957 . . . . 0.0 110.583 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.47 48.68 5.21 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.403 ' OD2' ' OD1' ' A' ' 22' ' ' ASP . 13.6 m-20 -117.9 -72.69 0.68 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -1.131 . . . . 0.0 110.26 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.21 -10.52 4.43 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.6 p -132.33 150.26 52.19 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.136 -1.214 . . . . 0.0 110.364 -179.827 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 70.8 mt -97.12 131.62 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.222 -0.923 . . . . 0.0 110.241 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.8 t -120.72 -174.07 2.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.344 -0.847 . . . . 0.0 110.18 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.7 p -75.27 -31.84 60.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.223 -0.923 . . . . 0.0 110.692 -179.68 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -65.8 -59.76 3.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.116 -0.99 . . . . 0.0 109.805 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -57.21 -56.27 23.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.388 -0.82 . . . . 0.0 109.484 179.526 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.963 HD22 HD11 ' A' ' 52' ' ' ILE . 10.9 tp -57.22 -22.56 41.82 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.231 -0.918 . . . . 0.0 109.297 179.085 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.85 -42.62 96.91 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.8 m -69.21 -25.16 64.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.512 -0.993 . . . . 0.0 109.712 179.287 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.515 HG21 ' HA ' ' A' ' 19' ' ' PHE . 37.3 t -76.74 -33.43 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.415 -0.803 . . . . 0.0 110.956 -179.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.7 tpp -90.07 -23.48 21.41 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.921 -1.112 . . . . 0.0 110.898 -179.318 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.7 ttm-85 -90.91 -32.55 15.96 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.09 -1.006 . . . . 0.0 110.629 -179.752 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 71.1 m -79.94 -21.71 43.52 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.116 -0.99 . . . . 0.0 110.404 -179.752 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 mp -135.35 80.12 1.82 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 110.438 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.89 -54.06 0.52 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 50.48 74.25 0.23 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.214 -1.168 . . . . 0.0 109.871 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.524 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 2.6 t30 -152.22 -66.27 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.222 -0.924 . . . . 0.0 110.376 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.524 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 43.7 Cg_endo -71.56 -160.75 0.09 OUTLIER 'Trans proline' 0 C--N 1.317 -1.086 0 O-C-N 123.241 1.127 . . . . 0.0 110.145 179.458 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 40.2 p -147.09 -178.46 6.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.205 -0.935 . . . . 0.0 109.85 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -65.47 -32.89 74.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 110.05 179.838 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.34 -62.68 1.29 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.124 -0.985 . . . . 0.0 109.537 179.448 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -51.85 -27.56 13.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.184 -0.947 . . . . 0.0 109.042 179.062 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.871 HD21 HD23 ' A' ' 32' ' ' LEU . 6.2 tt -68.88 -43.88 74.41 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.478 -0.764 . . . . 0.0 109.472 179.332 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -53.46 -42.77 67.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.38 -0.825 . . . . 0.0 109.021 179.104 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -65.47 -33.92 77.07 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.452 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 0.5 OUTLIER -68.45 -20.3 64.62 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.587 -0.696 . . . . 0.0 109.359 179.001 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.963 HD11 HD22 ' A' ' 32' ' ' LEU . 32.4 mm -87.09 -26.5 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.399 -0.813 . . . . 0.0 110.087 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -73.79 -30.47 62.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.0 110.537 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.659 ' HG3' HG23 ' A' ' 55' ' ' VAL . 8.4 pt-20 -71.64 -26.74 62.68 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.088 -1.008 . . . . 0.0 110.204 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.659 HG23 ' HG3' ' A' ' 54' ' ' GLU . 96.3 t -90.17 -30.46 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.163 -0.961 . . . . 0.0 109.717 179.608 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -76.48 115.92 16.68 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.438 -0.789 . . . . 0.0 110.206 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.69 18.88 21.46 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.256 -0.902 . . . . 0.0 110.239 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.433 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 61.6 m-20 -112.02 -65.72 1.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.354 -0.841 . . . . 0.0 109.968 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.16 -12.6 2.09 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -70.11 -36.7 75.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.971 -1.311 . . . . 0.0 110.534 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 119.73 -63.64 0.46 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 48.9 p -69.25 170.56 9.99 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.17 -1.194 . . . . 0.0 110.724 -179.437 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.602 HD13 HG11 ' A' ' 55' ' ' VAL . 89.1 mt -115.09 149.46 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.244 -0.91 . . . . 0.0 110.309 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.469 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 55.5 m-20 -98.37 -166.24 1.34 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 110.209 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.581 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 10.2 t80 -81.47 -38.26 0.93 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.162 -0.961 . . . . 0.0 112.118 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.6 Cg_endo -72.39 -25.9 17.77 Favored 'Trans proline' 0 C--O 1.209 -0.938 0 O-C-N 122.817 0.904 . . . . 0.0 111.269 -178.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.433 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 63.4 mt-10 -76.05 -33.61 59.61 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.827 -1.171 . . . . 0.0 109.524 179.421 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.479 ' CZ ' ' SD ' ' A' ' 72' ' ' MET . 12.6 t80 -75.38 -53.0 9.45 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.537 -0.727 . . . . 0.0 110.064 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.675 HD13 ' O ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -65.31 -20.83 66.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.509 -0.745 . . . . 0.0 110.408 -179.824 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.423 ' CB ' ' O ' ' A' ' 66' ' ' PRO . 50.6 m -91.38 -22.97 20.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.907 -1.12 . . . . 0.0 111.18 -179.595 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.634 ' SD ' HG13 ' A' ' 55' ' ' VAL . 60.0 ttp -86.99 -43.64 12.2 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.877 -1.139 . . . . 0.0 111.153 -179.241 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.479 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 43.2 mtt -82.84 -34.56 26.82 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.905 -1.122 . . . . 0.0 110.595 -179.473 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -69.0 -8.58 46.15 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.141 -0.975 . . . . 0.0 110.66 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.4 tpt85 -40.16 -36.9 0.55 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.551 -0.718 . . . . 0.0 110.77 -179.566 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -73.4 88.14 1.57 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.296 -0.877 . . . . 0.0 109.586 179.395 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 50.7 ttp -105.2 131.85 52.15 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.259 -0.901 . . . . 0.0 110.812 -179.243 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -141.29 112.92 7.64 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.291 -0.881 . . . . 0.0 109.682 179.424 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.435 ' O ' HG23 ' A' ' 79' ' ' THR . 27.1 m-20 -113.75 134.17 54.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.18 -0.95 . . . . 0.0 110.712 -179.459 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 78' ' ' ASP . 0.6 OUTLIER -155.58 153.38 30.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.425 -0.797 . . . . 0.0 109.894 179.593 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 51.5 p-10 -150.58 153.44 35.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.301 -0.874 . . . . 0.0 110.248 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.7 t -122.9 -55.23 1.8 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.336 -0.852 . . . . 0.0 109.852 179.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -96.88 88.26 4.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 109.855 179.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -159.12 77.52 0.73 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.169 -0.957 . . . . 0.0 110.345 -179.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -90.7 -24.49 20.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 110.142 179.831 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.4 mt -69.62 -40.68 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.367 -0.833 . . . . 0.0 110.309 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.6 ttp180 -67.96 -56.87 7.39 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.17 -0.957 . . . . 0.0 110.034 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -47.78 -47.81 30.55 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.256 -0.903 . . . . 0.0 110.111 179.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.718 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -54.82 -54.49 41.58 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.302 -0.874 . . . . 0.0 110.107 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -49.93 -28.7 7.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.291 -0.881 . . . . 0.0 110.259 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -71.97 -47.01 55.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.144 -0.973 . . . . 0.0 110.643 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 88' ' ' ALA . 35.9 m -70.9 -20.14 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.17 -0.956 . . . . 0.0 110.4 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.555 ' CE2' ' H2 ' ' A' ' 154' ' ' WW7 . 25.5 m-85 -95.35 -12.85 25.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.325 -0.859 . . . . 0.0 110.345 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -107.18 73.87 0.95 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.167 -0.958 . . . . 0.0 110.59 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -74.98 -36.46 62.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.171 -0.956 . . . . 0.0 109.995 179.639 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.8 p30 -74.54 -25.41 59.29 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.312 -0.867 . . . . 0.0 110.51 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 76.46 60.79 2.93 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.433 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 26.0 p-10 -124.33 -10.07 7.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.357 -1.084 . . . . 0.0 110.476 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.526 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 86.27 16.03 63.36 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.08 -1.057 . . . . 0.0 110.493 179.005 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.557 ' CD1' ' NE2' ' A' ' 135' ' ' GLN . 38.2 m-85 -142.1 138.31 31.6 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.188 -1.184 . . . . 0.0 110.26 179.875 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.43 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 25.6 mt -94.06 129.75 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.327 -0.858 . . . . 0.0 110.16 -179.748 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.7 t -114.91 166.09 12.16 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.285 -0.885 . . . . 0.0 109.977 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.46 -26.56 68.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.297 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.42 -69.83 0.27 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.282 -0.886 . . . . 0.0 110.266 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.483 ' O ' HG23 ' A' ' 108' ' ' VAL . 37.1 mt-10 -52.71 -38.78 61.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 110.212 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.625 HD22 HG13 ' A' ' 121' ' ' VAL . 4.0 tt -52.69 -46.21 67.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.094 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.785 ' O ' HG22 ' A' ' 110' ' ' THR . 2.6 ttm-85 -66.72 -37.85 85.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.362 -0.836 . . . . 0.0 110.045 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -61.4 -23.86 66.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.165 -0.959 . . . . 0.0 110.248 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 104' ' ' GLU . 50.0 t -87.28 -41.0 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.119 -0.988 . . . . 0.0 110.616 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.6 mmt -68.17 -57.79 5.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.137 -0.977 . . . . 0.0 110.521 -179.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.785 HG22 ' O ' ' A' ' 106' ' ' ARG . 9.8 t -50.13 -23.86 2.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.303 -0.873 . . . . 0.0 110.401 -179.772 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -79.43 -50.37 10.9 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.18 -0.95 . . . . 0.0 110.276 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.8 mt -60.75 -23.47 64.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.208 -0.933 . . . . 0.0 110.302 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.427 ' O ' ' HG2' ' A' ' 114' ' ' GLU . . . 102.88 90.97 2.17 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 1.3 mm-40 -155.3 -164.46 1.77 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.326 -1.102 . . . . 0.0 110.029 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.69 99.56 2.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.131 -0.981 . . . . 0.0 110.28 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.6 mp -137.52 135.62 36.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.326 -0.859 . . . . 0.0 110.204 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.608 HG22 ' OE2' ' A' ' 120' ' ' GLU . 13.1 t -75.78 172.18 13.09 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.228 -0.92 . . . . 0.0 109.949 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 53.7 m-20 -59.95 -41.58 92.17 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.241 -0.912 . . . . 0.0 110.299 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.456 ' OE1' ' N ' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -53.26 -47.72 68.88 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.164 -0.96 . . . . 0.0 110.811 -179.672 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.608 ' OE2' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -54.37 -56.22 20.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.99 -1.069 . . . . 0.0 110.897 -179.605 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.625 HG13 HD22 ' A' ' 105' ' ' LEU . 84.1 t -52.96 -44.74 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.913 -1.117 . . . . 0.0 110.675 -179.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 118' ' ' ASP . 1.5 m-20 -62.51 -30.8 71.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.145 -0.972 . . . . 0.0 110.611 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -72.48 -28.48 62.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.072 -1.018 . . . . 0.0 110.057 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.4 mtp -74.29 -45.77 45.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -0.874 . . . . 0.0 110.215 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.682 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 30.0 mm -64.65 -39.85 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.305 -0.872 . . . . 0.0 110.408 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.4 mtp180 -67.76 -51.0 54.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.158 -0.964 . . . . 0.0 110.115 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -55.41 -35.17 65.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.17 -0.956 . . . . 0.0 109.781 179.56 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -75.82 -28.72 58.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.361 -0.837 . . . . 0.0 109.812 179.685 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.401 ' OD2' ' HA2' ' A' ' 132' ' ' GLY . 16.0 t0 -71.92 91.93 1.23 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -0.871 . . . . 0.0 110.119 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 96.2 mt -73.14 -32.61 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.217 -0.927 . . . . 0.0 110.717 -179.615 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 23.4 p30 -99.59 -18.54 17.3 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.232 -0.918 . . . . 0.0 110.505 -179.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.467 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 77.0 72.11 1.14 Allowed Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.974 -1.108 . . . . 0.0 110.337 179.438 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.406 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 76.4 m-20 -113.93 6.1 16.44 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.072 -1.251 . . . . 0.0 110.118 179.175 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.32 16.3 69.45 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.557 ' NE2' ' CD1' ' A' ' 99' ' ' TYR . 11.2 pt20 -170.16 165.46 9.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.115 -1.226 . . . . 0.0 110.166 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.43 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 52.4 t -106.71 107.58 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.177 -0.952 . . . . 0.0 110.386 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -77.74 163.08 26.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.363 -0.836 . . . . 0.0 110.142 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.782 ' O ' HG23 ' A' ' 142' ' ' VAL . 33.0 t80 -51.47 -30.16 18.92 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.24 -0.913 . . . . 0.0 110.278 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -70.47 -59.29 2.93 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.2 -0.937 . . . . 0.0 110.474 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' A' ' 128' ' ' ALA . 56.3 mt-10 -54.16 -25.66 23.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 0.0 110.221 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.548 ' CZ ' ' HE2' ' A' ' 145' ' ' MET . 16.7 t80 -77.93 -35.39 50.54 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.312 -0.867 . . . . 0.0 110.137 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 138' ' ' TYR . 97.0 t -75.24 -22.83 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 110.364 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -83.31 -46.83 12.16 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.275 -0.89 . . . . 0.0 110.459 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.627 ' HE3' ' HG2' ' A' ' 145' ' ' MET . 0.2 OUTLIER -70.3 -13.22 62.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.027 -1.046 . . . . 0.0 110.293 -179.788 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.921 ' HE3' ' HN1' ' A' ' 154' ' ' WW7 . 13.4 mmt -89.28 -61.01 1.8 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.285 -0.884 . . . . 0.0 109.994 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.478 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 9.5 t -111.33 -17.16 13.21 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.188 -0.945 . . . . 0.0 110.105 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 146' ' ' THR . . . 58.01 108.7 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.324 -0.86 . . . . 0.0 110.273 179.821 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.9 tptt . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.2 179.974 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' WW7 . . . . . 0.516 ' H3 ' ' CZ ' ' A' ' 19' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' WW7 . . . . . 0.921 ' HN1' ' HE3' ' A' ' 145' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.293 0.568 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -77.65 130.54 36.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.258 -0.901 . . . . 0.0 110.168 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.449 ' O ' ' NE2' ' A' ' 3' ' ' GLN . 1.0 OUTLIER -168.42 76.75 0.13 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.276 -0.89 . . . . 0.0 110.121 179.955 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.6 mt -105.26 177.36 4.87 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.312 -0.868 . . . . 0.0 110.203 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.5 t -109.4 -30.39 7.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 109.796 179.69 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -78.49 -28.21 46.31 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.222 -0.924 . . . . 0.0 109.719 179.378 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -76.78 -32.11 57.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.846 . . . . 0.0 109.728 179.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -65.38 -49.71 68.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.426 -0.796 . . . . 0.0 110.03 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.7 mt -68.48 -45.98 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.203 -0.936 . . . . 0.0 109.584 179.508 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 13' ' ' LYS . . . -59.32 -25.69 64.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.374 -0.828 . . . . 0.0 109.48 179.36 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.432 ' HA ' ' OE1' ' A' ' 11' ' ' GLU . 5.3 tp10 -69.59 -50.23 46.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.309 -0.87 . . . . 0.0 109.071 179.323 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -67.11 -17.24 64.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.368 -0.832 . . . . 0.0 109.58 179.075 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 25.6 mtpt -76.59 -49.49 16.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.153 -0.967 . . . . 0.0 109.796 179.596 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.9 -41.95 88.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.187 -0.946 . . . . 0.0 109.791 179.378 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.08 -49.99 67.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 109.791 179.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.454 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 40.3 t80 -54.68 -28.45 47.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.921 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.0 m -80.8 -32.73 35.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.342 -0.849 . . . . 0.0 109.497 179.63 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.636 ' O ' HD23 ' A' ' 18' ' ' LEU . 3.2 tt -69.57 -18.03 63.6 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.42 -0.8 . . . . 0.0 109.646 179.483 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.538 ' CE2' ' H3 ' ' A' ' 153' ' ' WW7 . 5.1 m-30 -96.7 -45.14 6.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.421 -0.799 . . . . 0.0 109.953 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.623 ' OD1' 'CA ' ' A' ' 149' ' ' ' CA' . 24.8 t0 -78.86 104.63 9.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.386 -0.821 . . . . 0.0 110.313 -179.741 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.425 ' HE2' ' O ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -110.4 64.68 0.61 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.161 -0.962 . . . . 0.0 110.837 -179.688 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.405 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 13.7 p-10 -170.89 -36.82 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.033 -1.042 . . . . 0.0 110.612 179.771 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.57 100.31 2.45 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 -179.293 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 24.7 p-10 -176.97 -29.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.242 -1.152 . . . . 0.0 111.014 -179.619 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.812 ' O ' HG23 ' A' ' 26' ' ' THR . . . 88.21 52.83 2.79 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.812 HG23 ' O ' ' A' ' 25' ' ' GLY . 0.3 OUTLIER -169.93 150.36 3.85 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.185 -1.186 . . . . 0.0 110.314 179.817 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.2 109.09 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.34 -0.85 . . . . 0.0 110.364 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.556 ' HA ' HG22 ' A' ' 62' ' ' THR . 65.6 p -93.24 -167.15 1.66 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.26 -0.9 . . . . 0.0 110.115 179.807 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.559 HG22 HD12 ' A' ' 52' ' ' ILE . 9.3 p -84.67 -20.7 30.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.23 -0.919 . . . . 0.0 110.207 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -72.69 -60.26 2.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.237 -0.914 . . . . 0.0 109.94 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.411 ' OE1' ' HA ' ' A' ' 20' ' ' ASP . 93.1 mt-10 -56.57 -49.29 75.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 109.624 179.5 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.445 ' O ' ' HB ' ' A' ' 35' ' ' VAL . 3.6 tp -60.73 -31.94 71.23 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.292 -0.88 . . . . 0.0 109.265 179.293 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.8 -42.33 94.46 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.709 -1.757 . . . . 0.0 108.709 179.298 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 66.9 m -71.58 -24.78 61.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -1.113 . . . . 0.0 109.477 179.311 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 32' ' ' LEU . 51.1 t -70.96 -34.84 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.413 -0.805 . . . . 0.0 110.279 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 21.9 mmt -90.76 -23.14 20.74 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.214 -0.929 . . . . 0.0 110.439 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.408 ' NH2' ' HG2' ' A' ' 37' ' ' ARG . 6.7 ttp85 -80.49 -31.8 37.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 110.238 -179.771 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.2 m -92.38 -31.98 15.13 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.148 -0.97 . . . . 0.0 110.569 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.436 ' CG ' ' O ' ' A' ' 35' ' ' VAL . 66.9 mt -86.08 -71.98 0.52 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.141 -0.975 . . . . 0.0 110.496 -179.754 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -118.77 88.74 0.45 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -62.49 123.01 17.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.284 -1.127 . . . . 0.0 110.036 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.503 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.9 OUTLIER 179.47 -59.31 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.175 -0.953 . . . . 0.0 110.305 -179.906 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 42' ' ' ASN . 42.2 Cg_endo -68.41 158.43 57.65 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.593 1.312 . . . . 0.0 110.69 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 71.7 p -107.8 -138.21 0.37 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.368 -0.832 . . . . 0.0 109.619 179.826 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -99.16 -40.33 8.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.93 -1.106 . . . . 0.0 109.82 179.589 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.01 -59.42 2.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.306 -0.872 . . . . 0.0 109.915 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 37.2 tt0 -54.9 -30.59 58.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 109.792 179.587 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' A' ' 44' ' ' THR . 7.5 tt -64.17 -52.6 58.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.358 -0.839 . . . . 0.0 109.775 179.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -52.92 -35.54 58.54 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.269 -0.894 . . . . 0.0 109.053 179.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 8.5 t70 -61.64 -41.76 97.94 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.383 -0.823 . . . . 0.0 109.524 179.297 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.432 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 32.1 ttp -68.18 -19.77 64.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.383 -0.823 . . . . 0.0 109.565 179.538 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.559 HD12 HG22 ' A' ' 29' ' ' THR . 22.9 mt -83.57 -24.95 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.238 -0.914 . . . . 0.0 110.077 179.59 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -65.65 -46.18 80.15 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.162 -0.961 . . . . 0.0 110.07 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.59 ' HG3' HG23 ' A' ' 55' ' ' VAL . 21.3 pt-20 -59.45 -31.38 69.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.174 -0.954 . . . . 0.0 109.683 179.637 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.888 HG13 ' HE2' ' A' ' 71' ' ' MET . 75.8 t -87.0 -16.96 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.394 -0.816 . . . . 0.0 110.004 179.536 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.43 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 6.6 t0 -110.5 87.99 2.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.284 -0.885 . . . . 0.0 110.091 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.24 -12.65 61.85 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.253 -0.904 . . . . 0.0 110.752 -179.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -72.2 -59.3 2.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.14 -0.975 . . . . 0.0 110.439 -179.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.9 -1.35 21.35 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.349 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 20.2 p30 -69.96 -31.09 68.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.148 -1.207 . . . . 0.0 110.116 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.456 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 120.86 -59.8 0.55 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.556 HG22 ' HA ' ' A' ' 28' ' ' THR . 50.1 p -91.15 166.37 13.0 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.18 -1.188 . . . . 0.0 110.756 -179.447 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.8 mt -102.95 137.34 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.384 -0.822 . . . . 0.0 110.132 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.432 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 51.1 m-20 -92.62 178.44 5.8 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.273 -0.892 . . . . 0.0 110.305 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.584 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 25.2 t80 -71.66 -44.27 12.15 Favored Pre-proline 0 N--CA 1.486 1.357 0 O-C-N 121.166 -0.959 . . . . 0.0 111.069 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.3 Cg_endo -71.35 -21.6 26.29 Favored 'Trans proline' 0 C--N 1.324 -0.763 0 O-C-N 123.109 1.057 . . . . 0.0 109.874 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.43 ' OE2' ' HA ' ' A' ' 56' ' ' ASP . 84.7 tt0 -83.73 -30.51 26.65 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.38 -0.825 . . . . 0.0 109.265 178.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.454 ' CE2' ' HB2' ' A' ' 16' ' ' PHE . 43.2 t80 -70.81 -47.06 61.48 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.534 -0.729 . . . . 0.0 109.853 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.68 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 4.9 tt -74.28 -27.99 60.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.329 -0.857 . . . . 0.0 109.874 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.508 ' HA ' ' HB2' ' A' ' 74' ' ' ARG . 18.2 m -80.52 -16.67 53.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.224 -0.923 . . . . 0.0 110.142 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.888 ' HE2' HG13 ' A' ' 55' ' ' VAL . 14.3 tmm? -88.36 -46.8 8.87 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.304 -0.872 . . . . 0.0 110.856 -179.523 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.412 ' HE3' ' HE3' ' A' ' 71' ' ' MET . 58.0 mtt -90.85 -59.49 2.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.01 -1.056 . . . . 0.0 111.275 -179.219 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 69' ' ' LEU . . . -57.34 -50.99 71.17 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.258 -0.901 . . . . 0.0 111.121 -178.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.508 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 0.7 OUTLIER -60.62 -69.3 0.23 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.154 -0.966 . . . . 0.0 110.816 -179.178 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 74' ' ' ARG . 6.6 tptp 55.32 102.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.319 -0.863 . . . . 0.0 110.289 -179.426 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -90.18 -165.31 1.32 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.291 -0.881 . . . . 0.0 110.221 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.9 pttt -141.08 156.12 46.04 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -0.834 . . . . 0.0 109.948 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -123.6 171.34 9.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.934 . . . . 0.0 110.482 -179.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.55 HG23 ' OD1' ' A' ' 80' ' ' ASP . 5.5 t -118.54 -16.83 9.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.307 -0.87 . . . . 0.0 110.348 -179.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.55 ' OD1' HG23 ' A' ' 79' ' ' THR . 31.3 m-20 -81.2 125.58 30.46 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.155 -0.966 . . . . 0.0 110.288 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' A' ' 82' ' ' GLU . 64.1 m -111.65 -38.09 5.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.2 -0.938 . . . . 0.0 110.21 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 81' ' ' SER . 28.7 tt0 59.81 167.71 0.07 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.288 -0.882 . . . . 0.0 110.181 -179.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -99.91 39.54 1.32 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.268 -0.895 . . . . 0.0 110.493 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -80.53 -47.13 14.69 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.208 -0.932 . . . . 0.0 109.809 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.699 HG21 HG22 ' A' ' 142' ' ' VAL . 17.0 mt -52.13 -22.91 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.312 -0.868 . . . . 0.0 109.732 179.603 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.9 ttm-85 -69.09 -51.26 40.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.318 -0.864 . . . . 0.0 109.827 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -55.42 -43.03 74.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.067 -1.02 . . . . 0.0 109.764 179.528 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.747 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -58.04 -56.08 26.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.894 . . . . 0.0 109.978 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -48.91 -30.85 6.38 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.19 -0.944 . . . . 0.0 110.586 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.6 ttp85 -70.33 -48.77 55.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.22 -0.925 . . . . 0.0 111.15 -179.362 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.747 HG22 ' O ' ' A' ' 88' ' ' ALA . 27.5 m -64.78 -26.99 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.808 -1.183 . . . . 0.0 110.521 -179.54 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.679 ' HA ' HG21 ' A' ' 108' ' ' VAL . 38.6 m-85 -88.27 -14.95 37.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.256 -0.903 . . . . 0.0 110.24 179.687 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.25 77.16 1.77 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.0 109.893 179.512 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -94.56 -21.9 18.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.268 -0.895 . . . . 0.0 110.707 -179.477 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 2.0 p30 -71.11 -14.52 62.33 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.132 -0.98 . . . . 0.0 110.775 -179.297 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.86 30.36 23.71 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.598 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.456 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 1.7 t-20 -76.0 -78.12 0.12 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.246 -1.15 . . . . 0.0 109.939 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 145.28 -16.61 1.89 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.521 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -133.57 155.29 49.89 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.228 -1.16 . . . . 0.0 109.577 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.432 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 18.5 mt -94.74 118.6 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 120.988 -1.07 . . . . 0.0 109.541 179.784 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.8 m -102.37 168.8 9.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 110.128 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.28 -44.98 89.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.177 -0.952 . . . . 0.0 110.178 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.4 -58.15 9.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.125 -0.984 . . . . 0.0 110.011 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -49.88 -50.17 46.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.17 -0.956 . . . . 0.0 109.946 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -48.89 -40.31 29.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.44 -0.787 . . . . 0.0 110.151 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.1 tpt85 -64.02 -42.7 97.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.241 -0.912 . . . . 0.0 109.839 179.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -59.84 -27.05 66.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.301 -0.874 . . . . 0.0 110.209 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.679 HG21 ' HA ' ' A' ' 92' ' ' PHE . 92.4 t -84.35 -68.46 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.319 -0.863 . . . . 0.0 110.999 -179.275 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.405 ' HB3' HD13 ' A' ' 116' ' ' LEU . 20.2 mmt -50.19 -27.88 6.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.235 -0.916 . . . . 0.0 110.681 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.7 m -75.51 -42.22 53.28 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.238 -0.914 . . . . 0.0 110.653 -179.734 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -87.76 -2.15 58.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.153 -0.967 . . . . 0.0 110.775 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.642 HD12 HG12 ' A' ' 108' ' ' VAL . 14.2 mt -88.57 -68.7 0.75 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.964 -1.085 . . . . 0.0 110.176 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 166.6 37.94 0.02 OUTLIER Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -135.43 154.45 51.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.264 -1.139 . . . . 0.0 110.263 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -120.52 99.48 6.58 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.32 -0.863 . . . . 0.0 110.21 179.759 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 116' ' ' LEU . 4.8 mp -110.3 -166.77 1.12 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.167 -0.958 . . . . 0.0 110.423 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.501 HG22 ' HG3' ' A' ' 120' ' ' GLU . 12.1 t -135.19 -164.74 1.57 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.371 -0.831 . . . . 0.0 109.632 179.668 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 118' ' ' ASP . 1.2 m-20 -81.08 -45.74 16.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.022 -1.048 . . . . 0.0 110.653 -179.704 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -58.7 -39.52 81.0 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.417 -0.802 . . . . 0.0 110.819 -179.605 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.501 ' HG3' HG22 ' A' ' 117' ' ' THR . 43.7 mt-10 -62.63 -49.89 73.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.117 -0.99 . . . . 0.0 110.766 -179.704 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 76.0 t -58.63 -37.4 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.101 -0.999 . . . . 0.0 110.43 -179.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -64.81 -47.77 76.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.141 -0.974 . . . . 0.0 110.294 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.414 ' HG2' ' OE2' ' A' ' 127' ' ' GLU . 6.4 tm-20 -66.3 -21.86 66.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.229 -0.919 . . . . 0.0 109.843 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 28.8 mmm -73.88 -56.5 4.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.389 -0.819 . . . . 0.0 110.231 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.697 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 22.3 mm -66.72 -25.42 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.296 -0.878 . . . . 0.0 110.344 -179.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -72.66 -57.98 3.71 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.194 -0.941 . . . . 0.0 110.225 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.445 ' CA ' ' OE1' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -63.05 -19.22 64.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 110.069 179.908 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.505 ' HB2' ' H6 ' ' A' ' 154' ' ' WW7 . . . -82.79 -34.2 27.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.256 -0.902 . . . . 0.0 110.013 179.674 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.87 90.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 110.114 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.673 HD12 ' HA ' ' A' ' 140' ' ' GLU . 92.5 mt -61.25 -18.9 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.895 . . . . 0.0 110.335 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.4 p30 -114.45 -30.34 6.58 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.217 -0.927 . . . . 0.0 110.195 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.458 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 89.39 80.62 1.32 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.432 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 33.0 p30 -139.1 13.76 2.63 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.334 -1.098 . . . . 0.0 110.565 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.25 24.6 76.13 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.159 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.432 ' HG3' ' OD1' ' A' ' 133' ' ' ASP . 0.3 OUTLIER -170.5 143.66 2.29 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.137 -1.214 . . . . 0.0 110.268 179.639 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.432 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 91.7 t -93.73 129.24 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 110.453 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -88.43 174.53 8.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.423 -0.798 . . . . 0.0 110.23 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.453 ' CD1' ' C ' ' A' ' 138' ' ' TYR . 8.0 t80 -68.03 -51.72 43.67 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.281 -0.887 . . . . 0.0 109.456 179.302 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -62.31 -40.99 98.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.331 -0.856 . . . . 0.0 109.789 179.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.673 ' HA ' HD12 ' A' ' 130' ' ' ILE . 31.5 mt-10 -65.25 -29.72 70.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 109.981 179.585 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.468 ' CD1' ' CE ' ' A' ' 144' ' ' MET . 78.6 t80 -74.12 -28.21 61.24 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.271 -0.893 . . . . 0.0 110.128 -179.827 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.699 HG22 HG21 ' A' ' 85' ' ' ILE . 60.3 t -88.46 -20.78 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.245 -0.909 . . . . 0.0 110.446 179.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -98.2 -17.35 19.04 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.356 -0.84 . . . . 0.0 110.904 -179.416 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.472 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 15.0 ptt? -81.32 -27.71 34.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.045 -1.034 . . . . 0.0 110.357 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.414 ' N ' ' HG3' ' A' ' 144' ' ' MET . 4.7 tpp -89.58 -68.56 0.77 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.9 . . . . 0.0 109.919 179.861 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 67.9 p -73.24 103.43 3.95 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.211 -0.931 . . . . 0.0 110.126 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -111.75 144.38 41.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 0.0 110.363 -179.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.218 179.971 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . 0.623 'CA ' ' OD1' ' A' ' 20' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' WW7 . . . . . 0.538 ' H3 ' ' CE2' ' A' ' 19' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' WW7 . . . . . 0.697 'CL1 ' HD13 ' A' ' 125' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.29 0.566 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -115.15 -161.76 0.79 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.161 -0.962 . . . . 0.0 109.95 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -138.34 -168.13 2.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.068 -1.02 . . . . 0.0 110.36 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.2 mt -94.95 -154.32 0.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.438 -0.788 . . . . 0.0 109.999 179.948 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.7 m -163.63 -63.17 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.319 -0.863 . . . . 0.0 110.014 179.948 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.0 -38.33 85.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.437 -0.789 . . . . 0.0 110.489 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -58.75 -44.0 90.44 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.192 -0.942 . . . . 0.0 110.789 -179.649 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -59.63 -48.0 83.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.077 -1.014 . . . . 0.0 109.986 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 61.8 mt -59.9 -30.07 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.155 -0.966 . . . . 0.0 109.665 179.545 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.97 -30.02 67.26 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.273 -0.892 . . . . 0.0 109.705 179.88 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 65.9 tt0 -69.77 -58.15 4.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.42 -0.8 . . . . 0.0 109.997 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -59.01 -36.26 74.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.175 -0.953 . . . . 0.0 109.439 179.426 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 9.6 tmtt? -65.36 -33.86 76.95 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.507 -0.746 . . . . 0.0 109.609 179.619 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 14.2 mm-40 -63.56 -42.67 98.33 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.358 -0.839 . . . . 0.0 109.634 179.421 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.432 ' HB1' ' CZ ' ' A' ' 19' ' ' PHE . . . -59.86 -48.22 82.58 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.329 -0.857 . . . . 0.0 110.041 179.695 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -55.43 -54.29 45.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.287 -0.883 . . . . 0.0 110.188 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.1 m -58.7 -27.75 65.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.154 -0.966 . . . . 0.0 109.827 179.653 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.753 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.4 tt -71.06 -32.23 68.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.441 -0.787 . . . . 0.0 110.05 -179.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.559 ' CD2' ' H3 ' ' A' ' 153' ' ' WW7 . 6.1 m-85 -84.31 -62.82 1.46 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.264 -0.897 . . . . 0.0 110.889 -179.184 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -82.12 85.1 6.83 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.226 -0.921 . . . . 0.0 110.625 -179.329 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' HD3' ' O ' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -106.48 52.74 0.71 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.141 -0.974 . . . . 0.0 109.972 179.375 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 1.7 p30 -137.08 -35.41 0.7 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.21 -0.931 . . . . 0.0 110.695 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 113.09 39.83 1.11 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.835 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -101.61 -33.0 10.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.357 -1.084 . . . . 0.0 110.032 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.58 -15.14 63.15 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.8 p -139.97 160.66 39.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.972 -1.31 . . . . 0.0 110.502 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.8 mt -103.17 111.99 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.362 -0.836 . . . . 0.0 109.983 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.581 HG22 ' CG2' ' A' ' 62' ' ' THR . 49.8 p -101.93 -164.9 1.14 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.211 -0.93 . . . . 0.0 110.263 -179.934 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.517 ' HA ' HD21 ' A' ' 48' ' ' LEU . 42.4 p -78.11 -36.58 47.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.221 -0.924 . . . . 0.0 110.243 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.5 mttm -68.58 -56.62 7.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 0.0 109.706 179.592 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.652 ' O ' HG22 ' A' ' 34' ' ' THR . 98.9 mt-10 -58.1 -40.9 82.32 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.284 -0.885 . . . . 0.0 109.626 179.413 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.716 HD23 ' CG ' ' A' ' 48' ' ' LEU . 7.0 tp -66.81 -26.76 67.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.26 -0.9 . . . . 0.0 109.401 179.186 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.0 -43.99 95.09 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.662 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.652 HG22 ' O ' ' A' ' 31' ' ' GLU . 7.0 t -75.41 -21.6 58.08 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.058 -1.26 . . . . 0.0 110.123 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.5 t -78.21 -29.81 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.2 -0.938 . . . . 0.0 109.972 179.535 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.8 mmt -90.17 -28.0 19.21 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.185 -0.947 . . . . 0.0 110.288 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.4 mtm180 -89.61 -17.51 28.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.234 -0.916 . . . . 0.0 110.447 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 34' ' ' THR . 29.7 t -49.6 -52.86 27.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.17 -0.957 . . . . 0.0 110.249 -179.766 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.26 61.32 1.53 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 110.214 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 41' ' ' GLN . . . -171.58 -62.57 0.04 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.416 ' HB2' ' O ' ' A' ' 40' ' ' GLY . 25.6 mt-30 54.81 102.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.232 -1.158 . . . . 0.0 110.115 -179.808 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.509 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 1.8 t30 -164.84 -63.03 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.343 -0.848 . . . . 0.0 110.077 179.839 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.509 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 45.2 Cg_endo -71.12 171.49 15.84 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.392 1.206 . . . . 0.0 109.9 179.608 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.432 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 81.1 p -120.27 -170.74 2.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.141 -0.974 . . . . 0.0 109.94 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -74.55 -29.03 61.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.127 -0.983 . . . . 0.0 110.197 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.07 -57.22 4.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.201 -0.937 . . . . 0.0 109.827 179.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -62.08 -24.72 67.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 0.0 109.889 179.616 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.716 ' CG ' HD23 ' A' ' 32' ' ' LEU . 4.8 tt -70.23 -52.99 18.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.312 -0.867 . . . . 0.0 109.677 179.506 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.467 ' N ' HD23 ' A' ' 48' ' ' LEU . 51.3 tt0 -54.33 -37.61 65.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.182 -0.949 . . . . 0.0 109.449 179.271 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -68.79 -35.55 77.17 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.356 -0.84 . . . . 0.0 109.296 179.386 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.442 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 54.5 ttp -68.51 -17.45 64.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.326 -0.859 . . . . 0.0 109.675 179.417 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.619 HD11 HD22 ' A' ' 32' ' ' LEU . 13.8 mt -88.25 -37.88 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.888 . . . . 0.0 109.769 179.43 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -53.49 -35.61 60.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.912 . . . . 0.0 110.022 179.603 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.483 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 7.4 pt-20 -71.22 -32.56 68.95 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.355 -0.841 . . . . 0.0 110.273 -179.824 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.73 HG13 ' SD ' ' A' ' 71' ' ' MET . 71.5 t -76.38 -67.94 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.121 -0.987 . . . . 0.0 109.588 179.544 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.698 ' OD1' 'CA ' ' A' ' 150' ' ' ' CA' . 20.3 t70 -46.01 125.55 6.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.506 -0.746 . . . . 0.0 110.176 179.787 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.83 -26.07 10.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.143 -0.973 . . . . 0.0 110.842 -179.589 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.609 ' OD2' 'CA ' ' A' ' 150' ' ' ' CA' . 2.8 p30 -70.03 -34.76 73.68 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.228 -0.92 . . . . 0.0 110.455 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.457 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 92.5 76.37 1.33 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.822 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.409 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 18.6 p-10 -142.9 -43.55 0.3 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.222 -1.163 . . . . 0.0 110.179 179.391 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.534 ' C ' HG23 ' A' ' 62' ' ' THR . . . 132.61 2.61 3.94 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.842 179.323 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.581 ' CG2' HG22 ' A' ' 28' ' ' THR . 49.5 p -154.24 167.17 30.79 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.803 -1.41 . . . . 0.0 111.093 -179.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.7 HD11 HG11 ' A' ' 55' ' ' VAL . 49.3 mt -104.98 146.25 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.385 -0.822 . . . . 0.0 109.775 179.662 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.443 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 48.7 m-20 -105.45 170.51 7.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.095 -1.003 . . . . 0.0 110.293 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.547 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 32.9 t80 -67.07 -42.3 40.3 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.877 . . . . 0.0 111.412 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 46.1 Cg_endo -74.73 -26.3 11.62 Favored 'Trans proline' 0 C--O 1.212 -0.782 0 O-C-N 123.087 1.046 . . . . 0.0 110.146 -179.587 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 71' ' ' MET . 35.1 tt0 -78.99 -27.95 43.41 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.289 -0.882 . . . . 0.0 109.369 179.378 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -74.57 -61.07 2.0 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.318 -0.864 . . . . 0.0 109.728 179.647 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.481 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 5.0 tt -56.92 -38.09 72.38 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.291 -0.88 . . . . 0.0 109.826 179.669 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.434 ' HB ' ' O ' ' A' ' 66' ' ' PRO . 52.1 m -73.77 -26.4 60.63 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.192 -0.943 . . . . 0.0 110.325 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.73 ' SD ' HG13 ' A' ' 55' ' ' VAL . 34.4 ttp -63.37 -50.18 70.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 110.208 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.473 ' CE ' ' CE ' ' A' ' 71' ' ' MET . 36.5 mtt -90.5 -15.2 31.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.286 -0.884 . . . . 0.0 111.188 -179.372 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.481 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -91.27 -9.68 44.25 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.955 -1.091 . . . . 0.0 111.23 -179.664 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.68 27.08 1.18 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.064 -1.022 . . . . 0.0 111.454 -178.765 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -89.19 116.55 27.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.888 -1.132 . . . . 0.0 110.047 179.316 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.407 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -155.05 169.5 23.96 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.186 -0.946 . . . . 0.0 110.188 -179.816 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.41 ' O ' ' C ' ' A' ' 78' ' ' ASP . 21.7 tttm -120.62 6.96 10.51 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.162 -0.961 . . . . 0.0 110.811 -179.84 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 77' ' ' LYS . 3.0 p30 37.05 -153.47 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.576 0 O-C-N 121.673 -0.642 . . . . 0.0 111.251 179.781 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.409 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 9.0 t -123.49 155.72 36.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -0.878 . . . . 0.0 110.501 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.55 138.25 52.67 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.37 -0.831 . . . . 0.0 110.128 179.921 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 71.1 m -146.34 -81.61 0.14 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.186 -0.947 . . . . 0.0 110.394 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -134.64 97.44 3.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 0.0 109.89 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.487 ' HB2' ' HB3' ' A' ' 86' ' ' ARG . 8.6 pt-20 -167.33 75.38 0.15 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.236 -0.915 . . . . 0.0 110.601 -179.323 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -71.89 -67.79 0.51 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.125 -0.985 . . . . 0.0 110.339 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.6 mt -53.44 -46.54 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.077 -1.014 . . . . 0.0 110.02 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.487 ' HB3' ' HB2' ' A' ' 83' ' ' GLU . 27.1 ttt180 -55.49 -42.38 74.33 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.178 -0.951 . . . . 0.0 109.071 179.437 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -49.6 -50.68 41.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.398 -0.814 . . . . 0.0 109.39 179.259 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.726 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -52.54 -44.73 65.97 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.358 -0.838 . . . . 0.0 109.281 179.134 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.448 ' CD1' HD11 ' A' ' 100' ' ' ILE . 4.0 t80 -54.16 -39.6 66.7 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.166 -0.958 . . . . 0.0 109.987 179.782 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -59.07 -51.37 70.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.231 -0.918 . . . . 0.0 110.242 -179.874 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.726 HG22 ' O ' ' A' ' 88' ' ' ALA . 26.6 m -68.28 -18.49 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.125 -0.985 . . . . 0.0 109.745 179.817 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.547 ' CE2' ' H3 ' ' A' ' 154' ' ' WW7 . 29.0 m-85 -103.41 4.38 36.13 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.36 -0.837 . . . . 0.0 110.317 179.657 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.414 ' OD2' ' HA2' ' A' ' 98' ' ' GLY . 59.1 t0 -146.19 70.21 1.22 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -0.939 . . . . 0.0 109.749 179.748 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -107.3 59.01 0.62 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 110.708 -179.557 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.2 p30 -138.31 -40.0 0.52 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.128 -0.983 . . . . 0.0 110.309 179.567 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.469 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 135.56 17.81 0.83 Allowed Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.225 -1.464 . . . . 0.0 111.827 178.846 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.469 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 27.6 p30 -131.58 -122.16 0.2 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.352 -1.675 . . . . 0.0 109.89 179.192 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.469 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . -170.09 44.53 0.2 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 23.5 m-85 -131.95 128.52 38.64 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.39 -1.065 . . . . 0.0 110.294 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.45 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 24.0 mt -95.92 124.38 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.195 -0.941 . . . . 0.0 109.972 179.702 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.4 t -113.51 157.55 21.87 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.256 -0.903 . . . . 0.0 110.258 -179.844 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.25 -26.54 12.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 110.15 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 106' ' ' ARG . . . -69.72 -59.31 3.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.198 -0.939 . . . . 0.0 110.09 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -51.92 -38.92 58.14 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.064 -1.022 . . . . 0.0 110.264 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.938 HD22 HG13 ' A' ' 121' ' ' VAL . 6.5 tt -59.1 -48.98 79.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 110.488 -179.796 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.597 ' O ' HG23 ' A' ' 110' ' ' THR . 0.0 OUTLIER -65.81 -21.7 66.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.907 -1.121 . . . . 0.0 109.999 -179.905 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.472 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 21.1 t-160 -72.3 -34.63 68.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.416 -0.802 . . . . 0.0 110.035 -179.969 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.467 HG21 ' CD1' ' A' ' 92' ' ' PHE . 96.8 t -78.88 -42.12 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.319 -0.863 . . . . 0.0 110.434 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 4.7 mmt -66.52 -56.96 8.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.215 -179.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.597 HG23 ' O ' ' A' ' 106' ' ' ARG . 44.1 p -46.61 -48.97 19.66 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.447 -0.783 . . . . 0.0 110.714 -179.819 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -59.13 -55.67 32.08 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.179 -0.95 . . . . 0.0 110.258 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 112' ' ' LEU . 79.6 mt -52.36 -72.6 0.05 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.14 -0.975 . . . . 0.0 109.924 179.658 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.08 40.37 0.02 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.869 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.804 ' O ' HD12 ' A' ' 116' ' ' LEU . 35.9 mm-40 -121.71 93.24 3.94 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.233 -1.157 . . . . 0.0 110.089 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -74.63 111.4 9.78 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.269 -0.894 . . . . 0.0 110.208 -179.89 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 114' ' ' GLU . 0.9 OUTLIER -117.43 177.56 4.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -0.862 . . . . 0.0 110.285 -179.939 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 59.0 m -100.87 158.87 15.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.334 -0.854 . . . . 0.0 110.173 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -59.91 -41.98 92.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.289 -0.882 . . . . 0.0 110.6 -179.765 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -60.08 -50.64 72.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.291 -0.881 . . . . 0.0 110.716 -179.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -53.23 -52.79 57.82 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.144 -0.972 . . . . 0.0 110.877 -179.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.938 HG13 HD22 ' A' ' 105' ' ' LEU . 95.5 t -55.32 -55.81 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.144 -0.973 . . . . 0.0 110.371 -179.607 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -54.54 -26.66 33.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.303 -0.873 . . . . 0.0 110.35 -179.693 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 7.1 tt0 -76.3 -34.71 59.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 110.069 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 72.0 mtp -67.58 -47.08 70.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.214 -0.929 . . . . 0.0 110.122 -179.919 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.91 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 29.6 mm -64.11 -45.0 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 110.234 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.5 -33.7 75.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.192 -0.942 . . . . 0.0 110.041 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 41.2 mm-40 -67.93 -33.95 75.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.018 179.79 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.528 ' HB3' ' CG2' ' A' ' 136' ' ' VAL . . . -71.18 -42.13 69.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.284 -0.885 . . . . 0.0 110.464 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -56.92 92.39 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.159 -0.963 . . . . 0.0 110.385 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.417 HD11 ' CB ' ' A' ' 143' ' ' GLN . 76.3 mt -64.4 -31.89 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.194 -0.941 . . . . 0.0 110.236 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 22.4 p30 -101.99 -18.58 15.58 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.193 -0.942 . . . . 0.0 110.536 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.454 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 77.3 75.7 0.91 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.645 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 40.4 m-20 -109.8 -49.3 3.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.227 -1.161 . . . . 0.0 110.053 179.711 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 157.17 -23.59 0.45 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.708 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -143.74 155.91 44.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.329 -1.1 . . . . 0.0 110.115 179.727 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.528 ' CG2' ' HB3' ' A' ' 128' ' ' ALA . 77.7 t -91.6 108.51 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.203 -0.936 . . . . 0.0 110.315 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -82.63 165.55 19.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.948 . . . . 0.0 110.249 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.545 ' O ' HG23 ' A' ' 142' ' ' VAL . 35.5 t80 -44.68 -34.46 2.23 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.369 -0.832 . . . . 0.0 111.766 -178.823 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -65.22 -67.05 0.47 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.867 -1.145 . . . . 0.0 110.726 -179.223 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -52.86 -26.16 13.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.207 -0.933 . . . . 0.0 110.359 -179.589 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.657 ' CE1' ' HE3' ' A' ' 145' ' ' MET . 7.9 t80 -68.44 -40.43 81.14 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 109.985 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 138' ' ' TYR . 43.5 t -82.01 -20.25 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.294 -0.879 . . . . 0.0 110.554 179.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.417 ' CB ' HD11 ' A' ' 130' ' ' ILE . 81.4 mm-40 -80.5 -28.25 37.54 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.341 -0.849 . . . . 0.0 110.696 -179.534 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.403 ' HG3' ' N ' ' A' ' 145' ' ' MET . 4.3 ptt? -84.53 -21.68 30.43 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.053 -1.029 . . . . 0.0 110.462 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.657 ' HE3' ' CE1' ' A' ' 141' ' ' PHE . 46.4 mtt -89.02 -39.83 13.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.203 -0.936 . . . . 0.0 110.524 -179.801 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.1 p -63.23 -68.12 0.37 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.207 -0.933 . . . . 0.0 110.383 -179.8 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -171.61 -178.95 2.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.221 -0.924 . . . . 0.0 110.152 179.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.154 -0.966 . . . . 0.0 110.179 -179.934 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . 0.698 'CA ' ' OD1' ' A' ' 56' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 153' ' ' WW7 . . . . . 0.57 ' C6 ' HG21 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 154' ' ' WW7 . . . . . 0.91 'CL1 ' HD13 ' A' ' 125' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 121.201 0.524 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -116.99 89.92 3.22 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.162 -0.961 . . . . 0.0 110.354 179.932 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -171.36 -44.66 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.184 -0.948 . . . . 0.0 110.024 179.915 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.821 ' O ' HG23 ' A' ' 5' ' ' THR . 7.1 mt -134.73 131.51 37.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.298 -0.876 . . . . 0.0 110.077 179.813 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.821 HG23 ' O ' ' A' ' 4' ' ' LEU . 0.4 OUTLIER -170.54 -61.29 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.287 -0.883 . . . . 0.0 110.307 -179.959 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.405 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 21.6 pt-20 -89.19 -23.65 22.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.352 -0.843 . . . . 0.0 110.497 -179.629 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -55.5 -54.61 41.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.167 -0.958 . . . . 0.0 109.969 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -50.97 -45.03 60.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.908 . . . . 0.0 109.788 179.581 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 31.3 mm -52.87 -40.92 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.884 . . . . 0.0 109.646 179.667 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -59.94 -44.4 94.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.361 -0.837 . . . . 0.0 109.89 179.615 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -53.29 -51.31 62.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 109.954 179.805 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -60.7 -33.87 73.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 109.896 179.737 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 72.1 mttt -66.07 -27.46 68.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.888 179.626 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -73.19 -53.05 11.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.35 -0.843 . . . . 0.0 109.913 179.763 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.444 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -58.89 -34.84 72.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.21 -0.931 . . . . 0.0 109.98 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -66.99 -54.25 23.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.883 . . . . 0.0 109.975 179.867 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.0 m -56.64 -21.39 26.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.238 -0.914 . . . . 0.0 110.021 179.654 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.814 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.1 tm? -78.6 -35.44 45.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.443 -0.786 . . . . 0.0 109.791 179.878 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.448 ' CE2' ' H3 ' ' A' ' 153' ' ' WW7 . 22.7 m-85 -70.46 -55.58 8.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.386 -0.821 . . . . 0.0 110.454 -179.889 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.442 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 0.5 OUTLIER -55.79 113.16 1.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.209 -0.932 . . . . 0.0 110.412 -179.897 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -109.96 54.58 0.66 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 110.143 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.456 ' OD2' ' HB2' ' A' ' 24' ' ' ASP . 10.2 p-10 -162.51 -37.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.111 -0.993 . . . . 0.0 110.598 -179.788 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.81 39.66 2.48 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.456 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 6.8 t70 -103.54 -67.67 0.88 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.369 -1.077 . . . . 0.0 110.101 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.531 ' C ' HG23 ' A' ' 26' ' ' THR . . . 135.92 23.47 0.55 Allowed Glycine 0 N--CA 1.499 2.842 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.621 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.531 HG23 ' C ' ' A' ' 25' ' ' GLY . 74.4 p -154.15 144.17 21.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.896 -1.355 . . . . 0.0 109.534 179.534 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.6 mt -96.37 107.18 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.109 -0.994 . . . . 0.0 110.328 -179.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.686 HG22 ' CG2' ' A' ' 62' ' ' THR . 72.4 p -103.28 -176.98 3.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.374 -0.829 . . . . 0.0 110.178 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.716 HG22 HD12 ' A' ' 52' ' ' ILE . 25.5 p -68.31 -26.68 65.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.277 -0.89 . . . . 0.0 110.14 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -68.67 -62.44 1.39 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.21 -0.931 . . . . 0.0 109.921 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.442 ' OE1' ' HA ' ' A' ' 20' ' ' ASP . 35.2 mt-10 -56.42 -55.36 34.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.325 -0.859 . . . . 0.0 109.458 179.602 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.817 HD23 HD21 ' A' ' 48' ' ' LEU . 6.6 tp -57.57 -23.77 52.49 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.177 -0.952 . . . . 0.0 109.296 179.144 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.487 ' HA2' ' CD1' ' A' ' 48' ' ' LEU . . . -62.85 -46.93 92.59 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.444 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.466 ' O ' ' CB ' ' A' ' 38' ' ' SER . 96.4 m -78.54 -14.45 59.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.332 -1.099 . . . . 0.0 109.934 179.636 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.445 ' HB ' ' HA ' ' A' ' 32' ' ' LEU . 50.5 t -78.77 -36.57 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.172 -0.955 . . . . 0.0 110.21 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.7 mmt -90.72 -38.09 13.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.352 -0.843 . . . . 0.0 110.756 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.7 mtm180 -75.74 -36.32 59.93 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.148 -0.97 . . . . 0.0 110.714 -179.497 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.645 ' O ' HD22 ' A' ' 39' ' ' LEU . 8.4 t -76.99 -23.93 52.24 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.876 -1.14 . . . . 0.0 110.054 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.645 HD22 ' O ' ' A' ' 38' ' ' SER . 3.9 mm? -119.85 56.61 0.95 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.314 -0.866 . . . . 0.0 110.169 179.8 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.49 56.95 0.07 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -48.43 104.92 0.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.178 -1.19 . . . . 0.0 110.479 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.539 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 5.9 m-20 -159.66 -63.61 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.318 -0.864 . . . . 0.0 110.329 179.314 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.539 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 46.6 Cg_endo -73.87 -179.32 4.49 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.332 1.175 . . . . 0.0 109.864 179.439 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 8.7 t -134.72 -175.64 3.96 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.108 -0.995 . . . . 0.0 110.102 -179.852 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.06 -42.0 93.58 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.034 -1.041 . . . . 0.0 110.333 -179.832 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.47 -68.46 0.38 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.22 -0.925 . . . . 0.0 110.411 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -47.14 -26.21 1.07 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.221 -0.924 . . . . 0.0 109.984 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.817 HD21 HD23 ' A' ' 32' ' ' LEU . 9.1 tt -70.56 -49.48 47.53 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.313 -0.867 . . . . 0.0 109.764 179.52 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -52.45 -41.18 63.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.118 -0.989 . . . . 0.0 109.222 179.224 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.78 -35.38 79.94 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.44 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 3.5 ttt -68.16 -15.05 63.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.646 -0.659 . . . . 0.0 109.573 179.007 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.716 HD12 HG22 ' A' ' 29' ' ' THR . 57.3 mt -88.56 -35.17 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.397 -0.814 . . . . 0.0 109.834 179.39 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -51.83 -45.38 63.93 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.274 -0.891 . . . . 0.0 110.657 -179.802 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.693 ' HG3' HG23 ' A' ' 55' ' ' VAL . 22.0 pt-20 -56.93 -34.27 67.81 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.177 -0.952 . . . . 0.0 110.476 -179.658 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.844 HG13 ' HE2' ' A' ' 71' ' ' MET . 95.3 t -84.49 -71.73 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.202 -0.936 . . . . 0.0 110.284 -179.696 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.433 ' HB2' ' CG1' ' A' ' 63' ' ' ILE . 24.2 t70 -56.53 124.33 17.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.335 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.34 5.29 21.48 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.23 -0.919 . . . . 0.0 110.702 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.83 -23.22 36.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.077 -1.015 . . . . 0.0 110.198 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.26 14.43 76.66 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.737 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -91.56 -37.39 13.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.014 -1.286 . . . . 0.0 110.165 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.14 -52.02 0.83 Allowed Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.231 179.567 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.686 ' CG2' HG22 ' A' ' 28' ' ' THR . 66.7 p -101.87 167.55 9.99 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.067 -1.255 . . . . 0.0 110.728 -179.379 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.446 HG23 ' CB ' ' A' ' 67' ' ' GLU . 48.7 mt -115.29 157.17 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.287 -0.883 . . . . 0.0 110.055 179.662 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.485 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 1.4 m-20 -112.6 -172.37 2.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.241 -0.912 . . . . 0.0 110.728 -179.648 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.572 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 50.3 t80 -65.3 -42.62 60.31 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.473 -0.767 . . . . 0.0 111.976 -179.686 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.5 Cg_endo -71.67 -33.35 10.56 Favored 'Trans proline' 0 C--N 1.323 -0.787 0 O-C-N 123.069 1.036 . . . . 0.0 110.893 -179.146 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.446 ' CB ' HG23 ' A' ' 63' ' ' ILE . 48.6 mt-10 -71.43 -30.16 65.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.021 -1.049 . . . . 0.0 108.844 179.169 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.491 ' CZ ' ' SD ' ' A' ' 72' ' ' MET . 64.9 t80 -73.46 -43.0 61.24 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.512 0.672 . . . . 0.0 109.654 179.738 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.49 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 15.5 tp -77.19 -12.12 59.91 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.49 -0.756 . . . . 0.0 110.344 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.7 m -90.68 -28.42 18.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.929 -1.107 . . . . 0.0 110.44 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.844 ' HE2' HG13 ' A' ' 55' ' ' VAL . 18.9 tmm? -90.61 -37.02 14.07 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.178 -0.951 . . . . 0.0 111.197 -179.488 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.491 ' SD ' ' CZ ' ' A' ' 68' ' ' PHE . 48.9 mtt -91.3 -11.8 36.97 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.112 -0.993 . . . . 0.0 111.975 -178.646 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' A' ' 69' ' ' LEU . . . -85.13 -23.5 28.4 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.772 -1.205 . . . . 0.0 111.126 -179.401 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.21 -51.95 13.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.983 -1.073 . . . . 0.0 110.513 -179.441 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.82 138.04 39.59 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.167 -0.958 . . . . 0.0 110.291 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 13.2 tpt -174.46 135.08 0.41 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.255 -0.903 . . . . 0.0 110.29 179.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.75 -165.53 1.37 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.312 -0.867 . . . . 0.0 110.512 -179.963 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -163.8 -62.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.429 -0.794 . . . . 0.0 109.912 179.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.65 119.22 38.47 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.333 -0.854 . . . . 0.0 109.755 179.664 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -112.21 66.43 0.64 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.2 -0.938 . . . . 0.0 110.391 -179.622 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.5 t -135.84 158.85 43.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 109.861 179.656 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -168.38 149.75 4.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.187 -0.946 . . . . 0.0 110.077 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 33.4 tt0 -131.17 24.05 4.88 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.332 -0.855 . . . . 0.0 109.882 179.887 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -77.36 -25.14 50.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.366 -0.834 . . . . 0.0 110.314 -179.848 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.732 HG12 HG22 ' A' ' 142' ' ' VAL . 3.8 tp -48.06 -34.87 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.168 -0.958 . . . . 0.0 109.536 179.834 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -59.95 -48.7 80.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.392 -0.818 . . . . 0.0 109.499 179.282 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.419 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 7.8 mm-40 -54.13 -41.6 68.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.255 -0.903 . . . . 0.0 109.563 179.39 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.15 -46.41 88.45 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.312 -0.867 . . . . 0.0 109.66 179.528 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.435 ' O ' ' HB3' ' A' ' 93' ' ' ASP . 0.4 OUTLIER -63.38 -20.82 65.86 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.179 179.736 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.419 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -74.05 -49.74 22.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.365 -0.834 . . . . 0.0 110.882 -179.489 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 92' ' ' PHE . 16.5 m -75.1 -41.04 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.133 -0.979 . . . . 0.0 111.416 -179.089 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 1.011 ' CE1' HD12 ' A' ' 105' ' ' LEU . 37.7 m-85 -72.78 -28.18 62.45 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.068 -1.02 . . . . 0.0 111.248 -179.141 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.435 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 10.4 t70 -111.15 51.6 0.77 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.859 -1.151 . . . . 0.0 110.348 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.74 2.63 32.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 110.49 179.882 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 3.0 p30 -85.96 -37.77 18.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.128 -0.983 . . . . 0.0 110.296 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 104.38 47.64 1.2 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.443 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 15.8 p-10 -122.77 -32.77 3.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.151 -1.205 . . . . 0.0 110.295 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.48 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 100.36 16.16 28.03 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.901 -1.142 . . . . 0.0 110.312 179.274 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 37.6 m-85 -144.79 161.44 39.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.051 -1.264 . . . . 0.0 110.303 179.762 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.548 HG23 ' HB3' ' A' ' 92' ' ' PHE . 23.0 mt -107.0 118.39 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.256 -0.903 . . . . 0.0 109.419 179.323 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.3 m -102.13 163.36 12.28 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.44 -0.788 . . . . 0.0 109.632 179.8 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.87 -49.76 76.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.063 -1.023 . . . . 0.0 110.167 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -50.43 -50.45 52.0 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.274 -0.891 . . . . 0.0 110.573 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -57.95 -45.73 86.19 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.356 -0.84 . . . . 0.0 110.136 -179.881 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.011 HD12 ' CE1' ' A' ' 92' ' ' PHE . 40.5 tp -59.15 -23.88 62.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.438 -0.789 . . . . 0.0 110.319 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.44 -43.3 27.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.307 -0.871 . . . . 0.0 110.403 -179.933 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.414 ' O ' ' OG1' ' A' ' 110' ' ' THR . 81.6 m-70 -68.18 -30.27 69.33 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.216 -0.927 . . . . 0.0 110.551 -179.927 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.706 HG11 ' CE1' ' A' ' 92' ' ' PHE . 48.1 t -75.17 -47.82 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.02 -1.05 . . . . 0.0 109.866 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.694 ' HE3' HD11 ' A' ' 105' ' ' LEU . 63.7 mtt -65.36 -10.42 33.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.174 -0.954 . . . . 0.0 110.509 179.911 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 107' ' ' HIS . 1.1 p -90.17 -26.41 20.16 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.018 -1.051 . . . . 0.0 109.858 179.245 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -88.47 -52.92 4.92 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.146 -0.971 . . . . 0.0 110.117 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.1 mt -47.73 -72.85 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.165 -0.959 . . . . 0.0 110.278 179.811 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 162.97 40.78 0.02 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.489 ' HB3' ' CD1' ' A' ' 116' ' ' LEU . 51.5 mt-10 -120.85 121.45 38.13 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.323 -1.104 . . . . 0.0 110.462 -179.786 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -106.81 66.03 0.68 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.206 -0.934 . . . . 0.0 110.109 179.702 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.489 ' CD1' ' HB3' ' A' ' 114' ' ' GLU . 3.4 mp -88.04 167.98 13.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.261 -0.899 . . . . 0.0 110.364 -179.895 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 22.9 m -86.24 163.21 17.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.334 -0.854 . . . . 0.0 109.969 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -60.77 -54.44 45.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.159 -0.963 . . . . 0.0 110.379 -179.805 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -47.07 -40.23 14.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.947 . . . . 0.0 110.276 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -56.76 -60.09 4.07 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.251 -0.906 . . . . 0.0 110.441 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.803 HG13 HD23 ' A' ' 105' ' ' LEU . 53.1 t -47.22 -39.72 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.143 -0.973 . . . . 0.0 110.371 -179.622 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -62.68 -44.07 97.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.135 -0.978 . . . . 0.0 109.99 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -69.11 -20.51 64.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.199 179.839 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.419 ' O ' ' H6 ' ' A' ' 154' ' ' WW7 . 85.1 mtp -77.78 -46.52 21.41 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.126 -0.984 . . . . 0.0 109.993 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.519 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 26.0 mm -65.57 -29.38 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.158 -0.964 . . . . 0.0 110.007 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -75.91 -54.79 6.36 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.2 -0.938 . . . . 0.0 110.132 179.576 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -54.94 -33.52 62.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.226 -0.921 . . . . 0.0 109.995 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.766 ' HB2' ' H6 ' ' A' ' 154' ' ' WW7 . . . -75.13 -37.43 61.41 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.209 -0.932 . . . . 0.0 109.811 179.701 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -57.89 95.46 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.317 -0.864 . . . . 0.0 109.809 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.433 HD12 ' HG2' ' A' ' 140' ' ' GLU . 21.8 mt -62.07 -46.96 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.888 . . . . 0.0 110.402 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 21.6 p30 -86.6 -19.69 28.99 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.185 -0.947 . . . . 0.0 110.059 179.854 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.445 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 67.48 65.56 2.69 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 178.871 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.426 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 34.4 m-20 -98.28 -35.62 10.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.178 -1.19 . . . . 0.0 109.719 179.048 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.75 -28.62 1.04 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 -179.664 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.412 ' O ' ' OE1' ' A' ' 135' ' ' GLN . 0.0 OUTLIER -137.08 169.62 17.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.471 -1.017 . . . . 0.0 109.709 179.589 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.777 HG21 'CL1 ' ' A' ' 154' ' ' WW7 . 84.4 t -99.28 145.23 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 120.97 -1.081 . . . . 0.0 110.752 -179.447 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -106.67 178.79 4.46 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.365 -0.835 . . . . 0.0 110.193 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.537 ' O ' HG23 ' A' ' 142' ' ' VAL . 13.7 t80 -69.07 -44.7 72.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.231 -0.918 . . . . 0.0 110.441 -179.997 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.58 -33.32 73.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.242 -0.911 . . . . 0.0 110.27 -179.735 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.433 ' HG2' HD12 ' A' ' 130' ' ' ILE . 48.3 mt-10 -71.27 -35.6 71.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.146 -0.971 . . . . 0.0 110.085 179.818 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.477 ' CE2' HG13 ' A' ' 85' ' ' ILE . 57.4 t80 -71.13 -32.72 69.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.212 -0.93 . . . . 0.0 110.657 -179.847 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.732 HG22 HG12 ' A' ' 85' ' ' ILE . 59.4 t -78.7 -29.54 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.12 -0.987 . . . . 0.0 110.72 -179.734 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.424 ' OE1' ' N ' ' A' ' 143' ' ' GLN . 0.6 OUTLIER -97.06 -9.74 27.46 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.129 -0.982 . . . . 0.0 111.456 -179.068 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.47 ' HG2' ' HA ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -89.31 -31.56 17.77 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.705 -1.247 . . . . 0.0 110.372 -179.958 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 56.0 ttm -85.97 -48.77 8.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.938 179.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.5 p -61.43 126.07 26.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.351 -0.843 . . . . 0.0 110.091 179.682 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -140.14 43.63 1.91 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.195 -0.941 . . . . 0.0 110.433 -179.895 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.2 mttm . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.282 179.725 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 153' ' ' WW7 . . . . . 0.486 ' O1 ' ' H8 ' ' A' ' 153' ' ' WW7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 154' ' ' WW7 . . . . . 0.777 'CL1 ' HG21 ' A' ' 136' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.168 0.509 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -96.1 -169.81 1.99 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.233 -0.917 . . . . 0.0 110.238 -179.986 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -168.97 115.74 0.62 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.311 -0.868 . . . . 0.0 109.946 179.685 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 80.7 mt -75.62 -158.06 0.08 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.414 -0.804 . . . . 0.0 110.613 -179.535 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.3 p -138.15 -178.97 5.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.452 -0.78 . . . . 0.0 110.072 179.833 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -82.63 -9.6 59.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.227 -0.92 . . . . 0.0 110.586 -179.88 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -62.08 -55.06 32.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.032 -1.042 . . . . 0.0 110.764 -179.661 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -59.76 -50.89 72.05 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.208 -0.932 . . . . 0.0 110.217 -179.544 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 12' ' ' PHE . 22.9 mt -48.91 -42.74 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.045 -1.034 . . . . 0.0 109.664 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.02 -43.1 99.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 109.571 179.301 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -58.65 -29.1 66.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 109.555 179.463 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 12.5 m-85 -72.91 -36.23 67.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.279 -0.888 . . . . 0.0 109.934 179.656 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -70.46 -27.1 63.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.917 . . . . 0.0 109.858 179.623 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.83 -43.83 52.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.352 -0.843 . . . . 0.0 109.845 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.56 -42.86 86.45 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.246 -0.909 . . . . 0.0 109.7 179.484 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -57.14 -44.62 83.54 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.269 -0.894 . . . . 0.0 109.651 179.685 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 98.3 p -64.12 -35.6 81.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -0.904 . . . . 0.0 109.337 179.388 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.676 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -58.69 -33.17 69.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.466 -0.771 . . . . 0.0 109.381 179.438 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.542 ' CE2' ' H3 ' ' A' ' 153' ' ' WW7 . 3.5 m-30 -87.09 -24.08 24.69 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.39 -0.819 . . . . 0.0 109.92 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.422 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 66.7 t0 -101.69 92.67 4.96 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.334 -0.854 . . . . 0.0 109.912 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.52 -14.29 15.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 110.59 -179.548 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -78.89 -37.34 40.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.184 -0.948 . . . . 0.0 110.299 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.72 83.13 1.71 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 23.5 p-10 -156.53 -32.41 0.09 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.122 -1.223 . . . . 0.0 111.207 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.451 ' C ' HG23 ' A' ' 26' ' ' THR . . . 101.81 22.85 9.76 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.56 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.451 HG23 ' C ' ' A' ' 25' ' ' GLY . 75.9 p -149.69 155.01 39.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.164 -1.198 . . . . 0.0 109.988 179.863 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.5 mt -109.43 124.93 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.069 -1.02 . . . . 0.0 110.218 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.801 HG22 HG21 ' A' ' 62' ' ' THR . 41.4 p -108.0 -159.01 0.67 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.426 -0.796 . . . . 0.0 110.189 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.794 HG22 HD12 ' A' ' 52' ' ' ILE . 32.0 p -90.23 -34.04 15.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.218 179.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.49 -58.88 6.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -0.906 . . . . 0.0 109.995 -179.952 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 19' ' ' PHE . 48.8 mt-10 -60.49 -54.64 43.03 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.32 -0.862 . . . . 0.0 109.709 179.831 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.646 HD23 HD11 ' A' ' 48' ' ' LEU . 2.8 tp -57.26 -20.18 26.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.269 -0.894 . . . . 0.0 109.713 179.533 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.35 -46.85 46.84 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 179.542 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.437 ' O ' ' CB ' ' A' ' 38' ' ' SER . 38.4 m -68.8 -20.22 64.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.447 -1.031 . . . . 0.0 109.805 179.349 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.857 ' O ' HD12 ' A' ' 39' ' ' LEU . 54.9 t -75.48 -58.1 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.385 -0.822 . . . . 0.0 110.332 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.506 ' CE ' ' CE ' ' A' ' 51' ' ' MET . 58.7 mtt -72.9 -18.8 61.38 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.279 -0.888 . . . . 0.0 110.785 -179.391 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -89.93 -29.33 18.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.021 -1.049 . . . . 0.0 110.09 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 34' ' ' THR . 40.5 t -82.41 -30.73 29.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.237 -0.915 . . . . 0.0 110.101 179.756 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.857 HD12 ' O ' ' A' ' 35' ' ' VAL . 1.3 mt -104.35 64.93 0.77 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.376 -0.828 . . . . 0.0 109.663 179.608 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.22 78.16 1.34 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.411 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -63.24 88.38 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.282 -1.128 . . . . 0.0 110.55 -179.459 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.534 ' CB ' ' CD ' ' A' ' 43' ' ' PRO . 3.2 m120 -114.28 -66.66 0.03 OUTLIER Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.375 -0.828 . . . . 0.0 110.689 179.72 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.534 ' CD ' ' CB ' ' A' ' 42' ' ' ASN . 47.1 Cg_endo -73.49 -169.44 0.54 Allowed 'Trans proline' 0 C--N 1.32 -0.934 0 O-C-N 123.092 1.048 . . . . 0.0 110.341 179.484 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 35.0 p -138.54 -175.3 4.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.321 -0.862 . . . . 0.0 110.07 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -66.56 -31.5 72.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.222 -0.923 . . . . 0.0 109.974 179.683 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.23 -67.28 0.5 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 0.0 109.953 179.73 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -50.6 -31.11 15.02 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.354 -0.841 . . . . 0.0 109.688 179.718 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.646 HD11 HD23 ' A' ' 32' ' ' LEU . 8.8 tt -65.63 -47.94 73.89 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.395 -0.815 . . . . 0.0 110.066 179.65 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.419 ' OE1' HG21 ' A' ' 29' ' ' THR . 4.6 tp-100 -54.46 -44.95 72.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 109.217 179.465 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 1.0 OUTLIER -67.87 -27.35 66.6 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.345 -0.847 . . . . 0.0 109.307 179.355 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.506 ' CE ' ' CE ' ' A' ' 36' ' ' MET . 20.2 ttp -76.15 -15.18 60.12 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.497 -0.752 . . . . 0.0 109.719 179.413 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.794 HD12 HG22 ' A' ' 29' ' ' THR . 6.4 mt -90.51 -38.45 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.132 -0.98 . . . . 0.0 109.823 179.378 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -52.99 -28.64 24.91 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.158 -0.964 . . . . 0.0 109.75 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.475 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 9.6 pt-20 -79.95 -33.84 39.27 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 109.541 179.245 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.475 ' N ' ' HG3' ' A' ' 54' ' ' GLU . 85.3 t -69.48 -65.76 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.192 -0.943 . . . . 0.0 109.202 178.973 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -56.35 101.51 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.435 -0.791 . . . . 0.0 109.845 179.419 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.43 58.36 0.8 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.128 -0.983 . . . . 0.0 110.711 -179.523 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.425 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 15.3 m-20 -141.81 -49.79 0.39 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.261 -0.899 . . . . 0.0 109.852 179.565 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.64 50.77 0.55 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.647 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.412 ' OD1' ' HB2' ' A' ' 58' ' ' ASP . 7.7 p-10 -129.14 -48.29 1.21 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.27 -1.135 . . . . 0.0 110.443 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.95 -86.66 0.13 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.3 -1.429 . . . . 0.0 110.8 179.6 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.801 HG21 HG22 ' A' ' 28' ' ' THR . 73.7 p -91.22 170.59 9.88 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.246 -1.149 . . . . 0.0 111.34 -178.662 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.423 ' CD1' HG11 ' A' ' 55' ' ' VAL . 33.1 mt -88.9 159.7 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.515 -0.741 . . . . 0.0 109.917 179.628 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.425 ' HB2' ' OE1' ' A' ' 67' ' ' GLU . 20.7 t0 -108.29 -176.93 3.19 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.276 -0.89 . . . . 0.0 110.417 -179.969 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.583 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 23.5 t80 -72.81 -43.79 8.49 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.406 -0.809 . . . . 0.0 111.174 179.86 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.7 Cg_endo -72.18 -19.08 26.45 Favored 'Trans proline' 0 C--O 1.213 -0.748 0 O-C-N 123.122 1.064 . . . . 0.0 110.562 -179.844 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.425 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 39.9 mt-10 -78.57 -27.81 45.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.021 -1.049 . . . . 0.0 108.919 179.029 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 7.5 t80 -76.88 -48.62 17.81 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.287 0.565 . . . . 0.0 110.419 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.739 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 17.0 tp -78.26 -17.39 56.73 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.193 -0.942 . . . . 0.0 111.236 -179.388 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.405 ' CB ' ' O ' ' A' ' 66' ' ' PRO . 43.1 m -87.77 -38.83 15.42 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.706 -1.246 . . . . 0.0 110.56 -179.797 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.525 ' CE ' ' HE3' ' A' ' 72' ' ' MET . 4.8 ptt? -78.38 -31.62 48.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.157 -0.964 . . . . 0.0 110.332 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.525 ' HE3' ' CE ' ' A' ' 71' ' ' MET . 48.2 mtt -89.79 -9.58 48.7 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.156 -0.965 . . . . 0.0 110.671 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . -83.53 -34.52 25.25 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.141 -0.974 . . . . 0.0 110.394 -179.808 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.98 59.65 1.19 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.38 -0.825 . . . . 0.0 110.161 -179.595 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.0 tttt -131.22 85.38 2.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 0.0 110.308 179.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 11.0 tpt -121.7 129.12 52.51 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.231 -0.918 . . . . 0.0 109.873 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -78.25 134.89 37.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.286 -0.884 . . . . 0.0 110.423 -179.764 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.414 ' O ' ' HB ' ' A' ' 79' ' ' THR . 33.4 t70 -152.08 79.94 1.25 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.304 -0.873 . . . . 0.0 110.359 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 78' ' ' ASP . 9.7 t -176.51 163.5 2.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.273 -0.892 . . . . 0.0 110.063 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -103.3 -171.26 1.91 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.163 -0.961 . . . . 0.0 110.245 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.6 t -50.62 -72.62 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.876 . . . . 0.0 110.359 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.484 ' HG2' ' HG3' ' A' ' 84' ' ' GLU . 44.5 tt0 -153.15 -71.23 0.14 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.196 -0.94 . . . . 0.0 110.187 -179.728 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 46.48 86.64 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.215 -0.928 . . . . 0.0 110.506 179.713 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.484 ' HG3' ' HG2' ' A' ' 82' ' ' GLU . 42.3 mt-10 -98.18 -34.61 10.67 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.116 -0.99 . . . . 0.0 110.322 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.4 HD11 HN22 ' A' ' 154' ' ' WW7 . 26.1 mm -67.02 -29.93 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.449 -179.913 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -56.52 10.03 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.158 -0.964 . . . . 0.0 109.838 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -55.08 -42.33 72.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.346 -0.846 . . . . 0.0 110.161 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.41 -39.3 92.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.9 . . . . 0.0 110.558 -179.667 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.44 ' O ' ' CB ' ' A' ' 93' ' ' ASP . 5.0 t80 -63.46 -33.26 75.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.914 -1.116 . . . . 0.0 110.387 -179.631 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -75.52 -55.04 6.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.086 -1.009 . . . . 0.0 111.003 -179.481 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.562 HG23 ' N ' ' A' ' 92' ' ' PHE . 19.2 m -56.26 -42.9 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.095 -1.003 . . . . 0.0 110.813 -179.35 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.752 ' CE1' HD12 ' A' ' 105' ' ' LEU . 30.3 m-85 -77.44 -20.77 54.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.135 -0.978 . . . . 0.0 110.211 179.88 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 89' ' ' PHE . 35.5 t0 -113.71 53.21 0.78 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.154 -0.966 . . . . 0.0 109.471 179.127 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -86.36 56.17 3.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.543 -0.723 . . . . 0.0 110.757 -179.419 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.462 ' OD2' ' HB2' ' A' ' 97' ' ' ASN . 26.3 p-10 -158.26 29.94 0.25 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.103 -0.998 . . . . 0.0 110.335 179.731 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.44 33.12 4.2 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.524 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.462 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 18.1 t-20 -91.93 -60.01 1.97 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.236 -1.155 . . . . 0.0 110.083 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.458 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 112.07 -5.49 27.14 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.742 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.559 ' CD1' ' NE2' ' A' ' 135' ' ' GLN . 37.3 m-85 -138.93 140.06 38.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.938 -1.331 . . . . 0.0 110.465 -179.826 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 39.5 mt -85.97 118.25 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.315 -0.866 . . . . 0.0 110.161 179.813 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.3 t -102.91 174.15 6.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.451 -0.781 . . . . 0.0 109.462 179.514 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.25 -41.21 73.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.039 -1.038 . . . . 0.0 109.988 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.42 -54.55 44.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.211 -0.931 . . . . 0.0 110.091 179.64 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.403 ' OE2' ' OD2' ' A' ' 95' ' ' ASP . 45.9 mt-10 -59.58 -45.34 92.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.224 -0.922 . . . . 0.0 110.043 179.765 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.857 HD23 HG13 ' A' ' 121' ' ' VAL . 32.5 tp -58.52 -21.12 51.26 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.429 -0.794 . . . . 0.0 110.534 -179.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.8 ttt-85 -83.52 -40.08 19.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.213 -0.929 . . . . 0.0 110.097 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -73.22 -22.65 60.39 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.28 -0.887 . . . . 0.0 110.125 179.88 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 97.3 t -89.92 -44.15 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -0.882 . . . . 0.0 110.068 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 4.7 mmt -49.5 -24.41 2.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.908 . . . . 0.0 110.163 179.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 64.6 p -82.34 -41.75 19.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 110.081 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -57.04 -45.18 83.36 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.234 -0.917 . . . . 0.0 110.177 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.421 ' HB2' ' OE1' ' A' ' 114' ' ' GLU . 80.4 mt -64.12 -55.91 18.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.317 -0.865 . . . . 0.0 110.31 -179.969 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 142.52 53.07 0.04 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.758 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.421 ' OE1' ' HB2' ' A' ' 112' ' ' LEU . 49.5 mp0 -139.11 -62.83 0.53 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.168 -1.195 . . . . 0.0 110.068 179.693 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 114' ' ' GLU . 70.3 tttt 55.78 104.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.299 -0.876 . . . . 0.0 110.417 179.751 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.58 -175.82 3.24 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.165 -0.959 . . . . 0.0 110.529 -179.948 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.428 HG23 ' H ' ' A' ' 120' ' ' GLU . 9.5 t -87.89 -177.8 5.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.361 -0.837 . . . . 0.0 110.184 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -68.96 -34.8 75.93 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.178 -0.951 . . . . 0.0 110.448 -179.875 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -65.47 -53.24 45.45 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.232 -0.917 . . . . 0.0 110.779 -179.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.428 ' H ' HG23 ' A' ' 117' ' ' THR . 5.7 mm-40 -54.32 -50.45 67.35 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.127 -0.983 . . . . 0.0 110.56 -179.54 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.857 HG13 HD23 ' A' ' 105' ' ' LEU . 56.1 t -56.44 -47.98 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.162 -0.961 . . . . 0.0 110.133 -179.978 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -62.68 -23.69 67.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.184 -0.948 . . . . 0.0 109.868 179.677 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.434 ' HG3' ' OE1' ' A' ' 127' ' ' GLU . 16.5 tp10 -75.07 -30.01 60.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.395 -0.816 . . . . 0.0 109.917 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.757 ' CE ' HD21 ' A' ' 105' ' ' LEU . 23.3 mtm -77.33 -46.24 23.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.368 -0.833 . . . . 0.0 110.1 -179.978 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.83 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 24.9 mm -68.7 -33.22 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.025 -1.047 . . . . 0.0 109.879 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -71.97 -55.86 6.69 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.392 -0.818 . . . . 0.0 110.636 -179.63 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.434 ' OE1' ' HG3' ' A' ' 123' ' ' GLU . 54.5 mt-10 -61.06 -36.4 79.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.176 -0.953 . . . . 0.0 110.116 -179.768 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.55 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -70.23 -26.98 64.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.814 179.799 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -63.3 94.69 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.867 . . . . 0.0 109.991 179.76 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 128' ' ' ALA . 97.8 mt -79.8 -43.94 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.218 -0.926 . . . . 0.0 110.854 -179.646 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 23.4 p30 -79.27 -19.51 50.4 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.016 -1.053 . . . . 0.0 110.791 -179.655 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 79.0 70.79 1.29 Allowed Glycine 0 N--CA 1.495 2.632 0 C-N-CA 120.031 -1.081 . . . . 0.0 110.53 179.344 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -125.5 -26.67 3.53 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.186 -1.185 . . . . 0.0 110.578 179.545 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 118.35 -37.43 3.24 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.689 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.559 ' NE2' ' CD1' ' A' ' 99' ' ' TYR . 9.0 pt20 -113.14 156.72 22.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.278 -1.13 . . . . 0.0 109.922 179.81 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.42 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 62.4 t -99.5 118.41 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.203 -0.935 . . . . 0.0 110.423 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 37.8 p30 -93.25 -163.93 1.11 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.244 -0.91 . . . . 0.0 110.131 179.669 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.554 ' O ' HG23 ' A' ' 142' ' ' VAL . 23.2 t80 -69.63 -62.55 1.34 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.095 -1.003 . . . . 0.0 111.127 -179.289 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -44.06 -59.48 2.29 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.275 -0.891 . . . . 0.0 111.191 -179.121 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 144' ' ' MET . 51.7 mt-10 -51.44 -51.37 55.48 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 121.198 -0.939 . . . . 0.0 110.538 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 137' ' ' ASN . 0.8 OUTLIER -54.08 -31.3 51.37 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.291 -0.88 . . . . 0.0 110.551 -179.582 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 138' ' ' TYR . 94.9 t -72.1 -62.86 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.285 -0.884 . . . . 0.0 110.691 -179.51 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -64.9 -9.66 22.84 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.222 -0.924 . . . . 0.0 110.87 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.55 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 49.3 ttp -59.46 -60.54 3.69 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.13 -0.981 . . . . 0.0 110.786 -179.704 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.453 ' HG3' ' HE3' ' A' ' 144' ' ' MET . 38.3 mtt -89.88 -44.3 10.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.448 -0.783 . . . . 0.0 110.857 -179.368 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.571 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 66.6 p -70.64 138.07 50.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.05 -1.031 . . . . 0.0 110.122 -179.901 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 146' ' ' THR . . . 62.57 164.06 0.1 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.273 -0.892 . . . . 0.0 110.298 -179.912 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.423 ' C ' ' CD ' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.251 -179.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 153' ' ' WW7 . . . . . 0.542 ' H3 ' ' CE2' ' A' ' 19' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 154' ' ' WW7 . . . . . 0.83 'CL1 ' HD13 ' A' ' 125' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.286 0.565 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -154.6 143.51 20.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.228 -0.92 . . . . 0.0 110.161 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.402 ' O ' ' OH ' ' A' ' 99' ' ' TYR . 47.2 mt-30 -133.22 87.87 2.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.281 -0.887 . . . . 0.0 110.365 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.26 -177.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.134 -0.979 . . . . 0.0 110.168 179.835 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.4 t -99.74 -28.1 13.33 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.148 -0.97 . . . . 0.0 110.468 -179.786 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -89.97 -34.35 16.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.183 -0.948 . . . . 0.0 110.08 179.9 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -66.49 -44.59 82.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.375 -0.828 . . . . 0.0 110.331 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.435 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 7.3 tt0 -55.67 -47.25 77.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 110.177 -179.856 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.0 mt -60.07 -40.6 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.052 -1.03 . . . . 0.0 109.482 179.427 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.79 -26.91 68.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.349 -0.844 . . . . 0.0 109.329 179.15 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 38.2 tt0 -67.64 -46.49 72.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.347 -0.846 . . . . 0.0 109.365 179.411 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -63.53 -32.11 73.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.908 . . . . 0.0 109.465 179.157 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.17 -40.44 82.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.5 -0.75 . . . . 0.0 110.165 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -63.14 -45.26 92.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.2 -0.937 . . . . 0.0 110.187 -179.835 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.33 -37.39 87.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.141 -0.974 . . . . 0.0 110.074 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -63.92 -37.38 87.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.189 -0.945 . . . . 0.0 109.945 179.862 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.9 m -65.9 -39.93 91.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.388 -0.82 . . . . 0.0 110.286 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.658 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.5 tm? -66.56 -35.96 81.49 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.183 -0.948 . . . . 0.0 110.13 -179.936 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.48 ' CE2' ' H3 ' ' A' ' 153' ' ' WW7 . 12.0 m-30 -69.65 -64.78 0.81 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.224 -0.923 . . . . 0.0 109.931 179.718 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -83.0 96.07 8.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.35 -0.844 . . . . 0.0 109.856 179.674 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.422 ' HD3' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -109.66 48.57 0.88 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.256 -0.902 . . . . 0.0 110.524 -179.758 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -131.22 -35.24 1.37 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.105 -0.997 . . . . 0.0 110.368 179.768 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.32 86.21 1.49 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 21.1 p-10 -178.13 -34.19 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.302 -1.117 . . . . 0.0 110.617 179.654 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.519 ' C ' HG23 ' A' ' 26' ' ' THR . . . 83.91 42.19 7.78 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.131 179.633 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.519 HG23 ' C ' ' A' ' 25' ' ' GLY . 59.3 p -151.28 107.47 3.44 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.095 -1.238 . . . . 0.0 110.389 179.875 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.4 mt -74.68 124.63 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.828 179.559 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.9 p -112.78 -157.21 0.61 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.332 -0.855 . . . . 0.0 110.08 -179.865 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.524 ' HA ' HD21 ' A' ' 48' ' ' LEU . 38.0 p -87.53 -27.06 22.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.212 -0.93 . . . . 0.0 110.253 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -70.72 -56.8 5.58 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.147 -0.97 . . . . 0.0 109.676 179.553 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.485 ' O ' HG23 ' A' ' 35' ' ' VAL . 50.8 mt-10 -57.27 -36.08 70.55 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.303 -0.873 . . . . 0.0 109.685 179.555 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.868 HD22 HD11 ' A' ' 52' ' ' ILE . 9.0 tp -68.87 -31.78 70.96 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.349 -0.845 . . . . 0.0 109.707 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.82 -41.6 98.77 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.413 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 66.1 m -72.42 -33.65 67.28 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.317 -1.108 . . . . 0.0 109.967 179.771 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 31' ' ' GLU . 53.7 t -71.15 -26.98 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.377 -0.827 . . . . 0.0 110.444 -179.958 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.1 mmt -86.91 -32.29 20.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 110.467 -179.619 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 -90.79 -11.07 40.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.228 -0.92 . . . . 0.0 110.775 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 97.3 p -97.41 -23.03 16.26 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.981 -1.074 . . . . 0.0 110.48 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.6 mt -107.79 -46.85 3.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.118 -0.989 . . . . 0.0 110.388 -179.871 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.65 84.01 0.1 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.3 tp60 -50.92 161.32 0.38 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.357 -1.084 . . . . 0.0 110.558 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.519 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.3 t30 177.03 -56.3 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.488 -0.758 . . . . 0.0 109.976 179.647 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 42' ' ' ASN . 54.6 Cg_endo -76.76 -163.2 0.19 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.483 1.254 . . . . 0.0 110.864 179.671 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.669 HG23 ' N ' ' A' ' 45' ' ' GLU . 11.1 t -137.18 -140.19 0.15 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.077 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.669 ' N ' HG23 ' A' ' 44' ' ' THR . 52.1 mt-10 -97.89 -45.22 6.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.818 -1.176 . . . . 0.0 110.031 179.593 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.51 -52.98 26.2 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.198 -0.939 . . . . 0.0 109.618 179.389 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -59.07 -20.91 57.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.364 -0.835 . . . . 0.0 109.723 179.639 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.753 ' HG ' HD23 ' A' ' 32' ' ' LEU . 7.9 tt -71.93 -53.43 13.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.895 . . . . 0.0 109.481 179.368 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -50.92 -42.76 59.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.219 179.253 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -63.92 -39.69 94.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.362 -0.837 . . . . 0.0 109.6 179.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.429 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 36.4 ttp -66.21 -19.42 65.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -0.878 . . . . 0.0 109.566 179.375 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.868 HD11 HD22 ' A' ' 32' ' ' LEU . 5.6 mm -84.26 -29.73 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.407 -0.808 . . . . 0.0 109.683 179.413 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -71.6 -46.42 59.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.398 -0.814 . . . . 0.0 110.888 -179.45 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.641 ' HG3' HG23 ' A' ' 55' ' ' VAL . 24.2 pt-20 -51.35 -33.96 31.83 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.101 -1.0 . . . . 0.0 110.379 -179.711 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.641 HG23 ' HG3' ' A' ' 54' ' ' GLU . 48.6 t -82.15 -39.77 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.247 -0.908 . . . . 0.0 110.147 179.943 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -78.31 111.72 14.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.395 -0.816 . . . . 0.0 110.562 -179.67 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.77 54.98 0.65 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.206 -0.934 . . . . 0.0 109.925 179.741 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -134.96 -53.91 0.81 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.401 -0.812 . . . . 0.0 109.891 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 128.45 60.54 0.12 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.662 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.491 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 6.8 p-10 -151.34 -52.78 0.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -1.115 . . . . 0.0 110.131 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.6 -5.89 9.87 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.785 179.032 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.5 p -120.96 141.69 50.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.79 -1.418 . . . . 0.0 110.573 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 77.1 mt -92.32 121.38 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -0.949 . . . . 0.0 110.11 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.421 ' OD2' ' HD2' ' A' ' 66' ' ' PRO . 9.7 t70 -84.2 -167.0 1.59 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.285 -0.885 . . . . 0.0 110.196 -179.778 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.59 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 40.5 t80 -78.32 -44.38 2.13 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.05 -1.031 . . . . 0.0 111.631 -179.674 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.0 Cg_endo -70.76 -21.56 28.68 Favored 'Trans proline' 0 N--CA 1.482 0.802 0 O-C-N 123.079 1.041 . . . . 0.0 110.505 -179.579 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 71' ' ' MET . 53.0 mt-10 -81.12 -27.78 35.4 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.191 -0.943 . . . . 0.0 109.174 179.227 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.554 ' CE2' ' HE1' ' A' ' 72' ' ' MET . 36.0 t80 -77.26 -36.38 54.48 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.492 -0.755 . . . . 0.0 109.813 179.612 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.549 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 13.7 tp -76.81 -32.49 57.66 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.404 -0.81 . . . . 0.0 110.235 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 97.1 m -80.88 -23.78 38.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.337 -0.852 . . . . 0.0 110.41 -179.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.616 ' HG3' HG13 ' A' ' 55' ' ' VAL . 13.8 tmm? -84.33 -45.3 12.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.256 -0.903 . . . . 0.0 110.372 -179.723 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.554 ' HE1' ' CE2' ' A' ' 68' ' ' PHE . 9.5 mtt -79.17 -16.42 56.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 110.671 -179.272 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 69' ' ' LEU . . . -54.2 -57.24 11.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.095 -1.003 . . . . 0.0 108.902 179.098 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -110.71 61.15 0.61 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.561 -0.712 . . . . 0.0 109.158 178.871 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.01 111.04 0.25 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.46 -0.775 . . . . 0.0 110.891 -179.13 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 13.9 mmt -88.56 96.15 10.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -0.889 . . . . 0.0 109.801 179.626 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -127.37 77.56 1.75 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.301 -0.875 . . . . 0.0 110.237 -179.589 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -149.49 176.21 10.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.353 -0.842 . . . . 0.0 110.132 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 70.9 p -111.41 -162.01 0.78 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -0.897 . . . . 0.0 110.039 179.82 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -100.06 97.48 8.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.333 -0.854 . . . . 0.0 110.124 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 75.4 m -152.52 -59.9 0.15 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.431 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -124.57 109.05 12.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.132 -0.98 . . . . 0.0 110.548 -179.824 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -103.35 -1.74 28.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.36 -0.838 . . . . 0.0 110.52 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -80.67 -36.71 32.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.119 -0.988 . . . . 0.0 110.64 -179.71 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.566 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 60.3 mt -55.76 -35.89 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.138 -0.976 . . . . 0.0 110.114 -179.781 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.0 tpt180 -64.4 -53.0 55.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.956 . . . . 0.0 109.358 179.346 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -57.29 -23.57 49.31 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.358 -0.839 . . . . 0.0 109.443 179.28 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 85' ' ' ILE . . . -67.92 -60.47 2.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.416 -0.802 . . . . 0.0 109.859 179.768 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -55.76 -24.17 33.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.175 -0.953 . . . . 0.0 110.16 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.496 ' NE ' ' HA ' ' A' ' 90' ' ' ARG . 8.6 tpm_? -73.0 -58.29 3.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.317 -0.864 . . . . 0.0 110.707 -179.723 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.2 m -70.36 -12.14 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.121 -0.987 . . . . 0.0 110.684 -179.592 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.543 ' CD2' ' H3 ' ' A' ' 154' ' ' WW7 . 10.6 m-85 -101.05 -13.31 18.27 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.091 -1.006 . . . . 0.0 110.606 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -132.71 44.44 2.86 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.094 -1.004 . . . . 0.0 110.329 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.71 3.57 22.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.118 -0.989 . . . . 0.0 110.769 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 3.0 p30 -70.58 -30.74 67.52 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.134 -0.979 . . . . 0.0 110.573 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.8 34.94 1.94 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -179.361 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.404 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 23.1 t-20 -110.16 -47.36 3.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.355 -1.085 . . . . 0.0 110.319 -179.679 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 125.24 -35.32 3.12 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.833 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 0.8 OUTLIER -132.8 169.56 16.55 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.075 -1.25 . . . . 0.0 109.663 -179.753 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 38.3 mt -80.63 129.19 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.112 -0.992 . . . . 0.0 109.62 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.9 t -118.56 174.02 6.5 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.333 -0.855 . . . . 0.0 109.814 179.714 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.19 -38.76 78.82 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.155 -0.966 . . . . 0.0 110.048 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.66 87.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.237 -0.915 . . . . 0.0 110.033 179.746 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.636 ' O ' HG23 ' A' ' 108' ' ' VAL . 33.1 mt-10 -62.03 -54.13 45.88 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.246 -0.909 . . . . 0.0 110.094 179.825 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.459 ' O ' HD23 ' A' ' 105' ' ' LEU . 4.3 tt -47.76 -34.36 8.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 110.1 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.8 ttt-85 -70.97 -44.05 66.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.293 -0.879 . . . . 0.0 110.329 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 48.1 m170 -69.94 -10.4 58.42 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.129 -0.982 . . . . 0.0 110.622 -179.824 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 104' ' ' GLU . 61.5 t -92.29 -57.06 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.124 -0.985 . . . . 0.0 110.538 -179.749 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.459 ' HE3' HD21 ' A' ' 105' ' ' LEU . 64.8 mtt -71.41 -26.81 62.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.194 -0.941 . . . . 0.0 110.584 -179.693 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.2 m -69.35 -42.32 75.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.201 -0.937 . . . . 0.0 110.29 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -75.02 -34.33 61.9 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.188 -0.945 . . . . 0.0 110.265 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.2 mt -60.62 -32.2 71.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.168 -0.958 . . . . 0.0 110.229 179.923 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.42 -13.7 4.28 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.64 134.55 34.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -1.175 . . . . 0.0 110.27 -179.961 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -101.61 120.23 40.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.945 . . . . 0.0 110.208 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.83 179.25 4.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.21 -0.931 . . . . 0.0 110.546 -179.766 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.527 HG22 ' H ' ' A' ' 118' ' ' ASP . 17.7 m -122.56 175.88 6.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.406 -0.809 . . . . 0.0 109.944 179.741 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.527 ' H ' HG22 ' A' ' 117' ' ' THR . 1.4 m-20 -65.54 -51.95 56.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.161 -0.962 . . . . 0.0 110.544 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -64.97 -34.82 79.35 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.084 -1.01 . . . . 0.0 110.446 -179.807 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.416 ' HA ' ' OE1' ' A' ' 120' ' ' GLU . 7.9 mm-40 -61.37 -46.04 91.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.108 -0.995 . . . . 0.0 110.079 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.4 t -64.06 -56.47 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 109.808 179.656 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -51.4 -26.3 7.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.975 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 120' ' ' GLU . 30.5 tt0 -70.09 -52.97 19.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.18 179.982 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 42.4 mtp -58.21 -48.22 81.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.174 -0.954 . . . . 0.0 110.141 179.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.705 HD13 'CL1 ' ' A' ' 154' ' ' WW7 . 25.7 mm -60.89 -29.24 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.072 -1.018 . . . . 0.0 109.599 179.585 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.402 ' HB3' ' O ' ' A' ' 123' ' ' GLU . 22.6 ttm180 -66.74 -40.83 88.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.374 -0.829 . . . . 0.0 109.991 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -70.48 -28.37 64.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.285 -0.884 . . . . 0.0 110.237 179.919 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.411 ' O ' HG13 ' A' ' 130' ' ' ILE . . . -80.32 -25.05 39.52 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.311 -0.868 . . . . 0.0 110.469 -179.819 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -70.11 92.16 0.73 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.227 -0.921 . . . . 0.0 109.995 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 128' ' ' ALA . 74.4 mt -85.31 -34.54 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.3 -0.875 . . . . 0.0 110.594 -179.639 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 6.3 p30 -84.98 -25.79 27.54 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.073 -1.017 . . . . 0.0 110.299 179.845 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.455 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 89.94 71.56 1.25 Allowed Glycine 0 N--CA 1.494 2.562 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.316 179.337 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.411 ' OD2' ' OD1' ' A' ' 131' ' ' ASP . 73.1 m-20 -136.5 -38.69 0.66 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.205 -1.173 . . . . 0.0 110.021 179.294 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 121.96 -7.28 10.12 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.507 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -126.61 150.92 48.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.157 -1.202 . . . . 0.0 110.153 179.953 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.2 t -115.2 109.41 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.19 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -82.34 -167.73 1.7 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.18 -0.95 . . . . 0.0 110.195 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -62.18 -45.22 94.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.255 -0.903 . . . . 0.0 111.284 -179.134 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -62.69 -56.73 14.99 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.942 -1.099 . . . . 0.0 110.921 -179.248 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 144' ' ' MET . 50.5 mt-10 -57.1 -24.27 52.89 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.13 -0.981 . . . . 0.0 110.725 -179.591 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.474 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 89.2 t80 -78.66 -35.09 45.78 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.232 -0.917 . . . . 0.0 110.944 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 84.6 t -83.09 -22.96 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.108 -0.995 . . . . 0.0 110.869 -179.509 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -92.53 -23.42 19.09 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.18 -0.95 . . . . 0.0 110.882 -179.617 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.493 ' HE2' ' HE3' ' A' ' 145' ' ' MET . 1.0 OUTLIER -71.29 -20.26 62.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.003 -1.061 . . . . 0.0 110.496 -179.707 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.493 ' HE3' ' HE2' ' A' ' 144' ' ' MET . 63.5 mtt -84.85 -70.37 0.58 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.223 -0.923 . . . . 0.0 110.537 -179.694 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 59.0 p -51.65 -28.43 14.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.2 -0.938 . . . . 0.0 110.183 -179.672 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 49.76 39.64 18.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.319 -0.863 . . . . 0.0 110.575 179.833 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.182 179.87 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 153' ' ' WW7 . . . . . 0.533 'CL1 ' HD13 ' A' ' 32' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 154' ' ' WW7 . . . . . 0.705 'CL1 ' HD13 ' A' ' 125' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 121.228 0.537 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -151.84 110.95 3.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.226 -0.921 . . . . 0.0 109.86 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -112.1 -58.3 2.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.179 -0.951 . . . . 0.0 110.47 -179.805 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.66 HD12 HG22 ' A' ' 5' ' ' THR . 0.6 OUTLIER -114.3 -155.45 0.57 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.899 . . . . 0.0 110.419 -179.574 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.66 HG22 HD12 ' A' ' 4' ' ' LEU . 8.2 t -64.73 168.83 5.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.859 . . . . 0.0 110.177 179.86 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.464 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.6 pt-20 -88.54 -9.72 51.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.203 -0.936 . . . . 0.0 110.119 179.673 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -65.34 -64.9 0.75 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.104 -0.998 . . . . 0.0 109.985 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.635 ' HB2' HD11 ' A' ' 4' ' ' LEU . 72.3 mt-30 -55.13 -39.97 70.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.144 -0.973 . . . . 0.0 109.476 179.685 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 6' ' ' GLU . 55.3 mt -56.8 -37.73 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.389 -0.819 . . . . 0.0 109.478 179.315 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.97 -43.06 99.63 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.278 -0.889 . . . . 0.0 109.341 179.386 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.03 -36.73 82.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.486 -0.759 . . . . 0.0 109.837 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -76.03 -20.08 58.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.406 -0.808 . . . . 0.0 109.665 179.525 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -79.53 -33.53 41.88 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.289 -0.882 . . . . 0.0 109.416 179.183 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -74.27 -39.95 62.65 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.391 -0.818 . . . . 0.0 109.857 179.735 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.75 -48.31 39.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.2 -0.938 . . . . 0.0 109.599 179.54 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.555 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 1.2 t80 -58.68 -34.07 70.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.415 -0.803 . . . . 0.0 109.47 179.334 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.2 t -72.11 -38.49 69.31 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.465 -0.772 . . . . 0.0 109.817 179.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.854 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.2 tm? -65.92 -24.06 66.75 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.526 -0.734 . . . . 0.0 109.663 179.768 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.462 ' HA ' ' CG2' ' A' ' 35' ' ' VAL . 17.0 m-85 -82.15 -59.29 2.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.323 -0.861 . . . . 0.0 110.339 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.417 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 7.9 t0 -76.52 97.49 4.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 109.772 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.442 ' HD2' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -110.53 46.37 1.05 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.068 -1.02 . . . . 0.0 110.843 -179.644 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.404 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 12.0 p-10 -132.33 -33.31 1.29 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.236 -0.915 . . . . 0.0 110.513 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.38 76.32 1.05 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.89 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 15.3 p-10 -159.49 -45.26 0.05 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.02 -1.283 . . . . 0.0 110.579 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.9 -2.97 25.79 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.728 -1.225 . . . . 0.0 110.324 179.674 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 63' ' ' ILE . 34.5 p -121.1 165.16 15.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.943 -1.328 . . . . 0.0 110.197 179.878 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.3 mt -112.64 130.24 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.187 -0.946 . . . . 0.0 110.094 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.6 p -114.5 177.05 4.78 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.429 -0.794 . . . . 0.0 109.895 -179.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.608 ' HA ' HD21 ' A' ' 48' ' ' LEU . 12.7 p -66.67 -28.67 68.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 0.0 110.112 179.877 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -57.66 6.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -0.933 . . . . 0.0 109.905 179.521 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.417 ' OE1' ' HA ' ' A' ' 20' ' ' ASP . 28.4 mt-10 -57.23 -56.01 27.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 0.0 110.123 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.061 HD22 HD11 ' A' ' 52' ' ' ILE . 1.4 tp -57.51 -24.71 57.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.855 179.665 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.408 ' HA2' ' CD1' ' A' ' 48' ' ' LEU . . . -65.74 -42.9 95.0 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.846 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.1 m -76.16 -23.14 54.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.3 -1.117 . . . . 0.0 110.04 179.835 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.462 ' CG2' ' HA ' ' A' ' 19' ' ' PHE . 54.9 t -72.57 -42.54 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.402 -0.811 . . . . 0.0 110.526 -179.727 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.408 ' SD ' H132 ' A' ' 153' ' ' WW7 . 22.5 mmt -90.13 -14.93 32.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.167 -0.958 . . . . 0.0 110.735 -179.692 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -90.65 -59.91 2.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.209 -0.932 . . . . 0.0 111.076 -179.348 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.0 m -59.76 -51.44 69.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.254 -0.904 . . . . 0.0 111.361 -178.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.9 mp -69.53 -30.45 68.29 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.1 -1.0 . . . . 0.0 111.207 -178.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 36' ' ' MET . . . -161.42 80.57 0.14 Allowed Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.229 -1.462 . . . . 0.0 110.422 -179.775 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -55.94 126.97 28.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.163 -1.198 . . . . 0.0 109.725 179.365 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.516 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 3.0 t30 -171.53 -60.91 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.224 -0.923 . . . . 0.0 110.609 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.516 ' HD3' ' HB3' ' A' ' 42' ' ' ASN . 44.1 Cg_endo -70.01 -161.84 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.249 1.131 . . . . 0.0 110.117 179.801 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 7.9 t -150.96 -178.67 6.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.931 . . . . 0.0 110.282 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -59.89 -33.6 72.06 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.246 -0.909 . . . . 0.0 110.464 -179.798 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.1 -70.66 0.25 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.211 -0.93 . . . . 0.0 110.257 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -49.76 -25.05 2.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.104 -0.997 . . . . 0.0 109.713 179.762 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.716 ' HG ' HD23 ' A' ' 32' ' ' LEU . 3.6 tt -65.21 -60.01 3.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.465 -0.772 . . . . 0.0 109.719 179.466 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.402 ' O ' ' OD1' ' A' ' 53' ' ' ASN . 8.9 tt0 -50.5 -33.91 23.17 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.296 -0.878 . . . . 0.0 109.756 179.616 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -61.57 -46.43 89.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.191 -0.943 . . . . 0.0 109.967 179.809 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.428 ' HA ' ' HG2' ' A' ' 54' ' ' GLU . 21.8 mtm -65.58 -22.59 66.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.929 . . . . 0.0 109.82 179.667 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.061 HD11 HD22 ' A' ' 32' ' ' LEU . 39.7 mm -80.88 -23.26 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.251 -0.906 . . . . 0.0 109.969 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 49' ' ' GLN . 5.1 m120 -88.34 -26.62 22.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.303 -0.873 . . . . 0.0 110.2 179.885 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.531 ' HG3' HG23 ' A' ' 55' ' ' VAL . 10.7 pt-20 -77.69 -24.3 49.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.201 -0.937 . . . . 0.0 110.075 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.531 HG23 ' HG3' ' A' ' 54' ' ' GLU . 78.8 t -88.86 -54.53 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.673 179.454 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.413 ' OD2' ' OD1' ' A' ' 60' ' ' ASN . 12.8 t70 -67.09 120.32 13.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.405 -0.809 . . . . 0.0 110.051 179.82 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.6 30.94 5.83 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.16 -0.962 . . . . 0.0 110.663 -179.66 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -113.33 -60.87 1.82 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.116 -0.99 . . . . 0.0 110.088 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.52 -18.25 1.3 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.729 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.413 ' OD1' ' OD2' ' A' ' 56' ' ' ASP . 17.0 p30 -69.52 -29.48 67.1 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.175 -1.191 . . . . 0.0 110.295 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.623 ' O ' HG22 ' A' ' 52' ' ' ILE . . . 99.18 -52.61 1.08 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.754 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.406 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 66.0 p -72.11 146.49 47.46 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.183 -1.186 . . . . 0.0 110.38 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.577 HD11 'CL1 ' ' A' ' 153' ' ' WW7 . 64.3 mt -86.43 161.09 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 110.254 179.908 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -111.81 -173.35 2.23 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.371 -0.831 . . . . 0.0 109.898 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.562 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 5.0 t80 -75.6 -44.82 4.25 Favored Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.235 -0.915 . . . . 0.0 111.423 -179.882 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.0 Cg_endo -73.33 -23.89 17.18 Favored 'Trans proline' 0 C--N 1.322 -0.845 0 O-C-N 123.288 1.151 . . . . 0.0 110.255 -179.259 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -77.23 -29.09 53.96 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.252 -0.905 . . . . 0.0 109.1 179.094 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.644 ' CE2' ' HE2' ' A' ' 72' ' ' MET . 47.8 t80 -73.54 -50.74 19.81 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.545 -0.722 . . . . 0.0 110.309 179.826 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.96 -30.98 71.26 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.304 -0.873 . . . . 0.0 110.965 -179.527 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 78.9 m -71.1 -40.91 71.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.172 -0.955 . . . . 0.0 110.983 -179.388 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.454 ' HE1' ' HE1' ' A' ' 72' ' ' MET . 0.0 OUTLIER -89.94 -9.37 49.07 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.903 -1.123 . . . . 0.0 110.95 -179.51 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.644 ' HE2' ' CE2' ' A' ' 68' ' ' PHE . 15.6 mmt -90.26 -19.89 23.6 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.989 -1.07 . . . . 0.0 110.556 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.62 -15.38 59.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.155 -0.966 . . . . 0.0 110.354 -179.874 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -97.02 46.81 1.04 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.094 -1.004 . . . . 0.0 110.303 -179.956 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.1 tttm -123.2 154.69 38.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.951 . . . . 0.0 109.93 179.885 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 39.1 ttp -107.46 107.88 18.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.04 -1.037 . . . . 0.0 110.397 -179.835 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -100.61 27.76 5.6 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.311 -0.868 . . . . 0.0 110.151 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -115.72 25.0 11.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -0.887 . . . . 0.0 110.214 -179.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 93.6 m -48.9 105.12 0.07 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.219 -0.926 . . . . 0.0 110.042 179.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -108.0 88.17 2.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.902 . . . . 0.0 110.169 -179.869 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.4 t -60.43 -176.94 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.216 -0.927 . . . . 0.0 110.247 -179.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -159.29 124.26 4.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.244 -0.91 . . . . 0.0 110.271 179.833 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -131.49 78.93 1.85 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.295 -0.878 . . . . 0.0 109.732 179.519 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -53.59 -30.97 44.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.46 -0.775 . . . . 0.0 110.883 -179.491 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.48 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 38.9 mt -64.93 -60.23 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.141 -0.974 . . . . 0.0 110.263 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -51.57 -50.49 60.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.174 -0.954 . . . . 0.0 109.711 179.922 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 49.7 mt-10 -50.05 -41.6 48.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 0.0 109.79 179.52 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 85' ' ' ILE . . . -56.2 -50.27 71.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.34 -0.85 . . . . 0.0 110.032 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.475 ' CZ ' ' O ' ' A' ' 98' ' ' GLY . 2.3 t80 -57.34 -28.76 63.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.262 -0.899 . . . . 0.0 110.213 179.983 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.413 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 3.7 tpt180 -71.1 -45.88 62.83 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.342 -0.849 . . . . 0.0 111.185 -179.442 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 88' ' ' ALA . 34.4 m -77.17 -20.35 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.088 -1.007 . . . . 0.0 110.775 -179.33 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.432 ' HA ' HG21 ' A' ' 108' ' ' VAL . 10.0 m-85 -89.58 -17.04 29.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.169 -0.957 . . . . 0.0 109.904 179.631 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.408 ' OD1' HG12 ' A' ' 100' ' ' ILE . 4.4 m-20 -126.89 81.32 2.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.295 -0.878 . . . . 0.0 110.144 179.863 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -104.35 49.96 0.8 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.398 -0.814 . . . . 0.0 110.483 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 3.1 p30 -141.56 -43.58 0.36 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.089 -1.007 . . . . 0.0 110.705 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.486 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 147.97 -57.18 0.49 Allowed Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.28 -1.438 . . . . 0.0 110.995 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.473 ' ND2' ' OD1' ' A' ' 95' ' ' ASP . 22.6 p30 -43.56 -31.23 0.7 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.141 -1.211 . . . . 0.0 111.161 -178.738 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.475 ' O ' ' CZ ' ' A' ' 89' ' ' PHE . . . 80.14 -8.19 53.01 Favored Glycine 0 N--CA 1.495 2.6 0 C-N-CA 119.803 -1.189 . . . . 0.0 110.477 179.561 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -89.41 131.81 35.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.962 -1.316 . . . . 0.0 109.989 179.917 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.409 HD11 ' CE1' ' A' ' 89' ' ' PHE . 16.6 mt -78.99 112.32 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.185 -0.947 . . . . 0.0 109.796 -179.949 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 44.6 t -96.56 155.91 16.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.264 -0.897 . . . . 0.0 110.154 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.64 -44.74 77.43 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.141 -0.974 . . . . 0.0 110.063 -179.956 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.96 -58.7 6.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.827 . . . . 0.0 110.016 179.844 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.718 ' O ' HG23 ' A' ' 108' ' ' VAL . 47.2 mt-10 -51.51 -38.99 56.74 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.317 -0.865 . . . . 0.0 110.224 179.847 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.79 HD12 HD11 ' A' ' 125' ' ' ILE . 0.4 OUTLIER -58.81 -41.82 87.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.349 -0.844 . . . . 0.0 109.829 179.937 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.419 ' O ' ' HB ' ' A' ' 110' ' ' THR . 48.1 ttp180 -68.2 -25.51 65.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.384 -0.822 . . . . 0.0 109.942 179.807 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -90.95 -12.66 35.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.329 -0.857 . . . . 0.0 110.373 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 104' ' ' GLU . 77.2 t -91.17 -64.61 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.255 -0.903 . . . . 0.0 110.316 -179.939 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.621 ' HA ' HD12 ' A' ' 112' ' ' LEU . 57.8 mtt -61.13 -51.18 70.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.251 -0.906 . . . . 0.0 110.367 -179.693 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 106' ' ' ARG . 36.8 m -50.99 -29.52 12.56 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.266 -0.896 . . . . 0.0 110.304 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -78.69 -46.09 19.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.184 -0.948 . . . . 0.0 110.406 -179.944 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.621 HD12 ' HA ' ' A' ' 109' ' ' MET . 12.8 mt -48.83 -73.98 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.143 -0.973 . . . . 0.0 110.109 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.85 66.59 0.02 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.872 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -136.9 -176.37 4.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.313 -1.11 . . . . 0.0 110.068 179.714 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -130.18 87.96 2.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.948 . . . . 0.0 110.374 -179.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.8 mt -125.93 -171.88 2.48 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.284 -0.885 . . . . 0.0 110.137 179.857 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.6 t -143.91 -159.95 1.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.138 -0.976 . . . . 0.0 110.201 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.63 -42.16 25.45 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.077 -1.014 . . . . 0.0 110.917 -179.525 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -59.61 -55.49 33.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.942 . . . . 0.0 111.125 -179.469 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -51.72 -38.48 55.39 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.196 -0.94 . . . . 0.0 111.058 -179.445 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 73.9 t -67.7 -47.47 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.158 -0.963 . . . . 0.0 110.457 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.79 -36.38 72.11 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.333 -0.855 . . . . 0.0 110.137 -179.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 36.6 tt0 -72.5 -35.15 68.07 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.324 -0.86 . . . . 0.0 109.633 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.411 ' HB3' ' HE3' ' A' ' 124' ' ' MET . 5.7 mmm -59.03 -60.34 4.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.271 -0.893 . . . . 0.0 109.936 179.466 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.79 HD11 HD12 ' A' ' 105' ' ' LEU . 27.9 mm -56.69 -41.89 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.372 -0.83 . . . . 0.0 110.376 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 16.5 ttp180 -57.09 -36.81 71.03 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -0.907 . . . . 0.0 110.191 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 49.7 mt-10 -67.09 -49.65 64.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.197 -0.94 . . . . 0.0 110.087 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.54 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -80.03 -2.33 43.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.349 -0.844 . . . . 0.0 110.665 -179.811 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 59.6 t0 -90.29 71.75 7.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.947 -1.096 . . . . 0.0 110.299 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.488 HG13 ' N ' ' A' ' 131' ' ' ASP . 23.4 pt -70.52 -41.94 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -0.929 . . . . 0.0 111.171 -179.561 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.488 ' N ' HG13 ' A' ' 130' ' ' ILE . 50.6 p-10 -67.28 -19.42 65.49 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.963 -1.086 . . . . 0.0 111.264 -179.173 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 75.45 75.93 0.8 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.909 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -146.35 15.0 1.29 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.379 -1.071 . . . . 0.0 110.56 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 60.27 34.89 86.54 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.684 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -171.01 167.16 7.32 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.13 -1.217 . . . . 0.0 110.061 179.563 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 84.6 t -131.0 120.29 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.155 -0.966 . . . . 0.0 110.18 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -94.54 -165.07 1.25 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.209 -0.932 . . . . 0.0 110.9 -179.637 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -66.91 -58.58 4.72 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.356 -0.84 . . . . 0.0 111.307 -178.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -47.61 -51.74 20.25 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.845 -1.159 . . . . 0.0 110.381 -179.548 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -58.71 -34.91 71.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.103 -0.998 . . . . 0.0 109.97 179.62 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.421 ' HA ' ' SD ' ' A' ' 144' ' ' MET . 6.5 t80 -64.94 -32.72 74.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.514 -0.741 . . . . 0.0 110.623 -179.762 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.4 t -82.96 -23.92 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.261 -0.899 . . . . 0.0 110.586 -179.471 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -90.26 -17.47 27.4 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.133 -0.979 . . . . 0.0 110.422 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.54 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 17.0 ptt? -90.09 -27.82 19.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.145 -0.972 . . . . 0.0 110.376 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 27.7 tpp -88.9 -65.45 1.02 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.287 -0.883 . . . . 0.0 110.439 -179.607 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 146' ' ' THR . 5.1 t -124.97 116.77 22.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.151 -0.968 . . . . 0.0 110.438 -179.771 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' A' ' 148' ' ' LYS . . . -135.56 -160.36 1.05 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.276 -0.89 . . . . 0.0 110.116 179.726 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 147' ' ' ALA . 42.7 tttp . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.346 179.898 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 153' ' ' WW7 . . . . . 0.577 'CL1 ' HD11 ' A' ' 63' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 154' ' ' WW7 . . . . . 0.43 ' H3 ' ' CD2' ' A' ' 92' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_